<?xml version="1.0" encoding="UTF-8"?><!-- generator="podbean/5.5" -->
<rss version="2.0"
     xmlns:content="http://purl.org/rss/1.0/modules/content/"
     xmlns:atom="http://www.w3.org/2005/Atom"
     xmlns:itunes="http://www.itunes.com/dtds/podcast-1.0.dtd"
     xmlns:spotify="http://www.spotify.com/ns/rss"
     xmlns:podcast="https://podcastindex.org/namespace/1.0"
    xmlns:media="http://search.yahoo.com/mrss/">

<channel>
    <title>Frankly Speaking About Family Medicine</title>
    <atom:link href="https://feed.podbean.com/primedfranklyspeaking/feed.xml" rel="self" type="application/rss+xml"/>
    <link>https://primedfranklyspeaking.podbean.com</link>
    <description>A weekly Podcast series covering newsworthy topics in primary care medicine. Thoughts? Suggestions? Email us at
FranklySpeaking@pri-med.com</description>
    <pubDate>Mon, 13 Jul 2026 05:30:00 +0000</pubDate>
    <generator>https://podbean.com/?v=5.5</generator>
    <language>en</language>
        <copyright>Copyright 2023 All rights reserved.</copyright>
    <category>Science</category>
    <ttl>1440</ttl>
    <itunes:type>episodic</itunes:type>
          <itunes:summary>A weekly Podcast series covering newsworthy topics in primary care medicine. Thoughts? Suggestions? Email us at
FranklySpeaking@pri-med.com</itunes:summary>
        <itunes:author>Pri-Med</itunes:author>
<itunes:category text="Science" />
    <itunes:owner>
        <itunes:name>Pri-Med</itunes:name>
            </itunes:owner>
    	<itunes:block>No</itunes:block>
	<itunes:explicit>false</itunes:explicit>
    <itunes:image href="https://pbcdn1.podbean.com/imglogo/image-logo/13721080/PRM-123_DPL_mediaplayer_frankly-speaking_x7npub.jpg" />
    <image>
        <url>https://pbcdn1.podbean.com/imglogo/image-logo/13721080/PRM-123_DPL_mediaplayer_frankly-speaking_x7npub.jpg</url>
        <title>Frankly Speaking About Family Medicine</title>
        <link>https://primedfranklyspeaking.podbean.com</link>
        <width>144</width>
        <height>144</height>
    </image>
    <item>
        <title>From Guidelines to Practice: Managing CKD in Primary Care - Frankly Speaking Ep 493</title>
        <itunes:title>From Guidelines to Practice: Managing CKD in Primary Care - Frankly Speaking Ep 493</itunes:title>
        <link>https://primedfranklyspeaking.podbean.com/e/from-guidelines-to-practice-managing-ckd-in-primary-care-frankly-speaking-ep-493/</link>
                    <comments>https://primedfranklyspeaking.podbean.com/e/from-guidelines-to-practice-managing-ckd-in-primary-care-frankly-speaking-ep-493/#comments</comments>        <pubDate>Mon, 13 Jul 2026 05:30:00 +0000</pubDate>
        <guid isPermaLink="false">primedfranklyspeaking.podbean.com/6b8363ec-7bc3-3ce2-b87c-a98b7a07fbbc</guid>
                                    <description><![CDATA[<p>Credits: 0.25 AMA PRA Category 1 Credit™
 
CME/CE Information and Claim Credit: <a href='https://www.pri-med.com/online-education/podcast/frankly-speaking-cme-493'>https://www.pri-med.com/online-education/podcast/frankly-speaking-cme-493</a></p>
<p>Overview: Chronic kidney disease (CKD) is increasingly managed in primary care—but are you up to date on the latest guidance? This episode reviews current clinical practice guidelines and standards of care to help you confidently diagnose and classify CKD, apply evidence-based management strategies, and know when nephrology referral is warranted.</p>
<p>Episode resource links:</p>
<ul>
<li><a href='https://doi.org/10.7326/ANNALS-25-03499'>https://doi.org/10.7326/ANNALS-25-03499</a></li>
<li>Diabetes Care. 2024;48(Supplement_1):S239-S251. doi:10.2337/dc25-S011</li>
</ul>
<p>Guest: Robert A. Baldor MD, FAAFP
 
Music Credit: Matthew Bugos</p>
<p>Thoughts? Suggestions? Email us at <a href='mailto:FranklySpeaking@pri-med.com'>FranklySpeaking@pri-med.com</a> </p>
<p>The views expressed in this podcast are those of Dr. Domino and his guests and do not necessarily reflect the views of Pri-Med.</p>
]]></description>
                                                            <content:encoded><![CDATA[<p>Credits: 0.25 AMA PRA Category 1 Credit™<br>
 <br>
CME/CE Information and Claim Credit: <a href='https://www.pri-med.com/online-education/podcast/frankly-speaking-cme-493'>https://www.pri-med.com/online-education/podcast/frankly-speaking-cme-493</a></p>
<p>Overview: Chronic kidney disease (CKD) is increasingly managed in primary care—but are you up to date on the latest guidance? This episode reviews current clinical practice guidelines and standards of care to help you confidently diagnose and classify CKD, apply evidence-based management strategies, and know when nephrology referral is warranted.</p>
<p>Episode resource links:</p>
<ul>
<li><a href='https://doi.org/10.7326/ANNALS-25-03499'>https://doi.org/10.7326/ANNALS-25-03499</a></li>
<li>Diabetes Care. 2024;48(Supplement_1):S239-S251. doi:10.2337/dc25-S011</li>
</ul>
<p>Guest: Robert A. Baldor MD, FAAFP<br>
 <br>
Music Credit: Matthew Bugos</p>
<p>Thoughts? Suggestions? Email us at <a href='mailto:FranklySpeaking@pri-med.com'>FranklySpeaking@pri-med.com</a> </p>
<p><em>The views expressed in this podcast are those of Dr. Domino and his guests and do not necessarily reflect the views of Pri-Med.</em></p>
]]></content:encoded>
                                    
        <enclosure url="https://mcdn.podbean.com/mf/web/rsp8fazawj9ihch2/frankly-speaking-493-ckd.mp3" length="20090990" type="audio/mpeg"/>
                <itunes:summary><![CDATA[Credits: 0.25 AMA PRA Category 1 Credit™ CME/CE Information and Claim Credit: https://www.pri-med.com/online-education/podcast/frankly-speaking-cme-493
Overview: Chronic kidney disease (CKD) is increasingly managed in primary care—but are you up to date on the latest guidance? This episode reviews current clinical practice guidelines and standards of care to help you confidently diagnose and classify CKD, apply evidence-based management strategies, and know when nephrology referral is warranted.
Episode resource links:

https://doi.org/10.7326/ANNALS-25-03499
Diabetes Care. 2024;48(Supplement_1):S239-S251. doi:10.2337/dc25-S011

Guest: Robert A. Baldor MD, FAAFP Music Credit: Matthew Bugos
Thoughts? Suggestions? Email us at FranklySpeaking@pri-med.com 
The views expressed in this podcast are those of Dr. Domino and his guests and do not necessarily reflect the views of Pri-Med.]]></itunes:summary>
        <itunes:author>Pri-Med</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>835</itunes:duration>
                        <itunes:episodeType>full</itunes:episodeType>
            </item>
    <item>
        <title>SPAN Small Changes to a Longer, Healthier Life - Frankly Speaking Ep 492</title>
        <itunes:title>SPAN Small Changes to a Longer, Healthier Life - Frankly Speaking Ep 492</itunes:title>
        <link>https://primedfranklyspeaking.podbean.com/e/span-small-changes-to-a-longer-healthier-life-frankly-speaking-ep-492/</link>
                    <comments>https://primedfranklyspeaking.podbean.com/e/span-small-changes-to-a-longer-healthier-life-frankly-speaking-ep-492/#comments</comments>        <pubDate>Mon, 06 Jul 2026 05:30:00 +0000</pubDate>
        <guid isPermaLink="false">primedfranklyspeaking.podbean.com/6bb5d5d5-500f-3a4c-9a4e-73cfaa79f72f</guid>
                                    <description><![CDATA[<p>Credits: 0.25 AMA PRA Category 1 Credit™
 
CME/CE Information and Claim Credit: <a href='https://www.pri-med.com/online-education/podcast/frankly-speaking-cme-492'>https://www.pri-med.com/online-education/podcast/frankly-speaking-cme-492</a></p>
<p>Overview: Small lifestyle changes can yield outsized results—and primary care clinicians are ideally positioned to drive that change. This episode explores the synergistic effects of the SPAN approach on lifespan and provides actionable strategies for guiding patients toward sustainable habits that improve long-term health.</p>
<p>Episode resource links:</p>
<ul>
<li>Koemel, et al; eClinicalMedicine, Volume 0, Issue 0, 103741, 2026</li>
</ul>
<p>Guest: Jillian Joseph, MPAS, PA-C
 
Music Credit: Matthew Bugos</p>
<p>Thoughts? Suggestions? Email us at <a href='mailto:FranklySpeaking@pri-med.com'>FranklySpeaking@pri-med.com</a> </p>
<p>The views expressed in this podcast are those of Dr. Domino and his guests and do not necessarily reflect the views of Pri-Med.</p>
]]></description>
                                                            <content:encoded><![CDATA[<p>Credits: 0.25 AMA PRA Category 1 Credit™<br>
 <br>
CME/CE Information and Claim Credit: <a href='https://www.pri-med.com/online-education/podcast/frankly-speaking-cme-492'>https://www.pri-med.com/online-education/podcast/frankly-speaking-cme-492</a></p>
<p>Overview: Small lifestyle changes can yield outsized results—and primary care clinicians are ideally positioned to drive that change. This episode explores the synergistic effects of the SPAN approach on lifespan and provides actionable strategies for guiding patients toward sustainable habits that improve long-term health.</p>
<p>Episode resource links:</p>
<ul>
<li>Koemel, et al; eClinicalMedicine, Volume 0, Issue 0, 103741, 2026</li>
</ul>
<p>Guest: Jillian Joseph, MPAS, PA-C<br>
 <br>
Music Credit: Matthew Bugos</p>
<p>Thoughts? Suggestions? Email us at <a href='mailto:FranklySpeaking@pri-med.com'>FranklySpeaking@pri-med.com</a> </p>
<p><em>The views expressed in this podcast are those of Dr. Domino and his guests and do not necessarily reflect the views of Pri-Med.</em></p>
]]></content:encoded>
                                    
        <enclosure url="https://mcdn.podbean.com/mf/web/hjwxsrhyvafgh3bq/frankly-speaking-492-activity-nutrition.mp3" length="12539927" type="audio/mpeg"/>
                <itunes:summary><![CDATA[Credits: 0.25 AMA PRA Category 1 Credit™ CME/CE Information and Claim Credit: https://www.pri-med.com/online-education/podcast/frankly-speaking-cme-492
Overview: Small lifestyle changes can yield outsized results—and primary care clinicians are ideally positioned to drive that change. This episode explores the synergistic effects of the SPAN approach on lifespan and provides actionable strategies for guiding patients toward sustainable habits that improve long-term health.
Episode resource links:

Koemel, et al; eClinicalMedicine, Volume 0, Issue 0, 103741, 2026

Guest: Jillian Joseph, MPAS, PA-C Music Credit: Matthew Bugos
Thoughts? Suggestions? Email us at FranklySpeaking@pri-med.com 
The views expressed in this podcast are those of Dr. Domino and his guests and do not necessarily reflect the views of Pri-Med.]]></itunes:summary>
        <itunes:author>Pri-Med</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>781</itunes:duration>
                        <itunes:episodeType>full</itunes:episodeType>
            </item>
    <item>
        <title>Pulse Oximetry—It’s Not Always Right - Frankly Speaking Ep 491</title>
        <itunes:title>Pulse Oximetry—It’s Not Always Right - Frankly Speaking Ep 491</itunes:title>
        <link>https://primedfranklyspeaking.podbean.com/e/pulse-oximetry%e2%80%94it-s-not-always-right-frankly-speaking-ep-491/</link>
                    <comments>https://primedfranklyspeaking.podbean.com/e/pulse-oximetry%e2%80%94it-s-not-always-right-frankly-speaking-ep-491/#comments</comments>        <pubDate>Mon, 29 Jun 2026 05:30:00 +0000</pubDate>
        <guid isPermaLink="false">primedfranklyspeaking.podbean.com/5a7c23ce-940f-3aa3-9ed4-76c9a7888170</guid>
                                    <description><![CDATA[<p>Credits: 0.25 AMA PRA Category 1 Credit™
 
CME/CE Information and Claim Credit: <a href='https://www.pri-med.com/online-education/podcast/frankly-speaking-cme-491'>https://www.pri-med.com/online-education/podcast/frankly-speaking-cme-491</a></p>
<p>Overview: Pulse oximetry is a cornerstone of patient monitoring, but limits to its accuracy can lead to important clinical implications. Tune in as we discuss the factors that can compromise oximetry accuracy—including skin tone—so you can make more informed, individualized treatment decisions.</p>
<p>Episode resource links:</p>
<ul>
<li>Martin DS, Doidge JC, Gould D, et al. The impact of skin tone on performance of pulse oximeters used by NHS England COVID Oximetry @home scheme: measurement and diagnostic accuracy study. BMJ. 2026;392:e085535.</li>
</ul>
<p>Guest: Alan M. Ehrlich, MD, FAAFP
 
Music Credit: Matthew Bugos</p>
<p>Thoughts? Suggestions? Email us at <a href='mailto:FranklySpeaking@pri-med.com'>FranklySpeaking@pri-med.com</a> </p>
<p>The views expressed in this podcast are those of Dr. Domino and his guests and do not necessarily reflect the views of Pri-Med.</p>
]]></description>
                                                            <content:encoded><![CDATA[<p>Credits: 0.25 AMA PRA Category 1 Credit™<br>
 <br>
CME/CE Information and Claim Credit: <a href='https://www.pri-med.com/online-education/podcast/frankly-speaking-cme-491'>https://www.pri-med.com/online-education/podcast/frankly-speaking-cme-491</a></p>
<p>Overview: Pulse oximetry is a cornerstone of patient monitoring, but limits to its accuracy can lead to important clinical implications. Tune in as we discuss the factors that can compromise oximetry accuracy—including skin tone—so you can make more informed, individualized treatment decisions.</p>
<p>Episode resource links:</p>
<ul>
<li>Martin DS, Doidge JC, Gould D, et al. The impact of skin tone on performance of pulse oximeters used by NHS England COVID Oximetry @home scheme: measurement and diagnostic accuracy study. BMJ. 2026;392:e085535.</li>
</ul>
<p>Guest: Alan M. Ehrlich, MD, FAAFP<br>
 <br>
Music Credit: Matthew Bugos</p>
<p>Thoughts? Suggestions? Email us at <a href='mailto:FranklySpeaking@pri-med.com'>FranklySpeaking@pri-med.com</a> </p>
<p><em>The views expressed in this podcast are those of Dr. Domino and his guests and do not necessarily reflect the views of Pri-Med.</em></p>
]]></content:encoded>
                                    
        <enclosure url="https://mcdn.podbean.com/mf/web/emnsfqfpvstyzx65/frankly-speaking-491-pulse-ox-skin-tone.mp3" length="10227506" type="audio/mpeg"/>
                <itunes:summary><![CDATA[Credits: 0.25 AMA PRA Category 1 Credit™ CME/CE Information and Claim Credit: https://www.pri-med.com/online-education/podcast/frankly-speaking-cme-491
Overview: Pulse oximetry is a cornerstone of patient monitoring, but limits to its accuracy can lead to important clinical implications. Tune in as we discuss the factors that can compromise oximetry accuracy—including skin tone—so you can make more informed, individualized treatment decisions.
Episode resource links:

Martin DS, Doidge JC, Gould D, et al. The impact of skin tone on performance of pulse oximeters used by NHS England COVID Oximetry @home scheme: measurement and diagnostic accuracy study. BMJ. 2026;392:e085535.

Guest: Alan M. Ehrlich, MD, FAAFP Music Credit: Matthew Bugos
Thoughts? Suggestions? Email us at FranklySpeaking@pri-med.com 
The views expressed in this podcast are those of Dr. Domino and his guests and do not necessarily reflect the views of Pri-Med.]]></itunes:summary>
        <itunes:author>Pri-Med</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>637</itunes:duration>
                        <itunes:episodeType>full</itunes:episodeType>
            </item>
    <item>
        <title>What Are We Missing? Recognizing Symptoms of Maternal Stroke - Frankly Speaking Ep 490</title>
        <itunes:title>What Are We Missing? Recognizing Symptoms of Maternal Stroke - Frankly Speaking Ep 490</itunes:title>
        <link>https://primedfranklyspeaking.podbean.com/e/what-are-we-missing-recognizing-symptoms-of-maternal-stroke-frankly-speaking-ep-490/</link>
                    <comments>https://primedfranklyspeaking.podbean.com/e/what-are-we-missing-recognizing-symptoms-of-maternal-stroke-frankly-speaking-ep-490/#comments</comments>        <pubDate>Mon, 22 Jun 2026 05:30:00 +0000</pubDate>
        <guid isPermaLink="false">primedfranklyspeaking.podbean.com/bddb7c67-8df1-3c2e-8326-aeacab034f2b</guid>
                                    <description><![CDATA[<p>Credits: 0.25 AMA PRA Category 1 Credit™
 
CME/CE Information and Claim Credit: <a href='https://www.pri-med.com/online-education/podcast/frankly-speaking-cme-490'>https://www.pri-med.com/online-education/podcast/frankly-speaking-cme-490</a></p>
<p>Overview: In the US, maternal morbidity and mortality rates are among the highest in the western world, and stroke is one of the leading causes—responsible for 1 of 12 maternal deaths. This rate is estimated to be much higher in high-risk pregnancies. Join us as we discuss a recent study examining rates of maternal stroke in which 1 in 4 women with stroke experienced a missed diagnostic opportunity and hear what these findings mean for your practice.</p>
<p>Episode resource links:</p>
<ul>
<li>Haghighi N, Bourscheid RM, Shang C, et al. Identifying missed diagnostic opportunities in maternal stroke. Stroke. 2026;57(2). doi:10.1161/STROKEAHA.125.052995</li>
<li><a href='https://jamanetwork.com/journals/jamanetworkopen/fullarticle/10.1001/jamanetworkopen.2025.4325?utm_source=openevidence&amp;utm_medium=referral'>Chen Y, Shiels MS, Uribe-Leitz T, et al. 2025. Pregnancy-Related Deaths in the US, 2018-2022. JAMA Network Open. </a></li>
<li><a href='https://pubmed.ncbi.nlm.nih.gov/33309560'>Lappen JR, Pettker CM, Louis JM. 2021. American Journal of Obstetrics and Gynecology. Society for Maternal-Fetal Medicine Consult Series #54: Assessing the Risk of Maternal morbidity and Mortality. American Journal of Obstetrics and Gynecology.</a></li>
<li><a href='https://www.ahajournals.org/doi/10.1161/STR.0000000000000514?url_ver=Z39.88-2003&amp;rfr_id=ori:rid:crossref.org&amp;rfr_dat=cr_pub%20%200pubmed'>Miller EC, Bello NA, Chen PR, et al 2026. Prevention and Treatment of Maternal Stroke in Pregnancy and Postpartum: A Scientific Statement from the American Heart Association. Stroke. </a></li>
<li><a href='https://www.ahajournals.org/doi/abs/10.1161/STR.0000000000000475?url_ver=Z39.88-2003&amp;rfr_id=ori:rid:crossref.org&amp;rfr_dat=cr_pub%20%200pubmed'>Bushnell C, Kernan WN, Sharrief AZ, et al. 2024. Guideline for the Primary Prevention of Stroke: A Guideline from the American Heart Association/¬American Stroke Association. Stroke.</a> </li>
</ul>
<p>Guest: Susan Feeney, DNP, FNP-BC, NP-C
 
Music Credit: Matthew Bugos</p>
<p>Thoughts? Suggestions? Email us at <a href='mailto:FranklySpeaking@pri-med.com'>FranklySpeaking@pri-med.com</a> </p>
<p>The views expressed in this podcast are those of Dr. Domino and his guests and do not necessarily reflect the views of Pri-Med.</p>
]]></description>
                                                            <content:encoded><![CDATA[<p>Credits: 0.25 AMA PRA Category 1 Credit™<br>
 <br>
CME/CE Information and Claim Credit: <a href='https://www.pri-med.com/online-education/podcast/frankly-speaking-cme-490'>https://www.pri-med.com/online-education/podcast/frankly-speaking-cme-490</a></p>
<p>Overview: In the US, maternal morbidity and mortality rates are among the highest in the western world, and stroke is one of the leading causes—responsible for 1 of 12 maternal deaths. This rate is estimated to be much higher in high-risk pregnancies. Join us as we discuss a recent study examining rates of maternal stroke in which 1 in 4 women with stroke experienced a missed diagnostic opportunity and hear what these findings mean for your practice.</p>
<p>Episode resource links:</p>
<ul>
<li>Haghighi N, Bourscheid RM, Shang C, et al. Identifying missed diagnostic opportunities in maternal stroke. Stroke. 2026;57(2). doi:10.1161/STROKEAHA.125.052995</li>
<li><a href='https://jamanetwork.com/journals/jamanetworkopen/fullarticle/10.1001/jamanetworkopen.2025.4325?utm_source=openevidence&amp;utm_medium=referral'>Chen Y, Shiels MS, Uribe-Leitz T, et al. 2025. Pregnancy-Related Deaths in the US, 2018-2022. JAMA Network Open. </a></li>
<li><a href='https://pubmed.ncbi.nlm.nih.gov/33309560'>Lappen JR, Pettker CM, Louis JM. 2021. American Journal of Obstetrics and Gynecology. Society for Maternal-Fetal Medicine Consult Series #54: Assessing the Risk of Maternal morbidity and Mortality. American Journal of Obstetrics and Gynecology.</a></li>
<li><a href='https://www.ahajournals.org/doi/10.1161/STR.0000000000000514?url_ver=Z39.88-2003&amp;rfr_id=ori:rid:crossref.org&amp;rfr_dat=cr_pub%20%200pubmed'>Miller EC, Bello NA, Chen PR, et al 2026. Prevention and Treatment of Maternal Stroke in Pregnancy and Postpartum: A Scientific Statement from the American Heart Association. Stroke. </a></li>
<li><a href='https://www.ahajournals.org/doi/abs/10.1161/STR.0000000000000475?url_ver=Z39.88-2003&amp;rfr_id=ori:rid:crossref.org&amp;rfr_dat=cr_pub%20%200pubmed'>Bushnell C, Kernan WN, Sharrief AZ, et al. 2024. Guideline for the Primary Prevention of Stroke: A Guideline from the American Heart Association/¬American Stroke Association. Stroke.</a> </li>
</ul>
<p>Guest: Susan Feeney, DNP, FNP-BC, NP-C<br>
 <br>
Music Credit: Matthew Bugos</p>
<p>Thoughts? Suggestions? Email us at <a href='mailto:FranklySpeaking@pri-med.com'>FranklySpeaking@pri-med.com</a> </p>
<p><em>The views expressed in this podcast are those of Dr. Domino and his guests and do not necessarily reflect the views of Pri-Med.</em></p>
]]></content:encoded>
                                    
        <enclosure url="https://mcdn.podbean.com/mf/web/aab627qkx5psqzpm/frankly-speaking-490-post-partum-cva.mp3" length="15562462" type="audio/mpeg"/>
                <itunes:summary><![CDATA[Credits: 0.25 AMA PRA Category 1 Credit™ CME/CE Information and Claim Credit: https://www.pri-med.com/online-education/podcast/frankly-speaking-cme-490
Overview: In the US, maternal morbidity and mortality rates are among the highest in the western world, and stroke is one of the leading causes—responsible for 1 of 12 maternal deaths. This rate is estimated to be much higher in high-risk pregnancies. Join us as we discuss a recent study examining rates of maternal stroke in which 1 in 4 women with stroke experienced a missed diagnostic opportunity and hear what these findings mean for your practice.
Episode resource links:

Haghighi N, Bourscheid RM, Shang C, et al. Identifying missed diagnostic opportunities in maternal stroke. Stroke. 2026;57(2). doi:10.1161/STROKEAHA.125.052995
Chen Y, Shiels MS, Uribe-Leitz T, et al. 2025. Pregnancy-Related Deaths in the US, 2018-2022. JAMA Network Open. 
Lappen JR, Pettker CM, Louis JM. 2021. American Journal of Obstetrics and Gynecology. Society for Maternal-Fetal Medicine Consult Series #54: Assessing the Risk of Maternal morbidity and Mortality. American Journal of Obstetrics and Gynecology.
Miller EC, Bello NA, Chen PR, et al 2026. Prevention and Treatment of Maternal Stroke in Pregnancy and Postpartum: A Scientific Statement from the American Heart Association. Stroke. 
Bushnell C, Kernan WN, Sharrief AZ, et al. 2024. Guideline for the Primary Prevention of Stroke: A Guideline from the American Heart Association/¬American Stroke Association. Stroke. 

Guest: Susan Feeney, DNP, FNP-BC, NP-C Music Credit: Matthew Bugos
Thoughts? Suggestions? Email us at FranklySpeaking@pri-med.com 
The views expressed in this podcast are those of Dr. Domino and his guests and do not necessarily reflect the views of Pri-Med.]]></itunes:summary>
        <itunes:author>Pri-Med</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>970</itunes:duration>
                        <itunes:episodeType>full</itunes:episodeType>
            </item>
    <item>
        <title>“Will I Get Heart Disease?” When Patients Ask for Lipoprotein(a) Testing - Frankly Speaking Ep 489</title>
        <itunes:title>“Will I Get Heart Disease?” When Patients Ask for Lipoprotein(a) Testing - Frankly Speaking Ep 489</itunes:title>
        <link>https://primedfranklyspeaking.podbean.com/e/will-i-get-heart-disease-when-patients-ask-for-lipoproteina-testing-frankly-speaking-ep-489/</link>
                    <comments>https://primedfranklyspeaking.podbean.com/e/will-i-get-heart-disease-when-patients-ask-for-lipoproteina-testing-frankly-speaking-ep-489/#comments</comments>        <pubDate>Mon, 15 Jun 2026 05:30:00 +0000</pubDate>
        <guid isPermaLink="false">primedfranklyspeaking.podbean.com/0a3513c9-1641-3fbe-9827-1890554ed91b</guid>
                                    <description><![CDATA[<p>Credits: 0.25 AMA PRA Category 1 Credit™
 
CME/CE Information and Claim Credit: <a href='https://www.pri-med.com/online-education/podcast/frankly-speaking-cme-489'>https://www.pri-med.com/online-education/podcast/frankly-speaking-cme-489</a></p>
<p>Overview: Join us as we discuss lipoprotein(a) testing—including when it adds value and when it may not. We review the evidence behind this increasingly requested cardiovascular risk marker, equipping you with the knowledge to counsel patients, understand current and emerging treatment options, and optimize evidence-based strategies to reduce overall cardiovascular disease risk.</p>
<p>Episode resource links:</p>
<ul>
<li>
<p>Eur J Clin Invest. 2025 Oct 3:e70127. doi: 10.1111/eci.70127.</p>
</li>
<li>
<p>Arterioscler Thromb Vasc Biol. 2022 Jan;42(1):e48-e60. doi: 10.1161/ATV.0000000000000147
Progress in Cardiovascular Diseases, 84, 2024, Pages 27-33, https://doi.org/10.1016/j.pcad.2024.05.007</p>
</li>
</ul>
<p>Guest: Jillian Joseph, MPAS, PA-C
 
Music Credit: Matthew Bugos</p>
<p>Thoughts? Suggestions? Email us at <a href='mailto:FranklySpeaking@pri-med.com'>FranklySpeaking@pri-med.com</a> </p>
<p>The views expressed in this podcast are those of Dr. Domino and his guests and do not necessarily reflect the views of Pri-Med.</p>
]]></description>
                                                            <content:encoded><![CDATA[<p>Credits: 0.25 AMA PRA Category 1 Credit™<br>
 <br>
CME/CE Information and Claim Credit: <a href='https://www.pri-med.com/online-education/podcast/frankly-speaking-cme-489'>https://www.pri-med.com/online-education/podcast/frankly-speaking-cme-489</a></p>
<p>Overview: Join us as we discuss lipoprotein(a) testing—including when it adds value and when it may not. We review the evidence behind this increasingly requested cardiovascular risk marker, equipping you with the knowledge to counsel patients, understand current and emerging treatment options, and optimize evidence-based strategies to reduce overall cardiovascular disease risk.</p>
<p>Episode resource links:</p>
<ul>
<li>
<p>Eur J Clin Invest. 2025 Oct 3:e70127. doi: 10.1111/eci.70127.</p>
</li>
<li>
<p>Arterioscler Thromb Vasc Biol. 2022 Jan;42(1):e48-e60. doi: 10.1161/ATV.0000000000000147<br>
Progress in Cardiovascular Diseases, 84, 2024, Pages 27-33, https://doi.org/10.1016/j.pcad.2024.05.007</p>
</li>
</ul>
<p>Guest: Jillian Joseph, MPAS, PA-C<br>
 <br>
Music Credit: Matthew Bugos</p>
<p>Thoughts? Suggestions? Email us at <a href='mailto:FranklySpeaking@pri-med.com'>FranklySpeaking@pri-med.com</a> </p>
<p><em>The views expressed in this podcast are those of Dr. Domino and his guests and do not necessarily reflect the views of Pri-Med.</em></p>
]]></content:encoded>
                                    
        <enclosure url="https://mcdn.podbean.com/mf/web/ykvg9m2wragssxxs/frankly-speaking-489-lipA-testing.mp3" length="9961472" type="audio/mpeg"/>
                <itunes:summary><![CDATA[Credits: 0.25 AMA PRA Category 1 Credit™ CME/CE Information and Claim Credit: https://www.pri-med.com/online-education/podcast/frankly-speaking-cme-489
Overview: Join us as we discuss lipoprotein(a) testing—including when it adds value and when it may not. We review the evidence behind this increasingly requested cardiovascular risk marker, equipping you with the knowledge to counsel patients, understand current and emerging treatment options, and optimize evidence-based strategies to reduce overall cardiovascular disease risk.
Episode resource links:


Eur J Clin Invest. 2025 Oct 3:e70127. doi: 10.1111/eci.70127.


Arterioscler Thromb Vasc Biol. 2022 Jan;42(1):e48-e60. doi: 10.1161/ATV.0000000000000147Progress in Cardiovascular Diseases, 84, 2024, Pages 27-33, https://doi.org/10.1016/j.pcad.2024.05.007


Guest: Jillian Joseph, MPAS, PA-C Music Credit: Matthew Bugos
Thoughts? Suggestions? Email us at FranklySpeaking@pri-med.com 
The views expressed in this podcast are those of Dr. Domino and his guests and do not necessarily reflect the views of Pri-Med.]]></itunes:summary>
        <itunes:author>Pri-Med</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>622</itunes:duration>
                        <itunes:episodeType>full</itunes:episodeType>
            </item>
    <item>
        <title>ADHD Medications Don’t Work the Way We Thought - Frankly Speaking Ep 488</title>
        <itunes:title>ADHD Medications Don’t Work the Way We Thought - Frankly Speaking Ep 488</itunes:title>
        <link>https://primedfranklyspeaking.podbean.com/e/adhd-medications-don-t-work-the-way-we-thought-frankly-speaking-ep-488/</link>
                    <comments>https://primedfranklyspeaking.podbean.com/e/adhd-medications-don-t-work-the-way-we-thought-frankly-speaking-ep-488/#comments</comments>        <pubDate>Mon, 08 Jun 2026 05:30:00 +0000</pubDate>
        <guid isPermaLink="false">primedfranklyspeaking.podbean.com/f9ca225b-1454-3731-a34f-99a97cef8214</guid>
                                    <description><![CDATA[<p>Credits: 0.25 AMA PRA Category 1 Credit™
 
CME/CE Information and Claim Credit: <a href='https://www.pri-med.com/online-education/podcast/frankly-speaking-cme-488'>https://www.pri-med.com/online-education/podcast/frankly-speaking-cme-488</a></p>
<p>Overview: Stimulants have long been used to treat attention-deficit/hyperactivity disorder (ADHD); however, their mechanisms of action have been unclear. In this episode, we review a study on functional MRI to assess brain function in patients with ADHD, providing insight into the effects of stimulant medications.</p>
<p>Episode resource links:</p>
<ul>
<li><a href='https://doi.org/10.1016/j.cell.2025.11.039'>https://doi.org/10.1016/j.cell.2025.11.039</a></li>
</ul>
<p>Guest: Robert A. Baldor MD, FAAFP
 
Music Credit: Matthew Bugos</p>
<p>Thoughts? Suggestions? Email us at <a href='mailto:FranklySpeaking@pri-med.com'>FranklySpeaking@pri-med.com</a> </p>
<p>The views expressed in this podcast are those of Dr. Domino and his guests and do not necessarily reflect the views of Pri-Med.</p>
]]></description>
                                                            <content:encoded><![CDATA[<p>Credits: 0.25 AMA PRA Category 1 Credit™<br>
 <br>
CME/CE Information and Claim Credit: <a href='https://www.pri-med.com/online-education/podcast/frankly-speaking-cme-488'>https://www.pri-med.com/online-education/podcast/frankly-speaking-cme-488</a></p>
<p>Overview: Stimulants have long been used to treat attention-deficit/hyperactivity disorder (ADHD); however, their mechanisms of action have been unclear. In this episode, we review a study on functional MRI to assess brain function in patients with ADHD, providing insight into the effects of stimulant medications.</p>
<p>Episode resource links:</p>
<ul>
<li><a href='https://doi.org/10.1016/j.cell.2025.11.039'>https://doi.org/10.1016/j.cell.2025.11.039</a></li>
</ul>
<p>Guest: Robert A. Baldor MD, FAAFP<br>
 <br>
Music Credit: Matthew Bugos</p>
<p>Thoughts? Suggestions? Email us at <a href='mailto:FranklySpeaking@pri-med.com'>FranklySpeaking@pri-med.com</a> </p>
<p><em>The views expressed in this podcast are those of Dr. Domino and his guests and do not necessarily reflect the views of Pri-Med.</em></p>
]]></content:encoded>
                                    
        <enclosure url="https://mcdn.podbean.com/mf/web/7b49ikcgwk4knw85/frankly-speaking-488-stimulants-in-adhd.mp3" length="13495759" type="audio/mpeg"/>
                <itunes:summary><![CDATA[Credits: 0.25 AMA PRA Category 1 Credit™ CME/CE Information and Claim Credit: https://www.pri-med.com/online-education/podcast/frankly-speaking-cme-488
Overview: Stimulants have long been used to treat attention-deficit/hyperactivity disorder (ADHD); however, their mechanisms of action have been unclear. In this episode, we review a study on functional MRI to assess brain function in patients with ADHD, providing insight into the effects of stimulant medications.
Episode resource links:

https://doi.org/10.1016/j.cell.2025.11.039

Guest: Robert A. Baldor MD, FAAFP Music Credit: Matthew Bugos
Thoughts? Suggestions? Email us at FranklySpeaking@pri-med.com 
The views expressed in this podcast are those of Dr. Domino and his guests and do not necessarily reflect the views of Pri-Med.]]></itunes:summary>
        <itunes:author>Pri-Med</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>841</itunes:duration>
                        <itunes:episodeType>full</itunes:episodeType>
            </item>
    <item>
        <title>High Stakes: Primary Care Approaches for Gambling Disorder - Frankly Speaking Ep 487</title>
        <itunes:title>High Stakes: Primary Care Approaches for Gambling Disorder - Frankly Speaking Ep 487</itunes:title>
        <link>https://primedfranklyspeaking.podbean.com/e/high-stakes-primary-care-approaches-for-gambling-disorder-frankly-speaking-ep-487/</link>
                    <comments>https://primedfranklyspeaking.podbean.com/e/high-stakes-primary-care-approaches-for-gambling-disorder-frankly-speaking-ep-487/#comments</comments>        <pubDate>Mon, 01 Jun 2026 05:30:00 +0000</pubDate>
        <guid isPermaLink="false">primedfranklyspeaking.podbean.com/2f54f929-599c-3d85-8be4-64338fd858a9</guid>
                                    <description><![CDATA[<p>Credits: 0.25 AMA PRA Category 1 Credit™
 
CME/CE Information and Claim Credit: <a href='https://www.pri-med.com/online-education/podcast/frankly-speaking-cme-487'>https://www.pri-med.com/online-education/podcast/frankly-speaking-cme-487</a></p>
<p>Overview: With online access driving a dramatic surge in gambling addiction, primary care clinicians are increasingly positioned on the front lines of identification and intervention. This episode brings you practical screening tools, evidence-based treatment strategies, and prevention approaches to confidently address gambling disorder in your patients.</p>
<p>Episode resource links:</p>
<ul>
<li>
<p>Yeola A, Allen MR, Desai N, et al. Growing Health Concern Regarding Gambling Addiction in the Age of Sportsbooks. JAMA Intern Med. 2025;185(4):382–389. doi:10.1001/jamainternmed.2024.8193</p>
</li>
<li>
<p>Moreira D, Azeredo A, Dias P. Risk Factors for Gambling Disorder: A Systematic Review. J Gambl Stud. 2023;39(2):483-511. doi:10.1007/s10899-023-10195-1</p>
</li>
<li>
<p>Ioannidis K, Del Giovane C, Tzagarakis C, et al. Pharmacological management of gambling disorder: A systematic review and network meta-analysis. Compr Psychiatry. 2025;137:152566. doi:10.1016/j.comppsych.2024.152566</p>
</li>
<li>
<p>Ulisse, K., Albitar, J., Aromin, J. T., &amp; Berry, J. (2025). Emerging Interventions in Behavioral Addictions: A Narrative Review of Psychedelics and Neuromodulation. Brain sciences, 15(9), 980. <a href='https://doi.org/10.3390/brainsci15090980'>https://doi.org/10.3390/brainsci15090980</a></p>
<p> </p>
</li>
<li>
<p><a href='https://www.mass.gov/info-details/identifying-a-gambling-disorder#:~:text=Contact-,Brief%20screening,these%20screens%20on%20The%20BASIS.'>Identifying a gambling disorder:  Mass.gov Practice Guidelines for Treating Gambling-Related Problems.  Includes brief screening, Assessment, Diagnosis, Hotlines and Resources.</a> </p>
</li>
<li>
<p><a href='https://apps.apple.com/us/app/gambling-addiction-calendar/id1112385176'>Gambling Addiction Calendar:  Free app</a> </p>
</li>
<li>
<p><a href='https://gamblershelp.com.au/get-help/help-yourself/reset-app/'>Reset App: Free</a></p>
</li>
</ul>
<p>Guest: Jill M. Terrien PhD, ANP-BC 
 
Music Credit: Matthew Bugos</p>
<p>Thoughts? Suggestions? Email us at <a href='mailto:FranklySpeaking@pri-med.com'>FranklySpeaking@pri-med.com</a> </p>
<p>The views expressed in this podcast are those of Dr. Domino and his guests and do not necessarily reflect the views of Pri-Med.</p>
]]></description>
                                                            <content:encoded><![CDATA[<p>Credits: 0.25 AMA PRA Category 1 Credit™<br>
 <br>
CME/CE Information and Claim Credit: <a href='https://www.pri-med.com/online-education/podcast/frankly-speaking-cme-487'>https://www.pri-med.com/online-education/podcast/frankly-speaking-cme-487</a></p>
<p>Overview: With online access driving a dramatic surge in gambling addiction, primary care clinicians are increasingly positioned on the front lines of identification and intervention. This episode brings you practical screening tools, evidence-based treatment strategies, and prevention approaches to confidently address gambling disorder in your patients.</p>
<p>Episode resource links:</p>
<ul>
<li>
<p>Yeola A, Allen MR, Desai N, et al. Growing Health Concern Regarding Gambling Addiction in the Age of Sportsbooks. JAMA Intern Med. 2025;185(4):382–389. doi:10.1001/jamainternmed.2024.8193</p>
</li>
<li>
<p>Moreira D, Azeredo A, Dias P. Risk Factors for Gambling Disorder: A Systematic Review. J Gambl Stud. 2023;39(2):483-511. doi:10.1007/s10899-023-10195-1</p>
</li>
<li>
<p>Ioannidis K, Del Giovane C, Tzagarakis C, et al. Pharmacological management of gambling disorder: A systematic review and network meta-analysis. Compr Psychiatry. 2025;137:152566. doi:10.1016/j.comppsych.2024.152566</p>
</li>
<li>
<p>Ulisse, K., Albitar, J., Aromin, J. T., &amp; Berry, J. (2025). Emerging Interventions in Behavioral Addictions: A Narrative Review of Psychedelics and Neuromodulation. Brain sciences, 15(9), 980. <a href='https://doi.org/10.3390/brainsci15090980'>https://doi.org/10.3390/brainsci15090980</a></p>
<p> </p>
</li>
<li>
<p><a href='https://www.mass.gov/info-details/identifying-a-gambling-disorder#:~:text=Contact-,Brief%20screening,these%20screens%20on%20The%20BASIS.'>Identifying a gambling disorder:  Mass.gov Practice Guidelines for Treating Gambling-Related Problems.  Includes brief screening, Assessment, Diagnosis, Hotlines and Resources.</a> </p>
</li>
<li>
<p><a href='https://apps.apple.com/us/app/gambling-addiction-calendar/id1112385176'>Gambling Addiction Calendar:  Free app</a> </p>
</li>
<li>
<p><a href='https://gamblershelp.com.au/get-help/help-yourself/reset-app/'>Reset App: Free</a></p>
</li>
</ul>
<p>Guest: Jill M. Terrien PhD, ANP-BC <br>
 <br>
Music Credit: Matthew Bugos</p>
<p>Thoughts? Suggestions? Email us at <a href='mailto:FranklySpeaking@pri-med.com'>FranklySpeaking@pri-med.com</a> </p>
<p><em>The views expressed in this podcast are those of Dr. Domino and his guests and do not necessarily reflect the views of Pri-Med.</em></p>
]]></content:encoded>
                                    
        <enclosure url="https://mcdn.podbean.com/mf/web/tz2jwqepeqvfvs34/frankly-speaking-487-gambling-addiction.mp3" length="16008708" type="audio/mpeg"/>
                <itunes:summary><![CDATA[Credits: 0.25 AMA PRA Category 1 Credit™ CME/CE Information and Claim Credit: https://www.pri-med.com/online-education/podcast/frankly-speaking-cme-487
Overview: With online access driving a dramatic surge in gambling addiction, primary care clinicians are increasingly positioned on the front lines of identification and intervention. This episode brings you practical screening tools, evidence-based treatment strategies, and prevention approaches to confidently address gambling disorder in your patients.
Episode resource links:


Yeola A, Allen MR, Desai N, et al. Growing Health Concern Regarding Gambling Addiction in the Age of Sportsbooks. JAMA Intern Med. 2025;185(4):382–389. doi:10.1001/jamainternmed.2024.8193


Moreira D, Azeredo A, Dias P. Risk Factors for Gambling Disorder: A Systematic Review. J Gambl Stud. 2023;39(2):483-511. doi:10.1007/s10899-023-10195-1


Ioannidis K, Del Giovane C, Tzagarakis C, et al. Pharmacological management of gambling disorder: A systematic review and network meta-analysis. Compr Psychiatry. 2025;137:152566. doi:10.1016/j.comppsych.2024.152566


Ulisse, K., Albitar, J., Aromin, J. T., &amp; Berry, J. (2025). Emerging Interventions in Behavioral Addictions: A Narrative Review of Psychedelics and Neuromodulation. Brain sciences, 15(9), 980. https://doi.org/10.3390/brainsci15090980
 


Identifying a gambling disorder:  Mass.gov Practice Guidelines for Treating Gambling-Related Problems.  Includes brief screening, Assessment, Diagnosis, Hotlines and Resources. 


Gambling Addiction Calendar:  Free app 


Reset App: Free


Guest: Jill M. Terrien PhD, ANP-BC  Music Credit: Matthew Bugos
Thoughts? Suggestions? Email us at FranklySpeaking@pri-med.com 
The views expressed in this podcast are those of Dr. Domino and his guests and do not necessarily reflect the views of Pri-Med.]]></itunes:summary>
        <itunes:author>Pri-Med</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>998</itunes:duration>
                        <itunes:episodeType>full</itunes:episodeType>
            </item>
    <item>
        <title>Medication Selection and Kidney Protection in Diabetes Management - Frankly Speaking Ep 486</title>
        <itunes:title>Medication Selection and Kidney Protection in Diabetes Management - Frankly Speaking Ep 486</itunes:title>
        <link>https://primedfranklyspeaking.podbean.com/e/medication-selection-and-kidney-protection-in-diabetes-management-frankly-speaking-ep-486/</link>
                    <comments>https://primedfranklyspeaking.podbean.com/e/medication-selection-and-kidney-protection-in-diabetes-management-frankly-speaking-ep-486/#comments</comments>        <pubDate>Mon, 25 May 2026 05:30:00 +0000</pubDate>
        <guid isPermaLink="false">primedfranklyspeaking.podbean.com/9c133e88-bcda-3c64-9f77-f1f34f074a00</guid>
                                    <description><![CDATA[<p>Credits: 0.25 AMA PRA Category 1 Credit™
 
CME/CE Information and Claim Credit: <a href='https://www.pri-med.com/online-education/podcast/frankly-speaking-cme-486'>https://www.pri-med.com/online-education/podcast/frankly-speaking-cme-486</a></p>
<p>Overview: Optimizing diabetes management starts with choosing the right medication for the patient. Listen in as we discuss current prescribing recommendations, empowering you to confidently compare medication classes and select therapies that best fit individual patient needs—while prioritizing kidney protection to reduce the risk of long-term complications.</p>
<p>Episode resource links:</p>
<ul>
<li>Jensen SK, Heide-Jørgensen U, Andersen IT, et al. SGLT2 Inhibitors vs GLP-1 Receptor Agonists for Kidney Outcomes in Individuals With Type 2 Diabetes. JAMA Intern Med. Published online January 20, 2026. doi:10.1001/jamainternmed.2025.7409</li>
<li>Samson SL, et al. American Association of Clinical Endocrinology consensus statement: comprehensive type 2 diabetes management algorithm—2023 update. Endocr Pract. 2023;29(5):305-340.</li>
</ul>
<p>Guest: Jillian Joseph, MPAS, PA-C
 
Music Credit: Matthew Bugos</p>
<p>Thoughts? Suggestions? Email us at <a href='mailto:FranklySpeaking@pri-med.com'>FranklySpeaking@pri-med.com</a> </p>
<p>The views expressed in this podcast are those of Dr. Domino and his guests and do not necessarily reflect the views of Pri-Med.</p>
]]></description>
                                                            <content:encoded><![CDATA[<p>Credits: 0.25 AMA PRA Category 1 Credit™<br>
 <br>
CME/CE Information and Claim Credit: <a href='https://www.pri-med.com/online-education/podcast/frankly-speaking-cme-486'>https://www.pri-med.com/online-education/podcast/frankly-speaking-cme-486</a></p>
<p>Overview: Optimizing diabetes management starts with choosing the right medication for the patient. Listen in as we discuss current prescribing recommendations, empowering you to confidently compare medication classes and select therapies that best fit individual patient needs—while prioritizing kidney protection to reduce the risk of long-term complications.</p>
<p>Episode resource links:</p>
<ul>
<li>Jensen SK, Heide-Jørgensen U, Andersen IT, et al. SGLT2 Inhibitors vs GLP-1 Receptor Agonists for Kidney Outcomes in Individuals With Type 2 Diabetes. JAMA Intern Med. Published online January 20, 2026. doi:10.1001/jamainternmed.2025.7409</li>
<li>Samson SL, et al. American Association of Clinical Endocrinology consensus statement: comprehensive type 2 diabetes management algorithm—2023 update. Endocr Pract. 2023;29(5):305-340.</li>
</ul>
<p>Guest: Jillian Joseph, MPAS, PA-C<br>
 <br>
Music Credit: Matthew Bugos</p>
<p>Thoughts? Suggestions? Email us at <a href='mailto:FranklySpeaking@pri-med.com'>FranklySpeaking@pri-med.com</a> </p>
<p><em>The views expressed in this podcast are those of Dr. Domino and his guests and do not necessarily reflect the views of Pri-Med.</em></p>
]]></content:encoded>
                                    
        <enclosure url="https://mcdn.podbean.com/mf/web/apdkeueh8grff28n/frankly-speaking-486-glp1-vs-sglt-in-ckd.mp3" length="13564275" type="audio/mpeg"/>
                <itunes:summary><![CDATA[Credits: 0.25 AMA PRA Category 1 Credit™ CME/CE Information and Claim Credit: https://www.pri-med.com/online-education/podcast/frankly-speaking-cme-486
Overview: Optimizing diabetes management starts with choosing the right medication for the patient. Listen in as we discuss current prescribing recommendations, empowering you to confidently compare medication classes and select therapies that best fit individual patient needs—while prioritizing kidney protection to reduce the risk of long-term complications.
Episode resource links:

Jensen SK, Heide-Jørgensen U, Andersen IT, et al. SGLT2 Inhibitors vs GLP-1 Receptor Agonists for Kidney Outcomes in Individuals With Type 2 Diabetes. JAMA Intern Med. Published online January 20, 2026. doi:10.1001/jamainternmed.2025.7409
Samson SL, et al. American Association of Clinical Endocrinology consensus statement: comprehensive type 2 diabetes management algorithm—2023 update. Endocr Pract. 2023;29(5):305-340.

Guest: Jillian Joseph, MPAS, PA-C Music Credit: Matthew Bugos
Thoughts? Suggestions? Email us at FranklySpeaking@pri-med.com 
The views expressed in this podcast are those of Dr. Domino and his guests and do not necessarily reflect the views of Pri-Med.]]></itunes:summary>
        <itunes:author>Pri-Med</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>845</itunes:duration>
                        <itunes:episodeType>full</itunes:episodeType>
            </item>
    <item>
        <title>Sound Check: Preventing Hearing Loss in Teens - Frankly Speaking Ep 485</title>
        <itunes:title>Sound Check: Preventing Hearing Loss in Teens - Frankly Speaking Ep 485</itunes:title>
        <link>https://primedfranklyspeaking.podbean.com/e/sound-check-preventing-hearing-loss-in-teens-frankly-speaking-ep-485/</link>
                    <comments>https://primedfranklyspeaking.podbean.com/e/sound-check-preventing-hearing-loss-in-teens-frankly-speaking-ep-485/#comments</comments>        <pubDate>Mon, 18 May 2026 05:30:00 +0000</pubDate>
        <guid isPermaLink="false">primedfranklyspeaking.podbean.com/c9f0fb3c-388b-35ec-a4f8-f207e07cdf9b</guid>
                                    <description><![CDATA[<p>Credits: 0.25 AMA PRA Category 1 Credit™
 
CME/CE Information and Claim Credit: <a href='https://www.pri-med.com/online-education/podcast/frankly-speaking-cme-485'>https://www.pri-med.com/online-education/podcast/frankly-speaking-cme-485</a></p>
<p>Overview: Teenagers are at higher susceptibility for hearing loss and often engage in behaviors that greatly increase their risk of permanent damage. In this episode, we look at current prevalence data and the pathophysiology of adolescent hearing loss, providing practical, office-ready prevention strategies to identify at-risk teens and intervene early.</p>
<p>Episode resource links:</p>
<ul>
<li>
<p>Reijers SNH, Vroegop JL, Paping DE, Pronk M, Goedegebure A, Kremer B, van der Schroeff MP. Longitudinal Insights into Sensorineural and Noise-Induced Hearing Loss in Adolescents Aged 13-18 Years. Otolaryngol Head Neck Surg. 2025 Dec;173(6):1385-1392. doi: 10.1002/ohn.70042. Epub 2025 Oct 14</p>
</li>
<li>
<p>Byeon H. Associations between adolescents' earphone usage in noisy environments, hearing loss, and self-reported hearing problems in a nationally representative sample of South Korean middle and high school students. Medicine (Baltimore). 2021 Jan 22;100(3):e24056. doi: 10.1097/MD.0000000000024056.</p>
</li>
</ul>
<p>Guest: Robert A. Baldor MD, FAAFP
 
Music Credit: Matthew Bugos</p>
<p>Thoughts? Suggestions? Email us at <a href='mailto:FranklySpeaking@pri-med.com'>FranklySpeaking@pri-med.com</a> </p>
<p>The views expressed in this podcast are those of Dr. Domino and his guests and do not necessarily reflect the views of Pri-Med.</p>
]]></description>
                                                            <content:encoded><![CDATA[<p>Credits: 0.25 AMA PRA Category 1 Credit™<br>
 <br>
CME/CE Information and Claim Credit: <a href='https://www.pri-med.com/online-education/podcast/frankly-speaking-cme-485'>https://www.pri-med.com/online-education/podcast/frankly-speaking-cme-485</a></p>
<p>Overview: Teenagers are at higher susceptibility for hearing loss and often engage in behaviors that greatly increase their risk of permanent damage. In this episode, we look at current prevalence data and the pathophysiology of adolescent hearing loss, providing practical, office-ready prevention strategies to identify at-risk teens and intervene early.</p>
<p>Episode resource links:</p>
<ul>
<li>
<p>Reijers SNH, Vroegop JL, Paping DE, Pronk M, Goedegebure A, Kremer B, van der Schroeff MP. Longitudinal Insights into Sensorineural and Noise-Induced Hearing Loss in Adolescents Aged 13-18 Years. Otolaryngol Head Neck Surg. 2025 Dec;173(6):1385-1392. doi: 10.1002/ohn.70042. Epub 2025 Oct 14</p>
</li>
<li>
<p>Byeon H. Associations between adolescents' earphone usage in noisy environments, hearing loss, and self-reported hearing problems in a nationally representative sample of South Korean middle and high school students. Medicine (Baltimore). 2021 Jan 22;100(3):e24056. doi: 10.1097/MD.0000000000024056.</p>
</li>
</ul>
<p>Guest: Robert A. Baldor MD, FAAFP<br>
 <br>
Music Credit: Matthew Bugos</p>
<p>Thoughts? Suggestions? Email us at <a href='mailto:FranklySpeaking@pri-med.com'>FranklySpeaking@pri-med.com</a> </p>
<p><em>The views expressed in this podcast are those of Dr. Domino and his guests and do not necessarily reflect the views of Pri-Med.</em></p>
]]></content:encoded>
                                    
        <enclosure url="https://mcdn.podbean.com/mf/web/5h4tj9a5h9de7vcc/frankly-speaking-485-hearing-loss-in-teens.mp3" length="11629292" type="audio/mpeg"/>
                <itunes:summary><![CDATA[Credits: 0.25 AMA PRA Category 1 Credit™ CME/CE Information and Claim Credit: https://www.pri-med.com/online-education/podcast/frankly-speaking-cme-485
Overview: Teenagers are at higher susceptibility for hearing loss and often engage in behaviors that greatly increase their risk of permanent damage. In this episode, we look at current prevalence data and the pathophysiology of adolescent hearing loss, providing practical, office-ready prevention strategies to identify at-risk teens and intervene early.
Episode resource links:


Reijers SNH, Vroegop JL, Paping DE, Pronk M, Goedegebure A, Kremer B, van der Schroeff MP. Longitudinal Insights into Sensorineural and Noise-Induced Hearing Loss in Adolescents Aged 13-18 Years. Otolaryngol Head Neck Surg. 2025 Dec;173(6):1385-1392. doi: 10.1002/ohn.70042. Epub 2025 Oct 14


Byeon H. Associations between adolescents' earphone usage in noisy environments, hearing loss, and self-reported hearing problems in a nationally representative sample of South Korean middle and high school students. Medicine (Baltimore). 2021 Jan 22;100(3):e24056. doi: 10.1097/MD.0000000000024056.


Guest: Robert A. Baldor MD, FAAFP Music Credit: Matthew Bugos
Thoughts? Suggestions? Email us at FranklySpeaking@pri-med.com 
The views expressed in this podcast are those of Dr. Domino and his guests and do not necessarily reflect the views of Pri-Med.]]></itunes:summary>
        <itunes:author>Pri-Med</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>725</itunes:duration>
                        <itunes:episodeType>full</itunes:episodeType>
            </item>
    <item>
        <title>Too Good to Be True? The Promises and Risks of Compounded Peptides - Frankly Speaking Ep 484</title>
        <itunes:title>Too Good to Be True? The Promises and Risks of Compounded Peptides - Frankly Speaking Ep 484</itunes:title>
        <link>https://primedfranklyspeaking.podbean.com/e/too-good-to-be-true-the-promises-and-risks-of-compounded-peptides-frankly-speaking-ep-484/</link>
                    <comments>https://primedfranklyspeaking.podbean.com/e/too-good-to-be-true-the-promises-and-risks-of-compounded-peptides-frankly-speaking-ep-484/#comments</comments>        <pubDate>Mon, 11 May 2026 05:30:00 +0000</pubDate>
        <guid isPermaLink="false">primedfranklyspeaking.podbean.com/b8ced1bf-64a2-398b-b4a5-b2fc35b887b3</guid>
                                    <description><![CDATA[<p>Credits: 0.25 AMA PRA Category 1 Credit™
 
CME/CE Information and Claim Credit: <a href='https://www.pri-med.com/online-education/podcast/frankly-speaking-cme-484'>https://www.pri-med.com/online-education/podcast/frankly-speaking-cme-484</a></p>
<p>Overview: Muscle growth, tissue repair, sexual function—compounded injectable peptides are marketed online for an expanding list of uses, and they’re showing up in your patients’ medicine cabinets. Join us as we explore this growing trend, evaluate the evidence behind the claims, and discuss how to counsel patients on potential safety risks.</p>
<p>Episode resource links:</p>
<ul>
<li>Expert Opin Drug Saf. 2026 Mar;25(3):581-588. doi: 10.1080/14740338.2025.2499670
HSS J. 2025 Jul 31;21(4):15563316251355551. doi: 10.1177/15563316251355551
JAMA 2017;318;(20):2004-2010. doi:10.1001/jama.2017.17069</li>
</ul>
<p>Guest: Robert A. Baldor MD, FAAFP
 
Music Credit: Matthew Bugos</p>
<p>Thoughts? Suggestions? Email us at <a href='mailto:FranklySpeaking@pri-med.com'>FranklySpeaking@pri-med.com</a> </p>
<p>The views expressed in this podcast are those of Dr. Domino and his guests and do not necessarily reflect the views of Pri-Med.</p>
]]></description>
                                                            <content:encoded><![CDATA[<p>Credits: 0.25 AMA PRA Category 1 Credit™<br>
 <br>
CME/CE Information and Claim Credit: <a href='https://www.pri-med.com/online-education/podcast/frankly-speaking-cme-484'>https://www.pri-med.com/online-education/podcast/frankly-speaking-cme-484</a></p>
<p>Overview: Muscle growth, tissue repair, sexual function—compounded injectable peptides are marketed online for an expanding list of uses, and they’re showing up in your patients’ medicine cabinets. Join us as we explore this growing trend, evaluate the evidence behind the claims, and discuss how to counsel patients on potential safety risks.</p>
<p>Episode resource links:</p>
<ul>
<li>Expert Opin Drug Saf. 2026 Mar;25(3):581-588. doi: 10.1080/14740338.2025.2499670<br>
HSS J. 2025 Jul 31;21(4):15563316251355551. doi: 10.1177/15563316251355551<br>
JAMA 2017;318;(20):2004-2010. doi:10.1001/jama.2017.17069</li>
</ul>
<p>Guest: Robert A. Baldor MD, FAAFP<br>
 <br>
Music Credit: Matthew Bugos</p>
<p>Thoughts? Suggestions? Email us at <a href='mailto:FranklySpeaking@pri-med.com'>FranklySpeaking@pri-med.com</a> </p>
<p><em>The views expressed in this podcast are those of Dr. Domino and his guests and do not necessarily reflect the views of Pri-Med.</em></p>
]]></content:encoded>
                                    
        <enclosure url="https://mcdn.podbean.com/mf/web/hruwutae2j6puky8/frankly-speaking-484-peptides.mp3" length="10035860" type="audio/mpeg"/>
                <itunes:summary><![CDATA[Credits: 0.25 AMA PRA Category 1 Credit™ CME/CE Information and Claim Credit: https://www.pri-med.com/online-education/podcast/frankly-speaking-cme-484
Overview: Muscle growth, tissue repair, sexual function—compounded injectable peptides are marketed online for an expanding list of uses, and they’re showing up in your patients’ medicine cabinets. Join us as we explore this growing trend, evaluate the evidence behind the claims, and discuss how to counsel patients on potential safety risks.
Episode resource links:

Expert Opin Drug Saf. 2026 Mar;25(3):581-588. doi: 10.1080/14740338.2025.2499670HSS J. 2025 Jul 31;21(4):15563316251355551. doi: 10.1177/15563316251355551JAMA 2017;318;(20):2004-2010. doi:10.1001/jama.2017.17069

Guest: Robert A. Baldor MD, FAAFP Music Credit: Matthew Bugos
Thoughts? Suggestions? Email us at FranklySpeaking@pri-med.com 
The views expressed in this podcast are those of Dr. Domino and his guests and do not necessarily reflect the views of Pri-Med.]]></itunes:summary>
        <itunes:author>Pri-Med</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>625</itunes:duration>
                        <itunes:episodeType>full</itunes:episodeType>
            </item>
    <item>
        <title>One and Done? Comparing Dosing Regimens for HPV Vaccination - Frankly Speaking Ep 483</title>
        <itunes:title>One and Done? Comparing Dosing Regimens for HPV Vaccination - Frankly Speaking Ep 483</itunes:title>
        <link>https://primedfranklyspeaking.podbean.com/e/one-and-done-comparing-dosing-regimens-for-hpv-vaccination-frankly-speaking-ep-483/</link>
                    <comments>https://primedfranklyspeaking.podbean.com/e/one-and-done-comparing-dosing-regimens-for-hpv-vaccination-frankly-speaking-ep-483/#comments</comments>        <pubDate>Mon, 04 May 2026 05:30:00 +0000</pubDate>
        <guid isPermaLink="false">primedfranklyspeaking.podbean.com/7d3ac8b3-a2ed-36c1-b051-b14151c1fffd</guid>
                                    <description><![CDATA[<p>Credits: 0.25 AMA PRA Category 1 Credit™
 
CME/CE Information and Claim Credit: <a href='https://www.pri-med.com/online-education/podcast/frankly-speaking-cme-483'>https://www.pri-med.com/online-education/podcast/frankly-speaking-cme-483</a></p>
<p>Overview: Human papilloma virus (HPV) vaccination can prevent most cases of cervical cancers, yet global coverage remains critically low. In this episode, we discuss the latest evidence on single-dose vs. two-dose HPV vaccination regimens, empowering you to counsel patients and families with confidence, address barriers to series completion, and maximize cancer prevention in your adolescent population.</p>
<p>Episode resource links:</p>
<ul>
<li>Noninferiority of One HPV Vaccine to Tow Doses.  The New England Journal of Medicine.  2025.  Kreimer AR, Porras C, Liu D, et al.</li>
<li>Cancer Prevention and Early Detection Facts and Figures.  American Cancer Society (2025).  2025.  Rick, Alteri, Deana Baptiste, Emily Butler Bell, et al.</li>
</ul>
<p>Guest: Anne Powell, MD
 
Music Credit: Matthew Bugos</p>
<p>Thoughts? Suggestions? Email us at <a href='mailto:FranklySpeaking@pri-med.com'>FranklySpeaking@pri-med.com</a> </p>
<p>The views expressed in this podcast are those of Dr. Domino and his guests and do not necessarily reflect the views of Pri-Med.</p>
]]></description>
                                                            <content:encoded><![CDATA[<p>Credits: 0.25 AMA PRA Category 1 Credit™<br>
 <br>
CME/CE Information and Claim Credit: <a href='https://www.pri-med.com/online-education/podcast/frankly-speaking-cme-483'>https://www.pri-med.com/online-education/podcast/frankly-speaking-cme-483</a></p>
<p>Overview: Human papilloma virus (HPV) vaccination can prevent most cases of cervical cancers, yet global coverage remains critically low. In this episode, we discuss the latest evidence on single-dose vs. two-dose HPV vaccination regimens, empowering you to counsel patients and families with confidence, address barriers to series completion, and maximize cancer prevention in your adolescent population.</p>
<p>Episode resource links:</p>
<ul>
<li>Noninferiority of One HPV Vaccine to Tow Doses.  The New England Journal of Medicine.  2025.  Kreimer AR, Porras C, Liu D, et al.</li>
<li>Cancer Prevention and Early Detection Facts and Figures.  American Cancer Society (2025).  2025.  Rick, Alteri, Deana Baptiste, Emily Butler Bell, et al.</li>
</ul>
<p>Guest: Anne Powell, MD<br>
 <br>
Music Credit: Matthew Bugos</p>
<p>Thoughts? Suggestions? Email us at <a href='mailto:FranklySpeaking@pri-med.com'>FranklySpeaking@pri-med.com</a> </p>
<p><em>The views expressed in this podcast are those of Dr. Domino and his guests and do not necessarily reflect the views of Pri-Med.</em></p>
]]></content:encoded>
                                    
        <enclosure url="https://mcdn.podbean.com/mf/web/v4mv6weyvdeww75b/frankly-speaking-483-hpv-vaccine.mp3" length="12289601" type="audio/mpeg"/>
                <itunes:summary><![CDATA[Credits: 0.25 AMA PRA Category 1 Credit™ CME/CE Information and Claim Credit: https://www.pri-med.com/online-education/podcast/frankly-speaking-cme-483
Overview: Human papilloma virus (HPV) vaccination can prevent most cases of cervical cancers, yet global coverage remains critically low. In this episode, we discuss the latest evidence on single-dose vs. two-dose HPV vaccination regimens, empowering you to counsel patients and families with confidence, address barriers to series completion, and maximize cancer prevention in your adolescent population.
Episode resource links:

Noninferiority of One HPV Vaccine to Tow Doses.  The New England Journal of Medicine.  2025.  Kreimer AR, Porras C, Liu D, et al.
Cancer Prevention and Early Detection Facts and Figures.  American Cancer Society (2025).  2025.  Rick, Alteri, Deana Baptiste, Emily Butler Bell, et al.

Guest: Anne Powell, MD Music Credit: Matthew Bugos
Thoughts? Suggestions? Email us at FranklySpeaking@pri-med.com 
The views expressed in this podcast are those of Dr. Domino and his guests and do not necessarily reflect the views of Pri-Med.]]></itunes:summary>
        <itunes:author>Pri-Med</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>766</itunes:duration>
                        <itunes:episodeType>full</itunes:episodeType>
            </item>
    <item>
        <title>Under the Skin: Stress, Inflammation, and the Mortality Gap - Frankly Speaking Ep 482</title>
        <itunes:title>Under the Skin: Stress, Inflammation, and the Mortality Gap - Frankly Speaking Ep 482</itunes:title>
        <link>https://primedfranklyspeaking.podbean.com/e/under-the-skin-stress-inflammation-and-the-mortality-gap-frankly-speaking-ep-482/</link>
                    <comments>https://primedfranklyspeaking.podbean.com/e/under-the-skin-stress-inflammation-and-the-mortality-gap-frankly-speaking-ep-482/#comments</comments>        <pubDate>Mon, 27 Apr 2026 05:30:00 +0000</pubDate>
        <guid isPermaLink="false">primedfranklyspeaking.podbean.com/221781c6-18fa-3536-bcb5-7b7a9ffc3270</guid>
                                    <description><![CDATA[<p>Credits: 0.25 AMA PRA Category 1 Credit™
 
CME/CE Information and Claim Credit: <a href='https://www.pri-med.com/online-education/podcast/frankly-speaking-cme-482'>https://www.pri-med.com/online-education/podcast/frankly-speaking-cme-482</a></p>
<p>Overview: In this episode, we discuss how stress—specifically cumulative stress—exposure throughout a lifetime can contribute to negative health concerns and outcomes. While stress impacts everyone, its effects highlight racial disparities in mortality between Black and White adults. Listen in as we discuss evidence on how structural factors shape health outcomes and how we can address stress-related disease burdens in clinical practice.</p>
<p>Guest: Mariyan L. Montaque, DNP, FNP-BC
 
Music Credit: Matthew Bugos</p>
<p>Thoughts? Suggestions? Email us at <a href='mailto:FranklySpeaking@pri-med.com'>FranklySpeaking@pri-med.com</a> </p>
<p>The views expressed in this podcast are those of Dr. Domino and his guests and do not necessarily reflect the views of Pri-Med.</p>
]]></description>
                                                            <content:encoded><![CDATA[<p>Credits: 0.25 AMA PRA Category 1 Credit™<br>
 <br>
CME/CE Information and Claim Credit: <a href='https://www.pri-med.com/online-education/podcast/frankly-speaking-cme-482'>https://www.pri-med.com/online-education/podcast/frankly-speaking-cme-482</a></p>
<p>Overview: In this episode, we discuss how stress—specifically cumulative stress—exposure throughout a lifetime can contribute to negative health concerns and outcomes. While stress impacts everyone, its effects highlight racial disparities in mortality between Black and White adults. Listen in as we discuss evidence on how structural factors shape health outcomes and how we can address stress-related disease burdens in clinical practice.</p>
<p>Guest: Mariyan L. Montaque, DNP, FNP-BC<br>
 <br>
Music Credit: Matthew Bugos</p>
<p>Thoughts? Suggestions? Email us at <a href='mailto:FranklySpeaking@pri-med.com'>FranklySpeaking@pri-med.com</a> </p>
<p><em>The views expressed in this podcast are those of Dr. Domino and his guests and do not necessarily reflect the views of Pri-Med.</em></p>
]]></content:encoded>
                                    
        <enclosure url="https://mcdn.podbean.com/mf/web/9tmiuu7vtxehem8f/frankly-speaking-482-racial-disparities.mp3" length="13167988" type="audio/mpeg"/>
                <itunes:summary><![CDATA[Credits: 0.25 AMA PRA Category 1 Credit™ CME/CE Information and Claim Credit: https://www.pri-med.com/online-education/podcast/frankly-speaking-cme-482
Overview: In this episode, we discuss how stress—specifically cumulative stress—exposure throughout a lifetime can contribute to negative health concerns and outcomes. While stress impacts everyone, its effects highlight racial disparities in mortality between Black and White adults. Listen in as we discuss evidence on how structural factors shape health outcomes and how we can address stress-related disease burdens in clinical practice.
Guest: Mariyan L. Montaque, DNP, FNP-BC Music Credit: Matthew Bugos
Thoughts? Suggestions? Email us at FranklySpeaking@pri-med.com 
The views expressed in this podcast are those of Dr. Domino and his guests and do not necessarily reflect the views of Pri-Med.]]></itunes:summary>
        <itunes:author>Pri-Med</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>820</itunes:duration>
                        <itunes:episodeType>full</itunes:episodeType>
            </item>
    <item>
        <title>From Guidance to Practice: Updates in CVD Screening - Frankly Speaking Ep 481</title>
        <itunes:title>From Guidance to Practice: Updates in CVD Screening - Frankly Speaking Ep 481</itunes:title>
        <link>https://primedfranklyspeaking.podbean.com/e/from-guidance-to-practice-updates-in-cvd-screening-frankly-speaking-ep-481/</link>
                    <comments>https://primedfranklyspeaking.podbean.com/e/from-guidance-to-practice-updates-in-cvd-screening-frankly-speaking-ep-481/#comments</comments>        <pubDate>Mon, 20 Apr 2026 05:30:00 +0000</pubDate>
        <guid isPermaLink="false">primedfranklyspeaking.podbean.com/0f13c0be-c0a2-3c53-a460-64b90e8f4a1b</guid>
                                    <description><![CDATA[<p>Credits: 0.25 AMA PRA Category 1 Credit™
 
CME/CE Information and Claim Credit: <a href='https://www.pri-med.com/online-education/podcast/frankly-speaking-cme-481'>https://www.pri-med.com/online-education/podcast/frankly-speaking-cme-481</a></p>
<p>Overview: Expand your prevention toolkit with new recommendations for cardiovascular disease screening. Listen in as we discuss how high-sensitivity C-reactive protein (hs-CRP) can guide screening for ongoing inflammation in patients who are at risk, the evidence behind primary and secondary prevention applications, and key limitations to keep in mind when applying these recommendations in practice.</p>
<p>Episode resource links:</p>
<ul>
<li>Mensah GA, Arnold N, Prabhu SD, Ridker PM, Welty FK. Inflammation and Cardiovascular Disease: 2025 ACC Scientific Statement: A Report of the American College of Cardiology. J Am Coll Cardiol. </li>
</ul>
<p>Guest: Alan M. Ehrlich, MD, FAAFP
 
Music Credit: Matthew Bugos</p>
<p>Thoughts? Suggestions? Email us at <a href='mailto:FranklySpeaking@pri-med.com'>FranklySpeaking@pri-med.com</a> </p>
<p>The views expressed in this podcast are those of Dr. Domino and his guests and do not necessarily reflect the views of Pri-Med.</p>
]]></description>
                                                            <content:encoded><![CDATA[<p>Credits: 0.25 AMA PRA Category 1 Credit™<br>
 <br>
CME/CE Information and Claim Credit: <a href='https://www.pri-med.com/online-education/podcast/frankly-speaking-cme-481'>https://www.pri-med.com/online-education/podcast/frankly-speaking-cme-481</a></p>
<p>Overview: Expand your prevention toolkit with new recommendations for cardiovascular disease screening. Listen in as we discuss how high-sensitivity C-reactive protein (hs-CRP) can guide screening for ongoing inflammation in patients who are at risk, the evidence behind primary and secondary prevention applications, and key limitations to keep in mind when applying these recommendations in practice.</p>
<p>Episode resource links:</p>
<ul>
<li>Mensah GA, Arnold N, Prabhu SD, Ridker PM, Welty FK. Inflammation and Cardiovascular Disease: 2025 ACC Scientific Statement: A Report of the American College of Cardiology. J Am Coll Cardiol. </li>
</ul>
<p>Guest: Alan M. Ehrlich, MD, FAAFP<br>
 <br>
Music Credit: Matthew Bugos</p>
<p>Thoughts? Suggestions? Email us at <a href='mailto:FranklySpeaking@pri-med.com'>FranklySpeaking@pri-med.com</a> </p>
<p><em>The views expressed in this podcast are those of Dr. Domino and his guests and do not necessarily reflect the views of Pri-Med.</em></p>
]]></content:encoded>
                                    
        <enclosure url="https://mcdn.podbean.com/mf/web/4wrb4xxkscp9xkze/frankly-speaking-481-crp-screening.mp3" length="12384560" type="audio/mpeg"/>
                <itunes:summary><![CDATA[Credits: 0.25 AMA PRA Category 1 Credit™ CME/CE Information and Claim Credit: https://www.pri-med.com/online-education/podcast/frankly-speaking-cme-481
Overview: Expand your prevention toolkit with new recommendations for cardiovascular disease screening. Listen in as we discuss how high-sensitivity C-reactive protein (hs-CRP) can guide screening for ongoing inflammation in patients who are at risk, the evidence behind primary and secondary prevention applications, and key limitations to keep in mind when applying these recommendations in practice.
Episode resource links:

Mensah GA, Arnold N, Prabhu SD, Ridker PM, Welty FK. Inflammation and Cardiovascular Disease: 2025 ACC Scientific Statement: A Report of the American College of Cardiology. J Am Coll Cardiol. 

Guest: Alan M. Ehrlich, MD, FAAFP Music Credit: Matthew Bugos
Thoughts? Suggestions? Email us at FranklySpeaking@pri-med.com 
The views expressed in this podcast are those of Dr. Domino and his guests and do not necessarily reflect the views of Pri-Med.]]></itunes:summary>
        <itunes:author>Pri-Med</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>772</itunes:duration>
                        <itunes:episodeType>full</itunes:episodeType>
            </item>
    <item>
        <title>Flexibility in Treatment: What Yoga Can Offer Patients with Knee Osteoarthritis - Frankly Speaking Ep 480</title>
        <itunes:title>Flexibility in Treatment: What Yoga Can Offer Patients with Knee Osteoarthritis - Frankly Speaking Ep 480</itunes:title>
        <link>https://primedfranklyspeaking.podbean.com/e/flexibility-in-treatment-what-yoga-can-offer-patients-with-knee-osteoarthritis-frankly-speaking-ep-480/</link>
                    <comments>https://primedfranklyspeaking.podbean.com/e/flexibility-in-treatment-what-yoga-can-offer-patients-with-knee-osteoarthritis-frankly-speaking-ep-480/#comments</comments>        <pubDate>Mon, 13 Apr 2026 05:30:00 +0000</pubDate>
        <guid isPermaLink="false">primedfranklyspeaking.podbean.com/c0f79dea-6c88-3bbd-9e4a-0ba9b3f35b1e</guid>
                                    <description><![CDATA[<p>Credits: 0.25 AMA PRA Category 1 Credit™
 
CME/CE Information and Claim Credit: <a href='https://www.pri-med.com/online-education/podcast/frankly-speaking-cme-480'>https://www.pri-med.com/online-education/podcast/frankly-speaking-cme-480</a></p>
<p>Overview: Tune in as we discuss nonsurgical options for managing knee osteoarthritis in primary care. This episode reviews current guidelines and highlights new research on yoga as an effective alternative to traditional strengthening exercises. Gain practical insights to help patients reduce pain, improve function, and delay surgery—all while expanding your integrative treatment toolkit.</p>
<p>Episode resource links:</p>
<ul>
<li>Abafita BJ, Singh A, Aitken D, et al. Yoga or strengthening exercise for knee osteoarthritis: a randomized clinical trial. JAMA Netw Open. 2025;8(4):e253698. doi:10.1001/jamanetworkopen.2025.3698 </li>
<li>Brophy, Robert H. MD; Fillingham, Yale A. MD. AAOS Clinical Practice Guideline Summary: Management of Osteoarthritis of the Knee (Nonarthroplasty), Third Edition. Journal of the American Academy of Orthopaedic Surgeons 30(9):p e721-e729, May 1, 2022. | DOI: 10.5435/JAAOS-D-21-01233 </li>
</ul>
<p>Guest: Jillian Joseph, MPAS, PA-C</p>
<p>Music Credit: Matthew Bugos</p>
<p>Thoughts? Suggestions? Email us at <a href='mailto:FranklySpeaking@pri-med.com'>FranklySpeaking@pri-med.com</a> </p>
<p>The views expressed in this podcast are those of Dr. Domino and his guests and do not necessarily reflect the views of Pri-Med.</p>
]]></description>
                                                            <content:encoded><![CDATA[<p>Credits: 0.25 AMA PRA Category 1 Credit™<br>
 <br>
CME/CE Information and Claim Credit: <a href='https://www.pri-med.com/online-education/podcast/frankly-speaking-cme-480'>https://www.pri-med.com/online-education/podcast/frankly-speaking-cme-480</a></p>
<p>Overview: Tune in as we discuss nonsurgical options for managing knee osteoarthritis in primary care. This episode reviews current guidelines and highlights new research on yoga as an effective alternative to traditional strengthening exercises. Gain practical insights to help patients reduce pain, improve function, and delay surgery—all while expanding your integrative treatment toolkit.</p>
<p>Episode resource links:</p>
<ul>
<li>Abafita BJ, Singh A, Aitken D, et al. Yoga or strengthening exercise for knee osteoarthritis: a randomized clinical trial. JAMA Netw Open. 2025;8(4):e253698. doi:10.1001/jamanetworkopen.2025.3698 </li>
<li>Brophy, Robert H. MD; Fillingham, Yale A. MD. AAOS Clinical Practice Guideline Summary: Management of Osteoarthritis of the Knee (Nonarthroplasty), Third Edition. Journal of the American Academy of Orthopaedic Surgeons 30(9):p e721-e729, May 1, 2022. | DOI: 10.5435/JAAOS-D-21-01233 </li>
</ul>
<p>Guest: Jillian Joseph, MPAS, PA-C</p>
<p>Music Credit: Matthew Bugos</p>
<p>Thoughts? Suggestions? Email us at <a href='mailto:FranklySpeaking@pri-med.com'>FranklySpeaking@pri-med.com</a> </p>
<p><em>The views expressed in this podcast are those of Dr. Domino and his guests and do not necessarily reflect the views of Pri-Med.</em></p>
]]></content:encoded>
                                    
        <enclosure url="https://mcdn.podbean.com/mf/web/4jwnvvywmcf6ds6w/frankly-speaking-480-yoga-knee-pain.mp3" length="10763235" type="audio/mpeg"/>
                <itunes:summary><![CDATA[Credits: 0.25 AMA PRA Category 1 Credit™ CME/CE Information and Claim Credit: https://www.pri-med.com/online-education/podcast/frankly-speaking-cme-480
Overview: Tune in as we discuss nonsurgical options for managing knee osteoarthritis in primary care. This episode reviews current guidelines and highlights new research on yoga as an effective alternative to traditional strengthening exercises. Gain practical insights to help patients reduce pain, improve function, and delay surgery—all while expanding your integrative treatment toolkit.
Episode resource links:

Abafita BJ, Singh A, Aitken D, et al. Yoga or strengthening exercise for knee osteoarthritis: a randomized clinical trial. JAMA Netw Open. 2025;8(4):e253698. doi:10.1001/jamanetworkopen.2025.3698 
Brophy, Robert H. MD; Fillingham, Yale A. MD. AAOS Clinical Practice Guideline Summary: Management of Osteoarthritis of the Knee (Nonarthroplasty), Third Edition. Journal of the American Academy of Orthopaedic Surgeons 30(9):p e721-e729, May 1, 2022. | DOI: 10.5435/JAAOS-D-21-01233 

Guest: Jillian Joseph, MPAS, PA-C
Music Credit: Matthew Bugos
Thoughts? Suggestions? Email us at FranklySpeaking@pri-med.com 
The views expressed in this podcast are those of Dr. Domino and his guests and do not necessarily reflect the views of Pri-Med.]]></itunes:summary>
        <itunes:author>Pri-Med</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>671</itunes:duration>
                        <itunes:episodeType>full</itunes:episodeType>
            </item>
    <item>
        <title>Can an ARB Help Prevent Migraine Attacks? - Frankly Speaking Ep 479</title>
        <itunes:title>Can an ARB Help Prevent Migraine Attacks? - Frankly Speaking Ep 479</itunes:title>
        <link>https://primedfranklyspeaking.podbean.com/e/can-an-arb-help-prevent-migraine-attacks-frankly-speaking-ep-479/</link>
                    <comments>https://primedfranklyspeaking.podbean.com/e/can-an-arb-help-prevent-migraine-attacks-frankly-speaking-ep-479/#comments</comments>        <pubDate>Mon, 06 Apr 2026 05:30:00 +0000</pubDate>
        <guid isPermaLink="false">primedfranklyspeaking.podbean.com/a53959c7-f046-3aa5-97a4-5d0a7c1fdb98</guid>
                                    <description><![CDATA[<p>Credits: 0.25 AMA PRA Category 1 Credit™
 
CME/CE Information and Claim Credit: <a href='https://www.pri-med.com/online-education/podcast/frankly-speaking-cme-479'>https://www.pri-med.com/online-education/podcast/frankly-speaking-cme-479</a></p>
<p>Overview: Listen in as we discuss how candesartan, an angiotensin receptor blocker (ARB), may offer a well-tolerated, cost-effective option for migraine attack prevention—even in normotensive patients. Learn to assess benefits, monitor for hypotension, and expand your preventive migraine toolkit with evidence-based insights that may improve adherence and access for patients struggling with traditional therapies.</p>
<p>Episode resource links:</p>
<ul>
<li>The Lancet. Neurology. 2025;24(10):817-827. doi:10.1016/S1474-4422(25)00269-8.</li>
<li>Cephalalgia : An International Journal of Headache. 2023;43(6):3331024231183166. doi:10.1177/03331024231183166.</li>
</ul>
<p>Guest: Robert A. Baldor MD, FAAFP
 
Music Credit: Matthew Bugos</p>
<p>Thoughts? Suggestions? Email us at <a href='mailto:FranklySpeaking@pri-med.com'>FranklySpeaking@pri-med.com</a> </p>
<p>The views expressed in this podcast are those of Dr. Domino and his guests and do not necessarily reflect the views of Pri-Med.</p>
]]></description>
                                                            <content:encoded><![CDATA[<p>Credits: 0.25 AMA PRA Category 1 Credit™<br>
 <br>
CME/CE Information and Claim Credit: <a href='https://www.pri-med.com/online-education/podcast/frankly-speaking-cme-479'>https://www.pri-med.com/online-education/podcast/frankly-speaking-cme-479</a></p>
<p>Overview: Listen in as we discuss how candesartan, an angiotensin receptor blocker (ARB), may offer a well-tolerated, cost-effective option for migraine attack prevention—even in normotensive patients. Learn to assess benefits, monitor for hypotension, and expand your preventive migraine toolkit with evidence-based insights that may improve adherence and access for patients struggling with traditional therapies.</p>
<p>Episode resource links:</p>
<ul>
<li>The Lancet. Neurology. 2025;24(10):817-827. doi:10.1016/S1474-4422(25)00269-8.</li>
<li>Cephalalgia : An International Journal of Headache. 2023;43(6):3331024231183166. doi:10.1177/03331024231183166.</li>
</ul>
<p>Guest: Robert A. Baldor MD, FAAFP<br>
 <br>
Music Credit: Matthew Bugos</p>
<p>Thoughts? Suggestions? Email us at <a href='mailto:FranklySpeaking@pri-med.com'>FranklySpeaking@pri-med.com</a> </p>
<p><em>The views expressed in this podcast are those of Dr. Domino and his guests and do not necessarily reflect the views of Pri-Med.</em></p>
]]></content:encoded>
                                    
        <enclosure url="https://mcdn.podbean.com/mf/web/znpdkhisdjxy7re5/frankly-speaking-479-arbs-migraineprproja9qb1.mp3" length="11582670" type="audio/mpeg"/>
                <itunes:summary><![CDATA[Credits: 0.25 AMA PRA Category 1 Credit™ CME/CE Information and Claim Credit: https://www.pri-med.com/online-education/podcast/frankly-speaking-cme-479
Overview: Listen in as we discuss how candesartan, an angiotensin receptor blocker (ARB), may offer a well-tolerated, cost-effective option for migraine attack prevention—even in normotensive patients. Learn to assess benefits, monitor for hypotension, and expand your preventive migraine toolkit with evidence-based insights that may improve adherence and access for patients struggling with traditional therapies.
Episode resource links:

The Lancet. Neurology. 2025;24(10):817-827. doi:10.1016/S1474-4422(25)00269-8.
Cephalalgia : An International Journal of Headache. 2023;43(6):3331024231183166. doi:10.1177/03331024231183166.

Guest: Robert A. Baldor MD, FAAFP Music Credit: Matthew Bugos
Thoughts? Suggestions? Email us at FranklySpeaking@pri-med.com 
The views expressed in this podcast are those of Dr. Domino and his guests and do not necessarily reflect the views of Pri-Med.]]></itunes:summary>
        <itunes:author>Pri-Med</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>722</itunes:duration>
                        <itunes:episodeType>full</itunes:episodeType>
            </item>
    <item>
        <title>GLP-1 RAs and Hair Loss—Evaluating and Managing a Potential Side Effect - Frankly Speaking Ep 478</title>
        <itunes:title>GLP-1 RAs and Hair Loss—Evaluating and Managing a Potential Side Effect - Frankly Speaking Ep 478</itunes:title>
        <link>https://primedfranklyspeaking.podbean.com/e/glp-1-ras-and-hair-loss%e2%80%94evaluating-and-managing-a-potential-side-effect-frankly-speaking-ep-478/</link>
                    <comments>https://primedfranklyspeaking.podbean.com/e/glp-1-ras-and-hair-loss%e2%80%94evaluating-and-managing-a-potential-side-effect-frankly-speaking-ep-478/#comments</comments>        <pubDate>Mon, 30 Mar 2026 05:30:00 +0000</pubDate>
        <guid isPermaLink="false">primedfranklyspeaking.podbean.com/a0c49230-1d22-35b7-98ba-c34dab2be481</guid>
                                    <description><![CDATA[<p>Credits: 0.25 AMA PRA Category 1 Credit™
 
CME/CE Information and Claim Credit: <a href='https://www.pri-med.com/online-education/podcast/frankly-speaking-cme-478'>https://www.pri-med.com/online-education/podcast/frankly-speaking-cme-478</a></p>
<p>Overview: As glucagon-like peptide-1 receptor agonists (GLP-1 RAs) become increasingly common in managing obesity, it is important for clinicians to recognize lesser-known adverse effects. This episode highlights the potential link between GLP-1 RAs and alopecia, equipping you to better evaluate, counsel, and manage patients reporting hair loss.</p>
<p>Episode resource links:</p>
<ul>
<li>Alsuwailem OA, Alanazi R, Almutairi HM, Asiree RH, Almutairi W, Almutairi TM, Zamandar A, Alkhames S. Hair Loss Associated With Glucagon-Like Peptide-1 (GLP-1) Receptor Agonist Use: A Systematic Review. Cureus. 2025 Sep 16;17(9):e92454. </li>
</ul>
<p>Guest: Alan M. Ehrlich, MD, FAAFP
 
Music Credit: Matthew Bugos</p>
<p>Thoughts? Suggestions? Email us at <a href='mailto:FranklySpeaking@pri-med.com'>FranklySpeaking@pri-med.com</a> </p>
<p>The views expressed in this podcast are those of Dr. Domino and his guests and do not necessarily reflect the views of Pri-Med.</p>
]]></description>
                                                            <content:encoded><![CDATA[<p>Credits: 0.25 AMA PRA Category 1 Credit™<br>
 <br>
CME/CE Information and Claim Credit: <a href='https://www.pri-med.com/online-education/podcast/frankly-speaking-cme-478'>https://www.pri-med.com/online-education/podcast/frankly-speaking-cme-478</a></p>
<p>Overview: As glucagon-like peptide-1 receptor agonists (GLP-1 RAs) become increasingly common in managing obesity, it is important for clinicians to recognize lesser-known adverse effects. This episode highlights the potential link between GLP-1 RAs and alopecia, equipping you to better evaluate, counsel, and manage patients reporting hair loss.</p>
<p>Episode resource links:</p>
<ul>
<li>Alsuwailem OA, Alanazi R, Almutairi HM, Asiree RH, Almutairi W, Almutairi TM, Zamandar A, Alkhames S. Hair Loss Associated With Glucagon-Like Peptide-1 (GLP-1) Receptor Agonist Use: A Systematic Review. Cureus. 2025 Sep 16;17(9):e92454. </li>
</ul>
<p>Guest: Alan M. Ehrlich, MD, FAAFP<br>
 <br>
Music Credit: Matthew Bugos</p>
<p>Thoughts? Suggestions? Email us at <a href='mailto:FranklySpeaking@pri-med.com'>FranklySpeaking@pri-med.com</a> </p>
<p><em>The views expressed in this podcast are those of Dr. Domino and his guests and do not necessarily reflect the views of Pri-Med.</em></p>
]]></content:encoded>
                                    
        <enclosure url="https://mcdn.podbean.com/mf/web/qq8nb6kiqp329xex/frankly-speaking-478-hair-loss-glp1prprojafr9w.mp3" length="9185833" type="audio/mpeg"/>
                <itunes:summary><![CDATA[Credits: 0.25 AMA PRA Category 1 Credit™ CME/CE Information and Claim Credit: https://www.pri-med.com/online-education/podcast/frankly-speaking-cme-478
Overview: As glucagon-like peptide-1 receptor agonists (GLP-1 RAs) become increasingly common in managing obesity, it is important for clinicians to recognize lesser-known adverse effects. This episode highlights the potential link between GLP-1 RAs and alopecia, equipping you to better evaluate, counsel, and manage patients reporting hair loss.
Episode resource links:

Alsuwailem OA, Alanazi R, Almutairi HM, Asiree RH, Almutairi W, Almutairi TM, Zamandar A, Alkhames S. Hair Loss Associated With Glucagon-Like Peptide-1 (GLP-1) Receptor Agonist Use: A Systematic Review. Cureus. 2025 Sep 16;17(9):e92454. 

Guest: Alan M. Ehrlich, MD, FAAFP Music Credit: Matthew Bugos
Thoughts? Suggestions? Email us at FranklySpeaking@pri-med.com 
The views expressed in this podcast are those of Dr. Domino and his guests and do not necessarily reflect the views of Pri-Med.]]></itunes:summary>
        <itunes:author>Pri-Med</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>572</itunes:duration>
                        <itunes:episodeType>full</itunes:episodeType>
            </item>
    <item>
        <title>AI Scribing in Practice: Balancing Patient Considerations and Clinician Wellbeing - Frankly Speaking Ep 477</title>
        <itunes:title>AI Scribing in Practice: Balancing Patient Considerations and Clinician Wellbeing - Frankly Speaking Ep 477</itunes:title>
        <link>https://primedfranklyspeaking.podbean.com/e/ai-scribing-in-practice-balancing-patient-considerations-and-clinician-wellbeing-frankly-speaking-ep-477/</link>
                    <comments>https://primedfranklyspeaking.podbean.com/e/ai-scribing-in-practice-balancing-patient-considerations-and-clinician-wellbeing-frankly-speaking-ep-477/#comments</comments>        <pubDate>Mon, 23 Mar 2026 05:30:00 +0000</pubDate>
        <guid isPermaLink="false">primedfranklyspeaking.podbean.com/32691939-ac5c-30fc-8e85-44f56ebb195c</guid>
                                    <description><![CDATA[<p>Credits: 0.25 AMA PRA Category 1 Credit™
 
CME/CE Information and Claim Credit: <a href='https://www.pri-med.com/online-education/podcast/frankly-speaking-cme-477'>https://www.pri-med.com/online-education/podcast/frankly-speaking-cme-477</a></p>
<p>Overview: With rising administrative demands, many clinicians are considering artificial intelligence (AI) scribes—this episode unpacks what you need to know before incorporating this technology. We explore key benefits like reduced burnout and improved workflow, along with ethical, legal, and safety considerations to help you make informed decisions about integrating AI scribing into your practice.</p>
<p>Episode resource links:</p>
<ul>
<li>Cohen IG, Ritzman J, Cahill RF. Ambient Listening—Legal and Ethical Issues. JAMA Netw Open.2025;8(2):e2460642. doi:10.1001/jamanetworkopen.2024.60642</li>
<li>Olson KD, Meeker D, Troup M, et al. Use of Ambient AI Scribes to Reduce Administrative Burden and Professional Burnout. JAMA Netw Open. 2025;8(10):e2534976. doi:10.1001/jamanetworkopen.2025.34976</li>
<li><a href='https://www.healio.com/news/dermatology/20251210/ai-scribes-hold-transformative-potential-for-improving-physician-burden-patient-care'>https://www.healio.com/news/dermatology/20251210/ai-scribes-hold-transformative-potential-for-improving-physician-burden-patient-care</a></li>
</ul>
<p>Guest: Jillian Joseph, MPAS, PA-C
 
Music Credit: Matthew Bugos</p>
<p>Thoughts? Suggestions? Email us at <a href='mailto:FranklySpeaking@pri-med.com'>FranklySpeaking@pri-med.com</a> </p>
<p>The views expressed in this podcast are those of Dr. Domino and his guests and do not necessarily reflect the views of Pri-Med.</p>
]]></description>
                                                            <content:encoded><![CDATA[<p>Credits: 0.25 AMA PRA Category 1 Credit™<br>
 <br>
CME/CE Information and Claim Credit: <a href='https://www.pri-med.com/online-education/podcast/frankly-speaking-cme-477'>https://www.pri-med.com/online-education/podcast/frankly-speaking-cme-477</a></p>
<p>Overview: With rising administrative demands, many clinicians are considering artificial intelligence (AI) scribes—this episode unpacks what you need to know before incorporating this technology. We explore key benefits like reduced burnout and improved workflow, along with ethical, legal, and safety considerations to help you make informed decisions about integrating AI scribing into your practice.</p>
<p>Episode resource links:</p>
<ul>
<li>Cohen IG, Ritzman J, Cahill RF. Ambient Listening—Legal and Ethical Issues. JAMA Netw Open.2025;8(2):e2460642. doi:10.1001/jamanetworkopen.2024.60642</li>
<li>Olson KD, Meeker D, Troup M, et al. Use of Ambient AI Scribes to Reduce Administrative Burden and Professional Burnout. JAMA Netw Open. 2025;8(10):e2534976. doi:10.1001/jamanetworkopen.2025.34976</li>
<li><a href='https://www.healio.com/news/dermatology/20251210/ai-scribes-hold-transformative-potential-for-improving-physician-burden-patient-care'>https://www.healio.com/news/dermatology/20251210/ai-scribes-hold-transformative-potential-for-improving-physician-burden-patient-care</a></li>
</ul>
<p>Guest: Jillian Joseph, MPAS, PA-C<br>
 <br>
Music Credit: Matthew Bugos</p>
<p>Thoughts? Suggestions? Email us at <a href='mailto:FranklySpeaking@pri-med.com'>FranklySpeaking@pri-med.com</a> </p>
<p><em>The views expressed in this podcast are those of Dr. Domino and his guests and do not necessarily reflect the views of Pri-Med.</em></p>
]]></content:encoded>
                                    
        <enclosure url="https://mcdn.podbean.com/mf/web/yx7pkjuinhyma6cz/frankly-speaking-477-scribes.mp3" length="13206919" type="audio/mpeg"/>
                <itunes:summary><![CDATA[Credits: 0.25 AMA PRA Category 1 Credit™ CME/CE Information and Claim Credit: https://www.pri-med.com/online-education/podcast/frankly-speaking-cme-477
Overview: With rising administrative demands, many clinicians are considering artificial intelligence (AI) scribes—this episode unpacks what you need to know before incorporating this technology. We explore key benefits like reduced burnout and improved workflow, along with ethical, legal, and safety considerations to help you make informed decisions about integrating AI scribing into your practice.
Episode resource links:

Cohen IG, Ritzman J, Cahill RF. Ambient Listening—Legal and Ethical Issues. JAMA Netw Open.2025;8(2):e2460642. doi:10.1001/jamanetworkopen.2024.60642
Olson KD, Meeker D, Troup M, et al. Use of Ambient AI Scribes to Reduce Administrative Burden and Professional Burnout. JAMA Netw Open. 2025;8(10):e2534976. doi:10.1001/jamanetworkopen.2025.34976
https://www.healio.com/news/dermatology/20251210/ai-scribes-hold-transformative-potential-for-improving-physician-burden-patient-care

Guest: Jillian Joseph, MPAS, PA-C Music Credit: Matthew Bugos
Thoughts? Suggestions? Email us at FranklySpeaking@pri-med.com 
The views expressed in this podcast are those of Dr. Domino and his guests and do not necessarily reflect the views of Pri-Med.]]></itunes:summary>
        <itunes:author>Pri-Med</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>823</itunes:duration>
                        <itunes:episodeType>full</itunes:episodeType>
            </item>
    <item>
        <title>Melatonin: Is a “Natural” Sleep Aid as Harmless as We Think? - Frankly Speaking Ep 476</title>
        <itunes:title>Melatonin: Is a “Natural” Sleep Aid as Harmless as We Think? - Frankly Speaking Ep 476</itunes:title>
        <link>https://primedfranklyspeaking.podbean.com/e/melatonin-is-a-natural-sleep-aid-as-harmless-as-we-think-frankly-speaking-ep-476/</link>
                    <comments>https://primedfranklyspeaking.podbean.com/e/melatonin-is-a-natural-sleep-aid-as-harmless-as-we-think-frankly-speaking-ep-476/#comments</comments>        <pubDate>Mon, 16 Mar 2026 05:30:00 +0000</pubDate>
        <guid isPermaLink="false">primedfranklyspeaking.podbean.com/82e92e2d-9dcf-3daa-aa43-5cb467e53b2f</guid>
                                    <description><![CDATA[<p>Credits: 0.25 AMA PRA Category 1 Credit™
 
CME/CE Information and Claim Credit: <a href='https://www.pri-med.com/online-education/podcast/frankly-speaking-cme-476'>https://www.pri-med.com/online-education/podcast/frankly-speaking-cme-476</a></p>
<p>Overview: Melatonin is widely used and often perceived as a safe, natural solution for insomnia. However, a new preliminary study raises concerns about long-term melatonin use and increased risk of heart failure, hospitalization, and all-cause mortality in patients with chronic insomnia. In this episode, we review the findings, discuss how they fit with existing evidence, explore limitations, and offer practical guidance for clinicians counseling patients about sleep supplements.</p>
<p>Episode resource links:</p>
<ul>
<li>American Heart Association Scientific Sessions 2025 – Abstract 4371606
AHA Scientific Statement: Multidimensional Sleep Health and Cardiometabolic Risk (Circulation, 2025)</li>
<li>Li et al. Lancet Diabetes &amp; Endocrinology, 2024</li>
<li>American Academy of Sleep Medicine Clinical Practice Guidelines</li>
<li>AHA Life’s Essential 8 &amp; Sleep Health Resources

</li>
</ul>
<p>Guest: Mariyan Montaque, DNP, FNP-BC
 
Music Credit: Matthew Bugos</p>
<p>Thoughts? Suggestions? Email us at <a href='mailto:FranklySpeaking@pri-med.com'>FranklySpeaking@pri-med.com</a> </p>
<p>The views expressed in this podcast are those of Dr. Domino and his guests and do not necessarily reflect the views of Pri-Med.</p>
]]></description>
                                                            <content:encoded><![CDATA[<p>Credits: 0.25 AMA PRA Category 1 Credit™<br>
 <br>
CME/CE Information and Claim Credit: <a href='https://www.pri-med.com/online-education/podcast/frankly-speaking-cme-476'>https://www.pri-med.com/online-education/podcast/frankly-speaking-cme-476</a></p>
<p>Overview: Melatonin is widely used and often perceived as a safe, natural solution for insomnia. However, a new preliminary study raises concerns about long-term melatonin use and increased risk of heart failure, hospitalization, and all-cause mortality in patients with chronic insomnia. In this episode, we review the findings, discuss how they fit with existing evidence, explore limitations, and offer practical guidance for clinicians counseling patients about sleep supplements.</p>
<p>Episode resource links:</p>
<ul>
<li>American Heart Association Scientific Sessions 2025 – Abstract 4371606<br>
AHA Scientific Statement: Multidimensional Sleep Health and Cardiometabolic Risk (Circulation, 2025)</li>
<li>Li et al. Lancet Diabetes &amp; Endocrinology, 2024</li>
<li>American Academy of Sleep Medicine Clinical Practice Guidelines</li>
<li>AHA Life’s Essential 8 &amp; Sleep Health Resources<br>
<br>
</li>
</ul>
<p>Guest: Mariyan Montaque, DNP, FNP-BC<br>
 <br>
Music Credit: Matthew Bugos</p>
<p>Thoughts? Suggestions? Email us at <a href='mailto:FranklySpeaking@pri-med.com'>FranklySpeaking@pri-med.com</a> </p>
<p><em>The views expressed in this podcast are those of Dr. Domino and his guests and do not necessarily reflect the views of Pri-Med.</em></p>
]]></content:encoded>
                                    
        <enclosure url="https://mcdn.podbean.com/mf/web/m67wmkjby5rjb6ii/frankly-speaking-476-melatonin-safe.mp3" length="10181079" type="audio/mpeg"/>
                <itunes:summary><![CDATA[Credits: 0.25 AMA PRA Category 1 Credit™ CME/CE Information and Claim Credit: https://www.pri-med.com/online-education/podcast/frankly-speaking-cme-476
Overview: Melatonin is widely used and often perceived as a safe, natural solution for insomnia. However, a new preliminary study raises concerns about long-term melatonin use and increased risk of heart failure, hospitalization, and all-cause mortality in patients with chronic insomnia. In this episode, we review the findings, discuss how they fit with existing evidence, explore limitations, and offer practical guidance for clinicians counseling patients about sleep supplements.
Episode resource links:

American Heart Association Scientific Sessions 2025 – Abstract 4371606AHA Scientific Statement: Multidimensional Sleep Health and Cardiometabolic Risk (Circulation, 2025)
Li et al. Lancet Diabetes &amp; Endocrinology, 2024
American Academy of Sleep Medicine Clinical Practice Guidelines
AHA Life’s Essential 8 &amp; Sleep Health Resources

Guest: Mariyan Montaque, DNP, FNP-BC Music Credit: Matthew Bugos
Thoughts? Suggestions? Email us at FranklySpeaking@pri-med.com 
The views expressed in this podcast are those of Dr. Domino and his guests and do not necessarily reflect the views of Pri-Med.]]></itunes:summary>
        <itunes:author>Pri-Med</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>634</itunes:duration>
                        <itunes:episodeType>full</itunes:episodeType>
            </item>
    <item>
        <title>New Complaint? Wait! Could It Be a Medication Side Effect? - Frankly Speaking Ep 475</title>
        <itunes:title>New Complaint? Wait! Could It Be a Medication Side Effect? - Frankly Speaking Ep 475</itunes:title>
        <link>https://primedfranklyspeaking.podbean.com/e/new-complaint-wait-could-it-be-a-medication-side-effect-frankly-speaking-ep-475/</link>
                    <comments>https://primedfranklyspeaking.podbean.com/e/new-complaint-wait-could-it-be-a-medication-side-effect-frankly-speaking-ep-475/#comments</comments>        <pubDate>Mon, 09 Mar 2026 05:30:00 +0000</pubDate>
        <guid isPermaLink="false">primedfranklyspeaking.podbean.com/6c133157-53e9-34b0-9ce6-a70fc84db5f9</guid>
                                    <description><![CDATA[<p>Credits: 0.25 AMA PRA Category 1 Credit™
 
CME/CE Information and Claim Credit: <a href='https://www.pri-med.com/online-education/podcast/frankly-speaking-cme-475'>https://www.pri-med.com/online-education/podcast/frankly-speaking-cme-475</a></p>
<p>Overview: A prescribing cascade occurs when adverse effects of a medication are mistaken for a new condition and treated with additional drugs. Older adults experiencing polypharmacy are most at risk. The impact of prescribing cascades can be substantial, leading to falls, organ injury, unnecessary imaging and tests, and more. Join us as we explore how to recognize and prevent these harmful cascades in your patients.</p>
<p>Episode resource links:</p>
<ul>
<li>
<p>Adrien  O, Mohammad  AK, Hugtenburg  JG,  et al.  Prescribing cascades with recommendations to prevent or reverse them: a systematic review.   Drugs Aging. 2023;40(12):1085-1100. doi:10.1007/s40266-023-01072-yPubMedGoogle ScholarCrossref</p>
<p> </p>
</li>
<li>
<p>Brath  H, Mehta  N, Savage  RD,  et al.  What is known about preventing, detecting, and reversing prescribing cascades: a scoping review.   J Am Geriatr Soc. 2018;66(11):2079-2085. doi:10.1111/jgs.15543PubMedGoogle ScholarCrossref</p>
<p> </p>
</li>
<li>
<p>Daunt R, McGettigan S, Kelly L, Curtin D, O'Mahony D. Detection of Potential Prescribing Cascades in Multimorbid Older Patients Hospitalised with Acute Illness-An Observational Prospective Prevalence Study. Drugs Aging. 2025;42(6):535-546. doi:10.1007/s40266-025-01201-9</p>
<p> </p>
</li>
<li>
<p>Growdon ME, Tjota N, Campbell R, et al. Decision-Making and Downstream Outcomes of the Gabapentinoid-Diuretic Prescribing Cascade. JAMA Netw Open. 2025;8(12):e2545274. doi:10.1001/jamanetworkopen.2025.45274</p>
<p> </p>
</li>
<li>
<p>McCarthy  LM, Savage  R, Dalton  K,  et al.  ThinkCascades: a tool for identifying clinically important prescribing cascades affecting older people.   Drugs Aging. 2022;39(10):829-840. doi:10.1007/s40266-022-00964-9PubMedGoogle ScholarCrossref</p>
<p> </p>
</li>
<li>
<p>O’Mahony, D., Cherubini, A., Guiteras, A.R. et al. STOPP/START criteria for potentially inappropriate prescribing in older people: version 3. Eur Geriatr Med 14, 625–632 (2023). <a href='https://doi.org/10.1007/s41999-023-00777-y'>https://doi.org/10.1007/s41999-023-00777-y</a></p>
<p> </p>
</li>
<li>
<p>Rochon, P.A., O’Mahony, D., Cherubini, A. et al. International expert panel’s potentially inappropriate prescribing cascades (PIPC) list. Eur Geriatr Med 16, 1573–1584 (2025). <a href='https://doi.org/10.1007/s41999-025-01215-x'>https://doi.org/10.1007/s41999-025-01215-x</a></p>
<p> </p>
</li>
<li>
<p>Young EH, Pan S, Yap AG, Reveles KR, Bhakta K. Polypharmacy prevalence in older adults seen in United States physician offices from 2009 to 2016. PLoS One. 2021;16(8):e0255642. Published 2021 Aug 3. doi:10.1371/journal.pone.0255642</p>
</li>
</ul>
<p>Guest: Susan Feeney, DNP, FNP-BC, NP-C
 
Music Credit: Matthew Bugos</p>
<p>Thoughts? Suggestions? Email us at <a href='mailto:FranklySpeaking@pri-med.com'>FranklySpeaking@pri-med.com</a> </p>
<p>The views expressed in this podcast are those of Dr. Domino and his guests and do not necessarily reflect the views of Pri-Med.</p>
]]></description>
                                                            <content:encoded><![CDATA[<p>Credits: 0.25 AMA PRA Category 1 Credit™<br>
 <br>
CME/CE Information and Claim Credit: <a href='https://www.pri-med.com/online-education/podcast/frankly-speaking-cme-475'>https://www.pri-med.com/online-education/podcast/frankly-speaking-cme-475</a></p>
<p>Overview: A prescribing cascade occurs when adverse effects of a medication are mistaken for a new condition and treated with additional drugs. Older adults experiencing polypharmacy are most at risk. The impact of prescribing cascades can be substantial, leading to falls, organ injury, unnecessary imaging and tests, and more. Join us as we explore how to recognize and prevent these harmful cascades in your patients.</p>
<p>Episode resource links:</p>
<ul>
<li>
<p>Adrien  O, Mohammad  AK, Hugtenburg  JG,  et al.  Prescribing cascades with recommendations to prevent or reverse them: a systematic review.   Drugs Aging. 2023;40(12):1085-1100. doi:10.1007/s40266-023-01072-yPubMedGoogle ScholarCrossref</p>
<p> </p>
</li>
<li>
<p>Brath  H, Mehta  N, Savage  RD,  et al.  What is known about preventing, detecting, and reversing prescribing cascades: a scoping review.   J Am Geriatr Soc. 2018;66(11):2079-2085. doi:10.1111/jgs.15543PubMedGoogle ScholarCrossref</p>
<p> </p>
</li>
<li>
<p>Daunt R, McGettigan S, Kelly L, Curtin D, O'Mahony D. Detection of Potential Prescribing Cascades in Multimorbid Older Patients Hospitalised with Acute Illness-An Observational Prospective Prevalence Study. Drugs Aging. 2025;42(6):535-546. doi:10.1007/s40266-025-01201-9</p>
<p> </p>
</li>
<li>
<p>Growdon ME, Tjota N, Campbell R, et al. Decision-Making and Downstream Outcomes of the Gabapentinoid-Diuretic Prescribing Cascade. JAMA Netw Open. 2025;8(12):e2545274. doi:10.1001/jamanetworkopen.2025.45274</p>
<p> </p>
</li>
<li>
<p>McCarthy  LM, Savage  R, Dalton  K,  et al.  ThinkCascades: a tool for identifying clinically important prescribing cascades affecting older people.   Drugs Aging. 2022;39(10):829-840. doi:10.1007/s40266-022-00964-9PubMedGoogle ScholarCrossref</p>
<p> </p>
</li>
<li>
<p>O’Mahony, D., Cherubini, A., Guiteras, A.R. et al. STOPP/START criteria for potentially inappropriate prescribing in older people: version 3. Eur Geriatr Med 14, 625–632 (2023). <a href='https://doi.org/10.1007/s41999-023-00777-y'>https://doi.org/10.1007/s41999-023-00777-y</a></p>
<p> </p>
</li>
<li>
<p>Rochon, P.A., O’Mahony, D., Cherubini, A. et al. International expert panel’s potentially inappropriate prescribing cascades (PIPC) list. Eur Geriatr Med 16, 1573–1584 (2025). <a href='https://doi.org/10.1007/s41999-025-01215-x'>https://doi.org/10.1007/s41999-025-01215-x</a></p>
<p> </p>
</li>
<li>
<p>Young EH, Pan S, Yap AG, Reveles KR, Bhakta K. Polypharmacy prevalence in older adults seen in United States physician offices from 2009 to 2016. PLoS One. 2021;16(8):e0255642. Published 2021 Aug 3. doi:10.1371/journal.pone.0255642</p>
</li>
</ul>
<p>Guest: Susan Feeney, DNP, FNP-BC, NP-C<br>
 <br>
Music Credit: Matthew Bugos</p>
<p>Thoughts? Suggestions? Email us at <a href='mailto:FranklySpeaking@pri-med.com'>FranklySpeaking@pri-med.com</a> </p>
<p><em>The views expressed in this podcast are those of Dr. Domino and his guests and do not necessarily reflect the views of Pri-Med.</em></p>
]]></content:encoded>
                                    
        <enclosure url="https://mcdn.podbean.com/mf/web/jg3ruik9t6vdycuk/frankly-speaking-475-prescribing-cascade_1prprojbqrcw.mp3" length="15997903" type="audio/mpeg"/>
                <itunes:summary><![CDATA[Credits: 0.25 AMA PRA Category 1 Credit™ CME/CE Information and Claim Credit: https://www.pri-med.com/online-education/podcast/frankly-speaking-cme-475
Overview: A prescribing cascade occurs when adverse effects of a medication are mistaken for a new condition and treated with additional drugs. Older adults experiencing polypharmacy are most at risk. The impact of prescribing cascades can be substantial, leading to falls, organ injury, unnecessary imaging and tests, and more. Join us as we explore how to recognize and prevent these harmful cascades in your patients.
Episode resource links:


Adrien  O, Mohammad  AK, Hugtenburg  JG,  et al.  Prescribing cascades with recommendations to prevent or reverse them: a systematic review.   Drugs Aging. 2023;40(12):1085-1100. doi:10.1007/s40266-023-01072-yPubMedGoogle ScholarCrossref
 


Brath  H, Mehta  N, Savage  RD,  et al.  What is known about preventing, detecting, and reversing prescribing cascades: a scoping review.   J Am Geriatr Soc. 2018;66(11):2079-2085. doi:10.1111/jgs.15543PubMedGoogle ScholarCrossref
 


Daunt R, McGettigan S, Kelly L, Curtin D, O'Mahony D. Detection of Potential Prescribing Cascades in Multimorbid Older Patients Hospitalised with Acute Illness-An Observational Prospective Prevalence Study. Drugs Aging. 2025;42(6):535-546. doi:10.1007/s40266-025-01201-9
 


Growdon ME, Tjota N, Campbell R, et al. Decision-Making and Downstream Outcomes of the Gabapentinoid-Diuretic Prescribing Cascade. JAMA Netw Open. 2025;8(12):e2545274. doi:10.1001/jamanetworkopen.2025.45274
 


McCarthy  LM, Savage  R, Dalton  K,  et al.  ThinkCascades: a tool for identifying clinically important prescribing cascades affecting older people.   Drugs Aging. 2022;39(10):829-840. doi:10.1007/s40266-022-00964-9PubMedGoogle ScholarCrossref
 


O’Mahony, D., Cherubini, A., Guiteras, A.R. et al. STOPP/START criteria for potentially inappropriate prescribing in older people: version 3. Eur Geriatr Med 14, 625–632 (2023). https://doi.org/10.1007/s41999-023-00777-y
 


Rochon, P.A., O’Mahony, D., Cherubini, A. et al. International expert panel’s potentially inappropriate prescribing cascades (PIPC) list. Eur Geriatr Med 16, 1573–1584 (2025). https://doi.org/10.1007/s41999-025-01215-x
 


Young EH, Pan S, Yap AG, Reveles KR, Bhakta K. Polypharmacy prevalence in older adults seen in United States physician offices from 2009 to 2016. PLoS One. 2021;16(8):e0255642. Published 2021 Aug 3. doi:10.1371/journal.pone.0255642


Guest: Susan Feeney, DNP, FNP-BC, NP-C Music Credit: Matthew Bugos
Thoughts? Suggestions? Email us at FranklySpeaking@pri-med.com 
The views expressed in this podcast are those of Dr. Domino and his guests and do not necessarily reflect the views of Pri-Med.]]></itunes:summary>
        <itunes:author>Pri-Med</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>998</itunes:duration>
                        <itunes:episodeType>full</itunes:episodeType>
            </item>
    <item>
        <title>Does Treating Depression Worsen Dementia? - Frankly Speaking Ep 474</title>
        <itunes:title>Does Treating Depression Worsen Dementia? - Frankly Speaking Ep 474</itunes:title>
        <link>https://primedfranklyspeaking.podbean.com/e/does-treating-depression-worsen-dementia-frankly-speaking-ep-474/</link>
                    <comments>https://primedfranklyspeaking.podbean.com/e/does-treating-depression-worsen-dementia-frankly-speaking-ep-474/#comments</comments>        <pubDate>Mon, 02 Mar 2026 05:30:00 +0000</pubDate>
        <guid isPermaLink="false">primedfranklyspeaking.podbean.com/c6cab545-7fe6-3145-9dc1-82d099882612</guid>
                                    <description><![CDATA[<p>Credits: 0.25 AMA PRA Category 1 Credit™
 
CME/CE Information and Claim Credit: <a href='https://www.pri-med.com/online-education/podcast/frankly-speaking-cme-474'>https://www.pri-med.com/online-education/podcast/frankly-speaking-cme-474</a></p>
<p>Overview: Depression affects many people with dementia, but some evidence suggests certain antidepressants may accelerate cognitive decline. This episode explores the potential risks of antidepressants in people with dementia, which medications require careful consideration, and how to make informed prescribing decisions that optimize patient outcomes while minimizing potential cognitive harm.</p>
<p>Episode resource links:</p>
<ul>
<li>Mo M, Abzhandadze T, Hoang MT, et al. Antidepressant use and cognitive decline in patients with dementia: a national cohort study. BMC Med. 2025;23(1):82. </li>
</ul>
<p>Guest: Alan M. Ehrlich, MD, FAAFP</p>
<p>Music Credit: Matthew Bugos</p>
<p>Thoughts? Suggestions? Email us at <a href='mailto:FranklySpeaking@pri-med.com'>FranklySpeaking@pri-med.com</a> </p>
<p>The views expressed in this podcast are those of Dr. Domino and his guests and do not necessarily reflect the views of Pri-Med.</p>
]]></description>
                                                            <content:encoded><![CDATA[<p>Credits: 0.25 AMA PRA Category 1 Credit™<br>
 <br>
CME/CE Information and Claim Credit: <a href='https://www.pri-med.com/online-education/podcast/frankly-speaking-cme-474'>https://www.pri-med.com/online-education/podcast/frankly-speaking-cme-474</a></p>
<p>Overview: Depression affects many people with dementia, but some evidence suggests certain antidepressants may accelerate cognitive decline. This episode explores the potential risks of antidepressants in people with dementia, which medications require careful consideration, and how to make informed prescribing decisions that optimize patient outcomes while minimizing potential cognitive harm.</p>
<p>Episode resource links:</p>
<ul>
<li>Mo M, Abzhandadze T, Hoang MT, et al. Antidepressant use and cognitive decline in patients with dementia: a national cohort study. BMC Med. 2025;23(1):82. </li>
</ul>
<p>Guest: Alan M. Ehrlich, MD, FAAFP</p>
<p>Music Credit: Matthew Bugos</p>
<p>Thoughts? Suggestions? Email us at <a href='mailto:FranklySpeaking@pri-med.com'>FranklySpeaking@pri-med.com</a> </p>
<p><em>The views expressed in this podcast are those of Dr. Domino and his guests and do not necessarily reflect the views of Pri-Med.</em></p>
]]></content:encoded>
                                    
        <enclosure url="https://mcdn.podbean.com/mf/web/ue6gxm4zumvb6itf/frankly-speaking-474-depression-dementia.mp3" length="9324764" type="audio/mpeg"/>
                <itunes:summary><![CDATA[Credits: 0.25 AMA PRA Category 1 Credit™ CME/CE Information and Claim Credit: https://www.pri-med.com/online-education/podcast/frankly-speaking-cme-474
Overview: Depression affects many people with dementia, but some evidence suggests certain antidepressants may accelerate cognitive decline. This episode explores the potential risks of antidepressants in people with dementia, which medications require careful consideration, and how to make informed prescribing decisions that optimize patient outcomes while minimizing potential cognitive harm.
Episode resource links:

Mo M, Abzhandadze T, Hoang MT, et al. Antidepressant use and cognitive decline in patients with dementia: a national cohort study. BMC Med. 2025;23(1):82. 

Guest: Alan M. Ehrlich, MD, FAAFP
Music Credit: Matthew Bugos
Thoughts? Suggestions? Email us at FranklySpeaking@pri-med.com 
The views expressed in this podcast are those of Dr. Domino and his guests and do not necessarily reflect the views of Pri-Med.]]></itunes:summary>
        <itunes:author>Pri-Med</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>581</itunes:duration>
                        <itunes:episodeType>full</itunes:episodeType>
            </item>
    <item>
        <title>Does PSA Testing for Prostate Cancer Save Lives? - Frankly Speaking Ep 473</title>
        <itunes:title>Does PSA Testing for Prostate Cancer Save Lives? - Frankly Speaking Ep 473</itunes:title>
        <link>https://primedfranklyspeaking.podbean.com/e/does-psa-testing-for-prostate-cancer-save-lives-frankly-speaking-ep-473/</link>
                    <comments>https://primedfranklyspeaking.podbean.com/e/does-psa-testing-for-prostate-cancer-save-lives-frankly-speaking-ep-473/#comments</comments>        <pubDate>Mon, 23 Feb 2026 05:30:00 +0000</pubDate>
        <guid isPermaLink="false">primedfranklyspeaking.podbean.com/0749bbf3-cacb-3ec1-a4c4-299ec0d0a608</guid>
                                    <description><![CDATA[<p>Credits: 0.25 AMA PRA Category 1 Credit™
 
CME/CE Information and Claim Credit: <a href='https://www.pri-med.com/online-education/podcast/frankly-speaking-cme-473'>https://www.pri-med.com/online-education/podcast/frankly-speaking-cme-473</a></p>
<p>Overview: Join us as we review long-term outcomes from a recently published trial on prostate-specific antigen (PSA) testing and prostate cancer mortality. Learn how updated evidence informs shared decision-making and balances early detection with potential harms. Equip yourself to guide patients through nuanced discussions on PSA testing’s limitations, mortality data, and meaningful clinical impact.</p>
<p>Episode resource links:</p>
<ul>
<li>N Engl J Med 2025;393:1669-80. DOI: 10.1056/NEJMoa2503223</li>
<li><a href='https://www.uspreventiveservicestaskforce.org/uspstf/recommendation/prostate-cancer-screening'>Recommendation: Prostate Cancer: Screening | United States Preventive Services Taskforce</a></li>
</ul>
<p>Guest: Robert A. Baldor MD, FAAFP</p>
<p>Music Credit: Matthew Bugos</p>
<p>Thoughts? Suggestions? Email us at <a href='mailto:FranklySpeaking@pri-med.com'>FranklySpeaking@pri-med.com</a> </p>
<p>The views expressed in this podcast are those of Dr. Domino and his guests and do not necessarily reflect the views of Pri-Med.</p>
]]></description>
                                                            <content:encoded><![CDATA[<p>Credits: 0.25 AMA PRA Category 1 Credit™<br>
 <br>
CME/CE Information and Claim Credit: <a href='https://www.pri-med.com/online-education/podcast/frankly-speaking-cme-473'>https://www.pri-med.com/online-education/podcast/frankly-speaking-cme-473</a></p>
<p>Overview: Join us as we review long-term outcomes from a recently published trial on prostate-specific antigen (PSA) testing and prostate cancer mortality. Learn how updated evidence informs shared decision-making and balances early detection with potential harms. Equip yourself to guide patients through nuanced discussions on PSA testing’s limitations, mortality data, and meaningful clinical impact.</p>
<p>Episode resource links:</p>
<ul>
<li>N Engl J Med 2025;393:1669-80. DOI: 10.1056/NEJMoa2503223</li>
<li><a href='https://www.uspreventiveservicestaskforce.org/uspstf/recommendation/prostate-cancer-screening'>Recommendation: Prostate Cancer: Screening | United States Preventive Services Taskforce</a></li>
</ul>
<p>Guest: Robert A. Baldor MD, FAAFP</p>
<p>Music Credit: Matthew Bugos</p>
<p>Thoughts? Suggestions? Email us at <a href='mailto:FranklySpeaking@pri-med.com'>FranklySpeaking@pri-med.com</a> </p>
<p><em>The views expressed in this podcast are those of Dr. Domino and his guests and do not necessarily reflect the views of Pri-Med.</em></p>
]]></content:encoded>
                                    
        <enclosure url="https://mcdn.podbean.com/mf/web/dfzd8hti6j9qeiv5/frankly-speaking-473-psa-screening.mp3" length="8675089" type="audio/mpeg"/>
                <itunes:summary><![CDATA[Credits: 0.25 AMA PRA Category 1 Credit™ CME/CE Information and Claim Credit: https://www.pri-med.com/online-education/podcast/frankly-speaking-cme-473
Overview: Join us as we review long-term outcomes from a recently published trial on prostate-specific antigen (PSA) testing and prostate cancer mortality. Learn how updated evidence informs shared decision-making and balances early detection with potential harms. Equip yourself to guide patients through nuanced discussions on PSA testing’s limitations, mortality data, and meaningful clinical impact.
Episode resource links:

N Engl J Med 2025;393:1669-80. DOI: 10.1056/NEJMoa2503223
Recommendation: Prostate Cancer: Screening | United States Preventive Services Taskforce

Guest: Robert A. Baldor MD, FAAFP
Music Credit: Matthew Bugos
Thoughts? Suggestions? Email us at FranklySpeaking@pri-med.com 
The views expressed in this podcast are those of Dr. Domino and his guests and do not necessarily reflect the views of Pri-Med.]]></itunes:summary>
        <itunes:author>Pri-Med</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>540</itunes:duration>
                        <itunes:episodeType>full</itunes:episodeType>
            </item>
    <item>
        <title>Hospital to Home: Optimizing Follow-Up After Discharge - Frankly Speaking Ep 472</title>
        <itunes:title>Hospital to Home: Optimizing Follow-Up After Discharge - Frankly Speaking Ep 472</itunes:title>
        <link>https://primedfranklyspeaking.podbean.com/e/hospital-to-home-optimizing-follow-up-after-discharge-frankly-speaking-ep-472/</link>
                    <comments>https://primedfranklyspeaking.podbean.com/e/hospital-to-home-optimizing-follow-up-after-discharge-frankly-speaking-ep-472/#comments</comments>        <pubDate>Mon, 16 Feb 2026 05:30:00 +0000</pubDate>
        <guid isPermaLink="false">primedfranklyspeaking.podbean.com/2519f2be-ff85-3931-96d4-e5e6a5555385</guid>
                                    <description><![CDATA[<p>Credits: 0.25 AMA PRA Category 1 Credit™
 
CME/CE Information and Claim Credit: <a href='https://www.pri-med.com/online-education/podcast/frankly-speaking-cme-472'>https://www.pri-med.com/online-education/podcast/frankly-speaking-cme-472</a></p>
<p>Overview: The transition from hospital to home is a valuable period for patients and clinicians. In this episode, we discuss which patients require follow-up, what should be reviewed during these appointments, and when follow-up should take place to help improve patient outcomes.</p>
<p>Episode resource links:</p>
<ul>
<li>
<p>Anderson, T. S., Herzig, S. J., Marcantonio, E. R., Yeh, R. W., Souza, J., &amp; Landon, B. E. (2024, April). Medicare transitional care management program and changes in timely postdischarge follow-up. In JAMA Health Forum (Vol. 5, No. 4, pp. e240417-e240417). American Medical Association.</p>
</li>
<li>
<p>Anderson, T. S., Wilson, L. M., Wang, B. X., Steinman, M. A., Schonberg, M. A., Marcantonio, E. R., &amp; Herzig, S. J. (2025). Medication Errors and Gaps in Medication Discharge Planning for Hospitalized Older Adults: A Prospective Cohort Study. Journal of general internal medicine, 1-10.</p>
<p> </p>
</li>
<li>
<p>Balasubramanian, I., Andres, E. B., &amp; Malhotra, C. (2025). Outpatient follow-up and 30-day readmissions: a systematic review and meta-analysis. JAMA Network Open, 8(11), e2541272-e2541272.</p>
</li>
</ul>
<p>Guest: Mariyan L. Montaque, DNP, FNP-BC</p>
<p>Music Credit: Matthew Bugos</p>
<p>Thoughts? Suggestions? Email us at <a href='mailto:FranklySpeaking@pri-med.com'>FranklySpeaking@pri-med.com</a> </p>
<p>The views expressed in this podcast are those of Dr. Domino and his guests and do not necessarily reflect the views of Pri-Med.</p>
]]></description>
                                                            <content:encoded><![CDATA[<p>Credits: 0.25 AMA PRA Category 1 Credit™<br>
 <br>
CME/CE Information and Claim Credit: <a href='https://www.pri-med.com/online-education/podcast/frankly-speaking-cme-472'>https://www.pri-med.com/online-education/podcast/frankly-speaking-cme-472</a></p>
<p>Overview: The transition from hospital to home is a valuable period for patients and clinicians. In this episode, we discuss which patients require follow-up, what should be reviewed during these appointments, and when follow-up should take place to help improve patient outcomes.</p>
<p>Episode resource links:</p>
<ul>
<li>
<p>Anderson, T. S., Herzig, S. J., Marcantonio, E. R., Yeh, R. W., Souza, J., &amp; Landon, B. E. (2024, April). Medicare transitional care management program and changes in timely postdischarge follow-up. In JAMA Health Forum (Vol. 5, No. 4, pp. e240417-e240417). American Medical Association.</p>
</li>
<li>
<p>Anderson, T. S., Wilson, L. M., Wang, B. X., Steinman, M. A., Schonberg, M. A., Marcantonio, E. R., &amp; Herzig, S. J. (2025). Medication Errors and Gaps in Medication Discharge Planning for Hospitalized Older Adults: A Prospective Cohort Study. Journal of general internal medicine, 1-10.</p>
<p> </p>
</li>
<li>
<p>Balasubramanian, I., Andres, E. B., &amp; Malhotra, C. (2025). Outpatient follow-up and 30-day readmissions: a systematic review and meta-analysis. JAMA Network Open, 8(11), e2541272-e2541272.</p>
</li>
</ul>
<p>Guest: Mariyan L. Montaque, DNP, FNP-BC</p>
<p>Music Credit: Matthew Bugos</p>
<p>Thoughts? Suggestions? Email us at <a href='mailto:FranklySpeaking@pri-med.com'>FranklySpeaking@pri-med.com</a> </p>
<p><em>The views expressed in this podcast are those of Dr. Domino and his guests and do not necessarily reflect the views of Pri-Med.</em></p>
]]></content:encoded>
                                    
        <enclosure url="https://mcdn.podbean.com/mf/web/nec7fphw9ew4p8cw/frankly-speaking-472-transitional-care.mp3" length="13831506" type="audio/mpeg"/>
                <itunes:summary><![CDATA[Credits: 0.25 AMA PRA Category 1 Credit™ CME/CE Information and Claim Credit: https://www.pri-med.com/online-education/podcast/frankly-speaking-cme-472
Overview: The transition from hospital to home is a valuable period for patients and clinicians. In this episode, we discuss which patients require follow-up, what should be reviewed during these appointments, and when follow-up should take place to help improve patient outcomes.
Episode resource links:


Anderson, T. S., Herzig, S. J., Marcantonio, E. R., Yeh, R. W., Souza, J., &amp; Landon, B. E. (2024, April). Medicare transitional care management program and changes in timely postdischarge follow-up. In JAMA Health Forum (Vol. 5, No. 4, pp. e240417-e240417). American Medical Association.


Anderson, T. S., Wilson, L. M., Wang, B. X., Steinman, M. A., Schonberg, M. A., Marcantonio, E. R., &amp; Herzig, S. J. (2025). Medication Errors and Gaps in Medication Discharge Planning for Hospitalized Older Adults: A Prospective Cohort Study. Journal of general internal medicine, 1-10.
 


Balasubramanian, I., Andres, E. B., &amp; Malhotra, C. (2025). Outpatient follow-up and 30-day readmissions: a systematic review and meta-analysis. JAMA Network Open, 8(11), e2541272-e2541272.


Guest: Mariyan L. Montaque, DNP, FNP-BC
Music Credit: Matthew Bugos
Thoughts? Suggestions? Email us at FranklySpeaking@pri-med.com 
The views expressed in this podcast are those of Dr. Domino and his guests and do not necessarily reflect the views of Pri-Med.]]></itunes:summary>
        <itunes:author>Pri-Med</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>862</itunes:duration>
                        <itunes:episodeType>full</itunes:episodeType>
            </item>
    <item>
        <title>Weekend Warrior or Daily Mover? Exercise Counseling for Patients with Diabetes - Frankly Speaking Ep 471</title>
        <itunes:title>Weekend Warrior or Daily Mover? Exercise Counseling for Patients with Diabetes - Frankly Speaking Ep 471</itunes:title>
        <link>https://primedfranklyspeaking.podbean.com/e/weekend-warrior-or-daily-mover-exercise-counseling-for-patients-with-diabetes-frankly-speaking-ep-471/</link>
                    <comments>https://primedfranklyspeaking.podbean.com/e/weekend-warrior-or-daily-mover-exercise-counseling-for-patients-with-diabetes-frankly-speaking-ep-471/#comments</comments>        <pubDate>Mon, 09 Feb 2026 05:30:00 +0000</pubDate>
        <guid isPermaLink="false">primedfranklyspeaking.podbean.com/24eb02d7-4e2a-336b-9eeb-2b1883610092</guid>
                                    <description><![CDATA[<p>Credits: 0.25 AMA PRA Category 1 Credit™
 
CME/CE Information and Claim Credit: <a href='https://www.pri-med.com/online-education/podcast/frankly-speaking-cme-471'>https://www.pri-med.com/online-education/podcast/frankly-speaking-cme-471</a></p>
<p>Overview: Discover how flexible physical activity patterns can reduce mortality and cardiovascular risk in patients with diabetes. This episode translates evidence on “weekend warrior” vs regular exercise into practical counseling strategies, empowering you to help time-constrained patients achieve the mortality benefits of weekly moderate-to-vigorous physical activity—regardless of scheduling pattern.</p>
<p>Episode resource links:</p>
<ul>
<li>Wu, Z., Sheng, C., Guo, Z., Zheng, Y., Zheng, D., Li, X., Guo, X., &amp; Li, H. (2025). Association of Weekend Warrior and Other Physical Activity Patterns With Mortality Among Adults With Diabetes : A Cohort Study. Annals of internal medicine, 178(9), 1279–1286. <a href='https://doi.org/10.7326/ANNALS-25-00640'>https://doi.org/10.7326/ANNALS-25-00640</a></li>
</ul>
<p>Guest: Jill M. Terrien PhD, ANP-BC </p>
<p>Music Credit: Matthew Bugos</p>
<p>Thoughts? Suggestions? Email us at <a href='mailto:FranklySpeaking@pri-med.com'>FranklySpeaking@pri-med.com</a> </p>
<p>The views expressed in this podcast are those of Dr. Domino and his guests and do not necessarily reflect the views of Pri-Med.</p>
]]></description>
                                                            <content:encoded><![CDATA[<p>Credits: 0.25 AMA PRA Category 1 Credit™<br>
 <br>
CME/CE Information and Claim Credit: <a href='https://www.pri-med.com/online-education/podcast/frankly-speaking-cme-471'>https://www.pri-med.com/online-education/podcast/frankly-speaking-cme-471</a></p>
<p>Overview: Discover how flexible physical activity patterns can reduce mortality and cardiovascular risk in patients with diabetes. This episode translates evidence on “weekend warrior” vs regular exercise into practical counseling strategies, empowering you to help time-constrained patients achieve the mortality benefits of weekly moderate-to-vigorous physical activity—regardless of scheduling pattern.</p>
<p>Episode resource links:</p>
<ul>
<li>Wu, Z., Sheng, C., Guo, Z., Zheng, Y., Zheng, D., Li, X., Guo, X., &amp; Li, H. (2025). Association of Weekend Warrior and Other Physical Activity Patterns With Mortality Among Adults With Diabetes : A Cohort Study. Annals of internal medicine, 178(9), 1279–1286. <a href='https://doi.org/10.7326/ANNALS-25-00640'>https://doi.org/10.7326/ANNALS-25-00640</a></li>
</ul>
<p>Guest: Jill M. Terrien PhD, ANP-BC </p>
<p>Music Credit: Matthew Bugos</p>
<p>Thoughts? Suggestions? Email us at <a href='mailto:FranklySpeaking@pri-med.com'>FranklySpeaking@pri-med.com</a> </p>
<p><em>The views expressed in this podcast are those of Dr. Domino and his guests and do not necessarily reflect the views of Pri-Med.</em></p>
]]></content:encoded>
                                    
        <enclosure url="https://mcdn.podbean.com/mf/web/ckpcqkhynnfwbyyt/frankly-speaking-471-exercise-for-diabetes.mp3" length="11743121" type="audio/mpeg"/>
                <itunes:summary><![CDATA[Credits: 0.25 AMA PRA Category 1 Credit™ CME/CE Information and Claim Credit: https://www.pri-med.com/online-education/podcast/frankly-speaking-cme-471
Overview: Discover how flexible physical activity patterns can reduce mortality and cardiovascular risk in patients with diabetes. This episode translates evidence on “weekend warrior” vs regular exercise into practical counseling strategies, empowering you to help time-constrained patients achieve the mortality benefits of weekly moderate-to-vigorous physical activity—regardless of scheduling pattern.
Episode resource links:

Wu, Z., Sheng, C., Guo, Z., Zheng, Y., Zheng, D., Li, X., Guo, X., &amp; Li, H. (2025). Association of Weekend Warrior and Other Physical Activity Patterns With Mortality Among Adults With Diabetes : A Cohort Study. Annals of internal medicine, 178(9), 1279–1286. https://doi.org/10.7326/ANNALS-25-00640

Guest: Jill M. Terrien PhD, ANP-BC 
Music Credit: Matthew Bugos
Thoughts? Suggestions? Email us at FranklySpeaking@pri-med.com 
The views expressed in this podcast are those of Dr. Domino and his guests and do not necessarily reflect the views of Pri-Med.]]></itunes:summary>
        <itunes:author>Pri-Med</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>732</itunes:duration>
                        <itunes:episodeType>full</itunes:episodeType>
            </item>
    <item>
        <title>Are the Kids All Right? Social Media’s Impact on Teen Mental Health - Frankly Speaking Ep 470</title>
        <itunes:title>Are the Kids All Right? Social Media’s Impact on Teen Mental Health - Frankly Speaking Ep 470</itunes:title>
        <link>https://primedfranklyspeaking.podbean.com/e/are-the-kids-all-right-social-media-s-impact-on-teen-mental-health-frankly-speaking-ep-470/</link>
                    <comments>https://primedfranklyspeaking.podbean.com/e/are-the-kids-all-right-social-media-s-impact-on-teen-mental-health-frankly-speaking-ep-470/#comments</comments>        <pubDate>Mon, 02 Feb 2026 05:30:00 +0000</pubDate>
        <guid isPermaLink="false">primedfranklyspeaking.podbean.com/5048ff33-2581-376c-8272-8bd7714b347a</guid>
                                    <description><![CDATA[<p>Credits: 0.25 AMA PRA Category 1 Credit™
 
CME/CE Information and Claim Credit: <a href='https://www.pri-med.com/online-education/podcast/frankly-speaking-cme-470'>https://www.pri-med.com/online-education/podcast/frankly-speaking-cme-470</a></p>
<p>Overview: Social media use is nearly ubiquitous among adolescents, raising concern about its role in rising rates of depression, anxiety, insomnia, and suicidality. Although prior evidence has been mixed, emerging studies offer new insights on the relationship between social media use and adolescent mental health. Join us as we review current literature and discuss potential strategies to mitigate negative impacts and improve outcomes.</p>
<p>Episode resource links:</p>
<ul>
<li>
<p>Calvert E, Cipriani M, Dwyer B, et al. Social Media Detox and Youth Mental Health. JAMA Netw Open. 2025;8(11):e2545245. doi:10.1001/jamanetworkopen.2025.45245
<a href='https://jamanetwork.com/journals/jamanetworkopen/fullarticle/2840489'>https://jamanetwork.com/journals/jamanetworkopen/fullarticle/2840489</a></p>
<p> </p>
</li>
<li>Clayborne ZM, Capaldi CA, Mehra VM. Associations between digital media use behaviours, screen time and positive mental health in youth: results from the 2019 Canadian Health Survey on Children and Youth. BMC Public Health. 2025;25(1):2303. Published 2025 Jul 3. doi:10.1186/s12889-025-22874-2</li>
<li>Grøntved A, Singhammer J, Froberg K, et al. A prospective study of screen time in adolescence and depression symptoms in young adulthood. Prev Med. 2015;81:108-113. doi:10.1016/j.ypmed.2015.08.009</li>
<li>Nagata JM, Memon Z, Talebloo J, et al. Prevalence and Patterns of Social Media Use in Early Adolescents. Acad Pediatr. 2025;25(4):102784. doi:10.1016/j.acap.2025.102784</li>
<li>Oberle E, Ji XR, Kerai S, Guhn M, Schonert-Reichl KA, Gadermann AM. Screen time and extracurricular activities as risk and protective factors for mental health in adolescence: A population-level study. Prev Med. 2020;141:106291. doi:10.1016/j.ypmed.2020.106291</li>
<li>Pieh C, Humer E, Hoenigl A, et al. Smartphone screen time reduction improves mental health: a randomized controlled trial. BMC Med. 2025;23(1):107. Published 2025 Feb 21. doi:10.1186/s12916-025-03944-z</li>
<li>Riehm KE, Feder KA, Tormohlen KN, et al. Associations Between Time Spent Using Social Media and Internalizing and Externalizing Problems Among US Youth. JAMA Psychiatry. 2019;76(12):1266–1273. doi:10.1001/jamapsychiatry.2019.2325</li>
<li>Varona MN, Muela A, Machimbarrena JM. Problematic use or addiction? A scoping review on conceptual and operational definitions of negative social networking sites use in adolescents. Addict Behav. 2022;134:107400. doi:10.1016/j.addbeh.2022.107400</li>
<li>Woolf SH. The Youth Mental Health Crisis in the United States: Epidemiology, Contributors, and Potential Solutions. Pediatrics. 2025;156(5):e2025070849. doi:10.1542/peds.2025-070849</li>
<li>Xiang AH, Martinez MP, Chow T, et al. Depression and Anxiety Among US Children and Young Adults. JAMA Netw Open. 2024;7(10):e2436906. doi:10.1001/jamanetworkopen.2024.36906</li>
<li>BBC: Australia has banned social media for kids under 16. How will it work? <a href='https://www.bbc.com/news/articles/cwyp9d3ddqyo'>https://www.bbc.com/news/articles/cwyp9d3ddqyo</a></li>
</ul>
<p>Guest: Susan Feeney, DNP, FNP-BC, NP-C
 
Music Credit: Matthew Bugos</p>
<p>Thoughts? Suggestions? Email us at <a href='mailto:FranklySpeaking@pri-med.com'>FranklySpeaking@pri-med.com</a> </p>
<p>The views expressed in this podcast are those of Dr. Domino and his guests and do not necessarily reflect the views of Pri-Med.</p>
]]></description>
                                                            <content:encoded><![CDATA[<p>Credits: 0.25 AMA PRA Category 1 Credit™<br>
 <br>
CME/CE Information and Claim Credit: <a href='https://www.pri-med.com/online-education/podcast/frankly-speaking-cme-470'>https://www.pri-med.com/online-education/podcast/frankly-speaking-cme-470</a></p>
<p>Overview: Social media use is nearly ubiquitous among adolescents, raising concern about its role in rising rates of depression, anxiety, insomnia, and suicidality. Although prior evidence has been mixed, emerging studies offer new insights on the relationship between social media use and adolescent mental health. Join us as we review current literature and discuss potential strategies to mitigate negative impacts and improve outcomes.</p>
<p>Episode resource links:</p>
<ul>
<li>
<p>Calvert E, Cipriani M, Dwyer B, et al. Social Media Detox and Youth Mental Health. JAMA Netw Open. 2025;8(11):e2545245. doi:10.1001/jamanetworkopen.2025.45245<br>
<a href='https://jamanetwork.com/journals/jamanetworkopen/fullarticle/2840489'>https://jamanetwork.com/journals/jamanetworkopen/fullarticle/2840489</a></p>
<p> </p>
</li>
<li>Clayborne ZM, Capaldi CA, Mehra VM. Associations between digital media use behaviours, screen time and positive mental health in youth: results from the 2019 Canadian Health Survey on Children and Youth. BMC Public Health. 2025;25(1):2303. Published 2025 Jul 3. doi:10.1186/s12889-025-22874-2</li>
<li>Grøntved A, Singhammer J, Froberg K, et al. A prospective study of screen time in adolescence and depression symptoms in young adulthood. Prev Med. 2015;81:108-113. doi:10.1016/j.ypmed.2015.08.009</li>
<li>Nagata JM, Memon Z, Talebloo J, et al. Prevalence and Patterns of Social Media Use in Early Adolescents. Acad Pediatr. 2025;25(4):102784. doi:10.1016/j.acap.2025.102784</li>
<li>Oberle E, Ji XR, Kerai S, Guhn M, Schonert-Reichl KA, Gadermann AM. Screen time and extracurricular activities as risk and protective factors for mental health in adolescence: A population-level study. Prev Med. 2020;141:106291. doi:10.1016/j.ypmed.2020.106291</li>
<li>Pieh C, Humer E, Hoenigl A, et al. Smartphone screen time reduction improves mental health: a randomized controlled trial. BMC Med. 2025;23(1):107. Published 2025 Feb 21. doi:10.1186/s12916-025-03944-z</li>
<li>Riehm KE, Feder KA, Tormohlen KN, et al. Associations Between Time Spent Using Social Media and Internalizing and Externalizing Problems Among US Youth. JAMA Psychiatry. 2019;76(12):1266–1273. doi:10.1001/jamapsychiatry.2019.2325</li>
<li>Varona MN, Muela A, Machimbarrena JM. Problematic use or addiction? A scoping review on conceptual and operational definitions of negative social networking sites use in adolescents. Addict Behav. 2022;134:107400. doi:10.1016/j.addbeh.2022.107400</li>
<li>Woolf SH. The Youth Mental Health Crisis in the United States: Epidemiology, Contributors, and Potential Solutions. Pediatrics. 2025;156(5):e2025070849. doi:10.1542/peds.2025-070849</li>
<li>Xiang AH, Martinez MP, Chow T, et al. Depression and Anxiety Among US Children and Young Adults. JAMA Netw Open. 2024;7(10):e2436906. doi:10.1001/jamanetworkopen.2024.36906</li>
<li>BBC: Australia has banned social media for kids under 16. How will it work? <a href='https://www.bbc.com/news/articles/cwyp9d3ddqyo'>https://www.bbc.com/news/articles/cwyp9d3ddqyo</a></li>
</ul>
<p>Guest: Susan Feeney, DNP, FNP-BC, NP-C<br>
 <br>
Music Credit: Matthew Bugos</p>
<p>Thoughts? Suggestions? Email us at <a href='mailto:FranklySpeaking@pri-med.com'>FranklySpeaking@pri-med.com</a> </p>
<p><em>The views expressed in this podcast are those of Dr. Domino and his guests and do not necessarily reflect the views of Pri-Med.</em></p>
]]></content:encoded>
                                    
        <enclosure url="https://mcdn.podbean.com/mf/web/qdmva8jiaz9trhyx/frankly-speaking-470-social-media-teens.mp3" length="16840117" type="audio/mpeg"/>
                <itunes:summary><![CDATA[Credits: 0.25 AMA PRA Category 1 Credit™ CME/CE Information and Claim Credit: https://www.pri-med.com/online-education/podcast/frankly-speaking-cme-470
Overview: Social media use is nearly ubiquitous among adolescents, raising concern about its role in rising rates of depression, anxiety, insomnia, and suicidality. Although prior evidence has been mixed, emerging studies offer new insights on the relationship between social media use and adolescent mental health. Join us as we review current literature and discuss potential strategies to mitigate negative impacts and improve outcomes.
Episode resource links:


Calvert E, Cipriani M, Dwyer B, et al. Social Media Detox and Youth Mental Health. JAMA Netw Open. 2025;8(11):e2545245. doi:10.1001/jamanetworkopen.2025.45245https://jamanetwork.com/journals/jamanetworkopen/fullarticle/2840489
 

Clayborne ZM, Capaldi CA, Mehra VM. Associations between digital media use behaviours, screen time and positive mental health in youth: results from the 2019 Canadian Health Survey on Children and Youth. BMC Public Health. 2025;25(1):2303. Published 2025 Jul 3. doi:10.1186/s12889-025-22874-2
Grøntved A, Singhammer J, Froberg K, et al. A prospective study of screen time in adolescence and depression symptoms in young adulthood. Prev Med. 2015;81:108-113. doi:10.1016/j.ypmed.2015.08.009
Nagata JM, Memon Z, Talebloo J, et al. Prevalence and Patterns of Social Media Use in Early Adolescents. Acad Pediatr. 2025;25(4):102784. doi:10.1016/j.acap.2025.102784
Oberle E, Ji XR, Kerai S, Guhn M, Schonert-Reichl KA, Gadermann AM. Screen time and extracurricular activities as risk and protective factors for mental health in adolescence: A population-level study. Prev Med. 2020;141:106291. doi:10.1016/j.ypmed.2020.106291
Pieh C, Humer E, Hoenigl A, et al. Smartphone screen time reduction improves mental health: a randomized controlled trial. BMC Med. 2025;23(1):107. Published 2025 Feb 21. doi:10.1186/s12916-025-03944-z
Riehm KE, Feder KA, Tormohlen KN, et al. Associations Between Time Spent Using Social Media and Internalizing and Externalizing Problems Among US Youth. JAMA Psychiatry. 2019;76(12):1266–1273. doi:10.1001/jamapsychiatry.2019.2325
Varona MN, Muela A, Machimbarrena JM. Problematic use or addiction? A scoping review on conceptual and operational definitions of negative social networking sites use in adolescents. Addict Behav. 2022;134:107400. doi:10.1016/j.addbeh.2022.107400
Woolf SH. The Youth Mental Health Crisis in the United States: Epidemiology, Contributors, and Potential Solutions. Pediatrics. 2025;156(5):e2025070849. doi:10.1542/peds.2025-070849
Xiang AH, Martinez MP, Chow T, et al. Depression and Anxiety Among US Children and Young Adults. JAMA Netw Open. 2024;7(10):e2436906. doi:10.1001/jamanetworkopen.2024.36906
BBC: Australia has banned social media for kids under 16. How will it work? https://www.bbc.com/news/articles/cwyp9d3ddqyo

Guest: Susan Feeney, DNP, FNP-BC, NP-C Music Credit: Matthew Bugos
Thoughts? Suggestions? Email us at FranklySpeaking@pri-med.com 
The views expressed in this podcast are those of Dr. Domino and his guests and do not necessarily reflect the views of Pri-Med.]]></itunes:summary>
        <itunes:author>Pri-Med</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>1050</itunes:duration>
                        <itunes:episodeType>full</itunes:episodeType>
            </item>
    <item>
        <title>Options, Access, Comfort: Self-Collected HPV Tests for Cervical Cancer Screening - Frankly Speaking Ep 469</title>
        <itunes:title>Options, Access, Comfort: Self-Collected HPV Tests for Cervical Cancer Screening - Frankly Speaking Ep 469</itunes:title>
        <link>https://primedfranklyspeaking.podbean.com/e/options-access-comfort-self-collected-hpv-tests-for-cervical-cancer-screening-frankly-speaking-ep-469/</link>
                    <comments>https://primedfranklyspeaking.podbean.com/e/options-access-comfort-self-collected-hpv-tests-for-cervical-cancer-screening-frankly-speaking-ep-469/#comments</comments>        <pubDate>Mon, 26 Jan 2026 05:30:00 +0000</pubDate>
        <guid isPermaLink="false">primedfranklyspeaking.podbean.com/0d94d10b-823e-3a0d-8228-0d6fa39776f3</guid>
                                    <description><![CDATA[<p>Credits: 0.25 AMA PRA Category 1 Credit™
 
CME/CE Information and Claim Credit: <a href='https://www.pri-med.com/online-education/podcast/frankly-speaking-cme-469'>https://www.pri-med.com/online-education/podcast/frankly-speaking-cme-469</a></p>
<p>Overview: Tune in to hear how self-collected vaginal human papillomavirus (HPV) testing has potential to expand access to cervical cancer screening and reduce barriers for your patients. This episode reviews cervical cancer screening guidelines, follow-up recommendations, and how to consider offering self-collection as an option to increase screening rates and improve preventive care in your practice.</p>
<p>Episode resource links:</p>
<ul>
<li>CA CancerJClin.2026;e70041. DOI:10.3322/caac.70041</li>
<li>US Food and Drug Administration (FDA). Device Classification Under Section 513(f)(2)(De Novo). Device for home collection and transport of vaginal specimens by lay users for use in an approved HPV molecular assay. FDA; 2025. <a href='mailto:FranklySpeaking@pri-med.com'>FranklySpeaking@pri-med.com</a> </p>
<p>The views expressed in this podcast are those of Dr. Domino and his guests and do not necessarily reflect the views of Pri-Med.</p>
]]></description>
                                                            <content:encoded><![CDATA[<p>Credits: 0.25 AMA PRA Category 1 Credit™<br>
 <br>
CME/CE Information and Claim Credit: <a href='https://www.pri-med.com/online-education/podcast/frankly-speaking-cme-469'>https://www.pri-med.com/online-education/podcast/frankly-speaking-cme-469</a></p>
<p>Overview: Tune in to hear how self-collected vaginal human papillomavirus (HPV) testing has potential to expand access to cervical cancer screening and reduce barriers for your patients. This episode reviews cervical cancer screening guidelines, follow-up recommendations, and how to consider offering self-collection as an option to increase screening rates and improve preventive care in your practice.</p>
<p>Episode resource links:</p>
<ul>
<li>CA CancerJClin.2026;e70041. DOI:10.3322/caac.70041</li>
<li>US Food and Drug Administration (FDA). Device Classification Under Section 513(f)(2)(De Novo). Device for home collection and transport of vaginal specimens by lay users for use in an approved HPV molecular assay. FDA; 2025. <a href='mailto:FranklySpeaking@pri-med.com'>FranklySpeaking@pri-med.com</a> </p>
<p><em>The views expressed in this podcast are those of Dr. Domino and his guests and do not necessarily reflect the views of Pri-Med.</em></p>
]]></content:encoded>
                                    
        <enclosure url="https://mcdn.podbean.com/mf/web/wgbfha9pkykbbv2z/frankly-speaking-469-cervical-cancer.mp3" length="10897808" type="audio/mpeg"/>
                <itunes:summary><![CDATA[Credits: 0.25 AMA PRA Category 1 Credit™ CME/CE Information and Claim Credit: https://www.pri-med.com/online-education/podcast/frankly-speaking-cme-469
Overview: Tune in to hear how self-collected vaginal human papillomavirus (HPV) testing has potential to expand access to cervical cancer screening and reduce barriers for your patients. This episode reviews cervical cancer screening guidelines, follow-up recommendations, and how to consider offering self-collection as an option to increase screening rates and improve preventive care in your practice.
Episode resource links:

CA CancerJClin.2026;e70041. DOI:10.3322/caac.70041
US Food and Drug Administration (FDA). Device Classification Under Section 513(f)(2)(De Novo). Device for home collection and transport of vaginal specimens by lay users for use in an approved HPV molecular assay. FDA; 2025. https://www. accessdata.fda.gov/scripts/cdrh/cfdocs/cfpmn/denovo.cfm? id=DEN240045

Guest: Robert A. Baldor MD, FAAFPMusic Credit: Matthew Bugos
Thoughts? Suggestions? Email us at FranklySpeaking@pri-med.com 
The views expressed in this podcast are those of Dr. Domino and his guests and do not necessarily reflect the views of Pri-Med.]]></itunes:summary>
        <itunes:author>Pri-Med</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>679</itunes:duration>
                        <itunes:episodeType>full</itunes:episodeType>
            </item>
    <item>
        <title>Digesting the Inverted Food Pyramid and Best Evidence on Healthy Eating in 2026 - Frankly Speaking Nutrition Update</title>
        <itunes:title>Digesting the Inverted Food Pyramid and Best Evidence on Healthy Eating in 2026 - Frankly Speaking Nutrition Update</itunes:title>
        <link>https://primedfranklyspeaking.podbean.com/e/digesting-the-inverted-food-pyramid-and-best-evidence-on-healthy-eating-in-2026-frankly-speaking-nutrition-update/</link>
                    <comments>https://primedfranklyspeaking.podbean.com/e/digesting-the-inverted-food-pyramid-and-best-evidence-on-healthy-eating-in-2026-frankly-speaking-nutrition-update/#comments</comments>        <pubDate>Wed, 21 Jan 2026 05:30:00 +0000</pubDate>
        <guid isPermaLink="false">primedfranklyspeaking.podbean.com/04427028-b558-3d90-ad48-87bd25902d7b</guid>
                                    <description><![CDATA[<p>Credits: 0.25 AMA PRA Category 1 Credit™
 
CME/CE Information and Claim Credit: <a href='https://www.pri-med.com/online-education/podcast/frankly-speaking-nutrition-update'>https://www.pri-med.com/online-education/podcast/frankly-speaking-nutrition-update</a></p>
<p>Overview: In this episode, we explore the latest changes to the USDA’s nutrition guidelines, trace the history of the food pyramid, and examine the evidence behind current guidance. Come away with tips to counsel patients on nutrition that supports long-term health and reduces chronic disease risk.</p>
<p>Episode resource links:</p>
<ul>
<li>Review the history of nutrition recommendations from the United States Department of Agriculture (USDA)</li>
<li>Analyze the USDA’s 2026 food guidelines</li>
</ul>
<p>Guest: Alan M. Ehrlich, MD, FAAFP
 
Music Credit: Matthew Bugos</p>
<p>Thoughts? Suggestions? Email us at <a href='mailto:FranklySpeaking@pri-med.com'>FranklySpeaking@pri-med.com</a> </p>
<p>The views expressed in this podcast are those of Dr. Domino and his guests and do not necessarily reflect the views of Pri-Med.</p>
]]></description>
                                                            <content:encoded><![CDATA[<p>Credits: 0.25 AMA PRA Category 1 Credit™<br>
 <br>
CME/CE Information and Claim Credit: <a href='https://www.pri-med.com/online-education/podcast/frankly-speaking-nutrition-update'>https://www.pri-med.com/online-education/podcast/frankly-speaking-nutrition-update</a></p>
<p>Overview: In this episode, we explore the latest changes to the USDA’s nutrition guidelines, trace the history of the food pyramid, and examine the evidence behind current guidance. Come away with tips to counsel patients on nutrition that supports long-term health and reduces chronic disease risk.</p>
<p>Episode resource links:</p>
<ul>
<li>Review the history of nutrition recommendations from the United States Department of Agriculture (USDA)</li>
<li>Analyze the USDA’s 2026 food guidelines</li>
</ul>
<p>Guest: Alan M. Ehrlich, MD, FAAFP<br>
 <br>
Music Credit: Matthew Bugos</p>
<p>Thoughts? Suggestions? Email us at <a href='mailto:FranklySpeaking@pri-med.com'>FranklySpeaking@pri-med.com</a> </p>
<p><em>The views expressed in this podcast are those of Dr. Domino and his guests and do not necessarily reflect the views of Pri-Med.</em></p>
]]></content:encoded>
                                    
        <enclosure url="https://mcdn.podbean.com/mf/web/q3p728ba9gb93x4a/episode-special-nutrition-update-2026.mp3" length="18951468" type="audio/mpeg"/>
                <itunes:summary><![CDATA[Credits: 0.25 AMA PRA Category 1 Credit™ CME/CE Information and Claim Credit: https://www.pri-med.com/online-education/podcast/frankly-speaking-nutrition-update
Overview: In this episode, we explore the latest changes to the USDA’s nutrition guidelines, trace the history of the food pyramid, and examine the evidence behind current guidance. Come away with tips to counsel patients on nutrition that supports long-term health and reduces chronic disease risk.
Episode resource links:

Review the history of nutrition recommendations from the United States Department of Agriculture (USDA)
Analyze the USDA’s 2026 food guidelines

Guest: Alan M. Ehrlich, MD, FAAFP Music Credit: Matthew Bugos
Thoughts? Suggestions? Email us at FranklySpeaking@pri-med.com 
The views expressed in this podcast are those of Dr. Domino and his guests and do not necessarily reflect the views of Pri-Med.]]></itunes:summary>
        <itunes:author>Pri-Med</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>1182</itunes:duration>
                        <itunes:episodeType>full</itunes:episodeType>
            </item>
    <item>
        <title>Are You Still Recommending Aspirin for Primary Prevention? - Frankly Speaking Ep 468</title>
        <itunes:title>Are You Still Recommending Aspirin for Primary Prevention? - Frankly Speaking Ep 468</itunes:title>
        <link>https://primedfranklyspeaking.podbean.com/e/are-you-still-recommending-aspirin-for-primary-prevention-frankly-speaking-ep-467/</link>
                    <comments>https://primedfranklyspeaking.podbean.com/e/are-you-still-recommending-aspirin-for-primary-prevention-frankly-speaking-ep-467/#comments</comments>        <pubDate>Mon, 19 Jan 2026 05:30:00 +0000</pubDate>
        <guid isPermaLink="false">primedfranklyspeaking.podbean.com/3b923ab9-1188-3fe8-b6c2-3846801d5498</guid>
                                    <description><![CDATA[<p>Credits: 0.25 AMA PRA Category 1 Credit™
 
CME/CE Information and Claim Credit: <a href='https://www.pri-med.com/online-education/podcast/frankly-speaking-cme-468'>https://www.pri-med.com/online-education/podcast/frankly-speaking-cme-468</a></p>
<p>Overview: We first discussed aspirin use for primary prevention of cardiovascular disease in 2022 when the USPSTF recommended against it. In this follow-up episode, we review new trial data reinforcing that guidance and help you translate the evidence into safer prevention strategies. Build confidence in supporting patients with evidence-based approaches to reduce cardiovascular risk.</p>
<p>Episode resource links:</p>
<ul>
<li>Aspirin, cardiovascular events, and major bleeding in older adults: extended follow-up of the ASPREE trial. Eur Heart J. 2025 Aug 12:ehaf514. doi: 10.1093/eurheartj/ehaf514. Epub ahead of print. PMID: 40796244.</li>
</ul>
<p>Guest: Robert A. Baldor MD, FAAFP
 
Music Credit: Matthew Bugos</p>
<p>Thoughts? Suggestions? Email us at <a href='mailto:FranklySpeaking@pri-med.com'>FranklySpeaking@pri-med.com</a></p>
<p>The views expressed in this podcast are those of Dr. Domino and his guests and do not necessarily reflect the views of Pri-Med.</p>
]]></description>
                                                            <content:encoded><![CDATA[<p>Credits: 0.25 AMA PRA Category 1 Credit™<br>
 <br>
CME/CE Information and Claim Credit: <a href='https://www.pri-med.com/online-education/podcast/frankly-speaking-cme-468'>https://www.pri-med.com/online-education/podcast/frankly-speaking-cme-468</a></p>
<p>Overview: We first discussed aspirin use for primary prevention of cardiovascular disease in 2022 when the USPSTF recommended against it. In this follow-up episode, we review new trial data reinforcing that guidance and help you translate the evidence into safer prevention strategies. Build confidence in supporting patients with evidence-based approaches to reduce cardiovascular risk.</p>
<p>Episode resource links:</p>
<ul>
<li>Aspirin, cardiovascular events, and major bleeding in older adults: extended follow-up of the ASPREE trial. Eur Heart J. 2025 Aug 12:ehaf514. doi: 10.1093/eurheartj/ehaf514. Epub ahead of print. PMID: 40796244.</li>
</ul>
<p>Guest: Robert A. Baldor MD, FAAFP<br>
 <br>
Music Credit: Matthew Bugos</p>
<p>Thoughts? Suggestions? Email us at <a href='mailto:FranklySpeaking@pri-med.com'>FranklySpeaking@pri-med.com</a></p>
<p><em>The views expressed in this podcast are those of Dr. Domino and his guests and do not necessarily reflect the views of Pri-Med.</em></p>
]]></content:encoded>
                                    
        <enclosure url="https://mcdn.podbean.com/mf/web/debmji7n42merkxu/episode-467-aspirin-CV-events.mp3" length="9360689" type="audio/mpeg"/>
                <itunes:summary><![CDATA[Credits: 0.25 AMA PRA Category 1 Credit™ CME/CE Information and Claim Credit: https://www.pri-med.com/online-education/podcast/frankly-speaking-cme-468
Overview: We first discussed aspirin use for primary prevention of cardiovascular disease in 2022 when the USPSTF recommended against it. In this follow-up episode, we review new trial data reinforcing that guidance and help you translate the evidence into safer prevention strategies. Build confidence in supporting patients with evidence-based approaches to reduce cardiovascular risk.
Episode resource links:

Aspirin, cardiovascular events, and major bleeding in older adults: extended follow-up of the ASPREE trial. Eur Heart J. 2025 Aug 12:ehaf514. doi: 10.1093/eurheartj/ehaf514. Epub ahead of print. PMID: 40796244.

Guest: Robert A. Baldor MD, FAAFP Music Credit: Matthew Bugos
Thoughts? Suggestions? Email us at FranklySpeaking@pri-med.com
The views expressed in this podcast are those of Dr. Domino and his guests and do not necessarily reflect the views of Pri-Med.]]></itunes:summary>
        <itunes:author>Pri-Med</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>583</itunes:duration>
                        <itunes:episodeType>full</itunes:episodeType>
            </item>
    <item>
        <title>Meningitis Makes a Comeback (Along with Other Infections) - Frankly Speaking Vaccine Update</title>
        <itunes:title>Meningitis Makes a Comeback (Along with Other Infections) - Frankly Speaking Vaccine Update</itunes:title>
        <link>https://primedfranklyspeaking.podbean.com/e/meningitis-makes-a-comeback-along-with-other-infections-frankly-speaking-vaccine-update/</link>
                    <comments>https://primedfranklyspeaking.podbean.com/e/meningitis-makes-a-comeback-along-with-other-infections-frankly-speaking-vaccine-update/#comments</comments>        <pubDate>Wed, 14 Jan 2026 21:08:12 +0000</pubDate>
        <guid isPermaLink="false">primedfranklyspeaking.podbean.com/d6bfc84b-a23e-3521-8ade-8bf896834376</guid>
                                    <description><![CDATA[<p>Credits: 0.25 AMA PRA Category 1 Credit™
 
CME/CE Information and Claim Credit: <a href='https://www.pri-med.com/online-education/podcast/frankly-speaking-cme-vaccine-update'>https://www.pri-med.com/online-education/podcast/frankly-speaking-cme-vaccine-update</a></p>
<p>Overview: In this episode, we discuss the recently updated US childhood vaccine schedule, including key changes and the rationale behind these recommendations. We also talk about the risks of vaccine-preventable illnesses and review vaccine efficacy and safety considerations—helping you navigate evolving guidance and protect patients in primary care.</p>
<p>Episode resource links:</p>
<ul>
<li>RSV:  Pediatrics. 2024. Curns AT, Rha B, Lively JY, et al.
J Infect Dis. 2022 Aug 15;226(Suppl 2):S154-S163. doi: 10.1093/infdis/jiac120</li>
<li>Hep B: N Engl J Med 2019;380:2041-2050  DOI: 10.1056/NEJMra181047
Clin Infect Dis. 2021 Nov 2;73(9):e3317-e3323. doi: 10.1093/cid/ciaa898. </li>
<li>Meningococcal Vaccines and disease: MMWR. Morbidity and Mortality Weekly Report. 2024. Collins JP, Crowe SJ, Ortega-Sanchez IR, et al.
Vaccine. 2019. Wang B, Santoreneos R, Giles L, Haji Ali Afzali H, Marshall H.</li>
</ul>
<p>Guest: Jillian Joseph, MPAS, PA-C

Music Credit: Matthew Bugos</p>
<p>Thoughts? Suggestions? Email us at <a href='mailto:FranklySpeaking@pri-med.com'>FranklySpeaking@pri-med.com</a></p>
<p>The views expressed in this podcast are those of Dr. Domino and his guests and do not necessarily reflect the views of Pri-Med.</p>
<p> </p>
]]></description>
                                                            <content:encoded><![CDATA[<p>Credits: 0.25 AMA PRA Category 1 Credit™<br>
 <br>
CME/CE Information and Claim Credit: <a href='https://www.pri-med.com/online-education/podcast/frankly-speaking-cme-vaccine-update'>https://www.pri-med.com/online-education/podcast/frankly-speaking-cme-vaccine-update</a></p>
<p>Overview: In this episode, we discuss the recently updated US childhood vaccine schedule, including key changes and the rationale behind these recommendations. We also talk about the risks of vaccine-preventable illnesses and review vaccine efficacy and safety considerations—helping you navigate evolving guidance and protect patients in primary care.</p>
<p>Episode resource links:</p>
<ul>
<li>RSV:  Pediatrics. 2024. Curns AT, Rha B, Lively JY, et al.<br>
J Infect Dis. 2022 Aug 15;226(Suppl 2):S154-S163. doi: 10.1093/infdis/jiac120</li>
<li>Hep B: N Engl J Med 2019;380:2041-2050  DOI: 10.1056/NEJMra181047<br>
Clin Infect Dis. 2021 Nov 2;73(9):e3317-e3323. doi: 10.1093/cid/ciaa898. </li>
<li>Meningococcal Vaccines and disease: MMWR. Morbidity and Mortality Weekly Report. 2024. Collins JP, Crowe SJ, Ortega-Sanchez IR, et al.<br>
Vaccine. 2019. Wang B, Santoreneos R, Giles L, Haji Ali Afzali H, Marshall H.</li>
</ul>
<p>Guest: Jillian Joseph, MPAS, PA-C<br>
<br>
Music Credit: Matthew Bugos</p>
<p>Thoughts? Suggestions? Email us at <a href='mailto:FranklySpeaking@pri-med.com'>FranklySpeaking@pri-med.com</a></p>
<p><em>The views expressed in this podcast are those of Dr. Domino and his guests and do not necessarily reflect the views of Pri-Med.</em></p>
<p> </p>
]]></content:encoded>
                                    
        <enclosure url="https://mcdn.podbean.com/mf/web/u8u7mqwwwd86xqwg/episode-special-vaccine-update-2026.mp3" length="12865962" type="audio/mpeg"/>
                <itunes:summary><![CDATA[Credits: 0.25 AMA PRA Category 1 Credit™ CME/CE Information and Claim Credit: https://www.pri-med.com/online-education/podcast/frankly-speaking-cme-vaccine-update
Overview: In this episode, we discuss the recently updated US childhood vaccine schedule, including key changes and the rationale behind these recommendations. We also talk about the risks of vaccine-preventable illnesses and review vaccine efficacy and safety considerations—helping you navigate evolving guidance and protect patients in primary care.
Episode resource links:

RSV:  Pediatrics. 2024. Curns AT, Rha B, Lively JY, et al.J Infect Dis. 2022 Aug 15;226(Suppl 2):S154-S163. doi: 10.1093/infdis/jiac120
Hep B: N Engl J Med 2019;380:2041-2050  DOI: 10.1056/NEJMra181047Clin Infect Dis. 2021 Nov 2;73(9):e3317-e3323. doi: 10.1093/cid/ciaa898. 
Meningococcal Vaccines and disease: MMWR. Morbidity and Mortality Weekly Report. 2024. Collins JP, Crowe SJ, Ortega-Sanchez IR, et al.Vaccine. 2019. Wang B, Santoreneos R, Giles L, Haji Ali Afzali H, Marshall H.

Guest: Jillian Joseph, MPAS, PA-CMusic Credit: Matthew Bugos
Thoughts? Suggestions? Email us at FranklySpeaking@pri-med.com
The views expressed in this podcast are those of Dr. Domino and his guests and do not necessarily reflect the views of Pri-Med.
 ]]></itunes:summary>
        <itunes:author>Pri-Med</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>802</itunes:duration>
                        <itunes:episodeType>full</itunes:episodeType>
            </item>
    <item>
        <title>Babies Can Acquire STIs: The Rationale for Hepatitis B Vaccination at Birth - Frankly Speaking Ep 467</title>
        <itunes:title>Babies Can Acquire STIs: The Rationale for Hepatitis B Vaccination at Birth - Frankly Speaking Ep 467</itunes:title>
        <link>https://primedfranklyspeaking.podbean.com/e/babies-can-acquire-stis-the-rationale-for-hepatitis-b-vaccination-at-birth-frankly-speaking-ep-467/</link>
                    <comments>https://primedfranklyspeaking.podbean.com/e/babies-can-acquire-stis-the-rationale-for-hepatitis-b-vaccination-at-birth-frankly-speaking-ep-467/#comments</comments>        <pubDate>Mon, 12 Jan 2026 05:30:00 +0000</pubDate>
        <guid isPermaLink="false">primedfranklyspeaking.podbean.com/19831c08-4ea2-3b83-b48f-3e700b5a588c</guid>
                                    <description><![CDATA[<p>Credits: 0.25 AMA PRA Category 1 Credit™
 
CME/CE Information and Claim Credit: <a href='https://www.pri-med.com/online-education/podcast/frankly-speaking-cme-467'>https://www.pri-med.com/online-education/podcast/frankly-speaking-cme-467</a></p>
<p>Overview: Join us as we discuss recent changes to newborn hepatitis B vaccination recommendations and review the risks, benefits, and rationale for immunizing this patient population. Come away with confidence to navigate new guidance, thoughtfully address parental concerns, and provide evidence-based care that promotes both infant and public health.</p>
<p>Episode resource links:</p>
<ul>
<li>N Engl J Med 2019;380:2041-2050  DOI: 10.1056/NEJMra181047</li>
<li>Clin Infect Dis. 2021 Nov 2;73(9):e3317-e3323. doi: 10.1093/cid/ciaa898. </li>
</ul>
<p>Guest: Robert A. Baldor MD, FAAFP
 
Music Credit: Matthew Bugos</p>
<p>Thoughts? Suggestions? Email us at <a href='mailto:FranklySpeaking@pri-med.com'>FranklySpeaking@pri-med.com</a></p>
<p> </p>
]]></description>
                                                            <content:encoded><![CDATA[<p>Credits: 0.25 AMA PRA Category 1 Credit™<br>
 <br>
CME/CE Information and Claim Credit: <a href='https://www.pri-med.com/online-education/podcast/frankly-speaking-cme-467'>https://www.pri-med.com/online-education/podcast/frankly-speaking-cme-467</a></p>
<p>Overview: Join us as we discuss recent changes to newborn hepatitis B vaccination recommendations and review the risks, benefits, and rationale for immunizing this patient population. Come away with confidence to navigate new guidance, thoughtfully address parental concerns, and provide evidence-based care that promotes both infant and public health.</p>
<p>Episode resource links:</p>
<ul>
<li>N Engl J Med 2019;380:2041-2050  DOI: 10.1056/NEJMra181047</li>
<li>Clin Infect Dis. 2021 Nov 2;73(9):e3317-e3323. doi: 10.1093/cid/ciaa898. </li>
</ul>
<p>Guest: Robert A. Baldor MD, FAAFP<br>
 <br>
Music Credit: Matthew Bugos</p>
<p>Thoughts? Suggestions? Email us at <a href='mailto:FranklySpeaking@pri-med.com'>FranklySpeaking@pri-med.com</a></p>
<p> </p>
]]></content:encoded>
                                    
        <enclosure url="https://mcdn.podbean.com/mf/web/cr45332xnwxs2v98/episode-467-hepb-vaccine.mp3" length="12044446" type="audio/mpeg"/>
                <itunes:summary><![CDATA[Credits: 0.25 AMA PRA Category 1 Credit™ CME/CE Information and Claim Credit: https://www.pri-med.com/online-education/podcast/frankly-speaking-cme-467
Overview: Join us as we discuss recent changes to newborn hepatitis B vaccination recommendations and review the risks, benefits, and rationale for immunizing this patient population. Come away with confidence to navigate new guidance, thoughtfully address parental concerns, and provide evidence-based care that promotes both infant and public health.
Episode resource links:

N Engl J Med 2019;380:2041-2050  DOI: 10.1056/NEJMra181047
Clin Infect Dis. 2021 Nov 2;73(9):e3317-e3323. doi: 10.1093/cid/ciaa898. 

Guest: Robert A. Baldor MD, FAAFP Music Credit: Matthew Bugos
Thoughts? Suggestions? Email us at FranklySpeaking@pri-med.com
 ]]></itunes:summary>
        <itunes:author>Pri-Med</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>750</itunes:duration>
                        <itunes:episodeType>full</itunes:episodeType>
            </item>
    <item>
        <title>Potatoes and T2DM Risk: Which Preparations Made the Cut? - Frankly Speaking Ep 466</title>
        <itunes:title>Potatoes and T2DM Risk: Which Preparations Made the Cut? - Frankly Speaking Ep 466</itunes:title>
        <link>https://primedfranklyspeaking.podbean.com/e/potatoes-and-t2dm-risk-which-preparations-made-the-cut-frankly-speaking-ep-466/</link>
                    <comments>https://primedfranklyspeaking.podbean.com/e/potatoes-and-t2dm-risk-which-preparations-made-the-cut-frankly-speaking-ep-466/#comments</comments>        <pubDate>Mon, 05 Jan 2026 05:30:00 +0000</pubDate>
        <guid isPermaLink="false">primedfranklyspeaking.podbean.com/69ebe146-1603-3688-af86-4104cbfdcf02</guid>
                                    <description><![CDATA[<p>Credits: 0.25 AMA PRA Category 1 Credit™
 
CME/CE Information and Claim Credit: <a href='https://www.pri-med.com/online-education/podcast/frankly-speaking-cme-466'>https://www.pri-med.com/online-education/podcast/frankly-speaking-cme-466</a></p>
<p>Overview: Concerns over eating carbohydrate-rich potatoes have been raised over the last decade with numerous studies suggesting worrisome effects on health. Tune in as we unpack findings from a large study that examined the relationship between potato intake and the risk of developing type 2 diabetes mellitus (T2DM), helping you apply evolving nutrition science to patient counseling.</p>
<p>Episode resource links:</p>
<ul>
<li>BMJ 2025;390:e082121 http://dx.doi.org/10.1136/bmj-2024‑082121</li>
</ul>
<p>Guest: Robert A. Baldor MD, FAAFP
 
Music Credit: Matthew Bugos</p>
<p>Thoughts? Suggestions? Email us at <a href='mailto:FranklySpeaking@pri-med.com'>FranklySpeaking@pri-med.com</a></p>
<p> </p>
]]></description>
                                                            <content:encoded><![CDATA[<p>Credits: 0.25 AMA PRA Category 1 Credit™<br>
 <br>
CME/CE Information and Claim Credit: <a href='https://www.pri-med.com/online-education/podcast/frankly-speaking-cme-466'>https://www.pri-med.com/online-education/podcast/frankly-speaking-cme-466</a></p>
<p>Overview: Concerns over eating carbohydrate-rich potatoes have been raised over the last decade with numerous studies suggesting worrisome effects on health. Tune in as we unpack findings from a large study that examined the relationship between potato intake and the risk of developing type 2 diabetes mellitus (T2DM), helping you apply evolving nutrition science to patient counseling.</p>
<p>Episode resource links:</p>
<ul>
<li>BMJ 2025;390:e082121 http://dx.doi.org/10.1136/bmj-2024‑082121</li>
</ul>
<p>Guest: Robert A. Baldor MD, FAAFP<br>
 <br>
Music Credit: Matthew Bugos</p>
<p>Thoughts? Suggestions? Email us at <a href='mailto:FranklySpeaking@pri-med.com'>FranklySpeaking@pri-med.com</a></p>
<p> </p>
]]></content:encoded>
                                    
        <enclosure url="https://mcdn.podbean.com/mf/web/faqty7akaf7snt2h/episode-466-potatoes.mp3" length="10329247" type="audio/mpeg"/>
                <itunes:summary><![CDATA[Credits: 0.25 AMA PRA Category 1 Credit™ CME/CE Information and Claim Credit: https://www.pri-med.com/online-education/podcast/frankly-speaking-cme-466
Overview: Concerns over eating carbohydrate-rich potatoes have been raised over the last decade with numerous studies suggesting worrisome effects on health. Tune in as we unpack findings from a large study that examined the relationship between potato intake and the risk of developing type 2 diabetes mellitus (T2DM), helping you apply evolving nutrition science to patient counseling.
Episode resource links:

BMJ 2025;390:e082121 http://dx.doi.org/10.1136/bmj-2024‑082121

Guest: Robert A. Baldor MD, FAAFP Music Credit: Matthew Bugos
Thoughts? Suggestions? Email us at FranklySpeaking@pri-med.com
 ]]></itunes:summary>
        <itunes:author>Pri-Med</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>643</itunes:duration>
                        <itunes:episodeType>full</itunes:episodeType>
            </item>
    <item>
        <title>Aspirin Plus Anticoagulation: What Are the Risks? - Frankly Speaking Ep 465</title>
        <itunes:title>Aspirin Plus Anticoagulation: What Are the Risks? - Frankly Speaking Ep 465</itunes:title>
        <link>https://primedfranklyspeaking.podbean.com/e/aspirin-plus-anticoagulation-what-are-the-risks-frankly-speaking-ep-465/</link>
                    <comments>https://primedfranklyspeaking.podbean.com/e/aspirin-plus-anticoagulation-what-are-the-risks-frankly-speaking-ep-465/#comments</comments>        <pubDate>Mon, 29 Dec 2025 05:30:00 +0000</pubDate>
        <guid isPermaLink="false">primedfranklyspeaking.podbean.com/6217cea5-bbdd-35f8-b4d3-2df0c0ce7157</guid>
                                    <description><![CDATA[<p>Credits: 0.25 AMA PRA Category 1 Credit™
 
CME/CE Information and Claim Credit: <a href='https://www.pri-med.com/online-education/podcast/frankly-speaking-cme-465'>https://www.pri-med.com/online-education/podcast/frankly-speaking-cme-465</a></p>
<p>Overview: Many patients with coronary artery disease take aspirin, but how should clinicians navigate management when an anticoagulant is also needed? In this episode, we review indications for therapy, explore evidence on dual use, and discuss how to counsel patients on balancing cardiovascular benefits with the risks of combination therapy.</p>
<p>Episode resource links:</p>
<ul>
<li>
<p>Lemesle G, Didier R, Steg PG, et al. Aspirin in Patients with Chronic Coronary Syndrome Receiving Oral Anticoagulation. N Engl J Med. Published online August 31, 2025.</p>
<p><a href='https://www.nejm.org/doi/full/10.1056/NEJMoa2507532'>https://www.nejm.org/doi/full/10.1056/NEJMoa2507532</a></p>
</li>
</ul>
<p>Guest: Alan M. Ehrlich, MD, FAAFP
 
Music Credit: Matthew Bugos</p>
<p>Thoughts? Suggestions? Email us at <a href='mailto:FranklySpeaking@pri-med.com'>FranklySpeaking@pri-med.com</a></p>
<p> </p>
]]></description>
                                                            <content:encoded><![CDATA[<p>Credits: 0.25 AMA PRA Category 1 Credit™<br>
 <br>
CME/CE Information and Claim Credit: <a href='https://www.pri-med.com/online-education/podcast/frankly-speaking-cme-465'>https://www.pri-med.com/online-education/podcast/frankly-speaking-cme-465</a></p>
<p>Overview: Many patients with coronary artery disease take aspirin, but how should clinicians navigate management when an anticoagulant is also needed? In this episode, we review indications for therapy, explore evidence on dual use, and discuss how to counsel patients on balancing cardiovascular benefits with the risks of combination therapy.</p>
<p>Episode resource links:</p>
<ul>
<li>
<p>Lemesle G, Didier R, Steg PG, et al. Aspirin in Patients with Chronic Coronary Syndrome Receiving Oral Anticoagulation. <em>N Engl J Med</em>. Published online August 31, 2025.</p>
<p><a href='https://www.nejm.org/doi/full/10.1056/NEJMoa2507532'>https://www.nejm.org/doi/full/10.1056/NEJMoa2507532</a></p>
</li>
</ul>
<p>Guest: Alan M. Ehrlich, MD, FAAFP<br>
 <br>
Music Credit: Matthew Bugos</p>
<p>Thoughts? Suggestions? Email us at <a href='mailto:FranklySpeaking@pri-med.com'>FranklySpeaking@pri-med.com</a></p>
<p> </p>
]]></content:encoded>
                                    
        <enclosure url="https://mcdn.podbean.com/mf/web/ieqiy8ek4quvj7qn/frankly-speaking-ep-465-afib-anticoagulant.mp4" length="179378025" type="video/mp4"/>
                <itunes:summary><![CDATA[Credits: 0.25 AMA PRA Category 1 Credit™ CME/CE Information and Claim Credit: https://www.pri-med.com/online-education/podcast/frankly-speaking-cme-465
Overview: Many patients with coronary artery disease take aspirin, but how should clinicians navigate management when an anticoagulant is also needed? In this episode, we review indications for therapy, explore evidence on dual use, and discuss how to counsel patients on balancing cardiovascular benefits with the risks of combination therapy.
Episode resource links:


Lemesle G, Didier R, Steg PG, et al. Aspirin in Patients with Chronic Coronary Syndrome Receiving Oral Anticoagulation. N Engl J Med. Published online August 31, 2025.
https://www.nejm.org/doi/full/10.1056/NEJMoa2507532


Guest: Alan M. Ehrlich, MD, FAAFP Music Credit: Matthew Bugos
Thoughts? Suggestions? Email us at FranklySpeaking@pri-med.com
 ]]></itunes:summary>
        <itunes:author>Pri-Med</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>645</itunes:duration>
                        <itunes:episodeType>full</itunes:episodeType>
            </item>
    <item>
        <title>A Spark of Motivation: Leveraging Lung Cancer Screening to Drive Change - Frankly Speaking Ep 464</title>
        <itunes:title>A Spark of Motivation: Leveraging Lung Cancer Screening to Drive Change - Frankly Speaking Ep 464</itunes:title>
        <link>https://primedfranklyspeaking.podbean.com/e/a-spark-of-motivation-leveraging-lung-cancer-screening-to-drive-change-frankly-speaking-ep-464/</link>
                    <comments>https://primedfranklyspeaking.podbean.com/e/a-spark-of-motivation-leveraging-lung-cancer-screening-to-drive-change-frankly-speaking-ep-464/#comments</comments>        <pubDate>Mon, 22 Dec 2025 05:30:00 +0000</pubDate>
        <guid isPermaLink="false">primedfranklyspeaking.podbean.com/9d4fc364-4e1e-325c-aedc-b97368eaca7b</guid>
                                    <description><![CDATA[<p>Credits: 0.25 AMA PRA Category 1 Credit™
 
CME/CE Information and Claim Credit: <a href='https://www.pri-med.com/online-education/podcast/frankly-speaking-cme-464'>https://www.pri-med.com/online-education/podcast/frankly-speaking-cme-464</a></p>
<p>Overview: Beyond detecting disease early, lung cancer screening provides an opportunity to encourage smoking cessation. In this episode, we review USPSTF guidelines, compare screening effectiveness, and explore how the use of a pulmonary function test (PFT) and a lung age estimator can help people who smoke better understand their risks and inspire behavior change.</p>
<p>Episode resource links:</p>
<ul>
<li>USPSTF: <a href='https://www.uspreventiveservicestaskforce.org/uspstf/recommendation/lung-cancer-screening'>https://www.uspreventiveservicestaskforce.org/uspstf/recommendation/lung-cancer-screening</a>
BMJ (Clinical Research Ed.). 2008;336(7644):598-600. doi:10.1136/bmj.39503.582396.25.</li>
<li>BMC Public Health. 2022;22(1):1164. doi:10.1186/s12889-022-13583-1.</li>
</ul>
<p>Guest: Robert A. Baldor MD, FAAFP</p>
<p>Music Credit: Matthew Bugos</p>
<p>Thoughts? Suggestions? Email us at <a href='mailto:FranklySpeaking@pri-med.com'>FranklySpeaking@pri-med.com</a></p>
<p> </p>
]]></description>
                                                            <content:encoded><![CDATA[<p>Credits: 0.25 AMA PRA Category 1 Credit™<br>
 <br>
CME/CE Information and Claim Credit: <a href='https://www.pri-med.com/online-education/podcast/frankly-speaking-cme-464'>https://www.pri-med.com/online-education/podcast/frankly-speaking-cme-464</a></p>
<p>Overview: Beyond detecting disease early, lung cancer screening provides an opportunity to encourage smoking cessation. In this episode, we review USPSTF guidelines, compare screening effectiveness, and explore how the use of a pulmonary function test (PFT) and a lung age estimator can help people who smoke better understand their risks and inspire behavior change.</p>
<p>Episode resource links:</p>
<ul>
<li>USPSTF: <a href='https://www.uspreventiveservicestaskforce.org/uspstf/recommendation/lung-cancer-screening'>https://www.uspreventiveservicestaskforce.org/uspstf/recommendation/lung-cancer-screening</a><br>
BMJ (Clinical Research Ed.). 2008;336(7644):598-600. doi:10.1136/bmj.39503.582396.25.</li>
<li>BMC Public Health. 2022;22(1):1164. doi:10.1186/s12889-022-13583-1.</li>
</ul>
<p>Guest: Robert A. Baldor MD, FAAFP</p>
<p>Music Credit: Matthew Bugos</p>
<p>Thoughts? Suggestions? Email us at <a href='mailto:FranklySpeaking@pri-med.com'>FranklySpeaking@pri-med.com</a></p>
<p> </p>
]]></content:encoded>
                                    
        <enclosure url="https://mcdn.podbean.com/mf/web/9x2dppnb85iu8jyb/episode-464-lung-damage.mp3" length="10975526" type="audio/mpeg"/>
                <itunes:summary><![CDATA[Credits: 0.25 AMA PRA Category 1 Credit™ CME/CE Information and Claim Credit: https://www.pri-med.com/online-education/podcast/frankly-speaking-cme-464
Overview: Beyond detecting disease early, lung cancer screening provides an opportunity to encourage smoking cessation. In this episode, we review USPSTF guidelines, compare screening effectiveness, and explore how the use of a pulmonary function test (PFT) and a lung age estimator can help people who smoke better understand their risks and inspire behavior change.
Episode resource links:

USPSTF: https://www.uspreventiveservicestaskforce.org/uspstf/recommendation/lung-cancer-screeningBMJ (Clinical Research Ed.). 2008;336(7644):598-600. doi:10.1136/bmj.39503.582396.25.
BMC Public Health. 2022;22(1):1164. doi:10.1186/s12889-022-13583-1.

Guest: Robert A. Baldor MD, FAAFP
Music Credit: Matthew Bugos
Thoughts? Suggestions? Email us at FranklySpeaking@pri-med.com
 ]]></itunes:summary>
        <itunes:author>Pri-Med</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>684</itunes:duration>
                        <itunes:episodeType>full</itunes:episodeType>
            </item>
    <item>
        <title>Rethinking Chronic Back Pain: Practical Behavioral Interventions for Primary Care - Frankly Speaking Ep 463</title>
        <itunes:title>Rethinking Chronic Back Pain: Practical Behavioral Interventions for Primary Care - Frankly Speaking Ep 463</itunes:title>
        <link>https://primedfranklyspeaking.podbean.com/e/rethinking-chronic-back-pain-practical-behavioral-interventions-for-primary-care-frankly-speaking-ep-463/</link>
                    <comments>https://primedfranklyspeaking.podbean.com/e/rethinking-chronic-back-pain-practical-behavioral-interventions-for-primary-care-frankly-speaking-ep-463/#comments</comments>        <pubDate>Mon, 15 Dec 2025 05:30:00 +0000</pubDate>
        <guid isPermaLink="false">primedfranklyspeaking.podbean.com/c32a90cd-4fa6-39f2-aa5b-4bc041bb1d48</guid>
                                    <description><![CDATA[<p>Credits: 0.25 AMA PRA Category 1 Credit™
 
CME/CE Information and Claim Credit: <a href='https://www.pri-med.com/online-education/podcast/frankly-speaking-cme-463'>https://www.pri-med.com/online-education/podcast/frankly-speaking-cme-463</a></p>
<p>Overview: Listen in as we discuss how integrating behavioral therapies into the management of chronic back pain can improve function, reduce opioid use, and empower patients. Boost your clinical toolkit with evidence-based strategies that enhance outcomes while aligning with evolving guidelines for safer, multimodal approaches to chronic pain care.</p>
<p>Episode resource links:</p>
<ul>
<li>Zgierska AE, Edwards RR, Barrett B, et al. Mindfulness vs Cognitive Behavioral Therapy for Chronic Low Back Pain Treated With Opioids: A Randomized Clinical Trial. JAMA Netw Open. 2025;8(4):e253204. doi:10.1001/jamanetworkopen.2025.3204</li>
<li>Dowell D, Ragan KR, Jones CM, Baldwin GT, Chou R. CDC Clinical Practice Guideline for Prescribing Opioids for Pain - United States, 2022. MMWR Recomm Rep. 2022 Nov 4;71(3):1-95. doi: 10.15585/mmwr.rr7103a1. PMID: 36327391; PMCID: PMC9639433.</li>
</ul>
<p>Guest: Jillian Joseph, MPAS, PA-C</p>
<p>Music Credit: Matthew Bugos</p>
<p>Thoughts? Suggestions? Email us at <a href='mailto:FranklySpeaking@pri-med.com'>FranklySpeaking@pri-med.com</a></p>
<p> </p>
]]></description>
                                                            <content:encoded><![CDATA[<p>Credits: 0.25 AMA PRA Category 1 Credit™<br>
 <br>
CME/CE Information and Claim Credit: <a href='https://www.pri-med.com/online-education/podcast/frankly-speaking-cme-463'>https://www.pri-med.com/online-education/podcast/frankly-speaking-cme-463</a></p>
<p>Overview: Listen in as we discuss how integrating behavioral therapies into the management of chronic back pain can improve function, reduce opioid use, and empower patients. Boost your clinical toolkit with evidence-based strategies that enhance outcomes while aligning with evolving guidelines for safer, multimodal approaches to chronic pain care.</p>
<p>Episode resource links:</p>
<ul>
<li>Zgierska AE, Edwards RR, Barrett B, et al. Mindfulness vs Cognitive Behavioral Therapy for Chronic Low Back Pain Treated With Opioids: A Randomized Clinical Trial. JAMA Netw Open. 2025;8(4):e253204. doi:10.1001/jamanetworkopen.2025.3204</li>
<li>Dowell D, Ragan KR, Jones CM, Baldwin GT, Chou R. CDC Clinical Practice Guideline for Prescribing Opioids for Pain - United States, 2022. MMWR Recomm Rep. 2022 Nov 4;71(3):1-95. doi: 10.15585/mmwr.rr7103a1. PMID: 36327391; PMCID: PMC9639433.</li>
</ul>
<p>Guest: Jillian Joseph, MPAS, PA-C</p>
<p>Music Credit: Matthew Bugos</p>
<p>Thoughts? Suggestions? Email us at <a href='mailto:FranklySpeaking@pri-med.com'>FranklySpeaking@pri-med.com</a></p>
<p> </p>
]]></content:encoded>
                                    
        <enclosure url="https://mcdn.podbean.com/mf/web/2a8s79ihysvh7ja8/episode-463-low-back-pain.mp3" length="16427692" type="audio/mpeg"/>
                <itunes:summary><![CDATA[Credits: 0.25 AMA PRA Category 1 Credit™ CME/CE Information and Claim Credit: https://www.pri-med.com/online-education/podcast/frankly-speaking-cme-463
Overview: Listen in as we discuss how integrating behavioral therapies into the management of chronic back pain can improve function, reduce opioid use, and empower patients. Boost your clinical toolkit with evidence-based strategies that enhance outcomes while aligning with evolving guidelines for safer, multimodal approaches to chronic pain care.
Episode resource links:

Zgierska AE, Edwards RR, Barrett B, et al. Mindfulness vs Cognitive Behavioral Therapy for Chronic Low Back Pain Treated With Opioids: A Randomized Clinical Trial. JAMA Netw Open. 2025;8(4):e253204. doi:10.1001/jamanetworkopen.2025.3204
Dowell D, Ragan KR, Jones CM, Baldwin GT, Chou R. CDC Clinical Practice Guideline for Prescribing Opioids for Pain - United States, 2022. MMWR Recomm Rep. 2022 Nov 4;71(3):1-95. doi: 10.15585/mmwr.rr7103a1. PMID: 36327391; PMCID: PMC9639433.

Guest: Jillian Joseph, MPAS, PA-C
Music Credit: Matthew Bugos
Thoughts? Suggestions? Email us at FranklySpeaking@pri-med.com
 ]]></itunes:summary>
        <itunes:author>Pri-Med</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>1024</itunes:duration>
                        <itunes:episodeType>full</itunes:episodeType>
            </item>
    <item>
        <title>Migraine Relief Starts Here: Current Management Tools for PCPs - Frankly Speaking Ep 462</title>
        <itunes:title>Migraine Relief Starts Here: Current Management Tools for PCPs - Frankly Speaking Ep 462</itunes:title>
        <link>https://primedfranklyspeaking.podbean.com/e/migraine-relief-starts-here-current-management-tools-for-pcps-frankly-speaking-ep-462/</link>
                    <comments>https://primedfranklyspeaking.podbean.com/e/migraine-relief-starts-here-current-management-tools-for-pcps-frankly-speaking-ep-462/#comments</comments>        <pubDate>Mon, 08 Dec 2025 05:30:00 +0000</pubDate>
        <guid isPermaLink="false">primedfranklyspeaking.podbean.com/d9640073-ede3-3e1a-8ac6-4f5c72bc1a78</guid>
                                    <description><![CDATA[<p>Credits: 0.25 AMA PRA Category 1 Credit™
 
CME/CE Information and Claim Credit: <a href='https://www.pri-med.com/online-education/podcast/frankly-speaking-cme-462'>https://www.pri-med.com/online-education/podcast/frankly-speaking-cme-462</a></p>
<p>Overview: In this episode, we examine migraine—a leading cause of disability worldwide that is often underdiagnosed and undertreated in primary care. You’ll learn how to distinguish migraine from other headache disorders, identify who is most affected, and explore both acute pharmacologic options and preventive strategies that can reduce attack frequency and improve patients’ quality of life.</p>
<p>Episode resource links:</p>
<ul>
<li>El Hussein, M. T., &amp; Fraser, L. (2025). Pharmacologic Management of Migraine in Primary Care: Nurse Practitioner Guide. The Journal for Nurse Practitioners, 21(9), 105501.</li>
<li>Qaseem, A., Tice, J. A., Etxeandia-Ikobaltzeta, I., Wilt, T. J., Harrod, C. S., Cooney, T. G., ... &amp; Yost, J. (2025). Pharmacologic treatments of acute episodic migraine headache in outpatient settings: a clinical guideline from the American College of Physicians. Annals of internal medicine, 178(4), 571-578.</li>
<li>Charles, A. C., Tepper, S. J., &amp; Ailani, J. (2025). State of the art in the management of migraine—A response to the American College of Physicians migraine preventive treatment guideline. Headache: The Journal of Head and Face Pain.</li>
<li>Vélez-Jiménez MK, et al. Comprehensive Preventive Treatments for Episodic Migraine: Systematic Review. Front Neurol. 2025</li>
<li>Lanteri-Minet, M., Casarotto, C., Bretin, O., Collin, C., Gugenheim, M., Raclot, V., ... &amp; Lefebvre, H. (2025). Prevalence, characteristics and management of migraine patients with triptan failure in primary care: the EMR France-Mig study. The Journal of Headache and Pain, 26(1), 153.</li>
</ul>
<p>Guest: Mariyan L. Montaque, DNP, FNP-BC
 
Music Credit: Matthew Bugos</p>
<p>Thoughts? Suggestions? Email us at <a href='mailto:FranklySpeaking@pri-med.com'>FranklySpeaking@pri-med.com</a></p>
<p> </p>
]]></description>
                                                            <content:encoded><![CDATA[<p>Credits: 0.25 AMA PRA Category 1 Credit™<br>
 <br>
CME/CE Information and Claim Credit: <a href='https://www.pri-med.com/online-education/podcast/frankly-speaking-cme-462'>https://www.pri-med.com/online-education/podcast/frankly-speaking-cme-462</a></p>
<p>Overview: In this episode, we examine migraine—a leading cause of disability worldwide that is often underdiagnosed and undertreated in primary care. You’ll learn how to distinguish migraine from other headache disorders, identify who is most affected, and explore both acute pharmacologic options and preventive strategies that can reduce attack frequency and improve patients’ quality of life.</p>
<p>Episode resource links:</p>
<ul>
<li>El Hussein, M. T., &amp; Fraser, L. (2025). Pharmacologic Management of Migraine in Primary Care: Nurse Practitioner Guide. The Journal for Nurse Practitioners, 21(9), 105501.</li>
<li>Qaseem, A., Tice, J. A., Etxeandia-Ikobaltzeta, I., Wilt, T. J., Harrod, C. S., Cooney, T. G., ... &amp; Yost, J. (2025). Pharmacologic treatments of acute episodic migraine headache in outpatient settings: a clinical guideline from the American College of Physicians. Annals of internal medicine, 178(4), 571-578.</li>
<li>Charles, A. C., Tepper, S. J., &amp; Ailani, J. (2025). State of the art in the management of migraine—A response to the American College of Physicians migraine preventive treatment guideline. Headache: The Journal of Head and Face Pain.</li>
<li>Vélez-Jiménez MK, et al. Comprehensive Preventive Treatments for Episodic Migraine: Systematic Review. Front Neurol. 2025</li>
<li>Lanteri-Minet, M., Casarotto, C., Bretin, O., Collin, C., Gugenheim, M., Raclot, V., ... &amp; Lefebvre, H. (2025). Prevalence, characteristics and management of migraine patients with triptan failure in primary care: the EMR France-Mig study. The Journal of Headache and Pain, 26(1), 153.</li>
</ul>
<p>Guest: Mariyan L. Montaque, DNP, FNP-BC<br>
 <br>
Music Credit: Matthew Bugos</p>
<p>Thoughts? Suggestions? Email us at <a href='mailto:FranklySpeaking@pri-med.com'>FranklySpeaking@pri-med.com</a></p>
<p> </p>
]]></content:encoded>
                                    
        <enclosure url="https://mcdn.podbean.com/mf/web/vaepjw63rszfgp9p/frankly-speaking-ep-462-migraine.mp4" length="185360598" type="video/mp4"/>
                <itunes:summary><![CDATA[Credits: 0.25 AMA PRA Category 1 Credit™ CME/CE Information and Claim Credit: https://www.pri-med.com/online-education/podcast/frankly-speaking-cme-462
Overview: In this episode, we examine migraine—a leading cause of disability worldwide that is often underdiagnosed and undertreated in primary care. You’ll learn how to distinguish migraine from other headache disorders, identify who is most affected, and explore both acute pharmacologic options and preventive strategies that can reduce attack frequency and improve patients’ quality of life.
Episode resource links:

El Hussein, M. T., &amp; Fraser, L. (2025). Pharmacologic Management of Migraine in Primary Care: Nurse Practitioner Guide. The Journal for Nurse Practitioners, 21(9), 105501.
Qaseem, A., Tice, J. A., Etxeandia-Ikobaltzeta, I., Wilt, T. J., Harrod, C. S., Cooney, T. G., ... &amp; Yost, J. (2025). Pharmacologic treatments of acute episodic migraine headache in outpatient settings: a clinical guideline from the American College of Physicians. Annals of internal medicine, 178(4), 571-578.
Charles, A. C., Tepper, S. J., &amp; Ailani, J. (2025). State of the art in the management of migraine—A response to the American College of Physicians migraine preventive treatment guideline. Headache: The Journal of Head and Face Pain.
Vélez-Jiménez MK, et al. Comprehensive Preventive Treatments for Episodic Migraine: Systematic Review. Front Neurol. 2025
Lanteri-Minet, M., Casarotto, C., Bretin, O., Collin, C., Gugenheim, M., Raclot, V., ... &amp; Lefebvre, H. (2025). Prevalence, characteristics and management of migraine patients with triptan failure in primary care: the EMR France-Mig study. The Journal of Headache and Pain, 26(1), 153.

Guest: Mariyan L. Montaque, DNP, FNP-BC Music Credit: Matthew Bugos
Thoughts? Suggestions? Email us at FranklySpeaking@pri-med.com
 ]]></itunes:summary>
        <itunes:author>Pri-Med</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>678</itunes:duration>
                        <itunes:episodeType>full</itunes:episodeType>
            </item>
    <item>
        <title>A Clearer Path for Complicated UTIs: Updated Guidance, Streamlined Care - Frankly Speaking Ep 461</title>
        <itunes:title>A Clearer Path for Complicated UTIs: Updated Guidance, Streamlined Care - Frankly Speaking Ep 461</itunes:title>
        <link>https://primedfranklyspeaking.podbean.com/e/a-clearer-path-for-complicated-utis-updated-guidance-streamlined-care-frankly-speaking-ep-461/</link>
                    <comments>https://primedfranklyspeaking.podbean.com/e/a-clearer-path-for-complicated-utis-updated-guidance-streamlined-care-frankly-speaking-ep-461/#comments</comments>        <pubDate>Mon, 01 Dec 2025 05:30:00 +0000</pubDate>
        <guid isPermaLink="false">primedfranklyspeaking.podbean.com/5982425a-3b2a-3b63-a69e-6b18618ee015</guid>
                                    <description><![CDATA[<p>Credits: 0.25 AMA PRA Category 1 Credit™
 
CME/CE Information and Claim Credit: <a href='https://www.pri-med.com/online-education/podcast/frankly-speaking-cme-461'>https://www.pri-med.com/online-education/podcast/frankly-speaking-cme-461</a></p>
<p>Overview: Complicated urinary tract infections (UTIs) are common in primary care but can be difficult to approach. In this episode, you’ll learn how to identify complicated UTIs, methodically address them, and incorporate new guidance on outpatient management and antibiotic selection to improve diagnosis and treatment for your patients.</p>
<p>Episode resource links:</p>
<ul>
<li>Complicated Urinary Tract Infections (cUTI): Clinical Guidelines for Treatment and Management <a href='https://www.idsociety.org/practice-guideline/complicated-urinary-tract-infections'>https://www.idsociety.org/practice-guideline/complicated-urinary-tract-infections</a></li>
<li>Koehl J, Spolsdoff D, Negaard B, et al. Cephalosporins for Outpatient Pyelonephritis in the Emergency Department: COPY-ED Study. Ann Emerg Med. 2025;85(3):240-248. <a href='https://pubmed.ncbi.nlm.nih.gov/39570254/'>https://pubmed.ncbi.nlm.nih.gov/39570254/</a></li>
</ul>
<p>Guest: Alan M. Ehrlich, MD, FAAFP
 
Music Credit: Matthew Bugos</p>
<p>Thoughts? Suggestions? Email us at <a href='mailto:FranklySpeaking@pri-med.com'>FranklySpeaking@pri-med.com</a></p>
<p> </p>
]]></description>
                                                            <content:encoded><![CDATA[<p>Credits: 0.25 AMA PRA Category 1 Credit™<br>
 <br>
CME/CE Information and Claim Credit: <a href='https://www.pri-med.com/online-education/podcast/frankly-speaking-cme-461'>https://www.pri-med.com/online-education/podcast/frankly-speaking-cme-461</a></p>
<p>Overview: Complicated urinary tract infections (UTIs) are common in primary care but can be difficult to approach. In this episode, you’ll learn how to identify complicated UTIs, methodically address them, and incorporate new guidance on outpatient management and antibiotic selection to improve diagnosis and treatment for your patients.</p>
<p>Episode resource links:</p>
<ul>
<li>Complicated Urinary Tract Infections (cUTI): Clinical Guidelines for Treatment and Management <a href='https://www.idsociety.org/practice-guideline/complicated-urinary-tract-infections'>https://www.idsociety.org/practice-guideline/complicated-urinary-tract-infections</a></li>
<li>Koehl J, Spolsdoff D, Negaard B, et al. Cephalosporins for Outpatient Pyelonephritis in the Emergency Department: COPY-ED Study. Ann Emerg Med. 2025;85(3):240-248. <a href='https://pubmed.ncbi.nlm.nih.gov/39570254/'>https://pubmed.ncbi.nlm.nih.gov/39570254/</a></li>
</ul>
<p>Guest: Alan M. Ehrlich, MD, FAAFP<br>
 <br>
Music Credit: Matthew Bugos</p>
<p>Thoughts? Suggestions? Email us at <a href='mailto:FranklySpeaking@pri-med.com'>FranklySpeaking@pri-med.com</a></p>
<p> </p>
]]></content:encoded>
                                    
        <enclosure url="https://mcdn.podbean.com/mf/web/5b6qn3x4vxhbatab/frankly-speaking-ep-461-UTI-guidelines.mp4" length="188837553" type="video/mp4"/>
                <itunes:summary><![CDATA[Credits: 0.25 AMA PRA Category 1 Credit™ CME/CE Information and Claim Credit: https://www.pri-med.com/online-education/podcast/frankly-speaking-cme-461
Overview: Complicated urinary tract infections (UTIs) are common in primary care but can be difficult to approach. In this episode, you’ll learn how to identify complicated UTIs, methodically address them, and incorporate new guidance on outpatient management and antibiotic selection to improve diagnosis and treatment for your patients.
Episode resource links:

Complicated Urinary Tract Infections (cUTI): Clinical Guidelines for Treatment and Management https://www.idsociety.org/practice-guideline/complicated-urinary-tract-infections
Koehl J, Spolsdoff D, Negaard B, et al. Cephalosporins for Outpatient Pyelonephritis in the Emergency Department: COPY-ED Study. Ann Emerg Med. 2025;85(3):240-248. https://pubmed.ncbi.nlm.nih.gov/39570254/

Guest: Alan M. Ehrlich, MD, FAAFP Music Credit: Matthew Bugos
Thoughts? Suggestions? Email us at FranklySpeaking@pri-med.com
 ]]></itunes:summary>
        <itunes:author>Pri-Med</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>684</itunes:duration>
                        <itunes:episodeType>full</itunes:episodeType>
            </item>
    <item>
        <title>How Often Should Patients with Hypertension Check Their Blood Pressure at Home? - Frankly Speaking Ep 460</title>
        <itunes:title>How Often Should Patients with Hypertension Check Their Blood Pressure at Home? - Frankly Speaking Ep 460</itunes:title>
        <link>https://primedfranklyspeaking.podbean.com/e/how-often-should-patients-with-hypertension-check-their-blood-pressure-at-home-frankly-speaking-ep-460/</link>
                    <comments>https://primedfranklyspeaking.podbean.com/e/how-often-should-patients-with-hypertension-check-their-blood-pressure-at-home-frankly-speaking-ep-460/#comments</comments>        <pubDate>Mon, 24 Nov 2025 05:30:00 +0000</pubDate>
        <guid isPermaLink="false">primedfranklyspeaking.podbean.com/8b7da564-29da-3242-8821-609e32b3384b</guid>
                                    <description><![CDATA[<p>Credits: 0.25 AMA PRA Category 1 Credit™
 
CME/CE Information and Claim Credit: <a href='https://www.pri-med.com/online-education/podcast/frankly-speaking-cme-460'>https://www.pri-med.com/online-education/podcast/frankly-speaking-cme-460</a></p>
<p>Overview: Join us as we discuss how frequently patients with stable hypertension should monitor their blood pressure at home. Hear insights from two trials to help you provide evidence-based, cost-conscious guidance—reducing unnecessary alarms while supporting better long-term management.</p>
<p>Episode resource links:</p>
<ul>
<li>Rose, Francesa; Stevens, Richard S.a; Morton, Kate S.b; Yardley, Lucyc; McManus, Richard J.a,d. How often should self-monitoring of blood pressure be repeated? A secondary analysis of data from two randomized controlled trials. Journal of Hypertension ():10.1097/HJH.0000000000004123, August 20, 2025. | DOI: 10.1097/HJH.0000000000004123</li>
</ul>
<p>Guest: Robert A. Baldor MD, FAAFP
 
Music Credit: Matthew Bugos</p>
<p>Thoughts? Suggestions? Email us at <a href='mailto:FranklySpeaking@pri-med.com'>FranklySpeaking@pri-med.com</a></p>
<p> </p>
]]></description>
                                                            <content:encoded><![CDATA[<p>Credits: 0.25 AMA PRA Category 1 Credit™<br>
 <br>
CME/CE Information and Claim Credit: <a href='https://www.pri-med.com/online-education/podcast/frankly-speaking-cme-460'>https://www.pri-med.com/online-education/podcast/frankly-speaking-cme-460</a></p>
<p>Overview: Join us as we discuss how frequently patients with stable hypertension should monitor their blood pressure at home. Hear insights from two trials to help you provide evidence-based, cost-conscious guidance—reducing unnecessary alarms while supporting better long-term management.</p>
<p>Episode resource links:</p>
<ul>
<li>Rose, Francesa; Stevens, Richard S.a; Morton, Kate S.b; Yardley, Lucyc; McManus, Richard J.a,d. How often should self-monitoring of blood pressure be repeated? A secondary analysis of data from two randomized controlled trials. Journal of Hypertension ():10.1097/HJH.0000000000004123, August 20, 2025. | DOI: 10.1097/HJH.0000000000004123</li>
</ul>
<p>Guest: Robert A. Baldor MD, FAAFP<br>
 <br>
Music Credit: Matthew Bugos</p>
<p>Thoughts? Suggestions? Email us at <a href='mailto:FranklySpeaking@pri-med.com'>FranklySpeaking@pri-med.com</a></p>
<p> </p>
]]></content:encoded>
                                    
        <enclosure url="https://mcdn.podbean.com/mf/web/bnqfk2ufutb4imq4/frankly-speaking-460-blood-pressure-monitoring.mp3" length="9890708" type="audio/mpeg"/>
                <itunes:summary><![CDATA[Credits: 0.25 AMA PRA Category 1 Credit™ CME/CE Information and Claim Credit: https://www.pri-med.com/online-education/podcast/frankly-speaking-cme-460
Overview: Join us as we discuss how frequently patients with stable hypertension should monitor their blood pressure at home. Hear insights from two trials to help you provide evidence-based, cost-conscious guidance—reducing unnecessary alarms while supporting better long-term management.
Episode resource links:

Rose, Francesa; Stevens, Richard S.a; Morton, Kate S.b; Yardley, Lucyc; McManus, Richard J.a,d. How often should self-monitoring of blood pressure be repeated? A secondary analysis of data from two randomized controlled trials. Journal of Hypertension ():10.1097/HJH.0000000000004123, August 20, 2025. | DOI: 10.1097/HJH.0000000000004123

Guest: Robert A. Baldor MD, FAAFP Music Credit: Matthew Bugos
Thoughts? Suggestions? Email us at FranklySpeaking@pri-med.com
 ]]></itunes:summary>
        <itunes:author>Pri-Med</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>616</itunes:duration>
                        <itunes:episodeType>full</itunes:episodeType>
            </item>
    <item>
        <title>Thinking Ahead: Reducing Cognitive Decline Risk Through Lifestyle Interventions - Frankly Speaking Ep 459</title>
        <itunes:title>Thinking Ahead: Reducing Cognitive Decline Risk Through Lifestyle Interventions - Frankly Speaking Ep 459</itunes:title>
        <link>https://primedfranklyspeaking.podbean.com/e/thinking-ahead-reducing-cognitive-decline-risk-through-lifestyle-interventions-frankly-speaking-ep-459/</link>
                    <comments>https://primedfranklyspeaking.podbean.com/e/thinking-ahead-reducing-cognitive-decline-risk-through-lifestyle-interventions-frankly-speaking-ep-459/#comments</comments>        <pubDate>Mon, 17 Nov 2025 05:30:00 +0000</pubDate>
        <guid isPermaLink="false">primedfranklyspeaking.podbean.com/9cf8d9fa-7dfa-3895-94b9-e8d39a4d9678</guid>
                                    <description><![CDATA[<p>Credits: 0.25 AMA PRA Category 1 Credit™
 
CME/CE Information and Claim Credit: <a href='https://www.pri-med.com/online-education/podcast/frankly-speaking-cme-459'>https://www.pri-med.com/online-education/podcast/frankly-speaking-cme-459</a></p>
<p>Overview: Cognitive decline risk may be reduced through modifiable lifestyle factors, creating an opportunity for early intervention in primary care. Join us as we review findings from the US POINTER trial, which evaluated the impact of structured vs. self-guided lifestyle interventions on the risk of cognitive decline in older adults. Come away with tips to apply this evidence in real-world scenarios with your patients.</p>
<p>Episode resource links:</p>
<ul>
<li>Baker LD, Espeland MA, Whitmer RA, et al. Structured vs self-guided multidomain lifestyle interventions for global cognitive function: The US POINTER randomized clinical trial. JAMA. 2025;334(8):681-691. doi:10.1001/jama.2025.12923</li>
<li>Livingston G, Huntley J, Liu KY, et al. Dementia prevention, intervention, and care: 2024 report of the Lancet standing Commission. Lancet. 2024;404(10421):572-628. doi:10.1016/S0140-6736(24)01296-0</li>
</ul>
<p>Guest: Jillian Joseph, MPAS, PA-C</p>
<p>Music Credit: Matthew Bugos</p>
<p>Thoughts? Suggestions? Email us at <a href='mailto:FranklySpeaking@pri-med.com'>FranklySpeaking@pri-med.com </a></p>
<p> </p>
]]></description>
                                                            <content:encoded><![CDATA[<p>Credits: 0.25 AMA PRA Category 1 Credit™<br>
 <br>
CME/CE Information and Claim Credit: <a href='https://www.pri-med.com/online-education/podcast/frankly-speaking-cme-459'>https://www.pri-med.com/online-education/podcast/frankly-speaking-cme-459</a></p>
<p>Overview: Cognitive decline risk may be reduced through modifiable lifestyle factors, creating an opportunity for early intervention in primary care. Join us as we review findings from the US POINTER trial, which evaluated the impact of structured vs. self-guided lifestyle interventions on the risk of cognitive decline in older adults. Come away with tips to apply this evidence in real-world scenarios with your patients.</p>
<p>Episode resource links:</p>
<ul>
<li>Baker LD, Espeland MA, Whitmer RA, et al. Structured vs self-guided multidomain lifestyle interventions for global cognitive function: The US POINTER randomized clinical trial. JAMA. 2025;334(8):681-691. doi:10.1001/jama.2025.12923</li>
<li>Livingston G, Huntley J, Liu KY, et al. Dementia prevention, intervention, and care: 2024 report of the Lancet standing Commission. Lancet. 2024;404(10421):572-628. doi:10.1016/S0140-6736(24)01296-0</li>
</ul>
<p>Guest: Jillian Joseph, MPAS, PA-C</p>
<p>Music Credit: Matthew Bugos</p>
<p>Thoughts? Suggestions? Email us at <a href='mailto:FranklySpeaking@pri-med.com'>FranklySpeaking@pri-med.com </a></p>
<p> </p>
]]></content:encoded>
                                    
        <enclosure url="https://mcdn.podbean.com/mf/web/tfsydzh3jiitpurv/frankly-speaking-459-lifestyle-cognition.mp3" length="11895769" type="audio/mpeg"/>
                <itunes:summary><![CDATA[Credits: 0.25 AMA PRA Category 1 Credit™ CME/CE Information and Claim Credit: https://www.pri-med.com/online-education/podcast/frankly-speaking-cme-459
Overview: Cognitive decline risk may be reduced through modifiable lifestyle factors, creating an opportunity for early intervention in primary care. Join us as we review findings from the US POINTER trial, which evaluated the impact of structured vs. self-guided lifestyle interventions on the risk of cognitive decline in older adults. Come away with tips to apply this evidence in real-world scenarios with your patients.
Episode resource links:

Baker LD, Espeland MA, Whitmer RA, et al. Structured vs self-guided multidomain lifestyle interventions for global cognitive function: The US POINTER randomized clinical trial. JAMA. 2025;334(8):681-691. doi:10.1001/jama.2025.12923
Livingston G, Huntley J, Liu KY, et al. Dementia prevention, intervention, and care: 2024 report of the Lancet standing Commission. Lancet. 2024;404(10421):572-628. doi:10.1016/S0140-6736(24)01296-0

Guest: Jillian Joseph, MPAS, PA-C
Music Credit: Matthew Bugos
Thoughts? Suggestions? Email us at FranklySpeaking@pri-med.com 
 ]]></itunes:summary>
        <itunes:author>Pri-Med</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>741</itunes:duration>
                        <itunes:episodeType>full</itunes:episodeType>
            </item>
    <item>
        <title>Caffeine Contrasts: Coffee, Energy Drinks, and Suicide Risk Screening - Frankly Speaking Ep 458</title>
        <itunes:title>Caffeine Contrasts: Coffee, Energy Drinks, and Suicide Risk Screening - Frankly Speaking Ep 458</itunes:title>
        <link>https://primedfranklyspeaking.podbean.com/e/caffeine-contrasts-coffee-energy-drinks-and-suicide-risk-screening-frankly-speaking-ep-458/</link>
                    <comments>https://primedfranklyspeaking.podbean.com/e/caffeine-contrasts-coffee-energy-drinks-and-suicide-risk-screening-frankly-speaking-ep-458/#comments</comments>        <pubDate>Mon, 10 Nov 2025 05:30:00 +0000</pubDate>
        <guid isPermaLink="false">primedfranklyspeaking.podbean.com/d5b7eaf1-4e2f-3253-9dbb-8ae43e9566f5</guid>
                                    <description><![CDATA[<p>Credits: 0.25 AMA PRA Category 1 Credit™
 
CME/CE Information and Claim Credit: <a href='https://www.pri-med.com/online-education/podcast/frankly-speaking-cme-458'>https://www.pri-med.com/online-education/podcast/frankly-speaking-cme-458</a></p>
<p>Overview: In this episode, we explore the relationship between caffeine consumption and suicide risk. Hear how coffee may offer protective effects—while energy drinks raise concern—and gain practical tips for screening patients for caffeine and substance use as part of suicide risk assessment in primary care.</p>
<p>Episode resource links:</p>
<ul>
<li>
<p>Low, C.E.; Chew, N.S.M.; Loke, S.; Tan, J.Y.; Phee, S.; Lee, A.R.Y.B.; Ho, C.S.H. Association of Coffee and Energy Drink Intake with Suicide Attempts and Suicide Ideation: A Systematic Review and Meta-Analysis. Nutrients 2025, 17, 1911. https://doi.org/10.3390/ nu17111911</p>
<p> </p>
</li>
<li>
<p>Costantino, A., Maiese, A., Lazzari, J., Casula, C., Turillazzi, E., Frati, P., &amp; Fineschi, V. (2023). The Dark Side of Energy Drinks: A Comprehensive Review of Their Impact on the Human Body. Nutrients, 15(18), 3922. <a href='https://doi.org/10.3390/nu15183922'>https://doi.org/10.3390/nu15183922</a></p>
</li>
</ul>
<p>Guest: Jill M. Terrien PhD, ANP-BC 
 
Music Credit: Matthew Bugos</p>
<p>Thoughts? Suggestions? Email us at <a href='mailto:FranklySpeaking@pri-med.com'>FranklySpeaking@pri-med.com</a></p>
<p> </p>
]]></description>
                                                            <content:encoded><![CDATA[<p>Credits: 0.25 AMA PRA Category 1 Credit™<br>
 <br>
CME/CE Information and Claim Credit: <a href='https://www.pri-med.com/online-education/podcast/frankly-speaking-cme-458'>https://www.pri-med.com/online-education/podcast/frankly-speaking-cme-458</a></p>
<p>Overview: In this episode, we explore the relationship between caffeine consumption and suicide risk. Hear how coffee may offer protective effects—while energy drinks raise concern—and gain practical tips for screening patients for caffeine and substance use as part of suicide risk assessment in primary care.</p>
<p>Episode resource links:</p>
<ul>
<li>
<p>Low, C.E.; Chew, N.S.M.; Loke, S.; Tan, J.Y.; Phee, S.; Lee, A.R.Y.B.; Ho, C.S.H. Association of Coffee and Energy Drink Intake with Suicide Attempts and Suicide Ideation: A Systematic Review and Meta-Analysis. Nutrients 2025, 17, 1911. https://doi.org/10.3390/ nu17111911</p>
<p> </p>
</li>
<li>
<p>Costantino, A., Maiese, A., Lazzari, J., Casula, C., Turillazzi, E., Frati, P., &amp; Fineschi, V. (2023). The Dark Side of Energy Drinks: A Comprehensive Review of Their Impact on the Human Body. Nutrients, 15(18), 3922. <a href='https://doi.org/10.3390/nu15183922'>https://doi.org/10.3390/nu15183922</a></p>
</li>
</ul>
<p>Guest: Jill M. Terrien PhD, ANP-BC <br>
 <br>
Music Credit: Matthew Bugos</p>
<p>Thoughts? Suggestions? Email us at <a href='mailto:FranklySpeaking@pri-med.com'>FranklySpeaking@pri-med.com</a></p>
<p> </p>
]]></content:encoded>
                                    
        <enclosure url="https://mcdn.podbean.com/mf/web/eb5q9252c6kcp8i7/frankly-speaking-458-suicide-energy-drinks.mp3" length="12653311" type="audio/mpeg"/>
                <itunes:summary><![CDATA[Credits: 0.25 AMA PRA Category 1 Credit™ CME/CE Information and Claim Credit: https://www.pri-med.com/online-education/podcast/frankly-speaking-cme-458
Overview: In this episode, we explore the relationship between caffeine consumption and suicide risk. Hear how coffee may offer protective effects—while energy drinks raise concern—and gain practical tips for screening patients for caffeine and substance use as part of suicide risk assessment in primary care.
Episode resource links:


Low, C.E.; Chew, N.S.M.; Loke, S.; Tan, J.Y.; Phee, S.; Lee, A.R.Y.B.; Ho, C.S.H. Association of Coffee and Energy Drink Intake with Suicide Attempts and Suicide Ideation: A Systematic Review and Meta-Analysis. Nutrients 2025, 17, 1911. https://doi.org/10.3390/ nu17111911
 


Costantino, A., Maiese, A., Lazzari, J., Casula, C., Turillazzi, E., Frati, P., &amp; Fineschi, V. (2023). The Dark Side of Energy Drinks: A Comprehensive Review of Their Impact on the Human Body. Nutrients, 15(18), 3922. https://doi.org/10.3390/nu15183922


Guest: Jill M. Terrien PhD, ANP-BC  Music Credit: Matthew Bugos
Thoughts? Suggestions? Email us at FranklySpeaking@pri-med.com
 ]]></itunes:summary>
        <itunes:author>Pri-Med</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>788</itunes:duration>
                        <itunes:episodeType>full</itunes:episodeType>
            </item>
    <item>
        <title>When Sweet Turns Sour: The Risks of Artificial Sugars - Frankly Speaking Ep 457</title>
        <itunes:title>When Sweet Turns Sour: The Risks of Artificial Sugars - Frankly Speaking Ep 457</itunes:title>
        <link>https://primedfranklyspeaking.podbean.com/e/when-sweet-turns-sour-the-risks-of-artificial-sugars-frankly-speaking-ep-457/</link>
                    <comments>https://primedfranklyspeaking.podbean.com/e/when-sweet-turns-sour-the-risks-of-artificial-sugars-frankly-speaking-ep-457/#comments</comments>        <pubDate>Mon, 03 Nov 2025 05:30:00 +0000</pubDate>
        <guid isPermaLink="false">primedfranklyspeaking.podbean.com/7ea2eea6-eae6-344d-8bb5-05f93194d945</guid>
                                    <description><![CDATA[<p>Credits: 0.25 AMA PRA Category 1 Credit™
 
CME/CE Information and Claim Credit: <a href='https://www.pri-med.com/online-education/podcast/frankly-speaking-cme-457'>https://www.pri-med.com/online-education/podcast/frankly-speaking-cme-457</a></p>
<p>Overview: Many patients turn to low- and no-calorie sweeteners to help with weight loss and lower diabetes risk, but do these alternatives actually deliver? In this episode, we review common artificial sweeteners and explore evidence on hunger, cardiovascular, diabetes, and dementia risks to understand how sugar substitutes can impact long-term health outcomes in your patients.</p>
<p>Episode resource links:</p>
<ul>
<li>fMRI Data: Nat Metab 7, 574–585 (2025). <a href='https://doi.org/10.1038/s42255-025-01227-8'>https://doi.org/10.1038/s42255-025-01227-8</a></li>
<li>Adverse effects: Adv Nutr. 2023 Jul;14(4):710-717. doi: 10.1016/j.advnut.2023.05.010</li>
<li>Dementia Data: Neurology® 2025;105:e214023. doi:10.1212/WNL.0000000000214023</li>
<li>Stevia: Obes Rev. 2025 Jun;26(6):e13902. doi: 10.1111/obr.13902</li>
<li>High Fructose Corn Syrup:  Nutrition Reviews. 2021;79(2):209-226. 
doi:10.1093/nutrit/nuaa077</li>
</ul>
<p>Guest: Robert A. Baldor MD, FAAFP</p>
<p>Music Credit: Matthew Bugos</p>
<p>Thoughts? Suggestions? Email us at <a href='mailto:FranklySpeaking@pri-med.com'>FranklySpeaking@pri-med.com </a></p>
<p> </p>
]]></description>
                                                            <content:encoded><![CDATA[<p>Credits: 0.25 AMA PRA Category 1 Credit™<br>
 <br>
CME/CE Information and Claim Credit: <a href='https://www.pri-med.com/online-education/podcast/frankly-speaking-cme-457'>https://www.pri-med.com/online-education/podcast/frankly-speaking-cme-457</a></p>
<p>Overview: Many patients turn to low- and no-calorie sweeteners to help with weight loss and lower diabetes risk, but do these alternatives actually deliver? In this episode, we review common artificial sweeteners and explore evidence on hunger, cardiovascular, diabetes, and dementia risks to understand how sugar substitutes can impact long-term health outcomes in your patients.</p>
<p>Episode resource links:</p>
<ul>
<li>fMRI Data: Nat Metab 7, 574–585 (2025). <a href='https://doi.org/10.1038/s42255-025-01227-8'>https://doi.org/10.1038/s42255-025-01227-8</a></li>
<li>Adverse effects: Adv Nutr. 2023 Jul;14(4):710-717. doi: 10.1016/j.advnut.2023.05.010</li>
<li>Dementia Data: Neurology® 2025;105:e214023. doi:10.1212/WNL.0000000000214023</li>
<li>Stevia: Obes Rev. 2025 Jun;26(6):e13902. doi: 10.1111/obr.13902</li>
<li>High Fructose Corn Syrup:  Nutrition Reviews. 2021;79(2):209-226. <br>
doi:10.1093/nutrit/nuaa077</li>
</ul>
<p>Guest: Robert A. Baldor MD, FAAFP</p>
<p>Music Credit: Matthew Bugos</p>
<p>Thoughts? Suggestions? Email us at <a href='mailto:FranklySpeaking@pri-med.com'>FranklySpeaking@pri-med.com </a></p>
<p> </p>
]]></content:encoded>
                                    
        <enclosure url="https://mcdn.podbean.com/mf/web/njrivuv6e23ajtea/frankly-speaking-447-articial-sweeteners.mp3" length="10499613" type="audio/mpeg"/>
                <itunes:summary><![CDATA[Credits: 0.25 AMA PRA Category 1 Credit™ CME/CE Information and Claim Credit: https://www.pri-med.com/online-education/podcast/frankly-speaking-cme-457
Overview: Many patients turn to low- and no-calorie sweeteners to help with weight loss and lower diabetes risk, but do these alternatives actually deliver? In this episode, we review common artificial sweeteners and explore evidence on hunger, cardiovascular, diabetes, and dementia risks to understand how sugar substitutes can impact long-term health outcomes in your patients.
Episode resource links:

fMRI Data: Nat Metab 7, 574–585 (2025). https://doi.org/10.1038/s42255-025-01227-8
Adverse effects: Adv Nutr. 2023 Jul;14(4):710-717. doi: 10.1016/j.advnut.2023.05.010
Dementia Data: Neurology® 2025;105:e214023. doi:10.1212/WNL.0000000000214023
Stevia: Obes Rev. 2025 Jun;26(6):e13902. doi: 10.1111/obr.13902
High Fructose Corn Syrup:  Nutrition Reviews. 2021;79(2):209-226. doi:10.1093/nutrit/nuaa077

Guest: Robert A. Baldor MD, FAAFP
Music Credit: Matthew Bugos
Thoughts? Suggestions? Email us at FranklySpeaking@pri-med.com 
 ]]></itunes:summary>
        <itunes:author>Pri-Med</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>654</itunes:duration>
                        <itunes:episodeType>full</itunes:episodeType>
            </item>
    <item>
        <title>It Doesn’t Have to Be That Way: Managing IUD Placement Pain and Anxiety - Frankly Speaking Ep 456</title>
        <itunes:title>It Doesn’t Have to Be That Way: Managing IUD Placement Pain and Anxiety - Frankly Speaking Ep 456</itunes:title>
        <link>https://primedfranklyspeaking.podbean.com/e/it-doesn-t-have-to-be-that-way-managing-iud-placement-pain-and-anxiety-frankly-speaking-ep-456/</link>
                    <comments>https://primedfranklyspeaking.podbean.com/e/it-doesn-t-have-to-be-that-way-managing-iud-placement-pain-and-anxiety-frankly-speaking-ep-456/#comments</comments>        <pubDate>Mon, 27 Oct 2025 05:30:00 +0000</pubDate>
        <guid isPermaLink="false">primedfranklyspeaking.podbean.com/d10c0706-8a19-32b9-9aad-be3e54c12b34</guid>
                                    <description><![CDATA[<p>Credits: 0.25 AMA PRA Category 1 Credit™
 
CME/CE Information and Claim Credit: <a href='https://www.pri-med.com/online-education/podcast/frankly-speaking-cme-456'>https://www.pri-med.com/online-education/podcast/frankly-speaking-cme-456</a></p>
<p>Overview: Experiences of significant pain and anxiety during intrauterine device (IUD) insertion may lead patients to forgo this effective contraceptive option. Listen in as we discuss how to reduce procedural pain, address anxiety, and foster trust using updated guidelines and shared decision-making to improve patient satisfaction and support informed contraceptive choices.</p>
<p>Episode resource links:</p>
<ul>
<li>Charles, D. N., Nagarsheth, M., &amp; Oshman, L. (2025). Pain Management for IUD Insertion in Primary Care. American Family Physician, 111(4), 299-301.</li>
<li>Dempsey, A., Aucoin, C., Stallings, W., Kulangara, A., &amp; Sundstrom, B. (2025). Beyond pain medication: striving toward more patient-centered placement of intrauterine devices. Contraception, 110944.</li>
<li>Estevez, E., Hem-Lee-Forsyth, S., Viechweg, N. D., John, S., &amp; Menor, S. P. (2024). Advancing pain management protocols for intrauterine device insertion: integrating evidence-based strategies into clinical practice. Cureus, 16(6).</li>
<li>Hoover, K., &amp; Riley, K. (2025). Pain Management for In-Office Uterine and Cervical Procedures.</li>
</ul>
<p>Guest: Mariyan L. Montaque, DNP, FNP-BC
 
Music Credit: Matthew Bugos</p>
<p>Thoughts? Suggestions? Email us at <a href='mailto:FranklySpeaking@pri-med.com'>FranklySpeaking@pri-med.com</a></p>
<p> </p>
]]></description>
                                                            <content:encoded><![CDATA[<p>Credits: 0.25 AMA PRA Category 1 Credit™<br>
 <br>
CME/CE Information and Claim Credit: <a href='https://www.pri-med.com/online-education/podcast/frankly-speaking-cme-456'>https://www.pri-med.com/online-education/podcast/frankly-speaking-cme-456</a></p>
<p>Overview: Experiences of significant pain and anxiety during intrauterine device (IUD) insertion may lead patients to forgo this effective contraceptive option. Listen in as we discuss how to reduce procedural pain, address anxiety, and foster trust using updated guidelines and shared decision-making to improve patient satisfaction and support informed contraceptive choices.</p>
<p>Episode resource links:</p>
<ul>
<li>Charles, D. N., Nagarsheth, M., &amp; Oshman, L. (2025). Pain Management for IUD Insertion in Primary Care. American Family Physician, 111(4), 299-301.</li>
<li>Dempsey, A., Aucoin, C., Stallings, W., Kulangara, A., &amp; Sundstrom, B. (2025). Beyond pain medication: striving toward more patient-centered placement of intrauterine devices. Contraception, 110944.</li>
<li>Estevez, E., Hem-Lee-Forsyth, S., Viechweg, N. D., John, S., &amp; Menor, S. P. (2024). Advancing pain management protocols for intrauterine device insertion: integrating evidence-based strategies into clinical practice. Cureus, 16(6).</li>
<li>Hoover, K., &amp; Riley, K. (2025). Pain Management for In-Office Uterine and Cervical Procedures.</li>
</ul>
<p>Guest: Mariyan L. Montaque, DNP, FNP-BC<br>
 <br>
Music Credit: Matthew Bugos</p>
<p>Thoughts? Suggestions? Email us at <a href='mailto:FranklySpeaking@pri-med.com'>FranklySpeaking@pri-med.com</a></p>
<p> </p>
]]></content:encoded>
                                    
        <enclosure url="https://mcdn.podbean.com/mf/web/yjqe5whwgfzu554e/frankly-speaking-ep-456-IUD.mp4" length="221001346" type="video/mp4"/>
                <itunes:summary><![CDATA[Credits: 0.25 AMA PRA Category 1 Credit™ CME/CE Information and Claim Credit: https://www.pri-med.com/online-education/podcast/frankly-speaking-cme-456
Overview: Experiences of significant pain and anxiety during intrauterine device (IUD) insertion may lead patients to forgo this effective contraceptive option. Listen in as we discuss how to reduce procedural pain, address anxiety, and foster trust using updated guidelines and shared decision-making to improve patient satisfaction and support informed contraceptive choices.
Episode resource links:

Charles, D. N., Nagarsheth, M., &amp; Oshman, L. (2025). Pain Management for IUD Insertion in Primary Care. American Family Physician, 111(4), 299-301.
Dempsey, A., Aucoin, C., Stallings, W., Kulangara, A., &amp; Sundstrom, B. (2025). Beyond pain medication: striving toward more patient-centered placement of intrauterine devices. Contraception, 110944.
Estevez, E., Hem-Lee-Forsyth, S., Viechweg, N. D., John, S., &amp; Menor, S. P. (2024). Advancing pain management protocols for intrauterine device insertion: integrating evidence-based strategies into clinical practice. Cureus, 16(6).
Hoover, K., &amp; Riley, K. (2025). Pain Management for In-Office Uterine and Cervical Procedures.

Guest: Mariyan L. Montaque, DNP, FNP-BC Music Credit: Matthew Bugos
Thoughts? Suggestions? Email us at FranklySpeaking@pri-med.com
 ]]></itunes:summary>
        <itunes:author>Pri-Med</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>802</itunes:duration>
                        <itunes:episodeType>full</itunes:episodeType>
            </item>
    <item>
        <title>Microhematuria and the Right Time to Refer: Guideline Updates - Frankly Speaking Ep 455</title>
        <itunes:title>Microhematuria and the Right Time to Refer: Guideline Updates - Frankly Speaking Ep 455</itunes:title>
        <link>https://primedfranklyspeaking.podbean.com/e/microhematuria-and-the-right-time-to-refer-guideline-updates-frankly-speaking-ep-455/</link>
                    <comments>https://primedfranklyspeaking.podbean.com/e/microhematuria-and-the-right-time-to-refer-guideline-updates-frankly-speaking-ep-455/#comments</comments>        <pubDate>Mon, 20 Oct 2025 05:30:00 +0000</pubDate>
        <guid isPermaLink="false">primedfranklyspeaking.podbean.com/fc88a660-2f00-370e-ae37-587dbd2984bc</guid>
                                    <description><![CDATA[<p>Credits: 0.25 AMA PRA Category 1 Credit™
 
CME/CE Information and Claim Credit: <a href='https://www.pri-med.com/online-education/podcast/frankly-speaking-cme-455'>https://www.pri-med.com/online-education/podcast/frankly-speaking-cme-455</a></p>
<p>Overview: Microscopic hematuria is common in primary care, but not every patient needs an urgent urology referral. Tune in to learn how to apply the latest evidence-based guidelines to risk-stratify patients and confidently manage workup and follow-up from your clinic, improving care while reducing unnecessary testing.</p>
<p>Episode resource links:</p>
<ul>
<li>Barocas DA, Lotan Y, Matulewicz RS, Raman JD, Westerman ME, Kirkby E, Pak L, Souter L. Updates to Microhematuria: AUA/SUFU Guideline (2025). J Urol. 0(0). doi: 10.1097/JU.0000000000004490.</li>
</ul>
<p>Guest: Robert A. Baldor MD, FAAFP
 
Music Credit: Matthew Bugos</p>
<p>Thoughts? Suggestions? Email us at <a href='mailto:FranklySpeaking@pri-med.com'>FranklySpeaking@pri-med.com</a></p>
<p> </p>
]]></description>
                                                            <content:encoded><![CDATA[<p>Credits: 0.25 AMA PRA Category 1 Credit™<br>
 <br>
CME/CE Information and Claim Credit: <a href='https://www.pri-med.com/online-education/podcast/frankly-speaking-cme-455'>https://www.pri-med.com/online-education/podcast/frankly-speaking-cme-455</a></p>
<p>Overview: Microscopic hematuria is common in primary care, but not every patient needs an urgent urology referral. Tune in to learn how to apply the latest evidence-based guidelines to risk-stratify patients and confidently manage workup and follow-up from your clinic, improving care while reducing unnecessary testing.</p>
<p>Episode resource links:</p>
<ul>
<li>Barocas DA, Lotan Y, Matulewicz RS, Raman JD, Westerman ME, Kirkby E, Pak L, Souter L. Updates to Microhematuria: AUA/SUFU Guideline (2025). J Urol. 0(0). doi: 10.1097/JU.0000000000004490.</li>
</ul>
<p>Guest: Robert A. Baldor MD, FAAFP<br>
 <br>
Music Credit: Matthew Bugos</p>
<p>Thoughts? Suggestions? Email us at <a href='mailto:FranklySpeaking@pri-med.com'>FranklySpeaking@pri-med.com</a></p>
<p> </p>
]]></content:encoded>
                                    
        <enclosure url="https://mcdn.podbean.com/mf/web/qjptkz5ijkb9hkb8/frankly-speaking-ep-455-microhematuria.mp4" length="195663346" type="video/mp4"/>
                <itunes:summary><![CDATA[Credits: 0.25 AMA PRA Category 1 Credit™ CME/CE Information and Claim Credit: https://www.pri-med.com/online-education/podcast/frankly-speaking-cme-455
Overview: Microscopic hematuria is common in primary care, but not every patient needs an urgent urology referral. Tune in to learn how to apply the latest evidence-based guidelines to risk-stratify patients and confidently manage workup and follow-up from your clinic, improving care while reducing unnecessary testing.
Episode resource links:

Barocas DA, Lotan Y, Matulewicz RS, Raman JD, Westerman ME, Kirkby E, Pak L, Souter L. Updates to Microhematuria: AUA/SUFU Guideline (2025). J Urol. 0(0). doi: 10.1097/JU.0000000000004490.

Guest: Robert A. Baldor MD, FAAFP Music Credit: Matthew Bugos
Thoughts? Suggestions? Email us at FranklySpeaking@pri-med.com
 ]]></itunes:summary>
        <itunes:author>Pri-Med</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>698</itunes:duration>
                        <itunes:episodeType>full</itunes:episodeType>
            </item>
    <item>
        <title>Don’t Wait to Medicate—Evidence for Early Intervention in Hypertension - Frankly Speaking Ep 454</title>
        <itunes:title>Don’t Wait to Medicate—Evidence for Early Intervention in Hypertension - Frankly Speaking Ep 454</itunes:title>
        <link>https://primedfranklyspeaking.podbean.com/e/don-t-wait-to-medicate%e2%80%94evidence-for-early-intervention-in-hypertension-frankly-speaking-ep-454/</link>
                    <comments>https://primedfranklyspeaking.podbean.com/e/don-t-wait-to-medicate%e2%80%94evidence-for-early-intervention-in-hypertension-frankly-speaking-ep-454/#comments</comments>        <pubDate>Mon, 13 Oct 2025 05:30:00 +0000</pubDate>
        <guid isPermaLink="false">primedfranklyspeaking.podbean.com/92ceb615-1369-3c65-9c53-eae1350317c5</guid>
                                    <description><![CDATA[<p>Credits: 0.25 AMA PRA Category 1 Credit™
 
CME/CE Information and Claim Credit: <a href='https://www.pri-med.com/online-education/podcast/frankly-speaking-cme-454'>https://www.pri-med.com/online-education/podcast/frankly-speaking-cme-454</a></p>
<p>Overview: Treating hypertension within the first month can significantly improve long-term blood pressure control. This episode reviews new evidence and practical strategies to help you initiate timely therapy, optimize follow-up, and improve outcomes for patients with newly diagnosed, uncontrolled hypertension. Gain actionable insights to close a critical care gap.</p>
<p>Episode resource links:</p>
<ul>
<li>Barrett, R. B., Riesser, B., Martin, B., Sachdev, N., Rakotz, M. K., Sutherland, S. E., &amp; Egan, B. M. (2025). Treatment in the First Month After Hypertension Diagnosis Improves Blood Pressure Control. Hypertension (Dallas, Tex. : 1979), 82(6), 1129–1136. <a href='https://doi.org/10.1161/HYPERTENSIONAHA.124.23508'>https://doi.org/10.1161/HYPERTENSIONAHA.124.23508</a></li>
<li><a href='https://www.mayoclinic.org/diseases-conditions/high-blood-pressure/in-depth/high-blood-pressure/art-20046974'>For your patients: 10 Ways to Control High Blood Pressure Without Medication</a> </li>
<li><a href='https://www.hopkinsmedicine.org/health/conditions-and-diseases/high-blood-pressure-hypertension/natural-ways-to-lower-blood-pressure'>For your patients: Natural Ways to Lower Blood Pressure</a> </li>
</ul>
<p>Guest: Jill M. Terrien PhD, ANP-BC 
 
Music Credit: Matthew Bugos</p>
<p>Thoughts? Suggestions? Email us at <a href='mailto:FranklySpeaking@pri-med.com'>FranklySpeaking@pri-med.com</a></p>
<p> </p>
]]></description>
                                                            <content:encoded><![CDATA[<p>Credits: 0.25 AMA PRA Category 1 Credit™<br>
 <br>
CME/CE Information and Claim Credit: <a href='https://www.pri-med.com/online-education/podcast/frankly-speaking-cme-454'>https://www.pri-med.com/online-education/podcast/frankly-speaking-cme-454</a></p>
<p>Overview: Treating hypertension within the first month can significantly improve long-term blood pressure control. This episode reviews new evidence and practical strategies to help you initiate timely therapy, optimize follow-up, and improve outcomes for patients with newly diagnosed, uncontrolled hypertension. Gain actionable insights to close a critical care gap.</p>
<p>Episode resource links:</p>
<ul>
<li>Barrett, R. B., Riesser, B., Martin, B., Sachdev, N., Rakotz, M. K., Sutherland, S. E., &amp; Egan, B. M. (2025). Treatment in the First Month After Hypertension Diagnosis Improves Blood Pressure Control. Hypertension (Dallas, Tex. : 1979), 82(6), 1129–1136. <a href='https://doi.org/10.1161/HYPERTENSIONAHA.124.23508'>https://doi.org/10.1161/HYPERTENSIONAHA.124.23508</a></li>
<li><a href='https://www.mayoclinic.org/diseases-conditions/high-blood-pressure/in-depth/high-blood-pressure/art-20046974'>For your patients: 10 Ways to Control High Blood Pressure Without Medication</a> </li>
<li><a href='https://www.hopkinsmedicine.org/health/conditions-and-diseases/high-blood-pressure-hypertension/natural-ways-to-lower-blood-pressure'>For your patients: Natural Ways to Lower Blood Pressure</a> </li>
</ul>
<p>Guest: Jill M. Terrien PhD, ANP-BC <br>
 <br>
Music Credit: Matthew Bugos</p>
<p>Thoughts? Suggestions? Email us at <a href='mailto:FranklySpeaking@pri-med.com'>FranklySpeaking@pri-med.com</a></p>
<p> </p>
]]></content:encoded>
                                    
        <enclosure url="https://mcdn.podbean.com/mf/web/pgeqfpfmyyim58yu/frankly-speaking-454-hypertension-tx.mp3" length="13721835" type="audio/mpeg"/>
                <itunes:summary><![CDATA[Credits: 0.25 AMA PRA Category 1 Credit™ CME/CE Information and Claim Credit: https://www.pri-med.com/online-education/podcast/frankly-speaking-cme-454
Overview: Treating hypertension within the first month can significantly improve long-term blood pressure control. This episode reviews new evidence and practical strategies to help you initiate timely therapy, optimize follow-up, and improve outcomes for patients with newly diagnosed, uncontrolled hypertension. Gain actionable insights to close a critical care gap.
Episode resource links:

Barrett, R. B., Riesser, B., Martin, B., Sachdev, N., Rakotz, M. K., Sutherland, S. E., &amp; Egan, B. M. (2025). Treatment in the First Month After Hypertension Diagnosis Improves Blood Pressure Control. Hypertension (Dallas, Tex. : 1979), 82(6), 1129–1136. https://doi.org/10.1161/HYPERTENSIONAHA.124.23508
For your patients: 10 Ways to Control High Blood Pressure Without Medication 
For your patients: Natural Ways to Lower Blood Pressure 

Guest: Jill M. Terrien PhD, ANP-BC  Music Credit: Matthew Bugos
Thoughts? Suggestions? Email us at FranklySpeaking@pri-med.com
 ]]></itunes:summary>
        <itunes:author>Pri-Med</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>855</itunes:duration>
                        <itunes:episodeType>full</itunes:episodeType>
            </item>
    <item>
        <title>Don’t Forget the Shingles Vaccine - Frankly Speaking Ep 453</title>
        <itunes:title>Don’t Forget the Shingles Vaccine - Frankly Speaking Ep 453</itunes:title>
        <link>https://primedfranklyspeaking.podbean.com/e/don-t-forget-the-shingles-vaccine-frankly-speaking-ep-453/</link>
                    <comments>https://primedfranklyspeaking.podbean.com/e/don-t-forget-the-shingles-vaccine-frankly-speaking-ep-453/#comments</comments>        <pubDate>Mon, 06 Oct 2025 05:30:00 +0000</pubDate>
        <guid isPermaLink="false">primedfranklyspeaking.podbean.com/441dc6eb-8a36-3766-bf2b-849342254ff7</guid>
                                    <description><![CDATA[<p>Credits: 0.25 AMA PRA Category 1 Credit™
 
CME/CE Information and Claim Credit: <a href='https://www.pri-med.com/online-education/podcast/frankly-speaking-cme-453'>https://www.pri-med.com/online-education/podcast/frankly-speaking-cme-453</a></p>
<p>Overview: Many patients are still hesitant about the shingles vaccine, but the benefits go far beyond preventing a painful rash. Hear how varicella zoster vaccination can also reduce the risks of postherpetic neuralgia, dementia, and cardiovascular events, giving you powerful tools to guide more informed patient decisions.</p>
<p>Episode resource links:</p>
<ul>
<li>Dementia: Neurol Sci. 2024 Jan;45(1):27-36.  doi: 10.1007/s10072-023-07038-7
CV: J Infect Dis. 2025 Feb 28:jiaf105. doi: 10.1093/infdis/jiaf105 </li>
</ul>
<p>Guest: Robert A. Baldor MD, FAAFP

Music Credit: Matthew Bugos</p>
<p>Thoughts? Suggestions? Email us at <a href='mailto:FranklySpeaking@pri-med.com'>FranklySpeaking@pri-med.com</a></p>
<p> </p>
]]></description>
                                                            <content:encoded><![CDATA[<p>Credits: 0.25 AMA PRA Category 1 Credit™<br>
 <br>
CME/CE Information and Claim Credit: <a href='https://www.pri-med.com/online-education/podcast/frankly-speaking-cme-453'>https://www.pri-med.com/online-education/podcast/frankly-speaking-cme-453</a></p>
<p>Overview: Many patients are still hesitant about the shingles vaccine, but the benefits go far beyond preventing a painful rash. Hear how varicella zoster vaccination can also reduce the risks of postherpetic neuralgia, dementia, and cardiovascular events, giving you powerful tools to guide more informed patient decisions.</p>
<p>Episode resource links:</p>
<ul>
<li>Dementia: Neurol Sci. 2024 Jan;45(1):27-36.  doi: 10.1007/s10072-023-07038-7<br>
CV: J Infect Dis. 2025 Feb 28:jiaf105. doi: 10.1093/infdis/jiaf105 </li>
</ul>
<p>Guest: Robert A. Baldor MD, FAAFP<br>
<br>
Music Credit: Matthew Bugos</p>
<p>Thoughts? Suggestions? Email us at <a href='mailto:FranklySpeaking@pri-med.com'>FranklySpeaking@pri-med.com</a></p>
<p> </p>
]]></content:encoded>
                                    
        <enclosure url="https://mcdn.podbean.com/mf/web/dbn3uhdgm4xqx9bs/frankly-speaking-453-zoster-vaccine.mp3" length="11970737" type="audio/mpeg"/>
                <itunes:summary><![CDATA[Credits: 0.25 AMA PRA Category 1 Credit™ CME/CE Information and Claim Credit: https://www.pri-med.com/online-education/podcast/frankly-speaking-cme-453
Overview: Many patients are still hesitant about the shingles vaccine, but the benefits go far beyond preventing a painful rash. Hear how varicella zoster vaccination can also reduce the risks of postherpetic neuralgia, dementia, and cardiovascular events, giving you powerful tools to guide more informed patient decisions.
Episode resource links:

Dementia: Neurol Sci. 2024 Jan;45(1):27-36.  doi: 10.1007/s10072-023-07038-7CV: J Infect Dis. 2025 Feb 28:jiaf105. doi: 10.1093/infdis/jiaf105 

Guest: Robert A. Baldor MD, FAAFPMusic Credit: Matthew Bugos
Thoughts? Suggestions? Email us at FranklySpeaking@pri-med.com
 ]]></itunes:summary>
        <itunes:author>Pri-Med</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>746</itunes:duration>
                        <itunes:episodeType>full</itunes:episodeType>
            </item>
    <item>
        <title>Autism and Acetaminophen—Separating Fact from Misinformation - Frankly Speaking Ep 452</title>
        <itunes:title>Autism and Acetaminophen—Separating Fact from Misinformation - Frankly Speaking Ep 452</itunes:title>
        <link>https://primedfranklyspeaking.podbean.com/e/autism-and-acetaminophen%e2%80%94separating-fact-from-misinformation-frankly-speaking-ep-452/</link>
                    <comments>https://primedfranklyspeaking.podbean.com/e/autism-and-acetaminophen%e2%80%94separating-fact-from-misinformation-frankly-speaking-ep-452/#comments</comments>        <pubDate>Mon, 29 Sep 2025 05:30:00 +0000</pubDate>
        <guid isPermaLink="false">primedfranklyspeaking.podbean.com/618737a6-303f-308f-8573-3a4220ae9c3e</guid>
                                    <description><![CDATA[<p>Credits: 0.25 AMA PRA Category 1 Credit™
 
CME/CE Information and Claim Credit: <a href='https://www.pri-med.com/online-education/podcast/frankly-speaking-cme-452'>https://www.pri-med.com/online-education/podcast/frankly-speaking-cme-452</a></p>
<p>Overview: The healthcare landscape is evolving rapidly, and clinicians are navigating conflicting guidance on established, evidence-based recommendations. Recent news suggest acetaminophen use during pregnancy causes autism spectrum disorder (ASD), which is not the consensus of medical experts based on available data. When guidance from various sources conflicts with established research, clinicians face challenges in providing evidence-based care. Join us to review the current evidence on acetaminophen and ASD risk. </p>
<p>Episode resource links:</p>
<ul>
<li>
<p>Ahlqvist VH, Sjöqvist H, Dalman C, et al. Acetaminophen Use During Pregnancy and Children’s Risk of Autism, ADHD, and Intellectual Disability. JAMA. 2024;331(14):1205–1214. doi:10.1001/jama.2024.3172</p>
<p> </p>
</li>
<li>
<p>Damkier, P., Gram, E. B., Ceulemans, M., Panchaud, A., Cleary, B., Chambers, C., Weber-Schoendorfer, C., Kennedy, D., Hodson, K., Grant, K. S., Diav-Citrin, O., Običan, S. G., Shechtman, S., &amp; Alwan, S. (2025). Acetaminophen in Pregnancy and Attention-Deficit and Hyperactivity Disorder and Autism Spectrum Disorder. Obstetrics and gynecology, 145(2), 168–176. <a href='https://doi.org/10.1097/AOG.0000000000005802'>https://doi.org/10.1097/AOG.0000000000005802</a></p>
<p> </p>
</li>
<li>
<p>Ji Y, Azuine RE, Zhang Y, et al. Association of Cord Plasma Biomarkers of In Utero Acetaminophen Exposure With Risk of Attention-Deficit/Hyperactivity Disorder and Autism Spectrum Disorder in Childhood. JAMA Psychiatry. 2020;77(2):180–189. doi:10.1001/jamapsychiatry.2019.3259</p>
<p> </p>
</li>
<li>
<p>Hirota T, King BH.  Autism Spectrum Disorder: A Review. JAMA. 2023;329(2):157–168. doi:10.1001/jama.2022.23661</p>
<p> </p>
</li>
<li>
<p>Liu, X., Zou, M., Sun, C., Wu, L., &amp; Chen, W. X. (2022). Prenatal Folic Acid Supplements and Offspring's Autism Spectrum Disorder: A Meta-analysis and Meta-regression. Journal of autism and developmental disorders, 52(2), 522–539. <a href='https://doi.org/10.1007/s10803-021-04951-8'>https://doi.org/10.1007/s10803-021-04951-8</a></p>
<p> </p>
</li>
<li>
<p>DSM-5-TR: Neurocognitive Disorders Supplement; October 2022. <a href='https://psychiatryonline.org/pb-assets/dsm/update/DSM-5-TR_Neurocognitive-Disorders-Supplement_2022_APA_Publishing.pdf'>https://psychiatryonline.org/pb-assets/dsm/update/DSM-5-TR_Neurocognitive-Disorders-Supplement_2022_APA_Publishing.pdf</a>

</p>
</li>
<li>
<p><a href='https://www.npr.org/sections/shots-health-news/2025/09/06/nx-s1-5532143/hhs-responds-to-report-about-autism-and-acetaminophen'>https://www.npr.org/sections/shots-health-news/2025/09/06/nx-s1-5532143/hhs-responds-to-report-about-autism-and-acetaminophen</a></p>
</li>
</ul>
<p>Guest: Susan Feeney, DNP, FNP-BC, NP-C
 
Music Credit: Matthew Bugos</p>
<p>Thoughts? Suggestions? Email us at <a href='mailto:FranklySpeaking@pri-med.com'>FranklySpeaking@pri-med.com </a></p>
<p> </p>
]]></description>
                                                            <content:encoded><![CDATA[<p>Credits: 0.25 AMA PRA Category 1 Credit™<br>
 <br>
CME/CE Information and Claim Credit: <a href='https://www.pri-med.com/online-education/podcast/frankly-speaking-cme-452'>https://www.pri-med.com/online-education/podcast/frankly-speaking-cme-452</a></p>
<p>Overview: The healthcare landscape is evolving rapidly, and clinicians are navigating conflicting guidance on established, evidence-based recommendations. Recent news suggest acetaminophen use during pregnancy causes autism spectrum disorder (ASD), which is not the consensus of medical experts based on available data. When guidance from various sources conflicts with established research, clinicians face challenges in providing evidence-based care. Join us to review the current evidence on acetaminophen and ASD risk. </p>
<p>Episode resource links:</p>
<ul>
<li>
<p>Ahlqvist VH, Sjöqvist H, Dalman C, et al. Acetaminophen Use During Pregnancy and Children’s Risk of Autism, ADHD, and Intellectual Disability. JAMA. 2024;331(14):1205–1214. doi:10.1001/jama.2024.3172</p>
<p> </p>
</li>
<li>
<p>Damkier, P., Gram, E. B., Ceulemans, M., Panchaud, A., Cleary, B., Chambers, C., Weber-Schoendorfer, C., Kennedy, D., Hodson, K., Grant, K. S., Diav-Citrin, O., Običan, S. G., Shechtman, S., &amp; Alwan, S. (2025). Acetaminophen in Pregnancy and Attention-Deficit and Hyperactivity Disorder and Autism Spectrum Disorder. Obstetrics and gynecology, 145(2), 168–176. <a href='https://doi.org/10.1097/AOG.0000000000005802'>https://doi.org/10.1097/AOG.0000000000005802</a></p>
<p> </p>
</li>
<li>
<p>Ji Y, Azuine RE, Zhang Y, et al. Association of Cord Plasma Biomarkers of In Utero Acetaminophen Exposure With Risk of Attention-Deficit/Hyperactivity Disorder and Autism Spectrum Disorder in Childhood. JAMA Psychiatry. 2020;77(2):180–189. doi:10.1001/jamapsychiatry.2019.3259</p>
<p> </p>
</li>
<li>
<p>Hirota T, King BH.  Autism Spectrum Disorder: A Review. JAMA. 2023;329(2):157–168. doi:10.1001/jama.2022.23661</p>
<p> </p>
</li>
<li>
<p>Liu, X., Zou, M., Sun, C., Wu, L., &amp; Chen, W. X. (2022). Prenatal Folic Acid Supplements and Offspring's Autism Spectrum Disorder: A Meta-analysis and Meta-regression. Journal of autism and developmental disorders, 52(2), 522–539. <a href='https://doi.org/10.1007/s10803-021-04951-8'>https://doi.org/10.1007/s10803-021-04951-8</a></p>
<p> </p>
</li>
<li>
<p>DSM-5-TR: Neurocognitive Disorders Supplement; October 2022. <a href='https://psychiatryonline.org/pb-assets/dsm/update/DSM-5-TR_Neurocognitive-Disorders-Supplement_2022_APA_Publishing.pdf'>https://psychiatryonline.org/pb-assets/dsm/update/DSM-5-TR_Neurocognitive-Disorders-Supplement_2022_APA_Publishing.pdf</a><br>
<br>
</p>
</li>
<li>
<p><a href='https://www.npr.org/sections/shots-health-news/2025/09/06/nx-s1-5532143/hhs-responds-to-report-about-autism-and-acetaminophen'>https://www.npr.org/sections/shots-health-news/2025/09/06/nx-s1-5532143/hhs-responds-to-report-about-autism-and-acetaminophen</a></p>
</li>
</ul>
<p>Guest: Susan Feeney, DNP, FNP-BC, NP-C<br>
 <br>
Music Credit: Matthew Bugos</p>
<p>Thoughts? Suggestions? Email us at <a href='mailto:FranklySpeaking@pri-med.com'>FranklySpeaking@pri-med.com </a></p>
<p> </p>
]]></content:encoded>
                                    
        <enclosure url="https://mcdn.podbean.com/mf/web/28rtj3r3ng4j4cwu/frankly-speaking-452-acetaminophen-autism.mp3" length="16346308" type="audio/mpeg"/>
                <itunes:summary><![CDATA[Credits: 0.25 AMA PRA Category 1 Credit™ CME/CE Information and Claim Credit: https://www.pri-med.com/online-education/podcast/frankly-speaking-cme-452
Overview: The healthcare landscape is evolving rapidly, and clinicians are navigating conflicting guidance on established, evidence-based recommendations. Recent news suggest acetaminophen use during pregnancy causes autism spectrum disorder (ASD), which is not the consensus of medical experts based on available data. When guidance from various sources conflicts with established research, clinicians face challenges in providing evidence-based care. Join us to review the current evidence on acetaminophen and ASD risk. 
Episode resource links:


Ahlqvist VH, Sjöqvist H, Dalman C, et al. Acetaminophen Use During Pregnancy and Children’s Risk of Autism, ADHD, and Intellectual Disability. JAMA. 2024;331(14):1205–1214. doi:10.1001/jama.2024.3172
 


Damkier, P., Gram, E. B., Ceulemans, M., Panchaud, A., Cleary, B., Chambers, C., Weber-Schoendorfer, C., Kennedy, D., Hodson, K., Grant, K. S., Diav-Citrin, O., Običan, S. G., Shechtman, S., &amp; Alwan, S. (2025). Acetaminophen in Pregnancy and Attention-Deficit and Hyperactivity Disorder and Autism Spectrum Disorder. Obstetrics and gynecology, 145(2), 168–176. https://doi.org/10.1097/AOG.0000000000005802
 


Ji Y, Azuine RE, Zhang Y, et al. Association of Cord Plasma Biomarkers of In Utero Acetaminophen Exposure With Risk of Attention-Deficit/Hyperactivity Disorder and Autism Spectrum Disorder in Childhood. JAMA Psychiatry. 2020;77(2):180–189. doi:10.1001/jamapsychiatry.2019.3259
 


Hirota T, King BH.  Autism Spectrum Disorder: A Review. JAMA. 2023;329(2):157–168. doi:10.1001/jama.2022.23661
 


Liu, X., Zou, M., Sun, C., Wu, L., &amp; Chen, W. X. (2022). Prenatal Folic Acid Supplements and Offspring's Autism Spectrum Disorder: A Meta-analysis and Meta-regression. Journal of autism and developmental disorders, 52(2), 522–539. https://doi.org/10.1007/s10803-021-04951-8
 


DSM-5-TR: Neurocognitive Disorders Supplement; October 2022. https://psychiatryonline.org/pb-assets/dsm/update/DSM-5-TR_Neurocognitive-Disorders-Supplement_2022_APA_Publishing.pdf


https://www.npr.org/sections/shots-health-news/2025/09/06/nx-s1-5532143/hhs-responds-to-report-about-autism-and-acetaminophen


Guest: Susan Feeney, DNP, FNP-BC, NP-C Music Credit: Matthew Bugos
Thoughts? Suggestions? Email us at FranklySpeaking@pri-med.com 
 ]]></itunes:summary>
        <itunes:author>Pri-Med</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>1019</itunes:duration>
                        <itunes:episodeType>full</itunes:episodeType>
            </item>
    <item>
        <title>A Side-by-Side Look at GLP-1 RAs for Weight Loss - Frankly Speaking Ep 451</title>
        <itunes:title>A Side-by-Side Look at GLP-1 RAs for Weight Loss - Frankly Speaking Ep 451</itunes:title>
        <link>https://primedfranklyspeaking.podbean.com/e/a-side-by-side-look-at-glp-1-ras-for-weight-loss-frankly-speaking-ep-451/</link>
                    <comments>https://primedfranklyspeaking.podbean.com/e/a-side-by-side-look-at-glp-1-ras-for-weight-loss-frankly-speaking-ep-451/#comments</comments>        <pubDate>Mon, 22 Sep 2025 05:30:00 +0000</pubDate>
        <guid isPermaLink="false">primedfranklyspeaking.podbean.com/519e8e0a-b7ba-3690-8a27-402fb6c0d341</guid>
                                    <description><![CDATA[<p>Credits: 0.25 AMA PRA Category 1 Credit™
 
CME/CE Information and Claim Credit: <a href='https://www.pri-med.com/online-education/podcast/frankly-speaking-cme-451'>https://www.pri-med.com/online-education/podcast/frankly-speaking-cme-451</a></p>
<p>Overview: The obesity epidemic has fueled a demand for weight loss medications. Trials have directly compared medications—specifically glucagon-like peptide-1 receptor agonists (GLP-1 RAs)—with a recent study doing just that. Tune in as we explore the evidence comparing semaglutide and tirzepatide for weight loss outcomes up to 1 year.</p>
<p>Episode resource links:</p>
<ul>
<li>Rodriguez PJ, Goodwin Cartwright BM, Gratzl S, et al. Semaglutide vs Tirzepatide for Weight Loss in Adults With Overweight or Obesity. JAMA Intern Med. 2024;184(9):1056-1064. </li>
<li>Moiz A, Filion KB, Toutounchi H, et al. Efficacy and Safety of Glucagon-Like Peptide-1 Receptor Agonists for Weight Loss Among Adults Without Diabetes : A Systematic Review of Randomized Controlled Trials. Ann Intern Med. 2025;178(2):199-217. </li>
<li>Wen J, Syed B, Nadora D, et al. Tirzepatide Versus Semaglutide on Weight Loss in Type 2 Diabetes Patients: A Systematic Review and Meta-Analysis of Direct Comparative Studies. Endocrinol Diabetes Metab. 2025;8(3):e70045. </li>
</ul>
<p>Guest: Alan M. Ehrlich, MD, FAAFP

Music Credit: Matthew Bugos</p>
<p>Thoughts? Suggestions? Email us at <a href='mailto:FranklySpeaking@pri-med.com'>FranklySpeaking@pri-med.com</a></p>
<p> </p>
]]></description>
                                                            <content:encoded><![CDATA[<p>Credits: 0.25 AMA PRA Category 1 Credit™<br>
 <br>
CME/CE Information and Claim Credit: <a href='https://www.pri-med.com/online-education/podcast/frankly-speaking-cme-451'>https://www.pri-med.com/online-education/podcast/frankly-speaking-cme-451</a></p>
<p>Overview: The obesity epidemic has fueled a demand for weight loss medications. Trials have directly compared medications—specifically glucagon-like peptide-1 receptor agonists (GLP-1 RAs)—with a recent study doing just that. Tune in as we explore the evidence comparing semaglutide and tirzepatide for weight loss outcomes up to 1 year.</p>
<p>Episode resource links:</p>
<ul>
<li>Rodriguez PJ, Goodwin Cartwright BM, Gratzl S, et al. Semaglutide vs Tirzepatide for Weight Loss in Adults With Overweight or Obesity. JAMA Intern Med. 2024;184(9):1056-1064. </li>
<li>Moiz A, Filion KB, Toutounchi H, et al. Efficacy and Safety of Glucagon-Like Peptide-1 Receptor Agonists for Weight Loss Among Adults Without Diabetes : A Systematic Review of Randomized Controlled Trials. Ann Intern Med. 2025;178(2):199-217. </li>
<li>Wen J, Syed B, Nadora D, et al. Tirzepatide Versus Semaglutide on Weight Loss in Type 2 Diabetes Patients: A Systematic Review and Meta-Analysis of Direct Comparative Studies. Endocrinol Diabetes Metab. 2025;8(3):e70045. </li>
</ul>
<p>Guest: Alan M. Ehrlich, MD, FAAFP<br>
<br>
Music Credit: Matthew Bugos</p>
<p>Thoughts? Suggestions? Email us at <a href='mailto:FranklySpeaking@pri-med.com'>FranklySpeaking@pri-med.com</a></p>
<p> </p>
]]></content:encoded>
                                    
        <enclosure url="https://mcdn.podbean.com/mf/web/xeyuqpcf26czy8xi/frankly-speaking-451-glp1.mp3" length="11866682" type="audio/mpeg"/>
                <itunes:summary><![CDATA[Credits: 0.25 AMA PRA Category 1 Credit™ CME/CE Information and Claim Credit: https://www.pri-med.com/online-education/podcast/frankly-speaking-cme-451
Overview: The obesity epidemic has fueled a demand for weight loss medications. Trials have directly compared medications—specifically glucagon-like peptide-1 receptor agonists (GLP-1 RAs)—with a recent study doing just that. Tune in as we explore the evidence comparing semaglutide and tirzepatide for weight loss outcomes up to 1 year.
Episode resource links:

Rodriguez PJ, Goodwin Cartwright BM, Gratzl S, et al. Semaglutide vs Tirzepatide for Weight Loss in Adults With Overweight or Obesity. JAMA Intern Med. 2024;184(9):1056-1064. 
Moiz A, Filion KB, Toutounchi H, et al. Efficacy and Safety of Glucagon-Like Peptide-1 Receptor Agonists for Weight Loss Among Adults Without Diabetes : A Systematic Review of Randomized Controlled Trials. Ann Intern Med. 2025;178(2):199-217. 
Wen J, Syed B, Nadora D, et al. Tirzepatide Versus Semaglutide on Weight Loss in Type 2 Diabetes Patients: A Systematic Review and Meta-Analysis of Direct Comparative Studies. Endocrinol Diabetes Metab. 2025;8(3):e70045. 

Guest: Alan M. Ehrlich, MD, FAAFPMusic Credit: Matthew Bugos
Thoughts? Suggestions? Email us at FranklySpeaking@pri-med.com
 ]]></itunes:summary>
        <itunes:author>Pri-Med</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>739</itunes:duration>
                        <itunes:episodeType>full</itunes:episodeType>
            </item>
    <item>
        <title>Trying to Quit—Effective Cessation Strategies for Teens Who Vape - Frankly Speaking Ep 450</title>
        <itunes:title>Trying to Quit—Effective Cessation Strategies for Teens Who Vape - Frankly Speaking Ep 450</itunes:title>
        <link>https://primedfranklyspeaking.podbean.com/e/trying-to-quit%e2%80%94effective-cessation-strategies-for-teens-who-vape-frankly-speaking-ep-450/</link>
                    <comments>https://primedfranklyspeaking.podbean.com/e/trying-to-quit%e2%80%94effective-cessation-strategies-for-teens-who-vape-frankly-speaking-ep-450/#comments</comments>        <pubDate>Mon, 15 Sep 2025 05:30:00 +0000</pubDate>
        <guid isPermaLink="false">primedfranklyspeaking.podbean.com/be7f20b4-f634-3f41-8916-64a4372bd463</guid>
                                    <description><![CDATA[<p>Credits: 0.25 AMA PRA Category 1 Credit™
 
CME/CE Information and Claim Credit: <a href='https://www.pri-med.com/online-education/podcast/frankly-speaking-cme-450'>https://www.pri-med.com/online-education/podcast/frankly-speaking-cme-450</a></p>
<p>Overview: Use of e-cigarettes has increased significantly over the last several years and their popularity continues to grow, notably among adolescents and young adults. Recent evidence indicates that the majority of teens and young adults who vape consider quitting; however, nicotine addiction has historically been difficult to treat in this population. Join us as we discuss the prevalence of vaping, associated harms, and new evidence on the effectiveness of varenicline on cessation. </p>
<p>Episode resource links:</p>
<ul>
<li>CDC https://www.cdc.gov/tobacco/e-cigarettes/youth.html</li>
<li>Evins, A. E., Cather, C., Reeder, H. T., Evohr, B., Potter, K., Pachas, G. N., Gray, K. M., Levy, S., Rigotti, N. A., Iroegbulem, V., Dufour, J., Casottana, K., Costello, M. A., Gilman, J. M., &amp; Schuster, R. M. (2025). Varenicline for Youth Nicotine Vaping Cessation: A Randomized Clinical Trial. JAMA, e253810. Advance online publication. <a href='https://doi.org/10.1001/jama.2025.3810'>https://doi.org/10.1001/jama.2025.3810</a></li>
<li>Lindson N, Butler AR, McRobbie H, et al. Electronic cigarettes for smoking cessation. Cochrane Database Syst Rev. 2024;1(1):CD010216. Published 2024 Jan 8. doi:10.1002/14651858.CD010216.pub8</li>
<li>Park-Lee E, Ren C, Sawdey MD, et al. Notes from the Field: E-Cigarette Use Among Middle and High School Students — National Youth Tobacco Survey, United States, 2021. MMWR Morb Mortal Wkly Rep 2021;70:1387–1389. DOI: <a href='http://dx.doi.org/10.15585/mmwr.mm7039a4external%20icon'>http://dx.doi.org/10.15585/mmwr.mm7039a4external icon</a>; </li>
<li>Tuisku A, Rahkola M, Nieminen P, Toljamo T. Electronic Cigarettes vs Varenicline for Smoking Cessation in Adults: A Randomized Clinical Trial. JAMA Intern Med. 2024;184(8):915–921. doi:10.1001/jamainternmed.2024.1822</li>
<li>Zhang, L., Gentzke, A., Trivers, K. F., &amp; VanFrank, B. (2022). Tobacco Cessation Behaviors Among U.S. Middle and High School Students, 2020. The Journal of adolescent health : official publication of the Society for Adolescent Medicine, 70(1), 147–154. <a href='https://doi.org/10.1016/j.jadohealth.2021.07.011'>https://doi.org/10.1016/j.jadohealth.2021.07.011</a></li>
</ul>
<p>Guest: Susan Feeney, DNP, FNP-BC, NP-C

Music Credit: Matthew Bugos</p>
<p>Thoughts? Suggestions? Email us at <a href='mailto:FranklySpeaking@pri-med.com'>FranklySpeaking@pri-med.com</a></p>
<p> </p>
]]></description>
                                                            <content:encoded><![CDATA[<p>Credits: 0.25 AMA PRA Category 1 Credit™<br>
 <br>
CME/CE Information and Claim Credit: <a href='https://www.pri-med.com/online-education/podcast/frankly-speaking-cme-450'>https://www.pri-med.com/online-education/podcast/frankly-speaking-cme-450</a></p>
<p>Overview: Use of e-cigarettes has increased significantly over the last several years and their popularity continues to grow, notably among adolescents and young adults. Recent evidence indicates that the majority of teens and young adults who vape consider quitting; however, nicotine addiction has historically been difficult to treat in this population. Join us as we discuss the prevalence of vaping, associated harms, and new evidence on the effectiveness of varenicline on cessation. </p>
<p>Episode resource links:</p>
<ul>
<li>CDC https://www.cdc.gov/tobacco/e-cigarettes/youth.html</li>
<li>Evins, A. E., Cather, C., Reeder, H. T., Evohr, B., Potter, K., Pachas, G. N., Gray, K. M., Levy, S., Rigotti, N. A., Iroegbulem, V., Dufour, J., Casottana, K., Costello, M. A., Gilman, J. M., &amp; Schuster, R. M. (2025). Varenicline for Youth Nicotine Vaping Cessation: A Randomized Clinical Trial. JAMA, e253810. Advance online publication. <a href='https://doi.org/10.1001/jama.2025.3810'>https://doi.org/10.1001/jama.2025.3810</a></li>
<li>Lindson N, Butler AR, McRobbie H, et al. Electronic cigarettes for smoking cessation. Cochrane Database Syst Rev. 2024;1(1):CD010216. Published 2024 Jan 8. doi:10.1002/14651858.CD010216.pub8</li>
<li>Park-Lee E, Ren C, Sawdey MD, et al. Notes from the Field: E-Cigarette Use Among Middle and High School Students — National Youth Tobacco Survey, United States, 2021. MMWR Morb Mortal Wkly Rep 2021;70:1387–1389. DOI: <a href='http://dx.doi.org/10.15585/mmwr.mm7039a4external%20icon'>http://dx.doi.org/10.15585/mmwr.mm7039a4external icon</a>; </li>
<li>Tuisku A, Rahkola M, Nieminen P, Toljamo T. Electronic Cigarettes vs Varenicline for Smoking Cessation in Adults: A Randomized Clinical Trial. JAMA Intern Med. 2024;184(8):915–921. doi:10.1001/jamainternmed.2024.1822</li>
<li>Zhang, L., Gentzke, A., Trivers, K. F., &amp; VanFrank, B. (2022). Tobacco Cessation Behaviors Among U.S. Middle and High School Students, 2020. The Journal of adolescent health : official publication of the Society for Adolescent Medicine, 70(1), 147–154. <a href='https://doi.org/10.1016/j.jadohealth.2021.07.011'>https://doi.org/10.1016/j.jadohealth.2021.07.011</a></li>
</ul>
<p>Guest: Susan Feeney, DNP, FNP-BC, NP-C<br>
<br>
Music Credit: Matthew Bugos</p>
<p>Thoughts? Suggestions? Email us at <a href='mailto:FranklySpeaking@pri-med.com'>FranklySpeaking@pri-med.com</a></p>
<p> </p>
]]></content:encoded>
                                    
        <enclosure url="https://mcdn.podbean.com/mf/web/um5mdtdt4uzx336n/frankly-speaking-450-vaping.mp4" length="300611719" type="video/mp4"/>
                <itunes:summary><![CDATA[Credits: 0.25 AMA PRA Category 1 Credit™ CME/CE Information and Claim Credit: https://www.pri-med.com/online-education/podcast/frankly-speaking-cme-450
Overview: Use of e-cigarettes has increased significantly over the last several years and their popularity continues to grow, notably among adolescents and young adults. Recent evidence indicates that the majority of teens and young adults who vape consider quitting; however, nicotine addiction has historically been difficult to treat in this population. Join us as we discuss the prevalence of vaping, associated harms, and new evidence on the effectiveness of varenicline on cessation. 
Episode resource links:

CDC https://www.cdc.gov/tobacco/e-cigarettes/youth.html
Evins, A. E., Cather, C., Reeder, H. T., Evohr, B., Potter, K., Pachas, G. N., Gray, K. M., Levy, S., Rigotti, N. A., Iroegbulem, V., Dufour, J., Casottana, K., Costello, M. A., Gilman, J. M., &amp; Schuster, R. M. (2025). Varenicline for Youth Nicotine Vaping Cessation: A Randomized Clinical Trial. JAMA, e253810. Advance online publication. https://doi.org/10.1001/jama.2025.3810
Lindson N, Butler AR, McRobbie H, et al. Electronic cigarettes for smoking cessation. Cochrane Database Syst Rev. 2024;1(1):CD010216. Published 2024 Jan 8. doi:10.1002/14651858.CD010216.pub8
Park-Lee E, Ren C, Sawdey MD, et al. Notes from the Field: E-Cigarette Use Among Middle and High School Students — National Youth Tobacco Survey, United States, 2021. MMWR Morb Mortal Wkly Rep 2021;70:1387–1389. DOI: http://dx.doi.org/10.15585/mmwr.mm7039a4external icon; 
Tuisku A, Rahkola M, Nieminen P, Toljamo T. Electronic Cigarettes vs Varenicline for Smoking Cessation in Adults: A Randomized Clinical Trial. JAMA Intern Med. 2024;184(8):915–921. doi:10.1001/jamainternmed.2024.1822
Zhang, L., Gentzke, A., Trivers, K. F., &amp; VanFrank, B. (2022). Tobacco Cessation Behaviors Among U.S. Middle and High School Students, 2020. The Journal of adolescent health : official publication of the Society for Adolescent Medicine, 70(1), 147–154. https://doi.org/10.1016/j.jadohealth.2021.07.011

Guest: Susan Feeney, DNP, FNP-BC, NP-CMusic Credit: Matthew Bugos
Thoughts? Suggestions? Email us at FranklySpeaking@pri-med.com
 ]]></itunes:summary>
        <itunes:author>Pri-Med</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>1052</itunes:duration>
                <itunes:episode>7</itunes:episode>
        <itunes:episodeType>full</itunes:episodeType>
            </item>
    <item>
        <title>DASHing Away Colon Cancer - Frankly Speaking Ep 449</title>
        <itunes:title>DASHing Away Colon Cancer - Frankly Speaking Ep 449</itunes:title>
        <link>https://primedfranklyspeaking.podbean.com/e/dashing-away-colon-cancer-frankly-speaking-ep-449/</link>
                    <comments>https://primedfranklyspeaking.podbean.com/e/dashing-away-colon-cancer-frankly-speaking-ep-449/#comments</comments>        <pubDate>Thu, 04 Sep 2025 05:30:00 +0000</pubDate>
        <guid isPermaLink="false">primedfranklyspeaking.podbean.com/52da57a0-fda0-3b96-9c9f-d2764d414274</guid>
                                    <description><![CDATA[<p>Credits: 0.25 AMA PRA Category 1 Credit™
 
CME/CE Information and Claim Credit: <a href='https://www.pri-med.com/online-education/podcast/frankly-speaking-cme-449'>https://www.pri-med.com/online-education/podcast/frankly-speaking-cme-449</a></p>
<p>Overview: In this episode, we discuss new evidence linking high compliance with the Dietary Approaches to Stop Hypertension (DASH) diet to lower risks of colorectal cancer, reinforcing the DASH diet’s well-established role in managing hypertension while also highlighting its potential to reduce cancer risk. Gain practical insights into translating these findings into actionable nutrition guidance to support your patients’ overall health.</p>
<p>Episode resource links:</p>
<ul>
<li>Explain the risk factors for development of colorectal cancers</li>
<li>Review the Dietary Approaches to Stop Hypertension (DASH) and discuss the proposed mechanisms for colorectal cancer reduction by following this approach</li>
<li>Apply evidence from a meta-analysis to support dietary counseling strategies aimed at cancer prevention in clinical settings</li>
</ul>
<p>Guest: Jillian Joseph, MPAS, PA-C
 
Music Credit: Matthew Bugos</p>
<p>Thoughts? Suggestions? Email us at <a href='mailto:FranklySpeaking@pri-med.com'>FranklySpeaking@pri-med.com</a></p>
<p> </p>
]]></description>
                                                            <content:encoded><![CDATA[<p>Credits: 0.25 AMA PRA Category 1 Credit™<br>
 <br>
CME/CE Information and Claim Credit: <a href='https://www.pri-med.com/online-education/podcast/frankly-speaking-cme-449'>https://www.pri-med.com/online-education/podcast/frankly-speaking-cme-449</a></p>
<p>Overview: In this episode, we discuss new evidence linking high compliance with the Dietary Approaches to Stop Hypertension (DASH) diet to lower risks of colorectal cancer, reinforcing the DASH diet’s well-established role in managing hypertension while also highlighting its potential to reduce cancer risk. Gain practical insights into translating these findings into actionable nutrition guidance to support your patients’ overall health.</p>
<p>Episode resource links:</p>
<ul>
<li>Explain the risk factors for development of colorectal cancers</li>
<li>Review the Dietary Approaches to Stop Hypertension (DASH) and discuss the proposed mechanisms for colorectal cancer reduction by following this approach</li>
<li>Apply evidence from a meta-analysis to support dietary counseling strategies aimed at cancer prevention in clinical settings</li>
</ul>
<p>Guest: Jillian Joseph, MPAS, PA-C<br>
 <br>
Music Credit: Matthew Bugos</p>
<p>Thoughts? Suggestions? Email us at <a href='mailto:FranklySpeaking@pri-med.com'>FranklySpeaking@pri-med.com</a></p>
<p> </p>
]]></content:encoded>
                                    
        <enclosure url="https://mcdn.podbean.com/mf/web/yt9jmhyk7ys87wgf/frankly-speaking-449-crc-dash.mp3" length="12446284" type="audio/mpeg"/>
                <itunes:summary><![CDATA[Credits: 0.25 AMA PRA Category 1 Credit™ CME/CE Information and Claim Credit: https://www.pri-med.com/online-education/podcast/frankly-speaking-cme-449
Overview: In this episode, we discuss new evidence linking high compliance with the Dietary Approaches to Stop Hypertension (DASH) diet to lower risks of colorectal cancer, reinforcing the DASH diet’s well-established role in managing hypertension while also highlighting its potential to reduce cancer risk. Gain practical insights into translating these findings into actionable nutrition guidance to support your patients’ overall health.
Episode resource links:

Explain the risk factors for development of colorectal cancers
Review the Dietary Approaches to Stop Hypertension (DASH) and discuss the proposed mechanisms for colorectal cancer reduction by following this approach
Apply evidence from a meta-analysis to support dietary counseling strategies aimed at cancer prevention in clinical settings

Guest: Jillian Joseph, MPAS, PA-C Music Credit: Matthew Bugos
Thoughts? Suggestions? Email us at FranklySpeaking@pri-med.com
 ]]></itunes:summary>
        <itunes:author>Pri-Med</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>775</itunes:duration>
                        <itunes:episodeType>full</itunes:episodeType>
            </item>
    <item>
        <title>Foods Rich in Flavan-3-Ols Reduce Blood Pressure - Frankly Speaking Ep 448</title>
        <itunes:title>Foods Rich in Flavan-3-Ols Reduce Blood Pressure - Frankly Speaking Ep 448</itunes:title>
        <link>https://primedfranklyspeaking.podbean.com/e/foods-rich-in-flavan-3-ols-reduce-blood-pressure-frankly-speaking-ep-448/</link>
                    <comments>https://primedfranklyspeaking.podbean.com/e/foods-rich-in-flavan-3-ols-reduce-blood-pressure-frankly-speaking-ep-448/#comments</comments>        <pubDate>Mon, 01 Sep 2025 05:30:00 +0000</pubDate>
        <guid isPermaLink="false">primedfranklyspeaking.podbean.com/061edc2d-4038-324e-83b4-5b4914f1c63f</guid>
                                    <description><![CDATA[<p>Credits: 0.25 AMA PRA Category 1 Credit™
 
CME/CE Information and Claim Credit: <a href='https://www.pri-med.com/online-education/podcast/frankly-speaking-cme-448'>https://www.pri-med.com/online-education/podcast/frankly-speaking-cme-448</a></p>
<p>Overview: Join us to discover how flavan-3-ols, found in tea, cocoa, and select fruits, can support cardiovascular prevention. Learn how to translate emerging evidence on blood pressure and vascular health into practical dietary guidance that empowers your patients and complements standard hypertension care.</p>
<p>Episode resource links:</p>
<ul>
<li>European Journal of Preventive Cardiology (2025) 00, 1–13. <a href='https://doi.org/10.1093/eurjpc/zwaf173'>https://doi.org/10.1093/eurjpc/zwaf173</a></li>
</ul>
<p>Guest: Robert A. Baldor MD, FAAFP
 
Music Credit: Matthew Bugos</p>
<p>Thoughts? Suggestions? Email us at <a href='mailto:FranklySpeaking@pri-med.com'>FranklySpeaking@pri-med.com</a></p>
<p> </p>
]]></description>
                                                            <content:encoded><![CDATA[<p>Credits: 0.25 AMA PRA Category 1 Credit™<br>
 <br>
CME/CE Information and Claim Credit: <a href='https://www.pri-med.com/online-education/podcast/frankly-speaking-cme-448'>https://www.pri-med.com/online-education/podcast/frankly-speaking-cme-448</a></p>
<p>Overview: Join us to discover how flavan-3-ols, found in tea, cocoa, and select fruits, can support cardiovascular prevention. Learn how to translate emerging evidence on blood pressure and vascular health into practical dietary guidance that empowers your patients and complements standard hypertension care.</p>
<p>Episode resource links:</p>
<ul>
<li>European Journal of Preventive Cardiology (2025) 00, 1–13. <a href='https://doi.org/10.1093/eurjpc/zwaf173'>https://doi.org/10.1093/eurjpc/zwaf173</a></li>
</ul>
<p>Guest: Robert A. Baldor MD, FAAFP<br>
 <br>
Music Credit: Matthew Bugos</p>
<p>Thoughts? Suggestions? Email us at <a href='mailto:FranklySpeaking@pri-med.com'>FranklySpeaking@pri-med.com</a></p>
<p> </p>
]]></content:encoded>
                                    
        <enclosure url="https://mcdn.podbean.com/mf/web/2rqub64mfu77z3u9/frankly-speaking-448-flavinoid.mp3" length="11760732" type="audio/mpeg"/>
                <itunes:summary><![CDATA[Credits: 0.25 AMA PRA Category 1 Credit™ CME/CE Information and Claim Credit: https://www.pri-med.com/online-education/podcast/frankly-speaking-cme-448
Overview: Join us to discover how flavan-3-ols, found in tea, cocoa, and select fruits, can support cardiovascular prevention. Learn how to translate emerging evidence on blood pressure and vascular health into practical dietary guidance that empowers your patients and complements standard hypertension care.
Episode resource links:

European Journal of Preventive Cardiology (2025) 00, 1–13. https://doi.org/10.1093/eurjpc/zwaf173

Guest: Robert A. Baldor MD, FAAFP Music Credit: Matthew Bugos
Thoughts? Suggestions? Email us at FranklySpeaking@pri-med.com
 ]]></itunes:summary>
        <itunes:author>Pri-Med</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>732</itunes:duration>
                        <itunes:episodeType>full</itunes:episodeType>
            </item>
    <item>
        <title>Never Too Late to Quit: Years Gained with Tobacco Cessation at Any Age - Frankly Speaking Ep 447</title>
        <itunes:title>Never Too Late to Quit: Years Gained with Tobacco Cessation at Any Age - Frankly Speaking Ep 447</itunes:title>
        <link>https://primedfranklyspeaking.podbean.com/e/never-too-late-to-quit-years-gained-with-tobacco-cessation-at-any-age-frankly-speaking-ep-447/</link>
                    <comments>https://primedfranklyspeaking.podbean.com/e/never-too-late-to-quit-years-gained-with-tobacco-cessation-at-any-age-frankly-speaking-ep-447/#comments</comments>        <pubDate>Mon, 25 Aug 2025 05:30:00 +0000</pubDate>
        <guid isPermaLink="false">primedfranklyspeaking.podbean.com/46037606-e782-3fbc-8eeb-d3e6cb532411</guid>
                                    <description><![CDATA[<p>Credits: 0.25 AMA PRA Category 1 Credit™
 
CME/CE Information and Claim Credit: <a href='https://www.pri-med.com/online-education/podcast/frankly-speaking-cme-447'>https://www.pri-med.com/online-education/podcast/frankly-speaking-cme-447</a></p>
<p>Overview: New data show that quitting smoking—even at age 65 or 75—can still add years to life. In this episode, we review the latest evidence on life expectancy gains and equip you with effective, evidence-based tools to support tobacco cessation and motivate patients at any age.</p>
<p>Episode resource links:</p>
<ul>
<li>Le,Thuy TT., Mendez, D. , &amp; Warner, K. (2024). The Benefits of Quitting Smoking at Different Ages. American Journal of Preventive Medicine, 67 (5), 684-688. <a href='https://doi.org/10.1016/j.amepre.2024.06.020.%20'>https://doi.org/10.1016/j.amepre.2024.06.020.   </a></li>
<li>What are the treatments for tobacco dependence? National Institute on Drug Abuse <a href='https://nida.nih.gov/publications/research-reports/tobacco-nicotine-e-cigarettes/what-are-treatments-tobacco-dependence'>https://nida.nih.gov/publications/research-reports/tobacco-nicotine-e-cigarettes/what-are-treatments-tobacco-dependence</a></li>
<li>Smokefree.gov offers Apps, counseling, texting support, tools and tips for your patient to build your quit plan</li>
<li>Selby, P., &amp; Zawertailo, L. (2022). Tobacco Addiction. The New England journal of medicine, 387(4), 345–354. <a href='https://doi.org/10.1056/NEJMcp2032393'>https://doi.org/10.1056/NEJMcp2032393</a></li>
</ul>
<p>Guest: Jill M. Terrien PhD, ANP-BC 

Music Credit: Matthew Bugos</p>
<p>Thoughts? Suggestions? Email us at <a href='mailto:FranklySpeaking@pri-med.com'>FranklySpeaking@pri-med.com</a></p>
<p> </p>
]]></description>
                                                            <content:encoded><![CDATA[<p>Credits: 0.25 AMA PRA Category 1 Credit™<br>
 <br>
CME/CE Information and Claim Credit: <a href='https://www.pri-med.com/online-education/podcast/frankly-speaking-cme-447'>https://www.pri-med.com/online-education/podcast/frankly-speaking-cme-447</a></p>
<p>Overview: New data show that quitting smoking—even at age 65 or 75—can still add years to life. In this episode, we review the latest evidence on life expectancy gains and equip you with effective, evidence-based tools to support tobacco cessation and motivate patients at any age.</p>
<p>Episode resource links:</p>
<ul>
<li>Le,Thuy TT., Mendez, D. , &amp; Warner, K. (2024). The Benefits of Quitting Smoking at Different Ages. American Journal of Preventive Medicine, 67 (5), 684-688. <a href='https://doi.org/10.1016/j.amepre.2024.06.020.%20'>https://doi.org/10.1016/j.amepre.2024.06.020.   </a></li>
<li>What are the treatments for tobacco dependence? National Institute on Drug Abuse <a href='https://nida.nih.gov/publications/research-reports/tobacco-nicotine-e-cigarettes/what-are-treatments-tobacco-dependence'>https://nida.nih.gov/publications/research-reports/tobacco-nicotine-e-cigarettes/what-are-treatments-tobacco-dependence</a></li>
<li>Smokefree.gov offers Apps, counseling, texting support, tools and tips for your patient to build your quit plan</li>
<li>Selby, P., &amp; Zawertailo, L. (2022). Tobacco Addiction. The New England journal of medicine, 387(4), 345–354. <a href='https://doi.org/10.1056/NEJMcp2032393'>https://doi.org/10.1056/NEJMcp2032393</a></li>
</ul>
<p>Guest: Jill M. Terrien PhD, ANP-BC <br>
<br>
Music Credit: Matthew Bugos</p>
<p>Thoughts? Suggestions? Email us at <a href='mailto:FranklySpeaking@pri-med.com'>FranklySpeaking@pri-med.com</a></p>
<p> </p>
]]></content:encoded>
                                    
        <enclosure url="https://mcdn.podbean.com/mf/web/y2rmei8ujvu595t6/frankly-speaking-447-smoking.mp3" length="13664021" type="audio/mpeg"/>
                <itunes:summary><![CDATA[Credits: 0.25 AMA PRA Category 1 Credit™ CME/CE Information and Claim Credit: https://www.pri-med.com/online-education/podcast/frankly-speaking-cme-447
Overview: New data show that quitting smoking—even at age 65 or 75—can still add years to life. In this episode, we review the latest evidence on life expectancy gains and equip you with effective, evidence-based tools to support tobacco cessation and motivate patients at any age.
Episode resource links:

Le,Thuy TT., Mendez, D. , &amp; Warner, K. (2024). The Benefits of Quitting Smoking at Different Ages. American Journal of Preventive Medicine, 67 (5), 684-688. https://doi.org/10.1016/j.amepre.2024.06.020.   
What are the treatments for tobacco dependence? National Institute on Drug Abuse https://nida.nih.gov/publications/research-reports/tobacco-nicotine-e-cigarettes/what-are-treatments-tobacco-dependence
Smokefree.gov offers Apps, counseling, texting support, tools and tips for your patient to build your quit plan
Selby, P., &amp; Zawertailo, L. (2022). Tobacco Addiction. The New England journal of medicine, 387(4), 345–354. https://doi.org/10.1056/NEJMcp2032393

Guest: Jill M. Terrien PhD, ANP-BC Music Credit: Matthew Bugos
Thoughts? Suggestions? Email us at FranklySpeaking@pri-med.com
 ]]></itunes:summary>
        <itunes:author>Pri-Med</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>851</itunes:duration>
                        <itunes:episodeType>full</itunes:episodeType>
            </item>
    <item>
        <title>Patient Portal SOS! Strategies to Tame the In-Basket - Frankly Speaking Ep 446</title>
        <itunes:title>Patient Portal SOS! Strategies to Tame the In-Basket - Frankly Speaking Ep 446</itunes:title>
        <link>https://primedfranklyspeaking.podbean.com/e/patient-portal-sos-strategies-to-tame-the-in-basket-frankly-speaking-ep-446/</link>
                    <comments>https://primedfranklyspeaking.podbean.com/e/patient-portal-sos-strategies-to-tame-the-in-basket-frankly-speaking-ep-446/#comments</comments>        <pubDate>Mon, 18 Aug 2025 05:30:00 +0000</pubDate>
        <guid isPermaLink="false">primedfranklyspeaking.podbean.com/6e5d712c-ea7c-3a15-ba99-7b20bece0e69</guid>
                                    <description><![CDATA[<p>Credits: 0.25 AMA PRA Category 1 Credit™
 
CME/CE Information and Claim Credit: <a href='https://www.pri-med.com/online-education/podcast/frankly-speaking-cme-446'>https://www.pri-med.com/online-education/podcast/frankly-speaking-cme-446</a></p>
<p>Overview: Overwhelmed by in-basket tasks? Discover a practical scheduling intervention that gives you time during the clinic day to manage portal messages. Learn how “portal practice slots” can reduce burnout, improve workflow, and empower you to advocate for changes that support sustainable, high-quality primary care.</p>
<p>Episode resource links:</p>
<ul>
<li>J Gen Intern Med. DOI: 10.1007/s11606-025-09582-8</li>
</ul>
<p>Guest: Robert A. Baldor MD, FAAFP

Music Credit: Matthew Bugos</p>
<p>Thoughts? Suggestions? Email us at <a href='mailto:FranklySpeaking@pri-med.com'>FranklySpeaking@pri-med.com</a></p>
<p> </p>
]]></description>
                                                            <content:encoded><![CDATA[<p>Credits: 0.25 AMA PRA Category 1 Credit™<br>
 <br>
CME/CE Information and Claim Credit: <a href='https://www.pri-med.com/online-education/podcast/frankly-speaking-cme-446'>https://www.pri-med.com/online-education/podcast/frankly-speaking-cme-446</a></p>
<p>Overview: Overwhelmed by in-basket tasks? Discover a practical scheduling intervention that gives you time during the clinic day to manage portal messages. Learn how “portal practice slots” can reduce burnout, improve workflow, and empower you to advocate for changes that support sustainable, high-quality primary care.</p>
<p>Episode resource links:</p>
<ul>
<li>J Gen Intern Med. DOI: 10.1007/s11606-025-09582-8</li>
</ul>
<p>Guest: Robert A. Baldor MD, FAAFP<br>
<br>
Music Credit: Matthew Bugos</p>
<p>Thoughts? Suggestions? Email us at <a href='mailto:FranklySpeaking@pri-med.com'>FranklySpeaking@pri-med.com</a></p>
<p> </p>
]]></content:encoded>
                                    
        <enclosure url="https://mcdn.podbean.com/mf/web/b7679hnfzhujhsuj/frankly-speaking-446-managing-portal-messages.mp4" length="194077719" type="video/mp4"/>
                <itunes:summary><![CDATA[Credits: 0.25 AMA PRA Category 1 Credit™ CME/CE Information and Claim Credit: https://www.pri-med.com/online-education/podcast/frankly-speaking-cme-446
Overview: Overwhelmed by in-basket tasks? Discover a practical scheduling intervention that gives you time during the clinic day to manage portal messages. Learn how “portal practice slots” can reduce burnout, improve workflow, and empower you to advocate for changes that support sustainable, high-quality primary care.
Episode resource links:

J Gen Intern Med. DOI: 10.1007/s11606-025-09582-8

Guest: Robert A. Baldor MD, FAAFPMusic Credit: Matthew Bugos
Thoughts? Suggestions? Email us at FranklySpeaking@pri-med.com
 ]]></itunes:summary>
        <itunes:author>Pri-Med</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>698</itunes:duration>
                        <itunes:episodeType>full</itunes:episodeType>
            </item>
    <item>
        <title>Metformin: A Fresh Angle for Treating Knee Osteoarthritis - Frankly Speaking Ep 445</title>
        <itunes:title>Metformin: A Fresh Angle for Treating Knee Osteoarthritis - Frankly Speaking Ep 445</itunes:title>
        <link>https://primedfranklyspeaking.podbean.com/e/metformin-a-fresh-angle-for-treating-knee-osteoarthritis-frankly-speaking-ep-445/</link>
                    <comments>https://primedfranklyspeaking.podbean.com/e/metformin-a-fresh-angle-for-treating-knee-osteoarthritis-frankly-speaking-ep-445/#comments</comments>        <pubDate>Mon, 11 Aug 2025 05:30:00 +0000</pubDate>
        <guid isPermaLink="false">primedfranklyspeaking.podbean.com/9b2abf32-7dbd-3543-ab8c-7200fb33dcf5</guid>
                                    <description><![CDATA[<p>Credits: 0.25 AMA PRA Category 1 Credit™
 
CME/CE Information and Claim Credit: <a href='https://www.pri-med.com/online-education/podcast/frankly-speaking-cme-445'>https://www.pri-med.com/online-education/podcast/frankly-speaking-cme-445</a></p>
<p>Overview: Managing knee osteoarthritis (OA) in patients with obesity can be challenging, especially when standard treatments fall short. In this episode, we discuss emerging evidence on the use of metformin to reduce knee pain in patients without diabetes and explore how this option could expand your approach to OA management.</p>
<p>Episode resource links:</p>
<ul>
<li>Pan F, Wang Y, Lim YZ, et al. Metformin for Knee Osteoarthritis in Patients With Overweight or Obesity: A Randomized Clinical Trial. JAMA. 2025;333(20):1804-1812. </li>
</ul>
<p>Guest: Alan M. Ehrlich, MD, FAAFP
 
Music Credit: Matthew Bugos</p>
<p>Thoughts? Suggestions? Email us at <a href='mailto:FranklySpeaking@pri-med.com'>FranklySpeaking@pri-med.com </a></p>
<p> </p>
]]></description>
                                                            <content:encoded><![CDATA[<p>Credits: 0.25 AMA PRA Category 1 Credit™<br>
 <br>
CME/CE Information and Claim Credit: <a href='https://www.pri-med.com/online-education/podcast/frankly-speaking-cme-445'>https://www.pri-med.com/online-education/podcast/frankly-speaking-cme-445</a></p>
<p>Overview: Managing knee osteoarthritis (OA) in patients with obesity can be challenging, especially when standard treatments fall short. In this episode, we discuss emerging evidence on the use of metformin to reduce knee pain in patients without diabetes and explore how this option could expand your approach to OA management.</p>
<p>Episode resource links:</p>
<ul>
<li>Pan F, Wang Y, Lim YZ, et al. Metformin for Knee Osteoarthritis in Patients With Overweight or Obesity: A Randomized Clinical Trial. JAMA. 2025;333(20):1804-1812. </li>
</ul>
<p>Guest: Alan M. Ehrlich, MD, FAAFP<br>
 <br>
Music Credit: Matthew Bugos</p>
<p>Thoughts? Suggestions? Email us at <a href='mailto:FranklySpeaking@pri-med.com'>FranklySpeaking@pri-med.com </a></p>
<p> </p>
]]></content:encoded>
                                    
        <enclosure url="https://mcdn.podbean.com/mf/web/tkrfkv9cfvpb5e8j/frankly-speaking-445-metformin-osteoarthritis.mp3" length="10329771" type="audio/mpeg"/>
                <itunes:summary><![CDATA[Credits: 0.25 AMA PRA Category 1 Credit™ CME/CE Information and Claim Credit: https://www.pri-med.com/online-education/podcast/frankly-speaking-cme-445
Overview: Managing knee osteoarthritis (OA) in patients with obesity can be challenging, especially when standard treatments fall short. In this episode, we discuss emerging evidence on the use of metformin to reduce knee pain in patients without diabetes and explore how this option could expand your approach to OA management.
Episode resource links:

Pan F, Wang Y, Lim YZ, et al. Metformin for Knee Osteoarthritis in Patients With Overweight or Obesity: A Randomized Clinical Trial. JAMA. 2025;333(20):1804-1812. 

Guest: Alan M. Ehrlich, MD, FAAFP Music Credit: Matthew Bugos
Thoughts? Suggestions? Email us at FranklySpeaking@pri-med.com 
 ]]></itunes:summary>
        <itunes:author>Pri-Med</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>643</itunes:duration>
                        <itunes:episodeType>full</itunes:episodeType>
            </item>
    <item>
        <title>Treating Two: Partnering Up Against Bacterial Vaginosis Recurrence - Frankly Speaking Ep 444</title>
        <itunes:title>Treating Two: Partnering Up Against Bacterial Vaginosis Recurrence - Frankly Speaking Ep 444</itunes:title>
        <link>https://primedfranklyspeaking.podbean.com/e/treating-two-partnering-up-against-bacterial-vaginosis-recurrence-frankly-speaking-ep-444/</link>
                    <comments>https://primedfranklyspeaking.podbean.com/e/treating-two-partnering-up-against-bacterial-vaginosis-recurrence-frankly-speaking-ep-444/#comments</comments>        <pubDate>Mon, 04 Aug 2025 05:30:00 +0000</pubDate>
        <guid isPermaLink="false">primedfranklyspeaking.podbean.com/26418b73-a07a-3c8f-9be4-cf8e6e2001ba</guid>
                                    <description><![CDATA[<p>Credits: 0.25 AMA PRA Category 1 Credit™
 
CME/CE Information and Claim Credit: <a href='https://www.pri-med.com/online-education/podcast/frankly-speaking-cme-444'>https://www.pri-med.com/online-education/podcast/frankly-speaking-cme-444</a></p>
<p>Overview: An estimated 30% of women worldwide are affected by bacterial vaginosis (BV), and although treatment is typically successful, recurrence rates remain high. Traditional strategies, such as treating male partners, have not significantly reduced recurrence. In this episode, we discuss a recent study that used a new approach to partner treatment and review its potential to reduce BV recurrence.</p>
<p>Episode resource links:</p>
<ul>
<li>Vodstrcil LA, Plummer EL, Fairley CK, et al. Male-partner treatment to prevent bacterial vaginosis.  The New England Journal of Medicine. 2025; 392 (10): 947-957. doi: 10.1056/NEJMoa2405404.</li>
<li>DynaMed: <a href='https://www-dynamed-com.umassmed.idm.oclc.org/condition/bacterial-vaginosis-bv#GUID-E1A22CF7-D0AC-4247-B1F8-54D1CD26FC1A'>https://www-dynamed-com.umassmed.idm.oclc.org/condition/bacterial-vaginosis-bv#GUID-E1A22CF7-D0AC-4247-B1F8-54D1CD26FC1A</a></li>
</ul>
<p>Guest: Susan Feeney, DNP, FNP
 
Music Credit: Matthew Bugos</p>
<p>Thoughts? Suggestions? Email us at <a href='mailto:FranklySpeaking@pri-med.com'>FranklySpeaking@pri-med.com </a></p>
<p> </p>
]]></description>
                                                            <content:encoded><![CDATA[<p>Credits: 0.25 AMA PRA Category 1 Credit™<br>
 <br>
CME/CE Information and Claim Credit: <a href='https://www.pri-med.com/online-education/podcast/frankly-speaking-cme-444'>https://www.pri-med.com/online-education/podcast/frankly-speaking-cme-444</a></p>
<p>Overview: An estimated 30% of women worldwide are affected by bacterial vaginosis (BV), and although treatment is typically successful, recurrence rates remain high. Traditional strategies, such as treating male partners, have not significantly reduced recurrence. In this episode, we discuss a recent study that used a new approach to partner treatment and review its potential to reduce BV recurrence.</p>
<p>Episode resource links:</p>
<ul>
<li>Vodstrcil LA, Plummer EL, Fairley CK, et al. Male-partner treatment to prevent bacterial vaginosis.  The New England Journal of Medicine. 2025; 392 (10): 947-957. doi: 10.1056/NEJMoa2405404.</li>
<li>DynaMed: <a href='https://www-dynamed-com.umassmed.idm.oclc.org/condition/bacterial-vaginosis-bv#GUID-E1A22CF7-D0AC-4247-B1F8-54D1CD26FC1A'>https://www-dynamed-com.umassmed.idm.oclc.org/condition/bacterial-vaginosis-bv#GUID-E1A22CF7-D0AC-4247-B1F8-54D1CD26FC1A</a></li>
</ul>
<p>Guest: Susan Feeney, DNP, FNP<br>
 <br>
Music Credit: Matthew Bugos</p>
<p>Thoughts? Suggestions? Email us at <a href='mailto:FranklySpeaking@pri-med.com'>FranklySpeaking@pri-med.com </a></p>
<p> </p>
]]></content:encoded>
                                    
        <enclosure url="https://mcdn.podbean.com/mf/web/dd3uwgkbtzdginhv/frankly-speaking-444-bacterial-vaginosis.mp4" length="239944864" type="video/mp4"/>
                <itunes:summary><![CDATA[Credits: 0.25 AMA PRA Category 1 Credit™ CME/CE Information and Claim Credit: https://www.pri-med.com/online-education/podcast/frankly-speaking-cme-444
Overview: An estimated 30% of women worldwide are affected by bacterial vaginosis (BV), and although treatment is typically successful, recurrence rates remain high. Traditional strategies, such as treating male partners, have not significantly reduced recurrence. In this episode, we discuss a recent study that used a new approach to partner treatment and review its potential to reduce BV recurrence.
Episode resource links:

Vodstrcil LA, Plummer EL, Fairley CK, et al. Male-partner treatment to prevent bacterial vaginosis.  The New England Journal of Medicine. 2025; 392 (10): 947-957. doi: 10.1056/NEJMoa2405404.
DynaMed: https://www-dynamed-com.umassmed.idm.oclc.org/condition/bacterial-vaginosis-bv#GUID-E1A22CF7-D0AC-4247-B1F8-54D1CD26FC1A

Guest: Susan Feeney, DNP, FNP Music Credit: Matthew Bugos
Thoughts? Suggestions? Email us at FranklySpeaking@pri-med.com 
 ]]></itunes:summary>
        <itunes:author>Pri-Med</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>842</itunes:duration>
                        <itunes:episodeType>full</itunes:episodeType>
            </item>
    <item>
        <title>Steps That Count: Reducing Cancer Risk Through Physical Activity - Frankly Speaking Ep 443</title>
        <itunes:title>Steps That Count: Reducing Cancer Risk Through Physical Activity - Frankly Speaking Ep 443</itunes:title>
        <link>https://primedfranklyspeaking.podbean.com/e/steps-that-count-reducing-cancer-risk-through-physical-activity-frankly-speaking-ep-443/</link>
                    <comments>https://primedfranklyspeaking.podbean.com/e/steps-that-count-reducing-cancer-risk-through-physical-activity-frankly-speaking-ep-443/#comments</comments>        <pubDate>Mon, 28 Jul 2025 05:30:00 +0000</pubDate>
        <guid isPermaLink="false">primedfranklyspeaking.podbean.com/d23865c9-caf4-3e01-955a-5cbe4210273f</guid>
                                    <description><![CDATA[<p>Credits: 0.25 AMA PRA Category 1 Credit™
 
CME/CE Information and Claim Credit: <a href='https://www.pri-med.com/online-education/podcast/frankly-speaking-cme-443'>https://www.pri-med.com/online-education/podcast/frankly-speaking-cme-443</a></p>
<p>Overview: In this episode, we evaluate the correlation between an increase in physical activity and step count and a reduction in cancer risk. We break down new evidence, equipping you with practical guidance for counseling patients on simple, impactful behavior changes to support long-term health.</p>
<p>Episode resource links:</p>
<ul>
<li>Shreves AH, Small SR, Walmsley R, et al. Amount and intensity of daily total physical activity, step count and risk of incident cancer in the UK Biobank. Br J Sports Med. Published online 2025. doi:10.1136/bjsports-2024-109360</li>
<li>Islami, F., Goding Sauer, A., Miller, K.D., Siegel, R.L., Fedewa, S.A., Jacobs, E.J., McCullough, M.L., Patel, A.V., Ma, J., Soerjomataram, I., Flanders, W.D., Brawley, O.W., Gapstur, S.M. and Jemal, A. (2018), Proportion and number of cancer cases and deaths attributable to potentially modifiable risk factors in the United States. CA: A Cancer Journal for Clinicians, 68: 31-54. https://doi.org/10.3322/caac.21440</li>
</ul>
<p>Guest: Jillian Joseph, PA-C
 
Music Credit: Matthew Bugos</p>
<p>Thoughts? Suggestions? Email us at <a href='mailto:FranklySpeaking@pri-med.com'>FranklySpeaking@pri-med.com </a></p>
<p> </p>
]]></description>
                                                            <content:encoded><![CDATA[<p>Credits: 0.25 AMA PRA Category 1 Credit™<br>
 <br>
CME/CE Information and Claim Credit: <a href='https://www.pri-med.com/online-education/podcast/frankly-speaking-cme-443'>https://www.pri-med.com/online-education/podcast/frankly-speaking-cme-443</a></p>
<p>Overview: In this episode, we evaluate the correlation between an increase in physical activity and step count and a reduction in cancer risk. We break down new evidence, equipping you with practical guidance for counseling patients on simple, impactful behavior changes to support long-term health.</p>
<p>Episode resource links:</p>
<ul>
<li>Shreves AH, Small SR, Walmsley R, et al. Amount and intensity of daily total physical activity, step count and risk of incident cancer in the UK Biobank. Br J Sports Med. Published online 2025. doi:10.1136/bjsports-2024-109360</li>
<li>Islami, F., Goding Sauer, A., Miller, K.D., Siegel, R.L., Fedewa, S.A., Jacobs, E.J., McCullough, M.L., Patel, A.V., Ma, J., Soerjomataram, I., Flanders, W.D., Brawley, O.W., Gapstur, S.M. and Jemal, A. (2018), Proportion and number of cancer cases and deaths attributable to potentially modifiable risk factors in the United States. CA: A Cancer Journal for Clinicians, 68: 31-54. https://doi.org/10.3322/caac.21440</li>
</ul>
<p>Guest: Jillian Joseph, PA-C<br>
 <br>
Music Credit: Matthew Bugos</p>
<p>Thoughts? Suggestions? Email us at <a href='mailto:FranklySpeaking@pri-med.com'>FranklySpeaking@pri-med.com </a></p>
<p> </p>
]]></content:encoded>
                                    
        <enclosure url="https://mcdn.podbean.com/mf/web/qwj8ud9uf7c6uz4z/frankly-speaking-443-cancer-exercise.mp4" length="2164166659" type="video/mp4"/>
                <itunes:summary><![CDATA[Credits: 0.25 AMA PRA Category 1 Credit™ CME/CE Information and Claim Credit: https://www.pri-med.com/online-education/podcast/frankly-speaking-cme-443
Overview: In this episode, we evaluate the correlation between an increase in physical activity and step count and a reduction in cancer risk. We break down new evidence, equipping you with practical guidance for counseling patients on simple, impactful behavior changes to support long-term health.
Episode resource links:

Shreves AH, Small SR, Walmsley R, et al. Amount and intensity of daily total physical activity, step count and risk of incident cancer in the UK Biobank. Br J Sports Med. Published online 2025. doi:10.1136/bjsports-2024-109360
Islami, F., Goding Sauer, A., Miller, K.D., Siegel, R.L., Fedewa, S.A., Jacobs, E.J., McCullough, M.L., Patel, A.V., Ma, J., Soerjomataram, I., Flanders, W.D., Brawley, O.W., Gapstur, S.M. and Jemal, A. (2018), Proportion and number of cancer cases and deaths attributable to potentially modifiable risk factors in the United States. CA: A Cancer Journal for Clinicians, 68: 31-54. https://doi.org/10.3322/caac.21440

Guest: Jillian Joseph, PA-C Music Credit: Matthew Bugos
Thoughts? Suggestions? Email us at FranklySpeaking@pri-med.com 
 ]]></itunes:summary>
        <itunes:author>Pri-Med</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>937</itunes:duration>
                        <itunes:episodeType>full</itunes:episodeType>
            </item>
    <item>
        <title>Osteoporosis Screening Update: Changing Guidelines and Practical Steps - Frankly Speaking Ep 442</title>
        <itunes:title>Osteoporosis Screening Update: Changing Guidelines and Practical Steps - Frankly Speaking Ep 442</itunes:title>
        <link>https://primedfranklyspeaking.podbean.com/e/osteoporosis-screening-update-changing-guidelines-and-practical-steps-frankly-speaking-ep-442/</link>
                    <comments>https://primedfranklyspeaking.podbean.com/e/osteoporosis-screening-update-changing-guidelines-and-practical-steps-frankly-speaking-ep-442/#comments</comments>        <pubDate>Mon, 21 Jul 2025 05:30:00 +0000</pubDate>
        <guid isPermaLink="false">primedfranklyspeaking.podbean.com/1d4db2df-b203-3b95-a8be-32f84b5cfd37</guid>
                                    <description><![CDATA[<p>Credits: 0.25 AMA PRA Category 1 Credit™
 
CME/CE Information and Claim Credit: <a href='https://www.pri-med.com/online-education/podcast/frankly-speaking-cme-442'>https://www.pri-med.com/online-education/podcast/frankly-speaking-cme-442</a></p>
<p>Overview: Listen in as we review the USPSTF’s recently proposed recommendations for screening women who are at risk for developing osteoporosis. Gain confidence to navigate these changes and engage patients in shared decision-making to ensure timely, evidence-based preventive care.</p>
<p>Episode resource links:</p>
<ul>
<li>JAMA. 2025;333(6):498–508. doi:10.1001/jama.2024.27154</li>
</ul>
<p>Guest: Robert A. Baldor MD, FAAFP
 
Music Credit: Matthew Bugos</p>
<p>Thoughts? Suggestions? Email us at <a href='mailto:FranklySpeaking@pri-med.com'>FranklySpeaking@pri-med.com</a></p>
<p> </p>
]]></description>
                                                            <content:encoded><![CDATA[<p>Credits: 0.25 AMA PRA Category 1 Credit™<br>
 <br>
CME/CE Information and Claim Credit: <a href='https://www.pri-med.com/online-education/podcast/frankly-speaking-cme-442'>https://www.pri-med.com/online-education/podcast/frankly-speaking-cme-442</a></p>
<p>Overview: Listen in as we review the USPSTF’s recently proposed recommendations for screening women who are at risk for developing osteoporosis. Gain confidence to navigate these changes and engage patients in shared decision-making to ensure timely, evidence-based preventive care.</p>
<p>Episode resource links:</p>
<ul>
<li>JAMA. 2025;333(6):498–508. doi:10.1001/jama.2024.27154</li>
</ul>
<p>Guest: Robert A. Baldor MD, FAAFP<br>
 <br>
Music Credit: Matthew Bugos</p>
<p>Thoughts? Suggestions? Email us at <a href='mailto:FranklySpeaking@pri-med.com'>FranklySpeaking@pri-med.com</a></p>
<p> </p>
]]></content:encoded>
                                    
        <enclosure url="https://mcdn.podbean.com/mf/web/fgqini94rbwsheg8/frankly-speaking-442-osteoporosis.mp3" length="9247740" type="audio/mpeg"/>
                <itunes:summary><![CDATA[Credits: 0.25 AMA PRA Category 1 Credit™ CME/CE Information and Claim Credit: https://www.pri-med.com/online-education/podcast/frankly-speaking-cme-442
Overview: Listen in as we review the USPSTF’s recently proposed recommendations for screening women who are at risk for developing osteoporosis. Gain confidence to navigate these changes and engage patients in shared decision-making to ensure timely, evidence-based preventive care.
Episode resource links:

JAMA. 2025;333(6):498–508. doi:10.1001/jama.2024.27154

Guest: Robert A. Baldor MD, FAAFP Music Credit: Matthew Bugos
Thoughts? Suggestions? Email us at FranklySpeaking@pri-med.com
 ]]></itunes:summary>
        <itunes:author>Pri-Med</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>575</itunes:duration>
                        <itunes:episodeType>full</itunes:episodeType>
            </item>
    <item>
        <title>Breathing Better for Sleep Apnea, COPD, Asthma, and More! - Frankly Speaking Ep 441</title>
        <itunes:title>Breathing Better for Sleep Apnea, COPD, Asthma, and More! - Frankly Speaking Ep 441</itunes:title>
        <link>https://primedfranklyspeaking.podbean.com/e/breathing-better-for-sleep-apnea-copd-asthma-and-more-frankly-speaking-ep-441/</link>
                    <comments>https://primedfranklyspeaking.podbean.com/e/breathing-better-for-sleep-apnea-copd-asthma-and-more-frankly-speaking-ep-441/#comments</comments>        <pubDate>Mon, 14 Jul 2025 05:30:00 +0000</pubDate>
        <guid isPermaLink="false">primedfranklyspeaking.podbean.com/a53c8c45-0e7c-3ffb-b525-5c62d9f6aa04</guid>
                                    <description><![CDATA[<p>Credits: 0.25 AMA PRA Category 1 Credit™
 
CME/CE Information and Claim Credit: <a href='https://www.pri-med.com/online-education/podcast/frankly-speaking-cme-441'>https://www.pri-med.com/online-education/podcast/frankly-speaking-cme-441</a></p>
<p>Overview: Explore the evidence behind inspiratory and expiratory strength training to improve sleep quality, reduce daytime fatigue, ease COPD symptoms, and lower blood pressure. This episode offers practical guidance on how you can integrate this simple, affordable intervention to support better breathing and overall health in your patients.</p>
<p>Episode resource links:</p>
<ul>
<li>OSA: Journal of Sleep Research. 2024;33(3):e13941. doi:10.1111/jsr.13941.
Sleep &amp; Breathing = Schlaf &amp; Atmung. 2022;26(4):1527-1537. doi:10.1007/s11325-021-02536-4.</li>
<li>HTN: Journal of Applied Physiology (Bethesda, Md. : 1985). 2020;129(3):449-458. doi:10.1152/japplphysiol.00024.2020.
COPD: Chest. 2003;124(4):1357-64. doi:10.1378/chest.124.4.1357.
Sleep: Sleep. 2016;39(6):1179-85. doi:10.5665/sleep.5826.</li>
</ul>
<p>Guest: Robert A. Baldor MD, FAAFP
 
Music Credit: Matthew Bugos</p>
<p>Thoughts? Suggestions? Email us at <a href='mailto:FranklySpeaking@pri-med.com'>FranklySpeaking@pri-med.com</a></p>
<p> </p>
]]></description>
                                                            <content:encoded><![CDATA[<p>Credits: 0.25 AMA PRA Category 1 Credit™<br>
 <br>
CME/CE Information and Claim Credit: <a href='https://www.pri-med.com/online-education/podcast/frankly-speaking-cme-441'>https://www.pri-med.com/online-education/podcast/frankly-speaking-cme-441</a></p>
<p>Overview: Explore the evidence behind inspiratory and expiratory strength training to improve sleep quality, reduce daytime fatigue, ease COPD symptoms, and lower blood pressure. This episode offers practical guidance on how you can integrate this simple, affordable intervention to support better breathing and overall health in your patients.</p>
<p>Episode resource links:</p>
<ul>
<li>OSA: Journal of Sleep Research. 2024;33(3):e13941. doi:10.1111/jsr.13941.<br>
Sleep &amp; Breathing = Schlaf &amp; Atmung. 2022;26(4):1527-1537. doi:10.1007/s11325-021-02536-4.</li>
<li>HTN: Journal of Applied Physiology (Bethesda, Md. : 1985). 2020;129(3):449-458. doi:10.1152/japplphysiol.00024.2020.<br>
COPD: Chest. 2003;124(4):1357-64. doi:10.1378/chest.124.4.1357.<br>
Sleep: Sleep. 2016;39(6):1179-85. doi:10.5665/sleep.5826.</li>
</ul>
<p>Guest: Robert A. Baldor MD, FAAFP<br>
 <br>
Music Credit: Matthew Bugos</p>
<p>Thoughts? Suggestions? Email us at <a href='mailto:FranklySpeaking@pri-med.com'>FranklySpeaking@pri-med.com</a></p>
<p> </p>
]]></content:encoded>
                                    
        <enclosure url="https://mcdn.podbean.com/mf/web/687s7hqunbwh9db8/frankly-speaking-441-inspiratory-expiratory-exercises.mp3" length="10895502" type="audio/mpeg"/>
                <itunes:summary><![CDATA[Credits: 0.25 AMA PRA Category 1 Credit™ CME/CE Information and Claim Credit: https://www.pri-med.com/online-education/podcast/frankly-speaking-cme-441
Overview: Explore the evidence behind inspiratory and expiratory strength training to improve sleep quality, reduce daytime fatigue, ease COPD symptoms, and lower blood pressure. This episode offers practical guidance on how you can integrate this simple, affordable intervention to support better breathing and overall health in your patients.
Episode resource links:

OSA: Journal of Sleep Research. 2024;33(3):e13941. doi:10.1111/jsr.13941.Sleep &amp; Breathing = Schlaf &amp; Atmung. 2022;26(4):1527-1537. doi:10.1007/s11325-021-02536-4.
HTN: Journal of Applied Physiology (Bethesda, Md. : 1985). 2020;129(3):449-458. doi:10.1152/japplphysiol.00024.2020.COPD: Chest. 2003;124(4):1357-64. doi:10.1378/chest.124.4.1357.Sleep: Sleep. 2016;39(6):1179-85. doi:10.5665/sleep.5826.

Guest: Robert A. Baldor MD, FAAFP Music Credit: Matthew Bugos
Thoughts? Suggestions? Email us at FranklySpeaking@pri-med.com
 ]]></itunes:summary>
        <itunes:author>Pri-Med</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>678</itunes:duration>
                        <itunes:episodeType>full</itunes:episodeType>
            </item>
    <item>
        <title>Finding Energy in the Path Forward: A New Lead in Chronic Fatigue Treatment - Frankly Speaking Ep 440</title>
        <itunes:title>Finding Energy in the Path Forward: A New Lead in Chronic Fatigue Treatment - Frankly Speaking Ep 440</itunes:title>
        <link>https://primedfranklyspeaking.podbean.com/e/finding-energy-in-the-path-forward-a-new-lead-in-chronic-fatigue-treatment-frankly-speaking-ep-440/</link>
                    <comments>https://primedfranklyspeaking.podbean.com/e/finding-energy-in-the-path-forward-a-new-lead-in-chronic-fatigue-treatment-frankly-speaking-ep-440/#comments</comments>        <pubDate>Mon, 07 Jul 2025 05:30:00 +0000</pubDate>
        <guid isPermaLink="false">primedfranklyspeaking.podbean.com/acca9328-09ae-3323-9264-28c1c2fba24a</guid>
                                    <description><![CDATA[<p>Credits: 0.25 AMA PRA Category 1 Credit™
 
CME/CE Information and Claim Credit: <a href='https://www.pri-med.com/online-education/podcast/frankly-speaking-cme-440'>https://www.pri-med.com/online-education/podcast/frankly-speaking-cme-440</a></p>
<p>Overview: Explore current and emerging treatments for myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS), a debilitating condition with no known cause or cure. Learn how oxaloacetate may offer new hope for patients struggling with ME/CFS, and gain practical guidance to support informed, evidence-based conversations with your patients.</p>
<p>Episode resource links:</p>
<ul>
<li>Cash A, Vernon SD, Rond C, Bateman L, et al. RESTORE ME: a RCT of oxaloacetate for improving fatigue in patients with myalgic encephalomyelitis/chronic fatigue syndrome. Front Neurol. 2024 Nov 27;15:1483876. </li>
<li>Cash A, Kaufman DL. Oxaloacetate Treatment For Mental And Physical Fatigue In Myalgic Encephalomyelitis/Chronic Fatigue Syndrome (ME/CFS) and Long-COVID fatigue patients: a non-randomized controlled clinical trial. J Transl Med. 2022 Jun 28;20(1):295. </li>
<li>CDC ME/CFS Basics <a href='https://www.cdc.gov/me-cfs/about/index.html#:~:text=Myalgic%20encephalomyelitis%2Fchronic%20fatigue%20syndrome%20(ME%2FCFS)%20is,no%20known%20cause%20or%20cure.'>Myalgic Encephalomyelitis/Chronic Fatigue Syndrome</a></li>
</ul>
<p>Guest: Alan M. Ehrlich, MD, FAAFP
 
Music Credit: Matthew Bugos</p>
<p>Thoughts? Suggestions? Email us at <a href='mailto:FranklySpeaking@pri-med.com'>FranklySpeaking@pri-med.com</a></p>
<p> </p>
]]></description>
                                                            <content:encoded><![CDATA[<p>Credits: 0.25 AMA PRA Category 1 Credit™<br>
 <br>
CME/CE Information and Claim Credit: <a href='https://www.pri-med.com/online-education/podcast/frankly-speaking-cme-440'>https://www.pri-med.com/online-education/podcast/frankly-speaking-cme-440</a></p>
<p>Overview: Explore current and emerging treatments for myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS), a debilitating condition with no known cause or cure. Learn how oxaloacetate may offer new hope for patients struggling with ME/CFS, and gain practical guidance to support informed, evidence-based conversations with your patients.</p>
<p>Episode resource links:</p>
<ul>
<li>Cash A, Vernon SD, Rond C, Bateman L, et al. RESTORE ME: a RCT of oxaloacetate for improving fatigue in patients with myalgic encephalomyelitis/chronic fatigue syndrome. Front Neurol. 2024 Nov 27;15:1483876. </li>
<li>Cash A, Kaufman DL. Oxaloacetate Treatment For Mental And Physical Fatigue In Myalgic Encephalomyelitis/Chronic Fatigue Syndrome (ME/CFS) and Long-COVID fatigue patients: a non-randomized controlled clinical trial. J Transl Med. 2022 Jun 28;20(1):295. </li>
<li>CDC ME/CFS Basics <a href='https://www.cdc.gov/me-cfs/about/index.html#:~:text=Myalgic%20encephalomyelitis%2Fchronic%20fatigue%20syndrome%20(ME%2FCFS)%20is,no%20known%20cause%20or%20cure.'>Myalgic Encephalomyelitis/Chronic Fatigue Syndrome</a></li>
</ul>
<p>Guest: Alan M. Ehrlich, MD, FAAFP<br>
 <br>
Music Credit: Matthew Bugos</p>
<p>Thoughts? Suggestions? Email us at <a href='mailto:FranklySpeaking@pri-med.com'>FranklySpeaking@pri-med.com</a></p>
<p> </p>
]]></content:encoded>
                                    
        <enclosure url="https://mcdn.podbean.com/mf/web/yedwnq46va6zaham/frankly-speaking-440-chronic-fatigue.mp3" length="13467875" type="audio/mpeg"/>
                <itunes:summary><![CDATA[Credits: 0.25 AMA PRA Category 1 Credit™ CME/CE Information and Claim Credit: https://www.pri-med.com/online-education/podcast/frankly-speaking-cme-440
Overview: Explore current and emerging treatments for myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS), a debilitating condition with no known cause or cure. Learn how oxaloacetate may offer new hope for patients struggling with ME/CFS, and gain practical guidance to support informed, evidence-based conversations with your patients.
Episode resource links:

Cash A, Vernon SD, Rond C, Bateman L, et al. RESTORE ME: a RCT of oxaloacetate for improving fatigue in patients with myalgic encephalomyelitis/chronic fatigue syndrome. Front Neurol. 2024 Nov 27;15:1483876. 
Cash A, Kaufman DL. Oxaloacetate Treatment For Mental And Physical Fatigue In Myalgic Encephalomyelitis/Chronic Fatigue Syndrome (ME/CFS) and Long-COVID fatigue patients: a non-randomized controlled clinical trial. J Transl Med. 2022 Jun 28;20(1):295. 
CDC ME/CFS Basics Myalgic Encephalomyelitis/Chronic Fatigue Syndrome

Guest: Alan M. Ehrlich, MD, FAAFP Music Credit: Matthew Bugos
Thoughts? Suggestions? Email us at FranklySpeaking@pri-med.com
 ]]></itunes:summary>
        <itunes:author>Pri-Med</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>839</itunes:duration>
                        <itunes:episodeType>full</itunes:episodeType>
            </item>
    <item>
        <title>Is Vitamin K the Way? Rethinking Treatments for Nocturnal Leg Cramps - Frankly Speaking Ep 439</title>
        <itunes:title>Is Vitamin K the Way? Rethinking Treatments for Nocturnal Leg Cramps - Frankly Speaking Ep 439</itunes:title>
        <link>https://primedfranklyspeaking.podbean.com/e/is-vitamin-k-the-way-rethinking-treatments-for-nocturnal-leg-cramps-frankly-speaking-ep-439/</link>
                    <comments>https://primedfranklyspeaking.podbean.com/e/is-vitamin-k-the-way-rethinking-treatments-for-nocturnal-leg-cramps-frankly-speaking-ep-439/#comments</comments>        <pubDate>Mon, 30 Jun 2025 05:34:00 +0000</pubDate>
        <guid isPermaLink="false">primedfranklyspeaking.podbean.com/b9c5bc6f-475a-379b-a01c-78e8e699238f</guid>
                                    <description><![CDATA[<p>Credits: 0.25 AMA PRA Category 1 Credit™
 
CME/CE Information and Claim Credit: <a href='https://www.pri-med.com/online-education/podcast/frankly-speaking-cme-439'>https://www.pri-med.com/online-education/podcast/frankly-speaking-cme-439</a></p>
<p>Overview: Nocturnal leg cramps (NLCs) are common in older adults, but current treatments often fall short or carry risks. Listen in as we explore new evidence on the safety and efficacy of vitamin K2 as a potential treatment for NLCs. Come away with practical insights to help you improve the sleep and quality of life of your patients.</p>
<p>Episode resource links:</p>
<ul>
<li>JAMA Intern Med. 2024;184(12):1443-1447. doi:10.1001/jamainternmed.2024.5726</li>
</ul>
<p>Guest: Robert A. Baldor MD, FAAFP
 
Music Credit: Matthew Bugos</p>
<p>Thoughts? Suggestions? Email us at <a href='mailto:FranklySpeaking@pri-med.com'>FranklySpeaking@pri-med.com</a></p>
<p> </p>
]]></description>
                                                            <content:encoded><![CDATA[<p>Credits: 0.25 AMA PRA Category 1 Credit™<br>
 <br>
CME/CE Information and Claim Credit: <a href='https://www.pri-med.com/online-education/podcast/frankly-speaking-cme-439'>https://www.pri-med.com/online-education/podcast/frankly-speaking-cme-439</a></p>
<p>Overview: Nocturnal leg cramps (NLCs) are common in older adults, but current treatments often fall short or carry risks. Listen in as we explore new evidence on the safety and efficacy of vitamin K2 as a potential treatment for NLCs. Come away with practical insights to help you improve the sleep and quality of life of your patients.</p>
<p>Episode resource links:</p>
<ul>
<li>JAMA Intern Med. 2024;184(12):1443-1447. doi:10.1001/jamainternmed.2024.5726</li>
</ul>
<p>Guest: Robert A. Baldor MD, FAAFP<br>
 <br>
Music Credit: Matthew Bugos</p>
<p>Thoughts? Suggestions? Email us at <a href='mailto:FranklySpeaking@pri-med.com'>FranklySpeaking@pri-med.com</a></p>
<p> </p>
]]></content:encoded>
                                    
        <enclosure url="https://mcdn.podbean.com/mf/web/y3ffzu4jtihvh255/frankly-speaking-439-vitaminK.mp3" length="10249803" type="audio/mpeg"/>
                <itunes:summary><![CDATA[Credits: 0.25 AMA PRA Category 1 Credit™ CME/CE Information and Claim Credit: https://www.pri-med.com/online-education/podcast/frankly-speaking-cme-439
Overview: Nocturnal leg cramps (NLCs) are common in older adults, but current treatments often fall short or carry risks. Listen in as we explore new evidence on the safety and efficacy of vitamin K2 as a potential treatment for NLCs. Come away with practical insights to help you improve the sleep and quality of life of your patients.
Episode resource links:

JAMA Intern Med. 2024;184(12):1443-1447. doi:10.1001/jamainternmed.2024.5726

Guest: Robert A. Baldor MD, FAAFP Music Credit: Matthew Bugos
Thoughts? Suggestions? Email us at FranklySpeaking@pri-med.com
 ]]></itunes:summary>
        <itunes:author>Pri-Med</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>638</itunes:duration>
                        <itunes:episodeType>full</itunes:episodeType>
            </item>
    <item>
        <title>Brain Gains: The Cognitive Benefits of Physical Activity - Frankly Speaking Ep 438</title>
        <itunes:title>Brain Gains: The Cognitive Benefits of Physical Activity - Frankly Speaking Ep 438</itunes:title>
        <link>https://primedfranklyspeaking.podbean.com/e/brain-gains-the-cognitive-benefits-of-physical-activity-frankly-speaking-ep-438/</link>
                    <comments>https://primedfranklyspeaking.podbean.com/e/brain-gains-the-cognitive-benefits-of-physical-activity-frankly-speaking-ep-438/#comments</comments>        <pubDate>Wed, 18 Jun 2025 05:30:00 +0000</pubDate>
        <guid isPermaLink="false">primedfranklyspeaking.podbean.com/4b8df437-a15c-384b-8573-562b6bdfffc8</guid>
                                    <description><![CDATA[<p>Credits: 0.25 AMA PRA Category 1 Credit™
 
CME/CE Information and Claim Credit: <a href='https://www.pri-med.com/online-education/podcast/frankly-speaking-cme-438'>https://www.pri-med.com/online-education/podcast/frankly-speaking-cme-438</a></p>
<p>Overview: In this episode, we review a major umbrella study linking physical activity to improvements in memory, executive function, and general cognition—offering you practical insights to guide patient counseling and provide evidence-based, nonpharmacologic strategies for dementia prevention and cognitive enhancement.</p>
<p>Episode resource links:</p>
<ul>
<li>Singh B, Bennett H, Miatke A, et al. Br J Sports Med. doi:10.1136/</li>
</ul>
<p>Guest: Robert A. Baldor MD, FAAFP
 
Music Credit: Matthew Bugos</p>
<p>Thoughts? Suggestions? Email us at <a href='mailto:FranklySpeaking@pri-med.com'>FranklySpeaking@pri-med.com</a></p>
<p> </p>
]]></description>
                                                            <content:encoded><![CDATA[<p>Credits: 0.25 AMA PRA Category 1 Credit™<br>
 <br>
CME/CE Information and Claim Credit: <a href='https://www.pri-med.com/online-education/podcast/frankly-speaking-cme-438'>https://www.pri-med.com/online-education/podcast/frankly-speaking-cme-438</a></p>
<p>Overview: In this episode, we review a major umbrella study linking physical activity to improvements in memory, executive function, and general cognition—offering you practical insights to guide patient counseling and provide evidence-based, nonpharmacologic strategies for dementia prevention and cognitive enhancement.</p>
<p>Episode resource links:</p>
<ul>
<li>Singh B, Bennett H, Miatke A, et al. Br J Sports Med. doi:10.1136/</li>
</ul>
<p>Guest: Robert A. Baldor MD, FAAFP<br>
 <br>
Music Credit: Matthew Bugos</p>
<p>Thoughts? Suggestions? Email us at <a href='mailto:FranklySpeaking@pri-med.com'>FranklySpeaking@pri-med.com</a></p>
<p> </p>
]]></content:encoded>
                                    
        <enclosure url="https://mcdn.podbean.com/mf/web/isqhaxgnecbz4de5/frankly-speaking-438-exercise-for-cognition.mp3" length="11645117" type="audio/mpeg"/>
                <itunes:summary><![CDATA[Credits: 0.25 AMA PRA Category 1 Credit™ CME/CE Information and Claim Credit: https://www.pri-med.com/online-education/podcast/frankly-speaking-cme-438
Overview: In this episode, we review a major umbrella study linking physical activity to improvements in memory, executive function, and general cognition—offering you practical insights to guide patient counseling and provide evidence-based, nonpharmacologic strategies for dementia prevention and cognitive enhancement.
Episode resource links:

Singh B, Bennett H, Miatke A, et al. Br J Sports Med. doi:10.1136/

Guest: Robert A. Baldor MD, FAAFP Music Credit: Matthew Bugos
Thoughts? Suggestions? Email us at FranklySpeaking@pri-med.com
 ]]></itunes:summary>
        <itunes:author>Pri-Med</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>725</itunes:duration>
                        <itunes:episodeType>full</itunes:episodeType>
            </item>
    <item>
        <title>A Success Story: The HPV Vaccine - Frankly Speaking Ep 437</title>
        <itunes:title>A Success Story: The HPV Vaccine - Frankly Speaking Ep 437</itunes:title>
        <link>https://primedfranklyspeaking.podbean.com/e/a-success-story-the-hpv-vaccine-frankly-speaking-ep-437/</link>
                    <comments>https://primedfranklyspeaking.podbean.com/e/a-success-story-the-hpv-vaccine-frankly-speaking-ep-437/#comments</comments>        <pubDate>Mon, 16 Jun 2025 05:29:00 +0000</pubDate>
        <guid isPermaLink="false">primedfranklyspeaking.podbean.com/8cfa8c8b-43b6-3046-9c2f-32f5d5d4a610</guid>
                                    <description><![CDATA[<p>Credits: 0.25 AMA PRA Category 1 Credit™
 
CME/CE Information and Claim Credit: <a href='https://www.pri-med.com/online-education/podcast/frankly-speaking-cme-437'>https://www.pri-med.com/online-education/podcast/frankly-speaking-cme-437</a></p>
<p>Overview: This episode reviews the remarkable impact of the human papillomavirus (HPV) vaccine from 2008–2022, including significant declines in cervical precancer rates. Tune in for key data insights and updated HPV vaccination guidelines to help you close care gaps and strengthen cancer prevention efforts in your practice.</p>
<p>Episode resource links:</p>
<ul>
<li>Gargano JW, Stefanos R, Dahl RM, et al. Trends in Cervical Precancers Identified Through Population-Based Surveillance — Human Papillomavirus Vaccine Impact Monitoring Project, Five Sites, United States, 2008–2022. MMWR Morb Mortal Wkly Rep 2025;74:96–101. DOI: <a href='http://dx.doi.org/10.15585/mmwr.mm7406a4'>http://dx.doi.org/10.15585/mmwr.mm7406a4</a>
• <a href='https://www.cdc.gov/vaccines/vpd/hpv/hcp/recommendations.html#:~:text=HPV%20Vaccine%20%5B1page%5D-,Dosing%20Schedules,aged%209%20through%2026%20years'>HPV Vaccination Recommendations: Dosing and Schedule</a>
• <a href='https://www.cdc.gov/hpv/media/pdfs/2024/07/talking_to_parents_hpv.pdf?CDC_AAref_Val=https://www.cdc.gov/hpv/hcp/for-hcp-tipsheet-hpv.pdf'>Talking to parents about HPV vaccine</a></li>
</ul>
<p>Guest: Jill M. Terrien PhD, ANP-BC 
 
Music Credit: Matthew Bugos</p>
<p>Thoughts? Suggestions? Email us at <a href='mailto:FranklySpeaking@pri-med.com'>FranklySpeaking@pri-med.com </a></p>
<p> </p>
]]></description>
                                                            <content:encoded><![CDATA[<p>Credits: 0.25 AMA PRA Category 1 Credit™<br>
 <br>
CME/CE Information and Claim Credit: <a href='https://www.pri-med.com/online-education/podcast/frankly-speaking-cme-437'>https://www.pri-med.com/online-education/podcast/frankly-speaking-cme-437</a></p>
<p>Overview: This episode reviews the remarkable impact of the human papillomavirus (HPV) vaccine from 2008–2022, including significant declines in cervical precancer rates. Tune in for key data insights and updated HPV vaccination guidelines to help you close care gaps and strengthen cancer prevention efforts in your practice.</p>
<p>Episode resource links:</p>
<ul>
<li>Gargano JW, Stefanos R, Dahl RM, et al. Trends in Cervical Precancers Identified Through Population-Based Surveillance — Human Papillomavirus Vaccine Impact Monitoring Project, Five Sites, United States, 2008–2022. MMWR Morb Mortal Wkly Rep 2025;74:96–101. DOI: <a href='http://dx.doi.org/10.15585/mmwr.mm7406a4'>http://dx.doi.org/10.15585/mmwr.mm7406a4</a><br>
• <a href='https://www.cdc.gov/vaccines/vpd/hpv/hcp/recommendations.html#:~:text=HPV%20Vaccine%20%5B1page%5D-,Dosing%20Schedules,aged%209%20through%2026%20years'>HPV Vaccination Recommendations: Dosing and Schedule</a><br>
• <a href='https://www.cdc.gov/hpv/media/pdfs/2024/07/talking_to_parents_hpv.pdf?CDC_AAref_Val=https://www.cdc.gov/hpv/hcp/for-hcp-tipsheet-hpv.pdf'>Talking to parents about HPV vaccine</a></li>
</ul>
<p>Guest: Jill M. Terrien PhD, ANP-BC <br>
 <br>
Music Credit: Matthew Bugos</p>
<p>Thoughts? Suggestions? Email us at <a href='mailto:FranklySpeaking@pri-med.com'>FranklySpeaking@pri-med.com </a></p>
<p> </p>
]]></content:encoded>
                                    
        <enclosure url="https://mcdn.podbean.com/mf/web/5q9nxk3e2d2iset6/frankly-speaking-437-hpv-vaccine-video.mp4" length="226041012" type="video/mp4"/>
                <itunes:summary><![CDATA[Credits: 0.25 AMA PRA Category 1 Credit™ CME/CE Information and Claim Credit: https://www.pri-med.com/online-education/podcast/frankly-speaking-cme-437
Overview: This episode reviews the remarkable impact of the human papillomavirus (HPV) vaccine from 2008–2022, including significant declines in cervical precancer rates. Tune in for key data insights and updated HPV vaccination guidelines to help you close care gaps and strengthen cancer prevention efforts in your practice.
Episode resource links:

Gargano JW, Stefanos R, Dahl RM, et al. Trends in Cervical Precancers Identified Through Population-Based Surveillance — Human Papillomavirus Vaccine Impact Monitoring Project, Five Sites, United States, 2008–2022. MMWR Morb Mortal Wkly Rep 2025;74:96–101. DOI: http://dx.doi.org/10.15585/mmwr.mm7406a4• HPV Vaccination Recommendations: Dosing and Schedule• Talking to parents about HPV vaccine

Guest: Jill M. Terrien PhD, ANP-BC  Music Credit: Matthew Bugos
Thoughts? Suggestions? Email us at FranklySpeaking@pri-med.com 
 ]]></itunes:summary>
        <itunes:author>Pri-Med</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>814</itunes:duration>
                        <itunes:episodeType>full</itunes:episodeType>
            </item>
    <item>
        <title>Rethinking ICS in COPD: Reducing Harm with Guideline-Based Strategies - Frankly Speaking Ep 436</title>
        <itunes:title>Rethinking ICS in COPD: Reducing Harm with Guideline-Based Strategies - Frankly Speaking Ep 436</itunes:title>
        <link>https://primedfranklyspeaking.podbean.com/e/rethinking-ics-in-copd-reducing-harm-with-guideline-based-strategies-frankly-speaking-ep-436/</link>
                    <comments>https://primedfranklyspeaking.podbean.com/e/rethinking-ics-in-copd-reducing-harm-with-guideline-based-strategies-frankly-speaking-ep-436/#comments</comments>        <pubDate>Mon, 09 Jun 2025 13:27:34 +0000</pubDate>
        <guid isPermaLink="false">primedfranklyspeaking.podbean.com/918d9ad8-9f26-3355-a1d2-b43cc592748a</guid>
                                    <description><![CDATA[<p>Credits: 0.25 AMA PRA Category 1 Credit™
 
CME/CE Information and Claim Credit: <a href='https://www.pri-med.com/online-education/podcast/frankly-speaking-cme-436'>https://www.pri-med.com/online-education/podcast/frankly-speaking-cme-436</a></p>
<p>Overview: Many patients with chronic obstructive pulmonary disease (COPD) are improperly treated with inhaled corticosteroids (ICS), increasing their risk of harm. This episode explores the latest evidence on long-term ICS risks and provides practical guidance to help you align COPD care with current guidelines—improving outcomes while minimizing adverse effects like pneumonia, cataracts, type 2 diabetes mellitus, and osteoporosis.</p>
<p>Episode resource links:</p>
<ul>
<li>Pace WD, Callen E, Gaona-Villarreal G, Shaikh A, Yawn BP. Adverse outcomes associated with inhaled corticosteroid use in individuals with chronic obstructive pulmonary disease. Ann Fam Med. 2025;23(2):127-135. doi:10.1370/afm.240030</li>
<li>Pocket Guide to COPD Diagnosis, Management, and Prevention: A Guide for Healthcare Professionals. 2025 Edition. Global Initiative for Chronic Obstructive Lung Disease. <a href='https://goldcopd.org/2025-gold-report/'>https://goldcopd.org/2025-gold-report/</a></li>
</ul>
<p>Guest: Jillian Joseph, PA-C
 
Music Credit: Matthew Bugos</p>
<p>Thoughts? Suggestions? Email us at <a href='mailto:FranklySpeaking@pri-med.com'>FranklySpeaking@pri-med.com </a></p>
<p> </p>
]]></description>
                                                            <content:encoded><![CDATA[<p>Credits: 0.25 AMA PRA Category 1 Credit™<br>
 <br>
CME/CE Information and Claim Credit: <a href='https://www.pri-med.com/online-education/podcast/frankly-speaking-cme-436'>https://www.pri-med.com/online-education/podcast/frankly-speaking-cme-436</a></p>
<p>Overview: Many patients with chronic obstructive pulmonary disease (COPD) are improperly treated with inhaled corticosteroids (ICS), increasing their risk of harm. This episode explores the latest evidence on long-term ICS risks and provides practical guidance to help you align COPD care with current guidelines—improving outcomes while minimizing adverse effects like pneumonia, cataracts, type 2 diabetes mellitus, and osteoporosis.</p>
<p>Episode resource links:</p>
<ul>
<li>Pace WD, Callen E, Gaona-Villarreal G, Shaikh A, Yawn BP. Adverse outcomes associated with inhaled corticosteroid use in individuals with chronic obstructive pulmonary disease. Ann Fam Med. 2025;23(2):127-135. doi:10.1370/afm.240030</li>
<li>Pocket Guide to COPD Diagnosis, Management, and Prevention: A Guide for Healthcare Professionals. 2025 Edition. Global Initiative for Chronic Obstructive Lung Disease. <a href='https://goldcopd.org/2025-gold-report/'>https://goldcopd.org/2025-gold-report/</a></li>
</ul>
<p>Guest: Jillian Joseph, PA-C<br>
 <br>
Music Credit: Matthew Bugos</p>
<p>Thoughts? Suggestions? Email us at <a href='mailto:FranklySpeaking@pri-med.com'>FranklySpeaking@pri-med.com </a></p>
<p> </p>
]]></content:encoded>
                                    
        <enclosure url="https://mcdn.podbean.com/mf/web/w69zszc9if9g295s/frankly-speaking-436-COPD-video.mp4" length="251199255" type="video/mp4"/>
                <itunes:summary><![CDATA[Credits: 0.25 AMA PRA Category 1 Credit™ CME/CE Information and Claim Credit: https://www.pri-med.com/online-education/podcast/frankly-speaking-cme-436
Overview: Many patients with chronic obstructive pulmonary disease (COPD) are improperly treated with inhaled corticosteroids (ICS), increasing their risk of harm. This episode explores the latest evidence on long-term ICS risks and provides practical guidance to help you align COPD care with current guidelines—improving outcomes while minimizing adverse effects like pneumonia, cataracts, type 2 diabetes mellitus, and osteoporosis.
Episode resource links:

Pace WD, Callen E, Gaona-Villarreal G, Shaikh A, Yawn BP. Adverse outcomes associated with inhaled corticosteroid use in individuals with chronic obstructive pulmonary disease. Ann Fam Med. 2025;23(2):127-135. doi:10.1370/afm.240030
Pocket Guide to COPD Diagnosis, Management, and Prevention: A Guide for Healthcare Professionals. 2025 Edition. Global Initiative for Chronic Obstructive Lung Disease. https://goldcopd.org/2025-gold-report/

Guest: Jillian Joseph, PA-C Music Credit: Matthew Bugos
Thoughts? Suggestions? Email us at FranklySpeaking@pri-med.com 
 ]]></itunes:summary>
        <itunes:author>Pri-Med</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>885</itunes:duration>
                        <itunes:episodeType>full</itunes:episodeType>
            </item>
    <item>
        <title>Can’t Sleep? The Impact of Screen Time on Rest - Frankly Speaking Ep 435</title>
        <itunes:title>Can’t Sleep? The Impact of Screen Time on Rest - Frankly Speaking Ep 435</itunes:title>
        <link>https://primedfranklyspeaking.podbean.com/e/can-t-sleep-the-impact-of-screen-time-on-rest-frankly-speaking-ep-435/</link>
                    <comments>https://primedfranklyspeaking.podbean.com/e/can-t-sleep-the-impact-of-screen-time-on-rest-frankly-speaking-ep-435/#comments</comments>        <pubDate>Mon, 02 Jun 2025 05:30:00 +0000</pubDate>
        <guid isPermaLink="false">primedfranklyspeaking.podbean.com/f8a065cf-2a8b-3270-9a13-1e9052d7d3e9</guid>
                                    <description><![CDATA[<p>Credits: 0.25 AMA PRA Category 1 Credit™
 
CME/CE Information and Claim Credit: <a href='https://www.pri-med.com/online-education/podcast/frankly-speaking-cme-435'>https://www.pri-med.com/online-education/podcast/frankly-speaking-cme-435</a></p>
<p>Overview: In this episode, we discuss how screen time—from adolescence through adulthood—can disrupt sleep more than we might realize. Hear what the latest research says about topics like blue light and sleep duration, discover practical strategies to sleep smarter in this digital world, and learn how sleep deprivation can impact the health of your patients.</p>
<p>Episode resource links:</p>
<ul>
<li>Zhong, C., Masters, M., Donzella, S. M., Diver, W. R., &amp; Patel, A. V. (2025). Electronic Screen Use and Sleep Duration and Timing in Adults. JAMA Network Open, 8(3), e252493-e252493.</li>
<li>Liu, Y. (2016). Prevalence of healthy sleep duration among adults—United States, 2014. MMWR. Morbidity and mortality weekly report, 65.</li>
<li>Centers for Disease Control and Prevention (CDC). (2017). Announcement: sleep awareness week, April 23–29, 2017. Morb Mortal Wkly Rep (MMWR), 66(15), 411.</li>
<li>Chaput, J. P., Dutil, C., Featherstone, R., Ross, R., Giangregorio, L., Saunders, T. J., ... &amp; Carrier, J. (2020). Sleep duration and health in adults: an overview of systematic reviews. Applied Physiology, Nutrition, and Metabolism, 45(10), S218-S231.</li>
<li>Hartley, S., Royant-Parola, S., Zayoud, A., Gremy, I., &amp; Matulonga, B. (2022). Do both timing and duration of screen use affect sleep patterns in adolescents?. Plos one, 17(10), e0276226.</li>
<li>Salfi, F., Amicucci, G., Corigliano, D., D’Atri, A., Viselli, L., Tempesta, D., &amp; Ferrara, M. (2021). Changes of evening exposure to electronic devices during the COVID-19 lockdown affect the time course of sleep disturbances. Sleep, 44(9), zsab080.</li>
<li>He, J. W., Tu, Z. H., Xiao, L., Su, T., &amp; Tang, Y. X. (2020). Effect of restricting bedtime mobile phone use on sleep, arousal, mood, and working memory: a randomized pilot trial. PloS one, 15(2), e0228756.</li>
</ul>
<p>Guest: Mariyan L. Montaque, DNP, FNP-BC
 
Music Credit: Matthew Bugos</p>
<p>Thoughts? Suggestions? Email us at <a href='mailto:FranklySpeaking@pri-med.com'>FranklySpeaking@pri-med.com </a></p>
<p> </p>
]]></description>
                                                            <content:encoded><![CDATA[<p>Credits: 0.25 AMA PRA Category 1 Credit™<br>
 <br>
CME/CE Information and Claim Credit: <a href='https://www.pri-med.com/online-education/podcast/frankly-speaking-cme-435'>https://www.pri-med.com/online-education/podcast/frankly-speaking-cme-435</a></p>
<p>Overview: In this episode, we discuss how screen time—from adolescence through adulthood—can disrupt sleep more than we might realize. Hear what the latest research says about topics like blue light and sleep duration, discover practical strategies to sleep smarter in this digital world, and learn how sleep deprivation can impact the health of your patients.</p>
<p>Episode resource links:</p>
<ul>
<li>Zhong, C., Masters, M., Donzella, S. M., Diver, W. R., &amp; Patel, A. V. (2025). Electronic Screen Use and Sleep Duration and Timing in Adults. JAMA Network Open, 8(3), e252493-e252493.</li>
<li>Liu, Y. (2016). Prevalence of healthy sleep duration among adults—United States, 2014. MMWR. Morbidity and mortality weekly report, 65.</li>
<li>Centers for Disease Control and Prevention (CDC). (2017). Announcement: sleep awareness week, April 23–29, 2017. Morb Mortal Wkly Rep (MMWR), 66(15), 411.</li>
<li>Chaput, J. P., Dutil, C., Featherstone, R., Ross, R., Giangregorio, L., Saunders, T. J., ... &amp; Carrier, J. (2020). Sleep duration and health in adults: an overview of systematic reviews. Applied Physiology, Nutrition, and Metabolism, 45(10), S218-S231.</li>
<li>Hartley, S., Royant-Parola, S., Zayoud, A., Gremy, I., &amp; Matulonga, B. (2022). Do both timing and duration of screen use affect sleep patterns in adolescents?. Plos one, 17(10), e0276226.</li>
<li>Salfi, F., Amicucci, G., Corigliano, D., D’Atri, A., Viselli, L., Tempesta, D., &amp; Ferrara, M. (2021). Changes of evening exposure to electronic devices during the COVID-19 lockdown affect the time course of sleep disturbances. Sleep, 44(9), zsab080.</li>
<li>He, J. W., Tu, Z. H., Xiao, L., Su, T., &amp; Tang, Y. X. (2020). Effect of restricting bedtime mobile phone use on sleep, arousal, mood, and working memory: a randomized pilot trial. PloS one, 15(2), e0228756.</li>
</ul>
<p>Guest: Mariyan L. Montaque, DNP, FNP-BC<br>
 <br>
Music Credit: Matthew Bugos</p>
<p>Thoughts? Suggestions? Email us at <a href='mailto:FranklySpeaking@pri-med.com'>FranklySpeaking@pri-med.com </a></p>
<p> </p>
]]></content:encoded>
                                    
        <enclosure url="https://mcdn.podbean.com/mf/web/empqzhmzij2yfcam/frankly-speaking-435-screentime-bedtime.mp3" length="10985147" type="audio/mpeg"/>
                <itunes:summary><![CDATA[Credits: 0.25 AMA PRA Category 1 Credit™ CME/CE Information and Claim Credit: https://www.pri-med.com/online-education/podcast/frankly-speaking-cme-435
Overview: In this episode, we discuss how screen time—from adolescence through adulthood—can disrupt sleep more than we might realize. Hear what the latest research says about topics like blue light and sleep duration, discover practical strategies to sleep smarter in this digital world, and learn how sleep deprivation can impact the health of your patients.
Episode resource links:

Zhong, C., Masters, M., Donzella, S. M., Diver, W. R., &amp; Patel, A. V. (2025). Electronic Screen Use and Sleep Duration and Timing in Adults. JAMA Network Open, 8(3), e252493-e252493.
Liu, Y. (2016). Prevalence of healthy sleep duration among adults—United States, 2014. MMWR. Morbidity and mortality weekly report, 65.
Centers for Disease Control and Prevention (CDC). (2017). Announcement: sleep awareness week, April 23–29, 2017. Morb Mortal Wkly Rep (MMWR), 66(15), 411.
Chaput, J. P., Dutil, C., Featherstone, R., Ross, R., Giangregorio, L., Saunders, T. J., ... &amp; Carrier, J. (2020). Sleep duration and health in adults: an overview of systematic reviews. Applied Physiology, Nutrition, and Metabolism, 45(10), S218-S231.
Hartley, S., Royant-Parola, S., Zayoud, A., Gremy, I., &amp; Matulonga, B. (2022). Do both timing and duration of screen use affect sleep patterns in adolescents?. Plos one, 17(10), e0276226.
Salfi, F., Amicucci, G., Corigliano, D., D’Atri, A., Viselli, L., Tempesta, D., &amp; Ferrara, M. (2021). Changes of evening exposure to electronic devices during the COVID-19 lockdown affect the time course of sleep disturbances. Sleep, 44(9), zsab080.
He, J. W., Tu, Z. H., Xiao, L., Su, T., &amp; Tang, Y. X. (2020). Effect of restricting bedtime mobile phone use on sleep, arousal, mood, and working memory: a randomized pilot trial. PloS one, 15(2), e0228756.

Guest: Mariyan L. Montaque, DNP, FNP-BC Music Credit: Matthew Bugos
Thoughts? Suggestions? Email us at FranklySpeaking@pri-med.com 
 ]]></itunes:summary>
        <itunes:author>Pri-Med</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>684</itunes:duration>
                        <itunes:episodeType>full</itunes:episodeType>
            </item>
    <item>
        <title>Is Butter Bad, or Is It Back? - Frankly Speaking Ep 434</title>
        <itunes:title>Is Butter Bad, or Is It Back? - Frankly Speaking Ep 434</itunes:title>
        <link>https://primedfranklyspeaking.podbean.com/e/is-butter-bad-or-is-it-back-frankly-speaking-ep-434/</link>
                    <comments>https://primedfranklyspeaking.podbean.com/e/is-butter-bad-or-is-it-back-frankly-speaking-ep-434/#comments</comments>        <pubDate>Mon, 26 May 2025 05:30:00 +0000</pubDate>
        <guid isPermaLink="false">primedfranklyspeaking.podbean.com/9322b281-84b5-3ec2-8513-6bb97dabe9cb</guid>
                                    <description><![CDATA[<p>Credits: 0.25 AMA PRA Category 1 Credit™
 
CME/CE Information and Claim Credit: <a href='https://www.pri-med.com/online-education/podcast/frankly-speaking-cme-434'>https://www.pri-med.com/online-education/podcast/frankly-speaking-cme-434</a></p>
<p>Overview: Is butter back on the menu? This episode breaks down a recent study on butter consumption and mortality risk, examines the origins of saturated fat concerns, and offers patient-centered guidance. Gain practical tools to address outdated nutrition beliefs and guide patients toward realistic, heart-healthy dietary choices rooted in the latest evidence.</p>
<p>Episode resource links:</p>
<ul>
<li>JAMA Intern Med. Published online March 6, 2025. doi:10.1001/jamainternmed.2025.0205
PLoS One</li>
<li>2016 Jun 29;11(6):e0158118. doi: 10.1371/journal.pone.0158118</li>
</ul>
<p>Guest: Robert A. Baldor MD, FAAFP
 
Music Credit: Matthew Bugos</p>
<p>Thoughts? Suggestions? Email us at <a href='mailto:FranklySpeaking@pri-med.com'>FranklySpeaking@pri-med.com </a></p>
<p> </p>
]]></description>
                                                            <content:encoded><![CDATA[<p>Credits: 0.25 AMA PRA Category 1 Credit™<br>
 <br>
CME/CE Information and Claim Credit: <a href='https://www.pri-med.com/online-education/podcast/frankly-speaking-cme-434'>https://www.pri-med.com/online-education/podcast/frankly-speaking-cme-434</a></p>
<p>Overview: Is butter back on the menu? This episode breaks down a recent study on butter consumption and mortality risk, examines the origins of saturated fat concerns, and offers patient-centered guidance. Gain practical tools to address outdated nutrition beliefs and guide patients toward realistic, heart-healthy dietary choices rooted in the latest evidence.</p>
<p>Episode resource links:</p>
<ul>
<li>JAMA Intern Med. Published online March 6, 2025. doi:10.1001/jamainternmed.2025.0205<br>
PLoS One</li>
<li>2016 Jun 29;11(6):e0158118. doi: 10.1371/journal.pone.0158118</li>
</ul>
<p>Guest: Robert A. Baldor MD, FAAFP<br>
 <br>
Music Credit: Matthew Bugos</p>
<p>Thoughts? Suggestions? Email us at <a href='mailto:FranklySpeaking@pri-med.com'>FranklySpeaking@pri-med.com </a></p>
<p> </p>
]]></content:encoded>
                                    
        <enclosure url="https://mcdn.podbean.com/mf/web/b5bfrhq3rqf2qk8e/frankly-speaking-434-butter.mp3" length="12147826" type="audio/mpeg"/>
                <itunes:summary><![CDATA[Credits: 0.25 AMA PRA Category 1 Credit™ CME/CE Information and Claim Credit: https://www.pri-med.com/online-education/podcast/frankly-speaking-cme-434
Overview: Is butter back on the menu? This episode breaks down a recent study on butter consumption and mortality risk, examines the origins of saturated fat concerns, and offers patient-centered guidance. Gain practical tools to address outdated nutrition beliefs and guide patients toward realistic, heart-healthy dietary choices rooted in the latest evidence.
Episode resource links:

JAMA Intern Med. Published online March 6, 2025. doi:10.1001/jamainternmed.2025.0205PLoS One
2016 Jun 29;11(6):e0158118. doi: 10.1371/journal.pone.0158118

Guest: Robert A. Baldor MD, FAAFP Music Credit: Matthew Bugos
Thoughts? Suggestions? Email us at FranklySpeaking@pri-med.com 
 ]]></itunes:summary>
        <itunes:author>Pri-Med</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>757</itunes:duration>
                        <itunes:episodeType>full</itunes:episodeType>
            </item>
    <item>
        <title>Can Vaping Help with Smoking Cessation? Understanding the Risks of Dual Use - Frankly Speaking Ep 433</title>
        <itunes:title>Can Vaping Help with Smoking Cessation? Understanding the Risks of Dual Use - Frankly Speaking Ep 433</itunes:title>
        <link>https://primedfranklyspeaking.podbean.com/e/can-vaping-help-with-smoking-cessation-understanding-the-risks-of-dual-use-frankly-speaking-ep-433/</link>
                    <comments>https://primedfranklyspeaking.podbean.com/e/can-vaping-help-with-smoking-cessation-understanding-the-risks-of-dual-use-frankly-speaking-ep-433/#comments</comments>        <pubDate>Mon, 19 May 2025 05:30:00 +0000</pubDate>
        <guid isPermaLink="false">primedfranklyspeaking.podbean.com/ed0e5b28-b041-3512-9731-7601634cb554</guid>
                                    <description><![CDATA[<p>Credits: 0.25 AMA PRA Category 1 Credit™
 
CME/CE Information and Claim Credit: <a href='https://www.pri-med.com/online-education/podcast/frankly-speaking-cme-433'>https://www.pri-med.com/online-education/podcast/frankly-speaking-cme-433</a></p>
<p>Overview: E-cigarette use has risen significantly, especially among adolescents and young adults. Many people begin vaping alongside conventional cigarettes in an effort to quit or reduce smoking. But risks are emerging, challenging the belief that vaping is safer than combustible cigarettes. Join us as we explore the latest evidence on vaping, dual use, and the associated health risks.</p>
<p>Episode resource links:</p>
<ul>
<li>Hamoud J, Hanewinkel R, Andreas S, et al. A Systematic Review Investigating the Impact of Dual Use of E-Cigarettes and Conventional Cigarettes on Smoking Cessation. ERJ Open Res 2024; in press (<a href='https://doi.org/10.1183/23120541.00902-2024'>https://doi.org/10.1183/23120541.00902-2024</a>).</li>
<li>Lindson N, Butler AR, McRobbie H, et al. Electronic cigarettes for smoking cessation. Cochrane Database Syst Rev. 2024;1(1):CD010216. Published 2024 Jan 8. doi:10.1002/14651858.CD010216.pub8</li>
<li>Pisinger C, Rasmussen SKB. The Health Effects of Real-World Dual Use of Electronic and Conventional Cigarettes versus the Health Effects of Exclusive Smoking of Conventional Cigarettes: A Systematic Review. Int J Environ Res Public Health. 2022;19(20):13687. Published 2022 Oct 21. doi:10.3390/ijerph192013687</li>
<li><a href='https://press.rsna.org/timssnet/media/pressreleases/PDF/pressreleasePDF.cfm?ID=2539'>Nabbout, M. RSNA Press Release: Vaping Causes Immediate Effects on Vascular Function.</a> </li>
<li><a href='https://www.nih.gov/news-events/news-releases/nih-funded-studies-show-damaging-effects-vaping-smoking-blood-vessels'>NIH-funded studies show damaging effects of vaping, smoking on blood vessels. </a></li>
<li><a href='https://www.cdc.gov/nchs/data/databriefs/db475.pdf'>Kramarow, EA &amp; Elgaddal, MS. Current Electorinc Cigarette Use Amoing Adults Aged 19 and Over: US, 2021. NCHS Data Brief, #475, Juky 2023.</a> </li>
<li>CDC/NCHS Data: <a href='https://www.cdc.gov/nchs/fastats/smoking.htm'>https://www.cdc.gov/nchs/fastats/smoking.htm</a></li>
</ul>
<p>Guest: Susan Feeney, DNP, FNP-BC, NP-C
 
Music Credit: Matthew Bugos</p>
<p>Thoughts? Suggestions? Email us at <a href='mailto:FranklySpeaking@pri-med.com'>FranklySpeaking@pri-med.com</a></p>
<p> </p>
]]></description>
                                                            <content:encoded><![CDATA[<p>Credits: 0.25 AMA PRA Category 1 Credit™<br>
 <br>
CME/CE Information and Claim Credit: <a href='https://www.pri-med.com/online-education/podcast/frankly-speaking-cme-433'>https://www.pri-med.com/online-education/podcast/frankly-speaking-cme-433</a></p>
<p>Overview: E-cigarette use has risen significantly, especially among adolescents and young adults. Many people begin vaping alongside conventional cigarettes in an effort to quit or reduce smoking. But risks are emerging, challenging the belief that vaping is safer than combustible cigarettes. Join us as we explore the latest evidence on vaping, dual use, and the associated health risks.</p>
<p>Episode resource links:</p>
<ul>
<li>Hamoud J, Hanewinkel R, Andreas S, et al. A Systematic Review Investigating the Impact of Dual Use of E-Cigarettes and Conventional Cigarettes on Smoking Cessation. ERJ Open Res 2024; in press (<a href='https://doi.org/10.1183/23120541.00902-2024'>https://doi.org/10.1183/23120541.00902-2024</a>).</li>
<li>Lindson N, Butler AR, McRobbie H, et al. Electronic cigarettes for smoking cessation. Cochrane Database Syst Rev. 2024;1(1):CD010216. Published 2024 Jan 8. doi:10.1002/14651858.CD010216.pub8</li>
<li>Pisinger C, Rasmussen SKB. The Health Effects of Real-World Dual Use of Electronic and Conventional Cigarettes versus the Health Effects of Exclusive Smoking of Conventional Cigarettes: A Systematic Review. Int J Environ Res Public Health. 2022;19(20):13687. Published 2022 Oct 21. doi:10.3390/ijerph192013687</li>
<li><a href='https://press.rsna.org/timssnet/media/pressreleases/PDF/pressreleasePDF.cfm?ID=2539'>Nabbout, M. RSNA Press Release: Vaping Causes Immediate Effects on Vascular Function.</a> </li>
<li><a href='https://www.nih.gov/news-events/news-releases/nih-funded-studies-show-damaging-effects-vaping-smoking-blood-vessels'>NIH-funded studies show damaging effects of vaping, smoking on blood vessels. </a></li>
<li><a href='https://www.cdc.gov/nchs/data/databriefs/db475.pdf'>Kramarow, EA &amp; Elgaddal, MS. Current Electorinc Cigarette Use Amoing Adults Aged 19 and Over: US, 2021. NCHS Data Brief, #475, Juky 2023.</a> </li>
<li>CDC/NCHS Data: <a href='https://www.cdc.gov/nchs/fastats/smoking.htm'>https://www.cdc.gov/nchs/fastats/smoking.htm</a></li>
</ul>
<p>Guest: Susan Feeney, DNP, FNP-BC, NP-C<br>
 <br>
Music Credit: Matthew Bugos</p>
<p>Thoughts? Suggestions? Email us at <a href='mailto:FranklySpeaking@pri-med.com'>FranklySpeaking@pri-med.com</a></p>
<p> </p>
]]></content:encoded>
                                    
        <enclosure url="https://mcdn.podbean.com/mf/web/rshhig2akme287qh/frankly-speaking-433-vaping.mp3" length="10247126" type="audio/mpeg"/>
                <itunes:summary><![CDATA[Credits: 0.25 AMA PRA Category 1 Credit™ CME/CE Information and Claim Credit: https://www.pri-med.com/online-education/podcast/frankly-speaking-cme-433
Overview: E-cigarette use has risen significantly, especially among adolescents and young adults. Many people begin vaping alongside conventional cigarettes in an effort to quit or reduce smoking. But risks are emerging, challenging the belief that vaping is safer than combustible cigarettes. Join us as we explore the latest evidence on vaping, dual use, and the associated health risks.
Episode resource links:

Hamoud J, Hanewinkel R, Andreas S, et al. A Systematic Review Investigating the Impact of Dual Use of E-Cigarettes and Conventional Cigarettes on Smoking Cessation. ERJ Open Res 2024; in press (https://doi.org/10.1183/23120541.00902-2024).
Lindson N, Butler AR, McRobbie H, et al. Electronic cigarettes for smoking cessation. Cochrane Database Syst Rev. 2024;1(1):CD010216. Published 2024 Jan 8. doi:10.1002/14651858.CD010216.pub8
Pisinger C, Rasmussen SKB. The Health Effects of Real-World Dual Use of Electronic and Conventional Cigarettes versus the Health Effects of Exclusive Smoking of Conventional Cigarettes: A Systematic Review. Int J Environ Res Public Health. 2022;19(20):13687. Published 2022 Oct 21. doi:10.3390/ijerph192013687
Nabbout, M. RSNA Press Release: Vaping Causes Immediate Effects on Vascular Function. 
NIH-funded studies show damaging effects of vaping, smoking on blood vessels. 
Kramarow, EA &amp; Elgaddal, MS. Current Electorinc Cigarette Use Amoing Adults Aged 19 and Over: US, 2021. NCHS Data Brief, #475, Juky 2023. 
CDC/NCHS Data: https://www.cdc.gov/nchs/fastats/smoking.htm

Guest: Susan Feeney, DNP, FNP-BC, NP-C Music Credit: Matthew Bugos
Thoughts? Suggestions? Email us at FranklySpeaking@pri-med.com
 ]]></itunes:summary>
        <itunes:author>Pri-Med</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>638</itunes:duration>
                        <itunes:episodeType>full</itunes:episodeType>
            </item>
    <item>
        <title>From Diagnosis to Dialogue: Managing Measles in Primary Care - Frankly Speaking Ep 432</title>
        <itunes:title>From Diagnosis to Dialogue: Managing Measles in Primary Care - Frankly Speaking Ep 432</itunes:title>
        <link>https://primedfranklyspeaking.podbean.com/e/from-diagnosis-to-dialogue-managing-measles-in-primary-care-frankly-speaking-ep-432/</link>
                    <comments>https://primedfranklyspeaking.podbean.com/e/from-diagnosis-to-dialogue-managing-measles-in-primary-care-frankly-speaking-ep-432/#comments</comments>        <pubDate>Mon, 12 May 2025 05:30:00 +0000</pubDate>
        <guid isPermaLink="false">primedfranklyspeaking.podbean.com/081abaff-96d1-3512-ac49-4bfdb7c00e5a</guid>
                                    <description><![CDATA[<p>Credits: 0.25 AMA PRA Category 1 Credit™
 
CME/CE Information and Claim Credit: <a href='https://www.pri-med.com/online-education/podcast/frankly-speaking-cme-432'>https://www.pri-med.com/online-education/podcast/frankly-speaking-cme-432</a></p>
<p>Overview: With measles outbreaks on the rise in the United States and globally, it’s important to skillfully recognize cases and effectively promote vaccination. This episode offers practical tips to identify measles and support patient conversations, helping you protect individual patients and strengthen community health.</p>
<p>Episode resource links:</p>
<ul>
<li><a href='https://www.cdc.gov/han/2025/han00522.html'>CDC Health Alert Network, March 7, 2025</a></li>
<li><a href='https://www.cdc.gov/measles/data-research/index.html'>CDC Measles (Rubeola)</a></li>
<li><a href='https://www.unicef.org/press-releases/european-region-reports-highest-number-measles-cases-more-25-years-unicef-whoeurope'>UNICEF press release</a></li>
</ul>
<p>Guest: Alan M. Ehrlich, MD, FAAFP </p>
<p>Music Credit: Matthew Bugos</p>
<p>Thoughts? Suggestions? Email us at <a href='mailto:FranklySpeaking@pri-med.com'>FranklySpeaking@pri-med.com </a></p>
<p> </p>
]]></description>
                                                            <content:encoded><![CDATA[<p>Credits: 0.25 AMA PRA Category 1 Credit™<br>
 <br>
CME/CE Information and Claim Credit: <a href='https://www.pri-med.com/online-education/podcast/frankly-speaking-cme-432'>https://www.pri-med.com/online-education/podcast/frankly-speaking-cme-432</a></p>
<p>Overview: With measles outbreaks on the rise in the United States and globally, it’s important to skillfully recognize cases and effectively promote vaccination. This episode offers practical tips to identify measles and support patient conversations, helping you protect individual patients and strengthen community health.</p>
<p>Episode resource links:</p>
<ul>
<li><a href='https://www.cdc.gov/han/2025/han00522.html'>CDC Health Alert Network, March 7, 2025</a></li>
<li><a href='https://www.cdc.gov/measles/data-research/index.html'>CDC Measles (Rubeola)</a></li>
<li><a href='https://www.unicef.org/press-releases/european-region-reports-highest-number-measles-cases-more-25-years-unicef-whoeurope'>UNICEF press release</a></li>
</ul>
<p>Guest: Alan M. Ehrlich, MD, FAAFP </p>
<p>Music Credit: Matthew Bugos</p>
<p>Thoughts? Suggestions? Email us at <a href='mailto:FranklySpeaking@pri-med.com'>FranklySpeaking@pri-med.com </a></p>
<p> </p>
]]></content:encoded>
                                    
        <enclosure url="https://mcdn.podbean.com/mf/web/qiajxxucvfrfitbe/frankly-speaking-432-measles.mp3" length="14183667" type="audio/mpeg"/>
                <itunes:summary><![CDATA[Credits: 0.25 AMA PRA Category 1 Credit™ CME/CE Information and Claim Credit: https://www.pri-med.com/online-education/podcast/frankly-speaking-cme-432
Overview: With measles outbreaks on the rise in the United States and globally, it’s important to skillfully recognize cases and effectively promote vaccination. This episode offers practical tips to identify measles and support patient conversations, helping you protect individual patients and strengthen community health.
Episode resource links:

CDC Health Alert Network, March 7, 2025
CDC Measles (Rubeola)
UNICEF press release

Guest: Alan M. Ehrlich, MD, FAAFP 
Music Credit: Matthew Bugos
Thoughts? Suggestions? Email us at FranklySpeaking@pri-med.com 
 ]]></itunes:summary>
        <itunes:author>Pri-Med</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>884</itunes:duration>
                        <itunes:episodeType>full</itunes:episodeType>
            </item>
    <item>
        <title>Working Together to Eliminate Hepatitis B by 2030 - Frankly Speaking Ep 431</title>
        <itunes:title>Working Together to Eliminate Hepatitis B by 2030 - Frankly Speaking Ep 431</itunes:title>
        <link>https://primedfranklyspeaking.podbean.com/e/working-together-to-eliminate-hepatitis-b-by-2030-frankly-speaking-ep-431/</link>
                    <comments>https://primedfranklyspeaking.podbean.com/e/working-together-to-eliminate-hepatitis-b-by-2030-frankly-speaking-ep-431/#comments</comments>        <pubDate>Mon, 05 May 2025 05:30:00 +0000</pubDate>
        <guid isPermaLink="false">primedfranklyspeaking.podbean.com/33e546ec-9760-3377-a5ff-8adb31bb5589</guid>
                                    <description><![CDATA[<p>Credits: 0.25 AMA PRA Category 1 Credit™
 
CME/CE Information and Claim Credit: <a href='https://www.pri-med.com/online-education/podcast/frankly-speaking-cme-431'>https://www.pri-med.com/online-education/podcast/frankly-speaking-cme-431</a></p>
<p>Overview: Tune in as we discuss the updated WHO and CDC hepatitis B guidelines, specifically focusing on screening, vaccination, and management. Learn how to apply these recommendations in clinical practice to support the WHO’s goal to eliminate hepatitis B by 2030.</p>
<p>Guest: Mariyan L. Montaque, DNP, FNP-BC
 
Music Credit: Matthew Bugos</p>
<p>Thoughts? Suggestions? Email us at FranklySpeaking@pri-med.com </p>
]]></description>
                                                            <content:encoded><![CDATA[<p>Credits: 0.25 AMA PRA Category 1 Credit™<br>
 <br>
CME/CE Information and Claim Credit: <a href='https://www.pri-med.com/online-education/podcast/frankly-speaking-cme-431'>https://www.pri-med.com/online-education/podcast/frankly-speaking-cme-431</a></p>
<p>Overview: Tune in as we discuss the updated WHO and CDC hepatitis B guidelines, specifically focusing on screening, vaccination, and management. Learn how to apply these recommendations in clinical practice to support the WHO’s goal to eliminate hepatitis B by 2030.</p>
<p>Guest: Mariyan L. Montaque, DNP, FNP-BC<br>
 <br>
Music Credit: Matthew Bugos</p>
<p>Thoughts? Suggestions? Email us at FranklySpeaking@pri-med.com </p>
]]></content:encoded>
                                    
        <enclosure url="https://mcdn.podbean.com/mf/web/k4knd4v9t6w5g5ay/frankly-speaking-431-hepB.mp3" length="9767660" type="audio/mpeg"/>
                <itunes:summary><![CDATA[Credits: 0.25 AMA PRA Category 1 Credit™ CME/CE Information and Claim Credit: https://www.pri-med.com/online-education/podcast/frankly-speaking-cme-431
Overview: Tune in as we discuss the updated WHO and CDC hepatitis B guidelines, specifically focusing on screening, vaccination, and management. Learn how to apply these recommendations in clinical practice to support the WHO’s goal to eliminate hepatitis B by 2030.
Guest: Mariyan L. Montaque, DNP, FNP-BC Music Credit: Matthew Bugos
Thoughts? Suggestions? Email us at FranklySpeaking@pri-med.com ]]></itunes:summary>
        <itunes:author>Pri-Med</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>608</itunes:duration>
                        <itunes:episodeType>full</itunes:episodeType>
            </item>
    <item>
        <title>A Clear Path to Acne Management: Key Takeaways from the Latest Guidelines - Frankly Speaking Ep 430</title>
        <itunes:title>A Clear Path to Acne Management: Key Takeaways from the Latest Guidelines - Frankly Speaking Ep 430</itunes:title>
        <link>https://primedfranklyspeaking.podbean.com/e/a-clear-path-to-acne-management-key-takeaways-from-the-latest-guidelines-frankly-speaking-ep-430/</link>
                    <comments>https://primedfranklyspeaking.podbean.com/e/a-clear-path-to-acne-management-key-takeaways-from-the-latest-guidelines-frankly-speaking-ep-430/#comments</comments>        <pubDate>Mon, 28 Apr 2025 13:21:48 +0000</pubDate>
        <guid isPermaLink="false">primedfranklyspeaking.podbean.com/026a1e55-983e-3656-ad09-4f418a207785</guid>
                                    <description><![CDATA[<p>Credits: 0.25 AMA PRA Category 1 Credit™
 
CME/CE Information and Claim Credit: <a href='https://www.pri-med.com/online-education/podcast/frankly-speaking-cme-430'>https://www.pri-med.com/online-education/podcast/frankly-speaking-cme-430</a></p>
<p>Overview: Stay up to date with the latest evidence-based acne treatment guidelines from the American Academy of Dermatology (AAD). Learn how to optimize topical and oral therapies, minimize antibiotic resistance, and apply new best practices to improve outcomes for adolescents and young adults. Don’t miss these key updates for enhancing patient care.</p>
<p>Episode resource links:</p>
<ul>
<li>J Am Acad Dermatol 2024;90:1006.e1-30. doi.org/10.1016/j.jaad.2023.12.017</li>
</ul>
<p>Guest: Robert A. Baldor MD, FAAFP
 
Music Credit: Matthew Bugos</p>
<p>Thoughts? Suggestions? Email us at <a href='mailto:FranklySpeaking@pri-med.com'>FranklySpeaking@pri-med.com </a></p>
<p> </p>
]]></description>
                                                            <content:encoded><![CDATA[<p>Credits: 0.25 AMA PRA Category 1 Credit™<br>
 <br>
CME/CE Information and Claim Credit: <a href='https://www.pri-med.com/online-education/podcast/frankly-speaking-cme-430'>https://www.pri-med.com/online-education/podcast/frankly-speaking-cme-430</a></p>
<p>Overview: Stay up to date with the latest evidence-based acne treatment guidelines from the American Academy of Dermatology (AAD). Learn how to optimize topical and oral therapies, minimize antibiotic resistance, and apply new best practices to improve outcomes for adolescents and young adults. Don’t miss these key updates for enhancing patient care.</p>
<p>Episode resource links:</p>
<ul>
<li>J Am Acad Dermatol 2024;90:1006.e1-30. doi.org/10.1016/j.jaad.2023.12.017</li>
</ul>
<p>Guest: Robert A. Baldor MD, FAAFP<br>
 <br>
Music Credit: Matthew Bugos</p>
<p>Thoughts? Suggestions? Email us at <a href='mailto:FranklySpeaking@pri-med.com'>FranklySpeaking@pri-med.com </a></p>
<p> </p>
]]></content:encoded>
                                    
        <enclosure url="https://mcdn.podbean.com/mf/web/6ap4qbz2t9p8nnqe/frankly-speaking-430-acne.mp3" length="10429315" type="audio/mpeg"/>
                <itunes:summary><![CDATA[Credits: 0.25 AMA PRA Category 1 Credit™ CME/CE Information and Claim Credit: https://www.pri-med.com/online-education/podcast/frankly-speaking-cme-430
Overview: Stay up to date with the latest evidence-based acne treatment guidelines from the American Academy of Dermatology (AAD). Learn how to optimize topical and oral therapies, minimize antibiotic resistance, and apply new best practices to improve outcomes for adolescents and young adults. Don’t miss these key updates for enhancing patient care.
Episode resource links:

J Am Acad Dermatol 2024;90:1006.e1-30. doi.org/10.1016/j.jaad.2023.12.017

Guest: Robert A. Baldor MD, FAAFP Music Credit: Matthew Bugos
Thoughts? Suggestions? Email us at FranklySpeaking@pri-med.com 
 ]]></itunes:summary>
        <itunes:author>Pri-Med</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>650</itunes:duration>
                        <itunes:episodeType>full</itunes:episodeType>
            </item>
    <item>
        <title>Colorectal Cancer Screening—Does the New Blood Test Measure Up? - Frankly Speaking Ep 429</title>
        <itunes:title>Colorectal Cancer Screening—Does the New Blood Test Measure Up? - Frankly Speaking Ep 429</itunes:title>
        <link>https://primedfranklyspeaking.podbean.com/e/colorectal-cancer-screening%e2%80%94does-the-new-blood-test-measure-up-frankly-speaking-ep-429/</link>
                    <comments>https://primedfranklyspeaking.podbean.com/e/colorectal-cancer-screening%e2%80%94does-the-new-blood-test-measure-up-frankly-speaking-ep-429/#comments</comments>        <pubDate>Mon, 21 Apr 2025 04:30:00 +0000</pubDate>
        <guid isPermaLink="false">primedfranklyspeaking.podbean.com/d107d954-451a-3011-90ab-8628236c87cb</guid>
                                    <description><![CDATA[<p>Credits: 0.25 AMA PRA Category 1 Credit™
 
CME/CE Information and Claim Credit: <a href='https://www.pri-med.com/online-education/podcast/frankly-speaking-cme-429'>https://www.pri-med.com/online-education/podcast/frankly-speaking-cme-429</a></p>
<p>Overview: Colorectal cancer screening saves lives, yet many patients remain unscreened. This episode explores current screening methods, the evidence behind the new DNA blood test, and how it compares to existing options. Gain practical insights to guide patient discussions and improve screening rates in your practice.</p>
<p>Episode resource links:</p>
<ul>
<li>N Engl J Med. 2024 Mar 14;390(11):973-983. doi: 10.1056/NEJMoa2304714</li>
<li>N Engl J Med 2024;390:984-93. DOI: 10.1056/NEJMoa2310336</li>
</ul>
<p>Guest: Jillian Joseph, MPAS, PA-C</p>
<p>Music Credit: Matthew Bugos</p>
<p>Thoughts? Suggestions? Email us at <a href='mailto:FranklySpeaking@pri-med.com'>FranklySpeaking@pri-med.com </a></p>
<p> </p>
]]></description>
                                                            <content:encoded><![CDATA[<p>Credits: 0.25 AMA PRA Category 1 Credit™<br>
 <br>
CME/CE Information and Claim Credit: <a href='https://www.pri-med.com/online-education/podcast/frankly-speaking-cme-429'>https://www.pri-med.com/online-education/podcast/frankly-speaking-cme-429</a></p>
<p>Overview: Colorectal cancer screening saves lives, yet many patients remain unscreened. This episode explores current screening methods, the evidence behind the new DNA blood test, and how it compares to existing options. Gain practical insights to guide patient discussions and improve screening rates in your practice.</p>
<p>Episode resource links:</p>
<ul>
<li>N Engl J Med. 2024 Mar 14;390(11):973-983. doi: 10.1056/NEJMoa2304714</li>
<li>N Engl J Med 2024;390:984-93. DOI: 10.1056/NEJMoa2310336</li>
</ul>
<p>Guest: Jillian Joseph, MPAS, PA-C</p>
<p>Music Credit: Matthew Bugos</p>
<p>Thoughts? Suggestions? Email us at <a href='mailto:FranklySpeaking@pri-med.com'>FranklySpeaking@pri-med.com </a></p>
<p> </p>
]]></content:encoded>
                                    
        <enclosure url="https://mcdn.podbean.com/mf/web/h2tpfn8grukgb4mp/frankly-speaking-429-colerectal-cancer.mp3" length="13924719" type="audio/mpeg"/>
                <itunes:summary><![CDATA[Credits: 0.25 AMA PRA Category 1 Credit™ CME/CE Information and Claim Credit: https://www.pri-med.com/online-education/podcast/frankly-speaking-cme-429
Overview: Colorectal cancer screening saves lives, yet many patients remain unscreened. This episode explores current screening methods, the evidence behind the new DNA blood test, and how it compares to existing options. Gain practical insights to guide patient discussions and improve screening rates in your practice.
Episode resource links:

N Engl J Med. 2024 Mar 14;390(11):973-983. doi: 10.1056/NEJMoa2304714
N Engl J Med 2024;390:984-93. DOI: 10.1056/NEJMoa2310336

Guest: Jillian Joseph, MPAS, PA-C
Music Credit: Matthew Bugos
Thoughts? Suggestions? Email us at FranklySpeaking@pri-med.com 
 ]]></itunes:summary>
        <itunes:author>Pri-Med</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>868</itunes:duration>
                        <itunes:episodeType>full</itunes:episodeType>
            </item>
    <item>
        <title>Adding to the Playbook: Primary Prevention of Stroke and Life’s Essential 8 - Frankly Speaking Ep 428</title>
        <itunes:title>Adding to the Playbook: Primary Prevention of Stroke and Life’s Essential 8 - Frankly Speaking Ep 428</itunes:title>
        <link>https://primedfranklyspeaking.podbean.com/e/adding-to-the-playbook-primary-prevention-of-stroke-and-life-s-essential-8-frankly-speaking-ep-428/</link>
                    <comments>https://primedfranklyspeaking.podbean.com/e/adding-to-the-playbook-primary-prevention-of-stroke-and-life-s-essential-8-frankly-speaking-ep-428/#comments</comments>        <pubDate>Mon, 14 Apr 2025 06:30:00 +0000</pubDate>
        <guid isPermaLink="false">primedfranklyspeaking.podbean.com/2d2b2dcf-f52d-3101-8875-6120b2998cec</guid>
                                    <description><![CDATA[<p>Credits: 0.25 AMA PRA Category 1 Credit™
 
CME/CE Information and Claim Credit: <a href='https://www.pri-med.com/online-education/podcast/frankly-speaking-cme-428'>https://www.pri-med.com/online-education/podcast/frankly-speaking-cme-428</a></p>
<p>Overview: Stay ahead in stroke prevention with the latest guidelines. In this episode, we cover new considerations for social determinants of health, interventions across the lifespan, and evidence-based strategies to reduce stroke risk. Learn how to integrate these updates into primary care for more effective patient outcomes.</p>
<p>Episode resource links:</p>
<ul>
<li>
<p>Bushnell, C., Kernan, W. N., Sharrief, A. Z., Chaturvedi, S., Cole, J. W., Cornwell, W. K., 3rd, Cosby-Gaither, C., Doyle, S., Goldstein, L. B., Lennon, O., Levine, D. A., Love, M., Miller, E., Nguyen-Huynh, M., Rasmussen-Winkler, J., Rexrode, K. M., Rosendale, N., Sarma, S., Shimbo, D., Simpkins, A. N., … Whelton, P. K. (2024). 2024 Guideline for the Primary Prevention of Stroke: A Guideline From the American Heart Association/American Stroke Association. Stroke, 55(12), e344–e424. <a href='https://doi.org/10.1161/STR.0000000000000475'>https://doi.org/10.1161/STR.0000000000000475</a></p>
</li>
<li>
<p>Ravichandran, S., Gajjar, P., Walker, M. E., Prescott, B., Tsao, C. W., Jha, M., Rao, P., Miller, P., Larson, M. G., Vasan, R. S., Shah, R. V., Xanthakis, V., Lewis, G. D., &amp; Nayor, M. (2024). Life's Essential 8 Cardiovascular Health Score and Cardiorespiratory Fitness in the Community. Journal of the American Heart Association, 13(9), e032944. <a href='https://doi.org/10.1161/JAHA.123.032944'>https://doi.org/10.1161/JAHA.123.032944</a></p>
</li>
<li>
<p>Kumar, M., Orkaby, A., Tighe, C., Villareal, D. T., Billingsley, H., Nanna, M. G., Kwak, M. J., Rohant, N., Patel, S., Goyal, P., Hummel, S., Al-Malouf, C., Kolimas, A., Krishnaswami, A., Rich, M. W., Kirkpatrick, J., Damluji, A. A., Kuchel, G. A., Forman, D. E., &amp; Alexander, K. P. (2023). Life's Essential 8: Optimizing Health in Older Adults. JACC. Advances, 2(7), 100560. <a href='https://doi.org/10.1016/j.jacadv.2023.100560'>https://doi.org/10.1016/j.jacadv.2023.100560</a></p>
</li>
<li>
<p>Life’s Essential 8 tools for providers and patient information: <a href='https://www.heart.org/en/healthy-living/healthy-lifestyle/lifes-essential-8'>https://www.heart.org/en/healthy-living/healthy-lifestyle/lifes-essential-8</a></p>
</li>
</ul>
<p>Guest: Jill M. Terrien PhD, ANP-BC
 
Music Credit: Matthew Bugos</p>
<p>Thoughts? Suggestions? Email us at <a href='mailto:FranklySpeaking@pri-med.com'>FranklySpeaking@pri-med.com </a></p>
<p> </p>
]]></description>
                                                            <content:encoded><![CDATA[<p>Credits: 0.25 AMA PRA Category 1 Credit™<br>
 <br>
CME/CE Information and Claim Credit: <a href='https://www.pri-med.com/online-education/podcast/frankly-speaking-cme-428'>https://www.pri-med.com/online-education/podcast/frankly-speaking-cme-428</a></p>
<p>Overview: Stay ahead in stroke prevention with the latest guidelines. In this episode, we cover new considerations for social determinants of health, interventions across the lifespan, and evidence-based strategies to reduce stroke risk. Learn how to integrate these updates into primary care for more effective patient outcomes.</p>
<p>Episode resource links:</p>
<ul>
<li>
<p>Bushnell, C., Kernan, W. N., Sharrief, A. Z., Chaturvedi, S., Cole, J. W., Cornwell, W. K., 3rd, Cosby-Gaither, C., Doyle, S., Goldstein, L. B., Lennon, O., Levine, D. A., Love, M., Miller, E., Nguyen-Huynh, M., Rasmussen-Winkler, J., Rexrode, K. M., Rosendale, N., Sarma, S., Shimbo, D., Simpkins, A. N., … Whelton, P. K. (2024). 2024 Guideline for the Primary Prevention of Stroke: A Guideline From the American Heart Association/American Stroke Association. Stroke, 55(12), e344–e424. <a href='https://doi.org/10.1161/STR.0000000000000475'>https://doi.org/10.1161/STR.0000000000000475</a></p>
</li>
<li>
<p>Ravichandran, S., Gajjar, P., Walker, M. E., Prescott, B., Tsao, C. W., Jha, M., Rao, P., Miller, P., Larson, M. G., Vasan, R. S., Shah, R. V., Xanthakis, V., Lewis, G. D., &amp; Nayor, M. (2024). Life's Essential 8 Cardiovascular Health Score and Cardiorespiratory Fitness in the Community. Journal of the American Heart Association, 13(9), e032944. <a href='https://doi.org/10.1161/JAHA.123.032944'>https://doi.org/10.1161/JAHA.123.032944</a></p>
</li>
<li>
<p>Kumar, M., Orkaby, A., Tighe, C., Villareal, D. T., Billingsley, H., Nanna, M. G., Kwak, M. J., Rohant, N., Patel, S., Goyal, P., Hummel, S., Al-Malouf, C., Kolimas, A., Krishnaswami, A., Rich, M. W., Kirkpatrick, J., Damluji, A. A., Kuchel, G. A., Forman, D. E., &amp; Alexander, K. P. (2023). Life's Essential 8: Optimizing Health in Older Adults. JACC. Advances, 2(7), 100560. <a href='https://doi.org/10.1016/j.jacadv.2023.100560'>https://doi.org/10.1016/j.jacadv.2023.100560</a></p>
</li>
<li>
<p>Life’s Essential 8 tools for providers and patient information: <a href='https://www.heart.org/en/healthy-living/healthy-lifestyle/lifes-essential-8'>https://www.heart.org/en/healthy-living/healthy-lifestyle/lifes-essential-8</a></p>
</li>
</ul>
<p>Guest: Jill M. Terrien PhD, ANP-BC<br>
 <br>
Music Credit: Matthew Bugos</p>
<p>Thoughts? Suggestions? Email us at <a href='mailto:FranklySpeaking@pri-med.com'>FranklySpeaking@pri-med.com </a></p>
<p> </p>
]]></content:encoded>
                                    
        <enclosure url="https://mcdn.podbean.com/mf/web/k73jxb9fy5j6xh53/frankly-speaking-428-stroke.mp3" length="18844626" type="audio/mpeg"/>
                <itunes:summary><![CDATA[Credits: 0.25 AMA PRA Category 1 Credit™ CME/CE Information and Claim Credit: https://www.pri-med.com/online-education/podcast/frankly-speaking-cme-428
Overview: Stay ahead in stroke prevention with the latest guidelines. In this episode, we cover new considerations for social determinants of health, interventions across the lifespan, and evidence-based strategies to reduce stroke risk. Learn how to integrate these updates into primary care for more effective patient outcomes.
Episode resource links:


Bushnell, C., Kernan, W. N., Sharrief, A. Z., Chaturvedi, S., Cole, J. W., Cornwell, W. K., 3rd, Cosby-Gaither, C., Doyle, S., Goldstein, L. B., Lennon, O., Levine, D. A., Love, M., Miller, E., Nguyen-Huynh, M., Rasmussen-Winkler, J., Rexrode, K. M., Rosendale, N., Sarma, S., Shimbo, D., Simpkins, A. N., … Whelton, P. K. (2024). 2024 Guideline for the Primary Prevention of Stroke: A Guideline From the American Heart Association/American Stroke Association. Stroke, 55(12), e344–e424. https://doi.org/10.1161/STR.0000000000000475


Ravichandran, S., Gajjar, P., Walker, M. E., Prescott, B., Tsao, C. W., Jha, M., Rao, P., Miller, P., Larson, M. G., Vasan, R. S., Shah, R. V., Xanthakis, V., Lewis, G. D., &amp; Nayor, M. (2024). Life's Essential 8 Cardiovascular Health Score and Cardiorespiratory Fitness in the Community. Journal of the American Heart Association, 13(9), e032944. https://doi.org/10.1161/JAHA.123.032944


Kumar, M., Orkaby, A., Tighe, C., Villareal, D. T., Billingsley, H., Nanna, M. G., Kwak, M. J., Rohant, N., Patel, S., Goyal, P., Hummel, S., Al-Malouf, C., Kolimas, A., Krishnaswami, A., Rich, M. W., Kirkpatrick, J., Damluji, A. A., Kuchel, G. A., Forman, D. E., &amp; Alexander, K. P. (2023). Life's Essential 8: Optimizing Health in Older Adults. JACC. Advances, 2(7), 100560. https://doi.org/10.1016/j.jacadv.2023.100560


Life’s Essential 8 tools for providers and patient information: https://www.heart.org/en/healthy-living/healthy-lifestyle/lifes-essential-8


Guest: Jill M. Terrien PhD, ANP-BC Music Credit: Matthew Bugos
Thoughts? Suggestions? Email us at FranklySpeaking@pri-med.com 
 ]]></itunes:summary>
        <itunes:author>Pri-Med</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>784</itunes:duration>
                        <itunes:episodeType>full</itunes:episodeType>
            </item>
    <item>
        <title>Movement Matters—Is There an Optimal Exercise Routine for Treating Hypertension? - Frankly Speaking Ep 427</title>
        <itunes:title>Movement Matters—Is There an Optimal Exercise Routine for Treating Hypertension? - Frankly Speaking Ep 427</itunes:title>
        <link>https://primedfranklyspeaking.podbean.com/e/movement-matters%e2%80%94is-there-an-optimal-exercise-routine-for-treating-hypertension-frankly-speaking-ep-427/</link>
                    <comments>https://primedfranklyspeaking.podbean.com/e/movement-matters%e2%80%94is-there-an-optimal-exercise-routine-for-treating-hypertension-frankly-speaking-ep-427/#comments</comments>        <pubDate>Mon, 07 Apr 2025 06:30:00 +0000</pubDate>
        <guid isPermaLink="false">primedfranklyspeaking.podbean.com/35d2064e-95be-31a3-a03b-b0b0ed58235d</guid>
                                    <description><![CDATA[<p>Credits: 0.25 AMA PRA Category 1 Credit™
 
CME/CE Information and Claim Credit: <a href='https://www.pri-med.com/online-education/podcast/frankly-speaking-cme-427'>https://www.pri-med.com/online-education/podcast/frankly-speaking-cme-427</a></p>
<p>Overview: Discover how to optimize hypertension management with evidence-based exercise prescriptions. This episode reviews a large-scale meta-analysis on the effectiveness of various exercise routines for lowering blood pressure, helping you confidently integrate nonpharmacologic strategies into patient care. Learn which exercises work best and when to recommend them for improved cardiovascular health.</p>
<p>Episode resource links:</p>
<ul>
<li>Edwards JJ, Deenmamode AHP, Griffiths M, et al. Br J Sports Med 2023;57:1317–1326.</li>
</ul>
<p>Guest: Robert A. Baldor MD, FAAFP
 
Music Credit: Matthew Bugos</p>
<p>Thoughts? Suggestions? Email us at <a href='mailto:FranklySpeaking@pri-med.com'>FranklySpeaking@pri-med.com</a></p>
<p> </p>
]]></description>
                                                            <content:encoded><![CDATA[<p>Credits: 0.25 AMA PRA Category 1 Credit™<br>
 <br>
CME/CE Information and Claim Credit: <a href='https://www.pri-med.com/online-education/podcast/frankly-speaking-cme-427'>https://www.pri-med.com/online-education/podcast/frankly-speaking-cme-427</a></p>
<p>Overview: Discover how to optimize hypertension management with evidence-based exercise prescriptions. This episode reviews a large-scale meta-analysis on the effectiveness of various exercise routines for lowering blood pressure, helping you confidently integrate nonpharmacologic strategies into patient care. Learn which exercises work best and when to recommend them for improved cardiovascular health.</p>
<p>Episode resource links:</p>
<ul>
<li>Edwards JJ, Deenmamode AHP, Griffiths M, et al. Br J Sports Med 2023;57:1317–1326.</li>
</ul>
<p>Guest: Robert A. Baldor MD, FAAFP<br>
 <br>
Music Credit: Matthew Bugos</p>
<p>Thoughts? Suggestions? Email us at <a href='mailto:FranklySpeaking@pri-med.com'>FranklySpeaking@pri-med.com</a></p>
<p> </p>
]]></content:encoded>
                                    
        <enclosure url="https://mcdn.podbean.com/mf/web/6chjdg3cb72ath8v/frankly-speaking-427-exercise.mp3" length="7326032" type="audio/mpeg"/>
                <itunes:summary><![CDATA[Credits: 0.25 AMA PRA Category 1 Credit™ CME/CE Information and Claim Credit: https://www.pri-med.com/online-education/podcast/frankly-speaking-cme-427
Overview: Discover how to optimize hypertension management with evidence-based exercise prescriptions. This episode reviews a large-scale meta-analysis on the effectiveness of various exercise routines for lowering blood pressure, helping you confidently integrate nonpharmacologic strategies into patient care. Learn which exercises work best and when to recommend them for improved cardiovascular health.
Episode resource links:

Edwards JJ, Deenmamode AHP, Griffiths M, et al. Br J Sports Med 2023;57:1317–1326.

Guest: Robert A. Baldor MD, FAAFP Music Credit: Matthew Bugos
Thoughts? Suggestions? Email us at FranklySpeaking@pri-med.com
 ]]></itunes:summary>
        <itunes:author>Pri-Med</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>456</itunes:duration>
                        <itunes:episodeType>full</itunes:episodeType>
            </item>
    <item>
        <title>Morning Cups of Joe Are the Way to Go - Frankly Speaking Ep 426</title>
        <itunes:title>Morning Cups of Joe Are the Way to Go - Frankly Speaking Ep 426</itunes:title>
        <link>https://primedfranklyspeaking.podbean.com/e/morning-cups-of-joe-are-the-way-to-go-frankly-speaking-ep-426/</link>
                    <comments>https://primedfranklyspeaking.podbean.com/e/morning-cups-of-joe-are-the-way-to-go-frankly-speaking-ep-426/#comments</comments>        <pubDate>Mon, 31 Mar 2025 06:30:00 +0000</pubDate>
        <guid isPermaLink="false">primedfranklyspeaking.podbean.com/fd77ee9e-a241-39e4-b935-840e566f05de</guid>
                                    <description><![CDATA[<p>Credits: 0.25 AMA PRA Category 1 Credit™
 
CME/CE Information and Claim Credit: <a href='https://www.pri-med.com/online-education/podcast/frankly-speaking-cme-426'>https://www.pri-med.com/online-education/podcast/frankly-speaking-cme-426</a></p>
<p>Overview: Drinking coffee offers potential health benefits—but does timing affect outcomes? This episode dives into new research on how morning vs. all-day coffee consumption impacts cardiovascular disease and all-cause mortality risk. Gain practical insights to optimize patient recommendations based on the latest evidence.</p>
<p>Episode resource links:</p>
<ul>
<li>European Heart Journal (2025) 00, 1–11 <a href='https://doi.org/10.1093/eurheartj/ehae871'>https://doi.org/10.1093/eurheartj/ehae871</a></li>
<li>The Journal of Clinical Endocrinology &amp; Metabolism, 2024, 00, 1–11 <a href='https://doi.org/10.1210/clinem/dgae552'>https://doi.org/10.1210/clinem/dgae552</a></li>
</ul>
<p>Guest: Jillian Joseph, MPAS, PA-C
 
Music Credit: Matthew Bugos</p>
<p>Thoughts? Suggestions? Email us at <a href='mailto:FranklySpeaking@pri-med.com'>FranklySpeaking@pri-med.com</a></p>
<p> </p>
]]></description>
                                                            <content:encoded><![CDATA[<p>Credits: 0.25 AMA PRA Category 1 Credit™<br>
 <br>
CME/CE Information and Claim Credit: <a href='https://www.pri-med.com/online-education/podcast/frankly-speaking-cme-426'>https://www.pri-med.com/online-education/podcast/frankly-speaking-cme-426</a></p>
<p>Overview: Drinking coffee offers potential health benefits—but does timing affect outcomes? This episode dives into new research on how morning vs. all-day coffee consumption impacts cardiovascular disease and all-cause mortality risk. Gain practical insights to optimize patient recommendations based on the latest evidence.</p>
<p>Episode resource links:</p>
<ul>
<li>European Heart Journal (2025) 00, 1–11 <a href='https://doi.org/10.1093/eurheartj/ehae871'>https://doi.org/10.1093/eurheartj/ehae871</a></li>
<li>The Journal of Clinical Endocrinology &amp; Metabolism, 2024, 00, 1–11 <a href='https://doi.org/10.1210/clinem/dgae552'>https://doi.org/10.1210/clinem/dgae552</a></li>
</ul>
<p>Guest: Jillian Joseph, MPAS, PA-C<br>
 <br>
Music Credit: Matthew Bugos</p>
<p>Thoughts? Suggestions? Email us at <a href='mailto:FranklySpeaking@pri-med.com'>FranklySpeaking@pri-med.com</a></p>
<p> </p>
]]></content:encoded>
                                    
        <enclosure url="https://mcdn.podbean.com/mf/web/ah5vixhipex6pncc/frankly-speaking-426-coffee.mp3" length="9824156" type="audio/mpeg"/>
                <itunes:summary><![CDATA[Credits: 0.25 AMA PRA Category 1 Credit™ CME/CE Information and Claim Credit: https://www.pri-med.com/online-education/podcast/frankly-speaking-cme-426
Overview: Drinking coffee offers potential health benefits—but does timing affect outcomes? This episode dives into new research on how morning vs. all-day coffee consumption impacts cardiovascular disease and all-cause mortality risk. Gain practical insights to optimize patient recommendations based on the latest evidence.
Episode resource links:

European Heart Journal (2025) 00, 1–11 https://doi.org/10.1093/eurheartj/ehae871
The Journal of Clinical Endocrinology &amp; Metabolism, 2024, 00, 1–11 https://doi.org/10.1210/clinem/dgae552

Guest: Jillian Joseph, MPAS, PA-C Music Credit: Matthew Bugos
Thoughts? Suggestions? Email us at FranklySpeaking@pri-med.com
 ]]></itunes:summary>
        <itunes:author>Pri-Med</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>612</itunes:duration>
                        <itunes:episodeType>full</itunes:episodeType>
            </item>
    <item>
        <title>Obstructive Sleep Apnea Breakthroughs: Emerging and Newly Approved Treatment Updates - Frankly Speaking Ep 425</title>
        <itunes:title>Obstructive Sleep Apnea Breakthroughs: Emerging and Newly Approved Treatment Updates - Frankly Speaking Ep 425</itunes:title>
        <link>https://primedfranklyspeaking.podbean.com/e/obstructive-sleep-apnea-breakthroughs-emerging-and-newly-approved-treatment-updates-frankly-speaking-ep-425/</link>
                    <comments>https://primedfranklyspeaking.podbean.com/e/obstructive-sleep-apnea-breakthroughs-emerging-and-newly-approved-treatment-updates-frankly-speaking-ep-425/#comments</comments>        <pubDate>Mon, 24 Mar 2025 00:30:00 +0000</pubDate>
        <guid isPermaLink="false">primedfranklyspeaking.podbean.com/3e659b4a-717d-3314-a4e1-03bad8494f13</guid>
                                    <description><![CDATA[<p>Credits: 0.25 AMA PRA Category 1 Credit™
 
CME/CE Information and Claim Credit: <a href='https://www.pri-med.com/online-education/podcast/frankly-speaking-cme-425'>https://www.pri-med.com/online-education/podcast/frankly-speaking-cme-425</a></p>
<p>Overview: In this episode we discuss updates on the treatment and management of obstructive sleep apnea (OSA). This is a common health concern, but it is often underdiagnosed and can have significant health impacts. We review its prevalence and standard treatments, highlighting the recently used medication therapy that has been found to be effective in treating OSA, particularly in individuals with obesity. </p>
<p>Episode resource links:</p>
<ul>
<li><a href='https://www.aafp.org/pubs/afp/issues/2023/0300/uspstf-obstructive-sleep-apnea.html'>https://www.aafp.org/pubs/afp/issues/2023/0300/uspstf-obstructive-sleep-apnea.html</a></li>
<li><a href='https://emedicine.medscape.com/article/295807-overview'>https://emedicine.medscape.com/article/295807-overview</a></li>
<li>Malhotra, A., Grunstein, R. R., Fietze, I., Weaver, T. E., Redline, S., Azarbarzin, A., ... &amp; Bednarik, J. (2024). Tirzepatide for the Treatment of Obstructive Sleep Apnea and Obesity. New England Journal of Medicine.</li>
<li>Mangione, C. M., Barry, M. J., Nicholson, W. K., Cabana, M., Chelmow, D., Coker, T. R., ... &amp; US Preventive Services Task Force. (2022). Screening for obstructive sleep apnea in adults: US Preventive Services Task Force recommendation statement. Jama, 328(19), 1945-1950.</li>
<li><a href='https://aasm.org/rising-prevalence-of-sleep-apnea-in-u-s-threatens-public-health/'>https://aasm.org/rising-prevalence-of-sleep-apnea-in-u-s-threatens-public-health/</a></li>
</ul>
<p>Guest: Mariyan L. Montaque, DNP, FNP-BC

 Music Credit: Matthew Bugos</p>
<p>Thoughts? Suggestions? Email us at <a href='mailto:FranklySpeaking@pri-med.com'>FranklySpeaking@pri-med.com</a></p>
<p> </p>
]]></description>
                                                            <content:encoded><![CDATA[<p>Credits: 0.25 AMA PRA Category 1 Credit™<br>
 <br>
CME/CE Information and Claim Credit: <a href='https://www.pri-med.com/online-education/podcast/frankly-speaking-cme-425'>https://www.pri-med.com/online-education/podcast/frankly-speaking-cme-425</a></p>
<p>Overview: In this episode we discuss updates on the treatment and management of obstructive sleep apnea (OSA). This is a common health concern, but it is often underdiagnosed and can have significant health impacts. We review its prevalence and standard treatments, highlighting the recently used medication therapy that has been found to be effective in treating OSA, particularly in individuals with obesity. </p>
<p>Episode resource links:</p>
<ul>
<li><a href='https://www.aafp.org/pubs/afp/issues/2023/0300/uspstf-obstructive-sleep-apnea.html'>https://www.aafp.org/pubs/afp/issues/2023/0300/uspstf-obstructive-sleep-apnea.html</a></li>
<li><a href='https://emedicine.medscape.com/article/295807-overview'>https://emedicine.medscape.com/article/295807-overview</a></li>
<li>Malhotra, A., Grunstein, R. R., Fietze, I., Weaver, T. E., Redline, S., Azarbarzin, A., ... &amp; Bednarik, J. (2024). Tirzepatide for the Treatment of Obstructive Sleep Apnea and Obesity. New England Journal of Medicine.</li>
<li>Mangione, C. M., Barry, M. J., Nicholson, W. K., Cabana, M., Chelmow, D., Coker, T. R., ... &amp; US Preventive Services Task Force. (2022). Screening for obstructive sleep apnea in adults: US Preventive Services Task Force recommendation statement. Jama, 328(19), 1945-1950.</li>
<li><a href='https://aasm.org/rising-prevalence-of-sleep-apnea-in-u-s-threatens-public-health/'>https://aasm.org/rising-prevalence-of-sleep-apnea-in-u-s-threatens-public-health/</a></li>
</ul>
<p>Guest: Mariyan L. Montaque, DNP, FNP-BC<br>
<br>
 Music Credit: Matthew Bugos</p>
<p>Thoughts? Suggestions? Email us at <a href='mailto:FranklySpeaking@pri-med.com'>FranklySpeaking@pri-med.com</a></p>
<p> </p>
]]></content:encoded>
                                    
        <enclosure url="https://mcdn.podbean.com/mf/web/jzivmpr2nzxj9tzi/frankly-speaking-425-sleep-apnea.mp3" length="12162515" type="audio/mpeg"/>
                <itunes:summary><![CDATA[Credits: 0.25 AMA PRA Category 1 Credit™ CME/CE Information and Claim Credit: https://www.pri-med.com/online-education/podcast/frankly-speaking-cme-425
Overview: In this episode we discuss updates on the treatment and management of obstructive sleep apnea (OSA). This is a common health concern, but it is often underdiagnosed and can have significant health impacts. We review its prevalence and standard treatments, highlighting the recently used medication therapy that has been found to be effective in treating OSA, particularly in individuals with obesity. 
Episode resource links:

https://www.aafp.org/pubs/afp/issues/2023/0300/uspstf-obstructive-sleep-apnea.html
https://emedicine.medscape.com/article/295807-overview
Malhotra, A., Grunstein, R. R., Fietze, I., Weaver, T. E., Redline, S., Azarbarzin, A., ... &amp; Bednarik, J. (2024). Tirzepatide for the Treatment of Obstructive Sleep Apnea and Obesity. New England Journal of Medicine.
Mangione, C. M., Barry, M. J., Nicholson, W. K., Cabana, M., Chelmow, D., Coker, T. R., ... &amp; US Preventive Services Task Force. (2022). Screening for obstructive sleep apnea in adults: US Preventive Services Task Force recommendation statement. Jama, 328(19), 1945-1950.
https://aasm.org/rising-prevalence-of-sleep-apnea-in-u-s-threatens-public-health/

Guest: Mariyan L. Montaque, DNP, FNP-BC Music Credit: Matthew Bugos
Thoughts? Suggestions? Email us at FranklySpeaking@pri-med.com
 ]]></itunes:summary>
        <itunes:author>Pri-Med</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>758</itunes:duration>
                        <itunes:episodeType>full</itunes:episodeType>
            </item>
    <item>
        <title>UTI Guidelines for Primary Care: What’s New in Diagnosis, Treatment, and Prevention? - Frankly Speaking Ep 424</title>
        <itunes:title>UTI Guidelines for Primary Care: What’s New in Diagnosis, Treatment, and Prevention? - Frankly Speaking Ep 424</itunes:title>
        <link>https://primedfranklyspeaking.podbean.com/e/uti-guidelines-for-primary-care-what-s-new-in-diagnosis-treatment-and-prevention-frankly-speaking-ep-424/</link>
                    <comments>https://primedfranklyspeaking.podbean.com/e/uti-guidelines-for-primary-care-what-s-new-in-diagnosis-treatment-and-prevention-frankly-speaking-ep-424/#comments</comments>        <pubDate>Mon, 17 Mar 2025 05:30:00 +0000</pubDate>
        <guid isPermaLink="false">primedfranklyspeaking.podbean.com/ec4926b9-a484-3d2f-9529-5c07a4f8221d</guid>
                                    <description><![CDATA[<p style="margin: 0in; font-family: Calibri; font-size: 11.0pt;">Credits: 0.25 AMA PRA Category 1 Credit™</p>
<p style="margin: 0in; font-family: Calibri; font-size: 11.0pt;"> </p>
<p style="margin: 0in; font-family: Calibri; font-size: 11.0pt;">CME/CE Information and Claim Credit: <a href='https://www.pri-med.com/online-education/podcast/frankly-speaking-cme-424'>https://www.pri-med.com/online-education/podcast/frankly-speaking-cme-424</a></p>
<p style="margin: 0in; font-family: Calibri; font-size: 11.0pt;"> </p>
<p style="margin: 0in; font-family: Calibri; font-size: 11.0pt;">Overview: Urinary tract infections (UTIs) are one of the most common infections seen in primary care. In this episode, we discuss the latest guidelines addressing the diagnosis, treatment, and prevention of UTIs. Tune in to enhance your clinical expertise and provide superior care to your patients with UTIs.</p>
<p style="margin: 0in; font-family: Calibri; font-size: 11.0pt;"> </p>
<p style="margin: 0in; font-family: Calibri; font-size: 11.0pt;">Episode resource links:</p>
<ul>
<li style="font-family:Calibri;font-size:11pt;">Nelson Z, Aslan AT, Beahm NP, et al. Guidelines for the Prevention, Diagnosis, and Management of Urinary Tract Infections in Pediatrics and Adults: A WikiGuidelines Group Consensus Statement. JAMA Netw Open. 2024 Nov 4;7(11):e2444495</li>
</ul>
<p style="margin: 0in; font-family: Calibri; font-size: 11.0pt;"> </p>
<p style="margin: 0in; font-family: Calibri; font-size: 11.0pt;">Guest: Alan M. Ehrlich, MD, FAAFP</p>
<p style="margin: 0in; font-family: Calibri; font-size: 11.0pt;"> </p>
<p style="margin: 0in; font-family: Calibri; font-size: 11.0pt;">Music Credit: Matthew Bugos</p>
<p style="margin: 0in; font-family: Calibri; font-size: 11.0pt;"> </p>
<p style="margin: 0in; font-family: Calibri; font-size: 11.0pt;">Thoughts? Suggestions? Email us at <a href='mailto:FranklySpeaking@pri-med.com'>FranklySpeaking@pri-med.com</a> </p>
]]></description>
                                                            <content:encoded><![CDATA[<p style="margin: 0in; font-family: Calibri; font-size: 11.0pt;">Credits: 0.25 AMA PRA Category 1 Credit™</p>
<p style="margin: 0in; font-family: Calibri; font-size: 11.0pt;"> </p>
<p style="margin: 0in; font-family: Calibri; font-size: 11.0pt;">CME/CE Information and Claim Credit: <a href='https://www.pri-med.com/online-education/podcast/frankly-speaking-cme-424'>https://www.pri-med.com/online-education/podcast/frankly-speaking-cme-424</a></p>
<p style="margin: 0in; font-family: Calibri; font-size: 11.0pt;"> </p>
<p style="margin: 0in; font-family: Calibri; font-size: 11.0pt;">Overview: Urinary tract infections (UTIs) are one of the most common infections seen in primary care. In this episode, we discuss the latest guidelines addressing the diagnosis, treatment, and prevention of UTIs. Tune in to enhance your clinical expertise and provide superior care to your patients with UTIs.</p>
<p style="margin: 0in; font-family: Calibri; font-size: 11.0pt;"> </p>
<p style="margin: 0in; font-family: Calibri; font-size: 11.0pt;">Episode resource links:</p>
<ul>
<li style="font-family:Calibri;font-size:11pt;">Nelson Z, Aslan AT, Beahm NP, et al. Guidelines for the Prevention, Diagnosis, and Management of Urinary Tract Infections in Pediatrics and Adults: A WikiGuidelines Group Consensus Statement. JAMA Netw Open. 2024 Nov 4;7(11):e2444495</li>
</ul>
<p style="margin: 0in; font-family: Calibri; font-size: 11.0pt;"> </p>
<p style="margin: 0in; font-family: Calibri; font-size: 11.0pt;">Guest: Alan M. Ehrlich, MD, FAAFP</p>
<p style="margin: 0in; font-family: Calibri; font-size: 11.0pt;"> </p>
<p style="margin: 0in; font-family: Calibri; font-size: 11.0pt;">Music Credit: Matthew Bugos</p>
<p style="margin: 0in; font-family: Calibri; font-size: 11.0pt;"> </p>
<p style="margin: 0in; font-family: Calibri; font-size: 11.0pt;">Thoughts? Suggestions? Email us at <a href='mailto:FranklySpeaking@pri-med.com'>FranklySpeaking@pri-med.com</a> </p>
]]></content:encoded>
                                    
        <enclosure url="https://mcdn.podbean.com/mf/web/3hfazxgkmr7h8jzt/frankly-speaking-424-uti-guidelines.mp3" length="14722953" type="audio/mpeg"/>
                <itunes:summary><![CDATA[Credits: 0.25 AMA PRA Category 1 Credit™
 
CME/CE Information and Claim Credit: https://www.pri-med.com/online-education/podcast/frankly-speaking-cme-424
 
Overview: Urinary tract infections (UTIs) are one of the most common infections seen in primary care. In this episode, we discuss the latest guidelines addressing the diagnosis, treatment, and prevention of UTIs. Tune in to enhance your clinical expertise and provide superior care to your patients with UTIs.
 
Episode resource links:

Nelson Z, Aslan AT, Beahm NP, et al. Guidelines for the Prevention, Diagnosis, and Management of Urinary Tract Infections in Pediatrics and Adults: A WikiGuidelines Group Consensus Statement. JAMA Netw Open. 2024 Nov 4;7(11):e2444495

 
Guest: Alan M. Ehrlich, MD, FAAFP
 
Music Credit: Matthew Bugos
 
Thoughts? Suggestions? Email us at FranklySpeaking@pri-med.com ]]></itunes:summary>
        <itunes:author>Pri-Med</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>918</itunes:duration>
                        <itunes:episodeType>full</itunes:episodeType>
            </item>
    <item>
        <title>Toddlers and Screen Time—How Much Is Too Much? - Frankly Speaking Ep 423</title>
        <itunes:title>Toddlers and Screen Time—How Much Is Too Much? - Frankly Speaking Ep 423</itunes:title>
        <link>https://primedfranklyspeaking.podbean.com/e/toddlers-and-screen-time%e2%80%94how-much-is-too-much-frankly-speaking-ep-423/</link>
                    <comments>https://primedfranklyspeaking.podbean.com/e/toddlers-and-screen-time%e2%80%94how-much-is-too-much-frankly-speaking-ep-423/#comments</comments>        <pubDate>Mon, 10 Mar 2025 05:30:00 +0000</pubDate>
        <guid isPermaLink="false">primedfranklyspeaking.podbean.com/856e28f5-8039-3991-a271-f6f47520d55d</guid>
                                    <description><![CDATA[<p>Credits: 0.25 AMA PRA Category 1 Credit™
 
CME/CE Information and Claim Credit: <a href='https://www.pri-med.com/online-education/podcast/frankly-speaking-cme-423'>https://www.pri-med.com/online-education/podcast/frankly-speaking-cme-423</a></p>
<p>Overview: The use of electronic devices has increased across all ages, cultures, and socio-economic levels. Usage was also affected by the COVID-19 pandemic. There is a growing body of evidence that screen time can impact cognition and executive function in developing minds, and both the American Academy of Pediatrics (AAP) and the WHO have recommendations on screen time exposure for children. Join us as we discuss recent evidence looking at the impact of screentime on toddlers’ cognition and executive function over time. </p>
<p>Episode resource links:</p>
<ul>
<li>
<p>Fitzpatrick, C., Florit, E., Lemieux, A., Garon-Carrier, G, Mason, L. Associations between preschooler screentime trajectories and executive function. Academic Pediatrics, Volume 0, Issue 0, 102603.</p>
</li>
<li>
<p>Schmidt-Persson J, Rasmussen MGB, Sørensen SO, et al. Screen Media Use and Mental Health of Children and Adolescents: A Secondary Analysis of a Randomized Clinical Trial. JAMA Netw Open. 2024;7(7):e2419881. doi:10.1001/jamanetworkopen.2024.19881</p>
</li>
<li>
<p><a href='https://www.aap.org/en/patient-care/media-and-children/center-of-excellence-on-social-media-and-youth-mental-health/qa-portal/qa-portal-library/qa-portal-library-questions/screen-time-guidelines/?srsltid=AfmBOoqS66UNQsxbVk_juYJz-vJbyt7l7Ebi-WMiCXB5OTCMT2ygsGBD'>AAP Screen Time Guidelines</a></p>
</li>
<li>
<p>Schmidt-Persson J, Rasmussen MGB, Sørensen SO, et al. Screen Media Use and Mental Health of Children and Adolescents: A Secondary Analysis of a Randomized Clinical Trial. JAMA Netw Open. 2024;7(7):e2419881. doi:10.1001/jamanetworkopen.2024.19881</p>
</li>
<li>
<p>Raj D, Ahmad N, Mohd Zulkefli NA, Lim PY. Stop and Play Digital Health Education Intervention for Reducing Excessive Screen Time Among Preschoolers From Low Socioeconomic Families: Cluster Randomized Controlled Trial. J Med Internet Res. 2023;25:e40955. Published 2023 May 4. doi:10.2196/40955</p>
</li>
</ul>
<p>Guest: Susan Feeney, DNP, FNP-BC, NP-C</p>
<p>Music Credit: Matthew Bugos</p>
<p>Thoughts? Suggestions? Email us at <a href='mailto:FranklySpeaking@pri-med.com'>FranklySpeaking@pri-med.com </a></p>
<p> </p>
]]></description>
                                                            <content:encoded><![CDATA[<p>Credits: 0.25 AMA PRA Category 1 Credit™<br>
 <br>
CME/CE Information and Claim Credit: <a href='https://www.pri-med.com/online-education/podcast/frankly-speaking-cme-423'>https://www.pri-med.com/online-education/podcast/frankly-speaking-cme-423</a></p>
<p>Overview: The use of electronic devices has increased across all ages, cultures, and socio-economic levels. Usage was also affected by the COVID-19 pandemic. There is a growing body of evidence that screen time can impact cognition and executive function in developing minds, and both the American Academy of Pediatrics (AAP) and the WHO have recommendations on screen time exposure for children. Join us as we discuss recent evidence looking at the impact of screentime on toddlers’ cognition and executive function over time. </p>
<p>Episode resource links:</p>
<ul>
<li>
<p>Fitzpatrick, C., Florit, E., Lemieux, A., Garon-Carrier, G, Mason, L. Associations between preschooler screentime trajectories and executive function. Academic Pediatrics, Volume 0, Issue 0, 102603.</p>
</li>
<li>
<p>Schmidt-Persson J, Rasmussen MGB, Sørensen SO, et al. Screen Media Use and Mental Health of Children and Adolescents: A Secondary Analysis of a Randomized Clinical Trial. JAMA Netw Open. 2024;7(7):e2419881. doi:10.1001/jamanetworkopen.2024.19881</p>
</li>
<li>
<p><a href='https://www.aap.org/en/patient-care/media-and-children/center-of-excellence-on-social-media-and-youth-mental-health/qa-portal/qa-portal-library/qa-portal-library-questions/screen-time-guidelines/?srsltid=AfmBOoqS66UNQsxbVk_juYJz-vJbyt7l7Ebi-WMiCXB5OTCMT2ygsGBD'>AAP Screen Time Guidelines</a></p>
</li>
<li>
<p>Schmidt-Persson J, Rasmussen MGB, Sørensen SO, et al. Screen Media Use and Mental Health of Children and Adolescents: A Secondary Analysis of a Randomized Clinical Trial. JAMA Netw Open. 2024;7(7):e2419881. doi:10.1001/jamanetworkopen.2024.19881</p>
</li>
<li>
<p>Raj D, Ahmad N, Mohd Zulkefli NA, Lim PY. Stop and Play Digital Health Education Intervention for Reducing Excessive Screen Time Among Preschoolers From Low Socioeconomic Families: Cluster Randomized Controlled Trial. J Med Internet Res. 2023;25:e40955. Published 2023 May 4. doi:10.2196/40955</p>
</li>
</ul>
<p>Guest: Susan Feeney, DNP, FNP-BC, NP-C</p>
<p>Music Credit: Matthew Bugos</p>
<p>Thoughts? Suggestions? Email us at <a href='mailto:FranklySpeaking@pri-med.com'>FranklySpeaking@pri-med.com </a></p>
<p> </p>
]]></content:encoded>
                                    
        <enclosure url="https://mcdn.podbean.com/mf/web/qds7fnsuwb6qq7qw/frankly-speaking-423-screen-time.mp3" length="14244213" type="audio/mpeg"/>
                <itunes:summary><![CDATA[Credits: 0.25 AMA PRA Category 1 Credit™ CME/CE Information and Claim Credit: https://www.pri-med.com/online-education/podcast/frankly-speaking-cme-423
Overview: The use of electronic devices has increased across all ages, cultures, and socio-economic levels. Usage was also affected by the COVID-19 pandemic. There is a growing body of evidence that screen time can impact cognition and executive function in developing minds, and both the American Academy of Pediatrics (AAP) and the WHO have recommendations on screen time exposure for children. Join us as we discuss recent evidence looking at the impact of screentime on toddlers’ cognition and executive function over time. 
Episode resource links:


Fitzpatrick, C., Florit, E., Lemieux, A., Garon-Carrier, G, Mason, L. Associations between preschooler screentime trajectories and executive function. Academic Pediatrics, Volume 0, Issue 0, 102603.


Schmidt-Persson J, Rasmussen MGB, Sørensen SO, et al. Screen Media Use and Mental Health of Children and Adolescents: A Secondary Analysis of a Randomized Clinical Trial. JAMA Netw Open. 2024;7(7):e2419881. doi:10.1001/jamanetworkopen.2024.19881


AAP Screen Time Guidelines


Schmidt-Persson J, Rasmussen MGB, Sørensen SO, et al. Screen Media Use and Mental Health of Children and Adolescents: A Secondary Analysis of a Randomized Clinical Trial. JAMA Netw Open. 2024;7(7):e2419881. doi:10.1001/jamanetworkopen.2024.19881


Raj D, Ahmad N, Mohd Zulkefli NA, Lim PY. Stop and Play Digital Health Education Intervention for Reducing Excessive Screen Time Among Preschoolers From Low Socioeconomic Families: Cluster Randomized Controlled Trial. J Med Internet Res. 2023;25:e40955. Published 2023 May 4. doi:10.2196/40955


Guest: Susan Feeney, DNP, FNP-BC, NP-C
Music Credit: Matthew Bugos
Thoughts? Suggestions? Email us at FranklySpeaking@pri-med.com 
 ]]></itunes:summary>
        <itunes:author>Pri-Med</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>888</itunes:duration>
                        <itunes:episodeType>full</itunes:episodeType>
            </item>
    <item>
        <title>The Wine Debate: Cardiovascular Benefits Vs Cancer Risks - Frankly Speaking Ep 422</title>
        <itunes:title>The Wine Debate: Cardiovascular Benefits Vs Cancer Risks - Frankly Speaking Ep 422</itunes:title>
        <link>https://primedfranklyspeaking.podbean.com/e/the-wine-debate-cardiovascular-benefits-vs-cancer-risks-frankly-speaking-ep-422/</link>
                    <comments>https://primedfranklyspeaking.podbean.com/e/the-wine-debate-cardiovascular-benefits-vs-cancer-risks-frankly-speaking-ep-422/#comments</comments>        <pubDate>Mon, 03 Mar 2025 00:30:00 +0000</pubDate>
        <guid isPermaLink="false">primedfranklyspeaking.podbean.com/53fe7a6a-2278-3a9e-9c26-7cdf70d58fd8</guid>
                                    <description><![CDATA[<p>Credits: 0.25 AMA PRA Category 1 Credit™
 
CME/CE Information and Claim Credit: <a href='https://www.pri-med.com/online-education/podcast/frankly-speaking-cme-422'>https://www.pri-med.com/online-education/podcast/frankly-speaking-cme-422</a></p>
<p>Overview: Conflicting data on alcohol’s health effects leave clinicians uncertain about patient guidance. In this episode, we review the PREDIMED trial’s findings on wine and cardiovascular outcomes, explore objective biomarkers for intake, and examine the National Academy of Sciences’ recent report to clarify the risks and benefits of moderate consumption, giving you confidence in counseling patients.</p>
<p>Episode resource links:</p>
<ul>
<li>
<p>Inés Domínguez-López, Rosa M Lamuela-Raventós, Cristina Razquin, et al. Urinary tartaric acid as a biomarker of wine consumption and cardiovascular risk: the PREDIMED trial, European Heart Journal, 2024;, ehae804, <a href='https://doi.org/10.1093/eurheartj/ehae804'>https://doi.org/10.1093/eurheartj/ehae804</a></p>
<p> </p>
<p> </p>
</li>
<li>
<p>National Academies of Sciences, Engineering, and Medicine. 2025. Review of Evidence on Alcohol and Health. Washington, DC: The National Academies Press. <a href='https://doi.org/10.17226/28582'>https://doi.org/10.17226/28582</a></p>
<p> </p>
</li>
</ul>
<p>Guest: Robert A. Baldor MD, FAAFP</p>
<p>Music Credit: Matthew Bugos</p>
<p>Thoughts? Suggestions? Email us at <a href='mailto:FranklySpeaking@pri-med.com'>FranklySpeaking@pri-med.com</a></p>
<p> </p>
]]></description>
                                                            <content:encoded><![CDATA[<p>Credits: 0.25 AMA PRA Category 1 Credit™<br>
 <br>
CME/CE Information and Claim Credit: <a href='https://www.pri-med.com/online-education/podcast/frankly-speaking-cme-422'>https://www.pri-med.com/online-education/podcast/frankly-speaking-cme-422</a></p>
<p>Overview: Conflicting data on alcohol’s health effects leave clinicians uncertain about patient guidance. In this episode, we review the PREDIMED trial’s findings on wine and cardiovascular outcomes, explore objective biomarkers for intake, and examine the National Academy of Sciences’ recent report to clarify the risks and benefits of moderate consumption, giving you confidence in counseling patients.</p>
<p>Episode resource links:</p>
<ul>
<li>
<p>Inés Domínguez-López, Rosa M Lamuela-Raventós, Cristina Razquin, et al. Urinary tartaric acid as a biomarker of wine consumption and cardiovascular risk: the PREDIMED trial, European Heart Journal, 2024;, ehae804, <a href='https://doi.org/10.1093/eurheartj/ehae804'>https://doi.org/10.1093/eurheartj/ehae804</a></p>
<p> </p>
<p> </p>
</li>
<li>
<p>National Academies of Sciences, Engineering, and Medicine. 2025. Review of Evidence on Alcohol and Health. Washington, DC: The National Academies Press. <a href='https://doi.org/10.17226/28582'>https://doi.org/10.17226/28582</a></p>
<p> </p>
</li>
</ul>
<p>Guest: Robert A. Baldor MD, FAAFP</p>
<p>Music Credit: Matthew Bugos</p>
<p>Thoughts? Suggestions? Email us at <a href='mailto:FranklySpeaking@pri-med.com'>FranklySpeaking@pri-med.com</a></p>
<p> </p>
]]></content:encoded>
                                    
        <enclosure url="https://mcdn.podbean.com/mf/web/hmsz9mtfjg4znu3x/frankly-speaking-422-wine-for-health.mp3" length="8748445" type="audio/mpeg"/>
                <itunes:summary><![CDATA[Credits: 0.25 AMA PRA Category 1 Credit™ CME/CE Information and Claim Credit: https://www.pri-med.com/online-education/podcast/frankly-speaking-cme-422
Overview: Conflicting data on alcohol’s health effects leave clinicians uncertain about patient guidance. In this episode, we review the PREDIMED trial’s findings on wine and cardiovascular outcomes, explore objective biomarkers for intake, and examine the National Academy of Sciences’ recent report to clarify the risks and benefits of moderate consumption, giving you confidence in counseling patients.
Episode resource links:


Inés Domínguez-López, Rosa M Lamuela-Raventós, Cristina Razquin, et al. Urinary tartaric acid as a biomarker of wine consumption and cardiovascular risk: the PREDIMED trial, European Heart Journal, 2024;, ehae804, https://doi.org/10.1093/eurheartj/ehae804
 
 


National Academies of Sciences, Engineering, and Medicine. 2025. Review of Evidence on Alcohol and Health. Washington, DC: The National Academies Press. https://doi.org/10.17226/28582
 


Guest: Robert A. Baldor MD, FAAFP
Music Credit: Matthew Bugos
Thoughts? Suggestions? Email us at FranklySpeaking@pri-med.com
 ]]></itunes:summary>
        <itunes:author>Pri-Med</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>545</itunes:duration>
                        <itunes:episodeType>full</itunes:episodeType>
            </item>
    <item>
        <title>The Nurse Practitioner Will See You Now - Frankly Speaking Ep 421</title>
        <itunes:title>The Nurse Practitioner Will See You Now - Frankly Speaking Ep 421</itunes:title>
        <link>https://primedfranklyspeaking.podbean.com/e/the-nurse-practitioner-will-see-you-now-frankly-speaking-ep-421/</link>
                    <comments>https://primedfranklyspeaking.podbean.com/e/the-nurse-practitioner-will-see-you-now-frankly-speaking-ep-421/#comments</comments>        <pubDate>Mon, 24 Feb 2025 05:30:00 +0000</pubDate>
        <guid isPermaLink="false">primedfranklyspeaking.podbean.com/b7e7d880-2d26-3bb9-b922-54494ea3be45</guid>
                                    <description><![CDATA[<p>Credits: 0.25 AMA PRA Category 1 Credit™
 
CME/CE Information and Claim Credit: <a href='https://www.pri-med.com/online-education/podcast/frankly-speaking-cme-421'>https://www.pri-med.com/online-education/podcast/frankly-speaking-cme-421</a></p>
<p>Overview: Join us as we discuss a recent meta-analysis examining randomized controlled trials to investigate healthcare costs, quality of care, and patient well-being when delivered by advanced nurse practitioners (ANPs). Explore the evidence behind ANPs’ effectiveness and their potential to enhance patient outcomes while optimizing healthcare resources.</p>
<p>Episode resource links:</p>
<ul>
<li>
<p>Melati Fajarini, Agus Setiawan, Chien-Mei Sung, Ruey Chen, Doresses Liu, Chiu-Kuei Lee, Shu-Fen Niu, Kuei-Ru Chou, Effects of advanced practice nurses on health-care costs, quality of care, and patient well-being: A meta-analysis of randomized controlled trials, International Journal of Nursing Studies, Volume 162, 2025,104953, ISSN 0020-7489, <a href='https://doi.org/10.1016/j.ijnurstu.2024.104953'>https://doi.org/10.1016/j.ijnurstu.2024.104953</a></p>
</li>
<li>
<p><a href='https://www.bloomberg.com/news/features/2024-07-24/is-the-nurse-practitioner-job-boom-putting-us-health-care-at-risk?utm_source=website&amp;utm_medium=share&amp;utm_campaign=copy'>The miseducation of America’s nurse practitioners, July 24, 2024</a> </p>
<p> </p>
<p> </p>
</li>
<li>
<p>Perloff, J., Clarke, S., DesRoches, C. M., O'Reilly-Jacob, M., &amp; Buerhaus, P. (2019). Association of State-Level Restrictions in Nurse Practitioner Scope of Practice With the Quality of Primary Care Provided to Medicare Beneficiaries. Medical care research and review : MCRR, 76(5), 597–626. <a href='https://doi.org/10.1177/1077558717732402'>https://doi.org/10.1177/1077558717732402</a></p>
<p> </p>
</li>
<li>
<p>Yang, B. K., Johantgen, M. E., Trinkoff, A. M., Idzik, S. R., Wince, J., &amp; Tomlinson, C. (2021). State Nurse Practitioner Practice Regulations and U.S. Health Care Delivery Outcomes: A Systematic Review. Medical care research and review : MCRR, 78(3), 183–196. <a href='https://doi.org/10.1177/1077558719901216'>https://doi.org/10.1177/1077558719901216</a></p>
<p> </p>
</li>
<li>
<p>Taylor K (2023) Bridging the Gap to Health Care Access: The Role of the Nurse Practitioner. Int Arch Public Health Community Med 7:091. doi.org/10.23937/2643-4512/1710091</p>
</li>
</ul>
<p>Guest: Susan Feeney, DNP, FNP-BC, NP-C, Jill M. Terrien PhD, ANP-BC </p>
<p>Music Credit: Matthew Bugos</p>
<p>Thoughts? Suggestions? Email us at <a href='mailto:FranklySpeaking@pri-med.com'>FranklySpeaking@pri-med.com</a></p>
<p> </p>
]]></description>
                                                            <content:encoded><![CDATA[<p>Credits: 0.25 AMA PRA Category 1 Credit™<br>
 <br>
CME/CE Information and Claim Credit: <a href='https://www.pri-med.com/online-education/podcast/frankly-speaking-cme-421'>https://www.pri-med.com/online-education/podcast/frankly-speaking-cme-421</a></p>
<p>Overview: Join us as we discuss a recent meta-analysis examining randomized controlled trials to investigate healthcare costs, quality of care, and patient well-being when delivered by advanced nurse practitioners (ANPs). Explore the evidence behind ANPs’ effectiveness and their potential to enhance patient outcomes while optimizing healthcare resources.</p>
<p>Episode resource links:</p>
<ul>
<li>
<p>Melati Fajarini, Agus Setiawan, Chien-Mei Sung, Ruey Chen, Doresses Liu, Chiu-Kuei Lee, Shu-Fen Niu, Kuei-Ru Chou, Effects of advanced practice nurses on health-care costs, quality of care, and patient well-being: A meta-analysis of randomized controlled trials, International Journal of Nursing Studies, Volume 162, 2025,104953, ISSN 0020-7489, <a href='https://doi.org/10.1016/j.ijnurstu.2024.104953'>https://doi.org/10.1016/j.ijnurstu.2024.104953</a></p>
</li>
<li>
<p><a href='https://www.bloomberg.com/news/features/2024-07-24/is-the-nurse-practitioner-job-boom-putting-us-health-care-at-risk?utm_source=website&amp;utm_medium=share&amp;utm_campaign=copy'>The miseducation of America’s nurse practitioners, July 24, 2024</a> </p>
<p> </p>
<p> </p>
</li>
<li>
<p>Perloff, J., Clarke, S., DesRoches, C. M., O'Reilly-Jacob, M., &amp; Buerhaus, P. (2019). Association of State-Level Restrictions in Nurse Practitioner Scope of Practice With the Quality of Primary Care Provided to Medicare Beneficiaries. Medical care research and review : MCRR, 76(5), 597–626. <a href='https://doi.org/10.1177/1077558717732402'>https://doi.org/10.1177/1077558717732402</a></p>
<p> </p>
</li>
<li>
<p>Yang, B. K., Johantgen, M. E., Trinkoff, A. M., Idzik, S. R., Wince, J., &amp; Tomlinson, C. (2021). State Nurse Practitioner Practice Regulations and U.S. Health Care Delivery Outcomes: A Systematic Review. Medical care research and review : MCRR, 78(3), 183–196. <a href='https://doi.org/10.1177/1077558719901216'>https://doi.org/10.1177/1077558719901216</a></p>
<p> </p>
</li>
<li>
<p>Taylor K (2023) Bridging the Gap to Health Care Access: The Role of the Nurse Practitioner. Int Arch Public Health Community Med 7:091. doi.org/10.23937/2643-4512/1710091</p>
</li>
</ul>
<p>Guest: Susan Feeney, DNP, FNP-BC, NP-C, Jill M. Terrien PhD, ANP-BC </p>
<p>Music Credit: Matthew Bugos</p>
<p>Thoughts? Suggestions? Email us at <a href='mailto:FranklySpeaking@pri-med.com'>FranklySpeaking@pri-med.com</a></p>
<p> </p>
]]></content:encoded>
                                    
        <enclosure url="https://mcdn.podbean.com/mf/web/ihktvz2drpa6842n/frankly-speaking-421-importance-of-apn.mp3" length="18353800" type="audio/mpeg"/>
                <itunes:summary><![CDATA[Credits: 0.25 AMA PRA Category 1 Credit™ CME/CE Information and Claim Credit: https://www.pri-med.com/online-education/podcast/frankly-speaking-cme-421
Overview: Join us as we discuss a recent meta-analysis examining randomized controlled trials to investigate healthcare costs, quality of care, and patient well-being when delivered by advanced nurse practitioners (ANPs). Explore the evidence behind ANPs’ effectiveness and their potential to enhance patient outcomes while optimizing healthcare resources.
Episode resource links:


Melati Fajarini, Agus Setiawan, Chien-Mei Sung, Ruey Chen, Doresses Liu, Chiu-Kuei Lee, Shu-Fen Niu, Kuei-Ru Chou, Effects of advanced practice nurses on health-care costs, quality of care, and patient well-being: A meta-analysis of randomized controlled trials, International Journal of Nursing Studies, Volume 162, 2025,104953, ISSN 0020-7489, https://doi.org/10.1016/j.ijnurstu.2024.104953


The miseducation of America’s nurse practitioners, July 24, 2024 
 
 


Perloff, J., Clarke, S., DesRoches, C. M., O'Reilly-Jacob, M., &amp; Buerhaus, P. (2019). Association of State-Level Restrictions in Nurse Practitioner Scope of Practice With the Quality of Primary Care Provided to Medicare Beneficiaries. Medical care research and review : MCRR, 76(5), 597–626. https://doi.org/10.1177/1077558717732402
 


Yang, B. K., Johantgen, M. E., Trinkoff, A. M., Idzik, S. R., Wince, J., &amp; Tomlinson, C. (2021). State Nurse Practitioner Practice Regulations and U.S. Health Care Delivery Outcomes: A Systematic Review. Medical care research and review : MCRR, 78(3), 183–196. https://doi.org/10.1177/1077558719901216
 


Taylor K (2023) Bridging the Gap to Health Care Access: The Role of the Nurse Practitioner. Int Arch Public Health Community Med 7:091. doi.org/10.23937/2643-4512/1710091


Guest: Susan Feeney, DNP, FNP-BC, NP-C, Jill M. Terrien PhD, ANP-BC 
Music Credit: Matthew Bugos
Thoughts? Suggestions? Email us at FranklySpeaking@pri-med.com
 ]]></itunes:summary>
        <itunes:author>Pri-Med</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>1145</itunes:duration>
                        <itunes:episodeType>full</itunes:episodeType>
            </item>
    <item>
        <title>“I Guess I Won’t Have Another”—Alcohol and Cancer Risk - Frankly Speaking Ep 420</title>
        <itunes:title>“I Guess I Won’t Have Another”—Alcohol and Cancer Risk - Frankly Speaking Ep 420</itunes:title>
        <link>https://primedfranklyspeaking.podbean.com/e/i-guess-i-won-t-have-another-%e2%80%94alcohol-and-cancer-risk-frankly-speaking-ep-420/</link>
                    <comments>https://primedfranklyspeaking.podbean.com/e/i-guess-i-won-t-have-another-%e2%80%94alcohol-and-cancer-risk-frankly-speaking-ep-420/#comments</comments>        <pubDate>Mon, 17 Feb 2025 05:30:00 +0000</pubDate>
        <guid isPermaLink="false">primedfranklyspeaking.podbean.com/3cb59add-b5d9-3068-b755-34f9f83924f5</guid>
                                    <description><![CDATA[<p>Credits: 0.25 AMA PRA Category 1 Credit™
 
CME/CE Information and Claim Credit: <a href='https://www.pri-med.com/online-education/podcast/frankly-speaking-cme-420'>https://www.pri-med.com/online-education/podcast/frankly-speaking-cme-420</a></p>
<p>Overview: Listen in as we discuss the US Surgeon General’s new advisory on the impact of alcohol on cancer incidence and mortality. We review the latest data, explore alcohol’s role in carcinogenesis, and provide evidence-based guidance to help you counsel patients on safer consumption and cancer prevention.</p>
<p>Episode resource links:</p>
<ul>
<li><a href='https://www.hhs.gov/about/news/2025/01/03/us-surgeon-general-issues-new-advisory-link-alcohol-cancer-risk.html'>U.S. Surgeon General Issues New Advisory on Link Between Alcohol and Cancer Risk | HHS.gov</a></li>
</ul>
<p>Guest: Jillian Joseph, MPAS, PA-C</p>
<p>Music Credit: Matthew Bugos</p>
<p>Thoughts? Suggestions? Email us at <a href='mailto:FranklySpeaking@pri-med.com'>FranklySpeaking@pri-med.com </a></p>
<p> </p>
]]></description>
                                                            <content:encoded><![CDATA[<p>Credits: 0.25 AMA PRA Category 1 Credit™<br>
 <br>
CME/CE Information and Claim Credit: <a href='https://www.pri-med.com/online-education/podcast/frankly-speaking-cme-420'>https://www.pri-med.com/online-education/podcast/frankly-speaking-cme-420</a></p>
<p>Overview: Listen in as we discuss the US Surgeon General’s new advisory on the impact of alcohol on cancer incidence and mortality. We review the latest data, explore alcohol’s role in carcinogenesis, and provide evidence-based guidance to help you counsel patients on safer consumption and cancer prevention.</p>
<p>Episode resource links:</p>
<ul>
<li><a href='https://www.hhs.gov/about/news/2025/01/03/us-surgeon-general-issues-new-advisory-link-alcohol-cancer-risk.html'>U.S. Surgeon General Issues New Advisory on Link Between Alcohol and Cancer Risk | HHS.gov</a></li>
</ul>
<p>Guest: Jillian Joseph, MPAS, PA-C</p>
<p>Music Credit: Matthew Bugos</p>
<p>Thoughts? Suggestions? Email us at <a href='mailto:FranklySpeaking@pri-med.com'>FranklySpeaking@pri-med.com </a></p>
<p> </p>
]]></content:encoded>
                                    
        <enclosure url="https://mcdn.podbean.com/mf/web/88vph9ub9d6h6kxb/frankly-speaking-420-alcohol-and-cancer.mp3" length="13027244" type="audio/mpeg"/>
                <itunes:summary><![CDATA[Credits: 0.25 AMA PRA Category 1 Credit™ CME/CE Information and Claim Credit: https://www.pri-med.com/online-education/podcast/frankly-speaking-cme-420
Overview: Listen in as we discuss the US Surgeon General’s new advisory on the impact of alcohol on cancer incidence and mortality. We review the latest data, explore alcohol’s role in carcinogenesis, and provide evidence-based guidance to help you counsel patients on safer consumption and cancer prevention.
Episode resource links:

U.S. Surgeon General Issues New Advisory on Link Between Alcohol and Cancer Risk | HHS.gov

Guest: Jillian Joseph, MPAS, PA-C
Music Credit: Matthew Bugos
Thoughts? Suggestions? Email us at FranklySpeaking@pri-med.com 
 ]]></itunes:summary>
        <itunes:author>Pri-Med</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>812</itunes:duration>
                        <itunes:episodeType>full</itunes:episodeType>
            </item>
    <item>
        <title>Fluoride in Drinking Water: Why Is There Controversy? - Frankly Speaking Ep 419</title>
        <itunes:title>Fluoride in Drinking Water: Why Is There Controversy? - Frankly Speaking Ep 419</itunes:title>
        <link>https://primedfranklyspeaking.podbean.com/e/fluoride-in-drinking-water-why-is-there-controversy-frankly-speaking-ep-419/</link>
                    <comments>https://primedfranklyspeaking.podbean.com/e/fluoride-in-drinking-water-why-is-there-controversy-frankly-speaking-ep-419/#comments</comments>        <pubDate>Mon, 10 Feb 2025 05:30:00 +0000</pubDate>
        <guid isPermaLink="false">primedfranklyspeaking.podbean.com/c1fd41b1-1f40-3c8d-875b-48265ba290e8</guid>
                                    <description><![CDATA[<p>Credits: 0.25 AMA PRA Category 1 Credit™
 
CME/CE Information and Claim Credit: <a href='https://www.pri-med.com/online-education/podcast/frankly-speaking-cme-419'>https://www.pri-med.com/online-education/podcast/frankly-speaking-cme-419</a></p>
<p>Overview: Water fluoridation has been an area of periodic controversy since it was first introduced in the 1950s. This episode dives into recent reports on the benefits and potential impacts of water fluoridation on children’s IQ. Gain valuable insights and feel prepared when addressing patient questions about this topic.</p>
<p>Episode resource links:</p>
<ul>
<li>Taylor KW, Eftim SE, Sibrizzi CA, et al. Fluoride Exposure and Children’s IQ Scores: A Systematic Review and Meta-Analysis. JAMA Pediatr. Published online January 06, 2025. </li>
<li>Iheozor-Ejiofor Z, Walsh T, Lewis SR, Riley P, Boyers D, Clarkson JE, Worthington HV, Glenny AM, O'Malley L. Water fluoridation for the prevention of dental caries. Cochrane Database Syst Rev. 2024 Oct 4;10(10):CD010856. </li>
<li>Schluter PJ, Hobbs M, Atkins H, Mattingley B, Lee M. Association Between Community Water Fluoridation and Severe Dental Caries Experience in 4-Year-Old New Zealand Children. JAMA Pediatr. 2020 Oct 1;174(10):969-976</li>
</ul>
<p>Guest: Alan M. Ehrlich, MD, FAAFP
 
Music Credit: Matthew Bugos</p>
<p>Thoughts? Suggestions? Email us at <a href='mailto:FranklySpeaking@pri-med.com'>FranklySpeaking@pri-med.com </a></p>
<p> </p>
]]></description>
                                                            <content:encoded><![CDATA[<p>Credits: 0.25 AMA PRA Category 1 Credit™<br>
 <br>
CME/CE Information and Claim Credit: <a href='https://www.pri-med.com/online-education/podcast/frankly-speaking-cme-419'>https://www.pri-med.com/online-education/podcast/frankly-speaking-cme-419</a></p>
<p>Overview: Water fluoridation has been an area of periodic controversy since it was first introduced in the 1950s. This episode dives into recent reports on the benefits and potential impacts of water fluoridation on children’s IQ. Gain valuable insights and feel prepared when addressing patient questions about this topic.</p>
<p>Episode resource links:</p>
<ul>
<li>Taylor KW, Eftim SE, Sibrizzi CA, et al. Fluoride Exposure and Children’s IQ Scores: A Systematic Review and Meta-Analysis. JAMA Pediatr. Published online January 06, 2025. </li>
<li>Iheozor-Ejiofor Z, Walsh T, Lewis SR, Riley P, Boyers D, Clarkson JE, Worthington HV, Glenny AM, O'Malley L. Water fluoridation for the prevention of dental caries. Cochrane Database Syst Rev. 2024 Oct 4;10(10):CD010856. </li>
<li>Schluter PJ, Hobbs M, Atkins H, Mattingley B, Lee M. Association Between Community Water Fluoridation and Severe Dental Caries Experience in 4-Year-Old New Zealand Children. JAMA Pediatr. 2020 Oct 1;174(10):969-976</li>
</ul>
<p>Guest: Alan M. Ehrlich, MD, FAAFP<br>
 <br>
Music Credit: Matthew Bugos</p>
<p>Thoughts? Suggestions? Email us at <a href='mailto:FranklySpeaking@pri-med.com'>FranklySpeaking@pri-med.com </a></p>
<p> </p>
]]></content:encoded>
                                    
        <enclosure url="https://mcdn.podbean.com/mf/web/qbymb2hrks7nmfzj/frankly-speaking-419-flouridated-water.mp3" length="11879860" type="audio/mpeg"/>
                <itunes:summary><![CDATA[Credits: 0.25 AMA PRA Category 1 Credit™ CME/CE Information and Claim Credit: https://www.pri-med.com/online-education/podcast/frankly-speaking-cme-419
Overview: Water fluoridation has been an area of periodic controversy since it was first introduced in the 1950s. This episode dives into recent reports on the benefits and potential impacts of water fluoridation on children’s IQ. Gain valuable insights and feel prepared when addressing patient questions about this topic.
Episode resource links:

Taylor KW, Eftim SE, Sibrizzi CA, et al. Fluoride Exposure and Children’s IQ Scores: A Systematic Review and Meta-Analysis. JAMA Pediatr. Published online January 06, 2025. 
Iheozor-Ejiofor Z, Walsh T, Lewis SR, Riley P, Boyers D, Clarkson JE, Worthington HV, Glenny AM, O'Malley L. Water fluoridation for the prevention of dental caries. Cochrane Database Syst Rev. 2024 Oct 4;10(10):CD010856. 
Schluter PJ, Hobbs M, Atkins H, Mattingley B, Lee M. Association Between Community Water Fluoridation and Severe Dental Caries Experience in 4-Year-Old New Zealand Children. JAMA Pediatr. 2020 Oct 1;174(10):969-976

Guest: Alan M. Ehrlich, MD, FAAFP Music Credit: Matthew Bugos
Thoughts? Suggestions? Email us at FranklySpeaking@pri-med.com 
 ]]></itunes:summary>
        <itunes:author>Pri-Med</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>740</itunes:duration>
                        <itunes:episodeType>full</itunes:episodeType>
            </item>
    <item>
        <title>My Tummy Hurts—Reasonable Options for Fluid Replacement in Mildly Dehydrated Children  - Frankly Speaking Ep 418</title>
        <itunes:title>My Tummy Hurts—Reasonable Options for Fluid Replacement in Mildly Dehydrated Children  - Frankly Speaking Ep 418</itunes:title>
        <link>https://primedfranklyspeaking.podbean.com/e/my-tummy-hurts%e2%80%94reasonable-options-for-fluid-replacement-in-mildly-dehydrated-children-frankly-speaking-ep-418/</link>
                    <comments>https://primedfranklyspeaking.podbean.com/e/my-tummy-hurts%e2%80%94reasonable-options-for-fluid-replacement-in-mildly-dehydrated-children-frankly-speaking-ep-418/#comments</comments>        <pubDate>Mon, 03 Feb 2025 00:30:00 +0000</pubDate>
        <guid isPermaLink="false">primedfranklyspeaking.podbean.com/5bb6f818-bd15-3d34-9a64-c0f5ff911264</guid>
                                    <description><![CDATA[<p>Credits: 0.25 AMA PRA Category 1 Credit™
 
CME/CE Information and Claim Credit: <a href='https://www.pri-med.com/online-education/podcast/frankly-speaking-cme-418'>https://www.pri-med.com/online-education/podcast/frankly-speaking-cme-418</a></p>
<p>Overview: Acute episodes of nausea, vomiting, and diarrhea due to gastroenteritis in children are common complaints seen in primary and urgent care settings. Join us as we discuss recent evidence suggesting that apple juice can be as effective as commercial electrolyte solutions, offering a cost-effective and convenient option for oral replacement therapy for mild dehydration.</p>
<p>Episode resource links:</p>
<ul>
<li>Freedman SB, Willan AR, Boutis K, Schuh S. Effect of Dilute Apple Juice and Preferred Fluids vs Electrolyte Maintenance Solution on Treatment Failure Among Children With Mild Gastroenteritis: A Randomized Clinical Trial. JAMA. 2016;315(18):1966-1974. doi:10.1001/jama.2016.5352</li>
<li>Goldman RD, Friedman JN, Parkin PC. Validation of the clinical dehydration scale for children with acute gastroenteritis. Pediatrics. 2008;122(3):545-549. doi:10.1542/peds.2007-3141</li>
<li>Jauregui J, Nelson D, Choo E, et al. External validation and comparison of three pediatric clinical dehydration scales. PLoS One. 2014;9(5):e95739. Published 2014 May 2. doi:10.1371/journal.pone.0095739</li>
<li><a href='https://primarycarenotebook.com/pages/haematology/world-health-organization-who-scale-for-dehydration'>https://primarycarenotebook.com/pages/haematology/world-health-organization-who-scale-for-dehydration</a></li>
<li><a href='https://www.healthychildren.org/English/health-issues/injuries-emergencies/Pages/dehydration.aspx?_gl=1*17s87m7*_ga*MTIxMTgzMjM2Mi4xNzMyMzgxMDQ2*_ga_FD9D3XZVQQ*MTczMjM4MTA0Ni4xLjEuMTczMjM4MTE1OS4wLjAuMA..'>AAP: Signs of Dehydration in infant and children</a></li>
<li><a href='https://primarycarenotebook.com/pages/haematology/world-health-organization-who-scale-for-dehydration'>https://primarycarenotebook.com/pages/haematology/world-health-organization-who-scale-for-dehydration</a></li>
</ul>
<p>Guest: Susan Feeney, DNP, FNP-BC, NP-C </p>
<p>Music Credit: Matthew Bugos</p>
<p>Thoughts? Suggestions? Email us at <a href='mailto:FranklySpeaking@pri-med.com'>FranklySpeaking@pri-med.com </a></p>
<p> </p>
]]></description>
                                                            <content:encoded><![CDATA[<p>Credits: 0.25 AMA PRA Category 1 Credit™<br>
 <br>
CME/CE Information and Claim Credit: <a href='https://www.pri-med.com/online-education/podcast/frankly-speaking-cme-418'>https://www.pri-med.com/online-education/podcast/frankly-speaking-cme-418</a></p>
<p>Overview: Acute episodes of nausea, vomiting, and diarrhea due to gastroenteritis in children are common complaints seen in primary and urgent care settings. Join us as we discuss recent evidence suggesting that apple juice can be as effective as commercial electrolyte solutions, offering a cost-effective and convenient option for oral replacement therapy for mild dehydration.</p>
<p>Episode resource links:</p>
<ul>
<li>Freedman SB, Willan AR, Boutis K, Schuh S. Effect of Dilute Apple Juice and Preferred Fluids vs Electrolyte Maintenance Solution on Treatment Failure Among Children With Mild Gastroenteritis: A Randomized Clinical Trial. JAMA. 2016;315(18):1966-1974. doi:10.1001/jama.2016.5352</li>
<li>Goldman RD, Friedman JN, Parkin PC. Validation of the clinical dehydration scale for children with acute gastroenteritis. Pediatrics. 2008;122(3):545-549. doi:10.1542/peds.2007-3141</li>
<li>Jauregui J, Nelson D, Choo E, et al. External validation and comparison of three pediatric clinical dehydration scales. PLoS One. 2014;9(5):e95739. Published 2014 May 2. doi:10.1371/journal.pone.0095739</li>
<li><a href='https://primarycarenotebook.com/pages/haematology/world-health-organization-who-scale-for-dehydration'>https://primarycarenotebook.com/pages/haematology/world-health-organization-who-scale-for-dehydration</a></li>
<li><a href='https://www.healthychildren.org/English/health-issues/injuries-emergencies/Pages/dehydration.aspx?_gl=1*17s87m7*_ga*MTIxMTgzMjM2Mi4xNzMyMzgxMDQ2*_ga_FD9D3XZVQQ*MTczMjM4MTA0Ni4xLjEuMTczMjM4MTE1OS4wLjAuMA..'>AAP: Signs of Dehydration in infant and children</a></li>
<li><a href='https://primarycarenotebook.com/pages/haematology/world-health-organization-who-scale-for-dehydration'>https://primarycarenotebook.com/pages/haematology/world-health-organization-who-scale-for-dehydration</a></li>
</ul>
<p>Guest: Susan Feeney, DNP, FNP-BC, NP-C </p>
<p>Music Credit: Matthew Bugos</p>
<p>Thoughts? Suggestions? Email us at <a href='mailto:FranklySpeaking@pri-med.com'>FranklySpeaking@pri-med.com </a></p>
<p> </p>
]]></content:encoded>
                                    
        <enclosure url="https://mcdn.podbean.com/mf/web/7a3azf2jhurg94d4/frankly-speaking-418-apple-juice.mp3" length="13371484" type="audio/mpeg"/>
                <itunes:summary><![CDATA[Credits: 0.25 AMA PRA Category 1 Credit™ CME/CE Information and Claim Credit: https://www.pri-med.com/online-education/podcast/frankly-speaking-cme-418
Overview: Acute episodes of nausea, vomiting, and diarrhea due to gastroenteritis in children are common complaints seen in primary and urgent care settings. Join us as we discuss recent evidence suggesting that apple juice can be as effective as commercial electrolyte solutions, offering a cost-effective and convenient option for oral replacement therapy for mild dehydration.
Episode resource links:

Freedman SB, Willan AR, Boutis K, Schuh S. Effect of Dilute Apple Juice and Preferred Fluids vs Electrolyte Maintenance Solution on Treatment Failure Among Children With Mild Gastroenteritis: A Randomized Clinical Trial. JAMA. 2016;315(18):1966-1974. doi:10.1001/jama.2016.5352
Goldman RD, Friedman JN, Parkin PC. Validation of the clinical dehydration scale for children with acute gastroenteritis. Pediatrics. 2008;122(3):545-549. doi:10.1542/peds.2007-3141
Jauregui J, Nelson D, Choo E, et al. External validation and comparison of three pediatric clinical dehydration scales. PLoS One. 2014;9(5):e95739. Published 2014 May 2. doi:10.1371/journal.pone.0095739
https://primarycarenotebook.com/pages/haematology/world-health-organization-who-scale-for-dehydration
AAP: Signs of Dehydration in infant and children
https://primarycarenotebook.com/pages/haematology/world-health-organization-who-scale-for-dehydration

Guest: Susan Feeney, DNP, FNP-BC, NP-C 
Music Credit: Matthew Bugos
Thoughts? Suggestions? Email us at FranklySpeaking@pri-med.com 
 ]]></itunes:summary>
        <itunes:author>Pri-Med</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>834</itunes:duration>
                        <itunes:episodeType>full</itunes:episodeType>
            </item>
    <item>
        <title>A Matter of the Heart—Screening Guidelines for Cardiovascular Disease - Frankly Speaking Ep 417</title>
        <itunes:title>A Matter of the Heart—Screening Guidelines for Cardiovascular Disease - Frankly Speaking Ep 417</itunes:title>
        <link>https://primedfranklyspeaking.podbean.com/e/a-matter-of-the-heart%e2%80%94screening-guidelines-for-cardiovascular-disease-frankly-speaking-ep-417/</link>
                    <comments>https://primedfranklyspeaking.podbean.com/e/a-matter-of-the-heart%e2%80%94screening-guidelines-for-cardiovascular-disease-frankly-speaking-ep-417/#comments</comments>        <pubDate>Mon, 27 Jan 2025 00:30:00 +0000</pubDate>
        <guid isPermaLink="false">primedfranklyspeaking.podbean.com/037e5ce5-303e-3e4b-8277-72ae0067281f</guid>
                                    <description><![CDATA[<p style="margin: 0in; font-family: Calibri; font-size: 11.0pt;">Credits: 0.25 AMA PRA Category 1 Credit™</p>
<p style="margin: 0in; font-family: Calibri; font-size: 11.0pt;"> </p>
<p style="margin: 0in; font-family: Calibri; font-size: 11.0pt;">CME/CE Information and Claim Credit: <a href='https://www.pri-med.com/online-education/podcast/frankly-speaking-cme-417'>https://www.pri-med.com/online-education/podcast/frankly-speaking-cme-417</a></p>
<p style="margin: 0in; font-family: Calibri; font-size: 11.0pt;"> </p>
<p style="margin: 0in; font-family: Calibri; font-size: 11.0pt;">Overview: Joseph is a 57 year old male who presents today for his routine annual exam. He is a healthy male, who is active and has no complaints today. He reports that since he was seen last he generally has been doing well but did have a ER visit for persistent cough in the setting of recovering from Covid. While in the Emergency Department he did undergo testing. On a CT Chest scan there was an incidental finding of moderate coronary artery calcifications.  He asked today, what does moderate coronary artery calcification? Is my heart ok, my dad had a heart attack at 60. </p>
<p style="margin: 0in; font-family: Calibri; font-size: 11.0pt;"> </p>
<p style="margin: 0in; font-family: Calibri; font-size: 11.0pt;">Episode resource links:</p>
<ul>
<li style="font-family:Calibri;font-size:11pt;">
<p><a href='https://www.who.int/news-room/fact-sheets/detail/cardiovascular-diseases-(cvds)'>https://www.who.int/news-room/fact-sheets/detail/cardiovascular-diseases-(cvds)</a></p>
</li>
<li style="font-family:Calibri;font-size:11pt;">
<p><a href='https://odphp.health.gov/healthypeople/objectives-and-data/browse-objectives/heart-disease-and-stroke#:~:text=Heart%20disease%20and%20stroke%20can,and%20high%20cholesterol%20through%20treatment'>https://odphp.health.gov/healthypeople/objectives-and-data/browse-objectives/heart-disease-and-stroke#:~:text=Heart%20disease%20and%20stroke%20can,and%20high%20cholesterol%20through%20treatment</a>.</p>
</li>
<li style="font-family:Calibri;font-size:11pt;">
<p>Vikulova, D. N., Lee, M. K., Humphries, K. H., Pinheiro-Muller, D., Dawes, M., Pimstone, S. N., &amp; Brunham, L. R. (2024). Preventive Lipid-Lowering Therapy and Interactions With Health Care in Patients Who Develop Premature Coronary Artery Disease. JACC: Advances, 101316.</p>
<p> </p>
</li>
<li style="font-family:Calibri;font-size:11pt;">
<p>Maron, D. J., Budoff, M. J., Sky, J. C., Bommer, W. J., Epstein, S. D., Fisher, D. A., ... &amp; DeMaria, A. N. (2024). Coronary Artery Calcium Staging to Guide Preventive Interventions: A Proposal and Call to Action. JACC: Advances, 3(11), 101287.</p>
</li>
<li style="font-family:Calibri;font-size:11pt;">
<p><a href='https://www.cdc.gov/heart-disease-family-history/about/index.html'>https://www.cdc.gov/heart-disease-family-history/about/index.html</a></p>
</li>
</ul>
<p style="margin: 0in; font-family: Calibri; font-size: 11.0pt;"> </p>
<p style="margin: 0in; font-family: Calibri; font-size: 11.0pt;">Guest: Mariyan L. Montaque, DNP, FNP-BC</p>
<p style="margin: 0in; font-family: Calibri; font-size: 11.0pt;"> </p>
<p style="margin: 0in; font-family: Calibri; font-size: 11.0pt;">Music Credit: Matthew Bugos</p>
<p style="margin: 0in; font-family: Calibri; font-size: 11.0pt;"> </p>
<p style="margin: 0in; font-family: Calibri; font-size: 11.0pt;">Thoughts? Suggestions? Email us at <a href='mailto:FranklySpeaking@pri-med.com'>FranklySpeaking@pri-med.com</a> </p>
]]></description>
                                                            <content:encoded><![CDATA[<p style="margin: 0in; font-family: Calibri; font-size: 11.0pt;">Credits: 0.25 AMA PRA Category 1 Credit™</p>
<p style="margin: 0in; font-family: Calibri; font-size: 11.0pt;"> </p>
<p style="margin: 0in; font-family: Calibri; font-size: 11.0pt;">CME/CE Information and Claim Credit: <a href='https://www.pri-med.com/online-education/podcast/frankly-speaking-cme-417'>https://www.pri-med.com/online-education/podcast/frankly-speaking-cme-417</a></p>
<p style="margin: 0in; font-family: Calibri; font-size: 11.0pt;"> </p>
<p style="margin: 0in; font-family: Calibri; font-size: 11.0pt;">Overview: Joseph is a 57 year old male who presents today for his routine annual exam. He is a healthy male, who is active and has no complaints today. He reports that since he was seen last he generally has been doing well but did have a ER visit for persistent cough in the setting of recovering from Covid. While in the Emergency Department he did undergo testing. On a CT Chest scan there was an incidental finding of moderate coronary artery calcifications.  He asked today, what does moderate coronary artery calcification? Is my heart ok, my dad had a heart attack at 60. </p>
<p style="margin: 0in; font-family: Calibri; font-size: 11.0pt;"> </p>
<p style="margin: 0in; font-family: Calibri; font-size: 11.0pt;">Episode resource links:</p>
<ul>
<li style="font-family:Calibri;font-size:11pt;">
<p><a href='https://www.who.int/news-room/fact-sheets/detail/cardiovascular-diseases-(cvds)'>https://www.who.int/news-room/fact-sheets/detail/cardiovascular-diseases-(cvds)</a></p>
</li>
<li style="font-family:Calibri;font-size:11pt;">
<p><a href='https://odphp.health.gov/healthypeople/objectives-and-data/browse-objectives/heart-disease-and-stroke#:~:text=Heart%20disease%20and%20stroke%20can,and%20high%20cholesterol%20through%20treatment'>https://odphp.health.gov/healthypeople/objectives-and-data/browse-objectives/heart-disease-and-stroke#:~:text=Heart%20disease%20and%20stroke%20can,and%20high%20cholesterol%20through%20treatment</a>.</p>
</li>
<li style="font-family:Calibri;font-size:11pt;">
<p>Vikulova, D. N., Lee, M. K., Humphries, K. H., Pinheiro-Muller, D., Dawes, M., Pimstone, S. N., &amp; Brunham, L. R. (2024). Preventive Lipid-Lowering Therapy and Interactions With Health Care in Patients Who Develop Premature Coronary Artery Disease. JACC: Advances, 101316.</p>
<p> </p>
</li>
<li style="font-family:Calibri;font-size:11pt;">
<p>Maron, D. J., Budoff, M. J., Sky, J. C., Bommer, W. J., Epstein, S. D., Fisher, D. A., ... &amp; DeMaria, A. N. (2024). Coronary Artery Calcium Staging to Guide Preventive Interventions: A Proposal and Call to Action. JACC: Advances, 3(11), 101287.</p>
</li>
<li style="font-family:Calibri;font-size:11pt;">
<p><a href='https://www.cdc.gov/heart-disease-family-history/about/index.html'>https://www.cdc.gov/heart-disease-family-history/about/index.html</a></p>
</li>
</ul>
<p style="margin: 0in; font-family: Calibri; font-size: 11.0pt;"> </p>
<p style="margin: 0in; font-family: Calibri; font-size: 11.0pt;">Guest: Mariyan L. Montaque, DNP, FNP-BC</p>
<p style="margin: 0in; font-family: Calibri; font-size: 11.0pt;"> </p>
<p style="margin: 0in; font-family: Calibri; font-size: 11.0pt;">Music Credit: Matthew Bugos</p>
<p style="margin: 0in; font-family: Calibri; font-size: 11.0pt;"> </p>
<p style="margin: 0in; font-family: Calibri; font-size: 11.0pt;">Thoughts? Suggestions? Email us at <a href='mailto:FranklySpeaking@pri-med.com'>FranklySpeaking@pri-med.com</a> </p>
]]></content:encoded>
                                    
        <enclosure url="https://mcdn.podbean.com/mf/web/3ny9pxqyexwa8rgx/frankly-speaking-417-CAD-screening.mp3" length="11083685" type="audio/mpeg"/>
                <itunes:summary><![CDATA[Credits: 0.25 AMA PRA Category 1 Credit™
 
CME/CE Information and Claim Credit: https://www.pri-med.com/online-education/podcast/frankly-speaking-cme-417
 
Overview: Joseph is a 57 year old male who presents today for his routine annual exam. He is a healthy male, who is active and has no complaints today. He reports that since he was seen last he generally has been doing well but did have a ER visit for persistent cough in the setting of recovering from Covid. While in the Emergency Department he did undergo testing. On a CT Chest scan there was an incidental finding of moderate coronary artery calcifications.  He asked today, what does moderate coronary artery calcification? Is my heart ok, my dad had a heart attack at 60. 
 
Episode resource links:


https://www.who.int/news-room/fact-sheets/detail/cardiovascular-diseases-(cvds)


https://odphp.health.gov/healthypeople/objectives-and-data/browse-objectives/heart-disease-and-stroke#:~:text=Heart%20disease%20and%20stroke%20can,and%20high%20cholesterol%20through%20treatment.


Vikulova, D. N., Lee, M. K., Humphries, K. H., Pinheiro-Muller, D., Dawes, M., Pimstone, S. N., &amp; Brunham, L. R. (2024). Preventive Lipid-Lowering Therapy and Interactions With Health Care in Patients Who Develop Premature Coronary Artery Disease. JACC: Advances, 101316.
 


Maron, D. J., Budoff, M. J., Sky, J. C., Bommer, W. J., Epstein, S. D., Fisher, D. A., ... &amp; DeMaria, A. N. (2024). Coronary Artery Calcium Staging to Guide Preventive Interventions: A Proposal and Call to Action. JACC: Advances, 3(11), 101287.


https://www.cdc.gov/heart-disease-family-history/about/index.html


 
Guest: Mariyan L. Montaque, DNP, FNP-BC
 
Music Credit: Matthew Bugos
 
Thoughts? Suggestions? Email us at FranklySpeaking@pri-med.com ]]></itunes:summary>
        <itunes:author>Pri-Med</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>690</itunes:duration>
                        <itunes:episodeType>full</itunes:episodeType>
            </item>
    <item>
        <title>My Back Still Hurts! Nonpharmacologic Approaches to Chronic Back Pain - Frankly Speaking Ep 416</title>
        <itunes:title>My Back Still Hurts! Nonpharmacologic Approaches to Chronic Back Pain - Frankly Speaking Ep 416</itunes:title>
        <link>https://primedfranklyspeaking.podbean.com/e/my-back-still-hurts-nonpharmacologic-approaches-to-chronic-back-pain-frankly-speaking-ep-416/</link>
                    <comments>https://primedfranklyspeaking.podbean.com/e/my-back-still-hurts-nonpharmacologic-approaches-to-chronic-back-pain-frankly-speaking-ep-416/#comments</comments>        <pubDate>Mon, 20 Jan 2025 00:30:00 +0000</pubDate>
        <guid isPermaLink="false">primedfranklyspeaking.podbean.com/2ed83c6a-f479-3900-bb3e-e8175a2f72c0</guid>
                                    <description><![CDATA[<p>Credits: 0.25 AMA PRA Category 1 Credit™
 
CME/CE Information and Claim Credit: <a href='https://www.pri-med.com/online-education/podcast/frankly-speaking-cme-416'>https://www.pri-med.com/online-education/podcast/frankly-speaking-cme-416</a></p>
<p>Overview: Listen in as we discuss chronic sacroiliac (SI) dysfunction and the role of nonpharmacological therapies, including acupuncture, in managing back pain and improving function. Hear evidence-based considerations for integrating acupuncture into your practice to offer effective, medication-free options for patients with chronic SI pain.</p>
<p>Episode resource links:</p>
<ul>
<li>Kim G, Kim D, Moon H, et al. Acupuncture and Acupoints for Low Back Pain: Systematic Review and Meta-Analysis. Am J Chin Med. 2023;51(2):223-247. doi:10.1142/S0192415X23500131</li>
<li>Mu J, Furlan AD, Lam WY, Hsu MY, Ning Z, Lao L. Acupuncture for chronic nonspecific low back pain. Cochrane Database Syst Rev. 2020;12(12):CD013814. Published 2020 Dec 11. doi:10.1002/14651858.CD013814</li>
<li>Tu J-F et al. Acupuncture vs sham acupuncture for chronic sciatica from herniated disk: A randomized clinical trial. JAMA Intern Med 2024 Oct 14; [e-pub]. (https://doi.org/10.1001/jamainternmed.2024.5463)</li>
<li>Wu M, Fan C, Liu H, et al. The Effectiveness of Acupuncture for Low Back Pain: An Umbrella Review and Meta-Analysis. Am J Chin Med. 2024;52(4):905-923. doi:10.1142/S0192415X2450037X 
<a href='https://www-dynamed-com.umassmed.idm.oclc.org/condition/sciatica'>https://www-dynamed-com.umassmed.idm.oclc.org/condition/sciatica</a></li>
</ul>
<p>Guest: Susan Feeney, DNP, FNP
 
Music Credit: Matthew Bugos</p>
<p>Thoughts? Suggestions? Email us at <a href='mailto:FranklySpeaking@pri-med.com'>FranklySpeaking@pri-med.com </a></p>
<p> </p>
]]></description>
                                                            <content:encoded><![CDATA[<p>Credits: 0.25 AMA PRA Category 1 Credit™<br>
 <br>
CME/CE Information and Claim Credit: <a href='https://www.pri-med.com/online-education/podcast/frankly-speaking-cme-416'>https://www.pri-med.com/online-education/podcast/frankly-speaking-cme-416</a></p>
<p>Overview: Listen in as we discuss chronic sacroiliac (SI) dysfunction and the role of nonpharmacological therapies, including acupuncture, in managing back pain and improving function. Hear evidence-based considerations for integrating acupuncture into your practice to offer effective, medication-free options for patients with chronic SI pain.</p>
<p>Episode resource links:</p>
<ul>
<li>Kim G, Kim D, Moon H, et al. Acupuncture and Acupoints for Low Back Pain: Systematic Review and Meta-Analysis. Am J Chin Med. 2023;51(2):223-247. doi:10.1142/S0192415X23500131</li>
<li>Mu J, Furlan AD, Lam WY, Hsu MY, Ning Z, Lao L. Acupuncture for chronic nonspecific low back pain. Cochrane Database Syst Rev. 2020;12(12):CD013814. Published 2020 Dec 11. doi:10.1002/14651858.CD013814</li>
<li>Tu J-F et al. Acupuncture vs sham acupuncture for chronic sciatica from herniated disk: A randomized clinical trial. JAMA Intern Med 2024 Oct 14; [e-pub]. (https://doi.org/10.1001/jamainternmed.2024.5463)</li>
<li>Wu M, Fan C, Liu H, et al. The Effectiveness of Acupuncture for Low Back Pain: An Umbrella Review and Meta-Analysis. Am J Chin Med. 2024;52(4):905-923. doi:10.1142/S0192415X2450037X <br>
<a href='https://www-dynamed-com.umassmed.idm.oclc.org/condition/sciatica'>https://www-dynamed-com.umassmed.idm.oclc.org/condition/sciatica</a></li>
</ul>
<p>Guest: Susan Feeney, DNP, FNP<br>
 <br>
Music Credit: Matthew Bugos</p>
<p>Thoughts? Suggestions? Email us at <a href='mailto:FranklySpeaking@pri-med.com'>FranklySpeaking@pri-med.com </a></p>
<p> </p>
]]></content:encoded>
                                    
        <enclosure url="https://mcdn.podbean.com/mf/web/wt3riqp68zwd2xnm/frankly-speaking-416-accupuncture-back-pain.mp3" length="13834674" type="audio/mpeg"/>
                <itunes:summary><![CDATA[Credits: 0.25 AMA PRA Category 1 Credit™ CME/CE Information and Claim Credit: https://www.pri-med.com/online-education/podcast/frankly-speaking-cme-416
Overview: Listen in as we discuss chronic sacroiliac (SI) dysfunction and the role of nonpharmacological therapies, including acupuncture, in managing back pain and improving function. Hear evidence-based considerations for integrating acupuncture into your practice to offer effective, medication-free options for patients with chronic SI pain.
Episode resource links:

Kim G, Kim D, Moon H, et al. Acupuncture and Acupoints for Low Back Pain: Systematic Review and Meta-Analysis. Am J Chin Med. 2023;51(2):223-247. doi:10.1142/S0192415X23500131
Mu J, Furlan AD, Lam WY, Hsu MY, Ning Z, Lao L. Acupuncture for chronic nonspecific low back pain. Cochrane Database Syst Rev. 2020;12(12):CD013814. Published 2020 Dec 11. doi:10.1002/14651858.CD013814
Tu J-F et al. Acupuncture vs sham acupuncture for chronic sciatica from herniated disk: A randomized clinical trial. JAMA Intern Med 2024 Oct 14; [e-pub]. (https://doi.org/10.1001/jamainternmed.2024.5463)
Wu M, Fan C, Liu H, et al. The Effectiveness of Acupuncture for Low Back Pain: An Umbrella Review and Meta-Analysis. Am J Chin Med. 2024;52(4):905-923. doi:10.1142/S0192415X2450037X https://www-dynamed-com.umassmed.idm.oclc.org/condition/sciatica

Guest: Susan Feeney, DNP, FNP Music Credit: Matthew Bugos
Thoughts? Suggestions? Email us at FranklySpeaking@pri-med.com 
 ]]></itunes:summary>
        <itunes:author>Pri-Med</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>863</itunes:duration>
                        <itunes:episodeType>full</itunes:episodeType>
            </item>
    <item>
        <title>It’s Time to Equip Patients with PEP - Frankly Speaking Ep 415</title>
        <itunes:title>It’s Time to Equip Patients with PEP - Frankly Speaking Ep 415</itunes:title>
        <link>https://primedfranklyspeaking.podbean.com/e/it-s-time-to-equip-patients-with-pep-frankly-speaking-ep-415/</link>
                    <comments>https://primedfranklyspeaking.podbean.com/e/it-s-time-to-equip-patients-with-pep-frankly-speaking-ep-415/#comments</comments>        <pubDate>Mon, 13 Jan 2025 10:30:00 +0000</pubDate>
        <guid isPermaLink="false">primedfranklyspeaking.podbean.com/25c62635-9c4d-3dc9-ac91-c2169d2d0330</guid>
                                    <description><![CDATA[<p>Credits: 0.25 AMA PRA Category 1 Credit™
 
CME/CE Information and Claim Credit: <a href='https://www.pri-med.com/online-education/podcast/frankly-speaking-cme-415'>https://www.pri-med.com/online-education/podcast/frankly-speaking-cme-415</a></p>
<p>Overview: Join us as we discuss the role of postexposure prophylaxis (PEP) in reducing the incidence and adverse outcomes of sexually transmitted infections (STIs), including chlamydia, gonorrhea, and syphilis. Discover when, why, and how to prescribe PEP to better provide your patients with effective prevention options to help reduce rising STI rates and disproportionate impacts on women.</p>
<p>Episode resource links:</p>
<ul>
<li>Stewart, J., Oware, K., Donnell, D., Violette, L. R., Odoyo, J., Soge, O. O., ... &amp; Baeten, J. M. (2023). Doxycycline prophylaxis to prevent sexually transmitted infections in women. New England Journal of Medicine, 389(25), 2331-2340.</li>
<li><a href='https://www.cdc.gov/sti/php/from-the-director/doxy-pep-sti-prevention-strategy.html#:~:text=Doxy%20PEP%20has%20proven%20to,syphilis%2C%20chlamydia%2C%20gonorrhea).'>https://www.cdc.gov/sti/php/from-the-director/doxy-pep-sti-prevention-strategy.html#:~:text=Doxy%20PEP%20has%20proven%20to,syphilis%2C%20chlamydia%2C%20gonorrhea).</a></li>
</ul>
<p>Guest: Mariyan L. Montaque, DNP, FNP-BC</p>
<p>Music Credit: Matthew Bugos</p>
<p>Thoughts? Suggestions? Email us at <a href='mailto:FranklySpeaking@pri-med.com'>FranklySpeaking@pri-med.com </a></p>
<p> </p>
]]></description>
                                                            <content:encoded><![CDATA[<p>Credits: 0.25 AMA PRA Category 1 Credit™<br>
 <br>
CME/CE Information and Claim Credit: <a href='https://www.pri-med.com/online-education/podcast/frankly-speaking-cme-415'>https://www.pri-med.com/online-education/podcast/frankly-speaking-cme-415</a></p>
<p>Overview: Join us as we discuss the role of postexposure prophylaxis (PEP) in reducing the incidence and adverse outcomes of sexually transmitted infections (STIs), including chlamydia, gonorrhea, and syphilis. Discover when, why, and how to prescribe PEP to better provide your patients with effective prevention options to help reduce rising STI rates and disproportionate impacts on women.</p>
<p>Episode resource links:</p>
<ul>
<li>Stewart, J., Oware, K., Donnell, D., Violette, L. R., Odoyo, J., Soge, O. O., ... &amp; Baeten, J. M. (2023). Doxycycline prophylaxis to prevent sexually transmitted infections in women. New England Journal of Medicine, 389(25), 2331-2340.</li>
<li><a href='https://www.cdc.gov/sti/php/from-the-director/doxy-pep-sti-prevention-strategy.html#:~:text=Doxy%20PEP%20has%20proven%20to,syphilis%2C%20chlamydia%2C%20gonorrhea).'>https://www.cdc.gov/sti/php/from-the-director/doxy-pep-sti-prevention-strategy.html#:~:text=Doxy%20PEP%20has%20proven%20to,syphilis%2C%20chlamydia%2C%20gonorrhea).</a></li>
</ul>
<p>Guest: Mariyan L. Montaque, DNP, FNP-BC</p>
<p>Music Credit: Matthew Bugos</p>
<p>Thoughts? Suggestions? Email us at <a href='mailto:FranklySpeaking@pri-med.com'>FranklySpeaking@pri-med.com </a></p>
<p> </p>
]]></content:encoded>
                                    
        <enclosure url="https://mcdn.podbean.com/mf/web/cehn322gr698fdz7/frankly-speaking-415-pep-and-prep.mp3" length="10977713" type="audio/mpeg"/>
                <itunes:summary><![CDATA[Credits: 0.25 AMA PRA Category 1 Credit™ CME/CE Information and Claim Credit: https://www.pri-med.com/online-education/podcast/frankly-speaking-cme-415
Overview: Join us as we discuss the role of postexposure prophylaxis (PEP) in reducing the incidence and adverse outcomes of sexually transmitted infections (STIs), including chlamydia, gonorrhea, and syphilis. Discover when, why, and how to prescribe PEP to better provide your patients with effective prevention options to help reduce rising STI rates and disproportionate impacts on women.
Episode resource links:

Stewart, J., Oware, K., Donnell, D., Violette, L. R., Odoyo, J., Soge, O. O., ... &amp; Baeten, J. M. (2023). Doxycycline prophylaxis to prevent sexually transmitted infections in women. New England Journal of Medicine, 389(25), 2331-2340.
https://www.cdc.gov/sti/php/from-the-director/doxy-pep-sti-prevention-strategy.html#:~:text=Doxy%20PEP%20has%20proven%20to,syphilis%2C%20chlamydia%2C%20gonorrhea).

Guest: Mariyan L. Montaque, DNP, FNP-BC
Music Credit: Matthew Bugos
Thoughts? Suggestions? Email us at FranklySpeaking@pri-med.com 
 ]]></itunes:summary>
        <itunes:author>Pri-Med</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>684</itunes:duration>
                        <itunes:episodeType>full</itunes:episodeType>
            </item>
    <item>
        <title>Is Standing Better than Sitting for Decreasing Cardiovascular Risk?  - Frankly Speaking Ep 414</title>
        <itunes:title>Is Standing Better than Sitting for Decreasing Cardiovascular Risk?  - Frankly Speaking Ep 414</itunes:title>
        <link>https://primedfranklyspeaking.podbean.com/e/is-standing-better-than-sitting-for-decreasing-cardiovascular-risk-frankly-speaking-ep-414/</link>
                    <comments>https://primedfranklyspeaking.podbean.com/e/is-standing-better-than-sitting-for-decreasing-cardiovascular-risk-frankly-speaking-ep-414/#comments</comments>        <pubDate>Mon, 06 Jan 2025 00:30:00 +0000</pubDate>
        <guid isPermaLink="false">primedfranklyspeaking.podbean.com/939b7297-0dbc-3bdc-b12e-6687b03b7c07</guid>
                                    <description><![CDATA[<p>Credits: 0.25 AMA PRA Category 1 Credit™
 
CME/CE Information and Claim Credit: <a href='https://www.pri-med.com/online-education/podcast/frankly-speaking-cme-414'>https://www.pri-med.com/online-education/podcast/frankly-speaking-cme-414</a></p>
<p>Overview: Standing desks are a popular choice for people with sedentary jobs who want to increase their physical activity. In this episode, we look at the latest data on the benefits and risks of prolonged standing and provide actionable strategies to help patients reduce cardiovascular risk through informed movement choices.</p>
<p>Episode resource links:</p>
<ul>
<li>Ahmadi MN, Coenen P, Straker L, Stamatakis E. Device-measured stationary behaviour and cardiovascular and orthostatic circulatory disease incidence. Int J Epidemiol. 2024 Oct 13;53(6):dyae136. doi: 10.1093/ije/dyae136. PMID: 39412356; PMCID: PMC11481281.</li>
</ul>
<p>Guest: Alan M. Ehrlich, MD, FAAFP </p>
<p>Music Credit: Matthew Bugos</p>
<p>Thoughts? Suggestions? Email us at <a href='mailto:FranklySpeaking@pri-med.com'>FranklySpeaking@pri-med.com </a></p>
<p> </p>
]]></description>
                                                            <content:encoded><![CDATA[<p>Credits: 0.25 AMA PRA Category 1 Credit™<br>
 <br>
CME/CE Information and Claim Credit: <a href='https://www.pri-med.com/online-education/podcast/frankly-speaking-cme-414'>https://www.pri-med.com/online-education/podcast/frankly-speaking-cme-414</a></p>
<p>Overview: Standing desks are a popular choice for people with sedentary jobs who want to increase their physical activity. In this episode, we look at the latest data on the benefits and risks of prolonged standing and provide actionable strategies to help patients reduce cardiovascular risk through informed movement choices.</p>
<p>Episode resource links:</p>
<ul>
<li>Ahmadi MN, Coenen P, Straker L, Stamatakis E. Device-measured stationary behaviour and cardiovascular and orthostatic circulatory disease incidence. Int J Epidemiol. 2024 Oct 13;53(6):dyae136. doi: 10.1093/ije/dyae136. PMID: 39412356; PMCID: PMC11481281.</li>
</ul>
<p>Guest: Alan M. Ehrlich, MD, FAAFP </p>
<p>Music Credit: Matthew Bugos</p>
<p>Thoughts? Suggestions? Email us at <a href='mailto:FranklySpeaking@pri-med.com'>FranklySpeaking@pri-med.com </a></p>
<p> </p>
]]></content:encoded>
                                    
        <enclosure url="https://mcdn.podbean.com/mf/web/kkh3zn2sb9ufwvyf/frankly-speaking-414-standing-desks.mp3" length="9099354" type="audio/mpeg"/>
                <itunes:summary><![CDATA[Credits: 0.25 AMA PRA Category 1 Credit™ CME/CE Information and Claim Credit: https://www.pri-med.com/online-education/podcast/frankly-speaking-cme-414
Overview: Standing desks are a popular choice for people with sedentary jobs who want to increase their physical activity. In this episode, we look at the latest data on the benefits and risks of prolonged standing and provide actionable strategies to help patients reduce cardiovascular risk through informed movement choices.
Episode resource links:

Ahmadi MN, Coenen P, Straker L, Stamatakis E. Device-measured stationary behaviour and cardiovascular and orthostatic circulatory disease incidence. Int J Epidemiol. 2024 Oct 13;53(6):dyae136. doi: 10.1093/ije/dyae136. PMID: 39412356; PMCID: PMC11481281.

Guest: Alan M. Ehrlich, MD, FAAFP 
Music Credit: Matthew Bugos
Thoughts? Suggestions? Email us at FranklySpeaking@pri-med.com 
 ]]></itunes:summary>
        <itunes:author>Pri-Med</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>567</itunes:duration>
                        <itunes:episodeType>full</itunes:episodeType>
            </item>
    <item>
        <title>A Vitamin for Skin Cancer Prevention? - Frankly Speaking Ep 413</title>
        <itunes:title>A Vitamin for Skin Cancer Prevention? - Frankly Speaking Ep 413</itunes:title>
        <link>https://primedfranklyspeaking.podbean.com/e/a-vitamin-for-skin-cancer-prevention-frankly-speaking-ep-413/</link>
                    <comments>https://primedfranklyspeaking.podbean.com/e/a-vitamin-for-skin-cancer-prevention-frankly-speaking-ep-413/#comments</comments>        <pubDate>Mon, 30 Dec 2024 00:30:00 +0000</pubDate>
        <guid isPermaLink="false">primedfranklyspeaking.podbean.com/8df9d405-73dc-3f00-abdd-0aa9a642790c</guid>
                                    <description><![CDATA[<p>Credits: 0.25 AMA PRA Category 1 Credit™
 
CME/CE Information and Claim Credit: <a href='https://www.pri-med.com/online-education/podcast/frankly-speaking-cme-413'>https://www.pri-med.com/online-education/podcast/frankly-speaking-cme-413</a></p>
<p>Overview: Listen in to learn about the role of nicotinamide (vitamin B3) in reducing the risk of certain skin cancers. This episode reviews key prevention strategies, the latest evidence on skin cancer management, and practical approaches to support patients with sun-damaged skin.</p>
<p>Episode resource links:</p>
<ul>
<li>Discuss the prevalence of basal cell and squamous cell carcinomas </li>
<li>Review the potential benefits of nicotinamide (vitamin B3) for the prevention of skin abnormalities</li>
<li>Identify additional methods to prevent skin cancer</li>
</ul>
<p>Guest: Alan M. Ehrlich, MD, FAAFP
 
Music Credit: Matthew Bugos</p>
<p>Thoughts? Suggestions? Email us at <a href='mailto:FranklySpeaking@pri-med.com'>FranklySpeaking@pri-med.com </a></p>
<p> </p>
]]></description>
                                                            <content:encoded><![CDATA[<p>Credits: 0.25 AMA PRA Category 1 Credit™<br>
 <br>
CME/CE Information and Claim Credit: <a href='https://www.pri-med.com/online-education/podcast/frankly-speaking-cme-413'>https://www.pri-med.com/online-education/podcast/frankly-speaking-cme-413</a></p>
<p>Overview: Listen in to learn about the role of nicotinamide (vitamin B3) in reducing the risk of certain skin cancers. This episode reviews key prevention strategies, the latest evidence on skin cancer management, and practical approaches to support patients with sun-damaged skin.</p>
<p>Episode resource links:</p>
<ul>
<li>Discuss the prevalence of basal cell and squamous cell carcinomas </li>
<li>Review the potential benefits of nicotinamide (vitamin B3) for the prevention of skin abnormalities</li>
<li>Identify additional methods to prevent skin cancer</li>
</ul>
<p>Guest: Alan M. Ehrlich, MD, FAAFP<br>
 <br>
Music Credit: Matthew Bugos</p>
<p>Thoughts? Suggestions? Email us at <a href='mailto:FranklySpeaking@pri-med.com'>FranklySpeaking@pri-med.com </a></p>
<p> </p>
]]></content:encoded>
                                    
        <enclosure url="https://mcdn.podbean.com/mf/web/imdnub9upr7chnz8/frankly-speaking-413-skin-cancer-nicotinaminde.mp3" length="11451142" type="audio/mpeg"/>
                <itunes:summary><![CDATA[Credits: 0.25 AMA PRA Category 1 Credit™ CME/CE Information and Claim Credit: https://www.pri-med.com/online-education/podcast/frankly-speaking-cme-413
Overview: Listen in to learn about the role of nicotinamide (vitamin B3) in reducing the risk of certain skin cancers. This episode reviews key prevention strategies, the latest evidence on skin cancer management, and practical approaches to support patients with sun-damaged skin.
Episode resource links:

Discuss the prevalence of basal cell and squamous cell carcinomas 
Review the potential benefits of nicotinamide (vitamin B3) for the prevention of skin abnormalities
Identify additional methods to prevent skin cancer

Guest: Alan M. Ehrlich, MD, FAAFP Music Credit: Matthew Bugos
Thoughts? Suggestions? Email us at FranklySpeaking@pri-med.com 
 ]]></itunes:summary>
        <itunes:author>Pri-Med</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>714</itunes:duration>
                        <itunes:episodeType>full</itunes:episodeType>
            </item>
    <item>
        <title>Positioning is Everything for Accurate BPs! - Frankly Speaking Ep 412</title>
        <itunes:title>Positioning is Everything for Accurate BPs! - Frankly Speaking Ep 412</itunes:title>
        <link>https://primedfranklyspeaking.podbean.com/e/positioning-is-everything-for-accurate-bps-frankly-speaking-ep-412/</link>
                    <comments>https://primedfranklyspeaking.podbean.com/e/positioning-is-everything-for-accurate-bps-frankly-speaking-ep-412/#comments</comments>        <pubDate>Mon, 23 Dec 2024 00:30:00 +0000</pubDate>
        <guid isPermaLink="false">primedfranklyspeaking.podbean.com/090467b0-3509-358f-9e59-ed775aff1371</guid>
                                    <description><![CDATA[<p>Credits: 0.25 AMA PRA Category 1 Credit™
 
CME/CE Information and Claim Credit: <a href='https://www.pri-med.com/online-education/podcast/frankly-speaking-cme-412'>https://www.pri-med.com/online-education/podcast/frankly-speaking-cme-412</a></p>
<p>Overview: Discover how improper arm positioning can lead to inaccurate blood pressure readings and influence hypertension management as we discuss a recent randomized controlled trial. Hear evidence-based techniques to ensure proper arm and cuff positioning, improving hypertension diagnosis in your clinical practice.</p>
<p>Episode resource links:</p>
<ul>
<li>JAMA Intern Med. Published online October 7, 2024. doi:10.1001/jamainternmed.2024.5213</li>
</ul>
<p>Guest: Robert A. Baldor MD, FAAFP</p>
<p>Music Credit: Matthew Bugos</p>
<p>Thoughts? Suggestions? Email us at <a href='mailto:FranklySpeaking@pri-med.com'>FranklySpeaking@pri-med.com</a></p>
<p> </p>
]]></description>
                                                            <content:encoded><![CDATA[<p>Credits: 0.25 AMA PRA Category 1 Credit™<br>
 <br>
CME/CE Information and Claim Credit: <a href='https://www.pri-med.com/online-education/podcast/frankly-speaking-cme-412'>https://www.pri-med.com/online-education/podcast/frankly-speaking-cme-412</a></p>
<p>Overview: Discover how improper arm positioning can lead to inaccurate blood pressure readings and influence hypertension management as we discuss a recent randomized controlled trial. Hear evidence-based techniques to ensure proper arm and cuff positioning, improving hypertension diagnosis in your clinical practice.</p>
<p>Episode resource links:</p>
<ul>
<li>JAMA Intern Med. Published online October 7, 2024. doi:10.1001/jamainternmed.2024.5213</li>
</ul>
<p>Guest: Robert A. Baldor MD, FAAFP</p>
<p>Music Credit: Matthew Bugos</p>
<p>Thoughts? Suggestions? Email us at <a href='mailto:FranklySpeaking@pri-med.com'>FranklySpeaking@pri-med.com</a></p>
<p> </p>
]]></content:encoded>
                                    
        <enclosure url="https://mcdn.podbean.com/mf/web/xbqt6c76ct9d2p7w/frankly-speaking-412-BP-positioning.mp3" length="7791794" type="audio/mpeg"/>
                <itunes:summary><![CDATA[Credits: 0.25 AMA PRA Category 1 Credit™ CME/CE Information and Claim Credit: https://www.pri-med.com/online-education/podcast/frankly-speaking-cme-412
Overview: Discover how improper arm positioning can lead to inaccurate blood pressure readings and influence hypertension management as we discuss a recent randomized controlled trial. Hear evidence-based techniques to ensure proper arm and cuff positioning, improving hypertension diagnosis in your clinical practice.
Episode resource links:

JAMA Intern Med. Published online October 7, 2024. doi:10.1001/jamainternmed.2024.5213

Guest: Robert A. Baldor MD, FAAFP
Music Credit: Matthew Bugos
Thoughts? Suggestions? Email us at FranklySpeaking@pri-med.com
 ]]></itunes:summary>
        <itunes:author>Pri-Med</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>485</itunes:duration>
                        <itunes:episodeType>full</itunes:episodeType>
            </item>
    <item>
        <title>Don’t Miss the Red Flags for Early-Onset Colorectal Cancer - Frankly Speaking Ep 411</title>
        <itunes:title>Don’t Miss the Red Flags for Early-Onset Colorectal Cancer - Frankly Speaking Ep 411</itunes:title>
        <link>https://primedfranklyspeaking.podbean.com/e/don-t-miss-the-red-flags-for-early-onset-colorectal-cancer-frankly-speaking-ep-411/</link>
                    <comments>https://primedfranklyspeaking.podbean.com/e/don-t-miss-the-red-flags-for-early-onset-colorectal-cancer-frankly-speaking-ep-411/#comments</comments>        <pubDate>Mon, 16 Dec 2024 00:30:00 +0000</pubDate>
        <guid isPermaLink="false">primedfranklyspeaking.podbean.com/72f8c10b-78d7-3163-91c3-8930f9979c02</guid>
                                    <description><![CDATA[<p>Credits: 0.25 AMA PRA Category 1 Credit™
 
CME/CE Information and Claim Credit: <a href='https://www.pri-med.com/online-education/podcast/frankly-speaking-cme-411'>https://www.pri-med.com/online-education/podcast/frankly-speaking-cme-411</a></p>
<p>Overview: This episode focuses on the rising prevalence of early-onset colorectal cancer and its critical indicators. Learn to recognize key symptoms, ensure timely diagnostic workups, and effectively address red flags to prevent delayed diagnosis.</p>
<p>Episode resource links:</p>
<ul>
<li>
<p>Demb, J., Kolb, J. M., Dounel, J., Fritz, C. D. L., Advani, S. M., Cao, Y., Coppernoll-Blach, P., Dwyer, A. J., Perea, J., Heskett, K. M., Holowatyj, A. N., Lieu, C. H., Singh, S., Spaander, M. C. W., Vuik, F. E. R., &amp; Gupta, S. (2024). Red Flag Signs and Symptoms for Patients With Early-Onset Colorectal Cancer: A Systematic Review and Meta-Analysis. JAMA network open, 7(5), e2413157. <a href='https://doi.org/10.1001/jamanetworkopen.2024.13157'>https://doi.org/10.1001/jamanetworkopen.2024.13157</a></p>
</li>
<li>
<p>US Preventive Services Task Force Screening Guidelines for Colorectal Cancer: <a href='https://www.uspreventiveservicestaskforce.org/uspstf/recommendation/colorectal-cancer-screening'>https://www.uspreventiveservicestaskforce.org/uspstf/recommendation/colorectal-cancer-screening</a></p>
</li>
<li>
<p>American Cancer Society Infographic for Patients:  Colorectal Cancer:  Catching it Early <a href='https://www.cancer.org/cancer/types/colon-rectal-cancer/prevention-infographic.html'>https://www.cancer.org/cancer/types/colon-rectal-cancer/prevention-infographic.html</a></p>
</li>
<li>
<p>Gómez-Molina R, Suárez M, Martínez R, Chilet M, Bauça JM, Mateo J. Utility of Stool-Based Tests for Colorectal Cancer Detection: A Comprehensive Review. Healthcare. 2024; 12(16):1645. <a href='https://doi.org/10.3390/healthcare12161645'>https://doi.org/10.3390/healthcare12161645</a></p>
</li>
</ul>
<p>Guest: Jill M. Terrien PhD, ANP-BC </p>
<p>Music Credit: Matthew Bugos</p>
<p>Thoughts? Suggestions? Email us at <a href='mailto:FranklySpeaking@pri-med.com'>FranklySpeaking@pri-med.com </a></p>
<p> </p>
]]></description>
                                                            <content:encoded><![CDATA[<p>Credits: 0.25 AMA PRA Category 1 Credit™<br>
 <br>
CME/CE Information and Claim Credit: <a href='https://www.pri-med.com/online-education/podcast/frankly-speaking-cme-411'>https://www.pri-med.com/online-education/podcast/frankly-speaking-cme-411</a></p>
<p>Overview: This episode focuses on the rising prevalence of early-onset colorectal cancer and its critical indicators. Learn to recognize key symptoms, ensure timely diagnostic workups, and effectively address red flags to prevent delayed diagnosis.</p>
<p>Episode resource links:</p>
<ul>
<li>
<p>Demb, J., Kolb, J. M., Dounel, J., Fritz, C. D. L., Advani, S. M., Cao, Y., Coppernoll-Blach, P., Dwyer, A. J., Perea, J., Heskett, K. M., Holowatyj, A. N., Lieu, C. H., Singh, S., Spaander, M. C. W., Vuik, F. E. R., &amp; Gupta, S. (2024). Red Flag Signs and Symptoms for Patients With Early-Onset Colorectal Cancer: A Systematic Review and Meta-Analysis. JAMA network open, 7(5), e2413157. <a href='https://doi.org/10.1001/jamanetworkopen.2024.13157'>https://doi.org/10.1001/jamanetworkopen.2024.13157</a></p>
</li>
<li>
<p>US Preventive Services Task Force Screening Guidelines for Colorectal Cancer: <a href='https://www.uspreventiveservicestaskforce.org/uspstf/recommendation/colorectal-cancer-screening'>https://www.uspreventiveservicestaskforce.org/uspstf/recommendation/colorectal-cancer-screening</a></p>
</li>
<li>
<p>American Cancer Society Infographic for Patients:  Colorectal Cancer:  Catching it Early <a href='https://www.cancer.org/cancer/types/colon-rectal-cancer/prevention-infographic.html'>https://www.cancer.org/cancer/types/colon-rectal-cancer/prevention-infographic.html</a></p>
</li>
<li>
<p>Gómez-Molina R, Suárez M, Martínez R, Chilet M, Bauça JM, Mateo J. Utility of Stool-Based Tests for Colorectal Cancer Detection: A Comprehensive Review. Healthcare. 2024; 12(16):1645. <a href='https://doi.org/10.3390/healthcare12161645'>https://doi.org/10.3390/healthcare12161645</a></p>
</li>
</ul>
<p>Guest: Jill M. Terrien PhD, ANP-BC </p>
<p>Music Credit: Matthew Bugos</p>
<p>Thoughts? Suggestions? Email us at <a href='mailto:FranklySpeaking@pri-med.com'>FranklySpeaking@pri-med.com </a></p>
<p> </p>
]]></content:encoded>
                                    
        <enclosure url="https://mcdn.podbean.com/mf/web/ac8d7ymgyrjxbhgx/frankly-speaking-411-collerectal-cancer-red-flags.mp3" length="11493866" type="audio/mpeg"/>
                <itunes:summary><![CDATA[Credits: 0.25 AMA PRA Category 1 Credit™ CME/CE Information and Claim Credit: https://www.pri-med.com/online-education/podcast/frankly-speaking-cme-411
Overview: This episode focuses on the rising prevalence of early-onset colorectal cancer and its critical indicators. Learn to recognize key symptoms, ensure timely diagnostic workups, and effectively address red flags to prevent delayed diagnosis.
Episode resource links:


Demb, J., Kolb, J. M., Dounel, J., Fritz, C. D. L., Advani, S. M., Cao, Y., Coppernoll-Blach, P., Dwyer, A. J., Perea, J., Heskett, K. M., Holowatyj, A. N., Lieu, C. H., Singh, S., Spaander, M. C. W., Vuik, F. E. R., &amp; Gupta, S. (2024). Red Flag Signs and Symptoms for Patients With Early-Onset Colorectal Cancer: A Systematic Review and Meta-Analysis. JAMA network open, 7(5), e2413157. https://doi.org/10.1001/jamanetworkopen.2024.13157


US Preventive Services Task Force Screening Guidelines for Colorectal Cancer: https://www.uspreventiveservicestaskforce.org/uspstf/recommendation/colorectal-cancer-screening


American Cancer Society Infographic for Patients:  Colorectal Cancer:  Catching it Early https://www.cancer.org/cancer/types/colon-rectal-cancer/prevention-infographic.html


Gómez-Molina R, Suárez M, Martínez R, Chilet M, Bauça JM, Mateo J. Utility of Stool-Based Tests for Colorectal Cancer Detection: A Comprehensive Review. Healthcare. 2024; 12(16):1645. https://doi.org/10.3390/healthcare12161645


Guest: Jill M. Terrien PhD, ANP-BC 
Music Credit: Matthew Bugos
Thoughts? Suggestions? Email us at FranklySpeaking@pri-med.com 
 ]]></itunes:summary>
        <itunes:author>Pri-Med</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>716</itunes:duration>
                        <itunes:episodeType>full</itunes:episodeType>
            </item>
    <item>
        <title>To D or Not to D? New Guidance on Vitamin Supplementation - Frankly Speaking Ep 410</title>
        <itunes:title>To D or Not to D? New Guidance on Vitamin Supplementation - Frankly Speaking Ep 410</itunes:title>
        <link>https://primedfranklyspeaking.podbean.com/e/to-d-or-not-to-d-new-guidance-on-vitamin-supplementation-frankly-speaking-ep-410/</link>
                    <comments>https://primedfranklyspeaking.podbean.com/e/to-d-or-not-to-d-new-guidance-on-vitamin-supplementation-frankly-speaking-ep-410/#comments</comments>        <pubDate>Mon, 09 Dec 2024 00:30:00 +0000</pubDate>
        <guid isPermaLink="false">primedfranklyspeaking.podbean.com/d9add590-9618-38b8-bbd5-0d58ca80e665</guid>
                                    <description><![CDATA[<p>Credits: 0.25 AMA PRA Category 1 Credit™
 
CME/CE Information and Claim Credit: <a href='https://www.pri-med.com/online-education/podcast/frankly-speaking-cme-410'>https://www.pri-med.com/online-education/podcast/frankly-speaking-cme-410</a></p>
<p>Overview: In this episode, we discuss the latest updates on vitamin D. Learn about its link to common disorders, when to consider supplementation, and what the most recent practice guideline says about vitamin D and disease prevention—empowering you to make informed decisions and improve patient care without unnecessary screenings or treatments.</p>
<p>Episode resource links:</p>
<ul>
<li>Marie B Demay, Anastassios G Pittas, Daniel D Bikle, Dima L Diab, Mairead E Kiely, Marise Lazaretti-Castro, Paul Lips, Deborah M Mitchell, M Hassan Murad, Shelley Powers, Sudhaker D Rao, Robert Scragg, John A Tayek, Amy M Valent, Judith M E Walsh, Christopher R McCartney, Vitamin D for the Prevention of Disease: An Endocrine Society Clinical Practice Guideline, The Journal of Clinical Endocrinology &amp; Metabolism, Volume 109, Issue 8, August 2024, Pages 1907–1947, https://doi.org/10.1210/clinem/dgae290</li>
<li>Michael F. Holick, Neil C. Binkley, Heike A. Bischoff-Ferrari, Catherine M. Gordon, David A. Hanley, Robert P. Heaney, M. Hassan Murad, Connie M. Weaver, Evaluation, Treatment, and Prevention of Vitamin D Deficiency: an Endocrine Society Clinical Practice Guideline, The Journal of Clinical Endocrinology &amp; Metabolism, Volume 96, Issue 7, 1 July 2011, Pages 1911–1930, https://doi.org/10.1210/jc.2011-0385</li>
</ul>
<p>Guest: Jillian Joseph, PA-C
 
Music Credit: Matthew Bugos</p>
<p>Thoughts? Suggestions? Email us at <a href='mailto:FranklySpeaking@pri-med.com'>FranklySpeaking@pri-med.com</a></p>
<p> </p>
]]></description>
                                                            <content:encoded><![CDATA[<p>Credits: 0.25 AMA PRA Category 1 Credit™<br>
 <br>
CME/CE Information and Claim Credit: <a href='https://www.pri-med.com/online-education/podcast/frankly-speaking-cme-410'>https://www.pri-med.com/online-education/podcast/frankly-speaking-cme-410</a></p>
<p>Overview: In this episode, we discuss the latest updates on vitamin D. Learn about its link to common disorders, when to consider supplementation, and what the most recent practice guideline says about vitamin D and disease prevention—empowering you to make informed decisions and improve patient care without unnecessary screenings or treatments.</p>
<p>Episode resource links:</p>
<ul>
<li>Marie B Demay, Anastassios G Pittas, Daniel D Bikle, Dima L Diab, Mairead E Kiely, Marise Lazaretti-Castro, Paul Lips, Deborah M Mitchell, M Hassan Murad, Shelley Powers, Sudhaker D Rao, Robert Scragg, John A Tayek, Amy M Valent, Judith M E Walsh, Christopher R McCartney, Vitamin D for the Prevention of Disease: An Endocrine Society Clinical Practice Guideline, The Journal of Clinical Endocrinology &amp; Metabolism, Volume 109, Issue 8, August 2024, Pages 1907–1947, https://doi.org/10.1210/clinem/dgae290</li>
<li>Michael F. Holick, Neil C. Binkley, Heike A. Bischoff-Ferrari, Catherine M. Gordon, David A. Hanley, Robert P. Heaney, M. Hassan Murad, Connie M. Weaver, Evaluation, Treatment, and Prevention of Vitamin D Deficiency: an Endocrine Society Clinical Practice Guideline, The Journal of Clinical Endocrinology &amp; Metabolism, Volume 96, Issue 7, 1 July 2011, Pages 1911–1930, https://doi.org/10.1210/jc.2011-0385</li>
</ul>
<p>Guest: Jillian Joseph, PA-C<br>
 <br>
Music Credit: Matthew Bugos</p>
<p>Thoughts? Suggestions? Email us at <a href='mailto:FranklySpeaking@pri-med.com'>FranklySpeaking@pri-med.com</a></p>
<p> </p>
]]></content:encoded>
                                    
        <enclosure url="https://mcdn.podbean.com/mf/web/33eb2utkc5ky68ui/frankly-speaking-410-vitamin-D.mp3" length="10675423" type="audio/mpeg"/>
                <itunes:summary><![CDATA[Credits: 0.25 AMA PRA Category 1 Credit™ CME/CE Information and Claim Credit: https://www.pri-med.com/online-education/podcast/frankly-speaking-cme-410
Overview: In this episode, we discuss the latest updates on vitamin D. Learn about its link to common disorders, when to consider supplementation, and what the most recent practice guideline says about vitamin D and disease prevention—empowering you to make informed decisions and improve patient care without unnecessary screenings or treatments.
Episode resource links:

Marie B Demay, Anastassios G Pittas, Daniel D Bikle, Dima L Diab, Mairead E Kiely, Marise Lazaretti-Castro, Paul Lips, Deborah M Mitchell, M Hassan Murad, Shelley Powers, Sudhaker D Rao, Robert Scragg, John A Tayek, Amy M Valent, Judith M E Walsh, Christopher R McCartney, Vitamin D for the Prevention of Disease: An Endocrine Society Clinical Practice Guideline, The Journal of Clinical Endocrinology &amp; Metabolism, Volume 109, Issue 8, August 2024, Pages 1907–1947, https://doi.org/10.1210/clinem/dgae290
Michael F. Holick, Neil C. Binkley, Heike A. Bischoff-Ferrari, Catherine M. Gordon, David A. Hanley, Robert P. Heaney, M. Hassan Murad, Connie M. Weaver, Evaluation, Treatment, and Prevention of Vitamin D Deficiency: an Endocrine Society Clinical Practice Guideline, The Journal of Clinical Endocrinology &amp; Metabolism, Volume 96, Issue 7, 1 July 2011, Pages 1911–1930, https://doi.org/10.1210/jc.2011-0385

Guest: Jillian Joseph, PA-C Music Credit: Matthew Bugos
Thoughts? Suggestions? Email us at FranklySpeaking@pri-med.com
 ]]></itunes:summary>
        <itunes:author>Pri-Med</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>665</itunes:duration>
                        <itunes:episodeType>full</itunes:episodeType>
            </item>
    <item>
        <title>Bright Light Therapy for Depression: Useful in Any Season - Frankly Speaking Ep 409</title>
        <itunes:title>Bright Light Therapy for Depression: Useful in Any Season - Frankly Speaking Ep 409</itunes:title>
        <link>https://primedfranklyspeaking.podbean.com/e/bright-light-therapy-for-depression-useful-in-any-season-frankly-speaking-ep-409/</link>
                    <comments>https://primedfranklyspeaking.podbean.com/e/bright-light-therapy-for-depression-useful-in-any-season-frankly-speaking-ep-409/#comments</comments>        <pubDate>Mon, 02 Dec 2024 16:10:00 +0000</pubDate>
        <guid isPermaLink="false">primedfranklyspeaking.podbean.com/ed62a98c-8602-39da-ab18-b61d854cb97b</guid>
                                    <description><![CDATA[<p>Credits: 0.25 AMA PRA Category 1 Credit™
 
CME/CE Information and Claim Credit: <a href='https://www.pri-med.com/online-education/podcast/frankly-speaking-cme-409'>https://www.pri-med.com/online-education/podcast/frankly-speaking-cme-409</a></p>
<p>Overview: Listen in as we discuss how bright light therapy extends beyond seasonal affective disorder, potentially offering benefits for nonseasonal depression. Learn how to counsel patients effectively on its use and integrate this treatment into your practice, enhancing patient care and broadening treatment strategies for depression.</p>
<p>Episode resource links:</p>
<ul>
<li>Menegaz de Almeida A, Aquino de Moraes FC, Cavalcanti Souza ME, Cavalcanti Orestes Cardoso JH, Tamashiro F, Miranda C, Fernandes L, Kreuz M, Alves Kelly F. Bright Light Therapy for Nonseasonal Depressive Disorders: A Systematic Review and Meta-Analysis. JAMA Psychiatry. 2024 Oct 2:e242871 </li>
</ul>
<p>Guest: Alan M. Ehrlich, MD, FAAFP
 
Music Credit: Matthew Bugos</p>
<p>Thoughts? Suggestions? Email us at <a href='mailto:FranklySpeaking@pri-med.com'>FranklySpeaking@pri-med.com </a></p>
<p> </p>
]]></description>
                                                            <content:encoded><![CDATA[<p>Credits: 0.25 AMA PRA Category 1 Credit™<br>
 <br>
CME/CE Information and Claim Credit: <a href='https://www.pri-med.com/online-education/podcast/frankly-speaking-cme-409'>https://www.pri-med.com/online-education/podcast/frankly-speaking-cme-409</a></p>
<p>Overview: Listen in as we discuss how bright light therapy extends beyond seasonal affective disorder, potentially offering benefits for nonseasonal depression. Learn how to counsel patients effectively on its use and integrate this treatment into your practice, enhancing patient care and broadening treatment strategies for depression.</p>
<p>Episode resource links:</p>
<ul>
<li>Menegaz de Almeida A, Aquino de Moraes FC, Cavalcanti Souza ME, Cavalcanti Orestes Cardoso JH, Tamashiro F, Miranda C, Fernandes L, Kreuz M, Alves Kelly F. Bright Light Therapy for Nonseasonal Depressive Disorders: A Systematic Review and Meta-Analysis. JAMA Psychiatry. 2024 Oct 2:e242871 </li>
</ul>
<p>Guest: Alan M. Ehrlich, MD, FAAFP<br>
 <br>
Music Credit: Matthew Bugos</p>
<p>Thoughts? Suggestions? Email us at <a href='mailto:FranklySpeaking@pri-med.com'>FranklySpeaking@pri-med.com </a></p>
<p> </p>
]]></content:encoded>
                                    
        <enclosure url="https://mcdn.podbean.com/mf/web/t3jtee9ngcc2ugwp/frankly-speaking-409-light-for-depression.mp3" length="9994290" type="audio/mpeg"/>
                <itunes:summary><![CDATA[Credits: 0.25 AMA PRA Category 1 Credit™ CME/CE Information and Claim Credit: https://www.pri-med.com/online-education/podcast/frankly-speaking-cme-409
Overview: Listen in as we discuss how bright light therapy extends beyond seasonal affective disorder, potentially offering benefits for nonseasonal depression. Learn how to counsel patients effectively on its use and integrate this treatment into your practice, enhancing patient care and broadening treatment strategies for depression.
Episode resource links:

Menegaz de Almeida A, Aquino de Moraes FC, Cavalcanti Souza ME, Cavalcanti Orestes Cardoso JH, Tamashiro F, Miranda C, Fernandes L, Kreuz M, Alves Kelly F. Bright Light Therapy for Nonseasonal Depressive Disorders: A Systematic Review and Meta-Analysis. JAMA Psychiatry. 2024 Oct 2:e242871 

Guest: Alan M. Ehrlich, MD, FAAFP Music Credit: Matthew Bugos
Thoughts? Suggestions? Email us at FranklySpeaking@pri-med.com 
 ]]></itunes:summary>
        <itunes:author>Pri-Med</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>623</itunes:duration>
                        <itunes:episodeType>full</itunes:episodeType>
            </item>
    <item>
        <title>Teenage Suicide and Social Media Use - Frankly Speaking Ep 408</title>
        <itunes:title>Teenage Suicide and Social Media Use - Frankly Speaking Ep 408</itunes:title>
        <link>https://primedfranklyspeaking.podbean.com/e/teenage-suicide-and-social-media-use-frankly-speaking-ep-408/</link>
                    <comments>https://primedfranklyspeaking.podbean.com/e/teenage-suicide-and-social-media-use-frankly-speaking-ep-408/#comments</comments>        <pubDate>Mon, 25 Nov 2024 00:30:00 +0000</pubDate>
        <guid isPermaLink="false">primedfranklyspeaking.podbean.com/f54b1a0f-af68-3f45-ada6-5b11ff719fcb</guid>
                                    <description><![CDATA[<p>Credits: 0.25 AMA PRA Category 1 Credit™
 
CME/CE Information and Claim Credit: https://www.pri-med.com/online-education/podcast/frankly-speaking-cme-408</p>
<p>Overview: This episode explores the connection between adolescent mental health and social media use. We discuss actionable strategies for clinicians, emphasizing practical screening, effective conversation starters, and tech tools to guide families. Improve outcomes by learning to balance screen time discussions and proactive mental health interventions in primary care.</p>
<p>Episode resource links:</p>
<p>JAMA Netw Open. 2024 Jul 1;7(7):e2419881. doi: 10.1001/jamanetworkopen.2024.19881
<a href='https://www.cdc.gov/healthyyouth/data/yrbs/yrbs_data_summary_and_trends.htm'>https://www.cdc.gov/healthyyouth/data/yrbs/yrbs_data_summary_and_trends.htm</a></p>
<p>
Guest: Alan M. Ehrlich, MD, FAAFP
 
Music Credit: Matthew Bugos</p>
<p>Thoughts? Suggestions? Email us at <a href='mailto:FranklySpeaking@pri-med.com'>FranklySpeaking@pri-med.com </a></p>
<p> </p>
<p> </p>
]]></description>
                                                            <content:encoded><![CDATA[<p>Credits: 0.25 AMA PRA Category 1 Credit™<br>
 <br>
CME/CE Information and Claim Credit: https://www.pri-med.com/online-education/podcast/frankly-speaking-cme-408</p>
<p>Overview: This episode explores the connection between adolescent mental health and social media use. We discuss actionable strategies for clinicians, emphasizing practical screening, effective conversation starters, and tech tools to guide families. Improve outcomes by learning to balance screen time discussions and proactive mental health interventions in primary care.</p>
<p>Episode resource links:</p>
<p>JAMA Netw Open. 2024 Jul 1;7(7):e2419881. doi: 10.1001/jamanetworkopen.2024.19881<br>
<a href='https://www.cdc.gov/healthyyouth/data/yrbs/yrbs_data_summary_and_trends.htm'>https://www.cdc.gov/healthyyouth/data/yrbs/yrbs_data_summary_and_trends.htm</a></p>
<p><br>
Guest: Alan M. Ehrlich, MD, FAAFP<br>
 <br>
Music Credit: Matthew Bugos</p>
<p>Thoughts? Suggestions? Email us at <a href='mailto:FranklySpeaking@pri-med.com'>FranklySpeaking@pri-med.com </a></p>
<p> </p>
<p> </p>
]]></content:encoded>
                                    
        <enclosure url="https://mcdn.podbean.com/mf/web/eexic5a9sfdsfjyi/frankly-speaking-408-social-media-teen-suicide.mp3" length="13661167" type="audio/mpeg"/>
                <itunes:summary><![CDATA[Credits: 0.25 AMA PRA Category 1 Credit™ CME/CE Information and Claim Credit: https://www.pri-med.com/online-education/podcast/frankly-speaking-cme-408
Overview: This episode explores the connection between adolescent mental health and social media use. We discuss actionable strategies for clinicians, emphasizing practical screening, effective conversation starters, and tech tools to guide families. Improve outcomes by learning to balance screen time discussions and proactive mental health interventions in primary care.
Episode resource links:
JAMA Netw Open. 2024 Jul 1;7(7):e2419881. doi: 10.1001/jamanetworkopen.2024.19881https://www.cdc.gov/healthyyouth/data/yrbs/yrbs_data_summary_and_trends.htm
Guest: Alan M. Ehrlich, MD, FAAFP Music Credit: Matthew Bugos
Thoughts? Suggestions? Email us at FranklySpeaking@pri-med.com 
 
 ]]></itunes:summary>
        <itunes:author>Pri-Med</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>852</itunes:duration>
                        <itunes:episodeType>full</itunes:episodeType>
            </item>
    <item>
        <title>Breast Cancer Risk and IUD Use - Frankly Speaking Ep 407</title>
        <itunes:title>Breast Cancer Risk and IUD Use - Frankly Speaking Ep 407</itunes:title>
        <link>https://primedfranklyspeaking.podbean.com/e/breast-cancer-risk-and-iud-use-frankly-speaking-ep-407/</link>
                    <comments>https://primedfranklyspeaking.podbean.com/e/breast-cancer-risk-and-iud-use-frankly-speaking-ep-407/#comments</comments>        <pubDate>Mon, 18 Nov 2024 00:30:00 +0000</pubDate>
        <guid isPermaLink="false">primedfranklyspeaking.podbean.com/9fc3eeee-6742-3bc0-9191-5f9503b734d9</guid>
                                    <description><![CDATA[<p>Credits: 0.25 AMA PRA Category 1 Credit™
 
CME/CE Information and Claim Credit: <a href='https://www.pri-med.com/online-education/podcast/frankly-speaking-cme-407'>https://www.pri-med.com/online-education/podcast/frankly-speaking-cme-407</a></p>
<p>Overview: Join us as we review the risks and benefits of contraceptive options, focusing on levonorgestrel intrauterine devices (IUDs) and their potential link to breast cancer risk. Hear the data and key considerations to help patients make informed decisions, balancing benefits and risks effectively in your primary care practice.</p>
<p>Episode resource links:</p>
<ul><li>Mørch LS, Meaidi A, Corn G, Hargreave M, Wessel Skovlund C. Breast Cancer in Users of Levonorgestrel-Releasing Intrauterine Systems. JAMA. Published online October 16, 2024. doi:10.1001/jama.2024.18575</li>
<li><a href='https://www.nytimes.com/2024/10/16/well/iud-breast-cancer-mirena-skyla.html?smid=url-share'>https://www.nytimes.com/2024/10/16/well/iud-breast-cancer-mirena-skyla.html?smid=url-share</a></li>
</ul>
<p>Guest: Jillian Joseph, PA-C
 
Music Credit: Matthew Bugos</p>
<p>Thoughts? Suggestions? Email us at <a href='mailto:FranklySpeaking@pri-med.com'>FranklySpeaking@pri-med.com</a></p>
<p> </p>
]]></description>
                                                            <content:encoded><![CDATA[<p>Credits: 0.25 AMA PRA Category 1 Credit™<br>
 <br>
CME/CE Information and Claim Credit: <a href='https://www.pri-med.com/online-education/podcast/frankly-speaking-cme-407'>https://www.pri-med.com/online-education/podcast/frankly-speaking-cme-407</a></p>
<p>Overview: Join us as we review the risks and benefits of contraceptive options, focusing on levonorgestrel intrauterine devices (IUDs) and their potential link to breast cancer risk. Hear the data and key considerations to help patients make informed decisions, balancing benefits and risks effectively in your primary care practice.</p>
<p>Episode resource links:</p>
<ul><li>Mørch LS, Meaidi A, Corn G, Hargreave M, Wessel Skovlund C. Breast Cancer in Users of Levonorgestrel-Releasing Intrauterine Systems. JAMA. Published online October 16, 2024. doi:10.1001/jama.2024.18575</li>
<li><a href='https://www.nytimes.com/2024/10/16/well/iud-breast-cancer-mirena-skyla.html?smid=url-share'>https://www.nytimes.com/2024/10/16/well/iud-breast-cancer-mirena-skyla.html?smid=url-share</a></li>
</ul>
<p>Guest: Jillian Joseph, PA-C<br>
 <br>
Music Credit: Matthew Bugos</p>
<p>Thoughts? Suggestions? Email us at <a href='mailto:FranklySpeaking@pri-med.com'>FranklySpeaking@pri-med.com</a></p>
<p> </p>
]]></content:encoded>
                                    
        <enclosure url="https://mcdn.podbean.com/mf/web/yhfgtjunngvih3ys/frankly-speaking-407-contraception-breast-cancer.mp3" length="12772823" type="audio/mpeg"/>
                <itunes:summary><![CDATA[Credits: 0.25 AMA PRA Category 1 Credit™ CME/CE Information and Claim Credit: https://www.pri-med.com/online-education/podcast/frankly-speaking-cme-407
Overview: Join us as we review the risks and benefits of contraceptive options, focusing on levonorgestrel intrauterine devices (IUDs) and their potential link to breast cancer risk. Hear the data and key considerations to help patients make informed decisions, balancing benefits and risks effectively in your primary care practice.
Episode resource links:
Mørch LS, Meaidi A, Corn G, Hargreave M, Wessel Skovlund C. Breast Cancer in Users of Levonorgestrel-Releasing Intrauterine Systems. JAMA. Published online October 16, 2024. doi:10.1001/jama.2024.18575
https://www.nytimes.com/2024/10/16/well/iud-breast-cancer-mirena-skyla.html?smid=url-share
Guest: Jillian Joseph, PA-C Music Credit: Matthew Bugos
Thoughts? Suggestions? Email us at FranklySpeaking@pri-med.com
 ]]></itunes:summary>
        <itunes:author>Pri-Med</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>796</itunes:duration>
                        <itunes:episodeType>full</itunes:episodeType>
            </item>
    <item>
        <title>The Nose Knows: Nasal Therapies on the Rise - Frankly Speaking Ep 406</title>
        <itunes:title>The Nose Knows: Nasal Therapies on the Rise - Frankly Speaking Ep 406</itunes:title>
        <link>https://primedfranklyspeaking.podbean.com/e/the-nose-knows-nasal-therapies-on-the-rise-frankly-speaking-ep-406/</link>
                    <comments>https://primedfranklyspeaking.podbean.com/e/the-nose-knows-nasal-therapies-on-the-rise-frankly-speaking-ep-406/#comments</comments>        <pubDate>Mon, 11 Nov 2024 00:30:00 +0000</pubDate>
        <guid isPermaLink="false">primedfranklyspeaking.podbean.com/95ce6c30-6a74-30d8-a544-54518af8d9c9</guid>
                                    <description><![CDATA[<p>Credits: 0.25 AMA PRA Category 1 Credit™
 
CME/CE Information and Claim Credit: <a href='https://www.pri-med.com/online-education/podcast/frankly-speaking-cme-406'>https://www.pri-med.com/online-education/podcast/frankly-speaking-cme-406</a></p>
<p>Overview: An increasing number of therapies are being formulated for nasal delivery. This episode reviews the use of 3 of these therapies: at-home flu vaccines, epinephrine for allergic reactions, and saline nasal sprays for the common cold. Hear how these newly available treatments can increase options for care in your clinical practice.</p>
<p>Episode resource links:</p>
<ul><li>Flu Vaccine: Vaccine. 2015 Jul 31;33(32):3894-9.  doi: 10.1016/j.vaccine.2015.06.061. Epub 2015 Jun 25.</li>
<li>Nasal Saline: <a href='https://k4.ersnet.org/prod/v2/Front/Program?e=549'>https://k4.ersnet.org/prod/v2/Front/Program?e=549</a></li>
<li>Nasal Epinephrine: <a href='https://www.fda.gov/news-events/press-announcements/fda-approves-first-nasal-spray-treatment-anaphylaxis'>https://www.fda.gov/news-events/press-announcements/fda-approves-first-nasal-spray-treatment-anaphylaxis</a></li>
</ul>
<p>Guest: Robert A. Baldor MD, FAAFP </p>
<p>Music Credit: Matthew Bugos</p>
<p>Thoughts? Suggestions? Email us at <a href='mailto:FranklySpeaking@pri-med.com'>FranklySpeaking@pri-med.com </a></p>
<p> </p>
]]></description>
                                                            <content:encoded><![CDATA[<p>Credits: 0.25 AMA PRA Category 1 Credit™<br>
 <br>
CME/CE Information and Claim Credit: <a href='https://www.pri-med.com/online-education/podcast/frankly-speaking-cme-406'>https://www.pri-med.com/online-education/podcast/frankly-speaking-cme-406</a></p>
<p>Overview: An increasing number of therapies are being formulated for nasal delivery. This episode reviews the use of 3 of these therapies: at-home flu vaccines, epinephrine for allergic reactions, and saline nasal sprays for the common cold. Hear how these newly available treatments can increase options for care in your clinical practice.</p>
<p>Episode resource links:</p>
<ul><li>Flu Vaccine: Vaccine. 2015 Jul 31;33(32):3894-9.  doi: 10.1016/j.vaccine.2015.06.061. Epub 2015 Jun 25.</li>
<li>Nasal Saline: <a href='https://k4.ersnet.org/prod/v2/Front/Program?e=549'>https://k4.ersnet.org/prod/v2/Front/Program?e=549</a></li>
<li>Nasal Epinephrine: <a href='https://www.fda.gov/news-events/press-announcements/fda-approves-first-nasal-spray-treatment-anaphylaxis'>https://www.fda.gov/news-events/press-announcements/fda-approves-first-nasal-spray-treatment-anaphylaxis</a></li>
</ul>
<p>Guest: Robert A. Baldor MD, FAAFP </p>
<p>Music Credit: Matthew Bugos</p>
<p>Thoughts? Suggestions? Email us at <a href='mailto:FranklySpeaking@pri-med.com'>FranklySpeaking@pri-med.com </a></p>
<p> </p>
]]></content:encoded>
                                    
        <enclosure url="https://mcdn.podbean.com/mf/web/xfj7e9mrqw2auhae/frankly-speaking-406-nose-knows.mp3" length="9658149" type="audio/mpeg"/>
                <itunes:summary><![CDATA[Credits: 0.25 AMA PRA Category 1 Credit™ CME/CE Information and Claim Credit: https://www.pri-med.com/online-education/podcast/frankly-speaking-cme-406
Overview: An increasing number of therapies are being formulated for nasal delivery. This episode reviews the use of 3 of these therapies: at-home flu vaccines, epinephrine for allergic reactions, and saline nasal sprays for the common cold. Hear how these newly available treatments can increase options for care in your clinical practice.
Episode resource links:
Flu Vaccine: Vaccine. 2015 Jul 31;33(32):3894-9.  doi: 10.1016/j.vaccine.2015.06.061. Epub 2015 Jun 25.
Nasal Saline: https://k4.ersnet.org/prod/v2/Front/Program?e=549
Nasal Epinephrine: https://www.fda.gov/news-events/press-announcements/fda-approves-first-nasal-spray-treatment-anaphylaxis
Guest: Robert A. Baldor MD, FAAFP 
Music Credit: Matthew Bugos
Thoughts? Suggestions? Email us at FranklySpeaking@pri-med.com 
 ]]></itunes:summary>
        <itunes:author>Pri-Med</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>602</itunes:duration>
                        <itunes:episodeType>full</itunes:episodeType>
            </item>
    <item>
        <title>The PREVENT Risk Calculator: A New Equation for Predicting Heart Health - Frankly Speaking Ep 405</title>
        <itunes:title>The PREVENT Risk Calculator: A New Equation for Predicting Heart Health - Frankly Speaking Ep 405</itunes:title>
        <link>https://primedfranklyspeaking.podbean.com/e/the-prevent-risk-calculator-a-new-equation-for-predicting-heart-health-frankly-speaking-ep-405/</link>
                    <comments>https://primedfranklyspeaking.podbean.com/e/the-prevent-risk-calculator-a-new-equation-for-predicting-heart-health-frankly-speaking-ep-405/#comments</comments>        <pubDate>Mon, 04 Nov 2024 00:30:00 +0000</pubDate>
        <guid isPermaLink="false">primedfranklyspeaking.podbean.com/c8e0712b-1423-3c4e-871c-de12760a5930</guid>
                                    <description><![CDATA[<p>Credits: 0.25 AMA PRA Category 1 Credit™
 
CME/CE Information and Claim Credit: <a href='https://www.pri-med.com/online-education/podcast/frankly-speaking-cme-405'>https://www.pri-med.com/online-education/podcast/frankly-speaking-cme-405</a></p>
<p>Overview: Explore the American Heart Association’s (AHA) newly validated risk calculator, designed to assess the likelihood of cardiovascular disease and heart failure in patients aged 30-79 years. Hear which risk factors are included, why they matter, and how this tool can enhance your preventive care strategies in primary care practice.</p>
<p>Episode resource links:</p>
<ul><li>Hypertension. 2024;81:00–00. DOI: 10.1161/HYPERTENSIONAHA.124.22998.)</li>
<li><a href='https://doi.org/10.1161/CIRCULATIONAHA.123.067626'>https://doi.org/10.1161/CIRCULATIONAHA.123.067626</a></li>
<li>The calculator: <a href='https://professional.heart.org/en/guidelines-and-statements/prevent-calculator'>https://professional.heart.org/en/guidelines-and-statements/prevent-calculator</a></li>
</ul>
<p>Guest: Robert A. Baldor MD, FAAFP </p>
<p>Music Credit: Matthew Bugos</p>
<p>Thoughts? Suggestions? Email us at <a href='mailto:FranklySpeaking@pri-med.com'>FranklySpeaking@pri-med.com </a></p>
<p> </p>
]]></description>
                                                            <content:encoded><![CDATA[<p>Credits: 0.25 AMA PRA Category 1 Credit™<br>
 <br>
CME/CE Information and Claim Credit: <a href='https://www.pri-med.com/online-education/podcast/frankly-speaking-cme-405'>https://www.pri-med.com/online-education/podcast/frankly-speaking-cme-405</a></p>
<p>Overview: Explore the American Heart Association’s (AHA) newly validated risk calculator, designed to assess the likelihood of cardiovascular disease and heart failure in patients aged 30-79 years. Hear which risk factors are included, why they matter, and how this tool can enhance your preventive care strategies in primary care practice.</p>
<p>Episode resource links:</p>
<ul><li>Hypertension. 2024;81:00–00. DOI: 10.1161/HYPERTENSIONAHA.124.22998.)</li>
<li><a href='https://doi.org/10.1161/CIRCULATIONAHA.123.067626'>https://doi.org/10.1161/CIRCULATIONAHA.123.067626</a></li>
<li>The calculator: <a href='https://professional.heart.org/en/guidelines-and-statements/prevent-calculator'>https://professional.heart.org/en/guidelines-and-statements/prevent-calculator</a></li>
</ul>
<p>Guest: Robert A. Baldor MD, FAAFP </p>
<p>Music Credit: Matthew Bugos</p>
<p>Thoughts? Suggestions? Email us at <a href='mailto:FranklySpeaking@pri-med.com'>FranklySpeaking@pri-med.com </a></p>
<p> </p>
]]></content:encoded>
                                    
        <enclosure url="https://mcdn.podbean.com/mf/web/kszbb3zhr47frpe6/frankly-speaking-405-preventing-heart-disease.mp3" length="10593956" type="audio/mpeg"/>
                <itunes:summary><![CDATA[Credits: 0.25 AMA PRA Category 1 Credit™ CME/CE Information and Claim Credit: https://www.pri-med.com/online-education/podcast/frankly-speaking-cme-405
Overview: Explore the American Heart Association’s (AHA) newly validated risk calculator, designed to assess the likelihood of cardiovascular disease and heart failure in patients aged 30-79 years. Hear which risk factors are included, why they matter, and how this tool can enhance your preventive care strategies in primary care practice.
Episode resource links:
Hypertension. 2024;81:00–00. DOI: 10.1161/HYPERTENSIONAHA.124.22998.)
https://doi.org/10.1161/CIRCULATIONAHA.123.067626
The calculator: https://professional.heart.org/en/guidelines-and-statements/prevent-calculator
Guest: Robert A. Baldor MD, FAAFP 
Music Credit: Matthew Bugos
Thoughts? Suggestions? Email us at FranklySpeaking@pri-med.com 
 ]]></itunes:summary>
        <itunes:author>Pri-Med</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>660</itunes:duration>
                        <itunes:episodeType>full</itunes:episodeType>
            </item>
    <item>
        <title>“Not Tonight”—The Impact of Female Sexual Dysfunction on Women’s Well-Being - Frankly Speaking Ep 404</title>
        <itunes:title>“Not Tonight”—The Impact of Female Sexual Dysfunction on Women’s Well-Being - Frankly Speaking Ep 404</itunes:title>
        <link>https://primedfranklyspeaking.podbean.com/e/not-tonight-%e2%80%94the-impact-of-female-sexual-dysfunction-on-women-s-well-being-frankly-speaking-ep-404/</link>
                    <comments>https://primedfranklyspeaking.podbean.com/e/not-tonight-%e2%80%94the-impact-of-female-sexual-dysfunction-on-women-s-well-being-frankly-speaking-ep-404/#comments</comments>        <pubDate>Mon, 28 Oct 2024 00:30:00 +0000</pubDate>
        <guid isPermaLink="false">primedfranklyspeaking.podbean.com/2c9732f8-115e-3133-9222-bdd06547a518</guid>
                                    <description><![CDATA[<p>Credits: 0.25 AMA PRA Category 1 Credit™
 
CME/CE Information and Claim Credit: <a href='https://www.pri-med.com/online-education/podcast/frankly-speaking-cme-405'>https://www.pri-med.com/online-education/podcast/frankly-speaking-cme-404</a></p>
<p>Overview: It’s estimated that between 40%-60% of women report some degree of sexual dysfunction, which can have a significant impact on an individual’s quality of life and personal relationships. Even though most clinicians understand the importance and relevance of female sexual dysfunction (FSD), they may not be aware of its prevalence, effective treatments, or how best to inquire about it. Join us as we discuss this condition, its impact on women, and evidence on effective treatments.</p>
<p>Episode resource links:</p>
<ul>
<li>Cristine Homsi Jorge, Kari Bø, Camila Chiazuto Catai, Luiz Gustavo Oliveira Brito, Patricia Driusso, Merete Kolberg Tennfjord. Pelvic floor muscle training as treatment for female sexual dysfunction: a systematic review and meta-analysis. American Journal of Obstetrics and Gynecology. Volume 231, Issue 1, 2024,Pages 51-66.e1,ISSN 0002-9378, <a href='https://doi.org/10.1016/j.ajog.2024.01.001.(https://www.sciencedirect.com/science/article/pii/S0002937824000061)'>https://doi.org/10.1016/j.ajog.2024.01.001.(https://www.sciencedirect.com/science/article/pii/S0002937824000061)</a></li>
<li>Davis, SR. Sexual dysfunction in women. New England Journal of Medicine. V 391. N 8; P 736-745. <a href='https://www.nejm.org/doi/full/10.1056/NEJMcp2313307'>https://www.nejm.org/doi/full/10.1056/NEJMcp2313307</a></li>
<li>Johnson, Isabella MS; Thurman, Andrea Ries MD; Cornell, Katherine A. BS; Hatheway, Jessica MBA; Dart, Clint MS; Brainard, C. Paige MD; Friend, David R. PhD; Goldstein, Andrew MD. Preliminary Efficacy of Topical Sildenafil Cream for the Treatment of Female Sexual Arousal Disorder: A Randomized Controlled Trial. Obstetrics &amp; Gynecology ():10.1097/AOG.0000000000005648, June 18, 2024. | DOI: 10.1097/AOG.0000000000005648</li>
<li>Kamrul-Hasan, A.B.M, Hannan, M A A, Muhammad S, M, Aalpona, Fatema, T Z, Nagendra, L., Selim, S,  Dutta, D, D. Role of flibanserin in managing hypoactive sexual desire disorder in women: A systematic review and meta-analysis. Medicine 103(25):p e38592, June 21, 2024. | DOI: 10.1097/MD.0000000000038592</li>
<li>Yao H, Zhang X, Sun F, Tang G, Wu J, Zhou Z. The efficacy of intravaginal electrical stimulation (IVES) in treating female with urinary incontinence symptom from meta-analysis of nine randomized controlled trials. Front Neurol. 2022;13:933679. Published 2022 Sep 13. doi:10.3389/fneur.2022.933679</li>
<li>Huang H, Ding G, Li M, Deng Y, Cheng Y, Jin H.(2023) Menopause and stress urinary incontinence: The risk factors of stress urinary incontinence in perimenopausal and postmenopausal women. J Obstet Gynaecol Res. 49(10): 2509–2518. <a href='https://doi.org/10.1111/jog.15742'>https://doi.org/10.1111/jog.15742</a></li>
<li>Tunn, R., Baessler, K., Knüpfer, S., &amp; Hampel, C. (2023). Urinary Incontinence and Pelvic Organ Prolapse in Women. Deutsches Arzteblatt international, 120(5), 71–80. <a href='https://doi.org/10.3238/arztebl.m2022.0406'>https://doi.org/10.3238/arztebl.m2022.0406</a></li>
</ul>
<p>Guest: Susan Feeney, DNP, FNP-BC, NP-C, Jill M. Terrien, PhD, ANP-BC</p>
<p>Music Credit: Matthew Bugos</p>
<p>Thoughts? Suggestions? Email us at <a href='mailto:FranklySpeaking@pri-med.com'>FranklySpeaking@pri-med.com</a></p>
<p> </p>
]]></description>
                                                            <content:encoded><![CDATA[<p>Credits: 0.25 AMA PRA Category 1 Credit™<br>
 <br>
CME/CE Information and Claim Credit: <a href='https://www.pri-med.com/online-education/podcast/frankly-speaking-cme-405'>https://www.pri-med.com/online-education/podcast/frankly-speaking-cme-404</a></p>
<p>Overview: It’s estimated that between 40%-60% of women report some degree of sexual dysfunction, which can have a significant impact on an individual’s quality of life and personal relationships. Even though most clinicians understand the importance and relevance of female sexual dysfunction (FSD), they may not be aware of its prevalence, effective treatments, or how best to inquire about it. Join us as we discuss this condition, its impact on women, and evidence on effective treatments.</p>
<p>Episode resource links:</p>
<ul>
<li>Cristine Homsi Jorge, Kari Bø, Camila Chiazuto Catai, Luiz Gustavo Oliveira Brito, Patricia Driusso, Merete Kolberg Tennfjord. Pelvic floor muscle training as treatment for female sexual dysfunction: a systematic review and meta-analysis. American Journal of Obstetrics and Gynecology. Volume 231, Issue 1, 2024,Pages 51-66.e1,ISSN 0002-9378, <a href='https://doi.org/10.1016/j.ajog.2024.01.001.(https://www.sciencedirect.com/science/article/pii/S0002937824000061)'>https://doi.org/10.1016/j.ajog.2024.01.001.(https://www.sciencedirect.com/science/article/pii/S0002937824000061)</a></li>
<li>Davis, SR. Sexual dysfunction in women. New England Journal of Medicine. V 391. N 8; P 736-745. <a href='https://www.nejm.org/doi/full/10.1056/NEJMcp2313307'>https://www.nejm.org/doi/full/10.1056/NEJMcp2313307</a></li>
<li>Johnson, Isabella MS; Thurman, Andrea Ries MD; Cornell, Katherine A. BS; Hatheway, Jessica MBA; Dart, Clint MS; Brainard, C. Paige MD; Friend, David R. PhD; Goldstein, Andrew MD. Preliminary Efficacy of Topical Sildenafil Cream for the Treatment of Female Sexual Arousal Disorder: A Randomized Controlled Trial. Obstetrics &amp; Gynecology ():10.1097/AOG.0000000000005648, June 18, 2024. | DOI: 10.1097/AOG.0000000000005648</li>
<li>Kamrul-Hasan, A.B.M, Hannan, M A A, Muhammad S, M, Aalpona, Fatema, T Z, Nagendra, L., Selim, S,  Dutta, D, D. Role of flibanserin in managing hypoactive sexual desire disorder in women: A systematic review and meta-analysis. Medicine 103(25):p e38592, June 21, 2024. | DOI: 10.1097/MD.0000000000038592</li>
<li>Yao H, Zhang X, Sun F, Tang G, Wu J, Zhou Z. The efficacy of intravaginal electrical stimulation (IVES) in treating female with urinary incontinence symptom from meta-analysis of nine randomized controlled trials. Front Neurol. 2022;13:933679. Published 2022 Sep 13. doi:10.3389/fneur.2022.933679</li>
<li>Huang H, Ding G, Li M, Deng Y, Cheng Y, Jin H.(2023) Menopause and stress urinary incontinence: The risk factors of stress urinary incontinence in perimenopausal and postmenopausal women. J Obstet Gynaecol Res. 49(10): 2509–2518. <a href='https://doi.org/10.1111/jog.15742'>https://doi.org/10.1111/jog.15742</a></li>
<li>Tunn, R., Baessler, K., Knüpfer, S., &amp; Hampel, C. (2023). Urinary Incontinence and Pelvic Organ Prolapse in Women. Deutsches Arzteblatt international, 120(5), 71–80. <a href='https://doi.org/10.3238/arztebl.m2022.0406'>https://doi.org/10.3238/arztebl.m2022.0406</a></li>
</ul>
<p>Guest: Susan Feeney, DNP, FNP-BC, NP-C, Jill M. Terrien, PhD, ANP-BC</p>
<p>Music Credit: Matthew Bugos</p>
<p>Thoughts? Suggestions? Email us at <a href='mailto:FranklySpeaking@pri-med.com'>FranklySpeaking@pri-med.com</a></p>
<p> </p>
]]></content:encoded>
                                    
        <enclosure url="https://mcdn.podbean.com/mf/web/bvwrg6372k2bddsc/frankly-speaking-404-pelvic-floor-east.mp3" length="15663615" type="audio/mpeg"/>
                <itunes:summary><![CDATA[Credits: 0.25 AMA PRA Category 1 Credit™ CME/CE Information and Claim Credit: https://www.pri-med.com/online-education/podcast/frankly-speaking-cme-404
Overview: It’s estimated that between 40%-60% of women report some degree of sexual dysfunction, which can have a significant impact on an individual’s quality of life and personal relationships. Even though most clinicians understand the importance and relevance of female sexual dysfunction (FSD), they may not be aware of its prevalence, effective treatments, or how best to inquire about it. Join us as we discuss this condition, its impact on women, and evidence on effective treatments.
Episode resource links:

Cristine Homsi Jorge, Kari Bø, Camila Chiazuto Catai, Luiz Gustavo Oliveira Brito, Patricia Driusso, Merete Kolberg Tennfjord. Pelvic floor muscle training as treatment for female sexual dysfunction: a systematic review and meta-analysis. American Journal of Obstetrics and Gynecology. Volume 231, Issue 1, 2024,Pages 51-66.e1,ISSN 0002-9378, https://doi.org/10.1016/j.ajog.2024.01.001.(https://www.sciencedirect.com/science/article/pii/S0002937824000061)
Davis, SR. Sexual dysfunction in women. New England Journal of Medicine. V 391. N 8; P 736-745. https://www.nejm.org/doi/full/10.1056/NEJMcp2313307
Johnson, Isabella MS; Thurman, Andrea Ries MD; Cornell, Katherine A. BS; Hatheway, Jessica MBA; Dart, Clint MS; Brainard, C. Paige MD; Friend, David R. PhD; Goldstein, Andrew MD. Preliminary Efficacy of Topical Sildenafil Cream for the Treatment of Female Sexual Arousal Disorder: A Randomized Controlled Trial. Obstetrics &amp; Gynecology ():10.1097/AOG.0000000000005648, June 18, 2024. | DOI: 10.1097/AOG.0000000000005648
Kamrul-Hasan, A.B.M, Hannan, M A A, Muhammad S, M, Aalpona, Fatema, T Z, Nagendra, L., Selim, S,  Dutta, D, D. Role of flibanserin in managing hypoactive sexual desire disorder in women: A systematic review and meta-analysis. Medicine 103(25):p e38592, June 21, 2024. | DOI: 10.1097/MD.0000000000038592
Yao H, Zhang X, Sun F, Tang G, Wu J, Zhou Z. The efficacy of intravaginal electrical stimulation (IVES) in treating female with urinary incontinence symptom from meta-analysis of nine randomized controlled trials. Front Neurol. 2022;13:933679. Published 2022 Sep 13. doi:10.3389/fneur.2022.933679
Huang H, Ding G, Li M, Deng Y, Cheng Y, Jin H.(2023) Menopause and stress urinary incontinence: The risk factors of stress urinary incontinence in perimenopausal and postmenopausal women. J Obstet Gynaecol Res. 49(10): 2509–2518. https://doi.org/10.1111/jog.15742
Tunn, R., Baessler, K., Knüpfer, S., &amp; Hampel, C. (2023). Urinary Incontinence and Pelvic Organ Prolapse in Women. Deutsches Arzteblatt international, 120(5), 71–80. https://doi.org/10.3238/arztebl.m2022.0406

Guest: Susan Feeney, DNP, FNP-BC, NP-C, Jill M. Terrien, PhD, ANP-BC
Music Credit: Matthew Bugos
Thoughts? Suggestions? Email us at FranklySpeaking@pri-med.com
 ]]></itunes:summary>
        <itunes:author>Pri-Med</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>977</itunes:duration>
                        <itunes:episodeType>full</itunes:episodeType>
            </item>
    <item>
        <title>Starting Medications for T2DM: When Metformin Isn’t the First Choice - Frankly Speaking Ep 403</title>
        <itunes:title>Starting Medications for T2DM: When Metformin Isn’t the First Choice - Frankly Speaking Ep 403</itunes:title>
        <link>https://primedfranklyspeaking.podbean.com/e/starting-medications-for-t2dm-when-metformin-isn-t-the-first-choice-frankly-speaking-ep-403/</link>
                    <comments>https://primedfranklyspeaking.podbean.com/e/starting-medications-for-t2dm-when-metformin-isn-t-the-first-choice-frankly-speaking-ep-403/#comments</comments>        <pubDate>Mon, 21 Oct 2024 00:30:00 +0000</pubDate>
        <guid isPermaLink="false">primedfranklyspeaking.podbean.com/26e6d3d5-4653-350c-9873-e5217c80fcc8</guid>
                                    <description><![CDATA[<p>Credits: 0.25 AMA PRA Category 1 Credit™
 
CME/CE Information and Claim Credit: <a href='https://www.pri-med.com/online-education/podcast/frankly-speaking-cme-403'>https://www.pri-med.com/online-education/podcast/frankly-speaking-cme-403</a></p>
<p>Overview: Recorded live at Pri-Med East! - The American Diabetes Association (ADA) has updated their standards of care for patients with diabetes. In this episode, we discuss some of the changes in the initial selection of glucose-lowering medications for type 2 diabetes mellitus (T2DM), including when alternatives to metformin may be appropriate. Hear strategies for making personalized, guideline-recommended choices that enhance care for patients with T2DM.</p>
<p>Episode resource links:</p>
<ul><li>Pharmacologic Approaches to Glycemic Treatment. In: American Diabetes Association. Standardsof Care in Diabetes2024 - DiabetesCare 2024 Jan 1;47(Suppl 1):S1-S321</li>
</ul>
<p>Guest: Alan M. Ehrlich, MD, FAAFP </p>
<p>Music Credit: Matthew Bugos</p>
<p>Thoughts? Suggestions? Email us at <a href='mailto:FranklySpeaking@pri-med.com'>FranklySpeaking@pri-med.com </a></p>
<p> </p>
]]></description>
                                                            <content:encoded><![CDATA[<p>Credits: 0.25 AMA PRA Category 1 Credit™<br>
 <br>
CME/CE Information and Claim Credit: <a href='https://www.pri-med.com/online-education/podcast/frankly-speaking-cme-403'>https://www.pri-med.com/online-education/podcast/frankly-speaking-cme-403</a></p>
<p>Overview: Recorded live at Pri-Med East! - The American Diabetes Association (ADA) has updated their standards of care for patients with diabetes. In this episode, we discuss some of the changes in the initial selection of glucose-lowering medications for type 2 diabetes mellitus (T2DM), including when alternatives to metformin may be appropriate. Hear strategies for making personalized, guideline-recommended choices that enhance care for patients with T2DM.</p>
<p>Episode resource links:</p>
<ul><li>Pharmacologic Approaches to Glycemic Treatment. In: American Diabetes Association. Standardsof Care in Diabetes2024 - DiabetesCare 2024 Jan 1;47(Suppl 1):S1-S321</li>
</ul>
<p>Guest: Alan M. Ehrlich, MD, FAAFP </p>
<p>Music Credit: Matthew Bugos</p>
<p>Thoughts? Suggestions? Email us at <a href='mailto:FranklySpeaking@pri-med.com'>FranklySpeaking@pri-med.com </a></p>
<p> </p>
]]></content:encoded>
                                    
        <enclosure url="https://mcdn.podbean.com/mf/web/xtvkt4veu5b3qdtu/frankly-speaking-403-meds-type2-diabetes.mp3" length="12296437" type="audio/mpeg"/>
                <itunes:summary><![CDATA[Credits: 0.25 AMA PRA Category 1 Credit™ CME/CE Information and Claim Credit: https://www.pri-med.com/online-education/podcast/frankly-speaking-cme-403
Overview: Recorded live at Pri-Med East! - The American Diabetes Association (ADA) has updated their standards of care for patients with diabetes. In this episode, we discuss some of the changes in the initial selection of glucose-lowering medications for type 2 diabetes mellitus (T2DM), including when alternatives to metformin may be appropriate. Hear strategies for making personalized, guideline-recommended choices that enhance care for patients with T2DM.
Episode resource links:
Pharmacologic Approaches to Glycemic Treatment. In: American Diabetes Association. Standardsof Care in Diabetes2024 - DiabetesCare 2024 Jan 1;47(Suppl 1):S1-S321
Guest: Alan M. Ehrlich, MD, FAAFP 
Music Credit: Matthew Bugos
Thoughts? Suggestions? Email us at FranklySpeaking@pri-med.com 
 ]]></itunes:summary>
        <itunes:author>Pri-Med</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>767</itunes:duration>
                        <itunes:episodeType>full</itunes:episodeType>
            </item>
    <item>
        <title>Dialing in Hypertension Treatment: Managing Adverse Effects in Older Adults - Frankly Speaking Ep 402</title>
        <itunes:title>Dialing in Hypertension Treatment: Managing Adverse Effects in Older Adults - Frankly Speaking Ep 402</itunes:title>
        <link>https://primedfranklyspeaking.podbean.com/e/dialing-in-hypertension-treatment-managing-adverse-effects-in-older-adults-frankly-speaking-ep-402/</link>
                    <comments>https://primedfranklyspeaking.podbean.com/e/dialing-in-hypertension-treatment-managing-adverse-effects-in-older-adults-frankly-speaking-ep-402/#comments</comments>        <pubDate>Mon, 14 Oct 2024 00:30:00 +0000</pubDate>
        <guid isPermaLink="false">primedfranklyspeaking.podbean.com/0e275a62-fab4-36b2-af73-89d564bdff9e</guid>
                                    <description><![CDATA[<p>Credits: 0.25 AMA PRA Category 1 Credit™
 
CME/CE Information and Claim Credit: <a href='https://www.pri-med.com/online-education/podcast/frankly-speaking-cme-402'>https://www.pri-med.com/online-education/podcast/frankly-speaking-cme-402</a></p>
<p>Overview: Some blood pressure medications have been found to cause adverse side effects in older adults, such as itchy skin and an increased risk of stroke. Join us as we cover 2 recent publications that add clinical implications to which blood pressure medications we use. Come away feeling confident to improve hypertension outcomes in older patients.</p>
<p>Episode resource links:</p>
<ul><li>JAMA Dermatol. Published online May 22, 2024. doi:10.1001/jamadermatol.2024.1230</li>
<li>JAMA Netw Open. 2023;6(12):e2344998. doi:10.1001/jamanetworkopen.2023.44998</li>
</ul>
<p>Guest: Robert A. Baldor MD, FAAFP</p>
<p>Music Credit: Matthew Bugos</p>
<p>Thoughts? Suggestions? Email us at <a href='mailto:FranklySpeaking@pri-med.com'>FranklySpeaking@pri-med.com</a></p>
<p> </p>
]]></description>
                                                            <content:encoded><![CDATA[<p>Credits: 0.25 AMA PRA Category 1 Credit™<br>
 <br>
CME/CE Information and Claim Credit: <a href='https://www.pri-med.com/online-education/podcast/frankly-speaking-cme-402'>https://www.pri-med.com/online-education/podcast/frankly-speaking-cme-402</a></p>
<p>Overview: Some blood pressure medications have been found to cause adverse side effects in older adults, such as itchy skin and an increased risk of stroke. Join us as we cover 2 recent publications that add clinical implications to which blood pressure medications we use. Come away feeling confident to improve hypertension outcomes in older patients.</p>
<p>Episode resource links:</p>
<ul><li>JAMA Dermatol. Published online May 22, 2024. doi:10.1001/jamadermatol.2024.1230</li>
<li>JAMA Netw Open. 2023;6(12):e2344998. doi:10.1001/jamanetworkopen.2023.44998</li>
</ul>
<p>Guest: Robert A. Baldor MD, FAAFP</p>
<p>Music Credit: Matthew Bugos</p>
<p>Thoughts? Suggestions? Email us at <a href='mailto:FranklySpeaking@pri-med.com'>FranklySpeaking@pri-med.com</a></p>
<p> </p>
]]></content:encoded>
                                    
        <enclosure url="https://mcdn.podbean.com/mf/web/zf43f2u2tnupzecn/frankly-speaking-402-itching-in-aging.mp3" length="9631081" type="audio/mpeg"/>
                <itunes:summary><![CDATA[Credits: 0.25 AMA PRA Category 1 Credit™ CME/CE Information and Claim Credit: https://www.pri-med.com/online-education/podcast/frankly-speaking-cme-402
Overview: Some blood pressure medications have been found to cause adverse side effects in older adults, such as itchy skin and an increased risk of stroke. Join us as we cover 2 recent publications that add clinical implications to which blood pressure medications we use. Come away feeling confident to improve hypertension outcomes in older patients.
Episode resource links:
JAMA Dermatol. Published online May 22, 2024. doi:10.1001/jamadermatol.2024.1230
JAMA Netw Open. 2023;6(12):e2344998. doi:10.1001/jamanetworkopen.2023.44998
Guest: Robert A. Baldor MD, FAAFP
Music Credit: Matthew Bugos
Thoughts? Suggestions? Email us at FranklySpeaking@pri-med.com
 ]]></itunes:summary>
        <itunes:author>Pri-Med</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>600</itunes:duration>
                        <itunes:episodeType>full</itunes:episodeType>
            </item>
    <item>
        <title>Mind and Muscle: Exercise as Therapy for Depression - Frankly Speaking Ep 401</title>
        <itunes:title>Mind and Muscle: Exercise as Therapy for Depression - Frankly Speaking Ep 401</itunes:title>
        <link>https://primedfranklyspeaking.podbean.com/e/mind-and-muscle-exercise-as-therapy-for-depression-frankly-speaking-ep-401/</link>
                    <comments>https://primedfranklyspeaking.podbean.com/e/mind-and-muscle-exercise-as-therapy-for-depression-frankly-speaking-ep-401/#comments</comments>        <pubDate>Mon, 07 Oct 2024 00:30:00 +0000</pubDate>
        <guid isPermaLink="false">primedfranklyspeaking.podbean.com/875eeb60-5224-3fd3-a8bf-fa663e09c78a</guid>
                                    <description><![CDATA[<p>Credits: 0.25 AMA PRA Category 1 Credit™
 
CME/CE Information and Claim Credit: <a href='https://www.pri-med.com/online-education/podcast/frankly-speaking-cme-401'>https://www.pri-med.com/online-education/podcast/frankly-speaking-cme-401</a></p>
<p>Overview: Evidence has shown that exercise can improve mood, but how successful is it for treating depression compared to other therapies? What types and intensities are most effective? Discover insights from a recent meta-analysis on the effects of exercise on depression and strategies to promote it in those with major depression.</p>
<p>Episode resource links:</p>
<ul><li>Noetel M, Sanders T, Gallardo-GÃ³mez D, Taylor P, del Pozo Cruz B, van den Hoek D et al. Effect of exercise for depression: systematic review and network meta-analysis of randomised controlled trials BMJ 2024; 384 :e075847 doi:10.1136/bmj-2023-075847</li>
<li>Vancampfort, D., Hallgren, M., Firth, J., Rosenbaum, S., Schuch, F. B., Mugisha, J., Probst, M., Van Damme, T., Carvalho, A. F., &amp; Stubbs, B. (2017). Physical activity and suicidal ideation: a systematic review and meta-analysis. Journal of Affective Disorders. <a href='https://doi.org/10.1016/j.jad.2017.08.070'>https://doi.org/10.1016/j.jad.2017.08.070</a></li>
</ul>
<p>Guest: Susan Feeney, DNP, FNP-BC, NP-C</p>
<p>Music Credit: Matthew Bugos</p>
<p>Thoughts? Suggestions? Email us at <a href='mailto:FranklySpeaking@pri-med.com'>FranklySpeaking@pri-med.com</a></p>
<p> </p>
]]></description>
                                                            <content:encoded><![CDATA[<p>Credits: 0.25 AMA PRA Category 1 Credit™<br>
 <br>
CME/CE Information and Claim Credit: <a href='https://www.pri-med.com/online-education/podcast/frankly-speaking-cme-401'>https://www.pri-med.com/online-education/podcast/frankly-speaking-cme-401</a></p>
<p>Overview: Evidence has shown that exercise can improve mood, but how successful is it for treating depression compared to other therapies? What types and intensities are most effective? Discover insights from a recent meta-analysis on the effects of exercise on depression and strategies to promote it in those with major depression.</p>
<p>Episode resource links:</p>
<ul><li>Noetel M, Sanders T, Gallardo-GÃ³mez D, Taylor P, del Pozo Cruz B, van den Hoek D et al. Effect of exercise for depression: systematic review and network meta-analysis of randomised controlled trials BMJ 2024; 384 :e075847 doi:10.1136/bmj-2023-075847</li>
<li>Vancampfort, D., Hallgren, M., Firth, J., Rosenbaum, S., Schuch, F. B., Mugisha, J., Probst, M., Van Damme, T., Carvalho, A. F., &amp; Stubbs, B. (2017). Physical activity and suicidal ideation: a systematic review and meta-analysis. Journal of Affective Disorders. <a href='https://doi.org/10.1016/j.jad.2017.08.070'>https://doi.org/10.1016/j.jad.2017.08.070</a></li>
</ul>
<p>Guest: Susan Feeney, DNP, FNP-BC, NP-C</p>
<p>Music Credit: Matthew Bugos</p>
<p>Thoughts? Suggestions? Email us at <a href='mailto:FranklySpeaking@pri-med.com'>FranklySpeaking@pri-med.com</a></p>
<p> </p>
]]></content:encoded>
                                    
        <enclosure url="https://mcdn.podbean.com/mf/web/h7x33ff58m8umufw/frankly-speaking-401-exercise-for-depression.mp3" length="9648639" type="audio/mpeg"/>
                <itunes:summary><![CDATA[Credits: 0.25 AMA PRA Category 1 Credit™ CME/CE Information and Claim Credit: https://www.pri-med.com/online-education/podcast/frankly-speaking-cme-401
Overview: Evidence has shown that exercise can improve mood, but how successful is it for treating depression compared to other therapies? What types and intensities are most effective? Discover insights from a recent meta-analysis on the effects of exercise on depression and strategies to promote it in those with major depression.
Episode resource links:
Noetel M, Sanders T, Gallardo-GÃ³mez D, Taylor P, del Pozo Cruz B, van den Hoek D et al. Effect of exercise for depression: systematic review and network meta-analysis of randomised controlled trials BMJ 2024; 384 :e075847 doi:10.1136/bmj-2023-075847
Vancampfort, D., Hallgren, M., Firth, J., Rosenbaum, S., Schuch, F. B., Mugisha, J., Probst, M., Van Damme, T., Carvalho, A. F., &amp; Stubbs, B. (2017). Physical activity and suicidal ideation: a systematic review and meta-analysis. Journal of Affective Disorders. https://doi.org/10.1016/j.jad.2017.08.070
Guest: Susan Feeney, DNP, FNP-BC, NP-C
Music Credit: Matthew Bugos
Thoughts? Suggestions? Email us at FranklySpeaking@pri-med.com
 ]]></itunes:summary>
        <itunes:author>Pri-Med</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>601</itunes:duration>
                        <itunes:episodeType>full</itunes:episodeType>
            </item>
    <item>
        <title>Self-Collection Testing Brings Comfort to Care in Cervical Cancer Screening - Frankly Speaking Ep 400</title>
        <itunes:title>Self-Collection Testing Brings Comfort to Care in Cervical Cancer Screening - Frankly Speaking Ep 400</itunes:title>
        <link>https://primedfranklyspeaking.podbean.com/e/self-collection-testing-brings-comfort-to-care-in-cervical-cancer-screening-frankly-speaking-ep-400/</link>
                    <comments>https://primedfranklyspeaking.podbean.com/e/self-collection-testing-brings-comfort-to-care-in-cervical-cancer-screening-frankly-speaking-ep-400/#comments</comments>        <pubDate>Mon, 30 Sep 2024 00:30:00 +0000</pubDate>
        <guid isPermaLink="false">primedfranklyspeaking.podbean.com/030f8276-ed74-366f-acd6-d9b243ee091d</guid>
                                    <description><![CDATA[<p>Credits: 0.25 AMA PRA Category 1 Credit™
 
CME/CE Information and Claim Credit: <a href='https://www.pri-med.com/online-education/podcast/frankly-speaking-cme-400'>https://www.pri-med.com/online-education/podcast/frankly-speaking-cme-400</a></p>
<p>Overview: The FDA recently approved primary human papillomavirus (HPV) self-collection for cervical cancer screening in a healthcare setting. Join us as we explore how to counsel patients on this less invasive method and find out what’s on the horizon for at-home collection kits.</p>
<p>Episode resource links:</p>
<ul><li><a href='https://www.accessdata.fda.gov/scripts/cdrh/cfdocs/cfpma/pma.cfm?id=P160037'>https://www.accessdata.fda.gov/scripts/cdrh/cfdocs/cfpma/pma.cfm?id=P160037</a></li>
<li>Journal of Clinical Virology, 2020-06-01, Volume 127, Article 104375, Copyright © 2020 Elsevier B.V. </li>
<li>JAMA. 2023;330(20):1971-1981. doi:10.1001/jama.2023.21471</li>
</ul>
<p>Guest: Robert A. Baldor MD, FAAFP</p>
<p>Music Credit: Matthew Bugos</p>
<p>Thoughts? Suggestions? Email us at <a href='mailto:FranklySpeaking@pri-med.com'>FranklySpeaking@pri-med.com</a></p>
<p> </p>
]]></description>
                                                            <content:encoded><![CDATA[<p>Credits: 0.25 AMA PRA Category 1 Credit™<br>
 <br>
CME/CE Information and Claim Credit: <a href='https://www.pri-med.com/online-education/podcast/frankly-speaking-cme-400'>https://www.pri-med.com/online-education/podcast/frankly-speaking-cme-400</a></p>
<p>Overview: The FDA recently approved primary human papillomavirus (HPV) self-collection for cervical cancer screening in a healthcare setting. Join us as we explore how to counsel patients on this less invasive method and find out what’s on the horizon for at-home collection kits.</p>
<p>Episode resource links:</p>
<ul><li><a href='https://www.accessdata.fda.gov/scripts/cdrh/cfdocs/cfpma/pma.cfm?id=P160037'>https://www.accessdata.fda.gov/scripts/cdrh/cfdocs/cfpma/pma.cfm?id=P160037</a></li>
<li>Journal of Clinical Virology, 2020-06-01, Volume 127, Article 104375, Copyright © 2020 Elsevier B.V. </li>
<li>JAMA. 2023;330(20):1971-1981. doi:10.1001/jama.2023.21471</li>
</ul>
<p>Guest: Robert A. Baldor MD, FAAFP</p>
<p>Music Credit: Matthew Bugos</p>
<p>Thoughts? Suggestions? Email us at <a href='mailto:FranklySpeaking@pri-med.com'>FranklySpeaking@pri-med.com</a></p>
<p> </p>
]]></content:encoded>
                                    
        <enclosure url="https://mcdn.podbean.com/mf/web/aesszgpbsnh87s75/frankly-speaking-400-cervical-self-swab.mp3" length="8756232" type="audio/mpeg"/>
                <itunes:summary><![CDATA[Credits: 0.25 AMA PRA Category 1 Credit™ CME/CE Information and Claim Credit: https://www.pri-med.com/online-education/podcast/frankly-speaking-cme-400
Overview: The FDA recently approved primary human papillomavirus (HPV) self-collection for cervical cancer screening in a healthcare setting. Join us as we explore how to counsel patients on this less invasive method and find out what’s on the horizon for at-home collection kits.
Episode resource links:
https://www.accessdata.fda.gov/scripts/cdrh/cfdocs/cfpma/pma.cfm?id=P160037
Journal of Clinical Virology, 2020-06-01, Volume 127, Article 104375, Copyright © 2020 Elsevier B.V. 
JAMA. 2023;330(20):1971-1981. doi:10.1001/jama.2023.21471
Guest: Robert A. Baldor MD, FAAFP
Music Credit: Matthew Bugos
Thoughts? Suggestions? Email us at FranklySpeaking@pri-med.com
 ]]></itunes:summary>
        <itunes:author>Pri-Med</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>545</itunes:duration>
                        <itunes:episodeType>full</itunes:episodeType>
            </item>
    <item>
        <title>The Dual Advantage: Improving Alzheimer Care with Combination Therapy - Frankly Speaking Ep 399</title>
        <itunes:title>The Dual Advantage: Improving Alzheimer Care with Combination Therapy - Frankly Speaking Ep 399</itunes:title>
        <link>https://primedfranklyspeaking.podbean.com/e/the-dual-advantage-improving-alzheimer-care-with-combination-therapy-frankly-speaking-ep-399/</link>
                    <comments>https://primedfranklyspeaking.podbean.com/e/the-dual-advantage-improving-alzheimer-care-with-combination-therapy-frankly-speaking-ep-399/#comments</comments>        <pubDate>Mon, 23 Sep 2024 00:30:00 +0000</pubDate>
        <guid isPermaLink="false">primedfranklyspeaking.podbean.com/56f3e580-a6ae-31ad-8314-157c3a2d2467</guid>
                                    <description><![CDATA[<p>Credits: 0.25 AMA PRA Category 1 Credit™
 
CME/CE Information and Claim Credit: <a href='https://www.pri-med.com/online-education/podcast/frankly-speaking-cme-399'>https://www.pri-med.com/online-education/podcast/frankly-speaking-cme-399</a></p>
<p>Overview: In this episode, we look at a new study showing increased probability of survival for patients with Alzheimer disease (AD) who take donepezil and memantine together. We review current treatments for AD and address common hesitations in prescribing dual pharmacotherapy, providing vital insights for primary care clinicians.</p>
<p>Episode resource links:</p>
<ul><li>Yaghmaei, E., Lu, H., Ehwerhemuepha, L. et al. Combined use of Donepezil and Memantine increases the probability of five-year survival of Alzheimer’s disease patients.Commun Med 4, 99 (2024). https://doi.org/10.1038/s43856-024-00527-6</li>
<li>Guo J, Wang Z, Liu R, Huang Y, Zhang N, Zhang R. Memantine, Donepezil, or Combination Therapy-What is the best therapy for Alzheimer's Disease? A Network Meta-Analysis. Brain Behav. 2020 Nov;10(11):e01831. doi: 10.1002/brb3.1831. Epub 2020 Sep 10. PMID: 32914577; PMCID: PMC7667299.</li>
</ul>
<p>Guest: Jillian Joseph, MPAS, PA-C</p>
<p>Music Credit: Matthew Bugos</p>
<p>Thoughts? Suggestions? Email us at <a href='mailto:FranklySpeaking@pri-med.com'>FranklySpeaking@pri-med.com </a></p>
<p> </p>
]]></description>
                                                            <content:encoded><![CDATA[<p>Credits: 0.25 AMA PRA Category 1 Credit™<br>
 <br>
CME/CE Information and Claim Credit: <a href='https://www.pri-med.com/online-education/podcast/frankly-speaking-cme-399'>https://www.pri-med.com/online-education/podcast/frankly-speaking-cme-399</a></p>
<p>Overview: In this episode, we look at a new study showing increased probability of survival for patients with Alzheimer disease (AD) who take donepezil and memantine together. We review current treatments for AD and address common hesitations in prescribing dual pharmacotherapy, providing vital insights for primary care clinicians.</p>
<p>Episode resource links:</p>
<ul><li>Yaghmaei, E., Lu, H., Ehwerhemuepha, L. et al. Combined use of Donepezil and Memantine increases the probability of five-year survival of Alzheimer’s disease patients.Commun Med 4, 99 (2024). https://doi.org/10.1038/s43856-024-00527-6</li>
<li>Guo J, Wang Z, Liu R, Huang Y, Zhang N, Zhang R. Memantine, Donepezil, or Combination Therapy-What is the best therapy for Alzheimer's Disease? A Network Meta-Analysis. Brain Behav. 2020 Nov;10(11):e01831. doi: 10.1002/brb3.1831. Epub 2020 Sep 10. PMID: 32914577; PMCID: PMC7667299.</li>
</ul>
<p>Guest: Jillian Joseph, MPAS, PA-C</p>
<p>Music Credit: Matthew Bugos</p>
<p>Thoughts? Suggestions? Email us at <a href='mailto:FranklySpeaking@pri-med.com'>FranklySpeaking@pri-med.com </a></p>
<p> </p>
]]></content:encoded>
                                    
        <enclosure url="https://mcdn.podbean.com/mf/web/2i2g6nnzvcimetqs/frankly-speaking-399-dementia.mp3" length="9908017" type="audio/mpeg"/>
                <itunes:summary><![CDATA[Credits: 0.25 AMA PRA Category 1 Credit™ CME/CE Information and Claim Credit: https://www.pri-med.com/online-education/podcast/frankly-speaking-cme-399
Overview: In this episode, we look at a new study showing increased probability of survival for patients with Alzheimer disease (AD) who take donepezil and memantine together. We review current treatments for AD and address common hesitations in prescribing dual pharmacotherapy, providing vital insights for primary care clinicians.
Episode resource links:
Yaghmaei, E., Lu, H., Ehwerhemuepha, L. et al. Combined use of Donepezil and Memantine increases the probability of five-year survival of Alzheimer’s disease patients.Commun Med 4, 99 (2024). https://doi.org/10.1038/s43856-024-00527-6
Guo J, Wang Z, Liu R, Huang Y, Zhang N, Zhang R. Memantine, Donepezil, or Combination Therapy-What is the best therapy for Alzheimer's Disease? A Network Meta-Analysis. Brain Behav. 2020 Nov;10(11):e01831. doi: 10.1002/brb3.1831. Epub 2020 Sep 10. PMID: 32914577; PMCID: PMC7667299.
Guest: Jillian Joseph, MPAS, PA-C
Music Credit: Matthew Bugos
Thoughts? Suggestions? Email us at FranklySpeaking@pri-med.com 
 ]]></itunes:summary>
        <itunes:author>Pri-Med</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>617</itunes:duration>
                        <itunes:episodeType>full</itunes:episodeType>
            </item>
    <item>
        <title>Walk It Off: Preventing Recurrences of Low Back Pain - Frankly Speaking Ep 398</title>
        <itunes:title>Walk It Off: Preventing Recurrences of Low Back Pain - Frankly Speaking Ep 398</itunes:title>
        <link>https://primedfranklyspeaking.podbean.com/e/walk-it-off-preventing-recurrences-of-low-back-pain-frankly-speaking-ep-398/</link>
                    <comments>https://primedfranklyspeaking.podbean.com/e/walk-it-off-preventing-recurrences-of-low-back-pain-frankly-speaking-ep-398/#comments</comments>        <pubDate>Mon, 16 Sep 2024 00:30:00 +0000</pubDate>
        <guid isPermaLink="false">primedfranklyspeaking.podbean.com/147bf1bf-85a1-3fca-9c7b-bde2f481a01c</guid>
                                    <description><![CDATA[<p>Credits: 0.25 AMA PRA Category 1 Credit™
 
CME/CE Information and Claim Credit: <a href='https://www.pri-med.com/online-education/podcast/frankly-speaking-cme-398'>https://www.pri-med.com/online-education/podcast/frankly-speaking-cme-398</a></p>
<p>Overview: Low back pain is the leading cause of years lived with disability, with approximately 70% of individuals experiencing a recurrence within 12 months following recovery from an episode. Clinicians are poised to play a crucial role in encouraging patients to incorporate walking to prevent recurrences of low back pain.</p>
<p>Episode resource links:</p>
<ul><li>Pocovi NC, Lin CC, French SD, Graham PL, van Dongen JM, Latimer J, Merom D, Tiedemann A, Maher CG, Clavisi O, Tong SYK, Hancock MJ. Effectiveness and cost-effectiveness of an individualised, progressive walking and education intervention for the prevention of low back pain recurrence in Australia (WalkBack): a randomised controlled trial. Lancet. 2024 Jun 19:S0140-6736(24)00755-4. PMID: 38908392.</li>
</ul>
<p>Guest: Alan M. Ehrlich, MD, FAAFP </p>
<p>Music Credit: Richard Onorato</p>
<p>Thoughts? Suggestions? Email us at <a href='mailto:FranklySpeaking@pri-med.com'>FranklySpeaking@pri-med.com </a></p>
<p> </p>
]]></description>
                                                            <content:encoded><![CDATA[<p>Credits: 0.25 AMA PRA Category 1 Credit™<br>
 <br>
CME/CE Information and Claim Credit: <a href='https://www.pri-med.com/online-education/podcast/frankly-speaking-cme-398'>https://www.pri-med.com/online-education/podcast/frankly-speaking-cme-398</a></p>
<p>Overview: Low back pain is the leading cause of years lived with disability, with approximately 70% of individuals experiencing a recurrence within 12 months following recovery from an episode. Clinicians are poised to play a crucial role in encouraging patients to incorporate walking to prevent recurrences of low back pain.</p>
<p>Episode resource links:</p>
<ul><li>Pocovi NC, Lin CC, French SD, Graham PL, van Dongen JM, Latimer J, Merom D, Tiedemann A, Maher CG, Clavisi O, Tong SYK, Hancock MJ. Effectiveness and cost-effectiveness of an individualised, progressive walking and education intervention for the prevention of low back pain recurrence in Australia (WalkBack): a randomised controlled trial. Lancet. 2024 Jun 19:S0140-6736(24)00755-4. PMID: 38908392.</li>
</ul>
<p>Guest: Alan M. Ehrlich, MD, FAAFP </p>
<p>Music Credit: Richard Onorato</p>
<p>Thoughts? Suggestions? Email us at <a href='mailto:FranklySpeaking@pri-med.com'>FranklySpeaking@pri-med.com </a></p>
<p> </p>
]]></content:encoded>
                                    
        <enclosure url="https://mcdn.podbean.com/mf/web/5n8hfuiqgs3cdbx5/frankly-speaking-398-walking-back-pain.mp3" length="10157575" type="audio/mpeg"/>
                <itunes:summary><![CDATA[Credits: 0.25 AMA PRA Category 1 Credit™ CME/CE Information and Claim Credit: https://www.pri-med.com/online-education/podcast/frankly-speaking-cme-398
Overview: Low back pain is the leading cause of years lived with disability, with approximately 70% of individuals experiencing a recurrence within 12 months following recovery from an episode. Clinicians are poised to play a crucial role in encouraging patients to incorporate walking to prevent recurrences of low back pain.
Episode resource links:
Pocovi NC, Lin CC, French SD, Graham PL, van Dongen JM, Latimer J, Merom D, Tiedemann A, Maher CG, Clavisi O, Tong SYK, Hancock MJ. Effectiveness and cost-effectiveness of an individualised, progressive walking and education intervention for the prevention of low back pain recurrence in Australia (WalkBack): a randomised controlled trial. Lancet. 2024 Jun 19:S0140-6736(24)00755-4. PMID: 38908392.
Guest: Alan M. Ehrlich, MD, FAAFP 
Music Credit: Richard Onorato
Thoughts? Suggestions? Email us at FranklySpeaking@pri-med.com 
 ]]></itunes:summary>
        <itunes:author>Pri-Med</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>632</itunes:duration>
                        <itunes:episodeType>full</itunes:episodeType>
            </item>
    <item>
        <title>Does Testosterone Replacement Therapy Help Men Live Healthier Lives? - Frankly Speaking Ep 397</title>
        <itunes:title>Does Testosterone Replacement Therapy Help Men Live Healthier Lives? - Frankly Speaking Ep 397</itunes:title>
        <link>https://primedfranklyspeaking.podbean.com/e/does-testosterone-replacement-therapy-help-men-live-healthier-lives-frankly-speaking-ep-397/</link>
                    <comments>https://primedfranklyspeaking.podbean.com/e/does-testosterone-replacement-therapy-help-men-live-healthier-lives-frankly-speaking-ep-397/#comments</comments>        <pubDate>Mon, 09 Sep 2024 00:30:00 +0000</pubDate>
        <guid isPermaLink="false">primedfranklyspeaking.podbean.com/6ac9fe57-15b1-3171-9e05-121b0a87ec79</guid>
                                    <description><![CDATA[<p>Credits: 0.25 AMA PRA Category 1 Credit™
 
CME/CE Information and Claim Credit: <a href='https://www.pri-med.com/online-education/podcast/frankly-speaking-cme-397'>https://www.pri-med.com/online-education/podcast/frankly-speaking-cme-397</a></p>
<p>Overview: In this episode, we review the T Trials—a coordinated set of 7 research trials that assessed the efficacy of testosterone gel treatment in 7 functional domains for men aged 65 years or older. Hear best practices for determining testosterone levels and how to balance the benefits and risks of testosterone replacement therapy during patient discussions.</p>
<p>Episode resource links:</p>
<ul><li>Matsumoto AM. Testosterone Replacement in Men with Age-Related Low Testosterone: What Did We Learn From The Testosterone Trials? Curr Opin Endocr Metab Res. 2019 Jun;6:34-41. doi: 10.1016/j.coemr.2019.04.004. Epub 2019 Apr 25. PMID: 32043015; PMCID: PMC7009797. </li>
<li>The Journal of Clinical Endocrinology &amp; Metabolism, 2024, 00, 1–10 <a href='https://doi.org/10.1210/clinem/dgae085'>https://doi.org/10.1210/clinem/dgae085</a></li>
</ul>
<p>Guest: Robert A. Baldor MD, FAAFP</p>
<p>Music Credit: Richard Onorato</p>
<p>Thoughts? Suggestions? Email us at <a href='mailto:FranklySpeaking@pri-med.com'>FranklySpeaking@pri-med.com</a></p>
<p> </p>
]]></description>
                                                            <content:encoded><![CDATA[<p>Credits: 0.25 AMA PRA Category 1 Credit™<br>
 <br>
CME/CE Information and Claim Credit: <a href='https://www.pri-med.com/online-education/podcast/frankly-speaking-cme-397'>https://www.pri-med.com/online-education/podcast/frankly-speaking-cme-397</a></p>
<p>Overview: In this episode, we review the T Trials—a coordinated set of 7 research trials that assessed the efficacy of testosterone gel treatment in 7 functional domains for men aged 65 years or older. Hear best practices for determining testosterone levels and how to balance the benefits and risks of testosterone replacement therapy during patient discussions.</p>
<p>Episode resource links:</p>
<ul><li>Matsumoto AM. Testosterone Replacement in Men with Age-Related Low Testosterone: What Did We Learn From The Testosterone Trials? Curr Opin Endocr Metab Res. 2019 Jun;6:34-41. doi: 10.1016/j.coemr.2019.04.004. Epub 2019 Apr 25. PMID: 32043015; PMCID: PMC7009797. </li>
<li>The Journal of Clinical Endocrinology &amp; Metabolism, 2024, 00, 1–10 <a href='https://doi.org/10.1210/clinem/dgae085'>https://doi.org/10.1210/clinem/dgae085</a></li>
</ul>
<p>Guest: Robert A. Baldor MD, FAAFP</p>
<p>Music Credit: Richard Onorato</p>
<p>Thoughts? Suggestions? Email us at <a href='mailto:FranklySpeaking@pri-med.com'>FranklySpeaking@pri-med.com</a></p>
<p> </p>
]]></content:encoded>
                                    
        <enclosure url="https://mcdn.podbean.com/mf/web/mjkg6trc3mu7qiq2/frankly-speaking-397-testosterone.mp3" length="11025358" type="audio/mpeg"/>
                <itunes:summary><![CDATA[Credits: 0.25 AMA PRA Category 1 Credit™ CME/CE Information and Claim Credit: https://www.pri-med.com/online-education/podcast/frankly-speaking-cme-397
Overview: In this episode, we review the T Trials—a coordinated set of 7 research trials that assessed the efficacy of testosterone gel treatment in 7 functional domains for men aged 65 years or older. Hear best practices for determining testosterone levels and how to balance the benefits and risks of testosterone replacement therapy during patient discussions.
Episode resource links:
Matsumoto AM. Testosterone Replacement in Men with Age-Related Low Testosterone: What Did We Learn From The Testosterone Trials? Curr Opin Endocr Metab Res. 2019 Jun;6:34-41. doi: 10.1016/j.coemr.2019.04.004. Epub 2019 Apr 25. PMID: 32043015; PMCID: PMC7009797. 
The Journal of Clinical Endocrinology &amp; Metabolism, 2024, 00, 1–10 https://doi.org/10.1210/clinem/dgae085
Guest: Robert A. Baldor MD, FAAFP
Music Credit: Richard Onorato
Thoughts? Suggestions? Email us at FranklySpeaking@pri-med.com
 ]]></itunes:summary>
        <itunes:author>Pri-Med</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>687</itunes:duration>
                        <itunes:episodeType>full</itunes:episodeType>
            </item>
    <item>
        <title>Vapor Trail—The Latest on E-Cigarette Risks - Frankly Speaking Ep 396</title>
        <itunes:title>Vapor Trail—The Latest on E-Cigarette Risks - Frankly Speaking Ep 396</itunes:title>
        <link>https://primedfranklyspeaking.podbean.com/e/vapor-trail%e2%80%94the-latest-on-e-cigarette-risks-frankly-speaking-ep-396/</link>
                    <comments>https://primedfranklyspeaking.podbean.com/e/vapor-trail%e2%80%94the-latest-on-e-cigarette-risks-frankly-speaking-ep-396/#comments</comments>        <pubDate>Mon, 02 Sep 2024 00:30:00 +0000</pubDate>
        <guid isPermaLink="false">primedfranklyspeaking.podbean.com/0757bebf-90d3-3c49-9448-a80a6c1e54c6</guid>
                                    <description><![CDATA[<p>Credits: 0.25 AMA PRA Category 1 Credit™
 
CME/CE Information and Claim Credit: <a href='https://www.pri-med.com/online-education/podcast/frankly-speaking-cme-396'>https://www.pri-med.com/online-education/podcast/frankly-speaking-cme-396</a></p>
<p>Overview: Listen in as we discuss the health risks of e-cigarette use and dual use, emphasizing the importance of primary prevention and supporting patients in their cessation efforts. Discover the latest evidence on vaping’s impact on addiction, cardiovascular health, and lung cancer, and gain essential insights to better advise your patients.</p>
<p>Episode resource links:</p>
<ul><li>Bittoni MA, et al. Abstract 2213. Presented at: American Association for Cancer Research Annual Meeting; April 5-10, 2024; San Diego. (AACR 2024: Ohio State experts share new findings at annual meeting (press release). Available at: <a href='https://cancer.osu.edu/news/aacr-2024-ohio-state-experts-share-new-findings'>https://cancer.osu.edu/news/aacr-2024-ohio-state-experts-share-new-findings</a>. Posted April 5,2024. Accessed May 3, 2024.)</li>
<li>Hartmann-Boyce J, McRobbie H, Lindson N, et al. Electronic cigarettes for smoking cessation. Cochrane Database Syst Rev. Apr 29 2021;4:CD010216. doi:10.1002/14651858.CD010216.pub5</li>
<li>Hopkinson NS, et al "Association of time spent on social media with youth cigarette smoking and e-cigarette use in the UK: a national longitudinal study" Thorax 2024: DOI:10.1136/ thorax-2023-220569.</li>
<li>Y.W. Kim, E.J. Park, K.I. Kwak, A.-R. Choi, B.J. Lee, Y.J. Lee, J.S. Park, Y.-J. Cho, J.H. Lee, and C.-T. Lee. Association of Electronic Cigarette Use After Conventional Smoking Cessation With Lung Cancer Risk: A Nationwide Cohort Study (abstract). Am J Respir Crit Care Med 2024;209:A3051.</li>
<li>CDC: Health Effects of Vaping; <a href='https://www.cdc.gov/tobacco/e-cigarettes/health-effects.html'>https://www.cdc.gov/tobacco/e-cigarettes/health-effects.html</a></li>
<li>CDC:Dual Use of Tobacco Products; <a href='https://www.cdc.gov/tobacco/campaign/tips/diseases/dual-tobacco-use.html'>https://www.cdc.gov/tobacco/campaign/tips/diseases/dual-tobacco-use.html</a></li>
</ul>
<p>Guest: Susan Feeney, DNP, FNP-BC, NP-C </p>
<p>Music Credit: Richard Onorato</p>
<p>Thoughts? Suggestions? Email us at <a href='mailto:FranklySpeaking@pri-med.com'>FranklySpeaking@pri-med.com</a></p>
<p> </p>
]]></description>
                                                            <content:encoded><![CDATA[<p>Credits: 0.25 AMA PRA Category 1 Credit™<br>
 <br>
CME/CE Information and Claim Credit: <a href='https://www.pri-med.com/online-education/podcast/frankly-speaking-cme-396'>https://www.pri-med.com/online-education/podcast/frankly-speaking-cme-396</a></p>
<p>Overview: Listen in as we discuss the health risks of e-cigarette use and dual use, emphasizing the importance of primary prevention and supporting patients in their cessation efforts. Discover the latest evidence on vaping’s impact on addiction, cardiovascular health, and lung cancer, and gain essential insights to better advise your patients.</p>
<p>Episode resource links:</p>
<ul><li>Bittoni MA, et al. Abstract 2213. Presented at: American Association for Cancer Research Annual Meeting; April 5-10, 2024; San Diego. (AACR 2024: Ohio State experts share new findings at annual meeting (press release). Available at: <a href='https://cancer.osu.edu/news/aacr-2024-ohio-state-experts-share-new-findings'>https://cancer.osu.edu/news/aacr-2024-ohio-state-experts-share-new-findings</a>. Posted April 5,2024. Accessed May 3, 2024.)</li>
<li>Hartmann-Boyce J, McRobbie H, Lindson N, et al. Electronic cigarettes for smoking cessation. Cochrane Database Syst Rev. Apr 29 2021;4:CD010216. doi:10.1002/14651858.CD010216.pub5</li>
<li>Hopkinson NS, et al "Association of time spent on social media with youth cigarette smoking and e-cigarette use in the UK: a national longitudinal study" Thorax 2024: DOI:10.1136/ thorax-2023-220569.</li>
<li>Y.W. Kim, E.J. Park, K.I. Kwak, A.-R. Choi, B.J. Lee, Y.J. Lee, J.S. Park, Y.-J. Cho, J.H. Lee, and C.-T. Lee. Association of Electronic Cigarette Use After Conventional Smoking Cessation With Lung Cancer Risk: A Nationwide Cohort Study (abstract). Am J Respir Crit Care Med 2024;209:A3051.</li>
<li>CDC: Health Effects of Vaping; <a href='https://www.cdc.gov/tobacco/e-cigarettes/health-effects.html'>https://www.cdc.gov/tobacco/e-cigarettes/health-effects.html</a></li>
<li>CDC:Dual Use of Tobacco Products; <a href='https://www.cdc.gov/tobacco/campaign/tips/diseases/dual-tobacco-use.html'>https://www.cdc.gov/tobacco/campaign/tips/diseases/dual-tobacco-use.html</a></li>
</ul>
<p>Guest: Susan Feeney, DNP, FNP-BC, NP-C </p>
<p>Music Credit: Richard Onorato</p>
<p>Thoughts? Suggestions? Email us at <a href='mailto:FranklySpeaking@pri-med.com'>FranklySpeaking@pri-med.com</a></p>
<p> </p>
]]></content:encoded>
                                    
        <enclosure url="https://mcdn.podbean.com/mf/web/xz6kakqp8hvkhuk8/frankly-speaking-396-vaping.mp3" length="13975674" type="audio/mpeg"/>
                <itunes:summary><![CDATA[Credits: 0.25 AMA PRA Category 1 Credit™ CME/CE Information and Claim Credit: https://www.pri-med.com/online-education/podcast/frankly-speaking-cme-396
Overview: Listen in as we discuss the health risks of e-cigarette use and dual use, emphasizing the importance of primary prevention and supporting patients in their cessation efforts. Discover the latest evidence on vaping’s impact on addiction, cardiovascular health, and lung cancer, and gain essential insights to better advise your patients.
Episode resource links:
Bittoni MA, et al. Abstract 2213. Presented at: American Association for Cancer Research Annual Meeting; April 5-10, 2024; San Diego. (AACR 2024: Ohio State experts share new findings at annual meeting (press release). Available at: https://cancer.osu.edu/news/aacr-2024-ohio-state-experts-share-new-findings. Posted April 5,2024. Accessed May 3, 2024.)
Hartmann-Boyce J, McRobbie H, Lindson N, et al. Electronic cigarettes for smoking cessation. Cochrane Database Syst Rev. Apr 29 2021;4:CD010216. doi:10.1002/14651858.CD010216.pub5
Hopkinson NS, et al "Association of time spent on social media with youth cigarette smoking and e-cigarette use in the UK: a national longitudinal study" Thorax 2024: DOI:10.1136/ thorax-2023-220569.
Y.W. Kim, E.J. Park, K.I. Kwak, A.-R. Choi, B.J. Lee, Y.J. Lee, J.S. Park, Y.-J. Cho, J.H. Lee, and C.-T. Lee. Association of Electronic Cigarette Use After Conventional Smoking Cessation With Lung Cancer Risk: A Nationwide Cohort Study (abstract). Am J Respir Crit Care Med 2024;209:A3051.
CDC: Health Effects of Vaping; https://www.cdc.gov/tobacco/e-cigarettes/health-effects.html
CDC:Dual Use of Tobacco Products; https://www.cdc.gov/tobacco/campaign/tips/diseases/dual-tobacco-use.html
Guest: Susan Feeney, DNP, FNP-BC, NP-C 
Music Credit: Richard Onorato
Thoughts? Suggestions? Email us at FranklySpeaking@pri-med.com
 ]]></itunes:summary>
        <itunes:author>Pri-Med</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>871</itunes:duration>
                        <itunes:episodeType>full</itunes:episodeType>
            </item>
    <item>
        <title>Reeling in the Evidence—Do Fish Oil Supplements Prevent Cardiovascular Disease? - Frankly Speaking Ep 395</title>
        <itunes:title>Reeling in the Evidence—Do Fish Oil Supplements Prevent Cardiovascular Disease? - Frankly Speaking Ep 395</itunes:title>
        <link>https://primedfranklyspeaking.podbean.com/e/reeling-in-the-evidence%e2%80%94do-fish-oil-supplements-prevent-cardiovascular-disease-frankly-speaking-ep-395/</link>
                    <comments>https://primedfranklyspeaking.podbean.com/e/reeling-in-the-evidence%e2%80%94do-fish-oil-supplements-prevent-cardiovascular-disease-frankly-speaking-ep-395/#comments</comments>        <pubDate>Mon, 26 Aug 2024 00:30:00 +0000</pubDate>
        <guid isPermaLink="false">primedfranklyspeaking.podbean.com/05e05c38-39c7-3e89-99d2-9d679817c45c</guid>
                                    <description><![CDATA[<p>Credits: 0.25 AMA PRA Category 1 Credit™
 
CME/CE Information and Claim Credit: <a href='https://www.pri-med.com/online-education/podcast/frankly-speaking-cme-395'>https://www.pri-med.com/online-education/podcast/frankly-speaking-cme-395</a></p>
<p>Overview: This episode brings you an exploration of fish oil supplements and their potential effects on cardiovascular health. We dive into the evidence, highlighting fish oil’s role in primary prevention and its possible risks, such as increased atrial fibrillation. Gain practical recommendations to help you effectively advise your patients on the use of this popular supplement.</p>
<p>Episode resource links:</p>
<ul><li>Regular use of fish oil supplements and course of cardiovascular diseases: prospective cohort study
BMJ Medicine 2024;3:e000451. doi: 10.1136/bmjmed-2022-000451</li>
<li>Omega-3 Polyunsaturated Fatty Acid (Fish Oil) Supplementation and the Prevention of Clinical Cardiovascular Disease: 
A Science Advisory From the American Heart Association
Circulation. 2017;135:e867–e884 </li>
</ul>
<p>Guest: Robert A. Baldor MD, FAAFP </p>
<p>Music Credit: Richard Onorato</p>
<p>Thoughts? Suggestions? Email us at <a href='mailto:FranklySpeaking@pri-med.com'>FranklySpeaking@pri-med.com</a></p>
<p> </p>
]]></description>
                                                            <content:encoded><![CDATA[<p>Credits: 0.25 AMA PRA Category 1 Credit™<br>
 <br>
CME/CE Information and Claim Credit: <a href='https://www.pri-med.com/online-education/podcast/frankly-speaking-cme-395'>https://www.pri-med.com/online-education/podcast/frankly-speaking-cme-395</a></p>
<p>Overview: This episode brings you an exploration of fish oil supplements and their potential effects on cardiovascular health. We dive into the evidence, highlighting fish oil’s role in primary prevention and its possible risks, such as increased atrial fibrillation. Gain practical recommendations to help you effectively advise your patients on the use of this popular supplement.</p>
<p>Episode resource links:</p>
<ul><li>Regular use of fish oil supplements and course of cardiovascular diseases: prospective cohort study<br>
BMJ Medicine 2024;3:e000451. doi: 10.1136/bmjmed-2022-000451</li>
<li>Omega-3 Polyunsaturated Fatty Acid (Fish Oil) Supplementation and the Prevention of Clinical Cardiovascular Disease: <br>
A Science Advisory From the American Heart Association<br>
Circulation. 2017;135:e867–e884 </li>
</ul>
<p>Guest: Robert A. Baldor MD, FAAFP </p>
<p>Music Credit: Richard Onorato</p>
<p>Thoughts? Suggestions? Email us at <a href='mailto:FranklySpeaking@pri-med.com'>FranklySpeaking@pri-med.com</a></p>
<p> </p>
]]></content:encoded>
                                    
        <enclosure url="https://mcdn.podbean.com/mf/web/ew446wie63de4i4b/frankly-speaking-395-fish-oil-cardio-outcomes.mp3" length="9824893" type="audio/mpeg"/>
                <itunes:summary><![CDATA[Credits: 0.25 AMA PRA Category 1 Credit™ CME/CE Information and Claim Credit: https://www.pri-med.com/online-education/podcast/frankly-speaking-cme-395
Overview: This episode brings you an exploration of fish oil supplements and their potential effects on cardiovascular health. We dive into the evidence, highlighting fish oil’s role in primary prevention and its possible risks, such as increased atrial fibrillation. Gain practical recommendations to help you effectively advise your patients on the use of this popular supplement.
Episode resource links:
Regular use of fish oil supplements and course of cardiovascular diseases: prospective cohort studyBMJ Medicine 2024;3:e000451. doi: 10.1136/bmjmed-2022-000451
Omega-3 Polyunsaturated Fatty Acid (Fish Oil) Supplementation and the Prevention of Clinical Cardiovascular Disease: A Science Advisory From the American Heart AssociationCirculation. 2017;135:e867–e884 
Guest: Robert A. Baldor MD, FAAFP 
Music Credit: Richard Onorato
Thoughts? Suggestions? Email us at FranklySpeaking@pri-med.com
 ]]></itunes:summary>
        <itunes:author>Pri-Med</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>612</itunes:duration>
                        <itunes:episodeType>full</itunes:episodeType>
            </item>
    <item>
        <title>Physical Activity for Healthy Aging: How Much Is Enough? - Frankly Speaking Ep 394</title>
        <itunes:title>Physical Activity for Healthy Aging: How Much Is Enough? - Frankly Speaking Ep 394</itunes:title>
        <link>https://primedfranklyspeaking.podbean.com/e/physical-activity-for-healthy-aging-how-much-is-enough-frankly-speaking-ep-394/</link>
                    <comments>https://primedfranklyspeaking.podbean.com/e/physical-activity-for-healthy-aging-how-much-is-enough-frankly-speaking-ep-394/#comments</comments>        <pubDate>Mon, 19 Aug 2024 00:30:00 +0000</pubDate>
        <guid isPermaLink="false">primedfranklyspeaking.podbean.com/1c7625eb-d777-3c8c-8379-c2fa2b4521f9</guid>
                                    <description><![CDATA[<p>Credits: 0.25 AMA PRA Category 1 Credit™
 
CME/CE Information and Claim Credit: <a href='https://www.pri-med.com/online-education/podcast/frankly-speaking-cme-394'>https://www.pri-med.com/online-education/podcast/frankly-speaking-cme-394</a></p>
<p>Overview: Explore the keys to confidently promoting healthy aging in patients. In this insightful conversation, we identify behaviors impacting longevity and discuss practical steps to minimize risks, including diet, exercise, and sleep. Discover evidence-based insights on how even light physical activity can significantly improve patients’ odds of healthy aging.</p>
<p>Episode resource links:</p>
<ul><li>Shi H, Hu FB, Huang T, Schernhammer ES, Willett WC, Sun Q, Wang M. Sedentary Behaviors, Light-Intensity Physical Activity, and Healthy Aging. JAMA Netw Open. 2024 Jun 3;7(6):e2416300. doi: 10.1001/jamanetworkopen.2024.16300. PMID: 38861256; PMCID: PMC11167497.</li>
</ul>
<p>Guest: Jillian Joseph, MPAS, PA-C</p>
<p>Music Credit: Richard Onorato</p>
<p>Thoughts? Suggestions? Email us at <a href='mailto:FranklySpeaking@pri-med.com'>FranklySpeaking@pri-med.com</a> </p>
]]></description>
                                                            <content:encoded><![CDATA[<p>Credits: 0.25 AMA PRA Category 1 Credit™<br>
 <br>
CME/CE Information and Claim Credit: <a href='https://www.pri-med.com/online-education/podcast/frankly-speaking-cme-394'>https://www.pri-med.com/online-education/podcast/frankly-speaking-cme-394</a></p>
<p>Overview: Explore the keys to confidently promoting healthy aging in patients. In this insightful conversation, we identify behaviors impacting longevity and discuss practical steps to minimize risks, including diet, exercise, and sleep. Discover evidence-based insights on how even light physical activity can significantly improve patients’ odds of healthy aging.</p>
<p>Episode resource links:</p>
<ul><li>Shi H, Hu FB, Huang T, Schernhammer ES, Willett WC, Sun Q, Wang M. Sedentary Behaviors, Light-Intensity Physical Activity, and Healthy Aging. JAMA Netw Open. 2024 Jun 3;7(6):e2416300. doi: 10.1001/jamanetworkopen.2024.16300. PMID: 38861256; PMCID: PMC11167497.</li>
</ul>
<p>Guest: Jillian Joseph, MPAS, PA-C</p>
<p>Music Credit: Richard Onorato</p>
<p>Thoughts? Suggestions? Email us at <a href='mailto:FranklySpeaking@pri-med.com'>FranklySpeaking@pri-med.com</a> </p>
]]></content:encoded>
                                    
        <enclosure url="https://mcdn.podbean.com/mf/web/6zg9my9ir7min2jx/frankly-speaking-394-activity-healthy-aging.mp3" length="8120402" type="audio/mpeg"/>
                <itunes:summary><![CDATA[Credits: 0.25 AMA PRA Category 1 Credit™ CME/CE Information and Claim Credit: https://www.pri-med.com/online-education/podcast/frankly-speaking-cme-394
Overview: Explore the keys to confidently promoting healthy aging in patients. In this insightful conversation, we identify behaviors impacting longevity and discuss practical steps to minimize risks, including diet, exercise, and sleep. Discover evidence-based insights on how even light physical activity can significantly improve patients’ odds of healthy aging.
Episode resource links:
Shi H, Hu FB, Huang T, Schernhammer ES, Willett WC, Sun Q, Wang M. Sedentary Behaviors, Light-Intensity Physical Activity, and Healthy Aging. JAMA Netw Open. 2024 Jun 3;7(6):e2416300. doi: 10.1001/jamanetworkopen.2024.16300. PMID: 38861256; PMCID: PMC11167497.
Guest: Jillian Joseph, MPAS, PA-C
Music Credit: Richard Onorato
Thoughts? Suggestions? Email us at FranklySpeaking@pri-med.com ]]></itunes:summary>
        <itunes:author>Pri-Med</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>505</itunes:duration>
                        <itunes:episodeType>full</itunes:episodeType>
            </item>
    <item>
        <title>Gender Incongruence in Adolescents: Are Hormonal Therapies Helpful? - Frankly Speaking Ep 393</title>
        <itunes:title>Gender Incongruence in Adolescents: Are Hormonal Therapies Helpful? - Frankly Speaking Ep 393</itunes:title>
        <link>https://primedfranklyspeaking.podbean.com/e/gender-incongruence-in-adolescents-are-hormonal-therapies-helpful-frankly-speaking-ep-393/</link>
                    <comments>https://primedfranklyspeaking.podbean.com/e/gender-incongruence-in-adolescents-are-hormonal-therapies-helpful-frankly-speaking-ep-393/#comments</comments>        <pubDate>Mon, 12 Aug 2024 00:30:00 +0000</pubDate>
        <guid isPermaLink="false">primedfranklyspeaking.podbean.com/a83cdf2d-a2c9-3aa6-b7f8-161098825104</guid>
                                    <description><![CDATA[<p>Credits: 0.25 AMA PRA Category 1 Credit™
 
CME/CE Information and Claim Credit: <a href='https://www.pri-med.com/online-education/podcast/frankly-speaking-cme-393'>https://www.pri-med.com/online-education/podcast/frankly-speaking-cme-393</a></p>
<p>Overview: Adolescents seeking hormonal treatment for gender incongruence has become more common. A recent systematic review looking at the benefits and side effects found in clinical studies updates our current understanding of this approach. Gain insights and confidence to make informed and compassionate care decisions.</p>
<p>Episode resource links:</p>
<ul><li>Taylor J, Mitchell A, Hall R, Langton T, Fraser L, Hewitt CE. Masculinising and feminising hormone interventions for adolescents experiencing gender dysphoria or incongruence: a systematic review. Arch Dis Child. 2024 Apr 9:archdischild-2023-326670.
</li>
<li>Coleman E, et al. Standards of Care for the Health of Transgender and Gender Diverse People, Version 8. Int J Transgend Health. 2022 Sep 6;23(Suppl 1):S1-S259. 
</li>
<li><a href='https://www.pri-med.com/online-cme-ce/virtual-cme-program/primarycarenow-june-21-cme-1-lgbtq-health'>Gender Affirming Hormonal Care for the Primary Care Provider</a>
</li>
<li><a href='https://www.pri-med.com/online-cme-ce/virtual-cme-program/primarycarenow-june-20-cme-3-psychiatry'>Thriving for Transgender Youth</a>
</li>
<li><a href='https://www.pri-med.com/online-cme-ce/virtual-cme-program/primarycarenow-june-22-cme6-psychiatry'>Update on Trans-Competent Primary Care</a></li>
</ul>
<p>Guest: Alan M. Ehrlich, MD, FAAFP</p>
<p>Thoughts? Suggestions? Email us at <a href='mailto:FranklySpeaking@pri-med.com'>FranklySpeaking@pri-med.com</a> </p>
<p>Music Credit: Richard Onorato</p>
]]></description>
                                                            <content:encoded><![CDATA[<p>Credits: 0.25 AMA PRA Category 1 Credit™<br>
 <br>
CME/CE Information and Claim Credit: <a href='https://www.pri-med.com/online-education/podcast/frankly-speaking-cme-393'>https://www.pri-med.com/online-education/podcast/frankly-speaking-cme-393</a></p>
<p>Overview: Adolescents seeking hormonal treatment for gender incongruence has become more common. A recent systematic review looking at the benefits and side effects found in clinical studies updates our current understanding of this approach. Gain insights and confidence to make informed and compassionate care decisions.</p>
<p>Episode resource links:</p>
<ul><li>Taylor J, Mitchell A, Hall R, Langton T, Fraser L, Hewitt CE. Masculinising and feminising hormone interventions for adolescents experiencing gender dysphoria or incongruence: a systematic review. Arch Dis Child. 2024 Apr 9:archdischild-2023-326670.<br>
</li>
<li>Coleman E, et al. Standards of Care for the Health of Transgender and Gender Diverse People, Version 8. Int J Transgend Health. 2022 Sep 6;23(Suppl 1):S1-S259. <br>
</li>
<li><a href='https://www.pri-med.com/online-cme-ce/virtual-cme-program/primarycarenow-june-21-cme-1-lgbtq-health'>Gender Affirming Hormonal Care for the Primary Care Provider</a><br>
</li>
<li><a href='https://www.pri-med.com/online-cme-ce/virtual-cme-program/primarycarenow-june-20-cme-3-psychiatry'>Thriving for Transgender Youth</a><br>
</li>
<li><a href='https://www.pri-med.com/online-cme-ce/virtual-cme-program/primarycarenow-june-22-cme6-psychiatry'>Update on Trans-Competent Primary Care</a></li>
</ul>
<p>Guest: Alan M. Ehrlich, MD, FAAFP</p>
<p>Thoughts? Suggestions? Email us at <a href='mailto:FranklySpeaking@pri-med.com'>FranklySpeaking@pri-med.com</a> </p>
<p>Music Credit: Richard Onorato</p>
]]></content:encoded>
                                    
        <enclosure url="https://mcdn.podbean.com/mf/web/jaevfy9ce9kdgrbc/frankly-speaking-393-gender-incongruence.mp3" length="10247628" type="audio/mpeg"/>
                <itunes:summary><![CDATA[Credits: 0.25 AMA PRA Category 1 Credit™ CME/CE Information and Claim Credit: https://www.pri-med.com/online-education/podcast/frankly-speaking-cme-393
Overview: Adolescents seeking hormonal treatment for gender incongruence has become more common. A recent systematic review looking at the benefits and side effects found in clinical studies updates our current understanding of this approach. Gain insights and confidence to make informed and compassionate care decisions.
Episode resource links:
Taylor J, Mitchell A, Hall R, Langton T, Fraser L, Hewitt CE. Masculinising and feminising hormone interventions for adolescents experiencing gender dysphoria or incongruence: a systematic review. Arch Dis Child. 2024 Apr 9:archdischild-2023-326670.
Coleman E, et al. Standards of Care for the Health of Transgender and Gender Diverse People, Version 8. Int J Transgend Health. 2022 Sep 6;23(Suppl 1):S1-S259. 
Gender Affirming Hormonal Care for the Primary Care Provider
Thriving for Transgender Youth
Update on Trans-Competent Primary Care
Guest: Alan M. Ehrlich, MD, FAAFP
Thoughts? Suggestions? Email us at FranklySpeaking@pri-med.com 
Music Credit: Richard Onorato]]></itunes:summary>
        <itunes:author>Pri-Med</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>638</itunes:duration>
                        <itunes:episodeType>full</itunes:episodeType>
            </item>
    <item>
        <title>Vitamin D and Calcium: The Good, the Bad, the Valueless? - Frankly Speaking Ep 392</title>
        <itunes:title>Vitamin D and Calcium: The Good, the Bad, the Valueless? - Frankly Speaking Ep 392</itunes:title>
        <link>https://primedfranklyspeaking.podbean.com/e/vitamin-d-and-calcium-the-good-the-bad-the-valueless-frankly-speaking-ep-392/</link>
                    <comments>https://primedfranklyspeaking.podbean.com/e/vitamin-d-and-calcium-the-good-the-bad-the-valueless-frankly-speaking-ep-392/#comments</comments>        <pubDate>Mon, 05 Aug 2024 00:30:00 +0000</pubDate>
        <guid isPermaLink="false">primedfranklyspeaking.podbean.com/6ea9234b-dd42-3cc4-9d15-80f6ae1e81fa</guid>
                                    <description><![CDATA[<p>Credits: 0.25 AMA PRA Category 1 Credit™
 
CME/CE Information and Claim Credit: <a href='https://www.pri-med.com/online-education/podcast/frankly-speaking-cme-392'>https://www.pri-med.com/online-education/podcast/frankly-speaking-cme-392</a></p>
<p>Overview: Tune in as we explore a recent study that found no net all-cause benefit or harm from vitamin D and calcium supplementation. We review the study’s findings in detail and reflect on whether these supplements should be recommended to our patients based on the latest evidence.</p>
<p>Episode resource links:</p>
<ul><li>Ann Intern Med. doi:10.7326/M23-2598</li>
</ul>
<p>Guest: Robert A. Baldor MD, FAAFP</p>
<p>Music Credit: Richard Onorato</p>
<p>Thoughts? Suggestions? Email us at <a href='mailto:FranklySpeaking@pri-med.com'>FranklySpeaking@pri-med.com</a> </p>
]]></description>
                                                            <content:encoded><![CDATA[<p>Credits: 0.25 AMA PRA Category 1 Credit™<br>
 <br>
CME/CE Information and Claim Credit: <a href='https://www.pri-med.com/online-education/podcast/frankly-speaking-cme-392'>https://www.pri-med.com/online-education/podcast/frankly-speaking-cme-392</a></p>
<p>Overview: Tune in as we explore a recent study that found no net all-cause benefit or harm from vitamin D and calcium supplementation. We review the study’s findings in detail and reflect on whether these supplements should be recommended to our patients based on the latest evidence.</p>
<p>Episode resource links:</p>
<ul><li>Ann Intern Med. doi:10.7326/M23-2598</li>
</ul>
<p>Guest: Robert A. Baldor MD, FAAFP</p>
<p>Music Credit: Richard Onorato</p>
<p>Thoughts? Suggestions? Email us at <a href='mailto:FranklySpeaking@pri-med.com'>FranklySpeaking@pri-med.com</a> </p>
]]></content:encoded>
                                    
        <enclosure url="https://mcdn.podbean.com/mf/web/spkacgttrven7rje/frankly-speaking-392-vitaminD-calcium.mp3" length="10649397" type="audio/mpeg"/>
                <itunes:summary><![CDATA[Credits: 0.25 AMA PRA Category 1 Credit™ CME/CE Information and Claim Credit: https://www.pri-med.com/online-education/podcast/frankly-speaking-cme-392
Overview: Tune in as we explore a recent study that found no net all-cause benefit or harm from vitamin D and calcium supplementation. We review the study’s findings in detail and reflect on whether these supplements should be recommended to our patients based on the latest evidence.
Episode resource links:
Ann Intern Med. doi:10.7326/M23-2598
Guest: Robert A. Baldor MD, FAAFP
Music Credit: Richard Onorato
Thoughts? Suggestions? Email us at FranklySpeaking@pri-med.com ]]></itunes:summary>
        <itunes:author>Pri-Med</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>663</itunes:duration>
                        <itunes:episodeType>full</itunes:episodeType>
            </item>
    <item>
        <title>Bronchitis with Prolonged Cough: Do Antibiotics Help? - Frankly Speaking Ep 391</title>
        <itunes:title>Bronchitis with Prolonged Cough: Do Antibiotics Help? - Frankly Speaking Ep 391</itunes:title>
        <link>https://primedfranklyspeaking.podbean.com/e/bronchitis-with-prolonged-cough-do-antibiotics-help-frankly-speaking-ep-391/</link>
                    <comments>https://primedfranklyspeaking.podbean.com/e/bronchitis-with-prolonged-cough-do-antibiotics-help-frankly-speaking-ep-391/#comments</comments>        <pubDate>Mon, 29 Jul 2024 00:30:00 +0000</pubDate>
        <guid isPermaLink="false">primedfranklyspeaking.podbean.com/304b6c2f-241f-3106-b1e9-c0455e22b1f3</guid>
                                    <description><![CDATA[<p>Credits: 0.25 AMA PRA Category 1 Credit™
 
CME/CE Information and Claim Credit: <a href='https://www.pri-med.com/online-education/podcast/frankly-speaking-cme-391'>https://www.pri-med.com/online-education/podcast/frankly-speaking-cme-391</a></p>
<p>Overview: Cough is a frustrating complaint for patients and often leads to a prescription for antibiotics. Discover new data that reveals the ineffectiveness of antibiotics in treating acute bronchitis. Come away with valuable insights to enhance your practice and make informed treatment decisions, improving patient care and outcomes.</p>
<p>Episode resource links:</p>
<ul><li>Merenstein DJ, Barrett B, Ebell MH. Antibiotics Not Associated with Shorter Duration or Reduced Severity of Acute Lower Respiratory Tract Infection. J Gen Intern Med. Published online April 15, 2024. doi:10.1007/s11606-024-08758-y</li>
</ul>
<p>Guest: Alan M. Ehrlich, MD, FAAFP
 
Music Credit: Richard Onorato

Thoughts? Suggestions? Email us at <a href='mailto:FranklySpeaking@pri-med.com'>FranklySpeaking@pri-med.com</a> </p>
]]></description>
                                                            <content:encoded><![CDATA[<p>Credits: 0.25 AMA PRA Category 1 Credit™<br>
 <br>
CME/CE Information and Claim Credit: <a href='https://www.pri-med.com/online-education/podcast/frankly-speaking-cme-391'>https://www.pri-med.com/online-education/podcast/frankly-speaking-cme-391</a></p>
<p>Overview: Cough is a frustrating complaint for patients and often leads to a prescription for antibiotics. Discover new data that reveals the ineffectiveness of antibiotics in treating acute bronchitis. Come away with valuable insights to enhance your practice and make informed treatment decisions, improving patient care and outcomes.</p>
<p>Episode resource links:</p>
<ul><li>Merenstein DJ, Barrett B, Ebell MH. Antibiotics Not Associated with Shorter Duration or Reduced Severity of Acute Lower Respiratory Tract Infection. J Gen Intern Med. Published online April 15, 2024. doi:10.1007/s11606-024-08758-y</li>
</ul>
<p>Guest: Alan M. Ehrlich, MD, FAAFP<br>
 <br>
Music Credit: Richard Onorato<br>
<br>
Thoughts? Suggestions? Email us at <a href='mailto:FranklySpeaking@pri-med.com'>FranklySpeaking@pri-med.com</a> </p>
]]></content:encoded>
                                    
        <enclosure url="https://mcdn.podbean.com/mf/web/dzkdhrw7skqbi8d3/frankly-speaking-391-antibiotics-bronchitis.mp3" length="8581883" type="audio/mpeg"/>
                <itunes:summary><![CDATA[Credits: 0.25 AMA PRA Category 1 Credit™ CME/CE Information and Claim Credit: https://www.pri-med.com/online-education/podcast/frankly-speaking-cme-391
Overview: Cough is a frustrating complaint for patients and often leads to a prescription for antibiotics. Discover new data that reveals the ineffectiveness of antibiotics in treating acute bronchitis. Come away with valuable insights to enhance your practice and make informed treatment decisions, improving patient care and outcomes.
Episode resource links:
Merenstein DJ, Barrett B, Ebell MH. Antibiotics Not Associated with Shorter Duration or Reduced Severity of Acute Lower Respiratory Tract Infection. J Gen Intern Med. Published online April 15, 2024. doi:10.1007/s11606-024-08758-y
Guest: Alan M. Ehrlich, MD, FAAFP Music Credit: Richard OnoratoThoughts? Suggestions? Email us at FranklySpeaking@pri-med.com ]]></itunes:summary>
        <itunes:author>Pri-Med</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>534</itunes:duration>
                        <itunes:episodeType>full</itunes:episodeType>
            </item>
    <item>
        <title>Spot On: Evolving Strategies for Chickenpox Diagnosis - Frankly Speaking Ep 390</title>
        <itunes:title>Spot On: Evolving Strategies for Chickenpox Diagnosis - Frankly Speaking Ep 390</itunes:title>
        <link>https://primedfranklyspeaking.podbean.com/e/spot-on-evolving-strategies-for-chickenpox-diagnosis-frankly-speaking-ep-390/</link>
                    <comments>https://primedfranklyspeaking.podbean.com/e/spot-on-evolving-strategies-for-chickenpox-diagnosis-frankly-speaking-ep-390/#comments</comments>        <pubDate>Mon, 22 Jul 2024 00:30:00 +0000</pubDate>
        <guid isPermaLink="false">primedfranklyspeaking.podbean.com/dad1bb6f-eab3-3861-a146-a58c5b0a69cb</guid>
                                    <description><![CDATA[<p>Credits: 0.25 AMA PRA Category 1 Credit™
 
CME/CE Information and Claim Credit: <a href='https://www.pri-med.com/online-education/podcast/frankly-speaking-cme-390'>https://www.pri-med.com/online-education/podcast/frankly-speaking-cme-390</a></p>
<p>Overview: In 1995, the US launched a varicella vaccination program, leading to a significant drop in cases. However, breakthrough infections still occur, and clinical diagnosis has become less reliable as the virus has evolved. Join us to hear current recommendations for what to consider in the differential diagnosis and how emerging evidence may impact public health and your practice.</p>
<p>Episode resource links:</p>
<ul><li>Marin, M, Leung, J, Anderson, TC, Lopez, AS. Monitoring Varicella Vaccine Impact on Varicella Incidence in the United States: Surveillance Challenges and Changing Epidemiology, 1995–2019, The Journal of Infectious Diseases, Volume 226, Issue Supplement_4, 1 November 2022, Pages S392–S399, <a href='https://doi.org/10.1093/infdis/jiac221'>https://doi.org/10.1093/infdis/jiac221</a></li>
<li>Qiu L, Liu S, Zhang M, et al. The epidemiology of varicella and effectiveness of varicella vaccine in Ganyu, China: a long-term community surveillance study. BMC Public Health. 2023;23(1):1875. Published 2023 Sep 28. doi:10.1186/s12889-023-16304-4</li>
<li>Ruprecht A, Marin M, Strain AK, Harry K, Kenyon C. Notes from the Field: Expanded Laboratory Testing for Varicella — Minnesota, 2016–2023. MMWR Morb Mortal Wkly Rep 2024;73:245–246. DOI: <a href='http://dx.doi.org/10.15585/mmwr.mm7311a3'>http://dx.doi.org/10.15585/mmwr.mm7311a3</a></li>
<li>DynaMed – Chicken pox – Varicella (<a href='https://www-dynamed-com.umassmed.idm.oclc.org/condition/chickenpox#GUID-DFBFAA99-31E8-4553-AFDB-AA1988B1967A'>https://www-dynamed-com.umassmed.idm.oclc.org/condition/chickenpox#GUID-DFBFAA99-31E8-4553-AFDB-AA1988B1967A</a>):</li>
</ul>
<p>Guest: Susan Feeney, DNP, FNP-BC, NP-C
 
Music Credit: Richard Onorato</p>
]]></description>
                                                            <content:encoded><![CDATA[<p>Credits: 0.25 AMA PRA Category 1 Credit™<br>
 <br>
CME/CE Information and Claim Credit: <a href='https://www.pri-med.com/online-education/podcast/frankly-speaking-cme-390'>https://www.pri-med.com/online-education/podcast/frankly-speaking-cme-390</a></p>
<p>Overview: In 1995, the US launched a varicella vaccination program, leading to a significant drop in cases. However, breakthrough infections still occur, and clinical diagnosis has become less reliable as the virus has evolved. Join us to hear current recommendations for what to consider in the differential diagnosis and how emerging evidence may impact public health and your practice.</p>
<p>Episode resource links:</p>
<ul><li>Marin, M, Leung, J, Anderson, TC, Lopez, AS. Monitoring Varicella Vaccine Impact on Varicella Incidence in the United States: Surveillance Challenges and Changing Epidemiology, 1995–2019, The Journal of Infectious Diseases, Volume 226, Issue Supplement_4, 1 November 2022, Pages S392–S399, <a href='https://doi.org/10.1093/infdis/jiac221'>https://doi.org/10.1093/infdis/jiac221</a></li>
<li>Qiu L, Liu S, Zhang M, et al. The epidemiology of varicella and effectiveness of varicella vaccine in Ganyu, China: a long-term community surveillance study. BMC Public Health. 2023;23(1):1875. Published 2023 Sep 28. doi:10.1186/s12889-023-16304-4</li>
<li>Ruprecht A, Marin M, Strain AK, Harry K, Kenyon C. Notes from the Field: Expanded Laboratory Testing for Varicella — Minnesota, 2016–2023. MMWR Morb Mortal Wkly Rep 2024;73:245–246. DOI: <a href='http://dx.doi.org/10.15585/mmwr.mm7311a3'>http://dx.doi.org/10.15585/mmwr.mm7311a3</a></li>
<li>DynaMed – Chicken pox – Varicella (<a href='https://www-dynamed-com.umassmed.idm.oclc.org/condition/chickenpox#GUID-DFBFAA99-31E8-4553-AFDB-AA1988B1967A'>https://www-dynamed-com.umassmed.idm.oclc.org/condition/chickenpox#GUID-DFBFAA99-31E8-4553-AFDB-AA1988B1967A</a>):</li>
</ul>
<p>Guest: Susan Feeney, DNP, FNP-BC, NP-C<br>
 <br>
Music Credit: Richard Onorato</p>
]]></content:encoded>
                                    
        <enclosure url="https://mcdn.podbean.com/mf/web/2caqrqv32bsiry92/frankly-speaking-390-varicella.mp3" length="9710239" type="audio/mpeg"/>
                <itunes:summary><![CDATA[Credits: 0.25 AMA PRA Category 1 Credit™ CME/CE Information and Claim Credit: https://www.pri-med.com/online-education/podcast/frankly-speaking-cme-390
Overview: In 1995, the US launched a varicella vaccination program, leading to a significant drop in cases. However, breakthrough infections still occur, and clinical diagnosis has become less reliable as the virus has evolved. Join us to hear current recommendations for what to consider in the differential diagnosis and how emerging evidence may impact public health and your practice.
Episode resource links:
Marin, M, Leung, J, Anderson, TC, Lopez, AS. Monitoring Varicella Vaccine Impact on Varicella Incidence in the United States: Surveillance Challenges and Changing Epidemiology, 1995–2019, The Journal of Infectious Diseases, Volume 226, Issue Supplement_4, 1 November 2022, Pages S392–S399, https://doi.org/10.1093/infdis/jiac221
Qiu L, Liu S, Zhang M, et al. The epidemiology of varicella and effectiveness of varicella vaccine in Ganyu, China: a long-term community surveillance study. BMC Public Health. 2023;23(1):1875. Published 2023 Sep 28. doi:10.1186/s12889-023-16304-4
Ruprecht A, Marin M, Strain AK, Harry K, Kenyon C. Notes from the Field: Expanded Laboratory Testing for Varicella — Minnesota, 2016–2023. MMWR Morb Mortal Wkly Rep 2024;73:245–246. DOI: http://dx.doi.org/10.15585/mmwr.mm7311a3
DynaMed – Chicken pox – Varicella (https://www-dynamed-com.umassmed.idm.oclc.org/condition/chickenpox#GUID-DFBFAA99-31E8-4553-AFDB-AA1988B1967A):
Guest: Susan Feeney, DNP, FNP-BC, NP-C Music Credit: Richard Onorato]]></itunes:summary>
        <itunes:author>Pri-Med</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>604</itunes:duration>
                        <itunes:episodeType>full</itunes:episodeType>
            </item>
    <item>
        <title>Metabolic Markers for Mood: Looking Carefully at Lipids - Frankly Speaking Ep 389</title>
        <itunes:title>Metabolic Markers for Mood: Looking Carefully at Lipids - Frankly Speaking Ep 389</itunes:title>
        <link>https://primedfranklyspeaking.podbean.com/e/metabolic-markers-for-mood-looking-carefully-at-lipids-frankly-speaking-ep-389/</link>
                    <comments>https://primedfranklyspeaking.podbean.com/e/metabolic-markers-for-mood-looking-carefully-at-lipids-frankly-speaking-ep-389/#comments</comments>        <pubDate>Mon, 15 Jul 2024 00:30:00 +0000</pubDate>
        <guid isPermaLink="false">primedfranklyspeaking.podbean.com/5883855c-8406-3819-930e-8915fd28ead0</guid>
                                    <description><![CDATA[<p>Credits: 0.25 AMA PRA Category 1 Credit™
 
CME/CE Information and Claim Credit: <a href='https://www.pri-med.com/online-education/podcast/frankly-speaking-cme-389'>https://www.pri-med.com/online-education/podcast/frankly-speaking-cme-389</a></p>
<p>Overview: Let’s talk lipid panels and their potential to assess more than cardiovascular disease risk. Through a case scenario, we highlight a study on the potential link between metabolic markers and mood disorders such as depression and anxiety. Join us to learn how lipid panels could aid in early detection and intervention for these conditions.</p>
<p>Episode resource links:</p>
<ul><li>Chourpiliadis C, Zeng Y, Lovik A, Wei D, Valdimarsdóttir U, Song H, Hammar N, Fang F. Metabolic Profile and Long-Term Risk of Depression, Anxiety, and Stress-Related Disorders. JAMA Netw Open. 2024 Apr 1;7(4):e244525. doi: 10.1001/jamanetworkopen.2024.4525. PMID: 38564219; PMCID: PMC10988352.</li>
</ul>
<p>Guest: Jillian Joseph, MPAS, PA-C
 
Music Credit: Richard Onorato</p>
]]></description>
                                                            <content:encoded><![CDATA[<p>Credits: 0.25 AMA PRA Category 1 Credit™<br>
 <br>
CME/CE Information and Claim Credit: <a href='https://www.pri-med.com/online-education/podcast/frankly-speaking-cme-389'>https://www.pri-med.com/online-education/podcast/frankly-speaking-cme-389</a></p>
<p>Overview: Let’s talk lipid panels and their potential to assess more than cardiovascular disease risk. Through a case scenario, we highlight a study on the potential link between metabolic markers and mood disorders such as depression and anxiety. Join us to learn how lipid panels could aid in early detection and intervention for these conditions.</p>
<p>Episode resource links:</p>
<ul><li>Chourpiliadis C, Zeng Y, Lovik A, Wei D, Valdimarsdóttir U, Song H, Hammar N, Fang F. Metabolic Profile and Long-Term Risk of Depression, Anxiety, and Stress-Related Disorders. JAMA Netw Open. 2024 Apr 1;7(4):e244525. doi: 10.1001/jamanetworkopen.2024.4525. PMID: 38564219; PMCID: PMC10988352.</li>
</ul>
<p>Guest: Jillian Joseph, MPAS, PA-C<br>
 <br>
Music Credit: Richard Onorato</p>
]]></content:encoded>
                                    
        <enclosure url="https://mcdn.podbean.com/mf/web/4wzg4yc5hju8c3jx/frankly-speaking-389-metabolic-markers.mp3" length="7462104" type="audio/mpeg"/>
                <itunes:summary><![CDATA[Credits: 0.25 AMA PRA Category 1 Credit™ CME/CE Information and Claim Credit: https://www.pri-med.com/online-education/podcast/frankly-speaking-cme-389
Overview: Let’s talk lipid panels and their potential to assess more than cardiovascular disease risk. Through a case scenario, we highlight a study on the potential link between metabolic markers and mood disorders such as depression and anxiety. Join us to learn how lipid panels could aid in early detection and intervention for these conditions.
Episode resource links:
Chourpiliadis C, Zeng Y, Lovik A, Wei D, Valdimarsdóttir U, Song H, Hammar N, Fang F. Metabolic Profile and Long-Term Risk of Depression, Anxiety, and Stress-Related Disorders. JAMA Netw Open. 2024 Apr 1;7(4):e244525. doi: 10.1001/jamanetworkopen.2024.4525. PMID: 38564219; PMCID: PMC10988352.
Guest: Jillian Joseph, MPAS, PA-C Music Credit: Richard Onorato]]></itunes:summary>
        <itunes:author>Pri-Med</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>464</itunes:duration>
                        <itunes:episodeType>full</itunes:episodeType>
            </item>
    <item>
        <title>Give Them 5: Rethinking Treatment Durations for Pediatric Respiratory Infections - Frankly Speaking Ep 388</title>
        <itunes:title>Give Them 5: Rethinking Treatment Durations for Pediatric Respiratory Infections - Frankly Speaking Ep 388</itunes:title>
        <link>https://primedfranklyspeaking.podbean.com/e/give-them-5-rethinking-treatment-durations-for-pediatric-respiratory-infections-frankly-speaking-ep-388/</link>
                    <comments>https://primedfranklyspeaking.podbean.com/e/give-them-5-rethinking-treatment-durations-for-pediatric-respiratory-infections-frankly-speaking-ep-388/#comments</comments>        <pubDate>Mon, 08 Jul 2024 00:30:00 +0000</pubDate>
        <guid isPermaLink="false">primedfranklyspeaking.podbean.com/028ee651-1e52-33fa-b5f3-556f960f92c3</guid>
                                    <description><![CDATA[<p>Credits: 0.25 AMA PRA Category 1 Credit™
 
CME/CE Information and Claim Credit: <a href='https://www.pri-med.com/online-education/podcast/frankly-speaking-cme-388'>https://www.pri-med.com/online-education/podcast/frankly-speaking-cme-388</a></p>
<p>Overview: Tune in as expert faculty cover common upper respiratory infections in children and their treatment options, with a focus on achieving the best outcome while also lowering the risk of subsequent adverse events. Hear guideline recommendations and evidence on treatment durations to confidently make informed clinical decisions.</p>
<p>Episode resource links:</p>
<ul><li>Journal of the Pediatric Infectious Diseases Society, piae034, <a href='https://doi.org/10.1093/jpids/piae034'>https://doi.org/10.1093/jpids/piae034</a></li>
</ul>
<p>Guest: Jillian Joseph, MPAS, PA-C
 
Music Credit: Richard Onorato</p>
]]></description>
                                                            <content:encoded><![CDATA[<p>Credits: 0.25 AMA PRA Category 1 Credit™<br>
 <br>
CME/CE Information and Claim Credit: <a href='https://www.pri-med.com/online-education/podcast/frankly-speaking-cme-388'>https://www.pri-med.com/online-education/podcast/frankly-speaking-cme-388</a></p>
<p>Overview: Tune in as expert faculty cover common upper respiratory infections in children and their treatment options, with a focus on achieving the best outcome while also lowering the risk of subsequent adverse events. Hear guideline recommendations and evidence on treatment durations to confidently make informed clinical decisions.</p>
<p>Episode resource links:</p>
<ul><li>Journal of the Pediatric Infectious Diseases Society, piae034, <a href='https://doi.org/10.1093/jpids/piae034'>https://doi.org/10.1093/jpids/piae034</a></li>
</ul>
<p>Guest: Jillian Joseph, MPAS, PA-C<br>
 <br>
Music Credit: Richard Onorato</p>
]]></content:encoded>
                                    
        <enclosure url="https://mcdn.podbean.com/mf/web/e39zi8pj482pf4wg/frankly-speaking-388-5-for-URI.mp3" length="12112613" type="audio/mpeg"/>
                <itunes:summary><![CDATA[Credits: 0.25 AMA PRA Category 1 Credit™ CME/CE Information and Claim Credit: https://www.pri-med.com/online-education/podcast/frankly-speaking-cme-388
Overview: Tune in as expert faculty cover common upper respiratory infections in children and their treatment options, with a focus on achieving the best outcome while also lowering the risk of subsequent adverse events. Hear guideline recommendations and evidence on treatment durations to confidently make informed clinical decisions.
Episode resource links:
Journal of the Pediatric Infectious Diseases Society, piae034, https://doi.org/10.1093/jpids/piae034
Guest: Jillian Joseph, MPAS, PA-C Music Credit: Richard Onorato]]></itunes:summary>
        <itunes:author>Pri-Med</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>755</itunes:duration>
                        <itunes:episodeType>full</itunes:episodeType>
            </item>
    <item>
        <title>Measles—It’s Here! Would You Recognize It? - Frankly Speaking Ep 387</title>
        <itunes:title>Measles—It’s Here! Would You Recognize It? - Frankly Speaking Ep 387</itunes:title>
        <link>https://primedfranklyspeaking.podbean.com/e/measles%e2%80%94it-s-here-would-you-recognize-it-frankly-speaking-ep-387/</link>
                    <comments>https://primedfranklyspeaking.podbean.com/e/measles%e2%80%94it-s-here-would-you-recognize-it-frankly-speaking-ep-387/#comments</comments>        <pubDate>Sun, 30 Jun 2024 20:00:00 +0000</pubDate>
        <guid isPermaLink="false">primedfranklyspeaking.podbean.com/6d129509-e903-3ce3-949d-ff9e1a3706b4</guid>
                                    <description><![CDATA[<p>Credits: 0.25 AMA PRA Category 1 Credit™
 
CME/CE Information and Claim Credit: <a href='https://www.pri-med.com/online-education/podcast/frankly-speaking-cme-387'>https://www.pri-med.com/online-education/podcast/frankly-speaking-cme-387</a></p>
<p>Overview: Measles incidence in the US was low, with the CDC issuing it “elimination status.” In 2024, a cluster of measles cases threatened this status. Join us while we discuss this phenomenon and its impact on public health and practice, including who is at risk, how to recognize measles, and ways to manage this contagious and vaccine-preventable illness.</p>
<p>Episode resource links:</p>
<ul><li>Centers for Disease Control and Prevention (CDC): Measles Cases and Outbreaks. <a href='https://www.cdc.gov/measles/cases-outbreaks.html'>https://www.cdc.gov/measles/cases-outbreaks.html</a></li>
<li>Center for Infectious Disease Research and Policy (CIDRAP); University of Minnesota. <a href='https://www.cidrap.umn.edu/measles/us-measles-cases-top-120-la-county-tracks-case-multiple-exposures'>https://www.cidrap.umn.edu/measles/us-measles-cases-top-120-la-county-tracks-case-multiple-exposures</a></li>
<li>Center for Infectious Disease Research and Policy (CIDRAP); University of Minnesota. CDC: Spike in measles cases poses threat to US elimination status. <a href='https://www.cidrap.umn.edu/measles/cdc-spike-measles-cases-poses-threat-us-elimination-status'>https://www.cidrap.umn.edu/measles/cdc-spike-measles-cases-poses-threat-us-elimination-status</a></li>
<li><a href='https://www-dynamed-com.umassmed.idm.oclc.org/condition/measles#GUID-7F3DC983-F146-49BD-B647-A2EA7DA9FDE8'>DynaMed – Measles </a></li>
</ul>
<p>Guest: Susan Feeney, DNP, FNP-BC, NP-C
 
Music Credit: Richard Onorato</p>
]]></description>
                                                            <content:encoded><![CDATA[<p>Credits: 0.25 AMA PRA Category 1 Credit™<br>
 <br>
CME/CE Information and Claim Credit: <a href='https://www.pri-med.com/online-education/podcast/frankly-speaking-cme-387'>https://www.pri-med.com/online-education/podcast/frankly-speaking-cme-387</a></p>
<p>Overview: Measles incidence in the US was low, with the CDC issuing it “elimination status.” In 2024, a cluster of measles cases threatened this status. Join us while we discuss this phenomenon and its impact on public health and practice, including who is at risk, how to recognize measles, and ways to manage this contagious and vaccine-preventable illness.</p>
<p>Episode resource links:</p>
<ul><li>Centers for Disease Control and Prevention (CDC): Measles Cases and Outbreaks. <a href='https://www.cdc.gov/measles/cases-outbreaks.html'>https://www.cdc.gov/measles/cases-outbreaks.html</a></li>
<li>Center for Infectious Disease Research and Policy (CIDRAP); University of Minnesota. <a href='https://www.cidrap.umn.edu/measles/us-measles-cases-top-120-la-county-tracks-case-multiple-exposures'>https://www.cidrap.umn.edu/measles/us-measles-cases-top-120-la-county-tracks-case-multiple-exposures</a></li>
<li>Center for Infectious Disease Research and Policy (CIDRAP); University of Minnesota. CDC: Spike in measles cases poses threat to US elimination status. <a href='https://www.cidrap.umn.edu/measles/cdc-spike-measles-cases-poses-threat-us-elimination-status'>https://www.cidrap.umn.edu/measles/cdc-spike-measles-cases-poses-threat-us-elimination-status</a></li>
<li><a href='https://www-dynamed-com.umassmed.idm.oclc.org/condition/measles#GUID-7F3DC983-F146-49BD-B647-A2EA7DA9FDE8'>DynaMed – Measles </a></li>
</ul>
<p>Guest: Susan Feeney, DNP, FNP-BC, NP-C<br>
 <br>
Music Credit: Richard Onorato</p>
]]></content:encoded>
                                    
        <enclosure url="https://mcdn.podbean.com/mf/web/fvsdfqam7gjr3z6y/frankly-speaking-387-measles.mp3" length="10599749" type="audio/mpeg"/>
                <itunes:summary><![CDATA[Credits: 0.25 AMA PRA Category 1 Credit™ CME/CE Information and Claim Credit: https://www.pri-med.com/online-education/podcast/frankly-speaking-cme-387
Overview: Measles incidence in the US was low, with the CDC issuing it “elimination status.” In 2024, a cluster of measles cases threatened this status. Join us while we discuss this phenomenon and its impact on public health and practice, including who is at risk, how to recognize measles, and ways to manage this contagious and vaccine-preventable illness.
Episode resource links:
Centers for Disease Control and Prevention (CDC): Measles Cases and Outbreaks. https://www.cdc.gov/measles/cases-outbreaks.html
Center for Infectious Disease Research and Policy (CIDRAP); University of Minnesota. https://www.cidrap.umn.edu/measles/us-measles-cases-top-120-la-county-tracks-case-multiple-exposures
Center for Infectious Disease Research and Policy (CIDRAP); University of Minnesota. CDC: Spike in measles cases poses threat to US elimination status. https://www.cidrap.umn.edu/measles/cdc-spike-measles-cases-poses-threat-us-elimination-status
DynaMed – Measles 
Guest: Susan Feeney, DNP, FNP-BC, NP-C Music Credit: Richard Onorato]]></itunes:summary>
        <itunes:author>Pri-Med</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>660</itunes:duration>
                        <itunes:episodeType>full</itunes:episodeType>
            </item>
    <item>
        <title>Move to Improve: Prescribing Dance for Depression - Frankly Speaking Ep 386</title>
        <itunes:title>Move to Improve: Prescribing Dance for Depression - Frankly Speaking Ep 386</itunes:title>
        <link>https://primedfranklyspeaking.podbean.com/e/move-to-improve-prescribing-dance-for-depression-frankly-speaking-ep-386/</link>
                    <comments>https://primedfranklyspeaking.podbean.com/e/move-to-improve-prescribing-dance-for-depression-frankly-speaking-ep-386/#comments</comments>        <pubDate>Mon, 24 Jun 2024 00:30:00 +0000</pubDate>
        <guid isPermaLink="false">primedfranklyspeaking.podbean.com/94deb4f5-67ef-3ac6-aef4-7735cfe18502</guid>
                                    <description><![CDATA[<p>Credits: 0.25 AMA PRA Category 1 Credit™
 
CME/CE Information and Claim Credit: <a href='https://www.pri-med.com/online-education/podcast/frankly-speaking-cme-386'>https://www.pri-med.com/online-education/podcast/frankly-speaking-cme-386</a></p>
<p>Overview: Physical activity can be a key component of treating depression. In this episode, we discuss the powerful impact of exercise as a nonpharmacologic option, with a spotlight on the benefits of dance. Gain strategies to guide patients on depression therapies and discover why dance stands out among forms of exercise.</p>
<p>Episode resource links:</p>
<ul><li><a href='https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10870815/'>https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10870815/</a></li>
<li><a href='https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10813489/'>https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10813489/</a></li>
</ul>
<p>Guest: Alan M. Ehrlich, MD, FAAFP
 
Music Credit: Richard Onorato</p>
]]></description>
                                                            <content:encoded><![CDATA[<p>Credits: 0.25 AMA PRA Category 1 Credit™<br>
 <br>
CME/CE Information and Claim Credit: <a href='https://www.pri-med.com/online-education/podcast/frankly-speaking-cme-386'>https://www.pri-med.com/online-education/podcast/frankly-speaking-cme-386</a></p>
<p>Overview: Physical activity can be a key component of treating depression. In this episode, we discuss the powerful impact of exercise as a nonpharmacologic option, with a spotlight on the benefits of dance. Gain strategies to guide patients on depression therapies and discover why dance stands out among forms of exercise.</p>
<p>Episode resource links:</p>
<ul><li><a href='https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10870815/'>https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10870815/</a></li>
<li><a href='https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10813489/'>https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10813489/</a></li>
</ul>
<p>Guest: Alan M. Ehrlich, MD, FAAFP<br>
 <br>
Music Credit: Richard Onorato</p>
]]></content:encoded>
                                    
        <enclosure url="https://mcdn.podbean.com/mf/web/2t25yajm6bm6fhbu/frankly-speaking-386-dance-for-depression.mp3" length="8691163" type="audio/mpeg"/>
                <itunes:summary><![CDATA[Credits: 0.25 AMA PRA Category 1 Credit™ CME/CE Information and Claim Credit: https://www.pri-med.com/online-education/podcast/frankly-speaking-cme-386
Overview: Physical activity can be a key component of treating depression. In this episode, we discuss the powerful impact of exercise as a nonpharmacologic option, with a spotlight on the benefits of dance. Gain strategies to guide patients on depression therapies and discover why dance stands out among forms of exercise.
Episode resource links:
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10870815/
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10813489/
Guest: Alan M. Ehrlich, MD, FAAFP Music Credit: Richard Onorato]]></itunes:summary>
        <itunes:author>Pri-Med</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>541</itunes:duration>
                        <itunes:episodeType>full</itunes:episodeType>
            </item>
    <item>
        <title>The Cost-Effectiveness of Treatment Strategies for Obesity - Frankly Speaking Ep 385</title>
        <itunes:title>The Cost-Effectiveness of Treatment Strategies for Obesity - Frankly Speaking Ep 385</itunes:title>
        <link>https://primedfranklyspeaking.podbean.com/e/the-cost-effectiveness-of-treatment-strategies-for-obesity-frankly-speaking-ep-385/</link>
                    <comments>https://primedfranklyspeaking.podbean.com/e/the-cost-effectiveness-of-treatment-strategies-for-obesity-frankly-speaking-ep-385/#comments</comments>        <pubDate>Mon, 17 Jun 2024 00:30:00 +0000</pubDate>
        <guid isPermaLink="false">primedfranklyspeaking.podbean.com/7a0eb997-ace7-3656-933e-f15a16168486</guid>
                                    <description><![CDATA[<p>Credits: 0.25 AMA PRA Category 1 Credit™
 
CME/CE Information and Claim Credit: <a href='https://www.pri-med.com/online-education/podcast/frankly-speaking-cme-385'>https://www.pri-med.com/online-education/podcast/frankly-speaking-cme-385</a></p>
<p>Overview: Through the framework of a case-based scenario, this episode explores both pharmacological and surgical treatment options for obesity. We discuss the efficacy and cost challenges of injectable medications, insurance coverage, and alternative payment solutions. Gain valuable insights into the cost-effectiveness of treatments, including recent research on endoscopic sleeve gastroplasty, to better advise patients.</p>
<p>Episode resource links:</p>
<ul><li>Haseeb M, Chhatwal J, Xiao J, Jirapinyo P, Thompson CC. Semaglutide vs Endoscopic Sleeve Gastroplasty for Weight Loss. JAMA Netw Open. 2024;7(4):e246221. doi:10.1001/jamanetworkopen.2024.6221</li>
<li><a href='https://obesitymedicine.org/blog/does-insurance-cover-weight-loss-medication/'>https://obesitymedicine.org/blog/does-insurance-cover-weight-loss-medication/</a></li>
</ul>
<p>Guest: Jillian Joseph, PA-C
 
Music Credit: Richard Onorato</p>
]]></description>
                                                            <content:encoded><![CDATA[<p>Credits: 0.25 AMA PRA Category 1 Credit™<br>
 <br>
CME/CE Information and Claim Credit: <a href='https://www.pri-med.com/online-education/podcast/frankly-speaking-cme-385'>https://www.pri-med.com/online-education/podcast/frankly-speaking-cme-385</a></p>
<p>Overview: Through the framework of a case-based scenario, this episode explores both pharmacological and surgical treatment options for obesity. We discuss the efficacy and cost challenges of injectable medications, insurance coverage, and alternative payment solutions. Gain valuable insights into the cost-effectiveness of treatments, including recent research on endoscopic sleeve gastroplasty, to better advise patients.</p>
<p>Episode resource links:</p>
<ul><li>Haseeb M, Chhatwal J, Xiao J, Jirapinyo P, Thompson CC. Semaglutide vs Endoscopic Sleeve Gastroplasty for Weight Loss. JAMA Netw Open. 2024;7(4):e246221. doi:10.1001/jamanetworkopen.2024.6221</li>
<li><a href='https://obesitymedicine.org/blog/does-insurance-cover-weight-loss-medication/'>https://obesitymedicine.org/blog/does-insurance-cover-weight-loss-medication/</a></li>
</ul>
<p>Guest: Jillian Joseph, PA-C<br>
 <br>
Music Credit: Richard Onorato</p>
]]></content:encoded>
                                    
        <enclosure url="https://mcdn.podbean.com/mf/web/gbmza9abx2epyh8h/frankly-speaking-385-gastric-sleeve.mp3" length="10227668" type="audio/mpeg"/>
                <itunes:summary><![CDATA[Credits: 0.25 AMA PRA Category 1 Credit™ CME/CE Information and Claim Credit: https://www.pri-med.com/online-education/podcast/frankly-speaking-cme-385
Overview: Through the framework of a case-based scenario, this episode explores both pharmacological and surgical treatment options for obesity. We discuss the efficacy and cost challenges of injectable medications, insurance coverage, and alternative payment solutions. Gain valuable insights into the cost-effectiveness of treatments, including recent research on endoscopic sleeve gastroplasty, to better advise patients.
Episode resource links:
Haseeb M, Chhatwal J, Xiao J, Jirapinyo P, Thompson CC. Semaglutide vs Endoscopic Sleeve Gastroplasty for Weight Loss. JAMA Netw Open. 2024;7(4):e246221. doi:10.1001/jamanetworkopen.2024.6221
https://obesitymedicine.org/blog/does-insurance-cover-weight-loss-medication/
Guest: Jillian Joseph, PA-C Music Credit: Richard Onorato]]></itunes:summary>
        <itunes:author>Pri-Med</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>637</itunes:duration>
                        <itunes:episodeType>full</itunes:episodeType>
            </item>
    <item>
        <title>Fact-Checking Social Media: Pregnancy, Acetaminophen, and Autism - Frankly Speaking Ep 384</title>
        <itunes:title>Fact-Checking Social Media: Pregnancy, Acetaminophen, and Autism - Frankly Speaking Ep 384</itunes:title>
        <link>https://primedfranklyspeaking.podbean.com/e/fact-checking-social-media-pregnancy-acetaminophen-and-autism-frankly-speaking-ep-384/</link>
                    <comments>https://primedfranklyspeaking.podbean.com/e/fact-checking-social-media-pregnancy-acetaminophen-and-autism-frankly-speaking-ep-384/#comments</comments>        <pubDate>Mon, 10 Jun 2024 00:30:00 +0000</pubDate>
        <guid isPermaLink="false">primedfranklyspeaking.podbean.com/330b5d7a-41a3-3a02-8a03-b4395f8b7666</guid>
                                    <description><![CDATA[<p>Credits: 0.25 AMA PRA Category 1 Credit™
 
CME/CE Information and Claim Credit: <a href='https://www.pri-med.com/online-education/podcast/frankly-speaking-cme-384'>https://www.pri-med.com/online-education/podcast/frankly-speaking-cme-384</a></p>
<p>Overview: This episode investigates the inaccurate correlation made between acetaminophen use during pregnancy and an increased risk of developmental disorders, including autism spectrum disorder, in children. Expert faculty discuss the history of these claims, followed by a study evaluating outcomes in children, and emphasize the importance of evidence-based decision-making for patients and clinicians.</p>
<p>Episode resource links:</p>
<ul><li>Ahlqvist VH, Sjöqvist H, Dalman C, et al. Acetaminophen Use During Pregnancy and Children’s Risk of Autism, ADHD, and Intellectual Disability. JAMA. 2024;331(14):1205–1214. doi:10.1001/jama.2024.3172</li>
<li>Nat Rev Endocrinol. 2021 Dec;17(12):757-766. doi: 10.1038/s41574-021-00553-7</li>
</ul>
<p>Guest: Aylin Madore, MD, MEd
 
Music Credit: Richard Onorato</p>
]]></description>
                                                            <content:encoded><![CDATA[<p>Credits: 0.25 AMA PRA Category 1 Credit™<br>
 <br>
CME/CE Information and Claim Credit: <a href='https://www.pri-med.com/online-education/podcast/frankly-speaking-cme-384'>https://www.pri-med.com/online-education/podcast/frankly-speaking-cme-384</a></p>
<p>Overview: This episode investigates the inaccurate correlation made between acetaminophen use during pregnancy and an increased risk of developmental disorders, including autism spectrum disorder, in children. Expert faculty discuss the history of these claims, followed by a study evaluating outcomes in children, and emphasize the importance of evidence-based decision-making for patients and clinicians.</p>
<p>Episode resource links:</p>
<ul><li>Ahlqvist VH, Sjöqvist H, Dalman C, et al. Acetaminophen Use During Pregnancy and Children’s Risk of Autism, ADHD, and Intellectual Disability. JAMA. 2024;331(14):1205–1214. doi:10.1001/jama.2024.3172</li>
<li>Nat Rev Endocrinol. 2021 Dec;17(12):757-766. doi: 10.1038/s41574-021-00553-7</li>
</ul>
<p>Guest: Aylin Madore, MD, MEd<br>
 <br>
Music Credit: Richard Onorato</p>
]]></content:encoded>
                                    
        <enclosure url="https://mcdn.podbean.com/mf/web/hke2gqzxcmbuptcr/frankly-speaking-384-acetaminophen-austism.mp3" length="6918770" type="audio/mpeg"/>
                <itunes:summary><![CDATA[Credits: 0.25 AMA PRA Category 1 Credit™ CME/CE Information and Claim Credit: https://www.pri-med.com/online-education/podcast/frankly-speaking-cme-384
Overview: This episode investigates the inaccurate correlation made between acetaminophen use during pregnancy and an increased risk of developmental disorders, including autism spectrum disorder, in children. Expert faculty discuss the history of these claims, followed by a study evaluating outcomes in children, and emphasize the importance of evidence-based decision-making for patients and clinicians.
Episode resource links:
Ahlqvist VH, Sjöqvist H, Dalman C, et al. Acetaminophen Use During Pregnancy and Children’s Risk of Autism, ADHD, and Intellectual Disability. JAMA. 2024;331(14):1205–1214. doi:10.1001/jama.2024.3172
Nat Rev Endocrinol. 2021 Dec;17(12):757-766. doi: 10.1038/s41574-021-00553-7
Guest: Aylin Madore, MD, MEd Music Credit: Richard Onorato]]></itunes:summary>
        <itunes:author>Pri-Med</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>430</itunes:duration>
                <itunes:episode>6</itunes:episode>
        <itunes:episodeType>full</itunes:episodeType>
            </item>
    <item>
        <title>Beyond Reaction: Strategies for Mitigating the Food Allergy Surge - Frankly Speaking Ep 383</title>
        <itunes:title>Beyond Reaction: Strategies for Mitigating the Food Allergy Surge - Frankly Speaking Ep 383</itunes:title>
        <link>https://primedfranklyspeaking.podbean.com/e/beyond-reaction-strategies-for-mitigating-the-food-allergy-surge-frankly-speaking-ep-383/</link>
                    <comments>https://primedfranklyspeaking.podbean.com/e/beyond-reaction-strategies-for-mitigating-the-food-allergy-surge-frankly-speaking-ep-383/#comments</comments>        <pubDate>Mon, 03 Jun 2024 00:30:00 +0000</pubDate>
        <guid isPermaLink="false">primedfranklyspeaking.podbean.com/4c9c83c2-d1fe-3cc3-bf85-800c3a3c08cf</guid>
                                    <description><![CDATA[<p>Credits: 0.25 AMA PRA Category 1 Credit™
 
CME/CE Information and Claim Credit: <a href='https://www.pri-med.com/online-education/podcast/frankly-speaking-cme-383'>https://www.pri-med.com/online-education/podcast/frankly-speaking-cme-383</a></p>
<p>Overview: This episode highlights a growing concern—the prevalence of food allergies is on the rise. We underscore the importance for clinicians to help keep vulnerable populations safe through risk reduction strategies as well as the use of medication therapy. Feel empowered to prepare and safeguard patients from adverse reactions to food allergies.</p>
<p>Episode resource links:</p>
<ul><li>Abrams, E. M., &amp; Becker, A. B. (2015). Food introduction and allergy prevention in infants. CMAJ : Canadian Medical Association journal = journal de l'Association medicale canadienne, 187(17), 1297–1301. https://doi.org/10.1503/cmaj.150364</li>
<li>Elghoudi, A., &amp; Narchi, H. (2022). Food allergy in children-the current status and the way forward. World journal of clinical pediatrics, 11(3), 253–269. https://doi.org/10.5409/wjcp.v11.i3.253</li>
<li>Wood, R. A., Togias, A., Sicherer, S. H., Shreffler, W. G., Kim, E. H., Jones, S. M., ... &amp; Chinthrajah, R. S. (2024). Omalizumab for the Treatment of Multiple Food Allergies. New England Journal of Medicine.</li>
<li>https://www.foodallergy.org/living-food-allergies/food-allergy-essentials/food-allergy-anaphylaxis-emergency-care-plan</li>
<li>CDC.gov</li>
<li>https://acaai.org/</li>
</ul>
<p>Guest: Mariyan L. Montaque, DNP, FNP-BC
 
Music Credit: Richard Onorato</p>
]]></description>
                                                            <content:encoded><![CDATA[<p>Credits: 0.25 AMA PRA Category 1 Credit™<br>
 <br>
CME/CE Information and Claim Credit: <a href='https://www.pri-med.com/online-education/podcast/frankly-speaking-cme-383'>https://www.pri-med.com/online-education/podcast/frankly-speaking-cme-383</a></p>
<p>Overview: This episode highlights a growing concern—the prevalence of food allergies is on the rise. We underscore the importance for clinicians to help keep vulnerable populations safe through risk reduction strategies as well as the use of medication therapy. Feel empowered to prepare and safeguard patients from adverse reactions to food allergies.</p>
<p>Episode resource links:</p>
<ul><li>Abrams, E. M., &amp; Becker, A. B. (2015). Food introduction and allergy prevention in infants. CMAJ : Canadian Medical Association journal = journal de l'Association medicale canadienne, 187(17), 1297–1301. https://doi.org/10.1503/cmaj.150364</li>
<li>Elghoudi, A., &amp; Narchi, H. (2022). Food allergy in children-the current status and the way forward. World journal of clinical pediatrics, 11(3), 253–269. https://doi.org/10.5409/wjcp.v11.i3.253</li>
<li>Wood, R. A., Togias, A., Sicherer, S. H., Shreffler, W. G., Kim, E. H., Jones, S. M., ... &amp; Chinthrajah, R. S. (2024). Omalizumab for the Treatment of Multiple Food Allergies. New England Journal of Medicine.</li>
<li>https://www.foodallergy.org/living-food-allergies/food-allergy-essentials/food-allergy-anaphylaxis-emergency-care-plan</li>
<li>CDC.gov</li>
<li>https://acaai.org/</li>
</ul>
<p>Guest: Mariyan L. Montaque, DNP, FNP-BC<br>
 <br>
Music Credit: Richard Onorato</p>
]]></content:encoded>
                                    
        <enclosure url="https://mcdn.podbean.com/mf/web/9qfp6mcghcbtzac2/frankly-speaking-383-food-allergies.mp3" length="10007771" type="audio/mpeg"/>
                <itunes:summary><![CDATA[Credits: 0.25 AMA PRA Category 1 Credit™ CME/CE Information and Claim Credit: https://www.pri-med.com/online-education/podcast/frankly-speaking-cme-383
Overview: This episode highlights a growing concern—the prevalence of food allergies is on the rise. We underscore the importance for clinicians to help keep vulnerable populations safe through risk reduction strategies as well as the use of medication therapy. Feel empowered to prepare and safeguard patients from adverse reactions to food allergies.
Episode resource links:
Abrams, E. M., &amp; Becker, A. B. (2015). Food introduction and allergy prevention in infants. CMAJ : Canadian Medical Association journal = journal de l'Association medicale canadienne, 187(17), 1297–1301. https://doi.org/10.1503/cmaj.150364
Elghoudi, A., &amp; Narchi, H. (2022). Food allergy in children-the current status and the way forward. World journal of clinical pediatrics, 11(3), 253–269. https://doi.org/10.5409/wjcp.v11.i3.253
Wood, R. A., Togias, A., Sicherer, S. H., Shreffler, W. G., Kim, E. H., Jones, S. M., ... &amp; Chinthrajah, R. S. (2024). Omalizumab for the Treatment of Multiple Food Allergies. New England Journal of Medicine.
https://www.foodallergy.org/living-food-allergies/food-allergy-essentials/food-allergy-anaphylaxis-emergency-care-plan
CDC.gov
https://acaai.org/
Guest: Mariyan L. Montaque, DNP, FNP-BC Music Credit: Richard Onorato]]></itunes:summary>
        <itunes:author>Pri-Med</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>623</itunes:duration>
                        <itunes:episodeType>full</itunes:episodeType>
            </item>
    <item>
        <title>Time to Update Your CVD Risk Calculator? - Frankly Speaking Ep 382</title>
        <itunes:title>Time to Update Your CVD Risk Calculator? - Frankly Speaking Ep 382</itunes:title>
        <link>https://primedfranklyspeaking.podbean.com/e/time-to-update-your-cvd-risk-calculator-frankly-speaking-ep-382/</link>
                    <comments>https://primedfranklyspeaking.podbean.com/e/time-to-update-your-cvd-risk-calculator-frankly-speaking-ep-382/#comments</comments>        <pubDate>Mon, 27 May 2024 00:30:00 +0000</pubDate>
        <guid isPermaLink="false">primedfranklyspeaking.podbean.com/b646f838-3e69-360f-8079-fab463b591b0</guid>
                                    <description><![CDATA[<p>Credits: 0.25 AMA PRA Category 1 Credit™
 
CME/CE Information and Claim Credit: <a href='https://www.pri-med.com/online-education/podcast/frankly-speaking-cme-382'>https://www.pri-med.com/online-education/podcast/frankly-speaking-cme-382</a></p>
<p>Overview: Tune in as we discuss the AHA’s newly validated risk calculator designed to assess the risk of developing cardiovascular disease and heart failure in certain patients. We review which risk factor variables were included in the development of this new tool and whether to consider incorporating it in your practice.</p>
<p>Episode resource links:</p>
<ul><li><a href='https://doi.org/10.1161/CIRCULATIONAHA.123.067626'>https://doi.org/10.1161/CIRCULATIONAHA.123.067626</a></li>
<li>The calculator: <a href='https://professional.heart.org/en/guidelines-and-statements/prevent-calculator'>https://professional.heart.org/en/guidelines-and-statements/prevent-calculator</a></li>
</ul>
<p>Guest: Robert A. Baldor MD, FAAFP
 
Music Credit: Richard Onorato</p>
]]></description>
                                                            <content:encoded><![CDATA[<p>Credits: 0.25 AMA PRA Category 1 Credit™<br>
 <br>
CME/CE Information and Claim Credit: <a href='https://www.pri-med.com/online-education/podcast/frankly-speaking-cme-382'>https://www.pri-med.com/online-education/podcast/frankly-speaking-cme-382</a></p>
<p>Overview: Tune in as we discuss the AHA’s newly validated risk calculator designed to assess the risk of developing cardiovascular disease and heart failure in certain patients. We review which risk factor variables were included in the development of this new tool and whether to consider incorporating it in your practice.</p>
<p>Episode resource links:</p>
<ul><li><a href='https://doi.org/10.1161/CIRCULATIONAHA.123.067626'>https://doi.org/10.1161/CIRCULATIONAHA.123.067626</a></li>
<li>The calculator: <a href='https://professional.heart.org/en/guidelines-and-statements/prevent-calculator'>https://professional.heart.org/en/guidelines-and-statements/prevent-calculator</a></li>
</ul>
<p>Guest: Robert A. Baldor MD, FAAFP<br>
 <br>
Music Credit: Richard Onorato</p>
]]></content:encoded>
                                    
        <enclosure url="https://mcdn.podbean.com/mf/web/y4s3mrgewzd5nibq/frankly-speaking-382-CVD-risk-calculator.mp3" length="11556807" type="audio/mpeg"/>
                <itunes:summary><![CDATA[Credits: 0.25 AMA PRA Category 1 Credit™ CME/CE Information and Claim Credit: https://www.pri-med.com/online-education/podcast/frankly-speaking-cme-382
Overview: Tune in as we discuss the AHA’s newly validated risk calculator designed to assess the risk of developing cardiovascular disease and heart failure in certain patients. We review which risk factor variables were included in the development of this new tool and whether to consider incorporating it in your practice.
Episode resource links:
https://doi.org/10.1161/CIRCULATIONAHA.123.067626
The calculator: https://professional.heart.org/en/guidelines-and-statements/prevent-calculator
Guest: Robert A. Baldor MD, FAAFP Music Credit: Richard Onorato]]></itunes:summary>
        <itunes:author>Pri-Med</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>720</itunes:duration>
                        <itunes:episodeType>full</itunes:episodeType>
            </item>
    <item>
        <title>Do E-Cigarettes Help with Smoking Cessation? - Frankly Speaking Ep 381</title>
        <itunes:title>Do E-Cigarettes Help with Smoking Cessation? - Frankly Speaking Ep 381</itunes:title>
        <link>https://primedfranklyspeaking.podbean.com/e/do-e-cigarettes-help-with-smoking-cessation-frankly-speaking-ep-381/</link>
                    <comments>https://primedfranklyspeaking.podbean.com/e/do-e-cigarettes-help-with-smoking-cessation-frankly-speaking-ep-381/#comments</comments>        <pubDate>Mon, 20 May 2024 00:30:00 +0000</pubDate>
        <guid isPermaLink="false">primedfranklyspeaking.podbean.com/f211ac49-8108-3d50-91af-6519f71192b7</guid>
                                    <description><![CDATA[<p>Credits: 0.25 AMA PRA Category 1 Credit™
 
CME/CE Information and Claim Credit: <a href='https://www.pri-med.com/online-education/podcast/frankly-speaking-cme-381'>https://www.pri-med.com/online-education/podcast/frankly-speaking-cme-381</a></p>
<p>Overview: While the aerosol in e-cigarettes does contain toxicants and carcinogens, since it is not burned like combustible tobacco cigarettes, vaping exposes the user to fewer toxicants and chemicals. Many consider using e-cigarettes for smoking cessation, but evidence has been conflicting. Tune in as we discuss a recent review examining the efficacy of e-cigarettes in aiding smoking cessation and explore potential adverse effects associated with their usage.</p>
<p>Episode resource links:</p>
<ul><li>Lin, H. X., Liu, Z., Hajek, P., Zhang, W. T., Wu, Y., Zhu, B. C., Liu, H. H., Xiang, Q., Zhang, Y., Li, S. B., Pesola, F., &amp; Wang, Y. Y. (2024). Efficacy of Electronic Cigarettes vs Varenicline and Nicotine Chewing Gum as an Aid to Stop Smoking: A Randomized Clinical Trial. JAMA internal medicine, 10.1001/jamainternmed.2023.7846. Advance online publication. <a href='https://doi.org/10.1001/jamainternmed.2023.7846'>https://doi.org/10.1001/jamainternmed.2023.7846</a></li>
<li>Lindson, N., Butler, A. R., McRobbie, H., Bullen, C., Hajek, P., Begh, R., Theodoulou, A., Notley, C., Rigotti, N. A., Turner, T., Livingstone-Banks, J., Morris, T., &amp; Hartmann-Boyce, J. (2024). Electronic cigarettes for smoking cessation. The Cochrane database of systematic reviews, 1(1), CD010216. https://doi.org/10.1002/14651858.CD010216.pub8</li>
<li>Sanford BT, Brownstein NC, Baker NL, et al. Shift From Smoking Cigarettes to Vaping Nicotine in Young Adults. JAMA Intern Med. Published online November 13, 2023. doi:10.1001/jamainternmed.2023.5239</li>
</ul>
<p>Guest: Susan Feeney, DNP, FNP-BC, NP-C
 
Music Credit: Richard Onorato</p>
]]></description>
                                                            <content:encoded><![CDATA[<p>Credits: 0.25 AMA PRA Category 1 Credit™<br>
 <br>
CME/CE Information and Claim Credit: <a href='https://www.pri-med.com/online-education/podcast/frankly-speaking-cme-381'>https://www.pri-med.com/online-education/podcast/frankly-speaking-cme-381</a></p>
<p>Overview: While the aerosol in e-cigarettes does contain toxicants and carcinogens, since it is not burned like combustible tobacco cigarettes, vaping exposes the user to fewer toxicants and chemicals. Many consider using e-cigarettes for smoking cessation, but evidence has been conflicting. Tune in as we discuss a recent review examining the efficacy of e-cigarettes in aiding smoking cessation and explore potential adverse effects associated with their usage.</p>
<p>Episode resource links:</p>
<ul><li>Lin, H. X., Liu, Z., Hajek, P., Zhang, W. T., Wu, Y., Zhu, B. C., Liu, H. H., Xiang, Q., Zhang, Y., Li, S. B., Pesola, F., &amp; Wang, Y. Y. (2024). Efficacy of Electronic Cigarettes vs Varenicline and Nicotine Chewing Gum as an Aid to Stop Smoking: A Randomized Clinical Trial. JAMA internal medicine, 10.1001/jamainternmed.2023.7846. Advance online publication. <a href='https://doi.org/10.1001/jamainternmed.2023.7846'>https://doi.org/10.1001/jamainternmed.2023.7846</a></li>
<li>Lindson, N., Butler, A. R., McRobbie, H., Bullen, C., Hajek, P., Begh, R., Theodoulou, A., Notley, C., Rigotti, N. A., Turner, T., Livingstone-Banks, J., Morris, T., &amp; Hartmann-Boyce, J. (2024). Electronic cigarettes for smoking cessation. The Cochrane database of systematic reviews, 1(1), CD010216. https://doi.org/10.1002/14651858.CD010216.pub8</li>
<li>Sanford BT, Brownstein NC, Baker NL, et al. Shift From Smoking Cigarettes to Vaping Nicotine in Young Adults. JAMA Intern Med. Published online November 13, 2023. doi:10.1001/jamainternmed.2023.5239</li>
</ul>
<p>Guest: Susan Feeney, DNP, FNP-BC, NP-C<br>
 <br>
Music Credit: Richard Onorato</p>
]]></content:encoded>
                                    
        <enclosure url="https://mcdn.podbean.com/mf/web/9mak4hqjv46vq5tt/frankly-speaking-381-e-cigarettes.mp3" length="13418573" type="audio/mpeg"/>
                <itunes:summary><![CDATA[Credits: 0.25 AMA PRA Category 1 Credit™ CME/CE Information and Claim Credit: https://www.pri-med.com/online-education/podcast/frankly-speaking-cme-381
Overview: While the aerosol in e-cigarettes does contain toxicants and carcinogens, since it is not burned like combustible tobacco cigarettes, vaping exposes the user to fewer toxicants and chemicals. Many consider using e-cigarettes for smoking cessation, but evidence has been conflicting. Tune in as we discuss a recent review examining the efficacy of e-cigarettes in aiding smoking cessation and explore potential adverse effects associated with their usage.
Episode resource links:
Lin, H. X., Liu, Z., Hajek, P., Zhang, W. T., Wu, Y., Zhu, B. C., Liu, H. H., Xiang, Q., Zhang, Y., Li, S. B., Pesola, F., &amp; Wang, Y. Y. (2024). Efficacy of Electronic Cigarettes vs Varenicline and Nicotine Chewing Gum as an Aid to Stop Smoking: A Randomized Clinical Trial. JAMA internal medicine, 10.1001/jamainternmed.2023.7846. Advance online publication. https://doi.org/10.1001/jamainternmed.2023.7846
Lindson, N., Butler, A. R., McRobbie, H., Bullen, C., Hajek, P., Begh, R., Theodoulou, A., Notley, C., Rigotti, N. A., Turner, T., Livingstone-Banks, J., Morris, T., &amp; Hartmann-Boyce, J. (2024). Electronic cigarettes for smoking cessation. The Cochrane database of systematic reviews, 1(1), CD010216. https://doi.org/10.1002/14651858.CD010216.pub8
Sanford BT, Brownstein NC, Baker NL, et al. Shift From Smoking Cigarettes to Vaping Nicotine in Young Adults. JAMA Intern Med. Published online November 13, 2023. doi:10.1001/jamainternmed.2023.5239
Guest: Susan Feeney, DNP, FNP-BC, NP-C Music Credit: Richard Onorato]]></itunes:summary>
        <itunes:author>Pri-Med</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>836</itunes:duration>
                        <itunes:episodeType>full</itunes:episodeType>
            </item>
    <item>
        <title>ACE Inhibitors: Maybe Not for Hypertension Alone - Frankly Speaking Ep 380</title>
        <itunes:title>ACE Inhibitors: Maybe Not for Hypertension Alone - Frankly Speaking Ep 380</itunes:title>
        <link>https://primedfranklyspeaking.podbean.com/e/ace-inhibitors-maybe-not-for-hypertension-alone-frankly-speaking-ep-380/</link>
                    <comments>https://primedfranklyspeaking.podbean.com/e/ace-inhibitors-maybe-not-for-hypertension-alone-frankly-speaking-ep-380/#comments</comments>        <pubDate>Mon, 13 May 2024 00:30:00 +0000</pubDate>
        <guid isPermaLink="false">primedfranklyspeaking.podbean.com/18a403a4-4703-3e28-86c0-a291ce0d447e</guid>
                                    <description><![CDATA[<p>Credits: 0.25 AMA PRA Category 1 Credit™
 
CME/CE Information and Claim Credit: <a href='https://www.pri-med.com/online-education/podcast/frankly-speaking-cme-380'>https://www.pri-med.com/online-education/podcast/frankly-speaking-cme-380</a></p>
<p>Overview: This episode brings you a comparison of thiazide diuretics, angiotensin-converting enzyme (ACE) inhibitors, and calcium channel blockers on cardiovascular outcomes, stroke, and all-cause mortality. Gain evidence-based insights to help you make informed choices for your patients’ care.</p>
<p>Episode resource links:</p>
<ul><li><a href='https://pubmed.ncbi.nlm.nih.gov/38048133/#:~:text=JAMA%20Netw%20Open,10.1001/jamanetworkopen.2023.44998'>https://pubmed.ncbi.nlm.nih.gov/38048133/#:~:text=JAMA%20Netw%20Open,10.1001/jamanetworkopen.2023.44998</a></li>
</ul>
<p>Guest: Jillian Joseph, MPAS, PA-C
 
Music Credit: Richard Onorato</p>
]]></description>
                                                            <content:encoded><![CDATA[<p>Credits: 0.25 AMA PRA Category 1 Credit™<br>
 <br>
CME/CE Information and Claim Credit: <a href='https://www.pri-med.com/online-education/podcast/frankly-speaking-cme-380'>https://www.pri-med.com/online-education/podcast/frankly-speaking-cme-380</a></p>
<p>Overview: This episode brings you a comparison of thiazide diuretics, angiotensin-converting enzyme (ACE) inhibitors, and calcium channel blockers on cardiovascular outcomes, stroke, and all-cause mortality. Gain evidence-based insights to help you make informed choices for your patients’ care.</p>
<p>Episode resource links:</p>
<ul><li><a href='https://pubmed.ncbi.nlm.nih.gov/38048133/#:~:text=JAMA%20Netw%20Open,10.1001/jamanetworkopen.2023.44998'>https://pubmed.ncbi.nlm.nih.gov/38048133/#:~:text=JAMA%20Netw%20Open,10.1001/jamanetworkopen.2023.44998</a></li>
</ul>
<p>Guest: Jillian Joseph, MPAS, PA-C<br>
 <br>
Music Credit: Richard Onorato</p>
]]></content:encoded>
                                    
        <enclosure url="https://mcdn.podbean.com/mf/web/nkg39nwzr6hzxxzy/frankly-speaking-380-ACE-inhibitors.mp3" length="8697000" type="audio/mpeg"/>
                <itunes:summary><![CDATA[Credits: 0.25 AMA PRA Category 1 Credit™ CME/CE Information and Claim Credit: https://www.pri-med.com/online-education/podcast/frankly-speaking-cme-380
Overview: This episode brings you a comparison of thiazide diuretics, angiotensin-converting enzyme (ACE) inhibitors, and calcium channel blockers on cardiovascular outcomes, stroke, and all-cause mortality. Gain evidence-based insights to help you make informed choices for your patients’ care.
Episode resource links:
https://pubmed.ncbi.nlm.nih.gov/38048133/#:~:text=JAMA%20Netw%20Open,10.1001/jamanetworkopen.2023.44998
Guest: Jillian Joseph, MPAS, PA-C Music Credit: Richard Onorato]]></itunes:summary>
        <itunes:author>Pri-Med</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>541</itunes:duration>
                        <itunes:episodeType>full</itunes:episodeType>
            </item>
    <item>
        <title>Colchicine: It’s Not Just for Gout Anymore - Frankly Speaking Ep 379</title>
        <itunes:title>Colchicine: It’s Not Just for Gout Anymore - Frankly Speaking Ep 379</itunes:title>
        <link>https://primedfranklyspeaking.podbean.com/e/colchicine-it-s-not-just-for-gout-anymore-frankly-speaking-ep-379/</link>
                    <comments>https://primedfranklyspeaking.podbean.com/e/colchicine-it-s-not-just-for-gout-anymore-frankly-speaking-ep-379/#comments</comments>        <pubDate>Mon, 06 May 2024 00:30:00 +0000</pubDate>
        <guid isPermaLink="false">primedfranklyspeaking.podbean.com/693de10f-3826-3061-95a7-0d24ae91dd78</guid>
                                    <description><![CDATA[<p>Credits: 0.25 AMA PRA Category 1 Credit™
 
CME/CE Information and Claim Credit: <a href='https://www.pri-med.com/online-education/podcast/frankly-speaking-cme-379'>https://www.pri-med.com/online-education/podcast/frankly-speaking-cme-379</a></p>
<p>Overview: Recent data has shown that colchicine can improve outcomes in patients with known coronary artery disease (CAD), with consideration of colchicine now recommended by the American Heart Association (AHA). Hear valuable insights into the potential benefits and limitations to refine your clinical approach to managing CAD.</p>
<p>Episode resource links:</p>
<ul><li>Nidorf SM, Fiolet ATL, Mosterd A, et al. Colchicine in Patients with Chronic Coronary Disease. N Engl J Med. 2020;383(19):1838-1847. </li>
<li>Mohammadnia N, Los J, Opstal TSJ, et al. Colchicine and diabetes in patients with chronic coronary artery disease: insights from the LoDoCo2 randomized controlled trial. Front Cardiovasc Med. 2023;10:1244529. Published 2023 Oct 6. </li>
<li>Roubille F, Bouabdallaoui N, Kouz S, et al. Low-Dose Colchicine in Patients With Type 2 Diabetes and Recent Myocardial Infarction in the COLchicine Cardiovascular Outcomes Trial (COLCOT). Diabetes Care. Published online January 5, 2024. </li>
</ul>
<p>Guest: Alan M. Ehrlich, MD, FAAFP
 
Music Credit: Richard Onorato</p>
]]></description>
                                                            <content:encoded><![CDATA[<p>Credits: 0.25 AMA PRA Category 1 Credit™<br>
 <br>
CME/CE Information and Claim Credit: <a href='https://www.pri-med.com/online-education/podcast/frankly-speaking-cme-379'>https://www.pri-med.com/online-education/podcast/frankly-speaking-cme-379</a></p>
<p>Overview: Recent data has shown that colchicine can improve outcomes in patients with known coronary artery disease (CAD), with consideration of colchicine now recommended by the American Heart Association (AHA). Hear valuable insights into the potential benefits and limitations to refine your clinical approach to managing CAD.</p>
<p>Episode resource links:</p>
<ul><li>Nidorf SM, Fiolet ATL, Mosterd A, et al. Colchicine in Patients with Chronic Coronary Disease. N Engl J Med. 2020;383(19):1838-1847. </li>
<li>Mohammadnia N, Los J, Opstal TSJ, et al. Colchicine and diabetes in patients with chronic coronary artery disease: insights from the LoDoCo2 randomized controlled trial. Front Cardiovasc Med. 2023;10:1244529. Published 2023 Oct 6. </li>
<li>Roubille F, Bouabdallaoui N, Kouz S, et al. Low-Dose Colchicine in Patients With Type 2 Diabetes and Recent Myocardial Infarction in the COLchicine Cardiovascular Outcomes Trial (COLCOT). Diabetes Care. Published online January 5, 2024. </li>
</ul>
<p>Guest: Alan M. Ehrlich, MD, FAAFP<br>
 <br>
Music Credit: Richard Onorato</p>
]]></content:encoded>
                                    
        <enclosure url="https://mcdn.podbean.com/mf/web/gmmzg9a4433938jp/frankly-speaking-379-colchicine-CAD.mp3" length="9389468" type="audio/mpeg"/>
                <itunes:summary><![CDATA[Credits: 0.25 AMA PRA Category 1 Credit™ CME/CE Information and Claim Credit: https://www.pri-med.com/online-education/podcast/frankly-speaking-cme-379
Overview: Recent data has shown that colchicine can improve outcomes in patients with known coronary artery disease (CAD), with consideration of colchicine now recommended by the American Heart Association (AHA). Hear valuable insights into the potential benefits and limitations to refine your clinical approach to managing CAD.
Episode resource links:
Nidorf SM, Fiolet ATL, Mosterd A, et al. Colchicine in Patients with Chronic Coronary Disease. N Engl J Med. 2020;383(19):1838-1847. 
Mohammadnia N, Los J, Opstal TSJ, et al. Colchicine and diabetes in patients with chronic coronary artery disease: insights from the LoDoCo2 randomized controlled trial. Front Cardiovasc Med. 2023;10:1244529. Published 2023 Oct 6. 
Roubille F, Bouabdallaoui N, Kouz S, et al. Low-Dose Colchicine in Patients With Type 2 Diabetes and Recent Myocardial Infarction in the COLchicine Cardiovascular Outcomes Trial (COLCOT). Diabetes Care. Published online January 5, 2024. 
Guest: Alan M. Ehrlich, MD, FAAFP Music Credit: Richard Onorato]]></itunes:summary>
        <itunes:author>Pri-Med</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>585</itunes:duration>
                        <itunes:episodeType>full</itunes:episodeType>
            </item>
    <item>
        <title>Dementia News Roundup - Frankly Speaking Ep 378</title>
        <itunes:title>Dementia News Roundup - Frankly Speaking Ep 378</itunes:title>
        <link>https://primedfranklyspeaking.podbean.com/e/dementia-news-roundup-frankly-speaking-ep-378/</link>
                    <comments>https://primedfranklyspeaking.podbean.com/e/dementia-news-roundup-frankly-speaking-ep-378/#comments</comments>        <pubDate>Mon, 29 Apr 2024 00:30:00 +0000</pubDate>
        <guid isPermaLink="false">primedfranklyspeaking.podbean.com/835a923d-a4b1-3109-b846-b7b5848726d2</guid>
                                    <description><![CDATA[<p>Credits: 0.25 AMA PRA Category 1 Credit™
 
CME/CE Information and Claim Credit: <a href='https://www.pri-med.com/online-education/podcast/frankly-speaking-cme-378'>https://www.pri-med.com/online-education/podcast/frankly-speaking-cme-378</a></p>
<p>Overview: Effective treatments for dementia remain elusive. In this episode, we’re discussing dementia treatment developments gathered from recent publications, covering topics of drugs, exercise, and liver disease. Stay informed and equipped to offer the latest guidance to patients with dementia and their families.</p>
<p>Episode resource links:</p>
<ul><li>Ann Fam Med 2024;22:50-58. https://doi.org/10.1370/afm.3050</li>
<li>JAMA Netw Open. 2024;7(1):e2353965. doi:10.1001/jamanetworkopen.2023.53965</li>
</ul>
<p>Guest: Robert A. Baldor, MD, FAAFP
 
Music Credit: Richard Onorato</p>
]]></description>
                                                            <content:encoded><![CDATA[<p>Credits: 0.25 AMA PRA Category 1 Credit™<br>
 <br>
CME/CE Information and Claim Credit: <a href='https://www.pri-med.com/online-education/podcast/frankly-speaking-cme-378'>https://www.pri-med.com/online-education/podcast/frankly-speaking-cme-378</a></p>
<p>Overview: Effective treatments for dementia remain elusive. In this episode, we’re discussing dementia treatment developments gathered from recent publications, covering topics of drugs, exercise, and liver disease. Stay informed and equipped to offer the latest guidance to patients with dementia and their families.</p>
<p>Episode resource links:</p>
<ul><li>Ann Fam Med 2024;22:50-58. https://doi.org/10.1370/afm.3050</li>
<li>JAMA Netw Open. 2024;7(1):e2353965. doi:10.1001/jamanetworkopen.2023.53965</li>
</ul>
<p>Guest: Robert A. Baldor, MD, FAAFP<br>
 <br>
Music Credit: Richard Onorato</p>
]]></content:encoded>
                                    
        <enclosure url="https://mcdn.podbean.com/mf/web/3viiprpyybt5h2gb/frankly-speaking-378-dementia.mp3" length="10220274" type="audio/mpeg"/>
                <itunes:summary><![CDATA[Credits: 0.25 AMA PRA Category 1 Credit™ CME/CE Information and Claim Credit: https://www.pri-med.com/online-education/podcast/frankly-speaking-cme-378
Overview: Effective treatments for dementia remain elusive. In this episode, we’re discussing dementia treatment developments gathered from recent publications, covering topics of drugs, exercise, and liver disease. Stay informed and equipped to offer the latest guidance to patients with dementia and their families.
Episode resource links:
Ann Fam Med 2024;22:50-58. https://doi.org/10.1370/afm.3050
JAMA Netw Open. 2024;7(1):e2353965. doi:10.1001/jamanetworkopen.2023.53965
Guest: Robert A. Baldor, MD, FAAFP Music Credit: Richard Onorato]]></itunes:summary>
        <itunes:author>Pri-Med</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>637</itunes:duration>
                        <itunes:episodeType>full</itunes:episodeType>
            </item>
    <item>
        <title>To Treat or Not to Treat: Do Antibiotics Make a Difference with OME? - Frankly Speaking Ep 377</title>
        <itunes:title>To Treat or Not to Treat: Do Antibiotics Make a Difference with OME? - Frankly Speaking Ep 377</itunes:title>
        <link>https://primedfranklyspeaking.podbean.com/e/to-treat-or-not-to-treat-do-antibiotics-make-a-difference-with-ome-frankly-speaking-ep-377/</link>
                    <comments>https://primedfranklyspeaking.podbean.com/e/to-treat-or-not-to-treat-do-antibiotics-make-a-difference-with-ome-frankly-speaking-ep-377/#comments</comments>        <pubDate>Tue, 23 Apr 2024 13:26:18 +0000</pubDate>
        <guid isPermaLink="false">primedfranklyspeaking.podbean.com/05c9eacf-85ac-32ba-aeca-e8127a24a001</guid>
                                    <description><![CDATA[<p>Credits: 0.25 AMA PRA Category 1 Credit™
 
CME/CE Information and Claim Credit: <a href='https://www.pri-med.com/online-education/podcast/frankly-speaking-cme-377'>https://www.pri-med.com/online-education/podcast/frankly-speaking-cme-377</a></p>
<p>Overview: Fluid in the middle ear, or otitis media with effusion (OME), is common in children with upper respiratory infections and typically resolves without treatment. Most guidelines do not recommend antibiotics for treatment; however, they are often prescribed, and the persistence of effusion can cause a significant impact on quality of life. Join us as we discuss recent review findings on antibiotics in OME treatment and the potential impact on your practice.</p>
<p>Episode resource links:</p>
<ul><li>Mulvaney CA, Galbraith K, Webster KE, et al. Antibiotics for otitis media with effusion (OME) in children. Cochrane Database Syst Rev. 2023;10(10):CD015254. Published 2023 Oct 23. doi:10.1002/14651858.CD015254.pub2</li>
<li>Rosenfeld, R. M., Shin, J. J., Schwartz, S. R., Coggins, R., Gagnon, L., Hackell, J. M., Hoelting, D., Hunter, L. L., Kummer, A. W., Payne, S. C., Poe, D. S., Veling, M., Vila, P. M., Walsh, S. A., &amp; Corrigan, M. D. (2016). Clinical Practice Guideline: Otitis Media with Effusion (Update). Otolaryngology--head and neck surgery : official journal of American Academy of Otolaryngology-Head and Neck Surgery, 154(1 Suppl), S1–S41. https://doi.org/10.1177/0194599815623467</li>
</ul>
<p>Guest: Susan Feeney, DNP, FNP-BC, NP-C
 
Music Credit: Richard Onorato</p>
]]></description>
                                                            <content:encoded><![CDATA[<p>Credits: 0.25 AMA PRA Category 1 Credit™<br>
 <br>
CME/CE Information and Claim Credit: <a href='https://www.pri-med.com/online-education/podcast/frankly-speaking-cme-377'>https://www.pri-med.com/online-education/podcast/frankly-speaking-cme-377</a></p>
<p>Overview: Fluid in the middle ear, or otitis media with effusion (OME), is common in children with upper respiratory infections and typically resolves without treatment. Most guidelines do not recommend antibiotics for treatment; however, they are often prescribed, and the persistence of effusion can cause a significant impact on quality of life. Join us as we discuss recent review findings on antibiotics in OME treatment and the potential impact on your practice.</p>
<p>Episode resource links:</p>
<ul><li>Mulvaney CA, Galbraith K, Webster KE, et al. Antibiotics for otitis media with effusion (OME) in children. Cochrane Database Syst Rev. 2023;10(10):CD015254. Published 2023 Oct 23. doi:10.1002/14651858.CD015254.pub2</li>
<li>Rosenfeld, R. M., Shin, J. J., Schwartz, S. R., Coggins, R., Gagnon, L., Hackell, J. M., Hoelting, D., Hunter, L. L., Kummer, A. W., Payne, S. C., Poe, D. S., Veling, M., Vila, P. M., Walsh, S. A., &amp; Corrigan, M. D. (2016). Clinical Practice Guideline: Otitis Media with Effusion (Update). Otolaryngology--head and neck surgery : official journal of American Academy of Otolaryngology-Head and Neck Surgery, 154(1 Suppl), S1–S41. https://doi.org/10.1177/0194599815623467</li>
</ul>
<p>Guest: Susan Feeney, DNP, FNP-BC, NP-C<br>
 <br>
Music Credit: Richard Onorato</p>
]]></content:encoded>
                                    
        <enclosure url="https://mcdn.podbean.com/mf/web/epb3eifip8y5rzd3/frankly-speaking-377-antibiotics-otitis-media.mp3" length="10362825" type="audio/mpeg"/>
                <itunes:summary><![CDATA[Credits: 0.25 AMA PRA Category 1 Credit™ CME/CE Information and Claim Credit: https://www.pri-med.com/online-education/podcast/frankly-speaking-cme-377
Overview: Fluid in the middle ear, or otitis media with effusion (OME), is common in children with upper respiratory infections and typically resolves without treatment. Most guidelines do not recommend antibiotics for treatment; however, they are often prescribed, and the persistence of effusion can cause a significant impact on quality of life. Join us as we discuss recent review findings on antibiotics in OME treatment and the potential impact on your practice.
Episode resource links:
Mulvaney CA, Galbraith K, Webster KE, et al. Antibiotics for otitis media with effusion (OME) in children. Cochrane Database Syst Rev. 2023;10(10):CD015254. Published 2023 Oct 23. doi:10.1002/14651858.CD015254.pub2
Rosenfeld, R. M., Shin, J. J., Schwartz, S. R., Coggins, R., Gagnon, L., Hackell, J. M., Hoelting, D., Hunter, L. L., Kummer, A. W., Payne, S. C., Poe, D. S., Veling, M., Vila, P. M., Walsh, S. A., &amp; Corrigan, M. D. (2016). Clinical Practice Guideline: Otitis Media with Effusion (Update). Otolaryngology--head and neck surgery : official journal of American Academy of Otolaryngology-Head and Neck Surgery, 154(1 Suppl), S1–S41. https://doi.org/10.1177/0194599815623467
Guest: Susan Feeney, DNP, FNP-BC, NP-C Music Credit: Richard Onorato]]></itunes:summary>
        <itunes:author>Pri-Med</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>645</itunes:duration>
                        <itunes:episodeType>full</itunes:episodeType>
            </item>
    <item>
        <title>New Benefits Give SGLT2 Inhibitors Their Turn to Shine - Frankly Speaking Ep 376</title>
        <itunes:title>New Benefits Give SGLT2 Inhibitors Their Turn to Shine - Frankly Speaking Ep 376</itunes:title>
        <link>https://primedfranklyspeaking.podbean.com/e/new-benefits-give-sglt2-inhibitors-their-turn-to-shine-frankly-speaking-ep-376/</link>
                    <comments>https://primedfranklyspeaking.podbean.com/e/new-benefits-give-sglt2-inhibitors-their-turn-to-shine-frankly-speaking-ep-376/#comments</comments>        <pubDate>Mon, 15 Apr 2024 00:30:00 +0000</pubDate>
        <guid isPermaLink="false">primedfranklyspeaking.podbean.com/d71cd9a4-7346-37f7-9937-18e5be779eb8</guid>
                                    <description><![CDATA[<p>Credits: 0.25 AMA PRA Category 1 Credit™
 
CME/CE Information and Claim Credit: <a href='https://www.pri-med.com/online-education/podcast/frankly-speaking-cme-376'>https://www.pri-med.com/online-education/podcast/frankly-speaking-cme-376</a></p>
<p>Overview: While GLP-1 agents are center stage in the medical and lay press, drugs in the class of sodium-glucose cotransporter 2 inhibitors (SGLT2is) are also quite remarkable at improving a variety of health endpoints. This episode provides an overview of studies supporting the use of SGLT2is to improve patient outcomes.</p>
<p>Episode resource links:</p>
<ul><li>DM/HF:  Age Ageing 2024 Jan 2;53(1):afad254. doi: 10.1093/ageing/afad254</li>
<li>Kidney stones: JAMA Intern Med. 2024 Jan 29:e237660. doi: 10.1001/jamainternmed.2023.7660</li>
</ul>
<p>Guest: Susan Feeney, DNP, FNP-BC, NP-C
 
Music Credit: Richard Onorato</p>
]]></description>
                                                            <content:encoded><![CDATA[<p>Credits: 0.25 AMA PRA Category 1 Credit™<br>
 <br>
CME/CE Information and Claim Credit: <a href='https://www.pri-med.com/online-education/podcast/frankly-speaking-cme-376'>https://www.pri-med.com/online-education/podcast/frankly-speaking-cme-376</a></p>
<p>Overview: While GLP-1 agents are center stage in the medical and lay press, drugs in the class of sodium-glucose cotransporter 2 inhibitors (SGLT2is) are also quite remarkable at improving a variety of health endpoints. This episode provides an overview of studies supporting the use of SGLT2is to improve patient outcomes.</p>
<p>Episode resource links:</p>
<ul><li>DM/HF:  Age Ageing 2024 Jan 2;53(1):afad254. doi: 10.1093/ageing/afad254</li>
<li>Kidney stones: JAMA Intern Med. 2024 Jan 29:e237660. doi: 10.1001/jamainternmed.2023.7660</li>
</ul>
<p>Guest: Susan Feeney, DNP, FNP-BC, NP-C<br>
 <br>
Music Credit: Richard Onorato</p>
]]></content:encoded>
                                    
        <enclosure url="https://mcdn.podbean.com/mf/web/depxxz/frankly-speaking-376-SGLT2i-HF-kidney-stones.mp3" length="7959530" type="audio/mpeg"/>
                <itunes:summary><![CDATA[Credits: 0.25 AMA PRA Category 1 Credit™ CME/CE Information and Claim Credit: https://www.pri-med.com/online-education/podcast/frankly-speaking-cme-376
Overview: While GLP-1 agents are center stage in the medical and lay press, drugs in the class of sodium-glucose cotransporter 2 inhibitors (SGLT2is) are also quite remarkable at improving a variety of health endpoints. This episode provides an overview of studies supporting the use of SGLT2is to improve patient outcomes.
Episode resource links:
DM/HF:  Age Ageing 2024 Jan 2;53(1):afad254. doi: 10.1093/ageing/afad254
Kidney stones: JAMA Intern Med. 2024 Jan 29:e237660. doi: 10.1001/jamainternmed.2023.7660
Guest: Susan Feeney, DNP, FNP-BC, NP-C Music Credit: Richard Onorato]]></itunes:summary>
        <itunes:author>Pri-Med</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>495</itunes:duration>
                        <itunes:episodeType>full</itunes:episodeType>
            </item>
    <item>
        <title>Breast Cancer: Increased Incidence Doesn’t Mean Increased Mortality - Frankly Speaking Ep 375</title>
        <itunes:title>Breast Cancer: Increased Incidence Doesn’t Mean Increased Mortality - Frankly Speaking Ep 375</itunes:title>
        <link>https://primedfranklyspeaking.podbean.com/e/breast-cancer-increased-incidence-doesn-t-mean-increased-mortality-frankly-speaking-ep-375/</link>
                    <comments>https://primedfranklyspeaking.podbean.com/e/breast-cancer-increased-incidence-doesn-t-mean-increased-mortality-frankly-speaking-ep-375/#comments</comments>        <pubDate>Mon, 08 Apr 2024 00:30:00 +0000</pubDate>
        <guid isPermaLink="false">primedfranklyspeaking.podbean.com/65a09e8f-0755-35b0-8108-072d4b6e2400</guid>
                                    <description><![CDATA[<p>Credits: 0.25 AMA PRA Category 1 Credit™
 
CME/CE Information and Claim Credit: <a href='https://www.pri-med.com/online-education/podcast/frankly-speaking-cme-375'>https://www.pri-med.com/online-education/podcast/frankly-speaking-cme-375</a></p>
<p>Overview: Listen in as we discuss trends seen in breast cancer incidence over recent decades. Despite a notable rise in its prevalence, we’ve witnessed a decline in mortality rates. This positive shift owes itself to improvements in medication and screening efforts. Explore with us the multifaceted factors shaping this evolving landscape of breast cancer diagnosis and treatment.</p>
<p>Episode resource links:</p>
<ul><li><a href='https://www.cancer.org/cancer/types/breast-cancer/about/how-common-is-breast-cancer.html'>https://www.cancer.org/cancer/types/breast-cancer/about/how-common-is-breast-cancer.html</a></li>
<li><a href='https://www.uspreventiveservicestaskforce.org/uspstf/'>https://www.uspreventiveservicestaskforce.org/uspstf/</a></li>
<li>Caswell-Jin, J. L., Sun, L. P., Munoz, D., Lu, Y., Li, Y., Huang, H., ... &amp; Plevritis, S. K. (2024). Analysis of Breast Cancer Mortality in the US—1975 to 2019. JAMA, 331(3), 233-241.</li>
<li>Xu, S., Murtagh, S., Han, Y., Wan, F., &amp; Toriola, A. T. (2024). Breast Cancer Incidence Among US Women Aged 20 to 49 Years by Race, Stage, and Hormone Receptor Status. JAMA Network Open, 7(1), e2353331-e2353331.</li>
</ul>
<p>Guest: Mariyan L. Montaque, DNP, FNP-BC
 
Music Credit: Richard Onorato</p>
]]></description>
                                                            <content:encoded><![CDATA[<p>Credits: 0.25 AMA PRA Category 1 Credit™<br>
 <br>
CME/CE Information and Claim Credit: <a href='https://www.pri-med.com/online-education/podcast/frankly-speaking-cme-375'>https://www.pri-med.com/online-education/podcast/frankly-speaking-cme-375</a></p>
<p>Overview: Listen in as we discuss trends seen in breast cancer incidence over recent decades. Despite a notable rise in its prevalence, we’ve witnessed a decline in mortality rates. This positive shift owes itself to improvements in medication and screening efforts. Explore with us the multifaceted factors shaping this evolving landscape of breast cancer diagnosis and treatment.</p>
<p>Episode resource links:</p>
<ul><li><a href='https://www.cancer.org/cancer/types/breast-cancer/about/how-common-is-breast-cancer.html'>https://www.cancer.org/cancer/types/breast-cancer/about/how-common-is-breast-cancer.html</a></li>
<li><a href='https://www.uspreventiveservicestaskforce.org/uspstf/'>https://www.uspreventiveservicestaskforce.org/uspstf/</a></li>
<li>Caswell-Jin, J. L., Sun, L. P., Munoz, D., Lu, Y., Li, Y., Huang, H., ... &amp; Plevritis, S. K. (2024). Analysis of Breast Cancer Mortality in the US—1975 to 2019. JAMA, 331(3), 233-241.</li>
<li>Xu, S., Murtagh, S., Han, Y., Wan, F., &amp; Toriola, A. T. (2024). Breast Cancer Incidence Among US Women Aged 20 to 49 Years by Race, Stage, and Hormone Receptor Status. JAMA Network Open, 7(1), e2353331-e2353331.</li>
</ul>
<p>Guest: Mariyan L. Montaque, DNP, FNP-BC<br>
 <br>
Music Credit: Richard Onorato</p>
]]></content:encoded>
                                    
        <enclosure url="https://mcdn.podbean.com/mf/web/up2z68/frankly-speaking-375-breast-cancer.mp3" length="7860929" type="audio/mpeg"/>
                <itunes:summary><![CDATA[Credits: 0.25 AMA PRA Category 1 Credit™ CME/CE Information and Claim Credit: https://www.pri-med.com/online-education/podcast/frankly-speaking-cme-375
Overview: Listen in as we discuss trends seen in breast cancer incidence over recent decades. Despite a notable rise in its prevalence, we’ve witnessed a decline in mortality rates. This positive shift owes itself to improvements in medication and screening efforts. Explore with us the multifaceted factors shaping this evolving landscape of breast cancer diagnosis and treatment.
Episode resource links:
https://www.cancer.org/cancer/types/breast-cancer/about/how-common-is-breast-cancer.html
https://www.uspreventiveservicestaskforce.org/uspstf/
Caswell-Jin, J. L., Sun, L. P., Munoz, D., Lu, Y., Li, Y., Huang, H., ... &amp; Plevritis, S. K. (2024). Analysis of Breast Cancer Mortality in the US—1975 to 2019. JAMA, 331(3), 233-241.
Xu, S., Murtagh, S., Han, Y., Wan, F., &amp; Toriola, A. T. (2024). Breast Cancer Incidence Among US Women Aged 20 to 49 Years by Race, Stage, and Hormone Receptor Status. JAMA Network Open, 7(1), e2353331-e2353331.
Guest: Mariyan L. Montaque, DNP, FNP-BC Music Credit: Richard Onorato]]></itunes:summary>
        <itunes:author>Pri-Med</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>489</itunes:duration>
                        <itunes:episodeType>full</itunes:episodeType>
            </item>
    <item>
        <title>Sleep Lab in Your Pocket: Smartphone Diagnostics for Sleep Apnea - Frankly Speaking Ep 374</title>
        <itunes:title>Sleep Lab in Your Pocket: Smartphone Diagnostics for Sleep Apnea - Frankly Speaking Ep 374</itunes:title>
        <link>https://primedfranklyspeaking.podbean.com/e/sleep-lab-in-your-pocket-smartphone-diagnostics-for-sleep-apnea-frankly-speaking-ep-374/</link>
                    <comments>https://primedfranklyspeaking.podbean.com/e/sleep-lab-in-your-pocket-smartphone-diagnostics-for-sleep-apnea-frankly-speaking-ep-374/#comments</comments>        <pubDate>Mon, 01 Apr 2024 00:30:00 +0000</pubDate>
        <guid isPermaLink="false">primedfranklyspeaking.podbean.com/891018bd-435c-3e43-93ab-61489a6b6afc</guid>
                                    <description><![CDATA[<p>Credits: 0.25 AMA PRA Category 1 Credit™
 
CME/CE Information and Claim Credit: <a href='https://www.pri-med.com/online-education/podcast/frankly-speaking-cme-374'>https://www.pri-med.com/online-education/podcast/frankly-speaking-cme-374</a></p>
<p>Overview: This episode explores the use of data from smartphone recordings as a diagnostic tool for obstructive sleep apnea (OSA), highlighting at-home testing as a more accessible, convenient, and appropriate option for some patients. Hear how the evidence can inform your practice and improve the diagnosis and treatment of patients with OSA.</p>
<p>Episode resource links:</p>
<ul><li>Han SC, Kim D, Rhee CS, Cho SW, Le VL, Cho ES, Kim H, Yoon IY, Jang H, Hong J, Lee D, Kim JW. In-Home Smartphone-Based Prediction of Obstructive Sleep Apnea in Conjunction With Level 2 Home Polysomnography. JAMA Otolaryngol Head Neck Surg. 2024 Jan 1;150(1):22-29. doi: 10.1001/jamaoto.2023.3490. PMID: 37971771; PMCID: PMC10654929.</li>
<li><a href='https://www.uptodate.com/contents/obstructive-sleep-apnea-and-cardiovascular-disease-in-adults?search=untreated%20sleep%20apnea&amp;source=search_result&amp;selectedTitle=1~150&amp;usage_type=default&amp;display_rank=1#H4'>OSA and CV disease in adults, UpToDate</a></li>
<li><a href='https://www.uptodate.com/contents/home-sleep-apnea-testing-for-obstructive-sleep-apnea-in-adults?sectionName=Type%203%20devices%20(portable%20devices)&amp;search=prevalence%20of%20sleep%20apnea&amp;topicRef=7706&amp;anchor=H5&amp;source=see_link#H1316067475'>Home sleep apnea testing for adults, UpToDate</a></li>
</ul>
<p>Guest: Jillian Joseph, MPAS, PA-C
 
Music Credit: Richard Onorato</p>
]]></description>
                                                            <content:encoded><![CDATA[<p>Credits: 0.25 AMA PRA Category 1 Credit™<br>
 <br>
CME/CE Information and Claim Credit: <a href='https://www.pri-med.com/online-education/podcast/frankly-speaking-cme-374'>https://www.pri-med.com/online-education/podcast/frankly-speaking-cme-374</a></p>
<p>Overview: This episode explores the use of data from smartphone recordings as a diagnostic tool for obstructive sleep apnea (OSA), highlighting at-home testing as a more accessible, convenient, and appropriate option for some patients. Hear how the evidence can inform your practice and improve the diagnosis and treatment of patients with OSA.</p>
<p>Episode resource links:</p>
<ul><li>Han SC, Kim D, Rhee CS, Cho SW, Le VL, Cho ES, Kim H, Yoon IY, Jang H, Hong J, Lee D, Kim JW. In-Home Smartphone-Based Prediction of Obstructive Sleep Apnea in Conjunction With Level 2 Home Polysomnography. JAMA Otolaryngol Head Neck Surg. 2024 Jan 1;150(1):22-29. doi: 10.1001/jamaoto.2023.3490. PMID: 37971771; PMCID: PMC10654929.</li>
<li><a href='https://www.uptodate.com/contents/obstructive-sleep-apnea-and-cardiovascular-disease-in-adults?search=untreated%20sleep%20apnea&amp;source=search_result&amp;selectedTitle=1~150&amp;usage_type=default&amp;display_rank=1#H4'>OSA and CV disease in adults, UpToDate</a></li>
<li><a href='https://www.uptodate.com/contents/home-sleep-apnea-testing-for-obstructive-sleep-apnea-in-adults?sectionName=Type%203%20devices%20(portable%20devices)&amp;search=prevalence%20of%20sleep%20apnea&amp;topicRef=7706&amp;anchor=H5&amp;source=see_link#H1316067475'>Home sleep apnea testing for adults, UpToDate</a></li>
</ul>
<p>Guest: Jillian Joseph, MPAS, PA-C<br>
 <br>
Music Credit: Richard Onorato</p>
]]></content:encoded>
                                    
        <enclosure url="https://mcdn.podbean.com/mf/web/fs8iwt/frankly-speaking-374-smartphones-sleep-apnea.mp3" length="10585860" type="audio/mpeg"/>
                <itunes:summary><![CDATA[Credits: 0.25 AMA PRA Category 1 Credit™ CME/CE Information and Claim Credit: https://www.pri-med.com/online-education/podcast/frankly-speaking-cme-374
Overview: This episode explores the use of data from smartphone recordings as a diagnostic tool for obstructive sleep apnea (OSA), highlighting at-home testing as a more accessible, convenient, and appropriate option for some patients. Hear how the evidence can inform your practice and improve the diagnosis and treatment of patients with OSA.
Episode resource links:
Han SC, Kim D, Rhee CS, Cho SW, Le VL, Cho ES, Kim H, Yoon IY, Jang H, Hong J, Lee D, Kim JW. In-Home Smartphone-Based Prediction of Obstructive Sleep Apnea in Conjunction With Level 2 Home Polysomnography. JAMA Otolaryngol Head Neck Surg. 2024 Jan 1;150(1):22-29. doi: 10.1001/jamaoto.2023.3490. PMID: 37971771; PMCID: PMC10654929.
OSA and CV disease in adults, UpToDate
Home sleep apnea testing for adults, UpToDate
Guest: Jillian Joseph, MPAS, PA-C Music Credit: Richard Onorato]]></itunes:summary>
        <itunes:author>Pri-Med</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>659</itunes:duration>
                        <itunes:episodeType>full</itunes:episodeType>
            </item>
    <item>
        <title>Type 2 Diabetes Mellitus: Can Lifestyle Reverse It? - Frankly Speaking Ep 373</title>
        <itunes:title>Type 2 Diabetes Mellitus: Can Lifestyle Reverse It? - Frankly Speaking Ep 373</itunes:title>
        <link>https://primedfranklyspeaking.podbean.com/e/type-2-diabetes-mellitus-can-lifestyle-reverse-it-frankly-speaking-ep-373/</link>
                    <comments>https://primedfranklyspeaking.podbean.com/e/type-2-diabetes-mellitus-can-lifestyle-reverse-it-frankly-speaking-ep-373/#comments</comments>        <pubDate>Mon, 25 Mar 2024 00:30:00 +0000</pubDate>
        <guid isPermaLink="false">primedfranklyspeaking.podbean.com/6dc5340d-35c0-3be4-b17b-29cf2f72f739</guid>
                                    <description><![CDATA[<p>Credits: 0.25 AMA PRA Category 1 Credit™
 
CME/CE Information and Claim Credit: <a href='https://www.pri-med.com/online-education/podcast/frankly-speaking-cme-373'>https://www.pri-med.com/online-education/podcast/frankly-speaking-cme-373</a></p>
<p>Overview: In this episode, we review the effectiveness of intensive lifestyle intervention for type 2 diabetes mellitus (T2DM) remission. We unpack study findings on total diet replacement and consider its potential for improving weight loss and maintenance in patients. Tune in to enrich your clinical toolkit, empowering you to optimize patient outcomes and enhance quality of life.</p>
<p>Episode resource links:</p>
<ul><li>
<p>Hocking, S. L., Markovic, T. P., Lee, C. M. Y., Picone, T. J., Gudorf, K. E., &amp; Colagiuri, S. (2024). Intensive Lifestyle Intervention for Remission of Early Type 2 Diabetes in Primary Care in Australia: DiRECT-Aus. Diabetes care, 47(1), 66–70. <a href='https://doi.org/10.2337/dc23-0781'>https://doi.org/10.2337/dc23-0781</a></p>
<p> </p>
</li>
<li>
<p>Centers for Disease Control:  Diabetes Care for Providers: <a href='https://www.cdc.gov/diabetes/professional-info/index.html'>https://www.cdc.gov/diabetes/professional-info/index.html</a></p>
<p> </p>
</li>
<li>
<p>Optifast USA: <a href='https://www.optifast.com/'>https://www.optifast.com/</a></p>
<p> </p>
</li>
<li>
<p>Pattinson, A. L., Seimon, R. V., Harper, C., Nassar, N., Grech, A., Santoso, E. A., Franklin, J., Inan-Eroglu, E., Gibson, A. A., &amp; Sainsbury, A. (2021). Diet Quality following Total Meal Replacement Compared with Food-Based Weight-Loss Diets in Postmenopausal Women with Obesity: A Secondary Analysis of the TEMPO Diet Trial. The Journal of nutrition, 151(11), 3299–3312. <a href='https://doi.org/10.1093/jn/nxab311'>https://doi.org/10.1093/jn/nxab311</a></p>
</li>
</ul>
<p>Guest: Jill M. Terrien, PhD, ANP-BC 
 
Music Credit: Richard Onorato</p>
]]></description>
                                                            <content:encoded><![CDATA[<p>Credits: 0.25 AMA PRA Category 1 Credit™<br>
 <br>
CME/CE Information and Claim Credit: <a href='https://www.pri-med.com/online-education/podcast/frankly-speaking-cme-373'>https://www.pri-med.com/online-education/podcast/frankly-speaking-cme-373</a></p>
<p>Overview: In this episode, we review the effectiveness of intensive lifestyle intervention for type 2 diabetes mellitus (T2DM) remission. We unpack study findings on total diet replacement and consider its potential for improving weight loss and maintenance in patients. Tune in to enrich your clinical toolkit, empowering you to optimize patient outcomes and enhance quality of life.</p>
<p>Episode resource links:</p>
<ul><li>
<p>Hocking, S. L., Markovic, T. P., Lee, C. M. Y., Picone, T. J., Gudorf, K. E., &amp; Colagiuri, S. (2024). Intensive Lifestyle Intervention for Remission of Early Type 2 Diabetes in Primary Care in Australia: DiRECT-Aus. Diabetes care, 47(1), 66–70. <a href='https://doi.org/10.2337/dc23-0781'>https://doi.org/10.2337/dc23-0781</a></p>
<p> </p>
</li>
<li>
<p>Centers for Disease Control:  Diabetes Care for Providers: <a href='https://www.cdc.gov/diabetes/professional-info/index.html'>https://www.cdc.gov/diabetes/professional-info/index.html</a></p>
<p> </p>
</li>
<li>
<p>Optifast USA: <a href='https://www.optifast.com/'>https://www.optifast.com/</a></p>
<p> </p>
</li>
<li>
<p>Pattinson, A. L., Seimon, R. V., Harper, C., Nassar, N., Grech, A., Santoso, E. A., Franklin, J., Inan-Eroglu, E., Gibson, A. A., &amp; Sainsbury, A. (2021). Diet Quality following Total Meal Replacement Compared with Food-Based Weight-Loss Diets in Postmenopausal Women with Obesity: A Secondary Analysis of the TEMPO Diet Trial. The Journal of nutrition, 151(11), 3299–3312. <a href='https://doi.org/10.1093/jn/nxab311'>https://doi.org/10.1093/jn/nxab311</a></p>
</li>
</ul>
<p>Guest: Jill M. Terrien, PhD, ANP-BC <br>
 <br>
Music Credit: Richard Onorato</p>
]]></content:encoded>
                                    
        <enclosure url="https://mcdn.podbean.com/mf/web/mndv3h/frankly-speaking-373-T2DM-lifestyle-changes.mp3" length="10801581" type="audio/mpeg"/>
                <itunes:summary><![CDATA[Credits: 0.25 AMA PRA Category 1 Credit™ CME/CE Information and Claim Credit: https://www.pri-med.com/online-education/podcast/frankly-speaking-cme-373
Overview: In this episode, we review the effectiveness of intensive lifestyle intervention for type 2 diabetes mellitus (T2DM) remission. We unpack study findings on total diet replacement and consider its potential for improving weight loss and maintenance in patients. Tune in to enrich your clinical toolkit, empowering you to optimize patient outcomes and enhance quality of life.
Episode resource links:

Hocking, S. L., Markovic, T. P., Lee, C. M. Y., Picone, T. J., Gudorf, K. E., &amp; Colagiuri, S. (2024). Intensive Lifestyle Intervention for Remission of Early Type 2 Diabetes in Primary Care in Australia: DiRECT-Aus. Diabetes care, 47(1), 66–70. https://doi.org/10.2337/dc23-0781
 


Centers for Disease Control:  Diabetes Care for Providers: https://www.cdc.gov/diabetes/professional-info/index.html
 


Optifast USA: https://www.optifast.com/
 


Pattinson, A. L., Seimon, R. V., Harper, C., Nassar, N., Grech, A., Santoso, E. A., Franklin, J., Inan-Eroglu, E., Gibson, A. A., &amp; Sainsbury, A. (2021). Diet Quality following Total Meal Replacement Compared with Food-Based Weight-Loss Diets in Postmenopausal Women with Obesity: A Secondary Analysis of the TEMPO Diet Trial. The Journal of nutrition, 151(11), 3299–3312. https://doi.org/10.1093/jn/nxab311

Guest: Jill M. Terrien, PhD, ANP-BC  Music Credit: Richard Onorato]]></itunes:summary>
        <itunes:author>Pri-Med</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>673</itunes:duration>
                        <itunes:episodeType>full</itunes:episodeType>
            </item>
    <item>
        <title>Chocolate—Get the Lead Out! - Frankly Speaking Ep 372</title>
        <itunes:title>Chocolate—Get the Lead Out! - Frankly Speaking Ep 372</itunes:title>
        <link>https://primedfranklyspeaking.podbean.com/e/chocolate%e2%80%94get-the-lead-out-frankly-speaking-ep-372/</link>
                    <comments>https://primedfranklyspeaking.podbean.com/e/chocolate%e2%80%94get-the-lead-out-frankly-speaking-ep-372/#comments</comments>        <pubDate>Mon, 18 Mar 2024 00:30:00 +0000</pubDate>
        <guid isPermaLink="false">primedfranklyspeaking.podbean.com/a9db2393-25c5-350d-ba14-001e8e3227bd</guid>
                                    <description><![CDATA[<p>Credits: 0.25 AMA PRA Category 1 Credit™
 
CME/CE Information and Claim Credit: <a href='https://www.pri-med.com/online-education/podcast/frankly-speaking-cme-372'>https://www.pri-med.com/online-education/podcast/frankly-speaking-cme-372</a></p>
<p>Overview: Listen in as we unwrap Consumer Reports’ findings on heavy metals found in commonly consumed chocolate products. Our discussion looks into concerns about high levels of metals like lead and cadmium in these treats and offers advice on how to counsel your patients for worry-free chocolate enjoyment. </p>
<p>Episode resource links:</p>
<ul><li><a href='https://www.consumerreports.org/health/food-safety/a-third-of-chocolate-products-are-high-in-heavy-metals-a4844566398/'>A Third of Chocolate Products Are High in Heavy Metals, CR T - Consumer Reports</a></li>
</ul>
<p>Guest: Robert A. Baldor, MD, FAAFP
 
Music Credit: Richard Onorato</p>
]]></description>
                                                            <content:encoded><![CDATA[<p>Credits: 0.25 AMA PRA Category 1 Credit™<br>
 <br>
CME/CE Information and Claim Credit: <a href='https://www.pri-med.com/online-education/podcast/frankly-speaking-cme-372'>https://www.pri-med.com/online-education/podcast/frankly-speaking-cme-372</a></p>
<p>Overview: Listen in as we unwrap Consumer Reports’ findings on heavy metals found in commonly consumed chocolate products. Our discussion looks into concerns about high levels of metals like lead and cadmium in these treats and offers advice on how to counsel your patients for worry-free chocolate enjoyment. </p>
<p>Episode resource links:</p>
<ul><li><a href='https://www.consumerreports.org/health/food-safety/a-third-of-chocolate-products-are-high-in-heavy-metals-a4844566398/'>A Third of Chocolate Products Are High in Heavy Metals, CR T - Consumer Reports</a></li>
</ul>
<p>Guest: Robert A. Baldor, MD, FAAFP<br>
 <br>
Music Credit: Richard Onorato</p>
]]></content:encoded>
                                    
        <enclosure url="https://mcdn.podbean.com/mf/web/yazuy4/frankly-speaking-372-heavy-metals-chocolate.mp3" length="10111617" type="audio/mpeg"/>
                <itunes:summary><![CDATA[Credits: 0.25 AMA PRA Category 1 Credit™ CME/CE Information and Claim Credit: https://www.pri-med.com/online-education/podcast/frankly-speaking-cme-372
Overview: Listen in as we unwrap Consumer Reports’ findings on heavy metals found in commonly consumed chocolate products. Our discussion looks into concerns about high levels of metals like lead and cadmium in these treats and offers advice on how to counsel your patients for worry-free chocolate enjoyment. 
Episode resource links:
A Third of Chocolate Products Are High in Heavy Metals, CR T - Consumer Reports
Guest: Robert A. Baldor, MD, FAAFP Music Credit: Richard Onorato]]></itunes:summary>
        <itunes:author>Pri-Med</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>630</itunes:duration>
                        <itunes:episodeType>full</itunes:episodeType>
            </item>
    <item>
        <title>Beta-Blockers Post-Myocardial Infarction: Are They Still Needed? - Frankly Speaking Ep 371</title>
        <itunes:title>Beta-Blockers Post-Myocardial Infarction: Are They Still Needed? - Frankly Speaking Ep 371</itunes:title>
        <link>https://primedfranklyspeaking.podbean.com/e/beta-blockers-post-myocardial-infarction-are-they-still-needed-frankly-speaking-ep-371/</link>
                    <comments>https://primedfranklyspeaking.podbean.com/e/beta-blockers-post-myocardial-infarction-are-they-still-needed-frankly-speaking-ep-371/#comments</comments>        <pubDate>Mon, 11 Mar 2024 00:30:00 +0000</pubDate>
        <guid isPermaLink="false">primedfranklyspeaking.podbean.com/c9442742-f1c2-308d-a9d0-0cfb4ec19d70</guid>
                                    <description><![CDATA[<p>Credits: 0.25 AMA PRA Category 1 Credit™
 
CME/CE Information and Claim Credit: <a href='https://www.pri-med.com/online-education/podcast/frankly-speaking-cme-371'>https://www.pri-med.com/online-education/podcast/frankly-speaking-cme-371</a></p>
<p>Overview: Beta-blockers have traditionally been used indefinitely after a myocardial infarction (MI), but this is now only recommended for a subset of patients. Listen in as faculty review new recommendations for managing patients with chronic cardiac disease, including how to determine which patients are good candidates for beta-blocker therapy and for how long.</p>
<p>Episode resource links:</p>
<ul><li>Virani SS, Newby LK, Arnold SV, et al. 2023 AHA/ACC/ACCP/ASPC/NLA/PCNA Guideline for the Management of Patients With Chronic Coronary Disease: A Report of the American Heart Association/American College of Cardiology Joint Committee on Clinical Practice Guidelines [published correction appears in Circulation. 2023 Sep 26;148(13):e148] [published correction appears in Circulation. 2023 Dec 5;148(23):e186]. Circulation. 2023;148(9):e9-e119. </li>
<li>Joo SJ. Beta-blocker therapy in patients with acute myocardial infarction: not all patients need it. Acute Crit Care. 2023;38(3):251-260. </li>
</ul>
<p>Guest: Alan M. Ehrlich, MD, FAAFP
 
Music Credit: Richard Onorato</p>
]]></description>
                                                            <content:encoded><![CDATA[<p>Credits: 0.25 AMA PRA Category 1 Credit™<br>
 <br>
CME/CE Information and Claim Credit: <a href='https://www.pri-med.com/online-education/podcast/frankly-speaking-cme-371'>https://www.pri-med.com/online-education/podcast/frankly-speaking-cme-371</a></p>
<p>Overview: Beta-blockers have traditionally been used indefinitely after a myocardial infarction (MI), but this is now only recommended for a subset of patients. Listen in as faculty review new recommendations for managing patients with chronic cardiac disease, including how to determine which patients are good candidates for beta-blocker therapy and for how long.</p>
<p>Episode resource links:</p>
<ul><li>Virani SS, Newby LK, Arnold SV, et al. 2023 AHA/ACC/ACCP/ASPC/NLA/PCNA Guideline for the Management of Patients With Chronic Coronary Disease: A Report of the American Heart Association/American College of Cardiology Joint Committee on Clinical Practice Guidelines [published correction appears in Circulation. 2023 Sep 26;148(13):e148] [published correction appears in Circulation. 2023 Dec 5;148(23):e186]. Circulation. 2023;148(9):e9-e119. </li>
<li>Joo SJ. Beta-blocker therapy in patients with acute myocardial infarction: not all patients need it. Acute Crit Care. 2023;38(3):251-260. </li>
</ul>
<p>Guest: Alan M. Ehrlich, MD, FAAFP<br>
 <br>
Music Credit: Richard Onorato</p>
]]></content:encoded>
                                    
        <enclosure url="https://mcdn.podbean.com/mf/web/jq2scw/frankly-speaking-371-beta-blockers-post-MI.mp3" length="7371720" type="audio/mpeg"/>
                <itunes:summary><![CDATA[Credits: 0.25 AMA PRA Category 1 Credit™ CME/CE Information and Claim Credit: https://www.pri-med.com/online-education/podcast/frankly-speaking-cme-371
Overview: Beta-blockers have traditionally been used indefinitely after a myocardial infarction (MI), but this is now only recommended for a subset of patients. Listen in as faculty review new recommendations for managing patients with chronic cardiac disease, including how to determine which patients are good candidates for beta-blocker therapy and for how long.
Episode resource links:
Virani SS, Newby LK, Arnold SV, et al. 2023 AHA/ACC/ACCP/ASPC/NLA/PCNA Guideline for the Management of Patients With Chronic Coronary Disease: A Report of the American Heart Association/American College of Cardiology Joint Committee on Clinical Practice Guidelines [published correction appears in Circulation. 2023 Sep 26;148(13):e148] [published correction appears in Circulation. 2023 Dec 5;148(23):e186]. Circulation. 2023;148(9):e9-e119. 
Joo SJ. Beta-blocker therapy in patients with acute myocardial infarction: not all patients need it. Acute Crit Care. 2023;38(3):251-260. 
Guest: Alan M. Ehrlich, MD, FAAFP Music Credit: Richard Onorato]]></itunes:summary>
        <itunes:author>Pri-Med</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>459</itunes:duration>
                        <itunes:episodeType>full</itunes:episodeType>
            </item>
    <item>
        <title>Low Back Pain—More Evidence for the Effectiveness of Nonnarcotic Modalities - Frankly Speaking Ep 370</title>
        <itunes:title>Low Back Pain—More Evidence for the Effectiveness of Nonnarcotic Modalities - Frankly Speaking Ep 370</itunes:title>
        <link>https://primedfranklyspeaking.podbean.com/e/low-back-pain%e2%80%94more-evidence-for-the-effectiveness-of-nonnarcotic-modalities-frankly-speaking-ep-370/</link>
                    <comments>https://primedfranklyspeaking.podbean.com/e/low-back-pain%e2%80%94more-evidence-for-the-effectiveness-of-nonnarcotic-modalities-frankly-speaking-ep-370/#comments</comments>        <pubDate>Mon, 04 Mar 2024 00:30:00 +0000</pubDate>
        <guid isPermaLink="false">primedfranklyspeaking.podbean.com/4d93b53d-6530-3111-aea0-ead372c67c43</guid>
                                    <description><![CDATA[<p>Credits: 0.25 AMA PRA Category 1 Credit™
 
CME/CE Information and Claim Credit: <a href='https://www.pri-med.com/online-education/podcast/frankly-speaking-cme-370'>https://www.pri-med.com/online-education/podcast/frankly-speaking-cme-370</a></p>
<p>Overview: Low back pain is one of the most common symptoms presenting in primary care. Listen in as we analyze the results of a recent systematic review supporting the use of a variety of effective nonnarcotic treatments for this condition. Gain evidence-based insights to help you choose the most informed option for managing low back pain.</p>
<p>Episode resource links:</p>
<ul><li>Gianola S, Bargeri S, Del Castillo G, et al. Br J Sports Med 2022;56:41–50. doi.org/ 10. 1136/ bjsports- 2020- 103596).</li>
</ul>
<p>Guest: Robert A. Baldor, MD, FAAFP
 
Music Credit: Richard Onorato</p>
]]></description>
                                                            <content:encoded><![CDATA[<p>Credits: 0.25 AMA PRA Category 1 Credit™<br>
 <br>
CME/CE Information and Claim Credit: <a href='https://www.pri-med.com/online-education/podcast/frankly-speaking-cme-370'>https://www.pri-med.com/online-education/podcast/frankly-speaking-cme-370</a></p>
<p>Overview: Low back pain is one of the most common symptoms presenting in primary care. Listen in as we analyze the results of a recent systematic review supporting the use of a variety of effective nonnarcotic treatments for this condition. Gain evidence-based insights to help you choose the most informed option for managing low back pain.</p>
<p>Episode resource links:</p>
<ul><li>Gianola S, Bargeri S, Del Castillo G, et al. Br J Sports Med 2022;56:41–50. doi.org/ 10. 1136/ bjsports- 2020- 103596).</li>
</ul>
<p>Guest: Robert A. Baldor, MD, FAAFP<br>
 <br>
Music Credit: Richard Onorato</p>
]]></content:encoded>
                                    
        <enclosure url="https://mcdn.podbean.com/mf/web/2prrra/frankly-speaking-370-back-pain.mp3" length="10727056" type="audio/mpeg"/>
                <itunes:summary><![CDATA[Credits: 0.25 AMA PRA Category 1 Credit™ CME/CE Information and Claim Credit: https://www.pri-med.com/online-education/podcast/frankly-speaking-cme-370
Overview: Low back pain is one of the most common symptoms presenting in primary care. Listen in as we analyze the results of a recent systematic review supporting the use of a variety of effective nonnarcotic treatments for this condition. Gain evidence-based insights to help you choose the most informed option for managing low back pain.
Episode resource links:
Gianola S, Bargeri S, Del Castillo G, et al. Br J Sports Med 2022;56:41–50. doi.org/ 10. 1136/ bjsports- 2020- 103596).
Guest: Robert A. Baldor, MD, FAAFP Music Credit: Richard Onorato]]></itunes:summary>
        <itunes:author>Pri-Med</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>668</itunes:duration>
                        <itunes:episodeType>full</itunes:episodeType>
            </item>
    <item>
        <title>Be a Flamingo: 1-Legged Stance Test Predicts Risks - Frankly Speaking Ep 369</title>
        <itunes:title>Be a Flamingo: 1-Legged Stance Test Predicts Risks - Frankly Speaking Ep 369</itunes:title>
        <link>https://primedfranklyspeaking.podbean.com/e/be-a-flamingo-1-legged-stance-test-predicts-risks-frankly-speaking-ep-369/</link>
                    <comments>https://primedfranklyspeaking.podbean.com/e/be-a-flamingo-1-legged-stance-test-predicts-risks-frankly-speaking-ep-369/#comments</comments>        <pubDate>Mon, 26 Feb 2024 00:30:00 +0000</pubDate>
        <guid isPermaLink="false">primedfranklyspeaking.podbean.com/9bad3ba2-2977-3157-8e60-28ec5e90364e</guid>
                                    <description><![CDATA[<p>Credits: 0.25 AMA PRA Category 1 Credit™
 
CME/CE Information and Claim Credit: <a href='https://www.pri-med.com/online-education/podcast/frankly-speaking-cme-369'>https://www.pri-med.com/online-education/podcast/frankly-speaking-cme-369</a></p>
<p>Overview: Uncover a simple, 10-second intervention—the 1-legged stance test—for predicting the risk of falling in adults. Join us as we discuss how this swift assessment can help identify patients who are prone to falls, fractures, and increased mortality. This episode brings you a practical tool to enhance patient assessments and tailor interventions, contributing to a more proactive and personalized approach to care.</p>
<p>Episode resource links:</p>
<ul><li>JAMA. 2023;329(18):1605-1607. doi:10.1001/jama.2023.3054</li>
<li>Br J Sports Med. 2022;56:975–980.</li>
<li>Pharmacoepidemiol Drug Saf. 2021 Aug;30(8):1049-1056. doi: 10.1002/pds.5201</li>
<li>PLoS Med 18(11): e1003821. <a href='https://doi.org/10.1371/journal.pmed.1003821'>https://doi.org/10.1371/journal.pmed.1003821</a></li>
</ul>
<p>Guest: Jillian Joseph, MPAS, PA-C
 
Music Credit: Richard Onorato</p>
]]></description>
                                                            <content:encoded><![CDATA[<p>Credits: 0.25 AMA PRA Category 1 Credit™<br>
 <br>
CME/CE Information and Claim Credit: <a href='https://www.pri-med.com/online-education/podcast/frankly-speaking-cme-369'>https://www.pri-med.com/online-education/podcast/frankly-speaking-cme-369</a></p>
<p>Overview: Uncover a simple, 10-second intervention—the 1-legged stance test—for predicting the risk of falling in adults. Join us as we discuss how this swift assessment can help identify patients who are prone to falls, fractures, and increased mortality. This episode brings you a practical tool to enhance patient assessments and tailor interventions, contributing to a more proactive and personalized approach to care.</p>
<p>Episode resource links:</p>
<ul><li>JAMA. 2023;329(18):1605-1607. doi:10.1001/jama.2023.3054</li>
<li>Br J Sports Med. 2022;56:975–980.</li>
<li>Pharmacoepidemiol Drug Saf. 2021 Aug;30(8):1049-1056. doi: 10.1002/pds.5201</li>
<li>PLoS Med 18(11): e1003821. <a href='https://doi.org/10.1371/journal.pmed.1003821'>https://doi.org/10.1371/journal.pmed.1003821</a></li>
</ul>
<p>Guest: Jillian Joseph, MPAS, PA-C<br>
 <br>
Music Credit: Richard Onorato</p>
]]></content:encoded>
                                    
        <enclosure url="https://mcdn.podbean.com/mf/web/fsp9nd/frankly-speaking-369-10-second-balance-test.mp3" length="9116845" type="audio/mpeg"/>
                <itunes:summary><![CDATA[Credits: 0.25 AMA PRA Category 1 Credit™ CME/CE Information and Claim Credit: https://www.pri-med.com/online-education/podcast/frankly-speaking-cme-369
Overview: Uncover a simple, 10-second intervention—the 1-legged stance test—for predicting the risk of falling in adults. Join us as we discuss how this swift assessment can help identify patients who are prone to falls, fractures, and increased mortality. This episode brings you a practical tool to enhance patient assessments and tailor interventions, contributing to a more proactive and personalized approach to care.
Episode resource links:
JAMA. 2023;329(18):1605-1607. doi:10.1001/jama.2023.3054
Br J Sports Med. 2022;56:975–980.
Pharmacoepidemiol Drug Saf. 2021 Aug;30(8):1049-1056. doi: 10.1002/pds.5201
PLoS Med 18(11): e1003821. https://doi.org/10.1371/journal.pmed.1003821
Guest: Jillian Joseph, MPAS, PA-C Music Credit: Richard Onorato]]></itunes:summary>
        <itunes:author>Pri-Med</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>568</itunes:duration>
                        <itunes:episodeType>full</itunes:episodeType>
            </item>
    <item>
        <title>Data-Driven Perspectives on Prescriptive Authority and the Quality Quandary - Frankly Speaking Ep 368</title>
        <itunes:title>Data-Driven Perspectives on Prescriptive Authority and the Quality Quandary - Frankly Speaking Ep 368</itunes:title>
        <link>https://primedfranklyspeaking.podbean.com/e/data-driven-perspectives-on-prescriptive-authority-and-the-quality-quandary-frankly-speaking-ep-368/</link>
                    <comments>https://primedfranklyspeaking.podbean.com/e/data-driven-perspectives-on-prescriptive-authority-and-the-quality-quandary-frankly-speaking-ep-368/#comments</comments>        <pubDate>Mon, 19 Feb 2024 00:30:00 +0000</pubDate>
        <guid isPermaLink="false">primedfranklyspeaking.podbean.com/45ae646c-d4ef-320f-870c-62b6f5ae7e70</guid>
                                    <description><![CDATA[<p>Credits: 0.25 AMA PRA Category 1 Credit™
 
CME/CE Information and Claim Credit: <a href='https://www.pri-med.com/online-education/podcast/frankly-speaking-cme-368'>https://www.pri-med.com/online-education/podcast/frankly-speaking-cme-368</a></p>
<p>Overview: In this insightful episode, we explore compelling data comparing inappropriate prescribing practices among physicians and nonphysician prescribers. This discussion covers the nuances and restrictive scope of prescribing authority and aims to take an evidence-based approach to encouraging collaboration between clinicians and expanding patients’ access to care.</p>
<p>Episode resource links:</p>
<ul><li>Huynh, J., Alim, S. A., Chan, D. C., &amp; Studdert, D. M. (2023). Inappropriate Prescribing to Older Patients by Nurse Practitioners and Primary Care Physicians. Annals of internal medicine, 176(11), 1448–1455. <a href='https://doi.org/10.7326/M23-0827'>https://doi.org/10.7326/M23-0827</a></li>
<li>American Association of Nurse Practitioners <a href='https://www.aanp.org/'>https://www.aanp.org/</a></li>
<li>American Academy of Physician Associates <a href='https://www.aapa.org/'>https://www.aapa.org/</a></li>
<li>Jiao, S., Murimi, I. B., Stafford, R. S., Mojtabai, R., &amp; Alexander, G. C. (2018). Quality of Prescribing by Physicians, Nurse Practitioners, and Physician Assistants in the United States. Pharmacotherapy, 38(4), 417–427. <a href='https://doi.org/10.1002/phar.2095'>https://doi.org/10.1002/phar.2095</a></li>
<li>2023 Beers Criteria American Geriatrics Society: Free to read <a href='https://agsjournals.onlinelibrary.wiley.com/doi/epdf/10.1111/jgs.18372'>https://agsjournals.onlinelibrary.wiley.com/doi/epdf/10.1111/jgs.18372</a></li>
</ul>
<p>Guest: Jill M. Terrien PhD, ANP-BC 
 
Music Credit: Richard Onorato</p>
]]></description>
                                                            <content:encoded><![CDATA[<p>Credits: 0.25 AMA PRA Category 1 Credit™<br>
 <br>
CME/CE Information and Claim Credit: <a href='https://www.pri-med.com/online-education/podcast/frankly-speaking-cme-368'>https://www.pri-med.com/online-education/podcast/frankly-speaking-cme-368</a></p>
<p>Overview: In this insightful episode, we explore compelling data comparing inappropriate prescribing practices among physicians and nonphysician prescribers. This discussion covers the nuances and restrictive scope of prescribing authority and aims to take an evidence-based approach to encouraging collaboration between clinicians and expanding patients’ access to care.</p>
<p>Episode resource links:</p>
<ul><li>Huynh, J., Alim, S. A., Chan, D. C., &amp; Studdert, D. M. (2023). Inappropriate Prescribing to Older Patients by Nurse Practitioners and Primary Care Physicians. <em>Annals of internal medicine</em>, <em>176</em>(11), 1448–1455. <a href='https://doi.org/10.7326/M23-0827'>https://doi.org/10.7326/M23-0827</a></li>
<li>American Association of Nurse Practitioners <a href='https://www.aanp.org/'>https://www.aanp.org/</a></li>
<li>American Academy of Physician Associates <a href='https://www.aapa.org/'>https://www.aapa.org/</a></li>
<li>Jiao, S., Murimi, I. B., Stafford, R. S., Mojtabai, R., &amp; Alexander, G. C. (2018). Quality of Prescribing by Physicians, Nurse Practitioners, and Physician Assistants in the United States. <em>Pharmacotherapy</em>, <em>38</em>(4), 417–427. <a href='https://doi.org/10.1002/phar.2095'>https://doi.org/10.1002/phar.2095</a></li>
<li>2023 Beers Criteria American Geriatrics Society: Free to read <a href='https://agsjournals.onlinelibrary.wiley.com/doi/epdf/10.1111/jgs.18372'>https://agsjournals.onlinelibrary.wiley.com/doi/epdf/10.1111/jgs.18372</a></li>
</ul>
<p>Guest: Jill M. Terrien PhD, ANP-BC <br>
 <br>
Music Credit: Richard Onorato</p>
]]></content:encoded>
                                    
        <enclosure url="https://mcdn.podbean.com/mf/web/te62x4/episode-368-MD-NP-prescribing.mp3" length="7990360" type="audio/mpeg"/>
                <itunes:summary><![CDATA[Credits: 0.25 AMA PRA Category 1 Credit™ CME/CE Information and Claim Credit: https://www.pri-med.com/online-education/podcast/frankly-speaking-cme-368
Overview: In this insightful episode, we explore compelling data comparing inappropriate prescribing practices among physicians and nonphysician prescribers. This discussion covers the nuances and restrictive scope of prescribing authority and aims to take an evidence-based approach to encouraging collaboration between clinicians and expanding patients’ access to care.
Episode resource links:
Huynh, J., Alim, S. A., Chan, D. C., &amp; Studdert, D. M. (2023). Inappropriate Prescribing to Older Patients by Nurse Practitioners and Primary Care Physicians. Annals of internal medicine, 176(11), 1448–1455. https://doi.org/10.7326/M23-0827
American Association of Nurse Practitioners https://www.aanp.org/
American Academy of Physician Associates https://www.aapa.org/
Jiao, S., Murimi, I. B., Stafford, R. S., Mojtabai, R., &amp; Alexander, G. C. (2018). Quality of Prescribing by Physicians, Nurse Practitioners, and Physician Assistants in the United States. Pharmacotherapy, 38(4), 417–427. https://doi.org/10.1002/phar.2095
2023 Beers Criteria American Geriatrics Society: Free to read https://agsjournals.onlinelibrary.wiley.com/doi/epdf/10.1111/jgs.18372
Guest: Jill M. Terrien PhD, ANP-BC  Music Credit: Richard Onorato]]></itunes:summary>
        <itunes:author>Pri-Med</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>497</itunes:duration>
                        <itunes:episodeType>full</itunes:episodeType>
            </item>
    <item>
        <title>The Portfolio Diet—Another Approach to Eating Healthy? - Frankly Speaking Ep 367</title>
        <itunes:title>The Portfolio Diet—Another Approach to Eating Healthy? - Frankly Speaking Ep 367</itunes:title>
        <link>https://primedfranklyspeaking.podbean.com/e/the-portfolio-diet%e2%80%94another-approach-to-eating-healthy-frankly-speaking-ep-367/</link>
                    <comments>https://primedfranklyspeaking.podbean.com/e/the-portfolio-diet%e2%80%94another-approach-to-eating-healthy-frankly-speaking-ep-367/#comments</comments>        <pubDate>Mon, 12 Feb 2024 00:30:00 +0000</pubDate>
        <guid isPermaLink="false">primedfranklyspeaking.podbean.com/b51cd4fd-0466-3a67-b2c7-a89461feea5b</guid>
                                    <description><![CDATA[<p>Credits: 0.25 AMA PRA Category 1 Credit™
 
CME/CE Information and Claim Credit: <a href='https://www.pri-med.com/online-education/podcast/frankly-speaking-cme-367'>https://www.pri-med.com/online-education/podcast/frankly-speaking-cme-367</a></p>
<p>Overview: Join us for a look at the Portfolio Diet, a plant-based approach with potential to improve cardiovascular outcomes. We’ll take you through the details of this regimen and what the evidence says about its effect on the risks of cardiovascular diseases. Stay informed on the latest research and feel prepared to answer your patients’ questions about the Portfolio Diet.</p>
<p>Episode resource links:</p>
<ul><li>Circulation. 2023;148:00–00. DOI: 10.1161/CIRCULATIONAHA.123.065551</li>
</ul>
<p>Guest: Robert A. Baldor, MD, FAAFP
 
Music Credit: Richard Onorato</p>
]]></description>
                                                            <content:encoded><![CDATA[<p>Credits: 0.25 AMA PRA Category 1 Credit™<br>
 <br>
CME/CE Information and Claim Credit: <a href='https://www.pri-med.com/online-education/podcast/frankly-speaking-cme-367'>https://www.pri-med.com/online-education/podcast/frankly-speaking-cme-367</a></p>
<p>Overview: Join us for a look at the Portfolio Diet, a plant-based approach with potential to improve cardiovascular outcomes. We’ll take you through the details of this regimen and what the evidence says about its effect on the risks of cardiovascular diseases. Stay informed on the latest research and feel prepared to answer your patients’ questions about the Portfolio Diet.</p>
<p>Episode resource links:</p>
<ul><li>Circulation. 2023;148:00–00. DOI: 10.1161/CIRCULATIONAHA.123.065551</li>
</ul>
<p>Guest: Robert A. Baldor, MD, FAAFP<br>
 <br>
Music Credit: Richard Onorato</p>
]]></content:encoded>
                                    
        <enclosure url="https://mcdn.podbean.com/mf/web/hmprrk/episode-367-portfolio-diet.mp3" length="12145993" type="audio/mpeg"/>
                <itunes:summary><![CDATA[Credits: 0.25 AMA PRA Category 1 Credit™ CME/CE Information and Claim Credit: https://www.pri-med.com/online-education/podcast/frankly-speaking-cme-367
Overview: Join us for a look at the Portfolio Diet, a plant-based approach with potential to improve cardiovascular outcomes. We’ll take you through the details of this regimen and what the evidence says about its effect on the risks of cardiovascular diseases. Stay informed on the latest research and feel prepared to answer your patients’ questions about the Portfolio Diet.
Episode resource links:
Circulation. 2023;148:00–00. DOI: 10.1161/CIRCULATIONAHA.123.065551
Guest: Robert A. Baldor, MD, FAAFP Music Credit: Richard Onorato]]></itunes:summary>
        <itunes:author>Pri-Med</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>757</itunes:duration>
                        <itunes:episodeType>full</itunes:episodeType>
            </item>
    <item>
        <title>Synching Up: Time-Restricted Eating for T2DM Management - Frankly Speaking Ep 366</title>
        <itunes:title>Synching Up: Time-Restricted Eating for T2DM Management - Frankly Speaking Ep 366</itunes:title>
        <link>https://primedfranklyspeaking.podbean.com/e/synching-up-time-restricted-eating-for-t2dm-management-frankly-speaking-ep-366/</link>
                    <comments>https://primedfranklyspeaking.podbean.com/e/synching-up-time-restricted-eating-for-t2dm-management-frankly-speaking-ep-366/#comments</comments>        <pubDate>Mon, 05 Feb 2024 00:30:00 +0000</pubDate>
        <guid isPermaLink="false">primedfranklyspeaking.podbean.com/06f53788-da42-385c-8ca3-8c4633add4c8</guid>
                                    <description><![CDATA[<p>Credits: 0.25 AMA PRA Category 1 Credit™
 
CME/CE Information and Claim Credit: <a href='https://www.pri-med.com/online-education/podcast/frankly-speaking-cme-366'>https://www.pri-med.com/online-education/podcast/frankly-speaking-cme-366</a></p>
<p>Overview: Join us as we explore the nuances of healthy eating patterns, distinguishing between time-restricted and calorie-restricted approaches. We also review a randomized controlled trial that found time-restricted eating for people with type 2 diabetes mellitus (T2DM) can benefit HbA1c levels and weight reduction. Gain insights to elevate patient care in understanding and implementing these impactful dietary strategies.</p>
<p>Episode resource links:</p>
<ul><li>Pavlou V, Cienfuegos S, Lin S, et al. Effect of Time-Restricted Eating on Weight Loss in Adults With Type 2 Diabetes: A Randomized Clinical Trial. JAMA Netw Open. 2023;6(10):e2339337. doi:10.1001/jamanetworkopen.2023.39337</li>
<li>Jefcoate PW, Robertson MD, Ogden J, Johnston JD. Exploring Rates of Adherence and Barriers to Time-Restricted Eating. Nutrients. 2023 May 16;15(10):2336. doi: 10.3390/nu15102336. PMID: 37242218; PMCID: PMC10223820.</li>
</ul>
<p>Guest: Jillian Joseph, MPAS, PA-C
 
Music Credit: Richard Onorato</p>
]]></description>
                                                            <content:encoded><![CDATA[<p>Credits: 0.25 AMA PRA Category 1 Credit™<br>
 <br>
CME/CE Information and Claim Credit: <a href='https://www.pri-med.com/online-education/podcast/frankly-speaking-cme-366'>https://www.pri-med.com/online-education/podcast/frankly-speaking-cme-366</a></p>
<p>Overview: Join us as we explore the nuances of healthy eating patterns, distinguishing between time-restricted and calorie-restricted approaches. We also review a randomized controlled trial that found time-restricted eating for people with type 2 diabetes mellitus (T2DM) can benefit HbA1c levels and weight reduction. Gain insights to elevate patient care in understanding and implementing these impactful dietary strategies.</p>
<p>Episode resource links:</p>
<ul><li>Pavlou V, Cienfuegos S, Lin S, et al. Effect of Time-Restricted Eating on Weight Loss in Adults With Type 2 Diabetes: A Randomized Clinical Trial. JAMA Netw Open. 2023;6(10):e2339337. doi:10.1001/jamanetworkopen.2023.39337</li>
<li>Jefcoate PW, Robertson MD, Ogden J, Johnston JD. Exploring Rates of Adherence and Barriers to Time-Restricted Eating. Nutrients. 2023 May 16;15(10):2336. doi: 10.3390/nu15102336. PMID: 37242218; PMCID: PMC10223820.</li>
</ul>
<p>Guest: Jillian Joseph, MPAS, PA-C<br>
 <br>
Music Credit: Richard Onorato</p>
]]></content:encoded>
                                    
        <enclosure url="https://mcdn.podbean.com/mf/web/xwgydq/episode-366-diabetic-eating-patterns.mp3" length="11062545" type="audio/mpeg"/>
                <itunes:summary><![CDATA[Credits: 0.25 AMA PRA Category 1 Credit™ CME/CE Information and Claim Credit: https://www.pri-med.com/online-education/podcast/frankly-speaking-cme-366
Overview: Join us as we explore the nuances of healthy eating patterns, distinguishing between time-restricted and calorie-restricted approaches. We also review a randomized controlled trial that found time-restricted eating for people with type 2 diabetes mellitus (T2DM) can benefit HbA1c levels and weight reduction. Gain insights to elevate patient care in understanding and implementing these impactful dietary strategies.
Episode resource links:
Pavlou V, Cienfuegos S, Lin S, et al. Effect of Time-Restricted Eating on Weight Loss in Adults With Type 2 Diabetes: A Randomized Clinical Trial. JAMA Netw Open. 2023;6(10):e2339337. doi:10.1001/jamanetworkopen.2023.39337
Jefcoate PW, Robertson MD, Ogden J, Johnston JD. Exploring Rates of Adherence and Barriers to Time-Restricted Eating. Nutrients. 2023 May 16;15(10):2336. doi: 10.3390/nu15102336. PMID: 37242218; PMCID: PMC10223820.
Guest: Jillian Joseph, MPAS, PA-C Music Credit: Richard Onorato]]></itunes:summary>
        <itunes:author>Pri-Med</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>689</itunes:duration>
                        <itunes:episodeType>full</itunes:episodeType>
            </item>
    <item>
        <title>Your Gut Doesn’t Have to Be Irritated: Treatment Options for IBS - Frankly Speaking Ep 365</title>
        <itunes:title>Your Gut Doesn’t Have to Be Irritated: Treatment Options for IBS - Frankly Speaking Ep 365</itunes:title>
        <link>https://primedfranklyspeaking.podbean.com/e/your-gut-doesn-t-have-to-be-irritated-treatment-options-for-ibs-frankly-speaking-ep-365/</link>
                    <comments>https://primedfranklyspeaking.podbean.com/e/your-gut-doesn-t-have-to-be-irritated-treatment-options-for-ibs-frankly-speaking-ep-365/#comments</comments>        <pubDate>Mon, 29 Jan 2024 00:30:00 +0000</pubDate>
        <guid isPermaLink="false">primedfranklyspeaking.podbean.com/6d614b1c-78d1-39b7-9648-4bfa24090d39</guid>
                                    <description><![CDATA[<p>Credits: 0.25 AMA PRA Category 1 Credit™
 
CME/CE Information and Claim Credit: <a href='https://www.pri-med.com/online-education/podcast/frankly-speaking-cme-365'>https://www.pri-med.com/online-education/podcast/frankly-speaking-cme-365</a></p>
<p>Overview: The chronic nature of irritable bowel syndrome (IBS) necessitates persistence when trialing treatment options. After reviewing key identifiers of IBS, we discuss a second-line treatment’s efficacy in reducing symptoms and improving quality of life for patients with continued IBS symptoms. Tune in for valuable insights to make informed recommendations for your patients.</p>
<p>Episode resource links:</p>
<ul><li><a href='https://pubmed.ncbi.nlm.nih.gov/37858323/'>Amitriptyline at Low-Dose and Titrated for Irritable Bowel Syndrome as Second-Line Treatment in primary care (ATLANTIS</a>): a randomised, double-blind, placebo-controlled, phase 3 trial - PubMed (nih.gov)</li>
<li><a href='https://www.aafp.org/pubs/afp/issues/2005/1215/p2501.html'>https://www.aafp.org/pubs/afp/issues/2005/1215/p2501.html</a></li>
</ul>
<p>Guest: Mariyan L. Montaque, DNP, FNP-BC
 
Music Credit: Richard Onorato</p>
]]></description>
                                                            <content:encoded><![CDATA[<p>Credits: 0.25 AMA PRA Category 1 Credit™<br>
 <br>
CME/CE Information and Claim Credit: <a href='https://www.pri-med.com/online-education/podcast/frankly-speaking-cme-365'>https://www.pri-med.com/online-education/podcast/frankly-speaking-cme-365</a></p>
<p>Overview: The chronic nature of irritable bowel syndrome (IBS) necessitates persistence when trialing treatment options. After reviewing key identifiers of IBS, we discuss a second-line treatment’s efficacy in reducing symptoms and improving quality of life for patients with continued IBS symptoms. Tune in for valuable insights to make informed recommendations for your patients.</p>
<p>Episode resource links:</p>
<ul><li><a href='https://pubmed.ncbi.nlm.nih.gov/37858323/'>Amitriptyline at Low-Dose and Titrated for Irritable Bowel Syndrome as Second-Line Treatment in primary care (ATLANTIS</a>): a randomised, double-blind, placebo-controlled, phase 3 trial - PubMed (nih.gov)</li>
<li><a href='https://www.aafp.org/pubs/afp/issues/2005/1215/p2501.html'>https://www.aafp.org/pubs/afp/issues/2005/1215/p2501.html</a></li>
</ul>
<p>Guest: Mariyan L. Montaque, DNP, FNP-BC<br>
 <br>
Music Credit: Richard Onorato</p>
]]></content:encoded>
                                    
        <enclosure url="https://mcdn.podbean.com/mf/web/s6zdck/frankly-speaking-365-IBS.mp3" length="8773579" type="audio/mpeg"/>
                <itunes:summary><![CDATA[Credits: 0.25 AMA PRA Category 1 Credit™ CME/CE Information and Claim Credit: https://www.pri-med.com/online-education/podcast/frankly-speaking-cme-365
Overview: The chronic nature of irritable bowel syndrome (IBS) necessitates persistence when trialing treatment options. After reviewing key identifiers of IBS, we discuss a second-line treatment’s efficacy in reducing symptoms and improving quality of life for patients with continued IBS symptoms. Tune in for valuable insights to make informed recommendations for your patients.
Episode resource links:
Amitriptyline at Low-Dose and Titrated for Irritable Bowel Syndrome as Second-Line Treatment in primary care (ATLANTIS): a randomised, double-blind, placebo-controlled, phase 3 trial - PubMed (nih.gov)
https://www.aafp.org/pubs/afp/issues/2005/1215/p2501.html
Guest: Mariyan L. Montaque, DNP, FNP-BC Music Credit: Richard Onorato]]></itunes:summary>
        <itunes:author>Pri-Med</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>546</itunes:duration>
                        <itunes:episodeType>full</itunes:episodeType>
            </item>
    <item>
        <title>Can Saline Rinsing and Gargling Clear the Path to COVID-19 Relief? - Frankly Speaking Ep 364</title>
        <itunes:title>Can Saline Rinsing and Gargling Clear the Path to COVID-19 Relief? - Frankly Speaking Ep 364</itunes:title>
        <link>https://primedfranklyspeaking.podbean.com/e/can-saline-rinsing-and-gargling-clear-the-path-to-covid-19-relief-frankly-speaking-ep-364/</link>
                    <comments>https://primedfranklyspeaking.podbean.com/e/can-saline-rinsing-and-gargling-clear-the-path-to-covid-19-relief-frankly-speaking-ep-364/#comments</comments>        <pubDate>Mon, 22 Jan 2024 00:30:00 +0000</pubDate>
        <guid isPermaLink="false">primedfranklyspeaking.podbean.com/a04fc32b-2b2c-39ac-88a4-91e8d1ff9be5</guid>
                                    <description><![CDATA[<p>Credits: 0.25 AMA PRA Category 1 Credit™
 
CME/CE Information and Claim Credit: <a href='https://www.pri-med.com/online-education/podcast/frankly-speaking-cme-364'>https://www.pri-med.com/online-education/podcast/frankly-speaking-cme-364</a></p>
<p>Overview: In this episode, we explore a nonpharmacologic approach to easing symptoms of COVID-19 in patients who are at lower risk of progression. Supported by a small study, a nasal saline rinse and gargle regimen was associated with more rapid symptom resolution and lower hospitalization rates. Learn how a simple salt solution can be an effective step in preventing adverse outcomes of COVID-19 for patients who are at low risk.</p>
<p>Episode resource links:</p>
<ul><li>Am Col Allergy Asthma and Immunology: <a href='https://acaai.org/news/new-study-gargling-with-salt-water-may-help-prevent-covid-hospitalization/'>https://acaai.org/news/new-study-gargling-with-salt-water-may-help-prevent-covid-hospitalization/</a></li>
</ul>
<p>Guest: Jillian Joseph, MPAS, PA-C
 
Music Credit: Richard Onorato</p>
]]></description>
                                                            <content:encoded><![CDATA[<p>Credits: 0.25 AMA PRA Category 1 Credit™<br>
 <br>
CME/CE Information and Claim Credit: <a href='https://www.pri-med.com/online-education/podcast/frankly-speaking-cme-364'>https://www.pri-med.com/online-education/podcast/frankly-speaking-cme-364</a></p>
<p>Overview: In this episode, we explore a nonpharmacologic approach to easing symptoms of COVID-19 in patients who are at lower risk of progression. Supported by a small study, a nasal saline rinse and gargle regimen was associated with more rapid symptom resolution and lower hospitalization rates. Learn how a simple salt solution can be an effective step in preventing adverse outcomes of COVID-19 for patients who are at low risk.</p>
<p>Episode resource links:</p>
<ul><li>Am Col Allergy Asthma and Immunology: <a href='https://acaai.org/news/new-study-gargling-with-salt-water-may-help-prevent-covid-hospitalization/'>https://acaai.org/news/new-study-gargling-with-salt-water-may-help-prevent-covid-hospitalization/</a></li>
</ul>
<p>Guest: Jillian Joseph, MPAS, PA-C<br>
 <br>
Music Credit: Richard Onorato</p>
]]></content:encoded>
                                    
        <enclosure url="https://mcdn.podbean.com/mf/web/2kh9xm/frankly-speaking-364-salt-water-gargle-covid.mp3" length="8240962" type="audio/mpeg"/>
                <itunes:summary><![CDATA[Credits: 0.25 AMA PRA Category 1 Credit™ CME/CE Information and Claim Credit: https://www.pri-med.com/online-education/podcast/frankly-speaking-cme-364
Overview: In this episode, we explore a nonpharmacologic approach to easing symptoms of COVID-19 in patients who are at lower risk of progression. Supported by a small study, a nasal saline rinse and gargle regimen was associated with more rapid symptom resolution and lower hospitalization rates. Learn how a simple salt solution can be an effective step in preventing adverse outcomes of COVID-19 for patients who are at low risk.
Episode resource links:
Am Col Allergy Asthma and Immunology: https://acaai.org/news/new-study-gargling-with-salt-water-may-help-prevent-covid-hospitalization/
Guest: Jillian Joseph, MPAS, PA-C Music Credit: Richard Onorato]]></itunes:summary>
        <itunes:author>Pri-Med</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>513</itunes:duration>
                        <itunes:episodeType>full</itunes:episodeType>
            </item>
    <item>
        <title>Vitamins and Supplements for T2DM: What’s the Best Approach? - Frankly Speaking Ep 363</title>
        <itunes:title>Vitamins and Supplements for T2DM: What’s the Best Approach? - Frankly Speaking Ep 363</itunes:title>
        <link>https://primedfranklyspeaking.podbean.com/e/vitamins-and-supplements-for-t2dm-what-s-the-best-approach-frankly-speaking-ep-363/</link>
                    <comments>https://primedfranklyspeaking.podbean.com/e/vitamins-and-supplements-for-t2dm-what-s-the-best-approach-frankly-speaking-ep-363/#comments</comments>        <pubDate>Mon, 15 Jan 2024 00:30:00 +0000</pubDate>
        <guid isPermaLink="false">primedfranklyspeaking.podbean.com/cefb73ec-60ad-311e-a2f1-a8cf4d80aa1b</guid>
                                    <description><![CDATA[<p>Credits: 0.25 AMA PRA Category 1 Credit™
 
CME/CE Information and Claim Credit: <a href='https://www.pri-med.com/online-education/podcast/frankly-speaking-cme-363'>https://www.pri-med.com/online-education/podcast/frankly-speaking-cme-363</a></p>
<p>Overview: Patients often reach for vitamins and supplements in type 2 diabetes mellitus (T2DM) management, but what does the research show? In this episode, you’ll hear expert faculty discuss the efficacy of vitamins and supplements, debunk common myths, and explore the power of dietary changes and exercise. Deepen your knowledge to guide your patients toward taking evidence-based steps in their T2DM management.</p>
<p>Episode resource links:</p>
<ul><li>Cinnamon
J Pharmacy Practice. 2017;30(6):631-638.
J Med Food . 2011 Sep;14(9):884-9. doi: 10.1089/jmf.2010.0180
<a href='https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7577407/'>J Endocr Soc</a>. 2020 Nov 1; 4(11): bvaa094</li>
<li>Chromium
Biol Trace Elem Res. 2022 Feb;200(2):516-525. </li>
<li>Vitamin C
Diabetes Metab Syndr. 2023 Jul 7;17(8):102824.</li>
<li>Vitamin D
Ann Intern Med. 2023 Mar;176(3):355-363. doi: 10.7326/M22-301</li>
<li>Soluble Fiber:   <a href='https://www.ncbi.nlm.nih.gov/pubmed/30617143?dopt=Abstract'>Diabetes Care</a>. 2019 Jan 7. pii: dc181126. doi: 10.2337/dc18-1126</li>
</ul>
<p>Guest: Jillian Joseph, MPAS, PA-C
 
Music Credit: Richard Onorato</p>
]]></description>
                                                            <content:encoded><![CDATA[<p>Credits: 0.25 AMA PRA Category 1 Credit™<br>
 <br>
CME/CE Information and Claim Credit: <a href='https://www.pri-med.com/online-education/podcast/frankly-speaking-cme-363'>https://www.pri-med.com/online-education/podcast/frankly-speaking-cme-363</a></p>
<p>Overview: Patients often reach for vitamins and supplements in type 2 diabetes mellitus (T2DM) management, but what does the research show? In this episode, you’ll hear expert faculty discuss the efficacy of vitamins and supplements, debunk common myths, and explore the power of dietary changes and exercise. Deepen your knowledge to guide your patients toward taking evidence-based steps in their T2DM management.</p>
<p>Episode resource links:</p>
<ul><li>Cinnamon<br>
J Pharmacy Practice. 2017;30(6):631-638.<br>
J Med Food . 2011 Sep;14(9):884-9. doi: 10.1089/jmf.2010.0180<br>
<a href='https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7577407/'>J Endocr Soc</a>. 2020 Nov 1; 4(11): bvaa094</li>
<li>Chromium<br>
Biol Trace Elem Res. 2022 Feb;200(2):516-525. </li>
<li>Vitamin C<br>
Diabetes Metab Syndr. 2023 Jul 7;17(8):102824.</li>
<li>Vitamin D<br>
Ann Intern Med. 2023 Mar;176(3):355-363. doi: 10.7326/M22-301</li>
<li>Soluble Fiber:   <a href='https://www.ncbi.nlm.nih.gov/pubmed/30617143?dopt=Abstract'>Diabetes Care</a>. 2019 Jan 7. pii: dc181126. doi: 10.2337/dc18-1126</li>
</ul>
<p>Guest: Jillian Joseph, MPAS, PA-C<br>
 <br>
Music Credit: Richard Onorato</p>
]]></content:encoded>
                                    
        <enclosure url="https://mcdn.podbean.com/mf/web/8xqbx3/frankly-speaking-363-supplements-t2dm.mp3" length="12553668" type="audio/mpeg"/>
                <itunes:summary><![CDATA[Credits: 0.25 AMA PRA Category 1 Credit™ CME/CE Information and Claim Credit: https://www.pri-med.com/online-education/podcast/frankly-speaking-cme-363
Overview: Patients often reach for vitamins and supplements in type 2 diabetes mellitus (T2DM) management, but what does the research show? In this episode, you’ll hear expert faculty discuss the efficacy of vitamins and supplements, debunk common myths, and explore the power of dietary changes and exercise. Deepen your knowledge to guide your patients toward taking evidence-based steps in their T2DM management.
Episode resource links:
CinnamonJ Pharmacy Practice. 2017;30(6):631-638.J Med Food . 2011 Sep;14(9):884-9. doi: 10.1089/jmf.2010.0180J Endocr Soc. 2020 Nov 1; 4(11): bvaa094
ChromiumBiol Trace Elem Res. 2022 Feb;200(2):516-525. 
Vitamin CDiabetes Metab Syndr. 2023 Jul 7;17(8):102824.
Vitamin DAnn Intern Med. 2023 Mar;176(3):355-363. doi: 10.7326/M22-301
Soluble Fiber:   Diabetes Care. 2019 Jan 7. pii: dc181126. doi: 10.2337/dc18-1126
Guest: Jillian Joseph, MPAS, PA-C Music Credit: Richard Onorato]]></itunes:summary>
        <itunes:author>Pri-Med</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>782</itunes:duration>
                        <itunes:episodeType>full</itunes:episodeType>
            </item>
    <item>
        <title>”I Am Tired!” How Common is Iron Deficiency in Women? - Frankly Speaking Ep 362</title>
        <itunes:title>”I Am Tired!” How Common is Iron Deficiency in Women? - Frankly Speaking Ep 362</itunes:title>
        <link>https://primedfranklyspeaking.podbean.com/e/i-am-tired-how-common-is-iron-deficiency-in-women-frankly-speaking-ep-362/</link>
                    <comments>https://primedfranklyspeaking.podbean.com/e/i-am-tired-how-common-is-iron-deficiency-in-women-frankly-speaking-ep-362/#comments</comments>        <pubDate>Mon, 08 Jan 2024 00:30:00 +0000</pubDate>
        <guid isPermaLink="false">primedfranklyspeaking.podbean.com/316afead-669d-388c-9490-eb42c25ae8d2</guid>
                                    <description><![CDATA[<p>Credits: 0.25 AMA PRA Category 1 Credit™
 
CME/CE Information and Claim Credit: <a href='https://www.pri-med.com/online-education/podcast/frankly-speaking-cme-362'>https://www.pri-med.com/online-education/podcast/frankly-speaking-cme-362</a></p>
<p>Overview: Recorded live at Pri-Med East! Iron deficiency and IDA are common, especially in women of childbearing age, and often under diagnosed. These conditions carry with them risk for increased morbidity and mortality. Screening is focused on high-risk groups, specifically toddlers and pregnant women, however these conditions in women of childbearing age are also common. Please join us to discuss the recent data on the prevalence of ID/IDA, how to appropriately screen and treat this common condition. </p>
<p>Episode resource links:</p>
<ul><li>
<p>Weyand AC, Chaitoff A, Freed GL, Sholzberg M, Choi SW, McGann PT. Prevalence of Iron Deficiency and Iron-Deficiency Anemia in US Females Aged 12-21 Years, 2003-2020. JAMA. 2023;329(24):2191-2193. doi:10.1001/jama.2023.8020</p>
</li>
<li>
<p>Dyna-Med: <a href='https://www-dynamed-com.umassmed.idm.oclc.org/management/treatment-of-iron-deficiency-anemia-in-adults#IRON_DEFICIENCY_WITHOUT_ANEMIA'>https://www-dynamed-com.umassmed.idm.oclc.org/management/treatment-of-iron-deficiency-anemia-in-adults#IRON_DEFICIENCY_WITHOUT_ANEMIA</a></p>
<p> </p>
</li>
<li>
<p>NIH Iron Fact Sheet for Health Professionals: <a href='https://ods-od-nih-gov.umassmed.idm.oclc.org/factsheets/Iron-HealthProfessional/'>https://ods-od-nih-gov.umassmed.idm.oclc.org/factsheets/Iron-HealthProfessional/</a></p>
</li>
</ul>
<p>Guest: Susan Feeney, DNP, FNP-BC, NP-C
 
Music Credit: Richard Onorato</p>
]]></description>
                                                            <content:encoded><![CDATA[<p>Credits: 0.25 AMA PRA Category 1 Credit™<br>
 <br>
CME/CE Information and Claim Credit: <a href='https://www.pri-med.com/online-education/podcast/frankly-speaking-cme-362'>https://www.pri-med.com/online-education/podcast/frankly-speaking-cme-362</a></p>
<p>Overview: Recorded live at Pri-Med East! Iron deficiency and IDA are common, especially in women of childbearing age, and often under diagnosed. These conditions carry with them risk for increased morbidity and mortality. Screening is focused on high-risk groups, specifically toddlers and pregnant women, however these conditions in women of childbearing age are also common. Please join us to discuss the recent data on the prevalence of ID/IDA, how to appropriately screen and treat this common condition. </p>
<p>Episode resource links:</p>
<ul><li>
<p>Weyand AC, Chaitoff A, Freed GL, Sholzberg M, Choi SW, McGann PT. Prevalence of Iron Deficiency and Iron-Deficiency Anemia in US Females Aged 12-21 Years, 2003-2020. JAMA. 2023;329(24):2191-2193. doi:10.1001/jama.2023.8020</p>
</li>
<li>
<p>Dyna-Med: <a href='https://www-dynamed-com.umassmed.idm.oclc.org/management/treatment-of-iron-deficiency-anemia-in-adults#IRON_DEFICIENCY_WITHOUT_ANEMIA'>https://www-dynamed-com.umassmed.idm.oclc.org/management/treatment-of-iron-deficiency-anemia-in-adults#IRON_DEFICIENCY_WITHOUT_ANEMIA</a></p>
<p> </p>
</li>
<li>
<p>NIH Iron Fact Sheet for Health Professionals: <a href='https://ods-od-nih-gov.umassmed.idm.oclc.org/factsheets/Iron-HealthProfessional/'>https://ods-od-nih-gov.umassmed.idm.oclc.org/factsheets/Iron-HealthProfessional/</a></p>
</li>
</ul>
<p>Guest: Susan Feeney, DNP, FNP-BC, NP-C<br>
 <br>
Music Credit: Richard Onorato</p>
]]></content:encoded>
                                    
        <enclosure url="https://mcdn.podbean.com/mf/web/2vdnpw/frankly-speaking-362-anemia.mp3" length="8701820" type="audio/mpeg"/>
                <itunes:summary><![CDATA[Credits: 0.25 AMA PRA Category 1 Credit™ CME/CE Information and Claim Credit: https://www.pri-med.com/online-education/podcast/frankly-speaking-cme-362
Overview: Recorded live at Pri-Med East! Iron deficiency and IDA are common, especially in women of childbearing age, and often under diagnosed. These conditions carry with them risk for increased morbidity and mortality. Screening is focused on high-risk groups, specifically toddlers and pregnant women, however these conditions in women of childbearing age are also common. Please join us to discuss the recent data on the prevalence of ID/IDA, how to appropriately screen and treat this common condition. 
Episode resource links:

Weyand AC, Chaitoff A, Freed GL, Sholzberg M, Choi SW, McGann PT. Prevalence of Iron Deficiency and Iron-Deficiency Anemia in US Females Aged 12-21 Years, 2003-2020. JAMA. 2023;329(24):2191-2193. doi:10.1001/jama.2023.8020


Dyna-Med: https://www-dynamed-com.umassmed.idm.oclc.org/management/treatment-of-iron-deficiency-anemia-in-adults#IRON_DEFICIENCY_WITHOUT_ANEMIA
 


NIH Iron Fact Sheet for Health Professionals: https://ods-od-nih-gov.umassmed.idm.oclc.org/factsheets/Iron-HealthProfessional/

Guest: Susan Feeney, DNP, FNP-BC, NP-C Music Credit: Richard Onorato]]></itunes:summary>
        <itunes:author>Pri-Med</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>542</itunes:duration>
                        <itunes:episodeType>full</itunes:episodeType>
            </item>
    <item>
        <title>Psilocybin for Depression: Are Magic Mushrooms Doing the Trick? - Frankly Speaking Ep 361</title>
        <itunes:title>Psilocybin for Depression: Are Magic Mushrooms Doing the Trick? - Frankly Speaking Ep 361</itunes:title>
        <link>https://primedfranklyspeaking.podbean.com/e/psilocybin-for-depression-are-magic-mushrooms-doing-the-trick-frankly-speaking-ep-361/</link>
                    <comments>https://primedfranklyspeaking.podbean.com/e/psilocybin-for-depression-are-magic-mushrooms-doing-the-trick-frankly-speaking-ep-361/#comments</comments>        <pubDate>Mon, 01 Jan 2024 00:30:00 +0000</pubDate>
        <guid isPermaLink="false">primedfranklyspeaking.podbean.com/a16c11e6-ea3b-32e6-a441-ffcdd803869a</guid>
                                    <description><![CDATA[<p>Credits: 0.25 AMA PRA Category 1 Credit™
 
CME/CE Information and Claim Credit: <a href='https://www.pri-med.com/online-education/podcast/frankly-speaking-cme-361'>https://www.pri-med.com/online-education/podcast/frankly-speaking-cme-361</a></p>
<p>Overview: In this episode, we delve into a topic of growing interest in medicine—the use of psilocybin to treat depression. Join us as we discuss the pharmacotherapeutic action of psilocybin and the results of a recent study that has suggested that a one-time dose of psilocybin can be an effective treatment for depression. Hear valuable insights into the potential benefits and limitations and feel prepared to respond to patient questions about this treatment.</p>
<p>Episode resource links:</p>
<ul><li>JAMA. 2023;330(9):843-853. doi:10.1001/jama.2023.14530</li>
</ul>
<p>Guest: Robert A. Baldor MD, FAAFP
 
Music Credit: Richard Onorato</p>
]]></description>
                                                            <content:encoded><![CDATA[<p>Credits: 0.25 AMA PRA Category 1 Credit™<br>
 <br>
CME/CE Information and Claim Credit: <a href='https://www.pri-med.com/online-education/podcast/frankly-speaking-cme-361'>https://www.pri-med.com/online-education/podcast/frankly-speaking-cme-361</a></p>
<p>Overview: In this episode, we delve into a topic of growing interest in medicine—the use of psilocybin to treat depression. Join us as we discuss the pharmacotherapeutic action of psilocybin and the results of a recent study that has suggested that a one-time dose of psilocybin can be an effective treatment for depression. Hear valuable insights into the potential benefits and limitations and feel prepared to respond to patient questions about this treatment.</p>
<p>Episode resource links:</p>
<ul><li>JAMA. 2023;330(9):843-853. doi:10.1001/jama.2023.14530</li>
</ul>
<p>Guest: Robert A. Baldor MD, FAAFP<br>
 <br>
Music Credit: Richard Onorato</p>
]]></content:encoded>
                                    
        <enclosure url="https://mcdn.podbean.com/mf/web/x5wnhc/frankly-speaking-361-psilocybin-depression-old.mp3" length="10190609" type="audio/mpeg"/>
                <itunes:summary><![CDATA[Credits: 0.25 AMA PRA Category 1 Credit™ CME/CE Information and Claim Credit: https://www.pri-med.com/online-education/podcast/frankly-speaking-cme-361
Overview: In this episode, we delve into a topic of growing interest in medicine—the use of psilocybin to treat depression. Join us as we discuss the pharmacotherapeutic action of psilocybin and the results of a recent study that has suggested that a one-time dose of psilocybin can be an effective treatment for depression. Hear valuable insights into the potential benefits and limitations and feel prepared to respond to patient questions about this treatment.
Episode resource links:
JAMA. 2023;330(9):843-853. doi:10.1001/jama.2023.14530
Guest: Robert A. Baldor MD, FAAFP Music Credit: Richard Onorato]]></itunes:summary>
        <itunes:author>Pri-Med</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>635</itunes:duration>
                <itunes:episode>5</itunes:episode>
        <itunes:episodeType>full</itunes:episodeType>
            </item>
    <item>
        <title>Medical Myths: Grapefruit Juice, Broccoli, and Biotin - Frankly Speaking Ep 360</title>
        <itunes:title>Medical Myths: Grapefruit Juice, Broccoli, and Biotin - Frankly Speaking Ep 360</itunes:title>
        <link>https://primedfranklyspeaking.podbean.com/e/medical-myths-grapefruit-juice-broccoli-and-biotin-frankly-speaking-ep-360/</link>
                    <comments>https://primedfranklyspeaking.podbean.com/e/medical-myths-grapefruit-juice-broccoli-and-biotin-frankly-speaking-ep-360/#comments</comments>        <pubDate>Mon, 25 Dec 2023 00:30:00 +0000</pubDate>
        <guid isPermaLink="false">primedfranklyspeaking.podbean.com/5062e51f-2f45-3a8f-ade5-0c333249c4f4</guid>
                                    <description><![CDATA[<p>Credits: 0.25 AMA PRA Category 1 Credit™
 
CME/CE Information and Claim Credit: <a href='https://www.pri-med.com/online-education/podcast/frankly-speaking-cme-360'>https://www.pri-med.com/online-education/podcast/frankly-speaking-cme-360</a></p>
<p>Overview: Join us as we examine common medical myths encountered in primary care. Hear what the evidence has to say about grapefruit and statins, vitamin K-rich vegetables and warfarin, and biotin for treating hair loss. Stay informed, challenge assumptions, and enhance your practice with insights on these long-held beliefs.</p>
<p>Episode resource links:</p>
<ul><li>
<p>Grapefruit: Am J Med 2016; Vol 129 (1): 26-29, Br J Clin Pharmacol. 2011 Sep;72(3):434-41.</p>
<p> </p>
</li>
<li>
<p>Warfarin: Medicine (Baltimore). 2016 Mar;95(10):e2895</p>
<p> </p>
</li>
<li>
<p>Biotin: The Journal of Clinical and Aesthetic Dermatology. 2020;13(3):37-40</p>
</li>
</ul>
<p>Guest: Jillian Joseph, MPAS, PA-C, Susan Feeney, DNP, FNP-BC, NP-C
 
Music Credit: Richard Onorato</p>
]]></description>
                                                            <content:encoded><![CDATA[<p>Credits: 0.25 AMA PRA Category 1 Credit™<br>
 <br>
CME/CE Information and Claim Credit: <a href='https://www.pri-med.com/online-education/podcast/frankly-speaking-cme-360'>https://www.pri-med.com/online-education/podcast/frankly-speaking-cme-360</a></p>
<p>Overview: Join us as we examine common medical myths encountered in primary care. Hear what the evidence has to say about grapefruit and statins, vitamin K-rich vegetables and warfarin, and biotin for treating hair loss. Stay informed, challenge assumptions, and enhance your practice with insights on these long-held beliefs.</p>
<p>Episode resource links:</p>
<ul><li>
<p>Grapefruit: Am J Med 2016; Vol 129 (1): 26-29, Br J Clin Pharmacol. 2011 Sep;72(3):434-41.</p>
<p> </p>
</li>
<li>
<p>Warfarin: Medicine (Baltimore). 2016 Mar;95(10):e2895</p>
<p> </p>
</li>
<li>
<p>Biotin: The Journal of Clinical and Aesthetic Dermatology. 2020;13(3):37-40</p>
</li>
</ul>
<p>Guest: Jillian Joseph, MPAS, PA-C, Susan Feeney, DNP, FNP-BC, NP-C<br>
 <br>
Music Credit: Richard Onorato</p>
]]></content:encoded>
                                    
        <enclosure url="https://mcdn.podbean.com/mf/web/qg59ki/frankly-speaking-360-medical-myths.mp3" length="10817244" type="audio/mpeg"/>
                <itunes:summary><![CDATA[Credits: 0.25 AMA PRA Category 1 Credit™ CME/CE Information and Claim Credit: https://www.pri-med.com/online-education/podcast/frankly-speaking-cme-360
Overview: Join us as we examine common medical myths encountered in primary care. Hear what the evidence has to say about grapefruit and statins, vitamin K-rich vegetables and warfarin, and biotin for treating hair loss. Stay informed, challenge assumptions, and enhance your practice with insights on these long-held beliefs.
Episode resource links:

Grapefruit: Am J Med 2016; Vol 129 (1): 26-29, Br J Clin Pharmacol. 2011 Sep;72(3):434-41.
 


Warfarin: Medicine (Baltimore). 2016 Mar;95(10):e2895
 


Biotin: The Journal of Clinical and Aesthetic Dermatology. 2020;13(3):37-40

Guest: Jillian Joseph, MPAS, PA-C, Susan Feeney, DNP, FNP-BC, NP-C Music Credit: Richard Onorato]]></itunes:summary>
        <itunes:author>Pri-Med</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>674</itunes:duration>
                        <itunes:episodeType>full</itunes:episodeType>
            </item>
    <item>
        <title>Walking, Riding, Lifting—Is One Exercise Better than Another? - Frankly Speaking Ep 359</title>
        <itunes:title>Walking, Riding, Lifting—Is One Exercise Better than Another? - Frankly Speaking Ep 359</itunes:title>
        <link>https://primedfranklyspeaking.podbean.com/e/walking-riding-lifting%e2%80%94is-one-exercise-better-than-another-frankly-speaking-ep-359/</link>
                    <comments>https://primedfranklyspeaking.podbean.com/e/walking-riding-lifting%e2%80%94is-one-exercise-better-than-another-frankly-speaking-ep-359/#comments</comments>        <pubDate>Mon, 18 Dec 2023 00:30:00 +0000</pubDate>
        <guid isPermaLink="false">primedfranklyspeaking.podbean.com/88a0615d-a803-36cd-bc34-44c094796250</guid>
                                    <description><![CDATA[<p>Credits: 0.25 AMA PRA Category 1 Credit™
 
CME/CE Information and Claim Credit: <a href='https://www.pri-med.com/online-education/podcast/frankly-speaking-cme-359'>https://www.pri-med.com/online-education/podcast/frankly-speaking-cme-359</a></p>
<p>Overview: There is plenty of evidence linking exercise to improved overall health. It is associated with weight loss, improved biomarkers, improved sleep, and mood. The few studies comparing types and intensity of exercise have resulted in varied and inconsistent findings. Listen in as we discuss a recent prospective cohort study examining associations between combinations of exercise and reduction in all-cause, cardiovascular, and cancer mortality and how the evidence can inform your practice to improve patients’ health.</p>
<p>Episode resource links:</p>
<ul><li>
<p>López-Bueno, R., Ahmadi, M., Stamatakis, E., Yang, L., &amp; Del Pozo Cruz, B. (2023). Prospective Associations of Different Combinations of Aerobic and Muscle-Strengthening Activity With All-Cause, Cardiovascular, and Cancer Mortality. JAMA internal medicine, 183(9), 982–990. <a href='https://doi.org/10.1001/jamainternmed.2023.3093'>https://doi.org/10.1001/jamainternmed.2023.3093</a></p>
<p> </p>
</li>
<li>
<p>Standards of Care, 2023 American Diabetic Association. <a href='https://diabetesjournals.org/care/issue/46/Supplement_1'>https://diabetesjournals.org/care/issue/46/Supplement_1</a></p>
<p> </p>
</li>
<li>
<p><a href='https://www.heart.org/en/healthy-living/fitness/fitness-basics/aha-recs-for-physical-activity-in-adults'>https://www.heart.org/en/healthy-living/fitness/fitness-basics/aha-recs-for-physical-activity-in-adults</a></p>
<p> </p>
</li>
<li>
<p><a href='https://diabetes.org/health-wellness/fitness'>https://diabetes.org/health-wellness/fitness</a></p>
</li>
</ul>
<p>Guest: Susan Feeney, DNP, FNP-BC, NP-C
 
Music Credit: Richard Onorato</p>
]]></description>
                                                            <content:encoded><![CDATA[<p>Credits: 0.25 AMA PRA Category 1 Credit™<br>
 <br>
CME/CE Information and Claim Credit: <a href='https://www.pri-med.com/online-education/podcast/frankly-speaking-cme-359'>https://www.pri-med.com/online-education/podcast/frankly-speaking-cme-359</a></p>
<p>Overview: There is plenty of evidence linking exercise to improved overall health. It is associated with weight loss, improved biomarkers, improved sleep, and mood. The few studies comparing types and intensity of exercise have resulted in varied and inconsistent findings. Listen in as we discuss a recent prospective cohort study examining associations between combinations of exercise and reduction in all-cause, cardiovascular, and cancer mortality and how the evidence can inform your practice to improve patients’ health.</p>
<p>Episode resource links:</p>
<ul><li>
<p>López-Bueno, R., Ahmadi, M., Stamatakis, E., Yang, L., &amp; Del Pozo Cruz, B. (2023). Prospective Associations of Different Combinations of Aerobic and Muscle-Strengthening Activity With All-Cause, Cardiovascular, and Cancer Mortality. JAMA internal medicine, 183(9), 982–990. <a href='https://doi.org/10.1001/jamainternmed.2023.3093'>https://doi.org/10.1001/jamainternmed.2023.3093</a></p>
<p> </p>
</li>
<li>
<p>Standards of Care, 2023 American Diabetic Association. <a href='https://diabetesjournals.org/care/issue/46/Supplement_1'>https://diabetesjournals.org/care/issue/46/Supplement_1</a></p>
<p> </p>
</li>
<li>
<p><a href='https://www.heart.org/en/healthy-living/fitness/fitness-basics/aha-recs-for-physical-activity-in-adults'>https://www.heart.org/en/healthy-living/fitness/fitness-basics/aha-recs-for-physical-activity-in-adults</a></p>
<p> </p>
</li>
<li>
<p><a href='https://diabetes.org/health-wellness/fitness'>https://diabetes.org/health-wellness/fitness</a></p>
</li>
</ul>
<p>Guest: Susan Feeney, DNP, FNP-BC, NP-C<br>
 <br>
Music Credit: Richard Onorato</p>
]]></content:encoded>
                                    
        <enclosure url="https://mcdn.podbean.com/mf/web/crtmzy/frankly-speaking-359-exercise-type-and-MM.mp3" length="9330651" type="audio/mpeg"/>
                <itunes:summary><![CDATA[Credits: 0.25 AMA PRA Category 1 Credit™ CME/CE Information and Claim Credit: https://www.pri-med.com/online-education/podcast/frankly-speaking-cme-359
Overview: There is plenty of evidence linking exercise to improved overall health. It is associated with weight loss, improved biomarkers, improved sleep, and mood. The few studies comparing types and intensity of exercise have resulted in varied and inconsistent findings. Listen in as we discuss a recent prospective cohort study examining associations between combinations of exercise and reduction in all-cause, cardiovascular, and cancer mortality and how the evidence can inform your practice to improve patients’ health.
Episode resource links:

López-Bueno, R., Ahmadi, M., Stamatakis, E., Yang, L., &amp; Del Pozo Cruz, B. (2023). Prospective Associations of Different Combinations of Aerobic and Muscle-Strengthening Activity With All-Cause, Cardiovascular, and Cancer Mortality. JAMA internal medicine, 183(9), 982–990. https://doi.org/10.1001/jamainternmed.2023.3093
 


Standards of Care, 2023 American Diabetic Association. https://diabetesjournals.org/care/issue/46/Supplement_1
 


https://www.heart.org/en/healthy-living/fitness/fitness-basics/aha-recs-for-physical-activity-in-adults
 


https://diabetes.org/health-wellness/fitness

Guest: Susan Feeney, DNP, FNP-BC, NP-C Music Credit: Richard Onorato]]></itunes:summary>
        <itunes:author>Pri-Med</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>581</itunes:duration>
                        <itunes:episodeType>full</itunes:episodeType>
            </item>
    <item>
        <title>Prophylactic Power: Doxycycline’s Role in STI Prevention - Frankly Speaking Ep 358</title>
        <itunes:title>Prophylactic Power: Doxycycline’s Role in STI Prevention - Frankly Speaking Ep 358</itunes:title>
        <link>https://primedfranklyspeaking.podbean.com/e/prophylactic-power-doxycycline-s-role-in-sti-prevention-frankly-speaking-ep-358/</link>
                    <comments>https://primedfranklyspeaking.podbean.com/e/prophylactic-power-doxycycline-s-role-in-sti-prevention-frankly-speaking-ep-358/#comments</comments>        <pubDate>Mon, 11 Dec 2023 00:30:00 +0000</pubDate>
        <guid isPermaLink="false">primedfranklyspeaking.podbean.com/f7914f3f-b6aa-36f7-b587-e80ca57985ea</guid>
                                    <description><![CDATA[<p>Credits: 0.25 AMA PRA Category 1 Credit™
 
CME/CE Information and Claim Credit: <a href='https://www.pri-med.com/online-education/podcast/frankly-speaking-cme-358'>https://www.pri-med.com/online-education/podcast/frankly-speaking-cme-358</a></p>
<p>Overview: In this episode, we explore new data that could reshape how we approach sexually transmitted infection (STI) prevention in clinical practice. Discover how doxycycline can serve as prophylaxis for bacterial STIs in populations who are at high risk and come away with practical strategies for counseling patients on STI prevention. Tune in to enhance your clinical expertise and provide superior care to your patients.</p>
<p>Episode resource links:</p>
<ul><li>Luetkemeyer AF, Donnell D, Dombrowski JC, et al. Postexposure Doxycycline to Prevent Bacterial Sexually Transmitted Infections. N Engl J Med. 2023;388(14):1296-1306. </li>
</ul>
<p>Guest: Alan M. Ehrlich MD, FAAFP
 
Music Credit: Richard Onorato</p>
]]></description>
                                                            <content:encoded><![CDATA[<p>Credits: 0.25 AMA PRA Category 1 Credit™<br>
 <br>
CME/CE Information and Claim Credit: <a href='https://www.pri-med.com/online-education/podcast/frankly-speaking-cme-358'>https://www.pri-med.com/online-education/podcast/frankly-speaking-cme-358</a></p>
<p>Overview: In this episode, we explore new data that could reshape how we approach sexually transmitted infection (STI) prevention in clinical practice. Discover how doxycycline can serve as prophylaxis for bacterial STIs in populations who are at high risk and come away with practical strategies for counseling patients on STI prevention. Tune in to enhance your clinical expertise and provide superior care to your patients.</p>
<p>Episode resource links:</p>
<ul><li>Luetkemeyer AF, Donnell D, Dombrowski JC, et al. Postexposure Doxycycline to Prevent Bacterial Sexually Transmitted Infections. N Engl J Med. 2023;388(14):1296-1306. </li>
</ul>
<p>Guest: Alan M. Ehrlich MD, FAAFP<br>
 <br>
Music Credit: Richard Onorato</p>
]]></content:encoded>
                                    
        <enclosure url="https://mcdn.podbean.com/mf/web/crvx4p/frankly-speaking-358-doxycycline.mp3" length="9417502" type="audio/mpeg"/>
                <itunes:summary><![CDATA[Credits: 0.25 AMA PRA Category 1 Credit™ CME/CE Information and Claim Credit: https://www.pri-med.com/online-education/podcast/frankly-speaking-cme-358
Overview: In this episode, we explore new data that could reshape how we approach sexually transmitted infection (STI) prevention in clinical practice. Discover how doxycycline can serve as prophylaxis for bacterial STIs in populations who are at high risk and come away with practical strategies for counseling patients on STI prevention. Tune in to enhance your clinical expertise and provide superior care to your patients.
Episode resource links:
Luetkemeyer AF, Donnell D, Dombrowski JC, et al. Postexposure Doxycycline to Prevent Bacterial Sexually Transmitted Infections. N Engl J Med. 2023;388(14):1296-1306. 
Guest: Alan M. Ehrlich MD, FAAFP Music Credit: Richard Onorato]]></itunes:summary>
        <itunes:author>Pri-Med</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>586</itunes:duration>
                        <itunes:episodeType>full</itunes:episodeType>
            </item>
    <item>
        <title>Emergency Contraception—Can It Be More Effective? - Frankly Speaking Ep 357</title>
        <itunes:title>Emergency Contraception—Can It Be More Effective? - Frankly Speaking Ep 357</itunes:title>
        <link>https://primedfranklyspeaking.podbean.com/e/emergency-contraception%e2%80%94can-it-be-more-effective-frankly-speaking-ep-357/</link>
                    <comments>https://primedfranklyspeaking.podbean.com/e/emergency-contraception%e2%80%94can-it-be-more-effective-frankly-speaking-ep-357/#comments</comments>        <pubDate>Mon, 04 Dec 2023 00:30:00 +0000</pubDate>
        <guid isPermaLink="false">primedfranklyspeaking.podbean.com/b750ddaf-2f15-3bf4-a053-b1cad374e823</guid>
                                    <description><![CDATA[<p>Credits: 0.25 AMA PRA Category 1 Credit™
 
CME/CE Information and Claim Credit: <a href='https://www.pri-med.com/online-education/podcast/frankly-speaking-cme-357'>https://www.pri-med.com/online-education/podcast/frankly-speaking-cme-357</a></p>
<p>Overview: Progesterone-based emergency contraception (EC) is established as a method to reduce the risk of pregnancy after unprotected intercourse. This EC works by blocking or delaying ovulation. However, if taken after ovulation, there is a higher failure rate. A recent study showed increased efficacy of levonorgestrel when given with a COX-2 inhibitor (NSAID). Please join us as we discuss the results of the randomized controlled trial, including the efficacy of levonorgestrel when taken with piroxicam and their potential to reduce EC failure.</p>
<p>Episode resource links:</p>
<ul><li>Li, R. H. W., Lo, S. S. T., Gemzell-Danielsson, K., Fong, C. H. Y., Ho, P. C., &amp; Ng, E. H. Y. (2023). Oral emergency contraception with levonorgestrel plus piroxicam: a randomised double-blind placebo-controlled trial. Lancet (London, England), 402(10405), 851–858. https://doi.org/10.1016/S0140-6736(23)01240-0</li>
</ul>
<p>Guest: Susan Feeney, DNP, FNP-BC, NP-C
 
Music Credit: Richard Onorato</p>
]]></description>
                                                            <content:encoded><![CDATA[<p>Credits: 0.25 AMA PRA Category 1 Credit™<br>
 <br>
CME/CE Information and Claim Credit: <a href='https://www.pri-med.com/online-education/podcast/frankly-speaking-cme-357'>https://www.pri-med.com/online-education/podcast/frankly-speaking-cme-357</a></p>
<p>Overview: Progesterone-based emergency contraception (EC) is established as a method to reduce the risk of pregnancy after unprotected intercourse. This EC works by blocking or delaying ovulation. However, if taken after ovulation, there is a higher failure rate. A recent study showed increased efficacy of levonorgestrel when given with a COX-2 inhibitor (NSAID). Please join us as we discuss the results of the randomized controlled trial, including the efficacy of levonorgestrel when taken with piroxicam and their potential to reduce EC failure.</p>
<p>Episode resource links:</p>
<ul><li>Li, R. H. W., Lo, S. S. T., Gemzell-Danielsson, K., Fong, C. H. Y., Ho, P. C., &amp; Ng, E. H. Y. (2023). Oral emergency contraception with levonorgestrel plus piroxicam: a randomised double-blind placebo-controlled trial. Lancet (London, England), 402(10405), 851–858. https://doi.org/10.1016/S0140-6736(23)01240-0</li>
</ul>
<p>Guest: Susan Feeney, DNP, FNP-BC, NP-C<br>
 <br>
Music Credit: Richard Onorato</p>
]]></content:encoded>
                                    
        <enclosure url="https://mcdn.podbean.com/mf/web/6mavdk/frankly-speaking-357-emergency-contraception.mp3" length="8180934" type="audio/mpeg"/>
                <itunes:summary><![CDATA[Credits: 0.25 AMA PRA Category 1 Credit™ CME/CE Information and Claim Credit: https://www.pri-med.com/online-education/podcast/frankly-speaking-cme-357
Overview: Progesterone-based emergency contraception (EC) is established as a method to reduce the risk of pregnancy after unprotected intercourse. This EC works by blocking or delaying ovulation. However, if taken after ovulation, there is a higher failure rate. A recent study showed increased efficacy of levonorgestrel when given with a COX-2 inhibitor (NSAID). Please join us as we discuss the results of the randomized controlled trial, including the efficacy of levonorgestrel when taken with piroxicam and their potential to reduce EC failure.
Episode resource links:
Li, R. H. W., Lo, S. S. T., Gemzell-Danielsson, K., Fong, C. H. Y., Ho, P. C., &amp; Ng, E. H. Y. (2023). Oral emergency contraception with levonorgestrel plus piroxicam: a randomised double-blind placebo-controlled trial. Lancet (London, England), 402(10405), 851–858. https://doi.org/10.1016/S0140-6736(23)01240-0
Guest: Susan Feeney, DNP, FNP-BC, NP-C Music Credit: Richard Onorato]]></itunes:summary>
        <itunes:author>Pri-Med</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>509</itunes:duration>
                        <itunes:episodeType>full</itunes:episodeType>
            </item>
    <item>
        <title>Addressing Penicillin Allergies in Primary Care - Frankly Speaking Ep 356</title>
        <itunes:title>Addressing Penicillin Allergies in Primary Care - Frankly Speaking Ep 356</itunes:title>
        <link>https://primedfranklyspeaking.podbean.com/e/addressing-penicillin-allergies-in-primary-care-frankly-speaking-ep-356/</link>
                    <comments>https://primedfranklyspeaking.podbean.com/e/addressing-penicillin-allergies-in-primary-care-frankly-speaking-ep-356/#comments</comments>        <pubDate>Mon, 27 Nov 2023 00:30:00 +0000</pubDate>
        <guid isPermaLink="false">primedfranklyspeaking.podbean.com/6e1df0f1-09d1-3495-8e3e-83bd6d066b13</guid>
                                    <description><![CDATA[<p>Credits: 0.25 AMA PRA Category 1 Credit™
 
CME/CE Information and Claim Credit: <a href='https://www.pri-med.com/online-education/podcast/frankly-speaking-cme-356'>https://www.pri-med.com/online-education/podcast/frankly-speaking-cme-356</a></p>
<p>Overview: Patient-reported penicillin allergies are common; however, more than 95% of such patients have negative penicillin allergy testing and will tolerate subsequent antibiotic use. Currently, disproving a penicillin allergy includes negative skin testing followed by an oral challenge, which is considered the gold standard to remove the penicillin allergy label, as skin testing alone lacks 100% negative predictive value. Recent reports have suggested that low-risk individuals can be assessed with a direct oral challenge, but the safety and efficacy of such an approach has not been rigorously studied. Listen in as expert faculty discuss a recent randomized controlled trial that validates such an approach.</p>
<p>Episode resource links:</p>
<ul><li>Trubiano JA, Vogrin S, Chua KYL et al. <a href='http://www.qxmd.com/pubmed/32176248'>Development and Validation of a Penicillin Allergy Clinical Decision Rule</a>. JAMA Internal Med. Published March 16, 2020. doi:10.1001/jamainternmed.2020.0403</li>
<li>JAMA Intern Med. doi:10.1001/jamainternmed.2023.2986</li>
</ul>
<p>Guest: Robert A. Baldor MD, FAAFP
 
Music Credit: Richard Onorato</p>
]]></description>
                                                            <content:encoded><![CDATA[<p>Credits: 0.25 AMA PRA Category 1 Credit™<br>
 <br>
CME/CE Information and Claim Credit: <a href='https://www.pri-med.com/online-education/podcast/frankly-speaking-cme-356'>https://www.pri-med.com/online-education/podcast/frankly-speaking-cme-356</a></p>
<p>Overview: Patient-reported penicillin allergies are common; however, more than 95% of such patients have negative penicillin allergy testing and will tolerate subsequent antibiotic use. Currently, disproving a penicillin allergy includes negative skin testing followed by an oral challenge, which is considered the gold standard to remove the penicillin allergy label, as skin testing alone lacks 100% negative predictive value. Recent reports have suggested that low-risk individuals can be assessed with a direct oral challenge, but the safety and efficacy of such an approach has not been rigorously studied. Listen in as expert faculty discuss a recent randomized controlled trial that validates such an approach.</p>
<p>Episode resource links:</p>
<ul><li>Trubiano JA, Vogrin S, Chua KYL et al. <a href='http://www.qxmd.com/pubmed/32176248'>Development and Validation of a Penicillin Allergy Clinical Decision Rule</a>. JAMA Internal Med. Published March 16, 2020. doi:10.1001/jamainternmed.2020.0403</li>
<li>JAMA Intern Med. doi:10.1001/jamainternmed.2023.2986</li>
</ul>
<p>Guest: Robert A. Baldor MD, FAAFP<br>
 <br>
Music Credit: Richard Onorato</p>
]]></content:encoded>
                                    
        <enclosure url="https://mcdn.podbean.com/mf/web/pfrkur/frankly-speaking-356-penicillin-allergy.mp3" length="9286028" type="audio/mpeg"/>
                <itunes:summary><![CDATA[Credits: 0.25 AMA PRA Category 1 Credit™ CME/CE Information and Claim Credit: https://www.pri-med.com/online-education/podcast/frankly-speaking-cme-356
Overview: Patient-reported penicillin allergies are common; however, more than 95% of such patients have negative penicillin allergy testing and will tolerate subsequent antibiotic use. Currently, disproving a penicillin allergy includes negative skin testing followed by an oral challenge, which is considered the gold standard to remove the penicillin allergy label, as skin testing alone lacks 100% negative predictive value. Recent reports have suggested that low-risk individuals can be assessed with a direct oral challenge, but the safety and efficacy of such an approach has not been rigorously studied. Listen in as expert faculty discuss a recent randomized controlled trial that validates such an approach.
Episode resource links:
Trubiano JA, Vogrin S, Chua KYL et al. Development and Validation of a Penicillin Allergy Clinical Decision Rule. JAMA Internal Med. Published March 16, 2020. doi:10.1001/jamainternmed.2020.0403
JAMA Intern Med. doi:10.1001/jamainternmed.2023.2986
Guest: Robert A. Baldor MD, FAAFP Music Credit: Richard Onorato]]></itunes:summary>
        <itunes:author>Pri-Med</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>578</itunes:duration>
                        <itunes:episodeType>full</itunes:episodeType>
            </item>
    <item>
        <title>Keep Engaged and Moving to Prevent Dementia: Anything Is Better than Nothing! - Frankly Speaking Ep 355</title>
        <itunes:title>Keep Engaged and Moving to Prevent Dementia: Anything Is Better than Nothing! - Frankly Speaking Ep 355</itunes:title>
        <link>https://primedfranklyspeaking.podbean.com/e/keep-engaged-and-moving-to-prevent-dementia-anything-is-better-than-nothing-frankly-speaking-ep-355/</link>
                    <comments>https://primedfranklyspeaking.podbean.com/e/keep-engaged-and-moving-to-prevent-dementia-anything-is-better-than-nothing-frankly-speaking-ep-355/#comments</comments>        <pubDate>Mon, 20 Nov 2023 00:30:00 +0000</pubDate>
        <guid isPermaLink="false">primedfranklyspeaking.podbean.com/068ea7fd-0651-3d3b-a1cc-4fd371adec0c</guid>
                                    <description><![CDATA[<p>Credits: 0.25 AMA PRA Category 1 Credit™
 
CME/CE Information and Claim Credit: <a href='https://www.pri-med.com/online-cme-ce/podcast/frankly-speaking-cme-ep-355'>https://www.pri-med.com/online-cme-ce/podcast/frankly-speaking-cme-ep-355</a></p>
<p>Overview: Discover how primary care providers can actively combat dementia risk in aging patients. In this episode, expert faculty explore recent studies revealing the benefits of dementia prevention and evidence-based activities for reducing risks. Learn how to provide encouragement and social activity prescriptions during visits, and gain essential knowledge to preserve cognitive function, ultimately improving patient care and quality of life.</p>
<p>Episode resource links:</p>
<ul><li>Cho, G., Betensky, R. A., &amp; Chang, V. W. (2023). Internet usage and the prospective risk of dementia: A population-based cohort study. Journal of the American Geriatrics Society, 71(8), 2419–2429. https://doi.org/10.1111/jgs.18394</li>
<li>Raichlen DA, Aslan DH, Sayre MK, et al. (2023). Sedentary Behavior and Incident Dementia Among Older Adults. JAMA. 330(10):934–940. <a href='https://doi:10'>https://doi:10.1001/jama.2023.15231</a></li>
<li>Su, S., Shi, L., Zheng, Y., Sun, Y., Huang, X., Zhang, A., Que, J., Sun, X., Shi, J., Bao, Y., Deng, J., &amp; Lu, L. (2022). Leisure Activities and the Risk of Dementia: A Systematic Review and Meta-Analysis. Neurology, 99(15), e1651–e1663. Advance online publication. <a href='https://doi.org/10.1212/WNL.0000000000200929'>https://doi.org/10.1212/WNL.0000000000200929</a></li>
</ul>
<p>Guest: Jill M. Terrien PhD, ANP-BC 
 
Music Credit: Richard Onorato</p>
]]></description>
                                                            <content:encoded><![CDATA[<p>Credits: 0.25 AMA PRA Category 1 Credit™<br>
 <br>
CME/CE Information and Claim Credit: <a href='https://www.pri-med.com/online-cme-ce/podcast/frankly-speaking-cme-ep-355'>https://www.pri-med.com/online-cme-ce/podcast/frankly-speaking-cme-ep-355</a></p>
<p>Overview: Discover how primary care providers can actively combat dementia risk in aging patients. In this episode, expert faculty explore recent studies revealing the benefits of dementia prevention and evidence-based activities for reducing risks. Learn how to provide encouragement and social activity prescriptions during visits, and gain essential knowledge to preserve cognitive function, ultimately improving patient care and quality of life.</p>
<p>Episode resource links:</p>
<ul><li>Cho, G., Betensky, R. A., &amp; Chang, V. W. (2023). Internet usage and the prospective risk of dementia: A population-based cohort study. Journal of the American Geriatrics Society, 71(8), 2419–2429. https://doi.org/10.1111/jgs.18394</li>
<li>Raichlen DA, Aslan DH, Sayre MK, et al. (2023). Sedentary Behavior and Incident Dementia Among Older Adults. JAMA. 330(10):934–940. <a href='https://doi:10'>https://doi:10.1001/jama.2023.15231</a></li>
<li>Su, S., Shi, L., Zheng, Y., Sun, Y., Huang, X., Zhang, A., Que, J., Sun, X., Shi, J., Bao, Y., Deng, J., &amp; Lu, L. (2022). Leisure Activities and the Risk of Dementia: A Systematic Review and Meta-Analysis. Neurology, 99(15), e1651–e1663. Advance online publication. <a href='https://doi.org/10.1212/WNL.0000000000200929'>https://doi.org/10.1212/WNL.0000000000200929</a></li>
</ul>
<p>Guest: Jill M. Terrien PhD, ANP-BC <br>
 <br>
Music Credit: Richard Onorato</p>
]]></content:encoded>
                                    
        <enclosure url="https://mcdn.podbean.com/mf/web/pv7mb5/frankly-speaking-355-movement-for-dementia.mp3" length="12101700" type="audio/mpeg"/>
                <itunes:summary><![CDATA[Credits: 0.25 AMA PRA Category 1 Credit™ CME/CE Information and Claim Credit: https://www.pri-med.com/online-cme-ce/podcast/frankly-speaking-cme-ep-355
Overview: Discover how primary care providers can actively combat dementia risk in aging patients. In this episode, expert faculty explore recent studies revealing the benefits of dementia prevention and evidence-based activities for reducing risks. Learn how to provide encouragement and social activity prescriptions during visits, and gain essential knowledge to preserve cognitive function, ultimately improving patient care and quality of life.
Episode resource links:
Cho, G., Betensky, R. A., &amp; Chang, V. W. (2023). Internet usage and the prospective risk of dementia: A population-based cohort study. Journal of the American Geriatrics Society, 71(8), 2419–2429. https://doi.org/10.1111/jgs.18394
Raichlen DA, Aslan DH, Sayre MK, et al. (2023). Sedentary Behavior and Incident Dementia Among Older Adults. JAMA. 330(10):934–940. https://doi:10.1001/jama.2023.15231
Su, S., Shi, L., Zheng, Y., Sun, Y., Huang, X., Zhang, A., Que, J., Sun, X., Shi, J., Bao, Y., Deng, J., &amp; Lu, L. (2022). Leisure Activities and the Risk of Dementia: A Systematic Review and Meta-Analysis. Neurology, 99(15), e1651–e1663. Advance online publication. https://doi.org/10.1212/WNL.0000000000200929
Guest: Jill M. Terrien PhD, ANP-BC  Music Credit: Richard Onorato]]></itunes:summary>
        <itunes:author>Pri-Med</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>754</itunes:duration>
                        <itunes:episodeType>full</itunes:episodeType>
            </item>
    <item>
        <title>Clearing the Air: Are Antibiotics Necessary for Childhood Sinusitis? - Frankly Speaking Ep 354</title>
        <itunes:title>Clearing the Air: Are Antibiotics Necessary for Childhood Sinusitis? - Frankly Speaking Ep 354</itunes:title>
        <link>https://primedfranklyspeaking.podbean.com/e/clearing-the-air-are-antibiotics-necessary-for-childhood-sinusitis-frankly-speaking-ep-354/</link>
                    <comments>https://primedfranklyspeaking.podbean.com/e/clearing-the-air-are-antibiotics-necessary-for-childhood-sinusitis-frankly-speaking-ep-354/#comments</comments>        <pubDate>Mon, 13 Nov 2023 00:30:00 +0000</pubDate>
        <guid isPermaLink="false">primedfranklyspeaking.podbean.com/de727b31-8f28-3db2-8640-8ec06386f117</guid>
                                    <description><![CDATA[<p>Credits: 0.25 AMA PRA Category 1 Credit™
 
CME/CE Information and Claim Credit: <a href='https://www.pri-med.com/online-education/podcast/frankly-speaking-cme-354'>https://www.pri-med.com/online-education/podcast/frankly-speaking-cme-354</a></p>
<p>Overview: There is an overlap of acute sinusitis symptoms and viral upper respiratory tract infection, such that many children are treated unnecessarily with antibiotics. In this episode, we review 2 recent studies that inform recommendations on whether or not to treat childhood sinusitis with amoxicillin/clavulanate. Gain practical strategies and the confidence to appropriately address sinusitis in the children you treat.</p>
<p>Episode resource links:</p>
<ul><li>JAMA. 2023;330(4):349-358. doi:10.1001/jama.2023.10854</li>
<li>JAMA. 2023;330(11):1064-1073. doi:10.1001/jama.2023.15503</li>
<li>Journal of Pediatrics, The, 2019-04-01, Volume 207, Pages 103-108.e1</li>
</ul>
<p>Guest: Robert A. Baldor MD, FAAFP
 
Music Credit: Richard Onorato</p>
]]></description>
                                                            <content:encoded><![CDATA[<p>Credits: 0.25 AMA PRA Category 1 Credit™<br>
 <br>
CME/CE Information and Claim Credit: <a href='https://www.pri-med.com/online-education/podcast/frankly-speaking-cme-354'>https://www.pri-med.com/online-education/podcast/frankly-speaking-cme-354</a></p>
<p>Overview: There is an overlap of acute sinusitis symptoms and viral upper respiratory tract infection, such that many children are treated unnecessarily with antibiotics. In this episode, we review 2 recent studies that inform recommendations on whether or not to treat childhood sinusitis with amoxicillin/clavulanate. Gain practical strategies and the confidence to appropriately address sinusitis in the children you treat.</p>
<p>Episode resource links:</p>
<ul><li>JAMA. 2023;330(4):349-358. doi:10.1001/jama.2023.10854</li>
<li>JAMA. 2023;330(11):1064-1073. doi:10.1001/jama.2023.15503</li>
<li>Journal of Pediatrics, The, 2019-04-01, Volume 207, Pages 103-108.e1</li>
</ul>
<p>Guest: Robert A. Baldor MD, FAAFP<br>
 <br>
Music Credit: Richard Onorato</p>
]]></content:encoded>
                                    
        <enclosure url="https://mcdn.podbean.com/mf/web/y5pzeg/frankly-speaking-354-childhood-sinusitis.mp3" length="11490489" type="audio/mpeg"/>
                <itunes:summary><![CDATA[Credits: 0.25 AMA PRA Category 1 Credit™ CME/CE Information and Claim Credit: https://www.pri-med.com/online-education/podcast/frankly-speaking-cme-354
Overview: There is an overlap of acute sinusitis symptoms and viral upper respiratory tract infection, such that many children are treated unnecessarily with antibiotics. In this episode, we review 2 recent studies that inform recommendations on whether or not to treat childhood sinusitis with amoxicillin/clavulanate. Gain practical strategies and the confidence to appropriately address sinusitis in the children you treat.
Episode resource links:
JAMA. 2023;330(4):349-358. doi:10.1001/jama.2023.10854
JAMA. 2023;330(11):1064-1073. doi:10.1001/jama.2023.15503
Journal of Pediatrics, The, 2019-04-01, Volume 207, Pages 103-108.e1
Guest: Robert A. Baldor MD, FAAFP Music Credit: Richard Onorato]]></itunes:summary>
        <itunes:author>Pri-Med</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>716</itunes:duration>
                        <itunes:episodeType>full</itunes:episodeType>
            </item>
    <item>
        <title>RSV in Infants: An Ounce of Prevention - Frankly Speaking Ep 353</title>
        <itunes:title>RSV in Infants: An Ounce of Prevention - Frankly Speaking Ep 353</itunes:title>
        <link>https://primedfranklyspeaking.podbean.com/e/rsv-in-infants-an-ounce-of-prevention-frankly-speaking-ep-353/</link>
                    <comments>https://primedfranklyspeaking.podbean.com/e/rsv-in-infants-an-ounce-of-prevention-frankly-speaking-ep-353/#comments</comments>        <pubDate>Mon, 06 Nov 2023 00:30:00 +0000</pubDate>
        <guid isPermaLink="false">primedfranklyspeaking.podbean.com/787203b7-2fea-39a3-bd26-60a0dcc97094</guid>
                                    <description><![CDATA[<p>Credits: 0.25 AMA PRA Category 1 Credit™
 
CME/CE Information and Claim Credit: <a href='https://www.pri-med.com/online-education/podcast/frankly-speaking-cme-353'>https://www.pri-med.com/online-education/podcast/frankly-speaking-cme-353</a></p>
<p>Overview: Bronchiolitis caused by respiratory syncytial virus (RSV) infection in infants is common and can lead to hospitalization if severe. There are now 2 ways to prevent this: immunizing the mother during pregnancy or giving monoclonal antibodies. Listen in as we discuss the recommendations for RSV prevention and how to best incorporate them into your practice.</p>
<p>Episode resource links:</p>
<ul><li>Fleming-Dutra KE, Jones JM, Roper LE, et al. Use of the Pfizer Respiratory Syncytial Virus Vaccine During Pregnancy for the Prevention of Respiratory Syncytial Virus–Associated Lower Respiratory Tract Disease in Infants: Recommendations of the Advisory Committee on Immunization Practices — United States, 2023. MMWR Morb Mortal Wkly Rep 2023;72:1115–1122.</li>
<li>Jones JM, Fleming-Dutra KE, Prill MM, et al. Use of Nirsevimab for the Prevention of Respiratory Syncytial Virus Disease Among Infants and Young Children: Recommendations of the Advisory Committee on Immunization Practices — United States, 2023. MMWR Morb Mortal Wkly Rep 2023;72:920–925</li>
<li>Kampmann B, Madhi SA, Munjal I, et al. Bivalent Prefusion F Vaccine in Pregnancy to Prevent RSV Illness in Infants. N Engl J Med. 2023;388(16):1451-1464.</li>
</ul>
<p>Guest: Alan M. Ehrlich MD, FAAFP
 
Music Credit: Richard Onorato</p>
]]></description>
                                                            <content:encoded><![CDATA[<p>Credits: 0.25 AMA PRA Category 1 Credit™<br>
 <br>
CME/CE Information and Claim Credit: <a href='https://www.pri-med.com/online-education/podcast/frankly-speaking-cme-353'>https://www.pri-med.com/online-education/podcast/frankly-speaking-cme-353</a></p>
<p>Overview: Bronchiolitis caused by respiratory syncytial virus (RSV) infection in infants is common and can lead to hospitalization if severe. There are now 2 ways to prevent this: immunizing the mother during pregnancy or giving monoclonal antibodies. Listen in as we discuss the recommendations for RSV prevention and how to best incorporate them into your practice.</p>
<p>Episode resource links:</p>
<ul><li>Fleming-Dutra KE, Jones JM, Roper LE, et al. Use of the Pfizer Respiratory Syncytial Virus Vaccine During Pregnancy for the Prevention of Respiratory Syncytial Virus–Associated Lower Respiratory Tract Disease in Infants: Recommendations of the Advisory Committee on Immunization Practices — United States, 2023. MMWR Morb Mortal Wkly Rep 2023;72:1115–1122.</li>
<li>Jones JM, Fleming-Dutra KE, Prill MM, et al. Use of Nirsevimab for the Prevention of Respiratory Syncytial Virus Disease Among Infants and Young Children: Recommendations of the Advisory Committee on Immunization Practices — United States, 2023. MMWR Morb Mortal Wkly Rep 2023;72:920–925</li>
<li>Kampmann B, Madhi SA, Munjal I, et al. Bivalent Prefusion F Vaccine in Pregnancy to Prevent RSV Illness in Infants. N Engl J Med. 2023;388(16):1451-1464.</li>
</ul>
<p>Guest: Alan M. Ehrlich MD, FAAFP<br>
 <br>
Music Credit: Richard Onorato</p>
]]></content:encoded>
                                    
        <enclosure url="https://mcdn.podbean.com/mf/web/fnwcvz/frankly-speaking-353-rsv-infants.mp3" length="8037145" type="audio/mpeg"/>
                <itunes:summary><![CDATA[Credits: 0.25 AMA PRA Category 1 Credit™ CME/CE Information and Claim Credit: https://www.pri-med.com/online-education/podcast/frankly-speaking-cme-353
Overview: Bronchiolitis caused by respiratory syncytial virus (RSV) infection in infants is common and can lead to hospitalization if severe. There are now 2 ways to prevent this: immunizing the mother during pregnancy or giving monoclonal antibodies. Listen in as we discuss the recommendations for RSV prevention and how to best incorporate them into your practice.
Episode resource links:
Fleming-Dutra KE, Jones JM, Roper LE, et al. Use of the Pfizer Respiratory Syncytial Virus Vaccine During Pregnancy for the Prevention of Respiratory Syncytial Virus–Associated Lower Respiratory Tract Disease in Infants: Recommendations of the Advisory Committee on Immunization Practices — United States, 2023. MMWR Morb Mortal Wkly Rep 2023;72:1115–1122.
Jones JM, Fleming-Dutra KE, Prill MM, et al. Use of Nirsevimab for the Prevention of Respiratory Syncytial Virus Disease Among Infants and Young Children: Recommendations of the Advisory Committee on Immunization Practices — United States, 2023. MMWR Morb Mortal Wkly Rep 2023;72:920–925
Kampmann B, Madhi SA, Munjal I, et al. Bivalent Prefusion F Vaccine in Pregnancy to Prevent RSV Illness in Infants. N Engl J Med. 2023;388(16):1451-1464.
Guest: Alan M. Ehrlich MD, FAAFP Music Credit: Richard Onorato]]></itunes:summary>
        <itunes:author>Pri-Med</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>500</itunes:duration>
                        <itunes:episodeType>full</itunes:episodeType>
            </item>
    <item>
        <title>From Hype to Hope: COVID-19 Outpatient Treatment Recommendations - Frankly Speaking Ep 352</title>
        <itunes:title>From Hype to Hope: COVID-19 Outpatient Treatment Recommendations - Frankly Speaking Ep 352</itunes:title>
        <link>https://primedfranklyspeaking.podbean.com/e/from-hype-to-hope-covid-19-outpatient-treatment-recommendations-frankly-speaking-ep-352/</link>
                    <comments>https://primedfranklyspeaking.podbean.com/e/from-hype-to-hope-covid-19-outpatient-treatment-recommendations-frankly-speaking-ep-352/#comments</comments>        <pubDate>Mon, 30 Oct 2023 00:30:00 +0000</pubDate>
        <guid isPermaLink="false">primedfranklyspeaking.podbean.com/f98bc113-2791-3f53-b233-c8de92f550dc</guid>
                                    <description><![CDATA[<p>Credits: 0.25 AMA PRA Category 1 Credit™
 
CME/CE Information and Claim Credit: <a href='https://www.pri-med.com/online-education/podcast/frankly-speaking-cme-352'>https://www.pri-med.com/online-education/podcast/frankly-speaking-cme-352</a></p>
<p>Overview: Keep your practice at the forefront of outpatient COVID-19 management with this informative episode. Listen in as expert faculty discuss the latest recommendations and review ineffective treatments, helping you provide the best care during this new phase of the endemic.</p>
<p>Episode resource links:</p>
<ul><li><a href='https://www.covid19treatmentguidelines.nih.gov/management/clinical-management-of-adults/clinical-management-of-adults-summary/?utm_source=site&amp;utm_medium=home&amp;utm_campaign=highlights'>https://www.covid19treatmentguidelines.nih.gov/management/clinical-management-of-adults/clinical-management-of-adults-summary/?utm_source=site&amp;utm_medium=home&amp;utm_campaign=highlights</a></li>
<li>Abdool Karim, S. S., &amp; Devnarain, N. (2022). Time to stop using ineffective COVID-19 drugs. New England Journal of Medicine, 387(7), 654-655.</li>
<li>Hayden, M. K., Hanson, K. E., Englund, J. A., Lee, F., Lee, M. J., Loeb, M., ... &amp; Mustafa, R. A. (2023). The Infectious Diseases Society of America guidelines on the diagnosis of COVID-19: antigen testing. Clinical Infectious Diseases, ciad032.</li>
</ul>
<p>Guest: Mariyan L. Montaque, DNP, FNP-BC
 
Music Credit: Richard Onorato</p>
]]></description>
                                                            <content:encoded><![CDATA[<p>Credits: 0.25 AMA PRA Category 1 Credit™<br>
 <br>
CME/CE Information and Claim Credit: <a href='https://www.pri-med.com/online-education/podcast/frankly-speaking-cme-352'>https://www.pri-med.com/online-education/podcast/frankly-speaking-cme-352</a></p>
<p>Overview: Keep your practice at the forefront of outpatient COVID-19 management with this informative episode. Listen in as expert faculty discuss the latest recommendations and review ineffective treatments, helping you provide the best care during this new phase of the endemic.</p>
<p>Episode resource links:</p>
<ul><li><a href='https://www.covid19treatmentguidelines.nih.gov/management/clinical-management-of-adults/clinical-management-of-adults-summary/?utm_source=site&amp;utm_medium=home&amp;utm_campaign=highlights'>https://www.covid19treatmentguidelines.nih.gov/management/clinical-management-of-adults/clinical-management-of-adults-summary/?utm_source=site&amp;utm_medium=home&amp;utm_campaign=highlights</a></li>
<li>Abdool Karim, S. S., &amp; Devnarain, N. (2022). Time to stop using ineffective COVID-19 drugs. New England Journal of Medicine, 387(7), 654-655.</li>
<li>Hayden, M. K., Hanson, K. E., Englund, J. A., Lee, F., Lee, M. J., Loeb, M., ... &amp; Mustafa, R. A. (2023). The Infectious Diseases Society of America guidelines on the diagnosis of COVID-19: antigen testing. Clinical Infectious Diseases, ciad032.</li>
</ul>
<p>Guest: Mariyan L. Montaque, DNP, FNP-BC<br>
 <br>
Music Credit: Richard Onorato</p>
]]></content:encoded>
                                    
        <enclosure url="https://mcdn.podbean.com/mf/web/9k4hnq/frankly-speaking-352-covid-treatment.mp3" length="11139575" type="audio/mpeg"/>
                <itunes:summary><![CDATA[Credits: 0.25 AMA PRA Category 1 Credit™ CME/CE Information and Claim Credit: https://www.pri-med.com/online-education/podcast/frankly-speaking-cme-352
Overview: Keep your practice at the forefront of outpatient COVID-19 management with this informative episode. Listen in as expert faculty discuss the latest recommendations and review ineffective treatments, helping you provide the best care during this new phase of the endemic.
Episode resource links:
https://www.covid19treatmentguidelines.nih.gov/management/clinical-management-of-adults/clinical-management-of-adults-summary/?utm_source=site&amp;utm_medium=home&amp;utm_campaign=highlights
Abdool Karim, S. S., &amp; Devnarain, N. (2022). Time to stop using ineffective COVID-19 drugs. New England Journal of Medicine, 387(7), 654-655.
Hayden, M. K., Hanson, K. E., Englund, J. A., Lee, F., Lee, M. J., Loeb, M., ... &amp; Mustafa, R. A. (2023). The Infectious Diseases Society of America guidelines on the diagnosis of COVID-19: antigen testing. Clinical Infectious Diseases, ciad032.
Guest: Mariyan L. Montaque, DNP, FNP-BC Music Credit: Richard Onorato]]></itunes:summary>
        <itunes:author>Pri-Med</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>694</itunes:duration>
                        <itunes:episodeType>full</itunes:episodeType>
            </item>
    <item>
        <title>Screen Time and Developmental Delays in Children - Frankly Speaking Ep 351</title>
        <itunes:title>Screen Time and Developmental Delays in Children - Frankly Speaking Ep 351</itunes:title>
        <link>https://primedfranklyspeaking.podbean.com/e/screen-time-and-developmental-delays-in-children-frankly-speaking-ep-351/</link>
                    <comments>https://primedfranklyspeaking.podbean.com/e/screen-time-and-developmental-delays-in-children-frankly-speaking-ep-351/#comments</comments>        <pubDate>Mon, 23 Oct 2023 00:30:00 +0000</pubDate>
        <guid isPermaLink="false">primedfranklyspeaking.podbean.com/60a3ecbb-5b30-34e7-9f25-ef3e98564272</guid>
                                    <description><![CDATA[<p>Credits: 0.25 AMA PRA Category 1 Credit™
 
CME/CE Information and Claim Credit: <a href='https://www.pri-med.com/online-education/podcast/frankly-speaking-cme-351'>https://www.pri-med.com/online-education/podcast/frankly-speaking-cme-351</a></p>
<p>Overview: Live at Pri-Med East! In this episode, we will examine the association of developmental delays with amount of screen time in children.</p>
<p>Episode resource links:</p>
<ul><li><a href='https://jamanetwork.com/journals/jamapediatrics/fullarticle/2808593'>https://jamanetwork.com/journals/jamapediatrics/fullarticle/2808593</a></li>
<li><a href='https://www.aap.org/en/patient-care/media-and-children/center-of-excellence-on-social-media-and-youth-mental-health/social-media-and-youth-mental-health-q-and-a-portal/middle-childhood/middle-childhood-questions/screen-time-guidelines/'>https://www.aap.org/en/patient-care/media-and-children/center-of-excellence-on-social-media-and-youth-mental-health/social-media-and-youth-mental-health-q-and-a-portal/middle-childhood/middle-childhood-questions/screen-time-guidelines/</a></li>
<li><a href='https://www.aacap.org/AACAP/Families_and_Youth/Facts_for_Families/FFF-Guide/Children-And-Watching-TV-054.aspx'>https://www.aacap.org/AACAP/Families_and_Youth/Facts_for_Families/FFF-Guide/Children-And-Watching-TV-054.aspx</a></li>
</ul>
<p>Guest: Jillian Joseph, MSPAS, PA-C

Music Credit: Richard Onorato</p>
]]></description>
                                                            <content:encoded><![CDATA[<p>Credits: 0.25 AMA PRA Category 1 Credit™<br>
 <br>
CME/CE Information and Claim Credit: <a href='https://www.pri-med.com/online-education/podcast/frankly-speaking-cme-351'>https://www.pri-med.com/online-education/podcast/frankly-speaking-cme-351</a></p>
<p>Overview: Live at Pri-Med East! In this episode, we will examine the association of developmental delays with amount of screen time in children.</p>
<p>Episode resource links:</p>
<ul><li><a href='https://jamanetwork.com/journals/jamapediatrics/fullarticle/2808593'>https://jamanetwork.com/journals/jamapediatrics/fullarticle/2808593</a></li>
<li><a href='https://www.aap.org/en/patient-care/media-and-children/center-of-excellence-on-social-media-and-youth-mental-health/social-media-and-youth-mental-health-q-and-a-portal/middle-childhood/middle-childhood-questions/screen-time-guidelines/'>https://www.aap.org/en/patient-care/media-and-children/center-of-excellence-on-social-media-and-youth-mental-health/social-media-and-youth-mental-health-q-and-a-portal/middle-childhood/middle-childhood-questions/screen-time-guidelines/</a></li>
<li><a href='https://www.aacap.org/AACAP/Families_and_Youth/Facts_for_Families/FFF-Guide/Children-And-Watching-TV-054.aspx'>https://www.aacap.org/AACAP/Families_and_Youth/Facts_for_Families/FFF-Guide/Children-And-Watching-TV-054.aspx</a></li>
</ul>
<p>Guest: Jillian Joseph, MSPAS, PA-C<br>
<br>
Music Credit: Richard Onorato</p>
]]></content:encoded>
                                    
        <enclosure url="https://mcdn.podbean.com/mf/web/x67nfu/frankly-speaking-351-screentime-primed-east.mp3" length="9180368" type="audio/mpeg"/>
                <itunes:summary><![CDATA[Credits: 0.25 AMA PRA Category 1 Credit™ CME/CE Information and Claim Credit: https://www.pri-med.com/online-education/podcast/frankly-speaking-cme-351
Overview: Live at Pri-Med East! In this episode, we will examine the association of developmental delays with amount of screen time in children.
Episode resource links:
https://jamanetwork.com/journals/jamapediatrics/fullarticle/2808593
https://www.aap.org/en/patient-care/media-and-children/center-of-excellence-on-social-media-and-youth-mental-health/social-media-and-youth-mental-health-q-and-a-portal/middle-childhood/middle-childhood-questions/screen-time-guidelines/
https://www.aacap.org/AACAP/Families_and_Youth/Facts_for_Families/FFF-Guide/Children-And-Watching-TV-054.aspx
Guest: Jillian Joseph, MSPAS, PA-CMusic Credit: Richard Onorato]]></itunes:summary>
        <itunes:author>Pri-Med</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>572</itunes:duration>
                        <itunes:episodeType>full</itunes:episodeType>
            </item>
    <item>
        <title>Cracking into the Evidence: Does Eating Nuts Affect Cognitive Performance? - Frankly Speaking Ep 350</title>
        <itunes:title>Cracking into the Evidence: Does Eating Nuts Affect Cognitive Performance? - Frankly Speaking Ep 350</itunes:title>
        <link>https://primedfranklyspeaking.podbean.com/e/cracking-into-the-evidence-does-eating-nuts-affect-cognitive-performance-frankly-speaking-ep-350/</link>
                    <comments>https://primedfranklyspeaking.podbean.com/e/cracking-into-the-evidence-does-eating-nuts-affect-cognitive-performance-frankly-speaking-ep-350/#comments</comments>        <pubDate>Mon, 16 Oct 2023 11:01:07 +0000</pubDate>
        <guid isPermaLink="false">primedfranklyspeaking.podbean.com/ea82b398-8374-378f-8903-ef2e519d4e1d</guid>
                                    <description><![CDATA[<p>Credits: 0.25 AMA PRA Category 1 Credit™
 
CME/CE Information and Claim Credit: <a href='https://www.pri-med.com/online-education/podcast/frankly-speaking-cme-350'>https://www.pri-med.com/online-education/podcast/frankly-speaking-cme-350</a></p>
<p>Overview: Nuts have a reputation for providing a variety of health benefits, but how far do their nutritional superpowers reach? In this episode, we take a look at the findings of a study showing the association between nut consumption and cognitive performance. Listen in as expert faculty discuss the implications for managing patients at risk for cognitive decline.</p>
<p>Episode resource links:</p>
<ul><li>The American Journal of Clinical Nutrition <a href='https://doi.org/10.1016/j.ajcnut.2023.05.032'>https://doi.org/10.1016/j.ajcnut.2023.05.032</a></li>
</ul>
<p>Guest: Robert A. Baldor MD, FAAFP
 
Music Credit: Richard Onorato</p>
]]></description>
                                                            <content:encoded><![CDATA[<p>Credits: 0.25 AMA PRA Category 1 Credit™<br>
 <br>
CME/CE Information and Claim Credit: <a href='https://www.pri-med.com/online-education/podcast/frankly-speaking-cme-350'>https://www.pri-med.com/online-education/podcast/frankly-speaking-cme-350</a></p>
<p>Overview: Nuts have a reputation for providing a variety of health benefits, but how far do their nutritional superpowers reach? In this episode, we take a look at the findings of a study showing the association between nut consumption and cognitive performance. Listen in as expert faculty discuss the implications for managing patients at risk for cognitive decline.</p>
<p>Episode resource links:</p>
<ul><li>The American Journal of Clinical Nutrition <a href='https://doi.org/10.1016/j.ajcnut.2023.05.032'>https://doi.org/10.1016/j.ajcnut.2023.05.032</a></li>
</ul>
<p>Guest: Robert A. Baldor MD, FAAFP<br>
 <br>
Music Credit: Richard Onorato</p>
]]></content:encoded>
                                    
        <enclosure url="https://mcdn.podbean.com/mf/web/gtmzi7/frankly-speaking-350-nuts-for-memory.mp3" length="8943555" type="audio/mpeg"/>
                <itunes:summary><![CDATA[Credits: 0.25 AMA PRA Category 1 Credit™ CME/CE Information and Claim Credit: https://www.pri-med.com/online-education/podcast/frankly-speaking-cme-350
Overview: Nuts have a reputation for providing a variety of health benefits, but how far do their nutritional superpowers reach? In this episode, we take a look at the findings of a study showing the association between nut consumption and cognitive performance. Listen in as expert faculty discuss the implications for managing patients at risk for cognitive decline.
Episode resource links:
The American Journal of Clinical Nutrition https://doi.org/10.1016/j.ajcnut.2023.05.032
Guest: Robert A. Baldor MD, FAAFP Music Credit: Richard Onorato]]></itunes:summary>
        <itunes:author>Pri-Med</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>557</itunes:duration>
                        <itunes:episodeType>full</itunes:episodeType>
            </item>
    <item>
        <title>Bariatric Surgery: A Great Option to Lower Breast Cancer Risk - Frankly Speaking Ep 349</title>
        <itunes:title>Bariatric Surgery: A Great Option to Lower Breast Cancer Risk - Frankly Speaking Ep 349</itunes:title>
        <link>https://primedfranklyspeaking.podbean.com/e/bariatric-surgery-a-great-option-to-lower-breast-cancer-risk-frankly-speaking-ep-349/</link>
                    <comments>https://primedfranklyspeaking.podbean.com/e/bariatric-surgery-a-great-option-to-lower-breast-cancer-risk-frankly-speaking-ep-349/#comments</comments>        <pubDate>Mon, 09 Oct 2023 00:30:00 +0000</pubDate>
        <guid isPermaLink="false">primedfranklyspeaking.podbean.com/df7d56dd-5302-3f8d-ab14-b4ed094c1e77</guid>
                                    <description><![CDATA[<p>Credits: 0.25 AMA PRA Category 1 Credit™
 
CME/CE Information and Claim Credit: <a href='https://www.pri-med.com/online-education/podcast/frankly-speaking-cme-349'>https://www.pri-med.com/online-education/podcast/frankly-speaking-cme-349</a></p>
<p>Overview: Recent observational data has shown the potential for bariatric surgery to lower breast cancer risk in women with obesity. Tune in as faculty discuss what the evidence says about this connection and when to consider exploring the option for your patients’ weight-loss management.</p>
<p>Episode resource links:</p>
<ul><li>AMA Surg. 2023 Jun 1;158(6):634-641. doi: 10.1001/jamasurg.2023.0530.</li>
<li>J Natl Cancer Inst. 2003;95(16):1218.</li>
<li>J Natl Cancer Inst. 2015;107(2) Epub 2015 Mar 10. </li>
</ul>
<p>Guest: Robert A. Baldor MD, FAAFP
 
Music Credit: Richard Onorato</p>
]]></description>
                                                            <content:encoded><![CDATA[<p>Credits: 0.25 AMA PRA Category 1 Credit™<br>
 <br>
CME/CE Information and Claim Credit: <a href='https://www.pri-med.com/online-education/podcast/frankly-speaking-cme-349'>https://www.pri-med.com/online-education/podcast/frankly-speaking-cme-349</a></p>
<p>Overview: Recent observational data has shown the potential for bariatric surgery to lower breast cancer risk in women with obesity. Tune in as faculty discuss what the evidence says about this connection and when to consider exploring the option for your patients’ weight-loss management.</p>
<p>Episode resource links:</p>
<ul><li>AMA Surg. 2023 Jun 1;158(6):634-641. doi: 10.1001/jamasurg.2023.0530.</li>
<li>J Natl Cancer Inst. 2003;95(16):1218.</li>
<li>J Natl Cancer Inst. 2015;107(2) Epub 2015 Mar 10. </li>
</ul>
<p>Guest: Robert A. Baldor MD, FAAFP<br>
 <br>
Music Credit: Richard Onorato</p>
]]></content:encoded>
                                    
        <enclosure url="https://mcdn.podbean.com/mf/web/ttnxpt/frankly-speaking-349-bariatric-surgery-breast-cancer.mp3" length="9950009" type="audio/mpeg"/>
                <itunes:summary><![CDATA[Credits: 0.25 AMA PRA Category 1 Credit™ CME/CE Information and Claim Credit: https://www.pri-med.com/online-education/podcast/frankly-speaking-cme-349
Overview: Recent observational data has shown the potential for bariatric surgery to lower breast cancer risk in women with obesity. Tune in as faculty discuss what the evidence says about this connection and when to consider exploring the option for your patients’ weight-loss management.
Episode resource links:
AMA Surg. 2023 Jun 1;158(6):634-641. doi: 10.1001/jamasurg.2023.0530.
J Natl Cancer Inst. 2003;95(16):1218.
J Natl Cancer Inst. 2015;107(2) Epub 2015 Mar 10. 
Guest: Robert A. Baldor MD, FAAFP Music Credit: Richard Onorato]]></itunes:summary>
        <itunes:author>Pri-Med</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>620</itunes:duration>
                        <itunes:episodeType>full</itunes:episodeType>
            </item>
    <item>
        <title>Smart Prevention: Wearable Devices and Stroke Defense - Frankly Speaking Ep 348</title>
        <itunes:title>Smart Prevention: Wearable Devices and Stroke Defense - Frankly Speaking Ep 348</itunes:title>
        <link>https://primedfranklyspeaking.podbean.com/e/smart-prevention-wearable-devices-and-stroke-defense-frankly-speaking-ep-348/</link>
                    <comments>https://primedfranklyspeaking.podbean.com/e/smart-prevention-wearable-devices-and-stroke-defense-frankly-speaking-ep-348/#comments</comments>        <pubDate>Mon, 02 Oct 2023 00:30:00 +0000</pubDate>
        <guid isPermaLink="false">primedfranklyspeaking.podbean.com/7bde60e2-4ce4-3cbe-b99d-b05e260175ec</guid>
                                    <description><![CDATA[<p>Credits: 0.25 AMA PRA Category 1 Credit™
 
CME/CE Information and Claim Credit: <a href='https://www.pri-med.com/online-education/podcast/frankly-speaking-cme-348'>https://www.pri-med.com/online-education/podcast/frankly-speaking-cme-348</a></p>
<p>Overview: Discover how wearable fitness devices are transforming early detection of atrial fibrillation with their potential to reduce stroke risk. In this episode, we share insights on leveraging smartwatches to improve health outcomes and when to encourage their use in patient care.</p>
<p>Episode resource links:</p>
<ul><li>Bedi, A., Al Masri, M. K., Al Hennawi, H., Qadir, S., &amp; Ottman, P. (2023). The Integration of Artificial Intelligence Into Patient Care: A Case of Atrial Fibrillation Caught by a Smartwatch. Cureus, 15(3).</li>
<li>Long, K. Y., Shanmugam, K., &amp; Rana, M. E. (2023, January). An Evaluation of Smartwatch Contribution in Improving Human Health. In 2023 17th</li>
<li>International Conference on Ubiquitous Information Management and Communication (IMCOM) (pp. 1-4). IEEE.</li>
<li>Mattison, G., Canfell, O. J., Forrester, D., Dobbins, C., Smith, D., Reid, D., &amp; Sullivan, C. (2023). A step in the right direction: the potential role of smartwatches in supporting chronic disease prevention in health care. The Medical Journal of Australia, 218(9), 384-388.</li>
<li>Meza, C., Juega, J., Francisco, J., Santos, A., Duran, L., Rodriguez, M., ... &amp; Pagola, J. (2023). Accuracy of a Smartwatch to Assess Heart Rate Monitoring and Atrial Fibrillation in Stroke Patients. Sensors, 23(10), 4632.</li>
<li><a href='https://www.stroke.org/en/about-stroke/types-of-stroke/cryptogenic-stroke'>https://www.stroke.org/en/about-stroke/types-of-stroke/cryptogenic-stroke
</a>
 
</li>
</ul>
<p>Guest: Mariyan L. Montaque, DNP, FNP-BC
 
Music Credit: Richard Onorato</p>
]]></description>
                                                            <content:encoded><![CDATA[<p>Credits: 0.25 AMA PRA Category 1 Credit™<br>
 <br>
CME/CE Information and Claim Credit: <a href='https://www.pri-med.com/online-education/podcast/frankly-speaking-cme-348'>https://www.pri-med.com/online-education/podcast/frankly-speaking-cme-348</a></p>
<p>Overview: Discover how wearable fitness devices are transforming early detection of atrial fibrillation with their potential to reduce stroke risk. In this episode, we share insights on leveraging smartwatches to improve health outcomes and when to encourage their use in patient care.</p>
<p>Episode resource links:</p>
<ul><li>Bedi, A., Al Masri, M. K., Al Hennawi, H., Qadir, S., &amp; Ottman, P. (2023). The Integration of Artificial Intelligence Into Patient Care: A Case of Atrial Fibrillation Caught by a Smartwatch. Cureus, 15(3).</li>
<li>Long, K. Y., Shanmugam, K., &amp; Rana, M. E. (2023, January). An Evaluation of Smartwatch Contribution in Improving Human Health. In 2023 17th</li>
<li>International Conference on Ubiquitous Information Management and Communication (IMCOM) (pp. 1-4). IEEE.</li>
<li>Mattison, G., Canfell, O. J., Forrester, D., Dobbins, C., Smith, D., Reid, D., &amp; Sullivan, C. (2023). A step in the right direction: the potential role of smartwatches in supporting chronic disease prevention in health care. The Medical Journal of Australia, 218(9), 384-388.</li>
<li>Meza, C., Juega, J., Francisco, J., Santos, A., Duran, L., Rodriguez, M., ... &amp; Pagola, J. (2023). Accuracy of a Smartwatch to Assess Heart Rate Monitoring and Atrial Fibrillation in Stroke Patients. Sensors, 23(10), 4632.</li>
<li><a href='https://www.stroke.org/en/about-stroke/types-of-stroke/cryptogenic-stroke'>https://www.stroke.org/en/about-stroke/types-of-stroke/cryptogenic-stroke<br>
</a>
 
</li>
</ul>
<p>Guest: Mariyan L. Montaque, DNP, FNP-BC<br>
 <br>
Music Credit: Richard Onorato</p>
]]></content:encoded>
                                    
        <enclosure url="https://mcdn.podbean.com/mf/web/vjmt55/frankly-speaking-348-afib-smart-watches.mp3" length="8213214" type="audio/mpeg"/>
                <itunes:summary><![CDATA[Credits: 0.25 AMA PRA Category 1 Credit™ CME/CE Information and Claim Credit: https://www.pri-med.com/online-education/podcast/frankly-speaking-cme-348
Overview: Discover how wearable fitness devices are transforming early detection of atrial fibrillation with their potential to reduce stroke risk. In this episode, we share insights on leveraging smartwatches to improve health outcomes and when to encourage their use in patient care.
Episode resource links:
Bedi, A., Al Masri, M. K., Al Hennawi, H., Qadir, S., &amp; Ottman, P. (2023). The Integration of Artificial Intelligence Into Patient Care: A Case of Atrial Fibrillation Caught by a Smartwatch. Cureus, 15(3).
Long, K. Y., Shanmugam, K., &amp; Rana, M. E. (2023, January). An Evaluation of Smartwatch Contribution in Improving Human Health. In 2023 17th
International Conference on Ubiquitous Information Management and Communication (IMCOM) (pp. 1-4). IEEE.
Mattison, G., Canfell, O. J., Forrester, D., Dobbins, C., Smith, D., Reid, D., &amp; Sullivan, C. (2023). A step in the right direction: the potential role of smartwatches in supporting chronic disease prevention in health care. The Medical Journal of Australia, 218(9), 384-388.
Meza, C., Juega, J., Francisco, J., Santos, A., Duran, L., Rodriguez, M., ... &amp; Pagola, J. (2023). Accuracy of a Smartwatch to Assess Heart Rate Monitoring and Atrial Fibrillation in Stroke Patients. Sensors, 23(10), 4632.
https://www.stroke.org/en/about-stroke/types-of-stroke/cryptogenic-stroke
 

Guest: Mariyan L. Montaque, DNP, FNP-BC Music Credit: Richard Onorato]]></itunes:summary>
        <itunes:author>Pri-Med</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>511</itunes:duration>
                        <itunes:episodeType>full</itunes:episodeType>
            </item>
    <item>
        <title>A Wake-Up Call: Sleep Apnea’s Impact on Cognitive Health - Frankly Speaking Ep 347</title>
        <itunes:title>A Wake-Up Call: Sleep Apnea’s Impact on Cognitive Health - Frankly Speaking Ep 347</itunes:title>
        <link>https://primedfranklyspeaking.podbean.com/e/a-wake-up-call-sleep-apnea-s-impact-on-cognitive-health-frankly-speaking-ep-347/</link>
                    <comments>https://primedfranklyspeaking.podbean.com/e/a-wake-up-call-sleep-apnea-s-impact-on-cognitive-health-frankly-speaking-ep-347/#comments</comments>        <pubDate>Mon, 25 Sep 2023 00:30:00 +0000</pubDate>
        <guid isPermaLink="false">primedfranklyspeaking.podbean.com/fdd999b8-6756-3fac-9b44-c8ff395b960f</guid>
                                    <description><![CDATA[<p>Credits: 0.25 AMA PRA Category 1 Credit™
 
CME/CE Information and Claim Credit: <a href='https://www.pri-med.com/online-education/podcast/frankly-speaking-cme-347'>https://www.pri-med.com/online-education/podcast/frankly-speaking-cme-347</a></p>
<p>Overview: In this episode, we’re diving into recent research that uncovers a compelling link between obstructive sleep apnea and cognitive decline in older adults. Join expert faculty as they dissect the findings and provide invaluable insights to comprehensively address this connection in your practice.</p>
<p>Episode resource links:</p>
<ul><li>Discuss recent evidence that links obstructive sleep apnea (OSA) to cognitive decline risk in older people</li>
<li>Describe ways to incorporate this new evidence to identify OSA and reduce the risk of cognitive decline </li>
</ul>
<p>Guest: Susan Feeney, DNP, FNP-BC, NP-C
 
Music Credit: Richard Onorato</p>
]]></description>
                                                            <content:encoded><![CDATA[<p>Credits: 0.25 AMA PRA Category 1 Credit™<br>
 <br>
CME/CE Information and Claim Credit: <a href='https://www.pri-med.com/online-education/podcast/frankly-speaking-cme-347'>https://www.pri-med.com/online-education/podcast/frankly-speaking-cme-347</a></p>
<p>Overview: In this episode, we’re diving into recent research that uncovers a compelling link between obstructive sleep apnea and cognitive decline in older adults. Join expert faculty as they dissect the findings and provide invaluable insights to comprehensively address this connection in your practice.</p>
<p>Episode resource links:</p>
<ul><li>Discuss recent evidence that links obstructive sleep apnea (OSA) to cognitive decline risk in older people</li>
<li>Describe ways to incorporate this new evidence to identify OSA and reduce the risk of cognitive decline </li>
</ul>
<p>Guest: Susan Feeney, DNP, FNP-BC, NP-C<br>
 <br>
Music Credit: Richard Onorato</p>
]]></content:encoded>
                                    
        <enclosure url="https://mcdn.podbean.com/mf/web/pjujz7/frankly-speaking-347-sleep-apnea.mp3" length="9101556" type="audio/mpeg"/>
                <itunes:summary><![CDATA[Credits: 0.25 AMA PRA Category 1 Credit™ CME/CE Information and Claim Credit: https://www.pri-med.com/online-education/podcast/frankly-speaking-cme-347
Overview: In this episode, we’re diving into recent research that uncovers a compelling link between obstructive sleep apnea and cognitive decline in older adults. Join expert faculty as they dissect the findings and provide invaluable insights to comprehensively address this connection in your practice.
Episode resource links:
Discuss recent evidence that links obstructive sleep apnea (OSA) to cognitive decline risk in older people
Describe ways to incorporate this new evidence to identify OSA and reduce the risk of cognitive decline 
Guest: Susan Feeney, DNP, FNP-BC, NP-C Music Credit: Richard Onorato]]></itunes:summary>
        <itunes:author>Pri-Med</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>566</itunes:duration>
                        <itunes:episodeType>full</itunes:episodeType>
            </item>
    <item>
        <title>RSV Vaccine for Adults: Studies, Uses, and Patient Conversations - Frankly Speaking Ep 346</title>
        <itunes:title>RSV Vaccine for Adults: Studies, Uses, and Patient Conversations - Frankly Speaking Ep 346</itunes:title>
        <link>https://primedfranklyspeaking.podbean.com/e/rsv-vaccine-for-adults-studies-uses-and-patient-conversations-frankly-speaking-ep-346/</link>
                    <comments>https://primedfranklyspeaking.podbean.com/e/rsv-vaccine-for-adults-studies-uses-and-patient-conversations-frankly-speaking-ep-346/#comments</comments>        <pubDate>Mon, 18 Sep 2023 00:30:00 +0000</pubDate>
        <guid isPermaLink="false">primedfranklyspeaking.podbean.com/4c35760b-2335-3207-b4d3-6426849db49d</guid>
                                    <description><![CDATA[<p>Credits: 0.25 AMA PRA Category 1 Credit™
 
CME/CE Information and Claim Credit: <a href='https://www.pri-med.com/online-education/podcast/frankly-speaking-cme-346'>https://www.pri-med.com/online-education/podcast/frankly-speaking-cme-346</a></p>
<p>Overview: As we encounter more patients asking about the recent FDA approval of a new respiratory syncytial virus (RSV) vaccine for older adults, it’s crucial that we keep up to date. Join us as we review the supporting studies, indications, and precautions, giving you confidence in conversations with inquiring patients. </p>
<p>Episode resource links:</p>
<ul><li><a href='https://www.fda.gov/news-events/press-announcements/fda-approves-first-respiratory-syncytial-virus-rsv-vaccine'>https://www.fda.gov/news-events/press-announcements/fda-approves-first-respiratory-syncytial-virus-rsv-vaccine</a></li>
</ul>
<p>Guest: Robert A. Baldor MD, FAAFP
 
Music Credit: Richard Onorato</p>
]]></description>
                                                            <content:encoded><![CDATA[<p>Credits: 0.25 AMA PRA Category 1 Credit™<br>
 <br>
CME/CE Information and Claim Credit: <a href='https://www.pri-med.com/online-education/podcast/frankly-speaking-cme-346'>https://www.pri-med.com/online-education/podcast/frankly-speaking-cme-346</a></p>
<p>Overview: As we encounter more patients asking about the recent FDA approval of a new respiratory syncytial virus (RSV) vaccine for older adults, it’s crucial that we keep up to date. Join us as we review the supporting studies, indications, and precautions, giving you confidence in conversations with inquiring patients. </p>
<p>Episode resource links:</p>
<ul><li><a href='https://www.fda.gov/news-events/press-announcements/fda-approves-first-respiratory-syncytial-virus-rsv-vaccine'>https://www.fda.gov/news-events/press-announcements/fda-approves-first-respiratory-syncytial-virus-rsv-vaccine</a></li>
</ul>
<p>Guest: Robert A. Baldor MD, FAAFP<br>
 <br>
Music Credit: Richard Onorato</p>
]]></content:encoded>
                                    
        <enclosure url="https://mcdn.podbean.com/mf/web/ma9hy7/frankly-speaking-346-rsv-adults.mp3" length="10218908" type="audio/mpeg"/>
                <itunes:summary><![CDATA[Credits: 0.25 AMA PRA Category 1 Credit™ CME/CE Information and Claim Credit: https://www.pri-med.com/online-education/podcast/frankly-speaking-cme-346
Overview: As we encounter more patients asking about the recent FDA approval of a new respiratory syncytial virus (RSV) vaccine for older adults, it’s crucial that we keep up to date. Join us as we review the supporting studies, indications, and precautions, giving you confidence in conversations with inquiring patients. 
Episode resource links:
https://www.fda.gov/news-events/press-announcements/fda-approves-first-respiratory-syncytial-virus-rsv-vaccine
Guest: Robert A. Baldor MD, FAAFP Music Credit: Richard Onorato]]></itunes:summary>
        <itunes:author>Pri-Med</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>637</itunes:duration>
                        <itunes:episodeType>full</itunes:episodeType>
            </item>
    <item>
        <title>A Cool New Treatment for Hot Flashes? - Frankly Speaking Ep 345</title>
        <itunes:title>A Cool New Treatment for Hot Flashes? - Frankly Speaking Ep 345</itunes:title>
        <link>https://primedfranklyspeaking.podbean.com/e/a-cool-new-treatment-for-hot-flashes-frankly-speaking-ep-345/</link>
                    <comments>https://primedfranklyspeaking.podbean.com/e/a-cool-new-treatment-for-hot-flashes-frankly-speaking-ep-345/#comments</comments>        <pubDate>Mon, 11 Sep 2023 00:30:00 +0000</pubDate>
        <guid isPermaLink="false">primedfranklyspeaking.podbean.com/a5d6d0d5-1b73-3a2e-87fe-82fa39608259</guid>
                                    <description><![CDATA[<p>Credits: 0.25 AMA PRA Category 1 Credit™
 
CME/CE Information and Claim Credit: <a href='https://www.pri-med.com/online-education/podcast/frankly-speaking-cme-345'>https://www.pri-med.com/online-education/podcast/frankly-speaking-cme-345</a></p>
<p>Overview: In this episode, we discuss the findings of a recent Lancet publication on a novel neurokinin 3 (NK3) receptor antagonist for treating hot flashes. Tune in as we talk about how this nonhormonal treatment addresses menopausal hot flashes, the prescribing precautions issued by the FDA, and the implications for patients seeking your help with alleviating symptoms.</p>
<p>Episode resource links:</p>
<ul><li>Lancet 2023; 401: 1091–102. doi.org/10.1016/ S0140-6736(23)00085-5</li>
<li>Am Fam Physician. 2023;108(1):28-39</li>
</ul>
<p>Guest: Robert A. Baldor MD, FAAFP
 
Music Credit: Richard Onorato</p>
]]></description>
                                                            <content:encoded><![CDATA[<p>Credits: 0.25 AMA PRA Category 1 Credit™<br>
 <br>
CME/CE Information and Claim Credit: <a href='https://www.pri-med.com/online-education/podcast/frankly-speaking-cme-345'>https://www.pri-med.com/online-education/podcast/frankly-speaking-cme-345</a></p>
<p>Overview: In this episode, we discuss the findings of a recent Lancet publication on a novel neurokinin 3 (NK3) receptor antagonist for treating hot flashes. Tune in as we talk about how this nonhormonal treatment addresses menopausal hot flashes, the prescribing precautions issued by the FDA, and the implications for patients seeking your help with alleviating symptoms.</p>
<p>Episode resource links:</p>
<ul><li>Lancet 2023; 401: 1091–102. doi.org/10.1016/ S0140-6736(23)00085-5</li>
<li>Am Fam Physician. 2023;108(1):28-39</li>
</ul>
<p>Guest: Robert A. Baldor MD, FAAFP<br>
 <br>
Music Credit: Richard Onorato</p>
]]></content:encoded>
                                    
        <enclosure url="https://mcdn.podbean.com/mf/web/c4vrsb/frankly-speaking-345-hot-flashes.mp3" length="10714192" type="audio/mpeg"/>
                <itunes:summary><![CDATA[Credits: 0.25 AMA PRA Category 1 Credit™ CME/CE Information and Claim Credit: https://www.pri-med.com/online-education/podcast/frankly-speaking-cme-345
Overview: In this episode, we discuss the findings of a recent Lancet publication on a novel neurokinin 3 (NK3) receptor antagonist for treating hot flashes. Tune in as we talk about how this nonhormonal treatment addresses menopausal hot flashes, the prescribing precautions issued by the FDA, and the implications for patients seeking your help with alleviating symptoms.
Episode resource links:
Lancet 2023; 401: 1091–102. doi.org/10.1016/ S0140-6736(23)00085-5
Am Fam Physician. 2023;108(1):28-39
Guest: Robert A. Baldor MD, FAAFP Music Credit: Richard Onorato]]></itunes:summary>
        <itunes:author>Pri-Med</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>667</itunes:duration>
                <itunes:episode>4</itunes:episode>
        <itunes:episodeType>full</itunes:episodeType>
            </item>
    <item>
        <title>Risky Pain Management Choices in Patients with Dementia - Frankly Speaking Ep 344</title>
        <itunes:title>Risky Pain Management Choices in Patients with Dementia - Frankly Speaking Ep 344</itunes:title>
        <link>https://primedfranklyspeaking.podbean.com/e/risky-pain-management-choices-in-patients-with-dementia-frankly-speaking-ep-344/</link>
                    <comments>https://primedfranklyspeaking.podbean.com/e/risky-pain-management-choices-in-patients-with-dementia-frankly-speaking-ep-344/#comments</comments>        <pubDate>Mon, 04 Sep 2023 00:30:00 +0000</pubDate>
        <guid isPermaLink="false">primedfranklyspeaking.podbean.com/7f08ce56-9933-32e7-95c5-b0c01057f6b7</guid>
                                    <description><![CDATA[<p>Credits: 0.25 AMA PRA Category 1 Credit™
 
CME/CE Information and Claim Credit: <a href='https://www.pri-med.com/online-education/podcast/frankly-speaking-cme-344'>https://www.pri-med.com/online-education/podcast/frankly-speaking-cme-344</a></p>
<p>Overview: Navigating the intricate landscape of pain management in older patients with dementia can be challenging. Join us as we explore strategies for mitigating pain, consider the equilibrium between opioid benefits and risks, and discuss where to start when tailoring management plans for patients with dementia and joint pain. Don’t miss this important conversation.</p>
<p>Episode resource links:</p>
<ul><li><a href='https://www.neurologylive.com/view/mortality-risk-significantly-increased-with-new-opioid-use-older-adults-dementia'>https://www.neurologylive.com/view/mortality-risk-significantly-increased-with-new-opioid-use-older-adults-dementia</a></li>
<li><a href='https://www.practicalpainmanagement.com/resource-centers/opioid-prescribing-monitoring/risk-assessment-safe-opioid-prescribing-tools'>https://www.practicalpainmanagement.com/resource-centers/opioid-prescribing-monitoring/risk-assessment-safe-opioid-prescribing-tools</a></li>
</ul>
<p>Guest: Jillian Joseph, MPAS, PA-C
 
Music Credit: Richard Onorato</p>
]]></description>
                                                            <content:encoded><![CDATA[<p>Credits: 0.25 AMA PRA Category 1 Credit™<br>
 <br>
CME/CE Information and Claim Credit: <a href='https://www.pri-med.com/online-education/podcast/frankly-speaking-cme-344'>https://www.pri-med.com/online-education/podcast/frankly-speaking-cme-344</a></p>
<p>Overview: Navigating the intricate landscape of pain management in older patients with dementia can be challenging. Join us as we explore strategies for mitigating pain, consider the equilibrium between opioid benefits and risks, and discuss where to start when tailoring management plans for patients with dementia and joint pain. Don’t miss this important conversation.</p>
<p>Episode resource links:</p>
<ul><li><a href='https://www.neurologylive.com/view/mortality-risk-significantly-increased-with-new-opioid-use-older-adults-dementia'>https://www.neurologylive.com/view/mortality-risk-significantly-increased-with-new-opioid-use-older-adults-dementia</a></li>
<li><a href='https://www.practicalpainmanagement.com/resource-centers/opioid-prescribing-monitoring/risk-assessment-safe-opioid-prescribing-tools'>https://www.practicalpainmanagement.com/resource-centers/opioid-prescribing-monitoring/risk-assessment-safe-opioid-prescribing-tools</a></li>
</ul>
<p>Guest: Jillian Joseph, MPAS, PA-C<br>
 <br>
Music Credit: Richard Onorato</p>
]]></content:encoded>
                                    
        <enclosure url="https://mcdn.podbean.com/mf/web/qenkwb/frankly-speaking-344-dementia-opioids.mp3" length="10035163" type="audio/mpeg"/>
                <itunes:summary><![CDATA[Credits: 0.25 AMA PRA Category 1 Credit™ CME/CE Information and Claim Credit: https://www.pri-med.com/online-education/podcast/frankly-speaking-cme-344
Overview: Navigating the intricate landscape of pain management in older patients with dementia can be challenging. Join us as we explore strategies for mitigating pain, consider the equilibrium between opioid benefits and risks, and discuss where to start when tailoring management plans for patients with dementia and joint pain. Don’t miss this important conversation.
Episode resource links:
https://www.neurologylive.com/view/mortality-risk-significantly-increased-with-new-opioid-use-older-adults-dementia
https://www.practicalpainmanagement.com/resource-centers/opioid-prescribing-monitoring/risk-assessment-safe-opioid-prescribing-tools
Guest: Jillian Joseph, MPAS, PA-C Music Credit: Richard Onorato]]></itunes:summary>
        <itunes:author>Pri-Med</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>625</itunes:duration>
                        <itunes:episodeType>full</itunes:episodeType>
            </item>
    <item>
        <title>Screens Off, Play On: How Parental Phone Use Shapes Kids’ Physical Activity - Frankly Speaking Ep 343</title>
        <itunes:title>Screens Off, Play On: How Parental Phone Use Shapes Kids’ Physical Activity - Frankly Speaking Ep 343</itunes:title>
        <link>https://primedfranklyspeaking.podbean.com/e/screens-off-play-on-how-parental-phone-use-shapes-kids-physical-activity-frankly-speaking-ep-343/</link>
                    <comments>https://primedfranklyspeaking.podbean.com/e/screens-off-play-on-how-parental-phone-use-shapes-kids-physical-activity-frankly-speaking-ep-343/#comments</comments>        <pubDate>Mon, 28 Aug 2023 00:30:00 +0000</pubDate>
        <guid isPermaLink="false">primedfranklyspeaking.podbean.com/9fe7c9eb-df91-35bb-84a3-591e4201e0f6</guid>
                                    <description><![CDATA[<p>Credits: 0.25 AMA PRA Category 1 Credit™
 
CME/CE Information and Claim Credit: <a href='https://www.pri-med.com/online-education/podcast/frankly-speaking-cme-343'>https://www.pri-med.com/online-education/podcast/frankly-speaking-cme-343</a></p>
<p>Overview: In this episode, we take a look at a study exploring the effects on children’s activity levels when their parents reduce smartphone use. Listen in as we discuss compelling findings that shed light on the connection, and come away with guidance on how to navigate the evolving digital landscape to promote healthier, more active lifestyles among children.</p>
<p>Episode resource links:</p>
<ul><li>JAMA Pediatr. 2022 Aug; 176(8): 741–749
BMJ Open. 2019 Jan 3;9(1):e023191. doi: 10.1136/bmjopen-2018-023191</li>
</ul>
<p>Guest: Robert A. Baldor MD, FAAFP
 
Music Credit: Richard Onorato</p>
]]></description>
                                                            <content:encoded><![CDATA[<p>Credits: 0.25 AMA PRA Category 1 Credit™<br>
 <br>
CME/CE Information and Claim Credit: <a href='https://www.pri-med.com/online-education/podcast/frankly-speaking-cme-343'>https://www.pri-med.com/online-education/podcast/frankly-speaking-cme-343</a></p>
<p>Overview: In this episode, we take a look at a study exploring the effects on children’s activity levels when their parents reduce smartphone use. Listen in as we discuss compelling findings that shed light on the connection, and come away with guidance on how to navigate the evolving digital landscape to promote healthier, more active lifestyles among children.</p>
<p>Episode resource links:</p>
<ul><li>JAMA Pediatr. 2022 Aug; 176(8): 741–749<br>
BMJ Open. 2019 Jan 3;9(1):e023191. doi: 10.1136/bmjopen-2018-023191</li>
</ul>
<p>Guest: Robert A. Baldor MD, FAAFP<br>
 <br>
Music Credit: Richard Onorato</p>
]]></content:encoded>
                                    
        <enclosure url="https://mcdn.podbean.com/mf/web/9ez5tr/frankly-speaking-343-inactive-children-phones.mp3" length="10114789" type="audio/mpeg"/>
                <itunes:summary><![CDATA[Credits: 0.25 AMA PRA Category 1 Credit™ CME/CE Information and Claim Credit: https://www.pri-med.com/online-education/podcast/frankly-speaking-cme-343
Overview: In this episode, we take a look at a study exploring the effects on children’s activity levels when their parents reduce smartphone use. Listen in as we discuss compelling findings that shed light on the connection, and come away with guidance on how to navigate the evolving digital landscape to promote healthier, more active lifestyles among children.
Episode resource links:
JAMA Pediatr. 2022 Aug; 176(8): 741–749BMJ Open. 2019 Jan 3;9(1):e023191. doi: 10.1136/bmjopen-2018-023191
Guest: Robert A. Baldor MD, FAAFP Music Credit: Richard Onorato]]></itunes:summary>
        <itunes:author>Pri-Med</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>630</itunes:duration>
                        <itunes:episodeType>full</itunes:episodeType>
            </item>
    <item>
        <title>Beyond the Prescription Pad: Over-the-Counter Oral Contraceptive Gains FDA Approval - Frankly Speaking Ep 342</title>
        <itunes:title>Beyond the Prescription Pad: Over-the-Counter Oral Contraceptive Gains FDA Approval - Frankly Speaking Ep 342</itunes:title>
        <link>https://primedfranklyspeaking.podbean.com/e/beyond-the-prescription-pad-over-the-counter-oral-contraceptive-gains-fda-approval-frankly-speaking-ep-342/</link>
                    <comments>https://primedfranklyspeaking.podbean.com/e/beyond-the-prescription-pad-over-the-counter-oral-contraceptive-gains-fda-approval-frankly-speaking-ep-342/#comments</comments>        <pubDate>Mon, 21 Aug 2023 00:30:00 +0000</pubDate>
        <guid isPermaLink="false">primedfranklyspeaking.podbean.com/e182d91d-509b-3a8e-8822-bf0e34609ed3</guid>
                                    <description><![CDATA[<p>Credits: 0.25 AMA PRA Category 1 Credit™
 
CME/CE Information and Claim Credit: <a href='https://www.pri-med.com/online-education/podcast/frankly-speaking-cme-342'>https://www.pri-med.com/online-education/podcast/frankly-speaking-cme-342</a></p>
<p>Overview: In July of 2023, the FDA made a monumental decision to approve Opill, marking the first time an oral contraceptive will be made available without a prescription. The inaugural over-the-counter oral contraceptive is a progesterone-only pill. Join us to discuss the underlying rationales driving this decision and the prospective implications it might have on medical practice as well as women’s health.</p>
<p>Episode resource links:</p>
<ul><li>
<p>Biggs, AM, Ralph, L, Morris, N, Ehrenreich, K, Perritt, J, Kapp, N, Blanchard, K, White, K,  Barar, Grossman, RD.
A cross-sectional survey of U.S. abortion patients’ interest in obtaining medication abortion over the counter, Contraception, Volume 109, 2022, Pages 25-31, ISSN 0010-7824,
<a href='https://doi.org/10.1016/j.contraception.2022.01.010.'>https://doi.org/10.1016/j.contraception.2022.01.010.</a></p>
<p> </p>
</li>
<li>
<p>Chen, Q.J. Xiang, W.P. Zhang, D.K., Wang, R.P. Luo, Y.F. Kang, J.Z. Cheng, L.N. Efficacy and safety of a levonorgestrel enteric-coated tablet as an over-the-counter drug for emergency contraception: a Phase IV clinical trial, Human Reproduction, Volume 26, Issue 9, September 2011, Pages 2316–2321, <a href='https://doi.org/10.1093/humrep/der181'>https://doi.org/10.1093/humrep/der181</a></p>
<p> </p>
</li>
<li>
<p>Raine, TR; Ricciotti, N; Sokoloff, A; Brown, B; Hummel, A; Harper, C. An Over-the-Counter Simulation Study of a Single-Tablet Emergency Contraceptive in Young Females. Obstetrics &amp; Gynecology 119(4):p 772-779, April 2012. | DOI: 10.1097/AOG.0b013e31824c0aed</p>
<p> </p>
</li>
<li>
<p><a href='https://www.fda.gov/news-events/press-announcements/fda-approves-first-nonprescription-daily-oral-contraceptive'>https://www.fda.gov/news-events/press-announcements/fda-approves-first-nonprescription-daily-oral-contraceptive</a></p>
<p> </p>
</li>
<li>
<p><a href='https://www.accessdata.fda.gov/drugsatfda_docs/nda/2023/017031Orig1s041SumR.pdf'>https://www.accessdata.fda.gov/drugsatfda_docs/nda/2023/017031Orig1s041SumR.pdf</a></p>
</li>
</ul>
<p>Guest: Susan Feeney, DNP, FNP-BC, NP-C
 
Music Credit: Richard Onorato</p>
]]></description>
                                                            <content:encoded><![CDATA[<p>Credits: 0.25 AMA PRA Category 1 Credit™<br>
 <br>
CME/CE Information and Claim Credit: <a href='https://www.pri-med.com/online-education/podcast/frankly-speaking-cme-342'>https://www.pri-med.com/online-education/podcast/frankly-speaking-cme-342</a></p>
<p>Overview: In July of 2023, the FDA made a monumental decision to approve Opill, marking the first time an oral contraceptive will be made available without a prescription. The inaugural over-the-counter oral contraceptive is a progesterone-only pill. Join us to discuss the underlying rationales driving this decision and the prospective implications it might have on medical practice as well as women’s health.</p>
<p>Episode resource links:</p>
<ul><li>
<p>Biggs, AM, Ralph, L, Morris, N, Ehrenreich, K, Perritt, J, Kapp, N, Blanchard, K, White, K,  Barar, Grossman, RD.<br>
A cross-sectional survey of U.S. abortion patients’ interest in obtaining medication abortion over the counter, Contraception, Volume 109, 2022, Pages 25-31, ISSN 0010-7824,<br>
<a href='https://doi.org/10.1016/j.contraception.2022.01.010.'>https://doi.org/10.1016/j.contraception.2022.01.010.</a></p>
<p> </p>
</li>
<li>
<p>Chen, Q.J. Xiang, W.P. Zhang, D.K., Wang, R.P. Luo, Y.F. Kang, J.Z. Cheng, L.N. Efficacy and safety of a levonorgestrel enteric-coated tablet as an over-the-counter drug for emergency contraception: a Phase IV clinical trial, Human Reproduction, Volume 26, Issue 9, September 2011, Pages 2316–2321, <a href='https://doi.org/10.1093/humrep/der181'>https://doi.org/10.1093/humrep/der181</a></p>
<p> </p>
</li>
<li>
<p>Raine, TR; Ricciotti, N; Sokoloff, A; Brown, B; Hummel, A; Harper, C. An Over-the-Counter Simulation Study of a Single-Tablet Emergency Contraceptive in Young Females. Obstetrics &amp; Gynecology 119(4):p 772-779, April 2012. | DOI: 10.1097/AOG.0b013e31824c0aed</p>
<p> </p>
</li>
<li>
<p><a href='https://www.fda.gov/news-events/press-announcements/fda-approves-first-nonprescription-daily-oral-contraceptive'>https://www.fda.gov/news-events/press-announcements/fda-approves-first-nonprescription-daily-oral-contraceptive</a></p>
<p> </p>
</li>
<li>
<p><a href='https://www.accessdata.fda.gov/drugsatfda_docs/nda/2023/017031Orig1s041SumR.pdf'>https://www.accessdata.fda.gov/drugsatfda_docs/nda/2023/017031Orig1s041SumR.pdf</a></p>
</li>
</ul>
<p>Guest: Susan Feeney, DNP, FNP-BC, NP-C<br>
 <br>
Music Credit: Richard Onorato</p>
]]></content:encoded>
                                    
        <enclosure url="https://mcdn.podbean.com/mf/web/szj6g4/frankly-speaking-342-otc-contraception.mp3" length="10922669" type="audio/mpeg"/>
                <itunes:summary><![CDATA[Credits: 0.25 AMA PRA Category 1 Credit™ CME/CE Information and Claim Credit: https://www.pri-med.com/online-education/podcast/frankly-speaking-cme-342
Overview: In July of 2023, the FDA made a monumental decision to approve Opill, marking the first time an oral contraceptive will be made available without a prescription. The inaugural over-the-counter oral contraceptive is a progesterone-only pill. Join us to discuss the underlying rationales driving this decision and the prospective implications it might have on medical practice as well as women’s health.
Episode resource links:

Biggs, AM, Ralph, L, Morris, N, Ehrenreich, K, Perritt, J, Kapp, N, Blanchard, K, White, K,  Barar, Grossman, RD.A cross-sectional survey of U.S. abortion patients’ interest in obtaining medication abortion over the counter, Contraception, Volume 109, 2022, Pages 25-31, ISSN 0010-7824,https://doi.org/10.1016/j.contraception.2022.01.010.
 


Chen, Q.J. Xiang, W.P. Zhang, D.K., Wang, R.P. Luo, Y.F. Kang, J.Z. Cheng, L.N. Efficacy and safety of a levonorgestrel enteric-coated tablet as an over-the-counter drug for emergency contraception: a Phase IV clinical trial, Human Reproduction, Volume 26, Issue 9, September 2011, Pages 2316–2321, https://doi.org/10.1093/humrep/der181
 


Raine, TR; Ricciotti, N; Sokoloff, A; Brown, B; Hummel, A; Harper, C. An Over-the-Counter Simulation Study of a Single-Tablet Emergency Contraceptive in Young Females. Obstetrics &amp; Gynecology 119(4):p 772-779, April 2012. | DOI: 10.1097/AOG.0b013e31824c0aed
 


https://www.fda.gov/news-events/press-announcements/fda-approves-first-nonprescription-daily-oral-contraceptive
 


https://www.accessdata.fda.gov/drugsatfda_docs/nda/2023/017031Orig1s041SumR.pdf

Guest: Susan Feeney, DNP, FNP-BC, NP-C Music Credit: Richard Onorato]]></itunes:summary>
        <itunes:author>Pri-Med</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>680</itunes:duration>
                        <itunes:episodeType>full</itunes:episodeType>
            </item>
    <item>
        <title>Should We Personalize Our Approach to Treating Hypertension? - Frankly Speaking Ep 341</title>
        <itunes:title>Should We Personalize Our Approach to Treating Hypertension? - Frankly Speaking Ep 341</itunes:title>
        <link>https://primedfranklyspeaking.podbean.com/e/should-we-personalize-our-approach-to-treating-hypertension-frankly-speaking-ep-341/</link>
                    <comments>https://primedfranklyspeaking.podbean.com/e/should-we-personalize-our-approach-to-treating-hypertension-frankly-speaking-ep-341/#comments</comments>        <pubDate>Mon, 14 Aug 2023 00:30:00 +0000</pubDate>
        <guid isPermaLink="false">primedfranklyspeaking.podbean.com/c81f2b05-b629-3c82-921b-eb683a6403c8</guid>
                                    <description><![CDATA[<p>Credits: 0.25 AMA PRA Category 1 Credit™
 
CME/CE Information and Claim Credit: <a href='https://www.pri-med.com/online-education/podcast/frankly-speaking-cme-341'>https://www.pri-med.com/online-education/podcast/frankly-speaking-cme-341</a></p>
<p>Overview: Listen in as we review a recent JAMA publication of a randomized controlled trial that quantified the benefits of a targeted approach to prescribing antihypertensive medications. Don’t miss this opportunity to keep your management of patients with hypertension up to date.</p>
<p>Episode resource links:</p>
<ul><li>Sundström J, Lind L, Nawrouzi S, et al. Heterogeneity in blood pressure response to 4 antihypertensive drugs: a randomized clinical trial. JAMA. Published April 11, 2023. doi:10.1001/jama.2023.3322</li>
</ul>
<p>Guest: Robert A. Baldor MD, FAAFP
 
Music Credit: Richard Onorato</p>
]]></description>
                                                            <content:encoded><![CDATA[<p>Credits: 0.25 AMA PRA Category 1 Credit™<br>
 <br>
CME/CE Information and Claim Credit: <a href='https://www.pri-med.com/online-education/podcast/frankly-speaking-cme-341'>https://www.pri-med.com/online-education/podcast/frankly-speaking-cme-341</a></p>
<p>Overview: Listen in as we review a recent JAMA publication of a randomized controlled trial that quantified the benefits of a targeted approach to prescribing antihypertensive medications. Don’t miss this opportunity to keep your management of patients with hypertension up to date.</p>
<p>Episode resource links:</p>
<ul><li>Sundström J, Lind L, Nawrouzi S, et al. Heterogeneity in blood pressure response to 4 antihypertensive drugs: a randomized clinical trial. JAMA. Published April 11, 2023. doi:10.1001/jama.2023.3322</li>
</ul>
<p>Guest: Robert A. Baldor MD, FAAFP<br>
 <br>
Music Credit: Richard Onorato</p>
]]></content:encoded>
                                    
        <enclosure url="https://mcdn.podbean.com/mf/web/regw9k/frankly-speaking-341-hypertension.mp3" length="8846482" type="audio/mpeg"/>
                <itunes:summary><![CDATA[Credits: 0.25 AMA PRA Category 1 Credit™ CME/CE Information and Claim Credit: https://www.pri-med.com/online-education/podcast/frankly-speaking-cme-341
Overview: Listen in as we review a recent JAMA publication of a randomized controlled trial that quantified the benefits of a targeted approach to prescribing antihypertensive medications. Don’t miss this opportunity to keep your management of patients with hypertension up to date.
Episode resource links:
Sundström J, Lind L, Nawrouzi S, et al. Heterogeneity in blood pressure response to 4 antihypertensive drugs: a randomized clinical trial. JAMA. Published April 11, 2023. doi:10.1001/jama.2023.3322
Guest: Robert A. Baldor MD, FAAFP Music Credit: Richard Onorato]]></itunes:summary>
        <itunes:author>Pri-Med</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>551</itunes:duration>
                        <itunes:episodeType>full</itunes:episodeType>
            </item>
    <item>
        <title>Get Up, Move, and Feel Better: Exploring Physical Activity’s Link to Reduced Suicidal Ideation - Frankly Speaking Ep 340</title>
        <itunes:title>Get Up, Move, and Feel Better: Exploring Physical Activity’s Link to Reduced Suicidal Ideation - Frankly Speaking Ep 340</itunes:title>
        <link>https://primedfranklyspeaking.podbean.com/e/get-up-move-and-feel-better-exploring-physical-activity-s-link-to-reduced-suicidal-ideation-frankly-speaking-ep-340/</link>
                    <comments>https://primedfranklyspeaking.podbean.com/e/get-up-move-and-feel-better-exploring-physical-activity-s-link-to-reduced-suicidal-ideation-frankly-speaking-ep-340/#comments</comments>        <pubDate>Mon, 07 Aug 2023 00:30:00 +0000</pubDate>
        <guid isPermaLink="false">primedfranklyspeaking.podbean.com/597242bb-57b1-3d03-a631-16fb25581e11</guid>
                                    <description><![CDATA[<p>Credits: 0.25 AMA PRA Category 1 Credit™
 
CME/CE Information and Claim Credit: <a href='https://www.pri-med.com/online-education/podcast/frankly-speaking-cme-340'>https://www.pri-med.com/online-education/podcast/frankly-speaking-cme-340</a></p>
<p>Overview: Depression and anxiety rates are escalating, with a 36% increase in suicide cases between 2018 and 2021, as reported by the CDC. This distressing trend can be attributed to various significant stressors that have arisen in recent times, such as pandemic-related illness and isolation. Medications alone are not as effective as when other modalities are incorporated into the treatment regime. Recent meta-analysis has revealed a strong correlation between engaging in physical activity and reducing suicidal ideation across all levels. Listen in as we discuss these findings and explore practical strategies for their implementation in your clinical practice.</p>
<p>Episode resource links:</p>
<ul><li>Vancampfort, D., Hallgren, M., Firth, J., Rosenbaum, S., Schuch, F. B., Mugisha, J., Probst, M., Van Damme, T., Carvalho, A. F., &amp; Stubbs, B. (2017). Physical activity and suicidal ideation: a systematic review and meta-analysis. Journal of Affective Disorders. <a href='https://doi.org/10.1016/j.jad.2017.08.070'>https://doi.org/10.1016/j.jad.2017.08.070</a></li>
<li><a href='https://www.healio.com/news/primary-care/20230403/metaanalysis-exe'>https://www.healio.com/news/primary-care/20230403/metaanalysis-exe</a></li>
</ul>
<p>Guest: Susan Feeney, DNP, FNP-BC, NP-C
 
Music Credit: Richard Onorato</p>
]]></description>
                                                            <content:encoded><![CDATA[<p>Credits: 0.25 AMA PRA Category 1 Credit™<br>
 <br>
CME/CE Information and Claim Credit: <a href='https://www.pri-med.com/online-education/podcast/frankly-speaking-cme-340'>https://www.pri-med.com/online-education/podcast/frankly-speaking-cme-340</a></p>
<p>Overview: Depression and anxiety rates are escalating, with a 36% increase in suicide cases between 2018 and 2021, as reported by the CDC. This distressing trend can be attributed to various significant stressors that have arisen in recent times, such as pandemic-related illness and isolation. Medications alone are not as effective as when other modalities are incorporated into the treatment regime. Recent meta-analysis has revealed a strong correlation between engaging in physical activity and reducing suicidal ideation across all levels. Listen in as we discuss these findings and explore practical strategies for their implementation in your clinical practice.</p>
<p>Episode resource links:</p>
<ul><li>Vancampfort, D., Hallgren, M., Firth, J., Rosenbaum, S., Schuch, F. B., Mugisha, J., Probst, M., Van Damme, T., Carvalho, A. F., &amp; Stubbs, B. (2017). Physical activity and suicidal ideation: a systematic review and meta-analysis. Journal of Affective Disorders. <a href='https://doi.org/10.1016/j.jad.2017.08.070'>https://doi.org/10.1016/j.jad.2017.08.070</a></li>
<li><a href='https://www.healio.com/news/primary-care/20230403/metaanalysis-exe'>https://www.healio.com/news/primary-care/20230403/metaanalysis-exe</a></li>
</ul>
<p>Guest: Susan Feeney, DNP, FNP-BC, NP-C<br>
 <br>
Music Credit: Richard Onorato</p>
]]></content:encoded>
                                    
        <enclosure url="https://mcdn.podbean.com/mf/web/jndyat/frankly-speaking-340-suicidal-ideation.mp3" length="10287011" type="audio/mpeg"/>
                <itunes:summary><![CDATA[Credits: 0.25 AMA PRA Category 1 Credit™ CME/CE Information and Claim Credit: https://www.pri-med.com/online-education/podcast/frankly-speaking-cme-340
Overview: Depression and anxiety rates are escalating, with a 36% increase in suicide cases between 2018 and 2021, as reported by the CDC. This distressing trend can be attributed to various significant stressors that have arisen in recent times, such as pandemic-related illness and isolation. Medications alone are not as effective as when other modalities are incorporated into the treatment regime. Recent meta-analysis has revealed a strong correlation between engaging in physical activity and reducing suicidal ideation across all levels. Listen in as we discuss these findings and explore practical strategies for their implementation in your clinical practice.
Episode resource links:
Vancampfort, D., Hallgren, M., Firth, J., Rosenbaum, S., Schuch, F. B., Mugisha, J., Probst, M., Van Damme, T., Carvalho, A. F., &amp; Stubbs, B. (2017). Physical activity and suicidal ideation: a systematic review and meta-analysis. Journal of Affective Disorders. https://doi.org/10.1016/j.jad.2017.08.070
https://www.healio.com/news/primary-care/20230403/metaanalysis-exe
Guest: Susan Feeney, DNP, FNP-BC, NP-C Music Credit: Richard Onorato]]></itunes:summary>
        <itunes:author>Pri-Med</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>640</itunes:duration>
                        <itunes:episodeType>full</itunes:episodeType>
            </item>
    <item>
        <title>CBD Use and Liver Injury: Practical Considerations for Primary Care - Frankly Speaking Ep 339</title>
        <itunes:title>CBD Use and Liver Injury: Practical Considerations for Primary Care - Frankly Speaking Ep 339</itunes:title>
        <link>https://primedfranklyspeaking.podbean.com/e/cbd-use-and-liver-injury-practical-considerations-for-primary-care-frankly-speaking-ep-339/</link>
                    <comments>https://primedfranklyspeaking.podbean.com/e/cbd-use-and-liver-injury-practical-considerations-for-primary-care-frankly-speaking-ep-339/#comments</comments>        <pubDate>Mon, 31 Jul 2023 00:30:00 +0000</pubDate>
        <guid isPermaLink="false">primedfranklyspeaking.podbean.com/44517eaf-c4b8-3171-b130-9ea5627330ed</guid>
                                    <description><![CDATA[<p>Credits: 0.25 AMA PRA Category 1 Credit™
 
CME/CE Information and Claim Credit: <a href='https://www.pri-med.com/online-education/podcast/frankly-speaking-cme-339'>https://www.pri-med.com/online-education/podcast/frankly-speaking-cme-339</a></p>
<p>Overview: In this episode, we dive into a recent systematic review and meta-analysis confirming the association between cannabidiol (CBD) use and hepatotoxicity. Gain a deeper understanding of clinical applications and the delicate balance of risks and benefits when discussing CBD use with your patients.</p>
<p>Episode resource links:</p>
<ul><li>Lo LA, Christiansen A, Eadie L, Strickland JC, Kim DD, Boivin M, Barr AM, MacCallum CA. Cannabidiol-associated hepatotoxicity: A systematic review and meta-analysis. J Intern Med. 2023 Mar 13. doi: 10.1111/joim.13627. Epub ahead of print. PMID: 36912195.</li>
<li><a href='https://store.samhsa.gov/sites/default/files/pep22-06-04-003.pdf'>https://store.samhsa.gov/sites/default/files/pep22-06-04-003.pdf</a></li>
</ul>
<p>Guest: Jillian Joseph, MPAS, PA-C
 
Music Credit: Richard Onorato</p>
]]></description>
                                                            <content:encoded><![CDATA[<p>Credits: 0.25 AMA PRA Category 1 Credit™<br>
 <br>
CME/CE Information and Claim Credit: <a href='https://www.pri-med.com/online-education/podcast/frankly-speaking-cme-339'>https://www.pri-med.com/online-education/podcast/frankly-speaking-cme-339</a></p>
<p>Overview: In this episode, we dive into a recent systematic review and meta-analysis confirming the association between cannabidiol (CBD) use and hepatotoxicity. Gain a deeper understanding of clinical applications and the delicate balance of risks and benefits when discussing CBD use with your patients.</p>
<p>Episode resource links:</p>
<ul><li>Lo LA, Christiansen A, Eadie L, Strickland JC, Kim DD, Boivin M, Barr AM, MacCallum CA. Cannabidiol-associated hepatotoxicity: A systematic review and meta-analysis. J Intern Med. 2023 Mar 13. doi: 10.1111/joim.13627. Epub ahead of print. PMID: 36912195.</li>
<li><a href='https://store.samhsa.gov/sites/default/files/pep22-06-04-003.pdf'>https://store.samhsa.gov/sites/default/files/pep22-06-04-003.pdf</a></li>
</ul>
<p>Guest: Jillian Joseph, MPAS, PA-C<br>
 <br>
Music Credit: Richard Onorato</p>
]]></content:encoded>
                                    
        <enclosure url="https://mcdn.podbean.com/mf/web/figs66/frankly-speaking-339-cbd-use.mp3" length="8827910" type="audio/mpeg"/>
                <itunes:summary><![CDATA[Credits: 0.25 AMA PRA Category 1 Credit™ CME/CE Information and Claim Credit: https://www.pri-med.com/online-education/podcast/frankly-speaking-cme-339
Overview: In this episode, we dive into a recent systematic review and meta-analysis confirming the association between cannabidiol (CBD) use and hepatotoxicity. Gain a deeper understanding of clinical applications and the delicate balance of risks and benefits when discussing CBD use with your patients.
Episode resource links:
Lo LA, Christiansen A, Eadie L, Strickland JC, Kim DD, Boivin M, Barr AM, MacCallum CA. Cannabidiol-associated hepatotoxicity: A systematic review and meta-analysis. J Intern Med. 2023 Mar 13. doi: 10.1111/joim.13627. Epub ahead of print. PMID: 36912195.
https://store.samhsa.gov/sites/default/files/pep22-06-04-003.pdf
Guest: Jillian Joseph, MPAS, PA-C Music Credit: Richard Onorato]]></itunes:summary>
        <itunes:author>Pri-Med</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>550</itunes:duration>
                        <itunes:episodeType>full</itunes:episodeType>
            </item>
    <item>
        <title>Asthma May Induce Some Cancers—Can That Be Prevented? - Frankly Speaking Ep 338</title>
        <itunes:title>Asthma May Induce Some Cancers—Can That Be Prevented? - Frankly Speaking Ep 338</itunes:title>
        <link>https://primedfranklyspeaking.podbean.com/e/asthma-may-induce-some-cancers%e2%80%94can-that-be-prevented-frankly-speaking-ep-338/</link>
                    <comments>https://primedfranklyspeaking.podbean.com/e/asthma-may-induce-some-cancers%e2%80%94can-that-be-prevented-frankly-speaking-ep-338/#comments</comments>        <pubDate>Mon, 24 Jul 2023 00:30:00 +0000</pubDate>
        <guid isPermaLink="false">primedfranklyspeaking.podbean.com/e25bb690-a413-3755-9542-2d7b227a2bac</guid>
                                    <description><![CDATA[<p>Credits: 0.25 AMA PRA Category 1 Credit™
 
CME/CE Information and Claim Credit: <a href='https://www.pri-med.com/online-education/podcast/frankly-speaking-cme-338'>https://www.pri-med.com/online-education/podcast/frankly-speaking-cme-338</a></p>
<p>Overview: Listen in as we explore the connection between asthma and cancer. We examine new Global Initiative for Asthma (GINA) guidelines and recent observational data correlating an asthma diagnosis with an increased cancer risk. Don't miss out on this essential discussion that will empower you with valuable knowledge for enhanced patient care.</p>
<p>Episode resource links:</p>
<ul><li>Guo, Y, Bian, J, Chen, Z, et al. Cancer incidence after asthma diagnosis: Evidence from a large clinical research network in the United States. Cancer Med. 2023; 00: 1- 7. doi:10.1002/cam4.5875</li>
<li>GINA guidelines 2022: <a href='https://ginasthma.org/wp-content/uploads/2022/07/GINA-Main-Report-2022-FINAL-22-07-01-WMS.pdf'>https://ginasthma.org/wp-content/uploads/2022/07/GINA-Main-Report-2022-FINAL-22-07-01-WMS.pdf</a></li>
</ul>
<p>Guest: Robert A. Baldor MD, FAAFP
 
Music Credit: Richard Onorato</p>
]]></description>
                                                            <content:encoded><![CDATA[<p>Credits: 0.25 AMA PRA Category 1 Credit™<br>
 <br>
CME/CE Information and Claim Credit: <a href='https://www.pri-med.com/online-education/podcast/frankly-speaking-cme-338'>https://www.pri-med.com/online-education/podcast/frankly-speaking-cme-338</a></p>
<p>Overview: Listen in as we explore the connection between asthma and cancer. We examine new Global Initiative for Asthma (GINA) guidelines and recent observational data correlating an asthma diagnosis with an increased cancer risk. Don't miss out on this essential discussion that will empower you with valuable knowledge for enhanced patient care.</p>
<p>Episode resource links:</p>
<ul><li>Guo, Y, Bian, J, Chen, Z, et al. Cancer incidence after asthma diagnosis: Evidence from a large clinical research network in the United States. Cancer Med. 2023; 00: 1- 7. doi:10.1002/cam4.5875</li>
<li>GINA guidelines 2022: <a href='https://ginasthma.org/wp-content/uploads/2022/07/GINA-Main-Report-2022-FINAL-22-07-01-WMS.pdf'>https://ginasthma.org/wp-content/uploads/2022/07/GINA-Main-Report-2022-FINAL-22-07-01-WMS.pdf</a></li>
</ul>
<p>Guest: Robert A. Baldor MD, FAAFP<br>
 <br>
Music Credit: Richard Onorato</p>
]]></content:encoded>
                                    
        <enclosure url="https://mcdn.podbean.com/mf/web/zgk79z/frankly-speaking-338-asthma-collerectal-cancer.mp3" length="8432802" type="audio/mpeg"/>
                <itunes:summary><![CDATA[Credits: 0.25 AMA PRA Category 1 Credit™ CME/CE Information and Claim Credit: https://www.pri-med.com/online-education/podcast/frankly-speaking-cme-338
Overview: Listen in as we explore the connection between asthma and cancer. We examine new Global Initiative for Asthma (GINA) guidelines and recent observational data correlating an asthma diagnosis with an increased cancer risk. Don't miss out on this essential discussion that will empower you with valuable knowledge for enhanced patient care.
Episode resource links:
Guo, Y, Bian, J, Chen, Z, et al. Cancer incidence after asthma diagnosis: Evidence from a large clinical research network in the United States. Cancer Med. 2023; 00: 1- 7. doi:10.1002/cam4.5875
GINA guidelines 2022: https://ginasthma.org/wp-content/uploads/2022/07/GINA-Main-Report-2022-FINAL-22-07-01-WMS.pdf
Guest: Robert A. Baldor MD, FAAFP Music Credit: Richard Onorato]]></itunes:summary>
        <itunes:author>Pri-Med</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>525</itunes:duration>
                        <itunes:episodeType>full</itunes:episodeType>
            </item>
    <item>
        <title>When Is the Best Time to Take Blood Pressure Medications? - Frankly Speaking Ep 337</title>
        <itunes:title>When Is the Best Time to Take Blood Pressure Medications? - Frankly Speaking Ep 337</itunes:title>
        <link>https://primedfranklyspeaking.podbean.com/e/when-is-the-best-time-to-take-blood-pressure-medications-frankly-speaking-ep-337/</link>
                    <comments>https://primedfranklyspeaking.podbean.com/e/when-is-the-best-time-to-take-blood-pressure-medications-frankly-speaking-ep-337/#comments</comments>        <pubDate>Mon, 17 Jul 2023 00:30:00 +0000</pubDate>
        <guid isPermaLink="false">primedfranklyspeaking.podbean.com/cc841dc9-1481-3999-9811-c56b2dcf1204</guid>
                                    <description><![CDATA[<p>Credits: 0.25 AMA PRA Category 1 Credit™
 
CME/CE Information and Claim Credit: <a href='https://www.pri-med.com/online-education/podcast/frankly-speaking-cme-337'>https://www.pri-med.com/online-education/podcast/frankly-speaking-cme-337</a></p>
<p>Overview: There has been uncertainty as to the best time for patients to take blood pressure medications. Tune in as we review the Treatment in Morning versus Evening (TIME) study, which assessed whether morning or evening dosing improves cardiovascular outcomes.</p>
<p>Episode resource links:</p>
<ul><li>Mackenzie IS, Rogers A, Poulter NR, et al. Cardiovascular outcomes in adults with hypertension with evening versus morning dosing of usual antihypertensives in the UK (TIME study): a prospective, randomised, open-label, blinded-endpoint clinical trial. Lancet. 2022;400(10361):1417-1425. </li>
</ul>
<p>Guest: Alan M. Ehrlich MD, FAAFP
 
Music Credit: Richard Onorato</p>
]]></description>
                                                            <content:encoded><![CDATA[<p>Credits: 0.25 AMA PRA Category 1 Credit™<br>
 <br>
CME/CE Information and Claim Credit: <a href='https://www.pri-med.com/online-education/podcast/frankly-speaking-cme-337'>https://www.pri-med.com/online-education/podcast/frankly-speaking-cme-337</a></p>
<p>Overview: There has been uncertainty as to the best time for patients to take blood pressure medications. Tune in as we review the Treatment in Morning versus Evening (TIME) study, which assessed whether morning or evening dosing improves cardiovascular outcomes.</p>
<p>Episode resource links:</p>
<ul><li>Mackenzie IS, Rogers A, Poulter NR, et al. Cardiovascular outcomes in adults with hypertension with evening versus morning dosing of usual antihypertensives in the UK (TIME study): a prospective, randomised, open-label, blinded-endpoint clinical trial. Lancet. 2022;400(10361):1417-1425. </li>
</ul>
<p>Guest: Alan M. Ehrlich MD, FAAFP<br>
 <br>
Music Credit: Richard Onorato</p>
]]></content:encoded>
                                    
        <enclosure url="https://mcdn.podbean.com/mf/web/tvpbhp/frankly-speaking-337-bp-medicine-timing.mp3" length="9856046" type="audio/mpeg"/>
                <itunes:summary><![CDATA[Credits: 0.25 AMA PRA Category 1 Credit™ CME/CE Information and Claim Credit: https://www.pri-med.com/online-education/podcast/frankly-speaking-cme-337
Overview: There has been uncertainty as to the best time for patients to take blood pressure medications. Tune in as we review the Treatment in Morning versus Evening (TIME) study, which assessed whether morning or evening dosing improves cardiovascular outcomes.
Episode resource links:
Mackenzie IS, Rogers A, Poulter NR, et al. Cardiovascular outcomes in adults with hypertension with evening versus morning dosing of usual antihypertensives in the UK (TIME study): a prospective, randomised, open-label, blinded-endpoint clinical trial. Lancet. 2022;400(10361):1417-1425. 
Guest: Alan M. Ehrlich MD, FAAFP Music Credit: Richard Onorato]]></itunes:summary>
        <itunes:author>Pri-Med</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>614</itunes:duration>
                        <itunes:episodeType>full</itunes:episodeType>
            </item>
    <item>
        <title>Breathe Easy—Updated Recommendations for Asthma Management - Frankly Speaking Ep 336</title>
        <itunes:title>Breathe Easy—Updated Recommendations for Asthma Management - Frankly Speaking Ep 336</itunes:title>
        <link>https://primedfranklyspeaking.podbean.com/e/breathe-easy%e2%80%94updated-recommendations-for-asthma-management-frankly-speaking-ep-336/</link>
                    <comments>https://primedfranklyspeaking.podbean.com/e/breathe-easy%e2%80%94updated-recommendations-for-asthma-management-frankly-speaking-ep-336/#comments</comments>        <pubDate>Mon, 10 Jul 2023 00:30:00 +0000</pubDate>
        <guid isPermaLink="false">primedfranklyspeaking.podbean.com/e2db6903-7dce-3c9c-b9e9-d46f4bffce5e</guid>
                                    <description><![CDATA[<p>Credits: 0.25 AMA PRA Category 1 Credit™
 
CME/CE Information and Claim Credit: <a href='https://www.pri-med.com/online-education/podcast/frankly-speaking-cme-336'>https://www.pri-med.com/online-education/podcast/frankly-speaking-cme-336</a></p>
<p>Overview: In 2020, the National Asthma Education and Prevention Program (NAEPP) updated its guidelines for asthma management, incorporating significant changes. This marked the first update since 2007. A recent study revealed that &gt;280 providers of the new asthma guidelines had an average knowledge score of &lt;45%, indicating that these guidelines have likely not been fully incorporated into their practice. We invite you to join us as we discuss the new guidelines and explore strategies for integrating them into your practice.</p>
<p>Episode resource links:</p>
<ul><li>
<p>Cloutier MM, Dixon AE, Krishnan JA, Lemanske RF, Pace W, Schatz M. Managing Asthma in Adolescents and Adults: 2020 Asthma Guideline Update from the National Asthma Education and Prevention Program. JAMA. 2020;324(22):2301–2317. doi:10.1001/jama.2020.2197   <a href='https://jamanetwork.com/journals/jama/article-abstract/2773482'>https://jamanetwork.com/journals/jama/article-abstract/2773482</a></p>
</li>
<li>
<p><a href='https://www.jacionline.org/programs_abstracts'>https://www.jacionline.org/programs_abstracts</a></p>
</li>
<li>
<p><a href='https://www.healio.com/news/primary-care/20230225/physicians-show-lack-of-knowledge-on-latest-updates-to-asthma-management-guidelines'>https://www.healio.com/news/primary-care/20230225/physicians-show-lack-of-knowledge-on-latest-updates-to-asthma-management-guidelines</a></p>
<p> </p>
</li>
<li>
<p>Cloutier MM, Teach, SJ., Lemanske RF, Blake KV. The 2020 Focused Updates to the NIH Asthma Management Guidelines: Key Points for Pediatricians. PEDIATRICS Volume 147, number 6, June 2021:e2021050286; <a href='https://publications.aap.org/pediatrics/article/147/6/e2021050286/180305/The-2020-Focused-Updates-to-the-NIH-Asthma?autologincheck=redirected'>https://publications.aap.org/pediatrics/article/147/6/e2021050286/180305/The-2020-Focused-Updates-to-the-NIH-Asthma?autologincheck=redirected</a></p>
<p> </p>
</li>
<li>
<p>GINA Guidelines: <a href='https://ginasthma.org/pocket-guide-for-asthma-management-and-prevention/'>https://ginasthma.org/pocket-guide-for-asthma-management-and-prevention/</a></p>
</li>
<li>
<p>Pocket Guide: <a href='https://ginasthma.org/wp-content/uploads/2022/07/GINA-2022-Pocket-Guide-WMS.pdf'>https://ginasthma.org/wp-content/uploads/2022/07/GINA-2022-Pocket-Guide-WMS.pdf</a></p>
</li>
</ul>
<p>Guest: Susan Feeney, DNP, FNP-BC, NP-C
 
Music Credit: Richard Onorato</p>
]]></description>
                                                            <content:encoded><![CDATA[<p>Credits: 0.25 AMA PRA Category 1 Credit™<br>
 <br>
CME/CE Information and Claim Credit: <a href='https://www.pri-med.com/online-education/podcast/frankly-speaking-cme-336'>https://www.pri-med.com/online-education/podcast/frankly-speaking-cme-336</a></p>
<p>Overview: In 2020, the National Asthma Education and Prevention Program (NAEPP) updated its guidelines for asthma management, incorporating significant changes. This marked the first update since 2007. A recent study revealed that &gt;280 providers of the new asthma guidelines had an average knowledge score of &lt;45%, indicating that these guidelines have likely not been fully incorporated into their practice. We invite you to join us as we discuss the new guidelines and explore strategies for integrating them into your practice.</p>
<p>Episode resource links:</p>
<ul><li>
<p>Cloutier MM, Dixon AE, Krishnan JA, Lemanske RF, Pace W, Schatz M. Managing Asthma in Adolescents and Adults: 2020 Asthma Guideline Update from the National Asthma Education and Prevention Program. JAMA. 2020;324(22):2301–2317. doi:10.1001/jama.2020.2197   <a href='https://jamanetwork.com/journals/jama/article-abstract/2773482'>https://jamanetwork.com/journals/jama/article-abstract/2773482</a></p>
</li>
<li>
<p><a href='https://www.jacionline.org/programs_abstracts'>https://www.jacionline.org/programs_abstracts</a></p>
</li>
<li>
<p><a href='https://www.healio.com/news/primary-care/20230225/physicians-show-lack-of-knowledge-on-latest-updates-to-asthma-management-guidelines'>https://www.healio.com/news/primary-care/20230225/physicians-show-lack-of-knowledge-on-latest-updates-to-asthma-management-guidelines</a></p>
<p> </p>
</li>
<li>
<p>Cloutier MM, Teach, SJ., Lemanske RF, Blake KV. The 2020 Focused Updates to the NIH Asthma Management Guidelines: Key Points for Pediatricians. PEDIATRICS Volume 147, number 6, June 2021:e2021050286; <a href='https://publications.aap.org/pediatrics/article/147/6/e2021050286/180305/The-2020-Focused-Updates-to-the-NIH-Asthma?autologincheck=redirected'>https://publications.aap.org/pediatrics/article/147/6/e2021050286/180305/The-2020-Focused-Updates-to-the-NIH-Asthma?autologincheck=redirected</a></p>
<p> </p>
</li>
<li>
<p>GINA Guidelines: <a href='https://ginasthma.org/pocket-guide-for-asthma-management-and-prevention/'>https://ginasthma.org/pocket-guide-for-asthma-management-and-prevention/</a></p>
</li>
<li>
<p>Pocket Guide: <a href='https://ginasthma.org/wp-content/uploads/2022/07/GINA-2022-Pocket-Guide-WMS.pdf'>https://ginasthma.org/wp-content/uploads/2022/07/GINA-2022-Pocket-Guide-WMS.pdf</a></p>
</li>
</ul>
<p>Guest: Susan Feeney, DNP, FNP-BC, NP-C<br>
 <br>
Music Credit: Richard Onorato</p>
]]></content:encoded>
                                    
        <enclosure url="https://mcdn.podbean.com/mf/web/sy7cb7/frankly-speaking-336-asthma.mp3" length="10159196" type="audio/mpeg"/>
                <itunes:summary><![CDATA[Credits: 0.25 AMA PRA Category 1 Credit™ CME/CE Information and Claim Credit: https://www.pri-med.com/online-education/podcast/frankly-speaking-cme-336
Overview: In 2020, the National Asthma Education and Prevention Program (NAEPP) updated its guidelines for asthma management, incorporating significant changes. This marked the first update since 2007. A recent study revealed that &gt;280 providers of the new asthma guidelines had an average knowledge score of &lt;45%, indicating that these guidelines have likely not been fully incorporated into their practice. We invite you to join us as we discuss the new guidelines and explore strategies for integrating them into your practice.
Episode resource links:

Cloutier MM, Dixon AE, Krishnan JA, Lemanske RF, Pace W, Schatz M. Managing Asthma in Adolescents and Adults: 2020 Asthma Guideline Update from the National Asthma Education and Prevention Program. JAMA. 2020;324(22):2301–2317. doi:10.1001/jama.2020.2197   https://jamanetwork.com/journals/jama/article-abstract/2773482


https://www.jacionline.org/programs_abstracts


https://www.healio.com/news/primary-care/20230225/physicians-show-lack-of-knowledge-on-latest-updates-to-asthma-management-guidelines
 


Cloutier MM, Teach, SJ., Lemanske RF, Blake KV. The 2020 Focused Updates to the NIH Asthma Management Guidelines: Key Points for Pediatricians. PEDIATRICS Volume 147, number 6, June 2021:e2021050286; https://publications.aap.org/pediatrics/article/147/6/e2021050286/180305/The-2020-Focused-Updates-to-the-NIH-Asthma?autologincheck=redirected
 


GINA Guidelines: https://ginasthma.org/pocket-guide-for-asthma-management-and-prevention/


Pocket Guide: https://ginasthma.org/wp-content/uploads/2022/07/GINA-2022-Pocket-Guide-WMS.pdf

Guest: Susan Feeney, DNP, FNP-BC, NP-C Music Credit: Richard Onorato]]></itunes:summary>
        <itunes:author>Pri-Med</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>633</itunes:duration>
                        <itunes:episodeType>full</itunes:episodeType>
            </item>
    <item>
        <title>Does Metformin Make an Impact in Lowering Cardiovascular Risk in Patients with Prediabetes? - Frankly Speaking Ep 335</title>
        <itunes:title>Does Metformin Make an Impact in Lowering Cardiovascular Risk in Patients with Prediabetes? - Frankly Speaking Ep 335</itunes:title>
        <link>https://primedfranklyspeaking.podbean.com/e/does-metformin-make-an-impact-in-lowering-cardiovascular-risk-in-patients-with-prediabetes-frankly-speaking-ep-335/</link>
                    <comments>https://primedfranklyspeaking.podbean.com/e/does-metformin-make-an-impact-in-lowering-cardiovascular-risk-in-patients-with-prediabetes-frankly-speaking-ep-335/#comments</comments>        <pubDate>Mon, 03 Jul 2023 00:30:00 +0000</pubDate>
        <guid isPermaLink="false">primedfranklyspeaking.podbean.com/64377c7b-35b8-379f-9429-6e0bd02a3f65</guid>
                                    <description><![CDATA[<p>Credits: 0.25 AMA PRA Category 1 Credit™
 
CME/CE Information and Claim Credit: <a href='https://www.pri-med.com/online-education/podcast/frankly-speaking-cme-335'>https://www.pri-med.com/online-education/podcast/frankly-speaking-cme-335</a></p>
<p>Overview: In this episode, we review recent updates from the Diabetes Prevention Program (DPP) trial and Diabetes Prevention Program Outcomes Study (DPPOS). Join us as we discuss the impact of the updates on diabetes prevention strategies for cardiovascular outcomes.</p>
<p>Episode resource links:</p>
<ul><li>Goldberg RB, Orchard TJ, Crandall JP, Boyko EJ, Budoff M, Dabelea D, Gadde KM, Knowler WC, Lee CG, Nathan DM, Watson K, Temprosa M; Diabetes Prevention Program Research Group*. Effects of Long-term Metformin and Lifestyle Interventions on Cardiovascular Events in the Diabetes Prevention Program and Its Outcome Study. Circulation. 2022 May 31;145(22):1632-1641. doi: 10.1161/CIRCULATIONAHA.121.056756. Epub 2022 May 23. PMID: 35603600; PMCID: PMC9179081.</li>
<li>Galaviz KI, Weber MB, Suvada K BS, Gujral UP, Wei J, Merchant R, Dharanendra S, Haw JS, Narayan KMV, Ali MK. Interventions for Reversing Prediabetes: A Systematic Review and Meta-Analysis. Am J Prev Med. 2022 Apr;62(4):614-625. doi: 10.1016/j.amepre.2021.10.020. Epub 2022 Feb 10. PMID: 35151523.</li>
</ul>
<p>Guest: Jillian Joseph, MPAS, PA-C
 
Music Credit: Richard Onorato</p>
]]></description>
                                                            <content:encoded><![CDATA[<p>Credits: 0.25 AMA PRA Category 1 Credit™<br>
 <br>
CME/CE Information and Claim Credit: <a href='https://www.pri-med.com/online-education/podcast/frankly-speaking-cme-335'>https://www.pri-med.com/online-education/podcast/frankly-speaking-cme-335</a></p>
<p>Overview: In this episode, we review recent updates from the Diabetes Prevention Program (DPP) trial and Diabetes Prevention Program Outcomes Study (DPPOS). Join us as we discuss the impact of the updates on diabetes prevention strategies for cardiovascular outcomes.</p>
<p>Episode resource links:</p>
<ul><li>Goldberg RB, Orchard TJ, Crandall JP, Boyko EJ, Budoff M, Dabelea D, Gadde KM, Knowler WC, Lee CG, Nathan DM, Watson K, Temprosa M; Diabetes Prevention Program Research Group*. Effects of Long-term Metformin and Lifestyle Interventions on Cardiovascular Events in the Diabetes Prevention Program and Its Outcome Study. Circulation. 2022 May 31;145(22):1632-1641. doi: 10.1161/CIRCULATIONAHA.121.056756. Epub 2022 May 23. PMID: 35603600; PMCID: PMC9179081.</li>
<li>Galaviz KI, Weber MB, Suvada K BS, Gujral UP, Wei J, Merchant R, Dharanendra S, Haw JS, Narayan KMV, Ali MK. Interventions for Reversing Prediabetes: A Systematic Review and Meta-Analysis. Am J Prev Med. 2022 Apr;62(4):614-625. doi: 10.1016/j.amepre.2021.10.020. Epub 2022 Feb 10. PMID: 35151523.</li>
</ul>
<p>Guest: Jillian Joseph, MPAS, PA-C<br>
 <br>
Music Credit: Richard Onorato</p>
]]></content:encoded>
                                    
        <enclosure url="https://mcdn.podbean.com/mf/web/ry9mcn/frankly-speaking-335-prediabetes.mp3" length="10430921" type="audio/mpeg"/>
                <itunes:summary><![CDATA[Credits: 0.25 AMA PRA Category 1 Credit™ CME/CE Information and Claim Credit: https://www.pri-med.com/online-education/podcast/frankly-speaking-cme-335
Overview: In this episode, we review recent updates from the Diabetes Prevention Program (DPP) trial and Diabetes Prevention Program Outcomes Study (DPPOS). Join us as we discuss the impact of the updates on diabetes prevention strategies for cardiovascular outcomes.
Episode resource links:
Goldberg RB, Orchard TJ, Crandall JP, Boyko EJ, Budoff M, Dabelea D, Gadde KM, Knowler WC, Lee CG, Nathan DM, Watson K, Temprosa M; Diabetes Prevention Program Research Group*. Effects of Long-term Metformin and Lifestyle Interventions on Cardiovascular Events in the Diabetes Prevention Program and Its Outcome Study. Circulation. 2022 May 31;145(22):1632-1641. doi: 10.1161/CIRCULATIONAHA.121.056756. Epub 2022 May 23. PMID: 35603600; PMCID: PMC9179081.
Galaviz KI, Weber MB, Suvada K BS, Gujral UP, Wei J, Merchant R, Dharanendra S, Haw JS, Narayan KMV, Ali MK. Interventions for Reversing Prediabetes: A Systematic Review and Meta-Analysis. Am J Prev Med. 2022 Apr;62(4):614-625. doi: 10.1016/j.amepre.2021.10.020. Epub 2022 Feb 10. PMID: 35151523.
Guest: Jillian Joseph, MPAS, PA-C Music Credit: Richard Onorato]]></itunes:summary>
        <itunes:author>Pri-Med</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>650</itunes:duration>
                        <itunes:episodeType>full</itunes:episodeType>
            </item>
    <item>
        <title>What Do You Mean That Glass of Red Wine Is No Longer OK to Drink? - Frankly Speaking Ep 334</title>
        <itunes:title>What Do You Mean That Glass of Red Wine Is No Longer OK to Drink? - Frankly Speaking Ep 334</itunes:title>
        <link>https://primedfranklyspeaking.podbean.com/e/what-do-you-mean-that-glass-of-red-wine-is-no-longer-ok-to-drink-frankly-speaking-ep-334/</link>
                    <comments>https://primedfranklyspeaking.podbean.com/e/what-do-you-mean-that-glass-of-red-wine-is-no-longer-ok-to-drink-frankly-speaking-ep-334/#comments</comments>        <pubDate>Mon, 26 Jun 2023 00:30:00 +0000</pubDate>
        <guid isPermaLink="false">primedfranklyspeaking.podbean.com/2a3591eb-481c-3e8a-bb1e-19047b5bc38c</guid>
                                    <description><![CDATA[<p>Credits: 0.25 AMA PRA Category 1 Credit™
 
CME/CE Information and Claim Credit: <a href='https://www.pri-med.com/online-education/podcast/frankly-speaking-cme-334'>https://www.pri-med.com/online-education/podcast/frankly-speaking-cme-334</a></p>
<p>Overview: It can be tricky to navigate conflicting data when discussing alcohol intake with patients, so we’re here to discuss the topic’s most recent evidence. In this episode, we take a look at the findings to help you and your patients make informed decisions about daily alcohol consumption and their health.</p>
<p>Episode resource links:</p>
<ul><li>JAMA Network Open. 2023;6(3):e236185. doi:10.1001/jamanetworkopen.2023.6185</li>
</ul>
<p>Guest: Robert A. Baldor MD, FAAFP
 
Music Credit: Richard Onorato</p>
]]></description>
                                                            <content:encoded><![CDATA[<p>Credits: 0.25 AMA PRA Category 1 Credit™<br>
 <br>
CME/CE Information and Claim Credit: <a href='https://www.pri-med.com/online-education/podcast/frankly-speaking-cme-334'>https://www.pri-med.com/online-education/podcast/frankly-speaking-cme-334</a></p>
<p>Overview: It can be tricky to navigate conflicting data when discussing alcohol intake with patients, so we’re here to discuss the topic’s most recent evidence. In this episode, we take a look at the findings to help you and your patients make informed decisions about daily alcohol consumption and their health.</p>
<p>Episode resource links:</p>
<ul><li>JAMA Network Open. 2023;6(3):e236185. doi:10.1001/jamanetworkopen.2023.6185</li>
</ul>
<p>Guest: Robert A. Baldor MD, FAAFP<br>
 <br>
Music Credit: Richard Onorato</p>
]]></content:encoded>
                                    
        <enclosure url="https://mcdn.podbean.com/mf/web/3amx4u/frankly-speaking-334-wine-etoh.mp3" length="8240358" type="audio/mpeg"/>
                <itunes:summary><![CDATA[Credits: 0.25 AMA PRA Category 1 Credit™ CME/CE Information and Claim Credit: https://www.pri-med.com/online-education/podcast/frankly-speaking-cme-334
Overview: It can be tricky to navigate conflicting data when discussing alcohol intake with patients, so we’re here to discuss the topic’s most recent evidence. In this episode, we take a look at the findings to help you and your patients make informed decisions about daily alcohol consumption and their health.
Episode resource links:
JAMA Network Open. 2023;6(3):e236185. doi:10.1001/jamanetworkopen.2023.6185
Guest: Robert A. Baldor MD, FAAFP Music Credit: Richard Onorato]]></itunes:summary>
        <itunes:author>Pri-Med</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>513</itunes:duration>
                        <itunes:episodeType>full</itunes:episodeType>
            </item>
    <item>
        <title>Navigating Perceived Stress in Older Adults: From Awareness to Action - Frankly Speaking Ep 333</title>
        <itunes:title>Navigating Perceived Stress in Older Adults: From Awareness to Action - Frankly Speaking Ep 333</itunes:title>
        <link>https://primedfranklyspeaking.podbean.com/e/navigating-perceived-stress-in-older-adults-from-awareness-to-action-frankly-speaking-ep-333/</link>
                    <comments>https://primedfranklyspeaking.podbean.com/e/navigating-perceived-stress-in-older-adults-from-awareness-to-action-frankly-speaking-ep-333/#comments</comments>        <pubDate>Mon, 19 Jun 2023 00:30:00 +0000</pubDate>
        <guid isPermaLink="false">primedfranklyspeaking.podbean.com/5bc8d572-ddf5-3535-b46e-9ed1f47b7c56</guid>
                                    <description><![CDATA[<p>Credits: 0.25 AMA PRA Category 1 Credit™
 
CME/CE Information and Claim Credit: <a href='https://www.pri-med.com/online-education/podcast/frankly-speaking-cme-333'>https://www.pri-med.com/online-education/podcast/frankly-speaking-cme-333</a></p>
<p>Overview: Tune in as we discuss the potential consequences of perceived stress on the cognition and well-being of older adults. We explore screening and intervention opportunities to better help you recognize and manage stress in your patients aged ≥45 years.</p>
<p>Episode resource links:</p>
<ul><li>Kulshreshtha, A., Alonso, A., McClure, L. A., Hajjar, I., Manly, J. J., & Judd, S. (2023). Association of Stress With Cognitive Function Among Older Black and White US Adults. JAMA network open, 6(3), e231860. <a href='https://doi.org/10.1001/jamanetworkopen.2023.1860'>https://doi.org/10.1001/jamanetworkopen.2023.1860</a></li>
<li>Top 12 Apps for Mindfulness <a href='https://positivepsychology.com/mindfulness-apps/'>https://positivepsychology.com/mindfulness-apps/</a></li>
<li>15 Simple Ways to Relieve Stress <a href='https://www.healthline.com/nutrition/16-ways-relieve-stress-anxiety'>15 Simple Ways to Relieve Stress and Anxiety (healthline.com)</a></li>
</ul>
<p>Guest: Jill M. Terrien PhD, ANP-BC 
 
Music Credit: Richard Onorato</p>
]]></description>
                                                            <content:encoded><![CDATA[<p>Credits: 0.25 AMA PRA Category 1 Credit™<br>
 <br>
CME/CE Information and Claim Credit: <a href='https://www.pri-med.com/online-education/podcast/frankly-speaking-cme-333'>https://www.pri-med.com/online-education/podcast/frankly-speaking-cme-333</a></p>
<p>Overview: Tune in as we discuss the potential consequences of perceived stress on the cognition and well-being of older adults. We explore screening and intervention opportunities to better help you recognize and manage stress in your patients aged ≥45 years.</p>
<p>Episode resource links:</p>
<ul><li>Kulshreshtha, A., Alonso, A., McClure, L. A., Hajjar, I., Manly, J. J., & Judd, S. (2023). Association of Stress With Cognitive Function Among Older Black and White US Adults. JAMA network open, 6(3), e231860. <a href='https://doi.org/10.1001/jamanetworkopen.2023.1860'>https://doi.org/10.1001/jamanetworkopen.2023.1860</a></li>
<li>Top 12 Apps for Mindfulness <a href='https://positivepsychology.com/mindfulness-apps/'>https://positivepsychology.com/mindfulness-apps/</a></li>
<li>15 Simple Ways to Relieve Stress <a href='https://www.healthline.com/nutrition/16-ways-relieve-stress-anxiety'>15 Simple Ways to Relieve Stress and Anxiety (healthline.com)</a></li>
</ul>
<p>Guest: Jill M. Terrien PhD, ANP-BC <br>
 <br>
Music Credit: Richard Onorato</p>
]]></content:encoded>
                                    
        <enclosure url="https://mcdn.podbean.com/mf/web/yth8ie/frankly-speaking-333-cognition-and-stress.mp3" length="10035073" type="audio/mpeg"/>
                <itunes:summary><![CDATA[Credits: 0.25 AMA PRA Category 1 Credit™ CME/CE Information and Claim Credit: https://www.pri-med.com/online-education/podcast/frankly-speaking-cme-333
Overview: Tune in as we discuss the potential consequences of perceived stress on the cognition and well-being of older adults. We explore screening and intervention opportunities to better help you recognize and manage stress in your patients aged ≥45 years.
Episode resource links:
Kulshreshtha, A., Alonso, A., McClure, L. A., Hajjar, I., Manly, J. J., & Judd, S. (2023). Association of Stress With Cognitive Function Among Older Black and White US Adults. JAMA network open, 6(3), e231860. https://doi.org/10.1001/jamanetworkopen.2023.1860
Top 12 Apps for Mindfulness https://positivepsychology.com/mindfulness-apps/
15 Simple Ways to Relieve Stress 15 Simple Ways to Relieve Stress and Anxiety (healthline.com)
Guest: Jill M. Terrien PhD, ANP-BC  Music Credit: Richard Onorato]]></itunes:summary>
        <itunes:author>Pri-Med</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>625</itunes:duration>
                        <itunes:episodeType>full</itunes:episodeType>
            </item>
    <item>
        <title>Decoding Hyperlipidemia Management: What Does the Evidence Say? - Frankly Speaking Ep 332</title>
        <itunes:title>Decoding Hyperlipidemia Management: What Does the Evidence Say? - Frankly Speaking Ep 332</itunes:title>
        <link>https://primedfranklyspeaking.podbean.com/e/decoding-hyperlipidemia-management-what-does-the-evidence-say-frankly-speaking-ep-332/</link>
                    <comments>https://primedfranklyspeaking.podbean.com/e/decoding-hyperlipidemia-management-what-does-the-evidence-say-frankly-speaking-ep-332/#comments</comments>        <pubDate>Mon, 12 Jun 2023 00:30:00 +0000</pubDate>
        <guid isPermaLink="false">primedfranklyspeaking.podbean.com/c8e50313-c948-31ef-8016-7124a7fc79db</guid>
                                    <description><![CDATA[<p>Credits: 0.25 AMA PRA Category 1 Credit™
 
CME/CE Information and Claim Credit: <a href='https://www.pri-med.com/online-education/podcast/frankly-speaking-cme-332'>https://www.pri-med.com/online-education/podcast/frankly-speaking-cme-332</a></p>
<p>Overview: In this episode, we take a look at the dynamic landscape of hyperlipidemia management, discussing current guidelines for hyperlipidemia treatment and the interplay between evidence-based recommendations and expert opinions. Tune in to gain a broader understanding of hyperlipidemia management and unlock fresh perspectives to enhance patient care.</p>
<p>Episode resource links:</p>
<ul><li>JAMA Intern Med. March 14, 2022. doi:10.1001/jamainternmed.2022.0134</li>
<li>JAMA. Published online March 6, 2023. doi:10.1001/jama.2023.2487</li>
</ul>
<p>Guest: Robert A. Baldor MD, FAAFP
 
Music Credit: Richard Onorato</p>
]]></description>
                                                            <content:encoded><![CDATA[<p>Credits: 0.25 AMA PRA Category 1 Credit™<br>
 <br>
CME/CE Information and Claim Credit: <a href='https://www.pri-med.com/online-education/podcast/frankly-speaking-cme-332'>https://www.pri-med.com/online-education/podcast/frankly-speaking-cme-332</a></p>
<p>Overview: In this episode, we take a look at the dynamic landscape of hyperlipidemia management, discussing current guidelines for hyperlipidemia treatment and the interplay between evidence-based recommendations and expert opinions. Tune in to gain a broader understanding of hyperlipidemia management and unlock fresh perspectives to enhance patient care.</p>
<p>Episode resource links:</p>
<ul><li>JAMA Intern Med. March 14, 2022. doi:10.1001/jamainternmed.2022.0134</li>
<li>JAMA. Published online March 6, 2023. doi:10.1001/jama.2023.2487</li>
</ul>
<p>Guest: Robert A. Baldor MD, FAAFP<br>
 <br>
Music Credit: Richard Onorato</p>
]]></content:encoded>
                                    
        <enclosure url="https://mcdn.podbean.com/mf/web/drt38d/frankly-speaking-332-LDL.mp3" length="12483862" type="audio/mpeg"/>
                <itunes:summary><![CDATA[Credits: 0.25 AMA PRA Category 1 Credit™ CME/CE Information and Claim Credit: https://www.pri-med.com/online-education/podcast/frankly-speaking-cme-332
Overview: In this episode, we take a look at the dynamic landscape of hyperlipidemia management, discussing current guidelines for hyperlipidemia treatment and the interplay between evidence-based recommendations and expert opinions. Tune in to gain a broader understanding of hyperlipidemia management and unlock fresh perspectives to enhance patient care.
Episode resource links:
JAMA Intern Med. March 14, 2022. doi:10.1001/jamainternmed.2022.0134
JAMA. Published online March 6, 2023. doi:10.1001/jama.2023.2487
Guest: Robert A. Baldor MD, FAAFP Music Credit: Richard Onorato]]></itunes:summary>
        <itunes:author>Pri-Med</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>778</itunes:duration>
                        <itunes:episodeType>full</itunes:episodeType>
            </item>
    <item>
        <title>When to Start Screening for Breast Cancer—Does Race Make a Difference? - Frankly Speaking Ep 331</title>
        <itunes:title>When to Start Screening for Breast Cancer—Does Race Make a Difference? - Frankly Speaking Ep 331</itunes:title>
        <link>https://primedfranklyspeaking.podbean.com/e/when-to-start-screening-for-breast-cancer%e2%80%94does-race-make-a-difference-frankly-speaking-ep-331/</link>
                    <comments>https://primedfranklyspeaking.podbean.com/e/when-to-start-screening-for-breast-cancer%e2%80%94does-race-make-a-difference-frankly-speaking-ep-331/#comments</comments>        <pubDate>Mon, 05 Jun 2023 00:30:00 +0000</pubDate>
        <guid isPermaLink="false">primedfranklyspeaking.podbean.com/aac56f88-2762-3bc4-a245-514f028a38d9</guid>
                                    <description><![CDATA[<p>Credits: 0.25 AMA PRA Category 1 Credit™
 
CME/CE Information and Claim Credit: <a href='https://www.pri-med.com/online-education/podcast/frankly-speaking-cme-331'>https://www.pri-med.com/online-education/podcast/frankly-speaking-cme-331</a></p>
<p>Overview: Current recommendations for when to start breast cancer screening do not consider race or ethnicity, which may be a source of racial disparity in breast cancer outcomes. In this installment, we take a closer look at these recommendations and how you can incorporate them into individualized patient care.</p>
<p>Episode resource links:</p>
<ul><li>Chen T, Kharazmi E, Fallah M. Race and Ethnicity-Adjusted Age Recommendation for Initiating Breast Cancer Screening. JAMA Netw Open. 2023;6(4):e238893. Published 2023 Apr 3.</li>
<li>Siu AL; U.S. Preventive Services Task Force. Screening for Breast Cancer: U.S. Preventive Services Task Force Recommendation Statement [published correction appears in Ann Intern Med. 2016 Mar 15;164(6):448]. Ann Intern Med. 2016;164(4):279-296</li>
<li>Oeffinger KC, Fontham ET, Etzioni R, et al. Breast Cancer Screening for Women at Average Risk: 2015 Guideline Update From the American Cancer Society [published correction appears in JAMA. 2016 Apr 5;315(13):1406]. JAMA. 2015;314(15):1599-1614. </li>
<li>Draft Update of USPSTF Screening for Breast Cancer: <a href='https://www.uspreventiveservicestaskforce.org/uspstf/draft-recommendation/breast-cancer-screening-adults'>https://www.uspreventiveservicestaskforce.org/uspstf/draft-recommendation/breast-cancer-screening-adults</a></li>
</ul>
<p>Guest: Alan M. Ehrlich MD, FAAFP
 
Music Credit: Richard Onorato</p>
]]></description>
                                                            <content:encoded><![CDATA[<p>Credits: 0.25 AMA PRA Category 1 Credit™<br>
 <br>
CME/CE Information and Claim Credit: <a href='https://www.pri-med.com/online-education/podcast/frankly-speaking-cme-331'>https://www.pri-med.com/online-education/podcast/frankly-speaking-cme-331</a></p>
<p>Overview: Current recommendations for when to start breast cancer screening do not consider race or ethnicity, which may be a source of racial disparity in breast cancer outcomes. In this installment, we take a closer look at these recommendations and how you can incorporate them into individualized patient care.</p>
<p>Episode resource links:</p>
<ul><li>Chen T, Kharazmi E, Fallah M. Race and Ethnicity-Adjusted Age Recommendation for Initiating Breast Cancer Screening. JAMA Netw Open. 2023;6(4):e238893. Published 2023 Apr 3.</li>
<li>Siu AL; U.S. Preventive Services Task Force. Screening for Breast Cancer: U.S. Preventive Services Task Force Recommendation Statement [published correction appears in Ann Intern Med. 2016 Mar 15;164(6):448]. Ann Intern Med. 2016;164(4):279-296</li>
<li>Oeffinger KC, Fontham ET, Etzioni R, et al. Breast Cancer Screening for Women at Average Risk: 2015 Guideline Update From the American Cancer Society [published correction appears in JAMA. 2016 Apr 5;315(13):1406]. JAMA. 2015;314(15):1599-1614. </li>
<li>Draft Update of USPSTF Screening for Breast Cancer: <a href='https://www.uspreventiveservicestaskforce.org/uspstf/draft-recommendation/breast-cancer-screening-adults'>https://www.uspreventiveservicestaskforce.org/uspstf/draft-recommendation/breast-cancer-screening-adults</a></li>
</ul>
<p>Guest: Alan M. Ehrlich MD, FAAFP<br>
 <br>
Music Credit: Richard Onorato</p>
]]></content:encoded>
                                    
        <enclosure url="https://mcdn.podbean.com/mf/web/mnd3gj/frankly-speaking-331-breast-cancer-black-women.mp3" length="10686718" type="audio/mpeg"/>
                <itunes:summary><![CDATA[Credits: 0.25 AMA PRA Category 1 Credit™ CME/CE Information and Claim Credit: https://www.pri-med.com/online-education/podcast/frankly-speaking-cme-331
Overview: Current recommendations for when to start breast cancer screening do not consider race or ethnicity, which may be a source of racial disparity in breast cancer outcomes. In this installment, we take a closer look at these recommendations and how you can incorporate them into individualized patient care.
Episode resource links:
Chen T, Kharazmi E, Fallah M. Race and Ethnicity-Adjusted Age Recommendation for Initiating Breast Cancer Screening. JAMA Netw Open. 2023;6(4):e238893. Published 2023 Apr 3.
Siu AL; U.S. Preventive Services Task Force. Screening for Breast Cancer: U.S. Preventive Services Task Force Recommendation Statement [published correction appears in Ann Intern Med. 2016 Mar 15;164(6):448]. Ann Intern Med. 2016;164(4):279-296
Oeffinger KC, Fontham ET, Etzioni R, et al. Breast Cancer Screening for Women at Average Risk: 2015 Guideline Update From the American Cancer Society [published correction appears in JAMA. 2016 Apr 5;315(13):1406]. JAMA. 2015;314(15):1599-1614. 
Draft Update of USPSTF Screening for Breast Cancer: https://www.uspreventiveservicestaskforce.org/uspstf/draft-recommendation/breast-cancer-screening-adults
Guest: Alan M. Ehrlich MD, FAAFP Music Credit: Richard Onorato]]></itunes:summary>
        <itunes:author>Pri-Med</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>666</itunes:duration>
                        <itunes:episodeType>full</itunes:episodeType>
            </item>
    <item>
        <title>Long COVID: Strategies for Approaching Patient Care - Frankly Speaking Ep 330</title>
        <itunes:title>Long COVID: Strategies for Approaching Patient Care - Frankly Speaking Ep 330</itunes:title>
        <link>https://primedfranklyspeaking.podbean.com/e/long-covid-strategies-for-approaching-patient-care-frankly-speaking-ep-330/</link>
                    <comments>https://primedfranklyspeaking.podbean.com/e/long-covid-strategies-for-approaching-patient-care-frankly-speaking-ep-330/#comments</comments>        <pubDate>Mon, 29 May 2023 00:30:00 +0000</pubDate>
        <guid isPermaLink="false">primedfranklyspeaking.podbean.com/67fef35f-61b3-3901-bf9a-281332cdc46b</guid>
                                    <description><![CDATA[<p>Credits: 0.25 AMA PRA Category 1 Credit™
 
CME/CE Information and Claim Credit: <a href='https://www.pri-med.com/online-education/podcast/frankly-speaking-cme-330'>https://www.pri-med.com/online-education/podcast/frankly-speaking-cme-330</a></p>
<p>Overview: The CDC’s Household Pulse Survey data indicate that more than 10% of adults who contracted COVID-19 have had symptoms that lasted at least 3 months. While patients worry about long COVID, there are no specific tests to confirm its diagnosis. In this episode, we discuss a recent JAMA article that addresses the primary care approach to long COVID.</p>
<p>Episode resource links:</p>
<ul><li>Landhuis EW. How Primary Care Physicians Can Recognize and Treat Long COVID. JAMA. Published online May 03, 2023. doi:10.1001/jama.2023.6604</li>
<li>JAMA. 2022;328(16):1604. PMID: 36215063</li>
<li><a href='https://www.cdc.gov/coronavirus/2019-ncov/hcp/clinical-care/post-covid-conditions.html#management:~:text=Patients%20with%20Post-COVID%20Conditions%20may%2Cpacing%20for%20post-exertional%20malaise.'>Post-COVID Conditions: Information for Healthcare Providers (cdc.gov)</a></li>
</ul>
<p>Guest: Robert A. Baldor MD, FAAFP

Music Credit: Richard Onorato</p>
]]></description>
                                                            <content:encoded><![CDATA[<p>Credits: 0.25 AMA PRA Category 1 Credit™<br>
 <br>
CME/CE Information and Claim Credit: <a href='https://www.pri-med.com/online-education/podcast/frankly-speaking-cme-330'>https://www.pri-med.com/online-education/podcast/frankly-speaking-cme-330</a></p>
<p>Overview: The CDC’s Household Pulse Survey data indicate that more than 10% of adults who contracted COVID-19 have had symptoms that lasted at least 3 months. While patients worry about long COVID, there are no specific tests to confirm its diagnosis. In this episode, we discuss a recent JAMA article that addresses the primary care approach to long COVID.</p>
<p>Episode resource links:</p>
<ul><li>Landhuis EW. How Primary Care Physicians Can Recognize and Treat Long COVID. JAMA. Published online May 03, 2023. doi:10.1001/jama.2023.6604</li>
<li>JAMA. 2022;328(16):1604. PMID: 36215063</li>
<li><a href='https://www.cdc.gov/coronavirus/2019-ncov/hcp/clinical-care/post-covid-conditions.html#management:~:text=Patients%20with%20Post-COVID%20Conditions%20may%2Cpacing%20for%20post-exertional%20malaise.'>Post-COVID Conditions: Information for Healthcare Providers (cdc.gov)</a></li>
</ul>
<p>Guest: Robert A. Baldor MD, FAAFP<br>
<br>
Music Credit: Richard Onorato</p>
]]></content:encoded>
                                    
        <enclosure url="https://mcdn.podbean.com/mf/web/8h23m4/frankly-speaking-330-long-covid-_1.mp3" length="8957716" type="audio/mpeg"/>
                <itunes:summary><![CDATA[Credits: 0.25 AMA PRA Category 1 Credit™ CME/CE Information and Claim Credit: https://www.pri-med.com/online-education/podcast/frankly-speaking-cme-330
Overview: The CDC’s Household Pulse Survey data indicate that more than 10% of adults who contracted COVID-19 have had symptoms that lasted at least 3 months. While patients worry about long COVID, there are no specific tests to confirm its diagnosis. In this episode, we discuss a recent JAMA article that addresses the primary care approach to long COVID.
Episode resource links:
Landhuis EW. How Primary Care Physicians Can Recognize and Treat Long COVID. JAMA. Published online May 03, 2023. doi:10.1001/jama.2023.6604
JAMA. 2022;328(16):1604. PMID: 36215063
Post-COVID Conditions: Information for Healthcare Providers (cdc.gov)
Guest: Robert A. Baldor MD, FAAFPMusic Credit: Richard Onorato]]></itunes:summary>
        <itunes:author>Pri-Med</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>558</itunes:duration>
                        <itunes:episodeType>full</itunes:episodeType>
            </item>
    <item>
        <title>Can Cocoa or a Multivitamin Prevent Dementia? - Frankly Speaking Ep 329</title>
        <itunes:title>Can Cocoa or a Multivitamin Prevent Dementia? - Frankly Speaking Ep 329</itunes:title>
        <link>https://primedfranklyspeaking.podbean.com/e/can-cocoa-or-a-multivitamin-prevent-dementia-frankly-speaking-ep-329/</link>
                    <comments>https://primedfranklyspeaking.podbean.com/e/can-cocoa-or-a-multivitamin-prevent-dementia-frankly-speaking-ep-329/#comments</comments>        <pubDate>Mon, 22 May 2023 00:30:00 +0000</pubDate>
        <guid isPermaLink="false">primedfranklyspeaking.podbean.com/6247ee1d-6d28-3582-acf5-f680be299132</guid>
                                    <description><![CDATA[<p>Credits: 0.25 AMA PRA Category 1 Credit™
 
CME/CE Information and Claim Credit: <a href='https://www.pri-med.com/online-education/podcast/frankly-speaking-cme-329'>https://www.pri-med.com/online-education/podcast/frankly-speaking-cme-329</a></p>
<p>Overview: Do you have older patients asking for guidance on what supplements can be used to prevent cognitive decline? Listen in to hear the findings of a recent Alzheimer’s & Dementia publication of a randomized controlled trial looking at the benefits and harms related to using cocoa and multivitamins for preventing cognitive decline.</p>
<p>Episode resource links:</p>
<ul><li>Baker LD,Manson JE, Rapp SR, et al. Effects of cocoa extract and a multivitamin on cognitive function: A randomized clinical trial. Alzheimer’s Dement.2022;1-12. https://doi.org/10.1002/alz.12767</li>
<li>Recommendation: Vitamin, Mineral, and Multivitamin Supplementation to Prevent Cardiovascular Disease and Cancer: Preventive Medication | United States Preventive Services Taskforce <a href='https://www.uspreventiveservicestaskforce.org/uspstf/recommendation/vitamin-supplementation-to-prevent-cvd-and-cancer-preventive-medication'>https://www.uspreventiveservicestaskforce.org/uspstf/recommendation/vitamin-supplementation-to-prevent-cvd-and-cancer-preventive-medication</a></li>
</ul>
<p>Guest: Robert A. Baldor MD, FAAFP
 
Music Credit: Richard Onorato</p>
]]></description>
                                                            <content:encoded><![CDATA[<p>Credits: 0.25 AMA PRA Category 1 Credit™<br>
 <br>
CME/CE Information and Claim Credit: <a href='https://www.pri-med.com/online-education/podcast/frankly-speaking-cme-329'>https://www.pri-med.com/online-education/podcast/frankly-speaking-cme-329</a></p>
<p>Overview: Do you have older patients asking for guidance on what supplements can be used to prevent cognitive decline? Listen in to hear the findings of a recent Alzheimer’s & Dementia publication of a randomized controlled trial looking at the benefits and harms related to using cocoa and multivitamins for preventing cognitive decline.</p>
<p>Episode resource links:</p>
<ul><li>Baker LD,Manson JE, Rapp SR, et al. Effects of cocoa extract and a multivitamin on cognitive function: A randomized clinical trial. Alzheimer’s Dement.2022;1-12. https://doi.org/10.1002/alz.12767</li>
<li>Recommendation: Vitamin, Mineral, and Multivitamin Supplementation to Prevent Cardiovascular Disease and Cancer: Preventive Medication | United States Preventive Services Taskforce <a href='https://www.uspreventiveservicestaskforce.org/uspstf/recommendation/vitamin-supplementation-to-prevent-cvd-and-cancer-preventive-medication'>https://www.uspreventiveservicestaskforce.org/uspstf/recommendation/vitamin-supplementation-to-prevent-cvd-and-cancer-preventive-medication</a></li>
</ul>
<p>Guest: Robert A. Baldor MD, FAAFP<br>
 <br>
Music Credit: Richard Onorato</p>
]]></content:encoded>
                                    
        <enclosure url="https://mcdn.podbean.com/mf/web/c9bzaz/frankly-speaking-329-cocoa-cognition.mp3" length="9144906" type="audio/mpeg"/>
                <itunes:summary><![CDATA[Credits: 0.25 AMA PRA Category 1 Credit™ CME/CE Information and Claim Credit: https://www.pri-med.com/online-education/podcast/frankly-speaking-cme-329
Overview: Do you have older patients asking for guidance on what supplements can be used to prevent cognitive decline? Listen in to hear the findings of a recent Alzheimer’s & Dementia publication of a randomized controlled trial looking at the benefits and harms related to using cocoa and multivitamins for preventing cognitive decline.
Episode resource links:
Baker LD,Manson JE, Rapp SR, et al. Effects of cocoa extract and a multivitamin on cognitive function: A randomized clinical trial. Alzheimer’s Dement.2022;1-12. https://doi.org/10.1002/alz.12767
Recommendation: Vitamin, Mineral, and Multivitamin Supplementation to Prevent Cardiovascular Disease and Cancer: Preventive Medication | United States Preventive Services Taskforce https://www.uspreventiveservicestaskforce.org/uspstf/recommendation/vitamin-supplementation-to-prevent-cvd-and-cancer-preventive-medication
Guest: Robert A. Baldor MD, FAAFP Music Credit: Richard Onorato]]></itunes:summary>
        <itunes:author>Pri-Med</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>568</itunes:duration>
                        <itunes:episodeType>full</itunes:episodeType>
            </item>
    <item>
        <title>Live Longer by Eating Better - Frankly Speaking Ep 328</title>
        <itunes:title>Live Longer by Eating Better - Frankly Speaking Ep 328</itunes:title>
        <link>https://primedfranklyspeaking.podbean.com/e/live-longer-by-eating-better-frankly-speaking-ep-328/</link>
                    <comments>https://primedfranklyspeaking.podbean.com/e/live-longer-by-eating-better-frankly-speaking-ep-328/#comments</comments>        <pubDate>Mon, 15 May 2023 00:30:00 +0000</pubDate>
        <guid isPermaLink="false">primedfranklyspeaking.podbean.com/d413da3f-2d96-316c-be06-995ccf95ffa6</guid>
                                    <description><![CDATA[<p>Credits: 0.25 AMA PRA Category 1 Credit™
 
CME/CE Information and Claim Credit: <a href='https://www.pri-med.com/online-education/podcast/frankly-speaking-cme-328'>https://www.pri-med.com/online-education/podcast/frankly-speaking-cme-328</a></p>
<p>Overview: Are you tired of sifting through conflicting information about nutrition and mortality? Look no further than this podcast episode, where we dive deep into the latest dietary research. With so much conjecture and small data sets out there, it can be challenging to know what advice to give. Tune in to this discussion to gain valuable insights and to make informed recommendations about healthy eating habits for your patients.</p>
<p>Episode resource links:</p>
<ul><li>JAMA Intern Med. doi:10.1001/jamainternmed.2022.6117
Nutrients 2021 Jul 9;13(7):2342. doi: 10.3390/nu13072342.</li>
</ul>
<p>Guest: Robert A. Baldor MD, FAAFP
 
Music Credit: Richard Onorato</p>
]]></description>
                                                            <content:encoded><![CDATA[<p>Credits: 0.25 AMA PRA Category 1 Credit™<br>
 <br>
CME/CE Information and Claim Credit: <a href='https://www.pri-med.com/online-education/podcast/frankly-speaking-cme-328'>https://www.pri-med.com/online-education/podcast/frankly-speaking-cme-328</a></p>
<p>Overview: Are you tired of sifting through conflicting information about nutrition and mortality? Look no further than this podcast episode, where we dive deep into the latest dietary research. With so much conjecture and small data sets out there, it can be challenging to know what advice to give. Tune in to this discussion to gain valuable insights and to make informed recommendations about healthy eating habits for your patients.</p>
<p>Episode resource links:</p>
<ul><li>JAMA Intern Med. doi:10.1001/jamainternmed.2022.6117<br>
Nutrients 2021 Jul 9;13(7):2342. doi: 10.3390/nu13072342.</li>
</ul>
<p>Guest: Robert A. Baldor MD, FAAFP<br>
 <br>
Music Credit: Richard Onorato</p>
]]></content:encoded>
                                    
        <enclosure url="https://mcdn.podbean.com/mf/web/v3t9sa/frankly-speaking-328-healthy-eating.mp3" length="11699733" type="audio/mpeg"/>
                <itunes:summary><![CDATA[Credits: 0.25 AMA PRA Category 1 Credit™ CME/CE Information and Claim Credit: https://www.pri-med.com/online-education/podcast/frankly-speaking-cme-328
Overview: Are you tired of sifting through conflicting information about nutrition and mortality? Look no further than this podcast episode, where we dive deep into the latest dietary research. With so much conjecture and small data sets out there, it can be challenging to know what advice to give. Tune in to this discussion to gain valuable insights and to make informed recommendations about healthy eating habits for your patients.
Episode resource links:
JAMA Intern Med. doi:10.1001/jamainternmed.2022.6117Nutrients 2021 Jul 9;13(7):2342. doi: 10.3390/nu13072342.
Guest: Robert A. Baldor MD, FAAFP Music Credit: Richard Onorato]]></itunes:summary>
        <itunes:author>Pri-Med</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>728</itunes:duration>
                        <itunes:episodeType>full</itunes:episodeType>
            </item>
    <item>
        <title>As We Wave Goodbye to the Waiver!  - Frankly Speaking Ep 327</title>
        <itunes:title>As We Wave Goodbye to the Waiver!  - Frankly Speaking Ep 327</itunes:title>
        <link>https://primedfranklyspeaking.podbean.com/e/as-we-wave-goodbye-to-the-waiver/</link>
                    <comments>https://primedfranklyspeaking.podbean.com/e/as-we-wave-goodbye-to-the-waiver/#comments</comments>        <pubDate>Mon, 08 May 2023 00:30:00 +0000</pubDate>
        <guid isPermaLink="false">primedfranklyspeaking.podbean.com/9fd096a9-76b5-3357-b974-7977fd8e1106</guid>
                                    <description><![CDATA[<p>Credits: 0.25 AMA PRA Category 1 Credit™
 
CME/CE Information and Claim Credit: <a href='https://www.pri-med.com/online-education/podcast/frankly-speaking-cme-327'>https://www.pri-med.com/online-education/podcast/frankly-speaking-cme-327</a></p>
<p>Overview: Congress has recently made changes to help fight the opioid epidemic and allow for an increase in access to treatment for opioid use disorder (OUD). Join us as we review these changes, and learn how you can use them to promote health equity in a clinical setting.</p>
<p>Episode resource links:</p>
<ul><li>Hawk, K., Hoppe, J., Ketcham, E., LaPietra, A., Moulin, A., Nelson, L., ... & D’Onofrio, G. (2021). Consensus recommendations on the treatment of opioid use disorder in the emergency department. Annals of emergency medicine, 78(3), 434-442.</li>
<li>
<p>Jones, K. F., O'Reilly-Jacob, M., & Tierney, M. (2022). Eliminating the buprenorphine DEA X waiver is critical to promote health equity. Nursing outlook, 70(1), 5-7.</p>
</li>
<li>
<p>Jones, K. F. , Jacob, M. O. , Spetz, J. , Hailer, L. & Tierney, M.  (9000). Eliminate the buprenorphine DEA X waiver: Justification using a policy analysis approach.  Journal of Nursing Scholarship,  , doi: 10.1111/jnu.12871.</p>
</li>
</ul>
<p>Guest: Mariyan L. Montaque, DNP, FNP-BC

Music Credit: Richard Onorato</p>
]]></description>
                                                            <content:encoded><![CDATA[<p>Credits: 0.25 AMA PRA Category 1 Credit™<br>
 <br>
CME/CE Information and Claim Credit: <a href='https://www.pri-med.com/online-education/podcast/frankly-speaking-cme-327'>https://www.pri-med.com/online-education/podcast/frankly-speaking-cme-327</a></p>
<p>Overview: Congress has recently made changes to help fight the opioid epidemic and allow for an increase in access to treatment for opioid use disorder (OUD). Join us as we review these changes, and learn how you can use them to promote health equity in a clinical setting.</p>
<p>Episode resource links:</p>
<ul><li>Hawk, K., Hoppe, J., Ketcham, E., LaPietra, A., Moulin, A., Nelson, L., ... & D’Onofrio, G. (2021). Consensus recommendations on the treatment of opioid use disorder in the emergency department. <em>Annals of emergency medicine</em>, <em>78</em>(3), 434-442.</li>
<li>
<p>Jones, K. F., O'Reilly-Jacob, M., & Tierney, M. (2022). Eliminating the buprenorphine DEA X waiver is critical to promote health equity. <em>Nursing outlook</em>, <em>70</em>(1), 5-7.</p>
</li>
<li>
<p>Jones, K. F. , Jacob, M. O. , Spetz, J. , Hailer, L. & Tierney, M.  (9000). Eliminate the buprenorphine DEA X waiver: Justification using a policy analysis approach.  <em>Journal of Nursing Scholarship,  </em>, doi: 10.1111/jnu.12871.</p>
</li>
</ul>
<p>Guest: Mariyan L. Montaque, DNP, FNP-BC<br>
<br>
Music Credit: Richard Onorato</p>
]]></content:encoded>
                                    
        <enclosure url="https://mcdn.podbean.com/mf/web/wsuwfa/frankly-speaking-327-Xwaiver_1.mp3" length="9302249" type="audio/mpeg"/>
                <itunes:summary><![CDATA[Credits: 0.25 AMA PRA Category 1 Credit™ CME/CE Information and Claim Credit: https://www.pri-med.com/online-education/podcast/frankly-speaking-cme-327
Overview: Congress has recently made changes to help fight the opioid epidemic and allow for an increase in access to treatment for opioid use disorder (OUD). Join us as we review these changes, and learn how you can use them to promote health equity in a clinical setting.
Episode resource links:
Hawk, K., Hoppe, J., Ketcham, E., LaPietra, A., Moulin, A., Nelson, L., ... & D’Onofrio, G. (2021). Consensus recommendations on the treatment of opioid use disorder in the emergency department. Annals of emergency medicine, 78(3), 434-442.

Jones, K. F., O'Reilly-Jacob, M., & Tierney, M. (2022). Eliminating the buprenorphine DEA X waiver is critical to promote health equity. Nursing outlook, 70(1), 5-7.


Jones, K. F. , Jacob, M. O. , Spetz, J. , Hailer, L. & Tierney, M.  (9000). Eliminate the buprenorphine DEA X waiver: Justification using a policy analysis approach.  Journal of Nursing Scholarship,  , doi: 10.1111/jnu.12871.

Guest: Mariyan L. Montaque, DNP, FNP-BCMusic Credit: Richard Onorato]]></itunes:summary>
        <itunes:author>Pri-Med</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>578</itunes:duration>
                        <itunes:episodeType>full</itunes:episodeType>
            </item>
    <item>
        <title>Screening for Alcohol Use and Abuse: Prevention with a Capital P - Frankly Speaking Ep 326</title>
        <itunes:title>Screening for Alcohol Use and Abuse: Prevention with a Capital P - Frankly Speaking Ep 326</itunes:title>
        <link>https://primedfranklyspeaking.podbean.com/e/screening-for-alcohol-use-and-abuse-prevention-with-a-capital-p-frankly-speaking-ep-326/</link>
                    <comments>https://primedfranklyspeaking.podbean.com/e/screening-for-alcohol-use-and-abuse-prevention-with-a-capital-p-frankly-speaking-ep-326/#comments</comments>        <pubDate>Mon, 01 May 2023 00:30:00 +0000</pubDate>
        <guid isPermaLink="false">primedfranklyspeaking.podbean.com/016556ca-cd38-3532-986d-e318881b8102</guid>
                                    <description><![CDATA[<p>Credits: 0.25 AMA PRA Category 1 Credit™
 
CME/CE Information and Claim Credit: <a href='https://www.pri-med.com/online-education/podcast/frankly-speaking-cme-326'>https://www.pri-med.com/online-education/podcast/frankly-speaking-cme-326</a></p>
<p>Overview: Alcohol abuse has become more prevalent in the past decade, which means that primary care providers must play a crucial role in treating this preventable disorder. Don’t miss this discussion on the current state of alcohol abuse and how to use evidence-based screening tools for prevention.</p>
<p>Episode resource links:</p>
<ul><li>Esser,M., Leung, G., Sherk, A., Bohm, M., Liu, Y., Lu, H. & Naimi, T.  Estimated Deaths Attributable to Excessive Alcohol Use Among US Adults Aged 20 to 64 Years, 2015 to 2019. JAMA Network Open. 2022;5(11):e2239485. doi:10.1001/jamanetworkopen.2022.39485</li>
<li>National Institute on Drug Abuse Screening and Assessment Tools Resource Chart: <a href='https://nida.nih.gov/nidamed-medical-health-professionals/screening-tools-resources/chart-screening-tools'>https://nida.nih.gov/nidamed-medical-health-professionals/screening-tools-resources/chart-screening-tools</a></li>
<li>Substance Abuse and Mental Health Services Administration (SAMHSA):  National Help Line:  <a href='https://www.samhsa.gov/find-help/national-helpline'>https://www.samhsa.gov/find-help/national-helpline</a></li>
<li>Alcoholics Anonymous:  Find AA near you <a href='https://www.aa.org/find-aa'>https://www.aa.org/find-aa</a></li>
<li>Paradis, C., Butt, P., Shield, K., Poole, N., Wells, S., Naimi, T., Sherk, A., & the Low-Risk Alcohol Drinking Guidelines Scientific Expert Panels. (2023). Canada’s Guidance on Alcohol and Health: Final Report. Ottawa, Ont.: Canadian Centre on Substance Use and Addiction. </li>
<li>Fairbanks J, Umbreit A, Kolla BP, et al. Evidence-Based Pharmacotherapies for Alcohol Use Disorder: Clinical Pearls. Mayo Clin Proc. 2020;95(9):1964-1977. doi:10.1016/j.mayocp.2020.01.030</li>
</ul>
<p>Guest: Jill M. Terrien PhD, ANP-BC 

 Music Credit: Richard Onorato</p>
]]></description>
                                                            <content:encoded><![CDATA[<p>Credits: 0.25 AMA PRA Category 1 Credit™<br>
 <br>
CME/CE Information and Claim Credit: <a href='https://www.pri-med.com/online-education/podcast/frankly-speaking-cme-326'>https://www.pri-med.com/online-education/podcast/frankly-speaking-cme-326</a></p>
<p>Overview: Alcohol abuse has become more prevalent in the past decade, which means that primary care providers must play a crucial role in treating this preventable disorder. Don’t miss this discussion on the current state of alcohol abuse and how to use evidence-based screening tools for prevention.</p>
<p>Episode resource links:</p>
<ul><li>Esser,M., Leung, G., Sherk, A., Bohm, M., Liu, Y., Lu, H. & Naimi, T.  Estimated Deaths Attributable to Excessive Alcohol Use Among US Adults Aged 20 to 64 Years, 2015 to 2019. JAMA Network Open. 2022;5(11):e2239485. doi:10.1001/jamanetworkopen.2022.39485</li>
<li>National Institute on Drug Abuse Screening and Assessment Tools Resource Chart: <a href='https://nida.nih.gov/nidamed-medical-health-professionals/screening-tools-resources/chart-screening-tools'>https://nida.nih.gov/nidamed-medical-health-professionals/screening-tools-resources/chart-screening-tools</a></li>
<li>Substance Abuse and Mental Health Services Administration (SAMHSA):  National Help Line:  <a href='https://www.samhsa.gov/find-help/national-helpline'>https://www.samhsa.gov/find-help/national-helpline</a></li>
<li>Alcoholics Anonymous:  Find AA near you <a href='https://www.aa.org/find-aa'>https://www.aa.org/find-aa</a></li>
<li>Paradis, C., Butt, P., Shield, K., Poole, N., Wells, S., Naimi, T., Sherk, A., & the Low-Risk Alcohol Drinking Guidelines Scientific Expert Panels. (2023). Canada’s Guidance on Alcohol and Health: Final Report. Ottawa, Ont.: Canadian Centre on Substance Use and Addiction. </li>
<li>Fairbanks J, Umbreit A, Kolla BP, et al. Evidence-Based Pharmacotherapies for Alcohol Use Disorder: Clinical Pearls. Mayo Clin Proc. 2020;95(9):1964-1977. doi:10.1016/j.mayocp.2020.01.030</li>
</ul>
<p>Guest: Jill M. Terrien PhD, ANP-BC <br>
<br>
 Music Credit: Richard Onorato</p>
]]></content:encoded>
                                    
        <enclosure url="https://mcdn.podbean.com/mf/web/8siih7/frankly-speaking-326-alcohol-use-disorder_1.mp3" length="12178957" type="audio/mpeg"/>
                <itunes:summary><![CDATA[Credits: 0.25 AMA PRA Category 1 Credit™ CME/CE Information and Claim Credit: https://www.pri-med.com/online-education/podcast/frankly-speaking-cme-326
Overview: Alcohol abuse has become more prevalent in the past decade, which means that primary care providers must play a crucial role in treating this preventable disorder. Don’t miss this discussion on the current state of alcohol abuse and how to use evidence-based screening tools for prevention.
Episode resource links:
Esser,M., Leung, G., Sherk, A., Bohm, M., Liu, Y., Lu, H. & Naimi, T.  Estimated Deaths Attributable to Excessive Alcohol Use Among US Adults Aged 20 to 64 Years, 2015 to 2019. JAMA Network Open. 2022;5(11):e2239485. doi:10.1001/jamanetworkopen.2022.39485
National Institute on Drug Abuse Screening and Assessment Tools Resource Chart: https://nida.nih.gov/nidamed-medical-health-professionals/screening-tools-resources/chart-screening-tools
Substance Abuse and Mental Health Services Administration (SAMHSA):  National Help Line:  https://www.samhsa.gov/find-help/national-helpline
Alcoholics Anonymous:  Find AA near you https://www.aa.org/find-aa
Paradis, C., Butt, P., Shield, K., Poole, N., Wells, S., Naimi, T., Sherk, A., & the Low-Risk Alcohol Drinking Guidelines Scientific Expert Panels. (2023). Canada’s Guidance on Alcohol and Health: Final Report. Ottawa, Ont.: Canadian Centre on Substance Use and Addiction. 
Fairbanks J, Umbreit A, Kolla BP, et al. Evidence-Based Pharmacotherapies for Alcohol Use Disorder: Clinical Pearls. Mayo Clin Proc. 2020;95(9):1964-1977. doi:10.1016/j.mayocp.2020.01.030
Guest: Jill M. Terrien PhD, ANP-BC  Music Credit: Richard Onorato]]></itunes:summary>
        <itunes:author>Pri-Med</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>758</itunes:duration>
                        <itunes:episodeType>full</itunes:episodeType>
            </item>
    <item>
        <title>Treating Children and Adolescents with Obesity—Understanding the New AAP Clinical Practice Guidelines - Frankly Speaking Ep 325</title>
        <itunes:title>Treating Children and Adolescents with Obesity—Understanding the New AAP Clinical Practice Guidelines - Frankly Speaking Ep 325</itunes:title>
        <link>https://primedfranklyspeaking.podbean.com/e/treating-children-and-adolescents-with-obesity%e2%80%94understanding-the-new-aap-clinical-practice-guidelines-frankly-speaking-ep-325/</link>
                    <comments>https://primedfranklyspeaking.podbean.com/e/treating-children-and-adolescents-with-obesity%e2%80%94understanding-the-new-aap-clinical-practice-guidelines-frankly-speaking-ep-325/#comments</comments>        <pubDate>Mon, 24 Apr 2023 00:30:00 +0000</pubDate>
        <guid isPermaLink="false">primedfranklyspeaking.podbean.com/0ab4dd1e-75a5-3b11-947c-4cfa62d4ac2a</guid>
                                    <description><![CDATA[<p>Credits: 0.25 AMA PRA Category 1 Credit™
 
CME/CE Information and Claim Credit: <a href='https://www.pri-med.com/online-education/podcast/frankly-speaking-cme-325'>https://www.pri-med.com/online-education/podcast/frankly-speaking-cme-325</a></p>
<p>Overview: Obesity in children and adolescents is a complex and very often chronic condition. Besides encouraging healthy eating and increasing activity—both excellent behavioral measures—healthcare providers did not have a clear, evidence-based plan for managing this chronic condition until recently. In January, the AAP published its long-awaited new, evidence-based guidelines for the evaluation and treatment of children and adolescents with obesity. Greatly anticipated, it did, however, create some controversy. Please join us as we discuss the new guidelines, the evidence that it is based on, and how it may change practice. </p>
<p>Episode resource links:</p>
<ul><li>The American Academy of Pediatrics. Clinical Practice Guideline. S. E. Hampl. Clinical Practice Guideline for the Evaluation and Treatment of Children and Adolescents with Obesity. January 9, 2023.  Pediatrics e2022060640. <a href='https://doi.org/10.1542/peds.2022-060640'>https://doi.org/10.1542/peds.2022-060640</a></li>
<li>The American Academy of Pediatrics. S. E. Hampl. Executive Summary: Clinical Practice Guideline for the Evaluation and Treatment of Children and Adolescents with Obesity, January 9, 2023. Pediatrics e2022060641.https://doi.org/10.1542/peds.2022-060641;  <a href='https://publications.aap.org/pediatrics/article/doi/10.1542/peds.2022-060641/190440/Executive-Summary-Clinical-Practice-Guideline-for?autologincheck=redirected'>https://publications.aap.org/pediatrics/article/doi/10.1542/peds.2022-060641/190440/Executive-Summary-Clinical-Practice-Guideline-for?autologincheck=redirected</a></li>
<li>AAP News release <a href='https://www.aap.org/en/news-room/news-releases/aap/2022/american-academy-of-pediatrics-issues-its-first-comprehensive-guideline-on-evaluating-treating-children-and-adolescents-with-obesity/'>https://www.aap.org/en/news-room/news-releases/aap/2022/american-academy-of-pediatrics-issues-its-first-comprehensive-guideline-on-evaluating-treating-children-and-adolescents-with-obesity/ </a></li>
<li>The American Academy of Pediatrics Technical report; January 9, 2023. Appraisal of Clinical Care Practices for Child Obesity Treatment. Part I: Interventions. Pediatrics (2023) 151 (2): e2022060642.; <a href='https://doi.org/10.1542/peds.2022-060642'>https://doi.org/10.1542/peds.2022-060642</a></li>
<li>The American Academy of Pediatrics Technical report; January 9, 2023. Appraisal of Clinical Care Practices for Child Obesity Treatment. Part II: Comorbidities. Pediatrics (2023) 151 (2): e2022060643. https://doi.org/10.1542/peds.2022-060643</li>
<li> </li>
</ul>
<p>Guest: Susan Feeney, DNP, FNP-BC, NP-C
 
Music Credit: Richard Onorato</p>
]]></description>
                                                            <content:encoded><![CDATA[<p>Credits: 0.25 AMA PRA Category 1 Credit™<br>
 <br>
CME/CE Information and Claim Credit: <a href='https://www.pri-med.com/online-education/podcast/frankly-speaking-cme-325'>https://www.pri-med.com/online-education/podcast/frankly-speaking-cme-325</a></p>
<p>Overview: Obesity in children and adolescents is a complex and very often chronic condition. Besides encouraging healthy eating and increasing activity—both excellent behavioral measures—healthcare providers did not have a clear, evidence-based plan for managing this chronic condition until recently. In January, the AAP published its long-awaited new, evidence-based guidelines for the evaluation and treatment of children and adolescents with obesity. Greatly anticipated, it did, however, create some controversy. Please join us as we discuss the new guidelines, the evidence that it is based on, and how it may change practice. </p>
<p>Episode resource links:</p>
<ul><li>The American Academy of Pediatrics. Clinical Practice Guideline. S. E. Hampl. Clinical Practice Guideline for the Evaluation and Treatment of Children and Adolescents with Obesity. January 9, 2023.  Pediatrics e2022060640. <a href='https://doi.org/10.1542/peds.2022-060640'>https://doi.org/10.1542/peds.2022-060640</a></li>
<li>The American Academy of Pediatrics. S. E. Hampl. Executive Summary: Clinical Practice Guideline for the Evaluation and Treatment of Children and Adolescents with Obesity, January 9, 2023. Pediatrics e2022060641.https://doi.org/10.1542/peds.2022-060641;  <a href='https://publications.aap.org/pediatrics/article/doi/10.1542/peds.2022-060641/190440/Executive-Summary-Clinical-Practice-Guideline-for?autologincheck=redirected'>https://publications.aap.org/pediatrics/article/doi/10.1542/peds.2022-060641/190440/Executive-Summary-Clinical-Practice-Guideline-for?autologincheck=redirected</a></li>
<li>AAP News release <a href='https://www.aap.org/en/news-room/news-releases/aap/2022/american-academy-of-pediatrics-issues-its-first-comprehensive-guideline-on-evaluating-treating-children-and-adolescents-with-obesity/'>https://www.aap.org/en/news-room/news-releases/aap/2022/american-academy-of-pediatrics-issues-its-first-comprehensive-guideline-on-evaluating-treating-children-and-adolescents-with-obesity/ </a></li>
<li>The American Academy of Pediatrics Technical report; January 9, 2023. Appraisal of Clinical Care Practices for Child Obesity Treatment. Part I: Interventions. Pediatrics (2023) 151 (2): e2022060642.; <a href='https://doi.org/10.1542/peds.2022-060642'>https://doi.org/10.1542/peds.2022-060642</a></li>
<li>The American Academy of Pediatrics Technical report; January 9, 2023. Appraisal of Clinical Care Practices for Child Obesity Treatment. Part II: Comorbidities. Pediatrics (2023) 151 (2): e2022060643. https://doi.org/10.1542/peds.2022-060643</li>
<li> </li>
</ul>
<p>Guest: Susan Feeney, DNP, FNP-BC, NP-C<br>
 <br>
Music Credit: Richard Onorato</p>
]]></content:encoded>
                                    
        <enclosure url="https://mcdn.podbean.com/mf/web/2ak3hs/frankly-speaking-325-pediatric-obesity.mp3" length="7909909" type="audio/mpeg"/>
                <itunes:summary><![CDATA[Credits: 0.25 AMA PRA Category 1 Credit™ CME/CE Information and Claim Credit: https://www.pri-med.com/online-education/podcast/frankly-speaking-cme-325
Overview: Obesity in children and adolescents is a complex and very often chronic condition. Besides encouraging healthy eating and increasing activity—both excellent behavioral measures—healthcare providers did not have a clear, evidence-based plan for managing this chronic condition until recently. In January, the AAP published its long-awaited new, evidence-based guidelines for the evaluation and treatment of children and adolescents with obesity. Greatly anticipated, it did, however, create some controversy. Please join us as we discuss the new guidelines, the evidence that it is based on, and how it may change practice. 
Episode resource links:
The American Academy of Pediatrics. Clinical Practice Guideline. S. E. Hampl. Clinical Practice Guideline for the Evaluation and Treatment of Children and Adolescents with Obesity. January 9, 2023.  Pediatrics e2022060640. https://doi.org/10.1542/peds.2022-060640
The American Academy of Pediatrics. S. E. Hampl. Executive Summary: Clinical Practice Guideline for the Evaluation and Treatment of Children and Adolescents with Obesity, January 9, 2023. Pediatrics e2022060641.https://doi.org/10.1542/peds.2022-060641;  https://publications.aap.org/pediatrics/article/doi/10.1542/peds.2022-060641/190440/Executive-Summary-Clinical-Practice-Guideline-for?autologincheck=redirected
AAP News release https://www.aap.org/en/news-room/news-releases/aap/2022/american-academy-of-pediatrics-issues-its-first-comprehensive-guideline-on-evaluating-treating-children-and-adolescents-with-obesity/ 
The American Academy of Pediatrics Technical report; January 9, 2023. Appraisal of Clinical Care Practices for Child Obesity Treatment. Part I: Interventions. Pediatrics (2023) 151 (2): e2022060642.; https://doi.org/10.1542/peds.2022-060642
The American Academy of Pediatrics Technical report; January 9, 2023. Appraisal of Clinical Care Practices for Child Obesity Treatment. Part II: Comorbidities. Pediatrics (2023) 151 (2): e2022060643. https://doi.org/10.1542/peds.2022-060643
 
Guest: Susan Feeney, DNP, FNP-BC, NP-C Music Credit: Richard Onorato]]></itunes:summary>
        <itunes:author>Pri-Med</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>491</itunes:duration>
                        <itunes:episodeType>full</itunes:episodeType>
            </item>
    <item>
        <title>Is It OK to Let Your Infant Cry Themselves to Sleep? - Frankly Speaking Ep 324</title>
        <itunes:title>Is It OK to Let Your Infant Cry Themselves to Sleep? - Frankly Speaking Ep 324</itunes:title>
        <link>https://primedfranklyspeaking.podbean.com/e/is-it-ok-to-let-your-infant-cry-themselves-to-sleep-frankly-speaking-ep-324/</link>
                    <comments>https://primedfranklyspeaking.podbean.com/e/is-it-ok-to-let-your-infant-cry-themselves-to-sleep-frankly-speaking-ep-324/#comments</comments>        <pubDate>Mon, 17 Apr 2023 00:30:00 +0000</pubDate>
        <guid isPermaLink="false">primedfranklyspeaking.podbean.com/c7511aec-bc1c-353b-9ca5-6343881cbef0</guid>
                                    <description><![CDATA[<p>Credits: 0.25 AMA PRA Category 1 Credit™
 
CME/CE Information and Claim Credit: <a href='https://www.pri-med.com/online-education/podcast/frankly-speaking-cme-324'>https://www.pri-med.com/online-education/podcast/frankly-speaking-cme-324</a></p>
<p>Overview: Parents who struggle with infant sleep problems may turn to primary care providers for guidance to help their child, but what are the evidence-based options? Hear what the experts have to say about the findings of a recent Journal of Pediatrics study of parents’ use of a variety of behavioral interventions for infant sleep problems. </p>
<p>Episode resource links:</p>
<ul><li>Implementation of Behavioral Interventions for Infant Sleep Problems in Real-World Settings: J Pediatr. November 11, 2022. https://doi.org/10.1016/j.jpeds.2022.10.038</li>
<li>Blunden, S. and Dawson, D. (2020), Behavioural sleep interventions in infants: Plan B – Combining models of responsiveness to increase parental choice. J Paediatr Child Health, 56: 675-679. <a href='https://doi.org/10.1111/jpc.14818'>https://doi.org/10.1111/jpc.14818</a></li>
</ul>
<p>Guest: Robert A. Baldor MD, FAAFP
 
Music Credit: Richard Onorato</p>
]]></description>
                                                            <content:encoded><![CDATA[<p>Credits: 0.25 AMA PRA Category 1 Credit™<br>
 <br>
CME/CE Information and Claim Credit: <a href='https://www.pri-med.com/online-education/podcast/frankly-speaking-cme-324'>https://www.pri-med.com/online-education/podcast/frankly-speaking-cme-324</a></p>
<p>Overview: Parents who struggle with infant sleep problems may turn to primary care providers for guidance to help their child, but what are the evidence-based options? Hear what the experts have to say about the findings of a recent Journal of Pediatrics study of parents’ use of a variety of behavioral interventions for infant sleep problems. </p>
<p>Episode resource links:</p>
<ul><li>Implementation of Behavioral Interventions for Infant Sleep Problems in Real-World Settings: J Pediatr. November 11, 2022. https://doi.org/10.1016/j.jpeds.2022.10.038</li>
<li>Blunden, S. and Dawson, D. (2020), Behavioural sleep interventions in infants: Plan B – Combining models of responsiveness to increase parental choice. J Paediatr Child Health, 56: 675-679. <a href='https://doi.org/10.1111/jpc.14818'>https://doi.org/10.1111/jpc.14818</a></li>
</ul>
<p>Guest: Robert A. Baldor MD, FAAFP<br>
 <br>
Music Credit: Richard Onorato</p>
]]></content:encoded>
                                    
        <enclosure url="https://mcdn.podbean.com/mf/web/3vthbe/frankly-speaking-324-babies-and-sleep.mp3" length="11384859" type="audio/mpeg"/>
                <itunes:summary><![CDATA[Credits: 0.25 AMA PRA Category 1 Credit™ CME/CE Information and Claim Credit: https://www.pri-med.com/online-education/podcast/frankly-speaking-cme-324
Overview: Parents who struggle with infant sleep problems may turn to primary care providers for guidance to help their child, but what are the evidence-based options? Hear what the experts have to say about the findings of a recent Journal of Pediatrics study of parents’ use of a variety of behavioral interventions for infant sleep problems. 
Episode resource links:
Implementation of Behavioral Interventions for Infant Sleep Problems in Real-World Settings: J Pediatr. November 11, 2022. https://doi.org/10.1016/j.jpeds.2022.10.038
Blunden, S. and Dawson, D. (2020), Behavioural sleep interventions in infants: Plan B – Combining models of responsiveness to increase parental choice. J Paediatr Child Health, 56: 675-679. https://doi.org/10.1111/jpc.14818
Guest: Robert A. Baldor MD, FAAFP Music Credit: Richard Onorato]]></itunes:summary>
        <itunes:author>Pri-Med</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>708</itunes:duration>
                <itunes:episode>3</itunes:episode>
        <itunes:episodeType>full</itunes:episodeType>
            </item>
    <item>
        <title>Chalk It Up to Stress and Anxiety or Is There More to It? - Frankly Speaking Ep 323</title>
        <itunes:title>Chalk It Up to Stress and Anxiety or Is There More to It? - Frankly Speaking Ep 323</itunes:title>
        <link>https://primedfranklyspeaking.podbean.com/e/chalk-it-up-to-stress-and-anxiety-or-is-there-more-to-it-frankly-speaking-ep-323/</link>
                    <comments>https://primedfranklyspeaking.podbean.com/e/chalk-it-up-to-stress-and-anxiety-or-is-there-more-to-it-frankly-speaking-ep-323/#comments</comments>        <pubDate>Mon, 10 Apr 2023 00:30:00 +0000</pubDate>
        <guid isPermaLink="false">primedfranklyspeaking.podbean.com/4e9b5ab6-491b-36d3-9412-9cee04c0d1cb</guid>
                                    <description><![CDATA[<p>Credits: 0.25 AMA PRA Category 1 Credit™
 
CME/CE Information and Claim Credit: <a href='https://www.pri-med.com/online-education/podcast/frankly-speaking-cme-323'>https://www.pri-med.com/online-education/podcast/frankly-speaking-cme-323</a></p>
<p>Overview: This episode will explore a common syndrome that is often misdiagnosed and underdiagnosed. Listen in as we discuss the cardinal symptoms and diagnostic criteria for postural orthostatic tachycardia syndrome (POTS) and learn about different management options, including the benefits of salt. </p>
<p>Episode resource links:</p>
<ul><li>Zha K, Brook J, McLaughlin A, Blitshteyn S. Gluten-free diet in postural orthostatic tachycardia syndrome (POTS). Chronic Illness. 2022;0(0). doi:10.1177/17423953221076984</li>
<li>Cooperrider, J., Kriegler, J., Yunus, S., & Wilson, R. (2022). A Survey-Based Study Examining Differences in Perception of Postural Orthostatic Tachycardia Syndrome Between Patients and Primary Care Physicians. Cureus, 14(10).</li>
<li>Raj, S. R., Fedorowski, A., & Sheldon, R. S. (2022). Diagnosis and management of postural orthostatic tachycardia syndrome. Cmaj, 194(10), E378-E385.</li>
<li>Williams, E. L., Raj, S. R., Schondorf, R., Shen, W. K., Wieling, W., & Claydon, V. E. (2022). Salt supplementation in the management of orthostatic intolerance: Vasovagal syncope and postural orthostatic tachycardia syndrome. Autonomic neuroscience, 237, 102906.</li>
</ul>
<p>Guest: Mariyan L. Montaque, DNP, FNP-BC
 
Music Credit: Richard Onorato</p>
]]></description>
                                                            <content:encoded><![CDATA[<p>Credits: 0.25 AMA PRA Category 1 Credit™<br>
 <br>
CME/CE Information and Claim Credit: <a href='https://www.pri-med.com/online-education/podcast/frankly-speaking-cme-323'>https://www.pri-med.com/online-education/podcast/frankly-speaking-cme-323</a></p>
<p>Overview: This episode will explore a common syndrome that is often misdiagnosed and underdiagnosed. Listen in as we discuss the cardinal symptoms and diagnostic criteria for postural orthostatic tachycardia syndrome (POTS) and learn about different management options, including the benefits of salt. </p>
<p>Episode resource links:</p>
<ul><li>Zha K, Brook J, McLaughlin A, Blitshteyn S. Gluten-free diet in postural orthostatic tachycardia syndrome (POTS). Chronic Illness. 2022;0(0). doi:10.1177/17423953221076984</li>
<li>Cooperrider, J., Kriegler, J., Yunus, S., & Wilson, R. (2022). A Survey-Based Study Examining Differences in Perception of Postural Orthostatic Tachycardia Syndrome Between Patients and Primary Care Physicians. Cureus, 14(10).</li>
<li>Raj, S. R., Fedorowski, A., & Sheldon, R. S. (2022). Diagnosis and management of postural orthostatic tachycardia syndrome. Cmaj, 194(10), E378-E385.</li>
<li>Williams, E. L., Raj, S. R., Schondorf, R., Shen, W. K., Wieling, W., & Claydon, V. E. (2022). Salt supplementation in the management of orthostatic intolerance: Vasovagal syncope and postural orthostatic tachycardia syndrome. Autonomic neuroscience, 237, 102906.</li>
</ul>
<p>Guest: Mariyan L. Montaque, DNP, FNP-BC<br>
 <br>
Music Credit: Richard Onorato</p>
]]></content:encoded>
                                    
        <enclosure url="https://mcdn.podbean.com/mf/web/jsxsg4/frankly-speaking-323-POTS.mp3" length="8052632" type="audio/mpeg"/>
                <itunes:summary><![CDATA[Credits: 0.25 AMA PRA Category 1 Credit™ CME/CE Information and Claim Credit: https://www.pri-med.com/online-education/podcast/frankly-speaking-cme-323
Overview: This episode will explore a common syndrome that is often misdiagnosed and underdiagnosed. Listen in as we discuss the cardinal symptoms and diagnostic criteria for postural orthostatic tachycardia syndrome (POTS) and learn about different management options, including the benefits of salt. 
Episode resource links:
Zha K, Brook J, McLaughlin A, Blitshteyn S. Gluten-free diet in postural orthostatic tachycardia syndrome (POTS). Chronic Illness. 2022;0(0). doi:10.1177/17423953221076984
Cooperrider, J., Kriegler, J., Yunus, S., & Wilson, R. (2022). A Survey-Based Study Examining Differences in Perception of Postural Orthostatic Tachycardia Syndrome Between Patients and Primary Care Physicians. Cureus, 14(10).
Raj, S. R., Fedorowski, A., & Sheldon, R. S. (2022). Diagnosis and management of postural orthostatic tachycardia syndrome. Cmaj, 194(10), E378-E385.
Williams, E. L., Raj, S. R., Schondorf, R., Shen, W. K., Wieling, W., & Claydon, V. E. (2022). Salt supplementation in the management of orthostatic intolerance: Vasovagal syncope and postural orthostatic tachycardia syndrome. Autonomic neuroscience, 237, 102906.
Guest: Mariyan L. Montaque, DNP, FNP-BC Music Credit: Richard Onorato]]></itunes:summary>
        <itunes:author>Pri-Med</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>500</itunes:duration>
                        <itunes:episodeType>full</itunes:episodeType>
            </item>
    <item>
        <title>2022 CDC Clinical Practice Guidelines: What’s the Update on Prescribing Opioids for Pain? - Frankly Speaking Ep 322</title>
        <itunes:title>2022 CDC Clinical Practice Guidelines: What’s the Update on Prescribing Opioids for Pain? - Frankly Speaking Ep 322</itunes:title>
        <link>https://primedfranklyspeaking.podbean.com/e/2022-cdc-clinical-practice-guidelines-what-s-the-update-on-prescribing-opioids-for-pain-frankly-speaking-ep-322/</link>
                    <comments>https://primedfranklyspeaking.podbean.com/e/2022-cdc-clinical-practice-guidelines-what-s-the-update-on-prescribing-opioids-for-pain-frankly-speaking-ep-322/#comments</comments>        <pubDate>Mon, 03 Apr 2023 00:30:00 +0000</pubDate>
        <guid isPermaLink="false">primedfranklyspeaking.podbean.com/f3be4be1-251c-3c33-80f7-6e81da890a32</guid>
                                    <description><![CDATA[<p>Credits: 0.25 AMA PRA Category 1 Credit™
 
CME/CE Information and Claim Credit: <a href='https://www.pri-med.com/online-education/podcast/frankly-speaking-cme-322'>https://www.pri-med.com/online-education/podcast/frankly-speaking-cme-322</a></p>
<p>Overview: Patients deserve compassionate, safe, and effective pain management. But it’s important to remember that safe prescribing does not mean no prescribing. Join us as we discuss the 2022 CDC Clinical Practice Guidelines for prescribing opioids in the adult population. The updated and expanded guidelines can assist you in delivering patient-centered care for management of acute, subacute, and chronic pain.</p>
<p>Episode resource links:</p>
<ul><li>Dowell D, Ragan KR, Jones CM, Baldwin GT, Chou R. CDC Clinical Practice Guideline for Prescribing Opioids for Pain —United States, 2022. MMWR Recomm Rep 2022;71(No. RR-3):1–95. DOI: <a href='http://dx.doi.org/10.15585/mmwr.rr7103a1'>http://dx.doi.org/10.15585/mmwr.rr7103a1</a></li>
<li>Dowell D, Haegerich TM, Chou R. CDC Guideline for Prescribing Opioids for Chronic Pain—United States, 2016. 2016;315(15):1624–1645. doi:10.1001/jama.2016.1464</li>
</ul>
<p>Guest: Jill Terrien PhD, ANP-BC 
 
Music Credit: Richard Onorato</p>
]]></description>
                                                            <content:encoded><![CDATA[<p>Credits: 0.25 AMA PRA Category 1 Credit™<br>
 <br>
CME/CE Information and Claim Credit: <a href='https://www.pri-med.com/online-education/podcast/frankly-speaking-cme-322'>https://www.pri-med.com/online-education/podcast/frankly-speaking-cme-322</a></p>
<p>Overview: Patients deserve compassionate, safe, and effective pain management. But it’s important to remember that safe prescribing does not mean no prescribing. Join us as we discuss the 2022 CDC Clinical Practice Guidelines for prescribing opioids in the adult population. The updated and expanded guidelines can assist you in delivering patient-centered care for management of acute, subacute, and chronic pain.</p>
<p>Episode resource links:</p>
<ul><li>Dowell D, Ragan KR, Jones CM, Baldwin GT, Chou R. CDC Clinical Practice Guideline for Prescribing Opioids for Pain —United States, 2022. MMWR Recomm Rep 2022;71(No. RR-3):1–95. DOI: <a href='http://dx.doi.org/10.15585/mmwr.rr7103a1'>http://dx.doi.org/10.15585/mmwr.rr7103a1</a></li>
<li>Dowell D, Haegerich TM, Chou R. CDC Guideline for Prescribing Opioids for Chronic Pain—United States, 2016. 2016;315(15):1624–1645. doi:10.1001/jama.2016.1464</li>
</ul>
<p>Guest: Jill Terrien PhD, ANP-BC <br>
 <br>
Music Credit: Richard Onorato</p>
]]></content:encoded>
                                    
        <enclosure url="https://mcdn.podbean.com/mf/web/6u7jzj/frankly-speaking-322-opioid-guidelines_1.mp3" length="8798153" type="audio/mpeg"/>
                <itunes:summary><![CDATA[Credits: 0.25 AMA PRA Category 1 Credit™ CME/CE Information and Claim Credit: https://www.pri-med.com/online-education/podcast/frankly-speaking-cme-322
Overview: Patients deserve compassionate, safe, and effective pain management. But it’s important to remember that safe prescribing does not mean no prescribing. Join us as we discuss the 2022 CDC Clinical Practice Guidelines for prescribing opioids in the adult population. The updated and expanded guidelines can assist you in delivering patient-centered care for management of acute, subacute, and chronic pain.
Episode resource links:
Dowell D, Ragan KR, Jones CM, Baldwin GT, Chou R. CDC Clinical Practice Guideline for Prescribing Opioids for Pain —United States, 2022. MMWR Recomm Rep 2022;71(No. RR-3):1–95. DOI: http://dx.doi.org/10.15585/mmwr.rr7103a1
Dowell D, Haegerich TM, Chou R. CDC Guideline for Prescribing Opioids for Chronic Pain—United States, 2016. 2016;315(15):1624–1645. doi:10.1001/jama.2016.1464
Guest: Jill Terrien PhD, ANP-BC  Music Credit: Richard Onorato]]></itunes:summary>
        <itunes:author>Pri-Med</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>547</itunes:duration>
                        <itunes:episodeType>full</itunes:episodeType>
            </item>
    <item>
        <title>Menopausal Symptoms—Are You Providing the Best Care to Improve Function and Quality of Life? - Frankly Speaking Ep 321</title>
        <itunes:title>Menopausal Symptoms—Are You Providing the Best Care to Improve Function and Quality of Life? - Frankly Speaking Ep 321</itunes:title>
        <link>https://primedfranklyspeaking.podbean.com/e/menopausal-symptoms%e2%80%94are-you-providing-the-best-care-to-improve-function-and-quality-of-life-frankly-speaking-ep-321/</link>
                    <comments>https://primedfranklyspeaking.podbean.com/e/menopausal-symptoms%e2%80%94are-you-providing-the-best-care-to-improve-function-and-quality-of-life-frankly-speaking-ep-321/#comments</comments>        <pubDate>Mon, 27 Mar 2023 00:30:00 +0000</pubDate>
        <guid isPermaLink="false">primedfranklyspeaking.podbean.com/782b5b5f-2f72-37b1-9895-9915f812c023</guid>
                                    <description><![CDATA[<p>Credits: 0.25 AMA PRA Category 1 Credit™
 
CME/CE Information and Claim Credit: <a href='https://www.pri-med.com/online-education/podcast/frankly-speaking-cme-321'>https://www.pri-med.com/online-education/podcast/frankly-speaking-cme-321</a></p>
<p>Overview: Most perimenopausal and menopausal individuals will experience some symptoms. Up to 80% of women report some symptoms, with vasomotor symptoms being the most commonly reported; however, other symptoms such as sleep disturbance, sexual dysfunction, and mood can be present. These symptoms can have a tremendous negative impact on quality of life and well-being, yet many women remain untreated for their symptoms even though evidence-based treatments exist. Join us to discuss effective treatments and ways you can overcome barriers to providing evidence-based menopausal therapy.</p>
<p>Episode resource links:</p>
<ul><li>DePree, Barbara MD, NCMP, MMM1; Houghton, Katherine MSc2; Shiozawa, Aki DrPH, MBA3; Esterberg, Elizabeth MS4; King, Deanna D. MS, PhD3; Kim, Janet PhD3; Mancuso, Shayna DO, FACOG3. Treatment and resource utilization for menopausal symptoms in the United States: a retrospective review of real-world evidence from US electronic health records. Menopause 30(1):p 70-79, January 2023. | DOI: 10.1097/GME.0000000000002095 <a href='https://journals.lww.com/menopausejournal/Fulltext/2023/01000/Treatment_and_resource_utilization_for_menopausal.11.aspx'>https://journals.lww.com/menopausejournal/Fulltext/2023/01000/Treatment_and_resource_utilization_for_menopausal.11.aspx</a></li>
<li>The North Amrican Menopause Society. (NAMS) The 2022 Hormone Therapy Position Statement of the North American Menopause Society. Menopause: The Journal of the North American Menopause Society. 29 (7)  pp 767-794. DOI: 10.1097/GME.0000000000002028</li>
<li>The North American Menopause Society (NAMS). Menopause Practice: A Clinician's Guide. 6th Pepper Pike, Ohio. September 2019. </li>
</ul>
<p>Guest: Susan Feeney, DNP, FNP-BC, NP-C
 
Music Credit: Richard Onorato</p>
]]></description>
                                                            <content:encoded><![CDATA[<p>Credits: 0.25 AMA PRA Category 1 Credit™<br>
 <br>
CME/CE Information and Claim Credit: <a href='https://www.pri-med.com/online-education/podcast/frankly-speaking-cme-321'>https://www.pri-med.com/online-education/podcast/frankly-speaking-cme-321</a></p>
<p>Overview: Most perimenopausal and menopausal individuals will experience some symptoms. Up to 80% of women report some symptoms, with vasomotor symptoms being the most commonly reported; however, other symptoms such as sleep disturbance, sexual dysfunction, and mood can be present. These symptoms can have a tremendous negative impact on quality of life and well-being, yet many women remain untreated for their symptoms even though evidence-based treatments exist. Join us to discuss effective treatments and ways you can overcome barriers to providing evidence-based menopausal therapy.</p>
<p>Episode resource links:</p>
<ul><li>DePree, Barbara MD, NCMP, MMM1; Houghton, Katherine MSc2; Shiozawa, Aki DrPH, MBA3; Esterberg, Elizabeth MS4; King, Deanna D. MS, PhD3; Kim, Janet PhD3; Mancuso, Shayna DO, FACOG3. Treatment and resource utilization for menopausal symptoms in the United States: a retrospective review of real-world evidence from US electronic health records. <em>Menopause</em> 30(1):p 70-79, January 2023. | DOI: 10.1097/GME.0000000000002095 <a href='https://journals.lww.com/menopausejournal/Fulltext/2023/01000/Treatment_and_resource_utilization_for_menopausal.11.aspx'>https://journals.lww.com/menopausejournal/Fulltext/2023/01000/Treatment_and_resource_utilization_for_menopausal.11.aspx</a></li>
<li>The North Amrican Menopause Society. (NAMS) The 2022 Hormone Therapy Position Statement of the North American Menopause Society. <em>Menopause: The Journal of the North American Menopause Society. </em>29 (7)  pp 767-794. DOI: 10.1097/GME.0000000000002028</li>
<li>The North American Menopause Society (NAMS). Menopause Practice: A Clinician's Guide. 6th Pepper Pike, Ohio. September 2019. </li>
</ul>
<p>Guest: Susan Feeney, DNP, FNP-BC, NP-C<br>
 <br>
Music Credit: Richard Onorato</p>
]]></content:encoded>
                                    
        <enclosure url="https://mcdn.podbean.com/mf/web/ka2t5m/frankly-speaking-ep321-menopause.mp3" length="11247195" type="audio/mpeg"/>
                <itunes:summary><![CDATA[Credits: 0.25 AMA PRA Category 1 Credit™ CME/CE Information and Claim Credit: https://www.pri-med.com/online-education/podcast/frankly-speaking-cme-321
Overview: Most perimenopausal and menopausal individuals will experience some symptoms. Up to 80% of women report some symptoms, with vasomotor symptoms being the most commonly reported; however, other symptoms such as sleep disturbance, sexual dysfunction, and mood can be present. These symptoms can have a tremendous negative impact on quality of life and well-being, yet many women remain untreated for their symptoms even though evidence-based treatments exist. Join us to discuss effective treatments and ways you can overcome barriers to providing evidence-based menopausal therapy.
Episode resource links:
DePree, Barbara MD, NCMP, MMM1; Houghton, Katherine MSc2; Shiozawa, Aki DrPH, MBA3; Esterberg, Elizabeth MS4; King, Deanna D. MS, PhD3; Kim, Janet PhD3; Mancuso, Shayna DO, FACOG3. Treatment and resource utilization for menopausal symptoms in the United States: a retrospective review of real-world evidence from US electronic health records. Menopause 30(1):p 70-79, January 2023. | DOI: 10.1097/GME.0000000000002095 https://journals.lww.com/menopausejournal/Fulltext/2023/01000/Treatment_and_resource_utilization_for_menopausal.11.aspx
The North Amrican Menopause Society. (NAMS) The 2022 Hormone Therapy Position Statement of the North American Menopause Society. Menopause: The Journal of the North American Menopause Society. 29 (7)  pp 767-794. DOI: 10.1097/GME.0000000000002028
The North American Menopause Society (NAMS). Menopause Practice: A Clinician's Guide. 6th Pepper Pike, Ohio. September 2019. 
Guest: Susan Feeney, DNP, FNP-BC, NP-C Music Credit: Richard Onorato]]></itunes:summary>
        <itunes:author>Pri-Med</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>699</itunes:duration>
                        <itunes:episodeType>full</itunes:episodeType>
            </item>
    <item>
        <title>CURING Anxiety vs Treating Its Symptoms - Frankly Speaking Ep 320</title>
        <itunes:title>CURING Anxiety vs Treating Its Symptoms - Frankly Speaking Ep 320</itunes:title>
        <link>https://primedfranklyspeaking.podbean.com/e/curing-anxiety-vs-treating-its-symptoms-frankly-speaking-ep-320/</link>
                    <comments>https://primedfranklyspeaking.podbean.com/e/curing-anxiety-vs-treating-its-symptoms-frankly-speaking-ep-320/#comments</comments>        <pubDate>Mon, 20 Mar 2023 00:30:00 +0000</pubDate>
        <guid isPermaLink="false">primedfranklyspeaking.podbean.com/af830297-42bf-390f-ae1e-ea696b3b37bc</guid>
                                    <description><![CDATA[<p>Credits: 0.25 AMA PRA Category 1 Credit™
 
CME/CE Information and Claim Credit: <a href='https://www.pri-med.com/online-education/podcast/frankly-speaking-cme-320'>https://www.pri-med.com/online-education/podcast/frankly-speaking-cme-320</a></p>
<p>Overview: New evidence points to the efficacy of a simple approach to managing and potentially curing generalized anxiety disorder. Join us to discuss this simple intervention and to review the diagnosis and treatment options for this prevalent disorder.</p>
<p>Episode resource links:</p>
<ul><li>
<p>JAMA Psychiatry. 2023;80(1):13-21. doi:10.1001/jamapsychiatry.2022.3679</p>
</li>
<li><a href='https://positivepsychology.com/mindfulness-based-stress-reduction-mbsr/'>https://positivepsychology.com/mindfulness-based-stress-reduction-mbsr/</a></li>
</ul>
<p>Guest: Susan Feeney, DNP, FNP-BC, NP-C
 
Music Credit: Richard Onorato </p>
]]></description>
                                                            <content:encoded><![CDATA[<p>Credits: 0.25 AMA PRA Category 1 Credit™<br>
 <br>
CME/CE Information and Claim Credit: <a href='https://www.pri-med.com/online-education/podcast/frankly-speaking-cme-320'>https://www.pri-med.com/online-education/podcast/frankly-speaking-cme-320</a></p>
<p>Overview: New evidence points to the efficacy of a simple approach to managing and potentially curing generalized anxiety disorder. Join us to discuss this simple intervention and to review the diagnosis and treatment options for this prevalent disorder.</p>
<p>Episode resource links:</p>
<ul><li>
<p><em>JAMA Psychiatry. </em>2023;80(1):13-21. doi:10.1001/jamapsychiatry.2022.3679</p>
</li>
<li><a href='https://positivepsychology.com/mindfulness-based-stress-reduction-mbsr/'>https://positivepsychology.com/mindfulness-based-stress-reduction-mbsr/</a></li>
</ul>
<p>Guest: Susan Feeney, DNP, FNP-BC, NP-C<br>
 <br>
Music Credit: Richard Onorato </p>
]]></content:encoded>
                                    
        <enclosure url="https://mcdn.podbean.com/mf/web/xkbr22/frankly-speaking-ep320-GAD.mp3" length="10910738" type="audio/mpeg"/>
                <itunes:summary><![CDATA[Credits: 0.25 AMA PRA Category 1 Credit™ CME/CE Information and Claim Credit: https://www.pri-med.com/online-education/podcast/frankly-speaking-cme-320
Overview: New evidence points to the efficacy of a simple approach to managing and potentially curing generalized anxiety disorder. Join us to discuss this simple intervention and to review the diagnosis and treatment options for this prevalent disorder.
Episode resource links:

JAMA Psychiatry. 2023;80(1):13-21. doi:10.1001/jamapsychiatry.2022.3679

https://positivepsychology.com/mindfulness-based-stress-reduction-mbsr/
Guest: Susan Feeney, DNP, FNP-BC, NP-C Music Credit: Richard Onorato ]]></itunes:summary>
        <itunes:author>Pri-Med</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>679</itunes:duration>
                        <itunes:episodeType>full</itunes:episodeType>
            </item>
    <item>
        <title>Antibiotics for Infectious Conjunctivitis: Efficacy Is in the Eye of the Beholder - Frankly Speaking Ep 319</title>
        <itunes:title>Antibiotics for Infectious Conjunctivitis: Efficacy Is in the Eye of the Beholder - Frankly Speaking Ep 319</itunes:title>
        <link>https://primedfranklyspeaking.podbean.com/e/antibiotics-for-infectious-conjunctivitis-efficacy-is-in-the-eye-of-the-beholder-frankly-speaking-ep-319/</link>
                    <comments>https://primedfranklyspeaking.podbean.com/e/antibiotics-for-infectious-conjunctivitis-efficacy-is-in-the-eye-of-the-beholder-frankly-speaking-ep-319/#comments</comments>        <pubDate>Mon, 13 Mar 2023 00:30:00 +0000</pubDate>
        <guid isPermaLink="false">primedfranklyspeaking.podbean.com/1aae01c6-844e-3e2b-9789-b337622c4ab4</guid>
                                    <description><![CDATA[<p>Credits: 0.25 AMA PRA Category 1 Credit™
 
CME/CE Information and Claim Credit: <a href='https://www.pri-med.com/online-education/podcast/frankly-speaking-cme-319'>https://www.pri-med.com/online-education/podcast/frankly-speaking-cme-319</a></p>
<p>Overview: In children, bacterial infections are a common cause of infectious conjunctivitis. But, like many clinicians, you may be uncertain about the efficacy of using antibiotic drops in these pediatric patients. Join us to get an evidence-based answer to the important question, “Are antibiotic drops needed in children with acute infectious conjunctivitis?”</p>
<p>Episode resource links:</p>
<ul><li>
<p>Honkila M, Koskela U, Kontiokari T, et al. Effect of Topical Antibiotics on Duration of Acute Infective Conjunctivitis in Children: A Randomized Clinical Trial and a Systematic Review and Meta-analysis. JAMA Netw Open. 2022;5(10):e2234459. Published 2022 Oct 3.</p>
</li>
</ul>
<p>Guest: Alan M. Ehrlich, MD, FAAFP
 
Music Credit: Richard Onorato</p>
]]></description>
                                                            <content:encoded><![CDATA[<p>Credits: 0.25 AMA PRA Category 1 Credit™<br>
 <br>
CME/CE Information and Claim Credit: <a href='https://www.pri-med.com/online-education/podcast/frankly-speaking-cme-319'>https://www.pri-med.com/online-education/podcast/frankly-speaking-cme-319</a></p>
<p>Overview: In children, bacterial infections are a common cause of infectious conjunctivitis. But, like many clinicians, you may be uncertain about the efficacy of using antibiotic drops in these pediatric patients. Join us to get an evidence-based answer to the important question, “Are antibiotic drops needed in children with acute infectious conjunctivitis?”</p>
<p>Episode resource links:</p>
<ul><li>
<p>Honkila M, Koskela U, Kontiokari T, et al. Effect of Topical Antibiotics on Duration of Acute Infective Conjunctivitis in Children: A Randomized Clinical Trial and a Systematic Review and Meta-analysis. JAMA Netw Open. 2022;5(10):e2234459. Published 2022 Oct 3.</p>
</li>
</ul>
<p>Guest: Alan M. Ehrlich, MD, FAAFP<br>
 <br>
Music Credit: Richard Onorato</p>
]]></content:encoded>
                                    
        <enclosure url="https://mcdn.podbean.com/mf/web/6aes6c/frankly-speaking-ep319-conjunctivitis_1.mp3" length="9856953" type="audio/mpeg"/>
                <itunes:summary><![CDATA[Credits: 0.25 AMA PRA Category 1 Credit™ CME/CE Information and Claim Credit: https://www.pri-med.com/online-education/podcast/frankly-speaking-cme-319
Overview: In children, bacterial infections are a common cause of infectious conjunctivitis. But, like many clinicians, you may be uncertain about the efficacy of using antibiotic drops in these pediatric patients. Join us to get an evidence-based answer to the important question, “Are antibiotic drops needed in children with acute infectious conjunctivitis?”
Episode resource links:

Honkila M, Koskela U, Kontiokari T, et al. Effect of Topical Antibiotics on Duration of Acute Infective Conjunctivitis in Children: A Randomized Clinical Trial and a Systematic Review and Meta-analysis. JAMA Netw Open. 2022;5(10):e2234459. Published 2022 Oct 3.

Guest: Alan M. Ehrlich, MD, FAAFP Music Credit: Richard Onorato]]></itunes:summary>
        <itunes:author>Pri-Med</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>613</itunes:duration>
                        <itunes:episodeType>full</itunes:episodeType>
            </item>
    <item>
        <title>Do They Know I Don’t Know? Overcoming Impostor Syndrome - Frankly Speaking Ep 318</title>
        <itunes:title>Do They Know I Don’t Know? Overcoming Impostor Syndrome - Frankly Speaking Ep 318</itunes:title>
        <link>https://primedfranklyspeaking.podbean.com/e/do-they-know-i-don-t-know-overcoming-imposter-syndrome-frankly-speaking-ep-318/</link>
                    <comments>https://primedfranklyspeaking.podbean.com/e/do-they-know-i-don-t-know-overcoming-imposter-syndrome-frankly-speaking-ep-318/#comments</comments>        <pubDate>Mon, 06 Mar 2023 00:30:00 +0000</pubDate>
        <guid isPermaLink="false">primedfranklyspeaking.podbean.com/dcea4e77-b64c-3010-aa32-5ac74ffee55e</guid>
                                    <description><![CDATA[<p>Credits: 0.25 AMA PRA Category 1 Credit™
 
CME/CE Information and Claim Credit: <a href='https://www.pri-med.com/online-education/podcast/frankly-speaking-cme-318'>https://www.pri-med.com/online-education/podcast/frankly-speaking-cme-318</a></p>
<p>Overview: Have you ever experienced impostor syndrome? Or do you mentor someone struggling with this sense of inadequacy? If so, you won’t want to miss this podcast episode. You will formulate a clear definition of impostor syndrome, understand its components, and walk away with practical tips to help overcome it...</p>
<p>Episode resource links:</p>
<ul><li>
<p>J Am Coll Surg  2021 Nov;233(5):633-638.</p>
</li>
<li>
<p>Curr Pharm Teach Learn 2022 Feb;14(2):130-132.
doi: 10.1016/j.cptl.2021.11.019. Epub 2021 Dec 27</p>
</li>
</ul>
<p>Guest: Mariyan L. Montaque, DNP, FNP-BC & Susan Feeney, DNP, FNP-BC, NP-C & Jill M. Terrien, PhD, ANP-BC
 
Music Credit: Richard Onorato

To learn more about Primary Care Bootcamp for NPs and PAs: <a href='https://bootcamp.pri-med.com/app'>https://bootcamp.pri-med.com/app</a> </p>
]]></description>
                                                            <content:encoded><![CDATA[<p>Credits: 0.25 AMA PRA Category 1 Credit™<br>
 <br>
CME/CE Information and Claim Credit: <a href='https://www.pri-med.com/online-education/podcast/frankly-speaking-cme-318'>https://www.pri-med.com/online-education/podcast/frankly-speaking-cme-318</a></p>
<p>Overview: Have you ever experienced impostor syndrome? Or do you mentor someone struggling with this sense of inadequacy? If so, you won’t want to miss this podcast episode. You will formulate a clear definition of impostor syndrome, understand its components, and walk away with practical tips to help overcome it...</p>
<p>Episode resource links:</p>
<ul><li>
<p>J Am Coll Surg  2021 Nov;233(5):633-638.</p>
</li>
<li>
<p>Curr Pharm Teach Learn 2022 Feb;14(2):130-132.<br>
doi: 10.1016/j.cptl.2021.11.019. Epub 2021 Dec 27</p>
</li>
</ul>
<p>Guest: Mariyan L. Montaque, DNP, FNP-BC & Susan Feeney, DNP, FNP-BC, NP-C & Jill M. Terrien, PhD, ANP-BC<br>
 <br>
Music Credit: Richard Onorato<br>
<br>
To learn more about Primary Care Bootcamp for NPs and PAs: <a href='https://bootcamp.pri-med.com/app'>https://bootcamp.pri-med.com/app</a> </p>
]]></content:encoded>
                                    
        <enclosure url="https://mcdn.podbean.com/mf/web/xkd6zh/frankly-speaking-318-imposter-syndrome_1.mp3" length="18177021" type="audio/mpeg"/>
                <itunes:summary><![CDATA[Credits: 0.25 AMA PRA Category 1 Credit™ CME/CE Information and Claim Credit: https://www.pri-med.com/online-education/podcast/frankly-speaking-cme-318
Overview: Have you ever experienced impostor syndrome? Or do you mentor someone struggling with this sense of inadequacy? If so, you won’t want to miss this podcast episode. You will formulate a clear definition of impostor syndrome, understand its components, and walk away with practical tips to help overcome it...
Episode resource links:

J Am Coll Surg  2021 Nov;233(5):633-638.


Curr Pharm Teach Learn 2022 Feb;14(2):130-132.doi: 10.1016/j.cptl.2021.11.019. Epub 2021 Dec 27

Guest: Mariyan L. Montaque, DNP, FNP-BC & Susan Feeney, DNP, FNP-BC, NP-C & Jill M. Terrien, PhD, ANP-BC Music Credit: Richard OnoratoTo learn more about Primary Care Bootcamp for NPs and PAs: https://bootcamp.pri-med.com/app ]]></itunes:summary>
        <itunes:author>Pri-Med</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>1132</itunes:duration>
                        <itunes:episodeType>full</itunes:episodeType>
            </item>
    <item>
        <title>Exercise for Migraine Prophylaxis: Strength Training vs Aerobics - Frankly Speaking Ep 317</title>
        <itunes:title>Exercise for Migraine Prophylaxis: Strength Training vs Aerobics - Frankly Speaking Ep 317</itunes:title>
        <link>https://primedfranklyspeaking.podbean.com/e/exercise-for-migraine-prophylaxis-strength-training-vs-aerobics-frankly-speaking-ep-317/</link>
                    <comments>https://primedfranklyspeaking.podbean.com/e/exercise-for-migraine-prophylaxis-strength-training-vs-aerobics-frankly-speaking-ep-317/#comments</comments>        <pubDate>Mon, 27 Feb 2023 00:30:00 +0000</pubDate>
        <guid isPermaLink="false">primedfranklyspeaking.podbean.com/3302e6bb-ee75-3f1c-8c43-8d9146cd8c9c</guid>
                                    <description><![CDATA[<p>Credits: 0.25 AMA PRA Category 1 Credit™
 
CME/CE Information and Claim Credit: <a href='https://www.pri-med.com/online-education/podcast/frankly-speaking-cme-317'>https://www.pri-med.com/online-education/podcast/frankly-speaking-cme-317</a></p>
<p>Overview: Exercise has been shown to be an effective way of decreasing migraine frequency, but the best type of exercise for this has not been established. A systematic review compared strength training to both high-intensity aerobic exercise and low-intensity aerobic exercise.</p>
<p>Episode resource links:</p>
<ul><li>
<p>Woldeamanuel YW, Oliveira ABD. What is the efficacy of aerobic exercise versus strength training in the treatment of migraine? A systematic review and network meta-analysis of clinical trials. J Headache Pain. 2022;23(1):134. Published 2022 Oct 13.</p>
</li>
</ul>
<p>Guest: Alan M. Ehrlich, MD, FAAFP
 
Music Credit: Richard Onorato</p>
]]></description>
                                                            <content:encoded><![CDATA[<p>Credits: 0.25 AMA PRA Category 1 Credit™<br>
 <br>
CME/CE Information and Claim Credit: <a href='https://www.pri-med.com/online-education/podcast/frankly-speaking-cme-317'>https://www.pri-med.com/online-education/podcast/frankly-speaking-cme-317</a></p>
<p>Overview: Exercise has been shown to be an effective way of decreasing migraine frequency, but the best type of exercise for this has not been established. A systematic review compared strength training to both high-intensity aerobic exercise and low-intensity aerobic exercise.</p>
<p>Episode resource links:</p>
<ul><li>
<p>Woldeamanuel YW, Oliveira ABD. What is the efficacy of aerobic exercise versus strength training in the treatment of migraine? A systematic review and network meta-analysis of clinical trials. J Headache Pain. 2022;23(1):134. Published 2022 Oct 13.</p>
</li>
</ul>
<p>Guest: Alan M. Ehrlich, MD, FAAFP<br>
 <br>
Music Credit: Richard Onorato</p>
]]></content:encoded>
                                    
        <enclosure url="https://mcdn.podbean.com/mf/web/vw4auq/frankly-speaking-ep317-migraine.mp3" length="11579527" type="audio/mpeg"/>
                <itunes:summary><![CDATA[Credits: 0.25 AMA PRA Category 1 Credit™ CME/CE Information and Claim Credit: https://www.pri-med.com/online-education/podcast/frankly-speaking-cme-317
Overview: Exercise has been shown to be an effective way of decreasing migraine frequency, but the best type of exercise for this has not been established. A systematic review compared strength training to both high-intensity aerobic exercise and low-intensity aerobic exercise.
Episode resource links:

Woldeamanuel YW, Oliveira ABD. What is the efficacy of aerobic exercise versus strength training in the treatment of migraine? A systematic review and network meta-analysis of clinical trials. J Headache Pain. 2022;23(1):134. Published 2022 Oct 13.

Guest: Alan M. Ehrlich, MD, FAAFP Music Credit: Richard Onorato]]></itunes:summary>
        <itunes:author>Pri-Med</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>720</itunes:duration>
                        <itunes:episodeType>full</itunes:episodeType>
            </item>
    <item>
        <title>Proton Pump Inhibitors—We Know Their Benefits, But What Are Their Risks? - Frankly Speaking Ep 316</title>
        <itunes:title>Proton Pump Inhibitors—We Know Their Benefits, But What Are Their Risks? - Frankly Speaking Ep 316</itunes:title>
        <link>https://primedfranklyspeaking.podbean.com/e/proton-pump-inhibitors%e2%80%94we-know-their-benefits-but-what-are-their-risks-frankly-speaking-ep-316/</link>
                    <comments>https://primedfranklyspeaking.podbean.com/e/proton-pump-inhibitors%e2%80%94we-know-their-benefits-but-what-are-their-risks-frankly-speaking-ep-316/#comments</comments>        <pubDate>Mon, 20 Feb 2023 00:30:00 +0000</pubDate>
        <guid isPermaLink="false">primedfranklyspeaking.podbean.com/cf8cc9d8-f951-3d77-ab86-42c26a82a52e</guid>
                                    <description><![CDATA[<p>Credits: 0.25 AMA PRA Category 1 Credit™
 
CME/CE Information and Claim Credit: <a href='https://www.pri-med.com/online-education/podcast/frankly-speaking-cme-316'>https://www.pri-med.com/online-education/podcast/frankly-speaking-cme-316</a></p>
<p>Overview: While the benefits of proton pump inhibitors (PPIs) are widely known, the same cannot be said of the risks. These common medications are generally considered “safe,” but new data suggest the potential for long-term risks. Join us to discuss these long-term risks of PPI use and whether some of your patients should step down from PPIs to H2RAs. </p>
<p>Episode resource links:</p>
<ul><li>Gut : 28 September 2020. doi: 10.1136/gutjnl-2020-322557</li>
<li>Gut 2022 Jan; 71:16. (<a href='https://doi.org/10.1136/gutjnl-2021-325097'>https://doi.org/10.1136/gutjnl-2021-325097</a>)</li>
<li>Front Pharmacol. 2022 Sep 14;13:979215. doi: 10.3389/fphar.2022.979215. eCollection 2022</li>
</ul>
<p>Guest: Jill M. Terrien PhD, ANP-BC 
 
Music Credit: Richard Onorato</p>
]]></description>
                                                            <content:encoded><![CDATA[<p>Credits: 0.25 AMA PRA Category 1 Credit™<br>
 <br>
CME/CE Information and Claim Credit: <a href='https://www.pri-med.com/online-education/podcast/frankly-speaking-cme-316'>https://www.pri-med.com/online-education/podcast/frankly-speaking-cme-316</a></p>
<p>Overview: While the benefits of proton pump inhibitors (PPIs) are widely known, the same cannot be said of the risks. These common medications are generally considered “safe,” but new data suggest the potential for long-term risks. Join us to discuss these long-term risks of PPI use and whether some of your patients should step down from PPIs to H2RAs. </p>
<p>Episode resource links:</p>
<ul><li>Gut : 28 September 2020. doi: 10.1136/gutjnl-2020-322557</li>
<li>Gut 2022 Jan; 71:16. (<a href='https://doi.org/10.1136/gutjnl-2021-325097'>https://doi.org/10.1136/gutjnl-2021-325097</a>)</li>
<li>Front Pharmacol. 2022 Sep 14;13:979215. doi: 10.3389/fphar.2022.979215. eCollection 2022</li>
</ul>
<p>Guest: Jill M. Terrien PhD, ANP-BC <br>
 <br>
Music Credit: Richard Onorato</p>
]]></content:encoded>
                                    
        <enclosure url="https://mcdn.podbean.com/mf/web/rj8c2r/frankly-speaking-316-proton-pump-inhibitors.mp3" length="8729942" type="audio/mpeg"/>
                <itunes:summary><![CDATA[Credits: 0.25 AMA PRA Category 1 Credit™ CME/CE Information and Claim Credit: https://www.pri-med.com/online-education/podcast/frankly-speaking-cme-316
Overview: While the benefits of proton pump inhibitors (PPIs) are widely known, the same cannot be said of the risks. These common medications are generally considered “safe,” but new data suggest the potential for long-term risks. Join us to discuss these long-term risks of PPI use and whether some of your patients should step down from PPIs to H2RAs. 
Episode resource links:
Gut : 28 September 2020. doi: 10.1136/gutjnl-2020-322557
Gut 2022 Jan; 71:16. (https://doi.org/10.1136/gutjnl-2021-325097)
Front Pharmacol. 2022 Sep 14;13:979215. doi: 10.3389/fphar.2022.979215. eCollection 2022
Guest: Jill M. Terrien PhD, ANP-BC  Music Credit: Richard Onorato]]></itunes:summary>
        <itunes:author>Pri-Med</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>543</itunes:duration>
                        <itunes:episodeType>full</itunes:episodeType>
            </item>
    <item>
        <title>Exercise Patterns and Effect on Mortality - Frankly Speaking Ep 315</title>
        <itunes:title>Exercise Patterns and Effect on Mortality - Frankly Speaking Ep 315</itunes:title>
        <link>https://primedfranklyspeaking.podbean.com/e/exercise-patterns-and-effect-on-mortality-frankly-speaking-ep-315/</link>
                    <comments>https://primedfranklyspeaking.podbean.com/e/exercise-patterns-and-effect-on-mortality-frankly-speaking-ep-315/#comments</comments>        <pubDate>Mon, 13 Feb 2023 00:30:00 +0000</pubDate>
        <guid isPermaLink="false">primedfranklyspeaking.podbean.com/64313705-eae0-3547-9260-dc79dd8fa9db</guid>
                                    <description><![CDATA[<p>Credits: 0.25 AMA PRA Category 1 Credit™
 
CME/CE Information and Claim Credit: <a href='https://www.pri-med.com/online-education/podcast/frankly-speaking-cme-315'>https://www.pri-med.com/online-education/podcast/frankly-speaking-cme-315</a></p>
<p>Overview: A recent publication shows that being a “weekend warrior” exerciser provides the same benefit to mortality risk as spreading the physical activity out across the week. Listen to this podcast to hear the data from this study and to optimally counsel your patients on how to lower their mortality risk through physical activity.</p>
<p>Episode resource links:</p>
<ul><li>Physical Activity Guidelines for Americans, 2nd Edition.; 2018. <a href='https://health.gov/paguidelines/second-edition/pdf/Physical_Activity_Guidelines_2nd_edition.pdf'>https://health.gov/paguidelines/second-edition/pdf/Physical_Activity_Guidelines_2nd_edition.pdf</a>.
dos Santos M, Ferrari G, Lee DH, et al. Association of the “Weekend Warrior” and Other Leisure-time Physical Activity Patterns With All-Cause and Cause-Specific Mortality: A Nationwide Cohort Study. JAMA Intern Med.2022;182(8):840–848. doi:10.1001/jamainternmed.2022.2488</li>
</ul>
<p>Guest: Jillian Joseph, MPAS, PA-C
 
Music Credit: Richard Onorato</p>
]]></description>
                                                            <content:encoded><![CDATA[<p>Credits: 0.25 AMA PRA Category 1 Credit™<br>
 <br>
CME/CE Information and Claim Credit: <a href='https://www.pri-med.com/online-education/podcast/frankly-speaking-cme-315'>https://www.pri-med.com/online-education/podcast/frankly-speaking-cme-315</a></p>
<p>Overview: A recent publication shows that being a “weekend warrior” exerciser provides the same benefit to mortality risk as spreading the physical activity out across the week. Listen to this podcast to hear the data from this study and to optimally counsel your patients on how to lower their mortality risk through physical activity.</p>
<p>Episode resource links:</p>
<ul><li>Physical Activity Guidelines for Americans, 2nd Edition.; 2018. <a href='https://health.gov/paguidelines/second-edition/pdf/Physical_Activity_Guidelines_2nd_edition.pdf'>https://health.gov/paguidelines/second-edition/pdf/Physical_Activity_Guidelines_2nd_edition.pdf</a>.<br>
dos Santos M, Ferrari G, Lee DH, et al. Association of the “Weekend Warrior” and Other Leisure-time Physical Activity Patterns With All-Cause and Cause-Specific Mortality: A Nationwide Cohort Study. JAMA Intern Med.2022;182(8):840–848. doi:10.1001/jamainternmed.2022.2488</li>
</ul>
<p>Guest: Jillian Joseph, MPAS, PA-C<br>
 <br>
Music Credit: Richard Onorato</p>
]]></content:encoded>
                                    
        <enclosure url="https://mcdn.podbean.com/mf/web/8kcgpt/frankly-speaking-315-exercise-and-mortality.mp3" length="9680037" type="audio/mpeg"/>
                <itunes:summary><![CDATA[Credits: 0.25 AMA PRA Category 1 Credit™ CME/CE Information and Claim Credit: https://www.pri-med.com/online-education/podcast/frankly-speaking-cme-315
Overview: A recent publication shows that being a “weekend warrior” exerciser provides the same benefit to mortality risk as spreading the physical activity out across the week. Listen to this podcast to hear the data from this study and to optimally counsel your patients on how to lower their mortality risk through physical activity.
Episode resource links:
Physical Activity Guidelines for Americans, 2nd Edition.; 2018. https://health.gov/paguidelines/second-edition/pdf/Physical_Activity_Guidelines_2nd_edition.pdf.dos Santos M, Ferrari G, Lee DH, et al. Association of the “Weekend Warrior” and Other Leisure-time Physical Activity Patterns With All-Cause and Cause-Specific Mortality: A Nationwide Cohort Study. JAMA Intern Med.2022;182(8):840–848. doi:10.1001/jamainternmed.2022.2488
Guest: Jillian Joseph, MPAS, PA-C Music Credit: Richard Onorato]]></itunes:summary>
        <itunes:author>Pri-Med</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>603</itunes:duration>
                        <itunes:episodeType>full</itunes:episodeType>
            </item>
    <item>
        <title>Strokes: Which Vaccine Can Reduce Your Risks? - Frankly Speaking Ep 314</title>
        <itunes:title>Strokes: Which Vaccine Can Reduce Your Risks? - Frankly Speaking Ep 314</itunes:title>
        <link>https://primedfranklyspeaking.podbean.com/e/strokes-which-vaccine-can-reduce-your-risks-frankly-speaking-ep-314/</link>
                    <comments>https://primedfranklyspeaking.podbean.com/e/strokes-which-vaccine-can-reduce-your-risks-frankly-speaking-ep-314/#comments</comments>        <pubDate>Mon, 06 Feb 2023 00:30:00 +0000</pubDate>
        <guid isPermaLink="false">primedfranklyspeaking.podbean.com/11ac3269-9bc2-3332-91c9-5e0091932976</guid>
                                    <description><![CDATA[<p>Credits: 0.25 AMA PRA Category 1 Credit™
 
CME/CE Information and Claim Credit: <a href='https://www.pri-med.com/online-education/podcast/frankly-speaking-cme-314'>https://www.pri-med.com/online-education/podcast/frankly-speaking-cme-314</a></p>
<p>Overview: The herpes zoster virus, or shingles, is more than just a rash. Oftentimes we don’t consider the long-term risk of viruses, but we should. This episode focuses on the association between the herpes zoster virus and an increased risk of stroke. Join us to discuss data that show a reduction in stroke risk in individuals who receive the herpes zoster vaccine. </p>
<p>Episode resource links:</p>
<ul><li>Andrew N Bubak, Christina Coughlan, Janelle Posey, Anthony J Saviola, Christy S Niemeyer, Serena W R Lewis, Sara Bustos Lopez, Adriana Solano, Stephen K Tyring, Cassidy Delaney, Keith B Neeves, Ravi Mahalingam, Kirk C Hansen, Maria A Nagel, Zoster-Associated Prothrombotic Plasma Exosomes and Increased Stroke Risk, The Journal of Infectious Diseases, 2022;, jiac405, https://doi.org/10.1093/infdis/jiac405</li>
<li><a href='https://www.idse.net/Review-Articles/Article/10-22/Immunization-Vaccine-Updates-Beyond-COVID-19/68244'>https://www.idse.net/Review-Articles/Article/10-22/Immunization-Vaccine-Updates-Beyond-COVID-19/68244</a></li>
<li><a href='https://www.cdc.gov/shingles/index.html'>https://www.cdc.gov/shingles/index.html</a></li>
<li><a href='https://familydoctor.org/condition/shingles/'>https://familydoctor.org/condition/shingles/</a></li>
<li>Yang, Q., Chang, A., Tong, X., & Merritt, R. (2021). Herpes zoster vaccine live and risk of stroke among medicare beneficiaries: a population-based cohort study. Stroke, 52(5), 1712-1721.</li>
<li><a href='https://news.cuanschutz.edu/news-stories/researchers-reveal-why-shingles-can-cause-strokes'>https://news.cuanschutz.edu/news-stories/researchers-reveal-why-shingles-can-cause-strokes</a></li>
</ul>
<p>Guest: Mariyan L. Montaque, DNP, FNP-BC
 
Music Credit: Richard Onorato</p>
]]></description>
                                                            <content:encoded><![CDATA[<p>Credits: 0.25 AMA PRA Category 1 Credit™<br>
 <br>
CME/CE Information and Claim Credit: <a href='https://www.pri-med.com/online-education/podcast/frankly-speaking-cme-314'>https://www.pri-med.com/online-education/podcast/frankly-speaking-cme-314</a></p>
<p>Overview: The herpes zoster virus, or shingles, is more than just a rash. Oftentimes we don’t consider the long-term risk of viruses, but we should. This episode focuses on the association between the herpes zoster virus and an increased risk of stroke. Join us to discuss data that show a reduction in stroke risk in individuals who receive the herpes zoster vaccine. </p>
<p>Episode resource links:</p>
<ul><li>Andrew N Bubak, Christina Coughlan, Janelle Posey, Anthony J Saviola, Christy S Niemeyer, Serena W R Lewis, Sara Bustos Lopez, Adriana Solano, Stephen K Tyring, Cassidy Delaney, Keith B Neeves, Ravi Mahalingam, Kirk C Hansen, Maria A Nagel, Zoster-Associated Prothrombotic Plasma Exosomes and Increased Stroke Risk, The Journal of Infectious Diseases, 2022;, jiac405, https://doi.org/10.1093/infdis/jiac405</li>
<li><a href='https://www.idse.net/Review-Articles/Article/10-22/Immunization-Vaccine-Updates-Beyond-COVID-19/68244'>https://www.idse.net/Review-Articles/Article/10-22/Immunization-Vaccine-Updates-Beyond-COVID-19/68244</a></li>
<li><a href='https://www.cdc.gov/shingles/index.html'>https://www.cdc.gov/shingles/index.html</a></li>
<li><a href='https://familydoctor.org/condition/shingles/'>https://familydoctor.org/condition/shingles/</a></li>
<li>Yang, Q., Chang, A., Tong, X., & Merritt, R. (2021). Herpes zoster vaccine live and risk of stroke among medicare beneficiaries: a population-based cohort study. Stroke, 52(5), 1712-1721.</li>
<li><a href='https://news.cuanschutz.edu/news-stories/researchers-reveal-why-shingles-can-cause-strokes'>https://news.cuanschutz.edu/news-stories/researchers-reveal-why-shingles-can-cause-strokes</a></li>
</ul>
<p>Guest: Mariyan L. Montaque, DNP, FNP-BC<br>
 <br>
Music Credit: Richard Onorato</p>
]]></content:encoded>
                                    
        <enclosure url="https://mcdn.podbean.com/mf/web/nsqyaa/frankly-speaking-314-shingles-vaccine.mp3" length="8281999" type="audio/mpeg"/>
                <itunes:summary><![CDATA[Credits: 0.25 AMA PRA Category 1 Credit™ CME/CE Information and Claim Credit: https://www.pri-med.com/online-education/podcast/frankly-speaking-cme-314
Overview: The herpes zoster virus, or shingles, is more than just a rash. Oftentimes we don’t consider the long-term risk of viruses, but we should. This episode focuses on the association between the herpes zoster virus and an increased risk of stroke. Join us to discuss data that show a reduction in stroke risk in individuals who receive the herpes zoster vaccine. 
Episode resource links:
Andrew N Bubak, Christina Coughlan, Janelle Posey, Anthony J Saviola, Christy S Niemeyer, Serena W R Lewis, Sara Bustos Lopez, Adriana Solano, Stephen K Tyring, Cassidy Delaney, Keith B Neeves, Ravi Mahalingam, Kirk C Hansen, Maria A Nagel, Zoster-Associated Prothrombotic Plasma Exosomes and Increased Stroke Risk, The Journal of Infectious Diseases, 2022;, jiac405, https://doi.org/10.1093/infdis/jiac405
https://www.idse.net/Review-Articles/Article/10-22/Immunization-Vaccine-Updates-Beyond-COVID-19/68244
https://www.cdc.gov/shingles/index.html
https://familydoctor.org/condition/shingles/
Yang, Q., Chang, A., Tong, X., & Merritt, R. (2021). Herpes zoster vaccine live and risk of stroke among medicare beneficiaries: a population-based cohort study. Stroke, 52(5), 1712-1721.
https://news.cuanschutz.edu/news-stories/researchers-reveal-why-shingles-can-cause-strokes
Guest: Mariyan L. Montaque, DNP, FNP-BC Music Credit: Richard Onorato]]></itunes:summary>
        <itunes:author>Pri-Med</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>515</itunes:duration>
                        <itunes:episodeType>full</itunes:episodeType>
            </item>
    <item>
        <title>Screening for Depression and Suicide Risk in Adolescents—Do You Know What to Do? - Frankly Speaking Ep 313</title>
        <itunes:title>Screening for Depression and Suicide Risk in Adolescents—Do You Know What to Do? - Frankly Speaking Ep 313</itunes:title>
        <link>https://primedfranklyspeaking.podbean.com/e/screening-for-depression-and-suicide-risk-in-adolescents%e2%80%94do-you-know-what-to-do-frankly-speaking-ep-313/</link>
                    <comments>https://primedfranklyspeaking.podbean.com/e/screening-for-depression-and-suicide-risk-in-adolescents%e2%80%94do-you-know-what-to-do-frankly-speaking-ep-313/#comments</comments>        <pubDate>Mon, 30 Jan 2023 00:30:00 +0000</pubDate>
        <guid isPermaLink="false">primedfranklyspeaking.podbean.com/094386dd-aa49-32b8-b1f7-9b7076da8513</guid>
                                    <description><![CDATA[<p>Credits: 0.25 AMA PRA Category 1 Credit™
 
CME/CE Information and Claim Credit: <a href='https://www.pri-med.com/online-education/podcast/frankly-speaking-cme-313'>https://www.pri-med.com/online-education/podcast/frankly-speaking-cme-313</a></p>
<p>Overview: The prevalence of anxiety and depression has been increasing in US youth over the past decade with noted increases during the pandemic. The USPSTF recently released its recommendations supporting general screening for depression in 12- to 18-year-olds. Join us while we discuss the recommendations, the basis for these recommendations, how to integrate them into practice, and some strategies on how to support adolescents and families with a positive screen.</p>
<p>Episode resource links:</p>
<ul><li>CDC Children’s Mental Health: https://www.cdc.gov/childrensmentalhealth/depression.html
i. Data and Statistics on Children’s Mental Health <a href='https://www.cdc.gov/childrensmentalhealth/data.html'>https://www.cdc.gov/childrensmentalhealth/data.html</a></li>
<li>Screening for Depression and Suicide Risk in Children and Adolescents - US Preventive Services Task Force Recommendations Statement; JAMA. doi:10.1001/jama.2022.16946. Published online October 11, 2022. </li>
<li>US Preventive Services Task Force Recommendation Statement on Depression and Suicide Risk in Children and Adolescents: Screening. <a href='https://www.uspreventiveservicestaskforce.org/uspstf/recommendation/screening-depression-suicide-risk-children-adolescents'>https://www.uspreventiveservicestaskforce.org/uspstf/recommendation/screening-depression-suicide-risk-children-adolescents</a></li>
</ul>
<p>Guest: Susan Feeney, DNP, FNP-BC, NP-C
 
Music Credit: Richard Onorato</p>
]]></description>
                                                            <content:encoded><![CDATA[<p>Credits: 0.25 AMA PRA Category 1 Credit™<br>
 <br>
CME/CE Information and Claim Credit: <a href='https://www.pri-med.com/online-education/podcast/frankly-speaking-cme-313'>https://www.pri-med.com/online-education/podcast/frankly-speaking-cme-313</a></p>
<p>Overview: The prevalence of anxiety and depression has been increasing in US youth over the past decade with noted increases during the pandemic. The USPSTF recently released its recommendations supporting general screening for depression in 12- to 18-year-olds. Join us while we discuss the recommendations, the basis for these recommendations, how to integrate them into practice, and some strategies on how to support adolescents and families with a positive screen.</p>
<p>Episode resource links:</p>
<ul><li>CDC Children’s Mental Health: https://www.cdc.gov/childrensmentalhealth/depression.html<br>
i. Data and Statistics on Children’s Mental Health <a href='https://www.cdc.gov/childrensmentalhealth/data.html'>https://www.cdc.gov/childrensmentalhealth/data.html</a></li>
<li>Screening for Depression and Suicide Risk in Children and Adolescents - US Preventive Services Task Force Recommendations Statement; JAMA. doi:10.1001/jama.2022.16946. Published online October 11, 2022. </li>
<li>US Preventive Services Task Force Recommendation Statement on Depression and Suicide Risk in Children and Adolescents: Screening. <a href='https://www.uspreventiveservicestaskforce.org/uspstf/recommendation/screening-depression-suicide-risk-children-adolescents'>https://www.uspreventiveservicestaskforce.org/uspstf/recommendation/screening-depression-suicide-risk-children-adolescents</a></li>
</ul>
<p>Guest: Susan Feeney, DNP, FNP-BC, NP-C<br>
 <br>
Music Credit: Richard Onorato</p>
]]></content:encoded>
                                    
        <enclosure url="https://mcdn.podbean.com/mf/web/74gptc/frankly-speaking-313--suicide-screening-adolescents.mp3" length="12093014" type="audio/mpeg"/>
                <itunes:summary><![CDATA[Credits: 0.25 AMA PRA Category 1 Credit™ CME/CE Information and Claim Credit: https://www.pri-med.com/online-education/podcast/frankly-speaking-cme-313
Overview: The prevalence of anxiety and depression has been increasing in US youth over the past decade with noted increases during the pandemic. The USPSTF recently released its recommendations supporting general screening for depression in 12- to 18-year-olds. Join us while we discuss the recommendations, the basis for these recommendations, how to integrate them into practice, and some strategies on how to support adolescents and families with a positive screen.
Episode resource links:
CDC Children’s Mental Health: https://www.cdc.gov/childrensmentalhealth/depression.htmli. Data and Statistics on Children’s Mental Health https://www.cdc.gov/childrensmentalhealth/data.html
Screening for Depression and Suicide Risk in Children and Adolescents - US Preventive Services Task Force Recommendations Statement; JAMA. doi:10.1001/jama.2022.16946. Published online October 11, 2022. 
US Preventive Services Task Force Recommendation Statement on Depression and Suicide Risk in Children and Adolescents: Screening. https://www.uspreventiveservicestaskforce.org/uspstf/recommendation/screening-depression-suicide-risk-children-adolescents
Guest: Susan Feeney, DNP, FNP-BC, NP-C Music Credit: Richard Onorato]]></itunes:summary>
        <itunes:author>Pri-Med</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>751</itunes:duration>
                        <itunes:episodeType>full</itunes:episodeType>
            </item>
    <item>
        <title>5-Across: A 9-Letter Word That Can Improve Cognitive Function - Frankly Speaking Ep 312</title>
        <itunes:title>5-Across: A 9-Letter Word That Can Improve Cognitive Function - Frankly Speaking Ep 312</itunes:title>
        <link>https://primedfranklyspeaking.podbean.com/e/5-across-a-9-letter-word-that-can-improve-cognitive-function-frankly-speaking-ep-312/</link>
                    <comments>https://primedfranklyspeaking.podbean.com/e/5-across-a-9-letter-word-that-can-improve-cognitive-function-frankly-speaking-ep-312/#comments</comments>        <pubDate>Mon, 23 Jan 2023 00:30:00 +0000</pubDate>
        <guid isPermaLink="false">primedfranklyspeaking.podbean.com/74fb9268-7a3e-3589-bb83-dc213a2ce5a8</guid>
                                    <description><![CDATA[<p>Credits: 0.25 AMA PRA Category 1 Credit™
 
CME/CE Information and Claim Credit: <a href='https://www.pri-med.com/online-education/podcast/frankly-speaking-cme-312'>https://www.pri-med.com/online-education/podcast/frankly-speaking-cme-312</a></p>
<p>Overview: Brain training activities have been advocated to slow or prevent cognitive decline. Crossword puzzles can be cognitively demanding and have recently been shown to be superior to some of the brain training activities that have been promoted on apps and websites. Join us for discussion on how to counsel patients looking to improve their cognitive function.</p>
<p>Episode resource links:</p>
<ul><li>Pillai JA, Hall CB, Dickson DW, Buschke H, Lipton RB, Verghese J. Association of crossword puzzle participation with memory decline in persons who develop dementia. J Int Neuropsychol Soc. 2011;17(6):1006-1013. </li>
<li>Devanand DP et al. Computerized Games versus Crosswords Training in Mild Cognitive Impairment. NEJM Evidence October 27,2022</li>
</ul>
<p>Guest: Alan M. Ehrlich, MD, FAAFP
 
Music Credit: Richard Onorato</p>
]]></description>
                                                            <content:encoded><![CDATA[<p>Credits: 0.25 AMA PRA Category 1 Credit™<br>
 <br>
CME/CE Information and Claim Credit: <a href='https://www.pri-med.com/online-education/podcast/frankly-speaking-cme-312'>https://www.pri-med.com/online-education/podcast/frankly-speaking-cme-312</a></p>
<p>Overview: Brain training activities have been advocated to slow or prevent cognitive decline. Crossword puzzles can be cognitively demanding and have recently been shown to be superior to some of the brain training activities that have been promoted on apps and websites. Join us for discussion on how to counsel patients looking to improve their cognitive function.</p>
<p>Episode resource links:</p>
<ul><li>Pillai JA, Hall CB, Dickson DW, Buschke H, Lipton RB, Verghese J. Association of crossword puzzle participation with memory decline in persons who develop dementia. J Int Neuropsychol Soc. 2011;17(6):1006-1013. </li>
<li>Devanand DP et al. Computerized Games versus Crosswords Training in Mild Cognitive Impairment. NEJM Evidence October 27,2022</li>
</ul>
<p>Guest: Alan M. Ehrlich, MD, FAAFP<br>
 <br>
Music Credit: Richard Onorato</p>
]]></content:encoded>
                                    
        <enclosure url="https://mcdn.podbean.com/mf/web/tdcwbh/frankly-speaking-ep312-crossword-puzzles.mp3" length="9186562" type="audio/mpeg"/>
                <itunes:summary><![CDATA[Credits: 0.25 AMA PRA Category 1 Credit™ CME/CE Information and Claim Credit: https://www.pri-med.com/online-education/podcast/frankly-speaking-cme-312
Overview: Brain training activities have been advocated to slow or prevent cognitive decline. Crossword puzzles can be cognitively demanding and have recently been shown to be superior to some of the brain training activities that have been promoted on apps and websites. Join us for discussion on how to counsel patients looking to improve their cognitive function.
Episode resource links:
Pillai JA, Hall CB, Dickson DW, Buschke H, Lipton RB, Verghese J. Association of crossword puzzle participation with memory decline in persons who develop dementia. J Int Neuropsychol Soc. 2011;17(6):1006-1013. 
Devanand DP et al. Computerized Games versus Crosswords Training in Mild Cognitive Impairment. NEJM Evidence October 27,2022
Guest: Alan M. Ehrlich, MD, FAAFP Music Credit: Richard Onorato]]></itunes:summary>
        <itunes:author>Pri-Med</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>572</itunes:duration>
                        <itunes:episodeType>full</itunes:episodeType>
            </item>
    <item>
        <title>Reducing Senior Falls and Fractures with Milk? - Frankly Speaking Ep 311</title>
        <itunes:title>Reducing Senior Falls and Fractures with Milk? - Frankly Speaking Ep 311</itunes:title>
        <link>https://primedfranklyspeaking.podbean.com/e/reducing-senior-falls-and-fractures-with-milk-frankly-speaking-ep-311/</link>
                    <comments>https://primedfranklyspeaking.podbean.com/e/reducing-senior-falls-and-fractures-with-milk-frankly-speaking-ep-311/#comments</comments>        <pubDate>Mon, 16 Jan 2023 00:30:00 +0000</pubDate>
        <guid isPermaLink="false">primedfranklyspeaking.podbean.com/73bf73a8-96b3-3da7-b1d3-a10f4e8871ee</guid>
                                    <description><![CDATA[<p>Credits: 0.25 AMA PRA Category 1 Credit™
 
CME/CE Information and Claim Credit: <a href='https://www.pri-med.com/online-education/podcast/frankly-speaking-cme-311'>https://www.pri-med.com/online-education/podcast/frankly-speaking-cme-311</a></p>
<p>Overview: Join us to discuss the results of a randomized controlled trial that evaluated the influence of increased dairy intake on fractures in older adults. Learn how this simple intervention can significantly mitigate the risk of falls and fractures in this vulnerable population.</p>
<p>Episode resource links:</p>
<ul><li>BMJ 2021; 375 doi: https://doi.org/10.1136/bmj.n2364</li>
</ul>
<p>Guest: Jill M. Terrien PhD, ANP-BC 
 
Music Credit: Richard Onorato</p>
]]></description>
                                                            <content:encoded><![CDATA[<p>Credits: 0.25 AMA PRA Category 1 Credit™<br>
 <br>
CME/CE Information and Claim Credit: <a href='https://www.pri-med.com/online-education/podcast/frankly-speaking-cme-311'>https://www.pri-med.com/online-education/podcast/frankly-speaking-cme-311</a></p>
<p>Overview: Join us to discuss the results of a randomized controlled trial that evaluated the influence of increased dairy intake on fractures in older adults. Learn how this simple intervention can significantly mitigate the risk of falls and fractures in this vulnerable population.</p>
<p>Episode resource links:</p>
<ul><li>BMJ 2021; 375 doi: https://doi.org/10.1136/bmj.n2364</li>
</ul>
<p>Guest: Jill M. Terrien PhD, ANP-BC <br>
 <br>
Music Credit: Richard Onorato</p>
]]></content:encoded>
                                    
        <enclosure url="https://mcdn.podbean.com/mf/web/sspuzu/frankly-speaking-311-seniors-dairy.mp3" length="7612350" type="audio/mpeg"/>
                <itunes:summary><![CDATA[Credits: 0.25 AMA PRA Category 1 Credit™ CME/CE Information and Claim Credit: https://www.pri-med.com/online-education/podcast/frankly-speaking-cme-311
Overview: Join us to discuss the results of a randomized controlled trial that evaluated the influence of increased dairy intake on fractures in older adults. Learn how this simple intervention can significantly mitigate the risk of falls and fractures in this vulnerable population.
Episode resource links:
BMJ 2021; 375 doi: https://doi.org/10.1136/bmj.n2364
Guest: Jill M. Terrien PhD, ANP-BC  Music Credit: Richard Onorato]]></itunes:summary>
        <itunes:author>Pri-Med</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>473</itunes:duration>
                        <itunes:episodeType>full</itunes:episodeType>
            </item>
    <item>
        <title>A Cancer Diagnosis Doesn’t Have to Cancel Sex in Young Women - Frankly Speaking Ep 310</title>
        <itunes:title>A Cancer Diagnosis Doesn’t Have to Cancel Sex in Young Women - Frankly Speaking Ep 310</itunes:title>
        <link>https://primedfranklyspeaking.podbean.com/e/a-cancer-diagnosis-doesn-t-have-to-cancel-sex-in-young-women-frankly-speaking-ep-310/</link>
                    <comments>https://primedfranklyspeaking.podbean.com/e/a-cancer-diagnosis-doesn-t-have-to-cancel-sex-in-young-women-frankly-speaking-ep-310/#comments</comments>        <pubDate>Tue, 10 Jan 2023 00:30:00 +0000</pubDate>
        <guid isPermaLink="false">primedfranklyspeaking.podbean.com/16588bf5-be3f-345b-8518-44bcb548d77e</guid>
                                    <description><![CDATA[<p>Credits: 0.25 AMA PRA Category 1 Credit™
 
CME/CE Information and Claim Credit: <a href='https://www.pri-med.com/online-education/podcast/frankly-speaking-cme-310'>https://www.pri-med.com/online-education/podcast/frankly-speaking-cme-310</a></p>
<p>Overview: Join us as we discuss the importance of assessing for sexual dysfunction in young women with a cancer diagnosis. </p>
<p>Episode resource links:</p>
<ul><li>Lena Wettergren, Lars E. Eriksson, Charlotta Bergström, Christel Hedman,
Johan Ahlgren, Karin E. Smedby, Kristina Hellman, Roger Henriksson & Claudia Lampic (2022): Prevalence and risk factors for sexual dysfunction in young women following a cancer diagnosis – a population-based study, Acta Oncologica, DOI: 10.1080/0284186X.2022.2112283
<a href='https://doi.org/10.1080/0284186X.2022.2112283'>https://doi.org/10.1080/0284186X.2022.2112283</a></li>
</ul>
<p>Guest: Jill Terrien PhD, ANP-BC 
 
Music Credit: Richard Onorato</p>
]]></description>
                                                            <content:encoded><![CDATA[<p>Credits: 0.25 AMA PRA Category 1 Credit™<br>
 <br>
CME/CE Information and Claim Credit: <a href='https://www.pri-med.com/online-education/podcast/frankly-speaking-cme-310'>https://www.pri-med.com/online-education/podcast/frankly-speaking-cme-310</a></p>
<p>Overview: Join us as we discuss the importance of assessing for sexual dysfunction in young women with a cancer diagnosis. </p>
<p>Episode resource links:</p>
<ul><li>Lena Wettergren, Lars E. Eriksson, Charlotta Bergström, Christel Hedman,<br>
Johan Ahlgren, Karin E. Smedby, Kristina Hellman, Roger Henriksson & Claudia Lampic (2022): Prevalence and risk factors for sexual dysfunction in young women following a cancer diagnosis – a population-based study, Acta Oncologica, DOI: 10.1080/0284186X.2022.2112283<br>
<a href='https://doi.org/10.1080/0284186X.2022.2112283'>https://doi.org/10.1080/0284186X.2022.2112283</a></li>
</ul>
<p>Guest: Jill Terrien PhD, ANP-BC <br>
 <br>
Music Credit: Richard Onorato</p>
]]></content:encoded>
                                    
        <enclosure url="https://mcdn.podbean.com/mf/web/2phgwd/frankly-speaking-310-sexual-dysfx-women.mp3" length="10347557" type="audio/mpeg"/>
                <itunes:summary><![CDATA[Credits: 0.25 AMA PRA Category 1 Credit™ CME/CE Information and Claim Credit: https://www.pri-med.com/online-education/podcast/frankly-speaking-cme-310
Overview: Join us as we discuss the importance of assessing for sexual dysfunction in young women with a cancer diagnosis. 
Episode resource links:
Lena Wettergren, Lars E. Eriksson, Charlotta Bergström, Christel Hedman,Johan Ahlgren, Karin E. Smedby, Kristina Hellman, Roger Henriksson & Claudia Lampic (2022): Prevalence and risk factors for sexual dysfunction in young women following a cancer diagnosis – a population-based study, Acta Oncologica, DOI: 10.1080/0284186X.2022.2112283https://doi.org/10.1080/0284186X.2022.2112283
Guest: Jill Terrien PhD, ANP-BC  Music Credit: Richard Onorato]]></itunes:summary>
        <itunes:author>Pri-Med</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>644</itunes:duration>
                        <itunes:episodeType>full</itunes:episodeType>
            </item>
    <item>
        <title>Big and Strong: Vitamin D in the First Year of Life - Frankly Speaking Ep 309</title>
        <itunes:title>Big and Strong: Vitamin D in the First Year of Life - Frankly Speaking Ep 309</itunes:title>
        <link>https://primedfranklyspeaking.podbean.com/e/big-and-strong-vitamin-d-in-the-first-year-of-life-frankly-speaking-ep-309/</link>
                    <comments>https://primedfranklyspeaking.podbean.com/e/big-and-strong-vitamin-d-in-the-first-year-of-life-frankly-speaking-ep-309/#comments</comments>        <pubDate>Mon, 02 Jan 2023 00:30:00 +0000</pubDate>
        <guid isPermaLink="false">primedfranklyspeaking.podbean.com/35ab9d9a-9284-37d0-bc97-45d8af3fc8ad</guid>
                                    <description><![CDATA[<p>Credits: 0.25 AMA PRA Category 1 Credit™
 
CME/CE Information and Claim Credit: <a href='https://www.pri-med.com/online-education/podcast/frankly-speaking-cme-309'>https://www.pri-med.com/online-education/podcast/frankly-speaking-cme-309</a></p>
<p>Overview: Listen to this podcast to get answers to important questions about vitamin D supplementation in the first year of life. We will review a recent systematic review and meta-analysis on the relationship between vitamin D supplementation in the first year of life and outcomes, and we will discuss how these findings can be applied to your practice.</p>
<p>Episode resource links:</p>
<ul><li>Nutrients; 2021 Feb 5;13(2):524. doi: 10.3390/nu13020524</li>
</ul>
<p>Guest: Robert A. Baldor MD, FAAFP
 
Music Credit: Richard Onorato</p>
]]></description>
                                                            <content:encoded><![CDATA[<p>Credits: 0.25 AMA PRA Category 1 Credit™<br>
 <br>
CME/CE Information and Claim Credit: <a href='https://www.pri-med.com/online-education/podcast/frankly-speaking-cme-309'>https://www.pri-med.com/online-education/podcast/frankly-speaking-cme-309</a></p>
<p>Overview: Listen to this podcast to get answers to important questions about vitamin D supplementation in the first year of life. We will review a recent systematic review and meta-analysis on the relationship between vitamin D supplementation in the first year of life and outcomes, and we will discuss how these findings can be applied to your practice.</p>
<p>Episode resource links:</p>
<ul><li>Nutrients; 2021 Feb 5;13(2):524. doi: 10.3390/nu13020524</li>
</ul>
<p>Guest: Robert A. Baldor MD, FAAFP<br>
 <br>
Music Credit: Richard Onorato</p>
]]></content:encoded>
                                    
        <enclosure url="https://mcdn.podbean.com/mf/web/c9f6q9/frankly-speaking-309-vitamin-d-infants.mp3" length="9129774" type="audio/mpeg"/>
                <itunes:summary><![CDATA[Credits: 0.25 AMA PRA Category 1 Credit™ CME/CE Information and Claim Credit: https://www.pri-med.com/online-education/podcast/frankly-speaking-cme-309
Overview: Listen to this podcast to get answers to important questions about vitamin D supplementation in the first year of life. We will review a recent systematic review and meta-analysis on the relationship between vitamin D supplementation in the first year of life and outcomes, and we will discuss how these findings can be applied to your practice.
Episode resource links:
Nutrients; 2021 Feb 5;13(2):524. doi: 10.3390/nu13020524
Guest: Robert A. Baldor MD, FAAFP Music Credit: Richard Onorato]]></itunes:summary>
        <itunes:author>Pri-Med</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>569</itunes:duration>
                        <itunes:episodeType>full</itunes:episodeType>
            </item>
    <item>
        <title>Favorite Podcast of 2022 - Frankly Speaking Ep 308</title>
        <itunes:title>Favorite Podcast of 2022 - Frankly Speaking Ep 308</itunes:title>
        <link>https://primedfranklyspeaking.podbean.com/e/favorite-podcast-of-2022-frankly-speaking-ep-308/</link>
                    <comments>https://primedfranklyspeaking.podbean.com/e/favorite-podcast-of-2022-frankly-speaking-ep-308/#comments</comments>        <pubDate>Mon, 26 Dec 2022 00:30:00 +0000</pubDate>
        <guid isPermaLink="false">primedfranklyspeaking.podbean.com/dcf95a91-c3a8-3b62-a946-5af339ea9a64</guid>
                                    <description><![CDATA[<p>Credits: 0.25 AMA PRA Category 1 Credit™
 
CME/CE Information and Claim Credit: <a href='https://www.pri-med.com/online-education/podcast/frankly-speaking-cme-308'>https://www.pri-med.com/online-education/podcast/frankly-speaking-cme-308</a></p>
<p>Overview: In this episode, each podcaster will discuss the most impactful paper and podcast of the year.</p>
<p>Episode resource links:</p>
<ul><li><a href='https://www.pri-med.com/online-education/podcast/frankly-speaking-cme-302'>https://www.pri-med.com/online-education/podcast/frankly-speaking-cme-302</a></li>
<li><a href='https://www.pri-med.com/online-education/podcast/frankly-speaking-cme-299'>https://www.pri-med.com/online-education/podcast/frankly-speaking-cme-299</a></li>
<li><a href='https://www.pri-med.com/online-education/podcast/frankly-speaking-cme-289'>https://www.pri-med.com/online-education/podcast/frankly-speaking-cme-289</a></li>
<li><a href='https://www.pri-med.com/online-education/podcast/frankly-speaking-cme-281'>https://www.pri-med.com/online-education/podcast/frankly-speaking-cme-281</a></li>
<li><a href='https://www.pri-med.com/online-education/podcast/frankly-speaking-cme-275'>https://www.pri-med.com/online-education/podcast/frankly-speaking-cme-275</a></li>
<li><a href='https://www.pri-med.com/online-education/podcast/frankly-speaking-cme-268'>https://www.pri-med.com/online-education/podcast/frankly-speaking-cme-268</a></li>
</ul>
<p>Guest: Alan Ehrlich MD, FAAFP, Jillian Joseph, MPAS, PA-C, Susan Feeney, DNP, FNP-BC, NP-C, Mariyan L. Montaque, DNP, FNP-BC, Jill M. Terrien PhD, ANP-BC 
 
Music Credit: Richard Onorato</p>
]]></description>
                                                            <content:encoded><![CDATA[<p>Credits: 0.25 AMA PRA Category 1 Credit™<br>
 <br>
CME/CE Information and Claim Credit: <a href='https://www.pri-med.com/online-education/podcast/frankly-speaking-cme-308'>https://www.pri-med.com/online-education/podcast/frankly-speaking-cme-308</a></p>
<p>Overview: In this episode, each podcaster will discuss the most impactful paper and podcast of the year.</p>
<p>Episode resource links:</p>
<ul><li><a href='https://www.pri-med.com/online-education/podcast/frankly-speaking-cme-302'>https://www.pri-med.com/online-education/podcast/frankly-speaking-cme-302</a></li>
<li><a href='https://www.pri-med.com/online-education/podcast/frankly-speaking-cme-299'>https://www.pri-med.com/online-education/podcast/frankly-speaking-cme-299</a></li>
<li><a href='https://www.pri-med.com/online-education/podcast/frankly-speaking-cme-289'>https://www.pri-med.com/online-education/podcast/frankly-speaking-cme-289</a></li>
<li><a href='https://www.pri-med.com/online-education/podcast/frankly-speaking-cme-281'>https://www.pri-med.com/online-education/podcast/frankly-speaking-cme-281</a></li>
<li><a href='https://www.pri-med.com/online-education/podcast/frankly-speaking-cme-275'>https://www.pri-med.com/online-education/podcast/frankly-speaking-cme-275</a></li>
<li><a href='https://www.pri-med.com/online-education/podcast/frankly-speaking-cme-268'>https://www.pri-med.com/online-education/podcast/frankly-speaking-cme-268</a></li>
</ul>
<p>Guest: Alan Ehrlich MD, FAAFP, Jillian Joseph, MPAS, PA-C, Susan Feeney, DNP, FNP-BC, NP-C, Mariyan L. Montaque, DNP, FNP-BC, Jill M. Terrien PhD, ANP-BC <br>
 <br>
Music Credit: Richard Onorato</p>
]]></content:encoded>
                                    
        <enclosure url="https://mcdn.podbean.com/mf/web/5gk6dh/frankly-speaking-308-best-of-2022_1.mp3" length="12309279" type="audio/mpeg"/>
                <itunes:summary><![CDATA[Credits: 0.25 AMA PRA Category 1 Credit™ CME/CE Information and Claim Credit: https://www.pri-med.com/online-education/podcast/frankly-speaking-cme-308
Overview: In this episode, each podcaster will discuss the most impactful paper and podcast of the year.
Episode resource links:
https://www.pri-med.com/online-education/podcast/frankly-speaking-cme-302
https://www.pri-med.com/online-education/podcast/frankly-speaking-cme-299
https://www.pri-med.com/online-education/podcast/frankly-speaking-cme-289
https://www.pri-med.com/online-education/podcast/frankly-speaking-cme-281
https://www.pri-med.com/online-education/podcast/frankly-speaking-cme-275
https://www.pri-med.com/online-education/podcast/frankly-speaking-cme-268
Guest: Alan Ehrlich MD, FAAFP, Jillian Joseph, MPAS, PA-C, Susan Feeney, DNP, FNP-BC, NP-C, Mariyan L. Montaque, DNP, FNP-BC, Jill M. Terrien PhD, ANP-BC  Music Credit: Richard Onorato]]></itunes:summary>
        <itunes:author>Pri-Med</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>766</itunes:duration>
                        <itunes:episodeType>full</itunes:episodeType>
            </item>
    <item>
        <title>Should There Be a Contraindication to CPR? - Frankly Speaking Ep 307</title>
        <itunes:title>Should There Be a Contraindication to CPR? - Frankly Speaking Ep 307</itunes:title>
        <link>https://primedfranklyspeaking.podbean.com/e/should-there-be-a-contraindication-to-cpr-frankly-speaking-ep-307/</link>
                    <comments>https://primedfranklyspeaking.podbean.com/e/should-there-be-a-contraindication-to-cpr-frankly-speaking-ep-307/#comments</comments>        <pubDate>Mon, 19 Dec 2022 00:30:00 +0000</pubDate>
        <guid isPermaLink="false">primedfranklyspeaking.podbean.com/731da263-fdd0-3dc6-8cd9-9469ae09f67a</guid>
                                    <description><![CDATA[<p>Credits: 0.25 AMA PRA Category 1 Credit™
 
CME/CE Information and Claim Credit: <a href='https://www.pri-med.com/online-education/podcast/frankly-speaking-cme-307'>https://www.pri-med.com/online-education/podcast/frankly-speaking-cme-307</a></p>
<p>Overview: The COVID-19 epidemic resulted in overflowing ICUs and significant numbers of deaths among older adults. A recent study looked at the differences in outcomes between patients admitted with “No-code” vs “CPR” status and found no difference for high-risk individuals. Listen to this brief podcast to explore the data from this study and, in turn, give patients the information they need to make informed decisions regarding their desired code status on their advanced directives.</p>
<p>Guest: Robert A. Baldor MD, FAAFP
 
Music Credit: Richard Onorato</p>
]]></description>
                                                            <content:encoded><![CDATA[<p>Credits: 0.25 AMA PRA Category 1 Credit™<br>
 <br>
CME/CE Information and Claim Credit: <a href='https://www.pri-med.com/online-education/podcast/frankly-speaking-cme-307'>https://www.pri-med.com/online-education/podcast/frankly-speaking-cme-307</a></p>
<p>Overview: The COVID-19 epidemic resulted in overflowing ICUs and significant numbers of deaths among older adults. A recent study looked at the differences in outcomes between patients admitted with “No-code” vs “CPR” status and found no difference for high-risk individuals. Listen to this brief podcast to explore the data from this study and, in turn, give patients the information they need to make informed decisions regarding their desired code status on their advanced directives.</p>
<p>Guest: Robert A. Baldor MD, FAAFP<br>
 <br>
Music Credit: Richard Onorato</p>
]]></content:encoded>
                                    
        <enclosure url="https://mcdn.podbean.com/mf/web/juxxi4/frankly-speaking-307-contraindication-cpr.mp3" length="9210569" type="audio/mpeg"/>
                <itunes:summary><![CDATA[Credits: 0.25 AMA PRA Category 1 Credit™ CME/CE Information and Claim Credit: https://www.pri-med.com/online-education/podcast/frankly-speaking-cme-307
Overview: The COVID-19 epidemic resulted in overflowing ICUs and significant numbers of deaths among older adults. A recent study looked at the differences in outcomes between patients admitted with “No-code” vs “CPR” status and found no difference for high-risk individuals. Listen to this brief podcast to explore the data from this study and, in turn, give patients the information they need to make informed decisions regarding their desired code status on their advanced directives.
Guest: Robert A. Baldor MD, FAAFP Music Credit: Richard Onorato]]></itunes:summary>
        <itunes:author>Pri-Med</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>573</itunes:duration>
                        <itunes:episodeType>full</itunes:episodeType>
            </item>
    <item>
        <title>Preventing Peanut Allergies—Are You Following the Recommendations? - Frankly Speaking Ep 306</title>
        <itunes:title>Preventing Peanut Allergies—Are You Following the Recommendations? - Frankly Speaking Ep 306</itunes:title>
        <link>https://primedfranklyspeaking.podbean.com/e/preventing-peanut-allergies%e2%80%94are-you-following-the-recommendations-frankly-speaking-ep-306/</link>
                    <comments>https://primedfranklyspeaking.podbean.com/e/preventing-peanut-allergies%e2%80%94are-you-following-the-recommendations-frankly-speaking-ep-306/#comments</comments>        <pubDate>Mon, 12 Dec 2022 00:30:00 +0000</pubDate>
        <guid isPermaLink="false">primedfranklyspeaking.podbean.com/f9380345-be12-302b-b585-bfa64b00933a</guid>
                                    <description><![CDATA[<p>Credits: 0.25 AMA PRA Category 1 Credit™
 
CME/CE Information and Claim Credit: <a href='https://www.pri-med.com/online-education/podcast/frankly-speaking-cme-306'>https://www.pri-med.com/online-education/podcast/frankly-speaking-cme-306</a></p>
<p>Overview: In 2015, a landmark study, LEAP (Learning Early About Peanut Allergy), found that early introduction to peanuts, at 4 to 6 months, significantly reduced the incidence of peanut allergies in all children but especially in those at high risk for allergies. A recent survey of pediatric residents and attendings in a large academic center regarding knowledge and implementation of the guidelines uncovered a significant knowledge gap impacting the health of children. Join us as we discuss this gap and review the guidelines for preventing peanut allergies in infants and children.</p>
<p> </p>
<p>Episode resource links:</p>
<ul><li>Sandhu S, Hanono M, Nagarajan S, Vastardi MA. Knowledge assessment of early peanut introduction in a New York City population [published online ahead of print, 2022 Jun 18]. Ann Allergy Asthma Immunol. 2022;S1081-1206(22)00534-8. doi:10.1016/j.anai.2022.06.013</li>
<li>Greer FR, Sicherer SH, Burks AW, AAP COMMITTEE ON NUTRITION, AAP SECTION ON ALLERGY AND IMMUNOLOGY. The Effects of Early Nutritional Interventions on the Development of Atopic Disease in Infants and Children: The Role of Maternal Dietary Restriction, Breastfeeding, Hydrolyzed Formulas, and Timing of Introduction of Allergenic Complementary Foods. Pediatrics. 2019;143(4): e20190281</li>
<li>Togias A, Cooper SF, Acebal ML, et al. Addendum guidelines for the prevention of peanut allergy in the United States: Report of the National Institute of Allergy and Infectious Diseases-sponsored expert panel. Ann Allergy Asthma Immunol. 2017;118(2):166-173.e7. doi:10.1016/j.anai.2016.10.004</li>
<li>Fleischer DM, Sicherer S, Greenhawt M, et al. Consensus Communication on Early Peanut Introduction and Prevention of Peanut Allergy in High-Risk Infants. Pediatr Dermatol. 2016;33(1):103-106. doi:10.1111/pde.12685</li>
<li>Du Toit, G., Roberts, G., Sayre, P. H., Bahnson, H. T., Radulovic, S., Santos, A. F., Brough, H. A., Phippard, D., Basting, M., Feeney, M., Turcanu, V., Sever, M. L., Gomez Lorenzo, M., Plaut, M., Lack, G., & LEAP Study Team (2015). Randomized trial of peanut consumption in infants at risk for peanut allergy. The New England journal of medicine, 372(9), 803–813. <a href='https://doi.org/10.1056/NEJMoa1414850'>https://doi.org/10.1056/NEJMoa1414850</a></li>
<li>Koplin JJ, Soriano VX, Peters RL. Real-World LEAP Implementation. Curr Allergy Asthma Rep. 2021;22(6):61-66. doi:10.1007/s11882-022-01032-3</li>
<li><a href='https://www.fda.gov/food/cfsan-constituent-updates/fda-completes-review-notification-regarding-health-claim-related-peanut-allergies'>https://www.fda.gov/food/cfsan-constituent-updates/fda-completes-review-notification-regarding-health-claim-related-peanut-allergies</a></li>
</ul>
<p>Guest: Susan Feeney, DNP, FNP
 
Music Credit: Richard Onorato</p>
]]></description>
                                                            <content:encoded><![CDATA[<p>Credits: 0.25 AMA PRA Category 1 Credit™<br>
 <br>
CME/CE Information and Claim Credit: <a href='https://www.pri-med.com/online-education/podcast/frankly-speaking-cme-306'>https://www.pri-med.com/online-education/podcast/frankly-speaking-cme-306</a></p>
<p>Overview: In 2015, a landmark study, LEAP (Learning Early About Peanut Allergy), found that early introduction to peanuts, at 4 to 6 months, significantly reduced the incidence of peanut allergies in all children but especially in those at high risk for allergies. A recent survey of pediatric residents and attendings in a large academic center regarding knowledge and implementation of the guidelines uncovered a significant knowledge gap impacting the health of children. Join us as we discuss this gap and review the guidelines for preventing peanut allergies in infants and children.</p>
<p> </p>
<p>Episode resource links:</p>
<ul><li>Sandhu S, Hanono M, Nagarajan S, Vastardi MA. Knowledge assessment of early peanut introduction in a New York City population [published online ahead of print, 2022 Jun 18]. <em>Ann Allergy Asthma Immunol</em>. 2022;S1081-1206(22)00534-8. doi:10.1016/j.anai.2022.06.013</li>
<li>Greer FR, Sicherer SH, Burks AW, AAP COMMITTEE ON NUTRITION, AAP SECTION ON ALLERGY AND IMMUNOLOGY. The Effects of Early Nutritional Interventions on the Development of Atopic Disease in Infants and Children: The Role of Maternal Dietary Restriction, Breastfeeding, Hydrolyzed Formulas, and Timing of Introduction of Allergenic Complementary Foods. Pediatrics. 2019;143(4): e20190281</li>
<li>Togias A, Cooper SF, Acebal ML, et al. Addendum guidelines for the prevention of peanut allergy in the United States: Report of the National Institute of Allergy and Infectious Diseases-sponsored expert panel. <em>Ann Allergy Asthma Immunol</em>. 2017;118(2):166-173.e7. doi:10.1016/j.anai.2016.10.004</li>
<li>Fleischer DM, Sicherer S, Greenhawt M, et al. Consensus Communication on Early Peanut Introduction and Prevention of Peanut Allergy in High-Risk Infants. <em>Pediatr Dermatol</em>. 2016;33(1):103-106. doi:10.1111/pde.12685</li>
<li>Du Toit, G., Roberts, G., Sayre, P. H., Bahnson, H. T., Radulovic, S., Santos, A. F., Brough, H. A., Phippard, D., Basting, M., Feeney, M., Turcanu, V., Sever, M. L., Gomez Lorenzo, M., Plaut, M., Lack, G., & LEAP Study Team (2015). Randomized trial of peanut consumption in infants at risk for peanut allergy. <em>The New England journal of medicine</em>, <em>372</em>(9), 803–813. <a href='https://doi.org/10.1056/NEJMoa1414850'>https://doi.org/10.1056/NEJMoa1414850</a></li>
<li>Koplin JJ, Soriano VX, Peters RL. Real-World LEAP Implementation. <em>Curr Allergy Asthma Rep</em>. 2021;22(6):61-66. doi:10.1007/s11882-022-01032-3</li>
<li><a href='https://www.fda.gov/food/cfsan-constituent-updates/fda-completes-review-notification-regarding-health-claim-related-peanut-allergies'>https://www.fda.gov/food/cfsan-constituent-updates/fda-completes-review-notification-regarding-health-claim-related-peanut-allergies</a></li>
</ul>
<p>Guest: Susan Feeney, DNP, FNP<br>
 <br>
Music Credit: Richard Onorato</p>
]]></content:encoded>
                                    
        <enclosure url="https://mcdn.podbean.com/mf/web/6wus4p/frankly-speaking-ep306-peanut-allergy_1.mp3" length="12150199" type="audio/mpeg"/>
                <itunes:summary><![CDATA[Credits: 0.25 AMA PRA Category 1 Credit™ CME/CE Information and Claim Credit: https://www.pri-med.com/online-education/podcast/frankly-speaking-cme-306
Overview: In 2015, a landmark study, LEAP (Learning Early About Peanut Allergy), found that early introduction to peanuts, at 4 to 6 months, significantly reduced the incidence of peanut allergies in all children but especially in those at high risk for allergies. A recent survey of pediatric residents and attendings in a large academic center regarding knowledge and implementation of the guidelines uncovered a significant knowledge gap impacting the health of children. Join us as we discuss this gap and review the guidelines for preventing peanut allergies in infants and children.
 
Episode resource links:
Sandhu S, Hanono M, Nagarajan S, Vastardi MA. Knowledge assessment of early peanut introduction in a New York City population [published online ahead of print, 2022 Jun 18]. Ann Allergy Asthma Immunol. 2022;S1081-1206(22)00534-8. doi:10.1016/j.anai.2022.06.013
Greer FR, Sicherer SH, Burks AW, AAP COMMITTEE ON NUTRITION, AAP SECTION ON ALLERGY AND IMMUNOLOGY. The Effects of Early Nutritional Interventions on the Development of Atopic Disease in Infants and Children: The Role of Maternal Dietary Restriction, Breastfeeding, Hydrolyzed Formulas, and Timing of Introduction of Allergenic Complementary Foods. Pediatrics. 2019;143(4): e20190281
Togias A, Cooper SF, Acebal ML, et al. Addendum guidelines for the prevention of peanut allergy in the United States: Report of the National Institute of Allergy and Infectious Diseases-sponsored expert panel. Ann Allergy Asthma Immunol. 2017;118(2):166-173.e7. doi:10.1016/j.anai.2016.10.004
Fleischer DM, Sicherer S, Greenhawt M, et al. Consensus Communication on Early Peanut Introduction and Prevention of Peanut Allergy in High-Risk Infants. Pediatr Dermatol. 2016;33(1):103-106. doi:10.1111/pde.12685
Du Toit, G., Roberts, G., Sayre, P. H., Bahnson, H. T., Radulovic, S., Santos, A. F., Brough, H. A., Phippard, D., Basting, M., Feeney, M., Turcanu, V., Sever, M. L., Gomez Lorenzo, M., Plaut, M., Lack, G., & LEAP Study Team (2015). Randomized trial of peanut consumption in infants at risk for peanut allergy. The New England journal of medicine, 372(9), 803–813. https://doi.org/10.1056/NEJMoa1414850
Koplin JJ, Soriano VX, Peters RL. Real-World LEAP Implementation. Curr Allergy Asthma Rep. 2021;22(6):61-66. doi:10.1007/s11882-022-01032-3
https://www.fda.gov/food/cfsan-constituent-updates/fda-completes-review-notification-regarding-health-claim-related-peanut-allergies
Guest: Susan Feeney, DNP, FNP Music Credit: Richard Onorato]]></itunes:summary>
        <itunes:author>Pri-Med</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>754</itunes:duration>
                        <itunes:episodeType>full</itunes:episodeType>
            </item>
    <item>
        <title>Risks of Long-Term Use of PPIs - Frankly Speaking Ep 305</title>
        <itunes:title>Risks of Long-Term Use of PPIs - Frankly Speaking Ep 305</itunes:title>
        <link>https://primedfranklyspeaking.podbean.com/e/risks-of-long-term-use-of-ppis-frankly-speaking-ep-305/</link>
                    <comments>https://primedfranklyspeaking.podbean.com/e/risks-of-long-term-use-of-ppis-frankly-speaking-ep-305/#comments</comments>        <pubDate>Mon, 05 Dec 2022 00:30:00 +0000</pubDate>
        <guid isPermaLink="false">primedfranklyspeaking.podbean.com/1bbb2fd0-d232-3730-975c-01c27161df22</guid>
                                    <description><![CDATA[<p>Credits: 0.25 AMA PRA Category 1 Credit™
 
CME/CE Information and Claim Credit: <a href='https://www.pri-med.com/online-education/podcast/frankly-speaking-cme-305'>https://www.pri-med.com/online-education/podcast/frankly-speaking-cme-305</a></p>
<p>Overview: We will review the general treatment approach to gastroesophageal reflux disease (GERD) and the risks of using proton pump inhibitors (PPI) for long durations. In particular, we will examine a new study that links PPI use, in comparison with H2 receptor antagonist (H2RA) use, with a significant increase in the risk of gastric cancer. This episode will highlight the importance of looking at PPIs on a medication review and evaluating whether patients are taking them for longer than needed.</p>
<p> </p>
<p>Episode resource links:</p>
<ul><li>Abrahami D, McDonald EG, Schnitzer ME, et al. Proton pump inhibitors and risk of gastric cancer: population-based cohort study. Gut. 2022;71(1):16-24.</li>
</ul>
<p>Guest: Jillian Joseph, MPAS, PA-C
 
Music Credit: Richard Onorato</p>
]]></description>
                                                            <content:encoded><![CDATA[<p>Credits: 0.25 AMA PRA Category 1 Credit™<br>
 <br>
CME/CE Information and Claim Credit: <a href='https://www.pri-med.com/online-education/podcast/frankly-speaking-cme-305'>https://www.pri-med.com/online-education/podcast/frankly-speaking-cme-305</a></p>
<p>Overview: We will review the general treatment approach to gastroesophageal reflux disease (GERD) and the risks of using proton pump inhibitors (PPI) for long durations. In particular, we will examine a new study that links PPI use, in comparison with H2 receptor antagonist (H2RA) use, with a significant increase in the risk of gastric cancer. This episode will highlight the importance of looking at PPIs on a medication review and evaluating whether patients are taking them for longer than needed.</p>
<p> </p>
<p>Episode resource links:</p>
<ul><li>Abrahami D, McDonald EG, Schnitzer ME, et al. Proton pump inhibitors and risk of gastric cancer: population-based cohort study. Gut. 2022;71(1):16-24.</li>
</ul>
<p>Guest: Jillian Joseph, MPAS, PA-C<br>
 <br>
Music Credit: Richard Onorato</p>
]]></content:encoded>
                                    
        <enclosure url="https://mcdn.podbean.com/mf/web/zvm49f/frankly-speaking-ep305-PPI.mp3" length="9129435" type="audio/mpeg"/>
                <itunes:summary><![CDATA[Credits: 0.25 AMA PRA Category 1 Credit™ CME/CE Information and Claim Credit: https://www.pri-med.com/online-education/podcast/frankly-speaking-cme-305
Overview: We will review the general treatment approach to gastroesophageal reflux disease (GERD) and the risks of using proton pump inhibitors (PPI) for long durations. In particular, we will examine a new study that links PPI use, in comparison with H2 receptor antagonist (H2RA) use, with a significant increase in the risk of gastric cancer. This episode will highlight the importance of looking at PPIs on a medication review and evaluating whether patients are taking them for longer than needed.
 
Episode resource links:
Abrahami D, McDonald EG, Schnitzer ME, et al. Proton pump inhibitors and risk of gastric cancer: population-based cohort study. Gut. 2022;71(1):16-24.
Guest: Jillian Joseph, MPAS, PA-C Music Credit: Richard Onorato]]></itunes:summary>
        <itunes:author>Pri-Med</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>568</itunes:duration>
                        <itunes:episodeType>full</itunes:episodeType>
            </item>
    <item>
        <title>Selecting Medication for Depression: Do Genomics Matter? - Frankly Speaking Ep 304</title>
        <itunes:title>Selecting Medication for Depression: Do Genomics Matter? - Frankly Speaking Ep 304</itunes:title>
        <link>https://primedfranklyspeaking.podbean.com/e/selecting-medication-for-depression-do-genomics-matter-frankly-speaking-ep-304/</link>
                    <comments>https://primedfranklyspeaking.podbean.com/e/selecting-medication-for-depression-do-genomics-matter-frankly-speaking-ep-304/#comments</comments>        <pubDate>Mon, 28 Nov 2022 00:30:00 +0000</pubDate>
        <guid isPermaLink="false">primedfranklyspeaking.podbean.com/52c9c747-ecf6-39f5-b564-9394e6491555</guid>
                                    <description><![CDATA[<p>Credits: 0.25 AMA PRA Category 1 Credit™
 
CME/CE Information and Claim Credit: <a href='https://www.pri-med.com/online-education/podcast/frankly-speaking-cme-304'>https://www.pri-med.com/online-education/podcast/frankly-speaking-cme-304</a></p>
<p>Overview: Pharmacogenomic testing has been suggested as a way to personalize medicine, particularly where the metabolism of medications can vary significantly. Unfortunately, despite increasing use of this testing, there has been little evidence showing a benefit in clinical outcomes. Listen to this podcast to explore the data on clinical outcomes for pharmacogenetic testing and how to best select medication for patients with depression.</p>
<p>Episode resource links:</p>
<ul><li>Oslin DW, Lynch KG, Shih MC, et al. Effect of Pharmacogenomic Testing for Drug-Gene Interactions on Medication Selection and Remission of Symptoms in Major Depressive Disorder: The PRIME Care Randomized Clinical Trial. JAMA. 2022;328(2):151-161.</li>
</ul>
<p>Guest: Alan Ehrlich MD, FAAFP
 
Music Credit: Richard Onorato</p>
]]></description>
                                                            <content:encoded><![CDATA[<p>Credits: 0.25 AMA PRA Category 1 Credit™<br>
 <br>
CME/CE Information and Claim Credit: <a href='https://www.pri-med.com/online-education/podcast/frankly-speaking-cme-304'>https://www.pri-med.com/online-education/podcast/frankly-speaking-cme-304</a></p>
<p>Overview: Pharmacogenomic testing has been suggested as a way to personalize medicine, particularly where the metabolism of medications can vary significantly. Unfortunately, despite increasing use of this testing, there has been little evidence showing a benefit in clinical outcomes. Listen to this podcast to explore the data on clinical outcomes for pharmacogenetic testing and how to best select medication for patients with depression.</p>
<p>Episode resource links:</p>
<ul><li>Oslin DW, Lynch KG, Shih MC, et al. Effect of Pharmacogenomic Testing for Drug-Gene Interactions on Medication Selection and Remission of Symptoms in Major Depressive Disorder: The PRIME Care Randomized Clinical Trial. JAMA. 2022;328(2):151-161.</li>
</ul>
<p>Guest: Alan Ehrlich MD, FAAFP<br>
 <br>
Music Credit: Richard Onorato</p>
]]></content:encoded>
                                    
        <enclosure url="https://mcdn.podbean.com/mf/web/ufmt9x/frankly-speaking-304-depression_1.mp3" length="10067433" type="audio/mpeg"/>
                <itunes:summary><![CDATA[Credits: 0.25 AMA PRA Category 1 Credit™ CME/CE Information and Claim Credit: https://www.pri-med.com/online-education/podcast/frankly-speaking-cme-304
Overview: Pharmacogenomic testing has been suggested as a way to personalize medicine, particularly where the metabolism of medications can vary significantly. Unfortunately, despite increasing use of this testing, there has been little evidence showing a benefit in clinical outcomes. Listen to this podcast to explore the data on clinical outcomes for pharmacogenetic testing and how to best select medication for patients with depression.
Episode resource links:
Oslin DW, Lynch KG, Shih MC, et al. Effect of Pharmacogenomic Testing for Drug-Gene Interactions on Medication Selection and Remission of Symptoms in Major Depressive Disorder: The PRIME Care Randomized Clinical Trial. JAMA. 2022;328(2):151-161.
Guest: Alan Ehrlich MD, FAAFP Music Credit: Richard Onorato]]></itunes:summary>
        <itunes:author>Pri-Med</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>627</itunes:duration>
                        <itunes:episodeType>full</itunes:episodeType>
            </item>
    <item>
        <title>Time to Stop Recommending Vitamin D? - Frankly Speaking Ep 303</title>
        <itunes:title>Time to Stop Recommending Vitamin D? - Frankly Speaking Ep 303</itunes:title>
        <link>https://primedfranklyspeaking.podbean.com/e/time-to-stop-recommending-vitamin-d-frankly-speaking-ep-303/</link>
                    <comments>https://primedfranklyspeaking.podbean.com/e/time-to-stop-recommending-vitamin-d-frankly-speaking-ep-303/#comments</comments>        <pubDate>Mon, 21 Nov 2022 00:30:00 +0000</pubDate>
        <guid isPermaLink="false">primedfranklyspeaking.podbean.com/3e3f7a99-0312-3e2a-8749-1748bf0f2bd8</guid>
                                    <description><![CDATA[<p>Credits: 0.25 AMA PRA Category 1 Credit™
 
CME/CE Information and Claim Credit: <a href='https://www.pri-med.com/online-education/podcast/frankly-speaking-cme-303'>https://www.pri-med.com/online-education/podcast/frankly-speaking-cme-303</a></p>
<p>Overview: Millions of Americans take Vitamin D supplementation to prevent a variety of illnesses, from COVID-19 and osteoporosis to heart disease and cancer. While most studies have failed to show a benefit in preventing COVID-19, heart disease, and cancer, the evidence has been mixed, at best, in showing benefits for preventing bone fractures. Despite this, vitamin D supplementation remains popular for fracture prevention. Join us to review a study published in the New England Journal of Medicine that failed to find any benefits for preventing fractures.</p>
<p>Episode resource links:</p>
<ul><li>N Engl J Med 2022;387:299-309. DOI: 10.1056/NEJMoa2202106</li>
</ul>
<p>Guest: Robert A. Baldor MD, FAAFP
 
Music Credit: Richard Onorato</p>
]]></description>
                                                            <content:encoded><![CDATA[<p>Credits: 0.25 AMA PRA Category 1 Credit™<br>
 <br>
CME/CE Information and Claim Credit: <a href='https://www.pri-med.com/online-education/podcast/frankly-speaking-cme-303'>https://www.pri-med.com/online-education/podcast/frankly-speaking-cme-303</a></p>
<p>Overview: Millions of Americans take Vitamin D supplementation to prevent a variety of illnesses, from COVID-19 and osteoporosis to heart disease and cancer. While most studies have failed to show a benefit in preventing COVID-19, heart disease, and cancer, the evidence has been mixed, at best, in showing benefits for preventing bone fractures. Despite this, vitamin D supplementation remains popular for fracture prevention. Join us to review a study published in the New England Journal of Medicine that failed to find any benefits for preventing fractures.</p>
<p>Episode resource links:</p>
<ul><li>N Engl J Med 2022;387:299-309. DOI: 10.1056/NEJMoa2202106</li>
</ul>
<p>Guest: Robert A. Baldor MD, FAAFP<br>
 <br>
Music Credit: Richard Onorato</p>
]]></content:encoded>
                                    
        <enclosure url="https://mcdn.podbean.com/mf/web/huznbm/frankly-speaking-303-vitamin-d_1.mp3" length="9613126" type="audio/mpeg"/>
                <itunes:summary><![CDATA[Credits: 0.25 AMA PRA Category 1 Credit™ CME/CE Information and Claim Credit: https://www.pri-med.com/online-education/podcast/frankly-speaking-cme-303
Overview: Millions of Americans take Vitamin D supplementation to prevent a variety of illnesses, from COVID-19 and osteoporosis to heart disease and cancer. While most studies have failed to show a benefit in preventing COVID-19, heart disease, and cancer, the evidence has been mixed, at best, in showing benefits for preventing bone fractures. Despite this, vitamin D supplementation remains popular for fracture prevention. Join us to review a study published in the New England Journal of Medicine that failed to find any benefits for preventing fractures.
Episode resource links:
N Engl J Med 2022;387:299-309. DOI: 10.1056/NEJMoa2202106
Guest: Robert A. Baldor MD, FAAFP Music Credit: Richard Onorato]]></itunes:summary>
        <itunes:author>Pri-Med</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>597</itunes:duration>
                        <itunes:episodeType>full</itunes:episodeType>
            </item>
    <item>
        <title>New AACE Guidelines for Non-Alcoholic Fatty Liver Disease - Frankly Speaking Ep 302</title>
        <itunes:title>New AACE Guidelines for Non-Alcoholic Fatty Liver Disease - Frankly Speaking Ep 302</itunes:title>
        <link>https://primedfranklyspeaking.podbean.com/e/new-aace-guidelines-for-non-alcoholic-fatty-liver-disease-frankly-speaking-ep-302/</link>
                    <comments>https://primedfranklyspeaking.podbean.com/e/new-aace-guidelines-for-non-alcoholic-fatty-liver-disease-frankly-speaking-ep-302/#comments</comments>        <pubDate>Mon, 14 Nov 2022 00:30:00 +0000</pubDate>
        <guid isPermaLink="false">primedfranklyspeaking.podbean.com/825c474f-fb82-3a23-b50d-a926a36f2cc7</guid>
                                    <description><![CDATA[<p>Credits: 0.25 AMA PRA Category 1 Credit™
 </p>
<p> </p>
<p>CME/CE Information and Claim Credit: <a href='https://www.pri-med.com/online-education/podcast/frankly-speaking-cme-302'>https://www.pri-med.com/online-education/podcast/frankly-speaking-cme-302</a></p>
<p> </p>
<p>Overview: Non-alcoholic fatty liver disease (NAFLD) is the most common chronic liver disease in the United States, with a prevalence rate of more than 30% of US adults. Most have not been diagnosed or treated. Join us to discuss the new AACE guidance on the diagnosis and treatment of NAFLD to reduce the burden of this common disease.</p>
<p> </p>
<p>Episode resource links:</p>
<ul><li>AACE Guideline:  Endocrine Pract: May 2022, 28(5): 528-562</li>
<li>Coffee: Front Pharmacol. 2021 Dec 13;12:786596. doi: 10.3389/fphar.2021.786596</li>
</ul>
<p> </p>
<p>Guest: Robert A. Baldor, MD</p>
<p> </p>
<p>Music Credit: Richard Onorato
 </p>
]]></description>
                                                            <content:encoded><![CDATA[<p>Credits: 0.25 AMA PRA Category 1 Credit™<br>
 </p>
<p> </p>
<p>CME/CE Information and Claim Credit: <a href='https://www.pri-med.com/online-education/podcast/frankly-speaking-cme-302'>https://www.pri-med.com/online-education/podcast/frankly-speaking-cme-302</a></p>
<p> </p>
<p>Overview: Non-alcoholic fatty liver disease (NAFLD) is the most common chronic liver disease in the United States, with a prevalence rate of more than 30% of US adults. Most have not been diagnosed or treated. Join us to discuss the new AACE guidance on the diagnosis and treatment of NAFLD to reduce the burden of this common disease.</p>
<p> </p>
<p>Episode resource links:</p>
<ul><li>AACE Guideline:  Endocrine Pract: May 2022, 28(5): 528-562</li>
<li>Coffee: Front Pharmacol. 2021 Dec 13;12:786596. doi: 10.3389/fphar.2021.786596</li>
</ul>
<p> </p>
<p>Guest: Robert A. Baldor, MD</p>
<p> </p>
<p>Music Credit: Richard Onorato<br>
 </p>
]]></content:encoded>
                                    
        <enclosure url="https://mcdn.podbean.com/mf/web/568wgn/frankly-speaking-ep302-fatty-liver.mp3" length="10857473" type="audio/mpeg"/>
                <itunes:summary><![CDATA[Credits: 0.25 AMA PRA Category 1 Credit™ 
 
CME/CE Information and Claim Credit: https://www.pri-med.com/online-education/podcast/frankly-speaking-cme-302
 
Overview: Non-alcoholic fatty liver disease (NAFLD) is the most common chronic liver disease in the United States, with a prevalence rate of more than 30% of US adults. Most have not been diagnosed or treated. Join us to discuss the new AACE guidance on the diagnosis and treatment of NAFLD to reduce the burden of this common disease.
 
Episode resource links:
AACE Guideline:  Endocrine Pract: May 2022, 28(5): 528-562
Coffee: Front Pharmacol. 2021 Dec 13;12:786596. doi: 10.3389/fphar.2021.786596
 
Guest: Robert A. Baldor, MD
 
Music Credit: Richard Onorato ]]></itunes:summary>
        <itunes:author>Pri-Med</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>675</itunes:duration>
                        <itunes:episodeType>full</itunes:episodeType>
            </item>
    <item>
        <title>Walking and Osteoarthritis of the Knee: A Simple Strategy to Slow Cartilage Loss - Frankly Speaking Ep 301</title>
        <itunes:title>Walking and Osteoarthritis of the Knee: A Simple Strategy to Slow Cartilage Loss - Frankly Speaking Ep 301</itunes:title>
        <link>https://primedfranklyspeaking.podbean.com/e/walking-and-osteoarthritis-of-the-knee-a-simple-strategy-to-slow-cartilage-loss-frankly-speaking-ep-300/</link>
                    <comments>https://primedfranklyspeaking.podbean.com/e/walking-and-osteoarthritis-of-the-knee-a-simple-strategy-to-slow-cartilage-loss-frankly-speaking-ep-300/#comments</comments>        <pubDate>Mon, 07 Nov 2022 00:30:00 +0000</pubDate>
        <guid isPermaLink="false">primedfranklyspeaking.podbean.com/88f89409-a68a-372b-9305-c23a2d6c4260</guid>
                                    <description><![CDATA[<p>Credits: 0.25 AMA PRA Category 1 Credit™
 </p>
<p> </p>
<p>CME/CE Information and Claim Credit: <a href='https://www.pri-med.com/online-education/podcast/frankly-speaking-cme-301'>https://www.pri-med.com/online-education/podcast/frankly-speaking-cme-301</a></p>
<p> </p>
<p>Overview: In this episode, we will discuss a simple and inexpensive yet effective strategy for slowing the loss of knee joint cartilage in a patient with osteoarthritis: walking. Hear how recent evidence suggests that including a walking regimen into treatment plans may confer numerous benefits in this patient population.</p>
<p> </p>
<p>Episode resource links:</p>
<ul><li>Busse, JW, Sadeghirad, B., Oparin, Y. et al; Management of Acute Pain From Non–Low Back, Musculoskeletal Injuries: A Systematic Review and Network Meta-analysis of Randomized Trials. Ann Intern Med.2020;173:730-738. [Epub 18 August 2020]. doi:10.7326/M19-3601</li>
<li>Kolasinski, S.L., Neogi, T., Hochberg, M.C., Oatis, C., Guyatt, G., Block, J., Callahan, L., Copenhaver, C., Dodge, C., Felson, D., Gellar, K., Harvey, W.F., Hawker, G., Herzig, E., Kwoh, C.K., Nelson, A.E., Samuels, J., Scanzello, C., White, D., Wise, B., Altman, R.D., DiRenzo, D., Fontanarosa, J., Giradi, G., Ishimori, M., Misra, D., Shah, A.A., Shmagel, A.K., Thoma, L.M., Turgunbaev, M., Turner, A.S. and Reston, J. (2020), 2019 American College of Rheumatology/Arthritis Foundation Guideline for the Management of Osteoarthritis of the Hand, Hip, and Knee. Arthritis Care Res, 72: 149-162. <a href='https://doi.org/10.1002/acr.24131'>https://doi.org/10.1002/acr.24131</a></li>
<li>Lo GH, Vinod S, Richard MJ, et al. Association Between Walking for Exercise and Symptomatic and Structural Progression in Individuals with Knee Osteoarthritis: Data from the Osteoarthritis Initiative Cohort [published online ahead of print, 2022 Jun 8]. Arthritis Rheumatol. 2022;10.1002/art.42241. doi:10.1002/art.42241</li>
<li>Thudium C. Markers of synovial inflammation matrix turnover and symptoms. Presented at: OARSI 2022 World Congress on Osteoarthritis; April 7-10; Berlin, Germany (virtual meeting).</li>
<li>Ooman JMH. Babs on a mission: An experimental study on the effects of message framing and exemplification on treatment intentions of osteoarthritis patients. Presented at: OARSI 2022 World Congress on Osteoarthritis; April 7-10; Berlin, Germany (virtual meeting).</li>
<li>Zeng C, Doherty M, Persson MSM, et al. Comparative efficacy and safety of acetaminophen, topical and oral non-steroidal anti-inflammatory drugs for knee osteoarthritis: evidence from a network meta-analysis of randomized controlled trials and real-world data. Osteoarthritis Cartilage. 2021;29(9):1242-1251. doi:10.1016/j.joca.2021.06.004</li>
</ul>
<p> </p>
<p>Guest: Susan Feeney, DNP, FNP-BC, NP-C</p>
<p> </p>
<p>Music Credit: Richard Onorato
 </p>
]]></description>
                                                            <content:encoded><![CDATA[<p>Credits: 0.25 AMA PRA Category 1 Credit™<br>
 </p>
<p> </p>
<p>CME/CE Information and Claim Credit: <a href='https://www.pri-med.com/online-education/podcast/frankly-speaking-cme-301'>https://www.pri-med.com/online-education/podcast/frankly-speaking-cme-301</a></p>
<p> </p>
<p>Overview: In this episode, we will discuss a simple and inexpensive yet effective strategy for slowing the loss of knee joint cartilage in a patient with osteoarthritis: walking. Hear how recent evidence suggests that including a walking regimen into treatment plans may confer numerous benefits in this patient population.</p>
<p> </p>
<p>Episode resource links:</p>
<ul><li>Busse, JW, Sadeghirad, B., Oparin, Y. et al; Management of Acute Pain From Non–Low Back, Musculoskeletal Injuries: A Systematic Review and Network Meta-analysis of Randomized Trials. Ann Intern Med.2020;173:730-738. [Epub 18 August 2020]. doi:10.7326/M19-3601</li>
<li>Kolasinski, S.L., Neogi, T., Hochberg, M.C., Oatis, C., Guyatt, G., Block, J., Callahan, L., Copenhaver, C., Dodge, C., Felson, D., Gellar, K., Harvey, W.F., Hawker, G., Herzig, E., Kwoh, C.K., Nelson, A.E., Samuels, J., Scanzello, C., White, D., Wise, B., Altman, R.D., DiRenzo, D., Fontanarosa, J., Giradi, G., Ishimori, M., Misra, D., Shah, A.A., Shmagel, A.K., Thoma, L.M., Turgunbaev, M., Turner, A.S. and Reston, J. (2020), 2019 American College of Rheumatology/Arthritis Foundation Guideline for the Management of Osteoarthritis of the Hand, Hip, and Knee. Arthritis Care Res, 72: 149-162. <a href='https://doi.org/10.1002/acr.24131'>https://doi.org/10.1002/acr.24131</a></li>
<li>Lo GH, Vinod S, Richard MJ, et al. Association Between Walking for Exercise and Symptomatic and Structural Progression in Individuals with Knee Osteoarthritis: Data from the Osteoarthritis Initiative Cohort [published online ahead of print, 2022 Jun 8]. Arthritis Rheumatol. 2022;10.1002/art.42241. doi:10.1002/art.42241</li>
<li>Thudium C. Markers of synovial inflammation matrix turnover and symptoms. Presented at: OARSI 2022 World Congress on Osteoarthritis; April 7-10; Berlin, Germany (virtual meeting).</li>
<li>Ooman JMH. Babs on a mission: An experimental study on the effects of message framing and exemplification on treatment intentions of osteoarthritis patients. Presented at: OARSI 2022 World Congress on Osteoarthritis; April 7-10; Berlin, Germany (virtual meeting).</li>
<li>Zeng C, Doherty M, Persson MSM, et al. Comparative efficacy and safety of acetaminophen, topical and oral non-steroidal anti-inflammatory drugs for knee osteoarthritis: evidence from a network meta-analysis of randomized controlled trials and real-world data. Osteoarthritis Cartilage. 2021;29(9):1242-1251. doi:10.1016/j.joca.2021.06.004</li>
</ul>
<p> </p>
<p>Guest: Susan Feeney, DNP, FNP-BC, NP-C</p>
<p> </p>
<p>Music Credit: Richard Onorato<br>
 </p>
]]></content:encoded>
                                    
        <enclosure url="https://mcdn.podbean.com/mf/web/8jf7ju/frankly-speaking-301-OA-knee.mp3" length="10499430" type="audio/mpeg"/>
                <itunes:summary><![CDATA[Credits: 0.25 AMA PRA Category 1 Credit™ 
 
CME/CE Information and Claim Credit: https://www.pri-med.com/online-education/podcast/frankly-speaking-cme-301
 
Overview: In this episode, we will discuss a simple and inexpensive yet effective strategy for slowing the loss of knee joint cartilage in a patient with osteoarthritis: walking. Hear how recent evidence suggests that including a walking regimen into treatment plans may confer numerous benefits in this patient population.
 
Episode resource links:
Busse, JW, Sadeghirad, B., Oparin, Y. et al; Management of Acute Pain From Non–Low Back, Musculoskeletal Injuries: A Systematic Review and Network Meta-analysis of Randomized Trials. Ann Intern Med.2020;173:730-738. [Epub 18 August 2020]. doi:10.7326/M19-3601
Kolasinski, S.L., Neogi, T., Hochberg, M.C., Oatis, C., Guyatt, G., Block, J., Callahan, L., Copenhaver, C., Dodge, C., Felson, D., Gellar, K., Harvey, W.F., Hawker, G., Herzig, E., Kwoh, C.K., Nelson, A.E., Samuels, J., Scanzello, C., White, D., Wise, B., Altman, R.D., DiRenzo, D., Fontanarosa, J., Giradi, G., Ishimori, M., Misra, D., Shah, A.A., Shmagel, A.K., Thoma, L.M., Turgunbaev, M., Turner, A.S. and Reston, J. (2020), 2019 American College of Rheumatology/Arthritis Foundation Guideline for the Management of Osteoarthritis of the Hand, Hip, and Knee. Arthritis Care Res, 72: 149-162. https://doi.org/10.1002/acr.24131
Lo GH, Vinod S, Richard MJ, et al. Association Between Walking for Exercise and Symptomatic and Structural Progression in Individuals with Knee Osteoarthritis: Data from the Osteoarthritis Initiative Cohort [published online ahead of print, 2022 Jun 8]. Arthritis Rheumatol. 2022;10.1002/art.42241. doi:10.1002/art.42241
Thudium C. Markers of synovial inflammation matrix turnover and symptoms. Presented at: OARSI 2022 World Congress on Osteoarthritis; April 7-10; Berlin, Germany (virtual meeting).
Ooman JMH. Babs on a mission: An experimental study on the effects of message framing and exemplification on treatment intentions of osteoarthritis patients. Presented at: OARSI 2022 World Congress on Osteoarthritis; April 7-10; Berlin, Germany (virtual meeting).
Zeng C, Doherty M, Persson MSM, et al. Comparative efficacy and safety of acetaminophen, topical and oral non-steroidal anti-inflammatory drugs for knee osteoarthritis: evidence from a network meta-analysis of randomized controlled trials and real-world data. Osteoarthritis Cartilage. 2021;29(9):1242-1251. doi:10.1016/j.joca.2021.06.004
 
Guest: Susan Feeney, DNP, FNP-BC, NP-C
 
Music Credit: Richard Onorato ]]></itunes:summary>
        <itunes:author>Pri-Med</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>651</itunes:duration>
                        <itunes:episodeType>full</itunes:episodeType>
            </item>
    <item>
        <title>Cats Causing Psychosis! - Frankly Speaking Ep 300</title>
        <itunes:title>Cats Causing Psychosis! - Frankly Speaking Ep 300</itunes:title>
        <link>https://primedfranklyspeaking.podbean.com/e/cats-causing-psychosis-frankly-speaking-ep-300/</link>
                    <comments>https://primedfranklyspeaking.podbean.com/e/cats-causing-psychosis-frankly-speaking-ep-300/#comments</comments>        <pubDate>Mon, 31 Oct 2022 00:30:00 +0000</pubDate>
        <guid isPermaLink="false">primedfranklyspeaking.podbean.com/e86ad687-3d94-3035-b314-fe0d185c2c38</guid>
                                    <description><![CDATA[<p>Credits: 0.25 AMA PRA Category 1 Credit™
 </p>
<p> </p>
<p>CME/CE Information and Claim Credit: <a href='https://www.pri-med.com/online-education/podcast/frankly-speaking-cme-300'>https://www.pri-med.com/online-education/podcast/frankly-speaking-cme-300</a></p>
<p> </p>
<p>Overview: Most primary care clinicians are unaware of a possible association between childhood cat ownership and adult psychosis. Join us to hear the results of a recent retrospective study that suggests this link. Hear practical tips to share with patients who own an outdoor cat to help them avoid the toxoplasmosis that may be a potential etiologic agent for psychiatric illness.</p>
<p> </p>
<p>Episode resource links:</p>
<ul><li>
<p>Journal of Psychiatric Research. Volume 148, April 2022, Pages 197-203</p>
<p>doi.org/10.1016/j.jpsychires.2022.01.058</p>
</li>
</ul>
<p> </p>
<p>Guest: Robert A. Baldor, MD</p>
<p> </p>
<p>Music Credit: Richard Onorato
 </p>
]]></description>
                                                            <content:encoded><![CDATA[<p>Credits: 0.25 AMA PRA Category 1 Credit™<br>
 </p>
<p> </p>
<p>CME/CE Information and Claim Credit: <a href='https://www.pri-med.com/online-education/podcast/frankly-speaking-cme-300'>https://www.pri-med.com/online-education/podcast/frankly-speaking-cme-300</a></p>
<p> </p>
<p>Overview: Most primary care clinicians are unaware of a possible association between childhood cat ownership and adult psychosis. Join us to hear the results of a recent retrospective study that suggests this link. Hear practical tips to share with patients who own an outdoor cat to help them avoid the toxoplasmosis that may be a potential etiologic agent for psychiatric illness.</p>
<p> </p>
<p>Episode resource links:</p>
<ul><li>
<p>Journal of Psychiatric Research. Volume 148, April 2022, Pages 197-203</p>
<p>doi.org/10.1016/j.jpsychires.2022.01.058</p>
</li>
</ul>
<p> </p>
<p>Guest: Robert A. Baldor, MD</p>
<p> </p>
<p>Music Credit: Richard Onorato<br>
 </p>
]]></content:encoded>
                                    
        <enclosure url="https://mcdn.podbean.com/mf/web/k28pia/frankly-speaking-300-cats-and-psychosis.mp3" length="8202066" type="audio/mpeg"/>
                <itunes:summary><![CDATA[Credits: 0.25 AMA PRA Category 1 Credit™ 
 
CME/CE Information and Claim Credit: https://www.pri-med.com/online-education/podcast/frankly-speaking-cme-300
 
Overview: Most primary care clinicians are unaware of a possible association between childhood cat ownership and adult psychosis. Join us to hear the results of a recent retrospective study that suggests this link. Hear practical tips to share with patients who own an outdoor cat to help them avoid the toxoplasmosis that may be a potential etiologic agent for psychiatric illness.
 
Episode resource links:

Journal of Psychiatric Research. Volume 148, April 2022, Pages 197-203
doi.org/10.1016/j.jpsychires.2022.01.058

 
Guest: Robert A. Baldor, MD
 
Music Credit: Richard Onorato ]]></itunes:summary>
        <itunes:author>Pri-Med</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>510</itunes:duration>
                        <itunes:episodeType>full</itunes:episodeType>
            </item>
    <item>
        <title>Deprescribing in Patients with Dementia: Less Is More - Frankly Speaking Ep 299</title>
        <itunes:title>Deprescribing in Patients with Dementia: Less Is More - Frankly Speaking Ep 299</itunes:title>
        <link>https://primedfranklyspeaking.podbean.com/e/deprescribing-in-patients-with-dementia-less-is-more-frankly-speaking-ep-299/</link>
                    <comments>https://primedfranklyspeaking.podbean.com/e/deprescribing-in-patients-with-dementia-less-is-more-frankly-speaking-ep-299/#comments</comments>        <pubDate>Mon, 24 Oct 2022 00:30:00 +0000</pubDate>
        <guid isPermaLink="false">primedfranklyspeaking.podbean.com/d1f0167c-71b7-34b1-94f3-d5ac9689cd8c</guid>
                                    <description><![CDATA[<p>Credits: 0.25 AMA PRA Category 1 Credit™
 
CME/CE Information and Claim Credit: <a href='https://www.pri-med.com/online-education/podcast/frankly-speaking-cme-299'>https://www.pri-med.com/online-education/podcast/frankly-speaking-cme-299</a></p>
<p>Overview: Polypharmacy is a burden on patients with dementia. Adverse drug reactions, side effects, the cost, and inappropriate medications that may lead to falls and morbidity/mortality may be conferring more harm than benefit. Unfortunately, 44% of men and 57% of women >65 years take five or more nonprescription and/or prescription medications per day. Join us as we discuss methods for deprescribing polypharmacy in this patient population. </p>
<p>Episode resource links:</p>
<ul><li>Growdon, M. E., Gan, S., Yaffe, K., & Steinman, M. A. (2021). Polypharmacy among older adults with dementia compared with those without dementia in the United States. Journal of the American Geriatrics Society, 69(9), 2464–2475. PMID: 34101822 <a href='https://doi.org/10.1111/jgs.17291'>https://doi.org/10.1111/jgs.17291</a></li>
<li>Narayan, S. W., & Nishtala, P. S. (2017). Discontinuation of Preventive Medicines in Older People with Limited Life Expectancy: A Systematic Review. Drugs & aging, 34(10), 767–776. PMID: 28853000  <a href='https://doi.org/10.1007/s40266-017-0487-1'>https://doi.org/10.1007/s40266-017-0487-1</a></li>
</ul>
<p>Guest: Jill M. Terrien PhD, ANP-BC 
 
Music Credit: Richard Onorato
 </p>
]]></description>
                                                            <content:encoded><![CDATA[<p>Credits: 0.25 AMA PRA Category 1 Credit™<br>
 <br>
CME/CE Information and Claim Credit: <a href='https://www.pri-med.com/online-education/podcast/frankly-speaking-cme-299'>https://www.pri-med.com/online-education/podcast/frankly-speaking-cme-299</a></p>
<p>Overview: Polypharmacy is a burden on patients with dementia. Adverse drug reactions, side effects, the cost, and inappropriate medications that may lead to falls and morbidity/mortality may be conferring more harm than benefit. Unfortunately, 44% of men and 57% of women >65 years take five or more nonprescription and/or prescription medications per day. Join us as we discuss methods for deprescribing polypharmacy in this patient population. </p>
<p>Episode resource links:</p>
<ul><li>Growdon, M. E., Gan, S., Yaffe, K., & Steinman, M. A. (2021). Polypharmacy among older adults with dementia compared with those without dementia in the United States. Journal of the American Geriatrics Society, 69(9), 2464–2475. PMID: 34101822 <a href='https://doi.org/10.1111/jgs.17291'>https://doi.org/10.1111/jgs.17291</a></li>
<li>Narayan, S. W., & Nishtala, P. S. (2017). Discontinuation of Preventive Medicines in Older People with Limited Life Expectancy: A Systematic Review. Drugs & aging, 34(10), 767–776. PMID: 28853000  <a href='https://doi.org/10.1007/s40266-017-0487-1'>https://doi.org/10.1007/s40266-017-0487-1</a></li>
</ul>
<p>Guest: Jill M. Terrien PhD, ANP-BC <br>
 <br>
Music Credit: Richard Onorato<br>
 </p>
]]></content:encoded>
                                    
        <enclosure url="https://mcdn.podbean.com/mf/web/rka7pk/frankly-speaking-299-polypharmacy-dementia.mp3" length="10891821" type="audio/mpeg"/>
                <itunes:summary><![CDATA[Credits: 0.25 AMA PRA Category 1 Credit™ CME/CE Information and Claim Credit: https://www.pri-med.com/online-education/podcast/frankly-speaking-cme-299
Overview: Polypharmacy is a burden on patients with dementia. Adverse drug reactions, side effects, the cost, and inappropriate medications that may lead to falls and morbidity/mortality may be conferring more harm than benefit. Unfortunately, 44% of men and 57% of women >65 years take five or more nonprescription and/or prescription medications per day. Join us as we discuss methods for deprescribing polypharmacy in this patient population. 
Episode resource links:
Growdon, M. E., Gan, S., Yaffe, K., & Steinman, M. A. (2021). Polypharmacy among older adults with dementia compared with those without dementia in the United States. Journal of the American Geriatrics Society, 69(9), 2464–2475. PMID: 34101822 https://doi.org/10.1111/jgs.17291
Narayan, S. W., & Nishtala, P. S. (2017). Discontinuation of Preventive Medicines in Older People with Limited Life Expectancy: A Systematic Review. Drugs & aging, 34(10), 767–776. PMID: 28853000  https://doi.org/10.1007/s40266-017-0487-1
Guest: Jill M. Terrien PhD, ANP-BC  Music Credit: Richard Onorato ]]></itunes:summary>
        <itunes:author>Pri-Med</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>676</itunes:duration>
                        <itunes:episodeType>full</itunes:episodeType>
            </item>
    <item>
        <title>Leave the Antibiotics on the Shelf for Kids with Lower Respiratory Tract Infections - Frankly Speaking Ep 298</title>
        <itunes:title>Leave the Antibiotics on the Shelf for Kids with Lower Respiratory Tract Infections - Frankly Speaking Ep 298</itunes:title>
        <link>https://primedfranklyspeaking.podbean.com/e/leave-the-antibiotics-on-the-shelf-for-kids-with-lower-respiratory-tract-infections-frankly-speaking-ep-298/</link>
                    <comments>https://primedfranklyspeaking.podbean.com/e/leave-the-antibiotics-on-the-shelf-for-kids-with-lower-respiratory-tract-infections-frankly-speaking-ep-298/#comments</comments>        <pubDate>Mon, 17 Oct 2022 00:30:00 +0000</pubDate>
        <guid isPermaLink="false">primedfranklyspeaking.podbean.com/94df6a37-1342-32e6-b13b-4f1dbfb96373</guid>
                                    <description><![CDATA[<p>Credits: 0.25 AMA PRA Category 1 Credit™
 
CME/CE Information and Claim Credit: <a href='https://www.pri-med.com/online-education/podcast/frankly-speaking-cme-298'>https://www.pri-med.com/online-education/podcast/frankly-speaking-cme-298</a></p>
<p>Overview: :  Lower respiratory tract infections are a common presentation in children, and many of those children receive antibiotic prescriptions. Join us for this episode to review evidence that supports avoiding such treatment unless pneumonia or other bacterial infections are suspected.</p>
<p>Episode resource links:</p>
<ul><li>Little P, Francis NA, Stuart B, et al. Antibiotics for lower respiratory tract infection in children presenting in primary care in England (ARTIC PC): a double-blind, randomised, placebo-controlled trial. Lancet. 2021;398(10309):1417-1426</li>
</ul>
<p>Guest: Jillian Joseph, MSPAS, PA-C
 
Music Credit: Richard Onorato</p>
]]></description>
                                                            <content:encoded><![CDATA[<p>Credits: 0.25 AMA PRA Category 1 Credit™<br>
 <br>
CME/CE Information and Claim Credit: <a href='https://www.pri-med.com/online-education/podcast/frankly-speaking-cme-298'>https://www.pri-med.com/online-education/podcast/frankly-speaking-cme-298</a></p>
<p>Overview: :  Lower respiratory tract infections are a common presentation in children, and many of those children receive antibiotic prescriptions. Join us for this episode to review evidence that supports avoiding such treatment unless pneumonia or other bacterial infections are suspected.</p>
<p>Episode resource links:</p>
<ul><li>Little P, Francis NA, Stuart B, et al. Antibiotics for lower respiratory tract infection in children presenting in primary care in England (ARTIC PC): a double-blind, randomised, placebo-controlled trial. Lancet. 2021;398(10309):1417-1426</li>
</ul>
<p>Guest: Jillian Joseph, MSPAS, PA-C<br>
 <br>
Music Credit: Richard Onorato</p>
]]></content:encoded>
                                    
        <enclosure url="https://mcdn.podbean.com/mf/web/hqrdaw/frankly-speaking-298-amoxycilin.mp3" length="12556361" type="audio/mpeg"/>
                <itunes:summary><![CDATA[Credits: 0.25 AMA PRA Category 1 Credit™ CME/CE Information and Claim Credit: https://www.pri-med.com/online-education/podcast/frankly-speaking-cme-298
Overview: :  Lower respiratory tract infections are a common presentation in children, and many of those children receive antibiotic prescriptions. Join us for this episode to review evidence that supports avoiding such treatment unless pneumonia or other bacterial infections are suspected.
Episode resource links:
Little P, Francis NA, Stuart B, et al. Antibiotics for lower respiratory tract infection in children presenting in primary care in England (ARTIC PC): a double-blind, randomised, placebo-controlled trial. Lancet. 2021;398(10309):1417-1426
Guest: Jillian Joseph, MSPAS, PA-C Music Credit: Richard Onorato]]></itunes:summary>
        <itunes:author>Pri-Med</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>521</itunes:duration>
                        <itunes:episodeType>full</itunes:episodeType>
            </item>
    <item>
        <title>Probiotics to Prevent Diarrhea During Antibiotic Course in Children - Frankly Speaking EP 297</title>
        <itunes:title>Probiotics to Prevent Diarrhea During Antibiotic Course in Children - Frankly Speaking EP 297</itunes:title>
        <link>https://primedfranklyspeaking.podbean.com/e/probiotics-to-prevent-diarrhea-during-antibiotic-course-in-children-frankly-speaking-ep-297/</link>
                    <comments>https://primedfranklyspeaking.podbean.com/e/probiotics-to-prevent-diarrhea-during-antibiotic-course-in-children-frankly-speaking-ep-297/#comments</comments>        <pubDate>Mon, 10 Oct 2022 00:30:00 +0000</pubDate>
        <guid isPermaLink="false">primedfranklyspeaking.podbean.com/9437b096-2da1-3f4c-aa41-ac137db174de</guid>
                                    <description><![CDATA[<p>Credits: 0.25 AMA PRA Category 1 Credit™</p>
<p> </p>
<p>CME/CE Information and Claim Credit:<a href='https://www.pri-med.com/online-education/podcast/frankly-speaking-cme-297'> https://www.pri-med.com/online-education/podcast/frankly-speaking-cme-297</a></p>
<p> </p>
<p>Overview: The efficacy of probiotic formulations in the prevention of antibiotic-associated diarrhea remains unclear. Join us to review a recent study in JAMA Pediatrics that attempts to answer this question.</p>
<p> </p>
<p>Episode resource links:</p>
<ul><li>Multispecies Probiotic for the Prevention of Antibiotic-Associated Diarrhea in Children A Randomized Clinical Trial</li>
</ul>
<p> </p>
<p>Guest: Robert A. Baldor, MD</p>
<p> </p>
<p>Music Credit: Richard Onorato</p>
]]></description>
                                                            <content:encoded><![CDATA[<p>Credits: 0.25 AMA PRA Category 1 Credit™</p>
<p> </p>
<p>CME/CE Information and Claim Credit:<a href='https://www.pri-med.com/online-education/podcast/frankly-speaking-cme-297'> https://www.pri-med.com/online-education/podcast/frankly-speaking-cme-297</a></p>
<p> </p>
<p>Overview: The efficacy of probiotic formulations in the prevention of antibiotic-associated diarrhea remains unclear. Join us to review a recent study in JAMA Pediatrics that attempts to answer this question.</p>
<p> </p>
<p>Episode resource links:</p>
<ul><li>Multispecies Probiotic for the Prevention of Antibiotic-Associated Diarrhea in Children A Randomized Clinical Trial</li>
</ul>
<p> </p>
<p>Guest: Robert A. Baldor, MD</p>
<p> </p>
<p>Music Credit: Richard Onorato</p>
]]></content:encoded>
                                    
        <enclosure url="https://mcdn.podbean.com/mf/web/m6eyh3/frankly-speaking-297-probiotics.mp3" length="10721884" type="audio/mpeg"/>
                <itunes:summary><![CDATA[Credits: 0.25 AMA PRA Category 1 Credit™
 
CME/CE Information and Claim Credit: https://www.pri-med.com/online-education/podcast/frankly-speaking-cme-297
 
Overview: The efficacy of probiotic formulations in the prevention of antibiotic-associated diarrhea remains unclear. Join us to review a recent study in JAMA Pediatrics that attempts to answer this question.
 
Episode resource links:
Multispecies Probiotic for the Prevention of Antibiotic-Associated Diarrhea in Children A Randomized Clinical Trial
 
Guest: Robert A. Baldor, MD
 
Music Credit: Richard Onorato]]></itunes:summary>
        <itunes:author>Pri-Med</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>666</itunes:duration>
                        <itunes:episodeType>full</itunes:episodeType>
            </item>
    <item>
        <title>Preventing Overdose Deaths with Naloxone: Harm Reduction vs Encouraging Use - Frankly Speaking EP 296</title>
        <itunes:title>Preventing Overdose Deaths with Naloxone: Harm Reduction vs Encouraging Use - Frankly Speaking EP 296</itunes:title>
        <link>https://primedfranklyspeaking.podbean.com/e/preventing-overdose-deaths-with-naloxone-harm-reduction-vs-encouraging-use-frankly-speaking-ep-296/</link>
                    <comments>https://primedfranklyspeaking.podbean.com/e/preventing-overdose-deaths-with-naloxone-harm-reduction-vs-encouraging-use-frankly-speaking-ep-296/#comments</comments>        <pubDate>Mon, 03 Oct 2022 00:30:00 +0000</pubDate>
        <guid isPermaLink="false">primedfranklyspeaking.podbean.com/3462df34-9ad6-3808-a94c-91b568b7f896</guid>
                                    <description><![CDATA[<p>Credits: 0.25 AMA PRA Category 1 Credit™</p>
<p> </p>
<p>CME/CE Information and Claim Credit:<a href='https://www.pri-med.com/online-education/podcast/frankly-speaking-cme-296'> https://www.pri-med.com/online-education/podcast/frankly-speaking-cme-296</a></p>
<p> </p>
<p>Overview: The number of drug overdoses in the United States continues to rise in tandem with the growing opioid epidemic. In 2020, nearly 92,000 people died from drug overdoses in the United States, which was an approximate 31% increase in just one year. This episode will highlight perceived barriers to harm reduction and show primary care providers how they can play a key role in overdose prevention. </p>
<p> </p>
<p>Episode resource links:</p>
<ul><li>
<p><a href='https://www.cdc.gov/opioids/overdoseprevention/reverse-od.html'>https://www.cdc.gov/opioids/overdoseprevention/reverse-od.html</a></p>
</li>
<li>
<p><a href='https://www.cdc.gov/drugoverdose/deaths/index.html#:~:text=Drug%20Overdose%20Deaths%20Remain%20High&text=Opioids%E2%80%94mainly%20synthetic%20opioids%20(other,of%20all%20drug%20overdose%20deaths)'>https://www.cdc.gov/drugoverdose/deaths/index.html#:~:text=Drug%20Overdose%20Deaths%20Remain%20High&text=Opioids%E2%80%94mainly%20synthetic%20opioids%20(other,of%20all%20drug%20overdose%20deaths)</a>.</p>
</li>
<li>
<p>Bonner, L. (2022). As the opioid epidemic takes a turn for the worse, do we need more potent forms of naloxone?. Pharmacy Today, 28(3), 26.</p>
</li>
<li>
<p>Messmer, S., & Jarrett, J. (2022). When Naloxone Isn’t Enough. New England Journal of Medicine.</p>
</li>
<li>
<p>Tse, W. C., Djordjevic, F., Borja, V., Picco, L., Lam, T., Olsen, A., ... & Nielsen, S. (2022). Does naloxone provision lead to increased substance use? A systematic review to assess if there is evidence of a ‘moral hazard’associated with naloxone supply. International Journal of Drug Policy, 100, 103513.</p>
</li>
</ul>
<p> </p>
<p>Guest: Mariyan L. Montaque, DNP, FNP-BC</p>
<p> </p>
<p>Music Credit: Richard Onorato</p>
]]></description>
                                                            <content:encoded><![CDATA[<p>Credits: 0.25 AMA PRA Category 1 Credit™</p>
<p> </p>
<p>CME/CE Information and Claim Credit:<a href='https://www.pri-med.com/online-education/podcast/frankly-speaking-cme-296'> https://www.pri-med.com/online-education/podcast/frankly-speaking-cme-296</a></p>
<p> </p>
<p>Overview: The number of drug overdoses in the United States continues to rise in tandem with the growing opioid epidemic. In 2020, nearly 92,000 people died from drug overdoses in the United States, which was an approximate 31% increase in just one year. This episode will highlight perceived barriers to harm reduction and show primary care providers how they can play a key role in overdose prevention. </p>
<p> </p>
<p>Episode resource links:</p>
<ul><li>
<p><a href='https://www.cdc.gov/opioids/overdoseprevention/reverse-od.html'>https://www.cdc.gov/opioids/overdoseprevention/reverse-od.html</a></p>
</li>
<li>
<p><a href='https://www.cdc.gov/drugoverdose/deaths/index.html#:~:text=Drug%20Overdose%20Deaths%20Remain%20High&text=Opioids%E2%80%94mainly%20synthetic%20opioids%20(other,of%20all%20drug%20overdose%20deaths)'>https://www.cdc.gov/drugoverdose/deaths/index.html#:~:text=Drug%20Overdose%20Deaths%20Remain%20High&text=Opioids%E2%80%94mainly%20synthetic%20opioids%20(other,of%20all%20drug%20overdose%20deaths)</a>.</p>
</li>
<li>
<p>Bonner, L. (2022). As the opioid epidemic takes a turn for the worse, do we need more potent forms of naloxone?. <em>Pharmacy Today</em>, <em>28</em>(3), 26.</p>
</li>
<li>
<p>Messmer, S., & Jarrett, J. (2022). When Naloxone Isn’t Enough. <em>New England Journal of Medicine</em>.</p>
</li>
<li>
<p>Tse, W. C., Djordjevic, F., Borja, V., Picco, L., Lam, T., Olsen, A., ... & Nielsen, S. (2022). Does naloxone provision lead to increased substance use? A systematic review to assess if there is evidence of a ‘moral hazard’associated with naloxone supply. <em>International Journal of Drug Policy</em>, <em>100</em>, 103513.</p>
</li>
</ul>
<p> </p>
<p>Guest: Mariyan L. Montaque, DNP, FNP-BC</p>
<p> </p>
<p>Music Credit: Richard Onorato</p>
]]></content:encoded>
                                    
        <enclosure url="https://mcdn.podbean.com/mf/web/wdxhb7/frankly-speaking-296-overdose-naloxone.mp3" length="8700843" type="audio/mpeg"/>
                <itunes:summary><![CDATA[Credits: 0.25 AMA PRA Category 1 Credit™
 
CME/CE Information and Claim Credit: https://www.pri-med.com/online-education/podcast/frankly-speaking-cme-296
 
Overview: The number of drug overdoses in the United States continues to rise in tandem with the growing opioid epidemic. In 2020, nearly 92,000 people died from drug overdoses in the United States, which was an approximate 31% increase in just one year. This episode will highlight perceived barriers to harm reduction and show primary care providers how they can play a key role in overdose prevention. 
 
Episode resource links:

https://www.cdc.gov/opioids/overdoseprevention/reverse-od.html


https://www.cdc.gov/drugoverdose/deaths/index.html#:~:text=Drug%20Overdose%20Deaths%20Remain%20High&text=Opioids%E2%80%94mainly%20synthetic%20opioids%20(other,of%20all%20drug%20overdose%20deaths).


Bonner, L. (2022). As the opioid epidemic takes a turn for the worse, do we need more potent forms of naloxone?. Pharmacy Today, 28(3), 26.


Messmer, S., & Jarrett, J. (2022). When Naloxone Isn’t Enough. New England Journal of Medicine.


Tse, W. C., Djordjevic, F., Borja, V., Picco, L., Lam, T., Olsen, A., ... & Nielsen, S. (2022). Does naloxone provision lead to increased substance use? A systematic review to assess if there is evidence of a ‘moral hazard’associated with naloxone supply. International Journal of Drug Policy, 100, 103513.

 
Guest: Mariyan L. Montaque, DNP, FNP-BC
 
Music Credit: Richard Onorato]]></itunes:summary>
        <itunes:author>Pri-Med</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>540</itunes:duration>
                        <itunes:episodeType>full</itunes:episodeType>
            </item>
    <item>
        <title>Suspecting COPD: What If the Spirometry Result Is Normal? - Frankly Speaking EP 295</title>
        <itunes:title>Suspecting COPD: What If the Spirometry Result Is Normal? - Frankly Speaking EP 295</itunes:title>
        <link>https://primedfranklyspeaking.podbean.com/e/suspecting-copd-what-if-the-spirometry-result-is-normal-frankly-speaking-ep-295/</link>
                    <comments>https://primedfranklyspeaking.podbean.com/e/suspecting-copd-what-if-the-spirometry-result-is-normal-frankly-speaking-ep-295/#comments</comments>        <pubDate>Mon, 26 Sep 2022 00:30:00 +0000</pubDate>
        <guid isPermaLink="false">primedfranklyspeaking.podbean.com/0781c312-3fe7-35bd-b10e-5658abef7c9c</guid>
                                    <description><![CDATA[<p>Credits: 0.25 AMA PRA Category 1 Credit™</p>
<p> </p>
<p>CME/CE Information and Claim Credit:<a href='https://www.pri-med.com/online-education/podcast/frankly-speaking-cme-295'> https://www.pri-med.com/online-education/podcast/frankly-speaking-cme-295</a></p>
<p> </p>
<p>Overview: Chronic obstructive pulmonary disease (COPD) is typically diagnosed based on spirometry findings, but what if that finding isn’t what you expect? Spirometry measurements are compared to standard values for age, sex, and race. The use of race-based equations has been questioned in several clinical situations, and researchers are now raising similar concerns about the use of race-based equations in spirometry, which may lead to health inequities. Join us for an important discussion on how to overcome these potential disparities in diagnosing COPD.</p>
<p> </p>
<p>Episode resource links:</p>
<ul><li>
<p>Liu GY, Khan SS, Colangelo LA, et al. Comparing Racial Differences in Emphysema Prevalence Among Adults With Normal Spirometry: A Secondary Data Analysis of the CARDIA Lung Study [published online ahead of print, 2022 Jul 19]. Ann Intern Med. 2022;10.7326/M22-0205.</p>
</li>
</ul>
<p> </p>
<p>Guest: Alan Ehrlich MD, FAAFP</p>
<p> </p>
<p>Music Credit: Richard Onorato</p>
]]></description>
                                                            <content:encoded><![CDATA[<p>Credits: 0.25 AMA PRA Category 1 Credit™</p>
<p> </p>
<p>CME/CE Information and Claim Credit:<a href='https://www.pri-med.com/online-education/podcast/frankly-speaking-cme-295'> https://www.pri-med.com/online-education/podcast/frankly-speaking-cme-295</a></p>
<p> </p>
<p>Overview: Chronic obstructive pulmonary disease (COPD) is typically diagnosed based on spirometry findings, but what if that finding isn’t what you expect? Spirometry measurements are compared to standard values for age, sex, and race. The use of race-based equations has been questioned in several clinical situations, and researchers are now raising similar concerns about the use of race-based equations in spirometry, which may lead to health inequities. Join us for an important discussion on how to overcome these potential disparities in diagnosing COPD.</p>
<p> </p>
<p>Episode resource links:</p>
<ul><li>
<p>Liu GY, Khan SS, Colangelo LA, et al. Comparing Racial Differences in Emphysema Prevalence Among Adults With Normal Spirometry: A Secondary Data Analysis of the CARDIA Lung Study [published online ahead of print, 2022 Jul 19]. Ann Intern Med. 2022;10.7326/M22-0205.</p>
</li>
</ul>
<p> </p>
<p>Guest: Alan Ehrlich MD, FAAFP</p>
<p> </p>
<p>Music Credit: Richard Onorato</p>
]]></content:encoded>
                                    
        <enclosure url="https://mcdn.podbean.com/mf/web/5jns9u/frankly-speaking-295-copd-race-norms.mp3" length="9079489" type="audio/mpeg"/>
                <itunes:summary><![CDATA[Credits: 0.25 AMA PRA Category 1 Credit™
 
CME/CE Information and Claim Credit: https://www.pri-med.com/online-education/podcast/frankly-speaking-cme-295
 
Overview: Chronic obstructive pulmonary disease (COPD) is typically diagnosed based on spirometry findings, but what if that finding isn’t what you expect? Spirometry measurements are compared to standard values for age, sex, and race. The use of race-based equations has been questioned in several clinical situations, and researchers are now raising similar concerns about the use of race-based equations in spirometry, which may lead to health inequities. Join us for an important discussion on how to overcome these potential disparities in diagnosing COPD.
 
Episode resource links:

Liu GY, Khan SS, Colangelo LA, et al. Comparing Racial Differences in Emphysema Prevalence Among Adults With Normal Spirometry: A Secondary Data Analysis of the CARDIA Lung Study [published online ahead of print, 2022 Jul 19]. Ann Intern Med. 2022;10.7326/M22-0205.

 
Guest: Alan Ehrlich MD, FAAFP
 
Music Credit: Richard Onorato]]></itunes:summary>
        <itunes:author>Pri-Med</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>564</itunes:duration>
                        <itunes:episodeType>full</itunes:episodeType>
            </item>
    <item>
        <title>The Best Evidence for Treating Fibromyalgia - Frankly Speaking EP 294</title>
        <itunes:title>The Best Evidence for Treating Fibromyalgia - Frankly Speaking EP 294</itunes:title>
        <link>https://primedfranklyspeaking.podbean.com/e/the-best-evidence-for-treating-fibromyalgia-frankly-speaking-ep-294/</link>
                    <comments>https://primedfranklyspeaking.podbean.com/e/the-best-evidence-for-treating-fibromyalgia-frankly-speaking-ep-294/#comments</comments>        <pubDate>Mon, 19 Sep 2022 00:30:00 +0000</pubDate>
        <guid isPermaLink="false">primedfranklyspeaking.podbean.com/dda492b6-12f7-3a57-a8a2-8b455129a488</guid>
                                    <description><![CDATA[<p>Credits: 0.25 AMA PRA Category 1 Credit™</p>
<p> </p>
<p>CME/CE Information and Claim Credit:<a href='https://www.pri-med.com/online-education/podcast/frankly-speaking-cme-294'> https://www.pri-med.com/online-education/podcast/frankly-speaking-cme-294</a></p>
<p> </p>
<p>Overview: Fibromyalgia is a common and difficult to diagnose disease, with highly subjective symptoms. Another challenge is that treatment is dependent on a patient’s implementation lifestyle changes. This brief podcast walks you through the diagnosis of fibromyalgia and offers best evidence on effective treatments.</p>
<p> </p>
<p>Episode resource links:</p>
<ul><li>Mediations:  JAMA Netw Open. 2022;5(5):e2212939</li>
<li>Acupuncture:  <a href='https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8820460/'>J Pain Res.</a> 2022; 15: 315–329</li>
</ul>
<p> </p>
<p>Guest: Susan Feeney, DNP, FNP-BC, NP-C</p>
<p> </p>
<p>Music Credit: Richard Onorato</p>
]]></description>
                                                            <content:encoded><![CDATA[<p>Credits: 0.25 AMA PRA Category 1 Credit™</p>
<p> </p>
<p>CME/CE Information and Claim Credit:<a href='https://www.pri-med.com/online-education/podcast/frankly-speaking-cme-294'> https://www.pri-med.com/online-education/podcast/frankly-speaking-cme-294</a></p>
<p> </p>
<p>Overview: Fibromyalgia is a common and difficult to diagnose disease, with highly subjective symptoms. Another challenge is that treatment is dependent on a patient’s implementation lifestyle changes. This brief podcast walks you through the diagnosis of fibromyalgia and offers best evidence on effective treatments.</p>
<p> </p>
<p>Episode resource links:</p>
<ul><li>Mediations:  <em>JAMA Netw Open. </em>2022;5(5):e2212939</li>
<li>Acupuncture:  <a href='https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8820460/'>J Pain Res.</a> 2022; 15: 315–329</li>
</ul>
<p> </p>
<p>Guest: Susan Feeney, DNP, FNP-BC, NP-C</p>
<p> </p>
<p>Music Credit: Richard Onorato</p>
]]></content:encoded>
                                    
        <enclosure url="https://mcdn.podbean.com/mf/web/znwuxb/frankly-speaking-294-fibromyalgia.mp3" length="10955360" type="audio/mpeg"/>
                <itunes:summary><![CDATA[Credits: 0.25 AMA PRA Category 1 Credit™
 
CME/CE Information and Claim Credit: https://www.pri-med.com/online-education/podcast/frankly-speaking-cme-294
 
Overview: Fibromyalgia is a common and difficult to diagnose disease, with highly subjective symptoms. Another challenge is that treatment is dependent on a patient’s implementation lifestyle changes. This brief podcast walks you through the diagnosis of fibromyalgia and offers best evidence on effective treatments.
 
Episode resource links:
Mediations:  JAMA Netw Open. 2022;5(5):e2212939
Acupuncture:  J Pain Res. 2022; 15: 315–329
 
Guest: Susan Feeney, DNP, FNP-BC, NP-C
 
Music Credit: Richard Onorato]]></itunes:summary>
        <itunes:author>Pri-Med</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>681</itunes:duration>
                        <itunes:episodeType>full</itunes:episodeType>
            </item>
    <item>
        <title>Wait Before Writing That Antibiotic Prescription! Is it appropriate? - Frankly Speaking EP 293</title>
        <itunes:title>Wait Before Writing That Antibiotic Prescription! Is it appropriate? - Frankly Speaking EP 293</itunes:title>
        <link>https://primedfranklyspeaking.podbean.com/e/wait-before-writing-that-antibiotic-prescription-is-it-appropriate-frankly-speaking-ep-293/</link>
                    <comments>https://primedfranklyspeaking.podbean.com/e/wait-before-writing-that-antibiotic-prescription-is-it-appropriate-frankly-speaking-ep-293/#comments</comments>        <pubDate>Mon, 12 Sep 2022 00:30:00 +0000</pubDate>
        <guid isPermaLink="false">primedfranklyspeaking.podbean.com/c33d6180-e42f-3734-9547-7aadb90d7fd2</guid>
                                    <description><![CDATA[<p>Credits: 0.25 AMA PRA Category 1 Credit™</p>
<p> </p>
<p>CME/CE Information and Claim Credit:<a href='https://www.pri-med.com/online-education/podcast/frankly-speaking-cme-293'> https://www.pri-med.com/online-education/podcast/frankly-speaking-cme-293</a></p>
<p> </p>
<p>Overview: Evidence informs us that almost one-third of antibiotic prescriptions written for children in the United States are inappropriate, meaning they are not in line with evidence-based guidelines. Antibiotics are tremendous tools and beneficial when used appropriately; however, as with all pharmacological therapy, there are risks of adverse effects and healthcare cost. When prescribed inappropriately, they unnecessarily put children at risk and cause financial burden on individuals and the system. Please join the podcast team as we discuss recent evidence on these risks and burden and consider how this evidence can help improve practice. </p>
<p> </p>
<p>Episode resource links:</p>
<ul><li>Butler AM, Brown DS, Durkin MJ, et al. Association of Inappropriate Outpatient Pediatric Antibiotic Prescriptions With Adverse Drug Events and Health Care Expenditures. JAMA Netw Open.2022;5(5):e2214153. doi:10.1001/jamanetworkopen.2022.14153</li>
</ul>
<p> </p>
<p>Guest: Susan Feeney, DNP, FNP-BC, NP-C</p>
<p> </p>
<p>Music Credit: Richard Onorato</p>
]]></description>
                                                            <content:encoded><![CDATA[<p>Credits: 0.25 AMA PRA Category 1 Credit™</p>
<p> </p>
<p>CME/CE Information and Claim Credit:<a href='https://www.pri-med.com/online-education/podcast/frankly-speaking-cme-293'> https://www.pri-med.com/online-education/podcast/frankly-speaking-cme-293</a></p>
<p> </p>
<p>Overview: Evidence informs us that almost one-third of antibiotic prescriptions written for children in the United States are inappropriate, meaning they are not in line with evidence-based guidelines. Antibiotics are tremendous tools and beneficial when used appropriately; however, as with all pharmacological therapy, there are risks of adverse effects and healthcare cost. When prescribed inappropriately, they unnecessarily put children at risk and cause financial burden on individuals and the system. Please join the podcast team as we discuss recent evidence on these risks and burden and consider how this evidence can help improve practice. </p>
<p> </p>
<p>Episode resource links:</p>
<ul><li>Butler AM, Brown DS, Durkin MJ, et al. Association of Inappropriate Outpatient Pediatric Antibiotic Prescriptions With Adverse Drug Events and Health Care Expenditures. <em>JAMA Netw Open.</em>2022;5(5):e2214153. doi:10.1001/jamanetworkopen.2022.14153</li>
</ul>
<p> </p>
<p>Guest: Susan Feeney, DNP, FNP-BC, NP-C</p>
<p> </p>
<p>Music Credit: Richard Onorato</p>
]]></content:encoded>
                                    
        <enclosure url="https://mcdn.podbean.com/mf/web/9wubn9/frankly-speaking-293-antibiotics.mp3" length="11635840" type="audio/mpeg"/>
                <itunes:summary><![CDATA[Credits: 0.25 AMA PRA Category 1 Credit™
 
CME/CE Information and Claim Credit: https://www.pri-med.com/online-education/podcast/frankly-speaking-cme-293
 
Overview: Evidence informs us that almost one-third of antibiotic prescriptions written for children in the United States are inappropriate, meaning they are not in line with evidence-based guidelines. Antibiotics are tremendous tools and beneficial when used appropriately; however, as with all pharmacological therapy, there are risks of adverse effects and healthcare cost. When prescribed inappropriately, they unnecessarily put children at risk and cause financial burden on individuals and the system. Please join the podcast team as we discuss recent evidence on these risks and burden and consider how this evidence can help improve practice. 
 
Episode resource links:
Butler AM, Brown DS, Durkin MJ, et al. Association of Inappropriate Outpatient Pediatric Antibiotic Prescriptions With Adverse Drug Events and Health Care Expenditures. JAMA Netw Open.2022;5(5):e2214153. doi:10.1001/jamanetworkopen.2022.14153
 
Guest: Susan Feeney, DNP, FNP-BC, NP-C
 
Music Credit: Richard Onorato]]></itunes:summary>
        <itunes:author>Pri-Med</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>724</itunes:duration>
                        <itunes:episodeType>full</itunes:episodeType>
            </item>
    <item>
        <title>Reducing the Risk of Alcohol-Associated Liver Disease - Frankly Speaking EP 292</title>
        <itunes:title>Reducing the Risk of Alcohol-Associated Liver Disease - Frankly Speaking EP 292</itunes:title>
        <link>https://primedfranklyspeaking.podbean.com/e/reducing-the-risk-of-alcohol-associated-liver-disease-frankly-speaking-ep-292/</link>
                    <comments>https://primedfranklyspeaking.podbean.com/e/reducing-the-risk-of-alcohol-associated-liver-disease-frankly-speaking-ep-292/#comments</comments>        <pubDate>Mon, 05 Sep 2022 00:30:00 +0000</pubDate>
        <guid isPermaLink="false">primedfranklyspeaking.podbean.com/7c77852a-b473-31e2-95ef-78bc5213c021</guid>
                                    <description><![CDATA[<p>Credits: 0.25 AMA PRA Category 1 Credit™</p>
<p> </p>
<p>CME/CE Information and Claim Credit: <a href='https://www.pri-med.com/online-education/podcast/frankly-speaking-cme-291'>https://www.pri-med.com/online-education/podcast/frankly-speaking-cme-292</a></p>
<p> </p>
<p>Overview: Alcohol use disorder is common, but effective medications to treat this disorder are not widely prescribed in the outpatient primary care setting, despite being available and having relatively good formulary coverage. Join us to hear how the use of medical treatment can decrease the incidence and progression of alcohol-associated liver disease.</p>
<p> </p>
<p>Episode resource links:</p>
<ul><li>
<p>Augustin G. L. Vannier et al, Incidence and Progression of Alcohol-Associated Liver Disease After Medical Therapy for Alcohol Use Disorder, JAMA Network Open (2022).  <a href='https://dx.doi.org/10.1001/jamanetworkopen.2022.13014'>DOI: 10.1001/jamanetworkopen.2022.13014</a></p>
<p> </p>
</li>
<li>
<p>Tetreault JM, O'Connor PG. Risky drinking and alcohol use disorder: Epidemiology, pathogenesis, clinical manifestations, course, assessment, and diagnosis. <a href='https://www.uptodate.com/contents/risky-drinking-and-alcohol-use-disorder-epidemiology-pathogenesis-clinical-manifestations-course-assessment-and-diagnosis?search=alcohol+use+disorder&source=search_result&selectedTitle=2~150&usage_type=default&display_rank=2#H1137604302.'>UpToDate</a>. Published April 28, 2022. Accessed June 11, 2022. </p>
<p> </p>
</li>
<li>
<p>Holt SR, Tetrault, JM. Ambulatory Management of alcohol withdrawal. <a href='https://www.uptodate.com/contents/ambulatory-management-of-alcohol-withdrawal?search=alcohol%20withdrawal&source=search_result&selectedTitle=3~150&usage_type=default&display_rank=3#H4256607755'>UpToDate</a>. Published May 19, 2022. Accessed June 11, 2022.</p>
<p> </p>
</li>
<li>
<p>Holt SR. Approach to treating alcohol use disorder. <a href='https://www.uptodate.com/contents/approach-to-treating-alcohol-use-disorder?search=alcohol%20use%20disorder&source=search_result&selectedTitle=1~150&usage_type=default&display_rank=1'>UpToDate</a>. Published March 22, 2022. Accessed June 11, 2022.</p>
</li>
</ul>
<p> </p>
<p>Guest: Jillian Joseph, MSPAS, PA-C</p>
<p> </p>
<p>Music Credit: Richard Onorato</p>
]]></description>
                                                            <content:encoded><![CDATA[<p>Credits: 0.25 AMA PRA Category 1 Credit™</p>
<p> </p>
<p>CME/CE Information and Claim Credit: <a href='https://www.pri-med.com/online-education/podcast/frankly-speaking-cme-291'>https://www.pri-med.com/online-education/podcast/frankly-speaking-cme-292</a></p>
<p> </p>
<p>Overview: Alcohol use disorder is common, but effective medications to treat this disorder are not widely prescribed in the outpatient primary care setting, despite being available and having relatively good formulary coverage. Join us to hear how the use of medical treatment can decrease the incidence and progression of alcohol-associated liver disease.</p>
<p> </p>
<p>Episode resource links:</p>
<ul><li>
<p>Augustin G. L. Vannier et al, Incidence and Progression of Alcohol-Associated Liver Disease After Medical Therapy for Alcohol Use Disorder, <em>JAMA Network Open</em> (2022).  <a href='https://dx.doi.org/10.1001/jamanetworkopen.2022.13014'>DOI: 10.1001/jamanetworkopen.2022.13014</a></p>
<p> </p>
</li>
<li>
<p>Tetreault JM, O'Connor PG. Risky drinking and alcohol use disorder: Epidemiology, pathogenesis, clinical manifestations, course, assessment, and diagnosis. <a href='https://www.uptodate.com/contents/risky-drinking-and-alcohol-use-disorder-epidemiology-pathogenesis-clinical-manifestations-course-assessment-and-diagnosis?search=alcohol+use+disorder&source=search_result&selectedTitle=2~150&usage_type=default&display_rank=2#H1137604302.'>UpToDate</a>. Published April 28, 2022. Accessed June 11, 2022. </p>
<p> </p>
</li>
<li>
<p>Holt SR, Tetrault, JM. Ambulatory Management of alcohol withdrawal. <a href='https://www.uptodate.com/contents/ambulatory-management-of-alcohol-withdrawal?search=alcohol%20withdrawal&source=search_result&selectedTitle=3~150&usage_type=default&display_rank=3#H4256607755'>UpToDate</a>. Published May 19, 2022. Accessed June 11, 2022.</p>
<p> </p>
</li>
<li>
<p>Holt SR. Approach to treating alcohol use disorder. <a href='https://www.uptodate.com/contents/approach-to-treating-alcohol-use-disorder?search=alcohol%20use%20disorder&source=search_result&selectedTitle=1~150&usage_type=default&display_rank=1'>UpToDate</a>. Published March 22, 2022. Accessed June 11, 2022.</p>
</li>
</ul>
<p> </p>
<p>Guest: Jillian Joseph, MSPAS, PA-C</p>
<p> </p>
<p>Music Credit: Richard Onorato</p>
]]></content:encoded>
                                    
        <enclosure url="https://mcdn.podbean.com/mf/web/e4fxp5/frankly-speaking-292-alcohol.mp3" length="11653100" type="audio/mpeg"/>
                <itunes:summary><![CDATA[Credits: 0.25 AMA PRA Category 1 Credit™
 
CME/CE Information and Claim Credit: https://www.pri-med.com/online-education/podcast/frankly-speaking-cme-292
 
Overview: Alcohol use disorder is common, but effective medications to treat this disorder are not widely prescribed in the outpatient primary care setting, despite being available and having relatively good formulary coverage. Join us to hear how the use of medical treatment can decrease the incidence and progression of alcohol-associated liver disease.
 
Episode resource links:

Augustin G. L. Vannier et al, Incidence and Progression of Alcohol-Associated Liver Disease After Medical Therapy for Alcohol Use Disorder, JAMA Network Open (2022).  DOI: 10.1001/jamanetworkopen.2022.13014
 


Tetreault JM, O'Connor PG. Risky drinking and alcohol use disorder: Epidemiology, pathogenesis, clinical manifestations, course, assessment, and diagnosis. UpToDate. Published April 28, 2022. Accessed June 11, 2022. 
 


Holt SR, Tetrault, JM. Ambulatory Management of alcohol withdrawal. UpToDate. Published May 19, 2022. Accessed June 11, 2022.
 


Holt SR. Approach to treating alcohol use disorder. UpToDate. Published March 22, 2022. Accessed June 11, 2022.

 
Guest: Jillian Joseph, MSPAS, PA-C
 
Music Credit: Richard Onorato]]></itunes:summary>
        <itunes:author>Pri-Med</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>726</itunes:duration>
                        <itunes:episodeType>full</itunes:episodeType>
            </item>
    <item>
        <title>Is Less More When Treating BP in Older Adults? - Frankly Speaking EP 291</title>
        <itunes:title>Is Less More When Treating BP in Older Adults? - Frankly Speaking EP 291</itunes:title>
        <link>https://primedfranklyspeaking.podbean.com/e/is-less-more-when-treating-bp-in-older-adults-frankly-speaking-ep-291/</link>
                    <comments>https://primedfranklyspeaking.podbean.com/e/is-less-more-when-treating-bp-in-older-adults-frankly-speaking-ep-291/#comments</comments>        <pubDate>Mon, 29 Aug 2022 00:30:00 +0000</pubDate>
        <guid isPermaLink="false">primedfranklyspeaking.podbean.com/8f9f3c69-30af-308c-ab23-6a662de076ea</guid>
                                    <description><![CDATA[<p>Credits: 0.25 AMA PRA Category 1 Credit™</p>
<p> </p>
<p>CME/CE Information and Claim Credit: <a href='https://www.pri-med.com/online-education/podcast/frankly-speaking-cme-291'>https://www.pri-med.com/online-education/podcast/frankly-speaking-cme-291</a></p>
<p> </p>
<p>Overview: Concerns have been raised over guideline recommendations for lowering systolic blood pressure (BP) to 60 years. To achieve such targets often requires intensive BP treatments, which can result in harms from syncope or falls. Join us to review the results of a recently published meta-analysis done to estimate the time needed to potentially derive clinical benefit from such BP treatments in patients 60 years and older. </p>
<p> </p>
<p>Episode resource links:</p>
<ul><li>JAMA Intern Med. 2022;182(6):660-667. doi:10.1001/jamainternmed.2022.1657</li>
</ul>
<p> </p>
<p>Guest: Robert A. Baldor, MD</p>
<p> </p>
<p>Music Credit: Richard Onorato</p>
]]></description>
                                                            <content:encoded><![CDATA[<p>Credits: 0.25 AMA PRA Category 1 Credit™</p>
<p> </p>
<p>CME/CE Information and Claim Credit: <a href='https://www.pri-med.com/online-education/podcast/frankly-speaking-cme-291'>https://www.pri-med.com/online-education/podcast/frankly-speaking-cme-291</a></p>
<p> </p>
<p>Overview: Concerns have been raised over guideline recommendations for lowering systolic blood pressure (BP) to 60 years. To achieve such targets often requires intensive BP treatments, which can result in harms from syncope or falls. Join us to review the results of a recently published meta-analysis done to estimate the time needed to potentially derive clinical benefit from such BP treatments in patients 60 years and older. </p>
<p> </p>
<p>Episode resource links:</p>
<ul><li>JAMA Intern Med. 2022;182(6):660-667. doi:10.1001/jamainternmed.2022.1657</li>
</ul>
<p> </p>
<p>Guest: Robert A. Baldor, MD</p>
<p> </p>
<p>Music Credit: Richard Onorato</p>
]]></content:encoded>
                                    
        <enclosure url="https://mcdn.podbean.com/mf/web/4rivdw/frankly-speaking-291-elderly-bp.mp3" length="10372555" type="audio/mpeg"/>
                <itunes:summary><![CDATA[Credits: 0.25 AMA PRA Category 1 Credit™
 
CME/CE Information and Claim Credit: https://www.pri-med.com/online-education/podcast/frankly-speaking-cme-291
 
Overview: Concerns have been raised over guideline recommendations for lowering systolic blood pressure (BP) to 60 years. To achieve such targets often requires intensive BP treatments, which can result in harms from syncope or falls. Join us to review the results of a recently published meta-analysis done to estimate the time needed to potentially derive clinical benefit from such BP treatments in patients 60 years and older. 
 
Episode resource links:
JAMA Intern Med. 2022;182(6):660-667. doi:10.1001/jamainternmed.2022.1657
 
Guest: Robert A. Baldor, MD
 
Music Credit: Richard Onorato]]></itunes:summary>
        <itunes:author>Pri-Med</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>645</itunes:duration>
                        <itunes:episodeType>full</itunes:episodeType>
            </item>
    <item>
        <title>When Do Food Allergies Resolve? - Frankly Speaking EP 290</title>
        <itunes:title>When Do Food Allergies Resolve? - Frankly Speaking EP 290</itunes:title>
        <link>https://primedfranklyspeaking.podbean.com/e/when-do-food-allergies-resolve-frankly-speaking-ep290/</link>
                    <comments>https://primedfranklyspeaking.podbean.com/e/when-do-food-allergies-resolve-frankly-speaking-ep290/#comments</comments>        <pubDate>Mon, 22 Aug 2022 00:30:00 +0000</pubDate>
        <guid isPermaLink="false">primedfranklyspeaking.podbean.com/f084a9e3-55c9-37e7-b601-5214b3ee9c20</guid>
                                    <description><![CDATA[<p>Credits: 0.25 AMA PRA Category 1 Credit™</p>
<p> </p>
<p>CME/CE Information and Claim Credit:<a href='https://www.pri-med.com/online-education/podcast/frankly-speaking-cme-290'> https://www.pri-med.com/online-education/podcast/frankly-speaking-cme-290</a></p>
<p> </p>
<p>Overview: This brief podcast discusses the prevalence of egg and nut allergies in children, how to lower the risk of developing these allergies, and which patients are at greatest risk. Hear how to best counsel parents about their child’s allergies and help them anticipate their child’s future health.</p>
<p> </p>
<p>Episode resource links:</p>
<ul><li>The natural history of peanut and egg allergy in children up to age 6 years in the HealthNuts population-based longitudinal study; Am Aca Allergy, Asthma & Immunol 2022; <a href='https://doi.org/10.1016/j.jaci.2022.04.008'>https://doi.org/10.1016/j.jaci.2022.04.008</a></li>
</ul>
<ul><li>Dietary Interventions to pRevent Atopic Disease in Children, AAP 3/19: <a href='https://publications.aap.org/aapnews/news/8699'>https://publications.aap.org/aapnews/news/8699</a></li>
</ul>
<p> </p>
<p>Guest: Jill M. Terrien PhD, ANP-BC</p>
<p> </p>
<p>Music Credit: Richard Onorato</p>
]]></description>
                                                            <content:encoded><![CDATA[<p>Credits: 0.25 AMA PRA Category 1 Credit™</p>
<p> </p>
<p>CME/CE Information and Claim Credit:<a href='https://www.pri-med.com/online-education/podcast/frankly-speaking-cme-290'> https://www.pri-med.com/online-education/podcast/frankly-speaking-cme-290</a></p>
<p> </p>
<p>Overview: This brief podcast discusses the prevalence of egg and nut allergies in children, how to lower the risk of developing these allergies, and which patients are at greatest risk. Hear how to best counsel parents about their child’s allergies and help them anticipate their child’s future health.</p>
<p> </p>
<p>Episode resource links:</p>
<ul><li>The natural history of peanut and egg allergy in children up to age 6 years in the HealthNuts population-based longitudinal study; Am Aca Allergy, Asthma & Immunol 2022; <a href='https://doi.org/10.1016/j.jaci.2022.04.008'>https://doi.org/10.1016/j.jaci.2022.04.008</a></li>
</ul>
<ul><li>Dietary Interventions to pRevent Atopic Disease in Children, AAP 3/19: <a href='https://publications.aap.org/aapnews/news/8699'>https://publications.aap.org/aapnews/news/8699</a></li>
</ul>
<p> </p>
<p>Guest: Jill M. Terrien PhD, ANP-BC</p>
<p> </p>
<p>Music Credit: Richard Onorato</p>
]]></content:encoded>
                                    
        <enclosure url="https://mcdn.podbean.com/mf/web/7ijs7z/frankly-speaking-290-food-allergies.mp3" length="10063150" type="audio/mpeg"/>
                <itunes:summary><![CDATA[Credits: 0.25 AMA PRA Category 1 Credit™
 
CME/CE Information and Claim Credit: https://www.pri-med.com/online-education/podcast/frankly-speaking-cme-290
 
Overview: This brief podcast discusses the prevalence of egg and nut allergies in children, how to lower the risk of developing these allergies, and which patients are at greatest risk. Hear how to best counsel parents about their child’s allergies and help them anticipate their child’s future health.
 
Episode resource links:
The natural history of peanut and egg allergy in children up to age 6 years in the HealthNuts population-based longitudinal study; Am Aca Allergy, Asthma & Immunol 2022; https://doi.org/10.1016/j.jaci.2022.04.008
Dietary Interventions to pRevent Atopic Disease in Children, AAP 3/19: https://publications.aap.org/aapnews/news/8699
 
Guest: Jill M. Terrien PhD, ANP-BC
 
Music Credit: Richard Onorato]]></itunes:summary>
        <itunes:author>Pri-Med</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>626</itunes:duration>
                        <itunes:episodeType>full</itunes:episodeType>
            </item>
    <item>
        <title>Limit Screen Time to Increase Physical Activity - Frankly Speaking Ep 289</title>
        <itunes:title>Limit Screen Time to Increase Physical Activity - Frankly Speaking Ep 289</itunes:title>
        <link>https://primedfranklyspeaking.podbean.com/e/limit-screen-time-to-increase-physical-activity-frankly-speaking-ep-289/</link>
                    <comments>https://primedfranklyspeaking.podbean.com/e/limit-screen-time-to-increase-physical-activity-frankly-speaking-ep-289/#comments</comments>        <pubDate>Mon, 15 Aug 2022 00:30:00 +0000</pubDate>
        <guid isPermaLink="false">primedfranklyspeaking.podbean.com/60a64c65-eee1-3ed4-8a25-69991fba2b02</guid>
                                    <description><![CDATA[<p>Credits: 0.25 AMA PRA Category 1 Credit™
 
CME/CE Information and Claim Credit: <a href='https://www.pri-med.com/online-education/podcast/frankly-speaking-cme-289'>https://www.pri-med.com/online-education/podcast/frankly-speaking-cme-289</a></p>
<p>Overview: Excessive screen time has been associated with numerous adverse health outcomes. Join us for a look at a fascinating new study that explores how limiting screen time can increase physical activity in children. Listen to this brief podcast before you counsel your next patient on how screen time can affect their children’s (and their) health.</p>
<p>Episode resource links:</p>
<ul><li>
<p>Pedersen J,et al. Effects of Limiting Recreational Screen Media Use on Physical Activity and Sleep in Families With Children: A Cluster Randomized Clinical Trial. JAMA Pediatr. 2022 May 23:e221519</p>
</li>
<li>
<p>Screen Time and Children. American Academy of Child and Adolescent Psychiatry: <a href='https://www.aacap.org/AACAP/Families_and_Youth/Facts_for_Families/FFF-Guide/Children-And-Watching-TV-054.aspx'>https://www.aacap.org/AACAP/Families_and_Youth/Facts_for_Families/FFF-Guide/Children-And-Watching-TV-054.aspx</a></p>
</li>
</ul>
<p>Guest: Alan Ehrlich MD, FAAFP

Music Credit: Richard Onorato</p>
]]></description>
                                                            <content:encoded><![CDATA[<p>Credits: 0.25 AMA PRA Category 1 Credit™<br>
 <br>
CME/CE Information and Claim Credit: <a href='https://www.pri-med.com/online-education/podcast/frankly-speaking-cme-289'>https://www.pri-med.com/online-education/podcast/frankly-speaking-cme-289</a></p>
<p>Overview: Excessive screen time has been associated with numerous adverse health outcomes. Join us for a look at a fascinating new study that explores how limiting screen time can increase physical activity in children. Listen to this brief podcast before you counsel your next patient on how screen time can affect their children’s (and their) health.</p>
<p>Episode resource links:</p>
<ul><li>
<p>Pedersen J,et al. Effects of Limiting Recreational Screen Media Use on Physical Activity and Sleep in Families With Children: A Cluster Randomized Clinical Trial. JAMA Pediatr. 2022 May 23:e221519</p>
</li>
<li>
<p>Screen Time and Children. American Academy of Child and Adolescent Psychiatry: <a href='https://www.aacap.org/AACAP/Families_and_Youth/Facts_for_Families/FFF-Guide/Children-And-Watching-TV-054.aspx'>https://www.aacap.org/AACAP/Families_and_Youth/Facts_for_Families/FFF-Guide/Children-And-Watching-TV-054.aspx</a></p>
</li>
</ul>
<p>Guest: Alan Ehrlich MD, FAAFP<br>
<br>
Music Credit: Richard Onorato</p>
]]></content:encoded>
                                    
        <enclosure url="https://mcdn.podbean.com/mf/web/tenux2/frankly-speaking-289-screen-time.mp3" length="8376435" type="audio/mpeg"/>
                <itunes:summary><![CDATA[Credits: 0.25 AMA PRA Category 1 Credit™ CME/CE Information and Claim Credit: https://www.pri-med.com/online-education/podcast/frankly-speaking-cme-289
Overview: Excessive screen time has been associated with numerous adverse health outcomes. Join us for a look at a fascinating new study that explores how limiting screen time can increase physical activity in children. Listen to this brief podcast before you counsel your next patient on how screen time can affect their children’s (and their) health.
Episode resource links:

Pedersen J,et al. Effects of Limiting Recreational Screen Media Use on Physical Activity and Sleep in Families With Children: A Cluster Randomized Clinical Trial. JAMA Pediatr. 2022 May 23:e221519


Screen Time and Children. American Academy of Child and Adolescent Psychiatry: https://www.aacap.org/AACAP/Families_and_Youth/Facts_for_Families/FFF-Guide/Children-And-Watching-TV-054.aspx

Guest: Alan Ehrlich MD, FAAFPMusic Credit: Richard Onorato]]></itunes:summary>
        <itunes:author>Pri-Med</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>521</itunes:duration>
                        <itunes:episodeType>full</itunes:episodeType>
            </item>
    <item>
        <title>A Spoonful of Sugar in Your Cup of Joe—Does It Affect Your Health? - Frankly Speaking Ep 288</title>
        <itunes:title>A Spoonful of Sugar in Your Cup of Joe—Does It Affect Your Health? - Frankly Speaking Ep 288</itunes:title>
        <link>https://primedfranklyspeaking.podbean.com/e/a-spoonful-of-sugar-in-your-cup-of-joe%e2%80%94does-it-affect-your-health-frankly-speaking-ep-288/</link>
                    <comments>https://primedfranklyspeaking.podbean.com/e/a-spoonful-of-sugar-in-your-cup-of-joe%e2%80%94does-it-affect-your-health-frankly-speaking-ep-288/#comments</comments>        <pubDate>Mon, 08 Aug 2022 00:30:00 +0000</pubDate>
        <guid isPermaLink="false">primedfranklyspeaking.podbean.com/c922775c-fdaa-3e6a-a64a-48b318fb33ac</guid>
                                    <description><![CDATA[<p>Credits: 0.25 AMA PRA Category 1 Credit™
 
CME/CE Information and Claim Credit: <a href='https://www.pri-med.com/online-education/podcast/frankly-speaking-cme-288'>https://www.pri-med.com/online-education/podcast/frankly-speaking-cme-288</a></p>
<p>Overview: Coffee is one of the most consumed beverages worldwide. An estimated 500 million cups are consumed per day in the United States. As testimony to this, count the number of coffee shops available—most with drive-through access—the next time you are out for a drive. A growing body of evidence indicates that moderate coffee consumption (2-3 cups per day) is associated with reduction in all-cause mortality. What hasn’t been looked at closely is the effect of coffee with sugar and artificial sweeteners on these measures. Join us while we discuss recent evidence regarding consumption of coffee—with or without sweeteners—and its association with all-cause mortality.</p>
<p>Episode resource links:</p>
<ul><li>Liu D, Li ZH, Shen D, Zhang PD, Song WQ, Zhang WT, Huang QM, Chen PL, Zhang XR, Mao C. Association of Sugar-Sweetened, Artificially Sweetened, and Unsweetened Coffee Consumption With All-Cause and Cause-Specific Mortality : A Large Prospective Cohort Study. Ann Intern Med. 2022 May 31. doi: 10.7326/M21-2977. Epub ahead of print. PMID: 35635846.</li>
<li>Wee CC. The Potential Health Benefit of Coffee: Does a Spoonful of Sugar Make It All Go Away? Ann Intern Med. 2022 May 31. doi: 10.7326/M22-1465. Epub ahead of print. PMID: 35635845.</li>
</ul>
<p>Guest: Susan Feeney, DNP, FNP</p>
<p>Music Credit: Richard Onorato</p>
]]></description>
                                                            <content:encoded><![CDATA[<p>Credits: 0.25 AMA PRA Category 1 Credit™<br>
 <br>
CME/CE Information and Claim Credit: <a href='https://www.pri-med.com/online-education/podcast/frankly-speaking-cme-288'>https://www.pri-med.com/online-education/podcast/frankly-speaking-cme-288</a></p>
<p>Overview: Coffee is one of the most consumed beverages worldwide. An estimated 500 million cups are consumed per day in the United States. As testimony to this, count the number of coffee shops available—most with drive-through access—the next time you are out for a drive. A growing body of evidence indicates that moderate coffee consumption (2-3 cups per day) is associated with reduction in all-cause mortality. What hasn’t been looked at closely is the effect of coffee with sugar and artificial sweeteners on these measures. Join us while we discuss recent evidence regarding consumption of coffee—with or without sweeteners—and its association with all-cause mortality.</p>
<p>Episode resource links:</p>
<ul><li>Liu D, Li ZH, Shen D, Zhang PD, Song WQ, Zhang WT, Huang QM, Chen PL, Zhang XR, Mao C. Association of Sugar-Sweetened, Artificially Sweetened, and Unsweetened Coffee Consumption With All-Cause and Cause-Specific Mortality : A Large Prospective Cohort Study. Ann Intern Med. 2022 May 31. doi: 10.7326/M21-2977. Epub ahead of print. PMID: 35635846.</li>
<li>Wee CC. The Potential Health Benefit of Coffee: Does a Spoonful of Sugar Make It All Go Away? Ann Intern Med. 2022 May 31. doi: 10.7326/M22-1465. Epub ahead of print. PMID: 35635845.</li>
</ul>
<p>Guest: Susan Feeney, DNP, FNP</p>
<p>Music Credit: Richard Onorato</p>
]]></content:encoded>
                                    
        <enclosure url="https://mcdn.podbean.com/mf/web/kvuym5/frankly-speaking-288-coffee.mp3" length="9610880" type="audio/mpeg"/>
                <itunes:summary><![CDATA[Credits: 0.25 AMA PRA Category 1 Credit™ CME/CE Information and Claim Credit: https://www.pri-med.com/online-education/podcast/frankly-speaking-cme-288
Overview: Coffee is one of the most consumed beverages worldwide. An estimated 500 million cups are consumed per day in the United States. As testimony to this, count the number of coffee shops available—most with drive-through access—the next time you are out for a drive. A growing body of evidence indicates that moderate coffee consumption (2-3 cups per day) is associated with reduction in all-cause mortality. What hasn’t been looked at closely is the effect of coffee with sugar and artificial sweeteners on these measures. Join us while we discuss recent evidence regarding consumption of coffee—with or without sweeteners—and its association with all-cause mortality.
Episode resource links:
Liu D, Li ZH, Shen D, Zhang PD, Song WQ, Zhang WT, Huang QM, Chen PL, Zhang XR, Mao C. Association of Sugar-Sweetened, Artificially Sweetened, and Unsweetened Coffee Consumption With All-Cause and Cause-Specific Mortality : A Large Prospective Cohort Study. Ann Intern Med. 2022 May 31. doi: 10.7326/M21-2977. Epub ahead of print. PMID: 35635846.
Wee CC. The Potential Health Benefit of Coffee: Does a Spoonful of Sugar Make It All Go Away? Ann Intern Med. 2022 May 31. doi: 10.7326/M22-1465. Epub ahead of print. PMID: 35635845.
Guest: Susan Feeney, DNP, FNP
Music Credit: Richard Onorato]]></itunes:summary>
        <itunes:author>Pri-Med</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>598</itunes:duration>
                        <itunes:episodeType>full</itunes:episodeType>
            </item>
    <item>
        <title>Biennial Screening Could Decrease False Positives in Screening Mammography - Frankly Speaking Ep 287</title>
        <itunes:title>Biennial Screening Could Decrease False Positives in Screening Mammography - Frankly Speaking Ep 287</itunes:title>
        <link>https://primedfranklyspeaking.podbean.com/e/biennial-screening-could-decrease-false-positives-in-screening-mammography-frankly-speaking-ep-287/</link>
                    <comments>https://primedfranklyspeaking.podbean.com/e/biennial-screening-could-decrease-false-positives-in-screening-mammography-frankly-speaking-ep-287/#comments</comments>        <pubDate>Mon, 01 Aug 2022 00:30:00 +0000</pubDate>
        <guid isPermaLink="false">primedfranklyspeaking.podbean.com/31fc90fd-75b1-3191-9ae9-92df64d9a168</guid>
                                    <description><![CDATA[<p>Credits: 0.25 AMA PRA Category 1 Credit™
 
CME/CE Information and Claim Credit: <a href='https://www.pri-med.com/online-education/podcast/frankly-speaking-cme-287'>https://www.pri-med.com/online-education/podcast/frankly-speaking-cme-287</a></p>
<p>Overview: Join us to discuss the rates of false positives in mammography and how to decrease them. Specifically, this session reviews data from an observational comparative effectiveness study suggesting that the type of mammography, interval, and other factors can affect the probability of false positive results. </p>
<p>Episode resource links:</p>
<ul><li>Ho TH, Bissell MCS, Kerlikowske K, et al. Cumulative Probability of False-Positive Results After 10 Years of Screening With Digital Breast Tomosynthesis vs Digital Mammography. JAMA Netw Open. 2022;5(3):e222440. doi:10.1001/jamanetworkopen.2022.2440</li>
<li>Breast Cancer Screening Guidelines for Women (CDC Chart)—Last reviewed 9-2020 chrome-extension://efaidnbmnnnibpcajpcglclefindmkaj/https://www.cdc.gov/cancer/breast/pdf/breast-cancer-screening-guidelines-508.pdf</li>
<li>Canelo-Aybar, C., Posso, M., Montero, N. et al. Benefits and harms of annual, biennial, or triennial breast cancer mammography screening for women at average risk of breast cancer: a systematic review for the European Commission Initiative on Breast Cancer (ECIBC). Br J Cancer 126, 673–688 (2022). <a href='https://doi.org/10.1038/s41416-021-01521-8'>https://doi.org/10.1038/s41416-021-01521-8</a></li>
</ul>
<p>Guest: Jill M. Terrien PhD, ANP-BC 
 
Music Credit: Richard Onorato</p>
]]></description>
                                                            <content:encoded><![CDATA[<p>Credits: 0.25 AMA PRA Category 1 Credit™<br>
 <br>
CME/CE Information and Claim Credit: <a href='https://www.pri-med.com/online-education/podcast/frankly-speaking-cme-287'>https://www.pri-med.com/online-education/podcast/frankly-speaking-cme-287</a></p>
<p>Overview: Join us to discuss the rates of false positives in mammography and how to decrease them. Specifically, this session reviews data from an observational comparative effectiveness study suggesting that the type of mammography, interval, and other factors can affect the probability of false positive results. </p>
<p>Episode resource links:</p>
<ul><li>Ho TH, Bissell MCS, Kerlikowske K, et al. Cumulative Probability of False-Positive Results After 10 Years of Screening With Digital Breast Tomosynthesis vs Digital Mammography. JAMA Netw Open. 2022;5(3):e222440. doi:10.1001/jamanetworkopen.2022.2440</li>
<li>Breast Cancer Screening Guidelines for Women (CDC Chart)—Last reviewed 9-2020 chrome-extension://efaidnbmnnnibpcajpcglclefindmkaj/https://www.cdc.gov/cancer/breast/pdf/breast-cancer-screening-guidelines-508.pdf</li>
<li>Canelo-Aybar, C., Posso, M., Montero, N. et al. Benefits and harms of annual, biennial, or triennial breast cancer mammography screening for women at average risk of breast cancer: a systematic review for the European Commission Initiative on Breast Cancer (ECIBC). Br J Cancer 126, 673–688 (2022). <a href='https://doi.org/10.1038/s41416-021-01521-8'>https://doi.org/10.1038/s41416-021-01521-8</a></li>
</ul>
<p>Guest: Jill M. Terrien PhD, ANP-BC <br>
 <br>
Music Credit: Richard Onorato</p>
]]></content:encoded>
                                    
        <enclosure url="https://mcdn.podbean.com/mf/web/2wz9xt/frankly-speaking-287-breast-cancer.mp3" length="10271174" type="audio/mpeg"/>
                <itunes:summary><![CDATA[Credits: 0.25 AMA PRA Category 1 Credit™ CME/CE Information and Claim Credit: https://www.pri-med.com/online-education/podcast/frankly-speaking-cme-287
Overview: Join us to discuss the rates of false positives in mammography and how to decrease them. Specifically, this session reviews data from an observational comparative effectiveness study suggesting that the type of mammography, interval, and other factors can affect the probability of false positive results. 
Episode resource links:
Ho TH, Bissell MCS, Kerlikowske K, et al. Cumulative Probability of False-Positive Results After 10 Years of Screening With Digital Breast Tomosynthesis vs Digital Mammography. JAMA Netw Open. 2022;5(3):e222440. doi:10.1001/jamanetworkopen.2022.2440
Breast Cancer Screening Guidelines for Women (CDC Chart)—Last reviewed 9-2020 chrome-extension://efaidnbmnnnibpcajpcglclefindmkaj/https://www.cdc.gov/cancer/breast/pdf/breast-cancer-screening-guidelines-508.pdf
Canelo-Aybar, C., Posso, M., Montero, N. et al. Benefits and harms of annual, biennial, or triennial breast cancer mammography screening for women at average risk of breast cancer: a systematic review for the European Commission Initiative on Breast Cancer (ECIBC). Br J Cancer 126, 673–688 (2022). https://doi.org/10.1038/s41416-021-01521-8
Guest: Jill M. Terrien PhD, ANP-BC  Music Credit: Richard Onorato]]></itunes:summary>
        <itunes:author>Pri-Med</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>639</itunes:duration>
                <itunes:episode>2</itunes:episode>
        <itunes:episodeType>full</itunes:episodeType>
            </item>
    <item>
        <title>USPSTF: Aspirin No Longer Recommended for Primary Prevention - Frankly Speaking Ep 286</title>
        <itunes:title>USPSTF: Aspirin No Longer Recommended for Primary Prevention - Frankly Speaking Ep 286</itunes:title>
        <link>https://primedfranklyspeaking.podbean.com/e/uspstf-aspirin-no-longer-recommended-for-primary-prevention-frankly-speaking-ep-286/</link>
                    <comments>https://primedfranklyspeaking.podbean.com/e/uspstf-aspirin-no-longer-recommended-for-primary-prevention-frankly-speaking-ep-286/#comments</comments>        <pubDate>Mon, 25 Jul 2022 00:30:00 +0000</pubDate>
        <guid isPermaLink="false">primedfranklyspeaking.podbean.com/5be63a8c-c897-3bf8-b6a8-6f5f4790272b</guid>
                                    <description><![CDATA[<p>Credits: 0.25 AMA PRA Category 1 Credit™
 
CME/CE Information and Claim Credit: <a href='https://www.pri-med.com/online-education/podcast/frankly-speaking-cme-286'>https://www.pri-med.com/online-education/podcast/frankly-speaking-cme-286</a></p>
<p>Overview: The controversy surrounding whether to prescribe aspirin for primary prevention of cardiovascular disease in adult patients has left many clinicians unsure of the right approach. In this podcast, we’ll review the latest USPSTF recommendation on this topic and dig into the evidence behind the recommendation.</p>
<p>Episode resource links:</p>
<ul><li>JAMA. 2022;327(16):1577-1584. doi:10.1001/jama.2022.4983</li>
</ul>
<p>Guest: Robert A. Baldor MD, FAAFP
 
Music Credit: Richard Onorato</p>
]]></description>
                                                            <content:encoded><![CDATA[<p>Credits: 0.25 AMA PRA Category 1 Credit™<br>
 <br>
CME/CE Information and Claim Credit: <a href='https://www.pri-med.com/online-education/podcast/frankly-speaking-cme-286'>https://www.pri-med.com/online-education/podcast/frankly-speaking-cme-286</a></p>
<p>Overview: The controversy surrounding whether to prescribe aspirin for primary prevention of cardiovascular disease in adult patients has left many clinicians unsure of the right approach. In this podcast, we’ll review the latest USPSTF recommendation on this topic and dig into the evidence behind the recommendation.</p>
<p>Episode resource links:</p>
<ul><li>JAMA. 2022;327(16):1577-1584. doi:10.1001/jama.2022.4983</li>
</ul>
<p>Guest: Robert A. Baldor MD, FAAFP<br>
 <br>
Music Credit: Richard Onorato</p>
]]></content:encoded>
                                    
        <enclosure url="https://mcdn.podbean.com/mf/web/qs8hvd/frankly-speaking-286-aspirin.mp3" length="9489086" type="audio/mpeg"/>
                <itunes:summary><![CDATA[Credits: 0.25 AMA PRA Category 1 Credit™ CME/CE Information and Claim Credit: https://www.pri-med.com/online-education/podcast/frankly-speaking-cme-286
Overview: The controversy surrounding whether to prescribe aspirin for primary prevention of cardiovascular disease in adult patients has left many clinicians unsure of the right approach. In this podcast, we’ll review the latest USPSTF recommendation on this topic and dig into the evidence behind the recommendation.
Episode resource links:
JAMA. 2022;327(16):1577-1584. doi:10.1001/jama.2022.4983
Guest: Robert A. Baldor MD, FAAFP Music Credit: Richard Onorato]]></itunes:summary>
        <itunes:author>Pri-Med</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>591</itunes:duration>
                        <itunes:episodeType>full</itunes:episodeType>
            </item>
    <item>
        <title>Tirzepatide: A New Treatment for Diabetes - Frankly Speaking Ep 285</title>
        <itunes:title>Tirzepatide: A New Treatment for Diabetes - Frankly Speaking Ep 285</itunes:title>
        <link>https://primedfranklyspeaking.podbean.com/e/tirzepatide-a-new-treatment-for-diabetes-frankly-speaking-ep-285/</link>
                    <comments>https://primedfranklyspeaking.podbean.com/e/tirzepatide-a-new-treatment-for-diabetes-frankly-speaking-ep-285/#comments</comments>        <pubDate>Mon, 18 Jul 2022 00:30:00 +0000</pubDate>
        <guid isPermaLink="false">primedfranklyspeaking.podbean.com/56dbfc22-b528-3c49-81b0-4e52fe5a2c90</guid>
                                    <description><![CDATA[<p>Credits: 0.25 AMA PRA Category 1 Credit™
 
CME/CE Information and Claim Credit: <a href='https://www.pri-med.com/online-education/podcast/frankly-speaking-cme-285'>https://www.pri-med.com/online-education/podcast/frankly-speaking-cme-285</a></p>
<p>Overview: Join us for a closer look at tirzepatide, a first-in-class glucose-dependent insulinotropic peptide (GIP) and a glucagon-like peptide-1 receptor agonist (GLP-1 RA). See how this novel glucose-lowering agent can help raise the bar in both HbA1c lowering and weight loss in patients with type 2 diabetes mellitus.</p>
<p>Episode resource links:</p>
<ul><li>Karagiannis T, Avgerinos I, Liakos A, Del Prato S, Matthews DR, Tsapas A, Bekiari E. Management of type 2 diabetes with the dual GIP/GLP-1 receptor agonist tirzepatide: a systematic review and meta-analysis. Diabetologia. 2022 May 17:1–11.</li>
</ul>
<p>Guest: Alan Ehrlich MD, FAAFP
 
Music Credit: Richard Onorato</p>
]]></description>
                                                            <content:encoded><![CDATA[<p>Credits: 0.25 AMA PRA Category 1 Credit™<br>
 <br>
CME/CE Information and Claim Credit: <a href='https://www.pri-med.com/online-education/podcast/frankly-speaking-cme-285'>https://www.pri-med.com/online-education/podcast/frankly-speaking-cme-285</a></p>
<p>Overview: Join us for a closer look at tirzepatide, a first-in-class glucose-dependent insulinotropic peptide (GIP) and a glucagon-like peptide-1 receptor agonist (GLP-1 RA). See how this novel glucose-lowering agent can help raise the bar in both HbA1c lowering and weight loss in patients with type 2 diabetes mellitus.</p>
<p>Episode resource links:</p>
<ul><li>Karagiannis T, Avgerinos I, Liakos A, Del Prato S, Matthews DR, Tsapas A, Bekiari E. Management of type 2 diabetes with the dual GIP/GLP-1 receptor agonist tirzepatide: a systematic review and meta-analysis. Diabetologia. 2022 May 17:1–11.</li>
</ul>
<p>Guest: Alan Ehrlich MD, FAAFP<br>
 <br>
Music Credit: Richard Onorato</p>
]]></content:encoded>
                                    
        <enclosure url="https://mcdn.podbean.com/mf/web/ypm9f2/frankly-speaking-285-tirzepatide.mp3" length="10599130" type="audio/mpeg"/>
                <itunes:summary><![CDATA[Credits: 0.25 AMA PRA Category 1 Credit™ CME/CE Information and Claim Credit: https://www.pri-med.com/online-education/podcast/frankly-speaking-cme-285
Overview: Join us for a closer look at tirzepatide, a first-in-class glucose-dependent insulinotropic peptide (GIP) and a glucagon-like peptide-1 receptor agonist (GLP-1 RA). See how this novel glucose-lowering agent can help raise the bar in both HbA1c lowering and weight loss in patients with type 2 diabetes mellitus.
Episode resource links:
Karagiannis T, Avgerinos I, Liakos A, Del Prato S, Matthews DR, Tsapas A, Bekiari E. Management of type 2 diabetes with the dual GIP/GLP-1 receptor agonist tirzepatide: a systematic review and meta-analysis. Diabetologia. 2022 May 17:1–11.
Guest: Alan Ehrlich MD, FAAFP Music Credit: Richard Onorato]]></itunes:summary>
        <itunes:author>Pri-Med</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>660</itunes:duration>
                        <itunes:episodeType>full</itunes:episodeType>
            </item>
    <item>
        <title>What Are the Best Agents to Treat Male Baldness? - Frankly Speaking Ep 284</title>
        <itunes:title>What Are the Best Agents to Treat Male Baldness? - Frankly Speaking Ep 284</itunes:title>
        <link>https://primedfranklyspeaking.podbean.com/e/what-are-the-best-agents-to-treat-male-baldness-frankly-speaking-ep-284/</link>
                    <comments>https://primedfranklyspeaking.podbean.com/e/what-are-the-best-agents-to-treat-male-baldness-frankly-speaking-ep-284/#comments</comments>        <pubDate>Mon, 11 Jul 2022 00:30:00 +0000</pubDate>
        <guid isPermaLink="false">primedfranklyspeaking.podbean.com/771b9809-50a9-334b-b8da-128e083a9350</guid>
                                    <description><![CDATA[<p>Credits: 0.25 AMA PRA Category 1 Credit™
 
CME/CE Information and Claim Credit: <a href='https://www.pri-med.com/online-education/podcast/frankly-speaking-cme-284'>https://www.pri-med.com/online-education/podcast/frankly-speaking-cme-284</a></p>
<p>Overview: Most primary care clinicians treating patients with male androgenetic alopecia are unfamiliar with studies looking at off-label use of medications for this condition. In this episode, you will hear a review of an important recent meta-analysis published in JAMA Dermatology that highlights the efficacy of commonly used agents to treat this condition.</p>
<p>Episode resource links:</p>
<ul><li>JAMA Dermatol. doi:10.1001/jamadermatol.2021.5743</li>
</ul>
<p>Guest: Robert A. Baldor MD, FAAFP
 
Music Credit: Richard Onorato</p>
]]></description>
                                                            <content:encoded><![CDATA[<p>Credits: 0.25 AMA PRA Category 1 Credit™<br>
 <br>
CME/CE Information and Claim Credit: <a href='https://www.pri-med.com/online-education/podcast/frankly-speaking-cme-284'>https://www.pri-med.com/online-education/podcast/frankly-speaking-cme-284</a></p>
<p>Overview: Most primary care clinicians treating patients with male androgenetic alopecia are unfamiliar with studies looking at off-label use of medications for this condition. In this episode, you will hear a review of an important recent meta-analysis published in JAMA Dermatology that highlights the efficacy of commonly used agents to treat this condition.</p>
<p>Episode resource links:</p>
<ul><li>JAMA Dermatol. doi:10.1001/jamadermatol.2021.5743</li>
</ul>
<p>Guest: Robert A. Baldor MD, FAAFP<br>
 <br>
Music Credit: Richard Onorato</p>
]]></content:encoded>
                                    
        <enclosure url="https://mcdn.podbean.com/mf/web/nbxdgt/frankly-speaking-284-baldness.mp3" length="9190528" type="audio/mpeg"/>
                <itunes:summary><![CDATA[Credits: 0.25 AMA PRA Category 1 Credit™ CME/CE Information and Claim Credit: https://www.pri-med.com/online-education/podcast/frankly-speaking-cme-284
Overview: Most primary care clinicians treating patients with male androgenetic alopecia are unfamiliar with studies looking at off-label use of medications for this condition. In this episode, you will hear a review of an important recent meta-analysis published in JAMA Dermatology that highlights the efficacy of commonly used agents to treat this condition.
Episode resource links:
JAMA Dermatol. doi:10.1001/jamadermatol.2021.5743
Guest: Robert A. Baldor MD, FAAFP Music Credit: Richard Onorato]]></itunes:summary>
        <itunes:author>Pri-Med</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>572</itunes:duration>
                        <itunes:episodeType>full</itunes:episodeType>
            </item>
    <item>
        <title>Clearing the Air in COPD - Frankly Speaking Ep 283</title>
        <itunes:title>Clearing the Air in COPD - Frankly Speaking Ep 283</itunes:title>
        <link>https://primedfranklyspeaking.podbean.com/e/clearing-the-air-in-copd-frankly-speaking-ep-283/</link>
                    <comments>https://primedfranklyspeaking.podbean.com/e/clearing-the-air-in-copd-frankly-speaking-ep-283/#comments</comments>        <pubDate>Mon, 04 Jul 2022 00:30:00 +0000</pubDate>
        <guid isPermaLink="false">primedfranklyspeaking.podbean.com/7b7fe7ec-a016-3086-abc3-a9fc56eee9db</guid>
                                    <description><![CDATA[<p>Credits: 0.25 AMA PRA Category 1 Credit™
 
CME/CE Information and Claim Credit: <a href='https://www.pri-med.com/online-education/podcast/frankly-speaking-cme-283'>https://www.pri-med.com/online-education/podcast/frankly-speaking-cme-283</a></p>
<p>Overview: Listen to this podcast to hear a simple method to help those with COPD improve their symptom control and lower exacerbation rates. </p>
<p>Episode resource links:</p>
<ul><li>Am J Respir Crit Care Med Vol 205, Iss 4, pp 421–430, Feb 15, 2022</li>
</ul>
<p>Guest: Jillian Joseph, MSPAS, PA-C
 
Music Credit: Richard Onorato</p>
]]></description>
                                                            <content:encoded><![CDATA[<p>Credits: 0.25 AMA PRA Category 1 Credit™<br>
 <br>
CME/CE Information and Claim Credit: <a href='https://www.pri-med.com/online-education/podcast/frankly-speaking-cme-283'>https://www.pri-med.com/online-education/podcast/frankly-speaking-cme-283</a></p>
<p>Overview: Listen to this podcast to hear a simple method to help those with COPD improve their symptom control and lower exacerbation rates. </p>
<p>Episode resource links:</p>
<ul><li>Am J Respir Crit Care Med Vol 205, Iss 4, pp 421–430, Feb 15, 2022</li>
</ul>
<p>Guest: Jillian Joseph, MSPAS, PA-C<br>
 <br>
Music Credit: Richard Onorato</p>
]]></content:encoded>
                                    
        <enclosure url="https://mcdn.podbean.com/mf/web/2qev94/frankly-speaking-283-hepa-copd.mp3" length="10250343" type="audio/mpeg"/>
                <itunes:summary><![CDATA[Credits: 0.25 AMA PRA Category 1 Credit™ CME/CE Information and Claim Credit: https://www.pri-med.com/online-education/podcast/frankly-speaking-cme-283
Overview: Listen to this podcast to hear a simple method to help those with COPD improve their symptom control and lower exacerbation rates. 
Episode resource links:
Am J Respir Crit Care Med Vol 205, Iss 4, pp 421–430, Feb 15, 2022
Guest: Jillian Joseph, MSPAS, PA-C Music Credit: Richard Onorato]]></itunes:summary>
        <itunes:author>Pri-Med</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>638</itunes:duration>
                        <itunes:episodeType>full</itunes:episodeType>
            </item>
    <item>
        <title>A Primer on Monkeypox - Frankly Speaking Ep 282</title>
        <itunes:title>A Primer on Monkeypox - Frankly Speaking Ep 282</itunes:title>
        <link>https://primedfranklyspeaking.podbean.com/e/a-primer-on-monkeypox-frankly-speaking-ep-282/</link>
                    <comments>https://primedfranklyspeaking.podbean.com/e/a-primer-on-monkeypox-frankly-speaking-ep-282/#comments</comments>        <pubDate>Mon, 27 Jun 2022 00:30:00 +0000</pubDate>
        <guid isPermaLink="false">primedfranklyspeaking.podbean.com/439a2086-ae4f-3ed1-ad54-9c1447ea2529</guid>
                                    <description><![CDATA[<p>Credits: 0.25 AMA PRA Category 1 Credit™
 
CME/CE Information and Claim Credit: https://www.pri-med.com/online-education/podcast/frankly-speaking-cme-282</p>
<p>Overview: Monkeypox is endemic in certain parts of Africa, but outbreaks in Europe and North America have recently occurred. While still uncommon, clinicians need to be alert to the possibility of this diagnosis. This podcast gives you the tools you need to identify risk factors and distinguish the disease from other infections.</p>
<p>Episode resource links:</p>
<ul><li>World Health Organization Health Topics/Monkeypox <a href='https://www.who.int/health-topics/monkeypox#tab=tab_1'>https://www.who.int/health-topics/monkeypox#tab=tab_1</a></li>
<li>Disease outbreak New/Item/Multi-country monkeypox outbreak: situation update 6-10-2022 <a href='https://www.who.int/emergencies/disease-outbreak-news/item/2022-DON392'>https://www.who.int/emergencies/disease-outbreak-news/item/2022-DON392</a></li>
</ul>
<p>
Guest: Alan Ehrlich MD, FAAFP
 
Music Credit: Richard Onorato</p>
]]></description>
                                                            <content:encoded><![CDATA[<p>Credits: 0.25 AMA PRA Category 1 Credit™<br>
 <br>
CME/CE Information and Claim Credit: https://www.pri-med.com/online-education/podcast/frankly-speaking-cme-282</p>
<p>Overview: Monkeypox is endemic in certain parts of Africa, but outbreaks in Europe and North America have recently occurred. While still uncommon, clinicians need to be alert to the possibility of this diagnosis. This podcast gives you the tools you need to identify risk factors and distinguish the disease from other infections.</p>
<p>Episode resource links:</p>
<ul><li>World Health Organization Health Topics/Monkeypox <a href='https://www.who.int/health-topics/monkeypox#tab=tab_1'>https://www.who.int/health-topics/monkeypox#tab=tab_1</a></li>
<li>Disease outbreak New/Item/Multi-country monkeypox outbreak: situation update 6-10-2022 <a href='https://www.who.int/emergencies/disease-outbreak-news/item/2022-DON392'>https://www.who.int/emergencies/disease-outbreak-news/item/2022-DON392</a></li>
</ul>
<p><br>
Guest: Alan Ehrlich MD, FAAFP<br>
 <br>
Music Credit: Richard Onorato</p>
]]></content:encoded>
                                    
        <enclosure url="https://mcdn.podbean.com/mf/web/qdc66g/frankly-speaking-282-monkeypox.mp3" length="13489991" type="audio/mpeg"/>
                <itunes:summary><![CDATA[Credits: 0.25 AMA PRA Category 1 Credit™ CME/CE Information and Claim Credit: https://www.pri-med.com/online-education/podcast/frankly-speaking-cme-282
Overview: Monkeypox is endemic in certain parts of Africa, but outbreaks in Europe and North America have recently occurred. While still uncommon, clinicians need to be alert to the possibility of this diagnosis. This podcast gives you the tools you need to identify risk factors and distinguish the disease from other infections.
Episode resource links:
World Health Organization Health Topics/Monkeypox https://www.who.int/health-topics/monkeypox#tab=tab_1
Disease outbreak New/Item/Multi-country monkeypox outbreak: situation update 6-10-2022 https://www.who.int/emergencies/disease-outbreak-news/item/2022-DON392
Guest: Alan Ehrlich MD, FAAFP Music Credit: Richard Onorato]]></itunes:summary>
        <itunes:author>Pri-Med</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>841</itunes:duration>
                        <itunes:episodeType>full</itunes:episodeType>
            </item>
    <item>
        <title>Access to Care: Safety of Medication Abortion - Frankly Speaking Ep 281</title>
        <itunes:title>Access to Care: Safety of Medication Abortion - Frankly Speaking Ep 281</itunes:title>
        <link>https://primedfranklyspeaking.podbean.com/e/access-to-care-safety-of-medication-abortion-frankly-speaking-ep-281/</link>
                    <comments>https://primedfranklyspeaking.podbean.com/e/access-to-care-safety-of-medication-abortion-frankly-speaking-ep-281/#comments</comments>        <pubDate>Mon, 20 Jun 2022 00:30:00 +0000</pubDate>
        <guid isPermaLink="false">primedfranklyspeaking.podbean.com/a06dad4c-e360-302b-a796-b1b45ae0c6ba</guid>
                                    <description><![CDATA[<p>Credits: 0.25 AMA PRA Category 1 Credit™
 
CME/CE Information and Claim Credit: <a href='https://www.pri-med.com/online-education/podcast/frankly-speaking-cme-281'>https://www.pri-med.com/online-education/podcast/frankly-speaking-cme-281</a></p>
<p>Overview: Clinicians may hesitate to provide medication abortion without first performing a pelvic ultrasound or pelvic examination, but recent data may give clinicians more confidence in their decision to do so. This episode explores the evidence for the safety of telehealth-based, or no-test screening, approaches to providing medication abortion for pregnant women at less than 10 weeks’ gestation. </p>
<p>Episode resource links:</p>
<ul><li>Upadhyay UD, Raymond EG, Koenig LR, et al. Outcomes and Safety of History-Based Screening for Medication Abortion: A Retrospective Multicenter Cohort Study. JAMA Intern Med. Published online March 21, 2022. doi:10.1001/jamainternmed.2022.0217</li>
<li>Upadhyay UD, Koenig LR, Meckstroth KR. Safety and Efficacy of Telehealth Medication Abortions in the US During the COVID-19 Pandemic. JAMA Network Open. 2021;4(8):e2122320. doi:<a href='https://doi.org/10.1001/jamanetworkopen.2021.22320'>10.1001/jamanetworkopen.2021.22320</a></li>
<li>Endler M, Lavelanet A, Cleeve A, Ganatra B, Gomperts R, Gemzell-Danielsson K. Telemedicine for medical abortion: a systematic review. BJOG: An International Journal of Obstetrics & Gynaecology. 2019;126(9):1094-1102. doi:<a href='https://doi.org/10.1111/1471-0528.15684'>10.1111/1471-0528.15684</a></li>
</ul>
<p>Guest: Jillian Joseph, MSPAS, PA-C
 
Music Credit: Richard Onorato</p>
]]></description>
                                                            <content:encoded><![CDATA[<p>Credits: 0.25 AMA PRA Category 1 Credit™<br>
 <br>
CME/CE Information and Claim Credit: <a href='https://www.pri-med.com/online-education/podcast/frankly-speaking-cme-281'>https://www.pri-med.com/online-education/podcast/frankly-speaking-cme-281</a></p>
<p>Overview: Clinicians may hesitate to provide medication abortion without first performing a pelvic ultrasound or pelvic examination, but recent data may give clinicians more confidence in their decision to do so. This episode explores the evidence for the safety of telehealth-based, or no-test screening, approaches to providing medication abortion for pregnant women at less than 10 weeks’ gestation. </p>
<p>Episode resource links:</p>
<ul><li>Upadhyay UD, Raymond EG, Koenig LR, et al. Outcomes and Safety of History-Based Screening for Medication Abortion: A Retrospective Multicenter Cohort Study. JAMA Intern Med. Published online March 21, 2022. doi:10.1001/jamainternmed.2022.0217</li>
<li>Upadhyay UD, Koenig LR, Meckstroth KR. Safety and Efficacy of Telehealth Medication Abortions in the US During the COVID-19 Pandemic. JAMA Network Open. 2021;4(8):e2122320. doi:<a href='https://doi.org/10.1001/jamanetworkopen.2021.22320'>10.1001/jamanetworkopen.2021.22320</a></li>
<li>Endler M, Lavelanet A, Cleeve A, Ganatra B, Gomperts R, Gemzell-Danielsson K. Telemedicine for medical abortion: a systematic review. BJOG: An International Journal of Obstetrics & Gynaecology. 2019;126(9):1094-1102. doi:<a href='https://doi.org/10.1111/1471-0528.15684'>10.1111/1471-0528.15684</a></li>
</ul>
<p>Guest: Jillian Joseph, MSPAS, PA-C<br>
 <br>
Music Credit: Richard Onorato</p>
]]></content:encoded>
                                    
        <enclosure url="https://mcdn.podbean.com/mf/web/qme22t/frankly-speaking-281-medication-abortion-2.mp3" length="11807132" type="audio/mpeg"/>
                <itunes:summary><![CDATA[Credits: 0.25 AMA PRA Category 1 Credit™ CME/CE Information and Claim Credit: https://www.pri-med.com/online-education/podcast/frankly-speaking-cme-281
Overview: Clinicians may hesitate to provide medication abortion without first performing a pelvic ultrasound or pelvic examination, but recent data may give clinicians more confidence in their decision to do so. This episode explores the evidence for the safety of telehealth-based, or no-test screening, approaches to providing medication abortion for pregnant women at less than 10 weeks’ gestation. 
Episode resource links:
Upadhyay UD, Raymond EG, Koenig LR, et al. Outcomes and Safety of History-Based Screening for Medication Abortion: A Retrospective Multicenter Cohort Study. JAMA Intern Med. Published online March 21, 2022. doi:10.1001/jamainternmed.2022.0217
Upadhyay UD, Koenig LR, Meckstroth KR. Safety and Efficacy of Telehealth Medication Abortions in the US During the COVID-19 Pandemic. JAMA Network Open. 2021;4(8):e2122320. doi:10.1001/jamanetworkopen.2021.22320
Endler M, Lavelanet A, Cleeve A, Ganatra B, Gomperts R, Gemzell-Danielsson K. Telemedicine for medical abortion: a systematic review. BJOG: An International Journal of Obstetrics & Gynaecology. 2019;126(9):1094-1102. doi:10.1111/1471-0528.15684
Guest: Jillian Joseph, MSPAS, PA-C Music Credit: Richard Onorato]]></itunes:summary>
        <itunes:author>Pri-Med</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>736</itunes:duration>
                        <itunes:episodeType>full</itunes:episodeType>
            </item>
    <item>
        <title>Statins for Cardiovascular Disease—It’s All Relative - Frankly Speaking Ep 280</title>
        <itunes:title>Statins for Cardiovascular Disease—It’s All Relative - Frankly Speaking Ep 280</itunes:title>
        <link>https://primedfranklyspeaking.podbean.com/e/statins-for-cardiovascular-disease%e2%80%94it-s-all-relative-frankly-speaking-ep-280/</link>
                    <comments>https://primedfranklyspeaking.podbean.com/e/statins-for-cardiovascular-disease%e2%80%94it-s-all-relative-frankly-speaking-ep-280/#comments</comments>        <pubDate>Mon, 13 Jun 2022 00:30:00 +0000</pubDate>
        <guid isPermaLink="false">primedfranklyspeaking.podbean.com/19ced1ca-9bd3-341f-a35f-e023cd06d44b</guid>
                                    <description><![CDATA[<p>Credits: 0.25 AMA PRA Category 1 Credit™
 
CME/CE Information and Claim Credit: <a href='https://www.pri-med.com/online-education/podcast/frankly-speaking-cme-280'>https://www.pri-med.com/online-education/podcast/frankly-speaking-cme-280</a></p>
<p>Overview: Statins are widely used for lowering cholesterol in patients at risk for cardiovascular disease. While the benefit is more established with secondary prevention compared with primary prevention, most of the benefits are reported in relative risk reduction, which can exaggerate the benefit to an individual person. In this podcast, you’ll hear a discussion of a recent systematic review that looked at the absolute risk reduction and relative risk reduction with statins for preventing death, myocardial infarctions, and stroke.</p>
<p>Episode resource links:</p>
<ul><li>Byrne, P. , Demasi, M. , Jones, M. , et al. Evaluating the Association Between Low-Density Lipoprotein Cholesterol Reduction and Relative and Absolute Effects of Statin Treatment. JAMA Internal Medicine</li>
</ul>
<p>Guest: Alan Ehrlich MD, FAAFP

 
Music Credit: Richard Onorato</p>
]]></description>
                                                            <content:encoded><![CDATA[<p>Credits: 0.25 AMA PRA Category 1 Credit™<br>
 <br>
CME/CE Information and Claim Credit: <a href='https://www.pri-med.com/online-education/podcast/frankly-speaking-cme-280'>https://www.pri-med.com/online-education/podcast/frankly-speaking-cme-280</a></p>
<p>Overview: Statins are widely used for lowering cholesterol in patients at risk for cardiovascular disease. While the benefit is more established with secondary prevention compared with primary prevention, most of the benefits are reported in relative risk reduction, which can exaggerate the benefit to an individual person. In this podcast, you’ll hear a discussion of a recent systematic review that looked at the absolute risk reduction and relative risk reduction with statins for preventing death, myocardial infarctions, and stroke.</p>
<p>Episode resource links:</p>
<ul><li>Byrne, P. , Demasi, M. , Jones, M. , et al. Evaluating the Association Between Low-Density Lipoprotein Cholesterol Reduction and Relative and Absolute Effects of Statin Treatment. JAMA Internal Medicine</li>
</ul>
<p>Guest: Alan Ehrlich MD, FAAFP<br>
<br>
 <br>
Music Credit: Richard Onorato</p>
]]></content:encoded>
                                    
        <enclosure url="https://mcdn.podbean.com/mf/web/2vtvdy/frankly-speaking-280-reduction-in-statins.mp3" length="12361863" type="audio/mpeg"/>
                <itunes:summary><![CDATA[Credits: 0.25 AMA PRA Category 1 Credit™ CME/CE Information and Claim Credit: https://www.pri-med.com/online-education/podcast/frankly-speaking-cme-280
Overview: Statins are widely used for lowering cholesterol in patients at risk for cardiovascular disease. While the benefit is more established with secondary prevention compared with primary prevention, most of the benefits are reported in relative risk reduction, which can exaggerate the benefit to an individual person. In this podcast, you’ll hear a discussion of a recent systematic review that looked at the absolute risk reduction and relative risk reduction with statins for preventing death, myocardial infarctions, and stroke.
Episode resource links:
Byrne, P. , Demasi, M. , Jones, M. , et al. Evaluating the Association Between Low-Density Lipoprotein Cholesterol Reduction and Relative and Absolute Effects of Statin Treatment. JAMA Internal Medicine
Guest: Alan Ehrlich MD, FAAFP Music Credit: Richard Onorato]]></itunes:summary>
        <itunes:author>Pri-Med</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>770</itunes:duration>
                        <itunes:episodeType>full</itunes:episodeType>
            </item>
    <item>
        <title>Step It Up! But by How Much? - Frankly Speaking Ep 279</title>
        <itunes:title>Step It Up! But by How Much? - Frankly Speaking Ep 279</itunes:title>
        <link>https://primedfranklyspeaking.podbean.com/e/step-it-up-but-by-how-much-frankly-speaking-ep-279/</link>
                    <comments>https://primedfranklyspeaking.podbean.com/e/step-it-up-but-by-how-much-frankly-speaking-ep-279/#comments</comments>        <pubDate>Mon, 06 Jun 2022 00:30:00 +0000</pubDate>
        <guid isPermaLink="false">primedfranklyspeaking.podbean.com/fdf0f9c0-ac93-36a2-ab0e-b52d07e0b0df</guid>
                                    <description><![CDATA[<p>Credits: 0.25 AMA PRA Category 1 Credit™
 
CME/CE Information and Claim Credit: <a href='https://www.pri-med.com/online-education/podcast/frankly-speaking-cme-279'>https://www.pri-med.com/online-education/podcast/frankly-speaking-cme-279</a></p>
<p>Overview: Clinicians (and patients) know that walking is beneficial for overall health, but what are the specifics? How many steps per day lower health risks? What impact does walking have on mortality? What’s the best way to count steps? Join us to hear answers to these questions and more as we discuss evidence-based recommendations for steps/day.</p>
<p>Episode resource links:</p>
<ul><li>
<p>Paluch, A. E., Bajpai, S., Bassett, D. R., Carnethon, M. R., Ekelund, U., Evenson, K. R., Galuska, D. A., Jefferis, B. J., Kraus, W. E., Lee, I. M., Matthews, C. E., Omura, J. D., Patel, A. V., Pieper, C. F., Rees-Punia, E., Dallmeier, D., Klenk, J., Whincup, P. H., Dooley, E. E., Pettee Gabriel, K., … Steps for Health Collaborative (2022). Daily steps and all-cause mortality: a meta-analysis of 15 international cohorts. The Lancet. Public health, 7(3), e219–e228. <a href='https://doi.org/10.1016/S2468-2667(21)00302-9%20'>https://doi.org/10.1016/S2468-2667(21)00302-9  </a></p>
<p> </p>
</li>
<li>
<p><a href='https://www.cdc.gov/physicalactivity/index.html'>https://www.cdc.gov/physicalactivity/index.html</a> This website includes data, resources and information for patients and providers for physical activity.</p>
</li>
</ul>
<p>Guest: Jill M. Terrien PhD, ANP-BC 
 
Music Credit: Richard Onorato</p>
]]></description>
                                                            <content:encoded><![CDATA[<p>Credits: 0.25 AMA PRA Category 1 Credit™<br>
 <br>
CME/CE Information and Claim Credit: <a href='https://www.pri-med.com/online-education/podcast/frankly-speaking-cme-279'>https://www.pri-med.com/online-education/podcast/frankly-speaking-cme-279</a></p>
<p>Overview: Clinicians (and patients) know that walking is beneficial for overall health, but what are the specifics? How many steps per day lower health risks? What impact does walking have on mortality? What’s the best way to count steps? Join us to hear answers to these questions and more as we discuss evidence-based recommendations for steps/day.</p>
<p>Episode resource links:</p>
<ul><li>
<p>Paluch, A. E., Bajpai, S., Bassett, D. R., Carnethon, M. R., Ekelund, U., Evenson, K. R., Galuska, D. A., Jefferis, B. J., Kraus, W. E., Lee, I. M., Matthews, C. E., Omura, J. D., Patel, A. V., Pieper, C. F., Rees-Punia, E., Dallmeier, D., Klenk, J., Whincup, P. H., Dooley, E. E., Pettee Gabriel, K., … Steps for Health Collaborative (2022). Daily steps and all-cause mortality: a meta-analysis of 15 international cohorts. The Lancet. Public health, 7(3), e219–e228. <a href='https://doi.org/10.1016/S2468-2667(21)00302-9%20'>https://doi.org/10.1016/S2468-2667(21)00302-9  </a></p>
<p> </p>
</li>
<li>
<p><a href='https://www.cdc.gov/physicalactivity/index.html'>https://www.cdc.gov/physicalactivity/index.html</a> This website includes data, resources and information for patients and providers for physical activity.</p>
</li>
</ul>
<p>Guest: Jill M. Terrien PhD, ANP-BC <br>
 <br>
Music Credit: Richard Onorato</p>
]]></content:encoded>
                                    
        <enclosure url="https://mcdn.podbean.com/mf/web/5gy9a2/frankly-speaking-279-steps-to-health.mp3" length="9667767" type="audio/mpeg"/>
                <itunes:summary><![CDATA[Credits: 0.25 AMA PRA Category 1 Credit™ CME/CE Information and Claim Credit: https://www.pri-med.com/online-education/podcast/frankly-speaking-cme-279
Overview: Clinicians (and patients) know that walking is beneficial for overall health, but what are the specifics? How many steps per day lower health risks? What impact does walking have on mortality? What’s the best way to count steps? Join us to hear answers to these questions and more as we discuss evidence-based recommendations for steps/day.
Episode resource links:

Paluch, A. E., Bajpai, S., Bassett, D. R., Carnethon, M. R., Ekelund, U., Evenson, K. R., Galuska, D. A., Jefferis, B. J., Kraus, W. E., Lee, I. M., Matthews, C. E., Omura, J. D., Patel, A. V., Pieper, C. F., Rees-Punia, E., Dallmeier, D., Klenk, J., Whincup, P. H., Dooley, E. E., Pettee Gabriel, K., … Steps for Health Collaborative (2022). Daily steps and all-cause mortality: a meta-analysis of 15 international cohorts. The Lancet. Public health, 7(3), e219–e228. https://doi.org/10.1016/S2468-2667(21)00302-9  
 


https://www.cdc.gov/physicalactivity/index.html This website includes data, resources and information for patients and providers for physical activity.

Guest: Jill M. Terrien PhD, ANP-BC  Music Credit: Richard Onorato]]></itunes:summary>
        <itunes:author>Pri-Med</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>602</itunes:duration>
                        <itunes:episodeType>full</itunes:episodeType>
            </item>
    <item>
        <title>Forget About Weed - Frankly Speaking Ep 278</title>
        <itunes:title>Forget About Weed - Frankly Speaking Ep 278</itunes:title>
        <link>https://primedfranklyspeaking.podbean.com/e/forget-about-weed-frankly-speaking-ep-278/</link>
                    <comments>https://primedfranklyspeaking.podbean.com/e/forget-about-weed-frankly-speaking-ep-278/#comments</comments>        <pubDate>Mon, 30 May 2022 00:30:00 +0000</pubDate>
        <guid isPermaLink="false">primedfranklyspeaking.podbean.com/a40830f4-7de5-323d-8876-7e1150e3f1c6</guid>
                                    <description><![CDATA[<p>Credits: 0.25 AMA PRA Category 1 Credit™
 
CME/CE Information and Claim Credit: <a href='https://www.pri-med.com/online-education/podcast/frankly-speaking-cme-278'>https://www.pri-med.com/online-education/podcast/frankly-speaking-cme-278</a></p>
<p>Overview: Misconceptions abound on the long-term effects of chronic use of marijuana. This episode tackles these misconceptions head-on, highlighting new data on marijuana’s adverse effects on central nervous system function, including loss of memory, IQ points, and executive functioning. It’s a must-listen for clinicians caring for patients engaging in regular marijuana use.</p>
<p>Episode resource links:</p>
<ul><li>Am J Psych 8 Mar 2022 <a href='https://doi.org/10.1176/appi.ajp.2021.21060664'>https://doi.org/10.1176/appi.ajp.2021.21060664</a></li>
</ul>
<p>Guest: Jillian Joseph, MSPAS, PA-C
 
Music Credit: Richard Onorato</p>
]]></description>
                                                            <content:encoded><![CDATA[<p>Credits: 0.25 AMA PRA Category 1 Credit™<br>
 <br>
CME/CE Information and Claim Credit: <a href='https://www.pri-med.com/online-education/podcast/frankly-speaking-cme-278'>https://www.pri-med.com/online-education/podcast/frankly-speaking-cme-278</a></p>
<p>Overview: Misconceptions abound on the long-term effects of chronic use of marijuana. This episode tackles these misconceptions head-on, highlighting new data on marijuana’s adverse effects on central nervous system function, including loss of memory, IQ points, and executive functioning. It’s a must-listen for clinicians caring for patients engaging in regular marijuana use.</p>
<p>Episode resource links:</p>
<ul><li>Am J Psych 8 Mar 2022 <a href='https://doi.org/10.1176/appi.ajp.2021.21060664'>https://doi.org/10.1176/appi.ajp.2021.21060664</a></li>
</ul>
<p>Guest: Jillian Joseph, MSPAS, PA-C<br>
 <br>
Music Credit: Richard Onorato</p>
]]></content:encoded>
                                    
        <enclosure url="https://mcdn.podbean.com/mf/web/idzfn8/frankly-speaking-278-marijuana-memory.mp3" length="8702420" type="audio/mpeg"/>
                <itunes:summary><![CDATA[Credits: 0.25 AMA PRA Category 1 Credit™ CME/CE Information and Claim Credit: https://www.pri-med.com/online-education/podcast/frankly-speaking-cme-278
Overview: Misconceptions abound on the long-term effects of chronic use of marijuana. This episode tackles these misconceptions head-on, highlighting new data on marijuana’s adverse effects on central nervous system function, including loss of memory, IQ points, and executive functioning. It’s a must-listen for clinicians caring for patients engaging in regular marijuana use.
Episode resource links:
Am J Psych 8 Mar 2022 https://doi.org/10.1176/appi.ajp.2021.21060664
Guest: Jillian Joseph, MSPAS, PA-C Music Credit: Richard Onorato]]></itunes:summary>
        <itunes:author>Pri-Med</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>542</itunes:duration>
                        <itunes:episodeType>full</itunes:episodeType>
            </item>
    <item>
        <title>Pneumococcal Vaccines Simplified! - Frankly Speaking Ep 277</title>
        <itunes:title>Pneumococcal Vaccines Simplified! - Frankly Speaking Ep 277</itunes:title>
        <link>https://primedfranklyspeaking.podbean.com/e/pneumococcal-vaccines-simplified-frankly-speaking-ep-277/</link>
                    <comments>https://primedfranklyspeaking.podbean.com/e/pneumococcal-vaccines-simplified-frankly-speaking-ep-277/#comments</comments>        <pubDate>Mon, 23 May 2022 00:30:00 +0000</pubDate>
        <guid isPermaLink="false">primedfranklyspeaking.podbean.com/a1de2be5-4151-3d3c-bc02-b1122f450049</guid>
                                    <description><![CDATA[<p>Credits: 0.25 AMA PRA Category 1 Credit™
 
CME/CE Information and Claim Credit: <a href='https://www.pri-med.com/online-education/podcast/frankly-speaking-cme-277'>https://www.pri-med.com/online-education/podcast/frankly-speaking-cme-277</a></p>
<p>Overview: Join us to discuss a summary of the newly published guidelines for pneumococcal vaccines and to review the most recently approved vaccines. We’ll begin by describing the challenges from the previous guidelines and how these new guidelines address these challenges. Given the burden of pneumococcal disease and that vaccination is our best weapon to combat the disease, you won’t want to miss this episode. </p>
<p>Episode resource links:</p>
<ul><li>
<p>Morga, A., Kimura, T., Feng, Q., Rozario, N., & Schwartz, J. (2022). Compliance to Advisory Committee on Immunization Practices recommendations for pneumococcal vaccination. Vaccine.</p>
<p> </p>
</li>
<li>
<p><a href='https://www.medscape.com/viewarticle/967675#vp_1'>https://www.medscape.com/viewarticle/967675#vp_1</a></p>
<p> </p>
</li>
<li>
<p>Schulz, P. S., Moore, S. E., Smith, D., Javed, J., & Wilde, A. M. (2022, April). Missed Pneumococcal Vaccination Opportunities in Adults With Invasive Pneumococcal Disease in a Community Health System. In Open Forum Infectious Diseases (Vol. 9, No. 4, p. ofac075). US: Oxford University Press.</p>
<p> </p>
</li>
<li>
<p>Center for disease Control and Prevention Resources: App for iphone and android PneumoRecs</p>
</li>
</ul>
<p>Guest: Mariyan L. Montaque, DNP, FNP-BC
 
Music Credit: Richard Onorato</p>
]]></description>
                                                            <content:encoded><![CDATA[<p>Credits: 0.25 AMA PRA Category 1 Credit™<br>
 <br>
CME/CE Information and Claim Credit: <a href='https://www.pri-med.com/online-education/podcast/frankly-speaking-cme-277'>https://www.pri-med.com/online-education/podcast/frankly-speaking-cme-277</a></p>
<p>Overview: Join us to discuss a summary of the newly published guidelines for pneumococcal vaccines and to review the most recently approved vaccines. We’ll begin by describing the challenges from the previous guidelines and how these new guidelines address these challenges. Given the burden of pneumococcal disease and that vaccination is our best weapon to combat the disease, you won’t want to miss this episode. </p>
<p>Episode resource links:</p>
<ul><li>
<p>Morga, A., Kimura, T., Feng, Q., Rozario, N., & Schwartz, J. (2022). Compliance to Advisory Committee on Immunization Practices recommendations for pneumococcal vaccination. Vaccine.</p>
<p> </p>
</li>
<li>
<p><a href='https://www.medscape.com/viewarticle/967675#vp_1'>https://www.medscape.com/viewarticle/967675#vp_1</a></p>
<p> </p>
</li>
<li>
<p>Schulz, P. S., Moore, S. E., Smith, D., Javed, J., & Wilde, A. M. (2022, April). Missed Pneumococcal Vaccination Opportunities in Adults With Invasive Pneumococcal Disease in a Community Health System. In Open Forum Infectious Diseases (Vol. 9, No. 4, p. ofac075). US: Oxford University Press.</p>
<p> </p>
</li>
<li>
<p>Center for disease Control and Prevention Resources: App for iphone and android PneumoRecs</p>
</li>
</ul>
<p>Guest: Mariyan L. Montaque, DNP, FNP-BC<br>
 <br>
Music Credit: Richard Onorato</p>
]]></content:encoded>
                                    
        <enclosure url="https://mcdn.podbean.com/mf/web/m5k3nu/frankly-speaking-277-pneumococcal-vaccine.mp3" length="10967782" type="audio/mpeg"/>
                <itunes:summary><![CDATA[Credits: 0.25 AMA PRA Category 1 Credit™ CME/CE Information and Claim Credit: https://www.pri-med.com/online-education/podcast/frankly-speaking-cme-277
Overview: Join us to discuss a summary of the newly published guidelines for pneumococcal vaccines and to review the most recently approved vaccines. We’ll begin by describing the challenges from the previous guidelines and how these new guidelines address these challenges. Given the burden of pneumococcal disease and that vaccination is our best weapon to combat the disease, you won’t want to miss this episode. 
Episode resource links:

Morga, A., Kimura, T., Feng, Q., Rozario, N., & Schwartz, J. (2022). Compliance to Advisory Committee on Immunization Practices recommendations for pneumococcal vaccination. Vaccine.
 


https://www.medscape.com/viewarticle/967675#vp_1
 


Schulz, P. S., Moore, S. E., Smith, D., Javed, J., & Wilde, A. M. (2022, April). Missed Pneumococcal Vaccination Opportunities in Adults With Invasive Pneumococcal Disease in a Community Health System. In Open Forum Infectious Diseases (Vol. 9, No. 4, p. ofac075). US: Oxford University Press.
 


Center for disease Control and Prevention Resources: App for iphone and android PneumoRecs

Guest: Mariyan L. Montaque, DNP, FNP-BC Music Credit: Richard Onorato]]></itunes:summary>
        <itunes:author>Pri-Med</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>683</itunes:duration>
                        <itunes:episodeType>full</itunes:episodeType>
            </item>
    <item>
        <title>Does Acetaminophen Increase Stroke Risk? - Frankly Speaking Ep 276</title>
        <itunes:title>Does Acetaminophen Increase Stroke Risk? - Frankly Speaking Ep 276</itunes:title>
        <link>https://primedfranklyspeaking.podbean.com/e/does-acetaminophen-increase-stroke-risk-frankly-speaking-ep-276/</link>
                    <comments>https://primedfranklyspeaking.podbean.com/e/does-acetaminophen-increase-stroke-risk-frankly-speaking-ep-276/#comments</comments>        <pubDate>Mon, 16 May 2022 00:30:00 +0000</pubDate>
        <guid isPermaLink="false">primedfranklyspeaking.podbean.com/c684d17f-5ecb-3089-aae2-eff22871a9f7</guid>
                                    <description><![CDATA[<p>Credits: 0.25 AMA PRA Category 1 Credit™
 
CME/CE Information and Claim Credit: <a href='https://www.pri-med.com/online-education/podcast/frankly-speaking-cme-276'>https://www.pri-med.com/online-education/podcast/frankly-speaking-cme-276</a></p>
<p>Overview: The concerns over the use of NSAIDs have been well documented. The medications can raise blood pressure and have been linked to an increased risk of heart disease and stroke when used long term. These known risks, supported by the FDA’s warning in 2005, has prompted many clinicians to prescribe acetaminophen instead. But do acetaminophen products confer a lower risk of cardiovascular effects? Join us for this episode to review the results from recent trials assessing similar blood pressure effects from regular use of acetaminophen. </p>
<p>Episode resource links:</p>
<ul><li><a href='https://doi.org/10.1161/CIRCULATIONAHA.121.056015'>https://doi.org/10.1161/CIRCULATIONAHA.121.056015</a> Circulation. 2022;145:416–423</li>
<li><a href='https://doi.org/10.1093/eurheartj/ehac059'>https://doi.org/10.1093/eurheartj/ehac059</a>; European Heart Journal.  2,24,2022</li>
</ul>
<p>Guest: Robert A. Baldor MD, FAAFP
 
Music Credit: Richard Onorato</p>
]]></description>
                                                            <content:encoded><![CDATA[<p>Credits: 0.25 AMA PRA Category 1 Credit™<br>
 <br>
CME/CE Information and Claim Credit: <a href='https://www.pri-med.com/online-education/podcast/frankly-speaking-cme-276'>https://www.pri-med.com/online-education/podcast/frankly-speaking-cme-276</a></p>
<p>Overview: The concerns over the use of NSAIDs have been well documented. The medications can raise blood pressure and have been linked to an increased risk of heart disease and stroke when used long term. These known risks, supported by the FDA’s warning in 2005, has prompted many clinicians to prescribe acetaminophen instead. But do acetaminophen products confer a lower risk of cardiovascular effects? Join us for this episode to review the results from recent trials assessing similar blood pressure effects from regular use of acetaminophen. </p>
<p>Episode resource links:</p>
<ul><li><a href='https://doi.org/10.1161/CIRCULATIONAHA.121.056015'>https://doi.org/10.1161/CIRCULATIONAHA.121.056015</a> Circulation. 2022;145:416–423</li>
<li><a href='https://doi.org/10.1093/eurheartj/ehac059'>https://doi.org/10.1093/eurheartj/ehac059</a>; European Heart Journal.  2,24,2022</li>
</ul>
<p>Guest: Robert A. Baldor MD, FAAFP<br>
 <br>
Music Credit: Richard Onorato</p>
]]></content:encoded>
                                    
        <enclosure url="https://mcdn.podbean.com/mf/web/ws7ce7/frankly-speaking-276-APAP-and-stroke.mp3" length="9104770" type="audio/mpeg"/>
                <itunes:summary><![CDATA[Credits: 0.25 AMA PRA Category 1 Credit™ CME/CE Information and Claim Credit: https://www.pri-med.com/online-education/podcast/frankly-speaking-cme-276
Overview: The concerns over the use of NSAIDs have been well documented. The medications can raise blood pressure and have been linked to an increased risk of heart disease and stroke when used long term. These known risks, supported by the FDA’s warning in 2005, has prompted many clinicians to prescribe acetaminophen instead. But do acetaminophen products confer a lower risk of cardiovascular effects? Join us for this episode to review the results from recent trials assessing similar blood pressure effects from regular use of acetaminophen. 
Episode resource links:
https://doi.org/10.1161/CIRCULATIONAHA.121.056015 Circulation. 2022;145:416–423
https://doi.org/10.1093/eurheartj/ehac059; European Heart Journal.  2,24,2022
Guest: Robert A. Baldor MD, FAAFP Music Credit: Richard Onorato]]></itunes:summary>
        <itunes:author>Pri-Med</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>567</itunes:duration>
                        <itunes:episodeType>full</itunes:episodeType>
            </item>
    <item>
        <title>Breastfeeding Really Is Best—New Evidence for Improved Health in Infants - Frankly Speaking Ep 275</title>
        <itunes:title>Breastfeeding Really Is Best—New Evidence for Improved Health in Infants - Frankly Speaking Ep 275</itunes:title>
        <link>https://primedfranklyspeaking.podbean.com/e/breastfeeding-really-is-best%e2%80%94new-evidence-for-improved-health-in-infants-frankly-speaking-ep-275/</link>
                    <comments>https://primedfranklyspeaking.podbean.com/e/breastfeeding-really-is-best%e2%80%94new-evidence-for-improved-health-in-infants-frankly-speaking-ep-275/#comments</comments>        <pubDate>Mon, 09 May 2022 00:30:00 +0000</pubDate>
        <guid isPermaLink="false">primedfranklyspeaking.podbean.com/cc6330ef-9d91-366b-be27-b3f17ebd3dce</guid>
                                    <description><![CDATA[<p>Credits: 0.25 AMA PRA Category 1 Credit™
 
CME/CE Information and Claim Credit: <a href='https://www.pri-med.com/online-education/podcast/frankly-speaking-cme-275'>https://www.pri-med.com/online-education/podcast/frankly-speaking-cme-275</a></p>
<p>Overview: The multitude of benefits of breastfeeding for both mother and baby are well documented. However, we’ve seen mixed evidence for the relationship between breastfeeding and certain childhood lung conditions, with some studies suggesting an increase in risk. A recent study found that exclusive breastfeeding was associated with decreased lower respiratory tract infection (LRTI), asthma, and allergic rhinitis. A potential connection between these conditions, breastfeeding, and the infant’s gut microbiome was also found. Join us as we discuss these findings and how to incorporate them into your practice to improve the health of women and infants.</p>
<p>Episode resource links:</p>
<ul><li>Rosas-Salazar C, Shilts MH, Tang ZZ, Hong Q, Turi KN, Snyder BM, Wiggins DA, Lynch CE, Gebretsadik T, Peebles RS Jr, Anderson LJ, Das SR, Hartert TV. Exclusive Breastfeeding, the Early-life Microbiome and Immune Response, and Common Childhood Respiratory Illnesses. J Allergy Clin Immunol. 2022 Mar 10:S0091-6749(22)00292-5. doi: 10.1016/j.jaci.2022.02.023. Epub ahead of print. PMID: 35283139.</li>
<li>Rosas-Salazar C, Forno E, Brehm JM, Han YY, Acosta-Pérez E, Cloutier MM, Wakefield DB, Alvarez M, Colón-Semidey A, Canino G, Celedón JC. Breastfeeding duration and asthma in Puerto Rican children. Pediatr Pulmonol. 2015 Jun;50(6):527-34. doi: 10.1002/ppul.23061. Epub 2014 Aug 6. PMID: 25100626; PMCID: PMC4320027.</li>
<li>AAP Breastfeeding Guidelines. <a href='https://www.healthychildren.org/English/ages-stages/baby/breastfeeding/Pages/Where-We-Stand-Breastfeeding.aspx'>https://www.healthychildren.org/English/ages-stages/baby/breastfeeding/Pages/Where-We-Stand-Breastfeeding.aspx</a></li>
<li>ACOG. <a href='https://www.acog.org/womens-health/infographics/breastfeeding-benefits'>https://www.acog.org/womens-health/infographics/breastfeeding-benefits</a></li>
<li>CDC Recommendations and Benefits of Breastfeeding. <a href='https://www.cdc.gov/nutrition/infantandtoddlernutrition/breastfeeding/recommendations-benefits.html'>https://www.cdc.gov/nutrition/infantandtoddlernutrition/breastfeeding/recommendations-benefits.html</a></li>
<li>CDC Breastfeeding Report Card. <a href='https://www.cdc.gov/breastfeeding/data/reportcard.htm'>https://www.cdc.gov/breastfeeding/data/reportcard.htm</a></li>
<li>US Dietary Guidelines for Americans. <a href='https://www.dietaryguidelines.gov/sites/default/files/2020-12/Dietary_Guidelines_for_Americans_2020-2025.pdf#page=65'>https://www.dietaryguidelines.gov/sites/default/files/2020-12/Dietary_Guidelines_for_Americans_2020-2025.pdf#page=65</a></li>
</ul>
<p>Guest: Susan Feeney, DNP, FNP-BC, NP-C
 
Music Credit: Richard Onorato</p>
]]></description>
                                                            <content:encoded><![CDATA[<p>Credits: 0.25 AMA PRA Category 1 Credit™<br>
 <br>
CME/CE Information and Claim Credit: <a href='https://www.pri-med.com/online-education/podcast/frankly-speaking-cme-275'>https://www.pri-med.com/online-education/podcast/frankly-speaking-cme-275</a></p>
<p>Overview: The multitude of benefits of breastfeeding for both mother and baby are well documented. However, we’ve seen mixed evidence for the relationship between breastfeeding and certain childhood lung conditions, with some studies suggesting an increase in risk. A recent study found that exclusive breastfeeding was associated with decreased lower respiratory tract infection (LRTI), asthma, and allergic rhinitis. A potential connection between these conditions, breastfeeding, and the infant’s gut microbiome was also found. Join us as we discuss these findings and how to incorporate them into your practice to improve the health of women and infants.</p>
<p>Episode resource links:</p>
<ul><li>Rosas-Salazar C, Shilts MH, Tang ZZ, Hong Q, Turi KN, Snyder BM, Wiggins DA, Lynch CE, Gebretsadik T, Peebles RS Jr, Anderson LJ, Das SR, Hartert TV. Exclusive Breastfeeding, the Early-life Microbiome and Immune Response, and Common Childhood Respiratory Illnesses. J Allergy Clin Immunol. 2022 Mar 10:S0091-6749(22)00292-5. doi: 10.1016/j.jaci.2022.02.023. Epub ahead of print. PMID: 35283139.</li>
<li>Rosas-Salazar C, Forno E, Brehm JM, Han YY, Acosta-Pérez E, Cloutier MM, Wakefield DB, Alvarez M, Colón-Semidey A, Canino G, Celedón JC. Breastfeeding duration and asthma in Puerto Rican children. Pediatr Pulmonol. 2015 Jun;50(6):527-34. doi: 10.1002/ppul.23061. Epub 2014 Aug 6. PMID: 25100626; PMCID: PMC4320027.</li>
<li>AAP Breastfeeding Guidelines. <a href='https://www.healthychildren.org/English/ages-stages/baby/breastfeeding/Pages/Where-We-Stand-Breastfeeding.aspx'>https://www.healthychildren.org/English/ages-stages/baby/breastfeeding/Pages/Where-We-Stand-Breastfeeding.aspx</a></li>
<li>ACOG. <a href='https://www.acog.org/womens-health/infographics/breastfeeding-benefits'>https://www.acog.org/womens-health/infographics/breastfeeding-benefits</a></li>
<li>CDC Recommendations and Benefits of Breastfeeding. <a href='https://www.cdc.gov/nutrition/infantandtoddlernutrition/breastfeeding/recommendations-benefits.html'>https://www.cdc.gov/nutrition/infantandtoddlernutrition/breastfeeding/recommendations-benefits.html</a></li>
<li>CDC Breastfeeding Report Card. <a href='https://www.cdc.gov/breastfeeding/data/reportcard.htm'>https://www.cdc.gov/breastfeeding/data/reportcard.htm</a></li>
<li>US Dietary Guidelines for Americans. <a href='https://www.dietaryguidelines.gov/sites/default/files/2020-12/Dietary_Guidelines_for_Americans_2020-2025.pdf#page=65'>https://www.dietaryguidelines.gov/sites/default/files/2020-12/Dietary_Guidelines_for_Americans_2020-2025.pdf#page=65</a></li>
</ul>
<p>Guest: Susan Feeney, DNP, FNP-BC, NP-C<br>
 <br>
Music Credit: Richard Onorato</p>
]]></content:encoded>
                                    
        <enclosure url="https://mcdn.podbean.com/mf/web/z58mv3/frankly-speaking-275-breastfeeding-and-rhinitis.mp3" length="10001623" type="audio/mpeg"/>
                <itunes:summary><![CDATA[Credits: 0.25 AMA PRA Category 1 Credit™ CME/CE Information and Claim Credit: https://www.pri-med.com/online-education/podcast/frankly-speaking-cme-275
Overview: The multitude of benefits of breastfeeding for both mother and baby are well documented. However, we’ve seen mixed evidence for the relationship between breastfeeding and certain childhood lung conditions, with some studies suggesting an increase in risk. A recent study found that exclusive breastfeeding was associated with decreased lower respiratory tract infection (LRTI), asthma, and allergic rhinitis. A potential connection between these conditions, breastfeeding, and the infant’s gut microbiome was also found. Join us as we discuss these findings and how to incorporate them into your practice to improve the health of women and infants.
Episode resource links:
Rosas-Salazar C, Shilts MH, Tang ZZ, Hong Q, Turi KN, Snyder BM, Wiggins DA, Lynch CE, Gebretsadik T, Peebles RS Jr, Anderson LJ, Das SR, Hartert TV. Exclusive Breastfeeding, the Early-life Microbiome and Immune Response, and Common Childhood Respiratory Illnesses. J Allergy Clin Immunol. 2022 Mar 10:S0091-6749(22)00292-5. doi: 10.1016/j.jaci.2022.02.023. Epub ahead of print. PMID: 35283139.
Rosas-Salazar C, Forno E, Brehm JM, Han YY, Acosta-Pérez E, Cloutier MM, Wakefield DB, Alvarez M, Colón-Semidey A, Canino G, Celedón JC. Breastfeeding duration and asthma in Puerto Rican children. Pediatr Pulmonol. 2015 Jun;50(6):527-34. doi: 10.1002/ppul.23061. Epub 2014 Aug 6. PMID: 25100626; PMCID: PMC4320027.
AAP Breastfeeding Guidelines. https://www.healthychildren.org/English/ages-stages/baby/breastfeeding/Pages/Where-We-Stand-Breastfeeding.aspx
ACOG. https://www.acog.org/womens-health/infographics/breastfeeding-benefits
CDC Recommendations and Benefits of Breastfeeding. https://www.cdc.gov/nutrition/infantandtoddlernutrition/breastfeeding/recommendations-benefits.html
CDC Breastfeeding Report Card. https://www.cdc.gov/breastfeeding/data/reportcard.htm
US Dietary Guidelines for Americans. https://www.dietaryguidelines.gov/sites/default/files/2020-12/Dietary_Guidelines_for_Americans_2020-2025.pdf#page=65
Guest: Susan Feeney, DNP, FNP-BC, NP-C Music Credit: Richard Onorato]]></itunes:summary>
        <itunes:author>Pri-Med</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>623</itunes:duration>
                        <itunes:episodeType>full</itunes:episodeType>
            </item>
    <item>
        <title>Recurrent UTIs—Prevention Without Antibiotics - Frankly Speaking Ep 274</title>
        <itunes:title>Recurrent UTIs—Prevention Without Antibiotics - Frankly Speaking Ep 274</itunes:title>
        <link>https://primedfranklyspeaking.podbean.com/e/recurrent-utis%e2%80%94prevention-without-antibiotics-frankly-speaking-ep-274/</link>
                    <comments>https://primedfranklyspeaking.podbean.com/e/recurrent-utis%e2%80%94prevention-without-antibiotics-frankly-speaking-ep-274/#comments</comments>        <pubDate>Mon, 02 May 2022 00:30:00 +0000</pubDate>
        <guid isPermaLink="false">primedfranklyspeaking.podbean.com/ad0e566b-e8b4-3890-8d0a-566cb17a8379</guid>
                                    <description><![CDATA[<p>Credits: 0.25 AMA PRA Category 1 Credit™
 
CME/CE Information and Claim Credit: <a href='https://www.pri-med.com/online-education/podcast/frankly-speaking-cme-274'>https://www.pri-med.com/online-education/podcast/frankly-speaking-cme-274</a></p>
<p>Overview: Recurrent urinary tract infections (UTIs) can be a frustrating problem for both patients and clinicians. Antibiotics are often used, but a prevailing concern is that the overuse of antibiotics may lead to more resistant bacteria. This podcast discusses methenamine hippurate as an important nonantibiotic alternative for UTI prophylaxis.</p>
<p>Episode resource links:</p>
<ul><li>
<p>Harding C, Mossop H, Homer T, et al. Alternative to prophylactic antibiotics for the treatment of recurrent urinary tract infections in women: multicentre, open label, randomised, non-inferiority trial. BMJ. 2022 Mar 9;376:e068229. </p>
<p> </p>
</li>
<li>
<p>Lee BS, Bhuta T, Simpson JM, Craig JC. Methenamine hippurate for preventing urinary tract infections. Cochrane Database Syst Rev. 2012;10(10):CD003265. Published 2012 Oct 17. </p>
</li>
</ul>
<p>Guest: Alan Ehrlich MD, FAAFP
 
Music Credit: Richard Onorato</p>
]]></description>
                                                            <content:encoded><![CDATA[<p>Credits: 0.25 AMA PRA Category 1 Credit™<br>
 <br>
CME/CE Information and Claim Credit: <a href='https://www.pri-med.com/online-education/podcast/frankly-speaking-cme-274'>https://www.pri-med.com/online-education/podcast/frankly-speaking-cme-274</a></p>
<p>Overview: Recurrent urinary tract infections (UTIs) can be a frustrating problem for both patients and clinicians. Antibiotics are often used, but a prevailing concern is that the overuse of antibiotics may lead to more resistant bacteria. This podcast discusses methenamine hippurate as an important nonantibiotic alternative for UTI prophylaxis.</p>
<p>Episode resource links:</p>
<ul><li>
<p>Harding C, Mossop H, Homer T, et al. Alternative to prophylactic antibiotics for the treatment of recurrent urinary tract infections in women: multicentre, open label, randomised, non-inferiority trial. BMJ. 2022 Mar 9;376:e068229. </p>
<p> </p>
</li>
<li>
<p>Lee BS, Bhuta T, Simpson JM, Craig JC. Methenamine hippurate for preventing urinary tract infections. Cochrane Database Syst Rev. 2012;10(10):CD003265. Published 2012 Oct 17. </p>
</li>
</ul>
<p>Guest: Alan Ehrlich MD, FAAFP<br>
 <br>
Music Credit: Richard Onorato</p>
]]></content:encoded>
                                    
        <enclosure url="https://mcdn.podbean.com/mf/web/8ke7pj/frankly-speaking-274-recurrent-utis.mp3" length="10201498" type="audio/mpeg"/>
                <itunes:summary><![CDATA[Credits: 0.25 AMA PRA Category 1 Credit™ CME/CE Information and Claim Credit: https://www.pri-med.com/online-education/podcast/frankly-speaking-cme-274
Overview: Recurrent urinary tract infections (UTIs) can be a frustrating problem for both patients and clinicians. Antibiotics are often used, but a prevailing concern is that the overuse of antibiotics may lead to more resistant bacteria. This podcast discusses methenamine hippurate as an important nonantibiotic alternative for UTI prophylaxis.
Episode resource links:

Harding C, Mossop H, Homer T, et al. Alternative to prophylactic antibiotics for the treatment of recurrent urinary tract infections in women: multicentre, open label, randomised, non-inferiority trial. BMJ. 2022 Mar 9;376:e068229. 
 


Lee BS, Bhuta T, Simpson JM, Craig JC. Methenamine hippurate for preventing urinary tract infections. Cochrane Database Syst Rev. 2012;10(10):CD003265. Published 2012 Oct 17. 

Guest: Alan Ehrlich MD, FAAFP Music Credit: Richard Onorato]]></itunes:summary>
        <itunes:author>Pri-Med</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>635</itunes:duration>
                        <itunes:episodeType>full</itunes:episodeType>
            </item>
    <item>
        <title>A Smoke Screen? Is Secondhand Aerosol Exposure From E-Cigarettes harmful? - Frankly Speaking Ep 273</title>
        <itunes:title>A Smoke Screen? Is Secondhand Aerosol Exposure From E-Cigarettes harmful? - Frankly Speaking Ep 273</itunes:title>
        <link>https://primedfranklyspeaking.podbean.com/e/a-smoke-screen-is-secondhand-aerosol-exposure-from-e-cigarettes-harmful-frankly-speaking-ep-273/</link>
                    <comments>https://primedfranklyspeaking.podbean.com/e/a-smoke-screen-is-secondhand-aerosol-exposure-from-e-cigarettes-harmful-frankly-speaking-ep-273/#comments</comments>        <pubDate>Mon, 25 Apr 2022 00:30:00 +0000</pubDate>
        <guid isPermaLink="false">primedfranklyspeaking.podbean.com/42572962-4b38-3dd1-bfca-ac7333a0275b</guid>
                                    <description><![CDATA[<p>Credits: 0.25 AMA PRA Category 1 Credit™
 
CME/CE Information and Claim Credit: <a href='https://www.pri-med.com/online-education/podcast/frankly-speaking-cme-273'>https://www.pri-med.com/online-education/podcast/frankly-speaking-cme-273</a></p>
<p>Overview: The evidence continues to grow and evolve on the potential harms of e-cigarette use and on their efficacy and safety as a harm reduction strategy. One aspect of e-cigarette use that has not received much attention is the effect of secondhand exposure to the exhaled aerosol from e-cigarettes. Previous small studies have suggested some exposure risk, but a recent study of >2,000 participants found that secondhand exposure to e-cigarette aerosol increased the risk of bronchitic symptoms and shortness of breath in young adults. Join us as we discuss these findings and their implications to practice.</p>
<p>Episode resource links:</p>
<ul><li>
<p>Islam T, Braymiller J, Eckel SP, et al
Secondhand nicotine vaping at home and respiratory symptoms in young adults
Thorax Published Online First: 10 January 2022. doi: 10.1136/thoraxjnl-2021-217041</p>
</li>
<li>
<p>Caponnetto P, Caruso M, Maglia M, et al. Non-inferiority trial comparing cigarette consumption, adoption rates, acceptability, tolerability, and tobacco harm reduction potential in smokers switching to Heated Tobacco Products or electronic cigarettes: Study protocol for a randomized controlled trial. Article. Contemporary Clinical Trials Communications. 2020;17100518. doi:10.1016/j.conctc.2020.100518</p>
</li>
<li>
<p>Gaiha SM, et al. J Adolesc Health. Association Between Youth Smoking, Electronic Cigarette Use, and COVID-19. J Adolesc Health. Vol 67, issue 4, pp 519-523; DOI: https://doi.org/10.1015/j.jadolhealth.2020.07.002</p>
</li>
<li>
<p>Hartmann-Boyce J, McRobbie H, Lindson N, et al. Electronic cigarettes for smoking cessation. Cochrane Database Syst Rev. Apr 29 2021;4:CD010216. doi:10.1002/14651858.CD010216.pub5</p>
</li>
<li>
<p>Mayo Clinic. (2022, January 13). E-cigarette users who test positive for COVID-19 are more likely to experience COVID-19 symptoms. ScienceDaily. Retrieved January 17, 2022 from www.sciencedaily.com/releases/2022/01/220113151402.htm</p>
</li>
<li>
<p>McAlinden KD, Eapen MS, Lu W, Chia C, Haug G, Sohal SS. COVID-19 and vaping: risk for increased susceptibility to SARS-CoV-2 infection? Eur Respir J. 2020. vol. 1.</p>
<p> </p>
</li>
<li>
<p>McFadden, DD, Bornstein, SL, Vassallo, R, Salonen, BR, Nadir Bhuiyan, M, Schroeder, DR, Croghan, IK. Symptoms COVID 19 Positive Vapers Compared to COVID 19 Positive Non-vapers. Journal of Primary Care & Community Health, 2022; 13: 215013192110626 DOI: 10.1177/21501319211062672</p>
</li>
</ul>
<p>Guest: Susan Feeney, DNP, FNP-BC, NP-C
 
Music Credit: Richard Onorato</p>
]]></description>
                                                            <content:encoded><![CDATA[<p>Credits: 0.25 AMA PRA Category 1 Credit™<br>
 <br>
CME/CE Information and Claim Credit: <a href='https://www.pri-med.com/online-education/podcast/frankly-speaking-cme-273'>https://www.pri-med.com/online-education/podcast/frankly-speaking-cme-273</a></p>
<p>Overview: The evidence continues to grow and evolve on the potential harms of e-cigarette use and on their efficacy and safety as a harm reduction strategy. One aspect of e-cigarette use that has not received much attention is the effect of secondhand exposure to the exhaled aerosol from e-cigarettes. Previous small studies have suggested some exposure risk, but a recent study of >2,000 participants found that secondhand exposure to e-cigarette aerosol increased the risk of bronchitic symptoms and shortness of breath in young adults. Join us as we discuss these findings and their implications to practice.</p>
<p>Episode resource links:</p>
<ul><li>
<p>Islam T, Braymiller J, Eckel SP, et al<br>
Secondhand nicotine vaping at home and respiratory symptoms in young adults<br>
Thorax Published Online First: 10 January 2022. doi: 10.1136/thoraxjnl-2021-217041</p>
</li>
<li>
<p>Caponnetto P, Caruso M, Maglia M, et al. Non-inferiority trial comparing cigarette consumption, adoption rates, acceptability, tolerability, and tobacco harm reduction potential in smokers switching to Heated Tobacco Products or electronic cigarettes: Study protocol for a randomized controlled trial. Article. Contemporary Clinical Trials Communications. 2020;17100518. doi:10.1016/j.conctc.2020.100518</p>
</li>
<li>
<p>Gaiha SM, et al. J Adolesc Health. Association Between Youth Smoking, Electronic Cigarette Use, and COVID-19. J Adolesc Health. Vol 67, issue 4, pp 519-523; DOI: https://doi.org/10.1015/j.jadolhealth.2020.07.002</p>
</li>
<li>
<p>Hartmann-Boyce J, McRobbie H, Lindson N, et al. Electronic cigarettes for smoking cessation. Cochrane Database Syst Rev. Apr 29 2021;4:CD010216. doi:10.1002/14651858.CD010216.pub5</p>
</li>
<li>
<p>Mayo Clinic. (2022, January 13). E-cigarette users who test positive for COVID-19 are more likely to experience COVID-19 symptoms. ScienceDaily. Retrieved January 17, 2022 from www.sciencedaily.com/releases/2022/01/220113151402.htm</p>
</li>
<li>
<p>McAlinden KD, Eapen MS, Lu W, Chia C, Haug G, Sohal SS. COVID-19 and vaping: risk for increased susceptibility to SARS-CoV-2 infection? Eur Respir J. 2020. vol. 1.</p>
<p> </p>
</li>
<li>
<p>McFadden, DD, Bornstein, SL, Vassallo, R, Salonen, BR, Nadir Bhuiyan, M, Schroeder, DR, Croghan, IK. Symptoms COVID 19 Positive Vapers Compared to COVID 19 Positive Non-vapers. Journal of Primary Care & Community Health, 2022; 13: 215013192110626 DOI: 10.1177/21501319211062672</p>
</li>
</ul>
<p>Guest: Susan Feeney, DNP, FNP-BC, NP-C<br>
 <br>
Music Credit: Richard Onorato</p>
]]></content:encoded>
                                    
        <enclosure url="https://mcdn.podbean.com/mf/web/h3fq9m/frankly-speaking-273-e-cigarettes-2nd-hand-smoke-1.mp3" length="8604210" type="audio/mpeg"/>
                <itunes:summary><![CDATA[Credits: 0.25 AMA PRA Category 1 Credit™ CME/CE Information and Claim Credit: https://www.pri-med.com/online-education/podcast/frankly-speaking-cme-273
Overview: The evidence continues to grow and evolve on the potential harms of e-cigarette use and on their efficacy and safety as a harm reduction strategy. One aspect of e-cigarette use that has not received much attention is the effect of secondhand exposure to the exhaled aerosol from e-cigarettes. Previous small studies have suggested some exposure risk, but a recent study of >2,000 participants found that secondhand exposure to e-cigarette aerosol increased the risk of bronchitic symptoms and shortness of breath in young adults. Join us as we discuss these findings and their implications to practice.
Episode resource links:

Islam T, Braymiller J, Eckel SP, et alSecondhand nicotine vaping at home and respiratory symptoms in young adultsThorax Published Online First: 10 January 2022. doi: 10.1136/thoraxjnl-2021-217041


Caponnetto P, Caruso M, Maglia M, et al. Non-inferiority trial comparing cigarette consumption, adoption rates, acceptability, tolerability, and tobacco harm reduction potential in smokers switching to Heated Tobacco Products or electronic cigarettes: Study protocol for a randomized controlled trial. Article. Contemporary Clinical Trials Communications. 2020;17100518. doi:10.1016/j.conctc.2020.100518


Gaiha SM, et al. J Adolesc Health. Association Between Youth Smoking, Electronic Cigarette Use, and COVID-19. J Adolesc Health. Vol 67, issue 4, pp 519-523; DOI: https://doi.org/10.1015/j.jadolhealth.2020.07.002


Hartmann-Boyce J, McRobbie H, Lindson N, et al. Electronic cigarettes for smoking cessation. Cochrane Database Syst Rev. Apr 29 2021;4:CD010216. doi:10.1002/14651858.CD010216.pub5


Mayo Clinic. (2022, January 13). E-cigarette users who test positive for COVID-19 are more likely to experience COVID-19 symptoms. ScienceDaily. Retrieved January 17, 2022 from www.sciencedaily.com/releases/2022/01/220113151402.htm


McAlinden KD, Eapen MS, Lu W, Chia C, Haug G, Sohal SS. COVID-19 and vaping: risk for increased susceptibility to SARS-CoV-2 infection? Eur Respir J. 2020. vol. 1.
 


McFadden, DD, Bornstein, SL, Vassallo, R, Salonen, BR, Nadir Bhuiyan, M, Schroeder, DR, Croghan, IK. Symptoms COVID 19 Positive Vapers Compared to COVID 19 Positive Non-vapers. Journal of Primary Care & Community Health, 2022; 13: 215013192110626 DOI: 10.1177/21501319211062672

Guest: Susan Feeney, DNP, FNP-BC, NP-C Music Credit: Richard Onorato]]></itunes:summary>
        <itunes:author>Pri-Med</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>535</itunes:duration>
                        <itunes:episodeType>full</itunes:episodeType>
            </item>
    <item>
        <title>Estimating Jugular Venous Pressure: Point-of-Care Ultrasound Can Help - Frankly Speaking Ep 272</title>
        <itunes:title>Estimating Jugular Venous Pressure: Point-of-Care Ultrasound Can Help - Frankly Speaking Ep 272</itunes:title>
        <link>https://primedfranklyspeaking.podbean.com/e/estimating-jugular-venous-pressure-point-of-care-ultrasound-can-help-frankly-speaking-ep-272/</link>
                    <comments>https://primedfranklyspeaking.podbean.com/e/estimating-jugular-venous-pressure-point-of-care-ultrasound-can-help-frankly-speaking-ep-272/#comments</comments>        <pubDate>Mon, 18 Apr 2022 00:30:00 +0000</pubDate>
        <guid isPermaLink="false">primedfranklyspeaking.podbean.com/c0975ec3-8fc0-347a-b189-791ba4badd39</guid>
                                    <description><![CDATA[<p>Credits: 0.25 AMA PRA Category 1 Credit™
 
CME/CE Information and Claim Credit: <a href='https://www.pri-med.com/online-education/podcast/frankly-speaking-cme-272'>https://www.pri-med.com/online-education/podcast/frankly-speaking-cme-272</a></p>
<p>Overview: Clinicians need to accurately assess the degree of heart failure at the bedside to make appropriate management decisions. However, the common bedside practice of estimating right atrial pressure by measuring jugular venous pressure (JVP) has several accuracy limitations. This session focuses on the use of point-of-care ultrasound (POC-US) to improve the accuracy of JVP measurements. Join us to hear the salient findings from a recent study comparing POC-US measurements to right heart catheterization measurements, and walk away with a clear understanding of how POC-US can quickly and easily improve accuracy.</p>
<p>Episode resource links:</p>
<ul><li>Wang L, Harrison J, Dranow E, Aliyev N, Khor L. Accuracy of Ultrasound Jugular Venous Pressure Height in Predicting Central Venous Congestion. Ann Intern Med. 2021 Dec 28. doi: 10.7326/M21-2781. Epub ahead of print.</li>
</ul>
<p>Guest: Alan Ehrlich MD, FAAFP</p>
<p>Music Credit: Richard Onorato</p>
]]></description>
                                                            <content:encoded><![CDATA[<p>Credits: 0.25 AMA PRA Category 1 Credit™<br>
 <br>
CME/CE Information and Claim Credit: <a href='https://www.pri-med.com/online-education/podcast/frankly-speaking-cme-272'>https://www.pri-med.com/online-education/podcast/frankly-speaking-cme-272</a></p>
<p>Overview: Clinicians need to accurately assess the degree of heart failure at the bedside to make appropriate management decisions. However, the common bedside practice of estimating right atrial pressure by measuring jugular venous pressure (JVP) has several accuracy limitations. This session focuses on the use of point-of-care ultrasound (POC-US) to improve the accuracy of JVP measurements. Join us to hear the salient findings from a recent study comparing POC-US measurements to right heart catheterization measurements, and walk away with a clear understanding of how POC-US can quickly and easily improve accuracy.</p>
<p>Episode resource links:</p>
<ul><li>Wang L, Harrison J, Dranow E, Aliyev N, Khor L. Accuracy of Ultrasound Jugular Venous Pressure Height in Predicting Central Venous Congestion. Ann Intern Med. 2021 Dec 28. doi: 10.7326/M21-2781. Epub ahead of print.</li>
</ul>
<p>Guest: Alan Ehrlich MD, FAAFP</p>
<p>Music Credit: Richard Onorato</p>
]]></content:encoded>
                                    
        <enclosure url="https://mcdn.podbean.com/mf/web/ej2h67/frankly-speaking-272-pocus-for-JVP1.mp3" length="10701060" type="audio/mpeg"/>
                <itunes:summary><![CDATA[Credits: 0.25 AMA PRA Category 1 Credit™ CME/CE Information and Claim Credit: https://www.pri-med.com/online-education/podcast/frankly-speaking-cme-272
Overview: Clinicians need to accurately assess the degree of heart failure at the bedside to make appropriate management decisions. However, the common bedside practice of estimating right atrial pressure by measuring jugular venous pressure (JVP) has several accuracy limitations. This session focuses on the use of point-of-care ultrasound (POC-US) to improve the accuracy of JVP measurements. Join us to hear the salient findings from a recent study comparing POC-US measurements to right heart catheterization measurements, and walk away with a clear understanding of how POC-US can quickly and easily improve accuracy.
Episode resource links:
Wang L, Harrison J, Dranow E, Aliyev N, Khor L. Accuracy of Ultrasound Jugular Venous Pressure Height in Predicting Central Venous Congestion. Ann Intern Med. 2021 Dec 28. doi: 10.7326/M21-2781. Epub ahead of print.
Guest: Alan Ehrlich MD, FAAFP
Music Credit: Richard Onorato]]></itunes:summary>
        <itunes:author>Pri-Med</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>667</itunes:duration>
                        <itunes:episodeType>full</itunes:episodeType>
            </item>
    <item>
        <title>Cardiovascular Disease and Exercise - Frankly Speaking Ep 271</title>
        <itunes:title>Cardiovascular Disease and Exercise - Frankly Speaking Ep 271</itunes:title>
        <link>https://primedfranklyspeaking.podbean.com/e/cardiovascular-disease-and-exercise-frankly-speaking-ep-271/</link>
                    <comments>https://primedfranklyspeaking.podbean.com/e/cardiovascular-disease-and-exercise-frankly-speaking-ep-271/#comments</comments>        <pubDate>Mon, 11 Apr 2022 00:30:00 +0000</pubDate>
        <guid isPermaLink="false">primedfranklyspeaking.podbean.com/546c92c4-0912-344f-9a98-363673a3543f</guid>
                                    <description><![CDATA[<p>Credits: 0.25 AMA PRA Category 1 Credit™
 
CME/CE Information and Claim Credit: <a href='https://www.pri-med.com/online-education/podcast/frankly-speaking-cme-271'>https://www.pri-med.com/online-education/podcast/frankly-speaking-cme-271</a></p>
<p>Overview: Given the prevalence of cardiovascular disease (CVD) in the United States, it is key for primary care providers to counsel patients on the importance of exercise for CVD prevention. This brief podcast explores data that will help clinicians understand the need to prescribe exercise and rehabilitation in the primary care setting. You’ll walk away with clear guidance to offer patients and ultimately improve outcomes in CVD as well as multiple chronic diseases.</p>
<p>Episode resource links:</p>
<ul><li>
<p>Naci, H., & Ioannidis, J. P. (2015). Comparative effectiveness of exercise and drug interventions on mortality outcomes: metaepidemiological study. British journal of sports medicine, 49(21), 1414–1422. <a href='https://doi.org/10.1136/bjsports-2015-f5577rep'>https://doi.org/10.1136/bjsports-2015-f5577rep</a></p>
<p> </p>
</li>
<li>
<p>Sanchis-Gomar, F., Lavie, C. J., Marín, J., Perez-Quilis, C., Eijsvogels, T. M., O’Keefe, J. H., ... & Blair, S. N. (2021). Exercise effects on cardiovascular disease: from basic aspects to clinical evidence. Cardiovascular Research. </p>
</li>
</ul>
<p>Guest: Mariyan L. Montaque, DNP, FNP-BC
 
Music Credit: Richard Onorato</p>
]]></description>
                                                            <content:encoded><![CDATA[<p>Credits: 0.25 AMA PRA Category 1 Credit™<br>
 <br>
CME/CE Information and Claim Credit: <a href='https://www.pri-med.com/online-education/podcast/frankly-speaking-cme-271'>https://www.pri-med.com/online-education/podcast/frankly-speaking-cme-271</a></p>
<p>Overview: Given the prevalence of cardiovascular disease (CVD) in the United States, it is key for primary care providers to counsel patients on the importance of exercise for CVD prevention. This brief podcast explores data that will help clinicians understand the need to prescribe exercise and rehabilitation in the primary care setting. You’ll walk away with clear guidance to offer patients and ultimately improve outcomes in CVD as well as multiple chronic diseases.</p>
<p>Episode resource links:</p>
<ul><li>
<p>Naci, H., & Ioannidis, J. P. (2015). Comparative effectiveness of exercise and drug interventions on mortality outcomes: metaepidemiological study. British journal of sports medicine, 49(21), 1414–1422. <a href='https://doi.org/10.1136/bjsports-2015-f5577rep'>https://doi.org/10.1136/bjsports-2015-f5577rep</a></p>
<p> </p>
</li>
<li>
<p>Sanchis-Gomar, F., Lavie, C. J., Marín, J., Perez-Quilis, C., Eijsvogels, T. M., O’Keefe, J. H., ... & Blair, S. N. (2021). Exercise effects on cardiovascular disease: from basic aspects to clinical evidence. Cardiovascular Research. </p>
</li>
</ul>
<p>Guest: Mariyan L. Montaque, DNP, FNP-BC<br>
 <br>
Music Credit: Richard Onorato</p>
]]></content:encoded>
                                    
        <enclosure url="https://mcdn.podbean.com/mf/web/v59yws/frankly-speaking-271-cvd-and-covid-1.mp3" length="10355084" type="audio/mpeg"/>
                <itunes:summary><![CDATA[Credits: 0.25 AMA PRA Category 1 Credit™ CME/CE Information and Claim Credit: https://www.pri-med.com/online-education/podcast/frankly-speaking-cme-271
Overview: Given the prevalence of cardiovascular disease (CVD) in the United States, it is key for primary care providers to counsel patients on the importance of exercise for CVD prevention. This brief podcast explores data that will help clinicians understand the need to prescribe exercise and rehabilitation in the primary care setting. You’ll walk away with clear guidance to offer patients and ultimately improve outcomes in CVD as well as multiple chronic diseases.
Episode resource links:

Naci, H., & Ioannidis, J. P. (2015). Comparative effectiveness of exercise and drug interventions on mortality outcomes: metaepidemiological study. British journal of sports medicine, 49(21), 1414–1422. https://doi.org/10.1136/bjsports-2015-f5577rep
 


Sanchis-Gomar, F., Lavie, C. J., Marín, J., Perez-Quilis, C., Eijsvogels, T. M., O’Keefe, J. H., ... & Blair, S. N. (2021). Exercise effects on cardiovascular disease: from basic aspects to clinical evidence. Cardiovascular Research. 

Guest: Mariyan L. Montaque, DNP, FNP-BC Music Credit: Richard Onorato]]></itunes:summary>
        <itunes:author>Pri-Med</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>644</itunes:duration>
                        <itunes:episodeType>full</itunes:episodeType>
            </item>
    <item>
        <title>Boosting Weight Loss with Medications: New support for GLP-1 RAs - Frankly Speaking Ep 270</title>
        <itunes:title>Boosting Weight Loss with Medications: New support for GLP-1 RAs - Frankly Speaking Ep 270</itunes:title>
        <link>https://primedfranklyspeaking.podbean.com/e/boosting-weight-loss-with-medications-new-support-for-glp-1-ras/</link>
                    <comments>https://primedfranklyspeaking.podbean.com/e/boosting-weight-loss-with-medications-new-support-for-glp-1-ras/#comments</comments>        <pubDate>Mon, 04 Apr 2022 00:30:00 +0000</pubDate>
        <guid isPermaLink="false">primedfranklyspeaking.podbean.com/c35144e4-bd0b-3777-8fbd-3066445c9228</guid>
                                    <description><![CDATA[<p>Credits: 0.25 AMA PRA Category 1 Credit™
 
CME/CE Information and Claim Credit: <a href='https://www.pri-med.com/online-education/podcast/frankly-speaking-cme-270'>https://www.pri-med.com/online-education/podcast/frankly-speaking-cme-270</a></p>
<p>Overview: You know GLP-1 RAs are an important class of agents for weight loss, but do you know which drug within this class is right for your patient? This brief podcast walks you through the recent evidence from the STEP 8 randomized clinical trial, comparing the efficacy and adverse reaction profiles for 2 GLP-1 RAs: semaglutide (Wegovy) and liraglutide (Saxenda). This is a must-listen for anyone looking to optimally individualize care for patients with obesity.</p>
<p>Episode resource links:</p>
<ul><li>Rubino DM, Greenway FL, Khalid U, et al. Effect of Weekly Subcutaneous Semaglutide vs Daily Liraglutide on Body Weight in Adults With Overweight or Obesity Without Diabetes: The STEP 8 Randomized Clinical Trial. JAMA. 2022;327(2):138–150. doi:<a href='https://pubmed.ncbi.nlm.nih.gov/35015037/'>10.1001/jama.2021.23619</a></li>
</ul>
<p>Guest: Jillian Joseph, MSPAS, PA-C
 
Music Credit: Richard Onorato</p>
]]></description>
                                                            <content:encoded><![CDATA[<p>Credits: 0.25 AMA PRA Category 1 Credit™<br>
 <br>
CME/CE Information and Claim Credit: <a href='https://www.pri-med.com/online-education/podcast/frankly-speaking-cme-270'>https://www.pri-med.com/online-education/podcast/frankly-speaking-cme-270</a></p>
<p>Overview: You know GLP-1 RAs are an important class of agents for weight loss, but do you know which drug within this class is right for your patient? This brief podcast walks you through the recent evidence from the STEP 8 randomized clinical trial, comparing the efficacy and adverse reaction profiles for 2 GLP-1 RAs: semaglutide (Wegovy) and liraglutide (Saxenda). This is a must-listen for anyone looking to optimally individualize care for patients with obesity.</p>
<p>Episode resource links:</p>
<ul><li>Rubino DM, Greenway FL, Khalid U, et al. Effect of Weekly Subcutaneous Semaglutide vs Daily Liraglutide on Body Weight in Adults With Overweight or Obesity Without Diabetes: The STEP 8 Randomized Clinical Trial. JAMA. 2022;327(2):138–150. doi:<a href='https://pubmed.ncbi.nlm.nih.gov/35015037/'>10.1001/jama.2021.23619</a></li>
</ul>
<p>Guest: Jillian Joseph, MSPAS, PA-C<br>
 <br>
Music Credit: Richard Onorato</p>
]]></content:encoded>
                                    
        <enclosure url="https://mcdn.podbean.com/mf/web/3u6est/frankly-speaking-270-weight-loss-with-meds.mp3" length="9672766" type="audio/mpeg"/>
                <itunes:summary><![CDATA[Credits: 0.25 AMA PRA Category 1 Credit™ CME/CE Information and Claim Credit: https://www.pri-med.com/online-education/podcast/frankly-speaking-cme-270
Overview: You know GLP-1 RAs are an important class of agents for weight loss, but do you know which drug within this class is right for your patient? This brief podcast walks you through the recent evidence from the STEP 8 randomized clinical trial, comparing the efficacy and adverse reaction profiles for 2 GLP-1 RAs: semaglutide (Wegovy) and liraglutide (Saxenda). This is a must-listen for anyone looking to optimally individualize care for patients with obesity.
Episode resource links:
Rubino DM, Greenway FL, Khalid U, et al. Effect of Weekly Subcutaneous Semaglutide vs Daily Liraglutide on Body Weight in Adults With Overweight or Obesity Without Diabetes: The STEP 8 Randomized Clinical Trial. JAMA. 2022;327(2):138–150. doi:10.1001/jama.2021.23619
Guest: Jillian Joseph, MSPAS, PA-C Music Credit: Richard Onorato]]></itunes:summary>
        <itunes:author>Pri-Med</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>602</itunes:duration>
                        <itunes:episodeType>full</itunes:episodeType>
            </item>
    <item>
        <title>Screen Patients Early and Routinely for Prescription Drug Misuse - Frankly Speaking Ep 269</title>
        <itunes:title>Screen Patients Early and Routinely for Prescription Drug Misuse - Frankly Speaking Ep 269</itunes:title>
        <link>https://primedfranklyspeaking.podbean.com/e/screen-patients-early-and-routinely-for-prescription-drug-misuse-frankly-speaking-ep-269/</link>
                    <comments>https://primedfranklyspeaking.podbean.com/e/screen-patients-early-and-routinely-for-prescription-drug-misuse-frankly-speaking-ep-269/#comments</comments>        <pubDate>Mon, 28 Mar 2022 00:30:00 +0000</pubDate>
        <guid isPermaLink="false">primedfranklyspeaking.podbean.com/e9eb4226-5ec3-3131-9234-112451876058</guid>
                                    <description><![CDATA[<p>Credits: 0.25 AMA PRA Category 1 Credit™
 
CME/CE Information and Claim Credit: <a href='https://www.pri-med.com/online-education/podcast/frankly-speaking-cme-269'>https://www.pri-med.com/online-education/podcast/frankly-speaking-cme-269</a></p>
<p>Overview: Join us as we discuss the trajectories of prescription drug misuse from adolescence through adulthood. This session explores the findings from a longitudinal cohort study demonstrating the need for screening patients from adolescence through adulthood for substance use disorder. You’ll walk away with the tools and resources you need to accurately screen patients and determine next best steps for each individual.</p>
<p>Episode resource links:</p>
<ul><li>McCabe, S. E., Schulenberg, J. E., Schepis, T. S., Evans-Polce, R. J., Wilens, T. E., McCabe, V. V., & Veliz, P. T. (2022). Trajectories of Prescription Drug Misuse Among US Adults From Ages 18 to 50 Years. JAMA network open, 5(1), e2141995. <a href='https://doi.org/10.1001/jamanetworkopen.2021.41995%20PMID:%2034982159'>https://doi.org/10.1001/jamanetworkopen.2021.41995 PMID: 34982159</a></li>
<li>National Institute on Drug Abuse (NIDA) Drug Screening Tool for use in general medical settings:  <a href='https://archives.drugabuse.gov/nmassist/'>https://archives.drugabuse.gov/nmassist/</a></li>
<li>National Institute on Drug Abuse (NIDA) Evidence Based Screening and Assessment Tools and Resources (Includes adults and adolescents)   <a href='https://www.drugabuse.gov/nidamed-medical-health-professionals/screening-tools-resources/chart-screening-tools'>https://www.drugabuse.gov/nidamed-medical-health-professionals/screening-tools-resources/chart-screening-tools</a></li>
</ul>
<p>Guest: Jill M. Terrien PhD, ANP-BC
 
Music Credit: Richard Onorato</p>
]]></description>
                                                            <content:encoded><![CDATA[<p>Credits: 0.25 AMA PRA Category 1 Credit™<br>
 <br>
CME/CE Information and Claim Credit: <a href='https://www.pri-med.com/online-education/podcast/frankly-speaking-cme-269'>https://www.pri-med.com/online-education/podcast/frankly-speaking-cme-269</a></p>
<p>Overview: Join us as we discuss the trajectories of prescription drug misuse from adolescence through adulthood. This session explores the findings from a longitudinal cohort study demonstrating the need for screening patients from adolescence through adulthood for substance use disorder. You’ll walk away with the tools and resources you need to accurately screen patients and determine next best steps for each individual.</p>
<p>Episode resource links:</p>
<ul><li>McCabe, S. E., Schulenberg, J. E., Schepis, T. S., Evans-Polce, R. J., Wilens, T. E., McCabe, V. V., & Veliz, P. T. (2022). Trajectories of Prescription Drug Misuse Among US Adults From Ages 18 to 50 Years. JAMA network open, 5(1), e2141995. <a href='https://doi.org/10.1001/jamanetworkopen.2021.41995%20PMID:%2034982159'>https://doi.org/10.1001/jamanetworkopen.2021.41995 PMID: 34982159</a></li>
<li>National Institute on Drug Abuse (NIDA) Drug Screening Tool for use in general medical settings:  <a href='https://archives.drugabuse.gov/nmassist/'>https://archives.drugabuse.gov/nmassist/</a></li>
<li>National Institute on Drug Abuse (NIDA) Evidence Based Screening and Assessment Tools and Resources (Includes adults and adolescents)   <a href='https://www.drugabuse.gov/nidamed-medical-health-professionals/screening-tools-resources/chart-screening-tools'>https://www.drugabuse.gov/nidamed-medical-health-professionals/screening-tools-resources/chart-screening-tools</a></li>
</ul>
<p>Guest: Jill M. Terrien PhD, ANP-BC<br>
 <br>
Music Credit: Richard Onorato</p>
]]></content:encoded>
                                    
        <enclosure url="https://mcdn.podbean.com/mf/web/nveb5g/frankly-speaking-269-substance-abuse.mp3" length="9662831" type="audio/mpeg"/>
                <itunes:summary><![CDATA[Credits: 0.25 AMA PRA Category 1 Credit™ CME/CE Information and Claim Credit: https://www.pri-med.com/online-education/podcast/frankly-speaking-cme-269
Overview: Join us as we discuss the trajectories of prescription drug misuse from adolescence through adulthood. This session explores the findings from a longitudinal cohort study demonstrating the need for screening patients from adolescence through adulthood for substance use disorder. You’ll walk away with the tools and resources you need to accurately screen patients and determine next best steps for each individual.
Episode resource links:
McCabe, S. E., Schulenberg, J. E., Schepis, T. S., Evans-Polce, R. J., Wilens, T. E., McCabe, V. V., & Veliz, P. T. (2022). Trajectories of Prescription Drug Misuse Among US Adults From Ages 18 to 50 Years. JAMA network open, 5(1), e2141995. https://doi.org/10.1001/jamanetworkopen.2021.41995 PMID: 34982159
National Institute on Drug Abuse (NIDA) Drug Screening Tool for use in general medical settings:  https://archives.drugabuse.gov/nmassist/
National Institute on Drug Abuse (NIDA) Evidence Based Screening and Assessment Tools and Resources (Includes adults and adolescents)   https://www.drugabuse.gov/nidamed-medical-health-professionals/screening-tools-resources/chart-screening-tools
Guest: Jill M. Terrien PhD, ANP-BC Music Credit: Richard Onorato]]></itunes:summary>
        <itunes:author>Pri-Med</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>602</itunes:duration>
                        <itunes:episodeType>full</itunes:episodeType>
            </item>
    <item>
        <title>PrEP: Are We Educating Patients Effectively? - Frankly Speaking Ep 268</title>
        <itunes:title>PrEP: Are We Educating Patients Effectively? - Frankly Speaking Ep 268</itunes:title>
        <link>https://primedfranklyspeaking.podbean.com/e/prep-are-we-educating-patients-effectively-frankly-speaking-ep-268/</link>
                    <comments>https://primedfranklyspeaking.podbean.com/e/prep-are-we-educating-patients-effectively-frankly-speaking-ep-268/#comments</comments>        <pubDate>Mon, 21 Mar 2022 00:30:00 +0000</pubDate>
        <guid isPermaLink="false">primedfranklyspeaking.podbean.com/fb55383c-562d-3e12-ac5b-1ea3b6b5b5c4</guid>
                                    <description><![CDATA[<p>Credits: 0.25 AMA PRA Category 1 Credit™
 
CME/CE Information and Claim Credit: <a href='https://www.pri-med.com/online-education/podcast/frankly-speaking-cme-268'>https://www.pri-med.com/online-education/podcast/frankly-speaking-cme-268</a></p>
<p>Overview: This episode will help bring awareness to the importance of educating patients about post-exposure prophylaxis (PrEP) in the primary care setting. This talk will also discuss how to reduce the stigma surrounding this prevention method. Finally, you will hear about the newly FDA approved PrEP treatment option that could potentially improve outcomes for patients. 
 
Episode resource links:</p>
<ul><li>
<p>https://www.healio.com/news/infectious-disease/20211220/fda-approves-first-longacting-injectable-for-hiv-prevention
Philbin, M. M., Parish, C., Kinnard, E. N., Reed, S. E., Kerrigan, D., Alcaide, M. L., ... & Metsch, L. R. (2021). Interest in long-acting injectable pre-exposure prophylaxis (LAI PrEP) among women in the women’s interagency HIV study (WIHS): a qualitative study across six cities in the United States. AIDS and Behavior, 25(3), 667-678.</p>
<p> </p>
</li>
<li>
<p>Kim Y. S. (2021). Long-Acting Injectable Antiretroviral Agents for HIV Treatment and Prevention. Infection & chemotherapy, 53(4),      686–695. https://doi.org/10.3947/ic.2021.0136</p>
<p> </p>
</li>
<li>
<p>CDC Practice guidelines  <a href='https://www.cdc.gov/hiv/pdf/risk/prep/cdc-hiv-prep-guidelines-2021.pdf'>https://www.cdc.gov/hiv/pdf/risk/prep/cdc-hiv-prep-guidelines-2021.pdf</a></p>
</li>
</ul>
<p>Guest: Mariyan L. Montaque, DNP, FNP-BC
 
Music Credit: Richard Onorato</p>
]]></description>
                                                            <content:encoded><![CDATA[<p>Credits: 0.25 AMA PRA Category 1 Credit™<br>
 <br>
CME/CE Information and Claim Credit: <a href='https://www.pri-med.com/online-education/podcast/frankly-speaking-cme-268'>https://www.pri-med.com/online-education/podcast/frankly-speaking-cme-268</a></p>
<p>Overview: This episode will help bring awareness to the importance of educating patients about post-exposure prophylaxis (PrEP) in the primary care setting. This talk will also discuss how to reduce the stigma surrounding this prevention method. Finally, you will hear about the newly FDA approved PrEP treatment option that could potentially improve outcomes for patients. <br>
 <br>
Episode resource links:</p>
<ul><li>
<p>https://www.healio.com/news/infectious-disease/20211220/fda-approves-first-longacting-injectable-for-hiv-prevention<br>
Philbin, M. M., Parish, C., Kinnard, E. N., Reed, S. E., Kerrigan, D., Alcaide, M. L., ... & Metsch, L. R. (2021). Interest in long-acting injectable pre-exposure prophylaxis (LAI PrEP) among women in the women’s interagency HIV study (WIHS): a qualitative study across six cities in the United States. AIDS and Behavior, 25(3), 667-678.</p>
<p> </p>
</li>
<li>
<p>Kim Y. S. (2021). Long-Acting Injectable Antiretroviral Agents for HIV Treatment and Prevention. Infection & chemotherapy, 53(4),      686–695. https://doi.org/10.3947/ic.2021.0136</p>
<p> </p>
</li>
<li>
<p>CDC Practice guidelines  <a href='https://www.cdc.gov/hiv/pdf/risk/prep/cdc-hiv-prep-guidelines-2021.pdf'>https://www.cdc.gov/hiv/pdf/risk/prep/cdc-hiv-prep-guidelines-2021.pdf</a></p>
</li>
</ul>
<p>Guest: Mariyan L. Montaque, DNP, FNP-BC<br>
 <br>
Music Credit: Richard Onorato</p>
]]></content:encoded>
                                    
        <enclosure url="https://mcdn.podbean.com/mf/web/v4ffn7/frankly-speaking-268-PrEP.mp3" length="9744189" type="audio/mpeg"/>
                <itunes:summary><![CDATA[Credits: 0.25 AMA PRA Category 1 Credit™ CME/CE Information and Claim Credit: https://www.pri-med.com/online-education/podcast/frankly-speaking-cme-268
Overview: This episode will help bring awareness to the importance of educating patients about post-exposure prophylaxis (PrEP) in the primary care setting. This talk will also discuss how to reduce the stigma surrounding this prevention method. Finally, you will hear about the newly FDA approved PrEP treatment option that could potentially improve outcomes for patients.  Episode resource links:

https://www.healio.com/news/infectious-disease/20211220/fda-approves-first-longacting-injectable-for-hiv-preventionPhilbin, M. M., Parish, C., Kinnard, E. N., Reed, S. E., Kerrigan, D., Alcaide, M. L., ... & Metsch, L. R. (2021). Interest in long-acting injectable pre-exposure prophylaxis (LAI PrEP) among women in the women’s interagency HIV study (WIHS): a qualitative study across six cities in the United States. AIDS and Behavior, 25(3), 667-678.
 


Kim Y. S. (2021). Long-Acting Injectable Antiretroviral Agents for HIV Treatment and Prevention. Infection & chemotherapy, 53(4),      686–695. https://doi.org/10.3947/ic.2021.0136
 


CDC Practice guidelines  https://www.cdc.gov/hiv/pdf/risk/prep/cdc-hiv-prep-guidelines-2021.pdf

Guest: Mariyan L. Montaque, DNP, FNP-BC Music Credit: Richard Onorato]]></itunes:summary>
        <itunes:author>Pri-Med</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>606</itunes:duration>
                        <itunes:episodeType>full</itunes:episodeType>
            </item>
    <item>
        <title>Bad News for E-Cigarette Users—Possible Link Between E-Cigarettes And ED - Frankly Speaking Ep 267</title>
        <itunes:title>Bad News for E-Cigarette Users—Possible Link Between E-Cigarettes And ED - Frankly Speaking Ep 267</itunes:title>
        <link>https://primedfranklyspeaking.podbean.com/e/bad-news-for-e-cigarette-users%e2%80%94possible-link-between-e-cigarettes-and-ed-frankly-speaking-ep-267/</link>
                    <comments>https://primedfranklyspeaking.podbean.com/e/bad-news-for-e-cigarette-users%e2%80%94possible-link-between-e-cigarettes-and-ed-frankly-speaking-ep-267/#comments</comments>        <pubDate>Mon, 14 Mar 2022 00:30:00 +0000</pubDate>
        <guid isPermaLink="false">primedfranklyspeaking.podbean.com/2b4e29d9-ab2e-3ce3-b5fc-8eb27b34820e</guid>
                                    <description><![CDATA[<p>Credits: 0.25 AMA PRA Category 1 Credit™
 
CME/CE Information and Claim Credit: <a href='https://www.pri-med.com/online-education/podcast/frankly-speaking-cme-267'>https://www.pri-med.com/online-education/podcast/frankly-speaking-cme-267</a></p>
<p>Overview: The clinical literature is filled with new and evolving evidence on the use of e-cigarettes and potential harms. The question of their use as a harm reduction strategy is a hotly debated topic—pitting traditional combustible tobacco with its well-known effect on morbidity and mortality against electronic nicotine delivery systems (ENDS), which although not harmless, are considered less harmful than smoked cigarettes. Recent evidence is emerging on the potential cardiovascular risks posed by newer generations of ENDS with far greater delivery of nicotine. Join us while we discuss the findings from a recent study that examines ENDS use and associated increase rates of erectile dysfunction (ED) and how this information may impact your practice.</p>
<p>
Episode resource links:</p>
<ul><li>El-Shahawy O, Shah T, Obisesan OH, Durr M, Stokes AC, Uddin I, Pinjani R, Benjamin EJ, Mirbolouk M, Osei AD, Loney T, Sherman SE, Blaha MJ. Association of E-Cigarettes With Erectile Dysfunction: The Population Assessment of Tobacco and Health Study. Am J Prev Med. 2022 Jan;62(1):26-38. doi: 10.1016/j.amepre.2021.08.004. Epub 2021 Nov 30. PMID: 34922653.</li>
<li>Caponnetto P. Well-being and harm reduction, the consolidated reality of electronic cigarettes ten years later from this emerging phenomenon: A narrative review. Health Psychol Res. Dec 30 2020;8(3):9463. doi:10.4081/hpr.2020.9463</li>
<li>Hartmann-Boyce J, McRobbie H, Lindson N, et al. Electronic cigarettes for smoking cessation. Cochrane Database Syst Rev. Apr 29 2021;4:CD010216. doi:10.1002/14651858.CD010216.pub5</li>
</ul>
<p>Guest: Susan Feeney, DNP, FNP-BC, NP-
 
Music Credit: Richard Onorato</p>
]]></description>
                                                            <content:encoded><![CDATA[<p>Credits: 0.25 AMA PRA Category 1 Credit™<br>
 <br>
CME/CE Information and Claim Credit: <a href='https://www.pri-med.com/online-education/podcast/frankly-speaking-cme-267'>https://www.pri-med.com/online-education/podcast/frankly-speaking-cme-267</a></p>
<p>Overview: The clinical literature is filled with new and evolving evidence on the use of e-cigarettes and potential harms. The question of their use as a harm reduction strategy is a hotly debated topic—pitting traditional combustible tobacco with its well-known effect on morbidity and mortality against electronic nicotine delivery systems (ENDS), which although not harmless, are considered less harmful than smoked cigarettes. Recent evidence is emerging on the potential cardiovascular risks posed by newer generations of ENDS with far greater delivery of nicotine. Join us while we discuss the findings from a recent study that examines ENDS use and associated increase rates of erectile dysfunction (ED) and how this information may impact your practice.</p>
<p><br>
Episode resource links:</p>
<ul><li>El-Shahawy O, Shah T, Obisesan OH, Durr M, Stokes AC, Uddin I, Pinjani R, Benjamin EJ, Mirbolouk M, Osei AD, Loney T, Sherman SE, Blaha MJ. Association of E-Cigarettes With Erectile Dysfunction: The Population Assessment of Tobacco and Health Study. Am J Prev Med. 2022 Jan;62(1):26-38. doi: 10.1016/j.amepre.2021.08.004. Epub 2021 Nov 30. PMID: 34922653.</li>
<li>Caponnetto P. Well-being and harm reduction, the consolidated reality of electronic cigarettes ten years later from this emerging phenomenon: A narrative review. Health Psychol Res. Dec 30 2020;8(3):9463. doi:10.4081/hpr.2020.9463</li>
<li>Hartmann-Boyce J, McRobbie H, Lindson N, et al. Electronic cigarettes for smoking cessation. Cochrane Database Syst Rev. Apr 29 2021;4:CD010216. doi:10.1002/14651858.CD010216.pub5</li>
</ul>
<p>Guest: Susan Feeney, DNP, FNP-BC, NP-<br>
 <br>
Music Credit: Richard Onorato</p>
]]></content:encoded>
                                    
        <enclosure url="https://mcdn.podbean.com/mf/web/b3g4uj/frankly-speaking-267-e-cigarettes-and-ED.mp3" length="12358474" type="audio/mpeg"/>
                <itunes:summary><![CDATA[Credits: 0.25 AMA PRA Category 1 Credit™ CME/CE Information and Claim Credit: https://www.pri-med.com/online-education/podcast/frankly-speaking-cme-267
Overview: The clinical literature is filled with new and evolving evidence on the use of e-cigarettes and potential harms. The question of their use as a harm reduction strategy is a hotly debated topic—pitting traditional combustible tobacco with its well-known effect on morbidity and mortality against electronic nicotine delivery systems (ENDS), which although not harmless, are considered less harmful than smoked cigarettes. Recent evidence is emerging on the potential cardiovascular risks posed by newer generations of ENDS with far greater delivery of nicotine. Join us while we discuss the findings from a recent study that examines ENDS use and associated increase rates of erectile dysfunction (ED) and how this information may impact your practice.
Episode resource links:
El-Shahawy O, Shah T, Obisesan OH, Durr M, Stokes AC, Uddin I, Pinjani R, Benjamin EJ, Mirbolouk M, Osei AD, Loney T, Sherman SE, Blaha MJ. Association of E-Cigarettes With Erectile Dysfunction: The Population Assessment of Tobacco and Health Study. Am J Prev Med. 2022 Jan;62(1):26-38. doi: 10.1016/j.amepre.2021.08.004. Epub 2021 Nov 30. PMID: 34922653.
Caponnetto P. Well-being and harm reduction, the consolidated reality of electronic cigarettes ten years later from this emerging phenomenon: A narrative review. Health Psychol Res. Dec 30 2020;8(3):9463. doi:10.4081/hpr.2020.9463
Hartmann-Boyce J, McRobbie H, Lindson N, et al. Electronic cigarettes for smoking cessation. Cochrane Database Syst Rev. Apr 29 2021;4:CD010216. doi:10.1002/14651858.CD010216.pub5
Guest: Susan Feeney, DNP, FNP-BC, NP- Music Credit: Richard Onorato]]></itunes:summary>
        <itunes:author>Pri-Med</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>770</itunes:duration>
                        <itunes:episodeType>full</itunes:episodeType>
            </item>
    <item>
        <title>Fever Free: Acetaminophen or Ibuprofen? - Frankly Speaking Ep 266</title>
        <itunes:title>Fever Free: Acetaminophen or Ibuprofen? - Frankly Speaking Ep 266</itunes:title>
        <link>https://primedfranklyspeaking.podbean.com/e/fever-free-acetaminophen-or-ibuprofen-frankly-speaking-ep-266/</link>
                    <comments>https://primedfranklyspeaking.podbean.com/e/fever-free-acetaminophen-or-ibuprofen-frankly-speaking-ep-266/#comments</comments>        <pubDate>Mon, 07 Mar 2022 00:30:00 +0000</pubDate>
        <guid isPermaLink="false">primedfranklyspeaking.podbean.com/45203160-b9db-3814-b791-dda48290b09e</guid>
                                    <description><![CDATA[<p>Credits: 0.25 AMA PRA Category 1 Credit™
 
CME/CE Information and Claim Credit: <a href='https://www.pri-med.com/online-education/podcast/frankly-speaking-cme-266'>https://www.pri-med.com/online-education/podcast/frankly-speaking-cme-266</a></p>
<p>Overview: ‘Tis the season for pediatric fevers! Join us to review a recent meta-analysis looking at 18 studies with patients younger than 2 years old who received acetaminophen or ibuprofen for fever or pain to determine if one medication should be recommended first, before the other. After this session, you’ll be able to confidently advise parents of young children on how best to manage fever and/or pain at home with over-the-counter medications.
 
Episode resource links:</p>
<ul><li>Long B, Gottlieb M. Ibuprofen vs. Acetaminophen for Fever or Pain in Children Younger Than Two Years. Am Fam Physician. 2022 Jan ;105(1):19.</li>
<li>Wong T, Stang AS, Ganshorn H, Hartling L, Maconochie IK, Thomsen AM, Johnson DW. Combined and alternating paracetamol and ibuprofen therapy for febrile children. Evid Based Child Health. 2014 Sep;9(3):675-729. doi: 10.1002/ebch.1978. PMID: 25236309.</li>
<li>Sullivan JE, Farrar HC. Fever and Antipyretic Use in Children. Pediatrics (2011) 127 (3): 580-587. (Reaffirmed 2016)</li>
</ul>
<p>Guest: Jillian Joseph, MSPAS, PA-C
 
Music Credit: Richard Onorato</p>
]]></description>
                                                            <content:encoded><![CDATA[<p>Credits: 0.25 AMA PRA Category 1 Credit™<br>
 <br>
CME/CE Information and Claim Credit: <a href='https://www.pri-med.com/online-education/podcast/frankly-speaking-cme-266'>https://www.pri-med.com/online-education/podcast/frankly-speaking-cme-266</a></p>
<p>Overview: ‘Tis the season for pediatric fevers! Join us to review a recent meta-analysis looking at 18 studies with patients younger than 2 years old who received acetaminophen or ibuprofen for fever or pain to determine if one medication should be recommended first, before the other. After this session, you’ll be able to confidently advise parents of young children on how best to manage fever and/or pain at home with over-the-counter medications.<br>
 <br>
Episode resource links:</p>
<ul><li>Long B, Gottlieb M. Ibuprofen vs. Acetaminophen for Fever or Pain in Children Younger Than Two Years. Am Fam Physician. 2022 Jan ;105(1):19.</li>
<li>Wong T, Stang AS, Ganshorn H, Hartling L, Maconochie IK, Thomsen AM, Johnson DW. Combined and alternating paracetamol and ibuprofen therapy for febrile children. Evid Based Child Health. 2014 Sep;9(3):675-729. doi: 10.1002/ebch.1978. PMID: 25236309.</li>
<li>Sullivan JE, Farrar HC. Fever and Antipyretic Use in Children. Pediatrics (2011) 127 (3): 580-587. (Reaffirmed 2016)</li>
</ul>
<p>Guest: Jillian Joseph, MSPAS, PA-C<br>
 <br>
Music Credit: Richard Onorato</p>
]]></content:encoded>
                                    
        <enclosure url="https://mcdn.podbean.com/mf/web/jkwsge/frankly-speaking-266-acetaminophen-ibuprofen.mp3" length="8424786" type="audio/mpeg"/>
                <itunes:summary><![CDATA[Credits: 0.25 AMA PRA Category 1 Credit™ CME/CE Information and Claim Credit: https://www.pri-med.com/online-education/podcast/frankly-speaking-cme-266
Overview: ‘Tis the season for pediatric fevers! Join us to review a recent meta-analysis looking at 18 studies with patients younger than 2 years old who received acetaminophen or ibuprofen for fever or pain to determine if one medication should be recommended first, before the other. After this session, you’ll be able to confidently advise parents of young children on how best to manage fever and/or pain at home with over-the-counter medications. Episode resource links:
Long B, Gottlieb M. Ibuprofen vs. Acetaminophen for Fever or Pain in Children Younger Than Two Years. Am Fam Physician. 2022 Jan ;105(1):19.
Wong T, Stang AS, Ganshorn H, Hartling L, Maconochie IK, Thomsen AM, Johnson DW. Combined and alternating paracetamol and ibuprofen therapy for febrile children. Evid Based Child Health. 2014 Sep;9(3):675-729. doi: 10.1002/ebch.1978. PMID: 25236309.
Sullivan JE, Farrar HC. Fever and Antipyretic Use in Children. Pediatrics (2011) 127 (3): 580-587. (Reaffirmed 2016)
Guest: Jillian Joseph, MSPAS, PA-C Music Credit: Richard Onorato]]></itunes:summary>
        <itunes:author>Pri-Med</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>524</itunes:duration>
                        <itunes:episodeType>full</itunes:episodeType>
            </item>
    <item>
        <title>“Could It Be My Thyroid?” The Quandary of Subclinical Hypothyroidism - Frankly Speaking Ep 241</title>
        <itunes:title>“Could It Be My Thyroid?” The Quandary of Subclinical Hypothyroidism - Frankly Speaking Ep 241</itunes:title>
        <link>https://primedfranklyspeaking.podbean.com/e/could-it-be-my-thyroid-the-quandary-of-subclinical-hypothyroidism-frankly-speaking-ep-241/</link>
                    <comments>https://primedfranklyspeaking.podbean.com/e/could-it-be-my-thyroid-the-quandary-of-subclinical-hypothyroidism-frankly-speaking-ep-241/#comments</comments>        <pubDate>Thu, 03 Mar 2022 17:12:26 +0000</pubDate>
        <guid isPermaLink="false">primedfranklyspeaking.podbean.com/e9091ec7-e54f-386c-ab52-664bf2e00aec</guid>
                                    <description><![CDATA[<p style="margin:0in;font-family:Calibri;font-size:11pt;">Credits: 0.25 AMA PRA Category 1 Credit™</p>
<p style="margin:0in;font-family:Calibri;font-size:11pt;"> </p>
<p style="margin:0in;font-family:Calibri;font-size:11pt;">CME/CE Information and Claim Credit: <a href='https://www.pri-med.com/online-education/podcast/frankly-speaking-cme-241'>https://www.pri-med.com/online-education/podcast/frankly-speaking-cme-241</a></p>
<p style="margin:0in;font-family:Calibri;font-size:11pt;"> </p>
<p style="margin:0in;font-family:Calibri;font-size:11pt;">Overview: Seven percent of the US population has an active levothyroxine prescription, which is significantly greater than the number of people diagnosed with overt hypothyroidism. Many of these prescriptions appear to be for the treatment of subclinical hypothyroidism and other conditions in euthyroid individuals. Join us to uncover the latest findings on the use of levothyroxine and what the evidence tells us about appropriate use and misuse of this drug.</p>
<p style="margin:0in;font-family:Calibri;font-size:11pt;"> </p>
<p style="margin:0in;font-family:Calibri;font-size:11pt;">Episode resource links:</p>
<ul><li style="font-family:Calibri;font-size:11pt;">Brito, J., Ross, J., El Kawkgi, O., Maraka, S., Deng, Y., Shah, N., Lipska, K. & (9000). Levothyroxine Use in the United States, 2008-2018. JAMA Internal Medicine, Publish Ahead of Print, doi: 10.1001/jamainternmed.2021.2686.</li>
<li style="font-family:Calibri;font-size:11pt;">Johansen, M., Marcinek, J., Yun, J. & (2020). Thyroid Hormone Use in the United States, 1997–2016. Journal of the American Board of Family Medicine, 33 (2), 284-288. doi: 10.3122/jabfm.2020.02.190159.</li>
<li style="font-family:Calibri;font-size:11pt;">Jeffrey R. Garber, Rhoda H. Cobin,Hossein Gharib,James V. Hennessey, Irwin Klein, Jeffrey I. Mechanick, Rachel Pessah-Pollack, Peter A. Singer,Kenneth A. Woeber. Clinical Practice Guidelines for Hypothyroidism in Adults: Cosponsored by the American Association of Clinical Endocrinologists and the American Thyroid Association; November–December 2012.</li>
<li style="font-family:Calibri;font-size:11pt;"><a href='https://www.endocrinepractice.org/article/S1530-891X(20)43030-7/fulltext'>https://www.endocrinepractice.org/article/S1530-891X(20)43030-7/fulltext</a>; <a href='https://www.endocrinepractice.org/action/showPdf?pii=S1530-891X%2820%2943030-7'>https://www.endocrinepractice.org/action/showPdf?pii=S1530-891X%2820%2943030-7</a></li>
</ul>
<p style="margin:0in;font-family:Calibri;font-size:11pt;"> </p>
<p style="margin:0in;font-family:Calibri;font-size:11pt;">Guest: Susan Feeney, DNP, FNP-BC, NP-C</p>
<p style="margin:0in;font-family:Calibri;font-size:11pt;"> </p>
<p style="margin:0in;font-family:Calibri;font-size:11pt;">Music Credit: Richard Onorato</p>
]]></description>
                                                            <content:encoded><![CDATA[<p style="margin:0in;font-family:Calibri;font-size:11pt;">Credits: 0.25 AMA PRA Category 1 Credit™</p>
<p style="margin:0in;font-family:Calibri;font-size:11pt;"> </p>
<p style="margin:0in;font-family:Calibri;font-size:11pt;">CME/CE Information and Claim Credit: <a href='https://www.pri-med.com/online-education/podcast/frankly-speaking-cme-241'>https://www.pri-med.com/online-education/podcast/frankly-speaking-cme-241</a></p>
<p style="margin:0in;font-family:Calibri;font-size:11pt;"> </p>
<p style="margin:0in;font-family:Calibri;font-size:11pt;">Overview: Seven percent of the US population has an active levothyroxine prescription, which is significantly greater than the number of people diagnosed with overt hypothyroidism. Many of these prescriptions appear to be for the treatment of subclinical hypothyroidism and other conditions in euthyroid individuals. Join us to uncover the latest findings on the use of levothyroxine and what the evidence tells us about appropriate use and misuse of this drug.</p>
<p style="margin:0in;font-family:Calibri;font-size:11pt;"> </p>
<p style="margin:0in;font-family:Calibri;font-size:11pt;">Episode resource links:</p>
<ul><li style="font-family:Calibri;font-size:11pt;">Brito, J., Ross, J., El Kawkgi, O., Maraka, S., Deng, Y., Shah, N., Lipska, K. & (9000). Levothyroxine Use in the United States, 2008-2018. JAMA Internal Medicine, Publish Ahead of Print, doi: 10.1001/jamainternmed.2021.2686.</li>
<li style="font-family:Calibri;font-size:11pt;">Johansen, M., Marcinek, J., Yun, J. & (2020). Thyroid Hormone Use in the United States, 1997–2016. Journal of the American Board of Family Medicine, 33 (2), 284-288. doi: 10.3122/jabfm.2020.02.190159.</li>
<li style="font-family:Calibri;font-size:11pt;">Jeffrey R. Garber, Rhoda H. Cobin,Hossein Gharib,James V. Hennessey, Irwin Klein, Jeffrey I. Mechanick, Rachel Pessah-Pollack, Peter A. Singer,Kenneth A. Woeber. Clinical Practice Guidelines for Hypothyroidism in Adults: Cosponsored by the American Association of Clinical Endocrinologists and the American Thyroid Association; November–December 2012.</li>
<li style="font-family:Calibri;font-size:11pt;"><a href='https://www.endocrinepractice.org/article/S1530-891X(20)43030-7/fulltext'>https://www.endocrinepractice.org/article/S1530-891X(20)43030-7/fulltext</a>; <a href='https://www.endocrinepractice.org/action/showPdf?pii=S1530-891X%2820%2943030-7'>https://www.endocrinepractice.org/action/showPdf?pii=S1530-891X%2820%2943030-7</a></li>
</ul>
<p style="margin:0in;font-family:Calibri;font-size:11pt;"> </p>
<p style="margin:0in;font-family:Calibri;font-size:11pt;">Guest: Susan Feeney, DNP, FNP-BC, NP-C</p>
<p style="margin:0in;font-family:Calibri;font-size:11pt;"> </p>
<p style="margin:0in;font-family:Calibri;font-size:11pt;">Music Credit: Richard Onorato</p>
]]></content:encoded>
                                    
        <enclosure url="https://mcdn.podbean.com/mf/web/dve2av/frankly-speaking-241-levo-hypothyroid.mp3" length="10817783" type="audio/mpeg"/>
                <itunes:summary><![CDATA[Credits: 0.25 AMA PRA Category 1 Credit™
 
CME/CE Information and Claim Credit: https://www.pri-med.com/online-education/podcast/frankly-speaking-cme-241
 
Overview: Seven percent of the US population has an active levothyroxine prescription, which is significantly greater than the number of people diagnosed with overt hypothyroidism. Many of these prescriptions appear to be for the treatment of subclinical hypothyroidism and other conditions in euthyroid individuals. Join us to uncover the latest findings on the use of levothyroxine and what the evidence tells us about appropriate use and misuse of this drug.
 
Episode resource links:
Brito, J., Ross, J., El Kawkgi, O., Maraka, S., Deng, Y., Shah, N., Lipska, K. & (9000). Levothyroxine Use in the United States, 2008-2018. JAMA Internal Medicine, Publish Ahead of Print, doi: 10.1001/jamainternmed.2021.2686.
Johansen, M., Marcinek, J., Yun, J. & (2020). Thyroid Hormone Use in the United States, 1997–2016. Journal of the American Board of Family Medicine, 33 (2), 284-288. doi: 10.3122/jabfm.2020.02.190159.
Jeffrey R. Garber, Rhoda H. Cobin,Hossein Gharib,James V. Hennessey, Irwin Klein, Jeffrey I. Mechanick, Rachel Pessah-Pollack, Peter A. Singer,Kenneth A. Woeber. Clinical Practice Guidelines for Hypothyroidism in Adults: Cosponsored by the American Association of Clinical Endocrinologists and the American Thyroid Association; November–December 2012.
https://www.endocrinepractice.org/article/S1530-891X(20)43030-7/fulltext; https://www.endocrinepractice.org/action/showPdf?pii=S1530-891X%2820%2943030-7
 
Guest: Susan Feeney, DNP, FNP-BC, NP-C
 
Music Credit: Richard Onorato]]></itunes:summary>
        <itunes:author>Pri-Med</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>672</itunes:duration>
                        <itunes:episodeType>full</itunes:episodeType>
            </item>
    <item>
        <title>Fluvoxamine as a Treatment for COVID-19 - Frankly Speaking Ep 265</title>
        <itunes:title>Fluvoxamine as a Treatment for COVID-19 - Frankly Speaking Ep 265</itunes:title>
        <link>https://primedfranklyspeaking.podbean.com/e/fluvoxamine-as-a-treatment-for-covid-19-frankly-speaking-ep-265/</link>
                    <comments>https://primedfranklyspeaking.podbean.com/e/fluvoxamine-as-a-treatment-for-covid-19-frankly-speaking-ep-265/#comments</comments>        <pubDate>Mon, 28 Feb 2022 00:30:00 +0000</pubDate>
        <guid isPermaLink="false">primedfranklyspeaking.podbean.com/299f8a81-d5d2-3d93-bfd6-8dcf4101d495</guid>
                                    <description><![CDATA[<p>Credits: 0.25 AMA PRA Category 1 Credit™
 
CME/CE Information and Claim Credit: <a href='https://www.pri-med.com/online-education/podcast/frankly-speaking-cme-265'>https://www.pri-med.com/online-education/podcast/frankly-speaking-cme-265</a></p>
<p>Overview: Most cases of COVID-19 will resolve without interventions, but some patients are at high risk for complications. Several treatment options for high-risk patients are now available to help prevent the need for hospitalization. Join us to review a recent large, randomized trial evaluating fluvoxamine as a treatment for high-risk patients who were diagnosed with COVID-19.
 
Episode resource links:</p>
<ul><li>Reis G, et al. TOGETHER investigators. Effect of early treatment with fluvoxamine on risk of emergency care and hospitalisation among patients with COVID-19: the TOGETHER randomised, platform clinical trial. Lancet Glob Health. 2022 Jan;10(1):e42-e51</li>
<li>Berwanger O. Fluvoxamine for outpatients with COVID-19: where do we stand? Lancet Glob Health. 2022 Jan;10(1):e2-e3. doi: 10.1016/S2214-109X(21)00501-5</li>
<li><a href='https://activ6study.org/'>https://activ6study.org/</a></li>
</ul>
<p>Guest: Alan M. Ehrlich, MD, FAAFP
 
Music Credit: Richard Onorato</p>
]]></description>
                                                            <content:encoded><![CDATA[<p>Credits: 0.25 AMA PRA Category 1 Credit™<br>
 <br>
CME/CE Information and Claim Credit: <a href='https://www.pri-med.com/online-education/podcast/frankly-speaking-cme-265'>https://www.pri-med.com/online-education/podcast/frankly-speaking-cme-265</a></p>
<p>Overview: Most cases of COVID-19 will resolve without interventions, but some patients are at high risk for complications. Several treatment options for high-risk patients are now available to help prevent the need for hospitalization. Join us to review a recent large, randomized trial evaluating fluvoxamine as a treatment for high-risk patients who were diagnosed with COVID-19.<br>
 <br>
Episode resource links:</p>
<ul><li>Reis G, et al. TOGETHER investigators. Effect of early treatment with fluvoxamine on risk of emergency care and hospitalisation among patients with COVID-19: the TOGETHER randomised, platform clinical trial. Lancet Glob Health. 2022 Jan;10(1):e42-e51</li>
<li>Berwanger O. Fluvoxamine for outpatients with COVID-19: where do we stand? Lancet Glob Health. 2022 Jan;10(1):e2-e3. doi: 10.1016/S2214-109X(21)00501-5</li>
<li><a href='https://activ6study.org/'>https://activ6study.org/</a></li>
</ul>
<p>Guest: Alan M. Ehrlich, MD, FAAFP<br>
 <br>
Music Credit: Richard Onorato</p>
]]></content:encoded>
                                    
        <enclosure url="https://mcdn.podbean.com/mf/web/grfi7e/frankly-speaking-265-fluvoxamine-for-covid.mp3" length="11985206" type="audio/mpeg"/>
                <itunes:summary><![CDATA[Credits: 0.25 AMA PRA Category 1 Credit™ CME/CE Information and Claim Credit: https://www.pri-med.com/online-education/podcast/frankly-speaking-cme-265
Overview: Most cases of COVID-19 will resolve without interventions, but some patients are at high risk for complications. Several treatment options for high-risk patients are now available to help prevent the need for hospitalization. Join us to review a recent large, randomized trial evaluating fluvoxamine as a treatment for high-risk patients who were diagnosed with COVID-19. Episode resource links:
Reis G, et al. TOGETHER investigators. Effect of early treatment with fluvoxamine on risk of emergency care and hospitalisation among patients with COVID-19: the TOGETHER randomised, platform clinical trial. Lancet Glob Health. 2022 Jan;10(1):e42-e51
Berwanger O. Fluvoxamine for outpatients with COVID-19: where do we stand? Lancet Glob Health. 2022 Jan;10(1):e2-e3. doi: 10.1016/S2214-109X(21)00501-5
https://activ6study.org/
Guest: Alan M. Ehrlich, MD, FAAFP Music Credit: Richard Onorato]]></itunes:summary>
        <itunes:author>Pri-Med</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>747</itunes:duration>
                        <itunes:episodeType>full</itunes:episodeType>
            </item>
    <item>
        <title>COVID-19 and Children - Frankly Speaking Ep 264</title>
        <itunes:title>COVID-19 and Children - Frankly Speaking Ep 264</itunes:title>
        <link>https://primedfranklyspeaking.podbean.com/e/covid-19-and-children-frankly-speaking-ep-264/</link>
                    <comments>https://primedfranklyspeaking.podbean.com/e/covid-19-and-children-frankly-speaking-ep-264/#comments</comments>        <pubDate>Tue, 22 Feb 2022 19:40:31 +0000</pubDate>
        <guid isPermaLink="false">primedfranklyspeaking.podbean.com/d9c807a2-c6ea-35a8-80b6-556e83b23da8</guid>
                                    <description><![CDATA[<p>Credits: 0.25 AMA PRA Category 1 Credit™
 
CME/CE Information and Claim Credit: <a href='https://www.pri-med.com/online-education/podcast/frankly-speaking-cme-264'>https://www.pri-med.com/online-education/podcast/frankly-speaking-cme-264</a></p>
<p>Overview: Get answers to your questions on COVID-19 infection in children. Listen to this podcast to review outcomes and potential risk factors associated with acute COVID-19 infection in this population. Finally, learn the status of immunizations for children younger than 5 years of age.
 
Episode resource links:</p>
<ul><li>JAMA Netw Open. 2022;5(1):e2142322. doi:10.1001/jamanetworkopen.2021.42322</li>
</ul>
<p>Guest: Jillian Joseph, MSPAS, PA-C
 
Music Credit: Richard Onorato</p>
]]></description>
                                                            <content:encoded><![CDATA[<p>Credits: 0.25 AMA PRA Category 1 Credit™<br>
 <br>
CME/CE Information and Claim Credit: <a href='https://www.pri-med.com/online-education/podcast/frankly-speaking-cme-264'>https://www.pri-med.com/online-education/podcast/frankly-speaking-cme-264</a></p>
<p>Overview: Get answers to your questions on COVID-19 infection in children. Listen to this podcast to review outcomes and potential risk factors associated with acute COVID-19 infection in this population. Finally, learn the status of immunizations for children younger than 5 years of age.<br>
 <br>
Episode resource links:</p>
<ul><li>JAMA Netw Open. 2022;5(1):e2142322. doi:10.1001/jamanetworkopen.2021.42322</li>
</ul>
<p>Guest: Jillian Joseph, MSPAS, PA-C<br>
 <br>
Music Credit: Richard Onorato</p>
]]></content:encoded>
                                    
        <enclosure url="https://mcdn.podbean.com/mf/web/gjguy2/frankly-speaking-264-young-children-and-covid.mp3" length="7742449" type="audio/mpeg"/>
                <itunes:summary><![CDATA[Credits: 0.25 AMA PRA Category 1 Credit™ CME/CE Information and Claim Credit: https://www.pri-med.com/online-education/podcast/frankly-speaking-cme-264
Overview: Get answers to your questions on COVID-19 infection in children. Listen to this podcast to review outcomes and potential risk factors associated with acute COVID-19 infection in this population. Finally, learn the status of immunizations for children younger than 5 years of age. Episode resource links:
JAMA Netw Open. 2022;5(1):e2142322. doi:10.1001/jamanetworkopen.2021.42322
Guest: Jillian Joseph, MSPAS, PA-C Music Credit: Richard Onorato]]></itunes:summary>
        <itunes:author>Pri-Med</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>482</itunes:duration>
                        <itunes:episodeType>full</itunes:episodeType>
            </item>
    <item>
        <title>Oral Anti−COVID-19 Medications—a Game Changer? - Frankly Speaking Ep 263</title>
        <itunes:title>Oral Anti−COVID-19 Medications—a Game Changer? - Frankly Speaking Ep 263</itunes:title>
        <link>https://primedfranklyspeaking.podbean.com/e/oral-anti%e2%88%92covid-19-medications%e2%80%94a-game-changer-frankly-speaking-ep-263-1645730468/</link>
                    <comments>https://primedfranklyspeaking.podbean.com/e/oral-anti%e2%88%92covid-19-medications%e2%80%94a-game-changer-frankly-speaking-ep-263-1645730468/#comments</comments>        <pubDate>Mon, 14 Feb 2022 05:30:00 +0000</pubDate>
        <guid isPermaLink="false">4ff792fb-3a9a-41de-99b0-d5b0a483bf4c</guid>
                                    <description><![CDATA[<p>Credits: 0.25 AMA PRA Category 1 Credit™</p>
<p> </p>
<p>CME/CE Information and Claim Credit: <a href='https://www.pri-med.com/online-education/podcast/frankly-speaking-cme-263'>https://www.pri-med.com/online-education/podcast/frankly-speaking-cme-263</a></p>
<p> </p>
<p>Overview: The FDA’s recent emergency use authorization (EUA) for oral agents to treat COVID-19 means that primary care providers (PCPs) will be on the frontline of treating patients with COVID-19. Therefore, PCPs must understand who is eligible for such treatments and how to prescribe them. We will discuss the results of the recent FDA EUA for Pfizer’s Paxlovid and Merck’s molnupiravir antiviral agents and give you the information you need to confidently prescribe them.</p>
<p> </p>
<p>Episode resource links:</p>
<ul><li><a href='https://www.fda.gov/media/155054/download'>FACT SHEET FOR HEALTHCARE PROVIDERS: EMERGENCY USE AUTHORIZATION FOR MOLNUPIRAVIR (fda.gov)</a></li>
<li><a href='https://www.fda.gov/media/155050/download'>FACT SHEET FOR HEALTHCARE PROVIDERS: EMERGENCY USE AUTHORIZATION FOR PAXLOVID (fda.gov)</a></li>
</ul>
<p>Guest: Robert A. Baldor MD, FAAFP</p>
<p> </p>
<p>Music Credit: Richard Onorato</p>
]]></description>
                                                            <content:encoded><![CDATA[<p>Credits: 0.25 AMA PRA Category 1 Credit™</p>
<p> </p>
<p>CME/CE Information and Claim Credit: <a href='https://www.pri-med.com/online-education/podcast/frankly-speaking-cme-263'>https://www.pri-med.com/online-education/podcast/frankly-speaking-cme-263</a></p>
<p> </p>
<p>Overview: The FDA’s recent emergency use authorization (EUA) for oral agents to treat COVID-19 means that primary care providers (PCPs) will be on the frontline of treating patients with COVID-19. Therefore, PCPs must understand who is eligible for such treatments and how to prescribe them. We will discuss the results of the recent FDA EUA for Pfizer’s Paxlovid and Merck’s molnupiravir antiviral agents and give you the information you need to confidently prescribe them.</p>
<p> </p>
<p>Episode resource links:</p>
<ul><li><a href='https://www.fda.gov/media/155054/download'>FACT SHEET FOR HEALTHCARE PROVIDERS: EMERGENCY USE AUTHORIZATION FOR MOLNUPIRAVIR (fda.gov)</a></li>
<li><a href='https://www.fda.gov/media/155050/download'>FACT SHEET FOR HEALTHCARE PROVIDERS: EMERGENCY USE AUTHORIZATION FOR PAXLOVID (fda.gov)</a></li>
</ul>
<p>Guest: Robert A. Baldor MD, FAAFP</p>
<p> </p>
<p>Music Credit: Richard Onorato</p>
]]></content:encoded>
                                    
        <enclosure url="https://mcdn.podbean.com/mf/web/mflwp0/secure_primed_frankly-speaking-263-covid_oral_agents.mp3" length="12036728" type="audio/mpeg"/>
                <itunes:summary><![CDATA[Credits: 0.25 AMA PRA Category 1 Credit™
 
CME/CE Information and Claim Credit: https://www.pri-med.com/online-education/podcast/frankly-speaking-cme-263
 
Overview: The FDA’s recent emergency use authorization (EUA) for oral agents to treat COVID-19 means that primary care providers (PCPs) will be on the frontline of treating patients with COVID-19. Therefore, PCPs must understand who is eligible for such treatments and how to prescribe them. We will discuss the results of the recent FDA EUA for Pfizer’s Paxlovid and Merck’s molnupiravir antiviral agents and give you the information you need to confidently prescribe them.
 
Episode resource links:
FACT SHEET FOR HEALTHCARE PROVIDERS: EMERGENCY USE AUTHORIZATION FOR MOLNUPIRAVIR (fda.gov)
FACT SHEET FOR HEALTHCARE PROVIDERS: EMERGENCY USE AUTHORIZATION FOR PAXLOVID (fda.gov)
Guest: Robert A. Baldor MD, FAAFP
 
Music Credit: Richard Onorato]]></itunes:summary>
        <itunes:author>Pri-Med</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>751</itunes:duration>
                        <itunes:episodeType>full</itunes:episodeType>
        <itunes:image href="https://pbcdn1.podbean.com/imglogo/ep-logo/pbblog13721080/8180cf9ae5df3eacec47a6262e0bb169.png" />    </item>
    <item>
        <title>Menopausal Transition: Bothersome Symptoms Sooner Than You Expect! - Frankly Speaking Ep 262</title>
        <itunes:title>Menopausal Transition: Bothersome Symptoms Sooner Than You Expect! - Frankly Speaking Ep 262</itunes:title>
        <link>https://primedfranklyspeaking.podbean.com/e/menopausal-transition-bothersome-symptoms-sooner-than-you-expect-frankly-speaking-ep-262-1645730469/</link>
                    <comments>https://primedfranklyspeaking.podbean.com/e/menopausal-transition-bothersome-symptoms-sooner-than-you-expect-frankly-speaking-ep-262-1645730469/#comments</comments>        <pubDate>Mon, 07 Feb 2022 05:30:00 +0000</pubDate>
        <guid isPermaLink="false">2d8078bd-482f-428a-a218-ef59c6f29b81</guid>
                                    <description><![CDATA[<p>Credits: 0.25 AMA PRA Category 1 Credit™</p>
<p> </p>
<p>CME/CE Information and Claim Credit: <a href='https://www.pri-med.com/online-education/podcast/frankly-speaking-cme-262'>https://www.pri-med.com/online-education/podcast/frankly-speaking-cme-262</a></p>
<p> </p>
<p>Overview: Join us as we discuss menopausal transition and the unique qualities and symptoms that are bothersome to women at an early age.</p>
<p> </p>
<p>Episode resource links:</p>
<ul><li>Coslov, N., Richardson, M. K., & Woods, N. F. (2021). Symptom experience during the late reproductive stage and the menopausal transition: observations from the Women Living Better survey. Menopause (New York, N.Y.), 28(9), 1012–1025. https://doi.org/10.1097/GME.0000000000001805 https://pubmed.ncbi.nlm.nih.gov/34313615/
<p> </p>
</li>
<li>
<p>ACOG Practice Guidelines: Clinical Guidelines on the Management of Menopausal Symptoms: https://www.aafp.org/afp/2014/0901/p338.html</p>
</li>
<li>
<p>Women Living Better Website:  https://womenlivingbetter.org/</p>
</li>
<li>
<p>Maki, P. M., Kornstein, S. G., Joffe, H., Bromberger, J. T., Freeman, E. W., Athappilly, G., Bobo, W. V., Rubin, L. H., Koleva, H. K., Cohen, L. S., Soares, C. N., & Board of Trustees for The North American Menopause Society (NAMS) and the Women and Mood Disorders Task Force of the National Network of Depression Centers (2018). Guidelines for the evaluation and treatment of perimenopausal depression: summary and recommendations. Menopause (New York, N.Y.), 25(10), 1069–1085. https://doi.org/10.1097/GME.0000000000001174 https://pubmed.ncbi.nlm.nih.gov/30179986/</p>
</li>
<li>
<p>Johnson, A., Roberts, L., & Elkins, G. (2019). Complementary and Alternative Medicine for Menopause. Journal of evidence-based integrative medicine, 24, 2515690X19829380. https://doi.org/10.1177/2515690X19829380 https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6419242/</p>
</li>
<li>
<p>Barnard, N; Kahleova, H; Holtz, D; del Aguila, F; Neola, M; Crosby, Lelia M.& Holubkov, R (2021). The Women's Study for the Alleviation of Vasomotor Symptoms (WAVS): a randomized, controlled trial of a plant-based diet and whole soybeans for postmenopausal women, Menopause 28 (10), 1150-1156 doi: 10.1097/GME.0000000000001812</p>
</li>
</ul>
<p>Guest: Jill M. Terrien PhD, ANP-BC </p>
<p> </p>
<p>Music Credit: Richard Onorato</p>
]]></description>
                                                            <content:encoded><![CDATA[<p>Credits: 0.25 AMA PRA Category 1 Credit™</p>
<p> </p>
<p>CME/CE Information and Claim Credit: <a href='https://www.pri-med.com/online-education/podcast/frankly-speaking-cme-262'>https://www.pri-med.com/online-education/podcast/frankly-speaking-cme-262</a></p>
<p> </p>
<p>Overview: Join us as we discuss menopausal transition and the unique qualities and symptoms that are bothersome to women at an early age.</p>
<p> </p>
<p>Episode resource links:</p>
<ul><li>Coslov, N., Richardson, M. K., & Woods, N. F. (2021). Symptom experience during the late reproductive stage and the menopausal transition: observations from the Women Living Better survey. Menopause (New York, N.Y.), 28(9), 1012–1025. https://doi.org/10.1097/GME.0000000000001805 https://pubmed.ncbi.nlm.nih.gov/34313615/
<p> </p>
</li>
<li>
<p>ACOG Practice Guidelines: Clinical Guidelines on the Management of Menopausal Symptoms: https://www.aafp.org/afp/2014/0901/p338.html</p>
</li>
<li>
<p>Women Living Better Website:  https://womenlivingbetter.org/</p>
</li>
<li>
<p>Maki, P. M., Kornstein, S. G., Joffe, H., Bromberger, J. T., Freeman, E. W., Athappilly, G., Bobo, W. V., Rubin, L. H., Koleva, H. K., Cohen, L. S., Soares, C. N., & Board of Trustees for The North American Menopause Society (NAMS) and the Women and Mood Disorders Task Force of the National Network of Depression Centers (2018). Guidelines for the evaluation and treatment of perimenopausal depression: summary and recommendations. Menopause (New York, N.Y.), 25(10), 1069–1085. https://doi.org/10.1097/GME.0000000000001174 https://pubmed.ncbi.nlm.nih.gov/30179986/</p>
</li>
<li>
<p>Johnson, A., Roberts, L., & Elkins, G. (2019). Complementary and Alternative Medicine for Menopause. Journal of evidence-based integrative medicine, 24, 2515690X19829380. https://doi.org/10.1177/2515690X19829380 https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6419242/</p>
</li>
<li>
<p>Barnard, N; Kahleova, H; Holtz, D; del Aguila, F; Neola, M; Crosby, Lelia M.& Holubkov, R (2021). The Women's Study for the Alleviation of Vasomotor Symptoms (WAVS): a randomized, controlled trial of a plant-based diet and whole soybeans for postmenopausal women, Menopause 28 (10), 1150-1156 doi: 10.1097/GME.0000000000001812</p>
</li>
</ul>
<p>Guest: Jill M. Terrien PhD, ANP-BC </p>
<p> </p>
<p>Music Credit: Richard Onorato</p>
]]></content:encoded>
                                    
        <enclosure url="https://mcdn.podbean.com/mf/web/137yzs/secure_primed_frankly-speaking-262-menopausal_transition.mp3" length="11641932" type="audio/mpeg"/>
                <itunes:summary><![CDATA[Credits: 0.25 AMA PRA Category 1 Credit™
 
CME/CE Information and Claim Credit: https://www.pri-med.com/online-education/podcast/frankly-speaking-cme-262
 
Overview: Join us as we discuss menopausal transition and the unique qualities and symptoms that are bothersome to women at an early age.
 
Episode resource links:
Coslov, N., Richardson, M. K., & Woods, N. F. (2021). Symptom experience during the late reproductive stage and the menopausal transition: observations from the Women Living Better survey. Menopause (New York, N.Y.), 28(9), 1012–1025. https://doi.org/10.1097/GME.0000000000001805 https://pubmed.ncbi.nlm.nih.gov/34313615/
 


ACOG Practice Guidelines: Clinical Guidelines on the Management of Menopausal Symptoms: https://www.aafp.org/afp/2014/0901/p338.html


Women Living Better Website:  https://womenlivingbetter.org/


Maki, P. M., Kornstein, S. G., Joffe, H., Bromberger, J. T., Freeman, E. W., Athappilly, G., Bobo, W. V., Rubin, L. H., Koleva, H. K., Cohen, L. S., Soares, C. N., & Board of Trustees for The North American Menopause Society (NAMS) and the Women and Mood Disorders Task Force of the National Network of Depression Centers (2018). Guidelines for the evaluation and treatment of perimenopausal depression: summary and recommendations. Menopause (New York, N.Y.), 25(10), 1069–1085. https://doi.org/10.1097/GME.0000000000001174 https://pubmed.ncbi.nlm.nih.gov/30179986/


Johnson, A., Roberts, L., & Elkins, G. (2019). Complementary and Alternative Medicine for Menopause. Journal of evidence-based integrative medicine, 24, 2515690X19829380. https://doi.org/10.1177/2515690X19829380 https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6419242/


Barnard, N; Kahleova, H; Holtz, D; del Aguila, F; Neola, M; Crosby, Lelia M.& Holubkov, R (2021). The Women's Study for the Alleviation of Vasomotor Symptoms (WAVS): a randomized, controlled trial of a plant-based diet and whole soybeans for postmenopausal women, Menopause 28 (10), 1150-1156 doi: 10.1097/GME.0000000000001812

Guest: Jill M. Terrien PhD, ANP-BC 
 
Music Credit: Richard Onorato]]></itunes:summary>
        <itunes:author>Pri-Med</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>727</itunes:duration>
                        <itunes:episodeType>full</itunes:episodeType>
        <itunes:image href="https://pbcdn1.podbean.com/imglogo/ep-logo/pbblog13721080/008eb5cbb3c2781a299c01334cff9599.png" />    </item>
    <item>
        <title>Getting in the LOOP About Atrial Fibrillation and Stroke - Frankly Speaking Ep 261</title>
        <itunes:title>Getting in the LOOP About Atrial Fibrillation and Stroke - Frankly Speaking Ep 261</itunes:title>
        <link>https://primedfranklyspeaking.podbean.com/e/getting-in-the-loop-about-atrial-fibrillation-and-stroke-frankly-speaking-ep-261-1645730471/</link>
                    <comments>https://primedfranklyspeaking.podbean.com/e/getting-in-the-loop-about-atrial-fibrillation-and-stroke-frankly-speaking-ep-261-1645730471/#comments</comments>        <pubDate>Mon, 31 Jan 2022 05:30:00 +0000</pubDate>
        <guid isPermaLink="false">eb0f4a86-7111-4acc-a29a-d334e7f08548</guid>
                                    <description><![CDATA[<p>Credits: 0.25 AMA PRA Category 1 Credit™</p>
<p> </p>
<p>CME/CE Information and Claim Credit: <a href='https://www.pri-med.com/online-education/podcast/frankly-speaking-cme-261'>https://www.pri-med.com/online-education/podcast/frankly-speaking-cme-261</a></p>
<p> </p>
<p>Overview: Stroke is a major health problem, and the risk of stroke is five-times higher in individuals with atrial fibrillation (AF) than those without. AF can be asymptomatic or subclinical. In 18% of AF patients, the condition is only detected at the time of stroke. It is not known whether individuals whose AF is deterred via screening carry a similar risk to individuals with known AF. A recent randomized trial evaluated a screening program for AF in individuals at high risk of stroke; for individuals identified with AF, anticoagulation was given for stroke prevention.</p>
<p> </p>
<p>Episode resource links:</p>
<ul><li>Svendsen JH, Diederichsen SZ, Højberg S et al. Implantable loop recorder detection of atrial fibrillation to prevent stroke (The LOOP Study): a randomised controlled trial. Lancet. 2021 Oct 23;398(10310):1507-1516</li>
</ul>
<p>Guest: Alan Ehrlich MD, FAAFP</p>
<p> </p>
<p>Music Credit: Richard Onorato</p>
]]></description>
                                                            <content:encoded><![CDATA[<p>Credits: 0.25 AMA PRA Category 1 Credit™</p>
<p> </p>
<p>CME/CE Information and Claim Credit: <a href='https://www.pri-med.com/online-education/podcast/frankly-speaking-cme-261'>https://www.pri-med.com/online-education/podcast/frankly-speaking-cme-261</a></p>
<p> </p>
<p>Overview: Stroke is a major health problem, and the risk of stroke is five-times higher in individuals with atrial fibrillation (AF) than those without. AF can be asymptomatic or subclinical. In 18% of AF patients, the condition is only detected at the time of stroke. It is not known whether individuals whose AF is deterred via screening carry a similar risk to individuals with known AF. A recent randomized trial evaluated a screening program for AF in individuals at high risk of stroke; for individuals identified with AF, anticoagulation was given for stroke prevention.</p>
<p> </p>
<p>Episode resource links:</p>
<ul><li>Svendsen JH, Diederichsen SZ, Højberg S et al. Implantable loop recorder detection of atrial fibrillation to prevent stroke (The LOOP Study): a randomised controlled trial. Lancet. 2021 Oct 23;398(10310):1507-1516</li>
</ul>
<p>Guest: Alan Ehrlich MD, FAAFP</p>
<p> </p>
<p>Music Credit: Richard Onorato</p>
]]></content:encoded>
                                    
        <enclosure url="https://mcdn.podbean.com/mf/web/4ygw05/secure_primed_frankly-speaking-261-afib_and_smartwatch.mp3" length="12050455" type="audio/mpeg"/>
                <itunes:summary><![CDATA[Credits: 0.25 AMA PRA Category 1 Credit™
 
CME/CE Information and Claim Credit: https://www.pri-med.com/online-education/podcast/frankly-speaking-cme-261
 
Overview: Stroke is a major health problem, and the risk of stroke is five-times higher in individuals with atrial fibrillation (AF) than those without. AF can be asymptomatic or subclinical. In 18% of AF patients, the condition is only detected at the time of stroke. It is not known whether individuals whose AF is deterred via screening carry a similar risk to individuals with known AF. A recent randomized trial evaluated a screening program for AF in individuals at high risk of stroke; for individuals identified with AF, anticoagulation was given for stroke prevention.
 
Episode resource links:
Svendsen JH, Diederichsen SZ, Højberg S et al. Implantable loop recorder detection of atrial fibrillation to prevent stroke (The LOOP Study): a randomised controlled trial. Lancet. 2021 Oct 23;398(10310):1507-1516
Guest: Alan Ehrlich MD, FAAFP
 
Music Credit: Richard Onorato]]></itunes:summary>
        <itunes:author>Pri-Med</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>752</itunes:duration>
                        <itunes:episodeType>full</itunes:episodeType>
        <itunes:image href="https://pbcdn1.podbean.com/imglogo/ep-logo/pbblog13721080/2d9c00418a008477b8f0bce394c1b26b.png" />    </item>
    <item>
        <title>Avoiding Aspirin in the Elderly: More Than Increased Bleeding Risk - Frankly Speaking Ep 260</title>
        <itunes:title>Avoiding Aspirin in the Elderly: More Than Increased Bleeding Risk - Frankly Speaking Ep 260</itunes:title>
        <link>https://primedfranklyspeaking.podbean.com/e/avoiding-aspirin-in-the-elderly-more-than-increased-bleeding-risk-frankly-speaking-ep-260-1645730472/</link>
                    <comments>https://primedfranklyspeaking.podbean.com/e/avoiding-aspirin-in-the-elderly-more-than-increased-bleeding-risk-frankly-speaking-ep-260-1645730472/#comments</comments>        <pubDate>Mon, 24 Jan 2022 05:30:00 +0000</pubDate>
        <guid isPermaLink="false">0414ab88-7033-49f5-b928-76cc1bc6c8ba</guid>
                                    <description><![CDATA[<p>Credits: 0.25 AMA PRA Category 1 Credit™</p>
<p> </p>
<p>CME/CE Information and Claim Credit: <a href='https://www.pri-med.com/online-education/podcast/frankly-speaking-cme-260'>https://www.pri-med.com/online-education/podcast/frankly-speaking-cme-260</a></p>
<p> </p>
<p>Overview: We will review the current USPSTF recommendations regarding aspirin use to reduce the risk of CVD and colorectal cancer. Additionally, we will discuss as well as the findings of the ASPREE (ASPirin in reducing events in the elderly) randomized clinical trial.</p>
<p> </p>
<p>Episode resource links:</p>
<ul><li>POEMs: In Older Adults, Aspirin Increases the Risk of Metastatic of Stage 4 Cancers and Cancer Mortality. Barry, Henry C. Am Fam Physician. 2021 Sep; 104(2):online</li>
<li>Effect of Aspirin on Cancer Incidence and Mortality in Older Adults. McNeil, John. JNCI: Journal of the National Cancer Institute Volume: 113 Issue 3 (2021) ISSN: 0027-8874 Online ISSN: 1460-2105</li>
</ul>
<p>Guest: Jillian Joseph, MSPAS, PA-C</p>
<p> </p>
<p>Music Credit: Richard Onorato</p>
]]></description>
                                                            <content:encoded><![CDATA[<p>Credits: 0.25 AMA PRA Category 1 Credit™</p>
<p> </p>
<p>CME/CE Information and Claim Credit: <a href='https://www.pri-med.com/online-education/podcast/frankly-speaking-cme-260'>https://www.pri-med.com/online-education/podcast/frankly-speaking-cme-260</a></p>
<p> </p>
<p>Overview: We will review the current USPSTF recommendations regarding aspirin use to reduce the risk of CVD and colorectal cancer. Additionally, we will discuss as well as the findings of the ASPREE (ASPirin in reducing events in the elderly) randomized clinical trial.</p>
<p> </p>
<p>Episode resource links:</p>
<ul><li>POEMs: In Older Adults, Aspirin Increases the Risk of Metastatic of Stage 4 Cancers and Cancer Mortality. Barry, Henry C. Am Fam Physician. 2021 Sep; 104(2):online</li>
<li>Effect of Aspirin on Cancer Incidence and Mortality in Older Adults. McNeil, John. JNCI: Journal of the National Cancer Institute Volume: 113 Issue 3 (2021) ISSN: 0027-8874 Online ISSN: 1460-2105</li>
</ul>
<p>Guest: Jillian Joseph, MSPAS, PA-C</p>
<p> </p>
<p>Music Credit: Richard Onorato</p>
]]></content:encoded>
                                    
        <enclosure url="https://mcdn.podbean.com/mf/web/0jwtvc/secure_primed_frankly-speaking-260-aspirin_in_elderly.mp3" length="8058421" type="audio/mpeg"/>
                <itunes:summary><![CDATA[Credits: 0.25 AMA PRA Category 1 Credit™
 
CME/CE Information and Claim Credit: https://www.pri-med.com/online-education/podcast/frankly-speaking-cme-260
 
Overview: We will review the current USPSTF recommendations regarding aspirin use to reduce the risk of CVD and colorectal cancer. Additionally, we will discuss as well as the findings of the ASPREE (ASPirin in reducing events in the elderly) randomized clinical trial.
 
Episode resource links:
POEMs: In Older Adults, Aspirin Increases the Risk of Metastatic of Stage 4 Cancers and Cancer Mortality. Barry, Henry C. Am Fam Physician. 2021 Sep; 104(2):online
Effect of Aspirin on Cancer Incidence and Mortality in Older Adults. McNeil, John. JNCI: Journal of the National Cancer Institute Volume: 113 Issue 3 (2021) ISSN: 0027-8874 Online ISSN: 1460-2105
Guest: Jillian Joseph, MSPAS, PA-C
 
Music Credit: Richard Onorato]]></itunes:summary>
        <itunes:author>Pri-Med</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>503</itunes:duration>
                        <itunes:episodeType>full</itunes:episodeType>
        <itunes:image href="https://pbcdn1.podbean.com/imglogo/ep-logo/pbblog13721080/ae0ad5fe851807174f3e2368b9a8d5ea.png" />    </item>
    <item>
        <title>Improving Recovery from Concussion: New Evidence That May Help Post-Concussion Recuperation - Frankly Speaking Ep 259</title>
        <itunes:title>Improving Recovery from Concussion: New Evidence That May Help Post-Concussion Recuperation - Frankly Speaking Ep 259</itunes:title>
        <link>https://primedfranklyspeaking.podbean.com/e/improving-recovery-from-concussion-new-evidence-that-may-help-post-concussion-recuperation-frankly-speaking-ep-259-1645730473/</link>
                    <comments>https://primedfranklyspeaking.podbean.com/e/improving-recovery-from-concussion-new-evidence-that-may-help-post-concussion-recuperation-frankly-speaking-ep-259-1645730473/#comments</comments>        <pubDate>Mon, 17 Jan 2022 05:30:00 +0000</pubDate>
        <guid isPermaLink="false">b1e0f674-d512-410a-b29e-e30bb83bf283</guid>
                                    <description><![CDATA[<p>Credits: 0.25 AMA PRA Category 1 Credit™</p>
<p> </p>
<p>CME/CE Information and Claim Credit: <a href='https://www.pri-med.com/online-education/podcast/frankly-speaking-cme-259'>https://www.pri-med.com/online-education/podcast/frankly-speaking-cme-259</a></p>
<p> </p>
<p>Overview: Per CDC data, approximately 2.5 million Americans present each year to emergency departments with head injuries, and 15% of all high school students report experiencing at least one concussion. Current guidelines recommend physical and cognitive rest for 24-48 hours post-concussion with minimal guidance on screen time parameters. Recent evidence is emerging that supports avoidance of screen time and encouragement of aerobic activity as strategies to shorten and lessen post-concussion symptoms. Join us as we discuss 2 recent studies regarding screen-time and aerobic exercise that add critical information to best practice for reducing post-concussion symptoms.</p>
<p> </p>
<p>Episode resource links:</p>
<ul><li>
<p>John J Leddy, Christina L Master, Rebekah Mannix, Douglas J Wiebe, Matthew F Grady, William P Meehan, Eileen P Storey, Brian T Vernau, Naomi J Brown, Danielle Hunt, Fairuz Mohammed, Andrea Mallon, Kate Rownd, Kristy B Arbogast, Adam Cunningham, Mohammad N Haider, Andrew R Mayer, Barry S Willer. Early targeted heart rate aerobic exercise versus placebo stretching for sport-related concussion in adolescents: a randomised controlled trial. The Lancet Child & Adolescent Health, 2021; DOI: 10.1016/S2352-4642(21)00267-4</p>
<p> </p>
</li>
<li>
<p>Macnow T, Curran T, Tolliday C, et al. Effect of Screen Time on Recovery From Concussion: A Randomized Clinical Trial. JAMA Pediatr. Published online September 07, 2021. doi:10.1001/jamapediatrics.2021.2782
<a href='https://jamanetwork.com/journals/jamapediatrics/article-abstract/2783638#graphical-abstract-tab'>https://jamanetwork.com/journals/jamapediatrics/article-abstract/2783638#graphical-abstract-tab</a></p>
<p> </p>
</li>
<li>
<p>DePadilla L, Miller GF, Jones SE, Peterson AB, Breiding MJ. Self-reported concussions from playing a sport or being physically active among high school students—United States, 2017. MMWR Morb Mortal Wkly Rep. 2018;67(24):682-685. doi:10.15585/mmwr.mm6724a3</p>
<p> </p>
</li>
<li>
<p>University at Buffalo. (2021, September 30). Aerobic exercise after a sport-related concussion speeds recovery in adolescent athletes, study suggests: Daily aerobic exercise significantly reduced the risk of prolonged recovery. ScienceDaily. Retrieved October 2, 2021 from <a href='http://www.sciencedaily.com/releases/2021/09/210930213654.htm'>www.sciencedaily.com/releases/2021/09/210930213654.htm</a></p>
<p> </p>
</li>
<li>
<p>McCrory P ,Meeuwisse W,Dvorak J,etal. Consensus statement on concussion in sport—the 5th International Conference on Concussion in Sport held in Berlin, October 2016. Br J Sports Med. 2017;51(11):838-847. doi:10.1136/bjsports-2017- 097699</p>
<p> </p>
</li>
<li>
<p>Centers for Disease Control and Prevention. Recovery from concussion. Centers for Disease Control and Prevention; 2019. Accessed October 12, 2020. <a href='https://www.cdc.gov/headsup/basics/%20concussion_recovery.html.'>https://www.cdc.gov/headsup/basics/ concussion_recovery.html.</a></p>
</li>
</ul>
<p>Guest: Guest</p>
<p> </p>
<p>Music Credit: Richard Onorato</p>
]]></description>
                                                            <content:encoded><![CDATA[<p>Credits: 0.25 AMA PRA Category 1 Credit™</p>
<p> </p>
<p>CME/CE Information and Claim Credit: <a href='https://www.pri-med.com/online-education/podcast/frankly-speaking-cme-259'>https://www.pri-med.com/online-education/podcast/frankly-speaking-cme-259</a></p>
<p> </p>
<p>Overview: Per CDC data, approximately 2.5 million Americans present each year to emergency departments with head injuries, and 15% of all high school students report experiencing at least one concussion. Current guidelines recommend physical and cognitive rest for 24-48 hours post-concussion with minimal guidance on screen time parameters. Recent evidence is emerging that supports avoidance of screen time and encouragement of aerobic activity as strategies to shorten and lessen post-concussion symptoms. Join us as we discuss 2 recent studies regarding screen-time and aerobic exercise that add critical information to best practice for reducing post-concussion symptoms.</p>
<p> </p>
<p>Episode resource links:</p>
<ul><li>
<p>John J Leddy, Christina L Master, Rebekah Mannix, Douglas J Wiebe, Matthew F Grady, William P Meehan, Eileen P Storey, Brian T Vernau, Naomi J Brown, Danielle Hunt, Fairuz Mohammed, Andrea Mallon, Kate Rownd, Kristy B Arbogast, Adam Cunningham, Mohammad N Haider, Andrew R Mayer, Barry S Willer. Early targeted heart rate aerobic exercise versus placebo stretching for sport-related concussion in adolescents: a randomised controlled trial. The Lancet Child & Adolescent Health, 2021; DOI: 10.1016/S2352-4642(21)00267-4</p>
<p> </p>
</li>
<li>
<p>Macnow T, Curran T, Tolliday C, et al. Effect of Screen Time on Recovery From Concussion: A Randomized Clinical Trial. JAMA Pediatr. Published online September 07, 2021. doi:10.1001/jamapediatrics.2021.2782<br>
<a href='https://jamanetwork.com/journals/jamapediatrics/article-abstract/2783638#graphical-abstract-tab'>https://jamanetwork.com/journals/jamapediatrics/article-abstract/2783638#graphical-abstract-tab</a></p>
<p> </p>
</li>
<li>
<p>DePadilla L, Miller GF, Jones SE, Peterson AB, Breiding MJ. Self-reported concussions from playing a sport or being physically active among high school students—United States, 2017. MMWR Morb Mortal Wkly Rep. 2018;67(24):682-685. doi:10.15585/mmwr.mm6724a3</p>
<p> </p>
</li>
<li>
<p>University at Buffalo. (2021, September 30). Aerobic exercise after a sport-related concussion speeds recovery in adolescent athletes, study suggests: Daily aerobic exercise significantly reduced the risk of prolonged recovery. ScienceDaily. Retrieved October 2, 2021 from <a href='http://www.sciencedaily.com/releases/2021/09/210930213654.htm'>www.sciencedaily.com/releases/2021/09/210930213654.htm</a></p>
<p> </p>
</li>
<li>
<p>McCrory P ,Meeuwisse W,Dvorak J,etal. Consensus statement on concussion in sport—the 5th International Conference on Concussion in Sport held in Berlin, October 2016. Br J Sports Med. 2017;51(11):838-847. doi:10.1136/bjsports-2017- 097699</p>
<p> </p>
</li>
<li>
<p>Centers for Disease Control and Prevention. Recovery from concussion. Centers for Disease Control and Prevention; 2019. Accessed October 12, 2020. <a href='https://www.cdc.gov/headsup/basics/%20concussion_recovery.html.'>https://www.cdc.gov/headsup/basics/ concussion_recovery.html.</a></p>
</li>
</ul>
<p>Guest: Guest</p>
<p> </p>
<p>Music Credit: Richard Onorato</p>
]]></content:encoded>
                                    
        <enclosure url="https://mcdn.podbean.com/mf/web/vvhiko/secure_primed_frankly-speaking-259-concussion_and_screens.mp3" length="11045995" type="audio/mpeg"/>
                <itunes:summary><![CDATA[Credits: 0.25 AMA PRA Category 1 Credit™
 
CME/CE Information and Claim Credit: https://www.pri-med.com/online-education/podcast/frankly-speaking-cme-259
 
Overview: Per CDC data, approximately 2.5 million Americans present each year to emergency departments with head injuries, and 15% of all high school students report experiencing at least one concussion. Current guidelines recommend physical and cognitive rest for 24-48 hours post-concussion with minimal guidance on screen time parameters. Recent evidence is emerging that supports avoidance of screen time and encouragement of aerobic activity as strategies to shorten and lessen post-concussion symptoms. Join us as we discuss 2 recent studies regarding screen-time and aerobic exercise that add critical information to best practice for reducing post-concussion symptoms.
 
Episode resource links:

John J Leddy, Christina L Master, Rebekah Mannix, Douglas J Wiebe, Matthew F Grady, William P Meehan, Eileen P Storey, Brian T Vernau, Naomi J Brown, Danielle Hunt, Fairuz Mohammed, Andrea Mallon, Kate Rownd, Kristy B Arbogast, Adam Cunningham, Mohammad N Haider, Andrew R Mayer, Barry S Willer. Early targeted heart rate aerobic exercise versus placebo stretching for sport-related concussion in adolescents: a randomised controlled trial. The Lancet Child & Adolescent Health, 2021; DOI: 10.1016/S2352-4642(21)00267-4
 


Macnow T, Curran T, Tolliday C, et al. Effect of Screen Time on Recovery From Concussion: A Randomized Clinical Trial. JAMA Pediatr. Published online September 07, 2021. doi:10.1001/jamapediatrics.2021.2782https://jamanetwork.com/journals/jamapediatrics/article-abstract/2783638#graphical-abstract-tab
 


DePadilla L, Miller GF, Jones SE, Peterson AB, Breiding MJ. Self-reported concussions from playing a sport or being physically active among high school students—United States, 2017. MMWR Morb Mortal Wkly Rep. 2018;67(24):682-685. doi:10.15585/mmwr.mm6724a3
 


University at Buffalo. (2021, September 30). Aerobic exercise after a sport-related concussion speeds recovery in adolescent athletes, study suggests: Daily aerobic exercise significantly reduced the risk of prolonged recovery. ScienceDaily. Retrieved October 2, 2021 from www.sciencedaily.com/releases/2021/09/210930213654.htm
 


McCrory P ,Meeuwisse W,Dvorak J,etal. Consensus statement on concussion in sport—the 5th International Conference on Concussion in Sport held in Berlin, October 2016. Br J Sports Med. 2017;51(11):838-847. doi:10.1136/bjsports-2017- 097699
 


Centers for Disease Control and Prevention. Recovery from concussion. Centers for Disease Control and Prevention; 2019. Accessed October 12, 2020. https://www.cdc.gov/headsup/basics/ concussion_recovery.html.

Guest: Guest
 
Music Credit: Richard Onorato]]></itunes:summary>
        <itunes:author>Pri-Med</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>690</itunes:duration>
                        <itunes:episodeType>full</itunes:episodeType>
        <itunes:image href="https://pbcdn1.podbean.com/imglogo/ep-logo/pbblog13721080/e61751973a584a15ce710c5617594aa4.png" />    </item>
    <item>
        <title>A Brainy Approach to Treating Chronic Low Back Pain - Frankly Speaking Ep 258</title>
        <itunes:title>A Brainy Approach to Treating Chronic Low Back Pain - Frankly Speaking Ep 258</itunes:title>
        <link>https://primedfranklyspeaking.podbean.com/e/a-brainy-approach-to-treating-chronic-low-back-pain-frankly-speaking-ep-258-1645730474/</link>
                    <comments>https://primedfranklyspeaking.podbean.com/e/a-brainy-approach-to-treating-chronic-low-back-pain-frankly-speaking-ep-258-1645730474/#comments</comments>        <pubDate>Mon, 10 Jan 2022 05:30:00 +0000</pubDate>
        <guid isPermaLink="false">9e6b1512-24b8-41b6-ad35-44ce36392a67</guid>
                                    <description><![CDATA[<p>Credits: 0.25 AMA PRA Category 1 Credit™</p>
<p> </p>
<p>CME/CE Information and Claim Credit: <a href='https://www.pri-med.com/online-education/podcast/frankly-speaking-cme-258'>https://www.pri-med.com/online-education/podcast/frankly-speaking-cme-258</a></p>
<p> </p>
<p>Overview: Chronic pain affects 20% of people in the United States, and chronic low back pain is the most common cause of chronic pain. Although some treatments can reduce the severity of the pain, the persistence of chronic low back pain is a source of frustration for both patients and clinicians. Join us to discuss how behavioral and psychological therapy should be part of the treatment for chronic low back pain and how new approaches may be much more effective than existing therapies.</p>
<p> </p>
<p>Episode resource links:</p>
<ul><li>Ashar YK, Gordon A, Schubiner H, et al. Effect of Pain Reprocessing Therapy vs Placebo and Usual Care for Patients With Chronic Back Pain: A Randomized Clinical Trial. JAMA Psychiatry. Published online September 29, 2021.</li>
</ul>
<p>Guest: Alan Ehrlich MD, FAAFP</p>
<p> </p>
<p>Music Credit: Richard Onorato</p>
]]></description>
                                                            <content:encoded><![CDATA[<p>Credits: 0.25 AMA PRA Category 1 Credit™</p>
<p> </p>
<p>CME/CE Information and Claim Credit: <a href='https://www.pri-med.com/online-education/podcast/frankly-speaking-cme-258'>https://www.pri-med.com/online-education/podcast/frankly-speaking-cme-258</a></p>
<p> </p>
<p>Overview: Chronic pain affects 20% of people in the United States, and chronic low back pain is the most common cause of chronic pain. Although some treatments can reduce the severity of the pain, the persistence of chronic low back pain is a source of frustration for both patients and clinicians. Join us to discuss how behavioral and psychological therapy should be part of the treatment for chronic low back pain and how new approaches may be much more effective than existing therapies.</p>
<p> </p>
<p>Episode resource links:</p>
<ul><li>Ashar YK, Gordon A, Schubiner H, et al. Effect of Pain Reprocessing Therapy vs Placebo and Usual Care for Patients With Chronic Back Pain: A Randomized Clinical Trial. JAMA Psychiatry. Published online September 29, 2021.</li>
</ul>
<p>Guest: Alan Ehrlich MD, FAAFP</p>
<p> </p>
<p>Music Credit: Richard Onorato</p>
]]></content:encoded>
                                    
        <enclosure url="https://mcdn.podbean.com/mf/web/9vi4uk/secure_primed_frankly-speaking-258-chronic_pain.mp3" length="9774695" type="audio/mpeg"/>
                <itunes:summary><![CDATA[Credits: 0.25 AMA PRA Category 1 Credit™
 
CME/CE Information and Claim Credit: https://www.pri-med.com/online-education/podcast/frankly-speaking-cme-258
 
Overview: Chronic pain affects 20% of people in the United States, and chronic low back pain is the most common cause of chronic pain. Although some treatments can reduce the severity of the pain, the persistence of chronic low back pain is a source of frustration for both patients and clinicians. Join us to discuss how behavioral and psychological therapy should be part of the treatment for chronic low back pain and how new approaches may be much more effective than existing therapies.
 
Episode resource links:
Ashar YK, Gordon A, Schubiner H, et al. Effect of Pain Reprocessing Therapy vs Placebo and Usual Care for Patients With Chronic Back Pain: A Randomized Clinical Trial. JAMA Psychiatry. Published online September 29, 2021.
Guest: Alan Ehrlich MD, FAAFP
 
Music Credit: Richard Onorato]]></itunes:summary>
        <itunes:author>Pri-Med</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>609</itunes:duration>
                        <itunes:episodeType>full</itunes:episodeType>
        <itunes:image href="https://pbcdn1.podbean.com/imglogo/ep-logo/pbblog13721080/59b5722bf674ec4a4ab78e4100ace18b.png" />    </item>
    <item>
        <title>Recommendations for the Treatment of Gout - Frankly Speaking Ep 257</title>
        <itunes:title>Recommendations for the Treatment of Gout - Frankly Speaking Ep 257</itunes:title>
        <link>https://primedfranklyspeaking.podbean.com/e/recommendations-for-the-treatment-of-gout-frankly-speaking-ep-257-1645730475/</link>
                    <comments>https://primedfranklyspeaking.podbean.com/e/recommendations-for-the-treatment-of-gout-frankly-speaking-ep-257-1645730475/#comments</comments>        <pubDate>Mon, 03 Jan 2022 05:30:00 +0000</pubDate>
        <guid isPermaLink="false">082c80f4-0917-4085-89ef-e696a3045793</guid>
                                    <description><![CDATA[<p>Credits: 0.25 AMA PRA Category 1 Credit™</p>
<p> </p>
<p>CME/CE Information and Claim Credit: <a href='https://www.pri-med.com/online-education/podcast/frankly-speaking-cme-257'>https://www.pri-med.com/online-education/podcast/frankly-speaking-cme-257</a></p>
<p> </p>
<p>Overview: Gout is a common condition seen in primary care, and the incidence and prevalence continue to rise. Despite previous recommendations from the American College of Rheumatology, urate-lowering therapy is still underused. Listen to this episode for a concise overview of the American College of Rheumatology’s updates for the management of gout and walk away with a clear understanding of the first-line treatment options for acute gout flares.</p>
<p> </p>
<p>Episode resource links:</p>
<ul><li>Management of Gout: Update from the American College of Rheumatology. Dakkak, M., Lanney, H. Am Fam Physician. 2021 Aug ;104(2):209-210.</li>
<li>2020 American College of Rheumatology Guideline for the Management of Gout. Fitzgerald, J. D. et al. Arthritis Care Res (Hoboken). June 2020;72(6):744–760 [published corrections appear in Arthritis Care Res (Hoboken). 2020;72(8):1187, and Arthritis Care Res (Hoboken). 2021;73(3):458]</li>
</ul>
<p>Guest: Jillian Joseph, MSPAS, PA-C</p>
<p> </p>
<p>Music Credit: Richard Onorato</p>
]]></description>
                                                            <content:encoded><![CDATA[<p>Credits: 0.25 AMA PRA Category 1 Credit™</p>
<p> </p>
<p>CME/CE Information and Claim Credit: <a href='https://www.pri-med.com/online-education/podcast/frankly-speaking-cme-257'>https://www.pri-med.com/online-education/podcast/frankly-speaking-cme-257</a></p>
<p> </p>
<p>Overview: Gout is a common condition seen in primary care, and the incidence and prevalence continue to rise. Despite previous recommendations from the American College of Rheumatology, urate-lowering therapy is still underused. Listen to this episode for a concise overview of the American College of Rheumatology’s updates for the management of gout and walk away with a clear understanding of the first-line treatment options for acute gout flares.</p>
<p> </p>
<p>Episode resource links:</p>
<ul><li>Management of Gout: Update from the American College of Rheumatology. Dakkak, M., Lanney, H. Am Fam Physician. 2021 Aug ;104(2):209-210.</li>
<li>2020 American College of Rheumatology Guideline for the Management of Gout. Fitzgerald, J. D. et al. Arthritis Care Res (Hoboken). June 2020;72(6):744–760 [published corrections appear in Arthritis Care Res (Hoboken). 2020;72(8):1187, and Arthritis Care Res (Hoboken). 2021;73(3):458]</li>
</ul>
<p>Guest: Jillian Joseph, MSPAS, PA-C</p>
<p> </p>
<p>Music Credit: Richard Onorato</p>
]]></content:encoded>
                                    
        <enclosure url="https://mcdn.podbean.com/mf/web/3cex8l/secure_primed_frankly-speaking-257-gout.mp3" length="9252211" type="audio/mpeg"/>
                <itunes:summary><![CDATA[Credits: 0.25 AMA PRA Category 1 Credit™
 
CME/CE Information and Claim Credit: https://www.pri-med.com/online-education/podcast/frankly-speaking-cme-257
 
Overview: Gout is a common condition seen in primary care, and the incidence and prevalence continue to rise. Despite previous recommendations from the American College of Rheumatology, urate-lowering therapy is still underused. Listen to this episode for a concise overview of the American College of Rheumatology’s updates for the management of gout and walk away with a clear understanding of the first-line treatment options for acute gout flares.
 
Episode resource links:
Management of Gout: Update from the American College of Rheumatology. Dakkak, M., Lanney, H. Am Fam Physician. 2021 Aug ;104(2):209-210.
2020 American College of Rheumatology Guideline for the Management of Gout. Fitzgerald, J. D. et al. Arthritis Care Res (Hoboken). June 2020;72(6):744–760 [published corrections appear in Arthritis Care Res (Hoboken). 2020;72(8):1187, and Arthritis Care Res (Hoboken). 2021;73(3):458]
Guest: Jillian Joseph, MSPAS, PA-C
 
Music Credit: Richard Onorato]]></itunes:summary>
        <itunes:author>Pri-Med</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>577</itunes:duration>
                        <itunes:episodeType>full</itunes:episodeType>
        <itunes:image href="https://pbcdn1.podbean.com/imglogo/ep-logo/pbblog13721080/99430c34cc53aa63b2ef7c4d6f0a6875.png" />    </item>
    <item>
        <title>Favorite Podcast of 2021 - Frankly Speaking EP 256</title>
        <itunes:title>Favorite Podcast of 2021 - Frankly Speaking EP 256</itunes:title>
        <link>https://primedfranklyspeaking.podbean.com/e/favorite-podcast-of-2021-frankly-speaking-ep-256-1645730476/</link>
                    <comments>https://primedfranklyspeaking.podbean.com/e/favorite-podcast-of-2021-frankly-speaking-ep-256-1645730476/#comments</comments>        <pubDate>Mon, 27 Dec 2021 05:30:00 +0000</pubDate>
        <guid isPermaLink="false">443ceeb4-dd81-453f-8855-602eb6511d77</guid>
                                    <description><![CDATA[<p>Credits: 0.25 AMA PRA Category 1 Credit™</p>
<p> </p>
<p>CME/CE Information and Claim Credit: <a href='https://www.pri-med.com/online-education/podcast/frankly-speaking-cme-256'>https://www.pri-med.com/online-education/podcast/frankly-speaking-cme-256</a></p>
<p> </p>
<p>Overview: Live at Pri-Med East! In this episode, each podcaster will discuss the most impactful paper and podcast of the year.</p>
<p> </p>
<p>Episode resource links:</p>
<ul><li>Ngan, H.Y, et al (2021), Diabet Med, 38: e14525. <a href='https://doi.org/10.1111/dme.14525'>https://doi.org/10.1111/dme.14525</a></li>
<li>J Clin Gastroenterol 2021: DOI: 10.1097/MCG.0000000000001561</li>
<li>Mehta RS, etal. JAMA Intern Med. doi:10.1001/jamainternmed.2020.7238</li>
<li><a href='https://www.uspreventiveservicestaskforce.org/uspstf/draft-recommendation/aspirin-use-to-prevent-cardiovascular-disease-preventive-medication'>https://www.uspreventiveservicestaskforce.org/uspstf/draft-recommendation/aspirin-use-to-prevent-cardiovascular-disease-preventive-medication</a></li>
<li>Hypertension. 2021;78:591–603. DOI: 10.1161/HYPERTENSIONAHA.120.16667</li>
</ul>
<p> </p>
<p>Guest: Susan Feeney, DNP, FNP-BC, NP-C, Alan M. Ehrlich, MD, FAAFP, Jill M. Terrien, PhD, ANP-BC, Jillian Joseph, MSPAS, PA-C</p>
<p> </p>
<p>Music Credit: Richard Onorato</p>
]]></description>
                                                            <content:encoded><![CDATA[<p>Credits: 0.25 AMA PRA Category 1 Credit™</p>
<p> </p>
<p>CME/CE Information and Claim Credit: <a href='https://www.pri-med.com/online-education/podcast/frankly-speaking-cme-256'>https://www.pri-med.com/online-education/podcast/frankly-speaking-cme-256</a></p>
<p> </p>
<p>Overview: Live at Pri-Med East! In this episode, each podcaster will discuss the most impactful paper and podcast of the year.</p>
<p> </p>
<p>Episode resource links:</p>
<ul><li>Ngan, H.Y, et al (2021), Diabet Med, 38: e14525. <a href='https://doi.org/10.1111/dme.14525'>https://doi.org/10.1111/dme.14525</a></li>
<li>J Clin Gastroenterol 2021: DOI: 10.1097/MCG.0000000000001561</li>
<li>Mehta RS, etal. JAMA Intern Med. doi:10.1001/jamainternmed.2020.7238</li>
<li><a href='https://www.uspreventiveservicestaskforce.org/uspstf/draft-recommendation/aspirin-use-to-prevent-cardiovascular-disease-preventive-medication'>https://www.uspreventiveservicestaskforce.org/uspstf/draft-recommendation/aspirin-use-to-prevent-cardiovascular-disease-preventive-medication</a></li>
<li>Hypertension. 2021;78:591–603. DOI: 10.1161/HYPERTENSIONAHA.120.16667</li>
</ul>
<p> </p>
<p>Guest: Susan Feeney, DNP, FNP-BC, NP-C, Alan M. Ehrlich, MD, FAAFP, Jill M. Terrien, PhD, ANP-BC, Jillian Joseph, MSPAS, PA-C</p>
<p> </p>
<p>Music Credit: Richard Onorato</p>
]]></content:encoded>
                                    
        <enclosure url="https://mcdn.podbean.com/mf/web/0p5oqv/secure_primed_frankly-speaking-256-best_of_2021.mp3" length="18887411" type="audio/mpeg"/>
                <itunes:summary><![CDATA[Credits: 0.25 AMA PRA Category 1 Credit™
 
CME/CE Information and Claim Credit: https://www.pri-med.com/online-education/podcast/frankly-speaking-cme-256
 
Overview: Live at Pri-Med East! In this episode, each podcaster will discuss the most impactful paper and podcast of the year.
 
Episode resource links:
Ngan, H.Y, et al (2021), Diabet Med, 38: e14525. https://doi.org/10.1111/dme.14525
J Clin Gastroenterol 2021: DOI: 10.1097/MCG.0000000000001561
Mehta RS, etal. JAMA Intern Med. doi:10.1001/jamainternmed.2020.7238
https://www.uspreventiveservicestaskforce.org/uspstf/draft-recommendation/aspirin-use-to-prevent-cardiovascular-disease-preventive-medication
Hypertension. 2021;78:591–603. DOI: 10.1161/HYPERTENSIONAHA.120.16667
 
Guest: Susan Feeney, DNP, FNP-BC, NP-C, Alan M. Ehrlich, MD, FAAFP, Jill M. Terrien, PhD, ANP-BC, Jillian Joseph, MSPAS, PA-C
 
Music Credit: Richard Onorato]]></itunes:summary>
        <itunes:author>Pri-Med</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>1180</itunes:duration>
                        <itunes:episodeType>full</itunes:episodeType>
        <itunes:image href="https://pbcdn1.podbean.com/imglogo/ep-logo/pbblog13721080/721c0e1cee4f98944833fa9a31aead6d.png" />    </item>
    <item>
        <title>Peaceful, Easy Feeling: Can Mindfulness Exercise Improve Asthma-Related Quality of Life? - Frankly Speaking Ep 255</title>
        <itunes:title>Peaceful, Easy Feeling: Can Mindfulness Exercise Improve Asthma-Related Quality of Life? - Frankly Speaking Ep 255</itunes:title>
        <link>https://primedfranklyspeaking.podbean.com/e/peaceful-easy-feeling-can-mindfulness-exercise-improve-asthma-related-quality-of-life-frankly-speaking-ep-255-1645730477/</link>
                    <comments>https://primedfranklyspeaking.podbean.com/e/peaceful-easy-feeling-can-mindfulness-exercise-improve-asthma-related-quality-of-life-frankly-speaking-ep-255-1645730477/#comments</comments>        <pubDate>Mon, 20 Dec 2021 05:30:00 +0000</pubDate>
        <guid isPermaLink="false">ec57cf01-9798-4ebc-81ca-7dc4544dd7f7</guid>
                                    <description><![CDATA[<p>Credits: 0.25 AMA PRA Category 1 Credit™</p>
<p> </p>
<p>CME/CE Information and Claim Credit: <a href='https://www.pri-med.com/online-education/podcast/frankly-speaking-cme-255'>https://www.pri-med.com/online-education/podcast/frankly-speaking-cme-255</a></p>
<p> </p>
<p>Overview: Asthma is one of the most prevalent conditions, affecting almost 340 million individuals across the globe and approximately 25 million Americans, or 7.8% of the US population. Treatment is complex and goals of therapy are elusive for many. Anxiety and other concerns are common in those diagnosed with asthma and can worsen outcomes. A recent study from the UK found the use of a mindfulness app was associated with improved asthma-related quality-of-life indicators. Join us while we discuss this study’s implications for helping patients with asthma in primary care.</p>
<p> </p>
<p>Episode resource links:</p>
<ul><li>
<p>Ainsworth, B., Stanescu, S., Stuart, B., Russell, D., Liddiard, M., Djukanovic, R., & Thomas, M. (2021). A feasibility trial of a digital mindfulness-based intervention to improve asthma-related quality of life for primary care patients with asthma. Journal of Behavioral Medicine. Advance online publication. <a href='https://psycnet.apa.org/doi/10.1007/s10865-021-00249-3'>https://doi.org/10.1007/s10865-021-00249-3</a></p>
</li>
<li>
<p>CDC Most Recent National Asthma Data: <a href='https://www.cdc.gov/asthma/most_recent_national_asthma_data.htm'>https://www.cdc.gov/asthma/most_recent_national_asthma_data.htm</a></p>
</li>
</ul>
<p>Guest: Susan Feeney, DNP, FNP-BC, NP-C</p>
<p> </p>
<p>Music Credit: Richard Onorato</p>
<p> </p>
]]></description>
                                                            <content:encoded><![CDATA[<p>Credits: 0.25 AMA PRA Category 1 Credit™</p>
<p> </p>
<p>CME/CE Information and Claim Credit: <a href='https://www.pri-med.com/online-education/podcast/frankly-speaking-cme-255'>https://www.pri-med.com/online-education/podcast/frankly-speaking-cme-255</a></p>
<p> </p>
<p>Overview: Asthma is one of the most prevalent conditions, affecting almost 340 million individuals across the globe and approximately 25 million Americans, or 7.8% of the US population. Treatment is complex and goals of therapy are elusive for many. Anxiety and other concerns are common in those diagnosed with asthma and can worsen outcomes. A recent study from the UK found the use of a mindfulness app was associated with improved asthma-related quality-of-life indicators. Join us while we discuss this study’s implications for helping patients with asthma in primary care.</p>
<p> </p>
<p>Episode resource links:</p>
<ul><li>
<p>Ainsworth, B., Stanescu, S., Stuart, B., Russell, D., Liddiard, M., Djukanovic, R., & Thomas, M. (2021). A feasibility trial of a digital mindfulness-based intervention to improve asthma-related quality of life for primary care patients with asthma. <em>Journal of Behavioral Medicine.</em> Advance online publication. <a href='https://psycnet.apa.org/doi/10.1007/s10865-021-00249-3'>https://doi.org/10.1007/s10865-021-00249-3</a></p>
</li>
<li>
<p>CDC Most Recent National Asthma Data: <a href='https://www.cdc.gov/asthma/most_recent_national_asthma_data.htm'>https://www.cdc.gov/asthma/most_recent_national_asthma_data.htm</a></p>
</li>
</ul>
<p>Guest: Susan Feeney, DNP, FNP-BC, NP-C</p>
<p> </p>
<p>Music Credit: Richard Onorato</p>
<p> </p>
]]></content:encoded>
                                    
        <enclosure url="https://mcdn.podbean.com/mf/web/acstph/secure_primed_frankly-speaking-255-asthma-mindfulness.mp3" length="11054267" type="audio/mpeg"/>
                <itunes:summary><![CDATA[Credits: 0.25 AMA PRA Category 1 Credit™
 
CME/CE Information and Claim Credit: https://www.pri-med.com/online-education/podcast/frankly-speaking-cme-255
 
Overview: Asthma is one of the most prevalent conditions, affecting almost 340 million individuals across the globe and approximately 25 million Americans, or 7.8% of the US population. Treatment is complex and goals of therapy are elusive for many. Anxiety and other concerns are common in those diagnosed with asthma and can worsen outcomes. A recent study from the UK found the use of a mindfulness app was associated with improved asthma-related quality-of-life indicators. Join us while we discuss this study’s implications for helping patients with asthma in primary care.
 
Episode resource links:

Ainsworth, B., Stanescu, S., Stuart, B., Russell, D., Liddiard, M., Djukanovic, R., & Thomas, M. (2021). A feasibility trial of a digital mindfulness-based intervention to improve asthma-related quality of life for primary care patients with asthma. Journal of Behavioral Medicine. Advance online publication. https://doi.org/10.1007/s10865-021-00249-3


CDC Most Recent National Asthma Data: https://www.cdc.gov/asthma/most_recent_national_asthma_data.htm

Guest: Susan Feeney, DNP, FNP-BC, NP-C
 
Music Credit: Richard Onorato
 ]]></itunes:summary>
        <itunes:author>Pri-Med</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>689</itunes:duration>
                        <itunes:episodeType>full</itunes:episodeType>
        <itunes:image href="https://pbcdn1.podbean.com/imglogo/ep-logo/pbblog13721080/f95834a91b39579954bab367cedfbaca.png" />    </item>
    <item>
        <title>Older Adults and Loneliness—Avoid High-Risk Medications - Frankly Speaking Ep 254</title>
        <itunes:title>Older Adults and Loneliness—Avoid High-Risk Medications - Frankly Speaking Ep 254</itunes:title>
        <link>https://primedfranklyspeaking.podbean.com/e/older-adults-and-loneliness%e2%80%94avoid-high-risk-medications-frankly-speaking-ep-254-1645730479/</link>
                    <comments>https://primedfranklyspeaking.podbean.com/e/older-adults-and-loneliness%e2%80%94avoid-high-risk-medications-frankly-speaking-ep-254-1645730479/#comments</comments>        <pubDate>Mon, 13 Dec 2021 05:30:00 +0000</pubDate>
        <guid isPermaLink="false">a0c51133-1fd2-45ab-8c0d-ef7d6632bdb7</guid>
                                    <description><![CDATA[<p>Credits: 0.25 AMA PRA Category 1 Credit™</p>
<p> </p>
<p>CME/CE Information and Claim Credit: <a href='https://www.pri-med.com/online-education/podcast/frankly-speaking-cme-254-2'>https://www.pri-med.com/online-education/podcast/frankly-speaking-cme-254-2</a></p>
<p> </p>
<p>Overview: Older adults who suffer from loneliness may be at risk of overusing medications prescribed for pain, insomnia, depression, or anxiety. Replacing these medications with social interventions may improve outcomes and help patients avoid adverse consequences. Join us as we discuss the importance of reviewing medications and assessing for loneliness in older adults to prevent adverse events and outcomes.</p>
<p> </p>
<p>Episode resource links:</p>
<ul><li>Kotwal, A. A., Steinman, M. A., Cenzer, I., &amp; Smith, A. K. (2021). Use of High-risk Medications Among Lonely Older Adults: Results From a Nationally Representative Sample. JAMA internal medicine, e213775. Advance online publication. https://doi.org/10.1001/jamainternmed.2021.3775 https://pubmed.ncbi.nlm.nih.gov/34309620/</li>
<li>Education for Patients: Tips on Staying Connected—National Institutes on Aging https://www.nia.nih.gov/health/loneliness-and-social-isolation-tips-staying-connected</li>
</ul>
<p>Guest: Jill M. Terrien PhD, ANP-BC</p>
<p> </p>
<p>Music Credit: Richard Onorato</p>
]]></description>
                                                            <content:encoded><![CDATA[<p>Credits: 0.25 AMA PRA Category 1 Credit™</p>
<p> </p>
<p>CME/CE Information and Claim Credit: <a href='https://www.pri-med.com/online-education/podcast/frankly-speaking-cme-254-2'>https://www.pri-med.com/online-education/podcast/frankly-speaking-cme-254-2</a></p>
<p> </p>
<p>Overview: Older adults who suffer from loneliness may be at risk of overusing medications prescribed for pain, insomnia, depression, or anxiety. Replacing these medications with social interventions may improve outcomes and help patients avoid adverse consequences. Join us as we discuss the importance of reviewing medications and assessing for loneliness in older adults to prevent adverse events and outcomes.</p>
<p> </p>
<p>Episode resource links:</p>
<ul><li>Kotwal, A. A., Steinman, M. A., Cenzer, I., &amp; Smith, A. K. (2021). Use of High-risk Medications Among Lonely Older Adults: Results From a Nationally Representative Sample. JAMA internal medicine, e213775. Advance online publication. https://doi.org/10.1001/jamainternmed.2021.3775 https://pubmed.ncbi.nlm.nih.gov/34309620/</li>
<li>Education for Patients: Tips on Staying Connected—National Institutes on Aging https://www.nia.nih.gov/health/loneliness-and-social-isolation-tips-staying-connected</li>
</ul>
<p>Guest: Jill M. Terrien PhD, ANP-BC</p>
<p> </p>
<p>Music Credit: Richard Onorato</p>
]]></content:encoded>
                                    
        <enclosure url="https://mcdn.podbean.com/mf/web/oidych/secure_primed_frankly-speaking-254-loneliness.mp3" length="10222054" type="audio/mpeg"/>
                <itunes:summary><![CDATA[Credits: 0.25 AMA PRA Category 1 Credit™
 
CME/CE Information and Claim Credit: https://www.pri-med.com/online-education/podcast/frankly-speaking-cme-254-2
 
Overview: Older adults who suffer from loneliness may be at risk of overusing medications prescribed for pain, insomnia, depression, or anxiety. Replacing these medications with social interventions may improve outcomes and help patients avoid adverse consequences. Join us as we discuss the importance of reviewing medications and assessing for loneliness in older adults to prevent adverse events and outcomes.
 
Episode resource links:
Kotwal, A. A., Steinman, M. A., Cenzer, I., &amp; Smith, A. K. (2021). Use of High-risk Medications Among Lonely Older Adults: Results From a Nationally Representative Sample. JAMA internal medicine, e213775. Advance online publication. https://doi.org/10.1001/jamainternmed.2021.3775 https://pubmed.ncbi.nlm.nih.gov/34309620/
Education for Patients: Tips on Staying Connected—National Institutes on Aging https://www.nia.nih.gov/health/loneliness-and-social-isolation-tips-staying-connected
Guest: Jill M. Terrien PhD, ANP-BC
 
Music Credit: Richard Onorato]]></itunes:summary>
        <itunes:author>Pri-Med</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>637</itunes:duration>
                        <itunes:episodeType>full</itunes:episodeType>
        <itunes:image href="https://pbcdn1.podbean.com/imglogo/ep-logo/pbblog13721080/a50eff2479e1331cd6b78bacd76ede9f.png" />    </item>
    <item>
        <title>The End of ACE Inhibitors? - Frankly Speaking Ep 253</title>
        <itunes:title>The End of ACE Inhibitors? - Frankly Speaking Ep 253</itunes:title>
        <link>https://primedfranklyspeaking.podbean.com/e/the-end-of-ace-inhibitors-frankly-speaking-ep-253-1645730480/</link>
                    <comments>https://primedfranklyspeaking.podbean.com/e/the-end-of-ace-inhibitors-frankly-speaking-ep-253-1645730480/#comments</comments>        <pubDate>Mon, 06 Dec 2021 05:30:00 +0000</pubDate>
        <guid isPermaLink="false">b98a4def-8127-4d8b-a78e-7100c2e2d8b8</guid>
                                    <description><![CDATA[<p>Credits: 0.25 AMA PRA Category 1 Credit™</p>
<p> </p>
<p>CME/CE Information and Claim Credit: <a href='https://www.pri-med.com/online-education/podcast/frankly-speaking-cme-253'>https://www.pri-med.com/online-education/podcast/frankly-speaking-cme-253</a></p>
<p> </p>
<p>Overview: ACE (angiotensin-converting enzyme) inhibitors and ARBs (angiotensin receptor blockers) are both recommended as first-line treatments for hypertension. ACE inhibitors have known side effects, such as cough, that are frustrating for many patients, while ARBs appear to have less annoying side effects. This podcast will review a recently published retrospective, comparative cohort study comparing the effectiveness and safety of ACE inhibitors vs ARBs in the first-line treatment of hypertension.</p>
<p> </p>
<p>Episode resource links:</p>
<ul><li>
<p>Hypertension. 2021;78:591–603. DOI: 10.1161/HYPERTENSIONAHA.120.16667</p>
<p> </p>
</li>
<li>
<p>ACC/AHA/AAPA/ABC/ACPM/AGS/APhA/ASH/ASPC/ NMA/PCNA guideline for the prevention, detection, evaluation, and management of high blood pressure in adults: a report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines. J Am Coll Cardiol. 2018;71:e127–e248. doi: 10.1016/j.jacc.2017.11.006</p>
</li>
</ul>
<p>Guest: Robert A. Baldor MD, FAAFP</p>
<p> </p>
<p>Music Credit: Richard Onorato</p>
]]></description>
                                                            <content:encoded><![CDATA[<p>Credits: 0.25 AMA PRA Category 1 Credit™</p>
<p> </p>
<p>CME/CE Information and Claim Credit: <a href='https://www.pri-med.com/online-education/podcast/frankly-speaking-cme-253'>https://www.pri-med.com/online-education/podcast/frankly-speaking-cme-253</a></p>
<p> </p>
<p>Overview: ACE (angiotensin-converting enzyme) inhibitors and ARBs (angiotensin receptor blockers) are both recommended as first-line treatments for hypertension. ACE inhibitors have known side effects, such as cough, that are frustrating for many patients, while ARBs appear to have less annoying side effects. This podcast will review a recently published retrospective, comparative cohort study comparing the effectiveness and safety of ACE inhibitors vs ARBs in the first-line treatment of hypertension.</p>
<p> </p>
<p>Episode resource links:</p>
<ul><li>
<p>Hypertension. 2021;78:591–603. DOI: 10.1161/HYPERTENSIONAHA.120.16667</p>
<p> </p>
</li>
<li>
<p>ACC/AHA/AAPA/ABC/ACPM/AGS/APhA/ASH/ASPC/ NMA/PCNA guideline for the prevention, detection, evaluation, and management of high blood pressure in adults: a report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines. J Am Coll Cardiol. 2018;71:e127–e248. doi: 10.1016/j.jacc.2017.11.006</p>
</li>
</ul>
<p>Guest: Robert A. Baldor MD, FAAFP</p>
<p> </p>
<p>Music Credit: Richard Onorato</p>
]]></content:encoded>
                                    
        <enclosure url="https://mcdn.podbean.com/mf/web/hqbnxz/secure_primed_frankly-speaking-253-ACEi_vs_ARB.mp3" length="7718519" type="audio/mpeg"/>
                <itunes:summary><![CDATA[Credits: 0.25 AMA PRA Category 1 Credit™
 
CME/CE Information and Claim Credit: https://www.pri-med.com/online-education/podcast/frankly-speaking-cme-253
 
Overview: ACE (angiotensin-converting enzyme) inhibitors and ARBs (angiotensin receptor blockers) are both recommended as first-line treatments for hypertension. ACE inhibitors have known side effects, such as cough, that are frustrating for many patients, while ARBs appear to have less annoying side effects. This podcast will review a recently published retrospective, comparative cohort study comparing the effectiveness and safety of ACE inhibitors vs ARBs in the first-line treatment of hypertension.
 
Episode resource links:

Hypertension. 2021;78:591–603. DOI: 10.1161/HYPERTENSIONAHA.120.16667
 


ACC/AHA/AAPA/ABC/ACPM/AGS/APhA/ASH/ASPC/ NMA/PCNA guideline for the prevention, detection, evaluation, and management of high blood pressure in adults: a report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines. J Am Coll Cardiol. 2018;71:e127–e248. doi: 10.1016/j.jacc.2017.11.006

Guest: Robert A. Baldor MD, FAAFP
 
Music Credit: Richard Onorato]]></itunes:summary>
        <itunes:author>Pri-Med</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>481</itunes:duration>
                        <itunes:episodeType>full</itunes:episodeType>
        <itunes:image href="https://pbcdn1.podbean.com/imglogo/ep-logo/pbblog13721080/f1ff6b430db0469a30a14793268c59de.png" />    </item>
    <item>
        <title>Contraception: When Do We Start Them? - Frankly Speaking Ep 252</title>
        <itunes:title>Contraception: When Do We Start Them? - Frankly Speaking Ep 252</itunes:title>
        <link>https://primedfranklyspeaking.podbean.com/e/contraception-when-do-we-start-them-frankly-speaking-ep-252-1645730481/</link>
                    <comments>https://primedfranklyspeaking.podbean.com/e/contraception-when-do-we-start-them-frankly-speaking-ep-252-1645730481/#comments</comments>        <pubDate>Mon, 29 Nov 2021 05:30:00 +0000</pubDate>
        <guid isPermaLink="false">0af3de7f-7594-4a09-a3ed-4b4b60c826ee</guid>
                                    <description><![CDATA[<p>Credits: 0.25 AMA PRA Category 1 Credit™</p>
<p> </p>
<p>CME/CE Information and Claim Credit: <a href='https://www.pri-med.com/online-education/podcast/frankly-speaking-cme-252'>https://www.pri-med.com/online-education/podcast/frankly-speaking-cme-252</a></p>
<p> </p>
<p>Overview: For patients who would like to prevent pregnancy, many options—both hormonal and nonhormonal—exist. Despite the availability of multiple options, many patients do not use them because of either a lack of knowledge or a lack of access, the latter being especially true in uninsured and non−English-speaking communities. Research has shown over the years that while unintended pregnancies have decreased in the United States, more can be done, and primary care providers can play an important role in helping to further decrease and eliminate barriers to contraception.</p>
<p> </p>
<p>Episode resource links:</p>
<ul><li>Lesnewski, R. (2021). Initiating Hormonal Contraception. American Family Physician, 103(5), 291-300.</li>
</ul>
<p>Guest: Mariyan L. Montaque, DNP, FNP-BC</p>
<p> </p>
<p>Music Credit: Richard Onorato</p>
]]></description>
                                                            <content:encoded><![CDATA[<p>Credits: 0.25 AMA PRA Category 1 Credit™</p>
<p> </p>
<p>CME/CE Information and Claim Credit: <a href='https://www.pri-med.com/online-education/podcast/frankly-speaking-cme-252'>https://www.pri-med.com/online-education/podcast/frankly-speaking-cme-252</a></p>
<p> </p>
<p>Overview: For patients who would like to prevent pregnancy, many options—both hormonal and nonhormonal—exist. Despite the availability of multiple options, many patients do not use them because of either a lack of knowledge or a lack of access, the latter being especially true in uninsured and non−English-speaking communities. Research has shown over the years that while unintended pregnancies have decreased in the United States, more can be done, and primary care providers can play an important role in helping to further decrease and eliminate barriers to contraception.</p>
<p> </p>
<p>Episode resource links:</p>
<ul><li>Lesnewski, R. (2021). Initiating Hormonal Contraception. American Family Physician, 103(5), 291-300.</li>
</ul>
<p>Guest: Mariyan L. Montaque, DNP, FNP-BC</p>
<p> </p>
<p>Music Credit: Richard Onorato</p>
]]></content:encoded>
                                    
        <enclosure url="https://mcdn.podbean.com/mf/web/7a09mv/secure_primed_frankly-speaking-252-contraception.mp3" length="8419340" type="audio/mpeg"/>
                <itunes:summary><![CDATA[Credits: 0.25 AMA PRA Category 1 Credit™
 
CME/CE Information and Claim Credit: https://www.pri-med.com/online-education/podcast/frankly-speaking-cme-252
 
Overview: For patients who would like to prevent pregnancy, many options—both hormonal and nonhormonal—exist. Despite the availability of multiple options, many patients do not use them because of either a lack of knowledge or a lack of access, the latter being especially true in uninsured and non−English-speaking communities. Research has shown over the years that while unintended pregnancies have decreased in the United States, more can be done, and primary care providers can play an important role in helping to further decrease and eliminate barriers to contraception.
 
Episode resource links:
Lesnewski, R. (2021). Initiating Hormonal Contraception. American Family Physician, 103(5), 291-300.
Guest: Mariyan L. Montaque, DNP, FNP-BC
 
Music Credit: Richard Onorato]]></itunes:summary>
        <itunes:author>Pri-Med</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>524</itunes:duration>
                        <itunes:episodeType>full</itunes:episodeType>
        <itunes:image href="https://pbcdn1.podbean.com/imglogo/ep-logo/pbblog13721080/e9f44469c36859d48c98d5228b921e28.png" />    </item>
    <item>
        <title>Primary HPV Testing Alone for Cervical Cancer Screening: a Review of Recent Guideline Updates - Frankly Speaking Ep 251</title>
        <itunes:title>Primary HPV Testing Alone for Cervical Cancer Screening: a Review of Recent Guideline Updates - Frankly Speaking Ep 251</itunes:title>
        <link>https://primedfranklyspeaking.podbean.com/e/primary-hpv-testing-alone-for-cervical-cancer-screening-a-review-of-recent-guideline-updates-frankly-speaking-ep-251-1645730482/</link>
                    <comments>https://primedfranklyspeaking.podbean.com/e/primary-hpv-testing-alone-for-cervical-cancer-screening-a-review-of-recent-guideline-updates-frankly-speaking-ep-251-1645730482/#comments</comments>        <pubDate>Mon, 22 Nov 2021 05:30:00 +0000</pubDate>
        <guid isPermaLink="false">66569c78-08fa-44c6-8541-2561030d13e6</guid>
                                    <description><![CDATA[<p>Credits: 0.25 AMA PRA Category 1 Credit™</p>
<p> </p>
<p>CME/CE Information and Claim Credit: <a href='https://www.pri-med.com/online-education/podcast/frankly-speaking-cme-251'>https://www.pri-med.com/online-education/podcast/frankly-speaking-cme-251</a></p>
<p> </p>
<p>Overview: Primary care providers should be up to date on the changes to the guidelines for cervical cancer screening to be able to guide patients in shared decision-making about health maintenance. Join us to review the recent changes to cervical cancer screening guidelines as recommended by the American Cancer Society.</p>
<p> </p>
<p>Episode resource links:</p>
<ul><li>Cervical Cancer Screening: Updated Guidelines from the American Cancer Society. Am Fam Physician. 2021 Sep; 104(2):314-315.</li>
<li>American College of Obstetricians and Gynecologists. Updated cervical cancer screening guidelines. Practice advisory. April 2021. Accessed September 30, 2021. https://www.acog.org/clinical/clinical-guidance/practice-advisory/articles/2021/04/updated-cervical-cancer-screening-guidelines</li>
<li>Fontham, ETH, Wolf, AMD, Church, TR, et al. Cervical Cancer Screening for Individuals at Average Risk: 2020 Guideline Update from the American Cancer Society. CA Cancer J Clin. 2020. https://doi.org/10.3322/caac.21628.</li>
</ul>
<p>Guest: Jillian Joseph, MPAS, PA-C</p>
<p> </p>
<p>Music Credit: Richard Onorato</p>
]]></description>
                                                            <content:encoded><![CDATA[<p>Credits: 0.25 AMA PRA Category 1 Credit™</p>
<p> </p>
<p>CME/CE Information and Claim Credit: <a href='https://www.pri-med.com/online-education/podcast/frankly-speaking-cme-251'>https://www.pri-med.com/online-education/podcast/frankly-speaking-cme-251</a></p>
<p> </p>
<p>Overview: Primary care providers should be up to date on the changes to the guidelines for cervical cancer screening to be able to guide patients in shared decision-making about health maintenance. Join us to review the recent changes to cervical cancer screening guidelines as recommended by the American Cancer Society.</p>
<p> </p>
<p>Episode resource links:</p>
<ul><li>Cervical Cancer Screening: Updated Guidelines from the American Cancer Society. Am Fam Physician. 2021 Sep; 104(2):314-315.</li>
<li>American College of Obstetricians and Gynecologists. Updated cervical cancer screening guidelines. Practice advisory. April 2021. Accessed September 30, 2021. https://www.acog.org/clinical/clinical-guidance/practice-advisory/articles/2021/04/updated-cervical-cancer-screening-guidelines</li>
<li>Fontham, ETH, Wolf, AMD, Church, TR, et al. Cervical Cancer Screening for Individuals at Average Risk: 2020 Guideline Update from the American Cancer Society. CA Cancer J Clin. 2020. https://doi.org/10.3322/caac.21628.</li>
</ul>
<p>Guest: Jillian Joseph, MPAS, PA-C</p>
<p> </p>
<p>Music Credit: Richard Onorato</p>
]]></content:encoded>
                                    
        <enclosure url="https://mcdn.podbean.com/mf/web/jouylv/secure_primed_frankly-speaking-251-cervical-cancer.mp3" length="8719714" type="audio/mpeg"/>
                <itunes:summary><![CDATA[Credits: 0.25 AMA PRA Category 1 Credit™
 
CME/CE Information and Claim Credit: https://www.pri-med.com/online-education/podcast/frankly-speaking-cme-251
 
Overview: Primary care providers should be up to date on the changes to the guidelines for cervical cancer screening to be able to guide patients in shared decision-making about health maintenance. Join us to review the recent changes to cervical cancer screening guidelines as recommended by the American Cancer Society.
 
Episode resource links:
Cervical Cancer Screening: Updated Guidelines from the American Cancer Society. Am Fam Physician. 2021 Sep; 104(2):314-315.
American College of Obstetricians and Gynecologists. Updated cervical cancer screening guidelines. Practice advisory. April 2021. Accessed September 30, 2021. https://www.acog.org/clinical/clinical-guidance/practice-advisory/articles/2021/04/updated-cervical-cancer-screening-guidelines
Fontham, ETH, Wolf, AMD, Church, TR, et al. Cervical Cancer Screening for Individuals at Average Risk: 2020 Guideline Update from the American Cancer Society. CA Cancer J Clin. 2020. https://doi.org/10.3322/caac.21628.
Guest: Jillian Joseph, MPAS, PA-C
 
Music Credit: Richard Onorato]]></itunes:summary>
        <itunes:author>Pri-Med</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>543</itunes:duration>
                        <itunes:episodeType>full</itunes:episodeType>
        <itunes:image href="https://pbcdn1.podbean.com/imglogo/ep-logo/pbblog13721080/6364392de4a9a573f60f345394f53abc.png" />    </item>
    <item>
        <title>Time to Recommend the Use of Salt Substitutes for CVD Prevention? - Frankly Speaking Ep 250</title>
        <itunes:title>Time to Recommend the Use of Salt Substitutes for CVD Prevention? - Frankly Speaking Ep 250</itunes:title>
        <link>https://primedfranklyspeaking.podbean.com/e/time-to-recommend-the-use-of-salt-substitutes-for-cvd-prevention-frankly-speaking-ep-250-1645730483/</link>
                    <comments>https://primedfranklyspeaking.podbean.com/e/time-to-recommend-the-use-of-salt-substitutes-for-cvd-prevention-frankly-speaking-ep-250-1645730483/#comments</comments>        <pubDate>Mon, 15 Nov 2021 05:30:00 +0000</pubDate>
        <guid isPermaLink="false">e8d87f99-4c9c-4306-862b-afd536ef3e92</guid>
                                    <description><![CDATA[<p>Credits: 0.25 AMA PRA Category 1 Credit™</p>
<p> </p>
<p>CME/CE Information and Claim Credit: <a href='https://www.pri-med.com/online-education/podcast/frankly-speaking-cme-250'>https://www.pri-med.com/online-education/podcast/frankly-speaking-cme-250</a></p>
<p> </p>
<p>Overview: While the data conflict on how much sodium intake is optimal for preventing cardiovascular disease, it is clear that daily salt intake for most Americans exceeds what is recommended. However, restricting salt intake on an individual or on a public health level has been controversial. An interesting alternative is the use of salt substitutes, which can help to decrease sodium intake while increasing potassium intake, and both have been associated with lowering blood pressure. Join us to hear a discussion on the results of the recently published studies on salt and cardiovascular disease, along with an overview of the Salt Substitute and Stroke Study (SSaSS).</p>
<p> </p>
<p>Episode resource links:</p>
<ul><li>Neal B, Wu Y, Feng X, et al. Effect of salt substitution on cardiovascular events and death. N Engl J Med. DOI: 10.1056/NEJMoa2105675</li>
<li>O’Donnell M, Mente A, Alderman MH, et al. Salt and cardiovascular disease: insufficient evidence to recommend low sodium intake, European Heart Journal, Volume 41, Issue 35, 14 September 2020, Pages 3363–3373, https://doi.org/10.1093/eurheartj/ehaa586</li>
<li>Circulation. 2021;143:1542–1567. DOI: 10.1161/CIRCULATIONAHA.120.050371</li>
</ul>
<p>Guest: Robert A. Baldor MD, FAAFP</p>
<p> </p>
<p>Music Credit: Richard Onorato</p>
]]></description>
                                                            <content:encoded><![CDATA[<p>Credits: 0.25 AMA PRA Category 1 Credit™</p>
<p> </p>
<p>CME/CE Information and Claim Credit: <a href='https://www.pri-med.com/online-education/podcast/frankly-speaking-cme-250'>https://www.pri-med.com/online-education/podcast/frankly-speaking-cme-250</a></p>
<p> </p>
<p>Overview: While the data conflict on how much sodium intake is optimal for preventing cardiovascular disease, it is clear that daily salt intake for most Americans exceeds what is recommended. However, restricting salt intake on an individual or on a public health level has been controversial. An interesting alternative is the use of salt substitutes, which can help to decrease sodium intake while increasing potassium intake, and both have been associated with lowering blood pressure. Join us to hear a discussion on the results of the recently published studies on salt and cardiovascular disease, along with an overview of the Salt Substitute and Stroke Study (SSaSS).</p>
<p> </p>
<p>Episode resource links:</p>
<ul><li>Neal B, Wu Y, Feng X, et al. Effect of salt substitution on cardiovascular events and death. N Engl J Med. DOI: 10.1056/NEJMoa2105675</li>
<li>O’Donnell M, Mente A, Alderman MH, et al. Salt and cardiovascular disease: insufficient evidence to recommend low sodium intake, European Heart Journal, Volume 41, Issue 35, 14 September 2020, Pages 3363–3373, https://doi.org/10.1093/eurheartj/ehaa586</li>
<li>Circulation. 2021;143:1542–1567. DOI: 10.1161/CIRCULATIONAHA.120.050371</li>
</ul>
<p>Guest: Robert A. Baldor MD, FAAFP</p>
<p> </p>
<p>Music Credit: Richard Onorato</p>
]]></content:encoded>
                                    
        <enclosure url="https://mcdn.podbean.com/mf/web/m1xdgz/secure_primed_frankly-speaking-250-salt-substitute.mp3" length="9291855" type="audio/mpeg"/>
                <itunes:summary><![CDATA[Credits: 0.25 AMA PRA Category 1 Credit™
 
CME/CE Information and Claim Credit: https://www.pri-med.com/online-education/podcast/frankly-speaking-cme-250
 
Overview: While the data conflict on how much sodium intake is optimal for preventing cardiovascular disease, it is clear that daily salt intake for most Americans exceeds what is recommended. However, restricting salt intake on an individual or on a public health level has been controversial. An interesting alternative is the use of salt substitutes, which can help to decrease sodium intake while increasing potassium intake, and both have been associated with lowering blood pressure. Join us to hear a discussion on the results of the recently published studies on salt and cardiovascular disease, along with an overview of the Salt Substitute and Stroke Study (SSaSS).
 
Episode resource links:
Neal B, Wu Y, Feng X, et al. Effect of salt substitution on cardiovascular events and death. N Engl J Med. DOI: 10.1056/NEJMoa2105675
O’Donnell M, Mente A, Alderman MH, et al. Salt and cardiovascular disease: insufficient evidence to recommend low sodium intake, European Heart Journal, Volume 41, Issue 35, 14 September 2020, Pages 3363–3373, https://doi.org/10.1093/eurheartj/ehaa586
Circulation. 2021;143:1542–1567. DOI: 10.1161/CIRCULATIONAHA.120.050371
Guest: Robert A. Baldor MD, FAAFP
 
Music Credit: Richard Onorato]]></itunes:summary>
        <itunes:author>Pri-Med</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>579</itunes:duration>
                        <itunes:episodeType>full</itunes:episodeType>
        <itunes:image href="https://pbcdn1.podbean.com/imglogo/ep-logo/pbblog13721080/d8ec679f0a573edf7bc0205978f12d19.png" />    </item>
    <item>
        <title>Using DOACs for Valvular Atrial Fibrillation - Frankly Speaking Ep 249</title>
        <itunes:title>Using DOACs for Valvular Atrial Fibrillation - Frankly Speaking Ep 249</itunes:title>
        <link>https://primedfranklyspeaking.podbean.com/e/using-doacs-for-valvular-atrial-fibrillation-frankly-speaking-ep-249-1645730484/</link>
                    <comments>https://primedfranklyspeaking.podbean.com/e/using-doacs-for-valvular-atrial-fibrillation-frankly-speaking-ep-249-1645730484/#comments</comments>        <pubDate>Mon, 08 Nov 2021 05:30:00 +0000</pubDate>
        <guid isPermaLink="false">0b42499d-4d8d-4e77-afae-cf5cd9b584b7</guid>
                                    <description><![CDATA[<p>Credits: 0.25 AMA PRA Category 1 Credit™</p>
<p> </p>
<p>CME/CE Information and Claim Credit: <a href='https://www.pri-med.com/online-education/podcast/frankly-speaking-cme-249'>https://www.pri-med.com/online-education/podcast/frankly-speaking-cme-249</a></p>
<p> </p>
<p>Overview: For non-valvular atrial fibrillation, physicians, patients, and guideline organizations all prefer direct oral anticoagulants (DOACs) over vitamin K antagonists, such as warfarin, for thromboembolic prophylaxis. For those with valvular atrial fibrillation, the data for safety and efficacy have been limited because randomized trials comparing DOACs to warfarin often exclude patients with valvular atrial fibrillation. Join us to explore new data that shed light on the use of DOACs in valvular atrial fibrillation.</p>
<p> </p>
<p>Episode resource links:</p>
<ul><li>Dawwas GK, Dietrich E, Cuker A, Barnes GD, Leonard CE, Lewis JD. Effectiveness and Safety of Direct Oral Anticoagulants Versus Warfarin in Patients With Valvular Atrial Fibrillation : A Population-Based Cohort Study. Ann Intern Med. 2021;174(7):910-919.</li>
</ul>
<p>Guest: Alan Ehrlich MD, FAAFP</p>
<p> </p>
<p>Music Credit: Richard Onorato</p>
]]></description>
                                                            <content:encoded><![CDATA[<p>Credits: 0.25 AMA PRA Category 1 Credit™</p>
<p> </p>
<p>CME/CE Information and Claim Credit: <a href='https://www.pri-med.com/online-education/podcast/frankly-speaking-cme-249'>https://www.pri-med.com/online-education/podcast/frankly-speaking-cme-249</a></p>
<p> </p>
<p>Overview: For non-valvular atrial fibrillation, physicians, patients, and guideline organizations all prefer direct oral anticoagulants (DOACs) over vitamin K antagonists, such as warfarin, for thromboembolic prophylaxis. For those with valvular atrial fibrillation, the data for safety and efficacy have been limited because randomized trials comparing DOACs to warfarin often exclude patients with valvular atrial fibrillation. Join us to explore new data that shed light on the use of DOACs in valvular atrial fibrillation.</p>
<p> </p>
<p>Episode resource links:</p>
<ul><li>Dawwas GK, Dietrich E, Cuker A, Barnes GD, Leonard CE, Lewis JD. Effectiveness and Safety of Direct Oral Anticoagulants Versus Warfarin in Patients With Valvular Atrial Fibrillation : A Population-Based Cohort Study. Ann Intern Med. 2021;174(7):910-919.</li>
</ul>
<p>Guest: Alan Ehrlich MD, FAAFP</p>
<p> </p>
<p>Music Credit: Richard Onorato</p>
]]></content:encoded>
                                    
        <enclosure url="https://mcdn.podbean.com/mf/web/4r5a6j/secure_primed_frankly-speaking-249-DOAC-afib.mp3" length="10307721" type="audio/mpeg"/>
                <itunes:summary><![CDATA[Credits: 0.25 AMA PRA Category 1 Credit™
 
CME/CE Information and Claim Credit: https://www.pri-med.com/online-education/podcast/frankly-speaking-cme-249
 
Overview: For non-valvular atrial fibrillation, physicians, patients, and guideline organizations all prefer direct oral anticoagulants (DOACs) over vitamin K antagonists, such as warfarin, for thromboembolic prophylaxis. For those with valvular atrial fibrillation, the data for safety and efficacy have been limited because randomized trials comparing DOACs to warfarin often exclude patients with valvular atrial fibrillation. Join us to explore new data that shed light on the use of DOACs in valvular atrial fibrillation.
 
Episode resource links:
Dawwas GK, Dietrich E, Cuker A, Barnes GD, Leonard CE, Lewis JD. Effectiveness and Safety of Direct Oral Anticoagulants Versus Warfarin in Patients With Valvular Atrial Fibrillation : A Population-Based Cohort Study. Ann Intern Med. 2021;174(7):910-919.
Guest: Alan Ehrlich MD, FAAFP
 
Music Credit: Richard Onorato]]></itunes:summary>
        <itunes:author>Pri-Med</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>642</itunes:duration>
                        <itunes:episodeType>full</itunes:episodeType>
        <itunes:image href="https://pbcdn1.podbean.com/imglogo/ep-logo/pbblog13721080/e5dd1a3d63f288c29a8e5334893b36c8.png" />    </item>
    <item>
        <title>Aspirin—Not Really for Primary Prevention - Frankly Speaking Ep 248</title>
        <itunes:title>Aspirin—Not Really for Primary Prevention - Frankly Speaking Ep 248</itunes:title>
        <link>https://primedfranklyspeaking.podbean.com/e/aspirin%e2%80%94not-really-for-primary-prevention-frankly-speaking-ep-248-1645730485/</link>
                    <comments>https://primedfranklyspeaking.podbean.com/e/aspirin%e2%80%94not-really-for-primary-prevention-frankly-speaking-ep-248-1645730485/#comments</comments>        <pubDate>Mon, 01 Nov 2021 04:30:00 +0000</pubDate>
        <guid isPermaLink="false">6bac29e5-2524-4ae6-a6f0-d5bae2b28451</guid>
                                    <description><![CDATA[<p>Credits: 0.25 AMA PRA Category 1 Credit™</p>
<p> </p>
<p>CME/CE Information and Claim Credit: <a href='https://www.pri-med.com/online-education/podcast/frankly-speaking-cme-248'>https://www.pri-med.com/online-education/podcast/frankly-speaking-cme-248</a></p>
<p> </p>
<p>Overview: Join us to hear a discussion on the important changes the AHA/ACC and USPSTF have made to their positions on the use of aspirin for primary prevention of cardiovascular disease. The organizations note that while aspirin for primary prevention lowers the risk of a myocardial infarction, its harmful effects may outweigh its benefits. Learn the aspirin recommendations for your patients in their 40s, 50s, and 60s who are at higher risk for a cardiovascular event.</p>
<p> </p>
<p>Episode resource links:</p>
<ul><li>New: <a href='https://www.uspreventiveservicestaskforce.org/uspstf/draft-recommendation/aspirin-use-to-prevent-cardiovascular-disease-preventive-medication'>https://www.uspreventiveservicestaskforce.org/uspstf/draft-recommendation/aspirin-use-to-prevent-cardiovascular-disease-preventive-medication</a></li>
<li>Old: <a href='https://www.aafp.org/afp/2016/1015/od1.html'>https://www.aafp.org/afp/2016/1015/od1.html</a></li>
<li><a href='https://www.uspreventiveservicestaskforce.org/uspstf/document/RecommendationStatementFinal/aspirin-to-prevent-cardiovascular-disease-and-cancer'>https://www.uspreventiveservicestaskforce.org/uspstf/document/RecommendationStatementFinal/aspirin-to-prevent-cardiovascular-disease-and-cancer</a></li>
</ul>
<p>Guest: Jill M. Terrien PhD, ANP-BC</p>
<p> </p>
<p>Music Credit: Richard Onorato</p>
]]></description>
                                                            <content:encoded><![CDATA[<p>Credits: 0.25 AMA PRA Category 1 Credit™</p>
<p> </p>
<p>CME/CE Information and Claim Credit: <a href='https://www.pri-med.com/online-education/podcast/frankly-speaking-cme-248'>https://www.pri-med.com/online-education/podcast/frankly-speaking-cme-248</a></p>
<p> </p>
<p>Overview: Join us to hear a discussion on the important changes the AHA/ACC and USPSTF have made to their positions on the use of aspirin for primary prevention of cardiovascular disease. The organizations note that while aspirin for primary prevention lowers the risk of a myocardial infarction, its harmful effects may outweigh its benefits. Learn the aspirin recommendations for your patients in their 40s, 50s, and 60s who are at higher risk for a cardiovascular event.</p>
<p> </p>
<p>Episode resource links:</p>
<ul><li>New: <a href='https://www.uspreventiveservicestaskforce.org/uspstf/draft-recommendation/aspirin-use-to-prevent-cardiovascular-disease-preventive-medication'>https://www.uspreventiveservicestaskforce.org/uspstf/draft-recommendation/aspirin-use-to-prevent-cardiovascular-disease-preventive-medication</a></li>
<li>Old: <a href='https://www.aafp.org/afp/2016/1015/od1.html'>https://www.aafp.org/afp/2016/1015/od1.html</a></li>
<li><a href='https://www.uspreventiveservicestaskforce.org/uspstf/document/RecommendationStatementFinal/aspirin-to-prevent-cardiovascular-disease-and-cancer'>https://www.uspreventiveservicestaskforce.org/uspstf/document/RecommendationStatementFinal/aspirin-to-prevent-cardiovascular-disease-and-cancer</a></li>
</ul>
<p>Guest: Jill M. Terrien PhD, ANP-BC</p>
<p> </p>
<p>Music Credit: Richard Onorato</p>
]]></content:encoded>
                                    
        <enclosure url="https://mcdn.podbean.com/mf/web/vo0u60/secure_primed_frankly-speaking-248-aspirin.mp3" length="8620623" type="audio/mpeg"/>
                <itunes:summary><![CDATA[Credits: 0.25 AMA PRA Category 1 Credit™
 
CME/CE Information and Claim Credit: https://www.pri-med.com/online-education/podcast/frankly-speaking-cme-248
 
Overview: Join us to hear a discussion on the important changes the AHA/ACC and USPSTF have made to their positions on the use of aspirin for primary prevention of cardiovascular disease. The organizations note that while aspirin for primary prevention lowers the risk of a myocardial infarction, its harmful effects may outweigh its benefits. Learn the aspirin recommendations for your patients in their 40s, 50s, and 60s who are at higher risk for a cardiovascular event.
 
Episode resource links:
New: https://www.uspreventiveservicestaskforce.org/uspstf/draft-recommendation/aspirin-use-to-prevent-cardiovascular-disease-preventive-medication
Old: https://www.aafp.org/afp/2016/1015/od1.html
https://www.uspreventiveservicestaskforce.org/uspstf/document/RecommendationStatementFinal/aspirin-to-prevent-cardiovascular-disease-and-cancer
Guest: Jill M. Terrien PhD, ANP-BC
 
Music Credit: Richard Onorato]]></itunes:summary>
        <itunes:author>Pri-Med</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>537</itunes:duration>
                        <itunes:episodeType>full</itunes:episodeType>
        <itunes:image href="https://pbcdn1.podbean.com/imglogo/ep-logo/pbblog13721080/823e37ec19f574833e9fed14abe92c6f.png" />    </item>
    <item>
        <title>A Fishy Method to Prevent Migraines - Frankly Speaking Ep 247</title>
        <itunes:title>A Fishy Method to Prevent Migraines - Frankly Speaking Ep 247</itunes:title>
        <link>https://primedfranklyspeaking.podbean.com/e/a-fishy-method-to-prevent-migraines-frankly-speaking-ep-247-1645730487/</link>
                    <comments>https://primedfranklyspeaking.podbean.com/e/a-fishy-method-to-prevent-migraines-frankly-speaking-ep-247-1645730487/#comments</comments>        <pubDate>Tue, 26 Oct 2021 19:37:00 +0000</pubDate>
        <guid isPermaLink="false">d55fe388-4b94-4d82-8776-9257b11f7ba3</guid>
                                    <description><![CDATA[<p>Credits: 0.25 AMA PRA Category 1 Credit™</p>
<p> </p>
<p>CME/CE Information and Claim Credit: <a href='https://www.pri-med.com/online-education/podcast/frankly-speaking-cme-247'>https://www.pri-med.com/online-education/podcast/frankly-speaking-cme-247</a></p>
<p> </p>
<p>Overview: When it comes to chronic migraines, your first-line prevention is probably medication, but according to a new study, it may not have to be. Certain foods may play a role in increasing and decreasing migraine recurrence. Join us to review a recent randomized controlled trial aimed at preventing migraines in those with chronic migraines.</p>
<p> </p>
<p>Episode resource links:</p>
<ul><li>BMJ 2021; 374 :n1448 doi:10.1136/bmj.n1448; doi: https://doi.org/10.1136/bmj.n1448</li>
<li>The association of dietary patterns with migraine attack frequency in migrainous women. Nutritional Neuroscience 23:9, pages 724-730</li>
</ul>
<p>Guest: Alan Ehrlich MD, FAAFP</p>
<p> </p>
<p>Music Credit: Richard Onorato</p>
]]></description>
                                                            <content:encoded><![CDATA[<p>Credits: 0.25 AMA PRA Category 1 Credit™</p>
<p> </p>
<p>CME/CE Information and Claim Credit: <a href='https://www.pri-med.com/online-education/podcast/frankly-speaking-cme-247'>https://www.pri-med.com/online-education/podcast/frankly-speaking-cme-247</a></p>
<p> </p>
<p>Overview: When it comes to chronic migraines, your first-line prevention is probably medication, but according to a new study, it may not have to be. Certain foods may play a role in increasing and decreasing migraine recurrence. Join us to review a recent randomized controlled trial aimed at preventing migraines in those with chronic migraines.</p>
<p> </p>
<p>Episode resource links:</p>
<ul><li>BMJ 2021; 374 :n1448 doi:10.1136/bmj.n1448; doi: https://doi.org/10.1136/bmj.n1448</li>
<li>The association of dietary patterns with migraine attack frequency in migrainous women. Nutritional Neuroscience 23:9, pages 724-730</li>
</ul>
<p>Guest: Alan Ehrlich MD, FAAFP</p>
<p> </p>
<p>Music Credit: Richard Onorato</p>
]]></content:encoded>
                                    
        <enclosure url="https://mcdn.podbean.com/mf/web/k32hqy/secure_primed_frankly-speaking-247-migraine-fatty-fish.mp3" length="10254281" type="audio/mpeg"/>
                <itunes:summary><![CDATA[Credits: 0.25 AMA PRA Category 1 Credit™
 
CME/CE Information and Claim Credit: https://www.pri-med.com/online-education/podcast/frankly-speaking-cme-247
 
Overview: When it comes to chronic migraines, your first-line prevention is probably medication, but according to a new study, it may not have to be. Certain foods may play a role in increasing and decreasing migraine recurrence. Join us to review a recent randomized controlled trial aimed at preventing migraines in those with chronic migraines.
 
Episode resource links:
BMJ 2021; 374 :n1448 doi:10.1136/bmj.n1448; doi: https://doi.org/10.1136/bmj.n1448
The association of dietary patterns with migraine attack frequency in migrainous women. Nutritional Neuroscience 23:9, pages 724-730
Guest: Alan Ehrlich MD, FAAFP
 
Music Credit: Richard Onorato]]></itunes:summary>
        <itunes:author>Pri-Med</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>639</itunes:duration>
                        <itunes:episodeType>full</itunes:episodeType>
        <itunes:image href="https://pbcdn1.podbean.com/imglogo/ep-logo/pbblog13721080/088470b15068b2f0ca62e1a95571fd40.png" />    </item>
    <item>
        <title>Muscle Relaxants for Low Back Pain: Are They Worth the Risk? - Frankly Speaking Ep 246</title>
        <itunes:title>Muscle Relaxants for Low Back Pain: Are They Worth the Risk? - Frankly Speaking Ep 246</itunes:title>
        <link>https://primedfranklyspeaking.podbean.com/e/muscle-relaxants-for-low-back-pain-are-they-worth-the-risk-frankly-speaking-ep-246-1645730488/</link>
                    <comments>https://primedfranklyspeaking.podbean.com/e/muscle-relaxants-for-low-back-pain-are-they-worth-the-risk-frankly-speaking-ep-246-1645730488/#comments</comments>        <pubDate>Mon, 18 Oct 2021 04:30:00 +0000</pubDate>
        <guid isPermaLink="false">9ddf822a-a5d9-4d59-9216-13a8e98fb8e3</guid>
                                    <description><![CDATA[<p>Credits: 0.25 AMA PRA Category 1 Credit™</p>
<p> </p>
<p>CME/CE Information and Claim Credit: <a href='https://www.pri-med.com/online-education/podcast/frankly-speaking-cme-246'>https://www.pri-med.com/online-education/podcast/frankly-speaking-cme-246</a></p>
<p> </p>
<p>Overview: Low back pain often leads to disability and loss of income and is a significant burden on patients and the healthcare system. While muscle relaxants are the third most common prescribed drugs in the treatment of low back pain, recent data demonstrating its use and efficacy are limited. This session discusses a recent systematic review of the safety, efficacy, and accepted use of muscle relaxants in the treatment of low back pain. Don’t miss this opportunity to learn how to provide low back pain treatments that have clear benefits for your patients.</p>
<p> </p>
<p>Episode resource links:</p>
<ul><li>Cashin A G, Folly T, Bagg M K, Wewege M A, Jones M D, Ferraro M C et al. Efficacy, acceptability, and safety of muscle relaxants for adults with non-specific low back pain: systematic review and meta-analysis BMJ 2021; 374 :n1446 doi:10.1136/bmj.n1446 <a href='https://pubmed.ncbi.nlm.nih.gov/34233900/'>https://pubmed.ncbi.nlm.nih.gov/34233900/</a></li>
</ul>
<p>Guest: Jill M. Terrien PhD, ANP-BC</p>
<p> </p>
<p>Music Credit: Richard Onorato</p>
]]></description>
                                                            <content:encoded><![CDATA[<p>Credits: 0.25 AMA PRA Category 1 Credit™</p>
<p> </p>
<p>CME/CE Information and Claim Credit: <a href='https://www.pri-med.com/online-education/podcast/frankly-speaking-cme-246'>https://www.pri-med.com/online-education/podcast/frankly-speaking-cme-246</a></p>
<p> </p>
<p>Overview: Low back pain often leads to disability and loss of income and is a significant burden on patients and the healthcare system. While muscle relaxants are the third most common prescribed drugs in the treatment of low back pain, recent data demonstrating its use and efficacy are limited. This session discusses a recent systematic review of the safety, efficacy, and accepted use of muscle relaxants in the treatment of low back pain. Don’t miss this opportunity to learn how to provide low back pain treatments that have clear benefits for your patients.</p>
<p> </p>
<p>Episode resource links:</p>
<ul><li>Cashin A G, Folly T, Bagg M K, Wewege M A, Jones M D, Ferraro M C et al. Efficacy, acceptability, and safety of muscle relaxants for adults with non-specific low back pain: systematic review and meta-analysis BMJ 2021; 374 :n1446 doi:10.1136/bmj.n1446 <a href='https://pubmed.ncbi.nlm.nih.gov/34233900/'>https://pubmed.ncbi.nlm.nih.gov/34233900/</a></li>
</ul>
<p>Guest: Jill M. Terrien PhD, ANP-BC</p>
<p> </p>
<p>Music Credit: Richard Onorato</p>
]]></content:encoded>
                                    
        <enclosure url="https://mcdn.podbean.com/mf/web/k5t6m2/secure_primed_frankly-speaking-low-back-pain.mp3" length="8999449" type="audio/mpeg"/>
                <itunes:summary><![CDATA[Credits: 0.25 AMA PRA Category 1 Credit™
 
CME/CE Information and Claim Credit: https://www.pri-med.com/online-education/podcast/frankly-speaking-cme-246
 
Overview: Low back pain often leads to disability and loss of income and is a significant burden on patients and the healthcare system. While muscle relaxants are the third most common prescribed drugs in the treatment of low back pain, recent data demonstrating its use and efficacy are limited. This session discusses a recent systematic review of the safety, efficacy, and accepted use of muscle relaxants in the treatment of low back pain. Don’t miss this opportunity to learn how to provide low back pain treatments that have clear benefits for your patients.
 
Episode resource links:
Cashin A G, Folly T, Bagg M K, Wewege M A, Jones M D, Ferraro M C et al. Efficacy, acceptability, and safety of muscle relaxants for adults with non-specific low back pain: systematic review and meta-analysis BMJ 2021; 374 :n1446 doi:10.1136/bmj.n1446 https://pubmed.ncbi.nlm.nih.gov/34233900/
Guest: Jill M. Terrien PhD, ANP-BC
 
Music Credit: Richard Onorato]]></itunes:summary>
        <itunes:author>Pri-Med</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>561</itunes:duration>
                        <itunes:episodeType>full</itunes:episodeType>
        <itunes:image href="https://pbcdn1.podbean.com/imglogo/ep-logo/pbblog13721080/f2946db27b168bfb2ce0061ce82760c4.png" />    </item>
    <item>
        <title>MRI for Elevated PSA - Frankly Speaking Ep 245</title>
        <itunes:title>MRI for Elevated PSA - Frankly Speaking Ep 245</itunes:title>
        <link>https://primedfranklyspeaking.podbean.com/e/mri-for-elevated-psa-frankly-speaking-ep-245-1645730489/</link>
                    <comments>https://primedfranklyspeaking.podbean.com/e/mri-for-elevated-psa-frankly-speaking-ep-245-1645730489/#comments</comments>        <pubDate>Mon, 11 Oct 2021 04:30:00 +0000</pubDate>
        <guid isPermaLink="false">2ee17ef2-27b8-4b95-849e-05f65936d69d</guid>
                                    <description><![CDATA[<p>Credits: 0.25 AMA PRA Category 1 Credit™</p>
<p> </p>
<p>CME/CE Information and Claim Credit: <a href='https://www.pri-med.com/online-education/podcast/frankly-speaking-cme-245'>https://www.pri-med.com/online-education/podcast/frankly-speaking-cme-245</a></p>
<p> </p>
<p>Overview: When your patient has an elevated screening PSA level, your first inclination may be to refer for a biopsy, but have you considered obtaining a pre-biopsy MRI? In this podcast, we will review the appropriate management for an elevated screening PSA. You’ll want to hear about the new benefit of obtaining a pre-biopsy MRI to guide diagnostic procedures.</p>
<p> </p>
<p>Episode resource links:</p>
<ul><li>NEJM July 9, 2021; DOI: 10.1056/NEJMoa2100852\
Urology 2016 Apr;90:32-7. doi: 10.1016/j.urology.2015.11.046</li>
</ul>
<p>Guest: Frank J. Domino, MD</p>
<p> </p>
<p>Music Credit: Richard Onorato</p>
]]></description>
                                                            <content:encoded><![CDATA[<p>Credits: 0.25 AMA PRA Category 1 Credit™</p>
<p> </p>
<p>CME/CE Information and Claim Credit: <a href='https://www.pri-med.com/online-education/podcast/frankly-speaking-cme-245'>https://www.pri-med.com/online-education/podcast/frankly-speaking-cme-245</a></p>
<p> </p>
<p>Overview: When your patient has an elevated screening PSA level, your first inclination may be to refer for a biopsy, but have you considered obtaining a pre-biopsy MRI? In this podcast, we will review the appropriate management for an elevated screening PSA. You’ll want to hear about the new benefit of obtaining a pre-biopsy MRI to guide diagnostic procedures.</p>
<p> </p>
<p>Episode resource links:</p>
<ul><li>NEJM July 9, 2021; DOI: 10.1056/NEJMoa2100852\<br>
Urology 2016 Apr;90:32-7. doi: 10.1016/j.urology.2015.11.046</li>
</ul>
<p>Guest: Frank J. Domino, MD</p>
<p> </p>
<p>Music Credit: Richard Onorato</p>
]]></content:encoded>
                                    
        <enclosure url="https://mcdn.podbean.com/mf/web/7ic46f/secure_primed_frankly-speaking-245-MRI-prostate-cancer-screening.mp3" length="11359369" type="audio/mpeg"/>
                <itunes:summary><![CDATA[Credits: 0.25 AMA PRA Category 1 Credit™
 
CME/CE Information and Claim Credit: https://www.pri-med.com/online-education/podcast/frankly-speaking-cme-245
 
Overview: When your patient has an elevated screening PSA level, your first inclination may be to refer for a biopsy, but have you considered obtaining a pre-biopsy MRI? In this podcast, we will review the appropriate management for an elevated screening PSA. You’ll want to hear about the new benefit of obtaining a pre-biopsy MRI to guide diagnostic procedures.
 
Episode resource links:
NEJM July 9, 2021; DOI: 10.1056/NEJMoa2100852\Urology 2016 Apr;90:32-7. doi: 10.1016/j.urology.2015.11.046
Guest: Frank J. Domino, MD
 
Music Credit: Richard Onorato]]></itunes:summary>
        <itunes:author>Pri-Med</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>708</itunes:duration>
                        <itunes:episodeType>full</itunes:episodeType>
        <itunes:image href="https://pbcdn1.podbean.com/imglogo/ep-logo/pbblog13721080/a458e8165956326ff4604c2e06da85be.png" />    </item>
    <item>
        <title>Can Artificial Intelligence Predict and Prevent Suicide? - Frankly Speaking Ep 244</title>
        <itunes:title>Can Artificial Intelligence Predict and Prevent Suicide? - Frankly Speaking Ep 244</itunes:title>
        <link>https://primedfranklyspeaking.podbean.com/e/can-artificial-intelligence-predict-and-prevent-suicide-frankly-speaking-ep-244-1645730490/</link>
                    <comments>https://primedfranklyspeaking.podbean.com/e/can-artificial-intelligence-predict-and-prevent-suicide-frankly-speaking-ep-244-1645730490/#comments</comments>        <pubDate>Mon, 04 Oct 2021 04:30:00 +0000</pubDate>
        <guid isPermaLink="false">d3fc97ac-13d9-4d45-b023-5c0cf28d8663</guid>
                                    <description><![CDATA[<p>Credits: 0.25 AMA PRA Category 1 Credit™</p>
<p> </p>
<p>CME/CE Information and Claim Credit: <a href='https://www.pri-med.com/online-education/podcast/frankly-speaking-cme-244'>https://www.pri-med.com/online-education/podcast/frankly-speaking-cme-244</a></p>
<p> </p>
<p>Overview: Suicide and attempted suicide are significant health issues affecting the United States and the world. Are you aware of the tools available to you that can support suicide prevention strategies and save lives? Don’t miss this session to learn about how the use of an electronic health record in a large health system may help predict suicide attempts.</p>
<p> </p>
<p>Episode resource links:</p>
<ul><li>
<p>Walsh CG, Johnson KB, Ripperger M, Sperry S, Harris J, Clark N, Fielstein E, Novak L, Robinson K, Stead WW. Prospective Validation of an Electronic Health Record-Based, Real-Time Suicide Risk Model. JAMA Netw Open. 2021 Mar 1;4(3):e211428. doi: 10.1001/jamanetworkopen.2021.1428. PMID: 33710291; PMCID: PMC7955273 doi: 10.1001/jamanetworkopen.2021.1428</p>
</li>
<li>
<p>Liang, Angela, and Paul Nestadt S . "Suicide Risk in the COVID-19 Pandemic." Johns Hopkins Psychiatry Guide, 2021. Johns Hopkins Guide, www.hopkinsguides.com/hopkins/view/Johns_Hopkins_Psychiatry_Guide/787393/all/Suicide_Risk_in_the_COVID_19_Pandemic.</p>
</li>
</ul>
<p>Guest: Jill M. Terrien PhD, ANP-BC</p>
<p> </p>
<p>Music Credit: Richard Onorato</p>
]]></description>
                                                            <content:encoded><![CDATA[<p>Credits: 0.25 AMA PRA Category 1 Credit™</p>
<p> </p>
<p>CME/CE Information and Claim Credit: <a href='https://www.pri-med.com/online-education/podcast/frankly-speaking-cme-244'>https://www.pri-med.com/online-education/podcast/frankly-speaking-cme-244</a></p>
<p> </p>
<p>Overview: Suicide and attempted suicide are significant health issues affecting the United States and the world. Are you aware of the tools available to you that can support suicide prevention strategies and save lives? Don’t miss this session to learn about how the use of an electronic health record in a large health system may help predict suicide attempts.</p>
<p> </p>
<p>Episode resource links:</p>
<ul><li>
<p>Walsh CG, Johnson KB, Ripperger M, Sperry S, Harris J, Clark N, Fielstein E, Novak L, Robinson K, Stead WW. Prospective Validation of an Electronic Health Record-Based, Real-Time Suicide Risk Model. JAMA Netw Open. 2021 Mar 1;4(3):e211428. doi: 10.1001/jamanetworkopen.2021.1428. PMID: 33710291; PMCID: PMC7955273 doi: 10.1001/jamanetworkopen.2021.1428</p>
</li>
<li>
<p>Liang, Angela, and Paul Nestadt S . "Suicide Risk in the COVID-19 Pandemic." Johns Hopkins Psychiatry Guide, 2021. Johns Hopkins Guide, www.hopkinsguides.com/hopkins/view/Johns_Hopkins_Psychiatry_Guide/787393/all/Suicide_Risk_in_the_COVID_19_Pandemic.</p>
</li>
</ul>
<p>Guest: Jill M. Terrien PhD, ANP-BC</p>
<p> </p>
<p>Music Credit: Richard Onorato</p>
]]></content:encoded>
                                    
        <enclosure url="https://mcdn.podbean.com/mf/web/tjc6s2/secure_primed_frankly-speaking-244-AI-suicide-risk.mp3" length="13493231" type="audio/mpeg"/>
                <itunes:summary><![CDATA[Credits: 0.25 AMA PRA Category 1 Credit™
 
CME/CE Information and Claim Credit: https://www.pri-med.com/online-education/podcast/frankly-speaking-cme-244
 
Overview: Suicide and attempted suicide are significant health issues affecting the United States and the world. Are you aware of the tools available to you that can support suicide prevention strategies and save lives? Don’t miss this session to learn about how the use of an electronic health record in a large health system may help predict suicide attempts.
 
Episode resource links:

Walsh CG, Johnson KB, Ripperger M, Sperry S, Harris J, Clark N, Fielstein E, Novak L, Robinson K, Stead WW. Prospective Validation of an Electronic Health Record-Based, Real-Time Suicide Risk Model. JAMA Netw Open. 2021 Mar 1;4(3):e211428. doi: 10.1001/jamanetworkopen.2021.1428. PMID: 33710291; PMCID: PMC7955273 doi: 10.1001/jamanetworkopen.2021.1428


Liang, Angela, and Paul Nestadt S . "Suicide Risk in the COVID-19 Pandemic." Johns Hopkins Psychiatry Guide, 2021. Johns Hopkins Guide, www.hopkinsguides.com/hopkins/view/Johns_Hopkins_Psychiatry_Guide/787393/all/Suicide_Risk_in_the_COVID_19_Pandemic.

Guest: Jill M. Terrien PhD, ANP-BC
 
Music Credit: Richard Onorato]]></itunes:summary>
        <itunes:author>Pri-Med</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>841</itunes:duration>
                        <itunes:episodeType>full</itunes:episodeType>
        <itunes:image href="https://pbcdn1.podbean.com/imglogo/ep-logo/pbblog13721080/e054a20086a26943ebf3e96658d06908.png" />    </item>
    <item>
        <title>“Can You Hear Me Now?”— Aging, Hearing Impairment, and Physical Function - Frankly Speaking Ep 243</title>
        <itunes:title>“Can You Hear Me Now?”— Aging, Hearing Impairment, and Physical Function - Frankly Speaking Ep 243</itunes:title>
        <link>https://primedfranklyspeaking.podbean.com/e/can-you-hear-me-now-%e2%80%94-aging-hearing-impairment-and-physical-function-frankly-speaking-ep-243-1645730491/</link>
                    <comments>https://primedfranklyspeaking.podbean.com/e/can-you-hear-me-now-%e2%80%94-aging-hearing-impairment-and-physical-function-frankly-speaking-ep-243-1645730491/#comments</comments>        <pubDate>Mon, 27 Sep 2021 04:30:00 +0000</pubDate>
        <guid isPermaLink="false">9acae692-c42d-4f89-8e0f-558bb2d3e456</guid>
                                    <description><![CDATA[<p>Credits: 0.25 AMA PRA Category 1 Credit™</p>
<p> </p>
<p>CME/CE Information and Claim Credit: <a href='https://www.pri-med.com/online-education/podcast/frankly-speaking-cme-243'>https://www.pri-med.com/online-education/podcast/frankly-speaking-cme-243</a></p>
<p> </p>
<p>Overview: Evidence strongly supports a correlation between hearing impairment in older adults and decline in physical functioning. A recent population cohort study of older adults revealed that hearing impairment was associated with poorer physical function, reduced walking endurance, and accelerated decline. Join us while we discuss this evidence and how to apply it to your practice. You’ll walk away with strategies to promote hearing assessment and to help optimize physical functioning in your older adult patients.</p>
<p> </p>
<p>Episode resource links:</p>
<ul><li>
<p>Brenowitz WD, Wallhagen MI. Does Hearing Impairment Affect Physical Function?: Current Evidence, Potential Mechanisms, and Future Research Directions for Healthy Aging. JAMA Netw Open. 2021 Jun 1;4(6):e2114782. doi: 10.1001/jamanetworkopen.2021.14782. PMID: 34170308.</p>
</li>
<li>
<p>Martinez-Amezcua P, Powell D, Kuo PL, Reed NS, Sullivan KJ, Palta P, Szklo M, Sharrett R, Schrack JA, Lin FR, Deal JA. Association of Age-Related Hearing Impairment With Physical Functioning Among Community-Dwelling Older Adults in the US. JAMA Netw Open. 2021 Jun 1;4(6):e2113742. doi: 10.1001/jamanetworkopen.2021.13742. PMID: 34170305; PMCID: PMC8233700.</p>
</li>
<li>
<p>Martinez-Amezcua P, Kuo PL, Reed NS, Simonsick EM, Agrawal Y, Lin FR, Deal JA, Ferrucci L, Schrack JA. Association of hearing impairment with higher level physical functioning and walking endurance: Results from the Baltimore Longitudinal Study of Aging (BLSA). J Gerontol A Biol Sci Med Sci. 2021 May 18:glab144. doi: 10.1093/gerona/glab144. Epub ahead of print. PMID: 34003883.
Croll, P.H., Vinke, E.J., Armstrong, N.M. et al. Hearing loss and cognitive decline in the general population: a prospective cohort study. J Neurol 268, 860–871 (2021). https://doi.org/10.1007/s00415-020-10208-8</p>
</li>
</ul>
<p>Guest: Susan Feeney, DNP, FNP-BC, NP-C</p>
<p> </p>
<p>Music Credit: Richard Onorato</p>
]]></description>
                                                            <content:encoded><![CDATA[<p>Credits: 0.25 AMA PRA Category 1 Credit™</p>
<p> </p>
<p>CME/CE Information and Claim Credit: <a href='https://www.pri-med.com/online-education/podcast/frankly-speaking-cme-243'>https://www.pri-med.com/online-education/podcast/frankly-speaking-cme-243</a></p>
<p> </p>
<p>Overview: Evidence strongly supports a correlation between hearing impairment in older adults and decline in physical functioning. A recent population cohort study of older adults revealed that hearing impairment was associated with poorer physical function, reduced walking endurance, and accelerated decline. Join us while we discuss this evidence and how to apply it to your practice. You’ll walk away with strategies to promote hearing assessment and to help optimize physical functioning in your older adult patients.</p>
<p> </p>
<p>Episode resource links:</p>
<ul><li>
<p>Brenowitz WD, Wallhagen MI. Does Hearing Impairment Affect Physical Function?: Current Evidence, Potential Mechanisms, and Future Research Directions for Healthy Aging. JAMA Netw Open. 2021 Jun 1;4(6):e2114782. doi: 10.1001/jamanetworkopen.2021.14782. PMID: 34170308.</p>
</li>
<li>
<p>Martinez-Amezcua P, Powell D, Kuo PL, Reed NS, Sullivan KJ, Palta P, Szklo M, Sharrett R, Schrack JA, Lin FR, Deal JA. Association of Age-Related Hearing Impairment With Physical Functioning Among Community-Dwelling Older Adults in the US. JAMA Netw Open. 2021 Jun 1;4(6):e2113742. doi: 10.1001/jamanetworkopen.2021.13742. PMID: 34170305; PMCID: PMC8233700.</p>
</li>
<li>
<p>Martinez-Amezcua P, Kuo PL, Reed NS, Simonsick EM, Agrawal Y, Lin FR, Deal JA, Ferrucci L, Schrack JA. Association of hearing impairment with higher level physical functioning and walking endurance: Results from the Baltimore Longitudinal Study of Aging (BLSA). J Gerontol A Biol Sci Med Sci. 2021 May 18:glab144. doi: 10.1093/gerona/glab144. Epub ahead of print. PMID: 34003883.<br>
Croll, P.H., Vinke, E.J., Armstrong, N.M. et al. Hearing loss and cognitive decline in the general population: a prospective cohort study. J Neurol 268, 860–871 (2021). https://doi.org/10.1007/s00415-020-10208-8</p>
</li>
</ul>
<p>Guest: Susan Feeney, DNP, FNP-BC, NP-C</p>
<p> </p>
<p>Music Credit: Richard Onorato</p>
]]></content:encoded>
                                    
        <enclosure url="https://mcdn.podbean.com/mf/web/cka5bj/secure_primed_frankly-speaking-243-hearing-loss.mp3" length="9806672" type="audio/mpeg"/>
                <itunes:summary><![CDATA[Credits: 0.25 AMA PRA Category 1 Credit™
 
CME/CE Information and Claim Credit: https://www.pri-med.com/online-education/podcast/frankly-speaking-cme-243
 
Overview: Evidence strongly supports a correlation between hearing impairment in older adults and decline in physical functioning. A recent population cohort study of older adults revealed that hearing impairment was associated with poorer physical function, reduced walking endurance, and accelerated decline. Join us while we discuss this evidence and how to apply it to your practice. You’ll walk away with strategies to promote hearing assessment and to help optimize physical functioning in your older adult patients.
 
Episode resource links:

Brenowitz WD, Wallhagen MI. Does Hearing Impairment Affect Physical Function?: Current Evidence, Potential Mechanisms, and Future Research Directions for Healthy Aging. JAMA Netw Open. 2021 Jun 1;4(6):e2114782. doi: 10.1001/jamanetworkopen.2021.14782. PMID: 34170308.


Martinez-Amezcua P, Powell D, Kuo PL, Reed NS, Sullivan KJ, Palta P, Szklo M, Sharrett R, Schrack JA, Lin FR, Deal JA. Association of Age-Related Hearing Impairment With Physical Functioning Among Community-Dwelling Older Adults in the US. JAMA Netw Open. 2021 Jun 1;4(6):e2113742. doi: 10.1001/jamanetworkopen.2021.13742. PMID: 34170305; PMCID: PMC8233700.


Martinez-Amezcua P, Kuo PL, Reed NS, Simonsick EM, Agrawal Y, Lin FR, Deal JA, Ferrucci L, Schrack JA. Association of hearing impairment with higher level physical functioning and walking endurance: Results from the Baltimore Longitudinal Study of Aging (BLSA). J Gerontol A Biol Sci Med Sci. 2021 May 18:glab144. doi: 10.1093/gerona/glab144. Epub ahead of print. PMID: 34003883.Croll, P.H., Vinke, E.J., Armstrong, N.M. et al. Hearing loss and cognitive decline in the general population: a prospective cohort study. J Neurol 268, 860–871 (2021). https://doi.org/10.1007/s00415-020-10208-8

Guest: Susan Feeney, DNP, FNP-BC, NP-C
 
Music Credit: Richard Onorato]]></itunes:summary>
        <itunes:author>Pri-Med</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>611</itunes:duration>
                        <itunes:episodeType>full</itunes:episodeType>
        <itunes:image href="https://pbcdn1.podbean.com/imglogo/ep-logo/pbblog13721080/a532b6bb9362ceb3d0a722752ccd9a77.png" />    </item>
    <item>
        <title>Cutting Through the Fog: Recognizing Gluten-Induced Neurocognitive Impairment - Frankly Speaking Ep 242</title>
        <itunes:title>Cutting Through the Fog: Recognizing Gluten-Induced Neurocognitive Impairment - Frankly Speaking Ep 242</itunes:title>
        <link>https://primedfranklyspeaking.podbean.com/e/cutting-through-the-fog-recognizing-gluten-induced-neurocognitive-impairment-frankly-speaking-ep-242-1645730492/</link>
                    <comments>https://primedfranklyspeaking.podbean.com/e/cutting-through-the-fog-recognizing-gluten-induced-neurocognitive-impairment-frankly-speaking-ep-242-1645730492/#comments</comments>        <pubDate>Mon, 20 Sep 2021 04:30:00 +0000</pubDate>
        <guid isPermaLink="false">dbd02ec6-70b5-46ca-96c9-58b12050415a</guid>
                                    <description><![CDATA[<p>Credits: 0.25 AMA PRA Category 1 Credit™</p>
<p> </p>
<p>CME/CE Information and Claim Credit: <a href='https://www.pri-med.com/online-education/podcast/frankly-speaking-cme-242'>https://www.pri-med.com/online-education/podcast/frankly-speaking-cme-242</a></p>
<p> </p>
<p>Overview: Gluten exposure is known to cause a number of problems in both those with celiac disease and those with non-celiac gluten sensitivity. One aspect that has not received much attention from the research community is the neurocognitive impairment that can occur following gluten exposure in these individuals. Join us for this podcast to dive into a recent article that describes these effects.</p>
<p> </p>
<p>Episode resource links:</p>
<ul><li>Edwards George JB, Aideyan B, Yates K, et al. Gluten-induced Neurocognitive Impairment: Results of a Nationwide Study [published online ahead of print, 2021 May 28]. J Clin Gastroenterol. 2021</li>
</ul>
<p>Guest: Alan Ehrlich MD, FAAFP</p>
<p> </p>
<p>Music Credit: Richard Onorato</p>
]]></description>
                                                            <content:encoded><![CDATA[<p>Credits: 0.25 AMA PRA Category 1 Credit™</p>
<p> </p>
<p>CME/CE Information and Claim Credit: <a href='https://www.pri-med.com/online-education/podcast/frankly-speaking-cme-242'>https://www.pri-med.com/online-education/podcast/frankly-speaking-cme-242</a></p>
<p> </p>
<p>Overview: Gluten exposure is known to cause a number of problems in both those with celiac disease and those with non-celiac gluten sensitivity. One aspect that has not received much attention from the research community is the neurocognitive impairment that can occur following gluten exposure in these individuals. Join us for this podcast to dive into a recent article that describes these effects.</p>
<p> </p>
<p>Episode resource links:</p>
<ul><li>Edwards George JB, Aideyan B, Yates K, et al. Gluten-induced Neurocognitive Impairment: Results of a Nationwide Study [published online ahead of print, 2021 May 28]. J Clin Gastroenterol. 2021</li>
</ul>
<p>Guest: Alan Ehrlich MD, FAAFP</p>
<p> </p>
<p>Music Credit: Richard Onorato</p>
]]></content:encoded>
                                    
        <enclosure url="https://mcdn.podbean.com/mf/web/domert/secure_primed_frankly-speaking-242-gluten-neurocog.mp3" length="10723439" type="audio/mpeg"/>
                <itunes:summary><![CDATA[Credits: 0.25 AMA PRA Category 1 Credit™
 
CME/CE Information and Claim Credit: https://www.pri-med.com/online-education/podcast/frankly-speaking-cme-242
 
Overview: Gluten exposure is known to cause a number of problems in both those with celiac disease and those with non-celiac gluten sensitivity. One aspect that has not received much attention from the research community is the neurocognitive impairment that can occur following gluten exposure in these individuals. Join us for this podcast to dive into a recent article that describes these effects.
 
Episode resource links:
Edwards George JB, Aideyan B, Yates K, et al. Gluten-induced Neurocognitive Impairment: Results of a Nationwide Study [published online ahead of print, 2021 May 28]. J Clin Gastroenterol. 2021
Guest: Alan Ehrlich MD, FAAFP
 
Music Credit: Richard Onorato]]></itunes:summary>
        <itunes:author>Pri-Med</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>668</itunes:duration>
                        <itunes:episodeType>full</itunes:episodeType>
        <itunes:image href="https://pbcdn1.podbean.com/imglogo/ep-logo/pbblog13721080/7b1597b2346e74cf2e04e96626fbc1ba.png" />    </item>
    <item>
        <title>Continuous Glucose Monitoring (CGM) for Type 2 Diabetes Mellitus (T2DM) - Frankly Speaking Ep 240</title>
        <itunes:title>Continuous Glucose Monitoring (CGM) for Type 2 Diabetes Mellitus (T2DM) - Frankly Speaking Ep 240</itunes:title>
        <link>https://primedfranklyspeaking.podbean.com/e/continuous-glucose-monitoring-cgm-for-type-2-diabetes-mellitus-t2dm-frankly-speaking-ep-240-1645730493/</link>
                    <comments>https://primedfranklyspeaking.podbean.com/e/continuous-glucose-monitoring-cgm-for-type-2-diabetes-mellitus-t2dm-frankly-speaking-ep-240-1645730493/#comments</comments>        <pubDate>Mon, 06 Sep 2021 04:30:00 +0000</pubDate>
        <guid isPermaLink="false">2b1f96a7-17d3-403e-b400-236c83662615</guid>
                                    <description><![CDATA[<p>Credits: 0.25 AMA PRA Category 1 Credit™</p>
<p> </p>
<p>CME/CE Information and Claim Credit: <a href='https://www.pri-med.com/online-education/podcast/frankly-speaking-cme-240'>https://www.pri-med.com/online-education/podcast/frankly-speaking-cme-240</a></p>
<p> </p>
<p>Overview: Have you considered continuous glucose monitoring (CGM) for your patients with suboptimally controlled type 2 diabetes mellitus (T2DM) on at least 3 injections of insulin per day? This session will give you the information you need to confidently initiate CGM in appropriate patients. You’ll walk away with a clear understanding of the different CGM options and the benefits and challenges of CGM.</p>
<p> </p>
<p>Episode resource links:</p>
<ul><li>Ida S, Kaneko R, Murata K. Utility of Real-Time and Retrospective Continuous Glucose Monitoring in Patients with Type 2 Diabetes Mellitus: A Meta-Analysis of Randomized Controlled Trials. J Diabetes Res. 2019 Jan 15;2019:4684815. doi: 10.1155/2019/4684815. PMID: 30775385; PMCID: PMC6350576.</li>
<li>Maiorino et al. Diabetes Care. 2020;43:1146–1156</li>
</ul>
<p>Guest: Jillian Joseph, MPAS, PA-C</p>
<p> </p>
<p>Music Credit: Richard Onorato</p>
]]></description>
                                                            <content:encoded><![CDATA[<p>Credits: 0.25 AMA PRA Category 1 Credit™</p>
<p> </p>
<p>CME/CE Information and Claim Credit: <a href='https://www.pri-med.com/online-education/podcast/frankly-speaking-cme-240'>https://www.pri-med.com/online-education/podcast/frankly-speaking-cme-240</a></p>
<p> </p>
<p>Overview: Have you considered continuous glucose monitoring (CGM) for your patients with suboptimally controlled type 2 diabetes mellitus (T2DM) on at least 3 injections of insulin per day? This session will give you the information you need to confidently initiate CGM in appropriate patients. You’ll walk away with a clear understanding of the different CGM options and the benefits and challenges of CGM.</p>
<p> </p>
<p>Episode resource links:</p>
<ul><li>Ida S, Kaneko R, Murata K. Utility of Real-Time and Retrospective Continuous Glucose Monitoring in Patients with Type 2 Diabetes Mellitus: A Meta-Analysis of Randomized Controlled Trials. J Diabetes Res. 2019 Jan 15;2019:4684815. doi: 10.1155/2019/4684815. PMID: 30775385; PMCID: PMC6350576.</li>
<li>Maiorino et al. Diabetes Care. 2020;43:1146–1156</li>
</ul>
<p>Guest: Jillian Joseph, MPAS, PA-C</p>
<p> </p>
<p>Music Credit: Richard Onorato</p>
]]></content:encoded>
                                    
        <enclosure url="https://mcdn.podbean.com/mf/web/hot4bb/secure_primed_frankly-speaking-240-CGM-diabetes.mp3" length="8997712" type="audio/mpeg"/>
                <itunes:summary><![CDATA[Credits: 0.25 AMA PRA Category 1 Credit™
 
CME/CE Information and Claim Credit: https://www.pri-med.com/online-education/podcast/frankly-speaking-cme-240
 
Overview: Have you considered continuous glucose monitoring (CGM) for your patients with suboptimally controlled type 2 diabetes mellitus (T2DM) on at least 3 injections of insulin per day? This session will give you the information you need to confidently initiate CGM in appropriate patients. You’ll walk away with a clear understanding of the different CGM options and the benefits and challenges of CGM.
 
Episode resource links:
Ida S, Kaneko R, Murata K. Utility of Real-Time and Retrospective Continuous Glucose Monitoring in Patients with Type 2 Diabetes Mellitus: A Meta-Analysis of Randomized Controlled Trials. J Diabetes Res. 2019 Jan 15;2019:4684815. doi: 10.1155/2019/4684815. PMID: 30775385; PMCID: PMC6350576.
Maiorino et al. Diabetes Care. 2020;43:1146–1156
Guest: Jillian Joseph, MPAS, PA-C
 
Music Credit: Richard Onorato]]></itunes:summary>
        <itunes:author>Pri-Med</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>560</itunes:duration>
                        <itunes:episodeType>full</itunes:episodeType>
        <itunes:image href="https://pbcdn1.podbean.com/imglogo/ep-logo/pbblog13721080/32707e9755326d92bd7c6c38d250bbc8.png" />    </item>
    <item>
        <title>Update From the CDC: New Gonorrhea Guidelines - Frankly Speaking Ep 239</title>
        <itunes:title>Update From the CDC: New Gonorrhea Guidelines - Frankly Speaking Ep 239</itunes:title>
        <link>https://primedfranklyspeaking.podbean.com/e/update-from-the-cdc-new-gonorrhea-guidelines-frankly-speaking-ep-239-1645730495/</link>
                    <comments>https://primedfranklyspeaking.podbean.com/e/update-from-the-cdc-new-gonorrhea-guidelines-frankly-speaking-ep-239-1645730495/#comments</comments>        <pubDate>Mon, 30 Aug 2021 04:30:00 +0000</pubDate>
        <guid isPermaLink="false">d2450f7d-8b4d-41dd-8376-162ee105a924</guid>
                                    <description><![CDATA[<p>Credits: 0.25 AMA PRA Category 1 Credit™</p>
<p> </p>
<p>CME/CE Information and Claim Credit: <a href='https://www.pri-med.com/online-education/podcast/frankly-speaking-cme-239'>https://www.pri-med.com/online-education/podcast/frankly-speaking-cme-239</a></p>
<p> </p>
<p>Overview: Join us to discuss the CDC’s new guidelines for the management of sexually transmitted infections due to Neisseria gonorrhoeae. You’ll walk away with recommendations for how to address urogenital, rectal, and pharyngeal infections. You’ll also discover alternative regimens for patients allergic to first-line therapy and understand how to manage coinfection with chlamydia.</p>
<p> </p>
<p>Episode resource links:</p>
<ul><li>St. Cyr S, Barbee L, Workowski KA, et al. Update to CDC’s Treatment Guidelines for Gonococcal Infection, 2020. MMWR Morb Mortal Wkly Rep 2020;69:1911–191</li>
</ul>
<p>Guest: Alan Ehrlich MD, FAAFP</p>
<p> </p>
<p>Music Credit: Richard Onorato</p>
]]></description>
                                                            <content:encoded><![CDATA[<p>Credits: 0.25 AMA PRA Category 1 Credit™</p>
<p> </p>
<p>CME/CE Information and Claim Credit: <a href='https://www.pri-med.com/online-education/podcast/frankly-speaking-cme-239'>https://www.pri-med.com/online-education/podcast/frankly-speaking-cme-239</a></p>
<p> </p>
<p>Overview: Join us to discuss the CDC’s new guidelines for the management of sexually transmitted infections due to Neisseria gonorrhoeae. You’ll walk away with recommendations for how to address urogenital, rectal, and pharyngeal infections. You’ll also discover alternative regimens for patients allergic to first-line therapy and understand how to manage coinfection with chlamydia.</p>
<p> </p>
<p>Episode resource links:</p>
<ul><li>St. Cyr S, Barbee L, Workowski KA, et al. Update to CDC’s Treatment Guidelines for Gonococcal Infection, 2020. MMWR Morb Mortal Wkly Rep 2020;69:1911–191</li>
</ul>
<p>Guest: Alan Ehrlich MD, FAAFP</p>
<p> </p>
<p>Music Credit: Richard Onorato</p>
]]></content:encoded>
                                    
        <enclosure url="https://mcdn.podbean.com/mf/web/gt76dd/secure_primed_frankly-speaking-239-gonorrhea.mp3" length="8651127" type="audio/mpeg"/>
                <itunes:summary><![CDATA[Credits: 0.25 AMA PRA Category 1 Credit™
 
CME/CE Information and Claim Credit: https://www.pri-med.com/online-education/podcast/frankly-speaking-cme-239
 
Overview: Join us to discuss the CDC’s new guidelines for the management of sexually transmitted infections due to Neisseria gonorrhoeae. You’ll walk away with recommendations for how to address urogenital, rectal, and pharyngeal infections. You’ll also discover alternative regimens for patients allergic to first-line therapy and understand how to manage coinfection with chlamydia.
 
Episode resource links:
St. Cyr S, Barbee L, Workowski KA, et al. Update to CDC’s Treatment Guidelines for Gonococcal Infection, 2020. MMWR Morb Mortal Wkly Rep 2020;69:1911–191
Guest: Alan Ehrlich MD, FAAFP
 
Music Credit: Richard Onorato]]></itunes:summary>
        <itunes:author>Pri-Med</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>539</itunes:duration>
                        <itunes:episodeType>full</itunes:episodeType>
        <itunes:image href="https://pbcdn1.podbean.com/imglogo/ep-logo/pbblog13721080/94124d71a06b943735e66f3e7a1d68e8.png" />    </item>
    <item>
        <title>Lung Cancer Screening—Expanded Recommendations! - Frankly Speaking Ep 238</title>
        <itunes:title>Lung Cancer Screening—Expanded Recommendations! - Frankly Speaking Ep 238</itunes:title>
        <link>https://primedfranklyspeaking.podbean.com/e/lung-cancer-screening%e2%80%94expanded-recommendations-frankly-speaking-ep-238-1645730496/</link>
                    <comments>https://primedfranklyspeaking.podbean.com/e/lung-cancer-screening%e2%80%94expanded-recommendations-frankly-speaking-ep-238-1645730496/#comments</comments>        <pubDate>Mon, 23 Aug 2021 04:30:00 +0000</pubDate>
        <guid isPermaLink="false">40c49e8d-97fc-4c06-b777-4b86d0f866b2</guid>
                                    <description><![CDATA[<p>Credits: 0.25 AMA PRA Category 1 Credit™</p>
<p> </p>
<p>CME/CE Information and Claim Credit: <a href='https://www.pri-med.com/online-education/podcast/frankly-speaking-cme-238'>https://www.pri-med.com/online-education/podcast/frankly-speaking-cme-238</a></p>
<p> </p>
<p>Overview: Join us to discuss important changes in the 2021 USPSTF recommendation on lung cancer screening. Given lung cancer’s high prevalence and poor prognosis in later stages, it is important for primary care clinicians to know which patients to screen and what method to use. You’ll also learn the appropriate time to stop screening.</p>
<p> </p>
<p>Episode resource links:</p>
<ul><li>Screening for Lung Cancer US Preventive Services Task Force Recommendation Statement JAMA. 2021;325(10):962-970. doi:10.1001/jama.2021.1117</li>
</ul>
<p>Guest: Robert A. Baldor MD, FAAFP</p>
<p> </p>
<p>Music Credit: Richard Onorato</p>
]]></description>
                                                            <content:encoded><![CDATA[<p>Credits: 0.25 AMA PRA Category 1 Credit™</p>
<p> </p>
<p>CME/CE Information and Claim Credit: <a href='https://www.pri-med.com/online-education/podcast/frankly-speaking-cme-238'>https://www.pri-med.com/online-education/podcast/frankly-speaking-cme-238</a></p>
<p> </p>
<p>Overview: Join us to discuss important changes in the 2021 USPSTF recommendation on lung cancer screening. Given lung cancer’s high prevalence and poor prognosis in later stages, it is important for primary care clinicians to know which patients to screen and what method to use. You’ll also learn the appropriate time to stop screening.</p>
<p> </p>
<p>Episode resource links:</p>
<ul><li>Screening for Lung Cancer US Preventive Services Task Force Recommendation Statement JAMA. 2021;325(10):962-970. doi:10.1001/jama.2021.1117</li>
</ul>
<p>Guest: Robert A. Baldor MD, FAAFP</p>
<p> </p>
<p>Music Credit: Richard Onorato</p>
]]></content:encoded>
                                    
        <enclosure url="https://mcdn.podbean.com/mf/web/9ib8nl/secure_primed_frankly-speaking-238-lung-cancer.mp3" length="11362886" type="audio/mpeg"/>
                <itunes:summary><![CDATA[Credits: 0.25 AMA PRA Category 1 Credit™
 
CME/CE Information and Claim Credit: https://www.pri-med.com/online-education/podcast/frankly-speaking-cme-238
 
Overview: Join us to discuss important changes in the 2021 USPSTF recommendation on lung cancer screening. Given lung cancer’s high prevalence and poor prognosis in later stages, it is important for primary care clinicians to know which patients to screen and what method to use. You’ll also learn the appropriate time to stop screening.
 
Episode resource links:
Screening for Lung Cancer US Preventive Services Task Force Recommendation Statement JAMA. 2021;325(10):962-970. doi:10.1001/jama.2021.1117
Guest: Robert A. Baldor MD, FAAFP
 
Music Credit: Richard Onorato]]></itunes:summary>
        <itunes:author>Pri-Med</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>709</itunes:duration>
                        <itunes:episodeType>full</itunes:episodeType>
        <itunes:image href="https://pbcdn1.podbean.com/imglogo/ep-logo/pbblog13721080/0a909694626d1d86bb606e0e5943b233.png" />    </item>
    <item>
        <title>Identifying Risk in Women to Prevent CVD - Frankly Speaking Ep 237</title>
        <itunes:title>Identifying Risk in Women to Prevent CVD - Frankly Speaking Ep 237</itunes:title>
        <link>https://primedfranklyspeaking.podbean.com/e/identifying-risk-in-women-to-prevent-cvd-frankly-speaking-ep-237-1645730497/</link>
                    <comments>https://primedfranklyspeaking.podbean.com/e/identifying-risk-in-women-to-prevent-cvd-frankly-speaking-ep-237-1645730497/#comments</comments>        <pubDate>Mon, 16 Aug 2021 04:30:00 +0000</pubDate>
        <guid isPermaLink="false">36b762f7-dfdf-4b69-8d62-0b9723895340</guid>
                                    <description><![CDATA[<p>Credits: 0.25 AMA PRA Category 1 Credit™</p>
<p> </p>
<p>CME/CE Information and Claim Credit: <a href='https://www.pri-med.com/online-education/podcast/frankly-speaking-cme-237'>https://www.pri-med.com/online-education/podcast/frankly-speaking-cme-237</a></p>
<p> </p>
<p>Overview: Solid evidence shows that adverse pregnancy outcomes (APOs) correlate with an increased risk of cardiovascular disease (CVD) in women. Evidence is also becoming clearer that lactation and breastfeeding may have CV protective benefits as well. Social determinants of health play a significant role in these diseases; facts support that Black, Hispanic and Asian American women suffer from worse pregnancy outcomes than White American women. Join us while we discuss the recent American Heart Association (AHA) guideline update regarding the association of increased risk of CVD and metabolic disease with APOs and what can be done to reduce these risks.</p>
<p> </p>
<p>Episode resource links:</p>
<ul><li>Adverse Pregnancy Outcomes and Cardiovascular Disease Risk: Unique Opportunities for Cardiovascular Disease Prevention in Women. Nisha I. Parikh, MD, MPH, Chair, Juan M. Gonzalez, MD, Cheryl A.M. Anderson, PhD, Suzanne E. Judd, PhD, Kathryn M. Rexrode, MD, Mark A. Hlatky, MD, Erica P. Gunderson, PhD, Jennifer J. Stuart, ScD, Dhananjay Vaidya, PhD, Vice Chair, On behalf of the American Heart Association Council on Epidemiology and Prevention; Council on Arteriosclerosis, Thrombosis and Vascular Biology; Council on Cardiovascular and Stroke Nursing; and the Stroke Council. <a href='https://www.ahajournals.org/doi/abs/10.1161/CIR.000000000000096'>https://www.ahajournals.org/doi/abs/10.1161/CIR.000000000000096</a></li>
<li>Schwartz, EB. (reviewing Parikh NI et al. Circulation 2021 Mar 29). Preventing Heart Disease in Women: New Guidance from the American Heart Association. NEJM: Journal Watch, April 12, 2021. <a href='https://www.jwatch.org/na53433/2021/04/12/preventing-heart-disease-women-new-guidance-american-heart?ijkey=3l3eCvQLl'> https://www.jwatch.org/na53433/2021/04/12/preventing-heart-disease-women-new-guidance-american-heart?ijkey=3l3eCvQLl</a></li>
<li>Clinical Statements and Guidelines. AHA/ACOG Presidential Advisory. Volume 137, Issue 24, 12 June 2018, Pages e843-e852. <a href='https://doi.org/10.1161/CIR.0000000000000582'>https://doi.org/10.1161/CIR.0000000000000582</a></li>
<li><a href='https://www.jwatch.org/na53433/2021/04/12/preventing-heart-disease-women-new-guidance-american-heart'> https://www.jwatch.org/na53433/2021/04/12/preventing-heart-disease-women-new-guidance-american-heart</a></li>
</ul>
<p>Guest: Susan Feeney, DNP, FNP-BC, NP-C</p>
<p> </p>
<p>Music Credit: Richard Onorato</p>
]]></description>
                                                            <content:encoded><![CDATA[<p>Credits: 0.25 AMA PRA Category 1 Credit™</p>
<p> </p>
<p>CME/CE Information and Claim Credit: <a href='https://www.pri-med.com/online-education/podcast/frankly-speaking-cme-237'>https://www.pri-med.com/online-education/podcast/frankly-speaking-cme-237</a></p>
<p> </p>
<p>Overview: Solid evidence shows that adverse pregnancy outcomes (APOs) correlate with an increased risk of cardiovascular disease (CVD) in women. Evidence is also becoming clearer that lactation and breastfeeding may have CV protective benefits as well. Social determinants of health play a significant role in these diseases; facts support that Black, Hispanic and Asian American women suffer from worse pregnancy outcomes than White American women. Join us while we discuss the recent American Heart Association (AHA) guideline update regarding the association of increased risk of CVD and metabolic disease with APOs and what can be done to reduce these risks.</p>
<p> </p>
<p>Episode resource links:</p>
<ul><li>Adverse Pregnancy Outcomes and Cardiovascular Disease Risk: Unique Opportunities for Cardiovascular Disease Prevention in Women. Nisha I. Parikh, MD, MPH, Chair, Juan M. Gonzalez, MD, Cheryl A.M. Anderson, PhD, Suzanne E. Judd, PhD, Kathryn M. Rexrode, MD, Mark A. Hlatky, MD, Erica P. Gunderson, PhD, Jennifer J. Stuart, ScD, Dhananjay Vaidya, PhD, Vice Chair, On behalf of the American Heart Association Council on Epidemiology and Prevention; Council on Arteriosclerosis, Thrombosis and Vascular Biology; Council on Cardiovascular and Stroke Nursing; and the Stroke Council. <a href='https://www.ahajournals.org/doi/abs/10.1161/CIR.000000000000096'>https://www.ahajournals.org/doi/abs/10.1161/CIR.000000000000096</a></li>
<li>Schwartz, EB. (reviewing Parikh NI et al. Circulation 2021 Mar 29). Preventing Heart Disease in Women: New Guidance from the American Heart Association. NEJM: Journal Watch, April 12, 2021. <a href='https://www.jwatch.org/na53433/2021/04/12/preventing-heart-disease-women-new-guidance-american-heart?ijkey=3l3eCvQLl'> https://www.jwatch.org/na53433/2021/04/12/preventing-heart-disease-women-new-guidance-american-heart?ijkey=3l3eCvQLl</a></li>
<li>Clinical Statements and Guidelines. AHA/ACOG Presidential Advisory. Volume 137, Issue 24, 12 June 2018, Pages e843-e852. <a href='https://doi.org/10.1161/CIR.0000000000000582'>https://doi.org/10.1161/CIR.0000000000000582</a></li>
<li><a href='https://www.jwatch.org/na53433/2021/04/12/preventing-heart-disease-women-new-guidance-american-heart'> https://www.jwatch.org/na53433/2021/04/12/preventing-heart-disease-women-new-guidance-american-heart</a></li>
</ul>
<p>Guest: Susan Feeney, DNP, FNP-BC, NP-C</p>
<p> </p>
<p>Music Credit: Richard Onorato</p>
]]></content:encoded>
                                    
        <enclosure url="https://mcdn.podbean.com/mf/web/7ki1im/secure_primed_frankly-speaking-237-cvd-risk-women.mp3" length="9141377" type="audio/mpeg"/>
                <itunes:summary><![CDATA[Credits: 0.25 AMA PRA Category 1 Credit™
 
CME/CE Information and Claim Credit: https://www.pri-med.com/online-education/podcast/frankly-speaking-cme-237
 
Overview: Solid evidence shows that adverse pregnancy outcomes (APOs) correlate with an increased risk of cardiovascular disease (CVD) in women. Evidence is also becoming clearer that lactation and breastfeeding may have CV protective benefits as well. Social determinants of health play a significant role in these diseases; facts support that Black, Hispanic and Asian American women suffer from worse pregnancy outcomes than White American women. Join us while we discuss the recent American Heart Association (AHA) guideline update regarding the association of increased risk of CVD and metabolic disease with APOs and what can be done to reduce these risks.
 
Episode resource links:
Adverse Pregnancy Outcomes and Cardiovascular Disease Risk: Unique Opportunities for Cardiovascular Disease Prevention in Women. Nisha I. Parikh, MD, MPH, Chair, Juan M. Gonzalez, MD, Cheryl A.M. Anderson, PhD, Suzanne E. Judd, PhD, Kathryn M. Rexrode, MD, Mark A. Hlatky, MD, Erica P. Gunderson, PhD, Jennifer J. Stuart, ScD, Dhananjay Vaidya, PhD, Vice Chair, On behalf of the American Heart Association Council on Epidemiology and Prevention; Council on Arteriosclerosis, Thrombosis and Vascular Biology; Council on Cardiovascular and Stroke Nursing; and the Stroke Council. https://www.ahajournals.org/doi/abs/10.1161/CIR.000000000000096
Schwartz, EB. (reviewing Parikh NI et al. Circulation 2021 Mar 29). Preventing Heart Disease in Women: New Guidance from the American Heart Association. NEJM: Journal Watch, April 12, 2021.  https://www.jwatch.org/na53433/2021/04/12/preventing-heart-disease-women-new-guidance-american-heart?ijkey=3l3eCvQLl
Clinical Statements and Guidelines. AHA/ACOG Presidential Advisory. Volume 137, Issue 24, 12 June 2018, Pages e843-e852. https://doi.org/10.1161/CIR.0000000000000582
 https://www.jwatch.org/na53433/2021/04/12/preventing-heart-disease-women-new-guidance-american-heart
Guest: Susan Feeney, DNP, FNP-BC, NP-C
 
Music Credit: Richard Onorato]]></itunes:summary>
        <itunes:author>Pri-Med</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>570</itunes:duration>
                        <itunes:episodeType>full</itunes:episodeType>
        <itunes:image href="https://pbcdn1.podbean.com/imglogo/ep-logo/pbblog13721080/fefda45455121c22eb3e12acdde2f290.png" />    </item>
    <item>
        <title>Continuous Glucose Monitoring—What’s All the Hype? - Frankly Speaking Ep 236</title>
        <itunes:title>Continuous Glucose Monitoring—What’s All the Hype? - Frankly Speaking Ep 236</itunes:title>
        <link>https://primedfranklyspeaking.podbean.com/e/continuous-glucose-monitoring%e2%80%94what-s-all-the-hype-frankly-speaking-ep-236-1645730498/</link>
                    <comments>https://primedfranklyspeaking.podbean.com/e/continuous-glucose-monitoring%e2%80%94what-s-all-the-hype-frankly-speaking-ep-236-1645730498/#comments</comments>        <pubDate>Mon, 09 Aug 2021 04:30:00 +0000</pubDate>
        <guid isPermaLink="false">fc2b36c1-9c87-4740-8d5b-ae1195bd41f1</guid>
                                    <description><![CDATA[<p>Credits: 0.25 AMA PRA Category 1 Credit™</p>
<p> </p>
<p>CME/CE Information and Claim Credit: <a href='https://www.pri-med.com/online-education/podcast/frankly-speaking-cme-236'>https://www.pri-med.com/online-education/podcast/frankly-speaking-cme-236</a></p>
<p> </p>
<p>Overview: Continuous glucose monitoring (CGM) for patients with diabetes has been available for several years now, but its utility in managing diabetes care is unclear. Join us to discuss the results of a systematic review examining the benefits of CGM for patients with both type 1 and type 2 diabetes mellitus.</p>
<p> </p>
<p>Episode resource links:</p>
<ul><li>
<p>Effects of continuous glucose monitoring on metrics of glycemic control in diabetes: a systematic review with meta-analysis of randomized controlled trials. Diabetes Care. 2020;43(5):1146-1156.</p>
</li>
<li>
<p>Implementing Continuous Glucose Monitoring in Clinical Practice. www.aafp.org/fpm March/April 2021</p>
</li>
<li>
<p>Longo R, Sperling S. Personal versus professional continuous glucose monitoring: when to use which on whom. Diabetes Spectr. 2019;32(3):183-193.</p>
</li>
</ul>
<p> </p>
<p>Guest: Robert A. Baldor MD, FAAFP</p>
<p> </p>
<p>Music Credit: Richard Onorato</p>
]]></description>
                                                            <content:encoded><![CDATA[<p>Credits: 0.25 AMA PRA Category 1 Credit™</p>
<p> </p>
<p>CME/CE Information and Claim Credit: <a href='https://www.pri-med.com/online-education/podcast/frankly-speaking-cme-236'>https://www.pri-med.com/online-education/podcast/frankly-speaking-cme-236</a></p>
<p> </p>
<p>Overview: Continuous glucose monitoring (CGM) for patients with diabetes has been available for several years now, but its utility in managing diabetes care is unclear. Join us to discuss the results of a systematic review examining the benefits of CGM for patients with both type 1 and type 2 diabetes mellitus.</p>
<p> </p>
<p>Episode resource links:</p>
<ul><li>
<p>Effects of continuous glucose monitoring on metrics of glycemic control in diabetes: a systematic review with meta-analysis of randomized controlled trials. Diabetes Care. 2020;43(5):1146-1156.</p>
</li>
<li>
<p>Implementing Continuous Glucose Monitoring in Clinical Practice. www.aafp.org/fpm March/April 2021</p>
</li>
<li>
<p>Longo R, Sperling S. Personal versus professional continuous glucose monitoring: when to use which on whom. Diabetes Spectr. 2019;32(3):183-193.</p>
</li>
</ul>
<p> </p>
<p>Guest: Robert A. Baldor MD, FAAFP</p>
<p> </p>
<p>Music Credit: Richard Onorato</p>
]]></content:encoded>
                                    
        <enclosure url="https://mcdn.podbean.com/mf/web/b5xtis/secure_primed_frankly-speaking-236-glucose-monitoring.mp3" length="9634267" type="audio/mpeg"/>
                <itunes:summary><![CDATA[Credits: 0.25 AMA PRA Category 1 Credit™
 
CME/CE Information and Claim Credit: https://www.pri-med.com/online-education/podcast/frankly-speaking-cme-236
 
Overview: Continuous glucose monitoring (CGM) for patients with diabetes has been available for several years now, but its utility in managing diabetes care is unclear. Join us to discuss the results of a systematic review examining the benefits of CGM for patients with both type 1 and type 2 diabetes mellitus.
 
Episode resource links:

Effects of continuous glucose monitoring on metrics of glycemic control in diabetes: a systematic review with meta-analysis of randomized controlled trials. Diabetes Care. 2020;43(5):1146-1156.


Implementing Continuous Glucose Monitoring in Clinical Practice. www.aafp.org/fpm March/April 2021


Longo R, Sperling S. Personal versus professional continuous glucose monitoring: when to use which on whom. Diabetes Spectr. 2019;32(3):183-193.

 
Guest: Robert A. Baldor MD, FAAFP
 
Music Credit: Richard Onorato]]></itunes:summary>
        <itunes:author>Pri-Med</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>601</itunes:duration>
                        <itunes:episodeType>full</itunes:episodeType>
        <itunes:image href="https://pbcdn1.podbean.com/imglogo/ep-logo/pbblog13721080/0d383b6b1bc9b040a66ca0bd955777b6.png" />    </item>
    <item>
        <title>Nasal Steroids for Perennial Allergic Rhinitis: Is PRN Use Enough? - Frankly Speaking Ep 235</title>
        <itunes:title>Nasal Steroids for Perennial Allergic Rhinitis: Is PRN Use Enough? - Frankly Speaking Ep 235</itunes:title>
        <link>https://primedfranklyspeaking.podbean.com/e/nasal-steroids-for-perennial-allergic-rhinitis-is-prn-use-enough-frankly-speaking-ep-235-1645730499/</link>
                    <comments>https://primedfranklyspeaking.podbean.com/e/nasal-steroids-for-perennial-allergic-rhinitis-is-prn-use-enough-frankly-speaking-ep-235-1645730499/#comments</comments>        <pubDate>Mon, 02 Aug 2021 16:00:00 +0000</pubDate>
        <guid isPermaLink="false">98ae902a-a7ba-46e3-a811-4f4f4b3455fa</guid>
                                    <description><![CDATA[<p>Credits: 0.25 AMA PRA Category 1 Credit™</p>
<p> </p>
<p>CME/CE Information and Claim Credit: <a href='https://www.pri-med.com/online-education/podcast/frankly-speaking-cme-235'>https://www.pri-med.com/online-education/podcast/frankly-speaking-cme-235</a></p>
<p> </p>
<p>Overview: Perennial allergic rhinitis affects both children and adults, and management includes both allergy avoidance as well as medication management. Intranasal steroids are the mainstay of treatment and have traditionally required consistent use, but new data are emerging. Find out the results of a new study evaluating PRN use as an alternative approach.</p>
<p> </p>
<p>Episode resource links:</p>
<ul><li>Thongngarm T, Wongsa C, Phinyo P, Assanasen P, Tantilipikorn P, Sompornrattanaphan M. As-Needed Versus Regular Use of Fluticasone Furoate Nasal Spray in Patients with Moderate to Severe, Persistent, Perennial Allergic Rhinitis: A Randomized Controlled Trial. J Allergy Clin Immunol Pract. 2021 Mar;9(3):1365-1373</li>
</ul>
<p>Guest: Alan Ehrlich MD, FAAFP</p>
<p> </p>
<p>Music Credit: Richard Onorato</p>
]]></description>
                                                            <content:encoded><![CDATA[<p>Credits: 0.25 AMA PRA Category 1 Credit™</p>
<p> </p>
<p>CME/CE Information and Claim Credit: <a href='https://www.pri-med.com/online-education/podcast/frankly-speaking-cme-235'>https://www.pri-med.com/online-education/podcast/frankly-speaking-cme-235</a></p>
<p> </p>
<p>Overview: Perennial allergic rhinitis affects both children and adults, and management includes both allergy avoidance as well as medication management. Intranasal steroids are the mainstay of treatment and have traditionally required consistent use, but new data are emerging. Find out the results of a new study evaluating PRN use as an alternative approach.</p>
<p> </p>
<p>Episode resource links:</p>
<ul><li>Thongngarm T, Wongsa C, Phinyo P, Assanasen P, Tantilipikorn P, Sompornrattanaphan M. As-Needed Versus Regular Use of Fluticasone Furoate Nasal Spray in Patients with Moderate to Severe, Persistent, Perennial Allergic Rhinitis: A Randomized Controlled Trial. J Allergy Clin Immunol Pract. 2021 Mar;9(3):1365-1373</li>
</ul>
<p>Guest: Alan Ehrlich MD, FAAFP</p>
<p> </p>
<p>Music Credit: Richard Onorato</p>
]]></content:encoded>
                                    
        <enclosure url="https://mcdn.podbean.com/mf/web/9j2cah/secure_primed_frankly-speaking-235-nasal-steroids.mp3" length="8397476" type="audio/mpeg"/>
                <itunes:summary><![CDATA[Credits: 0.25 AMA PRA Category 1 Credit™
 
CME/CE Information and Claim Credit: https://www.pri-med.com/online-education/podcast/frankly-speaking-cme-235
 
Overview: Perennial allergic rhinitis affects both children and adults, and management includes both allergy avoidance as well as medication management. Intranasal steroids are the mainstay of treatment and have traditionally required consistent use, but new data are emerging. Find out the results of a new study evaluating PRN use as an alternative approach.
 
Episode resource links:
Thongngarm T, Wongsa C, Phinyo P, Assanasen P, Tantilipikorn P, Sompornrattanaphan M. As-Needed Versus Regular Use of Fluticasone Furoate Nasal Spray in Patients with Moderate to Severe, Persistent, Perennial Allergic Rhinitis: A Randomized Controlled Trial. J Allergy Clin Immunol Pract. 2021 Mar;9(3):1365-1373
Guest: Alan Ehrlich MD, FAAFP
 
Music Credit: Richard Onorato]]></itunes:summary>
        <itunes:author>Pri-Med</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>523</itunes:duration>
                        <itunes:episodeType>full</itunes:episodeType>
        <itunes:image href="https://pbcdn1.podbean.com/imglogo/ep-logo/pbblog13721080/e2fa45fc3efd6ec652f663ad59787a25.png" />    </item>
    <item>
        <title>Shorter Antibiotic Duration for Outpatient Infections - Frankly Speaking Ep 234</title>
        <itunes:title>Shorter Antibiotic Duration for Outpatient Infections - Frankly Speaking Ep 234</itunes:title>
        <link>https://primedfranklyspeaking.podbean.com/e/shorter-antibiotic-duration-for-outpatient-infections-frankly-speaking-ep-234-1645730500/</link>
                    <comments>https://primedfranklyspeaking.podbean.com/e/shorter-antibiotic-duration-for-outpatient-infections-frankly-speaking-ep-234-1645730500/#comments</comments>        <pubDate>Mon, 26 Jul 2021 04:30:00 +0000</pubDate>
        <guid isPermaLink="false">8efdfa74-69cb-48e4-bc7f-807eb9a25bdf</guid>
                                    <description><![CDATA[<p>Credits: 0.25 AMA PRA Category 1 Credit™</p>
<p> </p>
<p>CME/CE Information and Claim Credit: <a href='https://www.pri-med.com/online-education/podcast/frankly-speaking-cme-234'>https://www.pri-med.com/online-education/podcast/frankly-speaking-cme-234</a></p>
<p> </p>
<p>Overview: Many providers overtreat outpatient infections for fear of not treating until resolution or causing a complication, but this can lead to antibiotic resistance and adverse events. Join us to discuss the new ACP guidelines on antibiotic use in the outpatient setting and the pediatric treatment recommendations. Walk away with a clear understanding of the guidelines for optimal duration of antibiotic treatment for individuals with an outpatient infection.</p>
<p> </p>
<p>Episode resource links:</p>
<ul><li>ACP: Ann Intern Med. doi:10.7326/M20-7355; <a href='https://www.acpjournals.org/doi/pdf/10.7326/M20-7355'>https://www.acpjournals.org/doi/pdf/10.7326/M20-7355</a></li>
<li>Low risk for PCN allergy: Am J Respir Crit Care Med 2020 Feb 21; [e-pub]. (https://doi.org/10.1164/rccm.202001-0089LE); Mayo Clinic Proceedings 2018, 93 (1): 101-107</li>
</ul>
<p>Guest: Robert A. Baldor MD, FAAFP</p>
<p> </p>
<p>Music Credit: Richard Onorato</p>
]]></description>
                                                            <content:encoded><![CDATA[<p>Credits: 0.25 AMA PRA Category 1 Credit™</p>
<p> </p>
<p>CME/CE Information and Claim Credit: <a href='https://www.pri-med.com/online-education/podcast/frankly-speaking-cme-234'>https://www.pri-med.com/online-education/podcast/frankly-speaking-cme-234</a></p>
<p> </p>
<p>Overview: Many providers overtreat outpatient infections for fear of not treating until resolution or causing a complication, but this can lead to antibiotic resistance and adverse events. Join us to discuss the new ACP guidelines on antibiotic use in the outpatient setting and the pediatric treatment recommendations. Walk away with a clear understanding of the guidelines for optimal duration of antibiotic treatment for individuals with an outpatient infection.</p>
<p> </p>
<p>Episode resource links:</p>
<ul><li>ACP: Ann Intern Med. doi:10.7326/M20-7355; <a href='https://www.acpjournals.org/doi/pdf/10.7326/M20-7355'>https://www.acpjournals.org/doi/pdf/10.7326/M20-7355</a></li>
<li>Low risk for PCN allergy: Am J Respir Crit Care Med 2020 Feb 21; [e-pub]. (https://doi.org/10.1164/rccm.202001-0089LE); Mayo Clinic Proceedings 2018, 93 (1): 101-107</li>
</ul>
<p>Guest: Robert A. Baldor MD, FAAFP</p>
<p> </p>
<p>Music Credit: Richard Onorato</p>
]]></content:encoded>
                                    
        <enclosure url="https://mcdn.podbean.com/mf/web/sfrnt5/secure_primed_frankly-speaking-234-antibiotic-duration.mp3" length="9163118" type="audio/mpeg"/>
                <itunes:summary><![CDATA[Credits: 0.25 AMA PRA Category 1 Credit™
 
CME/CE Information and Claim Credit: https://www.pri-med.com/online-education/podcast/frankly-speaking-cme-234
 
Overview: Many providers overtreat outpatient infections for fear of not treating until resolution or causing a complication, but this can lead to antibiotic resistance and adverse events. Join us to discuss the new ACP guidelines on antibiotic use in the outpatient setting and the pediatric treatment recommendations. Walk away with a clear understanding of the guidelines for optimal duration of antibiotic treatment for individuals with an outpatient infection.
 
Episode resource links:
ACP: Ann Intern Med. doi:10.7326/M20-7355; https://www.acpjournals.org/doi/pdf/10.7326/M20-7355
Low risk for PCN allergy: Am J Respir Crit Care Med 2020 Feb 21; [e-pub]. (https://doi.org/10.1164/rccm.202001-0089LE); Mayo Clinic Proceedings 2018, 93 (1): 101-107
Guest: Robert A. Baldor MD, FAAFP
 
Music Credit: Richard Onorato]]></itunes:summary>
        <itunes:author>Pri-Med</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>571</itunes:duration>
                        <itunes:episodeType>full</itunes:episodeType>
        <itunes:image href="https://pbcdn1.podbean.com/imglogo/ep-logo/pbblog13721080/d2be9f9b409df8b8b0e483857ff67f06.png" />    </item>
    <item>
        <title>Taking the Distress out of Diabetes—Mindfulness and Acceptance Therapies May Help - Frankly Speaking Ep 233</title>
        <itunes:title>Taking the Distress out of Diabetes—Mindfulness and Acceptance Therapies May Help - Frankly Speaking Ep 233</itunes:title>
        <link>https://primedfranklyspeaking.podbean.com/e/taking-the-distress-out-of-diabetes%e2%80%94mindfulness-and-acceptance-therapies-may-help-frankly-speaking-ep-233-1645730501/</link>
                    <comments>https://primedfranklyspeaking.podbean.com/e/taking-the-distress-out-of-diabetes%e2%80%94mindfulness-and-acceptance-therapies-may-help-frankly-speaking-ep-233-1645730501/#comments</comments>        <pubDate>Mon, 19 Jul 2021 04:30:00 +0000</pubDate>
        <guid isPermaLink="false">c2fb2e38-feb5-44ec-90b0-2581d447a811</guid>
                                    <description><![CDATA[<p>Credits: 0.25 AMA PRA Category 1 Credit™</p>
<p> </p>
<p>CME/CE Information and Claim Credit: <a href='https://www.pri-med.com/online-education/podcast/frankly-speaking-cme-233'>https://www.pri-med.com/online-education/podcast/frankly-speaking-cme-233</a></p>
<p> </p>
<p>Overview: T2DM is an epidemic, and its impact on quantity of life is well documented. In most cases, treatment involves significant lifestyle changes in combination with medication. Distress about the T2DM diagnosis and necessary behavioral changes occurs in about one-third of people, and this distress is associated with poor glycemic management. Join us as we discuss a recent meta-analysis on mindfulness and learn how cognitive therapies may be effective in reducing distress and HbA1c.</p>
<p> </p>
<p>Episode resource links:</p>
<ul><li>Ngan, H.Y., Chong, Y.Y. and Chien, W.T. (2021), Effects of mindfulness‐ and acceptance‐based interventions on diabetes distress and glycaemic level in people with type 2 diabetes: Systematic review and meta‐analysis. Diabet Med, 38: e14525. https://doi.org/10.1111/dme.14525; https://onlinelibrary-wiley-com.umassmed.idm.oclc.org/doi/epdf/10.1111/dme.14525</li>
</ul>
<p>Guest: Susan Feeney, DNP, FNP-BC, NP-C</p>
<p> </p>
<p>Music Credit: Richard Onorato</p>
]]></description>
                                                            <content:encoded><![CDATA[<p>Credits: 0.25 AMA PRA Category 1 Credit™</p>
<p> </p>
<p>CME/CE Information and Claim Credit: <a href='https://www.pri-med.com/online-education/podcast/frankly-speaking-cme-233'>https://www.pri-med.com/online-education/podcast/frankly-speaking-cme-233</a></p>
<p> </p>
<p>Overview: T2DM is an epidemic, and its impact on quantity of life is well documented. In most cases, treatment involves significant lifestyle changes in combination with medication. Distress about the T2DM diagnosis and necessary behavioral changes occurs in about one-third of people, and this distress is associated with poor glycemic management. Join us as we discuss a recent meta-analysis on mindfulness and learn how cognitive therapies may be effective in reducing distress and HbA1c.</p>
<p> </p>
<p>Episode resource links:</p>
<ul><li>Ngan, H.Y., Chong, Y.Y. and Chien, W.T. (2021), Effects of mindfulness‐ and acceptance‐based interventions on diabetes distress and glycaemic level in people with type 2 diabetes: Systematic review and meta‐analysis. Diabet Med, 38: e14525. https://doi.org/10.1111/dme.14525; https://onlinelibrary-wiley-com.umassmed.idm.oclc.org/doi/epdf/10.1111/dme.14525</li>
</ul>
<p>Guest: Susan Feeney, DNP, FNP-BC, NP-C</p>
<p> </p>
<p>Music Credit: Richard Onorato</p>
]]></content:encoded>
                                    
        <enclosure url="https://mcdn.podbean.com/mf/web/gdhq0n/secure_primed_frankly-speaking-233-diabetes-stress.mp3" length="11272717" type="audio/mpeg"/>
                <itunes:summary><![CDATA[Credits: 0.25 AMA PRA Category 1 Credit™
 
CME/CE Information and Claim Credit: https://www.pri-med.com/online-education/podcast/frankly-speaking-cme-233
 
Overview: T2DM is an epidemic, and its impact on quantity of life is well documented. In most cases, treatment involves significant lifestyle changes in combination with medication. Distress about the T2DM diagnosis and necessary behavioral changes occurs in about one-third of people, and this distress is associated with poor glycemic management. Join us as we discuss a recent meta-analysis on mindfulness and learn how cognitive therapies may be effective in reducing distress and HbA1c.
 
Episode resource links:
Ngan, H.Y., Chong, Y.Y. and Chien, W.T. (2021), Effects of mindfulness‐ and acceptance‐based interventions on diabetes distress and glycaemic level in people with type 2 diabetes: Systematic review and meta‐analysis. Diabet Med, 38: e14525. https://doi.org/10.1111/dme.14525; https://onlinelibrary-wiley-com.umassmed.idm.oclc.org/doi/epdf/10.1111/dme.14525
Guest: Susan Feeney, DNP, FNP-BC, NP-C
 
Music Credit: Richard Onorato]]></itunes:summary>
        <itunes:author>Pri-Med</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>703</itunes:duration>
                        <itunes:episodeType>full</itunes:episodeType>
        <itunes:image href="https://pbcdn1.podbean.com/imglogo/ep-logo/pbblog13721080/015e2236398e6100ad184700dd82857d.png" />    </item>
    <item>
        <title>Community-Acquired Pneumonia: How Long Do We Need to Treat? - Frankly Speaking Ep 232</title>
        <itunes:title>Community-Acquired Pneumonia: How Long Do We Need to Treat? - Frankly Speaking Ep 232</itunes:title>
        <link>https://primedfranklyspeaking.podbean.com/e/community-acquired-pneumonia-how-long-do-we-need-to-treat-frankly-speaking-ep-232-1645730503/</link>
                    <comments>https://primedfranklyspeaking.podbean.com/e/community-acquired-pneumonia-how-long-do-we-need-to-treat-frankly-speaking-ep-232-1645730503/#comments</comments>        <pubDate>Mon, 12 Jul 2021 04:30:00 +0000</pubDate>
        <guid isPermaLink="false">a0f305c8-c65b-4439-a50d-81874fab52b4</guid>
                                    <description><![CDATA[<p>Credits: 0.25 AMA PRA Category 1 Credit™</p>
<p> </p>
<p>CME/CE Information and Claim Credit: <a href='https://www.pri-med.com/online-education/podcast/frankly-speaking-cme-232'>https://www.pri-med.com/online-education/podcast/frankly-speaking-cme-232</a></p>
<p> </p>
<p>Overview: For patients with community-acquired pneumonia (CAP), wide variation in the duration of treatment exists. Longer duration of treatment may increase the risk of adverse effects and lead to antibiotic resistance. However, shorter duration of treatment may result in treatment failure. See what new evidence shows may be the best antibiotics treatment duration in most patients with CAP.</p>
<p> </p>
<p>Episode resource links:</p>
<ul><li>Dinh A et al. Pneumonia Short Treatment (PTC) Study Group. Discontinuing β-lactam treatment after 3 days for patients with community-acquired pneumonia in non-critical care wards (PTC): a double-blind, randomised, placebo-controlled, non-inferiority trial. Lancet. 2021 Mar 27;397(10280):1195-1203</li>
<li>Metlay JP et al. Diagnosis and Treatment of Adults with Community-acquired Pneumonia. An Official Clinical Practice Guideline of the American Thoracic Society and Infectious Diseases Society of America. Am J Respir Crit Care Med. 2019 Oct 1;200(7):e45-e67.</li>
</ul>
<p>Guest: Alan Ehrlich MD, FAAFP</p>
<p> </p>
<p>Music Credit: Richard Onorato</p>
]]></description>
                                                            <content:encoded><![CDATA[<p>Credits: 0.25 AMA PRA Category 1 Credit™</p>
<p> </p>
<p>CME/CE Information and Claim Credit: <a href='https://www.pri-med.com/online-education/podcast/frankly-speaking-cme-232'>https://www.pri-med.com/online-education/podcast/frankly-speaking-cme-232</a></p>
<p> </p>
<p>Overview: For patients with community-acquired pneumonia (CAP), wide variation in the duration of treatment exists. Longer duration of treatment may increase the risk of adverse effects and lead to antibiotic resistance. However, shorter duration of treatment may result in treatment failure. See what new evidence shows may be the best antibiotics treatment duration in most patients with CAP.</p>
<p> </p>
<p>Episode resource links:</p>
<ul><li>Dinh A et al. Pneumonia Short Treatment (PTC) Study Group. Discontinuing β-lactam treatment after 3 days for patients with community-acquired pneumonia in non-critical care wards (PTC): a double-blind, randomised, placebo-controlled, non-inferiority trial. Lancet. 2021 Mar 27;397(10280):1195-1203</li>
<li>Metlay JP et al. Diagnosis and Treatment of Adults with Community-acquired Pneumonia. An Official Clinical Practice Guideline of the American Thoracic Society and Infectious Diseases Society of America. Am J Respir Crit Care Med. 2019 Oct 1;200(7):e45-e67.</li>
</ul>
<p>Guest: Alan Ehrlich MD, FAAFP</p>
<p> </p>
<p>Music Credit: Richard Onorato</p>
]]></content:encoded>
                                    
        <enclosure url="https://mcdn.podbean.com/mf/web/5gjfuo/secure_primed_frankly-speaking-232-community-aquired-pneumonia.mp3" length="9824791" type="audio/mpeg"/>
                <itunes:summary><![CDATA[Credits: 0.25 AMA PRA Category 1 Credit™
 
CME/CE Information and Claim Credit: https://www.pri-med.com/online-education/podcast/frankly-speaking-cme-232
 
Overview: For patients with community-acquired pneumonia (CAP), wide variation in the duration of treatment exists. Longer duration of treatment may increase the risk of adverse effects and lead to antibiotic resistance. However, shorter duration of treatment may result in treatment failure. See what new evidence shows may be the best antibiotics treatment duration in most patients with CAP.
 
Episode resource links:
Dinh A et al. Pneumonia Short Treatment (PTC) Study Group. Discontinuing β-lactam treatment after 3 days for patients with community-acquired pneumonia in non-critical care wards (PTC): a double-blind, randomised, placebo-controlled, non-inferiority trial. Lancet. 2021 Mar 27;397(10280):1195-1203
Metlay JP et al. Diagnosis and Treatment of Adults with Community-acquired Pneumonia. An Official Clinical Practice Guideline of the American Thoracic Society and Infectious Diseases Society of America. Am J Respir Crit Care Med. 2019 Oct 1;200(7):e45-e67.
Guest: Alan Ehrlich MD, FAAFP
 
Music Credit: Richard Onorato]]></itunes:summary>
        <itunes:author>Pri-Med</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>613</itunes:duration>
                        <itunes:episodeType>full</itunes:episodeType>
        <itunes:image href="https://pbcdn1.podbean.com/imglogo/ep-logo/pbblog13721080/06e3f7788aea53c7301f62e89d38d246.png" />    </item>
    <item>
        <title>Pain in EVERYONE’s Neck - Frankly Speaking Ep 231</title>
        <itunes:title>Pain in EVERYONE’s Neck - Frankly Speaking Ep 231</itunes:title>
        <link>https://primedfranklyspeaking.podbean.com/e/pain-in-everyone-s-neck-frankly-speaking-ep-231-1645730504/</link>
                    <comments>https://primedfranklyspeaking.podbean.com/e/pain-in-everyone-s-neck-frankly-speaking-ep-231-1645730504/#comments</comments>        <pubDate>Mon, 05 Jul 2021 04:30:00 +0000</pubDate>
        <guid isPermaLink="false">d59f831d-489a-4400-84e4-7ff4637713b5</guid>
                                    <description><![CDATA[<p>Credits: 0.25 AMA PRA Category 1 Credit™</p>
<p> </p>
<p>CME/CE Information and Claim Credit: <a href='https://www.pri-med.com/online-education/podcast/frankly-speaking-cme-231'>https://www.pri-med.com/online-education/podcast/frankly-speaking-cme-231</a></p>
<p> </p>
<p>Overview: Who couldn’t use a refresher on how to diagnose and treat neck pain in the primary care setting? Review the techniques for assessing neck pain, determining its cause, and providing relief. Immediately apply what you learn to start helping patients with neck pain feel better.</p>
<p> </p>
<p>Episode resource links:</p>
<ul><li>Am Fam Physician 2016 May 1;93(9):746-54.</li>
<li>Sub occipital Release: J Electromyogr Kinesiol 2016 Oct;30:31-7. doi: 10.1016/j.jelekin.2016.05.007</li>
<li>Self Myofascial Release: Spine 2020 Nov 1;45(21):E1367-E1375</li>
</ul>
<p>Guest: Robert A. Baldor MD, FAAFP/Frank</p>
<p> </p>
<p>Music Credit: Richard Onorato</p>
]]></description>
                                                            <content:encoded><![CDATA[<p>Credits: 0.25 AMA PRA Category 1 Credit™</p>
<p> </p>
<p>CME/CE Information and Claim Credit: <a href='https://www.pri-med.com/online-education/podcast/frankly-speaking-cme-231'>https://www.pri-med.com/online-education/podcast/frankly-speaking-cme-231</a></p>
<p> </p>
<p>Overview: Who couldn’t use a refresher on how to diagnose and treat neck pain in the primary care setting? Review the techniques for assessing neck pain, determining its cause, and providing relief. Immediately apply what you learn to start helping patients with neck pain feel better.</p>
<p> </p>
<p>Episode resource links:</p>
<ul><li>Am Fam Physician 2016 May 1;93(9):746-54.</li>
<li>Sub occipital Release: J Electromyogr Kinesiol 2016 Oct;30:31-7. doi: 10.1016/j.jelekin.2016.05.007</li>
<li>Self Myofascial Release: Spine 2020 Nov 1;45(21):E1367-E1375</li>
</ul>
<p>Guest: Robert A. Baldor MD, FAAFP/Frank</p>
<p> </p>
<p>Music Credit: Richard Onorato</p>
]]></content:encoded>
                                    
        <enclosure url="https://mcdn.podbean.com/mf/web/ioajnr/secure_primed_frankly-speaking-231-pain-in-the-neck.mp3" length="10565990" type="audio/mpeg"/>
                <itunes:summary><![CDATA[Credits: 0.25 AMA PRA Category 1 Credit™
 
CME/CE Information and Claim Credit: https://www.pri-med.com/online-education/podcast/frankly-speaking-cme-231
 
Overview: Who couldn’t use a refresher on how to diagnose and treat neck pain in the primary care setting? Review the techniques for assessing neck pain, determining its cause, and providing relief. Immediately apply what you learn to start helping patients with neck pain feel better.
 
Episode resource links:
Am Fam Physician 2016 May 1;93(9):746-54.
Sub occipital Release: J Electromyogr Kinesiol 2016 Oct;30:31-7. doi: 10.1016/j.jelekin.2016.05.007
Self Myofascial Release: Spine 2020 Nov 1;45(21):E1367-E1375
Guest: Robert A. Baldor MD, FAAFP/Frank
 
Music Credit: Richard Onorato]]></itunes:summary>
        <itunes:author>Pri-Med</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>659</itunes:duration>
                        <itunes:episodeType>full</itunes:episodeType>
        <itunes:image href="https://pbcdn1.podbean.com/imglogo/ep-logo/pbblog13721080/a4189b726c2bb0858b741bd8fa65c897.png" />    </item>
    <item>
        <title>Perioperative Management for Patients Taking DOACs - Frankly Speaking Ep 230</title>
        <itunes:title>Perioperative Management for Patients Taking DOACs - Frankly Speaking Ep 230</itunes:title>
        <link>https://primedfranklyspeaking.podbean.com/e/perioperative-management-for-patients-taking-doacs-frankly-speaking-ep-230-1645730505/</link>
                    <comments>https://primedfranklyspeaking.podbean.com/e/perioperative-management-for-patients-taking-doacs-frankly-speaking-ep-230-1645730505/#comments</comments>        <pubDate>Mon, 28 Jun 2021 04:30:00 +0000</pubDate>
        <guid isPermaLink="false">9bf40f1c-a668-4578-a6fb-5c30ce4d5640</guid>
                                    <description><![CDATA[<p>Credits: 0.25 AMA PRA Category 1 Credit™</p>
<p> </p>
<p>CME/CE Information and Claim Credit: <a href='https://www.pri-med.com/online-education/podcast/frankly-speaking-cme-230'>https://www.pri-med.com/online-education/podcast/frankly-speaking-cme-230</a></p>
<p> </p>
<p>Overview: Join us to discuss the results of the Perioperative Anticoagulation Use for Surgery Evaluation (PAUSE) cohort study, aimed at understanding the safety of using a simplified perioperative management approach for patients with atrial fibrillation taking DOACs. After this episode, you’ll be able to make sense of the controversy over current guidelines around surgical care in this patient population. More importantly, you’ll walk away with practical knowledge to help these patients minimize their risk of adverse events.</p>
<p> </p>
<p>Episode resource links:</p>
<ul><li>Perioperative Management of Patients With Atrial Fibrillation Receiving a Direct Oral Anticoagulant. JAMA Intern Med.2019; 179(11 ): 1469-14 78. doi: 10.1001 /jamainternmed.2019.2431</li>
</ul>
<p> </p>
<p>Guest: Robert A. Baldor MD, FAAFP</p>
<p> </p>
<p>Music Credit: Richard Onorato</p>
]]></description>
                                                            <content:encoded><![CDATA[<p>Credits: 0.25 AMA PRA Category 1 Credit™</p>
<p> </p>
<p>CME/CE Information and Claim Credit: <a href='https://www.pri-med.com/online-education/podcast/frankly-speaking-cme-230'>https://www.pri-med.com/online-education/podcast/frankly-speaking-cme-230</a></p>
<p> </p>
<p>Overview: Join us to discuss the results of the Perioperative Anticoagulation Use for Surgery Evaluation (PAUSE) cohort study, aimed at understanding the safety of using a simplified perioperative management approach for patients with atrial fibrillation taking DOACs. After this episode, you’ll be able to make sense of the controversy over current guidelines around surgical care in this patient population. More importantly, you’ll walk away with practical knowledge to help these patients minimize their risk of adverse events.</p>
<p> </p>
<p>Episode resource links:</p>
<ul><li>Perioperative Management of Patients With Atrial Fibrillation Receiving a Direct Oral Anticoagulant. JAMA Intern Med.2019; 179(11 ): 1469-14 78. doi: 10.1001 /jamainternmed.2019.2431</li>
</ul>
<p> </p>
<p>Guest: Robert A. Baldor MD, FAAFP</p>
<p> </p>
<p>Music Credit: Richard Onorato</p>
]]></content:encoded>
                                    
        <enclosure url="https://mcdn.podbean.com/mf/web/cw2m5g/secure_primed_frankly-speaking-230-anti-coagulants.mp3" length="9388339" type="audio/mpeg"/>
                <itunes:summary><![CDATA[Credits: 0.25 AMA PRA Category 1 Credit™
 
CME/CE Information and Claim Credit: https://www.pri-med.com/online-education/podcast/frankly-speaking-cme-230
 
Overview: Join us to discuss the results of the Perioperative Anticoagulation Use for Surgery Evaluation (PAUSE) cohort study, aimed at understanding the safety of using a simplified perioperative management approach for patients with atrial fibrillation taking DOACs. After this episode, you’ll be able to make sense of the controversy over current guidelines around surgical care in this patient population. More importantly, you’ll walk away with practical knowledge to help these patients minimize their risk of adverse events.
 
Episode resource links:
Perioperative Management of Patients With Atrial Fibrillation Receiving a Direct Oral Anticoagulant. JAMA Intern Med.2019; 179(11 ): 1469-14 78. doi: 10.1001 /jamainternmed.2019.2431
 
Guest: Robert A. Baldor MD, FAAFP
 
Music Credit: Richard Onorato]]></itunes:summary>
        <itunes:author>Pri-Med</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>585</itunes:duration>
                        <itunes:episodeType>full</itunes:episodeType>
        <itunes:image href="https://pbcdn1.podbean.com/imglogo/ep-logo/pbblog13721080/98e800b7f4a3c66a3bc9d9c477fb5124.png" />    </item>
    <item>
        <title>Acknowledging the Pain—Incorporating Trauma-Informed Care into Your Practice - Frankly Speaking Ep 229</title>
        <itunes:title>Acknowledging the Pain—Incorporating Trauma-Informed Care into Your Practice - Frankly Speaking Ep 229</itunes:title>
        <link>https://primedfranklyspeaking.podbean.com/e/acknowledging-the-pain%e2%80%94incorporating-trauma-informed-care-into-your-practice-frankly-speaking-ep-229-1645730506/</link>
                    <comments>https://primedfranklyspeaking.podbean.com/e/acknowledging-the-pain%e2%80%94incorporating-trauma-informed-care-into-your-practice-frankly-speaking-ep-229-1645730506/#comments</comments>        <pubDate>Mon, 21 Jun 2021 04:30:00 +0000</pubDate>
        <guid isPermaLink="false">866be94a-56c9-4a05-ae84-75862ff6f213</guid>
                                    <description><![CDATA[<p>Credits: 0.25 AMA PRA Category 1 Credit™</p>
<p> </p>
<p>CME/CE Information and Claim Credit: <a href='https://www.pri-med.com/online-education/podcast/frankly-speaking-cme-229'>https://www.pri-med.com/online-education/podcast/frankly-speaking-cme-229</a></p>
<p> </p>
<p>Overview: Ample evidence shows that adverse childhood experiences (ACEs) and trauma in adulthood may lead to poor health outcomes, such as cardiovascular disease and other chronic diseases. These traumas may also affect a person’s inclination to seek care and participate in plans of care. As a provider, it is important to consider this history and ensure the psychological and physical safety of these affected individuals. Join us to learn proven strategies to help you practice trauma-informed care, including how to recognize trauma and offer effective interventions to help patients dealing with these issues.</p>
<p> </p>
<p>Episode resource links:</p>
<ul><li>ACOG Committee Decision: Caring for Patients who have Experienced Trauma. Obstetrics and Gynecology. VOL. 37, NO. 4. April 2021. <a href='https://www.acog.org/clinical/clinical-guidance/committee-opinion/articles/2021/04/caring-for-patients-who-have-experienced-trauma'>https://www.acog.org/clinical/clinical-guidance/committee-opinion/articles/2021/04/caring-for-patients-who-have-experienced-trauma</a></li>
<li>Dicola, D. & Spaar, E. Intimate Partner Violence. American Family Physician. October 15, 2016, VOL. 94, NO. 8. <a href='http://www.aafp.org/afp'>www.aafp.org/afp</a></li>
<li><a href='https://www.cdc.gov/violenceprevention/aces/index.html'>https://www.cdc.gov/violenceprevention/aces/index.html</a></li>
<li><a href='https://store.samhsa.gov/sites/default/files/d7/priv/sma14-4816.pdf'>https://store.samhsa.gov/sites/default/files/d7/priv/sma14-4816.pdf</a></li>
</ul>
<p>Guest: Susan Feeney, DNP, FNP-BC, NP-C</p>
<p> </p>
<p>Music Credit: Richard Onorato</p>
]]></description>
                                                            <content:encoded><![CDATA[<p>Credits: 0.25 AMA PRA Category 1 Credit™</p>
<p> </p>
<p>CME/CE Information and Claim Credit: <a href='https://www.pri-med.com/online-education/podcast/frankly-speaking-cme-229'>https://www.pri-med.com/online-education/podcast/frankly-speaking-cme-229</a></p>
<p> </p>
<p>Overview: Ample evidence shows that adverse childhood experiences (ACEs) and trauma in adulthood may lead to poor health outcomes, such as cardiovascular disease and other chronic diseases. These traumas may also affect a person’s inclination to seek care and participate in plans of care. As a provider, it is important to consider this history and ensure the psychological and physical safety of these affected individuals. Join us to learn proven strategies to help you practice trauma-informed care, including how to recognize trauma and offer effective interventions to help patients dealing with these issues.</p>
<p> </p>
<p>Episode resource links:</p>
<ul><li>ACOG Committee Decision: Caring for Patients who have Experienced Trauma. Obstetrics and Gynecology. VOL. 37, NO. 4. April 2021. <a href='https://www.acog.org/clinical/clinical-guidance/committee-opinion/articles/2021/04/caring-for-patients-who-have-experienced-trauma'>https://www.acog.org/clinical/clinical-guidance/committee-opinion/articles/2021/04/caring-for-patients-who-have-experienced-trauma</a></li>
<li>Dicola, D. & Spaar, E. Intimate Partner Violence. American Family Physician. October 15, 2016, VOL. 94, NO. 8. <a href='http://www.aafp.org/afp'>www.aafp.org/afp</a></li>
<li><a href='https://www.cdc.gov/violenceprevention/aces/index.html'>https://www.cdc.gov/violenceprevention/aces/index.html</a></li>
<li><a href='https://store.samhsa.gov/sites/default/files/d7/priv/sma14-4816.pdf'>https://store.samhsa.gov/sites/default/files/d7/priv/sma14-4816.pdf</a></li>
</ul>
<p>Guest: Susan Feeney, DNP, FNP-BC, NP-C</p>
<p> </p>
<p>Music Credit: Richard Onorato</p>
]]></content:encoded>
                                    
        <enclosure url="https://mcdn.podbean.com/mf/web/c7xv9q/secure_primed_frankly-speaking-229-trauma-informed-care.mp3" length="10263158" type="audio/mpeg"/>
                <itunes:summary><![CDATA[Credits: 0.25 AMA PRA Category 1 Credit™
 
CME/CE Information and Claim Credit: https://www.pri-med.com/online-education/podcast/frankly-speaking-cme-229
 
Overview: Ample evidence shows that adverse childhood experiences (ACEs) and trauma in adulthood may lead to poor health outcomes, such as cardiovascular disease and other chronic diseases. These traumas may also affect a person’s inclination to seek care and participate in plans of care. As a provider, it is important to consider this history and ensure the psychological and physical safety of these affected individuals. Join us to learn proven strategies to help you practice trauma-informed care, including how to recognize trauma and offer effective interventions to help patients dealing with these issues.
 
Episode resource links:
ACOG Committee Decision: Caring for Patients who have Experienced Trauma. Obstetrics and Gynecology. VOL. 37, NO. 4. April 2021. https://www.acog.org/clinical/clinical-guidance/committee-opinion/articles/2021/04/caring-for-patients-who-have-experienced-trauma
Dicola, D. & Spaar, E. Intimate Partner Violence. American Family Physician. October 15, 2016, VOL. 94, NO. 8. www.aafp.org/afp
https://www.cdc.gov/violenceprevention/aces/index.html
https://store.samhsa.gov/sites/default/files/d7/priv/sma14-4816.pdf
Guest: Susan Feeney, DNP, FNP-BC, NP-C
 
Music Credit: Richard Onorato]]></itunes:summary>
        <itunes:author>Pri-Med</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>640</itunes:duration>
                        <itunes:episodeType>full</itunes:episodeType>
        <itunes:image href="https://pbcdn1.podbean.com/imglogo/ep-logo/pbblog13721080/3e37f08c79cb5ac3c55e324cc6ac6d50.png" />    </item>
    <item>
        <title>Antibiotics for Respiratory Tract Infections: Fewer May Be Better - Frankly Speaking Ep 228</title>
        <itunes:title>Antibiotics for Respiratory Tract Infections: Fewer May Be Better - Frankly Speaking Ep 228</itunes:title>
        <link>https://primedfranklyspeaking.podbean.com/e/antibiotics-for-respiratory-tract-infections-fewer-may-be-better-frankly-speaking-ep-228-1645730507/</link>
                    <comments>https://primedfranklyspeaking.podbean.com/e/antibiotics-for-respiratory-tract-infections-fewer-may-be-better-frankly-speaking-ep-228-1645730507/#comments</comments>        <pubDate>Mon, 14 Jun 2021 04:30:00 +0000</pubDate>
        <guid isPermaLink="false">8ab2f13b-a9dc-4ac1-9054-6548d7a5e1d3</guid>
                                    <description><![CDATA[<p>Credits: 0.25 AMA PRA Category 1 Credit™</p>
<p> </p>
<p>CME/CE Information and Claim Credit: <a href='https://www.pri-med.com/online-education/podcast/frankly-speaking-cme-228'>https://www.pri-med.com/online-education/podcast/frankly-speaking-cme-228</a></p>
<p> </p>
<p>Overview: Join us for this episode as we discuss the results of a systematic review examining the benefits and risks from delaying the use of antibiotics to treat patients in the community for a respiratory infection.</p>
<p> </p>
<p>Episode resource links:</p>
<ul><li>Delayed antibiotic prescribing for respiratory tract infections: individual patient data meta-analysis. BMJ 2021;372:n808 http://dx.doi.org/10.1136/bmj.n808</li>
</ul>
<p>Guest: Robert A. Baldor, MD, FAAFP</p>
<p> </p>
<p>Music Credit: Richard Onorato</p>
]]></description>
                                                            <content:encoded><![CDATA[<p>Credits: 0.25 AMA PRA Category 1 Credit™</p>
<p> </p>
<p>CME/CE Information and Claim Credit: <a href='https://www.pri-med.com/online-education/podcast/frankly-speaking-cme-228'>https://www.pri-med.com/online-education/podcast/frankly-speaking-cme-228</a></p>
<p> </p>
<p>Overview: Join us for this episode as we discuss the results of a systematic review examining the benefits and risks from delaying the use of antibiotics to treat patients in the community for a respiratory infection.</p>
<p> </p>
<p>Episode resource links:</p>
<ul><li>Delayed antibiotic prescribing for respiratory tract infections: individual patient data meta-analysis. BMJ 2021;372:n808 http://dx.doi.org/10.1136/bmj.n808</li>
</ul>
<p>Guest: Robert A. Baldor, MD, FAAFP</p>
<p> </p>
<p>Music Credit: Richard Onorato</p>
]]></content:encoded>
                                    
        <enclosure url="https://mcdn.podbean.com/mf/web/hin3bv/secure_primed_frankly-speaking-228-antibiotics.mp3" length="12629009" type="audio/mpeg"/>
                <itunes:summary><![CDATA[Credits: 0.25 AMA PRA Category 1 Credit™
 
CME/CE Information and Claim Credit: https://www.pri-med.com/online-education/podcast/frankly-speaking-cme-228
 
Overview: Join us for this episode as we discuss the results of a systematic review examining the benefits and risks from delaying the use of antibiotics to treat patients in the community for a respiratory infection.
 
Episode resource links:
Delayed antibiotic prescribing for respiratory tract infections: individual patient data meta-analysis. BMJ 2021;372:n808 http://dx.doi.org/10.1136/bmj.n808
Guest: Robert A. Baldor, MD, FAAFP
 
Music Credit: Richard Onorato]]></itunes:summary>
        <itunes:author>Pri-Med</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>788</itunes:duration>
                        <itunes:episodeType>full</itunes:episodeType>
        <itunes:image href="https://pbcdn1.podbean.com/imglogo/ep-logo/pbblog13721080/641e2d3a6d2be3a87570b15e1151a49c.png" />    </item>
    <item>
        <title>Protecting Feet in People With Diabetes: Monofilaments or Tuning Forks? - Frankly Speaking Ep 227</title>
        <itunes:title>Protecting Feet in People With Diabetes: Monofilaments or Tuning Forks? - Frankly Speaking Ep 227</itunes:title>
        <link>https://primedfranklyspeaking.podbean.com/e/protecting-feet-in-people-with-diabetes-monofilaments-or-tuning-forks-frankly-speaking-ep-227-1645730508/</link>
                    <comments>https://primedfranklyspeaking.podbean.com/e/protecting-feet-in-people-with-diabetes-monofilaments-or-tuning-forks-frankly-speaking-ep-227-1645730508/#comments</comments>        <pubDate>Mon, 07 Jun 2021 04:30:00 +0000</pubDate>
        <guid isPermaLink="false">16042dee-e035-4342-ab30-46921ed6f383</guid>
                                    <description><![CDATA[<p>Credits: 0.25 AMA PRA Category 1 Credit™</p>
<p> </p>
<p>CME/CE Information and Claim Credit: <a href='https://www.pri-med.com/online-education/podcast/frankly-speaking-cme-227'>https://www.pri-med.com/online-education/podcast/frankly-speaking-cme-227</a></p>
<p> </p>
<p>Overview: Join us as we discuss a recent review article on the evidence behind monofilament testing for peripheral neuropathy in people with diabetes.</p>
<p> </p>
<p>Episode resource links:</p>
<ul><li>
<p>J Diabetes Res. 2017; 2017: 8787261.</p>
</li>
<li>
<p>Diagnostic Accuracy of Monofilament Tests for Detecting Diabetic Peripheral Neuropathy: A Systematic Review and Meta-Analysis</p>
</li>
<li>
<p>Diabetes Care 2017 Jan;40(1):136-154</p>
</li>
</ul>
<p> </p>
<p>Guest: Robert A. Baldor MD, FAAFP</p>
<p> </p>
<p>Music Credit: Richard Onorato</p>
]]></description>
                                                            <content:encoded><![CDATA[<p>Credits: 0.25 AMA PRA Category 1 Credit™</p>
<p> </p>
<p>CME/CE Information and Claim Credit: <a href='https://www.pri-med.com/online-education/podcast/frankly-speaking-cme-227'>https://www.pri-med.com/online-education/podcast/frankly-speaking-cme-227</a></p>
<p> </p>
<p>Overview: Join us as we discuss a recent review article on the evidence behind monofilament testing for peripheral neuropathy in people with diabetes.</p>
<p> </p>
<p>Episode resource links:</p>
<ul><li>
<p>J Diabetes Res. 2017; 2017: 8787261.</p>
</li>
<li>
<p>Diagnostic Accuracy of Monofilament Tests for Detecting Diabetic Peripheral Neuropathy: A Systematic Review and Meta-Analysis</p>
</li>
<li>
<p>Diabetes Care 2017 Jan;40(1):136-154</p>
</li>
</ul>
<p> </p>
<p>Guest: Robert A. Baldor MD, FAAFP</p>
<p> </p>
<p>Music Credit: Richard Onorato</p>
]]></content:encoded>
                                    
        <enclosure url="https://mcdn.podbean.com/mf/web/pkawuz/secure_primed_frankly-speaking-227-peripheral-neuropathy.mp3" length="9634636" type="audio/mpeg"/>
                <itunes:summary><![CDATA[Credits: 0.25 AMA PRA Category 1 Credit™
 
CME/CE Information and Claim Credit: https://www.pri-med.com/online-education/podcast/frankly-speaking-cme-227
 
Overview: Join us as we discuss a recent review article on the evidence behind monofilament testing for peripheral neuropathy in people with diabetes.
 
Episode resource links:

J Diabetes Res. 2017; 2017: 8787261.


Diagnostic Accuracy of Monofilament Tests for Detecting Diabetic Peripheral Neuropathy: A Systematic Review and Meta-Analysis


Diabetes Care 2017 Jan;40(1):136-154

 
Guest: Robert A. Baldor MD, FAAFP
 
Music Credit: Richard Onorato]]></itunes:summary>
        <itunes:author>Pri-Med</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>601</itunes:duration>
                        <itunes:episodeType>full</itunes:episodeType>
        <itunes:image href="https://pbcdn1.podbean.com/imglogo/ep-logo/pbblog13721080/f29ee10855c9fa8d909884ec7bd1bfb2.png" />    </item>
    <item>
        <title>Risk-Stratifying Patients with a TIA - Frankly Speaking Ep 226</title>
        <itunes:title>Risk-Stratifying Patients with a TIA - Frankly Speaking Ep 226</itunes:title>
        <link>https://primedfranklyspeaking.podbean.com/e/risk-stratifying-patients-with-a-tia-frankly-speaking-ep-226-1645730510/</link>
                    <comments>https://primedfranklyspeaking.podbean.com/e/risk-stratifying-patients-with-a-tia-frankly-speaking-ep-226-1645730510/#comments</comments>        <pubDate>Mon, 31 May 2021 04:30:00 +0000</pubDate>
        <guid isPermaLink="false">a8287e0a-1dd2-48be-b7a1-6df6b7394971</guid>
                                    <description><![CDATA[<p>Credits: 0.25 AMA PRA Category 1 Credit™</p>
<p> </p>
<p>CME/CE Information and Claim Credit: <a href='https://www.pri-med.com/online-education/podcast/frankly-speaking-cme-226'>https://www.pri-med.com/online-education/podcast/frankly-speaking-cme-226</a></p>
<p> </p>
<p>Overview: Patients with a history of transient ischemic attack (TIA) are at increased risk of stroke in the future. The ABCD2 score is the most used risk assessment tool for people with acute TIA, but it is not recommended for this purpose by the National Institute for Heath and Care Excellence (NICE). Join us for today’s episode as we describe a new validated risk assessment tool developed in Canada you can use to classify patients as low, medium, or high-risk for stroke over the 7 days following a TIA.</p>
<p> </p>
<p>Episode References and Resource Links:</p>
<ul><li>Perry JJ et al. Prospective validation of Canadian TIA Score and comparison with ABCD2 and ABCD2i for subsequent stroke risk after transient ischaemic attack: multicentre prospective cohort study. BMJ. 2021 Feb 4;372:n49</li>
</ul>
<p> </p>
<p>Guest: Alan Ehrlich MD, FAAFP</p>
<p> </p>
<p>Music Credit: Richard Onorato</p>
]]></description>
                                                            <content:encoded><![CDATA[<p>Credits: 0.25 AMA PRA Category 1 Credit™</p>
<p> </p>
<p>CME/CE Information and Claim Credit: <a href='https://www.pri-med.com/online-education/podcast/frankly-speaking-cme-226'>https://www.pri-med.com/online-education/podcast/frankly-speaking-cme-226</a></p>
<p> </p>
<p>Overview: Patients with a history of transient ischemic attack (TIA) are at increased risk of stroke in the future. The ABCD2 score is the most used risk assessment tool for people with acute TIA, but it is not recommended for this purpose by the National Institute for Heath and Care Excellence (NICE). Join us for today’s episode as we describe a new validated risk assessment tool developed in Canada you can use to classify patients as low, medium, or high-risk for stroke over the 7 days following a TIA.</p>
<p> </p>
<p>Episode References and Resource Links:</p>
<ul><li>Perry JJ et al. Prospective validation of Canadian TIA Score and comparison with ABCD2 and ABCD2i for subsequent stroke risk after transient ischaemic attack: multicentre prospective cohort study. BMJ. 2021 Feb 4;372:n49</li>
</ul>
<p> </p>
<p>Guest: Alan Ehrlich MD, FAAFP</p>
<p> </p>
<p>Music Credit: Richard Onorato</p>
]]></content:encoded>
                                    
        <enclosure url="https://mcdn.podbean.com/mf/web/ujsobz/secure_primed_frankly-speaking-226-tia-risk-assessment.mp3" length="11585008" type="audio/mpeg"/>
                <itunes:summary><![CDATA[Credits: 0.25 AMA PRA Category 1 Credit™
 
CME/CE Information and Claim Credit: https://www.pri-med.com/online-education/podcast/frankly-speaking-cme-226
 
Overview: Patients with a history of transient ischemic attack (TIA) are at increased risk of stroke in the future. The ABCD2 score is the most used risk assessment tool for people with acute TIA, but it is not recommended for this purpose by the National Institute for Heath and Care Excellence (NICE). Join us for today’s episode as we describe a new validated risk assessment tool developed in Canada you can use to classify patients as low, medium, or high-risk for stroke over the 7 days following a TIA.
 
Episode References and Resource Links:
Perry JJ et al. Prospective validation of Canadian TIA Score and comparison with ABCD2 and ABCD2i for subsequent stroke risk after transient ischaemic attack: multicentre prospective cohort study. BMJ. 2021 Feb 4;372:n49
 
Guest: Alan Ehrlich MD, FAAFP
 
Music Credit: Richard Onorato]]></itunes:summary>
        <itunes:author>Pri-Med</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>723</itunes:duration>
                        <itunes:episodeType>full</itunes:episodeType>
        <itunes:image href="https://pbcdn1.podbean.com/imglogo/ep-logo/pbblog13721080/65165fb88bbc539f2c8d2e165bb478ba.png" />    </item>
    <item>
        <title>How Long Should You Continue Bisphosphonate Treatment for Osteoporosis? - Frankly Speaking Ep 225</title>
        <itunes:title>How Long Should You Continue Bisphosphonate Treatment for Osteoporosis? - Frankly Speaking Ep 225</itunes:title>
        <link>https://primedfranklyspeaking.podbean.com/e/how-long-should-you-continue-bisphosphonate-treatment-for-osteoporosis-frankly-speaking-ep-225-1645730511/</link>
                    <comments>https://primedfranklyspeaking.podbean.com/e/how-long-should-you-continue-bisphosphonate-treatment-for-osteoporosis-frankly-speaking-ep-225-1645730511/#comments</comments>        <pubDate>Mon, 24 May 2021 04:30:00 +0000</pubDate>
        <guid isPermaLink="false">464eeee5-180f-49e8-8ae8-fddb278fc9c8</guid>
                                    <description><![CDATA[<p>Credits: 0.25 AMA PRA Category 1 Credit™</p>
<p> </p>
<p>CME/CE Information and Claim Credit: <a href='https://www.pri-med.com/online-education/podcast/frankly-speaking-cme-225'>https://www.pri-med.com/online-education/podcast/frankly-speaking-cme-225</a></p>
<p> </p>
<p>Overview: Join us for this episode as we review the recently published (Dec. 2020) cohort study in JAMA on using bisphosphonates to prevent hip fractures. We will review the utility of bisphosphonates after 5 years and how to discuss their risks and benefits with patients.</p>
<p> </p>
<p>Episode resource links:</p>
<ul><li>JAMA.2020;3(12):e2025190.doi:10.1001/jamanetworkopen.2020.25190</li>
<li>JAMA. 2018;319(24):2521-2531. doi:10.1001/jama.2018.7498</li>
<li><a href='https://www.sheffield.ac.uk/FRAX/tool.aspx?country=9'>https://www.sheffield.ac.uk/FRAX/tool.aspx?country=9</a></li>
</ul>
<p>Guest: Robert A. Baldor MD, FAAFP</p>
<p> </p>
<p>Music Credit: Richard Onorato</p>
]]></description>
                                                            <content:encoded><![CDATA[<p>Credits: 0.25 AMA PRA Category 1 Credit™</p>
<p> </p>
<p>CME/CE Information and Claim Credit: <a href='https://www.pri-med.com/online-education/podcast/frankly-speaking-cme-225'>https://www.pri-med.com/online-education/podcast/frankly-speaking-cme-225</a></p>
<p> </p>
<p>Overview: Join us for this episode as we review the recently published (Dec. 2020) cohort study in JAMA on using bisphosphonates to prevent hip fractures. We will review the utility of bisphosphonates after 5 years and how to discuss their risks and benefits with patients.</p>
<p> </p>
<p>Episode resource links:</p>
<ul><li>JAMA.2020;3(12):e2025190.doi:10.1001/jamanetworkopen.2020.25190</li>
<li>JAMA. 2018;319(24):2521-2531. doi:10.1001/jama.2018.7498</li>
<li><a href='https://www.sheffield.ac.uk/FRAX/tool.aspx?country=9'>https://www.sheffield.ac.uk/FRAX/tool.aspx?country=9</a></li>
</ul>
<p>Guest: Robert A. Baldor MD, FAAFP</p>
<p> </p>
<p>Music Credit: Richard Onorato</p>
]]></content:encoded>
                                    
        <enclosure url="https://mcdn.podbean.com/mf/web/7qgm4g/secure_primed_frankly-speaking-225-bisphosphonate.mp3" length="8539020" type="audio/mpeg"/>
                <itunes:summary><![CDATA[Credits: 0.25 AMA PRA Category 1 Credit™
 
CME/CE Information and Claim Credit: https://www.pri-med.com/online-education/podcast/frankly-speaking-cme-225
 
Overview: Join us for this episode as we review the recently published (Dec. 2020) cohort study in JAMA on using bisphosphonates to prevent hip fractures. We will review the utility of bisphosphonates after 5 years and how to discuss their risks and benefits with patients.
 
Episode resource links:
JAMA.2020;3(12):e2025190.doi:10.1001/jamanetworkopen.2020.25190
JAMA. 2018;319(24):2521-2531. doi:10.1001/jama.2018.7498
https://www.sheffield.ac.uk/FRAX/tool.aspx?country=9
Guest: Robert A. Baldor MD, FAAFP
 
Music Credit: Richard Onorato]]></itunes:summary>
        <itunes:author>Pri-Med</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>532</itunes:duration>
                        <itunes:episodeType>full</itunes:episodeType>
        <itunes:image href="https://pbcdn1.podbean.com/imglogo/ep-logo/pbblog13721080/92a4958d8bb5e7b64052d6d79de3dcd0.png" />    </item>
    <item>
        <title>Do Sensible Shoes Improve Function for People with Knee Arthritis? - Frankly Speaking Ep 224</title>
        <itunes:title>Do Sensible Shoes Improve Function for People with Knee Arthritis? - Frankly Speaking Ep 224</itunes:title>
        <link>https://primedfranklyspeaking.podbean.com/e/do-sensible-shoes-improve-function-for-people-with-knee-arthritis-frankly-speaking-ep-224-1645730512/</link>
                    <comments>https://primedfranklyspeaking.podbean.com/e/do-sensible-shoes-improve-function-for-people-with-knee-arthritis-frankly-speaking-ep-224-1645730512/#comments</comments>        <pubDate>Mon, 17 May 2021 04:30:00 +0000</pubDate>
        <guid isPermaLink="false">e81cd45e-e1e9-4b1a-929a-51a61a66f966</guid>
                                    <description><![CDATA[<p>Credits: 0.25 AMA PRA Category 1 Credit™</p>
<p> </p>
<p>CME/CE Information and Claim Credit: <a href='https://www.pri-med.com/online-education/podcast/frankly-speaking-cme-224'>https://www.pri-med.com/online-education/podcast/frankly-speaking-cme-224</a></p>
<p> </p>
<p>Overview: More than 250 million individuals worldwide have osteoarthritis (OA) of the knee and the burden on individuals and healthcare systems is enormous. There is no cure for OA, with treatments such as NSAIDs and acetaminophen aimed towards symptom reduction and improved functioning. Most evidence-based guidelines include the use of supportive shoes, however little evidence exists on effectiveness of these types of shoes. It is also unclear what the characteristics of a supportive shoe are and what type of shoe is best for OA. Join us as we discuss a recent randomized controlled trial that compared 2 types of shoes, and their benefits in symptom reduction and functional improvement of knee OA</p>
<p> </p>
<p>Episode resource links:</p>
<ul><li>AAOS EBG: Lateral Wedge Insole. <a href='https://www.orthoguidelines.org/guideline-detail?id=1209&tab=all_guidelines'> https://www.orthoguidelines.org/guideline-detail?id=1209&tab=all_guidelines</a></li>
<li>AAOS EBG Treatment of Osteoarthritis of the Knee; <a href='https://www.aaos.org/globalassets/quality-and-practice-resources/osteoarthritis-of-the-knee/osteoarthritis-of-the-knee-2nd-editiion-clinical-practice-guideline.pdf'> https://www.aaos.org/globalassets/quality-and-practice-resources/osteoarthritis-of-the-knee/osteoarthritis-of-the-knee-2nd-editiion-clinical-practice-guideline.pdf</a></li>
</ul>
<p>Guest: Susan Feeney, DNP, FNP-BC, NP-C</p>
<p> </p>
<p>Music Credit: Richard Onorato</p>
]]></description>
                                                            <content:encoded><![CDATA[<p>Credits: 0.25 AMA PRA Category 1 Credit™</p>
<p> </p>
<p>CME/CE Information and Claim Credit: <a href='https://www.pri-med.com/online-education/podcast/frankly-speaking-cme-224'>https://www.pri-med.com/online-education/podcast/frankly-speaking-cme-224</a></p>
<p> </p>
<p>Overview: More than 250 million individuals worldwide have osteoarthritis (OA) of the knee and the burden on individuals and healthcare systems is enormous. There is no cure for OA, with treatments such as NSAIDs and acetaminophen aimed towards symptom reduction and improved functioning. Most evidence-based guidelines include the use of supportive shoes, however little evidence exists on effectiveness of these types of shoes. It is also unclear what the characteristics of a supportive shoe are and what type of shoe is best for OA. Join us as we discuss a recent randomized controlled trial that compared 2 types of shoes, and their benefits in symptom reduction and functional improvement of knee OA</p>
<p> </p>
<p>Episode resource links:</p>
<ul><li>AAOS EBG: Lateral Wedge Insole. <a href='https://www.orthoguidelines.org/guideline-detail?id=1209&tab=all_guidelines'> https://www.orthoguidelines.org/guideline-detail?id=1209&tab=all_guidelines</a></li>
<li>AAOS EBG Treatment of Osteoarthritis of the Knee; <a href='https://www.aaos.org/globalassets/quality-and-practice-resources/osteoarthritis-of-the-knee/osteoarthritis-of-the-knee-2nd-editiion-clinical-practice-guideline.pdf'> https://www.aaos.org/globalassets/quality-and-practice-resources/osteoarthritis-of-the-knee/osteoarthritis-of-the-knee-2nd-editiion-clinical-practice-guideline.pdf</a></li>
</ul>
<p>Guest: Susan Feeney, DNP, FNP-BC, NP-C</p>
<p> </p>
<p>Music Credit: Richard Onorato</p>
]]></content:encoded>
                                    
        <enclosure url="https://mcdn.podbean.com/mf/web/f7ys4v/secure_primed_frankly-speaking-224-shoes-knee-oa.mp3" length="9569220" type="audio/mpeg"/>
                <itunes:summary><![CDATA[Credits: 0.25 AMA PRA Category 1 Credit™
 
CME/CE Information and Claim Credit: https://www.pri-med.com/online-education/podcast/frankly-speaking-cme-224
 
Overview: More than 250 million individuals worldwide have osteoarthritis (OA) of the knee and the burden on individuals and healthcare systems is enormous. There is no cure for OA, with treatments such as NSAIDs and acetaminophen aimed towards symptom reduction and improved functioning. Most evidence-based guidelines include the use of supportive shoes, however little evidence exists on effectiveness of these types of shoes. It is also unclear what the characteristics of a supportive shoe are and what type of shoe is best for OA. Join us as we discuss a recent randomized controlled trial that compared 2 types of shoes, and their benefits in symptom reduction and functional improvement of knee OA
 
Episode resource links:
AAOS EBG: Lateral Wedge Insole.  https://www.orthoguidelines.org/guideline-detail?id=1209&tab=all_guidelines
AAOS EBG Treatment of Osteoarthritis of the Knee;  https://www.aaos.org/globalassets/quality-and-practice-resources/osteoarthritis-of-the-knee/osteoarthritis-of-the-knee-2nd-editiion-clinical-practice-guideline.pdf
Guest: Susan Feeney, DNP, FNP-BC, NP-C
 
Music Credit: Richard Onorato]]></itunes:summary>
        <itunes:author>Pri-Med</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>596</itunes:duration>
                        <itunes:episodeType>full</itunes:episodeType>
        <itunes:image href="https://pbcdn1.podbean.com/imglogo/ep-logo/pbblog13721080/bd697728384d92b41585c3a865cad61b.png" />    </item>
    <item>
        <title>Surviving Burnout: Caring for Ourselves - Frankly Speaking Ep 223</title>
        <itunes:title>Surviving Burnout: Caring for Ourselves - Frankly Speaking Ep 223</itunes:title>
        <link>https://primedfranklyspeaking.podbean.com/e/surviving-burnout-caring-for-ourselves-frankly-speaking-ep-223-1645730513/</link>
                    <comments>https://primedfranklyspeaking.podbean.com/e/surviving-burnout-caring-for-ourselves-frankly-speaking-ep-223-1645730513/#comments</comments>        <pubDate>Mon, 10 May 2021 04:30:00 +0000</pubDate>
        <guid isPermaLink="false">279dcc2d-4369-4f3c-b52e-b787659e92e8</guid>
                                    <description><![CDATA[<p>Credits: 0.25 AMA PRA Category 1 Credit™</p>
<p> </p>
<p>CME/CE Information and Claim Credit: <a href='https://www.pri-med.com/online-education/podcast/frankly-speaking-cme-223'>https://www.pri-med.com/online-education/podcast/frankly-speaking-cme-223</a></p>
<p> </p>
<p>Overview: Clinical psychologist Dr. Christine Runyan joins host, Dr. Frank Domino, in today’s episode to discuss the various self-care methods to help healthcare workers overcome stressors related to the COVID-19 pandemic, and to describe the potential future impact of the COVID-19 crisis on this population.</p>
<p> </p>
<p>Episode resource links:</p>
<ul><li><a href='https://tend.health/'>https://tend.health/</a></li>
<li><a href='https://www.pri-med.com/online-education/webcast/west-2019-well-being'> https://www.pri-med.com/online-education/webcast/west-2019-well-being</a></li>
<li><a href='https://www.pri-med.com/online-education/podcast/pri-med-podcasts-well-being'> https://www.pri-med.com/online-education/podcast/pri-med-podcasts-well-being</a></li>
</ul>
<p> </p>
<p>Guest: Christine Runyan, PhD, ABPP</p>
<p> </p>
<p>Music Credit: Richard Onorato</p>
]]></description>
                                                            <content:encoded><![CDATA[<p>Credits: 0.25 AMA PRA Category 1 Credit™</p>
<p> </p>
<p>CME/CE Information and Claim Credit: <a href='https://www.pri-med.com/online-education/podcast/frankly-speaking-cme-223'>https://www.pri-med.com/online-education/podcast/frankly-speaking-cme-223</a></p>
<p> </p>
<p>Overview: Clinical psychologist Dr. Christine Runyan joins host, Dr. Frank Domino, in today’s episode to discuss the various self-care methods to help healthcare workers overcome stressors related to the COVID-19 pandemic, and to describe the potential future impact of the COVID-19 crisis on this population.</p>
<p> </p>
<p>Episode resource links:</p>
<ul><li><a href='https://tend.health/'>https://tend.health/</a></li>
<li><a href='https://www.pri-med.com/online-education/webcast/west-2019-well-being'> https://www.pri-med.com/online-education/webcast/west-2019-well-being</a></li>
<li><a href='https://www.pri-med.com/online-education/podcast/pri-med-podcasts-well-being'> https://www.pri-med.com/online-education/podcast/pri-med-podcasts-well-being</a></li>
</ul>
<p> </p>
<p>Guest: Christine Runyan, PhD, ABPP</p>
<p> </p>
<p>Music Credit: Richard Onorato</p>
]]></content:encoded>
                                    
        <enclosure url="https://mcdn.podbean.com/mf/web/evg9on/secure_primed_frankly-speaking-223-runyan-provider-stress-1.mp3" length="21013972" type="audio/mpeg"/>
                <itunes:summary><![CDATA[Credits: 0.25 AMA PRA Category 1 Credit™
 
CME/CE Information and Claim Credit: https://www.pri-med.com/online-education/podcast/frankly-speaking-cme-223
 
Overview: Clinical psychologist Dr. Christine Runyan joins host, Dr. Frank Domino, in today’s episode to discuss the various self-care methods to help healthcare workers overcome stressors related to the COVID-19 pandemic, and to describe the potential future impact of the COVID-19 crisis on this population.
 
Episode resource links:
https://tend.health/
 https://www.pri-med.com/online-education/webcast/west-2019-well-being
 https://www.pri-med.com/online-education/podcast/pri-med-podcasts-well-being
 
Guest: Christine Runyan, PhD, ABPP
 
Music Credit: Richard Onorato]]></itunes:summary>
        <itunes:author>Pri-Med</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>1312</itunes:duration>
                        <itunes:episodeType>full</itunes:episodeType>
        <itunes:image href="https://pbcdn1.podbean.com/imglogo/ep-logo/pbblog13721080/d2dbd78c4992df22db3374dbfafdb2c2.png" />    </item>
    <item>
        <title>Save the Toenails! Topical Treatments for Onychomycosis - Frankly Speaking Ep 222</title>
        <itunes:title>Save the Toenails! Topical Treatments for Onychomycosis - Frankly Speaking Ep 222</itunes:title>
        <link>https://primedfranklyspeaking.podbean.com/e/save-the-toenails-topical-treatments-for-onychomycosis-frankly-speaking-ep-222-1645730514/</link>
                    <comments>https://primedfranklyspeaking.podbean.com/e/save-the-toenails-topical-treatments-for-onychomycosis-frankly-speaking-ep-222-1645730514/#comments</comments>        <pubDate>Mon, 03 May 2021 04:30:00 +0000</pubDate>
        <guid isPermaLink="false">55f8d778-fdf3-41da-93fc-524feb581d37</guid>
                                    <description><![CDATA[<p>Credits: 0.25 AMA PRA Category 1 Credit™</p>
<p> </p>
<p>CME/CE Information and Claim Credit: <a href='https://www.pri-med.com/online-education/podcast/frankly-speaking-cme-222'>https://www.pri-med.com/online-education/podcast/frankly-speaking-cme-222</a></p>
<p> </p>
<p>Overview: Join us for this episode as we discuss a recent Cochrane review of the safety and effectiveness of topical treatments for toenail onychomycosis, and review when and how to prescribe these agents for patients.</p>
<p> </p>
<p>Episode resource links:</p>
<ul><li>Topical and device-based treatments for fungal infections of the toenails. Cochrane Database Syst Rev. 2020; (1): CD012093</li>
</ul>
<p>Guest: Robert A. Baldor MD, FAAFP</p>
<p> </p>
<p>Music Credit: Richard Onorato</p>
]]></description>
                                                            <content:encoded><![CDATA[<p>Credits: 0.25 AMA PRA Category 1 Credit™</p>
<p> </p>
<p>CME/CE Information and Claim Credit: <a href='https://www.pri-med.com/online-education/podcast/frankly-speaking-cme-222'>https://www.pri-med.com/online-education/podcast/frankly-speaking-cme-222</a></p>
<p> </p>
<p>Overview: Join us for this episode as we discuss a recent Cochrane review of the safety and effectiveness of topical treatments for toenail onychomycosis, and review when and how to prescribe these agents for patients.</p>
<p> </p>
<p>Episode resource links:</p>
<ul><li>Topical and device-based treatments for fungal infections of the toenails. Cochrane Database Syst Rev. 2020; (1): CD012093</li>
</ul>
<p>Guest: Robert A. Baldor MD, FAAFP</p>
<p> </p>
<p>Music Credit: Richard Onorato</p>
]]></content:encoded>
                                    
        <enclosure url="https://mcdn.podbean.com/mf/web/sydxsj/secure_primed_frankly-speaking-222-antifungal.mp3" length="9236336" type="audio/mpeg"/>
                <itunes:summary><![CDATA[Credits: 0.25 AMA PRA Category 1 Credit™
 
CME/CE Information and Claim Credit: https://www.pri-med.com/online-education/podcast/frankly-speaking-cme-222
 
Overview: Join us for this episode as we discuss a recent Cochrane review of the safety and effectiveness of topical treatments for toenail onychomycosis, and review when and how to prescribe these agents for patients.
 
Episode resource links:
Topical and device-based treatments for fungal infections of the toenails. Cochrane Database Syst Rev. 2020; (1): CD012093
Guest: Robert A. Baldor MD, FAAFP
 
Music Credit: Richard Onorato]]></itunes:summary>
        <itunes:author>Pri-Med</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>576</itunes:duration>
                        <itunes:episodeType>full</itunes:episodeType>
        <itunes:image href="https://pbcdn1.podbean.com/imglogo/ep-logo/pbblog13721080/620632b45729241f80f5e1faf7e270b8.png" />    </item>
    <item>
        <title>With GERD, Diet and Lifestyle Win Out - Frankly Speaking Ep 221</title>
        <itunes:title>With GERD, Diet and Lifestyle Win Out - Frankly Speaking Ep 221</itunes:title>
        <link>https://primedfranklyspeaking.podbean.com/e/with-gerd-diet-and-lifestyle-win-out-frankly-speaking-ep-221-1645730515/</link>
                    <comments>https://primedfranklyspeaking.podbean.com/e/with-gerd-diet-and-lifestyle-win-out-frankly-speaking-ep-221-1645730515/#comments</comments>        <pubDate>Mon, 26 Apr 2021 04:30:00 +0000</pubDate>
        <guid isPermaLink="false">c951c910-d1a7-4c08-bf8d-ebc79a39571b</guid>
                                    <description><![CDATA[<p>Credits: 0.25 AMA PRA Category 1 Credit™</p>
<p> </p>
<p>CME/CE Information and Claim Credit: <a href='https://www.pri-med.com/online-education/podcast/frankly-speaking-cme-221'>https://www.pri-med.com/online-education/podcast/frankly-speaking-cme-221</a></p>
<p> </p>
<p>Overview: Join us as we discuss another finding of the Nurses Health Study II—this podcast focuses on the findings of a prospective look at GERD, and the effect of diet and lifestyle on the prevention of GERD.</p>
<p> </p>
<p>Episode resource links:</p>
<ul><li>
<p>Mehta RS, Nguyen LH, Ma W, Staller K, Song M, Chan AT. Association of Diet and Lifestyle With the Risk of Gastroesophageal Reflux Disease Symptoms in US Women. JAMA Intern Med. Published online January 04, 2021. doi:10.1001/jamainternmed.2020.7238</p>
</li>
<li>
<p>For Patients: Eating, Diet, & Nutrition for GER & GERD <a href='https://www.niddk.nih.gov/health-information/digestive-diseases/acid-reflux-ger-gerd-adults/eating-diet-nutrition'>https://www.niddk.nih.gov/health-information/digestive-diseases/acid-reflux-ger-gerd-adults/eating-diet-nutrition</a></p>
</li>
</ul>
<p>Guest: Jill M. Terrien PhD, ANP-BC</p>
<p> </p>
<p>Music Credit: Richard Onorato</p>
]]></description>
                                                            <content:encoded><![CDATA[<p>Credits: 0.25 AMA PRA Category 1 Credit™</p>
<p> </p>
<p>CME/CE Information and Claim Credit: <a href='https://www.pri-med.com/online-education/podcast/frankly-speaking-cme-221'>https://www.pri-med.com/online-education/podcast/frankly-speaking-cme-221</a></p>
<p> </p>
<p>Overview: Join us as we discuss another finding of the Nurses Health Study II—this podcast focuses on the findings of a prospective look at GERD, and the effect of diet and lifestyle on the prevention of GERD.</p>
<p> </p>
<p>Episode resource links:</p>
<ul><li>
<p>Mehta RS, Nguyen LH, Ma W, Staller K, Song M, Chan AT. Association of Diet and Lifestyle With the Risk of Gastroesophageal Reflux Disease Symptoms in US Women. JAMA Intern Med. Published online January 04, 2021. doi:10.1001/jamainternmed.2020.7238</p>
</li>
<li>
<p>For Patients: Eating, Diet, & Nutrition for GER & GERD <a href='https://www.niddk.nih.gov/health-information/digestive-diseases/acid-reflux-ger-gerd-adults/eating-diet-nutrition'>https://www.niddk.nih.gov/health-information/digestive-diseases/acid-reflux-ger-gerd-adults/eating-diet-nutrition</a></p>
</li>
</ul>
<p>Guest: Jill M. Terrien PhD, ANP-BC</p>
<p> </p>
<p>Music Credit: Richard Onorato</p>
]]></content:encoded>
                                    
        <enclosure url="https://mcdn.podbean.com/mf/web/ynny4w/secure_primed_frankly-speaking-221-gerd.mp3" length="11281366" type="audio/mpeg"/>
                <itunes:summary><![CDATA[Credits: 0.25 AMA PRA Category 1 Credit™
 
CME/CE Information and Claim Credit: https://www.pri-med.com/online-education/podcast/frankly-speaking-cme-221
 
Overview: Join us as we discuss another finding of the Nurses Health Study II—this podcast focuses on the findings of a prospective look at GERD, and the effect of diet and lifestyle on the prevention of GERD.
 
Episode resource links:

Mehta RS, Nguyen LH, Ma W, Staller K, Song M, Chan AT. Association of Diet and Lifestyle With the Risk of Gastroesophageal Reflux Disease Symptoms in US Women. JAMA Intern Med. Published online January 04, 2021. doi:10.1001/jamainternmed.2020.7238


For Patients: Eating, Diet, & Nutrition for GER & GERD https://www.niddk.nih.gov/health-information/digestive-diseases/acid-reflux-ger-gerd-adults/eating-diet-nutrition

Guest: Jill M. Terrien PhD, ANP-BC
 
Music Credit: Richard Onorato]]></itunes:summary>
        <itunes:author>Pri-Med</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>704</itunes:duration>
                        <itunes:episodeType>full</itunes:episodeType>
        <itunes:image href="https://pbcdn1.podbean.com/imglogo/ep-logo/pbblog13721080/92eb0f6616f92613eefe0a3db656025c.png" />    </item>
    <item>
        <title>Thawing The Frozen Shoulder - Frankly Speaking Ep 220</title>
        <itunes:title>Thawing The Frozen Shoulder - Frankly Speaking Ep 220</itunes:title>
        <link>https://primedfranklyspeaking.podbean.com/e/thawing-the-frozen-shoulder-frankly-speaking-ep-220-1645730516/</link>
                    <comments>https://primedfranklyspeaking.podbean.com/e/thawing-the-frozen-shoulder-frankly-speaking-ep-220-1645730516/#comments</comments>        <pubDate>Mon, 19 Apr 2021 04:30:00 +0000</pubDate>
        <guid isPermaLink="false">092b075e-1847-463a-84e2-13c01624d511</guid>
                                    <description><![CDATA[<p>Credits: 0.25 AMA PRA Category 1 Credit™</p>
<p> </p>
<p>CME/CE Information and Claim Credit: <a href='https://www.pri-med.com/online-education/podcast/frankly-speaking-cme-220'>https://www.pri-med.com/online-education/podcast/frankly-speaking-cme-220</a></p>
<p> </p>
<p>Overview: Join us for this episode as we review a recent meta-analysis that addresses best treatment modalities for adhesive capsulitis.</p>
<p> </p>
<p>Episode resource links:</p>
<ul><li>JAMA Netw Open. 2020 Dec 1;3(12):e2029581.</li>
</ul>
<p>Guest: Robert A. Baldor MD, FAAFP</p>
<p> </p>
<p>Music Credit: Richard Onorato</p>
]]></description>
                                                            <content:encoded><![CDATA[<p>Credits: 0.25 AMA PRA Category 1 Credit™</p>
<p> </p>
<p>CME/CE Information and Claim Credit: <a href='https://www.pri-med.com/online-education/podcast/frankly-speaking-cme-220'>https://www.pri-med.com/online-education/podcast/frankly-speaking-cme-220</a></p>
<p> </p>
<p>Overview: Join us for this episode as we review a recent meta-analysis that addresses best treatment modalities for adhesive capsulitis.</p>
<p> </p>
<p>Episode resource links:</p>
<ul><li>JAMA Netw Open. 2020 Dec 1;3(12):e2029581.</li>
</ul>
<p>Guest: Robert A. Baldor MD, FAAFP</p>
<p> </p>
<p>Music Credit: Richard Onorato</p>
]]></content:encoded>
                                    
        <enclosure url="https://mcdn.podbean.com/mf/web/obqu5p/secure_primed_frankly-speaking-220-frozen-shoulder.mp3" length="10479680" type="audio/mpeg"/>
                <itunes:summary><![CDATA[Credits: 0.25 AMA PRA Category 1 Credit™
 
CME/CE Information and Claim Credit: https://www.pri-med.com/online-education/podcast/frankly-speaking-cme-220
 
Overview: Join us for this episode as we review a recent meta-analysis that addresses best treatment modalities for adhesive capsulitis.
 
Episode resource links:
JAMA Netw Open. 2020 Dec 1;3(12):e2029581.
Guest: Robert A. Baldor MD, FAAFP
 
Music Credit: Richard Onorato]]></itunes:summary>
        <itunes:author>Pri-Med</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>654</itunes:duration>
                        <itunes:episodeType>full</itunes:episodeType>
        <itunes:image href="https://pbcdn1.podbean.com/imglogo/ep-logo/pbblog13721080/4a1aade8062d3662b0e4ecf457d071a9.png" />    </item>
    <item>
        <title>Nearsighted: Possible Connection Between COVID Lockdown and Increase in Childhood Myopia - Frankly Speaking Ep 219</title>
        <itunes:title>Nearsighted: Possible Connection Between COVID Lockdown and Increase in Childhood Myopia - Frankly Speaking Ep 219</itunes:title>
        <link>https://primedfranklyspeaking.podbean.com/e/nearsighted-possible-connection-between-covid-lockdown-and-increase-in-childhood-myopia-frankly-speaking-ep-219-1645730518/</link>
                    <comments>https://primedfranklyspeaking.podbean.com/e/nearsighted-possible-connection-between-covid-lockdown-and-increase-in-childhood-myopia-frankly-speaking-ep-219-1645730518/#comments</comments>        <pubDate>Mon, 12 Apr 2021 04:30:00 +0000</pubDate>
        <guid isPermaLink="false">e69cea2d-0fa7-43af-b049-80030748f841</guid>
                                    <description><![CDATA[<p>Credits: 0.25 AMA PRA Category 1 Credit™</p>
<p> </p>
<p>CME/CE Information and Claim Credit: <a href='https://www.pri-med.com/online-education/podcast/frankly-speaking-cme-219'>https://www.pri-med.com/online-education/podcast/frankly-speaking-cme-219</a></p>
<p> </p>
<p>Overview: The COVID pandemic and the precautionary changes in behavior put into practice are creating an immeasurable cost in ways that are still being identified – social isolation, stresses on mental health, as well as neglect of chronic disease management – to name a few. In a recent study out of China, it was found that 6, 7 and 8-year-olds had a significant increase in myopia associated with the lockdown and school closures. This level of myopia places these children at much greater risk of poor vision in adulthood. Join us as we discuss these findings and how they may impact prevention strategies and assessment parameters in children during and after the pandemic.</p>
<p> </p>
<p>Episode References:</p>
<ul><li>Klaver CCW, Polling JR, Enthoven CA. 2020 as the Year of Quarantine Myopia. JAMA Ophthalmol. Published online January 14, 2021. doi:10.1001/jamaophthalmol.2020.6231</li>
<li>Wang J, Li Y, Musch DC, et al. Progression of Myopia in School-Aged Children After COVID-19 Home Confinement. JAMA Ophthalmol. Published online January 14, 2021. doi:10.1001/jamaophthalmol.2020.6239</li>
</ul>
<p> </p>
<p>Guest: Susan Feeney, DNP, FNP-BC, NP-C</p>
<p> </p>
<p>Music Credit: Richard Onorato</p>
]]></description>
                                                            <content:encoded><![CDATA[<p>Credits: 0.25 AMA PRA Category 1 Credit™</p>
<p> </p>
<p>CME/CE Information and Claim Credit: <a href='https://www.pri-med.com/online-education/podcast/frankly-speaking-cme-219'>https://www.pri-med.com/online-education/podcast/frankly-speaking-cme-219</a></p>
<p> </p>
<p>Overview: The COVID pandemic and the precautionary changes in behavior put into practice are creating an immeasurable cost in ways that are still being identified – social isolation, stresses on mental health, as well as neglect of chronic disease management – to name a few. In a recent study out of China, it was found that 6, 7 and 8-year-olds had a significant increase in myopia associated with the lockdown and school closures. This level of myopia places these children at much greater risk of poor vision in adulthood. Join us as we discuss these findings and how they may impact prevention strategies and assessment parameters in children during and after the pandemic.</p>
<p> </p>
<p>Episode References:</p>
<ul><li>Klaver CCW, Polling JR, Enthoven CA. 2020 as the Year of Quarantine Myopia. JAMA Ophthalmol. Published online January 14, 2021. doi:10.1001/jamaophthalmol.2020.6231</li>
<li>Wang J, Li Y, Musch DC, et al. Progression of Myopia in School-Aged Children After COVID-19 Home Confinement. JAMA Ophthalmol. Published online January 14, 2021. doi:10.1001/jamaophthalmol.2020.6239</li>
</ul>
<p> </p>
<p>Guest: Susan Feeney, DNP, FNP-BC, NP-C</p>
<p> </p>
<p>Music Credit: Richard Onorato</p>
]]></content:encoded>
                                    
        <enclosure url="https://mcdn.podbean.com/mf/web/9ejewk/secure_primed_frankly-speaking-219-myopia1.mp3" length="9988734" type="audio/mpeg"/>
                <itunes:summary><![CDATA[Credits: 0.25 AMA PRA Category 1 Credit™
 
CME/CE Information and Claim Credit: https://www.pri-med.com/online-education/podcast/frankly-speaking-cme-219
 
Overview: The COVID pandemic and the precautionary changes in behavior put into practice are creating an immeasurable cost in ways that are still being identified – social isolation, stresses on mental health, as well as neglect of chronic disease management – to name a few. In a recent study out of China, it was found that 6, 7 and 8-year-olds had a significant increase in myopia associated with the lockdown and school closures. This level of myopia places these children at much greater risk of poor vision in adulthood. Join us as we discuss these findings and how they may impact prevention strategies and assessment parameters in children during and after the pandemic.
 
Episode References:
Klaver CCW, Polling JR, Enthoven CA. 2020 as the Year of Quarantine Myopia. JAMA Ophthalmol. Published online January 14, 2021. doi:10.1001/jamaophthalmol.2020.6231
Wang J, Li Y, Musch DC, et al. Progression of Myopia in School-Aged Children After COVID-19 Home Confinement. JAMA Ophthalmol. Published online January 14, 2021. doi:10.1001/jamaophthalmol.2020.6239
 
Guest: Susan Feeney, DNP, FNP-BC, NP-C
 
Music Credit: Richard Onorato]]></itunes:summary>
        <itunes:author>Pri-Med</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>623</itunes:duration>
                        <itunes:episodeType>full</itunes:episodeType>
        <itunes:image href="https://pbcdn1.podbean.com/imglogo/ep-logo/pbblog13721080/0c83bda9c09e227ad37f733667cd95f8.png" />    </item>
    <item>
        <title>Aspirin (ASA) to Prevent Colorectal Cancer - Frankly Speaking Ep 218</title>
        <itunes:title>Aspirin (ASA) to Prevent Colorectal Cancer - Frankly Speaking Ep 218</itunes:title>
        <link>https://primedfranklyspeaking.podbean.com/e/aspirin-asa-to-prevent-colorectal-cancer-frankly-speaking-ep-218-1645730519/</link>
                    <comments>https://primedfranklyspeaking.podbean.com/e/aspirin-asa-to-prevent-colorectal-cancer-frankly-speaking-ep-218-1645730519/#comments</comments>        <pubDate>Mon, 05 Apr 2021 04:30:00 +0000</pubDate>
        <guid isPermaLink="false">c2aecf4e-531b-4a98-8695-7a2829cd5615</guid>
                                    <description><![CDATA[<p>Credits: 0.25 AMA PRA Category 1 Credit™</p>
<p> </p>
<p>CME/CE Information and Claim Credit: <a href='https://www.pri-med.com/online-education/podcast/frankly-speaking-cme-218'>https://www.pri-med.com/online-education/podcast/frankly-speaking-cme-218</a></p>
<p> </p>
<p>Overview: Join us for this session where we will discuss the data behind the recent USPSTF recommendations on the use of ASA as a colorectal cancer (CRC) preventive agent, and when to incorporate this recommendation into practice.</p>
<p> </p>
<p>Episode resource links:</p>
<ul><li><a href='http://www.uspreventiveservicestaskforce.org/uspstf/recommendation/aspirin-to-prevent-cardiovascular-disease-and-cancer'>www.uspreventiveservicestaskforce.org/uspstf/recommendation/aspirin-to-prevent-cardiovascular-disease-and-cancer</a></li>
<li>doi:10.1001/jamaoncol.2020.7338</li>
<li>N Engl J Med 2018; 379:1519-1528 DOI: 10.1056/NEJMoa1803955</li>
</ul>
<p>Guest: Robert A. Baldor MD, FAAFP</p>
<p> </p>
<p>Music Credit: Richard Onorato</p>
]]></description>
                                                            <content:encoded><![CDATA[<p>Credits: 0.25 AMA PRA Category 1 Credit™</p>
<p> </p>
<p>CME/CE Information and Claim Credit: <a href='https://www.pri-med.com/online-education/podcast/frankly-speaking-cme-218'>https://www.pri-med.com/online-education/podcast/frankly-speaking-cme-218</a></p>
<p> </p>
<p>Overview: Join us for this session where we will discuss the data behind the recent USPSTF recommendations on the use of ASA as a colorectal cancer (CRC) preventive agent, and when to incorporate this recommendation into practice.</p>
<p> </p>
<p>Episode resource links:</p>
<ul><li><a href='http://www.uspreventiveservicestaskforce.org/uspstf/recommendation/aspirin-to-prevent-cardiovascular-disease-and-cancer'>www.uspreventiveservicestaskforce.org/uspstf/recommendation/aspirin-to-prevent-cardiovascular-disease-and-cancer</a></li>
<li>doi:10.1001/jamaoncol.2020.7338</li>
<li>N Engl J Med 2018; 379:1519-1528 DOI: 10.1056/NEJMoa1803955</li>
</ul>
<p>Guest: Robert A. Baldor MD, FAAFP</p>
<p> </p>
<p>Music Credit: Richard Onorato</p>
]]></content:encoded>
                                    
        <enclosure url="https://mcdn.podbean.com/mf/web/iixcr1/secure_primed_frankly-speaking-218-aspirin.mp3" length="9642443" type="audio/mpeg"/>
                <itunes:summary><![CDATA[Credits: 0.25 AMA PRA Category 1 Credit™
 
CME/CE Information and Claim Credit: https://www.pri-med.com/online-education/podcast/frankly-speaking-cme-218
 
Overview: Join us for this session where we will discuss the data behind the recent USPSTF recommendations on the use of ASA as a colorectal cancer (CRC) preventive agent, and when to incorporate this recommendation into practice.
 
Episode resource links:
www.uspreventiveservicestaskforce.org/uspstf/recommendation/aspirin-to-prevent-cardiovascular-disease-and-cancer
doi:10.1001/jamaoncol.2020.7338
N Engl J Med 2018; 379:1519-1528 DOI: 10.1056/NEJMoa1803955
Guest: Robert A. Baldor MD, FAAFP
 
Music Credit: Richard Onorato]]></itunes:summary>
        <itunes:author>Pri-Med</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>602</itunes:duration>
                        <itunes:episodeType>full</itunes:episodeType>
        <itunes:image href="https://pbcdn1.podbean.com/imglogo/ep-logo/pbblog13721080/ef62559e3e261c1db3fe87cb34ef49fa.png" />    </item>
    <item>
        <title>Direct Communication Improves Vaccine Receipt - Frankly Speaking Ep 217</title>
        <itunes:title>Direct Communication Improves Vaccine Receipt - Frankly Speaking Ep 217</itunes:title>
        <link>https://primedfranklyspeaking.podbean.com/e/direct-communication-improves-vaccine-receipt-frankly-speaking-ep-217-1645730520/</link>
                    <comments>https://primedfranklyspeaking.podbean.com/e/direct-communication-improves-vaccine-receipt-frankly-speaking-ep-217-1645730520/#comments</comments>        <pubDate>Mon, 29 Mar 2021 04:30:00 +0000</pubDate>
        <guid isPermaLink="false">68d2e9cd-c6a1-4c70-9259-119a5fc84a16</guid>
                                    <description><![CDATA[<p>Credits: 0.25 AMA PRA Category 1 Credit™</p>
<p> </p>
<p>CME/CE Information and Claim Credit: <a href='https://www.pri-med.com/online-education/podcast/frankly-speaking-cme-217'>https://www.pri-med.com/online-education/podcast/frankly-speaking-cme-217</a></p>
<p> </p>
<p>Overview: Join us as we review communication styles that influence vaccination uptake by the adolescent population. We will discuss a recent article examining the effects of provider’s recommendation styles with adolescent patients regarding HPV and meningococcal vaccines.</p>
<p> </p>
<p>Episode resource links:</p>
<ul><li>Anny T.H.R. Fenton, Chelsea Orefice, Terresa J. Eun, Dea Biancarelli, Amresh Hanchate, Mari-Lynn Drainoni, Rebecca B. Perkins, Effect of provider recommendation style on the length of adolescent vaccine discussions, Vaccine, Volume 39, Issue 6, 2021, Pages 1018-1023, ISSN 0264-410X,https://doi.org/10.1016/j.vaccine.2020.11.015. (https://www.sciencedirect.com/science/article/pii/S0264410X20314419)</li>
<li>HPV Vaccine recommendations CDC: <a href='https://www.cdc.gov/vaccines/vpd/hpv/hcp/recommendations.html'>https://www.cdc.gov/vaccines/vpd/hpv/hcp/recommendations.html</a></li>
<li>5 Ways to boost your HPV Vaccination Rates CDC: <a href='https://www.cdc.gov/hpv/hcp/boosting-vacc-rates.html'>https://www.cdc.gov/hpv/hcp/boosting-vacc-rates.html</a></li>
<li>Meningococcal Vaccine Recommendations CDC: <a href='https://www.cdc.gov/vaccines/vpd/mening/hcp/recommendations.html'>https://www.cdc.gov/vaccines/vpd/mening/hcp/recommendations.html</a></li>
</ul>
<p> </p>
<p>Guest: Jill M. Terrien PhD, ANP-BC</p>
<p> </p>
<p>Music Credit: Richard Onorato</p>
]]></description>
                                                            <content:encoded><![CDATA[<p>Credits: 0.25 AMA PRA Category 1 Credit™</p>
<p> </p>
<p>CME/CE Information and Claim Credit: <a href='https://www.pri-med.com/online-education/podcast/frankly-speaking-cme-217'>https://www.pri-med.com/online-education/podcast/frankly-speaking-cme-217</a></p>
<p> </p>
<p>Overview: Join us as we review communication styles that influence vaccination uptake by the adolescent population. We will discuss a recent article examining the effects of provider’s recommendation styles with adolescent patients regarding HPV and meningococcal vaccines.</p>
<p> </p>
<p>Episode resource links:</p>
<ul><li>Anny T.H.R. Fenton, Chelsea Orefice, Terresa J. Eun, Dea Biancarelli, Amresh Hanchate, Mari-Lynn Drainoni, Rebecca B. Perkins, Effect of provider recommendation style on the length of adolescent vaccine discussions, Vaccine, Volume 39, Issue 6, 2021, Pages 1018-1023, ISSN 0264-410X,https://doi.org/10.1016/j.vaccine.2020.11.015. (https://www.sciencedirect.com/science/article/pii/S0264410X20314419)</li>
<li>HPV Vaccine recommendations CDC: <a href='https://www.cdc.gov/vaccines/vpd/hpv/hcp/recommendations.html'>https://www.cdc.gov/vaccines/vpd/hpv/hcp/recommendations.html</a></li>
<li>5 Ways to boost your HPV Vaccination Rates CDC: <a href='https://www.cdc.gov/hpv/hcp/boosting-vacc-rates.html'>https://www.cdc.gov/hpv/hcp/boosting-vacc-rates.html</a></li>
<li>Meningococcal Vaccine Recommendations CDC: <a href='https://www.cdc.gov/vaccines/vpd/mening/hcp/recommendations.html'>https://www.cdc.gov/vaccines/vpd/mening/hcp/recommendations.html</a></li>
</ul>
<p> </p>
<p>Guest: Jill M. Terrien PhD, ANP-BC</p>
<p> </p>
<p>Music Credit: Richard Onorato</p>
]]></content:encoded>
                                    
        <enclosure url="https://mcdn.podbean.com/mf/web/e5iaoh/secure_primed_frankly-speaking-217-hpv-vaccine.mp3" length="9856193" type="audio/mpeg"/>
                <itunes:summary><![CDATA[Credits: 0.25 AMA PRA Category 1 Credit™
 
CME/CE Information and Claim Credit: https://www.pri-med.com/online-education/podcast/frankly-speaking-cme-217
 
Overview: Join us as we review communication styles that influence vaccination uptake by the adolescent population. We will discuss a recent article examining the effects of provider’s recommendation styles with adolescent patients regarding HPV and meningococcal vaccines.
 
Episode resource links:
Anny T.H.R. Fenton, Chelsea Orefice, Terresa J. Eun, Dea Biancarelli, Amresh Hanchate, Mari-Lynn Drainoni, Rebecca B. Perkins, Effect of provider recommendation style on the length of adolescent vaccine discussions, Vaccine, Volume 39, Issue 6, 2021, Pages 1018-1023, ISSN 0264-410X,https://doi.org/10.1016/j.vaccine.2020.11.015. (https://www.sciencedirect.com/science/article/pii/S0264410X20314419)
HPV Vaccine recommendations CDC: https://www.cdc.gov/vaccines/vpd/hpv/hcp/recommendations.html
5 Ways to boost your HPV Vaccination Rates CDC: https://www.cdc.gov/hpv/hcp/boosting-vacc-rates.html
Meningococcal Vaccine Recommendations CDC: https://www.cdc.gov/vaccines/vpd/mening/hcp/recommendations.html
 
Guest: Jill M. Terrien PhD, ANP-BC
 
Music Credit: Richard Onorato]]></itunes:summary>
        <itunes:author>Pri-Med</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>614</itunes:duration>
                        <itunes:episodeType>full</itunes:episodeType>
        <itunes:image href="https://pbcdn1.podbean.com/imglogo/ep-logo/pbblog13721080/df9f72804addda08522c7d21e58cacd2.png" />    </item>
    <item>
        <title>Curcumin for osteoarthritis - Frankly Speaking Ep 216</title>
        <itunes:title>Curcumin for osteoarthritis - Frankly Speaking Ep 216</itunes:title>
        <link>https://primedfranklyspeaking.podbean.com/e/curcumin-for-osteoarthritis-frankly-speaking-ep-216-1645730521/</link>
                    <comments>https://primedfranklyspeaking.podbean.com/e/curcumin-for-osteoarthritis-frankly-speaking-ep-216-1645730521/#comments</comments>        <pubDate>Mon, 22 Mar 2021 04:30:00 +0000</pubDate>
        <guid isPermaLink="false">2923051f-3e83-48c5-bebf-57a01f274b43</guid>
                                    <description><![CDATA[<p>Credits: 0.25 AMA PRA Category 1 Credit™</p>
<p> </p>
<p>CME/CE Information and Claim Credit: <a href='https://www.pri-med.com/online-education/podcast/frankly-speaking-cme-216'>https://www.pri-med.com/online-education/podcast/frankly-speaking-cme-216</a></p>
<p> </p>
<p>Overview: Osteoarthritis (OA) is a very common problem seen in the primary care setting, but pharmacologic treatments do not alter the course of the disease and they are often associated with side effects or contraindicated in many older patients. Curcumin is an herbal treatment that has been shown to be effective for treating symptoms of OA. Join us for this episode as we discuss the evidence for curcumin in treating OA, and how to counsel patients on its use.</p>
<p> </p>
<p>Episode resource links:</p>
<ul><li>Wang Z. et al. Effectiveness of Curcuma longa Extract for the Treatment of Symptoms and Effusion-Synovitis of Knee Osteoarthritis : A Randomized Trial. Ann Intern Med. 2020 Dec 1;173(11):861-869.</li>
<li>Daily JW, Yang M, Park S. Efficacy of Turmeric Extracts and Curcumin for Alleviating the Symptoms of Joint Arthritis: A Systematic Review and Meta-Analysis of Randomized Clinical Trials. J Med Food. 2016 Aug;19(8):717-29</li>
</ul>
<p>Guest: Alan Ehrlich MD, FAAFP</p>
<p> </p>
<p>Music Credit: Richard Onorato</p>
]]></description>
                                                            <content:encoded><![CDATA[<p>Credits: 0.25 AMA PRA Category 1 Credit™</p>
<p> </p>
<p>CME/CE Information and Claim Credit: <a href='https://www.pri-med.com/online-education/podcast/frankly-speaking-cme-216'>https://www.pri-med.com/online-education/podcast/frankly-speaking-cme-216</a></p>
<p> </p>
<p>Overview: Osteoarthritis (OA) is a very common problem seen in the primary care setting, but pharmacologic treatments do not alter the course of the disease and they are often associated with side effects or contraindicated in many older patients. Curcumin is an herbal treatment that has been shown to be effective for treating symptoms of OA. Join us for this episode as we discuss the evidence for curcumin in treating OA, and how to counsel patients on its use.</p>
<p> </p>
<p>Episode resource links:</p>
<ul><li>Wang Z. et al. Effectiveness of Curcuma longa Extract for the Treatment of Symptoms and Effusion-Synovitis of Knee Osteoarthritis : A Randomized Trial. Ann Intern Med. 2020 Dec 1;173(11):861-869.</li>
<li>Daily JW, Yang M, Park S. Efficacy of Turmeric Extracts and Curcumin for Alleviating the Symptoms of Joint Arthritis: A Systematic Review and Meta-Analysis of Randomized Clinical Trials. J Med Food. 2016 Aug;19(8):717-29</li>
</ul>
<p>Guest: Alan Ehrlich MD, FAAFP</p>
<p> </p>
<p>Music Credit: Richard Onorato</p>
]]></content:encoded>
                                    
        <enclosure url="https://mcdn.podbean.com/mf/web/wdjq64/secure_primed_frankly-speaking-216-curcumin.mp3" length="11029312" type="audio/mpeg"/>
                <itunes:summary><![CDATA[Credits: 0.25 AMA PRA Category 1 Credit™
 
CME/CE Information and Claim Credit: https://www.pri-med.com/online-education/podcast/frankly-speaking-cme-216
 
Overview: Osteoarthritis (OA) is a very common problem seen in the primary care setting, but pharmacologic treatments do not alter the course of the disease and they are often associated with side effects or contraindicated in many older patients. Curcumin is an herbal treatment that has been shown to be effective for treating symptoms of OA. Join us for this episode as we discuss the evidence for curcumin in treating OA, and how to counsel patients on its use.
 
Episode resource links:
Wang Z. et al. Effectiveness of Curcuma longa Extract for the Treatment of Symptoms and Effusion-Synovitis of Knee Osteoarthritis : A Randomized Trial. Ann Intern Med. 2020 Dec 1;173(11):861-869.
Daily JW, Yang M, Park S. Efficacy of Turmeric Extracts and Curcumin for Alleviating the Symptoms of Joint Arthritis: A Systematic Review and Meta-Analysis of Randomized Clinical Trials. J Med Food. 2016 Aug;19(8):717-29
Guest: Alan Ehrlich MD, FAAFP
 
Music Credit: Richard Onorato]]></itunes:summary>
        <itunes:author>Pri-Med</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>688</itunes:duration>
                        <itunes:episodeType>full</itunes:episodeType>
        <itunes:image href="https://pbcdn1.podbean.com/imglogo/ep-logo/pbblog13721080/f4cdb78b6a570c3709a207ac1e1347dd.png" />    </item>
    <item>
        <title>Managing Stress in Pregnancy: Good News Regarding Mind-Body Interventions (MBI) - Frankly Speaking Ep 215</title>
        <itunes:title>Managing Stress in Pregnancy: Good News Regarding Mind-Body Interventions (MBI) - Frankly Speaking Ep 215</itunes:title>
        <link>https://primedfranklyspeaking.podbean.com/e/managing-stress-in-pregnancy-good-news-regarding-mind-body-interventions-mbi-frankly-speaking-ep-215-1645730522/</link>
                    <comments>https://primedfranklyspeaking.podbean.com/e/managing-stress-in-pregnancy-good-news-regarding-mind-body-interventions-mbi-frankly-speaking-ep-215-1645730522/#comments</comments>        <pubDate>Mon, 15 Mar 2021 04:30:00 +0000</pubDate>
        <guid isPermaLink="false">861c072e-bd77-4ddc-b9dd-c1bb24a13e1e</guid>
                                    <description><![CDATA[<p>Credits: 0.25 AMA PRA Category 1 Credit™</p>
<p> </p>
<p>CME/CE Information and Claim Credit: <a href='https://www.pri-med.com/online-education/podcast/frankly-speaking-cme-215'>https://www.pri-med.com/online-education/podcast/frankly-speaking-cme-215</a> </p>
<p> </p>
<p>Overview: Times are stressful. Recent evidence has shown that stress, anxiety, and depression experienced by pregnant women may have a negative impact on the wellness of the newborn. Stress management is constrained during pregnancy due to concerns that pharmaceutical approaches may be harmful to the baby. Non-pharmaceutical approaches are accessible and safe. Join us as we review recent evidence on the effectiveness of mind-body interventions (MBI) in reducing stress and decreasing depression and anxiety in pregnant women, and discuss how MBI can be incorporated into patient care.</p>
<p> </p>
<p>Episode resource links:</p>
<ul><li><a href='https://www.pri-med.com/online-education/webcast/west-2019-well-being'> Re-Engineering Your Clinical Practice for Patient and Clinician Well-Being</a></li>
<li>Guo P, Zhang X, Liu N, Wang J, Chen D, Sun W, Li P, Zhang W. Mind-body interventions on stress management in pregnant women: A systematic review and meta-analysis of randomized controlled trials. J Adv Nurs. 2020 Oct 13. doi: 10.1111/jan.14588. Epub ahead of print. PMID: 33048358.</li>
<li>Leaviss J, Davis S, Ren S, Hamilton J, Scope A, Booth A, Sutton A, Parry G, Buszewicz M, Moss-Morris R, White P. Behavioural modification interventions for medically unexplained symptoms in primary care: systematic reviews and economic evaluation. Health Technol Assess. 2020 Sep;24(46):1-490. doi: 10.3310/hta24460. PMID: 32975190; PMCID: PMC7548871</li>
</ul>
<p> </p>
<p>Guest: Susan Feeney, DNP, FNP-BC, NP-C</p>
<p> </p>
<p>Music Credit: Richard Onorato</p>
]]></description>
                                                            <content:encoded><![CDATA[<p>Credits: 0.25 AMA PRA Category 1 Credit™</p>
<p> </p>
<p>CME/CE Information and Claim Credit: <a href='https://www.pri-med.com/online-education/podcast/frankly-speaking-cme-215'>https://www.pri-med.com/online-education/podcast/frankly-speaking-cme-215</a> </p>
<p> </p>
<p>Overview: Times are stressful. Recent evidence has shown that stress, anxiety, and depression experienced by pregnant women may have a negative impact on the wellness of the newborn. Stress management is constrained during pregnancy due to concerns that pharmaceutical approaches may be harmful to the baby. Non-pharmaceutical approaches are accessible and safe. Join us as we review recent evidence on the effectiveness of mind-body interventions (MBI) in reducing stress and decreasing depression and anxiety in pregnant women, and discuss how MBI can be incorporated into patient care.</p>
<p> </p>
<p>Episode resource links:</p>
<ul><li><a href='https://www.pri-med.com/online-education/webcast/west-2019-well-being'> Re-Engineering Your Clinical Practice for Patient and Clinician Well-Being</a></li>
<li>Guo P, Zhang X, Liu N, Wang J, Chen D, Sun W, Li P, Zhang W. Mind-body interventions on stress management in pregnant women: A systematic review and meta-analysis of randomized controlled trials. J Adv Nurs. 2020 Oct 13. doi: 10.1111/jan.14588. Epub ahead of print. PMID: 33048358.</li>
<li>Leaviss J, Davis S, Ren S, Hamilton J, Scope A, Booth A, Sutton A, Parry G, Buszewicz M, Moss-Morris R, White P. Behavioural modification interventions for medically unexplained symptoms in primary care: systematic reviews and economic evaluation. Health Technol Assess. 2020 Sep;24(46):1-490. doi: 10.3310/hta24460. PMID: 32975190; PMCID: PMC7548871</li>
</ul>
<p> </p>
<p>Guest: Susan Feeney, DNP, FNP-BC, NP-C</p>
<p> </p>
<p>Music Credit: Richard Onorato</p>
]]></content:encoded>
                                    
        <enclosure url="https://mcdn.podbean.com/mf/web/1c17fd/secure_primed_frankly-speaking-215-stress-reduction.mp3" length="14042614" type="audio/mpeg"/>
                <itunes:summary><![CDATA[Credits: 0.25 AMA PRA Category 1 Credit™
 
CME/CE Information and Claim Credit: https://www.pri-med.com/online-education/podcast/frankly-speaking-cme-215 
 
Overview: Times are stressful. Recent evidence has shown that stress, anxiety, and depression experienced by pregnant women may have a negative impact on the wellness of the newborn. Stress management is constrained during pregnancy due to concerns that pharmaceutical approaches may be harmful to the baby. Non-pharmaceutical approaches are accessible and safe. Join us as we review recent evidence on the effectiveness of mind-body interventions (MBI) in reducing stress and decreasing depression and anxiety in pregnant women, and discuss how MBI can be incorporated into patient care.
 
Episode resource links:
 Re-Engineering Your Clinical Practice for Patient and Clinician Well-Being
Guo P, Zhang X, Liu N, Wang J, Chen D, Sun W, Li P, Zhang W. Mind-body interventions on stress management in pregnant women: A systematic review and meta-analysis of randomized controlled trials. J Adv Nurs. 2020 Oct 13. doi: 10.1111/jan.14588. Epub ahead of print. PMID: 33048358.
Leaviss J, Davis S, Ren S, Hamilton J, Scope A, Booth A, Sutton A, Parry G, Buszewicz M, Moss-Morris R, White P. Behavioural modification interventions for medically unexplained symptoms in primary care: systematic reviews and economic evaluation. Health Technol Assess. 2020 Sep;24(46):1-490. doi: 10.3310/hta24460. PMID: 32975190; PMCID: PMC7548871
 
Guest: Susan Feeney, DNP, FNP-BC, NP-C
 
Music Credit: Richard Onorato]]></itunes:summary>
        <itunes:author>Pri-Med</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>876</itunes:duration>
                        <itunes:episodeType>full</itunes:episodeType>
        <itunes:image href="https://pbcdn1.podbean.com/imglogo/ep-logo/pbblog13721080/6ee58d61121ab6d49f0bfaf8cd66114e.png" />    </item>
    <item>
        <title>Teens and Vaping: A Gateway to Cigarette Smoking?  - Frankly Speaking Ep 214</title>
        <itunes:title>Teens and Vaping: A Gateway to Cigarette Smoking?  - Frankly Speaking Ep 214</itunes:title>
        <link>https://primedfranklyspeaking.podbean.com/e/teens-and-vaping-a-gateway-to-cigarette-smoking-frankly-speaking-ep-214-1645730523/</link>
                    <comments>https://primedfranklyspeaking.podbean.com/e/teens-and-vaping-a-gateway-to-cigarette-smoking-frankly-speaking-ep-214-1645730523/#comments</comments>        <pubDate>Mon, 08 Mar 2021 05:30:00 +0000</pubDate>
        <guid isPermaLink="false">00734a4f-1d2d-4928-8531-8f7c83965eed</guid>
                                    <description><![CDATA[<p>Credits: 0.25 AMA PRA Category 1 Credit™</p>
<p> </p>
<p>CME/CE Information and Claim Credit: <a href='https://www.pri-med.com/online-education/podcast/frankly-speaking-cme-214'>https://www.pri-med.com/online-education/podcast/frankly-speaking-cme-214</a></p>
<p> </p>
<p>Overview: Rates of electronic cigarettes or vaping in teens has increased exponentially over the last 3 years. Prior to the introduction of the sleek 4th generation vaping device, tobacco use in the teen population was decreasing, and rates were low. Recent evidence indicates that teens with low intention to smoke, once they start vaping, are at increased risk of smoking cigarettes in future. Join us as we discuss the implications of this new evidence on our clinical practice and discuss strategies to reduce risk to adolescents.</p>
<p> </p>
<p>Episode Resources:</p>
<ul><li>Barrington-Trimis JL, Kong G, Leventhal AM, et al. E-cigarette Use and Subsequent Smoking Frequency Among Adolescents. Pediatrics. 2018;142(6):e20180486</li>
<li>Gaiha SM, et al. J Adolesc Health. Association Between Youth Smoking, Electronic Cigarette Use, and COVID-19. J Adolesc Health. Vol 67, issue 4, pp 519-523; DOI: https://doi.org/10.1015/j.jadolhealth.2020.07.002</li>
<li>Owotomo O, Stritzel H, McCabe SE, et al. Smoking Intention and Progression from E-Cigarette Use to Cigarette Smoking. Pediatrics. 2020;146(6):e2020002881; DOI: 10.1542/peds.2020-002881
<a href='https://pediatrics.aappublications.org/content/early/2020/11/05/peds.2020-002881'> https://pediatrics.aappublications.org/content/early/2020/11/05/peds.2020-002881</a></li>
</ul>
<p>Guest: Susan Feeney, DNP, FNP-BC, NP-C</p>
<p> </p>
<p>Music Credit: Richard Onorato</p>
]]></description>
                                                            <content:encoded><![CDATA[<p>Credits: 0.25 AMA PRA Category 1 Credit™</p>
<p> </p>
<p>CME/CE Information and Claim Credit: <a href='https://www.pri-med.com/online-education/podcast/frankly-speaking-cme-214'>https://www.pri-med.com/online-education/podcast/frankly-speaking-cme-214</a></p>
<p> </p>
<p>Overview: Rates of electronic cigarettes or vaping in teens has increased exponentially over the last 3 years. Prior to the introduction of the sleek 4th generation vaping device, tobacco use in the teen population was decreasing, and rates were low. Recent evidence indicates that teens with low intention to smoke, once they start vaping, are at increased risk of smoking cigarettes in future. Join us as we discuss the implications of this new evidence on our clinical practice and discuss strategies to reduce risk to adolescents.</p>
<p> </p>
<p>Episode Resources:</p>
<ul><li>Barrington-Trimis JL, Kong G, Leventhal AM, et al. E-cigarette Use and Subsequent Smoking Frequency Among Adolescents. Pediatrics. 2018;142(6):e20180486</li>
<li>Gaiha SM, et al. J Adolesc Health. Association Between Youth Smoking, Electronic Cigarette Use, and COVID-19. J Adolesc Health. Vol 67, issue 4, pp 519-523; DOI: https://doi.org/10.1015/j.jadolhealth.2020.07.002</li>
<li>Owotomo O, Stritzel H, McCabe SE, et al. Smoking Intention and Progression from E-Cigarette Use to Cigarette Smoking. Pediatrics. 2020;146(6):e2020002881; DOI: 10.1542/peds.2020-002881<br>
<a href='https://pediatrics.aappublications.org/content/early/2020/11/05/peds.2020-002881'> https://pediatrics.aappublications.org/content/early/2020/11/05/peds.2020-002881</a></li>
</ul>
<p>Guest: Susan Feeney, DNP, FNP-BC, NP-C</p>
<p> </p>
<p>Music Credit: Richard Onorato</p>
]]></content:encoded>
                                    
        <enclosure url="https://mcdn.podbean.com/mf/web/6gdlnk/secure_primed_frankly-speaking-214-vaping.mp3" length="11379142" type="audio/mpeg"/>
                <itunes:summary><![CDATA[Credits: 0.25 AMA PRA Category 1 Credit™
 
CME/CE Information and Claim Credit: https://www.pri-med.com/online-education/podcast/frankly-speaking-cme-214
 
Overview: Rates of electronic cigarettes or vaping in teens has increased exponentially over the last 3 years. Prior to the introduction of the sleek 4th generation vaping device, tobacco use in the teen population was decreasing, and rates were low. Recent evidence indicates that teens with low intention to smoke, once they start vaping, are at increased risk of smoking cigarettes in future. Join us as we discuss the implications of this new evidence on our clinical practice and discuss strategies to reduce risk to adolescents.
 
Episode Resources:
Barrington-Trimis JL, Kong G, Leventhal AM, et al. E-cigarette Use and Subsequent Smoking Frequency Among Adolescents. Pediatrics. 2018;142(6):e20180486
Gaiha SM, et al. J Adolesc Health. Association Between Youth Smoking, Electronic Cigarette Use, and COVID-19. J Adolesc Health. Vol 67, issue 4, pp 519-523; DOI: https://doi.org/10.1015/j.jadolhealth.2020.07.002
Owotomo O, Stritzel H, McCabe SE, et al. Smoking Intention and Progression from E-Cigarette Use to Cigarette Smoking. Pediatrics. 2020;146(6):e2020002881; DOI: 10.1542/peds.2020-002881 https://pediatrics.aappublications.org/content/early/2020/11/05/peds.2020-002881
Guest: Susan Feeney, DNP, FNP-BC, NP-C
 
Music Credit: Richard Onorato]]></itunes:summary>
        <itunes:author>Pri-Med</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>710</itunes:duration>
                        <itunes:episodeType>full</itunes:episodeType>
        <itunes:image href="https://pbcdn1.podbean.com/imglogo/ep-logo/pbblog13721080/e480114cd435a7f293ba7c2bf972be38.png" />    </item>
    <item>
        <title>Clinical Guidelines:  Acute Pain Management of Musculoskeletal Injuries (Non-low Back) in the Outpatient Setting - Frankly Speaking Ep 213</title>
        <itunes:title>Clinical Guidelines:  Acute Pain Management of Musculoskeletal Injuries (Non-low Back) in the Outpatient Setting - Frankly Speaking Ep 213</itunes:title>
        <link>https://primedfranklyspeaking.podbean.com/e/clinical-guidelines-acute-pain-management-of-musculoskeletal-injuries-non-low-back-in-the-outpatient-setting-frankly-speaking-ep-213-1645730525/</link>
                    <comments>https://primedfranklyspeaking.podbean.com/e/clinical-guidelines-acute-pain-management-of-musculoskeletal-injuries-non-low-back-in-the-outpatient-setting-frankly-speaking-ep-213-1645730525/#comments</comments>        <pubDate>Mon, 01 Mar 2021 05:30:00 +0000</pubDate>
        <guid isPermaLink="false">a959613b-787d-4f37-ad88-5d226ab6476c</guid>
                                    <description><![CDATA[<p>Credits: 0.25 AMA PRA Category 1 Credit™</p>
<p> </p>
<p>CME/CE Information and Claim Credit: <a href='https://www.pri-med.com/online-education/podcast/frankly-speaking-cme-213'>https://www.pri-med.com/online-education/podcast/frankly-speaking-cme-213</a></p>
<p> </p>
<p>Overview: Join us as we discuss the American College of Physicians (ACP) and American Academy of Family Physicians (AAFP) newly released clinical guideline on the non-pharmacologic and pharmacologic management of acute pain from non-low back musculoskeletal injuries in adults.</p>
<p> </p>
<p>Guest: Jill Terrien PhD, ANP-BC</p>
<p> </p>
<p>Music Credit: Richard Onorato</p>
]]></description>
                                                            <content:encoded><![CDATA[<p>Credits: 0.25 AMA PRA Category 1 Credit™</p>
<p> </p>
<p>CME/CE Information and Claim Credit: <a href='https://www.pri-med.com/online-education/podcast/frankly-speaking-cme-213'>https://www.pri-med.com/online-education/podcast/frankly-speaking-cme-213</a></p>
<p> </p>
<p>Overview: Join us as we discuss the American College of Physicians (ACP) and American Academy of Family Physicians (AAFP) newly released clinical guideline on the non-pharmacologic and pharmacologic management of acute pain from non-low back musculoskeletal injuries in adults.</p>
<p> </p>
<p>Guest: Jill Terrien PhD, ANP-BC</p>
<p> </p>
<p>Music Credit: Richard Onorato</p>
]]></content:encoded>
                                    
        <enclosure url="https://mcdn.podbean.com/mf/web/l7d5k6/secure_primed_frankly-speaking-213-acute-pain.mp3" length="10028242" type="audio/mpeg"/>
                <itunes:summary><![CDATA[Credits: 0.25 AMA PRA Category 1 Credit™
 
CME/CE Information and Claim Credit: https://www.pri-med.com/online-education/podcast/frankly-speaking-cme-213
 
Overview: Join us as we discuss the American College of Physicians (ACP) and American Academy of Family Physicians (AAFP) newly released clinical guideline on the non-pharmacologic and pharmacologic management of acute pain from non-low back musculoskeletal injuries in adults.
 
Guest: Jill Terrien PhD, ANP-BC
 
Music Credit: Richard Onorato]]></itunes:summary>
        <itunes:author>Pri-Med</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>625</itunes:duration>
                        <itunes:episodeType>full</itunes:episodeType>
        <itunes:image href="https://pbcdn1.podbean.com/imglogo/ep-logo/pbblog13721080/ff35d73853d154a101d724207ed1583a.png" />    </item>
    <item>
        <title>COVID-19 in the Office: Outpatient Management</title>
        <itunes:title>COVID-19 in the Office: Outpatient Management</itunes:title>
        <link>https://primedfranklyspeaking.podbean.com/e/covid-19-in-the-office-outpatient-management-1645730526/</link>
                    <comments>https://primedfranklyspeaking.podbean.com/e/covid-19-in-the-office-outpatient-management-1645730526/#comments</comments>        <pubDate>Thu, 25 Feb 2021 16:07:00 +0000</pubDate>
        <guid isPermaLink="false">3909e56d-f997-4549-8f28-13df00b28851</guid>
                                    <description><![CDATA[<p> Credits: 0.50 AMA PRA Category 1 Credit™</p>
 <p>  </p>
 <p> CME/CE Information and Claim Credit: <a href='https://www.pri-med.com/online-education/podcast/frankly-speaking-cme-covid-sax'> https://www.pri-med.com/online-education/podcast/frankly-speaking-cme-covid-outpatient</a></p>
 <p>  </p>
 <p> Overview: So much has changed concerning COVID-19 management, but few interventions are clearly beneficial in the outpatient management of patients.  This podcast will try to answer some of the common questions community based providers have about handling their patients’ illness.

 Episode reference links: 
<a href='https://urldefense.proofpoint.com/v2/url?u=https-3A__www.vividtrial.org_&d=DwMFAg&c=83KBipq5ovie7yU0T2HUPg&r=Hpzv9JsHaxhURkVcEfTlh2WvvOdwYIvJ7SuRY1Ti8KA&m=k70ZaMODMIxUrT7U1lcxmLbzlckUTWhZeLtBqhdGTWY&s=nx9olxGcxBUHlPIqGdza3QUj0pyFkDukWfqv63vYKWk&e='> Vitamin D for COVID-19 (VIVID) study</a></p>
 <p> <a href='https://urldefense.proofpoint.com/v2/url?u=https-3A__stopcovidtrial.wustl.edu_&d=DwMFAg&c=83KBipq5ovie7yU0T2HUPg&r=Hpzv9JsHaxhURkVcEfTlh2WvvOdwYIvJ7SuRY1Ti8KA&m=k70ZaMODMIxUrT7U1lcxmLbzlckUTWhZeLtBqhdGTWY&s=_pH_P751oVw0BEonxi-5E8BvEWpXdA9QHfG3n0YmkwI&e='> STOP COVID Trial</a></p>
 <p> <a href='https://urldefense.proofpoint.com/v2/url?u=https-3A__www.riseabovecovid.org_en_&d=DwMFAg&c=83KBipq5ovie7yU0T2HUPg&r=Hpzv9JsHaxhURkVcEfTlh2WvvOdwYIvJ7SuRY1Ti8KA&m=k70ZaMODMIxUrT7U1lcxmLbzlckUTWhZeLtBqhdGTWY&s=FYigaKJEnmkTIo5FufESWQBOjrTOeJ-s5FXW28GGmbc&e='> Rise Above COVID</a></p>
 <p>  </p>
 <p> Guest: Paul E. Sax, MD</p>
 <p>  </p>
 <p> Music Credit: Richard Onorato</p>
]]></description>
                                                            <content:encoded><![CDATA[<p> Credits: 0.50 AMA PRA Category 1 Credit™</p>
 <p>  </p>
 <p> CME/CE Information and Claim Credit: <a href='https://www.pri-med.com/online-education/podcast/frankly-speaking-cme-covid-sax'> https://www.pri-med.com/online-education/podcast/frankly-speaking-cme-covid-outpatient</a></p>
 <p>  </p>
 <p> Overview: So much has changed concerning COVID-19 management, but few interventions are clearly beneficial in the outpatient management of patients.  This podcast will try to answer some of the common questions community based providers have about handling their patients’ illness.<br>
<br>
 Episode reference links: <br>
<a href='https://urldefense.proofpoint.com/v2/url?u=https-3A__www.vividtrial.org_&d=DwMFAg&c=83KBipq5ovie7yU0T2HUPg&r=Hpzv9JsHaxhURkVcEfTlh2WvvOdwYIvJ7SuRY1Ti8KA&m=k70ZaMODMIxUrT7U1lcxmLbzlckUTWhZeLtBqhdGTWY&s=nx9olxGcxBUHlPIqGdza3QUj0pyFkDukWfqv63vYKWk&e='> Vitamin D for COVID-19 (VIVID) study</a></p>
 <p> <a href='https://urldefense.proofpoint.com/v2/url?u=https-3A__stopcovidtrial.wustl.edu_&d=DwMFAg&c=83KBipq5ovie7yU0T2HUPg&r=Hpzv9JsHaxhURkVcEfTlh2WvvOdwYIvJ7SuRY1Ti8KA&m=k70ZaMODMIxUrT7U1lcxmLbzlckUTWhZeLtBqhdGTWY&s=_pH_P751oVw0BEonxi-5E8BvEWpXdA9QHfG3n0YmkwI&e='> STOP COVID Trial</a></p>
 <p> <a href='https://urldefense.proofpoint.com/v2/url?u=https-3A__www.riseabovecovid.org_en_&d=DwMFAg&c=83KBipq5ovie7yU0T2HUPg&r=Hpzv9JsHaxhURkVcEfTlh2WvvOdwYIvJ7SuRY1Ti8KA&m=k70ZaMODMIxUrT7U1lcxmLbzlckUTWhZeLtBqhdGTWY&s=FYigaKJEnmkTIo5FufESWQBOjrTOeJ-s5FXW28GGmbc&e='> Rise Above COVID</a></p>
 <p>  </p>
 <p> Guest: Paul E. Sax, MD</p>
 <p>  </p>
 <p> Music Credit: Richard Onorato</p>
]]></content:encoded>
                                    
        <enclosure url="https://mcdn.podbean.com/mf/web/vha5sm/secure_primed_frankly-speaking-covid-sax.mp3" length="27971978" type="audio/mpeg"/>
                <itunes:summary><![CDATA[ Credits: 0.50 AMA PRA Category 1 Credit™     CME/CE Information and Claim Credit:  https://www.pri-med.com/online-education/podcast/frankly-speaking-cme-covid-outpatient     Overview: So much has changed concerning COVID-19 management, but few interventions are clearly beneficial in the outpatient management of patients.  This podcast will try to answer some of the common questions community based providers have about handling their patients’ illness. Episode reference links:  Vitamin D for COVID-19 (VIVID) study   STOP COVID Trial   Rise Above COVID     Guest: Paul E. Sax, MD     Music Credit: Richard Onorato]]></itunes:summary>
        <itunes:author>Pri-Med</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>1747</itunes:duration>
                        <itunes:episodeType>full</itunes:episodeType>
        <itunes:image href="https://pbcdn1.podbean.com/imglogo/ep-logo/pbblog13721080/220a7b2a25b4a771ca258b33f1da65f2.png" />    </item>
    <item>
        <title>Vitamin D: What It Helps, and What It Doesn’t - Frankly Speaking Ep 212</title>
        <itunes:title>Vitamin D: What It Helps, and What It Doesn’t - Frankly Speaking Ep 212</itunes:title>
        <link>https://primedfranklyspeaking.podbean.com/e/vitamin-d-what-it-helps-and-what-it-doesn-t-frankly-speaking-ep-212-1645730527/</link>
                    <comments>https://primedfranklyspeaking.podbean.com/e/vitamin-d-what-it-helps-and-what-it-doesn-t-frankly-speaking-ep-212-1645730527/#comments</comments>        <pubDate>Mon, 22 Feb 2021 05:30:00 +0000</pubDate>
        <guid isPermaLink="false">435cf409-4212-4194-a2e2-9c050204ea2b</guid>
                                    <description><![CDATA[<p>Credits: 0.25 AMA PRA Category 1 Credit™</p>
<p> </p>
<p>CME/CE Information and Claim Credit: <a href='https://www.pri-med.com/online-education/podcast/frankly-speaking-cme-212'>https://www.pri-med.com/online-education/podcast/frankly-speaking-cme-212</a></p>
<p> </p>
<p>Overview: During this episode, we will review some of the recent data on Vitamin D supplementation and its association with cardiovascular outcomes, falls, vertigo, and general health.</p>
<p> </p>
<p>Guest: Susan Feeney, DNP, FNP-BC, NP-C</p>
<p> </p>
<p>Music Credit: Richard Onorato</p>
]]></description>
                                                            <content:encoded><![CDATA[<p>Credits: 0.25 AMA PRA Category 1 Credit™</p>
<p> </p>
<p>CME/CE Information and Claim Credit: <a href='https://www.pri-med.com/online-education/podcast/frankly-speaking-cme-212'>https://www.pri-med.com/online-education/podcast/frankly-speaking-cme-212</a></p>
<p> </p>
<p>Overview: During this episode, we will review some of the recent data on Vitamin D supplementation and its association with cardiovascular outcomes, falls, vertigo, and general health.</p>
<p> </p>
<p>Guest: Susan Feeney, DNP, FNP-BC, NP-C</p>
<p> </p>
<p>Music Credit: Richard Onorato</p>
]]></content:encoded>
                                    
        <enclosure url="https://mcdn.podbean.com/mf/web/z4pdgk/secure_primed_frankly-speaking-212-vitamin.mp3" length="14131981" type="audio/mpeg"/>
                <itunes:summary><![CDATA[Credits: 0.25 AMA PRA Category 1 Credit™
 
CME/CE Information and Claim Credit: https://www.pri-med.com/online-education/podcast/frankly-speaking-cme-212
 
Overview: During this episode, we will review some of the recent data on Vitamin D supplementation and its association with cardiovascular outcomes, falls, vertigo, and general health.
 
Guest: Susan Feeney, DNP, FNP-BC, NP-C
 
Music Credit: Richard Onorato]]></itunes:summary>
        <itunes:author>Pri-Med</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>884</itunes:duration>
                        <itunes:episodeType>full</itunes:episodeType>
        <itunes:image href="https://pbcdn1.podbean.com/imglogo/ep-logo/pbblog13721080/0155f046668f3918b6740b37d157a3eb.png" />    </item>
    <item>
        <title>Let’s Get Physical: Consider PT for Initial Treatment of Sciatica - Frankly Speaking Ep 211</title>
        <itunes:title>Let’s Get Physical: Consider PT for Initial Treatment of Sciatica - Frankly Speaking Ep 211</itunes:title>
        <link>https://primedfranklyspeaking.podbean.com/e/let-s-get-physical-consider-pt-for-initial-treatment-of-sciatica-frankly-speaking-ep-211-1645730528/</link>
                    <comments>https://primedfranklyspeaking.podbean.com/e/let-s-get-physical-consider-pt-for-initial-treatment-of-sciatica-frankly-speaking-ep-211-1645730528/#comments</comments>        <pubDate>Mon, 15 Feb 2021 05:30:00 +0000</pubDate>
        <guid isPermaLink="false">4ce13269-c179-4d22-a184-14b36ccf5d1d</guid>
                                    <description><![CDATA[<p>Credits: 0.25 AMA PRA Category 1 Credit™</p>
<p> </p>
<p>CME/CE Information and Claim Credit: <a href='https://www.pri-med.com/online-education/podcast/frankly-speaking-cme-211'>https://www.pri-med.com/online-education/podcast/frankly-speaking-cme-211</a></p>
<p> </p>
<p>Overview: There are various treatment options for patients with acute sciatica. Choosing the best option should be tailored to the specific needs of the patient, and when possible, include early recommendation for physical therapy (PT). In this episode we review research on use of PT for treatment of sciatica and discuss how you can incorporate PT recommendations into patient care.</p>
<p> </p>
<p><a href='https://drive.google.com/file/d/18PS803e8s8w7mm4mH0nPbNAwufUHrLEv/view'> Click here to view a prone piriformis release for sciatic pain</a></p>
<p> </p>
<p>Guest: Alan Ehrlich MD, FAAFP</p>
<p> </p>
<p>Music Credit: Richard Onorato</p>
]]></description>
                                                            <content:encoded><![CDATA[<p>Credits: 0.25 AMA PRA Category 1 Credit™</p>
<p> </p>
<p>CME/CE Information and Claim Credit: <a href='https://www.pri-med.com/online-education/podcast/frankly-speaking-cme-211'>https://www.pri-med.com/online-education/podcast/frankly-speaking-cme-211</a></p>
<p> </p>
<p>Overview: There are various treatment options for patients with acute sciatica. Choosing the best option should be tailored to the specific needs of the patient, and when possible, include early recommendation for physical therapy (PT). In this episode we review research on use of PT for treatment of sciatica and discuss how you can incorporate PT recommendations into patient care.</p>
<p> </p>
<p><a href='https://drive.google.com/file/d/18PS803e8s8w7mm4mH0nPbNAwufUHrLEv/view'> Click here to view a prone piriformis release for sciatic pain</a></p>
<p> </p>
<p>Guest: Alan Ehrlich MD, FAAFP</p>
<p> </p>
<p>Music Credit: Richard Onorato</p>
]]></content:encoded>
                                    
        <enclosure url="https://mcdn.podbean.com/mf/web/ldv3iw/secure_primed_frankly-speaking-211-sciatica.mp3" length="12747050" type="audio/mpeg"/>
                <itunes:summary><![CDATA[Credits: 0.25 AMA PRA Category 1 Credit™
 
CME/CE Information and Claim Credit: https://www.pri-med.com/online-education/podcast/frankly-speaking-cme-211
 
Overview: There are various treatment options for patients with acute sciatica. Choosing the best option should be tailored to the specific needs of the patient, and when possible, include early recommendation for physical therapy (PT). In this episode we review research on use of PT for treatment of sciatica and discuss how you can incorporate PT recommendations into patient care.
 
 Click here to view a prone piriformis release for sciatic pain
 
Guest: Alan Ehrlich MD, FAAFP
 
Music Credit: Richard Onorato]]></itunes:summary>
        <itunes:author>Pri-Med</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>795</itunes:duration>
                        <itunes:episodeType>full</itunes:episodeType>
        <itunes:image href="https://pbcdn1.podbean.com/imglogo/ep-logo/pbblog13721080/f52336cd5f4793ff5e12f5e7b6713632.png" />    </item>
    <item>
        <title>A Fundamental Change in Asthma Management! Treatment of Moderate to Severe Asthma Now Includes Combined ICS-LABA Therapy as Maintenance and Rescue The...</title>
        <itunes:title>A Fundamental Change in Asthma Management! Treatment of Moderate to Severe Asthma Now Includes Combined ICS-LABA Therapy as Maintenance and Rescue The...</itunes:title>
        <link>https://primedfranklyspeaking.podbean.com/e/a-fundamental-change-in-asthma-management-treatment-of-moderate-to-severe-asthma-now-includes-combined-ics-laba-therapy-as-maintenance-and-rescue-the-1645730529/</link>
                    <comments>https://primedfranklyspeaking.podbean.com/e/a-fundamental-change-in-asthma-management-treatment-of-moderate-to-severe-asthma-now-includes-combined-ics-laba-therapy-as-maintenance-and-rescue-the-1645730529/#comments</comments>        <pubDate>Mon, 08 Feb 2021 05:30:00 +0000</pubDate>
        <guid isPermaLink="false">92023935-decf-4ae4-916e-107823135ae9</guid>
                                    <description><![CDATA[<p> Credits: 0.25 AMA PRA Category 1 Credit™</p>
 <p>  </p>
 <p> CME/CE Information and Claim Credit: <a href='https://www.pri-med.com/online-education/podcast/frankly-speaking-cme-210'> https://www.pri-med.com/online-education/podcast/frankly-speaking-cme-210</a></p>
 <p>  </p>
 <p> Overview: This session will review the evidence used by the National Asthma Education and Prevention Program (NAEPP) in making their newer recommendations and the new asthma management protocols.</p>
 <p>  </p>
 <p> Guest: Robert A. Baldor, MD, FAAFP</p>
 <p>  </p>
 <p> Music Credit: Richard Onorato</p>
]]></description>
                                                            <content:encoded><![CDATA[<p> Credits: 0.25 AMA PRA Category 1 Credit™</p>
 <p>  </p>
 <p> CME/CE Information and Claim Credit: <a href='https://www.pri-med.com/online-education/podcast/frankly-speaking-cme-210'> https://www.pri-med.com/online-education/podcast/frankly-speaking-cme-210</a></p>
 <p>  </p>
 <p> Overview: This session will review the evidence used by the National Asthma Education and Prevention Program (NAEPP) in making their newer recommendations and the new asthma management protocols.</p>
 <p>  </p>
 <p> Guest: Robert A. Baldor, MD, FAAFP</p>
 <p>  </p>
 <p> Music Credit: Richard Onorato</p>
]]></content:encoded>
                                    
        <enclosure url="https://mcdn.podbean.com/mf/web/at0qbb/secure_primed_frankly-speaking-210-asthma.mp3" length="10852047" type="audio/mpeg"/>
                <itunes:summary><![CDATA[ Credits: 0.25 AMA PRA Category 1 Credit™     CME/CE Information and Claim Credit:  https://www.pri-med.com/online-education/podcast/frankly-speaking-cme-210     Overview: This session will review the evidence used by the National Asthma Education and Prevention Program (NAEPP) in making their newer recommendations and the new asthma management protocols.     Guest: Robert A. Baldor, MD, FAAFP     Music Credit: Richard Onorato]]></itunes:summary>
        <itunes:author>Pri-Med</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>677</itunes:duration>
                        <itunes:episodeType>full</itunes:episodeType>
        <itunes:image href="https://pbcdn1.podbean.com/imglogo/ep-logo/pbblog13721080/ae38c841cfc798f8705917539bd34d77.png" />    </item>
    <item>
        <title>PolyPill, One Pill, or No Pill? - Frankly Speaking Ep 209</title>
        <itunes:title>PolyPill, One Pill, or No Pill? - Frankly Speaking Ep 209</itunes:title>
        <link>https://primedfranklyspeaking.podbean.com/e/polypill-one-pill-or-no-pill-frankly-speaking-ep-209-1645730530/</link>
                    <comments>https://primedfranklyspeaking.podbean.com/e/polypill-one-pill-or-no-pill-frankly-speaking-ep-209-1645730530/#comments</comments>        <pubDate>Mon, 01 Feb 2021 05:30:00 +0000</pubDate>
        <guid isPermaLink="false">175f72a4-357f-40de-837f-e68b1e860ca0</guid>
                                    <description><![CDATA[<p>Credits: 0.25 AMA PRA Category 1 Credit™</p>
<p> </p>
<p>CME/CE Information and Claim Credit: <a href='https://www.pri-med.com/online-education/podcast/frankly-speaking-cme-209'>https://www.pri-med.com/online-education/podcast/frankly-speaking-cme-209</a></p>
<p> </p>
<p>Overview: In this episode, we will review a recent publication examining how the polypill might lower atherosclerotic cardiovascular disease (ASCVD) risk in the general population.</p>
<p> </p>
<p>Guest: Alan Ehrlich MD, FAAFP</p>
<p> </p>
<p>Music Credit: Richard Onorato</p>
]]></description>
                                                            <content:encoded><![CDATA[<p>Credits: 0.25 AMA PRA Category 1 Credit™</p>
<p> </p>
<p>CME/CE Information and Claim Credit: <a href='https://www.pri-med.com/online-education/podcast/frankly-speaking-cme-209'>https://www.pri-med.com/online-education/podcast/frankly-speaking-cme-209</a></p>
<p> </p>
<p>Overview: In this episode, we will review a recent publication examining how the polypill might lower atherosclerotic cardiovascular disease (ASCVD) risk in the general population.</p>
<p> </p>
<p>Guest: Alan Ehrlich MD, FAAFP</p>
<p> </p>
<p>Music Credit: Richard Onorato</p>
]]></content:encoded>
                                    
        <enclosure url="https://mcdn.podbean.com/mf/web/87fxp9/secure_primed_frankly-speaking-209-polypill.mp3" length="12155512" type="audio/mpeg"/>
                <itunes:summary><![CDATA[Credits: 0.25 AMA PRA Category 1 Credit™
 
CME/CE Information and Claim Credit: https://www.pri-med.com/online-education/podcast/frankly-speaking-cme-209
 
Overview: In this episode, we will review a recent publication examining how the polypill might lower atherosclerotic cardiovascular disease (ASCVD) risk in the general population.
 
Guest: Alan Ehrlich MD, FAAFP
 
Music Credit: Richard Onorato]]></itunes:summary>
        <itunes:author>Pri-Med</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>759</itunes:duration>
                        <itunes:episodeType>full</itunes:episodeType>
        <itunes:image href="https://pbcdn1.podbean.com/imglogo/ep-logo/pbblog13721080/8ce51e9f71536b4afa12d436cb8e998a.png" />    </item>
    <item>
        <title>USPSTF Colorectal Cancer Screening:  Back Up the Bus! - Frankly Speaking Ep 208</title>
        <itunes:title>USPSTF Colorectal Cancer Screening:  Back Up the Bus! - Frankly Speaking Ep 208</itunes:title>
        <link>https://primedfranklyspeaking.podbean.com/e/uspstf-colorectal-cancer-screening-back-up-the-bus-frankly-speaking-ep-208-1645730532/</link>
                    <comments>https://primedfranklyspeaking.podbean.com/e/uspstf-colorectal-cancer-screening-back-up-the-bus-frankly-speaking-ep-208-1645730532/#comments</comments>        <pubDate>Mon, 25 Jan 2021 05:30:00 +0000</pubDate>
        <guid isPermaLink="false">d35275e3-d9e5-4f99-ae88-9945bd842c47</guid>
                                    <description><![CDATA[<p>Credits: 0.25 AMA PRA Category 1 Credit™</p>
<p> </p>
<p>CME/CE Information and Claim Credit: <a href='https://www.pri-med.com/online-education/podcast/frankly-speaking-cme-208'>https://www.pri-med.com/online-education/podcast/frankly-speaking-cme-208 </a></p>
<p> </p>
<p>Overview: Join us as we review the United States Preventive Services Task Force’s (USPSTF) recently published draft recommendation statement on colorectal cancer (CRC) screening and the implications it has for primary care practice and your patients.</p>
<p> </p>
<p>Guest: Jill Terrien PhD, ANP-BC</p>
<p> </p>
<p>Music Credit: Richard Onorato</p>
]]></description>
                                                            <content:encoded><![CDATA[<p>Credits: 0.25 AMA PRA Category 1 Credit™</p>
<p> </p>
<p>CME/CE Information and Claim Credit: <a href='https://www.pri-med.com/online-education/podcast/frankly-speaking-cme-208'>https://www.pri-med.com/online-education/podcast/frankly-speaking-cme-208 </a></p>
<p> </p>
<p>Overview: Join us as we review the United States Preventive Services Task Force’s (USPSTF) recently published draft recommendation statement on colorectal cancer (CRC) screening and the implications it has for primary care practice and your patients.</p>
<p> </p>
<p>Guest: Jill Terrien PhD, ANP-BC</p>
<p> </p>
<p>Music Credit: Richard Onorato</p>
]]></content:encoded>
                                    
        <enclosure url="https://mcdn.podbean.com/mf/web/raka0v/secure_primed_frankly-speaking-208-colerectal-cancer-screening.mp3" length="10583969" type="audio/mpeg"/>
                <itunes:summary><![CDATA[Credits: 0.25 AMA PRA Category 1 Credit™
 
CME/CE Information and Claim Credit: https://www.pri-med.com/online-education/podcast/frankly-speaking-cme-208 
 
Overview: Join us as we review the United States Preventive Services Task Force’s (USPSTF) recently published draft recommendation statement on colorectal cancer (CRC) screening and the implications it has for primary care practice and your patients.
 
Guest: Jill Terrien PhD, ANP-BC
 
Music Credit: Richard Onorato]]></itunes:summary>
        <itunes:author>Pri-Med</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>660</itunes:duration>
                        <itunes:episodeType>full</itunes:episodeType>
        <itunes:image href="https://pbcdn1.podbean.com/imglogo/ep-logo/pbblog13721080/fc6dbc013358e694d87ad952019b0e22.png" />    </item>
    <item>
        <title>Statin Use in the Elderly – Start or Stop? - Frankly Speaking Ep 207</title>
        <itunes:title>Statin Use in the Elderly – Start or Stop? - Frankly Speaking Ep 207</itunes:title>
        <link>https://primedfranklyspeaking.podbean.com/e/statin-use-in-the-elderly-%e2%80%93-start-or-stop-frankly-speaking-ep-207-1645730533/</link>
                    <comments>https://primedfranklyspeaking.podbean.com/e/statin-use-in-the-elderly-%e2%80%93-start-or-stop-frankly-speaking-ep-207-1645730533/#comments</comments>        <pubDate>Mon, 18 Jan 2021 05:30:00 +0000</pubDate>
        <guid isPermaLink="false">66ba6132-2669-47c3-a874-4eedfa6ab065</guid>
                                    <description><![CDATA[<p>Credits: 0.25 AMA PRA Category 1 Credits™</p>
<p>Claim CME/CE credit: <a href='https://www.pri-med.com/online-education/podcast/frankly-speaking-cme-207'>https://www.pri-med.com/online-education/podcast/frankly-speaking-cme-207</a></p>
<p>Overview: Data are limited regarding statin therapy for primary prevention of atherosclerotic cardiovascular disease in adults 75 years and older. During this episode we will review recent studies on the use of statins in elderly patients and discuss how to consider this data in your clinical practice.</p>
<p>Guest: Robert Baldor, MD, FAAFP</p>
<p>Music Credit: Richard Onorato</p>
]]></description>
                                                            <content:encoded><![CDATA[<p>Credits: 0.25 AMA PRA Category 1 Credits™</p>
<p>Claim CME/CE credit: <a href='https://www.pri-med.com/online-education/podcast/frankly-speaking-cme-207'>https://www.pri-med.com/online-education/podcast/frankly-speaking-cme-207</a></p>
<p>Overview: Data are limited regarding statin therapy for primary prevention of atherosclerotic cardiovascular disease in adults 75 years and older. During this episode we will review recent studies on the use of statins in elderly patients and discuss how to consider this data in your clinical practice.</p>
<p>Guest: Robert Baldor, MD, FAAFP</p>
<p>Music Credit: Richard Onorato</p>
]]></content:encoded>
                                    
        <enclosure url="https://mcdn.podbean.com/mf/web/97qnxa/secure_primed_frankly-speaking-207-statins-elderly.mp3" length="10413736" type="audio/mpeg"/>
                <itunes:summary><![CDATA[Credits: 0.25 AMA PRA Category 1 Credits™
Claim CME/CE credit: https://www.pri-med.com/online-education/podcast/frankly-speaking-cme-207
Overview: Data are limited regarding statin therapy for primary prevention of atherosclerotic cardiovascular disease in adults 75 years and older. During this episode we will review recent studies on the use of statins in elderly patients and discuss how to consider this data in your clinical practice.
Guest: Robert Baldor, MD, FAAFP
Music Credit: Richard Onorato]]></itunes:summary>
        <itunes:author>Pri-Med</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>650</itunes:duration>
                        <itunes:episodeType>full</itunes:episodeType>
        <itunes:image href="https://pbcdn1.podbean.com/imglogo/ep-logo/pbblog13721080/7cafa8be0616eb8211c96ed1cc1ec174.png" />    </item>
    <item>
        <title>A Big Change for the 2021 Medicare Physician Fee Schedule: New Guidance on Coding</title>
        <itunes:title>A Big Change for the 2021 Medicare Physician Fee Schedule: New Guidance on Coding</itunes:title>
        <link>https://primedfranklyspeaking.podbean.com/e/a-big-change-for-the-2021-medicare-physician-fee-schedule-new-guidance-on-coding-1645730534/</link>
                    <comments>https://primedfranklyspeaking.podbean.com/e/a-big-change-for-the-2021-medicare-physician-fee-schedule-new-guidance-on-coding-1645730534/#comments</comments>        <pubDate>Tue, 12 Jan 2021 15:41:00 +0000</pubDate>
        <guid isPermaLink="false">9f76ecfb-e1bb-4307-b20f-f7e56a33ad31</guid>
                                    <description><![CDATA[<p>Credits: 0.25 AMA PRA Category 1 Credits™</p>
 <p>Claim CME/CE credit: <a href='https://www.pri-med.com/online-education/podcast/frankly-speaking-coding-update'> https://www.pri-med.com/online-education/podcast/frankly-speaking-coding-update</a></p>
 <p>Overview: This session will overview the new 2021 changes for outpatient E&M billing documentation requirements.</p>
 <p>Guest: Robert Baldor, MD, FAAFP</p>
 <p>Music Credit: Richard Onorato</p>
]]></description>
                                                            <content:encoded><![CDATA[<p>Credits: 0.25 AMA PRA Category 1 Credits™</p>
 <p>Claim CME/CE credit: <a href='https://www.pri-med.com/online-education/podcast/frankly-speaking-coding-update'> https://www.pri-med.com/online-education/podcast/frankly-speaking-coding-update</a></p>
 <p>Overview: This session will overview the new 2021 changes for outpatient E&M billing documentation requirements.</p>
 <p>Guest: Robert Baldor, MD, FAAFP</p>
 <p>Music Credit: Richard Onorato</p>
]]></content:encoded>
                                    
        <enclosure url="https://mcdn.podbean.com/mf/web/4bh50l/secure_primed_frankly-speaking-coding-special-baldor-fix.mp3" length="26009642" type="audio/mpeg"/>
                <itunes:summary><![CDATA[Credits: 0.25 AMA PRA Category 1 Credits™ Claim CME/CE credit:  https://www.pri-med.com/online-education/podcast/frankly-speaking-coding-update Overview: This session will overview the new 2021 changes for outpatient E&M billing documentation requirements. Guest: Robert Baldor, MD, FAAFP Music Credit: Richard Onorato]]></itunes:summary>
        <itunes:author>Pri-Med</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>812</itunes:duration>
                        <itunes:episodeType>full</itunes:episodeType>
        <itunes:image href="https://pbcdn1.podbean.com/imglogo/ep-logo/pbblog13721080/ad3a2c1f734e3cd390654bf72c7fbb00.png" />    </item>
    <item>
        <title>Making a Real Difference: High-Intensity Lifestyle Intervention Can Aid  Weight Loss in Individuals With Obesity in Underserved Populations - Frankly Speaking Ep 206</title>
        <itunes:title>Making a Real Difference: High-Intensity Lifestyle Intervention Can Aid  Weight Loss in Individuals With Obesity in Underserved Populations - Frankly Speaking Ep 206</itunes:title>
        <link>https://primedfranklyspeaking.podbean.com/e/making-a-real-difference-high-intensity-lifestyle-intervention-can-aid-weight-loss-in-individuals-with-obesity-in-underserved-populations-frankly-1645730535/</link>
                    <comments>https://primedfranklyspeaking.podbean.com/e/making-a-real-difference-high-intensity-lifestyle-intervention-can-aid-weight-loss-in-individuals-with-obesity-in-underserved-populations-frankly-1645730535/#comments</comments>        <pubDate>Mon, 11 Jan 2021 05:30:00 +0000</pubDate>
        <guid isPermaLink="false">754c119b-ad70-4883-81cf-f21974503a79</guid>
                                    <description><![CDATA[<p>Credits: 0.25 AMA PRA Category 1 Credits™</p>
<p>Claim CME/CE credit: <a href='https://www.pri-med.com/online-education/podcast/frankly-speaking-cme-206'>https://www.pri-med.com/online-education/podcast/frankly-speaking-cme-206</a></p>
<p>Overview: The evidence of the impact of obesity and sedentary lifestyles on health and disease states is well established. Finding and applying strategies to assist people with the necessary behavior changes is a monumental task, but for Americans who are at lower income levels and in traditionally underserved populations, the evidence on what is effective is tragically lacking. The social determinants of health (SDOH) impact all aspects of care delivery, from access to care, to knowing what really works. Join us as we discuss a recent randomized controlled trial that evaluated a strategy that demonstrated weight loss in underserved populations, and may have promise to aid in this important aspect of care.</p>
<p>Guest: Susan Feeney, DNP, FNP-BC, NP-C</p>
<p>Music Credit: Richard Onorato</p>
]]></description>
                                                            <content:encoded><![CDATA[<p>Credits: 0.25 AMA PRA Category 1 Credits™</p>
<p>Claim CME/CE credit: <a href='https://www.pri-med.com/online-education/podcast/frankly-speaking-cme-206'>https://www.pri-med.com/online-education/podcast/frankly-speaking-cme-206</a></p>
<p>Overview: The evidence of the impact of obesity and sedentary lifestyles on health and disease states is well established. Finding and applying strategies to assist people with the necessary behavior changes is a monumental task, but for Americans who are at lower income levels and in traditionally underserved populations, the evidence on what is effective is tragically lacking. The social determinants of health (SDOH) impact all aspects of care delivery, from access to care, to knowing what really works. Join us as we discuss a recent randomized controlled trial that evaluated a strategy that demonstrated weight loss in underserved populations, and may have promise to aid in this important aspect of care.</p>
<p>Guest: Susan Feeney, DNP, FNP-BC, NP-C</p>
<p>Music Credit: Richard Onorato</p>
]]></content:encoded>
                                    
        <enclosure url="https://mcdn.podbean.com/mf/web/kpkscj/secure_primed_frankly-speaking-206-obesity-low-income.mp3" length="12796779" type="audio/mpeg"/>
                <itunes:summary><![CDATA[Credits: 0.25 AMA PRA Category 1 Credits™
Claim CME/CE credit: https://www.pri-med.com/online-education/podcast/frankly-speaking-cme-206
Overview: The evidence of the impact of obesity and sedentary lifestyles on health and disease states is well established. Finding and applying strategies to assist people with the necessary behavior changes is a monumental task, but for Americans who are at lower income levels and in traditionally underserved populations, the evidence on what is effective is tragically lacking. The social determinants of health (SDOH) impact all aspects of care delivery, from access to care, to knowing what really works. Join us as we discuss a recent randomized controlled trial that evaluated a strategy that demonstrated weight loss in underserved populations, and may have promise to aid in this important aspect of care.
Guest: Susan Feeney, DNP, FNP-BC, NP-C
Music Credit: Richard Onorato]]></itunes:summary>
        <itunes:author>Pri-Med</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>799</itunes:duration>
                        <itunes:episodeType>full</itunes:episodeType>
        <itunes:image href="https://pbcdn1.podbean.com/imglogo/ep-logo/pbblog13721080/414ca697eb676495d2c85fc63f4bf044.png" />    </item>
    <item>
        <title>COVID-19 VACCINE:  Get the Facts and Bust the Myths - Frankly Speaking Covid Immunization Update</title>
        <itunes:title>COVID-19 VACCINE:  Get the Facts and Bust the Myths - Frankly Speaking Covid Immunization Update</itunes:title>
        <link>https://primedfranklyspeaking.podbean.com/e/covid-19-vaccine-get-the-facts-and-bust-the-myths-frankly-speaking-covid-immunization-update-1645730536/</link>
                    <comments>https://primedfranklyspeaking.podbean.com/e/covid-19-vaccine-get-the-facts-and-bust-the-myths-frankly-speaking-covid-immunization-update-1645730536/#comments</comments>        <pubDate>Fri, 08 Jan 2021 19:16:00 +0000</pubDate>
        <guid isPermaLink="false">d6cd9ad2-fe2f-4e1e-a6c4-8a86fe3eb83c</guid>
                                    <description><![CDATA[<p>Credits: 0.25 AMA PRA Category 1 Credits™</p>
 <p>Claim CME/CE credit: <a href='https://www.pri-med.com/online-education/podcast/frankly-speaking-cme-184'> https://www.pri-med.com/online-education/podcast/frankly-speaking-covid-immunization-update</a></p>
 <p>Overview: This podcast will give an overview of the two mRNA vaccines granted emergency use authorization in the US including their efficacy and side effect profile.</p>
 <p>Guest: Alan Ehrlich, MD</p>
 <p>Music Credit: Richard Onorato</p>
]]></description>
                                                            <content:encoded><![CDATA[<p>Credits: 0.25 AMA PRA Category 1 Credits™</p>
 <p>Claim CME/CE credit: <a href='https://www.pri-med.com/online-education/podcast/frankly-speaking-cme-184'> https://www.pri-med.com/online-education/podcast/frankly-speaking-covid-immunization-update</a></p>
 <p>Overview: This podcast will give an overview of the two mRNA vaccines granted emergency use authorization in the US including their efficacy and side effect profile.</p>
 <p>Guest: Alan Ehrlich, MD</p>
 <p>Music Credit: Richard Onorato</p>
]]></content:encoded>
                                    
        <enclosure url="https://mcdn.podbean.com/mf/web/5b3z31/secure_primed_frankly-speaking-special-covid-vaccine-1-8-21.mp3" length="23606381" type="audio/mpeg"/>
                <itunes:summary><![CDATA[Credits: 0.25 AMA PRA Category 1 Credits™ Claim CME/CE credit:  https://www.pri-med.com/online-education/podcast/frankly-speaking-covid-immunization-update Overview: This podcast will give an overview of the two mRNA vaccines granted emergency use authorization in the US including their efficacy and side effect profile. Guest: Alan Ehrlich, MD Music Credit: Richard Onorato]]></itunes:summary>
        <itunes:author>Pri-Med</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>1474</itunes:duration>
                        <itunes:episodeType>full</itunes:episodeType>
        <itunes:image href="https://pbcdn1.podbean.com/imglogo/ep-logo/pbblog13721080/e57d6cc456981ae69e88681978b3c2e4.png" />    </item>
    <item>
        <title>New-onset Atrial Fibrillation: Revisiting Rate vs. Rhythm Control - Frankly Speaking EP 205</title>
        <itunes:title>New-onset Atrial Fibrillation: Revisiting Rate vs. Rhythm Control - Frankly Speaking EP 205</itunes:title>
        <link>https://primedfranklyspeaking.podbean.com/e/new-onset-atrial-fibrillation-revisiting-rate-vs-rhythm-control-frankly-speaking-ep-205-1645730537/</link>
                    <comments>https://primedfranklyspeaking.podbean.com/e/new-onset-atrial-fibrillation-revisiting-rate-vs-rhythm-control-frankly-speaking-ep-205-1645730537/#comments</comments>        <pubDate>Mon, 04 Jan 2021 05:30:00 +0000</pubDate>
        <guid isPermaLink="false">fe8793c8-6b76-4211-84ce-42418510450d</guid>
                                    <description><![CDATA[<p>Credits: 0.25 AMA PRA Category 1 Credits™</p>
<p>Claim CME/CE credit: <a href='https://www.pri-med.com/online-education/podcast/frankly-speaking-cme-205'>https://www.pri-med.com/online-education/podcast/frankly-speaking-cme-205</a></p>
<p>Overview: In patients with new-onset atrial fibrillation, the decision to aim for rate control versus rhythm control is controversial. Older data suggested rhythm control did not result in better outcomes, but advances in medications and techniques have led to a new trial to evaluate this question.</p>
<p>Guest: Alan Ehrlich, MD</p>
<p>Music Credit: Richard Onorato</p>
]]></description>
                                                            <content:encoded><![CDATA[<p>Credits: 0.25 AMA PRA Category 1 Credits™</p>
<p>Claim CME/CE credit: <a href='https://www.pri-med.com/online-education/podcast/frankly-speaking-cme-205'>https://www.pri-med.com/online-education/podcast/frankly-speaking-cme-205</a></p>
<p>Overview: In patients with new-onset atrial fibrillation, the decision to aim for rate control versus rhythm control is controversial. Older data suggested rhythm control did not result in better outcomes, but advances in medications and techniques have led to a new trial to evaluate this question.</p>
<p>Guest: Alan Ehrlich, MD</p>
<p>Music Credit: Richard Onorato</p>
]]></content:encoded>
                                    
        <enclosure url="https://mcdn.podbean.com/mf/web/i1n5h9/secure_primed_frankly-speaking-ep205-afib-rate-rhythm.mp3" length="11584687" type="audio/mpeg"/>
                <itunes:summary><![CDATA[Credits: 0.25 AMA PRA Category 1 Credits™
Claim CME/CE credit: https://www.pri-med.com/online-education/podcast/frankly-speaking-cme-205
Overview: In patients with new-onset atrial fibrillation, the decision to aim for rate control versus rhythm control is controversial. Older data suggested rhythm control did not result in better outcomes, but advances in medications and techniques have led to a new trial to evaluate this question.
Guest: Alan Ehrlich, MD
Music Credit: Richard Onorato]]></itunes:summary>
        <itunes:author>Pri-Med</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>723</itunes:duration>
                        <itunes:episodeType>full</itunes:episodeType>
        <itunes:image href="https://pbcdn1.podbean.com/imglogo/ep-logo/pbblog13721080/032be1dc59671c6681e868e9c54116f0.png" />    </item>
    <item>
        <title>Treating Type 2 Diabetes Mellitus – A Clearer Framework - Frankly Speaking EP 204</title>
        <itunes:title>Treating Type 2 Diabetes Mellitus – A Clearer Framework - Frankly Speaking EP 204</itunes:title>
        <link>https://primedfranklyspeaking.podbean.com/e/treating-type-2-diabetes-mellitus-%e2%80%93-a-clearer-framework-frankly-speaking-ep-204-1645730538/</link>
                    <comments>https://primedfranklyspeaking.podbean.com/e/treating-type-2-diabetes-mellitus-%e2%80%93-a-clearer-framework-frankly-speaking-ep-204-1645730538/#comments</comments>        <pubDate>Mon, 28 Dec 2020 05:30:00 +0000</pubDate>
        <guid isPermaLink="false">bab7a4f2-4c53-4c1a-bb50-a236101a748b</guid>
                                    <description><![CDATA[<p>Credits: 0.25 AMA PRA Category 1 Credits™</p>
<p>Claim CME/CE credit: <a href='https://www.pri-med.com/online-education/podcast/frankly-speaking-cme-204'>https://www.pri-med.com/online-education/podcast/frankly-speaking-cme-204</a></p>
<p>Overview: The American Diabetes Association (ADA) has recently updated their guidelines for pharmacologic management of T2DM which addresses patients with various co-morbid conditions. This episode will overview these guidelines to help primary care clinicians hone treatment of their patients with T2DM.</p>
<p>Guest: Robert Baldor, MD, FAAFP</p>
<p>Music Credit: Richard Onorato</p>
]]></description>
                                                            <content:encoded><![CDATA[<p>Credits: 0.25 AMA PRA Category 1 Credits™</p>
<p>Claim CME/CE credit: <a href='https://www.pri-med.com/online-education/podcast/frankly-speaking-cme-204'>https://www.pri-med.com/online-education/podcast/frankly-speaking-cme-204</a></p>
<p>Overview: The American Diabetes Association (ADA) has recently updated their guidelines for pharmacologic management of T2DM which addresses patients with various co-morbid conditions. This episode will overview these guidelines to help primary care clinicians hone treatment of their patients with T2DM.</p>
<p>Guest: Robert Baldor, MD, FAAFP</p>
<p>Music Credit: Richard Onorato</p>
]]></content:encoded>
                                    
        <enclosure url="https://mcdn.podbean.com/mf/web/5lmbnq/secure_primed_frankly-speaking-ep-204-ada-update.mp3" length="12154907" type="audio/mpeg"/>
                <itunes:summary><![CDATA[Credits: 0.25 AMA PRA Category 1 Credits™
Claim CME/CE credit: https://www.pri-med.com/online-education/podcast/frankly-speaking-cme-204
Overview: The American Diabetes Association (ADA) has recently updated their guidelines for pharmacologic management of T2DM which addresses patients with various co-morbid conditions. This episode will overview these guidelines to help primary care clinicians hone treatment of their patients with T2DM.
Guest: Robert Baldor, MD, FAAFP
Music Credit: Richard Onorato]]></itunes:summary>
        <itunes:author>Pri-Med</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>759</itunes:duration>
        <itunes:season>1</itunes:season>
        <itunes:episode>1</itunes:episode>
        <itunes:episodeType>full</itunes:episodeType>
        <itunes:image href="https://pbcdn1.podbean.com/imglogo/ep-logo/pbblog13721080/65bebafc9154e57853145d40e00ffb1a.png" />    </item>
    <item>
        <title>No Good Reason to Go Nuts Over Coconut Oil - Frankly Speaking Ep 203</title>
        <itunes:title>No Good Reason to Go Nuts Over Coconut Oil - Frankly Speaking Ep 203</itunes:title>
        <link>https://primedfranklyspeaking.podbean.com/e/no-good-reason-to-go-nuts-over-coconut-oil-frankly-speaking-ep-203-1645730540/</link>
                    <comments>https://primedfranklyspeaking.podbean.com/e/no-good-reason-to-go-nuts-over-coconut-oil-frankly-speaking-ep-203-1645730540/#comments</comments>        <pubDate>Mon, 21 Dec 2020 05:30:00 +0000</pubDate>
        <guid isPermaLink="false">da7a4078-2e84-411d-bb50-4c976716f937</guid>
                                    <description><![CDATA[<p>Credits: 0.25 AMA PRA Category 1 Credits™</p>
<p>Claim CME/CE credit: <a href='https://www.pri-med.com/online-education/podcast/frankly-speaking-cme-203'>https://www.pri-med.com/online-education/podcast/frankly-speaking-cme-203</a></p>
<p>Overview: Join us as we discuss the risks of elevated cholesterol when consuming coconut oil.</p>
<p>Guest: Jill Terrien, PhD, ANP-BC</p>
<p>Music Credit: Richard Onorato</p>
]]></description>
                                                            <content:encoded><![CDATA[<p>Credits: 0.25 AMA PRA Category 1 Credits™</p>
<p>Claim CME/CE credit: <a href='https://www.pri-med.com/online-education/podcast/frankly-speaking-cme-203'>https://www.pri-med.com/online-education/podcast/frankly-speaking-cme-203</a></p>
<p>Overview: Join us as we discuss the risks of elevated cholesterol when consuming coconut oil.</p>
<p>Guest: Jill Terrien, PhD, ANP-BC</p>
<p>Music Credit: Richard Onorato</p>
]]></content:encoded>
                                    
        <enclosure url="https://mcdn.podbean.com/mf/web/q69594/secure_primed_frankly-speaking-episode-203-coconut-oil.mp3" length="10207589" type="audio/mpeg"/>
                <itunes:summary><![CDATA[Credits: 0.25 AMA PRA Category 1 Credits™
Claim CME/CE credit: https://www.pri-med.com/online-education/podcast/frankly-speaking-cme-203
Overview: Join us as we discuss the risks of elevated cholesterol when consuming coconut oil.
Guest: Jill Terrien, PhD, ANP-BC
Music Credit: Richard Onorato]]></itunes:summary>
        <itunes:author>Pri-Med</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>637</itunes:duration>
        <itunes:season>1</itunes:season>
        <itunes:episode>1</itunes:episode>
        <itunes:episodeType>full</itunes:episodeType>
        <itunes:image href="https://pbcdn1.podbean.com/imglogo/ep-logo/pbblog13721080/eb1dbe76af729c654b58861958279bc5.png" />    </item>
    <item>
        <title>COVID-19 Update: Vaccines, Working From Home, and So Much More - Frankly Speaking Ep 202</title>
        <itunes:title>COVID-19 Update: Vaccines, Working From Home, and So Much More - Frankly Speaking Ep 202</itunes:title>
        <link>https://primedfranklyspeaking.podbean.com/e/covid-19-update-vaccines-working-from-home-and-so-much-more-frankly-speaking-ep-202-1645730541/</link>
                    <comments>https://primedfranklyspeaking.podbean.com/e/covid-19-update-vaccines-working-from-home-and-so-much-more-frankly-speaking-ep-202-1645730541/#comments</comments>        <pubDate>Mon, 14 Dec 2020 05:30:00 +0000</pubDate>
        <guid isPermaLink="false">be592fe1-58d9-4c91-8a00-f769ac5710a8</guid>
                                    <description><![CDATA[<p>Credits: 0.25 AMA PRA Category 1 Credits™</p>
<p>Claim CME/CE credit: <a href='https://www.pri-med.com/online-education/podcast/frankly-speaking-cme-202'>https://www.pri-med.com/online-education/podcast/frankly-speaking-cme-202</a></p>
<p>Overview: There are many aspects of the COVID-19 pandemic that clinicians need to stay current with. In this episode we will briefly review ten hot topics related to COVID-19, including but not limited to: testing, vaccines, and reinfection.</p>
<p>Guest: Alan Ehrlich, MD, FAAFP</p>
<p>Music Credit: Richard Onorato</p>
]]></description>
                                                            <content:encoded><![CDATA[<p>Credits: 0.25 AMA PRA Category 1 Credits™</p>
<p>Claim CME/CE credit: <a href='https://www.pri-med.com/online-education/podcast/frankly-speaking-cme-202'>https://www.pri-med.com/online-education/podcast/frankly-speaking-cme-202</a></p>
<p>Overview: There are many aspects of the COVID-19 pandemic that clinicians need to stay current with. In this episode we will briefly review ten hot topics related to COVID-19, including but not limited to: testing, vaccines, and reinfection.</p>
<p>Guest: Alan Ehrlich, MD, FAAFP</p>
<p>Music Credit: Richard Onorato</p>
]]></content:encoded>
                                    
        <enclosure url="https://mcdn.podbean.com/mf/web/b49x06/secure_primed_frankly-speaking-ep-202-covid-update.mp3" length="25576615" type="audio/mpeg"/>
                <itunes:summary><![CDATA[Credits: 0.25 AMA PRA Category 1 Credits™
Claim CME/CE credit: https://www.pri-med.com/online-education/podcast/frankly-speaking-cme-202
Overview: There are many aspects of the COVID-19 pandemic that clinicians need to stay current with. In this episode we will briefly review ten hot topics related to COVID-19, including but not limited to: testing, vaccines, and reinfection.
Guest: Alan Ehrlich, MD, FAAFP
Music Credit: Richard Onorato]]></itunes:summary>
        <itunes:author>Pri-Med</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>1597</itunes:duration>
        <itunes:season>1</itunes:season>
        <itunes:episode>1</itunes:episode>
        <itunes:episodeType>full</itunes:episodeType>
        <itunes:image href="https://pbcdn1.podbean.com/imglogo/ep-logo/pbblog13721080/cf4b402d24bd5cdb7c4da46d306e7b4c.png" />    </item>
    <item>
        <title>Is it Time to Stop Checking LDL-C? - Frankly Speaking Ep 201</title>
        <itunes:title>Is it Time to Stop Checking LDL-C? - Frankly Speaking Ep 201</itunes:title>
        <link>https://primedfranklyspeaking.podbean.com/e/is-it-time-to-stop-checking-ldl-c-frankly-speaking-ep-201-1645730542/</link>
                    <comments>https://primedfranklyspeaking.podbean.com/e/is-it-time-to-stop-checking-ldl-c-frankly-speaking-ep-201-1645730542/#comments</comments>        <pubDate>Mon, 07 Dec 2020 05:30:00 +0000</pubDate>
        <guid isPermaLink="false">140b4560-0a27-4007-aa4b-5a4ea9c732ca</guid>
                                    <description><![CDATA[<p>Credits: 0.25 AMA PRA Category 1 Credits™</p>
<p>Claim CME/CE credit: <a href='https://www.pri-med.com/online-education/podcast/frankly-speaking-cme-201'>https://www.pri-med.com/online-education/podcast/frankly-speaking-cme-201</a></p>
<p>Overview: Various organizations develop guidelines to assist with patient care. This episode will review the most significant changes to the U.S. Department of Veterans Affairs and U.S. Department of Defense (VA/DoD) Clinical Practice Guidelines for the Management of Dyslipidemia for Cardiovascular Disease Risk Reduction.</p>
<p>Guest: Robert Baldor, MD, FAAFP</p>
<p>Music Credit: Richard Onorato</p>
]]></description>
                                                            <content:encoded><![CDATA[<p>Credits: 0.25 AMA PRA Category 1 Credits™</p>
<p>Claim CME/CE credit: <a href='https://www.pri-med.com/online-education/podcast/frankly-speaking-cme-201'>https://www.pri-med.com/online-education/podcast/frankly-speaking-cme-201</a></p>
<p>Overview: Various organizations develop guidelines to assist with patient care. This episode will review the most significant changes to the U.S. Department of Veterans Affairs and U.S. Department of Defense (VA/DoD) Clinical Practice Guidelines for the Management of Dyslipidemia for Cardiovascular Disease Risk Reduction.</p>
<p>Guest: Robert Baldor, MD, FAAFP</p>
<p>Music Credit: Richard Onorato</p>
]]></content:encoded>
                                    
        <enclosure url="https://mcdn.podbean.com/mf/web/eja3e5/secure_primed_frankly-speaking-201-ldl-test.mp3" length="12632973" type="audio/mpeg"/>
                <itunes:summary><![CDATA[Credits: 0.25 AMA PRA Category 1 Credits™
Claim CME/CE credit: https://www.pri-med.com/online-education/podcast/frankly-speaking-cme-201
Overview: Various organizations develop guidelines to assist with patient care. This episode will review the most significant changes to the U.S. Department of Veterans Affairs and U.S. Department of Defense (VA/DoD) Clinical Practice Guidelines for the Management of Dyslipidemia for Cardiovascular Disease Risk Reduction.
Guest: Robert Baldor, MD, FAAFP
Music Credit: Richard Onorato]]></itunes:summary>
        <itunes:author>Pri-Med</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>789</itunes:duration>
        <itunes:season>1</itunes:season>
        <itunes:episode>1</itunes:episode>
        <itunes:episodeType>full</itunes:episodeType>
        <itunes:image href="https://pbcdn1.podbean.com/imglogo/ep-logo/pbblog13721080/ff963c438256a1b1cdff383212205880.png" />    </item>
    <item>
        <title>Favorite Podcast of the Last 200! - Frankly Speaking Ep 200</title>
        <itunes:title>Favorite Podcast of the Last 200! - Frankly Speaking Ep 200</itunes:title>
        <link>https://primedfranklyspeaking.podbean.com/e/favorite-podcast-of-the-last-200-frankly-speaking-ep-200-1645730543/</link>
                    <comments>https://primedfranklyspeaking.podbean.com/e/favorite-podcast-of-the-last-200-frankly-speaking-ep-200-1645730543/#comments</comments>        <pubDate>Mon, 30 Nov 2020 05:30:00 +0000</pubDate>
        <guid isPermaLink="false">c496b7a1-b4f2-41e2-8321-55ba580cc2c6</guid>
                                    <description><![CDATA[<p>Credits: 0.25 AMA PRA Category 1 Credits™</p>
<p>Claim CME/CE credit: <a href='https://www.pri-med.com/online-education/podcast/frankly-speaking-cme-200'>https://www.pri-med.com/online-education/podcast/frankly-speaking-cme-200</a></p>
<p>Overview: Join us for the 200th episode of Frankly Speaking about Family Medicine! In this episode, each podcaster will review  their favorite topics since the inception of this podcast and will describe patient encounters where this practice changing knowledge was helpful.  </p>
<p>Guest: Alan Ehrlich, MD, FAAFP; Robert A. Baldor, MD, FAAFP; Susan Feeney, DNP, FNP-BC, NP-C; Jill Terrien, PhD, ANP-BC</p>
<p>Music Credit: Richard Onorato</p>
]]></description>
                                                            <content:encoded><![CDATA[<p>Credits: 0.25 AMA PRA Category 1 Credits™</p>
<p>Claim CME/CE credit: <a href='https://www.pri-med.com/online-education/podcast/frankly-speaking-cme-200'>https://www.pri-med.com/online-education/podcast/frankly-speaking-cme-200</a></p>
<p>Overview: Join us for the 200th episode of <em>Frankly Speaking about Family Medicine</em>! In this episode, each podcaster will review  their favorite topics since the inception of this podcast and will describe patient encounters where this practice changing knowledge was helpful.  </p>
<p>Guest: Alan Ehrlich, MD, FAAFP; Robert A. Baldor, MD, FAAFP; Susan Feeney, DNP, FNP-BC, NP-C; Jill Terrien, PhD, ANP-BC</p>
<p>Music Credit: Richard Onorato</p>
]]></content:encoded>
                                    
        <enclosure url="https://mcdn.podbean.com/mf/web/02gvi1/secure_primed_frankly-speaking-200th-episode.mp3" length="20471082" type="audio/mpeg"/>
                <itunes:summary><![CDATA[Credits: 0.25 AMA PRA Category 1 Credits™
Claim CME/CE credit: https://www.pri-med.com/online-education/podcast/frankly-speaking-cme-200
Overview: Join us for the 200th episode of Frankly Speaking about Family Medicine! In this episode, each podcaster will review  their favorite topics since the inception of this podcast and will describe patient encounters where this practice changing knowledge was helpful.  
Guest: Alan Ehrlich, MD, FAAFP; Robert A. Baldor, MD, FAAFP; Susan Feeney, DNP, FNP-BC, NP-C; Jill Terrien, PhD, ANP-BC
Music Credit: Richard Onorato]]></itunes:summary>
        <itunes:author>Pri-Med</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>1278</itunes:duration>
        <itunes:season>1</itunes:season>
        <itunes:episode>1</itunes:episode>
        <itunes:episodeType>full</itunes:episodeType>
        <itunes:image href="https://pbcdn1.podbean.com/imglogo/ep-logo/pbblog13721080/24162ed689e9558f2314cc0dfa050453.png" />    </item>
    <item>
        <title>Evaluation of Microhematuria: A Risk-based Approach - Frankly Speaking Ep 199</title>
        <itunes:title>Evaluation of Microhematuria: A Risk-based Approach - Frankly Speaking Ep 199</itunes:title>
        <link>https://primedfranklyspeaking.podbean.com/e/evaluation-of-microhematuria-a-risk-based-approach-frankly-speaking-ep-199-1645730544/</link>
                    <comments>https://primedfranklyspeaking.podbean.com/e/evaluation-of-microhematuria-a-risk-based-approach-frankly-speaking-ep-199-1645730544/#comments</comments>        <pubDate>Mon, 23 Nov 2020 05:30:00 +0000</pubDate>
        <guid isPermaLink="false">23ee763e-54a8-459f-a19c-64d9ebe929d1</guid>
                                    <description><![CDATA[<p>Credits: 0.25 AMA PRA Category 1 Credits™</p>
<p>Claim CME/CE credit: <a href='https://www.pri-med.com/online-education/podcast/frankly-speaking-cme-199'>https://www.pri-med.com/online-education/podcast/frankly-speaking-cme-199</a></p>
<p>Overview: Microhematuria is a common finding. It is usually benign, but it needs proper evaluation since it may also be a sign of malignancy. A risk-based approach can avoid unnecessary testing, while still identifying those patients with malignancy. Recent American Urological Association (AUA) guidelines use a validated risk-based approach.</p>
<p>Guest: Alan Ehrlich, MD</p>
<p>Music Credit: Richard Onorato</p>
]]></description>
                                                            <content:encoded><![CDATA[<p>Credits: 0.25 AMA PRA Category 1 Credits™</p>
<p>Claim CME/CE credit: <a href='https://www.pri-med.com/online-education/podcast/frankly-speaking-cme-199'>https://www.pri-med.com/online-education/podcast/frankly-speaking-cme-199</a></p>
<p>Overview: Microhematuria is a common finding. It is usually benign, but it needs proper evaluation since it may also be a sign of malignancy. A risk-based approach can avoid unnecessary testing, while still identifying those patients with malignancy. Recent American Urological Association (AUA) guidelines use a validated risk-based approach.</p>
<p>Guest: Alan Ehrlich, MD</p>
<p>Music Credit: Richard Onorato</p>
]]></content:encoded>
                                    
        <enclosure url="https://mcdn.podbean.com/mf/web/xmgnnx/secure_primed_frankly-speaking-199-microhematuria.mp3" length="13515664" type="audio/mpeg"/>
                <itunes:summary><![CDATA[Credits: 0.25 AMA PRA Category 1 Credits™
Claim CME/CE credit: https://www.pri-med.com/online-education/podcast/frankly-speaking-cme-199
Overview: Microhematuria is a common finding. It is usually benign, but it needs proper evaluation since it may also be a sign of malignancy. A risk-based approach can avoid unnecessary testing, while still identifying those patients with malignancy. Recent American Urological Association (AUA) guidelines use a validated risk-based approach.
Guest: Alan Ehrlich, MD
Music Credit: Richard Onorato]]></itunes:summary>
        <itunes:author>Pri-Med</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>844</itunes:duration>
        <itunes:season>1</itunes:season>
        <itunes:episode>1</itunes:episode>
        <itunes:episodeType>full</itunes:episodeType>
        <itunes:image href="https://pbcdn1.podbean.com/imglogo/ep-logo/pbblog13721080/ae4d7b6f1fde429f7e5a145a7c70a5ed.png" />    </item>
    <item>
        <title>“Just a Spoonful of Honey”: Evidence Supporting Honey for URTI Symptom Relief - Frankly Speaking Ep 198</title>
        <itunes:title>“Just a Spoonful of Honey”: Evidence Supporting Honey for URTI Symptom Relief - Frankly Speaking Ep 198</itunes:title>
        <link>https://primedfranklyspeaking.podbean.com/e/just-a-spoonful-of-honey-evidence-supporting-honey-for-urti-symptom-relief-frankly-speaking-ep-198-1645730545/</link>
                    <comments>https://primedfranklyspeaking.podbean.com/e/just-a-spoonful-of-honey-evidence-supporting-honey-for-urti-symptom-relief-frankly-speaking-ep-198-1645730545/#comments</comments>        <pubDate>Mon, 16 Nov 2020 05:30:00 +0000</pubDate>
        <guid isPermaLink="false">5675f628-c946-4bdc-acb0-7105f3c56816</guid>
                                    <description><![CDATA[<p>Credits: 0.25 AMA PRA Category 1 Credits™</p>
<p>Claim CME/CE credit: <a href='https://www.pri-med.com/online-education/podcast/frankly-speaking-cme-198'>https://www.pri-med.com/online-education/podcast/frankly-speaking-cme-198</a></p>
<p>Overview: Upper respiratory tract infections (URTI) are one of the most common conditions seen in primary care. Effective treatments for this acute, bothersome illness are limited; inappropriate antibiotic prescribing and use of therapeutics with little evidence of effectiveness are common. Join our discussion as we discuss a recent meta-analysis from the BMJ which suggests that honey, in any form, is superior to usual, common treatment for URTIs.</p>
<p>Guest: Susan Feeney, DNP, FNP-BC, NP-C</p>
<p>Music Credit: Richard Onorato</p>
]]></description>
                                                            <content:encoded><![CDATA[<p>Credits: 0.25 AMA PRA Category 1 Credits™</p>
<p>Claim CME/CE credit: <a href='https://www.pri-med.com/online-education/podcast/frankly-speaking-cme-198'>https://www.pri-med.com/online-education/podcast/frankly-speaking-cme-198</a></p>
<p>Overview: Upper respiratory tract infections (URTI) are one of the most common conditions seen in primary care. Effective treatments for this acute, bothersome illness are limited; inappropriate antibiotic prescribing and use of therapeutics with little evidence of effectiveness are common. Join our discussion as we discuss a recent meta-analysis from the BMJ which suggests that honey, in any form, is superior to usual, common treatment for URTIs.</p>
<p>Guest: Susan Feeney, DNP, FNP-BC, NP-C</p>
<p>Music Credit: Richard Onorato</p>
]]></content:encoded>
                                    
        <enclosure url="https://mcdn.podbean.com/mf/web/7tl1xj/secure_primed_frankly-speaking-198-honey.mp3" length="11960602" type="audio/mpeg"/>
                <itunes:summary><![CDATA[Credits: 0.25 AMA PRA Category 1 Credits™
Claim CME/CE credit: https://www.pri-med.com/online-education/podcast/frankly-speaking-cme-198
Overview: Upper respiratory tract infections (URTI) are one of the most common conditions seen in primary care. Effective treatments for this acute, bothersome illness are limited; inappropriate antibiotic prescribing and use of therapeutics with little evidence of effectiveness are common. Join our discussion as we discuss a recent meta-analysis from the BMJ which suggests that honey, in any form, is superior to usual, common treatment for URTIs.
Guest: Susan Feeney, DNP, FNP-BC, NP-C
Music Credit: Richard Onorato]]></itunes:summary>
        <itunes:author>Pri-Med</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>747</itunes:duration>
        <itunes:season>1</itunes:season>
        <itunes:episode>1</itunes:episode>
        <itunes:episodeType>full</itunes:episodeType>
        <itunes:image href="https://pbcdn1.podbean.com/imglogo/ep-logo/pbblog13721080/6e224de8a718d2e607ca158a2ed0522c.png" />    </item>
    <item>
        <title>Handling Upper Respiratory Symptoms During the COVID-19 Pandemic - Frankly Speaking Ep 197</title>
        <itunes:title>Handling Upper Respiratory Symptoms During the COVID-19 Pandemic - Frankly Speaking Ep 197</itunes:title>
        <link>https://primedfranklyspeaking.podbean.com/e/handling-upper-respiratory-symptoms-during-the-covid-19-pandemic-frankly-speaking-ep-197-1645730547/</link>
                    <comments>https://primedfranklyspeaking.podbean.com/e/handling-upper-respiratory-symptoms-during-the-covid-19-pandemic-frankly-speaking-ep-197-1645730547/#comments</comments>        <pubDate>Mon, 09 Nov 2020 05:30:00 +0000</pubDate>
        <guid isPermaLink="false">3db361fb-5a65-4625-8951-7203e13e1bd2</guid>
                                    <description><![CDATA[<p>Credits: 0.25 AMA PRA Category 1 Credits™</p>
<p>Claim CME/CE credit: <a href='https://www.pri-med.com/online-education/podcast/frankly-speaking-cme-197'>https://www.pri-med.com/online-education/podcast/frankly-speaking-cme-197</a></p>
<p>Overview: This episode will review how to best care for patients who present with respiratory symptoms during the fall and winter.</p>
<p>Guest: Alan Ehrlich, MD</p>
<p>Music Credit: Richard Onorato</p>
]]></description>
                                                            <content:encoded><![CDATA[<p>Credits: 0.25 AMA PRA Category 1 Credits™</p>
<p>Claim CME/CE credit: <a href='https://www.pri-med.com/online-education/podcast/frankly-speaking-cme-197'>https://www.pri-med.com/online-education/podcast/frankly-speaking-cme-197</a></p>
<p>Overview: This episode will review how to best care for patients who present with respiratory symptoms during the fall and winter.</p>
<p>Guest: Alan Ehrlich, MD</p>
<p>Music Credit: Richard Onorato</p>
]]></content:encoded>
                                    
        <enclosure url="https://mcdn.podbean.com/mf/web/zv9g91/secure_primed_frankly-speaking-ep197.mp3" length="15282204" type="audio/mpeg"/>
                <itunes:summary><![CDATA[Credits: 0.25 AMA PRA Category 1 Credits™
Claim CME/CE credit: https://www.pri-med.com/online-education/podcast/frankly-speaking-cme-197
Overview: This episode will review how to best care for patients who present with respiratory symptoms during the fall and winter.
Guest: Alan Ehrlich, MD
Music Credit: Richard Onorato]]></itunes:summary>
        <itunes:author>Pri-Med</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>954</itunes:duration>
        <itunes:season>1</itunes:season>
        <itunes:episode>1</itunes:episode>
        <itunes:episodeType>full</itunes:episodeType>
        <itunes:image href="https://pbcdn1.podbean.com/imglogo/ep-logo/pbblog13721080/beb256951fc86805dde7d07c2c9e66fb.png" />    </item>
    <item>
        <title>That Cup of Joe – Good for You! - Frankly Speaking Ep 196</title>
        <itunes:title>That Cup of Joe – Good for You! - Frankly Speaking Ep 196</itunes:title>
        <link>https://primedfranklyspeaking.podbean.com/e/that-cup-of-joe-%e2%80%93-good-for-you-frankly-speaking-ep-196/</link>
                    <comments>https://primedfranklyspeaking.podbean.com/e/that-cup-of-joe-%e2%80%93-good-for-you-frankly-speaking-ep-196/#comments</comments>        <pubDate>Mon, 02 Nov 2020 05:30:00 +0000</pubDate>
        <guid isPermaLink="false">1dbfcd6c-c2f4-42ad-a819-a2d54d812e8e</guid>
                                    <description><![CDATA[<p>Credits: 0.25 AMA PRA Category 1 Credits™</p>
<p>Claim CME/CE credit: <a href='https://www.pri-med.com/online-education/podcast/frankly-speaking-cme-196'>https://www.pri-med.com/online-education/podcast/frankly-speaking-cme-196</a></p>
<p>Overview: The New England Journal of Medicine recently published an evidence-based review of the benefits and harms related to caffeine and coffee consumption.</p>
<p>Guest: Robert Baldor, MD, FAAFP</p>
<p>Music Credit: Richard Onorato</p>
]]></description>
                                                            <content:encoded><![CDATA[<p>Credits: 0.25 AMA PRA Category 1 Credits™</p>
<p>Claim CME/CE credit: <a href='https://www.pri-med.com/online-education/podcast/frankly-speaking-cme-196'>https://www.pri-med.com/online-education/podcast/frankly-speaking-cme-196</a></p>
<p>Overview: The New England Journal of Medicine recently published an evidence-based review of the benefits and harms related to caffeine and coffee consumption.</p>
<p>Guest: Robert Baldor, MD, FAAFP</p>
<p>Music Credit: Richard Onorato</p>
]]></content:encoded>
                                    
        <enclosure url="https://mcdn.podbean.com/mf/web/leu4r0/secure_primed_frankly-speaking-196-coffee.mp3" length="10811347" type="audio/mpeg"/>
                <itunes:summary><![CDATA[Credits: 0.25 AMA PRA Category 1 Credits™
Claim CME/CE credit: https://www.pri-med.com/online-education/podcast/frankly-speaking-cme-196
Overview: The New England Journal of Medicine recently published an evidence-based review of the benefits and harms related to caffeine and coffee consumption.
Guest: Robert Baldor, MD, FAAFP
Music Credit: Richard Onorato]]></itunes:summary>
        <itunes:author>Pri-Med</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>675</itunes:duration>
        <itunes:season>1</itunes:season>
        <itunes:episode>1</itunes:episode>
        <itunes:episodeType>full</itunes:episodeType>
        <itunes:image href="https://pbcdn1.podbean.com/imglogo/ep-logo/pbblog13721080/f7dd318767b0c2bf2c33480ef2c0a4ff.png" />    </item>
    <item>
        <title>Peanut Allergies, Time to Follow the Guidelines? - Frankly Speaking Ep 195</title>
        <itunes:title>Peanut Allergies, Time to Follow the Guidelines? - Frankly Speaking Ep 195</itunes:title>
        <link>https://primedfranklyspeaking.podbean.com/e/peanut-allergies-time-to-follow-the-guidelines-frankly-speaking-ep-195/</link>
                    <comments>https://primedfranklyspeaking.podbean.com/e/peanut-allergies-time-to-follow-the-guidelines-frankly-speaking-ep-195/#comments</comments>        <pubDate>Mon, 26 Oct 2020 04:30:00 +0000</pubDate>
        <guid isPermaLink="false">f09d5c45-4397-44f2-8d67-33502e30f3ef</guid>
                                    <description><![CDATA[<p>Credits: 0.25 AMA PRA Category 1 Credits™</p>
<p>Claim CME/CE credit: <a href='https://www.pri-med.com/online-education/podcast/frankly-speaking-cme-195'>https://www.pri-med.com/online-education/podcast/frankly-speaking-cme-195</a></p>
<p>Overview: For patients who have hip replacement or knee arthroplasty there is an increased risk of venous thromboembolism This episode will review the effectiveness of aspirin for preventing VTE in this population</p>
<p>Guest: Robert Baldor, MD, FAAFP</p>
<p>Music Credit: Richard Onorato</p>
]]></description>
                                                            <content:encoded><![CDATA[<p>Credits: 0.25 AMA PRA Category 1 Credits™</p>
<p>Claim CME/CE credit: <a href='https://www.pri-med.com/online-education/podcast/frankly-speaking-cme-195'>https://www.pri-med.com/online-education/podcast/frankly-speaking-cme-195</a></p>
<p>Overview: For patients who have hip replacement or knee arthroplasty there is an increased risk of venous thromboembolism This episode will review the effectiveness of aspirin for preventing VTE in this population</p>
<p>Guest: Robert Baldor, MD, FAAFP</p>
<p>Music Credit: Richard Onorato</p>
]]></content:encoded>
                                    
        <enclosure url="https://mcdn.podbean.com/mf/web/4923hm/secure_primed_frankly-speaking-195.mp3" length="11772036" type="audio/mpeg"/>
                <itunes:summary><![CDATA[Credits: 0.25 AMA PRA Category 1 Credits™
Claim CME/CE credit: https://www.pri-med.com/online-education/podcast/frankly-speaking-cme-195
Overview: For patients who have hip replacement or knee arthroplasty there is an increased risk of venous thromboembolism This episode will review the effectiveness of aspirin for preventing VTE in this population
Guest: Robert Baldor, MD, FAAFP
Music Credit: Richard Onorato]]></itunes:summary>
        <itunes:author>Pri-Med</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>735</itunes:duration>
        <itunes:season>1</itunes:season>
        <itunes:episode>1</itunes:episode>
        <itunes:episodeType>full</itunes:episodeType>
        <itunes:image href="https://pbcdn1.podbean.com/imglogo/ep-logo/pbblog13721080/db581ee38544a60129ccb372cf93dd79.png" />    </item>
    <item>
        <title>Is There a Correlation Between Low-to-Moderate Alcohol Consumption and Improved Cognitive Function? - Frankly Speaking Ep 194</title>
        <itunes:title>Is There a Correlation Between Low-to-Moderate Alcohol Consumption and Improved Cognitive Function? - Frankly Speaking Ep 194</itunes:title>
        <link>https://primedfranklyspeaking.podbean.com/e/is-there-a-correlation-between-low-to-moderate-alcohol-consumption-and-improved-cognitive-function-frankly-speaking-ep-194/</link>
                    <comments>https://primedfranklyspeaking.podbean.com/e/is-there-a-correlation-between-low-to-moderate-alcohol-consumption-and-improved-cognitive-function-frankly-speaking-ep-194/#comments</comments>        <pubDate>Mon, 19 Oct 2020 04:30:00 +0000</pubDate>
        <guid isPermaLink="false">53749e1b-303b-4350-9880-9b3661693c8b</guid>
                                    <description><![CDATA[<p>Credits: 0.25 AMA PRA Category 1 Credits™</p>
<p>Claim CME/CE credit: <a href='https://www.pri-med.com/online-education/podcast/frankly-speaking-cme-194'>https://www.pri-med.com/online-education/podcast/frankly-speaking-cme-194</a></p>
<p>Overview: The available evidence on alcohol consumption and its relationship to health is abundant, varied, and often conflicting. The evidence that excessive consumption is associated with poor outcomes is consistent; however, evidence on low-to-moderate alcohol consumption has ranged from poor outcomes to no impact to improved outcomes. Join us while we discuss new evidence that reveals an association between low-to-moderate alcohol use in white middle-to-older aged adults and improved cognition.</p>
<p>Guest: Susan Feeney, DNP, FNP-BC</p>
<p>Music Credit: Richard Onorato</p>
]]></description>
                                                            <content:encoded><![CDATA[<p>Credits: 0.25 AMA PRA Category 1 Credits™</p>
<p>Claim CME/CE credit: <a href='https://www.pri-med.com/online-education/podcast/frankly-speaking-cme-194'>https://www.pri-med.com/online-education/podcast/frankly-speaking-cme-194</a></p>
<p>Overview: The available evidence on alcohol consumption and its relationship to health is abundant, varied, and often conflicting. The evidence that excessive consumption is associated with poor outcomes is consistent; however, evidence on low-to-moderate alcohol consumption has ranged from poor outcomes to no impact to improved outcomes. Join us while we discuss new evidence that reveals an association between low-to-moderate alcohol use in white middle-to-older aged adults and improved cognition.</p>
<p>Guest: Susan Feeney, DNP, FNP-BC</p>
<p>Music Credit: Richard Onorato</p>
]]></content:encoded>
                                    
        <enclosure url="https://mcdn.podbean.com/mf/web/4e6eo7/secure_primed_frankly-speaking-194.mp3" length="11591893" type="audio/mpeg"/>
                <itunes:summary><![CDATA[Credits: 0.25 AMA PRA Category 1 Credits™
Claim CME/CE credit: https://www.pri-med.com/online-education/podcast/frankly-speaking-cme-194
Overview: The available evidence on alcohol consumption and its relationship to health is abundant, varied, and often conflicting. The evidence that excessive consumption is associated with poor outcomes is consistent; however, evidence on low-to-moderate alcohol consumption has ranged from poor outcomes to no impact to improved outcomes. Join us while we discuss new evidence that reveals an association between low-to-moderate alcohol use in white middle-to-older aged adults and improved cognition.
Guest: Susan Feeney, DNP, FNP-BC
Music Credit: Richard Onorato]]></itunes:summary>
        <itunes:author>Pri-Med</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>723</itunes:duration>
        <itunes:season>1</itunes:season>
        <itunes:episode>1</itunes:episode>
        <itunes:episodeType>full</itunes:episodeType>
        <itunes:image href="https://pbcdn1.podbean.com/imglogo/ep-logo/pbblog13721080/ee3b945101aca0ce22fe7db1d18a5cc9.png" />    </item>
    <item>
        <title>Heads Up! 2020 Guideline Update on Cervical Cancer Screening - Frankly Speaking Ep 193</title>
        <itunes:title>Heads Up! 2020 Guideline Update on Cervical Cancer Screening - Frankly Speaking Ep 193</itunes:title>
        <link>https://primedfranklyspeaking.podbean.com/e/heads-up-2020-guideline-update-on-cervical-cancer-screening-frankly-speaking-ep-193/</link>
                    <comments>https://primedfranklyspeaking.podbean.com/e/heads-up-2020-guideline-update-on-cervical-cancer-screening-frankly-speaking-ep-193/#comments</comments>        <pubDate>Mon, 12 Oct 2020 04:30:00 +0000</pubDate>
        <guid isPermaLink="false">ec9ee401-b51d-40b6-a8bc-d135d524b47b</guid>
                                    <description><![CDATA[<p>Credits: 0.25 AMA PRA Category 1 Credits™</p>
<p>Claim CME/CE credit: <a href='https://www.pri-med.com/online-education/podcast/frankly-speaking-cme-193'>https://www.pri-med.com/online-education/podcast/frankly-speaking-cme-193</a></p>
<p>Overview: Join us as we discuss the American Cancer Society 2020 guideline update on cervical cancer screening for women of average risk</p>
<p>Guest: Jill Terrien PhD, ANP-BC</p>
<p>Music Credit: Richard Onorato</p>
]]></description>
                                                            <content:encoded><![CDATA[<p>Credits: 0.25 AMA PRA Category 1 Credits™</p>
<p>Claim CME/CE credit: <a href='https://www.pri-med.com/online-education/podcast/frankly-speaking-cme-193'>https://www.pri-med.com/online-education/podcast/frankly-speaking-cme-193</a></p>
<p>Overview: Join us as we discuss the American Cancer Society 2020 guideline update on cervical cancer screening for women of average risk</p>
<p>Guest: Jill Terrien PhD, ANP-BC</p>
<p>Music Credit: Richard Onorato</p>
]]></content:encoded>
                                    
        <enclosure url="https://mcdn.podbean.com/mf/web/irs5zx/secure_primed_frankly-speaking-ACS-update.mp3" length="8771349" type="audio/mpeg"/>
                <itunes:summary><![CDATA[Credits: 0.25 AMA PRA Category 1 Credits™
Claim CME/CE credit: https://www.pri-med.com/online-education/podcast/frankly-speaking-cme-193
Overview: Join us as we discuss the American Cancer Society 2020 guideline update on cervical cancer screening for women of average risk
Guest: Jill Terrien PhD, ANP-BC
Music Credit: Richard Onorato]]></itunes:summary>
        <itunes:author>Pri-Med</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>547</itunes:duration>
        <itunes:season>1</itunes:season>
        <itunes:episode>1</itunes:episode>
        <itunes:episodeType>full</itunes:episodeType>
        <itunes:image href="https://pbcdn1.podbean.com/imglogo/ep-logo/pbblog13721080/d6dc488ccd4be56efebc6ee59488c8cf.png" />    </item>
    <item>
        <title>Lung Cancer Screening: The U.S. Preventive Services Task Force Weights In - Frankly Speaking Ep 192</title>
        <itunes:title>Lung Cancer Screening: The U.S. Preventive Services Task Force Weights In - Frankly Speaking Ep 192</itunes:title>
        <link>https://primedfranklyspeaking.podbean.com/e/lung-cancer-screening-the-us-preventive-services-task-force-weights-in-frankly-speaking-ep-192/</link>
                    <comments>https://primedfranklyspeaking.podbean.com/e/lung-cancer-screening-the-us-preventive-services-task-force-weights-in-frankly-speaking-ep-192/#comments</comments>        <pubDate>Mon, 05 Oct 2020 04:30:00 +0000</pubDate>
        <guid isPermaLink="false">818e3b86-82f3-4390-892e-4438a5807519</guid>
                                    <description><![CDATA[<p>Credits: 0.25 AMA PRA Category 1 Credits™</p>
<p>Claim CME/CE credit: <a href='https://www.pri-med.com/online-education/podcast/frankly-speaking-cme-192'>https://www.pri-med.com/online-education/podcast/frankly-speaking-cme-192</a></p>
<p>Overview: Currently a low-dose CT scan is the only screening test for lung cancer that is recommended by the American Cancer Society. In July 202, the U.S. Preventive Services Task Force (USPSTF) issued a draft recommendation statement on screening for lung cancer. The USPSTF suggests annual screening with low-dose CT for individuals aged 50-80 who have a 20 pack-year smoking history and who currently smoke or have quit smoking within the past 15 years. These recommendations expand screening eligibility, but they also suggest that screening be discontinued if a person has not smoked for 15 years, develops a health problem that substantially limits life expectancy, or is unable or unwilling to have curative lung surgery.</p>
<p>Guest: Robert A. Baldor, MD, FAAFP</p>
<p>Music Credit: Richard Onorato</p>
]]></description>
                                                            <content:encoded><![CDATA[<p>Credits: 0.25 AMA PRA Category 1 Credits™</p>
<p>Claim CME/CE credit: <a href='https://www.pri-med.com/online-education/podcast/frankly-speaking-cme-192'>https://www.pri-med.com/online-education/podcast/frankly-speaking-cme-192</a></p>
<p>Overview: Currently a low-dose CT scan is the only screening test for lung cancer that is recommended by the American Cancer Society. In July 202, the U.S. Preventive Services Task Force (USPSTF) issued a draft recommendation statement on screening for lung cancer. The USPSTF suggests annual screening with low-dose CT for individuals aged 50-80 who have a 20 pack-year smoking history and who currently smoke or have quit smoking within the past 15 years. These recommendations expand screening eligibility, but they also suggest that screening be discontinued if a person has not smoked for 15 years, develops a health problem that substantially limits life expectancy, or is unable or unwilling to have curative lung surgery.</p>
<p>Guest: Robert A. Baldor, MD, FAAFP</p>
<p>Music Credit: Richard Onorato</p>
]]></content:encoded>
                                    
        <enclosure url="https://mcdn.podbean.com/mf/web/r07h6a/secure_primed_frankly-speaking-lung-cancer-192.mp3" length="10413462" type="audio/mpeg"/>
                <itunes:summary><![CDATA[Credits: 0.25 AMA PRA Category 1 Credits™
Claim CME/CE credit: https://www.pri-med.com/online-education/podcast/frankly-speaking-cme-192
Overview: Currently a low-dose CT scan is the only screening test for lung cancer that is recommended by the American Cancer Society. In July 202, the U.S. Preventive Services Task Force (USPSTF) issued a draft recommendation statement on screening for lung cancer. The USPSTF suggests annual screening with low-dose CT for individuals aged 50-80 who have a 20 pack-year smoking history and who currently smoke or have quit smoking within the past 15 years. These recommendations expand screening eligibility, but they also suggest that screening be discontinued if a person has not smoked for 15 years, develops a health problem that substantially limits life expectancy, or is unable or unwilling to have curative lung surgery.
Guest: Robert A. Baldor, MD, FAAFP
Music Credit: Richard Onorato]]></itunes:summary>
        <itunes:author>Pri-Med</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>650</itunes:duration>
        <itunes:season>1</itunes:season>
        <itunes:episode>1</itunes:episode>
        <itunes:episodeType>full</itunes:episodeType>
        <itunes:image href="https://pbcdn1.podbean.com/imglogo/ep-logo/pbblog13721080/893b68e0444c3269238e1027519286b8.png" />    </item>
    <item>
        <title>Testing is Appropriate at an Annual Health Exam: What, When, and WHY? - Frankly Speaking Ep 191</title>
        <itunes:title>Testing is Appropriate at an Annual Health Exam: What, When, and WHY? - Frankly Speaking Ep 191</itunes:title>
        <link>https://primedfranklyspeaking.podbean.com/e/testing-is-appropriate-at-an-annual-health-exam-what-when-and-why-frankly-speaking-ep-191/</link>
                    <comments>https://primedfranklyspeaking.podbean.com/e/testing-is-appropriate-at-an-annual-health-exam-what-when-and-why-frankly-speaking-ep-191/#comments</comments>        <pubDate>Mon, 28 Sep 2020 04:30:00 +0000</pubDate>
        <guid isPermaLink="false">cb350ce2-3cad-4691-a24e-ed99d4d9832f</guid>
                                    <description><![CDATA[<p>Credits: 0.25 AMA PRA Category 1 Credits™</p>
<p>Claim CME/CE credit: <a href='https://www.pri-med.com/online-education/podcast/frankly-speaking-cme-191'>https://www.pri-med.com/online-education/podcast/frankly-speaking-cme-191</a></p>
<p>Overview: Screening for asymptomatic conditions is an essential and important aspect of primary care. But what is the potential downstream impact to the patents and the healthcare system when low-risk individuals are screened? What are the benefits and the potential harms? Join us as we discuss a recent retrospective study on the downstream effects of low-value testing on low-risk people at their annual health exam and how this may impact your practice.</p>
<p>Guest: Susan Feeney, DNP, FNP-BC</p>
<p>Music Credit: Richard Onorato</p>
]]></description>
                                                            <content:encoded><![CDATA[<p>Credits: 0.25 AMA PRA Category 1 Credits™</p>
<p>Claim CME/CE credit: <a href='https://www.pri-med.com/online-education/podcast/frankly-speaking-cme-191'>https://www.pri-med.com/online-education/podcast/frankly-speaking-cme-191</a></p>
<p>Overview: Screening for asymptomatic conditions is an essential and important aspect of primary care. But what is the potential downstream impact to the patents and the healthcare system when low-risk individuals are screened? What are the benefits and the potential harms? Join us as we discuss a recent retrospective study on the downstream effects of low-value testing on low-risk people at their annual health exam and how this may impact your practice.</p>
<p>Guest: Susan Feeney, DNP, FNP-BC</p>
<p>Music Credit: Richard Onorato</p>
]]></content:encoded>
                                    
        <enclosure url="https://mcdn.podbean.com/mf/web/03a8yk/secure_primed_frankly-speaking-low-value-testing-ep-191.mp3" length="11300061" type="audio/mpeg"/>
                <itunes:summary><![CDATA[Credits: 0.25 AMA PRA Category 1 Credits™
Claim CME/CE credit: https://www.pri-med.com/online-education/podcast/frankly-speaking-cme-191
Overview: Screening for asymptomatic conditions is an essential and important aspect of primary care. But what is the potential downstream impact to the patents and the healthcare system when low-risk individuals are screened? What are the benefits and the potential harms? Join us as we discuss a recent retrospective study on the downstream effects of low-value testing on low-risk people at their annual health exam and how this may impact your practice.
Guest: Susan Feeney, DNP, FNP-BC
Music Credit: Richard Onorato]]></itunes:summary>
        <itunes:author>Pri-Med</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>705</itunes:duration>
        <itunes:season>1</itunes:season>
        <itunes:episode>1</itunes:episode>
        <itunes:episodeType>full</itunes:episodeType>
        <itunes:image href="https://pbcdn1.podbean.com/imglogo/ep-logo/pbblog13721080/7e5ce18858f6b6c3f8a25428101ad6c6.png" />    </item>
    <item>
        <title>Antibody Tests for COVID-19: What Do They Tell Us? - Frankly Speaking Ep 190</title>
        <itunes:title>Antibody Tests for COVID-19: What Do They Tell Us? - Frankly Speaking Ep 190</itunes:title>
        <link>https://primedfranklyspeaking.podbean.com/e/antibody-tests-for-covid-19-what-do-they-tell-us-frankly-speaking-ep-190/</link>
                    <comments>https://primedfranklyspeaking.podbean.com/e/antibody-tests-for-covid-19-what-do-they-tell-us-frankly-speaking-ep-190/#comments</comments>        <pubDate>Mon, 21 Sep 2020 04:30:00 +0000</pubDate>
        <guid isPermaLink="false">db556fe2-2ec8-4a4f-bb6c-7df936d5f531</guid>
                                    <description><![CDATA[<p>Credits: 0.25 AMA PRA Category 1 Credits™</p>
<p>Claim CME/CE credit: <a href='https://www.pri-med.com/online-education/podcast/frankly-speaking-cme-190'>https://www.pri-med.com/online-education/podcast/frankly-speaking-cme-190</a></p>
<p>Overview: A review of the latest evidence on antibody testing to identify current and past COVID-19 infection</p>
<p>Guest: Alan Ehrlich, MD</p>
<p>Music Credit: Richard Onorato</p>
]]></description>
                                                            <content:encoded><![CDATA[<p>Credits: 0.25 AMA PRA Category 1 Credits™</p>
<p>Claim CME/CE credit: <a href='https://www.pri-med.com/online-education/podcast/frankly-speaking-cme-190'>https://www.pri-med.com/online-education/podcast/frankly-speaking-cme-190</a></p>
<p>Overview: A review of the latest evidence on antibody testing to identify current and past COVID-19 infection</p>
<p>Guest: Alan Ehrlich, MD</p>
<p>Music Credit: Richard Onorato</p>
]]></content:encoded>
                                    
        <enclosure url="https://mcdn.podbean.com/mf/web/4nucg0/secure_primed_frankly-speaking-covid-19-antibody-testing-190.mp3" length="9837807" type="audio/mpeg"/>
                <itunes:summary><![CDATA[Credits: 0.25 AMA PRA Category 1 Credits™
Claim CME/CE credit: https://www.pri-med.com/online-education/podcast/frankly-speaking-cme-190
Overview: A review of the latest evidence on antibody testing to identify current and past COVID-19 infection
Guest: Alan Ehrlich, MD
Music Credit: Richard Onorato]]></itunes:summary>
        <itunes:author>Pri-Med</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>614</itunes:duration>
        <itunes:season>1</itunes:season>
        <itunes:episode>1</itunes:episode>
        <itunes:episodeType>full</itunes:episodeType>
        <itunes:image href="https://pbcdn1.podbean.com/imglogo/ep-logo/pbblog13721080/01a41ca8075c7b19568659ac2c2de870.png" />    </item>
    <item>
        <title>Influenza Immunization and Lower Mortality Rates in Diabetes - Frankly Speaking Ep 189</title>
        <itunes:title>Influenza Immunization and Lower Mortality Rates in Diabetes - Frankly Speaking Ep 189</itunes:title>
        <link>https://primedfranklyspeaking.podbean.com/e/influenza-immunization-and-lower-mortality-rates-in-diabetes-frankly-speaking-ep-189/</link>
                    <comments>https://primedfranklyspeaking.podbean.com/e/influenza-immunization-and-lower-mortality-rates-in-diabetes-frankly-speaking-ep-189/#comments</comments>        <pubDate>Mon, 14 Sep 2020 04:30:00 +0000</pubDate>
        <guid isPermaLink="false">f63d24f4-9fe1-4e5a-847a-540fd4b912c1</guid>
                                    <description><![CDATA[<p>Credits: 0.25 AMA PRA Category 1 Credits™</p>
<p>Claim CME/CE credit: <a href='https://www.pri-med.com/online-education/podcast/frankly-speaking-cme-189'>https://www.pri-med.com/online-education/podcast/frankly-speaking-cme-189</a></p>
<p>Overview: This session will discuss an observational study performed in Denmark on how receiving the influenza vaccine affected diabetics long-term outcomes.</p>
<p>Guest: Jill M. Terrien, PhD, ANP-BC</p>
<p>Music Credit: Richard Onorato</p>
]]></description>
                                                            <content:encoded><![CDATA[<p>Credits: 0.25 AMA PRA Category 1 Credits™</p>
<p>Claim CME/CE credit: <a href='https://www.pri-med.com/online-education/podcast/frankly-speaking-cme-189'>https://www.pri-med.com/online-education/podcast/frankly-speaking-cme-189</a></p>
<p>Overview: This session will discuss an observational study performed in Denmark on how receiving the influenza vaccine affected diabetics long-term outcomes.</p>
<p>Guest: Jill M. Terrien, PhD, ANP-BC</p>
<p>Music Credit: Richard Onorato</p>
]]></content:encoded>
                                    
        <enclosure url="https://mcdn.podbean.com/mf/web/a79x19/secure_primed_frankly-speaking-diabetes-flu-189.mp3" length="11559674" type="audio/mpeg"/>
                <itunes:summary><![CDATA[Credits: 0.25 AMA PRA Category 1 Credits™
Claim CME/CE credit: https://www.pri-med.com/online-education/podcast/frankly-speaking-cme-189
Overview: This session will discuss an observational study performed in Denmark on how receiving the influenza vaccine affected diabetics long-term outcomes.
Guest: Jill M. Terrien, PhD, ANP-BC
Music Credit: Richard Onorato]]></itunes:summary>
        <itunes:author>Pri-Med</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>721</itunes:duration>
        <itunes:season>1</itunes:season>
        <itunes:episode>1</itunes:episode>
        <itunes:episodeType>full</itunes:episodeType>
        <itunes:image href="https://pbcdn1.podbean.com/imglogo/ep-logo/pbblog13721080/5cbb5fe09baa50fcfdf61fbef7dcef77.png" />    </item>
    <item>
        <title>Hydroxychloroquine for COVID-19: Not Ready for Prime-Time - Frankly Speaking Ep 188</title>
        <itunes:title>Hydroxychloroquine for COVID-19: Not Ready for Prime-Time - Frankly Speaking Ep 188</itunes:title>
        <link>https://primedfranklyspeaking.podbean.com/e/hydroxychloroquine-for-covid-19-not-ready-for-prime-time-frankly-speaking-ep-188/</link>
                    <comments>https://primedfranklyspeaking.podbean.com/e/hydroxychloroquine-for-covid-19-not-ready-for-prime-time-frankly-speaking-ep-188/#comments</comments>        <pubDate>Mon, 07 Sep 2020 04:30:00 +0000</pubDate>
        <guid isPermaLink="false">2dde4203-be86-470c-be88-8b23f81ef22c</guid>
                                    <description><![CDATA[<p>Credits: 0.25 AMA PRA Category 1 Credits™</p>
<p>Claim CME/CE credit: <a href='https://www.pri-med.com/online-education/podcast/frankly-speaking-cme-188'>https://www.pri-med.com/online-education/podcast/frankly-speaking-cme-188</a></p>
<p>Overview: A review of the latest evidence regarding hydroxychloroquine (HCQ) as treatment for SARS-CoV-2 infection.</p>
<p>Guest: Alan Ehrlich, MD</p>
<p>Music Credit: Richard Onorato</p>
]]></description>
                                                            <content:encoded><![CDATA[<p>Credits: 0.25 AMA PRA Category 1 Credits™</p>
<p>Claim CME/CE credit: <a href='https://www.pri-med.com/online-education/podcast/frankly-speaking-cme-188'>https://www.pri-med.com/online-education/podcast/frankly-speaking-cme-188</a></p>
<p>Overview: A review of the latest evidence regarding hydroxychloroquine (HCQ) as treatment for SARS-CoV-2 infection.</p>
<p>Guest: Alan Ehrlich, MD</p>
<p>Music Credit: Richard Onorato</p>
]]></content:encoded>
                                    
        <enclosure url="https://mcdn.podbean.com/mf/web/uocttz/secure_primed_frankly-speaking-ep188-edited.mp3" length="13279216" type="audio/mpeg"/>
                <itunes:summary><![CDATA[Credits: 0.25 AMA PRA Category 1 Credits™
Claim CME/CE credit: https://www.pri-med.com/online-education/podcast/frankly-speaking-cme-188
Overview: A review of the latest evidence regarding hydroxychloroquine (HCQ) as treatment for SARS-CoV-2 infection.
Guest: Alan Ehrlich, MD
Music Credit: Richard Onorato]]></itunes:summary>
        <itunes:author>Pri-Med</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>829</itunes:duration>
        <itunes:season>1</itunes:season>
        <itunes:episode>1</itunes:episode>
        <itunes:episodeType>full</itunes:episodeType>
        <itunes:image href="https://pbcdn1.podbean.com/imglogo/ep-logo/pbblog13721080/1038c3c5a8d9b1d3d7b6af19be81eaf9.png" />    </item>
    <item>
        <title>Vitamin D and COVID-19 - Frankly Speaking Episode 187</title>
        <itunes:title>Vitamin D and COVID-19 - Frankly Speaking Episode 187</itunes:title>
        <link>https://primedfranklyspeaking.podbean.com/e/vitamin-d-and-covid-19-frankly-speaking-episode-187/</link>
                    <comments>https://primedfranklyspeaking.podbean.com/e/vitamin-d-and-covid-19-frankly-speaking-episode-187/#comments</comments>        <pubDate>Mon, 31 Aug 2020 04:30:00 +0000</pubDate>
        <guid isPermaLink="false">63eb7d9b-4e87-498a-b938-8f75425681df</guid>
                                    <description><![CDATA[<p>Credits: 0.25 AMA PRA Category 1 Credits™</p>
<p>Claim CME/CE credit: <a href='https://www.pri-med.com/online-education/podcast/frankly-speaking-cme-187'>https://www.pri-med.com/online-education/podcast/frankly-speaking-cme-187</a></p>
<p>Overview: This podcast will review what is known and theorized about vitamin D status, susceptibility to viral infections, and mortality from viral infections.</p>
<p>Guest: Alan Ehrlich, MD</p>
<p>Music Credit: Richard Onorato</p>
]]></description>
                                                            <content:encoded><![CDATA[<p>Credits: 0.25 AMA PRA Category 1 Credits™</p>
<p>Claim CME/CE credit: <a href='https://www.pri-med.com/online-education/podcast/frankly-speaking-cme-187'>https://www.pri-med.com/online-education/podcast/frankly-speaking-cme-187</a></p>
<p>Overview: This podcast will review what is known and theorized about vitamin D status, susceptibility to viral infections, and mortality from viral infections.</p>
<p>Guest: Alan Ehrlich, MD</p>
<p>Music Credit: Richard Onorato</p>
]]></content:encoded>
                                    
        <enclosure url="https://mcdn.podbean.com/mf/web/i6dv96/secure_primed_frankly-speaking-187-vitamin-d.mp3" length="21373595" type="audio/mpeg"/>
                <itunes:summary><![CDATA[Credits: 0.25 AMA PRA Category 1 Credits™
Claim CME/CE credit: https://www.pri-med.com/online-education/podcast/frankly-speaking-cme-187
Overview: This podcast will review what is known and theorized about vitamin D status, susceptibility to viral infections, and mortality from viral infections.
Guest: Alan Ehrlich, MD
Music Credit: Richard Onorato]]></itunes:summary>
        <itunes:author>Pri-Med</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>668</itunes:duration>
        <itunes:season>1</itunes:season>
        <itunes:episode>1</itunes:episode>
        <itunes:episodeType>full</itunes:episodeType>
        <itunes:image href="https://pbcdn1.podbean.com/imglogo/ep-logo/pbblog13721080/eec8deb677e031b6a2f966b9d810c1e1.png" />    </item>
    <item>
        <title>COVID-19: School Closing, Prevention, and Prognosis - Frankly Speaking Episode 186</title>
        <itunes:title>COVID-19: School Closing, Prevention, and Prognosis - Frankly Speaking Episode 186</itunes:title>
        <link>https://primedfranklyspeaking.podbean.com/e/covid-19-school-closing-prevention-and-prognosis-frankly-speaking-episode-186/</link>
                    <comments>https://primedfranklyspeaking.podbean.com/e/covid-19-school-closing-prevention-and-prognosis-frankly-speaking-episode-186/#comments</comments>        <pubDate>Mon, 24 Aug 2020 04:30:00 +0000</pubDate>
        <guid isPermaLink="false">301fca6b-5683-44ea-9064-5fad2a8dacb1</guid>
                                    <description><![CDATA[<p>Credits: 0.25 AMA PRA Category 1 Credits™</p>
<p>Claim CME/CE credit: <a href='https://www.pri-med.com/online-education/podcast/frankly-speaking-cme-186'>https://www.pri-med.com/online-education/podcast/frankly-speaking-cme-186</a></p>
<p>Overview: This episode will review current literature on COVID-19 data.</p>
<p>Guest: Susan Feeney, DNP, FNP-BC, NP-C</p>
<p>Music Credit: Richard Onorato</p>
]]></description>
                                                            <content:encoded><![CDATA[<p>Credits: 0.25 AMA PRA Category 1 Credits™</p>
<p>Claim CME/CE credit: <a href='https://www.pri-med.com/online-education/podcast/frankly-speaking-cme-186'>https://www.pri-med.com/online-education/podcast/frankly-speaking-cme-186</a></p>
<p>Overview: This episode will review current literature on COVID-19 data.</p>
<p>Guest: Susan Feeney, DNP, FNP-BC, NP-C</p>
<p>Music Credit: Richard Onorato</p>
]]></content:encoded>
                                    
        <enclosure url="https://mcdn.podbean.com/mf/web/kj45v2/secure_primed_frankly-speaking-ep186-covid-schools.mp3" length="27077775" type="audio/mpeg"/>
                <itunes:summary><![CDATA[Credits: 0.25 AMA PRA Category 1 Credits™
Claim CME/CE credit: https://www.pri-med.com/online-education/podcast/frankly-speaking-cme-186
Overview: This episode will review current literature on COVID-19 data.
Guest: Susan Feeney, DNP, FNP-BC, NP-C
Music Credit: Richard Onorato]]></itunes:summary>
        <itunes:author>Pri-Med</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>846</itunes:duration>
        <itunes:season>1</itunes:season>
        <itunes:episode>1</itunes:episode>
        <itunes:episodeType>full</itunes:episodeType>
        <itunes:image href="https://pbcdn1.podbean.com/imglogo/ep-logo/pbblog13721080/4266e0305b7f5a91e41e20615eaedc69.png" />    </item>
    <item>
        <title>A Change In Treating Mild Asthma - Frankly Speaking EP 185</title>
        <itunes:title>A Change In Treating Mild Asthma - Frankly Speaking EP 185</itunes:title>
        <link>https://primedfranklyspeaking.podbean.com/e/a-change-in-treating-mild-asthma-frankly-speaking-ep-185/</link>
                    <comments>https://primedfranklyspeaking.podbean.com/e/a-change-in-treating-mild-asthma-frankly-speaking-ep-185/#comments</comments>        <pubDate>Mon, 17 Aug 2020 04:30:00 +0000</pubDate>
        <guid isPermaLink="false">d244ff9f-7f1f-4f43-a9ed-d99922d2580b</guid>
                                    <description><![CDATA[<p>Credits: 0.25 AMA PRA Category 1 Credits™</p>
<p>Claim CME/CE credit: <a href='https://www.pri-med.com/online-education/podcast/frankly-speaking-cme-185'>https://www.pri-med.com/online-education/podcast/frankly-speaking-cme-185</a></p>
<p>Overview: This episode will review a study of using LABA with inhaled steroid rather than a short acting rescue inhaler.</p>
<p>Guest: Guest: Alan Ehrlich, MD</p>
<p>Music Credit: Richard Onorato</p>
]]></description>
                                                            <content:encoded><![CDATA[<p>Credits: 0.25 AMA PRA Category 1 Credits™</p>
<p>Claim CME/CE credit: <a href='https://www.pri-med.com/online-education/podcast/frankly-speaking-cme-185'>https://www.pri-med.com/online-education/podcast/frankly-speaking-cme-185</a></p>
<p>Overview: This episode will review a study of using LABA with inhaled steroid rather than a short acting rescue inhaler.</p>
<p>Guest: Guest: Alan Ehrlich, MD</p>
<p>Music Credit: Richard Onorato</p>
]]></content:encoded>
                                    
        <enclosure url="https://mcdn.podbean.com/mf/web/8zxu0n/secure_primed_frankly-speaking-185-mild-asthma-edited.mp3" length="11212999" type="audio/mpeg"/>
                <itunes:summary><![CDATA[Credits: 0.25 AMA PRA Category 1 Credits™
Claim CME/CE credit: https://www.pri-med.com/online-education/podcast/frankly-speaking-cme-185
Overview: This episode will review a study of using LABA with inhaled steroid rather than a short acting rescue inhaler.
Guest: Guest: Alan Ehrlich, MD
Music Credit: Richard Onorato]]></itunes:summary>
        <itunes:author>Pri-Med</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>700</itunes:duration>
        <itunes:season>1</itunes:season>
        <itunes:episode>1</itunes:episode>
        <itunes:episodeType>full</itunes:episodeType>
        <itunes:image href="https://pbcdn1.podbean.com/imglogo/ep-logo/pbblog13721080/9664b2733fda3ba6574f26064bf4e0d3.png" />    </item>
    <item>
        <title>Aspirin Can Prevent VTE After Hip or Knee Surgery - Frankly Speaking EP 184</title>
        <itunes:title>Aspirin Can Prevent VTE After Hip or Knee Surgery - Frankly Speaking EP 184</itunes:title>
        <link>https://primedfranklyspeaking.podbean.com/e/aspirin-can-prevent-vte-after-hip-or-knee-surgery-frankly-speaking-ep-184/</link>
                    <comments>https://primedfranklyspeaking.podbean.com/e/aspirin-can-prevent-vte-after-hip-or-knee-surgery-frankly-speaking-ep-184/#comments</comments>        <pubDate>Mon, 10 Aug 2020 04:30:00 +0000</pubDate>
        <guid isPermaLink="false">7a880316-2a7b-4855-b497-8d9709f2fc61</guid>
                                    <description><![CDATA[<p>Credits: 0.25 AMA PRA Category 1 Credits™</p>
<p>Claim CME/CE credit: <a href='https://www.pri-med.com/online-education/podcast/frankly-speaking-cme-184'>https://www.pri-med.com/online-education/podcast/frankly-speaking-cme-184</a></p>
<p>Overview: For patients who have hip replacement or knee arthroplasty there is an increased risk of venous thromboembolism (VTE). This episode will review the effectiveness of aspirin for preventing VTE in this population.</p>
<p>Guest: Guest: Alan Ehrlich, MD</p>
<p>Music Credit: Richard Onorato</p>
]]></description>
                                                            <content:encoded><![CDATA[<p>Credits: 0.25 AMA PRA Category 1 Credits™</p>
<p>Claim CME/CE credit: <a href='https://www.pri-med.com/online-education/podcast/frankly-speaking-cme-184'>https://www.pri-med.com/online-education/podcast/frankly-speaking-cme-184</a></p>
<p>Overview: For patients who have hip replacement or knee arthroplasty there is an increased risk of venous thromboembolism (VTE). This episode will review the effectiveness of aspirin for preventing VTE in this population.</p>
<p>Guest: Guest: Alan Ehrlich, MD</p>
<p>Music Credit: Richard Onorato</p>
]]></content:encoded>
                                    
        <enclosure url="https://mcdn.podbean.com/mf/web/kibs3x/secure_primed_frankly-speaking-184-venus-thromboembolism-edited.mp3" length="18126150" type="audio/mpeg"/>
                <itunes:summary><![CDATA[Credits: 0.25 AMA PRA Category 1 Credits™
Claim CME/CE credit: https://www.pri-med.com/online-education/podcast/frankly-speaking-cme-184
Overview: For patients who have hip replacement or knee arthroplasty there is an increased risk of venous thromboembolism (VTE). This episode will review the effectiveness of aspirin for preventing VTE in this population.
Guest: Guest: Alan Ehrlich, MD
Music Credit: Richard Onorato]]></itunes:summary>
        <itunes:author>Pri-Med</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>566</itunes:duration>
        <itunes:season>1</itunes:season>
        <itunes:episode>1</itunes:episode>
        <itunes:episodeType>full</itunes:episodeType>
        <itunes:image href="https://pbcdn1.podbean.com/imglogo/ep-logo/pbblog13721080/95fc6ef2d5800b7100a49ae4e176293c.png" />    </item>
    <item>
        <title>Counseling About Healthy Lifestyles: Time to Simplify - Frankly Speaking EP 183</title>
        <itunes:title>Counseling About Healthy Lifestyles: Time to Simplify - Frankly Speaking EP 183</itunes:title>
        <link>https://primedfranklyspeaking.podbean.com/e/counseling-about-healthy-lifestyles-time-to-simplify-frankly-speaking-ep-183/</link>
                    <comments>https://primedfranklyspeaking.podbean.com/e/counseling-about-healthy-lifestyles-time-to-simplify-frankly-speaking-ep-183/#comments</comments>        <pubDate>Mon, 03 Aug 2020 04:30:00 +0000</pubDate>
        <guid isPermaLink="false">598ca895-a368-42dd-9cb6-e17123670feb</guid>
                                    <description><![CDATA[<p>Credits: 0.25 AMA PRA Category 1 Credit™</p>
 <p>Claim CME/CE Credit: <a href='https://www.pri-med.com/online-education/podcast/frankly-speaking-cme-183'>https://www.pri-med.com/online-education/podcast/frankly-speaking-cme-183</a></p>
 <p>Overview: While it is well established that selected lifestyle factors are individually associated with lower risk of chronic diseases, it has been unclear which combinations of these factors are associated with disease-free life-years. This session presents the result of a recent meta-analysis that provides insights into this important subject.</p>
 <p>Guest: Robert Baldor, MD, FAAFP</p>
 <p>Music Credit: Richard Onorato</p>
]]></description>
                                                            <content:encoded><![CDATA[<p>Credits: 0.25 <em>AMA PRA Category 1 Credit</em>™</p>
 <p>Claim CME/CE Credit: <a href='https://www.pri-med.com/online-education/podcast/frankly-speaking-cme-183'>https://www.pri-med.com/online-education/podcast/frankly-speaking-cme-183</a></p>
 <p>Overview: While it is well established that selected lifestyle factors are individually associated with lower risk of chronic diseases, it has been unclear which combinations of these factors are associated with disease-free life-years. This session presents the result of a recent meta-analysis that provides insights into this important subject.</p>
 <p>Guest: Robert Baldor, MD, FAAFP</p>
 <p>Music Credit: Richard Onorato</p>
]]></content:encoded>
                                    
        <enclosure url="https://mcdn.podbean.com/mf/web/0g91aj/secure_primed_frankly-speaking-183-healthy-life-vitality.mp3" length="19609627" type="audio/mpeg"/>
                <itunes:summary><![CDATA[Credits: 0.25 AMA PRA Category 1 Credit™ Claim CME/CE Credit: https://www.pri-med.com/online-education/podcast/frankly-speaking-cme-183 Overview: While it is well established that selected lifestyle factors are individually associated with lower risk of chronic diseases, it has been unclear which combinations of these factors are associated with disease-free life-years. This session presents the result of a recent meta-analysis that provides insights into this important subject. Guest: Robert Baldor, MD, FAAFP Music Credit: Richard Onorato]]></itunes:summary>
        <itunes:author>Pri-Med</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>613</itunes:duration>
                                <itunes:image href="https://pbcdn1.podbean.com/imglogo/ep-logo/pbblog13721080/a8b4c62cc1cdcfb49d64f1e445a8a52a.png" />    </item>
    <item>
        <title>Testosterone for Low ‘T’? - Frankly Speaking Episode 182</title>
        <itunes:title>Testosterone for Low ‘T’? - Frankly Speaking Episode 182</itunes:title>
        <link>https://primedfranklyspeaking.podbean.com/e/testosterone-for-low-t-frankly-speaking-episode-182/</link>
                    <comments>https://primedfranklyspeaking.podbean.com/e/testosterone-for-low-t-frankly-speaking-episode-182/#comments</comments>        <pubDate>Mon, 27 Jul 2020 04:30:00 +0000</pubDate>
        <guid isPermaLink="false">fc91fdeb-8dea-452a-a04c-b8992478dd9e</guid>
                                    <description><![CDATA[<p>Credits: 0.25 AMA PRA Category 1 Credit™</p>
<p>Claim CME/CE Credit: <a href='https://www.pri-med.com/online-education/podcast/frankly-speaking-cme-182'>https://www.pri-med.com/online-education/podcast/frankly-speaking-cme-182</a></p>
<p>Overview: About 20% of men older than 60 experience low testosterone; however, the prevalence of low testosterone with sexual dysfunction symptoms is significantly lower. Although there is an association between advancing age, testosterone levels, and other quality of life factors, the exact causal relationship remains challenging. This latest guideline from the American College of Physicians (ACP) examines the evidence regarding testosterone replacement recommendations.</p>
<p>Guest: Robert Baldor, MD, FAAFP</p>
<p>Music Credit: Richard Onorato</p>
]]></description>
                                                            <content:encoded><![CDATA[<p>Credits: 0.25 <em>AMA PRA Category 1 Credit</em>™</p>
<p>Claim CME/CE Credit: <a href='https://www.pri-med.com/online-education/podcast/frankly-speaking-cme-182'>https://www.pri-med.com/online-education/podcast/frankly-speaking-cme-182</a></p>
<p>Overview: About 20% of men older than 60 experience low testosterone; however, the prevalence of low testosterone with sexual dysfunction symptoms is significantly lower. Although there is an association between advancing age, testosterone levels, and other quality of life factors, the exact causal relationship remains challenging. This latest guideline from the American College of Physicians (ACP) examines the evidence regarding testosterone replacement recommendations.</p>
<p>Guest: Robert Baldor, MD, FAAFP</p>
<p>Music Credit: Richard Onorato</p>
]]></content:encoded>
                                    
        <enclosure url="https://mcdn.podbean.com/mf/web/l2z238/secure_primed_frankly-speaking-182-testosterone-edited.mp3" length="24055931" type="audio/mpeg"/>
                <itunes:summary><![CDATA[Credits: 0.25 AMA PRA Category 1 Credit™
Claim CME/CE Credit: https://www.pri-med.com/online-education/podcast/frankly-speaking-cme-182
Overview: About 20% of men older than 60 experience low testosterone; however, the prevalence of low testosterone with sexual dysfunction symptoms is significantly lower. Although there is an association between advancing age, testosterone levels, and other quality of life factors, the exact causal relationship remains challenging. This latest guideline from the American College of Physicians (ACP) examines the evidence regarding testosterone replacement recommendations.
Guest: Robert Baldor, MD, FAAFP
Music Credit: Richard Onorato]]></itunes:summary>
        <itunes:author>Pri-Med</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>751</itunes:duration>
        <itunes:season>1</itunes:season>
        <itunes:episode>1</itunes:episode>
        <itunes:episodeType>full</itunes:episodeType>
        <itunes:image href="https://pbcdn1.podbean.com/imglogo/ep-logo/pbblog13721080/6548d740d9279b186e9ab12b7e1621df.png" />    </item>
    <item>
        <title>Weighted Vests Reduce Weight - Frankly Speaking EP 181</title>
        <itunes:title>Weighted Vests Reduce Weight - Frankly Speaking EP 181</itunes:title>
        <link>https://primedfranklyspeaking.podbean.com/e/weighted-vests-reduce-weight-frankly-speaking-ep-181/</link>
                    <comments>https://primedfranklyspeaking.podbean.com/e/weighted-vests-reduce-weight-frankly-speaking-ep-181/#comments</comments>        <pubDate>Mon, 20 Jul 2020 04:30:00 +0000</pubDate>
        <guid isPermaLink="false">16abec9a-b90e-497c-ae80-5eac7d61d84c</guid>
                                    <description><![CDATA[<p>Credits: 0.25 AMA PRA Category 1 Credit™</p>
<p>Claim CME/CE Credit: <a href='https://www.pri-med.com/online-education/podcast/frankly-speaking-cme-181'>https://www.pri-med.com/online-education/podcast/frankly-speaking-cme-181</a></p>
<p>Overview: This podcast reviews a recent study evaluating the benefit of adding a weighted vest to dietary interventions to promote weight loss and discusses its implications for clinical practice. </p>
<p>Guest: Alan Ehrlich, MD</p>
<p>Music Credit: Richard Onorato</p>
]]></description>
                                                            <content:encoded><![CDATA[<p>Credits: 0.25 <em>AMA PRA Category 1 Credit</em>™</p>
<p>Claim CME/CE Credit: <a href='https://www.pri-med.com/online-education/podcast/frankly-speaking-cme-181'>https://www.pri-med.com/online-education/podcast/frankly-speaking-cme-181</a></p>
<p>Overview: This podcast reviews a recent study evaluating the benefit of adding a weighted vest to dietary interventions to promote weight loss and discusses its implications for clinical practice. </p>
<p>Guest: Alan Ehrlich, MD</p>
<p>Music Credit: Richard Onorato</p>
]]></content:encoded>
                                    
        <enclosure url="https://mcdn.podbean.com/mf/web/jhlq2o/secure_primed_frankly-speaking-181-vests-edited.mp3" length="23850958" type="audio/mpeg"/>
                <itunes:summary><![CDATA[Credits: 0.25 AMA PRA Category 1 Credit™
Claim CME/CE Credit: https://www.pri-med.com/online-education/podcast/frankly-speaking-cme-181
Overview: This podcast reviews a recent study evaluating the benefit of adding a weighted vest to dietary interventions to promote weight loss and discusses its implications for clinical practice. 
Guest: Alan Ehrlich, MD
Music Credit: Richard Onorato]]></itunes:summary>
        <itunes:author>Pri-Med</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>596</itunes:duration>
        <itunes:season>1</itunes:season>
        <itunes:episode>1</itunes:episode>
        <itunes:episodeType>full</itunes:episodeType>
        <itunes:image href="https://pbcdn1.podbean.com/imglogo/ep-logo/pbblog13721080/8a46d72393f916c9a837ec5a04b3d777.png" />    </item>
    <item>
        <title>Gout - An Updated Treatment Guideline from the American College of Rheumatology - Frankly Speaking EP 180</title>
        <itunes:title>Gout - An Updated Treatment Guideline from the American College of Rheumatology - Frankly Speaking EP 180</itunes:title>
        <link>https://primedfranklyspeaking.podbean.com/e/gout-an-updated-treatment-guideline-from-the-american-college-of-rheumatology-frankly-speaking-ep-180/</link>
                    <comments>https://primedfranklyspeaking.podbean.com/e/gout-an-updated-treatment-guideline-from-the-american-college-of-rheumatology-frankly-speaking-ep-180/#comments</comments>        <pubDate>Mon, 13 Jul 2020 04:30:00 +0000</pubDate>
        <guid isPermaLink="false">1e7f9605-2057-4ae1-8ea6-4e93189cb800</guid>
                                    <description><![CDATA[<p>Credits: 0.25 AMA PRA Category 1 Credits™</p>
 <p>Claim CME/CE credit: <a href='https://www.pri-med.com/online-education/podcast/frankly-speaking-cme-180'> https://www.pri-med.com/online-education/podcast/frankly-speaking-cme-180</a></p>
 <p>Overview: The American College of Rheumatology (ACR) updated their 2012 guidelines for treating gout. To do this, they used established evidenced-based methods including population, intervention, comparator, outcomes (PICO) questions. </p>
 <p>Guest: Guest: Robert A. Baldor, MD, FAAFP</p>
 <p>Music Credit: Richard Onorato</p>
]]></description>
                                                            <content:encoded><![CDATA[<p>Credits: <em>0.25 AMA PRA Category 1 Credits</em>™</p>
 <p>Claim CME/CE credit: <a href='https://www.pri-med.com/online-education/podcast/frankly-speaking-cme-180'> https://www.pri-med.com/online-education/podcast/frankly-speaking-cme-180</a></p>
 <p>Overview: The American College of Rheumatology (ACR) updated their 2012 guidelines for treating gout. To do this, they used established evidenced-based methods including population, intervention, comparator, outcomes (PICO) questions. </p>
 <p>Guest: Guest: Robert A. Baldor, MD, FAAFP</p>
 <p>Music Credit: Richard Onorato</p>
]]></content:encoded>
                                    
        <enclosure url="https://mcdn.podbean.com/mf/web/2afobv/secure_primed_180-gout-finished.mp3" length="30246826" type="audio/mpeg"/>
                <itunes:summary><![CDATA[Credits: 0.25 AMA PRA Category 1 Credits™ Claim CME/CE credit:  https://www.pri-med.com/online-education/podcast/frankly-speaking-cme-180 Overview: The American College of Rheumatology (ACR) updated their 2012 guidelines for treating gout. To do this, they used established evidenced-based methods including population, intervention, comparator, outcomes (PICO) questions.  Guest: Guest: Robert A. Baldor, MD, FAAFP Music Credit: Richard Onorato]]></itunes:summary>
        <itunes:author>Pri-Med</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>756</itunes:duration>
                                <itunes:image href="https://pbcdn1.podbean.com/imglogo/ep-logo/pbblog13721080/74017a1b1cd765e03ccaa27feeae9afd.png" />    </item>
    <item>
        <title>For Osteoarthritis of the Knee, What’s the Point of Injecting Steroids? - Frankly Speaking EP 179</title>
        <itunes:title>For Osteoarthritis of the Knee, What’s the Point of Injecting Steroids? - Frankly Speaking EP 179</itunes:title>
        <link>https://primedfranklyspeaking.podbean.com/e/for-osteoarthritis-of-the-knee-what-s-the-point-of-injecting-steroids-frankly-speaking-ep-179/</link>
                    <comments>https://primedfranklyspeaking.podbean.com/e/for-osteoarthritis-of-the-knee-what-s-the-point-of-injecting-steroids-frankly-speaking-ep-179/#comments</comments>        <pubDate>Mon, 29 Jun 2020 04:30:00 +0000</pubDate>
        <guid isPermaLink="false">1c9b0167-58b8-4a5b-9106-15d752258d73</guid>
                                    <description><![CDATA[<p>Credits: 0.25 AMA PRA Category 1 Credits™</p>
 <p>Claim CME/CE credit: <a href='https://www.pri-med.com/online-education/podcast/frankly-speaking-cme-179'> https://www.pri-med.com/online-education/podcast/frankly-speaking-cme-179</a></p>
 <p>Overview: The comparative efficacy of corticosteroid and physical therapy for managing osteoarthritis of the knee is controversial. This podcast will review a recent randomized trial comparing the efficacy of the 2 treatments in 156 patients who were followed for 1 year.</p>
 <p>Guest: Guest: Alan Ehrlich, MD</p>
 <p>Music Credit: Richard Onorato</p>
]]></description>
                                                            <content:encoded><![CDATA[<p>Credits: <em>0.25 AMA PRA Category 1 Credits</em>™</p>
 <p>Claim CME/CE credit: <a href='https://www.pri-med.com/online-education/podcast/frankly-speaking-cme-179'> https://www.pri-med.com/online-education/podcast/frankly-speaking-cme-179</a></p>
 <p>Overview: The comparative efficacy of corticosteroid and physical therapy for managing osteoarthritis of the knee is controversial. This podcast will review a recent randomized trial comparing the efficacy of the 2 treatments in 156 patients who were followed for 1 year.</p>
 <p>Guest: Guest: Alan Ehrlich, MD</p>
 <p>Music Credit: Richard Onorato</p>
]]></content:encoded>
                                    
        <enclosure url="https://mcdn.podbean.com/mf/web/rlx1xh/secure_primed_179-osteoarth-finished.mp3" length="22999017" type="audio/mpeg"/>
                <itunes:summary><![CDATA[Credits: 0.25 AMA PRA Category 1 Credits™ Claim CME/CE credit:  https://www.pri-med.com/online-education/podcast/frankly-speaking-cme-179 Overview: The comparative efficacy of corticosteroid and physical therapy for managing osteoarthritis of the knee is controversial. This podcast will review a recent randomized trial comparing the efficacy of the 2 treatments in 156 patients who were followed for 1 year. Guest: Guest: Alan Ehrlich, MD Music Credit: Richard Onorato]]></itunes:summary>
        <itunes:author>Pri-Med</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>575</itunes:duration>
                                <itunes:image href="https://pbcdn1.podbean.com/imglogo/ep-logo/pbblog13721080/7aa3607198159c3b852a77f88461421a.png" />    </item>
    <item>
        <title>An Epidemic That Nobody is Talking About - Frankly Speaking EP 178</title>
        <itunes:title>An Epidemic That Nobody is Talking About - Frankly Speaking EP 178</itunes:title>
        <link>https://primedfranklyspeaking.podbean.com/e/an-epidemic-that-nobody-is-talking-about-frankly-speaking-ep-178/</link>
                    <comments>https://primedfranklyspeaking.podbean.com/e/an-epidemic-that-nobody-is-talking-about-frankly-speaking-ep-178/#comments</comments>        <pubDate>Mon, 22 Jun 2020 04:30:00 +0000</pubDate>
        <guid isPermaLink="false">ccfcddf5-a77a-41eb-bccd-e668f92571e1</guid>
                                    <description><![CDATA[<p>Credits: 0.25 AMA PRA Category 1 Credits™</p>
 <p>Claim CME/CE credit: <a href='https://www.pri-med.com/online-education/podcast/frankly-speaking-cme-178'> https://www.pri-med.com/online-education/podcast/frankly-speaking-cme-178</a></p>
 <p>Overview: As men age, over-active bladder (OAB) symptoms (urgency, frequency, nocturia) are commonly seen. Typically, these symptoms are secondary to the development of benign prostate hypertrophy (BPH). Alpha-blocking and/or antimuscarinic agents are commonly prescribed to treat such symptoms. In this podcast we review the COBALT study which examines the benefits of behavioral treatments (pelvic floor muscle training and fluid restriction before bedtime) alone or combined with drug therapy to treat OAB symptoms.</p>
 <p>Guest: Robert A. Baldor, MD, FAAFP</p>
 <p>Music Credit: Richard Onorato</p>
]]></description>
                                                            <content:encoded><![CDATA[<p>Credits: 0.25 <em>AMA PRA Category 1 Credits</em>™</p>
 <p>Claim CME/CE credit: <a href='https://www.pri-med.com/online-education/podcast/frankly-speaking-cme-178'> https://www.pri-med.com/online-education/podcast/frankly-speaking-cme-178</a></p>
 <p>Overview: As men age, over-active bladder (OAB) symptoms (urgency, frequency, nocturia) are commonly seen. Typically, these symptoms are secondary to the development of benign prostate hypertrophy (BPH). Alpha-blocking and/or antimuscarinic agents are commonly prescribed to treat such symptoms. In this podcast we review the COBALT study which examines the benefits of behavioral treatments (pelvic floor muscle training and fluid restriction before bedtime) alone or combined with drug therapy to treat OAB symptoms.</p>
 <p>Guest: Robert A. Baldor, MD, FAAFP</p>
 <p>Music Credit: Richard Onorato</p>
]]></content:encoded>
                                    
        <enclosure url="https://mcdn.podbean.com/mf/web/fpo65v/secure_primed_178-polypharmacy-finished.mp3" length="21284819" type="audio/mpeg"/>
                <itunes:summary><![CDATA[Credits: 0.25 AMA PRA Category 1 Credits™ Claim CME/CE credit:  https://www.pri-med.com/online-education/podcast/frankly-speaking-cme-178 Overview: As men age, over-active bladder (OAB) symptoms (urgency, frequency, nocturia) are commonly seen. Typically, these symptoms are secondary to the development of benign prostate hypertrophy (BPH). Alpha-blocking and/or antimuscarinic agents are commonly prescribed to treat such symptoms. In this podcast we review the COBALT study which examines the benefits of behavioral treatments (pelvic floor muscle training and fluid restriction before bedtime) alone or combined with drug therapy to treat OAB symptoms. Guest: Robert A. Baldor, MD, FAAFP Music Credit: Richard Onorato]]></itunes:summary>
        <itunes:author>Pri-Med</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>532</itunes:duration>
                                <itunes:image href="https://pbcdn1.podbean.com/imglogo/ep-logo/pbblog13721080/b93ba5ac0cfdb0b99a4c5e16b511936a.png" />    </item>
    <item>
        <title>Concussion Risk and Prevention Among High School Student Athletes - Frankly Speaking EP 177</title>
        <itunes:title>Concussion Risk and Prevention Among High School Student Athletes - Frankly Speaking EP 177</itunes:title>
        <link>https://primedfranklyspeaking.podbean.com/e/concussion-risk-and-prevention-among-high-school-student-athletes-frankly-speaking-ep-177/</link>
                    <comments>https://primedfranklyspeaking.podbean.com/e/concussion-risk-and-prevention-among-high-school-student-athletes-frankly-speaking-ep-177/#comments</comments>        <pubDate>Mon, 15 Jun 2020 04:30:00 +0000</pubDate>
        <guid isPermaLink="false">674d8da4-85d7-4ba5-8d75-eb4b67ee80d5</guid>
                                    <description><![CDATA[<p>Credits: 0.25 AMA PRA Category 1 Credits™</p>
 <p>Claim CME/CE credit: <a href='https://www.pri-med.com/online-education/podcast/frankly-speaking-cme-177'> https://www.pri-med.com/online-education/podcast/frankly-speaking-cme-177</a></p>
 <p>Overview: This session will discuss the latest evidence on concussion occurrence among high school athletes and review return-to play-guidelines and laws. It will also provide a nuanced and realistic discussion of concussion prevention.</p>
 <p>Guest: Guest: Hillary Mullan</p>
 <p>Music Credit: Richard Onorato</p>
]]></description>
                                                            <content:encoded><![CDATA[<p>Credits: 0.25 <em>AMA PRA Category 1 Credits</em>™</p>
 <p>Claim CME/CE credit: <a href='https://www.pri-med.com/online-education/podcast/frankly-speaking-cme-177'> https://www.pri-med.com/online-education/podcast/frankly-speaking-cme-177</a></p>
 <p>Overview: This session will discuss the latest evidence on concussion occurrence among high school athletes and review return-to play-guidelines and laws. It will also provide a nuanced and realistic discussion of concussion prevention.</p>
 <p>Guest: Guest: Hillary Mullan</p>
 <p>Music Credit: Richard Onorato</p>
]]></content:encoded>
                                    
        <enclosure url="https://mcdn.podbean.com/mf/web/9l565g/secure_primed_177-concussion-finished.mp3" length="17289753" type="audio/mpeg"/>
                <itunes:summary><![CDATA[Credits: 0.25 AMA PRA Category 1 Credits™ Claim CME/CE credit:  https://www.pri-med.com/online-education/podcast/frankly-speaking-cme-177 Overview: This session will discuss the latest evidence on concussion occurrence among high school athletes and review return-to play-guidelines and laws. It will also provide a nuanced and realistic discussion of concussion prevention. Guest: Guest: Hillary Mullan Music Credit: Richard Onorato]]></itunes:summary>
        <itunes:author>Pri-Med</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>432</itunes:duration>
                                <itunes:image href="https://pbcdn1.podbean.com/imglogo/ep-logo/pbblog13721080/2d6c93d10e4724e2438c7e390fdcd4ce.png" />    </item>
    <item>
        <title>Getting to Remission—Not Just Better: Can a Web-Based CBT Tool Help Resolve Residual Depressive Symptoms in People Treated for Depression? - Frankly S...</title>
        <itunes:title>Getting to Remission—Not Just Better: Can a Web-Based CBT Tool Help Resolve Residual Depressive Symptoms in People Treated for Depression? - Frankly S...</itunes:title>
        <link>https://primedfranklyspeaking.podbean.com/e/getting-toremission%e2%80%94notjustbetter-can-a-web-based-cbt-tool-help-resolveresidualdepressivesymptomsin-peopletreated-for-depressionfrankly-s/</link>
                    <comments>https://primedfranklyspeaking.podbean.com/e/getting-toremission%e2%80%94notjustbetter-can-a-web-based-cbt-tool-help-resolveresidualdepressivesymptomsin-peopletreated-for-depressionfrankly-s/#comments</comments>        <pubDate>Mon, 08 Jun 2020 04:30:00 +0000</pubDate>
        <guid isPermaLink="false">b9878abf-3840-4f7e-b8dd-99ca9008dd45</guid>
                                    <description><![CDATA[<p>Credits: 0.25 AMA PRA Category 1 Credits™</p>
 <p>Claim CME/CE credit: <a href='https://www.pri-med.com/online-education/podcast/frankly-speaking-cme-176'> https://www.pri-med.com/online-education/podcast/frankly-speaking-cme-176</a></p>
 <p>Overview: Achieving a euthymic state can be very challenging for individuals with depression and anxiety. Many people live with residual symptoms even while on anti-depressive medications. Changing pharmacotherapy, escalating doses, and adding medications are common. Join us while we discuss the results of a recent RCT of primary care patients, which demonstrated improved resolution of residual depressive symptoms for those who used a web-based CBT tool as adjunctive therapy.</p>
 <p>Guest: Guest: Susan Feeney, DNP, FNP-BC</p>
 <p>Music Credit: Richard Onorato</p>
]]></description>
                                                            <content:encoded><![CDATA[<p>Credits: <em>0.25 AMA PRA Category 1 Credits</em>™</p>
 <p>Claim CME/CE credit: <a href='https://www.pri-med.com/online-education/podcast/frankly-speaking-cme-176'> https://www.pri-med.com/online-education/podcast/frankly-speaking-cme-176</a></p>
 <p>Overview: Achieving a euthymic state can be very challenging for individuals with depression and anxiety. Many people live with residual symptoms even while on anti-depressive medications. Changing pharmacotherapy, escalating doses, and adding medications are common. Join us while we discuss the results of a recent RCT of primary care patients, which demonstrated improved resolution of residual depressive symptoms for those who used a web-based CBT tool as adjunctive therapy.</p>
 <p>Guest: Guest: Susan Feeney, DNP, FNP-BC</p>
 <p>Music Credit: Richard Onorato</p>
]]></content:encoded>
                                    
        <enclosure url="https://mcdn.podbean.com/mf/web/c9jgjx/secure_primed_176-remission-finished.mp3" length="25996342" type="audio/mpeg"/>
                <itunes:summary><![CDATA[Credits: 0.25 AMA PRA Category 1 Credits™ Claim CME/CE credit:  https://www.pri-med.com/online-education/podcast/frankly-speaking-cme-176 Overview: Achieving a euthymic state can be very challenging for individuals with depression and anxiety. Many people live with residual symptoms even while on anti-depressive medications. Changing pharmacotherapy, escalating doses, and adding medications are common. Join us while we discuss the results of a recent RCT of primary care patients, which demonstrated improved resolution of residual depressive symptoms for those who used a web-based CBT tool as adjunctive therapy. Guest: Guest: Susan Feeney, DNP, FNP-BC Music Credit: Richard Onorato]]></itunes:summary>
        <itunes:author>Pri-Med</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>649</itunes:duration>
                                <itunes:image href="https://pbcdn1.podbean.com/imglogo/ep-logo/pbblog13721080/810a8e48dc82599f04eeb132bebf3890.png" />    </item>
    <item>
        <title>Pap Smears and Bimanual Exams: Do Teens Really Need Them? - Frankly Speaking EP 175</title>
        <itunes:title>Pap Smears and Bimanual Exams: Do Teens Really Need Them? - Frankly Speaking EP 175</itunes:title>
        <link>https://primedfranklyspeaking.podbean.com/e/pap-smears-and-bimanual-exams-do-teens-really-need-them-frankly-speaking-ep-175/</link>
                    <comments>https://primedfranklyspeaking.podbean.com/e/pap-smears-and-bimanual-exams-do-teens-really-need-them-frankly-speaking-ep-175/#comments</comments>        <pubDate>Mon, 01 Jun 2020 04:30:00 +0000</pubDate>
        <guid isPermaLink="false">11596f96-5dc1-46cd-8ee4-25f19e6f900d</guid>
                                    <description><![CDATA[<p>Credits: 0.25 AMA PRA Category 1 Credits™</p>
 <p>Claim CME/CE credit: <a href='https://www.pri-med.com/online-education/podcast/frankly-speaking-cme-175'> https://www.pri-med.com/online-education/podcast/frankly-speaking-cme-175</a> </p>
 <p>Overview: Clinical practice guidelines from the American College of Obstetrics and Gynecology and the United States Preventive Services Task Force recommend against routine Pap smears and bimanual exams in adolescents. This recommendation includes those planning on starting oral contraceptives or with possible sexually transmitted diseases. A recent study found nearly half of all such exams in this age group lack indications. While the evidence indicates a new direction, clinicians have been slow to change their practice. Join us as we discuss the reasons for these guidelines and review appropriate indications for these exams. </p>
 <p>Guest: Alan Ehrlich MD, FAAFP</p>
 <p>Music Credit: Richard Onorato</p>
]]></description>
                                                            <content:encoded><![CDATA[<p>Credits: 0.25 <em>AMA PRA Category 1 Credits</em>™</p>
 <p>Claim CME/CE credit: <a href='https://www.pri-med.com/online-education/podcast/frankly-speaking-cme-175'> https://www.pri-med.com/online-education/podcast/frankly-speaking-cme-175</a> </p>
 <p>Overview: Clinical practice guidelines from the American College of Obstetrics and Gynecology and the United States Preventive Services Task Force recommend against routine Pap smears and bimanual exams in adolescents. This recommendation includes those planning on starting oral contraceptives or with possible sexually transmitted diseases. A recent study found nearly half of all such exams in this age group lack indications. While the evidence indicates a new direction, clinicians have been slow to change their practice. Join us as we discuss the reasons for these guidelines and review appropriate indications for these exams. </p>
 <p>Guest: Alan Ehrlich MD, FAAFP</p>
 <p>Music Credit: Richard Onorato</p>
]]></content:encoded>
                                    
        <enclosure url="https://mcdn.podbean.com/mf/web/d1uw4d/secure_primed_175-pap-finished.mp3" length="19411838" type="audio/mpeg"/>
                <itunes:summary><![CDATA[Credits: 0.25 AMA PRA Category 1 Credits™ Claim CME/CE credit:  https://www.pri-med.com/online-education/podcast/frankly-speaking-cme-175  Overview: Clinical practice guidelines from the American College of Obstetrics and Gynecology and the United States Preventive Services Task Force recommend against routine Pap smears and bimanual exams in adolescents. This recommendation includes those planning on starting oral contraceptives or with possible sexually transmitted diseases. A recent study found nearly half of all such exams in this age group lack indications. While the evidence indicates a new direction, clinicians have been slow to change their practice. Join us as we discuss the reasons for these guidelines and review appropriate indications for these exams.  Guest: Alan Ehrlich MD, FAAFP Music Credit: Richard Onorato]]></itunes:summary>
        <itunes:author>Pri-Med</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>485</itunes:duration>
                                <itunes:image href="https://pbcdn1.podbean.com/imglogo/ep-logo/pbblog13721080/19bb52b74adad028c613c6fca530c76f.png" />    </item>
    <item>
        <title>Frankly Speaking Update: COVID-19 and Special Populations (Recorded 5/22/20)</title>
        <itunes:title>Frankly Speaking Update: COVID-19 and Special Populations (Recorded 5/22/20)</itunes:title>
        <link>https://primedfranklyspeaking.podbean.com/e/frankly-speaking-update-covid-19-and-special-populations-recorded-52220/</link>
                    <comments>https://primedfranklyspeaking.podbean.com/e/frankly-speaking-update-covid-19-and-special-populations-recorded-52220/#comments</comments>        <pubDate>Wed, 27 May 2020 14:54:00 +0000</pubDate>
        <guid isPermaLink="false">64b0b62d-8b9b-4809-bfc2-9f3dada10b01</guid>
                                    <description><![CDATA[<p>Credits: 0.25 AMA PRA Category 1 Credits™</p>
 <p>Claim CME/CE credit: <a href='https://www.pri-med.com/online-education/podcast/frankly-speaking-cme-covid-19-5-27'> https://www.pri-med.com/online-education/podcast/frankly-speaking-cme-covid-19-5-27</a> </p>
 <p>Overview: Listen to this Q&A session about special topics on COVID-19 infection, including COVID in pregnancy and pediatric patients  </p>
 <p>Guest: Guest: Alan Ehrlich, MD</p>
 <p>Music Credit: Richard Onorato</p>
]]></description>
                                                            <content:encoded><![CDATA[<p>Credits: 0.25 <em>AMA PRA Category 1 Credit</em>s™</p>
 <p>Claim CME/CE credit: <a href='https://www.pri-med.com/online-education/podcast/frankly-speaking-cme-covid-19-5-27'> https://www.pri-med.com/online-education/podcast/frankly-speaking-cme-covid-19-5-27</a> </p>
 <p>Overview: Listen to this Q&A session about special topics on COVID-19 infection, including COVID in pregnancy and pediatric patients  </p>
 <p>Guest: Guest: Alan Ehrlich, MD</p>
 <p>Music Credit: Richard Onorato</p>
]]></content:encoded>
                                    
        <enclosure url="https://mcdn.podbean.com/mf/web/9ajgb0/secure_primed_Frankly-Speaking-Speacial-Update-5-27.mp3" length="41430150" type="audio/mpeg"/>
                <itunes:summary><![CDATA[Credits: 0.25 AMA PRA Category 1 Credits™ Claim CME/CE credit:  https://www.pri-med.com/online-education/podcast/frankly-speaking-cme-covid-19-5-27  Overview: Listen to this Q&A session about special topics on COVID-19 infection, including COVID in pregnancy and pediatric patients   Guest: Guest: Alan Ehrlich, MD Music Credit: Richard Onorato]]></itunes:summary>
        <itunes:author>Pri-Med</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>1036</itunes:duration>
                                <itunes:image href="https://pbcdn1.podbean.com/imglogo/ep-logo/pbblog13721080/534f04ce774aad0e764da9d959f8c2cc.png" />    </item>
    <item>
        <title>What Happened to My Furosemide?  Torsemide for Congestive Heart Failure - Frankly Speaking EP 174</title>
        <itunes:title>What Happened to My Furosemide?  Torsemide for Congestive Heart Failure - Frankly Speaking EP 174</itunes:title>
        <link>https://primedfranklyspeaking.podbean.com/e/what-happened-to-my-furosemide-torsemide-for-congestive-heart-failure-frankly-speaking-ep-174/</link>
                    <comments>https://primedfranklyspeaking.podbean.com/e/what-happened-to-my-furosemide-torsemide-for-congestive-heart-failure-frankly-speaking-ep-174/#comments</comments>        <pubDate>Mon, 25 May 2020 04:30:00 +0000</pubDate>
        <guid isPermaLink="false">25636a0f-0c65-47b5-a3d7-e6bad8fb7bb7</guid>
                                    <description><![CDATA[<p>Credits: 0.25 AMA PRA Category 1 Credits™</p>
 <p>Claim CME/CE credit: <a href='https://www.pri-med.com/online-education/podcast/frankly-speaking-cme-174'> https://www.pri-med.com/online-education/podcast/frankly-speaking-cme-174</a></p>
 <p>Overview: In this episodes, we will discuss a systematic review and meta-analysis that examines outcomes from the use of furosemide compared to torsemide in patients with congestive heart failure.</p>
 <p>Guest: Guest: Jill Terrien PhD, ANP-BC</p>
 <p>Music Credit: Richard Onorato</p>
]]></description>
                                                            <content:encoded><![CDATA[<p>Credits: 0.25 <em>AMA PRA Category 1 Credits</em>™</p>
 <p>Claim CME/CE credit: <a href='https://www.pri-med.com/online-education/podcast/frankly-speaking-cme-174'> https://www.pri-med.com/online-education/podcast/frankly-speaking-cme-174</a></p>
 <p>Overview: In this episodes, we will discuss a systematic review and meta-analysis that examines outcomes from the use of furosemide compared to torsemide in patients with congestive heart failure.</p>
 <p>Guest: Guest: Jill Terrien PhD, ANP-BC</p>
 <p>Music Credit: Richard Onorato</p>
]]></content:encoded>
                                    
        <enclosure url="https://mcdn.podbean.com/mf/web/tobii5/secure_primed_174-heart_-_Copy.mp3" length="21983703" type="audio/mpeg"/>
                <itunes:summary><![CDATA[Credits: 0.25 AMA PRA Category 1 Credits™ Claim CME/CE credit:  https://www.pri-med.com/online-education/podcast/frankly-speaking-cme-174 Overview: In this episodes, we will discuss a systematic review and meta-analysis that examines outcomes from the use of furosemide compared to torsemide in patients with congestive heart failure. Guest: Guest: Jill Terrien PhD, ANP-BC Music Credit: Richard Onorato]]></itunes:summary>
        <itunes:author>Pri-Med</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>549</itunes:duration>
                                <itunes:image href="https://pbcdn1.podbean.com/imglogo/ep-logo/pbblog13721080/0b964c4336c8f786673a0b15470d7724.png" />    </item>
    <item>
        <title>The Prescribing Cascade: What Is It and How Do We Prevent It? - Frankly Speaking EP 173</title>
        <itunes:title>The Prescribing Cascade: What Is It and How Do We Prevent It? - Frankly Speaking EP 173</itunes:title>
        <link>https://primedfranklyspeaking.podbean.com/e/the-prescribing-cascade-what-is-it-and-how-do-we-prevent-it-frankly-speaking-ep-173/</link>
                    <comments>https://primedfranklyspeaking.podbean.com/e/the-prescribing-cascade-what-is-it-and-how-do-we-prevent-it-frankly-speaking-ep-173/#comments</comments>        <pubDate>Mon, 18 May 2020 04:30:00 +0000</pubDate>
        <guid isPermaLink="false">e83fe87b-d243-4607-93d7-1eb661153edf</guid>
                                    <description><![CDATA[<p>Credits: 0.25 AMA PRA Category 1 Credits™</p>
 <p>Claim CME/CE credit: <a href='https://www.pri-med.com/online-education/podcast/frankly-speaking-cme-173'> https://www.pri-med.com/online-education/podcast/frankly-speaking-cme-173</a></p>
 <p>Overview: In primary care we are tasked with treating multiple conditions, therefore many of our patients are on numerous medications. Some of these medications are prescribed to deal with side effects of other medications. Often clinicians may not be aware that they are treating preventable drug side effects and wind up prescribing even more medications. This causes a cascade effect that results in significant polypharmacy. Join us while we discuss this common phenomenon and strategies to minimize or avoid it entirely.</p>
 <p>Guest: Guest: Susan Feeney, DNP, FNP-BC</p>
 <p>Music Credit: Richard Onorato</p>
]]></description>
                                                            <content:encoded><![CDATA[<p>Credits: 0.25 <em>AMA PRA Category 1 Credits</em>™</p>
 <p>Claim CME/CE credit: <a href='https://www.pri-med.com/online-education/podcast/frankly-speaking-cme-173'> https://www.pri-med.com/online-education/podcast/frankly-speaking-cme-173</a></p>
 <p>Overview: In primary care we are tasked with treating multiple conditions, therefore many of our patients are on numerous medications. Some of these medications are prescribed to deal with side effects of other medications. Often clinicians may not be aware that they are treating preventable drug side effects and wind up prescribing even more medications. This causes a cascade effect that results in significant polypharmacy. Join us while we discuss this common phenomenon and strategies to minimize or avoid it entirely.</p>
 <p>Guest: Guest: Susan Feeney, DNP, FNP-BC</p>
 <p>Music Credit: Richard Onorato</p>
]]></content:encoded>
                                    
        <enclosure url="https://mcdn.podbean.com/mf/web/w35mqq/secure_primed_173-prescribing-finished_-_Copy.mp3" length="20163366" type="audio/mpeg"/>
                <itunes:summary><![CDATA[Credits: 0.25 AMA PRA Category 1 Credits™ Claim CME/CE credit:  https://www.pri-med.com/online-education/podcast/frankly-speaking-cme-173 Overview: In primary care we are tasked with treating multiple conditions, therefore many of our patients are on numerous medications. Some of these medications are prescribed to deal with side effects of other medications. Often clinicians may not be aware that they are treating preventable drug side effects and wind up prescribing even more medications. This causes a cascade effect that results in significant polypharmacy. Join us while we discuss this common phenomenon and strategies to minimize or avoid it entirely. Guest: Guest: Susan Feeney, DNP, FNP-BC Music Credit: Richard Onorato]]></itunes:summary>
        <itunes:author>Pri-Med</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>629</itunes:duration>
                                <itunes:image href="https://pbcdn1.podbean.com/imglogo/ep-logo/pbblog13721080/c569606a0862bbbb9234c3fcedbe62b0.png" />    </item>
    <item>
        <title>Kegels for Men? - Frankly Speaking EP 172</title>
        <itunes:title>Kegels for Men? - Frankly Speaking EP 172</itunes:title>
        <link>https://primedfranklyspeaking.podbean.com/e/kegels-for-men-frankly-speaking-ep-172/</link>
                    <comments>https://primedfranklyspeaking.podbean.com/e/kegels-for-men-frankly-speaking-ep-172/#comments</comments>        <pubDate>Mon, 11 May 2020 04:30:00 +0000</pubDate>
        <guid isPermaLink="false">d7e12ddb-8bb6-4889-9592-1ae915ad9c8c</guid>
                                    <description><![CDATA[<p>Credits: 0.25 AMA PRA Category 1 Credits™</p>
 <p>Claim CME/CE credit: <a href='https://www.pri-med.com/online-education/podcast/frankly-speaking-cme-172'> https://www.pri-med.com/online-education/podcast/frankly-speaking-cme-172</a></p>
 <p>Overview: As men age, over-active bladder (OAB) symptoms (urgency, frequency, nocturia) are commonly seen. Typically, these symptoms are secondary to the development of benign prostate hypertrophy (BPH). Alpha-blocking and/or antimuscarinic agents are commonly prescribed to treat such symptoms. In this podcast we review the COBALT study which examines the benefits of behavioral treatments (pelvic floor muscle training and fluid restriction before bedtime) alone or combined with drug therapy to treat OAB symptoms.</p>
 <p>Guest: Robert A. Baldor, MD, FAAFP</p>
 <p>Music Credit: Richard Onorato</p>
]]></description>
                                                            <content:encoded><![CDATA[<p>Credits: 0.25 <em>AMA PRA Category 1 Credits</em>™</p>
 <p>Claim CME/CE credit: <a href='https://www.pri-med.com/online-education/podcast/frankly-speaking-cme-172'> https://www.pri-med.com/online-education/podcast/frankly-speaking-cme-172</a></p>
 <p>Overview: As men age, over-active bladder (OAB) symptoms (urgency, frequency, nocturia) are commonly seen. Typically, these symptoms are secondary to the development of benign prostate hypertrophy (BPH). Alpha-blocking and/or antimuscarinic agents are commonly prescribed to treat such symptoms. In this podcast we review the COBALT study which examines the benefits of behavioral treatments (pelvic floor muscle training and fluid restriction before bedtime) alone or combined with drug therapy to treat OAB symptoms.</p>
 <p>Guest: Robert A. Baldor, MD, FAAFP</p>
 <p>Music Credit: Richard Onorato</p>
]]></content:encoded>
                                    
        <enclosure url="https://mcdn.podbean.com/mf/web/au6m4s/secure_primed_172-kegals-men.mp3" length="20294076" type="audio/mpeg"/>
                <itunes:summary><![CDATA[Credits: 0.25 AMA PRA Category 1 Credits™ Claim CME/CE credit:  https://www.pri-med.com/online-education/podcast/frankly-speaking-cme-172 Overview: As men age, over-active bladder (OAB) symptoms (urgency, frequency, nocturia) are commonly seen. Typically, these symptoms are secondary to the development of benign prostate hypertrophy (BPH). Alpha-blocking and/or antimuscarinic agents are commonly prescribed to treat such symptoms. In this podcast we review the COBALT study which examines the benefits of behavioral treatments (pelvic floor muscle training and fluid restriction before bedtime) alone or combined with drug therapy to treat OAB symptoms. Guest: Robert A. Baldor, MD, FAAFP Music Credit: Richard Onorato]]></itunes:summary>
        <itunes:author>Pri-Med</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>506</itunes:duration>
                                <itunes:image href="https://pbcdn1.podbean.com/imglogo/ep-logo/pbblog13721080/b50f319936d77703ef309e77205e1779.png" />    </item>
    <item>
        <title>Caution! Falling Seniors Ahead! - Frankly Speaking EP 171</title>
        <itunes:title>Caution! Falling Seniors Ahead! - Frankly Speaking EP 171</itunes:title>
        <link>https://primedfranklyspeaking.podbean.com/e/caution-falling-seniors-ahead-frankly-speaking-ep-171/</link>
                    <comments>https://primedfranklyspeaking.podbean.com/e/caution-falling-seniors-ahead-frankly-speaking-ep-171/#comments</comments>        <pubDate>Mon, 04 May 2020 04:30:00 +0000</pubDate>
        <guid isPermaLink="false">41fef85c-b775-4d69-afcf-7306f73907a2</guid>
                                    <description><![CDATA[<p>Credits: 0.25 AMA PRA Category 1 Credits™</p>
<p>Claim CME/CE credit: <a href='https://www.pri-med.com/online-education/podcast/frankly-speaking-cme-171-2'>https://www.pri-med.com/online-education/podcast/frankly-speaking-cme-171-2</a></p>
<p>Overview: Join us as we discuss falls: a clinical issue that warrants regular assessment in adults over the age of 65.</p>
<p>Guest: Guest: Jill Terrien PhD, ANP-BC</p>
<p>Music Credit: Richard Onorato</p>
]]></description>
                                                            <content:encoded><![CDATA[<p>Credits: 0.25 <em>AMA PRA Category 1 Credits</em>™</p>
<p>Claim CME/CE credit: <a href='https://www.pri-med.com/online-education/podcast/frankly-speaking-cme-171-2'>https://www.pri-med.com/online-education/podcast/frankly-speaking-cme-171-2</a></p>
<p>Overview: Join us as we discuss falls: a clinical issue that warrants regular assessment in adults over the age of 65.</p>
<p>Guest: Guest: Jill Terrien PhD, ANP-BC</p>
<p>Music Credit: Richard Onorato</p>
]]></content:encoded>
                                    
        <enclosure url="https://mcdn.podbean.com/mf/web/b53xer/secure_primed_171-elderly-and-falling.mp3" length="23261896" type="audio/mpeg"/>
                <itunes:summary><![CDATA[Credits: 0.25 AMA PRA Category 1 Credits™
Claim CME/CE credit: https://www.pri-med.com/online-education/podcast/frankly-speaking-cme-171-2
Overview: Join us as we discuss falls: a clinical issue that warrants regular assessment in adults over the age of 65.
Guest: Guest: Jill Terrien PhD, ANP-BC
Music Credit: Richard Onorato]]></itunes:summary>
        <itunes:author>Pri-Med</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>581</itunes:duration>
        <itunes:season>1</itunes:season>
        <itunes:episode>1</itunes:episode>
        <itunes:episodeType>full</itunes:episodeType>
        <itunes:image href="https://pbcdn1.podbean.com/imglogo/ep-logo/pbblog13721080/858e8db906f7044bb43d911aad21f682.png" />    </item>
    <item>
        <title>Corticosteroid Injection for Plantar Fasciitis: All Pain, No Gain - Frankly Speaking EP 170</title>
        <itunes:title>Corticosteroid Injection for Plantar Fasciitis: All Pain, No Gain - Frankly Speaking EP 170</itunes:title>
        <link>https://primedfranklyspeaking.podbean.com/e/corticosteroid-injection-for-plantar-fasciitis-all-pain-no-gain-frankly-speaking-ep-170/</link>
                    <comments>https://primedfranklyspeaking.podbean.com/e/corticosteroid-injection-for-plantar-fasciitis-all-pain-no-gain-frankly-speaking-ep-170/#comments</comments>        <pubDate>Mon, 27 Apr 2020 04:30:00 +0000</pubDate>
        <guid isPermaLink="false">8d0577a1-1605-4e2f-b23d-396c69369718</guid>
                                    <description><![CDATA[<p>Credits: 0.25 AMA PRA Category 1 Credits™</p>
 <p>Claim CME/CE credit: <a href='https://www.pri-med.com/online-education/podcast/frankly-speaking-cme-169'> https://www.pri-med.com/online-education/podcast/frankly-speaking-cme-170</a></p>
 <p>Overview: Plantar fasciitis is a common and often unsuccessfully treated chronic, painful condition. Multiple interventions have been suggested with varying degrees of effectiveness. Corticosteroid injections are sometimes used, but the evidence for efficacy has been limited with significant bias present in many of the trials. A Cochrane review in 2017 found a small degree of short-term benefit. Since then, a number of additional trials have been performed, and a newer systematic review finds no benefit.</p>
 <p>Guest: Alan Ehrlich MD, FAAFP</p>
 <p>Music Credit: Richard Onorato</p>
]]></description>
                                                            <content:encoded><![CDATA[<p>Credits: 0.25 <em>AMA PRA Category 1 Credits</em>™</p>
 <p>Claim CME/CE credit: <a href='https://www.pri-med.com/online-education/podcast/frankly-speaking-cme-169'> https://www.pri-med.com/online-education/podcast/frankly-speaking-cme-170</a></p>
 <p>Overview: Plantar fasciitis is a common and often unsuccessfully treated chronic, painful condition. Multiple interventions have been suggested with varying degrees of effectiveness. Corticosteroid injections are sometimes used, but the evidence for efficacy has been limited with significant bias present in many of the trials. A Cochrane review in 2017 found a small degree of short-term benefit. Since then, a number of additional trials have been performed, and a newer systematic review finds no benefit.</p>
 <p>Guest: Alan Ehrlich MD, FAAFP</p>
 <p>Music Credit: Richard Onorato</p>
]]></content:encoded>
                                    
        <enclosure url="https://mcdn.podbean.com/mf/web/bm8xu5/secure_primed_170-corticosteroids-finished.mp3" length="19873264" type="audio/mpeg"/>
                <itunes:summary><![CDATA[Credits: 0.25 AMA PRA Category 1 Credits™ Claim CME/CE credit:  https://www.pri-med.com/online-education/podcast/frankly-speaking-cme-170 Overview: Plantar fasciitis is a common and often unsuccessfully treated chronic, painful condition. Multiple interventions have been suggested with varying degrees of effectiveness. Corticosteroid injections are sometimes used, but the evidence for efficacy has been limited with significant bias present in many of the trials. A Cochrane review in 2017 found a small degree of short-term benefit. Since then, a number of additional trials have been performed, and a newer systematic review finds no benefit. Guest: Alan Ehrlich MD, FAAFP Music Credit: Richard Onorato]]></itunes:summary>
        <itunes:author>Pri-Med</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>496</itunes:duration>
                                <itunes:image href="https://pbcdn1.podbean.com/imglogo/ep-logo/pbblog13721080/259eac11057a24e26a9588b7243b6af3.png" />    </item>
    <item>
        <title>5 Tools to Improve the Patient Encounter - Frankly Speaking EP 169</title>
        <itunes:title>5 Tools to Improve the Patient Encounter - Frankly Speaking EP 169</itunes:title>
        <link>https://primedfranklyspeaking.podbean.com/e/5-tools-to-improve-the-patient-encounter-frankly-speaking-ep-169/</link>
                    <comments>https://primedfranklyspeaking.podbean.com/e/5-tools-to-improve-the-patient-encounter-frankly-speaking-ep-169/#comments</comments>        <pubDate>Mon, 20 Apr 2020 04:30:00 +0000</pubDate>
        <guid isPermaLink="false">eeebf418-d4eb-4df3-a7bc-ece8d7aa79a2</guid>
                                    <description><![CDATA[<p>Credits: 0.25 AMA PRA Category 1 Credits™</p>
 <p>Claim CME/CE credit: <a href='https://www.pri-med.com/online-education/podcast/frankly-speaking-cme-169'> https://www.pri-med.com/online-education/podcast/frankly-speaking-cme-169</a></p>
 <p>Overview: Many providers are dissatisfied with patient visits because of issues such as time limits and technology burden. Join us as we discuss 5 practices that could improve satisfaction with visits for both patients and providers.</p>
 <p>Guest: Guest: Jill Terrien PhD, ANP-BC</p>
 <p>Music Credit: Richard Onorato</p>
]]></description>
                                                            <content:encoded><![CDATA[<p>Credits: 0.25 <em>AMA PRA Category 1 Credits</em>™</p>
 <p>Claim CME/CE credit: <a href='https://www.pri-med.com/online-education/podcast/frankly-speaking-cme-169'> https://www.pri-med.com/online-education/podcast/frankly-speaking-cme-169</a></p>
 <p>Overview: Many providers are dissatisfied with patient visits because of issues such as time limits and technology burden. Join us as we discuss 5 practices that could improve satisfaction with visits for both patients and providers.</p>
 <p>Guest: Guest: Jill Terrien PhD, ANP-BC</p>
 <p>Music Credit: Richard Onorato</p>
]]></content:encoded>
                                    
        <enclosure url="https://mcdn.podbean.com/mf/web/x7zzda/secure_primed_169-patient-finished_-_Copy.mp3" length="18341797" type="audio/mpeg"/>
                <itunes:summary><![CDATA[Credits: 0.25 AMA PRA Category 1 Credits™ Claim CME/CE credit:  https://www.pri-med.com/online-education/podcast/frankly-speaking-cme-169 Overview: Many providers are dissatisfied with patient visits because of issues such as time limits and technology burden. Join us as we discuss 5 practices that could improve satisfaction with visits for both patients and providers. Guest: Guest: Jill Terrien PhD, ANP-BC Music Credit: Richard Onorato]]></itunes:summary>
        <itunes:author>Pri-Med</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>458</itunes:duration>
        <itunes:season>1</itunes:season>
        <itunes:episode>1</itunes:episode>
        <itunes:episodeType>full</itunes:episodeType>
        <itunes:image href="https://pbcdn1.podbean.com/imglogo/ep-logo/pbblog13721080/b5b3dfc7db75cb61f2be89de160ffb0a.png" />    </item>
    <item>
        <title>“Make it Stop!” – can a simple and quick intervention help improve quit rates in your patients who smoke? - Frankly Speaking EP 168</title>
        <itunes:title>“Make it Stop!” – can a simple and quick intervention help improve quit rates in your patients who smoke? - Frankly Speaking EP 168</itunes:title>
        <link>https://primedfranklyspeaking.podbean.com/e/make-it-stop-%e2%80%93-can-a-simple-and-quick-intervention-help-improve-quit-rates-in-your-patients-who-smoke-frankly-speaking-ep-168/</link>
                    <comments>https://primedfranklyspeaking.podbean.com/e/make-it-stop-%e2%80%93-can-a-simple-and-quick-intervention-help-improve-quit-rates-in-your-patients-who-smoke-frankly-speaking-ep-168/#comments</comments>        <pubDate>Mon, 13 Apr 2020 04:30:00 +0000</pubDate>
        <guid isPermaLink="false">40f7f533-d448-4f0b-9b2f-0ca7639fff00</guid>
                                    <description><![CDATA[<p>Credits: 0.25 AMA PRA Category 1 Credits™</p>
 <p>Claim CME/CE credit: <a href='https://www.pri-med.com/online-education/podcast/frankly-speaking-cme-168'> https://www.pri-med.com/online-education/podcast/frankly-speaking-cme-168</a></p>
 <p>Overview: A recent RCT from Hong Kong found that a brief 1-minute standardized intervention (based on the AWARD Model and self-determination theory) was more effective than giving printed smoking cessation materials to semi-urgent and non-urgent emergency department patients at smoking abstinence at 12 months. Join us as we discuss the implications of this study on your practice and care of individuals who smoke.</p>
 <p>Guest: Guest: Susan Feeney, DNP, FNP-BC</p>
 <p>Music Credit: Richard Onorato</p>
]]></description>
                                                            <content:encoded><![CDATA[<p>Credits: 0.25 <em>AMA PRA Category 1 Credits</em>™</p>
 <p>Claim CME/CE credit: <a href='https://www.pri-med.com/online-education/podcast/frankly-speaking-cme-168'> https://www.pri-med.com/online-education/podcast/frankly-speaking-cme-168</a></p>
 <p>Overview: A recent RCT from Hong Kong found that a brief 1-minute standardized intervention (based on the AWARD Model and self-determination theory) was more effective than giving printed smoking cessation materials to semi-urgent and non-urgent emergency department patients at smoking abstinence at 12 months. Join us as we discuss the implications of this study on your practice and care of individuals who smoke.</p>
 <p>Guest: Guest: Susan Feeney, DNP, FNP-BC</p>
 <p>Music Credit: Richard Onorato</p>
]]></content:encoded>
                                    
        <enclosure url="https://mcdn.podbean.com/mf/web/hd7hgi/secure_primed_168-smoking-finished.mp3" length="25377375" type="audio/mpeg"/>
                <itunes:summary><![CDATA[Credits: 0.25 AMA PRA Category 1 Credits™ Claim CME/CE credit:  https://www.pri-med.com/online-education/podcast/frankly-speaking-cme-168 Overview: A recent RCT from Hong Kong found that a brief 1-minute standardized intervention (based on the AWARD Model and self-determination theory) was more effective than giving printed smoking cessation materials to semi-urgent and non-urgent emergency department patients at smoking abstinence at 12 months. Join us as we discuss the implications of this study on your practice and care of individuals who smoke. Guest: Guest: Susan Feeney, DNP, FNP-BC Music Credit: Richard Onorato]]></itunes:summary>
        <itunes:author>Pri-Med</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>634</itunes:duration>
        <itunes:season>1</itunes:season>
        <itunes:episode>1</itunes:episode>
        <itunes:episodeType>full</itunes:episodeType>
        <itunes:image href="https://pbcdn1.podbean.com/imglogo/ep-logo/pbblog13721080/c8c8488205a8d35016a0fbd0a3bede4e.png" />    </item>
    <item>
        <title>”B” is for Back Pain: How Vitamins May Benefit Acute Low Back Pain - Frankly Speaking EP 167</title>
        <itunes:title>”B” is for Back Pain: How Vitamins May Benefit Acute Low Back Pain - Frankly Speaking EP 167</itunes:title>
        <link>https://primedfranklyspeaking.podbean.com/e/b-is-for-back-pain-how-vitamins-may-benefit-acute-low-back-pain-frankly-speaking-ep-167/</link>
                    <comments>https://primedfranklyspeaking.podbean.com/e/b-is-for-back-pain-how-vitamins-may-benefit-acute-low-back-pain-frankly-speaking-ep-167/#comments</comments>        <pubDate>Mon, 06 Apr 2020 04:30:00 +0000</pubDate>
        <guid isPermaLink="false">ad373721-e710-49a9-9649-433bc21ed19e</guid>
                                    <description><![CDATA[<p>Credits: 0.25 AMA PRA Category 1 Credits™</p>
 <p>Claim CME/CE credit: <a href='https://www.pri-med.com/online-education/podcast/frankly-speaking-cme-167'> https://www.pri-med.com/online-education/podcast/frankly-speaking-cme-167</a></p>
 <p>Overview: Acute low back pain is a common problem and a frequent cause of inability to work. Although there are many treatments available, they often provide limited relief and have accompanying side effects. Listen to this episode to hear about how using certain vitamins may act as an adjunct treatment to speed recovery of acute low back pain.</p>
 <p>Guest: Alan Ehrlich MD, FAAFP</p>
 <p>Music Credit: Richard Onorato</p>
]]></description>
                                                            <content:encoded><![CDATA[<p>Credits: 0.25 <em>AMA PRA Category 1 Credits</em>™</p>
 <p>Claim CME/CE credit: <a href='https://www.pri-med.com/online-education/podcast/frankly-speaking-cme-167'> https://www.pri-med.com/online-education/podcast/frankly-speaking-cme-167</a></p>
 <p>Overview: Acute low back pain is a common problem and a frequent cause of inability to work. Although there are many treatments available, they often provide limited relief and have accompanying side effects. Listen to this episode to hear about how using certain vitamins may act as an adjunct treatment to speed recovery of acute low back pain.</p>
 <p>Guest: Alan Ehrlich MD, FAAFP</p>
 <p>Music Credit: Richard Onorato</p>
]]></content:encoded>
                                    
        <enclosure url="https://mcdn.podbean.com/mf/web/d54s11/secure_primed_167-Vitamins-finished.mp3" length="24595692" type="audio/mpeg"/>
                <itunes:summary><![CDATA[Credits: 0.25 AMA PRA Category 1 Credits™ Claim CME/CE credit:  https://www.pri-med.com/online-education/podcast/frankly-speaking-cme-167 Overview: Acute low back pain is a common problem and a frequent cause of inability to work. Although there are many treatments available, they often provide limited relief and have accompanying side effects. Listen to this episode to hear about how using certain vitamins may act as an adjunct treatment to speed recovery of acute low back pain. Guest: Alan Ehrlich MD, FAAFP Music Credit: Richard Onorato]]></itunes:summary>
        <itunes:author>Pri-Med</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>614</itunes:duration>
        <itunes:season>1</itunes:season>
        <itunes:episode>1</itunes:episode>
        <itunes:episodeType>full</itunes:episodeType>
        <itunes:image href="https://pbcdn1.podbean.com/imglogo/ep-logo/pbblog13721080/a1357863e419000c1b2df6079b390b16.png" />    </item>
    <item>
        <title>Ask the ID Expert: Common COVID-19 Questions in Primary Care (Recorded 3/28/20)</title>
        <itunes:title>Ask the ID Expert: Common COVID-19 Questions in Primary Care (Recorded 3/28/20)</itunes:title>
        <link>https://primedfranklyspeaking.podbean.com/e/ask-the-id-expert-common-covid-19-questions-in-primary-care-recorded-32820/</link>
                    <comments>https://primedfranklyspeaking.podbean.com/e/ask-the-id-expert-common-covid-19-questions-in-primary-care-recorded-32820/#comments</comments>        <pubDate>Mon, 30 Mar 2020 17:31:00 +0000</pubDate>
        <guid isPermaLink="false">db04fab3-0091-47a9-a7e9-386a719b2d4f</guid>
                                    <description><![CDATA[<p>Credits: 0.50 AMA PRA Category 1 Credits™</p>
 <p>Claim CME/CE credit: <a href='https://www.pri-med.com/online-education/podcast/ask-the-id-experts-covid19-coronavirus'> https://www.pri-med.com/online-education/podcast/ask-the-id-experts-covid19-coronavirus</a></p>
 <p>Overview: With information changing rapidly around the COVID-19 pandemic, it is difficult for primary care clinicians on the front lines of care to stay up to date on the most accurate information regarding prevention, testing, and treatment. Join this live discussion between family physician Dr. Frank Domino and infectious disease specialist Dr. Paul Sax as they discuss common questions related to COVID-19 that will help you give your patients the best possible care and advice during these uncertain times.

 Please note that any data, indications, and guidelines presented in this activity are current as of the recording on 3/28/2020 and they are subject to change as new information is published. </p>
 <p>Guest: Frank J. Domino, MD & Paul E. Sax, MD </p>
]]></description>
                                                            <content:encoded><![CDATA[<p>Credits: 0.50 <em>AMA PRA Category 1 Credits</em>™</p>
 <p>Claim CME/CE credit: <a href='https://www.pri-med.com/online-education/podcast/ask-the-id-experts-covid19-coronavirus'> https://www.pri-med.com/online-education/podcast/ask-the-id-experts-covid19-coronavirus</a></p>
 <p>Overview: With information changing rapidly around the COVID-19 pandemic, it is difficult for primary care clinicians on the front lines of care to stay up to date on the most accurate information regarding prevention, testing, and treatment. Join this live discussion between family physician Dr. Frank Domino and infectious disease specialist Dr. Paul Sax as they discuss common questions related to COVID-19 that will help you give your patients the best possible care and advice during these uncertain times.<br>
<br>
 Please note that any data, indications, and guidelines presented in this activity are current as of the recording on 3/28/2020 and they are subject to change as new information is published. </p>
 <p>Guest: Frank J. Domino, MD & Paul E. Sax, MD </p>
]]></content:encoded>
                                    
        <enclosure url="https://mcdn.podbean.com/mf/web/wkit1j/secure_primed_1297400.mp3" length="18600429" type="audio/mpeg"/>
                <itunes:summary><![CDATA[Credits: 0.50 AMA PRA Category 1 Credits™ Claim CME/CE credit:  https://www.pri-med.com/online-education/podcast/ask-the-id-experts-covid19-coronavirus Overview: With information changing rapidly around the COVID-19 pandemic, it is difficult for primary care clinicians on the front lines of care to stay up to date on the most accurate information regarding prevention, testing, and treatment. Join this live discussion between family physician Dr. Frank Domino and infectious disease specialist Dr. Paul Sax as they discuss common questions related to COVID-19 that will help you give your patients the best possible care and advice during these uncertain times. Please note that any data, indications, and guidelines presented in this activity are current as of the recording on 3/28/2020 and they are subject to change as new information is published.  Guest: Frank J. Domino, MD & Paul E. Sax, MD ]]></itunes:summary>
        <itunes:author>Pri-Med</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>2326</itunes:duration>
                                <itunes:image href="https://pbcdn1.podbean.com/imglogo/ep-logo/pbblog13721080/6d01bd038d8420f6fe3aec3d4ad02d20.png" />    </item>
    <item>
        <title>Alcohol and A-fib: Is Abstinence the Best Medicine? - Frankly Speaking EP 166</title>
        <itunes:title>Alcohol and A-fib: Is Abstinence the Best Medicine? - Frankly Speaking EP 166</itunes:title>
        <link>https://primedfranklyspeaking.podbean.com/e/alcohol-and-a-fib-is-abstinence-the-best-medicine-frankly-speaking-ep-166/</link>
                    <comments>https://primedfranklyspeaking.podbean.com/e/alcohol-and-a-fib-is-abstinence-the-best-medicine-frankly-speaking-ep-166/#comments</comments>        <pubDate>Mon, 30 Mar 2020 04:30:00 +0000</pubDate>
        <guid isPermaLink="false">207823f0-7478-4520-9045-d6541cd877ae</guid>
                                    <description><![CDATA[<p>Credits: 0.25 AMA PRA Category 1 Credits™</p>
 <p>Claim CME/CE credit: <a href='https://www.pri-med.com/online-education/podcast/frankly-speaking-cme-166'> https://www.pri-med.com/online-education/podcast/frankly-speaking-cme-166</a></p>
 <p>Overview: Alcohol consumption has been associated with negative cardiovascular outcomes, yet many clinicians still counsel patients that it is okay in moderation. Past observational studies have supported this idea, showing a dose-dependent relationship between alcohol consumption and the incidence of a-fib. In this episode we will explore the latest RCT out of Australia, which suggest that no level of alcohol intake is safe when it comes to a-fib.</p>
 <p>Guest: Robert A. Baldor, MD, FAAFP</p>
 <p>Music Credit: Richard Onorato</p>
]]></description>
                                                            <content:encoded><![CDATA[<p>Credits: 0.25 <em>AMA PRA Category 1 Credits</em>™</p>
 <p>Claim CME/CE credit: <a href='https://www.pri-med.com/online-education/podcast/frankly-speaking-cme-166'> https://www.pri-med.com/online-education/podcast/frankly-speaking-cme-166</a></p>
 <p>Overview: Alcohol consumption has been associated with negative cardiovascular outcomes, yet many clinicians still counsel patients that it is okay in moderation. Past observational studies have supported this idea, showing a dose-dependent relationship between alcohol consumption and the incidence of a-fib. In this episode we will explore the latest RCT out of Australia, which suggest that no level of alcohol intake is safe when it comes to a-fib.</p>
 <p>Guest: Robert A. Baldor, MD, FAAFP</p>
 <p>Music Credit: Richard Onorato</p>
]]></content:encoded>
                                    
        <enclosure url="https://mcdn.podbean.com/mf/web/ogm8fn/secure_primed_166-etoh-afib-finished.mp3" length="22918257" type="audio/mpeg"/>
                <itunes:summary><![CDATA[Credits: 0.25 AMA PRA Category 1 Credits™ Claim CME/CE credit:  https://www.pri-med.com/online-education/podcast/frankly-speaking-cme-166 Overview: Alcohol consumption has been associated with negative cardiovascular outcomes, yet many clinicians still counsel patients that it is okay in moderation. Past observational studies have supported this idea, showing a dose-dependent relationship between alcohol consumption and the incidence of a-fib. In this episode we will explore the latest RCT out of Australia, which suggest that no level of alcohol intake is safe when it comes to a-fib. Guest: Robert A. Baldor, MD, FAAFP Music Credit: Richard Onorato]]></itunes:summary>
        <itunes:author>Pri-Med</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>573</itunes:duration>
                                <itunes:image href="https://pbcdn1.podbean.com/imglogo/ep-logo/pbblog13721080/80f33396ce54742fb59d248045c87ef0.png" />    </item>
    <item>
        <title>Effective Tool or Diet Fad? Can Intermittent Fasting Decrease Weight and Improve Cardiovascular Markers?</title>
        <itunes:title>Effective Tool or Diet Fad? Can Intermittent Fasting Decrease Weight and Improve Cardiovascular Markers?</itunes:title>
        <link>https://primedfranklyspeaking.podbean.com/e/effective-tool-or-diet-fad-can-intermittent-fasting-decrease-weight-and-improve-cardiovascular-markers/</link>
                    <comments>https://primedfranklyspeaking.podbean.com/e/effective-tool-or-diet-fad-can-intermittent-fasting-decrease-weight-and-improve-cardiovascular-markers/#comments</comments>        <pubDate>Mon, 23 Mar 2020 04:30:00 +0000</pubDate>
        <guid isPermaLink="false">7fcae169-e48e-4e5e-9e46-1d982c5dc801</guid>
                                    <description><![CDATA[<p>Credits: 0.25 AMA PRA Category 1 Credits™</p>
<p>Claim CME/CE credit: <a href='https://www.pri-med.com/online-education/podcast/frankly-speaking-cme-165'>https://www.pri-med.com/online-education/podcast/frankly-speaking-cme-165</a>  </p>
<p>Overview: Obesity, dyslipidemia, and hypertension are significant challenges to public health and impact a growing number of Americans. Weight loss and dietary changes are effective in preventing CVD and DMII and reducing cardiometabolic complications, but can be difficult for many people. Growing evidence supports the use of timed fasting to promote weight loss and reduce these complications. Join us as we discuss a recent study that shows promising data regarding a 10-hour feeding window and improved CV markers.</p>
<p>Guest: Susan Feeney, DNP, FNP-BC</p>
<p>Music Credit: Richard Onorato</p>
]]></description>
                                                            <content:encoded><![CDATA[<p>Credits: 0.25 <em>AMA PRA Category 1 Credits</em>™</p>
<p>Claim CME/CE credit: <a href='https://www.pri-med.com/online-education/podcast/frankly-speaking-cme-165'>https://www.pri-med.com/online-education/podcast/frankly-speaking-cme-165</a>  </p>
<p>Overview: Obesity, dyslipidemia, and hypertension are significant challenges to public health and impact a growing number of Americans. Weight loss and dietary changes are effective in preventing CVD and DMII and reducing cardiometabolic complications, but can be difficult for many people. Growing evidence supports the use of timed fasting to promote weight loss and reduce these complications. Join us as we discuss a recent study that shows promising data regarding a 10-hour feeding window and improved CV markers.</p>
<p>Guest: Susan Feeney, DNP, FNP-BC</p>
<p>Music Credit: Richard Onorato</p>
]]></content:encoded>
                                    
        <enclosure url="https://mcdn.podbean.com/mf/web/e8kghz/secure_primed_165-Fasting-MetS-Live.mp3" length="11216192" type="audio/mpeg"/>
                <itunes:summary><![CDATA[Credits: 0.25 AMA PRA Category 1 Credits™
Claim CME/CE credit: https://www.pri-med.com/online-education/podcast/frankly-speaking-cme-165  
Overview: Obesity, dyslipidemia, and hypertension are significant challenges to public health and impact a growing number of Americans. Weight loss and dietary changes are effective in preventing CVD and DMII and reducing cardiometabolic complications, but can be difficult for many people. Growing evidence supports the use of timed fasting to promote weight loss and reduce these complications. Join us as we discuss a recent study that shows promising data regarding a 10-hour feeding window and improved CV markers.
Guest: Susan Feeney, DNP, FNP-BC
Music Credit: Richard Onorato]]></itunes:summary>
        <itunes:author>Pri-Med</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>700</itunes:duration>
        <itunes:season>1</itunes:season>
        <itunes:episode>1</itunes:episode>
        <itunes:episodeType>full</itunes:episodeType>
        <itunes:image href="https://pbcdn1.podbean.com/imglogo/ep-logo/pbblog13721080/d91b42da1042d18a55aaf2e5979478c1.png" />    </item>
    <item>
        <title>Frankly Speaking Update: Common Questions About Coronavirus (Recorded 3/21/20)</title>
        <itunes:title>Frankly Speaking Update: Common Questions About Coronavirus (Recorded 3/21/20)</itunes:title>
        <link>https://primedfranklyspeaking.podbean.com/e/frankly-speaking-update-common-questions-about-coronavirus-recorded-32120/</link>
                    <comments>https://primedfranklyspeaking.podbean.com/e/frankly-speaking-update-common-questions-about-coronavirus-recorded-32120/#comments</comments>        <pubDate>Sun, 22 Mar 2020 22:22:00 +0000</pubDate>
        <guid isPermaLink="false">7b8479ff-c641-49ee-872e-a4b3f2abdd2d</guid>
                                    <description><![CDATA[<p>Credits: 0.25 AMA PRA Category 1 Credits™</p>
 <p>Claim CME/CE credit: <a href='https://www.pri-med.com/online-education/podcast/frankly-speaking-cme-coronavirus'> https://www.pri-med.com/online-education/podcast/frankly-speaking-cme-coronavirus</a>  </p>
 <p>Overview: Review the latest data on the Pandemic in a patient centered manner </p>
 <p>Music Credit: Richard Onorato</p>
]]></description>
                                                            <content:encoded><![CDATA[<p>Credits: 0.25 <em>AMA PRA Category 1 Credits</em>™</p>
 <p>Claim CME/CE credit: <a href='https://www.pri-med.com/online-education/podcast/frankly-speaking-cme-coronavirus'> https://www.pri-med.com/online-education/podcast/frankly-speaking-cme-coronavirus</a>  </p>
 <p>Overview: Review the latest data on the Pandemic in a patient centered manner </p>
 <p>Music Credit: Richard Onorato</p>
]]></content:encoded>
                                    
        <enclosure url="https://mcdn.podbean.com/mf/web/oigdg2/secure_primed_Frankly_Speaking-coronavirus-edited.mp3" length="33691061" type="audio/mpeg"/>
                <itunes:summary><![CDATA[Credits: 0.25 AMA PRA Category 1 Credits™ Claim CME/CE credit:  https://www.pri-med.com/online-education/podcast/frankly-speaking-cme-coronavirus   Overview: Review the latest data on the Pandemic in a patient centered manner  Music Credit: Richard Onorato]]></itunes:summary>
        <itunes:author>Pri-Med</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>842</itunes:duration>
                                <itunes:image href="https://pbcdn1.podbean.com/imglogo/ep-logo/pbblog13721080/e15accea181fb2a82d5ef2930fe48626.png" />    </item>
    <item>
        <title>Coronavirus Update, March 6, 2020 - Frankly Speaking EP 164</title>
        <itunes:title>Coronavirus Update, March 6, 2020 - Frankly Speaking EP 164</itunes:title>
        <link>https://primedfranklyspeaking.podbean.com/e/coronavirus-update-march-6-2020-frankly-speaking-ep-164/</link>
                    <comments>https://primedfranklyspeaking.podbean.com/e/coronavirus-update-march-6-2020-frankly-speaking-ep-164/#comments</comments>        <pubDate>Fri, 13 Mar 2020 15:44:00 +0000</pubDate>
        <guid isPermaLink="false">048622b9-eb38-44e0-bafc-ed0d68c17c0a</guid>
                                    <description><![CDATA[<p>Credits: 0.25 AMA PRA Category 1 Credits™</p>
 <p>Claim CME/CE credit: <a href='https://www.pri-med.com/online-education/podcast/frankly-speaking-cme-164'> https://www.pri-med.com/online-education/podcast/frankly-speaking-cme-164</a>  </p>
 <p>Overview: Review the latest recommendations from the CDC to assist in responding to patient questions and concerns. </p>
 <p>Guest: Robert A. Baldor, MD, FAAFP</p>
 <p>Music Credit: Richard Onorato </p>
]]></description>
                                                            <content:encoded><![CDATA[<p>Credits: 0.25 <em>AMA PRA Category 1 Credits</em>™</p>
 <p>Claim CME/CE credit: <a href='https://www.pri-med.com/online-education/podcast/frankly-speaking-cme-164'> https://www.pri-med.com/online-education/podcast/frankly-speaking-cme-164</a>  </p>
 <p>Overview: Review the latest recommendations from the CDC to assist in responding to patient questions and concerns. </p>
 <p>Guest: Robert A. Baldor, MD, FAAFP</p>
 <p>Music Credit: Richard Onorato </p>
]]></content:encoded>
                                    
        <enclosure url="https://mcdn.podbean.com/mf/web/y9v91w/secure_primed_Edited-164-Coronavirus-final.mp3" length="19898520" type="audio/mpeg"/>
                <itunes:summary><![CDATA[Credits: 0.25 AMA PRA Category 1 Credits™ Claim CME/CE credit:  https://www.pri-med.com/online-education/podcast/frankly-speaking-cme-164   Overview: Review the latest recommendations from the CDC to assist in responding to patient questions and concerns.  Guest: Robert A. Baldor, MD, FAAFP Music Credit: Richard Onorato ]]></itunes:summary>
        <itunes:author>Pri-Med</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>497</itunes:duration>
                                <itunes:image href="https://pbcdn1.podbean.com/imglogo/ep-logo/pbblog13721080/87679dd2a4486c66df5ee3a7681b1885.png" />    </item>
    <item>
        <title>Safe Sex – Counseling Makes a Difference - Frankly Speaking EP 163 (Live from Pri-Med South)</title>
        <itunes:title>Safe Sex – Counseling Makes a Difference - Frankly Speaking EP 163 (Live from Pri-Med South)</itunes:title>
        <link>https://primedfranklyspeaking.podbean.com/e/safe-sex-%e2%80%93-counseling-makes-a-difference-frankly-speaking-ep-163-live-from-pri-med-south/</link>
                    <comments>https://primedfranklyspeaking.podbean.com/e/safe-sex-%e2%80%93-counseling-makes-a-difference-frankly-speaking-ep-163-live-from-pri-med-south/#comments</comments>        <pubDate>Mon, 09 Mar 2020 04:30:00 +0000</pubDate>
        <guid isPermaLink="false">f6c42030-5234-46fa-91b6-e6773a6d523f</guid>
                                    <description><![CDATA[<p>Credits: 0.25 AMA PRA Category 1 Credits™</p>
 <p>Claim CME/CE credit: <a href='https://www.pri-med.com/online-education/podcast/frankly-speaking-cme-163'> https://www.pri-med.com/online-education/podcast/frankly-speaking-cme-163</a>  </p>
 <p>Overview: STIs in the US are a major public health risk with an estimated 20 million new cases per year, more than half occurring in 15-24-year-olds. The USPSTF found intensive counseling in young adults to reduce the likelihood of STIs. Join us as we discuss how to apply these recommendations to your practice.</p>
 <p>Guest: Susan Feeney, DNP, FNP-BC, NP-C</p>
 <p>Music Credit: Richard Onorato</p>
]]></description>
                                                            <content:encoded><![CDATA[<p>Credits: 0.25 <em>AMA PRA Category 1 Credits</em>™</p>
 <p>Claim CME/CE credit: <a href='https://www.pri-med.com/online-education/podcast/frankly-speaking-cme-163'> https://www.pri-med.com/online-education/podcast/frankly-speaking-cme-163</a>  </p>
 <p>Overview: STIs in the US are a major public health risk with an estimated 20 million new cases per year, more than half occurring in 15-24-year-olds. The USPSTF found intensive counseling in young adults to reduce the likelihood of STIs. Join us as we discuss how to apply these recommendations to your practice.</p>
 <p>Guest: Susan Feeney, DNP, FNP-BC, NP-C</p>
 <p>Music Credit: Richard Onorato</p>
]]></content:encoded>
                                    
        <enclosure url="https://mcdn.podbean.com/mf/web/nwfjox/secure_primed_frankly-speaking-163-stds-new-outro.mp3" length="31893314" type="audio/mpeg"/>
                <itunes:summary><![CDATA[Credits: 0.25 AMA PRA Category 1 Credits™ Claim CME/CE credit:  https://www.pri-med.com/online-education/podcast/frankly-speaking-cme-163   Overview: STIs in the US are a major public health risk with an estimated 20 million new cases per year, more than half occurring in 15-24-year-olds. The USPSTF found intensive counseling in young adults to reduce the likelihood of STIs. Join us as we discuss how to apply these recommendations to your practice. Guest: Susan Feeney, DNP, FNP-BC, NP-C Music Credit: Richard Onorato]]></itunes:summary>
        <itunes:author>Pri-Med</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>797</itunes:duration>
                                <itunes:image href="https://pbcdn1.podbean.com/imglogo/ep-logo/pbblog13721080/49cd4bd843ce2a0233617c6a9de50be2.png" />    </item>
    <item>
        <title>Milk: Whole, Skim or Something In Between? - Frankly Speaking EP 162 (Live from Pri-Med South)</title>
        <itunes:title>Milk: Whole, Skim or Something In Between? - Frankly Speaking EP 162 (Live from Pri-Med South)</itunes:title>
        <link>https://primedfranklyspeaking.podbean.com/e/milk-whole-skim-or-something-in-between-frankly-speaking-ep-162-live-from-pri-med-south/</link>
                    <comments>https://primedfranklyspeaking.podbean.com/e/milk-whole-skim-or-something-in-between-frankly-speaking-ep-162-live-from-pri-med-south/#comments</comments>        <pubDate>Mon, 02 Mar 2020 05:30:00 +0000</pubDate>
        <guid isPermaLink="false">3bf7c463-9046-41a2-9f0a-21182cb32d85</guid>
                                    <description><![CDATA[<p>Credits: 0.25 AMA PRA Category 1 Credits™</p>
 <p>Claim CME/CE credit: <a href='https://www.pri-med.com/online-education/podcast/frankly-speaking-cme-162'> https://www.pri-med.com/online-education/podcast/frankly-speaking-cme-162</a>   </p>
 <p>Overview: This episode will review four recent publications that help guide milk consumption in children and adults. </p>
 <p>Guest: Susan Feeney, DNP, FNP-BC, NP-C</p>
 <p>Music Credit: Richard Onorato </p>
]]></description>
                                                            <content:encoded><![CDATA[<p>Credits: 0.25 <em>AMA PRA Category 1 Credits</em>™</p>
 <p>Claim CME/CE credit: <a href='https://www.pri-med.com/online-education/podcast/frankly-speaking-cme-162'> https://www.pri-med.com/online-education/podcast/frankly-speaking-cme-162</a>   </p>
 <p>Overview: This episode will review four recent publications that help guide milk consumption in children and adults. </p>
 <p>Guest: Susan Feeney, DNP, FNP-BC, NP-C</p>
 <p>Music Credit: Richard Onorato </p>
]]></content:encoded>
                                    
        <enclosure url="https://mcdn.podbean.com/mf/web/iy4ynu/secure_primed_Frankly_Speaking_162_Milk_--_edited.mp3" length="30691212" type="audio/mpeg"/>
                <itunes:summary><![CDATA[Credits: 0.25 AMA PRA Category 1 Credits™ Claim CME/CE credit:  https://www.pri-med.com/online-education/podcast/frankly-speaking-cme-162    Overview: This episode will review four recent publications that help guide milk consumption in children and adults.  Guest: Susan Feeney, DNP, FNP-BC, NP-C Music Credit: Richard Onorato ]]></itunes:summary>
        <itunes:author>Pri-Med</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>766</itunes:duration>
                                <itunes:image href="https://pbcdn1.podbean.com/imglogo/ep-logo/pbblog13721080/1d95999cc59d021c4964d3ad7c23e511.png" />    </item>
    <item>
        <title>Too Sweet! Rates of Prediabetes in US Adolescents and Young Adults - Frankly Speaking EP 161</title>
        <itunes:title>Too Sweet! Rates of Prediabetes in US Adolescents and Young Adults - Frankly Speaking EP 161</itunes:title>
        <link>https://primedfranklyspeaking.podbean.com/e/too-sweet-rates-of-prediabetes-in-us-adolescents-and-young-adults-frankly-speaking-ep-161/</link>
                    <comments>https://primedfranklyspeaking.podbean.com/e/too-sweet-rates-of-prediabetes-in-us-adolescents-and-young-adults-frankly-speaking-ep-161/#comments</comments>        <pubDate>Mon, 24 Feb 2020 05:30:00 +0000</pubDate>
        <guid isPermaLink="false">0f870cc8-7cdc-46bd-bd22-086f54972f67</guid>
                                    <description><![CDATA[<p>Credits: 0.25 AMA PRA Category 1 Credits™</p>
<p>Claim CME/CE credit: <a href='https://www.pri-med.com/online-education/podcast/frankly-speaking-cme-161'>https://www.pri-med.com/online-education/podcast/frankly-speaking-cme-161</a>  </p>
<p>Overview: The incidence and prevalence of prediabetes and Type II Diabetes Mellitus in adolescents and young adults has increased over the past decade. A recent cross-sectional study of 12 years of NHANES data suggests that this population has an associated increased cardiometabolic risk. Listen as our team discusses these findings and some prevention strategies to help improve health outcomes.  </p>
<p>Guest: Guest: Susan Feeney, DNP, FNP-BC, NP-C</p>
<p>Music Credit: Richard Onorato</p>
]]></description>
                                                            <content:encoded><![CDATA[<p>Credits: 0.25 AMA PRA Category 1 Credits™</p>
<p>Claim CME/CE credit: <a href='https://www.pri-med.com/online-education/podcast/frankly-speaking-cme-161'>https://www.pri-med.com/online-education/podcast/frankly-speaking-cme-161</a>  </p>
<p>Overview: The incidence and prevalence of prediabetes and Type II Diabetes Mellitus in adolescents and young adults has increased over the past decade. A recent cross-sectional study of 12 years of NHANES data suggests that this population has an associated increased cardiometabolic risk. Listen as our team discusses these findings and some prevention strategies to help improve health outcomes.  </p>
<p>Guest: Guest: Susan Feeney, DNP, FNP-BC, NP-C</p>
<p>Music Credit: Richard Onorato</p>
]]></content:encoded>
                                    
        <enclosure url="https://mcdn.podbean.com/mf/web/nb8fwr/secure_primed_Frankly_Speaking_161_Pre-diabetes-edited.mp3" length="26923171" type="audio/mpeg"/>
                <itunes:summary><![CDATA[Credits: 0.25 AMA PRA Category 1 Credits™
Claim CME/CE credit: https://www.pri-med.com/online-education/podcast/frankly-speaking-cme-161  
Overview: The incidence and prevalence of prediabetes and Type II Diabetes Mellitus in adolescents and young adults has increased over the past decade. A recent cross-sectional study of 12 years of NHANES data suggests that this population has an associated increased cardiometabolic risk. Listen as our team discusses these findings and some prevention strategies to help improve health outcomes.  
Guest: Guest: Susan Feeney, DNP, FNP-BC, NP-C
Music Credit: Richard Onorato]]></itunes:summary>
        <itunes:author>Pri-Med</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>673</itunes:duration>
        <itunes:season>1</itunes:season>
        <itunes:episode>1</itunes:episode>
        <itunes:episodeType>full</itunes:episodeType>
        <itunes:image href="https://pbcdn1.podbean.com/imglogo/ep-logo/pbblog13721080/08897024f49c6bbae01da728d9156ea3.png" />    </item>
    <item>
        <title>Treating Strep Throat in Half the Time - Frankly Speaking EP 160</title>
        <itunes:title>Treating Strep Throat in Half the Time - Frankly Speaking EP 160</itunes:title>
        <link>https://primedfranklyspeaking.podbean.com/e/treating-strep-throat-in-half-the-time-frankly-speaking-ep-160/</link>
                    <comments>https://primedfranklyspeaking.podbean.com/e/treating-strep-throat-in-half-the-time-frankly-speaking-ep-160/#comments</comments>        <pubDate>Mon, 17 Feb 2020 05:30:00 +0000</pubDate>
        <guid isPermaLink="false">22be3ade-a3db-497d-a98a-e82de17000f5</guid>
                                    <description><![CDATA[<p>Credits: 0.25 AMA PRA Category 1 Credits™</p>
 <p>Claim CME/CE credit: <a href='https://www.pri-med.com/online-education/podcast/frankly-speaking-cme-160'> https://www.pri-med.com/online-education/podcast/frankly-speaking-cme-160</a>    </p>
 <p>Overview: This episode will review clinical decision-making tools for diagnosing and treating streptococcal pharyngitis and will discuss a recent randomized controlled trial utilizing a 5-day course of Penicillin for treatment. </p>
 <p>Guest: Guest: Robert Baldor, MD, FAAFP</p>
 <p>Music Credit: Richard Onorato</p>
]]></description>
                                                            <content:encoded><![CDATA[<p>Credits: 0.25 AMA PRA Category 1 Credits™</p>
 <p>Claim CME/CE credit: <a href='https://www.pri-med.com/online-education/podcast/frankly-speaking-cme-160'> https://www.pri-med.com/online-education/podcast/frankly-speaking-cme-160</a>    </p>
 <p>Overview: This episode will review clinical decision-making tools for diagnosing and treating streptococcal pharyngitis and will discuss a recent randomized controlled trial utilizing a 5-day course of Penicillin for treatment. </p>
 <p>Guest: Guest: Robert Baldor, MD, FAAFP</p>
 <p>Music Credit: Richard Onorato</p>
]]></content:encoded>
                                    
        <enclosure url="https://mcdn.podbean.com/mf/web/2ckjbt/secure_primed_frankly-speaking-160-strep.mp3" length="25099481" type="audio/mpeg"/>
                <itunes:summary><![CDATA[Credits: 0.25 AMA PRA Category 1 Credits™ Claim CME/CE credit:  https://www.pri-med.com/online-education/podcast/frankly-speaking-cme-160     Overview: This episode will review clinical decision-making tools for diagnosing and treating streptococcal pharyngitis and will discuss a recent randomized controlled trial utilizing a 5-day course of Penicillin for treatment.  Guest: Guest: Robert Baldor, MD, FAAFP Music Credit: Richard Onorato]]></itunes:summary>
        <itunes:author>Pri-Med</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>627</itunes:duration>
                                <itunes:image href="https://pbcdn1.podbean.com/imglogo/ep-logo/pbblog13721080/61231f9a2885d44475778d9beddc2b6f.png" />    </item>
    <item>
        <title>Adolescent Mental Health: Family Relationships Matter - Frankly Speaking EP 159</title>
        <itunes:title>Adolescent Mental Health: Family Relationships Matter - Frankly Speaking EP 159</itunes:title>
        <link>https://primedfranklyspeaking.podbean.com/e/adolescent-mental-health-family-relationships-matter-frankly-speaking-ep-159/</link>
                    <comments>https://primedfranklyspeaking.podbean.com/e/adolescent-mental-health-family-relationships-matter-frankly-speaking-ep-159/#comments</comments>        <pubDate>Mon, 10 Feb 2020 05:30:00 +0000</pubDate>
        <guid isPermaLink="false">c1a13d16-9c5d-40e5-a668-3a8d5cbaee1d</guid>
                                    <description><![CDATA[<p>Credits: 0.25 AMA PRA Category 1 Credits™</p>
 <p>Claim CME/CE credit: <a href='https://www.pri-med.com/online-education/podcast/frankly-speaking-cme-159'> https://www.pri-med.com/online-education/podcast/frankly-speaking-cme-159 </a> </p>
 <p>Overview: Join us as we discuss data from the National Longitudinal Study of Adolescent to Adult Health examining how family relationships impact depression.  </p>
 <p>Guest: Guest: Jill Terrien PhD, ANP-BC</p>
 <p>Music Credit: Richard Onorato</p>
]]></description>
                                                            <content:encoded><![CDATA[<p>Credits: 0.25 AMA PRA Category 1 Credits™</p>
 <p>Claim CME/CE credit: <a href='https://www.pri-med.com/online-education/podcast/frankly-speaking-cme-159'> https://www.pri-med.com/online-education/podcast/frankly-speaking-cme-159 </a> </p>
 <p>Overview: Join us as we discuss data from the National Longitudinal Study of Adolescent to Adult Health examining how family relationships impact depression.  </p>
 <p>Guest: Guest: Jill Terrien PhD, ANP-BC</p>
 <p>Music Credit: Richard Onorato</p>
]]></content:encoded>
                                    
        <enclosure url="https://mcdn.podbean.com/mf/web/6c1w4r/secure_primed_frankly-speaking-cme-159-edited.mp3" length="24481815" type="audio/mpeg"/>
                <itunes:summary><![CDATA[Credits: 0.25 AMA PRA Category 1 Credits™ Claim CME/CE credit:  https://www.pri-med.com/online-education/podcast/frankly-speaking-cme-159   Overview: Join us as we discuss data from the National Longitudinal Study of Adolescent to Adult Health examining how family relationships impact depression.   Guest: Guest: Jill Terrien PhD, ANP-BC Music Credit: Richard Onorato]]></itunes:summary>
        <itunes:author>Pri-Med</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>612</itunes:duration>
                                <itunes:image href="https://pbcdn1.podbean.com/imglogo/ep-logo/pbblog13721080/15c2b8991218850f255239491751adb9.png" />    </item>
    <item>
        <title>Coronavirus: Frankly Speaking Special Update</title>
        <itunes:title>Coronavirus: Frankly Speaking Special Update</itunes:title>
        <link>https://primedfranklyspeaking.podbean.com/e/coronavirus-frankly-speaking-special-update/</link>
                    <comments>https://primedfranklyspeaking.podbean.com/e/coronavirus-frankly-speaking-special-update/#comments</comments>        <pubDate>Mon, 03 Feb 2020 16:24:00 +0000</pubDate>
        <guid isPermaLink="false">c19336c0-6518-49bb-a9a7-0d318065587e</guid>
                                    <description><![CDATA[<p>Listen to Dr. Frank Domino provide a timely update regarding the recent Coronavirus outbreak, and provide resources in order to get the most up-to-date information. </p>
]]></description>
                                                            <content:encoded><![CDATA[<p>Listen to Dr. Frank Domino provide a timely update regarding the recent Coronavirus outbreak, and provide resources in order to get the most up-to-date information. </p>
]]></content:encoded>
                                    
        <enclosure url="https://mcdn.podbean.com/mf/web/f69imi/secure_primed_coronavirus.mp3" length="7596570" type="audio/mpeg"/>
                <itunes:summary><![CDATA[Listen to Dr. Frank Domino provide a timely update regarding the recent Coronavirus outbreak, and provide resources in order to get the most up-to-date information. ]]></itunes:summary>
        <itunes:author>Pri-Med</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>190</itunes:duration>
                                <itunes:image href="https://pbcdn1.podbean.com/imglogo/ep-logo/pbblog13721080/0229c7a2e28b7d8e2f99d174620b7d1d.png" />    </item>
    <item>
        <title>The Dangers of Non-Nutritive Sweeteners: What Does the Data Say? - Frankly Speaking EP 158</title>
        <itunes:title>The Dangers of Non-Nutritive Sweeteners: What Does the Data Say? - Frankly Speaking EP 158</itunes:title>
        <link>https://primedfranklyspeaking.podbean.com/e/the-dangers-of-non-nutritive-sweeteners-what-does-the-data-say-frankly-speaking-ep-158/</link>
                    <comments>https://primedfranklyspeaking.podbean.com/e/the-dangers-of-non-nutritive-sweeteners-what-does-the-data-say-frankly-speaking-ep-158/#comments</comments>        <pubDate>Mon, 03 Feb 2020 05:30:00 +0000</pubDate>
        <guid isPermaLink="false">1980a08e-20d6-44f9-9158-888637458a08</guid>
                                    <description><![CDATA[<p>Credits: 0.25 AMA PRA Category 1 Credits™</p>
<p>Claim CME/CE credit: <a href='https://www.pri-med.com/online-education/podcast/frankly-speaking-cme-158'>https://www.pri-med.com/online-education/podcast/frankly-speaking-cme-158</a></p>
<p>Overview: Review the latest research on the impact of Non-Nutritive Sweeteners (NNS) on mortality, disease, and intermediate outcomes like microbiome and gut hormones. </p>
<p>Guest: Guest: Susan Feeney, DNP, FNP-BC</p>
<p>Music Credit: Richard Onorato</p>
]]></description>
                                                            <content:encoded><![CDATA[<p>Credits: 0.25 AMA PRA Category 1 Credits™</p>
<p>Claim CME/CE credit: <a href='https://www.pri-med.com/online-education/podcast/frankly-speaking-cme-158'>https://www.pri-med.com/online-education/podcast/frankly-speaking-cme-158</a></p>
<p>Overview: Review the latest research on the impact of Non-Nutritive Sweeteners (NNS) on mortality, disease, and intermediate outcomes like microbiome and gut hormones. </p>
<p>Guest: Guest: Susan Feeney, DNP, FNP-BC</p>
<p>Music Credit: Richard Onorato</p>
]]></content:encoded>
                                    
        <enclosure url="https://mcdn.podbean.com/mf/web/ch0wzx/secure_primed_frankly-speaking-cme-158-edited.mp3" length="10995458" type="audio/mpeg"/>
                <itunes:summary><![CDATA[Credits: 0.25 AMA PRA Category 1 Credits™
Claim CME/CE credit: https://www.pri-med.com/online-education/podcast/frankly-speaking-cme-158
Overview: Review the latest research on the impact of Non-Nutritive Sweeteners (NNS) on mortality, disease, and intermediate outcomes like microbiome and gut hormones. 
Guest: Guest: Susan Feeney, DNP, FNP-BC
Music Credit: Richard Onorato]]></itunes:summary>
        <itunes:author>Pri-Med</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>686</itunes:duration>
        <itunes:season>1</itunes:season>
        <itunes:episode>1</itunes:episode>
        <itunes:episodeType>full</itunes:episodeType>
        <itunes:image href="https://pbcdn1.podbean.com/imglogo/ep-logo/pbblog13721080/1db719b1ca4ea501cbd276d4d632e439.png" />    </item>
    <item>
        <title>Heartburn – Why “Test and Treat” Is Best - Frankly Speaking EP 157</title>
        <itunes:title>Heartburn – Why “Test and Treat” Is Best - Frankly Speaking EP 157</itunes:title>
        <link>https://primedfranklyspeaking.podbean.com/e/heartburn-%e2%80%93-why-test-and-treat-is-best-frankly-speaking-ep-157/</link>
                    <comments>https://primedfranklyspeaking.podbean.com/e/heartburn-%e2%80%93-why-test-and-treat-is-best-frankly-speaking-ep-157/#comments</comments>        <pubDate>Mon, 27 Jan 2020 05:30:00 +0000</pubDate>
        <guid isPermaLink="false">8cde46b2-b3b4-4a03-846e-fdaee2b923b7</guid>
                                    <description><![CDATA[<p>Credits: 0.25 AMA PRA Category 1 Credits™</p>
 <p>Claim CME/CE credit: <a href='https://www.pri-med.com/online-education/podcast/frankly-speaking-cme-157'> https://www.pri-med.com/online-education/podcast/frankly-speaking-cme-157</a></p>
 <p>Overview: Heartburn is a frequent complaint in primary care practices. The etiology is broad, from reflux to H. pylori infection and PUD. While many clinicians treat symptomatically, this may not lead to patient satisfaction. A recent network meta-analysis published in The BMJ, concluded that a ‘test and treat’ approach resulted in the lowest reports for patients to remain symptomatic at follow-up.</p>
 <p>Guest: Robert Baldor, MD, FAAFP</p>
 <p>Music Credit: Richard Onorato</p>
]]></description>
                                                            <content:encoded><![CDATA[<p>Credits: 0.25 AMA PRA Category 1 Credits™</p>
 <p>Claim CME/CE credit: <a href='https://www.pri-med.com/online-education/podcast/frankly-speaking-cme-157'> https://www.pri-med.com/online-education/podcast/frankly-speaking-cme-157</a></p>
 <p>Overview: Heartburn is a frequent complaint in primary care practices. The etiology is broad, from reflux to H. pylori infection and PUD. While many clinicians treat symptomatically, this may not lead to patient satisfaction. A recent network meta-analysis published in The BMJ, concluded that a ‘test and treat’ approach resulted in the lowest reports for patients to remain symptomatic at follow-up.</p>
 <p>Guest: Robert Baldor, MD, FAAFP</p>
 <p>Music Credit: Richard Onorato</p>
]]></content:encoded>
                                    
        <enclosure url="https://mcdn.podbean.com/mf/web/afmy0n/secure_primed_frankly-speaking-cme-157-final.mp3" length="21826483" type="audio/mpeg"/>
                <itunes:summary><![CDATA[Credits: 0.25 AMA PRA Category 1 Credits™ Claim CME/CE credit:  https://www.pri-med.com/online-education/podcast/frankly-speaking-cme-157 Overview: Heartburn is a frequent complaint in primary care practices. The etiology is broad, from reflux to H. pylori infection and PUD. While many clinicians treat symptomatically, this may not lead to patient satisfaction. A recent network meta-analysis published in The BMJ, concluded that a ‘test and treat’ approach resulted in the lowest reports for patients to remain symptomatic at follow-up. Guest: Robert Baldor, MD, FAAFP Music Credit: Richard Onorato]]></itunes:summary>
        <itunes:author>Pri-Med</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>681</itunes:duration>
                                <itunes:image href="https://pbcdn1.podbean.com/imglogo/ep-logo/pbblog13721080/5280ab46dd3f73758fa9b885b3a3942c.png" />    </item>
    <item>
        <title>Cannabis Use in Pregnancy: A Worrisome Trend - Frankly Speaking EP 156</title>
        <itunes:title>Cannabis Use in Pregnancy: A Worrisome Trend - Frankly Speaking EP 156</itunes:title>
        <link>https://primedfranklyspeaking.podbean.com/e/cannabis-use-in-pregnancy-a-worrisome-trend-frankly-speaking-ep-156/</link>
                    <comments>https://primedfranklyspeaking.podbean.com/e/cannabis-use-in-pregnancy-a-worrisome-trend-frankly-speaking-ep-156/#comments</comments>        <pubDate>Mon, 20 Jan 2020 05:30:00 +0000</pubDate>
        <guid isPermaLink="false">6e3d2bc6-4cdc-49a3-8d23-c8955b154673</guid>
                                    <description><![CDATA[<p>Credits: 0.25 AMA PRA Category 1 Credits™</p>
 <p>Claim CME/CE credit: <a href='https://www.pri-med.com/online-education/podcast/frankly-speaking-cme-156'> https://www.pri-med.com/online-education/podcast/frankly-speaking-cme-156</a></p>
 <p>Overview: Cannabis use has been increasing as numerous states have decriminalized or even legalized cannabis possession and use. As a result, the rates of pregnant women who use cannabis have been rising. Learn more about these trends and the risks associated with cannabis use in pregnancy.</p>
 <p>Guest: Alan Ehrlich MD, FAAFP</p>
 <p>Music Credit: Richard Onorato</p>
]]></description>
                                                            <content:encoded><![CDATA[<p>Credits: 0.25 AMA PRA Category 1 Credits™</p>
 <p>Claim CME/CE credit: <a href='https://www.pri-med.com/online-education/podcast/frankly-speaking-cme-156'> https://www.pri-med.com/online-education/podcast/frankly-speaking-cme-156</a></p>
 <p>Overview: Cannabis use has been increasing as numerous states have decriminalized or even legalized cannabis possession and use. As a result, the rates of pregnant women who use cannabis have been rising. Learn more about these trends and the risks associated with cannabis use in pregnancy.</p>
 <p>Guest: Alan Ehrlich MD, FAAFP</p>
 <p>Music Credit: Richard Onorato</p>
]]></content:encoded>
                                    
        <enclosure url="https://mcdn.podbean.com/mf/web/t5ry9a/secure_primed_frankly-speaking-cme-156-final.mp3" length="18187468" type="audio/mpeg"/>
                <itunes:summary><![CDATA[Credits: 0.25 AMA PRA Category 1 Credits™ Claim CME/CE credit:  https://www.pri-med.com/online-education/podcast/frankly-speaking-cme-156 Overview: Cannabis use has been increasing as numerous states have decriminalized or even legalized cannabis possession and use. As a result, the rates of pregnant women who use cannabis have been rising. Learn more about these trends and the risks associated with cannabis use in pregnancy. Guest: Alan Ehrlich MD, FAAFP Music Credit: Richard Onorato]]></itunes:summary>
        <itunes:author>Pri-Med</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>568</itunes:duration>
                                <itunes:image href="https://pbcdn1.podbean.com/imglogo/ep-logo/pbblog13721080/fc9d6d63656c3c453cf865c1cba5d507.png" />    </item>
    <item>
        <title>A Brief Update of the Guidelines on the Management of Type 2 Diabetes - Frankly Speaking EP 155</title>
        <itunes:title>A Brief Update of the Guidelines on the Management of Type 2 Diabetes - Frankly Speaking EP 155</itunes:title>
        <link>https://primedfranklyspeaking.podbean.com/e/a-brief-update-of-the-guidelines-on-the-management-of-type-2-diabetes-frankly-speaking-ep-155/</link>
                    <comments>https://primedfranklyspeaking.podbean.com/e/a-brief-update-of-the-guidelines-on-the-management-of-type-2-diabetes-frankly-speaking-ep-155/#comments</comments>        <pubDate>Mon, 13 Jan 2020 05:30:00 +0000</pubDate>
        <guid isPermaLink="false">9057450d-475b-4744-b89c-7da4bcdef33d</guid>
                                    <description><![CDATA[<p>Credits: 0.25 AMA PRA Category 1 Credits™</p>
 <p>Claim CME/CE credit: <a href='https://www.pri-med.com/online-education/podcast/frankly-speaking-cme-155'> https://www.pri-med.com/online-education/podcast/frankly-speaking-cme-155</a></p>
 <p>Overview: Join us as we discuss key points from the 2019 update to the American Diabetes Association and the European Association for the Study of Diabetes consensus report. This update is now reflected in the American Diabetes Association's Standards of Medical Care—2020. </p>
 <p>Guest: Jill Terrien PhD, ANP-BC</p>
 <p>Music Credit: Richard Onorato</p>
]]></description>
                                                            <content:encoded><![CDATA[<p>Credits: 0.25 AMA PRA Category 1 Credits™</p>
 <p>Claim CME/CE credit: <a href='https://www.pri-med.com/online-education/podcast/frankly-speaking-cme-155'> https://www.pri-med.com/online-education/podcast/frankly-speaking-cme-155</a></p>
 <p>Overview: Join us as we discuss key points from the 2019 update to the American Diabetes Association and the European Association for the Study of Diabetes consensus report. This update is now reflected in the American Diabetes Association's <em>Standards of Medical Care—2020</em>. </p>
 <p>Guest: Jill Terrien PhD, ANP-BC</p>
 <p>Music Credit: Richard Onorato</p>
]]></content:encoded>
                                    
        <enclosure url="https://mcdn.podbean.com/mf/web/kfnv95/secure_primed_frankly-speaking-cme-155_1.mp3" length="19465519" type="audio/mpeg"/>
                <itunes:summary><![CDATA[Credits: 0.25 AMA PRA Category 1 Credits™ Claim CME/CE credit:  https://www.pri-med.com/online-education/podcast/frankly-speaking-cme-155 Overview: Join us as we discuss key points from the 2019 update to the American Diabetes Association and the European Association for the Study of Diabetes consensus report. This update is now reflected in the American Diabetes Association's Standards of Medical Care—2020.  Guest: Jill Terrien PhD, ANP-BC Music Credit: Richard Onorato]]></itunes:summary>
        <itunes:author>Pri-Med</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>608</itunes:duration>
                                <itunes:image href="https://pbcdn1.podbean.com/imglogo/ep-logo/pbblog13721080/5e4dca5c04e662f5e48910ebf4cf645d.png" />    </item>
    <item>
        <title>Skip the Colonoscopy? - Frankly Speaking EP 154</title>
        <itunes:title>Skip the Colonoscopy? - Frankly Speaking EP 154</itunes:title>
        <link>https://primedfranklyspeaking.podbean.com/e/skip-the-colonoscopy-frankly-speaking-ep-154/</link>
                    <comments>https://primedfranklyspeaking.podbean.com/e/skip-the-colonoscopy-frankly-speaking-ep-154/#comments</comments>        <pubDate>Mon, 06 Jan 2020 14:36:00 +0000</pubDate>
        <guid isPermaLink="false">ec4b151c-e83b-48b5-ab1c-7f6e9b0f5bd1</guid>
                                    <description><![CDATA[<p>Credits: 0.25 AMA PRA Category 1 Credits™</p>
<p>Claim CME/CE credit: <a href='https://www.pri-med.com/online-education/podcast/frankly-speaking-cme-154'>https://www.pri-med.com/online-education/podcast/frankly-speaking-cme-154</a> </p>
<p>Overview: Join us as we discuss a recent report in the British Medical Journal that reviewed data on the effectiveness of colorectal cancer screening programs. The report presented new guidelines which recommend a “shared decision-making model,” and suggest that individuals with an estimated 15-year colorectal cancer risk below 3% undergo no screening at all. This session will review the recently published guidelines to understand the data behind their recommendations and discuss how best to implement such an approach in your practice. </p>
<p>Guest: Robert Baldor, MD,FAAFP </p>
<p>Music Credit: Richard Onorato</p>
]]></description>
                                                            <content:encoded><![CDATA[<p>Credits: 0.25 AMA PRA Category 1 Credits™</p>
<p>Claim CME/CE credit: <a href='https://www.pri-med.com/online-education/podcast/frankly-speaking-cme-154'>https://www.pri-med.com/online-education/podcast/frankly-speaking-cme-154</a> </p>
<p>Overview: Join us as we discuss a recent report in the <em>British Medical Journal</em> that reviewed data on the effectiveness of colorectal cancer screening programs. The report presented new guidelines which recommend a “shared decision-making model,” and suggest that individuals with an estimated 15-year colorectal cancer risk below 3% undergo no screening at all. This session will review the recently published guidelines to understand the data behind their recommendations and discuss how best to implement such an approach in your practice. </p>
<p>Guest: Robert Baldor, MD,FAAFP </p>
<p>Music Credit: Richard Onorato</p>
]]></content:encoded>
                                    
        <enclosure url="https://mcdn.podbean.com/mf/web/5zn7vd/secure_primed_frankly-speaking-154-colon-2.mp3" length="31414858" type="audio/mpeg"/>
                <itunes:summary><![CDATA[Credits: 0.25 AMA PRA Category 1 Credits™
Claim CME/CE credit: https://www.pri-med.com/online-education/podcast/frankly-speaking-cme-154 
Overview: Join us as we discuss a recent report in the British Medical Journal that reviewed data on the effectiveness of colorectal cancer screening programs. The report presented new guidelines which recommend a “shared decision-making model,” and suggest that individuals with an estimated 15-year colorectal cancer risk below 3% undergo no screening at all. This session will review the recently published guidelines to understand the data behind their recommendations and discuss how best to implement such an approach in your practice. 
Guest: Robert Baldor, MD,FAAFP 
Music Credit: Richard Onorato]]></itunes:summary>
        <itunes:author>Pri-Med</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>785</itunes:duration>
        <itunes:season>1</itunes:season>
        <itunes:episode>1</itunes:episode>
        <itunes:episodeType>full</itunes:episodeType>
        <itunes:image href="https://pbcdn1.podbean.com/imglogo/ep-logo/pbblog13721080/92e9228e76f7619c890526e43de8d5e9.png" />    </item>
    <item>
        <title>Improving Communication Between Parents and Teens - Frankly Speaking EP 153</title>
        <itunes:title>Improving Communication Between Parents and Teens - Frankly Speaking EP 153</itunes:title>
        <link>https://primedfranklyspeaking.podbean.com/e/improving-communication-between-parents-and-teens-frankly-speaking-ep-153/</link>
                    <comments>https://primedfranklyspeaking.podbean.com/e/improving-communication-between-parents-and-teens-frankly-speaking-ep-153/#comments</comments>        <pubDate>Mon, 30 Dec 2019 05:30:00 +0000</pubDate>
        <guid isPermaLink="false">ec2c08ee-7c72-42ba-8e06-edfb2fae44cb</guid>
                                    <description><![CDATA[<p>Credits: 0.25 AMA PRA Category 1 Credits™</p>
 <p>Claim CME/CE credit: <a href='https://www.pri-med.com/online-education/podcast/frankly-speaking-cme-153'> https://www.pri-med.com/online-education/podcast/frankly-speaking-cme-153</a> </p>
 <p>Overview: Discuss a recently published randomized controlled trial that examined methods to help parents improve their ability to discuss important health issues with their teenagers (ex. sexual activity, substance use).</p>
 <p>Guest: Jill Terrien PhD, ANP-BC</p>
 <p>Music Credit: Richard Onorato</p>
]]></description>
                                                            <content:encoded><![CDATA[<p>Credits: 0.25 AMA PRA Category 1 Credits™</p>
 <p>Claim CME/CE credit: <a href='https://www.pri-med.com/online-education/podcast/frankly-speaking-cme-153'> https://www.pri-med.com/online-education/podcast/frankly-speaking-cme-153</a> </p>
 <p>Overview: Discuss a recently published randomized controlled trial that examined methods to help parents improve their ability to discuss important health issues with their teenagers (ex. sexual activity, substance use).</p>
 <p>Guest: Jill Terrien PhD, ANP-BC</p>
 <p>Music Credit: Richard Onorato</p>
]]></content:encoded>
                                    
        <enclosure url="https://mcdn.podbean.com/mf/web/8hp28k/secure_primed_frankly-speaking-parent-teen-153.mp3" length="27066436" type="audio/mpeg"/>
                <itunes:summary><![CDATA[Credits: 0.25 AMA PRA Category 1 Credits™ Claim CME/CE credit:  https://www.pri-med.com/online-education/podcast/frankly-speaking-cme-153  Overview: Discuss a recently published randomized controlled trial that examined methods to help parents improve their ability to discuss important health issues with their teenagers (ex. sexual activity, substance use). Guest: Jill Terrien PhD, ANP-BC Music Credit: Richard Onorato]]></itunes:summary>
        <itunes:author>Pri-Med</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>676</itunes:duration>
                                <itunes:image href="https://pbcdn1.podbean.com/imglogo/ep-logo/pbblog13721080/67192afffa35db483235cd283ccdd445.png" />    </item>
    <item>
        <title>Winter’s Here – Time to Review the Latest Community-Acquired Pneumonia Guidelines - Frankly Speaking EP 152</title>
        <itunes:title>Winter’s Here – Time to Review the Latest Community-Acquired Pneumonia Guidelines - Frankly Speaking EP 152</itunes:title>
        <link>https://primedfranklyspeaking.podbean.com/e/winter-s-here-%e2%80%93-time-to-review-the-latest-community-acquired-pneumonia-guidelines-frankly-speaking-ep-152/</link>
                    <comments>https://primedfranklyspeaking.podbean.com/e/winter-s-here-%e2%80%93-time-to-review-the-latest-community-acquired-pneumonia-guidelines-frankly-speaking-ep-152/#comments</comments>        <pubDate>Mon, 23 Dec 2019 05:30:00 +0000</pubDate>
        <guid isPermaLink="false">ade5ea51-e78a-4293-bc7b-9ef20219e06e</guid>
                                    <description><![CDATA[<p>Credits: 0.25 AMA PRA Category 1 Credits™</p>
 <p>Claim CME/CE credit: <a href='https://www.pri-med.com/online-education/podcast/frankly-speaking-cme-152'>https://www.pri-med.com/online-education/podcast/frankly-speaking-cme-152</a></p>
 <p>Overview: The Infectious Disease Society of America in conjunction with the American Thoracic Society have updated their guidelines on diagnosing and treating Community Acquired Pneumonia (CAP) in adults. Recommended changes from the 2007 guidelines include how to address the growing issue of antibiotic resistance. We will review this latest recommendation, focusing on the best approach for outpatient care.</p>
 <p>Guest: Robert Baldor, MD, FAAFP</p>
 <p>Music Credit: Richard Onorato</p>
]]></description>
                                                            <content:encoded><![CDATA[<p>Credits: 0.25 AMA PRA Category 1 Credits™</p>
 <p>Claim CME/CE credit: <a href='https://www.pri-med.com/online-education/podcast/frankly-speaking-cme-152'>https://www.pri-med.com/online-education/podcast/frankly-speaking-cme-152</a></p>
 <p>Overview: The Infectious Disease Society of America in conjunction with the American Thoracic Society have updated their guidelines on diagnosing and treating Community Acquired Pneumonia (CAP) in adults. Recommended changes from the 2007 guidelines include how to address the growing issue of antibiotic resistance. We will review this latest recommendation, focusing on the best approach for outpatient care.</p>
 <p>Guest: Robert Baldor, MD, FAAFP</p>
 <p>Music Credit: Richard Onorato</p>
]]></content:encoded>
                                    
        <enclosure url="https://mcdn.podbean.com/mf/web/fqbreb/secure_primed_a.mp3" length="21101522" type="audio/mpeg"/>
                <itunes:summary><![CDATA[Credits: 0.25 AMA PRA Category 1 Credits™ Claim CME/CE credit: https://www.pri-med.com/online-education/podcast/frankly-speaking-cme-152 Overview: The Infectious Disease Society of America in conjunction with the American Thoracic Society have updated their guidelines on diagnosing and treating Community Acquired Pneumonia (CAP) in adults. Recommended changes from the 2007 guidelines include how to address the growing issue of antibiotic resistance. We will review this latest recommendation, focusing on the best approach for outpatient care. Guest: Robert Baldor, MD, FAAFP Music Credit: Richard Onorato]]></itunes:summary>
        <itunes:author>Pri-Med</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>659</itunes:duration>
                                <itunes:image href="https://pbcdn1.podbean.com/imglogo/ep-logo/pbblog13721080/718ba2f0a6fc602af9d2f94897269b9a.png" />    </item>
    <item>
        <title>Vaping: Health Threats in a Rapidly Changing Landscape - Frankly Speaking EP 151</title>
        <itunes:title>Vaping: Health Threats in a Rapidly Changing Landscape - Frankly Speaking EP 151</itunes:title>
        <link>https://primedfranklyspeaking.podbean.com/e/vaping-health-threats-in-a-rapidly-changing-landscape-frankly-speaking-ep-151/</link>
                    <comments>https://primedfranklyspeaking.podbean.com/e/vaping-health-threats-in-a-rapidly-changing-landscape-frankly-speaking-ep-151/#comments</comments>        <pubDate>Mon, 16 Dec 2019 05:30:00 +0000</pubDate>
        <guid isPermaLink="false">61c093e5-0318-42e3-b038-9a434d5afa47</guid>
                                    <description><![CDATA[<p>Credits: 0.25 AMA PRA Category 1 Credits™</p>
 <p>Claim CME/CE credit: <a href='https://www.pri-med.com/online-education/podcast/frankly-speaking-cme-151'> https://www.pri-med.com/online-education/podcast/frankly-speaking-cme-151</a></p>
 <p>Overview: Every day new information on e-cigarettes is in the media – the explosion of teen use with a resulting epidemic of nicotine addiction and most recently, increasing cases of serious lung related illness associated with vaping. Join us as we discuss this epidemic and the emergence of VAPI (Vaping Associated Pulmonary Injury)</p>
 <p>Guest: Susan Feeney, DNP, FNP-BC</p>
 <p>Music Credit: Richard Onorato</p>
]]></description>
                                                            <content:encoded><![CDATA[<p>Credits: 0.25 AMA PRA Category 1 Credits™</p>
 <p>Claim CME/CE credit: <a href='https://www.pri-med.com/online-education/podcast/frankly-speaking-cme-151'> https://www.pri-med.com/online-education/podcast/frankly-speaking-cme-151</a></p>
 <p>Overview: Every day new information on e-cigarettes is in the media – the explosion of teen use with a resulting epidemic of nicotine addiction and most recently, increasing cases of serious lung related illness associated with vaping. Join us as we discuss this epidemic and the emergence of VAPI (Vaping Associated Pulmonary Injury)</p>
 <p>Guest: Susan Feeney, DNP, FNP-BC</p>
 <p>Music Credit: Richard Onorato</p>
]]></content:encoded>
                                    
        <enclosure url="https://mcdn.podbean.com/mf/web/qu4azw/secure_primed_frankly-speaking-cme-151.mp3" length="22794679" type="audio/mpeg"/>
                <itunes:summary><![CDATA[Credits: 0.25 AMA PRA Category 1 Credits™ Claim CME/CE credit:  https://www.pri-med.com/online-education/podcast/frankly-speaking-cme-151 Overview: Every day new information on e-cigarettes is in the media – the explosion of teen use with a resulting epidemic of nicotine addiction and most recently, increasing cases of serious lung related illness associated with vaping. Join us as we discuss this epidemic and the emergence of VAPI (Vaping Associated Pulmonary Injury) Guest: Susan Feeney, DNP, FNP-BC Music Credit: Richard Onorato]]></itunes:summary>
        <itunes:author>Pri-Med</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>712</itunes:duration>
                                <itunes:image href="https://pbcdn1.podbean.com/imglogo/ep-logo/pbblog13721080/ff63f577c9ee9a8501a7700c11b7b531.png" />    </item>
    <item>
        <title>Red Meat: Confusion and Conflicts of Interest - Frankly Speaking EP 150</title>
        <itunes:title>Red Meat: Confusion and Conflicts of Interest - Frankly Speaking EP 150</itunes:title>
        <link>https://primedfranklyspeaking.podbean.com/e/red-meat-confusion-and-conflicts-of-interest-frankly-speaking-ep-150/</link>
                    <comments>https://primedfranklyspeaking.podbean.com/e/red-meat-confusion-and-conflicts-of-interest-frankly-speaking-ep-150/#comments</comments>        <pubDate>Mon, 09 Dec 2019 05:30:00 +0000</pubDate>
        <guid isPermaLink="false">2db7a55e-cd90-4174-aad7-6161ab59f647</guid>
                                    <description><![CDATA[<p>Credits: 0.25 AMA PRA Category 1 Credits™</p>
 <p>Claim CME/CE credit: <a href='https://www.pri-med.com/online-education/podcast/frankly-speaking-cme-150'> https://www.pri-med.com/online-education/podcast/frankly-speaking-cme-150</a> </p>
 <p>Overview: Join us as we review a landmark paper that reached the conclusion that limiting red meat would not have a large impact on patient outcomes.</p>
 <p>Guest: Robert A. Baldor, MD, FAAFP</p>
 <p>Music Credit: Richard Onorato</p>
]]></description>
                                                            <content:encoded><![CDATA[<p>Credits: 0.25 AMA PRA Category 1 Credits™</p>
 <p>Claim CME/CE credit: <a href='https://www.pri-med.com/online-education/podcast/frankly-speaking-cme-150'> https://www.pri-med.com/online-education/podcast/frankly-speaking-cme-150</a> </p>
 <p>Overview: Join us as we review a landmark paper that reached the conclusion that limiting red meat would not have a large impact on patient outcomes.</p>
 <p>Guest: Robert A. Baldor, MD, FAAFP</p>
 <p>Music Credit: Richard Onorato</p>
]]></content:encoded>
                                    
        <enclosure url="https://mcdn.podbean.com/mf/web/39atz2/secure_primed_frankly-speaking-cme-150.mp3" length="27085667" type="audio/mpeg"/>
                <itunes:summary><![CDATA[Credits: 0.25 AMA PRA Category 1 Credits™ Claim CME/CE credit:  https://www.pri-med.com/online-education/podcast/frankly-speaking-cme-150  Overview: Join us as we review a landmark paper that reached the conclusion that limiting red meat would not have a large impact on patient outcomes. Guest: Robert A. Baldor, MD, FAAFP Music Credit: Richard Onorato]]></itunes:summary>
        <itunes:author>Pri-Med</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>846</itunes:duration>
                                <itunes:image href="https://pbcdn1.podbean.com/imglogo/ep-logo/pbblog13721080/a1833e4eae03f7ee2d7056567fd4e247.png" />    </item>
    <item>
        <title>Transgender Care: Breaking the Barriers and Acknowledging Bias - Frankly Speaking EP 149</title>
        <itunes:title>Transgender Care: Breaking the Barriers and Acknowledging Bias - Frankly Speaking EP 149</itunes:title>
        <link>https://primedfranklyspeaking.podbean.com/e/transgender-care-breaking-the-barriers-and-acknowledging-bias-frankly-speaking-ep-149/</link>
                    <comments>https://primedfranklyspeaking.podbean.com/e/transgender-care-breaking-the-barriers-and-acknowledging-bias-frankly-speaking-ep-149/#comments</comments>        <pubDate>Mon, 02 Dec 2019 05:30:00 +0000</pubDate>
        <guid isPermaLink="false">b5c69b37-7739-464b-86cb-fca4afc450d8</guid>
                                    <description><![CDATA[<p>Credits: 0.25 AMA PRA Category 1 Credits™</p>
<p>Claim CME/CE credit: <a href='https://www.pri-med.com/online-education/podcast/frankly-speaking-cme-149'>https://www.pri-med.com/online-education/podcast/frankly-speaking-cme-149 </a></p>
<p>Overview: Join us as we discuss best practices for providing care to the transgender population. </p>
<p>Guest: Jill Terrien PhD, ANP-BC</p>
<p>Music Credit: Richard Onorato</p>
]]></description>
                                                            <content:encoded><![CDATA[<p>Credits: 0.25 AMA PRA Category 1 Credits™</p>
<p>Claim CME/CE credit: <a href='https://www.pri-med.com/online-education/podcast/frankly-speaking-cme-149'>https://www.pri-med.com/online-education/podcast/frankly-speaking-cme-149 </a></p>
<p>Overview: Join us as we discuss best practices for providing care to the transgender population. </p>
<p>Guest: Jill Terrien PhD, ANP-BC</p>
<p>Music Credit: Richard Onorato</p>
]]></content:encoded>
                                    
        <enclosure url="https://mcdn.podbean.com/mf/web/6wcylx/secure_primed_frankly-speaking-cme-149-edit.mp3" length="10484233" type="audio/mpeg"/>
                <itunes:summary><![CDATA[Credits: 0.25 AMA PRA Category 1 Credits™
Claim CME/CE credit: https://www.pri-med.com/online-education/podcast/frankly-speaking-cme-149 
Overview: Join us as we discuss best practices for providing care to the transgender population. 
Guest: Jill Terrien PhD, ANP-BC
Music Credit: Richard Onorato]]></itunes:summary>
        <itunes:author>Pri-Med</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>653</itunes:duration>
        <itunes:season>1</itunes:season>
        <itunes:episode>1</itunes:episode>
        <itunes:episodeType>full</itunes:episodeType>
        <itunes:image href="https://pbcdn1.podbean.com/imglogo/ep-logo/pbblog13721080/9ab146cb9135b6e546a3c805bc87ae5c.png" />    </item>
    <item>
        <title>Screening for Autism Spectrum Disorders: We Need Better Tools - Frankly Speaking EP 148</title>
        <itunes:title>Screening for Autism Spectrum Disorders: We Need Better Tools - Frankly Speaking EP 148</itunes:title>
        <link>https://primedfranklyspeaking.podbean.com/e/screening-for-autism-spectrum-disorders-we-need-better-tools-frankly-speaking-ep-148/</link>
                    <comments>https://primedfranklyspeaking.podbean.com/e/screening-for-autism-spectrum-disorders-we-need-better-tools-frankly-speaking-ep-148/#comments</comments>        <pubDate>Mon, 25 Nov 2019 05:30:00 +0000</pubDate>
        <guid isPermaLink="false">f578ac45-303b-4752-ae51-91434baa5384</guid>
                                    <description><![CDATA[<p>Credits: 0.25 AMA PRA Category 1 Credits™</p>
<p>Claim CME/CE credit: <a href='https://www.pri-med.com/online-education/podcast/frankly-speaking-cme-148'>https://www.pri-med.com/online-education/podcast/frankly-speaking-cme-148</a></p>
<p>Overview: Universal screening of young children is recommended by the American Academy of Pediatrics (AAP) for diagnosing Autism Spectrum Disorders (ASD), as early intervention leads to improvements in function. The U.S. Preventive Services Task Force (USPSTF), however, has concluded there isn't enough evidence about the efficacy of universal screening to recommend it. To assess the effectiveness of the Modified Checklist for Autism in Toddlers with Follow-Up (M-CHAT/F), a study of 26,000 children was completed at the Children's Hospital of Philadelphia. This episode will review the current guidelines for ASD screening and the results of this study—which revealed significant shortcomings in current screening tools—as well as discuss how to counsel concerned parents.</p>
<p>Guest: Robert Baldor, MD, FAAFP</p>
<p>Music Credit: Richard Onorato</p>
]]></description>
                                                            <content:encoded><![CDATA[<p>Credits: 0.25 AMA PRA Category 1 Credits™</p>
<p>Claim CME/CE credit: <a href='https://www.pri-med.com/online-education/podcast/frankly-speaking-cme-148'>https://www.pri-med.com/online-education/podcast/frankly-speaking-cme-148</a></p>
<p>Overview: Universal screening of young children is recommended by the American Academy of Pediatrics (AAP) for diagnosing Autism Spectrum Disorders (ASD), as early intervention leads to improvements in function. The U.S. Preventive Services Task Force (USPSTF), however, has concluded there isn't enough evidence about the efficacy of universal screening to recommend it. To assess the effectiveness of the Modified Checklist for Autism in Toddlers with Follow-Up (M-CHAT/F), a study of 26,000 children was completed at the Children's Hospital of Philadelphia. This episode will review the current guidelines for ASD screening and the results of this study—which revealed significant shortcomings in current screening tools—as well as discuss how to counsel concerned parents.</p>
<p>Guest: Robert Baldor, MD, FAAFP</p>
<p>Music Credit: Richard Onorato</p>
]]></content:encoded>
                                    
        <enclosure url="https://mcdn.podbean.com/mf/web/hyawzj/secure_primed_frankly-speaking-cme-148.mp3" length="18768269" type="audio/mpeg"/>
                <itunes:summary><![CDATA[Credits: 0.25 AMA PRA Category 1 Credits™
Claim CME/CE credit: https://www.pri-med.com/online-education/podcast/frankly-speaking-cme-148
Overview: Universal screening of young children is recommended by the American Academy of Pediatrics (AAP) for diagnosing Autism Spectrum Disorders (ASD), as early intervention leads to improvements in function. The U.S. Preventive Services Task Force (USPSTF), however, has concluded there isn't enough evidence about the efficacy of universal screening to recommend it. To assess the effectiveness of the Modified Checklist for Autism in Toddlers with Follow-Up (M-CHAT/F), a study of 26,000 children was completed at the Children's Hospital of Philadelphia. This episode will review the current guidelines for ASD screening and the results of this study—which revealed significant shortcomings in current screening tools—as well as discuss how to counsel concerned parents.
Guest: Robert Baldor, MD, FAAFP
Music Credit: Richard Onorato]]></itunes:summary>
        <itunes:author>Pri-Med</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>586</itunes:duration>
        <itunes:season>1</itunes:season>
        <itunes:episode>1</itunes:episode>
        <itunes:episodeType>full</itunes:episodeType>
        <itunes:image href="https://pbcdn1.podbean.com/imglogo/ep-logo/pbblog13721080/42d192c3273a30359544e4e4d562f373.png" />    </item>
    <item>
        <title>Put Your Phone Down: The Association Between Adolescent Mental Health and Social Media Use - Frankly Speaking EP 147</title>
        <itunes:title>Put Your Phone Down: The Association Between Adolescent Mental Health and Social Media Use - Frankly Speaking EP 147</itunes:title>
        <link>https://primedfranklyspeaking.podbean.com/e/put-your-phone-down-the-association-between-adolescent-mental-health-and-social-media-use-frankly-speaking-ep-147/</link>
                    <comments>https://primedfranklyspeaking.podbean.com/e/put-your-phone-down-the-association-between-adolescent-mental-health-and-social-media-use-frankly-speaking-ep-147/#comments</comments>        <pubDate>Mon, 18 Nov 2019 05:30:00 +0000</pubDate>
        <guid isPermaLink="false">101c4aac2ab24cf3b5e901cddac0adb2</guid>
                                    <description><![CDATA[<p>Credits: 0.25 AMA PRA Category 1 Credits™</p>
<p>Claim CME/CE credit: <a href='https://www.pri-med.com/online-education/podcast/frankly-speaking-cme-147'>https://www.pri-med.com/online-education/podcast/frankly-speaking-cme-147</a></p>
<p>Overview: Social media use is ubiquitous across American society. There has also been an increase in adolescent mood disorders, such as anxiety and depression, as well as teen suicidal behavior. Join us as we discuss the association between social media use and adolescent mental health. </p>
<p>Guest: Susan Feeney, DNP, FNP-BC </p>
<p>Music Credit: Richard Onorato</p>
]]></description>
                                                            <content:encoded><![CDATA[<p>Credits: 0.25 AMA PRA Category 1 Credits™</p>
<p>Claim CME/CE credit: <a href='https://www.pri-med.com/online-education/podcast/frankly-speaking-cme-147'>https://www.pri-med.com/online-education/podcast/frankly-speaking-cme-147</a></p>
<p>Overview: Social media use is ubiquitous across American society. There has also been an increase in adolescent mood disorders, such as anxiety and depression, as well as teen suicidal behavior. Join us as we discuss the association between social media use and adolescent mental health. </p>
<p>Guest: Susan Feeney, DNP, FNP-BC </p>
<p>Music Credit: Richard Onorato</p>
]]></content:encoded>
                                    
        <enclosure url="https://mcdn.podbean.com/mf/web/vbfnsc/secure_primed_frankly-speaking-cme-147-edited.mp3" length="12210972" type="audio/mpeg"/>
                <itunes:summary><![CDATA[Credits: 0.25 AMA PRA Category 1 Credits™
Claim CME/CE credit: https://www.pri-med.com/online-education/podcast/frankly-speaking-cme-147
Overview: Social media use is ubiquitous across American society. There has also been an increase in adolescent mood disorders, such as anxiety and depression, as well as teen suicidal behavior. Join us as we discuss the association between social media use and adolescent mental health. 
Guest: Susan Feeney, DNP, FNP-BC 
Music Credit: Richard Onorato]]></itunes:summary>
        <itunes:author>Pri-Med</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>762</itunes:duration>
        <itunes:season>1</itunes:season>
        <itunes:episode>1</itunes:episode>
        <itunes:episodeType>full</itunes:episodeType>
        <itunes:image href="https://pbcdn1.podbean.com/imglogo/ep-logo/pbblog13721080/c1f3cd21e55d195b6a7633b7b1b97d1b.png" />    </item>
    <item>
        <title>Breast Density and Supplemental Imaging: Detecting Advanced Breast Cancer - Frankly Speaking EP 146</title>
        <itunes:title>Breast Density and Supplemental Imaging: Detecting Advanced Breast Cancer - Frankly Speaking EP 146</itunes:title>
        <link>https://primedfranklyspeaking.podbean.com/e/breast-density-and-supplemental-imaging-detecting-advanced-breast-cancer-frankly-speaking-ep-146/</link>
                    <comments>https://primedfranklyspeaking.podbean.com/e/breast-density-and-supplemental-imaging-detecting-advanced-breast-cancer-frankly-speaking-ep-146/#comments</comments>        <pubDate>Mon, 11 Nov 2019 05:30:00 +0000</pubDate>
        <guid isPermaLink="false">20ce805c651647149cfcf37a6d15bb0d</guid>
                                    <description><![CDATA[<p>Credits: 0.25 AMA PRA Category 1 Credits™</p>
 <p>Claim CME/CE credit: <a href='https://www.pri-med.com/online-education/podcast/frankly-speaking-cme-146'>https://www.pri-med.com/online-education/podcast/frankly-speaking-cme-146</a></p>
 <p>Overview: Join us as we discuss breast density and the use of supplemental imaging to assess risk for advanced breast cancer.</p>
 <p>Guest: Jill Terrien PhD, ANP-BC</p>
 <p>Music Credit: Richard Onorato</p>
]]></description>
                                                            <content:encoded><![CDATA[<p>Credits: 0.25 AMA PRA Category 1 Credits™</p>
 <p>Claim CME/CE credit: <a href='https://www.pri-med.com/online-education/podcast/frankly-speaking-cme-146'>https://www.pri-med.com/online-education/podcast/frankly-speaking-cme-146</a></p>
 <p>Overview: Join us as we discuss breast density and the use of supplemental imaging to assess risk for advanced breast cancer.</p>
 <p>Guest: Jill Terrien PhD, ANP-BC</p>
 <p>Music Credit: Richard Onorato</p>
]]></content:encoded>
                                    
        <enclosure url="https://mcdn.podbean.com/mf/web/y4f63g/secure_primed_frankly-speaking-cme-146-w-east-outro.mp3" length="8620144" type="audio/mpeg"/>
                <itunes:summary><![CDATA[Credits: 0.25 AMA PRA Category 1 Credits™ Claim CME/CE credit: https://www.pri-med.com/online-education/podcast/frankly-speaking-cme-146 Overview: Join us as we discuss breast density and the use of supplemental imaging to assess risk for advanced breast cancer. Guest: Jill Terrien PhD, ANP-BC Music Credit: Richard Onorato]]></itunes:summary>
        <itunes:author>Pri-Med</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>537</itunes:duration>
                                <itunes:image href="https://pbcdn1.podbean.com/imglogo/ep-logo/pbblog13721080/231aa4eb8d169486216785f48fb85cc3.png" />    </item>
    <item>
        <title>COPD Exacerbations: Who Needs Antibiotics?  - Frankly Speaking EP 145</title>
        <itunes:title>COPD Exacerbations: Who Needs Antibiotics?  - Frankly Speaking EP 145</itunes:title>
        <link>https://primedfranklyspeaking.podbean.com/e/copd-exacerbations-who-needs-antibiotics-frankly-speaking-ep-145/</link>
                    <comments>https://primedfranklyspeaking.podbean.com/e/copd-exacerbations-who-needs-antibiotics-frankly-speaking-ep-145/#comments</comments>        <pubDate>Mon, 04 Nov 2019 05:30:00 +0000</pubDate>
        <guid isPermaLink="false">f0981699e4eb4dbbbd812aac901e1305</guid>
                                    <description><![CDATA[<p>Credits: 0.25 AMA PRA Category 1 Credits™</p>
 <p>Claim CME/CE credit: <a href='https://www.pri-med.com/online-education/podcast/frankly-speaking-cme-145'>https://www.pri-med.com/online-education/podcast/frankly-speaking-cme-145</a></p>
 <p>Overview: Patients with COPD frequently have exacerbations, often triggered by an acute upper respiratory infection (URI). C-reactive protein (CRP) testing is a new way of assessing whether or not antibiotics are needed to treat. </p>
 <p>Guest: Alan Ehrlich MD, FAAFP</p>
 <p>Music Credit: Richard Onorato</p>
]]></description>
                                                            <content:encoded><![CDATA[<p>Credits: 0.25 AMA PRA Category 1 Credits™</p>
 <p>Claim CME/CE credit: <a href='https://www.pri-med.com/online-education/podcast/frankly-speaking-cme-145'>https://www.pri-med.com/online-education/podcast/frankly-speaking-cme-145</a></p>
 <p>Overview: Patients with COPD frequently have exacerbations, often triggered by an acute upper respiratory infection (URI). C-reactive protein (CRP) testing is a new way of assessing whether or not antibiotics are needed to treat. </p>
 <p>Guest: Alan Ehrlich MD, FAAFP</p>
 <p>Music Credit: Richard Onorato</p>
]]></content:encoded>
                                    
        <enclosure url="https://mcdn.podbean.com/mf/web/s5ej7y/secure_primed_frankly-speaking-cme-145.mp3" length="20051202" type="audio/mpeg"/>
                <itunes:summary><![CDATA[Credits: 0.25 AMA PRA Category 1 Credits™ Claim CME/CE credit: https://www.pri-med.com/online-education/podcast/frankly-speaking-cme-145 Overview: Patients with COPD frequently have exacerbations, often triggered by an acute upper respiratory infection (URI). C-reactive protein (CRP) testing is a new way of assessing whether or not antibiotics are needed to treat.  Guest: Alan Ehrlich MD, FAAFP Music Credit: Richard Onorato]]></itunes:summary>
        <itunes:author>Pri-Med</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>626</itunes:duration>
                                <itunes:image href="https://pbcdn1.podbean.com/imglogo/ep-logo/pbblog13721080/f09d478eeee332ac8936f65109bcf6ea.png" />    </item>
    <item>
        <title>Getting Glutened: Early Childhood Gluten Consumption and the Risk of Celiac Disease  - Frankly Speaking EP 144</title>
        <itunes:title>Getting Glutened: Early Childhood Gluten Consumption and the Risk of Celiac Disease  - Frankly Speaking EP 144</itunes:title>
        <link>https://primedfranklyspeaking.podbean.com/e/getting-glutened-early-childhood-gluten-consumption-and-the-risk-of-celiac-disease-frankly-speaking-ep-144/</link>
                    <comments>https://primedfranklyspeaking.podbean.com/e/getting-glutened-early-childhood-gluten-consumption-and-the-risk-of-celiac-disease-frankly-speaking-ep-144/#comments</comments>        <pubDate>Mon, 28 Oct 2019 04:30:00 +0000</pubDate>
        <guid isPermaLink="false">443537d2b77c4f45835716f907b442aa</guid>
                                    <description><![CDATA[<p>Credits: 0.25 AMA PRA Category 1 Credits™</p>
 <p>Claim CME/CE credit: <a href='https://www.pri-med.com/online-education/podcast/frankly-speaking-cme-144'>https://www.pri-med.com/online-education/podcast/frankly-speaking-cme-144</a></p>
 <p>Overview: The degree to which early exposure to gluten-containing foods affects the risk of developing celiac disease is controversial. Join us as we discuss a recent Norwegian study suggesting that the timing of introduction of gluten in the diet may be less important than the amount of gluten in the diet at 18 months of age.</p>
 <p>Guest: Alan Ehrlich MD, FAAFP</p>
 <p>Music Credit: Richard Onorato</p>
]]></description>
                                                            <content:encoded><![CDATA[<p>Credits: 0.25 AMA PRA Category 1 Credits™</p>
 <p>Claim CME/CE credit: <a href='https://www.pri-med.com/online-education/podcast/frankly-speaking-cme-144'>https://www.pri-med.com/online-education/podcast/frankly-speaking-cme-144</a></p>
 <p>Overview: The degree to which early exposure to gluten-containing foods affects the risk of developing celiac disease is controversial. Join us as we discuss a recent Norwegian study suggesting that the timing of introduction of gluten in the diet may be less important than the amount of gluten in the diet at 18 months of age.</p>
 <p>Guest: Alan Ehrlich MD, FAAFP</p>
 <p>Music Credit: Richard Onorato</p>
]]></content:encoded>
                                    
        <enclosure url="https://mcdn.podbean.com/mf/web/mv7zwc/secure_primed_frankly-speaking-cme-144.mp3" length="21097492" type="audio/mpeg"/>
                <itunes:summary><![CDATA[Credits: 0.25 AMA PRA Category 1 Credits™ Claim CME/CE credit: https://www.pri-med.com/online-education/podcast/frankly-speaking-cme-144 Overview: The degree to which early exposure to gluten-containing foods affects the risk of developing celiac disease is controversial. Join us as we discuss a recent Norwegian study suggesting that the timing of introduction of gluten in the diet may be less important than the amount of gluten in the diet at 18 months of age. Guest: Alan Ehrlich MD, FAAFP Music Credit: Richard Onorato]]></itunes:summary>
        <itunes:author>Pri-Med</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>659</itunes:duration>
                                <itunes:image href="https://pbcdn1.podbean.com/imglogo/ep-logo/pbblog13721080/7f41279598d181f53462544499bb4713.jpg" />    </item>
    <item>
        <title>Antibiotic Use in the US: A Look into How Americans Use Antibiotics Without a Prescription  - Frankly Speaking EP 143</title>
        <itunes:title>Antibiotic Use in the US: A Look into How Americans Use Antibiotics Without a Prescription  - Frankly Speaking EP 143</itunes:title>
        <link>https://primedfranklyspeaking.podbean.com/e/antibiotic-use-in-the-us-a-look-into-how-americans-use-antibiotics-without-a-prescription-frankly-speaking-ep-143/</link>
                    <comments>https://primedfranklyspeaking.podbean.com/e/antibiotic-use-in-the-us-a-look-into-how-americans-use-antibiotics-without-a-prescription-frankly-speaking-ep-143/#comments</comments>        <pubDate>Mon, 21 Oct 2019 04:30:00 +0000</pubDate>
        <guid isPermaLink="false">d8292fb9295e4bf9825ef79f2e1279b5</guid>
                                    <description><![CDATA[<p>Credits: 0.25 AMA PRA Category 1 Credits™</p>
 <p>Claim CME/CE credit: <a href='https://www.pri-med.com/online-education/podcast/frankly-speaking-cme-143'>https://www.pri-med.com/online-education/podcast/frankly-speaking-cme-143</a></p>
 <p>Overview: A recent scoping review revealed that nonprescription antibiotic use is a prevalent and understudied public health concern in the US. Inappropriate antibiotic prescribing and use has been a well-documented concern and these new findings only reinforce the need for more comprehensive approaches to this problem. Join us while we discuss the scoping review findings and some strategies for implementing antibiotic stewardship into your practice.</p>
 <p>Guest: Susan Feeney, DNP, FNP-BC, NP-C</p>
 <p>Music Credit: Richard Onorato</p>
]]></description>
                                                            <content:encoded><![CDATA[<p>Credits: 0.25 AMA PRA Category 1 Credits™</p>
 <p>Claim CME/CE credit: <a href='https://www.pri-med.com/online-education/podcast/frankly-speaking-cme-143'>https://www.pri-med.com/online-education/podcast/frankly-speaking-cme-143</a></p>
 <p>Overview: A recent scoping review revealed that nonprescription antibiotic use is a prevalent and understudied public health concern in the US. Inappropriate antibiotic prescribing and use has been a well-documented concern and these new findings only reinforce the need for more comprehensive approaches to this problem. Join us while we discuss the scoping review findings and some strategies for implementing antibiotic stewardship into your practice.</p>
 <p>Guest: Susan Feeney, DNP, FNP-BC, NP-C</p>
 <p>Music Credit: Richard Onorato</p>
]]></content:encoded>
                                    
        <enclosure url="https://mcdn.podbean.com/mf/web/om6tb4/secure_primed_frankly-speaking-cme-143.mp3" length="22471050" type="audio/mpeg"/>
                <itunes:summary><![CDATA[Credits: 0.25 AMA PRA Category 1 Credits™ Claim CME/CE credit: https://www.pri-med.com/online-education/podcast/frankly-speaking-cme-143 Overview: A recent scoping review revealed that nonprescription antibiotic use is a prevalent and understudied public health concern in the US. Inappropriate antibiotic prescribing and use has been a well-documented concern and these new findings only reinforce the need for more comprehensive approaches to this problem. Join us while we discuss the scoping review findings and some strategies for implementing antibiotic stewardship into your practice. Guest: Susan Feeney, DNP, FNP-BC, NP-C Music Credit: Richard Onorato]]></itunes:summary>
        <itunes:author>Pri-Med</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>702</itunes:duration>
                                <itunes:image href="https://pbcdn1.podbean.com/imglogo/ep-logo/pbblog13721080/833f415f1c75c1fd89afc8785cae67bc.png" />    </item>
    <item>
        <title>Saving the Brain: How Long Is Too Long to Pursue Endovascular Reperfusion After a Stroke?  - Frankly Speaking EP 142</title>
        <itunes:title>Saving the Brain: How Long Is Too Long to Pursue Endovascular Reperfusion After a Stroke?  - Frankly Speaking EP 142</itunes:title>
        <link>https://primedfranklyspeaking.podbean.com/e/saving-the-brain-how-long-is-too-long-to-pursue-endovascular-reperfusion-after-a-stroke-frankly-speaking-ep-142/</link>
                    <comments>https://primedfranklyspeaking.podbean.com/e/saving-the-brain-how-long-is-too-long-to-pursue-endovascular-reperfusion-after-a-stroke-frankly-speaking-ep-142/#comments</comments>        <pubDate>Wed, 16 Oct 2019 17:50:00 +0000</pubDate>
        <guid isPermaLink="false">4359196e8091457487a7eda41c2f9552</guid>
                                    <description><![CDATA[<p>Credits: 0.25 AMA PRA Category 1 Credits™</p>
 <p>Claim CME/CE credit: <a href='https://www.pri-med.com/online-education/podcast/frankly-speaking-cme-142'>https://www.pri-med.com/online-education/podcast/frankly-speaking-cme-142</a></p>
 <p>Overview: There has been increasing interest in the use of endovascular reperfusion for patients who have suffered an ischemic stroke. The American Heart Association (AHA) and the American Stroke Association (ASA) have jointly developed a nationwide registry to evaluate the benefits of these techniques on stroke outcomes. During this episode we will review a recent retrospective cohort study of almost 7,000 patients presenting with an acute ischemic stroke that demonstrates a significant benefit to endovascular reperfusion, even several hours after the onset of symptoms.</p>
 <p>Guest: Robert A. Baldor, MD, FAAFP</p>
 <p>Music Credit: Richard Onorato</p>
]]></description>
                                                            <content:encoded><![CDATA[<p>Credits: 0.25 AMA PRA Category 1 Credits™</p>
 <p>Claim CME/CE credit: <a href='https://www.pri-med.com/online-education/podcast/frankly-speaking-cme-142'>https://www.pri-med.com/online-education/podcast/frankly-speaking-cme-142</a></p>
 <p>Overview: There has been increasing interest in the use of endovascular reperfusion for patients who have suffered an ischemic stroke. The American Heart Association (AHA) and the American Stroke Association (ASA) have jointly developed a nationwide registry to evaluate the benefits of these techniques on stroke outcomes. During this episode we will review a recent retrospective cohort study of almost 7,000 patients presenting with an acute ischemic stroke that demonstrates a significant benefit to endovascular reperfusion, even several hours after the onset of symptoms.</p>
 <p>Guest: Robert A. Baldor, MD, FAAFP</p>
 <p>Music Credit: Richard Onorato</p>
]]></content:encoded>
                                    
        <enclosure url="https://mcdn.podbean.com/mf/web/s6vuw4/secure_primed_frankly-speaking-cme-142.mp3" length="21418650" type="audio/mpeg"/>
                <itunes:summary><![CDATA[Credits: 0.25 AMA PRA Category 1 Credits™ Claim CME/CE credit: https://www.pri-med.com/online-education/podcast/frankly-speaking-cme-142 Overview: There has been increasing interest in the use of endovascular reperfusion for patients who have suffered an ischemic stroke. The American Heart Association (AHA) and the American Stroke Association (ASA) have jointly developed a nationwide registry to evaluate the benefits of these techniques on stroke outcomes. During this episode we will review a recent retrospective cohort study of almost 7,000 patients presenting with an acute ischemic stroke that demonstrates a significant benefit to endovascular reperfusion, even several hours after the onset of symptoms. Guest: Robert A. Baldor, MD, FAAFP Music Credit: Richard Onorato]]></itunes:summary>
        <itunes:author>Pri-Med</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>669</itunes:duration>
                                <itunes:image href="https://pbcdn1.podbean.com/imglogo/ep-logo/pbblog13721080/971771634f05a54ab96e24d41bf9c5e3.png" />    </item>
    <item>
        <title>Gun Safety in Pediatric Populations: Exploring New Data and Assessing Risk - Frankly Speaking EP 141</title>
        <itunes:title>Gun Safety in Pediatric Populations: Exploring New Data and Assessing Risk - Frankly Speaking EP 141</itunes:title>
        <link>https://primedfranklyspeaking.podbean.com/e/gun-safety-in-pediatric-populations-exploring-new-data-and-assessing-risk-frankly-speaking-ep-141/</link>
                    <comments>https://primedfranklyspeaking.podbean.com/e/gun-safety-in-pediatric-populations-exploring-new-data-and-assessing-risk-frankly-speaking-ep-141/#comments</comments>        <pubDate>Mon, 07 Oct 2019 04:30:00 +0000</pubDate>
        <guid isPermaLink="false">2b6622eaaf994012b4e548b96b605888</guid>
                                    <description><![CDATA[<p>Credits: 0.25 AMA PRA Category 1 Credits™</p>
 <p>Claim CME/CE credit: <a href='https://www.pri-med.com/online-education/podcast/frankly-speaking-cme-141'>https://www.pri-med.com/online-education/podcast/frankly-speaking-cme-141</a></p>
 <p>Overview: Join us as we discuss gun safety and injury prevention in primary care practice.</p>
 <p>Guest: Jill Terrien PhD, ANP-BC</p>
 <p>Music Credit: Richard Onorato</p>
]]></description>
                                                            <content:encoded><![CDATA[<p>Credits: 0.25 AMA PRA Category 1 Credits™</p>
 <p>Claim CME/CE credit: <a href='https://www.pri-med.com/online-education/podcast/frankly-speaking-cme-141'>https://www.pri-med.com/online-education/podcast/frankly-speaking-cme-141</a></p>
 <p>Overview: Join us as we discuss gun safety and injury prevention in primary care practice.</p>
 <p>Guest: Jill Terrien PhD, ANP-BC</p>
 <p>Music Credit: Richard Onorato</p>
]]></content:encoded>
                                    
        <enclosure url="https://mcdn.podbean.com/mf/web/tbjvi8/secure_primed_frankly-speaking-cme-141.mp3" length="19090962" type="audio/mpeg"/>
                <itunes:summary><![CDATA[Credits: 0.25 AMA PRA Category 1 Credits™ Claim CME/CE credit: https://www.pri-med.com/online-education/podcast/frankly-speaking-cme-141 Overview: Join us as we discuss gun safety and injury prevention in primary care practice. Guest: Jill Terrien PhD, ANP-BC Music Credit: Richard Onorato]]></itunes:summary>
        <itunes:author>Pri-Med</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>596</itunes:duration>
                                <itunes:image href="https://pbcdn1.podbean.com/imglogo/ep-logo/pbblog13721080/2e0c21b7b515be2d03b324702653c17f.png" />    </item>
    <item>
        <title>Weight Loss with Apps – Do they Work? - Frankly Speaking 140</title>
        <itunes:title>Weight Loss with Apps – Do they Work? - Frankly Speaking 140</itunes:title>
        <link>https://primedfranklyspeaking.podbean.com/e/weight-loss-with-apps-%e2%80%93-do-they-work-frankly-speaking-140/</link>
                    <comments>https://primedfranklyspeaking.podbean.com/e/weight-loss-with-apps-%e2%80%93-do-they-work-frankly-speaking-140/#comments</comments>        <pubDate>Mon, 30 Sep 2019 04:30:00 +0000</pubDate>
        <guid isPermaLink="false">0fa97e82c255432fb91e7e11fde10efe</guid>
                                    <description><![CDATA[<p>Credits: 0.25 AMA PRA Category 1 Credits™</p>
 <p>Claim CME/CE credit: <a href='https://www.pri-med.com/online-education/podcast/frankly-speaking-cme-140'>https://www.pri-med.com/online-education/podcast/frankly-speaking-cme-140</a></p>
 <p>Overview: This session will discuss the utility of digital apps and daily self-weight measurement for weight loss.</p>
 <p>Guest: Robert A. Baldor, MD, FAAFP</p>
 <p>Music Credit: Richard Onorato</p>
]]></description>
                                                            <content:encoded><![CDATA[<p>Credits: 0.25 AMA PRA Category 1 Credits™</p>
 <p>Claim CME/CE credit: <a href='https://www.pri-med.com/online-education/podcast/frankly-speaking-cme-140'>https://www.pri-med.com/online-education/podcast/frankly-speaking-cme-140</a></p>
 <p>Overview: This session will discuss the utility of digital apps and daily self-weight measurement for weight loss.</p>
 <p>Guest: Robert A. Baldor, MD, FAAFP</p>
 <p>Music Credit: Richard Onorato</p>
]]></content:encoded>
                                    
        <enclosure url="https://mcdn.podbean.com/mf/web/al1bht/secure_primed_frankly-speaking-cme-140.mp3" length="21618746" type="audio/mpeg"/>
                <itunes:summary><![CDATA[Credits: 0.25 AMA PRA Category 1 Credits™ Claim CME/CE credit: https://www.pri-med.com/online-education/podcast/frankly-speaking-cme-140 Overview: This session will discuss the utility of digital apps and daily self-weight measurement for weight loss. Guest: Robert A. Baldor, MD, FAAFP Music Credit: Richard Onorato]]></itunes:summary>
        <itunes:author>Pri-Med</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>675</itunes:duration>
                                <itunes:image href="https://pbcdn1.podbean.com/imglogo/ep-logo/pbblog13721080/8ad3750eda51d121ba59c02ef944bf19.png" />    </item>
    <item>
        <title>Needlepoint for the Heart: An Integrative Option for Chronic Stable Angina - Frankly Speaking EP 139</title>
        <itunes:title>Needlepoint for the Heart: An Integrative Option for Chronic Stable Angina - Frankly Speaking EP 139</itunes:title>
        <link>https://primedfranklyspeaking.podbean.com/e/needlepoint-for-the-heart-an-integrative-option-for-chronic-stable-angina-frankly-speaking-ep-139/</link>
                    <comments>https://primedfranklyspeaking.podbean.com/e/needlepoint-for-the-heart-an-integrative-option-for-chronic-stable-angina-frankly-speaking-ep-139/#comments</comments>        <pubDate>Mon, 23 Sep 2019 04:30:00 +0000</pubDate>
        <guid isPermaLink="false">0bdb88eedb334fa999151daf32408be0</guid>
                                    <description><![CDATA[<p>Credits: 0.25 AMA PRA Category 1 Credits™</p>
 <p>Claim CME/CE credit: <a href='https://www.pri-med.com/online-education/podcast/frankly-speaking-cme-139'>https://www.pri-med.com/online-education/podcast/frankly-speaking-cme-139</a></p>
 <p>Overview: Join us as we discuss acupuncture as an adjunctive therapy in patients with chronic stable angina.</p>
 <p>Guest: Jill Terrien PhD, ANP-BC</p>
 <p>Music Credit: Richard Onorato</p>
]]></description>
                                                            <content:encoded><![CDATA[<p>Credits: 0.25 AMA PRA Category 1 Credits™</p>
 <p>Claim CME/CE credit: <a href='https://www.pri-med.com/online-education/podcast/frankly-speaking-cme-139'>https://www.pri-med.com/online-education/podcast/frankly-speaking-cme-139</a></p>
 <p>Overview: Join us as we discuss acupuncture as an adjunctive therapy in patients with chronic stable angina.</p>
 <p>Guest: Jill Terrien PhD, ANP-BC</p>
 <p>Music Credit: Richard Onorato</p>
]]></content:encoded>
                                    
        <enclosure url="https://mcdn.podbean.com/mf/web/j762vb/secure_primed_frankly-speaking-cme-139.mp3" length="18568262" type="audio/mpeg"/>
                <itunes:summary><![CDATA[Credits: 0.25 AMA PRA Category 1 Credits™ Claim CME/CE credit: https://www.pri-med.com/online-education/podcast/frankly-speaking-cme-139 Overview: Join us as we discuss acupuncture as an adjunctive therapy in patients with chronic stable angina. Guest: Jill Terrien PhD, ANP-BC Music Credit: Richard Onorato]]></itunes:summary>
        <itunes:author>Pri-Med</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>580</itunes:duration>
                                <itunes:image href="https://pbcdn1.podbean.com/imglogo/ep-logo/pbblog13721080/6afe67f32b737a54b6f70f320306a61f.png" />    </item>
    <item>
        <title>What Does Exercise Have to Do with It: What Is the Relationship Between a Healthy Lifestyle and Genetic Risk of Dementia? - Frankly Speaking EP 138</title>
        <itunes:title>What Does Exercise Have to Do with It: What Is the Relationship Between a Healthy Lifestyle and Genetic Risk of Dementia? - Frankly Speaking EP 138</itunes:title>
        <link>https://primedfranklyspeaking.podbean.com/e/what-does-exercise-have-to-do-with-it-what-is-the-relationship-between-a-healthy-lifestyle-and-genetic-risk-of-dementia-frankly-speaking-ep-138/</link>
                    <comments>https://primedfranklyspeaking.podbean.com/e/what-does-exercise-have-to-do-with-it-what-is-the-relationship-between-a-healthy-lifestyle-and-genetic-risk-of-dementia-frankly-speaking-ep-138/#comments</comments>        <pubDate>Mon, 16 Sep 2019 04:30:00 +0000</pubDate>
        <guid isPermaLink="false">b677e9499e024a07aa8b4b65244e77f3</guid>
                                    <description><![CDATA[<p>Credits: 0.25 AMA PRA Category 1 Credits™</p>
 <p>Claim CME/CE credit: <a href='https://www.pri-med.com/online-education/podcast/frankly-speaking-cme-138'>https://www.pri-med.com/online-education/podcast/frankly-speaking-cme-138</a></p>
 <p>Overview: Genetic and lifestyle risk factors have been implicated in the development of Alzheimer’s dementia (AD) as well as other subtypes of dementia. Specific genetic protein mutations have been identified in individuals who develop AD. There is also an abundant amount of evidence that suggests the risk of dementia can be reduced by avoiding tobacco smoking, limiting alcohol consumption, keeping physically active, and maintaining a healthy diet. Join our discussion of a recent study that shows a healthy lifestyle is associated with decreased risk of dementia in those with both low and high genetic risk.</p>
 <p>Guest: Susan Feeney, DNP, FNP</p>
 <p>Music Credit: Richard Onorato </p>
]]></description>
                                                            <content:encoded><![CDATA[<p>Credits: 0.25 AMA PRA Category 1 Credits™</p>
 <p>Claim CME/CE credit: <a href='https://www.pri-med.com/online-education/podcast/frankly-speaking-cme-138'>https://www.pri-med.com/online-education/podcast/frankly-speaking-cme-138</a></p>
 <p>Overview: Genetic and lifestyle risk factors have been implicated in the development of Alzheimer’s dementia (AD) as well as other subtypes of dementia. Specific genetic protein mutations have been identified in individuals who develop AD. There is also an abundant amount of evidence that suggests the risk of dementia can be reduced by avoiding tobacco smoking, limiting alcohol consumption, keeping physically active, and maintaining a healthy diet. Join our discussion of a recent study that shows a healthy lifestyle is associated with decreased risk of dementia in those with both low and high genetic risk.</p>
 <p>Guest: Susan Feeney, DNP, FNP</p>
 <p>Music Credit: Richard Onorato </p>
]]></content:encoded>
                                    
        <enclosure url="https://mcdn.podbean.com/mf/web/8i1xen/secure_primed_frankly-speaking-cme-138.mp3" length="19366625" type="audio/mpeg"/>
                <itunes:summary><![CDATA[Credits: 0.25 AMA PRA Category 1 Credits™ Claim CME/CE credit: https://www.pri-med.com/online-education/podcast/frankly-speaking-cme-138 Overview: Genetic and lifestyle risk factors have been implicated in the development of Alzheimer’s dementia (AD) as well as other subtypes of dementia. Specific genetic protein mutations have been identified in individuals who develop AD. There is also an abundant amount of evidence that suggests the risk of dementia can be reduced by avoiding tobacco smoking, limiting alcohol consumption, keeping physically active, and maintaining a healthy diet. Join our discussion of a recent study that shows a healthy lifestyle is associated with decreased risk of dementia in those with both low and high genetic risk. Guest: Susan Feeney, DNP, FNP Music Credit: Richard Onorato ]]></itunes:summary>
        <itunes:author>Pri-Med</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>605</itunes:duration>
                                <itunes:image href="https://pbcdn1.podbean.com/imglogo/ep-logo/pbblog13721080/1a760cf2985bd6850e359f16a89cb999.png" />    </item>
    <item>
        <title>Statins After 75 Years of Age in Healthy Seniors? Still No - Frankly Speaking EP 137</title>
        <itunes:title>Statins After 75 Years of Age in Healthy Seniors? Still No - Frankly Speaking EP 137</itunes:title>
        <link>https://primedfranklyspeaking.podbean.com/e/statins-after-75-years-of-age-in-healthy-seniors-still-no-frankly-speaking-ep-137/</link>
                    <comments>https://primedfranklyspeaking.podbean.com/e/statins-after-75-years-of-age-in-healthy-seniors-still-no-frankly-speaking-ep-137/#comments</comments>        <pubDate>Mon, 09 Sep 2019 04:30:00 +0000</pubDate>
        <guid isPermaLink="false">34e4643bc6f54a93a2045c95542b1245</guid>
                                    <description><![CDATA[<p>Credits: 0.25 AMA PRA Category 1 Credits™</p>
 <p>Claim CME/CE credit: <a href='https://www.pri-med.com/online-education/podcast/frankly-speaking-cme-137'>https://www.pri-med.com/online-education/podcast/frankly-speaking-cme-137</a></p>
 <p>Overview: In this episode we expand on the rationale for not screening and treating hyperlipidemia in patients without CV disease, diabetes, renal failure or heart failure.</p>
 <p>Guest: Robert A. Baldor, MD</p>
 <p>Music Credit: Richard Onorato </p>
]]></description>
                                                            <content:encoded><![CDATA[<p>Credits: 0.25 AMA PRA Category 1 Credits™</p>
 <p>Claim CME/CE credit: <a href='https://www.pri-med.com/online-education/podcast/frankly-speaking-cme-137'>https://www.pri-med.com/online-education/podcast/frankly-speaking-cme-137</a></p>
 <p>Overview: In this episode we expand on the rationale for not screening and treating hyperlipidemia in patients without CV disease, diabetes, renal failure or heart failure.</p>
 <p>Guest: Robert A. Baldor, MD</p>
 <p>Music Credit: Richard Onorato </p>
]]></content:encoded>
                                    
        <enclosure url="https://mcdn.podbean.com/mf/web/qqsado/secure_primed_frankly-speaking-cme-137.mp3" length="21030527" type="audio/mpeg"/>
                <itunes:summary><![CDATA[Credits: 0.25 AMA PRA Category 1 Credits™ Claim CME/CE credit: https://www.pri-med.com/online-education/podcast/frankly-speaking-cme-137 Overview: In this episode we expand on the rationale for not screening and treating hyperlipidemia in patients without CV disease, diabetes, renal failure or heart failure. Guest: Robert A. Baldor, MD Music Credit: Richard Onorato ]]></itunes:summary>
        <itunes:author>Pri-Med</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>657</itunes:duration>
                                <itunes:image href="https://pbcdn1.podbean.com/imglogo/ep-logo/pbblog13721080/e4ebca744e20aac3c97788cc4e731ff9.png" />    </item>
    <item>
        <title>Boning Up on Treatment for Osteopenia - Frankly Speaking EP 136</title>
        <itunes:title>Boning Up on Treatment for Osteopenia - Frankly Speaking EP 136</itunes:title>
        <link>https://primedfranklyspeaking.podbean.com/e/boning-up-on-treatment-for-osteopenia-frankly-speaking-ep-136/</link>
                    <comments>https://primedfranklyspeaking.podbean.com/e/boning-up-on-treatment-for-osteopenia-frankly-speaking-ep-136/#comments</comments>        <pubDate>Mon, 02 Sep 2019 04:30:00 +0000</pubDate>
        <guid isPermaLink="false">695469e9d9c146228d10179e6f57637b</guid>
                                    <description><![CDATA[<p>Credits: 0.25 AMA PRA Category 1 Credits™</p>
<p>Claim CME/CE credit: <a href='https://www.pri-med.com/online-education/podcast/frankly-speaking-cme-136'>https://www.pri-med.com/online-education/podcast/frankly-speaking-cme-136</a></p>
<p>Overview: Bisphosphonates help prevent fractures in elderly women with osteoporosis, but their benefit in women with osteopenia has been unclear. A recent trial showed that a yearly injection of zoledronic acid can reduce fractures in women with osteopenia.</p>
<p>Guest: Alan Ehrlich MD, FAAFP</p>
<p>Music Credit: Richard Onorato </p>
]]></description>
                                                            <content:encoded><![CDATA[<p>Credits: 0.25 AMA PRA Category 1 Credits™</p>
<p>Claim CME/CE credit: <a href='https://www.pri-med.com/online-education/podcast/frankly-speaking-cme-136'>https://www.pri-med.com/online-education/podcast/frankly-speaking-cme-136</a></p>
<p>Overview: Bisphosphonates help prevent fractures in elderly women with osteoporosis, but their benefit in women with osteopenia has been unclear. A recent trial showed that a yearly injection of zoledronic acid can reduce fractures in women with osteopenia.</p>
<p>Guest: Alan Ehrlich MD, FAAFP</p>
<p>Music Credit: Richard Onorato </p>
]]></content:encoded>
                                    
        <enclosure url="https://mcdn.podbean.com/mf/web/u5eh0e/secure_primed_frankly-speaking-osteo-2.mp3" length="11759028" type="audio/mpeg"/>
                <itunes:summary><![CDATA[Credits: 0.25 AMA PRA Category 1 Credits™
Claim CME/CE credit: https://www.pri-med.com/online-education/podcast/frankly-speaking-cme-136
Overview: Bisphosphonates help prevent fractures in elderly women with osteoporosis, but their benefit in women with osteopenia has been unclear. A recent trial showed that a yearly injection of zoledronic acid can reduce fractures in women with osteopenia.
Guest: Alan Ehrlich MD, FAAFP
Music Credit: Richard Onorato ]]></itunes:summary>
        <itunes:author>Pri-Med</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>733</itunes:duration>
        <itunes:season>1</itunes:season>
        <itunes:episode>1</itunes:episode>
        <itunes:episodeType>full</itunes:episodeType>
        <itunes:image href="https://pbcdn1.podbean.com/imglogo/ep-logo/pbblog13721080/83a6a60624b3dade305ebe43aa4055f0.png" />    </item>
    <item>
        <title>What Channel Are You On? Video Visits for Primary Care - Frankly Speaking EP 135</title>
        <itunes:title>What Channel Are You On? Video Visits for Primary Care - Frankly Speaking EP 135</itunes:title>
        <link>https://primedfranklyspeaking.podbean.com/e/what-channel-are-you-on-video-visits-for-primary-care-frankly-speaking-ep-135/</link>
                    <comments>https://primedfranklyspeaking.podbean.com/e/what-channel-are-you-on-video-visits-for-primary-care-frankly-speaking-ep-135/#comments</comments>        <pubDate>Mon, 26 Aug 2019 04:30:00 +0000</pubDate>
        <guid isPermaLink="false">1e196e40944440acaee92e8d1146737e</guid>
                                    <description><![CDATA[<p>Credits: 0.25 AMA PRA Category 1 Credits™</p>
<p>Claim CME/CE credit: <a href='https://www.pri-med.com/online-education/podcast/frankly-speaking-cme-135'>https://www.pri-med.com/online-education/podcast/frankly-speaking-cme-135</a></p>
<p>Overview: Measles were declared eliminated in 2000; however, in June 2019, the CDC announced that there were > 1,000 cases identified in the US—the largest number of cases since 1992. Join us as we discuss the causes of this increase in a vaccine-preventable disease (VPD) and strategies for containing this looming public health concern.</p>
<p>Guest: Jill Terrien PhD, ANP-BC </p>
<p>Music Credit: Richard Onorato </p>
]]></description>
                                                            <content:encoded><![CDATA[<p>Credits: 0.25 AMA PRA Category 1 Credits™</p>
<p>Claim CME/CE credit: <a href='https://www.pri-med.com/online-education/podcast/frankly-speaking-cme-135'>https://www.pri-med.com/online-education/podcast/frankly-speaking-cme-135</a></p>
<p>Overview: Measles were declared eliminated in 2000; however, in June 2019, the CDC announced that there were > 1,000 cases identified in the US—the largest number of cases since 1992. Join us as we discuss the causes of this increase in a vaccine-preventable disease (VPD) and strategies for containing this looming public health concern.</p>
<p>Guest: Jill Terrien PhD, ANP-BC </p>
<p>Music Credit: Richard Onorato </p>
]]></content:encoded>
                                    
        <enclosure url="https://mcdn.podbean.com/mf/web/7ljm8z/secure_primed_frankly-speaking-video-visits-edited.mp3" length="9780470" type="audio/mpeg"/>
                <itunes:summary><![CDATA[Credits: 0.25 AMA PRA Category 1 Credits™
Claim CME/CE credit: https://www.pri-med.com/online-education/podcast/frankly-speaking-cme-135
Overview: Measles were declared eliminated in 2000; however, in June 2019, the CDC announced that there were > 1,000 cases identified in the US—the largest number of cases since 1992. Join us as we discuss the causes of this increase in a vaccine-preventable disease (VPD) and strategies for containing this looming public health concern.
Guest: Jill Terrien PhD, ANP-BC 
Music Credit: Richard Onorato ]]></itunes:summary>
        <itunes:author>Pri-Med</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>610</itunes:duration>
        <itunes:season>1</itunes:season>
        <itunes:episode>1</itunes:episode>
        <itunes:episodeType>full</itunes:episodeType>
        <itunes:image href="https://pbcdn1.podbean.com/imglogo/ep-logo/pbblog13721080/14fdf9b217a7c02aebd0437f8b94e8dd.png" />    </item>
    <item>
        <title>Back to the Future: Measles Resurgence and Vaccine Hesitancy - Frankly Speaking EP 134</title>
        <itunes:title>Back to the Future: Measles Resurgence and Vaccine Hesitancy - Frankly Speaking EP 134</itunes:title>
        <link>https://primedfranklyspeaking.podbean.com/e/back-to-the-future-measles-resurgence-and-vaccine-hesitancy-frankly-speaking-ep-134/</link>
                    <comments>https://primedfranklyspeaking.podbean.com/e/back-to-the-future-measles-resurgence-and-vaccine-hesitancy-frankly-speaking-ep-134/#comments</comments>        <pubDate>Mon, 19 Aug 2019 04:30:00 +0000</pubDate>
        <guid isPermaLink="false">88dd628fc2d840d1a1652d036468215a</guid>
                                    <description><![CDATA[<p>Credits: 0.25 AMA PRA Category 1 Credits™</p>
<p>Claim CME/CE credit: <a href='https://www.pri-med.com/online-education/podcast/frankly-speaking-cme-134'>https://www.pri-med.com/online-education/podcast/frankly-speaking-cme-134</a></p>
<p>Overview: Measles were declared eliminated in 2000; however, in June 2019, the CDC announced that there were > 1,000 cases identified in the US—the largest number of cases since 1992. Join us as we discuss the causes of this increase in a vaccine-preventable disease (VPD) and strategies for containing this looming public health concern.</p>
<p>Guest: Jill Terrien PhD, ANP-BC </p>
<p>Music Credit: Richard Onorato </p>
]]></description>
                                                            <content:encoded><![CDATA[<p>Credits: 0.25 AMA PRA Category 1 Credits™</p>
<p>Claim CME/CE credit: <a href='https://www.pri-med.com/online-education/podcast/frankly-speaking-cme-134'>https://www.pri-med.com/online-education/podcast/frankly-speaking-cme-134</a></p>
<p>Overview: Measles were declared eliminated in 2000; however, in June 2019, the CDC announced that there were > 1,000 cases identified in the US—the largest number of cases since 1992. Join us as we discuss the causes of this increase in a vaccine-preventable disease (VPD) and strategies for containing this looming public health concern.</p>
<p>Guest: Jill Terrien PhD, ANP-BC </p>
<p>Music Credit: Richard Onorato </p>
]]></content:encoded>
                                    
        <enclosure url="https://mcdn.podbean.com/mf/web/tvxc4q/secure_primed_frankly-speaking-134-vaccines.mp3" length="11079169" type="audio/mpeg"/>
                <itunes:summary><![CDATA[Credits: 0.25 AMA PRA Category 1 Credits™
Claim CME/CE credit: https://www.pri-med.com/online-education/podcast/frankly-speaking-cme-134
Overview: Measles were declared eliminated in 2000; however, in June 2019, the CDC announced that there were > 1,000 cases identified in the US—the largest number of cases since 1992. Join us as we discuss the causes of this increase in a vaccine-preventable disease (VPD) and strategies for containing this looming public health concern.
Guest: Jill Terrien PhD, ANP-BC 
Music Credit: Richard Onorato ]]></itunes:summary>
        <itunes:author>Pri-Med</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>691</itunes:duration>
        <itunes:season>1</itunes:season>
        <itunes:episode>1</itunes:episode>
        <itunes:episodeType>full</itunes:episodeType>
        <itunes:image href="https://pbcdn1.podbean.com/imglogo/ep-logo/pbblog13721080/2f343a610e8d84ada7149c11418d3b54.png" />    </item>
    <item>
        <title>An Uncomfortable Problem: Recurrent Urinary Tract Infections (UTIs) in Women - Frankly Speaking EP 133</title>
        <itunes:title>An Uncomfortable Problem: Recurrent Urinary Tract Infections (UTIs) in Women - Frankly Speaking EP 133</itunes:title>
        <link>https://primedfranklyspeaking.podbean.com/e/an-uncomfortable-problem-recurrent-urinary-tract-infections-utis-in-women-frankly-speaking-ep-133/</link>
                    <comments>https://primedfranklyspeaking.podbean.com/e/an-uncomfortable-problem-recurrent-urinary-tract-infections-utis-in-women-frankly-speaking-ep-133/#comments</comments>        <pubDate>Mon, 12 Aug 2019 04:30:00 +0000</pubDate>
        <guid isPermaLink="false">ff481653a90141f38636d164b07d109e</guid>
                                    <description><![CDATA[<p>Credits: 0.25 AMA PRA Category 1 Credits™</p>
<p>Claim CME/CE credit: <a href='https://www.pri-med.com/online-education/podcast/frankly-speaking-cme-133'>https://www.pri-med.com/online-education/podcast/frankly-speaking-cme-133</a></p>
<p>Overview: Join us as we discuss a new guideline for women with recurrent UTIs. </p>
<p>Guest: Jill Terrien PhD, ANP-BC </p>
<p>Music Credit: Richard Onorato </p>
]]></description>
                                                            <content:encoded><![CDATA[<p>Credits: 0.25 AMA PRA Category 1 Credits™</p>
<p>Claim CME/CE credit: <a href='https://www.pri-med.com/online-education/podcast/frankly-speaking-cme-133'>https://www.pri-med.com/online-education/podcast/frankly-speaking-cme-133</a></p>
<p>Overview: Join us as we discuss a new guideline for women with recurrent UTIs. </p>
<p>Guest: Jill Terrien PhD, ANP-BC </p>
<p>Music Credit: Richard Onorato </p>
]]></content:encoded>
                                    
        <enclosure url="https://mcdn.podbean.com/mf/web/u3gijh/secure_primed_frankly-speaking-UTI.mp3" length="12926949" type="audio/mpeg"/>
                <itunes:summary><![CDATA[Credits: 0.25 AMA PRA Category 1 Credits™
Claim CME/CE credit: https://www.pri-med.com/online-education/podcast/frankly-speaking-cme-133
Overview: Join us as we discuss a new guideline for women with recurrent UTIs. 
Guest: Jill Terrien PhD, ANP-BC 
Music Credit: Richard Onorato ]]></itunes:summary>
        <itunes:author>Pri-Med</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>806</itunes:duration>
        <itunes:season>1</itunes:season>
        <itunes:episode>1</itunes:episode>
        <itunes:episodeType>full</itunes:episodeType>
        <itunes:image href="https://pbcdn1.podbean.com/imglogo/ep-logo/pbblog13721080/352fa5251ef9ec54f35f592ca77876bf.png" />    </item>
    <item>
        <title>What Is Your Purpose in Life? Impact of Perceived Life Purpose on Life Expectancy - Frankly Speaking EP 132</title>
        <itunes:title>What Is Your Purpose in Life? Impact of Perceived Life Purpose on Life Expectancy - Frankly Speaking EP 132</itunes:title>
        <link>https://primedfranklyspeaking.podbean.com/e/what-is-your-purpose-in-life-impact-of-perceived-life-purpose-on-life-expectancy-frankly-speaking-ep-132/</link>
                    <comments>https://primedfranklyspeaking.podbean.com/e/what-is-your-purpose-in-life-impact-of-perceived-life-purpose-on-life-expectancy-frankly-speaking-ep-132/#comments</comments>        <pubDate>Mon, 05 Aug 2019 04:30:00 +0000</pubDate>
        <guid isPermaLink="false">52feb9f6215e4473b5b26d551f4f33bc</guid>
                                    <description><![CDATA[<p>Credits: 0.25 AMA PRA Category 1 Credits™</p>
<p>Claim CME/CE credit: <a href='https://www.pri-med.com/online-education/podcast/frankly-speaking-cme-132'>https://www.pri-med.com/online-education/podcast/frankly-speaking-cme-132</a></p>
<p>Overview: A recently published study looked at the association between a perceived life purpose (using modified Ryff and Keyes Scales of Psychological Well-being) and mortality in individuals participating in the Health and Retirement Study (HRS). The results seem to indicate that a strong sense of purpose to one’s life is associated with decreased mortality. Join us as we discuss the implications of this study and how to apply it in practice to improve your patients’ health and well-being as well as your own. </p>
<p>Guest: Susan Feeney, DNP, FNP</p>
<p>Music Credit: Richard Onorato </p>
]]></description>
                                                            <content:encoded><![CDATA[<p>Credits: 0.25 AMA PRA Category 1 Credits™</p>
<p>Claim CME/CE credit: <a href='https://www.pri-med.com/online-education/podcast/frankly-speaking-cme-132'>https://www.pri-med.com/online-education/podcast/frankly-speaking-cme-132</a></p>
<p>Overview: A recently published study looked at the association between a perceived life purpose (using modified Ryff and Keyes Scales of Psychological Well-being) and mortality in individuals participating in the Health and Retirement Study (HRS). The results seem to indicate that a strong sense of purpose to one’s life is associated with decreased mortality. Join us as we discuss the implications of this study and how to apply it in practice to improve your patients’ health and well-being as well as your own. </p>
<p>Guest: Susan Feeney, DNP, FNP</p>
<p>Music Credit: Richard Onorato </p>
]]></content:encoded>
                                    
        <enclosure url="https://mcdn.podbean.com/mf/web/inmlu1/secure_primed_frankly-speaking-purpose-final.mp3" length="11126671" type="audio/mpeg"/>
                <itunes:summary><![CDATA[Credits: 0.25 AMA PRA Category 1 Credits™
Claim CME/CE credit: https://www.pri-med.com/online-education/podcast/frankly-speaking-cme-132
Overview: A recently published study looked at the association between a perceived life purpose (using modified Ryff and Keyes Scales of Psychological Well-being) and mortality in individuals participating in the Health and Retirement Study (HRS). The results seem to indicate that a strong sense of purpose to one’s life is associated with decreased mortality. Join us as we discuss the implications of this study and how to apply it in practice to improve your patients’ health and well-being as well as your own. 
Guest: Susan Feeney, DNP, FNP
Music Credit: Richard Onorato ]]></itunes:summary>
        <itunes:author>Pri-Med</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>694</itunes:duration>
        <itunes:season>1</itunes:season>
        <itunes:episode>1</itunes:episode>
        <itunes:episodeType>full</itunes:episodeType>
        <itunes:image href="https://pbcdn1.podbean.com/imglogo/ep-logo/pbblog13721080/1bd608d6881f06242c9762b3dbd8bd2f.png" />    </item>
    <item>
        <title>Diagnosed Prostate Cancer: How to Choose A Treatment - Frankly Speaking EP 131</title>
        <itunes:title>Diagnosed Prostate Cancer: How to Choose A Treatment - Frankly Speaking EP 131</itunes:title>
        <link>https://primedfranklyspeaking.podbean.com/e/diagnosed-prostate-cancer-how-to-choose-a-treatment-frankly-speaking-ep-131/</link>
                    <comments>https://primedfranklyspeaking.podbean.com/e/diagnosed-prostate-cancer-how-to-choose-a-treatment-frankly-speaking-ep-131/#comments</comments>        <pubDate>Mon, 29 Jul 2019 04:30:00 +0000</pubDate>
        <guid isPermaLink="false">a220e98ac4574940a761db0b655a912b</guid>
                                    <description><![CDATA[<p>Credits: 0.25 AMA PRA Category 1 Credits™</p>
<p>Claim CME/CE credit: <a href='https://www.pri-med.com/online-education/podcast/frankly-speaking-cme-131'>https://www.pri-med.com/online-education/podcast/frankly-speaking-cme-131</a></p>
<p>Overview: After the debate on whether to screen for prostate cancer comes the debate on how to treat it. Options include “watchful waiting,” radiation, surgery, and androgen deprivation. This session will focus on how to help your patient diagnosed with prostate cancer decide on a treatment plan using a cohort-based decision tool. </p>
<p>Guest: Susan Feeney, DNP, FNP & Jill Terrien PhD, ANP-BC </p>
<p>Music Credit: Richard Onorato </p>
]]></description>
                                                            <content:encoded><![CDATA[<p>Credits: 0.25 AMA PRA Category 1 Credits™</p>
<p>Claim CME/CE credit: <a href='https://www.pri-med.com/online-education/podcast/frankly-speaking-cme-131'>https://www.pri-med.com/online-education/podcast/frankly-speaking-cme-131</a></p>
<p>Overview: After the debate on whether to screen for prostate cancer comes the debate on how to treat it. Options include “watchful waiting,” radiation, surgery, and androgen deprivation. This session will focus on how to help your patient diagnosed with prostate cancer decide on a treatment plan using a cohort-based decision tool. </p>
<p>Guest: Susan Feeney, DNP, FNP & Jill Terrien PhD, ANP-BC </p>
<p>Music Credit: Richard Onorato </p>
]]></content:encoded>
                                    
        <enclosure url="https://mcdn.podbean.com/mf/web/zfwrv3/secure_primed_frankly-speaking-131-prostate-edited.mp3" length="13757918" type="audio/mpeg"/>
                <itunes:summary><![CDATA[Credits: 0.25 AMA PRA Category 1 Credits™
Claim CME/CE credit: https://www.pri-med.com/online-education/podcast/frankly-speaking-cme-131
Overview: After the debate on whether to screen for prostate cancer comes the debate on how to treat it. Options include “watchful waiting,” radiation, surgery, and androgen deprivation. This session will focus on how to help your patient diagnosed with prostate cancer decide on a treatment plan using a cohort-based decision tool. 
Guest: Susan Feeney, DNP, FNP & Jill Terrien PhD, ANP-BC 
Music Credit: Richard Onorato ]]></itunes:summary>
        <itunes:author>Pri-Med</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>858</itunes:duration>
        <itunes:season>1</itunes:season>
        <itunes:episode>1</itunes:episode>
        <itunes:episodeType>full</itunes:episodeType>
        <itunes:image href="https://pbcdn1.podbean.com/imglogo/ep-logo/pbblog13721080/0d9f7c547490d2d471b3697eca6035eb.png" />    </item>
    <item>
        <title>Weed Indeed! - Frankly Speaking EP 130</title>
        <itunes:title>Weed Indeed! - Frankly Speaking EP 130</itunes:title>
        <link>https://primedfranklyspeaking.podbean.com/e/weed-indeed-frankly-speaking-ep-130/</link>
                    <comments>https://primedfranklyspeaking.podbean.com/e/weed-indeed-frankly-speaking-ep-130/#comments</comments>        <pubDate>Mon, 22 Jul 2019 04:00:00 +0000</pubDate>
        <guid isPermaLink="false">943ffba9b13b475aa81cd77e23e2bcfb</guid>
                                    <description><![CDATA[<p>Credits: 0.25 AMA PRA Category 1 Credits™</p>
<p>Claim CME/CE credit: <a href='https://www.pri-med.com/online-education/podcast/frankly-speaking-cme-130'>https://www.pri-med.com/online-education/podcast/frankly-speaking-cme-130</a></p>
<p>Overview: This study looked at hospitalizations following legislation that legalized marijuana use in Colorado compared to two states that have not legalized marijuana, New York and Oklahoma. The goal was to determine what impact this law might have on common and chronic conditions. It found hospitalizations for some conditions increased while issues of social anxiety disorder decreased</p>
<p>Guest: Alan M. Ehrlich, MD, FAAFP</p>
<p>Music Credit: Richard Onorato </p>
]]></description>
                                                            <content:encoded><![CDATA[<p>Credits: 0.25 AMA PRA Category 1 Credits™</p>
<p>Claim CME/CE credit: <a href='https://www.pri-med.com/online-education/podcast/frankly-speaking-cme-130'>https://www.pri-med.com/online-education/podcast/frankly-speaking-cme-130</a></p>
<p>Overview: This study looked at hospitalizations following legislation that legalized marijuana use in Colorado compared to two states that have not legalized marijuana, New York and Oklahoma. The goal was to determine what impact this law might have on common and chronic conditions. It found hospitalizations for some conditions increased while issues of social anxiety disorder decreased</p>
<p>Guest: Alan M. Ehrlich, MD, FAAFP</p>
<p>Music Credit: Richard Onorato </p>
]]></content:encoded>
                                    
        <enclosure url="https://mcdn.podbean.com/mf/web/ejom6q/secure_primed_frankly-speaking-marijuana-2.mp3" length="9394233" type="audio/mpeg"/>
                <itunes:summary><![CDATA[Credits: 0.25 AMA PRA Category 1 Credits™
Claim CME/CE credit: https://www.pri-med.com/online-education/podcast/frankly-speaking-cme-130
Overview: This study looked at hospitalizations following legislation that legalized marijuana use in Colorado compared to two states that have not legalized marijuana, New York and Oklahoma. The goal was to determine what impact this law might have on common and chronic conditions. It found hospitalizations for some conditions increased while issues of social anxiety disorder decreased
Guest: Alan M. Ehrlich, MD, FAAFP
Music Credit: Richard Onorato ]]></itunes:summary>
        <itunes:author>Pri-Med</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>586</itunes:duration>
        <itunes:season>1</itunes:season>
        <itunes:episode>1</itunes:episode>
        <itunes:episodeType>full</itunes:episodeType>
        <itunes:image href="https://pbcdn1.podbean.com/imglogo/ep-logo/pbblog13721080/374a0ef2c6f8769919767e21152cdc9d.png" />    </item>
    <item>
        <title>Mammography Screening: Sorting through Conflicting Guidelines - Frankly Speaking EP 129</title>
        <itunes:title>Mammography Screening: Sorting through Conflicting Guidelines - Frankly Speaking EP 129</itunes:title>
        <link>https://primedfranklyspeaking.podbean.com/e/mammography-screening-sorting-through-conflicting-guidelines-frankly-speaking-ep-129/</link>
                    <comments>https://primedfranklyspeaking.podbean.com/e/mammography-screening-sorting-through-conflicting-guidelines-frankly-speaking-ep-129/#comments</comments>        <pubDate>Mon, 15 Jul 2019 04:00:00 +0000</pubDate>
        <guid isPermaLink="false">54bab9b896674ad5987010cf680bb4b3</guid>
                                    <description><![CDATA[<p>Credits: 0.25 AMA PRA Category 1 Credits™</p>
<p>Claim CME/CE credit: <a href='https://www.pri-med.com/online-education/podcast/frankly-speaking-cme-129'>https://www.pri-med.com/online-education/podcast/frankly-speaking-cme-129</a></p>
<p>Overview: Multiple organizations have issued guidelines on breast cancer screening, but these guidelines are often conflicting. Recently, the American College of Physicians (ACP) reviewed the data supporting seven different guideline recommendations and issued new guidance on breast cancer screening for average-risk women. Join our discussion of the recommendations to help develop a consistent approach to breast cancer screening in your practice. </p>
<p>Guest: Alan M. Ehrlich, MD, FAAFP</p>
<p>Music Credit: Richard Onorato </p>
]]></description>
                                                            <content:encoded><![CDATA[<p>Credits: 0.25 AMA PRA Category 1 Credits™</p>
<p>Claim CME/CE credit: <a href='https://www.pri-med.com/online-education/podcast/frankly-speaking-cme-129'>https://www.pri-med.com/online-education/podcast/frankly-speaking-cme-129</a></p>
<p>Overview: Multiple organizations have issued guidelines on breast cancer screening, but these guidelines are often conflicting. Recently, the American College of Physicians (ACP) reviewed the data supporting seven different guideline recommendations and issued new guidance on breast cancer screening for average-risk women. Join our discussion of the recommendations to help develop a consistent approach to breast cancer screening in your practice. </p>
<p>Guest: Alan M. Ehrlich, MD, FAAFP</p>
<p>Music Credit: Richard Onorato </p>
]]></content:encoded>
                                    
        <enclosure url="https://mcdn.podbean.com/mf/web/2pssjp/secure_primed_mamogrophy-new-outro.mp3" length="10679230" type="audio/mpeg"/>
                <itunes:summary><![CDATA[Credits: 0.25 AMA PRA Category 1 Credits™
Claim CME/CE credit: https://www.pri-med.com/online-education/podcast/frankly-speaking-cme-129
Overview: Multiple organizations have issued guidelines on breast cancer screening, but these guidelines are often conflicting. Recently, the American College of Physicians (ACP) reviewed the data supporting seven different guideline recommendations and issued new guidance on breast cancer screening for average-risk women. Join our discussion of the recommendations to help develop a consistent approach to breast cancer screening in your practice. 
Guest: Alan M. Ehrlich, MD, FAAFP
Music Credit: Richard Onorato ]]></itunes:summary>
        <itunes:author>Pri-Med</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>666</itunes:duration>
        <itunes:season>1</itunes:season>
        <itunes:episode>1</itunes:episode>
        <itunes:episodeType>full</itunes:episodeType>
        <itunes:image href="https://pbcdn1.podbean.com/imglogo/ep-logo/pbblog13721080/30b968ee9d2e5a0c6e2d1a09393404f9.png" />    </item>
    <item>
        <title>The Challenges of Managing Bone Loss: Separating Fact from Fiction - Frankly Speaking EP 128</title>
        <itunes:title>The Challenges of Managing Bone Loss: Separating Fact from Fiction - Frankly Speaking EP 128</itunes:title>
        <link>https://primedfranklyspeaking.podbean.com/e/the-challenges-of-managing-bone-loss-separating-fact-from-fiction-frankly-speaking-ep-128/</link>
                    <comments>https://primedfranklyspeaking.podbean.com/e/the-challenges-of-managing-bone-loss-separating-fact-from-fiction-frankly-speaking-ep-128/#comments</comments>        <pubDate>Mon, 08 Jul 2019 04:00:00 +0000</pubDate>
        <guid isPermaLink="false">28fe2dc0a509410e956e8464cd8d0c87</guid>
                                    <description><![CDATA[<p>Credits: 0.25 AMA PRA Category 1 Credits™</p>
<p>Claim CME/CE credit: <a href='https://www.pri-med.com/online-education/podcast/frankly-speaking-cme-128'>https://www.pri-med.com/online-education/podcast/frankly-speaking-cme-128</a></p>
<p>Overview: Conflicting evidence-based guidelines and medication risks have complicated the care of individuals with low bone density. The Endocrine Society just released its most recent recommendations for pharmacologic management of postmenopausal women with osteoporosis. Their goal was to address the most challenging aspects of low bone density management with clear evidence-based guidance. Join us as we review their new recommendations, compare them with other guidelines, and discuss their impact on your practice. </p>
<p>Guest: Susan Feeney, DNP, FNP</p>
<p>Music Credit: Richard Onorato </p>
]]></description>
                                                            <content:encoded><![CDATA[<p>Credits: 0.25 AMA PRA Category 1 Credits™</p>
<p>Claim CME/CE credit: <a href='https://www.pri-med.com/online-education/podcast/frankly-speaking-cme-128'>https://www.pri-med.com/online-education/podcast/frankly-speaking-cme-128</a></p>
<p>Overview: Conflicting evidence-based guidelines and medication risks have complicated the care of individuals with low bone density. The Endocrine Society just released its most recent recommendations for pharmacologic management of postmenopausal women with osteoporosis. Their goal was to address the most challenging aspects of low bone density management with clear evidence-based guidance. Join us as we review their new recommendations, compare them with other guidelines, and discuss their impact on your practice. </p>
<p>Guest: Susan Feeney, DNP, FNP</p>
<p>Music Credit: Richard Onorato </p>
]]></content:encoded>
                                    
        <enclosure url="https://mcdn.podbean.com/mf/web/15jkqu/secure_primed_frankly-speaking-osteoporosis-128.mp3" length="13011192" type="audio/mpeg"/>
                <itunes:summary><![CDATA[Credits: 0.25 AMA PRA Category 1 Credits™
Claim CME/CE credit: https://www.pri-med.com/online-education/podcast/frankly-speaking-cme-128
Overview: Conflicting evidence-based guidelines and medication risks have complicated the care of individuals with low bone density. The Endocrine Society just released its most recent recommendations for pharmacologic management of postmenopausal women with osteoporosis. Their goal was to address the most challenging aspects of low bone density management with clear evidence-based guidance. Join us as we review their new recommendations, compare them with other guidelines, and discuss their impact on your practice. 
Guest: Susan Feeney, DNP, FNP
Music Credit: Richard Onorato ]]></itunes:summary>
        <itunes:author>Pri-Med</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>812</itunes:duration>
        <itunes:season>1</itunes:season>
        <itunes:episode>1</itunes:episode>
        <itunes:episodeType>full</itunes:episodeType>
        <itunes:image href="https://pbcdn1.podbean.com/imglogo/ep-logo/pbblog13721080/0bbc1677a983b116bff29b507afa2cc5.png" />    </item>
    <item>
        <title>Gabapentinoid Drugs Off-Label Use: Stay in Your Lane! - Frankly Speaking EP 127</title>
        <itunes:title>Gabapentinoid Drugs Off-Label Use: Stay in Your Lane! - Frankly Speaking EP 127</itunes:title>
        <link>https://primedfranklyspeaking.podbean.com/e/gabapentinoid-drugs-off-label-use-stay-in-your-lane-frankly-speaking-ep-127/</link>
                    <comments>https://primedfranklyspeaking.podbean.com/e/gabapentinoid-drugs-off-label-use-stay-in-your-lane-frankly-speaking-ep-127/#comments</comments>        <pubDate>Mon, 01 Jul 2019 04:00:00 +0000</pubDate>
        <guid isPermaLink="false">25c49d8f5d524aecb0abca2230e4a015</guid>
                                    <description><![CDATA[<p>Credits: 0.25 AMA PRA Category 1 Credits™</p>
<p>Claim CME/CE credit: <a href='https://www.pri-med.com/online-education/podcast/frankly-speaking-cme-127'>https://www.pri-med.com/online-education/podcast/frankly-speaking-cme-127</a></p>
<p>Overview: Join us as we discuss the increased off-label use of gabapentinoids most likely in response to the treatment of pain. </p>
<p>Guest: Jill Terrien PhD, ANP-BC </p>
<p>Music Credit: Richard Onorato </p>
]]></description>
                                                            <content:encoded><![CDATA[<p>Credits: 0.25 AMA PRA Category 1 Credits™</p>
<p>Claim CME/CE credit: <a href='https://www.pri-med.com/online-education/podcast/frankly-speaking-cme-127'>https://www.pri-med.com/online-education/podcast/frankly-speaking-cme-127</a></p>
<p>Overview: Join us as we discuss the increased off-label use of gabapentinoids most likely in response to the treatment of pain. </p>
<p>Guest: Jill Terrien PhD, ANP-BC </p>
<p>Music Credit: Richard Onorato </p>
]]></content:encoded>
                                    
        <enclosure url="https://mcdn.podbean.com/mf/web/33l734/secure_primed_frankly-speaking-cme-127-edited.mp3" length="10049454" type="audio/mpeg"/>
                <itunes:summary><![CDATA[Credits: 0.25 AMA PRA Category 1 Credits™
Claim CME/CE credit: https://www.pri-med.com/online-education/podcast/frankly-speaking-cme-127
Overview: Join us as we discuss the increased off-label use of gabapentinoids most likely in response to the treatment of pain. 
Guest: Jill Terrien PhD, ANP-BC 
Music Credit: Richard Onorato ]]></itunes:summary>
        <itunes:author>Pri-Med</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>627</itunes:duration>
        <itunes:season>1</itunes:season>
        <itunes:episode>1</itunes:episode>
        <itunes:episodeType>full</itunes:episodeType>
        <itunes:image href="https://pbcdn1.podbean.com/imglogo/ep-logo/pbblog13721080/70606f861cd130df5e1b06c31019bd8c.png" />    </item>
    <item>
        <title>Reading to Your Toddler: Is There a Difference Between Reading an Ebook and a Traditional Book? - Frankly Speaking EP 126</title>
        <itunes:title>Reading to Your Toddler: Is There a Difference Between Reading an Ebook and a Traditional Book? - Frankly Speaking EP 126</itunes:title>
        <link>https://primedfranklyspeaking.podbean.com/e/reading-to-your-toddler-is-there-a-difference-between-reading-an-ebook-and-a-traditional-book-frankly-speaking-ep-126/</link>
                    <comments>https://primedfranklyspeaking.podbean.com/e/reading-to-your-toddler-is-there-a-difference-between-reading-an-ebook-and-a-traditional-book-frankly-speaking-ep-126/#comments</comments>        <pubDate>Mon, 24 Jun 2019 04:30:00 +0000</pubDate>
        <guid isPermaLink="false">c79b44714118400d97a7dd224c865f22</guid>
                                    <description><![CDATA[<p>Credits: 0.25 AMA PRA Category 1 Credits™</p>
<p>Claim CME/CE credit: <a href='https://www.pri-med.com/online-education/podcast/frankly-speaking-cme-126'>https://www.pri-med.com/online-education/podcast/frankly-speaking-cme-126</a></p>
<p>Overview: Reading to young children is a well-established activity that can impact neuro-cognitive and emotional development in children. Since many parents use E-readers and other digital platforms to read to their kids, in this episode we will explore whether there is a difference or benefit to using a particular type of book. Join us as we discuss the recent findings on parent-toddler interactions when reading from a print book versus an E-reader.</p>
<p>Guest: Susan Feeney, DNP, FNP</p>
<p>Music Credit: Richard Onorato </p>
]]></description>
                                                            <content:encoded><![CDATA[<p>Credits: 0.25 AMA PRA Category 1 Credits™</p>
<p>Claim CME/CE credit: <a href='https://www.pri-med.com/online-education/podcast/frankly-speaking-cme-126'>https://www.pri-med.com/online-education/podcast/frankly-speaking-cme-126</a></p>
<p>Overview: Reading to young children is a well-established activity that can impact neuro-cognitive and emotional development in children. Since many parents use E-readers and other digital platforms to read to their kids, in this episode we will explore whether there is a difference or benefit to using a particular type of book. Join us as we discuss the recent findings on parent-toddler interactions when reading from a print book versus an E-reader.</p>
<p>Guest: Susan Feeney, DNP, FNP</p>
<p>Music Credit: Richard Onorato </p>
]]></content:encoded>
                                    
        <enclosure url="https://mcdn.podbean.com/mf/web/p2hanx/secure_primed_frankly-speaking-cme-126.mp3" length="20425568" type="audio/mpeg"/>
                <itunes:summary><![CDATA[Credits: 0.25 AMA PRA Category 1 Credits™
Claim CME/CE credit: https://www.pri-med.com/online-education/podcast/frankly-speaking-cme-126
Overview: Reading to young children is a well-established activity that can impact neuro-cognitive and emotional development in children. Since many parents use E-readers and other digital platforms to read to their kids, in this episode we will explore whether there is a difference or benefit to using a particular type of book. Join us as we discuss the recent findings on parent-toddler interactions when reading from a print book versus an E-reader.
Guest: Susan Feeney, DNP, FNP
Music Credit: Richard Onorato ]]></itunes:summary>
        <itunes:author>Pri-Med</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>638</itunes:duration>
        <itunes:season>1</itunes:season>
        <itunes:episode>1</itunes:episode>
        <itunes:episodeType>full</itunes:episodeType>
        <itunes:image href="https://pbcdn1.podbean.com/imglogo/ep-logo/pbblog13721080/9f9a021e1ce558811e8fc6eeadb12520.png" />    </item>
    <item>
        <title>Barriers to Physical Activity: Women’s Breast Size - Frankly Speaking EP 125</title>
        <itunes:title>Barriers to Physical Activity: Women’s Breast Size - Frankly Speaking EP 125</itunes:title>
        <link>https://primedfranklyspeaking.podbean.com/e/barriers-to-physical-activity-women-s-breast-size-frankly-speaking-ep-125/</link>
                    <comments>https://primedfranklyspeaking.podbean.com/e/barriers-to-physical-activity-women-s-breast-size-frankly-speaking-ep-125/#comments</comments>        <pubDate>Mon, 17 Jun 2019 04:30:00 +0000</pubDate>
        <guid isPermaLink="false">2fb10cf0f8e14562889a86d1e3d07d21</guid>
                                    <description><![CDATA[<p>Credits: 0.25 AMA PRA Category 1 Credits™</p>
<p>Claim CME/CE credit: <a href='https://www.pri-med.com/online-education/podcast/frankly-speaking-cme-125'>https://www.pri-med.com/online-education/podcast/frankly-speaking-cme-125</a></p>
<p>Overview: Join us as we discuss barriers to physical activity and how providers can help to address these issues, particularly in women with large breast size.</p>
<p>Guest: Jill Terrien PhD, ANP-BC</p>
<p>Music Credit: Richard Onorato </p>
]]></description>
                                                            <content:encoded><![CDATA[<p>Credits: 0.25 AMA PRA Category 1 Credits™</p>
<p>Claim CME/CE credit: <a href='https://www.pri-med.com/online-education/podcast/frankly-speaking-cme-125'>https://www.pri-med.com/online-education/podcast/frankly-speaking-cme-125</a></p>
<p>Overview: Join us as we discuss barriers to physical activity and how providers can help to address these issues, particularly in women with large breast size.</p>
<p>Guest: Jill Terrien PhD, ANP-BC</p>
<p>Music Credit: Richard Onorato </p>
]]></content:encoded>
                                    
        <enclosure url="https://mcdn.podbean.com/mf/web/izu6kw/secure_primed_frankly-speaking-cme-125.mp3" length="22325321" type="audio/mpeg"/>
                <itunes:summary><![CDATA[Credits: 0.25 AMA PRA Category 1 Credits™
Claim CME/CE credit: https://www.pri-med.com/online-education/podcast/frankly-speaking-cme-125
Overview: Join us as we discuss barriers to physical activity and how providers can help to address these issues, particularly in women with large breast size.
Guest: Jill Terrien PhD, ANP-BC
Music Credit: Richard Onorato ]]></itunes:summary>
        <itunes:author>Pri-Med</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>697</itunes:duration>
        <itunes:season>1</itunes:season>
        <itunes:episode>1</itunes:episode>
        <itunes:episodeType>full</itunes:episodeType>
        <itunes:image href="https://pbcdn1.podbean.com/imglogo/ep-logo/pbblog13721080/fe3c5c134cf2900317c653bbb825793f.png" />    </item>
    <item>
        <title>Saving Money on Insulin - Frankly Speaking EP 124</title>
        <itunes:title>Saving Money on Insulin - Frankly Speaking EP 124</itunes:title>
        <link>https://primedfranklyspeaking.podbean.com/e/saving-money-on-insulin-frankly-speaking-ep-124/</link>
                    <comments>https://primedfranklyspeaking.podbean.com/e/saving-money-on-insulin-frankly-speaking-ep-124/#comments</comments>        <pubDate>Mon, 10 Jun 2019 04:30:00 +0000</pubDate>
        <guid isPermaLink="false">759206eca27947f9bd7c9f216eb1ba80</guid>
                                    <description><![CDATA[<p>Credits: 0.25 AMA PRA Category 1 Credits™</p>
<p>Claim CME/CE credit: <a href='https://www.pri-med.com/online-education/podcast/frankly-speaking-cme-124'>https://www.pri-med.com/online-education/podcast/frankly-speaking-cme-124</a></p>
<p>Overview: When patients with T2DM have difficulty controlling their glucose with standard approaches, or are newly diagnosed but severely hyperglycemic, insulin is commonly used to help control their metabolism. Using long acting, once a day agents is a standard of care but in the last 15 years, the costs of insulin has skyrocketed. During this episode we will review a study examining the effects of using Neutral Protamine Hagedorn Insulin (NPH) rather than once a day insulin on A1c control and risk for hypoglycemia and discuss their findings, which suggest NPH can be used with equivalent glycemic control and with no additional risk.</p>
<p>Guest: Alan M. Ehrlich, MD, FAAFP</p>
<p>Music Credit: Richard Onorato </p>
]]></description>
                                                            <content:encoded><![CDATA[<p>Credits: 0.25 AMA PRA Category 1 Credits™</p>
<p>Claim CME/CE credit: <a href='https://www.pri-med.com/online-education/podcast/frankly-speaking-cme-124'>https://www.pri-med.com/online-education/podcast/frankly-speaking-cme-124</a></p>
<p>Overview: When patients with T2DM have difficulty controlling their glucose with standard approaches, or are newly diagnosed but severely hyperglycemic, insulin is commonly used to help control their metabolism. Using long acting, once a day agents is a standard of care but in the last 15 years, the costs of insulin has skyrocketed. During this episode we will review a study examining the effects of using Neutral Protamine Hagedorn Insulin (NPH) rather than once a day insulin on A1c control and risk for hypoglycemia and discuss their findings, which suggest NPH can be used with equivalent glycemic control and with no additional risk.</p>
<p>Guest: Alan M. Ehrlich, MD, FAAFP</p>
<p>Music Credit: Richard Onorato </p>
]]></content:encoded>
                                    
        <enclosure url="https://mcdn.podbean.com/mf/web/msv75l/secure_primed_frankly-speaking-cme-124.mp3" length="21337591" type="audio/mpeg"/>
                <itunes:summary><![CDATA[Credits: 0.25 AMA PRA Category 1 Credits™
Claim CME/CE credit: https://www.pri-med.com/online-education/podcast/frankly-speaking-cme-124
Overview: When patients with T2DM have difficulty controlling their glucose with standard approaches, or are newly diagnosed but severely hyperglycemic, insulin is commonly used to help control their metabolism. Using long acting, once a day agents is a standard of care but in the last 15 years, the costs of insulin has skyrocketed. During this episode we will review a study examining the effects of using Neutral Protamine Hagedorn Insulin (NPH) rather than once a day insulin on A1c control and risk for hypoglycemia and discuss their findings, which suggest NPH can be used with equivalent glycemic control and with no additional risk.
Guest: Alan M. Ehrlich, MD, FAAFP
Music Credit: Richard Onorato ]]></itunes:summary>
        <itunes:author>Pri-Med</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>666</itunes:duration>
        <itunes:season>1</itunes:season>
        <itunes:episode>1</itunes:episode>
        <itunes:episodeType>full</itunes:episodeType>
        <itunes:image href="https://pbcdn1.podbean.com/imglogo/ep-logo/pbblog13721080/a4584f4fb3f6ae91ed632dc49e21ab31.jpg" />    </item>
    <item>
        <title>Contraceptive Education: Educate Your Patients While They Wait - Frankly Speaking EP 123</title>
        <itunes:title>Contraceptive Education: Educate Your Patients While They Wait - Frankly Speaking EP 123</itunes:title>
        <link>https://primedfranklyspeaking.podbean.com/e/contraceptive-education-educate-your-patients-while-they-wait-frankly-speaking-ep-123/</link>
                    <comments>https://primedfranklyspeaking.podbean.com/e/contraceptive-education-educate-your-patients-while-they-wait-frankly-speaking-ep-123/#comments</comments>        <pubDate>Mon, 03 Jun 2019 04:00:00 +0000</pubDate>
        <guid isPermaLink="false">ecf0a7f5e04148afae471b0a5d32aac2</guid>
                                    <description><![CDATA[<p>Credits: 0.25 AMA PRA Category 1 Credits™</p>
<p>Claim CME/CE credit: <a href='https://www.pri-med.com/online-education/podcast/frankly-speaking-cme-123'>https://www.pri-med.com/online-education/podcast/frankly-speaking-cme-123</a></p>
<p>Overview: Join us as we discuss decision aids used to assess contraceptive knowledge and intentions that can be easily incorporated in primary care practice. </p>
<p>Guest: Jill Terrien PhD, ANP-BC</p>
<p>Music Credit: Richard Onorato </p>
]]></description>
                                                            <content:encoded><![CDATA[<p>Credits: 0.25 AMA PRA Category 1 Credits™</p>
<p>Claim CME/CE credit: <a href='https://www.pri-med.com/online-education/podcast/frankly-speaking-cme-123'>https://www.pri-med.com/online-education/podcast/frankly-speaking-cme-123</a></p>
<p>Overview: Join us as we discuss decision aids used to assess contraceptive knowledge and intentions that can be easily incorporated in primary care practice. </p>
<p>Guest: Jill Terrien PhD, ANP-BC</p>
<p>Music Credit: Richard Onorato </p>
]]></content:encoded>
                                    
        <enclosure url="https://mcdn.podbean.com/mf/web/pibqbr/secure_primed_frankly-speaking-ep-123-final.mp3" length="7419650" type="audio/mpeg"/>
                <itunes:summary><![CDATA[Credits: 0.25 AMA PRA Category 1 Credits™
Claim CME/CE credit: https://www.pri-med.com/online-education/podcast/frankly-speaking-cme-123
Overview: Join us as we discuss decision aids used to assess contraceptive knowledge and intentions that can be easily incorporated in primary care practice. 
Guest: Jill Terrien PhD, ANP-BC
Music Credit: Richard Onorato ]]></itunes:summary>
        <itunes:author>Pri-Med</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>462</itunes:duration>
        <itunes:season>1</itunes:season>
        <itunes:episode>1</itunes:episode>
        <itunes:episodeType>full</itunes:episodeType>
        <itunes:image href="https://pbcdn1.podbean.com/imglogo/ep-logo/pbblog13721080/0e9bd12ba141aa03d4ed1247f14e1523.jpg" />    </item>
    <item>
        <title>Fear Not the Fungus Treatment - Frankly Speaking EP 122</title>
        <itunes:title>Fear Not the Fungus Treatment - Frankly Speaking EP 122</itunes:title>
        <link>https://primedfranklyspeaking.podbean.com/e/fear-not-the-fungus-treatment-frankly-speaking-ep-122/</link>
                    <comments>https://primedfranklyspeaking.podbean.com/e/fear-not-the-fungus-treatment-frankly-speaking-ep-122/#comments</comments>        <pubDate>Mon, 27 May 2019 04:30:00 +0000</pubDate>
        <guid isPermaLink="false">292eaa09daae46d19399208a11badf0d</guid>
                                    <description><![CDATA[<p>Credits: 0.25 AMA PRA Category 1 Credits™</p>
<p>Claim CME/CE credit: <a href='https://www.pri-med.com/online-education/podcast/frankly-speaking-cme-122'>https://www.pri-med.com/online-education/podcast/frankly-speaking-cme-122</a></p>
<p>Overview: Since their arrival, oral anti-fungal agents have been thought to induce liver disease. Often, these medications are avoided or used with caution and frequent laboratory testing. Join us in a discussion of a recent study that builds on previous work showing the risk with using these agents is extremely small.</p>
<p>Guest: Susan Feeney, DNP, FNP</p>
<p>Landing Page: <a href='https://www.pri-med.com/online-education/podcast/frankly-speaking-cme-122'>https://www.pri-med.com/online-education/podcast/frankly-speaking-cme-122</a></p>
<p> </p>
]]></description>
                                                            <content:encoded><![CDATA[<p>Credits: 0.25 AMA PRA Category 1 Credits™</p>
<p>Claim CME/CE credit: <a href='https://www.pri-med.com/online-education/podcast/frankly-speaking-cme-122'>https://www.pri-med.com/online-education/podcast/frankly-speaking-cme-122</a></p>
<p>Overview: Since their arrival, oral anti-fungal agents have been thought to induce liver disease. Often, these medications are avoided or used with caution and frequent laboratory testing. Join us in a discussion of a recent study that builds on previous work showing the risk with using these agents is extremely small.</p>
<p>Guest: Susan Feeney, DNP, FNP</p>
<p>Landing Page: <a href='https://www.pri-med.com/online-education/podcast/frankly-speaking-cme-122'>https://www.pri-med.com/online-education/podcast/frankly-speaking-cme-122</a></p>
<p> </p>
]]></content:encoded>
                                    
        <enclosure url="https://mcdn.podbean.com/mf/web/s7tgwc/secure_primed_frankly-speaking-ep-122.mp3" length="20412592" type="audio/mpeg"/>
                <itunes:summary><![CDATA[Credits: 0.25 AMA PRA Category 1 Credits™
Claim CME/CE credit: https://www.pri-med.com/online-education/podcast/frankly-speaking-cme-122
Overview: Since their arrival, oral anti-fungal agents have been thought to induce liver disease. Often, these medications are avoided or used with caution and frequent laboratory testing. Join us in a discussion of a recent study that builds on previous work showing the risk with using these agents is extremely small.
Guest: Susan Feeney, DNP, FNP
Landing Page: https://www.pri-med.com/online-education/podcast/frankly-speaking-cme-122
 ]]></itunes:summary>
        <itunes:author>Pri-Med</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>637</itunes:duration>
        <itunes:season>1</itunes:season>
        <itunes:episode>1</itunes:episode>
        <itunes:episodeType>full</itunes:episodeType>
        <itunes:image href="https://pbcdn1.podbean.com/imglogo/ep-logo/pbblog13721080/f006ed8560e1e874da76bb469a33c7c1.jpg" />    </item>
    <item>
        <title>Preventing Perinatal Depression: Recommendations to Improve Outcomes for Moms and Their Babies - Frankly Speaking EP 121</title>
        <itunes:title>Preventing Perinatal Depression: Recommendations to Improve Outcomes for Moms and Their Babies - Frankly Speaking EP 121</itunes:title>
        <link>https://primedfranklyspeaking.podbean.com/e/preventing-perinatal-depression-recommendations-to-improve-outcomes-for-moms-and-their-babies-frankly-speaking-ep-121/</link>
                    <comments>https://primedfranklyspeaking.podbean.com/e/preventing-perinatal-depression-recommendations-to-improve-outcomes-for-moms-and-their-babies-frankly-speaking-ep-121/#comments</comments>        <pubDate>Mon, 20 May 2019 04:30:00 +0000</pubDate>
        <guid isPermaLink="false">edd76fbc361442b3a4d945f074c6ef7c</guid>
                                    <description><![CDATA[<p>Credits: 0.25 AMA PRA Category 1 Credits™</p>
<p>Claim CME/CE credit: <a href='https://www.pri-med.com/online-education/podcast/frankly-speaking-cme-121'>https://www.pri-med.com/online-education/podcast/frankly-speaking-cme-121</a></p>
<p>Overview: According to the latest data, 1 in 7 US women experience perinatal depression, described as depression occurring during pregnancy and up to one year after childbirth. There is compelling evidence that perinatal depression can have short and long-term effects on both women and their children. The USPSTF has published new recommendations encouraging clinicians to screen pregnant and postpartum persons for depression and provide those who are at increased risk of perinatal depression with counseling interventions. (Grade B recommendation).</p>
<p>Guest: Susan Feeney, DNP, FNP</p>
<p>Landing Page: https://www.pri-med.com/online-education/podcast/frankly-speaking-cme-121</p>
]]></description>
                                                            <content:encoded><![CDATA[<p>Credits: 0.25 AMA PRA Category 1 Credits™</p>
<p>Claim CME/CE credit: <a href='https://www.pri-med.com/online-education/podcast/frankly-speaking-cme-121'>https://www.pri-med.com/online-education/podcast/frankly-speaking-cme-121</a></p>
<p>Overview: According to the latest data, 1 in 7 US women experience perinatal depression, described as depression occurring during pregnancy and up to one year after childbirth. There is compelling evidence that perinatal depression can have short and long-term effects on both women and their children. The USPSTF has published new recommendations encouraging clinicians to screen pregnant and postpartum persons for depression and provide those who are at increased risk of perinatal depression with counseling interventions. (Grade B recommendation).</p>
<p>Guest: Susan Feeney, DNP, FNP</p>
<p>Landing Page: https://www.pri-med.com/online-education/podcast/frankly-speaking-cme-121</p>
]]></content:encoded>
                                    
        <enclosure url="https://mcdn.podbean.com/mf/web/vhr0xo/secure_primed_ep-121-frankly-speaking.mp3" length="20092810" type="audio/mpeg"/>
                <itunes:summary><![CDATA[Credits: 0.25 AMA PRA Category 1 Credits™
Claim CME/CE credit: https://www.pri-med.com/online-education/podcast/frankly-speaking-cme-121
Overview: According to the latest data, 1 in 7 US women experience perinatal depression, described as depression occurring during pregnancy and up to one year after childbirth. There is compelling evidence that perinatal depression can have short and long-term effects on both women and their children. The USPSTF has published new recommendations encouraging clinicians to screen pregnant and postpartum persons for depression and provide those who are at increased risk of perinatal depression with counseling interventions. (Grade B recommendation).
Guest: Susan Feeney, DNP, FNP
Landing Page: https://www.pri-med.com/online-education/podcast/frankly-speaking-cme-121]]></itunes:summary>
        <itunes:author>Pri-Med</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>628</itunes:duration>
        <itunes:season>1</itunes:season>
        <itunes:episode>1</itunes:episode>
        <itunes:episodeType>full</itunes:episodeType>
        <itunes:image href="https://pbcdn1.podbean.com/imglogo/ep-logo/pbblog13721080/792e46a99f0c3465057082c59997e3cb.jpg" />    </item>
    <item>
        <title>Artificial Sweeteners and Postmenopausal Women – Is there an Increased Risk for Stroke and CVD Events? - Frankly Speaking EP 120</title>
        <itunes:title>Artificial Sweeteners and Postmenopausal Women – Is there an Increased Risk for Stroke and CVD Events? - Frankly Speaking EP 120</itunes:title>
        <link>https://primedfranklyspeaking.podbean.com/e/artificial-sweeteners-and-postmenopausal-women-%e2%80%93-is-there-an-increased-risk-for-stroke-and-cvd-events-frankly-speaking-ep-120/</link>
                    <comments>https://primedfranklyspeaking.podbean.com/e/artificial-sweeteners-and-postmenopausal-women-%e2%80%93-is-there-an-increased-risk-for-stroke-and-cvd-events-frankly-speaking-ep-120/#comments</comments>        <pubDate>Mon, 13 May 2019 04:30:00 +0000</pubDate>
        <guid isPermaLink="false">b019837a616d4337a085a8ce2a1ef4bf</guid>
                                    <description><![CDATA[<p>Credits: 0.25 AMA PRA Category 1 Credits™</p>
<p>Claim CME/CE credit: <a href='https://www.pri-med.com/online-education/podcast/frankly-speaking-cme-120'>https://www.pri-med.com/online-education/podcast/frankly-speaking-cme-120</a></p>
<p>Overview: In a recent study of postmenopausal women in the WHI Observational Study who consumed > 2 ASB per day, there appeared to be an association between increased intake of ASB with increased risk of ischemic stroke, CVD, and all cause mortality. Join us as we discuss these findings, what it adds to our knowledge about ASB, and potential strategies to apply this new evidence into your practice.</p>
<p>Guest: Susan Feeney, DNP, FNP </p>
<p>Landing Page: <a href='https://www.pri-med.com/online-education/podcast/frankly-speaking-cme-120'>https://www.pri-med.com/online-education/podcast/frankly-speaking-cme-120</a></p>
<p> </p>
<p> </p>
]]></description>
                                                            <content:encoded><![CDATA[<p>Credits: 0.25 AMA PRA Category 1 Credits™</p>
<p>Claim CME/CE credit: <a href='https://www.pri-med.com/online-education/podcast/frankly-speaking-cme-120'>https://www.pri-med.com/online-education/podcast/frankly-speaking-cme-120</a></p>
<p>Overview: In a recent study of postmenopausal women in the WHI Observational Study who consumed > 2 ASB per day, there appeared to be an association between increased intake of ASB with increased risk of ischemic stroke, CVD, and all cause mortality. Join us as we discuss these findings, what it adds to our knowledge about ASB, and potential strategies to apply this new evidence into your practice.</p>
<p>Guest: Susan Feeney, DNP, FNP </p>
<p>Landing Page: <a href='https://www.pri-med.com/online-education/podcast/frankly-speaking-cme-120'>https://www.pri-med.com/online-education/podcast/frankly-speaking-cme-120</a></p>
<p> </p>
<p> </p>
]]></content:encoded>
                                    
        <enclosure url="https://mcdn.podbean.com/mf/web/1u4s19/secure_primed_ep-120-frankly-speaking-edit.mp3" length="9245594" type="audio/mpeg"/>
                <itunes:summary><![CDATA[Credits: 0.25 AMA PRA Category 1 Credits™
Claim CME/CE credit: https://www.pri-med.com/online-education/podcast/frankly-speaking-cme-120
Overview: In a recent study of postmenopausal women in the WHI Observational Study who consumed > 2 ASB per day, there appeared to be an association between increased intake of ASB with increased risk of ischemic stroke, CVD, and all cause mortality. Join us as we discuss these findings, what it adds to our knowledge about ASB, and potential strategies to apply this new evidence into your practice.
Guest: Susan Feeney, DNP, FNP 
Landing Page: https://www.pri-med.com/online-education/podcast/frankly-speaking-cme-120
 
 ]]></itunes:summary>
        <itunes:author>Pri-Med</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>576</itunes:duration>
        <itunes:season>1</itunes:season>
        <itunes:episode>1</itunes:episode>
        <itunes:episodeType>full</itunes:episodeType>
        <itunes:image href="https://pbcdn1.podbean.com/imglogo/ep-logo/pbblog13721080/81384628ada1dcb96bd0b32f399ca2ae.jpg" />    </item>
    <item>
        <title>Powerful Cancer Prevention: HPV Vaccination - Frankly Speaking EP 119</title>
        <itunes:title>Powerful Cancer Prevention: HPV Vaccination - Frankly Speaking EP 119</itunes:title>
        <link>https://primedfranklyspeaking.podbean.com/e/powerful-cancer-prevention-hpv-vaccination-frankly-speaking-ep-119/</link>
                    <comments>https://primedfranklyspeaking.podbean.com/e/powerful-cancer-prevention-hpv-vaccination-frankly-speaking-ep-119/#comments</comments>        <pubDate>Mon, 06 May 2019 04:30:00 +0000</pubDate>
        <guid isPermaLink="false">6d782344718e4289b07fc2cbcd1e4cdd</guid>
                                    <description><![CDATA[<p>Credits: 0.25 AMA PRA Category 1 Credits™</p>
<p>Claim CME/CE credit: <a href='https://www.pri-med.com/online-education/podcast/frankly-speaking-cme-119'>https://www.pri-med.com/online-education/podcast/frankly-speaking-cme-119</a></p>
<p>Overview: Join us as we discuss HPV vaccination and the growing evidence of the benefits to those who receive the vaccine and the protection of those who are not vaccinated.</p>
<p>Guest: Jill Terrien PhD, ANP-BC </p>
<p>Landing Page: <a href='https://www.pri-med.com/online-education/podcast/frankly-speaking-cme-119'>https://www.pri-med.com/online-education/podcast/frankly-speaking-cme-119</a></p>
<p> </p>
]]></description>
                                                            <content:encoded><![CDATA[<p>Credits: 0.25 AMA PRA Category 1 Credits™</p>
<p>Claim CME/CE credit: <a href='https://www.pri-med.com/online-education/podcast/frankly-speaking-cme-119'>https://www.pri-med.com/online-education/podcast/frankly-speaking-cme-119</a></p>
<p>Overview: Join us as we discuss HPV vaccination and the growing evidence of the benefits to those who receive the vaccine and the protection of those who are not vaccinated.</p>
<p>Guest: Jill Terrien PhD, ANP-BC </p>
<p>Landing Page: <a href='https://www.pri-med.com/online-education/podcast/frankly-speaking-cme-119'>https://www.pri-med.com/online-education/podcast/frankly-speaking-cme-119</a></p>
<p> </p>
]]></content:encoded>
                                    
        <enclosure url="https://mcdn.podbean.com/mf/web/73mlot/secure_primed_ep-119-frankly-speaking.mp3" length="15343625" type="audio/mpeg"/>
                <itunes:summary><![CDATA[Credits: 0.25 AMA PRA Category 1 Credits™
Claim CME/CE credit: https://www.pri-med.com/online-education/podcast/frankly-speaking-cme-119
Overview: Join us as we discuss HPV vaccination and the growing evidence of the benefits to those who receive the vaccine and the protection of those who are not vaccinated.
Guest: Jill Terrien PhD, ANP-BC 
Landing Page: https://www.pri-med.com/online-education/podcast/frankly-speaking-cme-119
 ]]></itunes:summary>
        <itunes:author>Pri-Med</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>479</itunes:duration>
        <itunes:season>1</itunes:season>
        <itunes:episode>1</itunes:episode>
        <itunes:episodeType>full</itunes:episodeType>
        <itunes:image href="https://pbcdn1.podbean.com/imglogo/ep-logo/pbblog13721080/8ded1ecca0b5debae401d45e233012df.jpg" />    </item>
    <item>
        <title>Avoiding Unnecessary Antibiotics: The Quick Take - Frankly Speaking EP 118</title>
        <itunes:title>Avoiding Unnecessary Antibiotics: The Quick Take - Frankly Speaking EP 118</itunes:title>
        <link>https://primedfranklyspeaking.podbean.com/e/avoiding-unnecessary-antibiotics-the-quick-take-frankly-speaking-ep-118/</link>
                    <comments>https://primedfranklyspeaking.podbean.com/e/avoiding-unnecessary-antibiotics-the-quick-take-frankly-speaking-ep-118/#comments</comments>        <pubDate>Mon, 29 Apr 2019 04:30:00 +0000</pubDate>
        <guid isPermaLink="false">2270bc47ad344439b7baee58e03c1781</guid>
                                    <description><![CDATA[<p>Credits: 0.25 AMA PRA Category 1 Credits™</p>
<p>Claim CME/CE credit: <a href='https://www.pri-med.com/online-education/podcast/frankly-speaking-cme-118'>https://www.pri-med.com/online-education/podcast/frankly-speaking-cme-118</a></p>
<p>Overview: Antibiotics are frequently prescribed for upper respiratory infections, even when they are likely due to viral etiologies, or will resolve just as quickly without antibiotics. Many clinicians believe convincing patients they do not need to take an antibiotic is time consuming and frustrating for both parties. In fact, patients are often receptive to information on appropriate use, and the conversation can be done efficiently with practice.</p>
<p>Guest: Alan Ehrlich MD, FAAFP</p>
<p>Landing Page: <a href='https://www.pri-med.com/online-education/podcast/frankly-speaking-cme-118'>https://www.pri-med.com/online-education/podcast/frankly-speaking-cme-118</a></p>
]]></description>
                                                            <content:encoded><![CDATA[<p>Credits: 0.25 AMA PRA Category 1 Credits™</p>
<p>Claim CME/CE credit: <a href='https://www.pri-med.com/online-education/podcast/frankly-speaking-cme-118'>https://www.pri-med.com/online-education/podcast/frankly-speaking-cme-118</a></p>
<p>Overview: Antibiotics are frequently prescribed for upper respiratory infections, even when they are likely due to viral etiologies, or will resolve just as quickly without antibiotics. Many clinicians believe convincing patients they do not need to take an antibiotic is time consuming and frustrating for both parties. In fact, patients are often receptive to information on appropriate use, and the conversation can be done efficiently with practice.</p>
<p>Guest: Alan Ehrlich MD, FAAFP</p>
<p>Landing Page: <a href='https://www.pri-med.com/online-education/podcast/frankly-speaking-cme-118'>https://www.pri-med.com/online-education/podcast/frankly-speaking-cme-118</a></p>
]]></content:encoded>
                                    
        <enclosure url="https://mcdn.podbean.com/mf/web/k5rvwu/secure_primed_ep-118-frankly-speaking.mp3" length="21275011" type="audio/mpeg"/>
                <itunes:summary><![CDATA[Credits: 0.25 AMA PRA Category 1 Credits™
Claim CME/CE credit: https://www.pri-med.com/online-education/podcast/frankly-speaking-cme-118
Overview: Antibiotics are frequently prescribed for upper respiratory infections, even when they are likely due to viral etiologies, or will resolve just as quickly without antibiotics. Many clinicians believe convincing patients they do not need to take an antibiotic is time consuming and frustrating for both parties. In fact, patients are often receptive to information on appropriate use, and the conversation can be done efficiently with practice.
Guest: Alan Ehrlich MD, FAAFP
Landing Page: https://www.pri-med.com/online-education/podcast/frankly-speaking-cme-118]]></itunes:summary>
        <itunes:author>Pri-Med</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>665</itunes:duration>
        <itunes:season>1</itunes:season>
        <itunes:episode>1</itunes:episode>
        <itunes:episodeType>full</itunes:episodeType>
        <itunes:image href="https://pbcdn1.podbean.com/imglogo/ep-logo/pbblog13721080/f680ecbad1eb98445107daa1385054eb.jpg" />    </item>
    <item>
        <title>Are E-Cigarettes Effective Tools for Smoking Cessation, or Are We Just Blowing Smoke? - Frankly Speaking EP 117</title>
        <itunes:title>Are E-Cigarettes Effective Tools for Smoking Cessation, or Are We Just Blowing Smoke? - Frankly Speaking EP 117</itunes:title>
        <link>https://primedfranklyspeaking.podbean.com/e/are-e-cigarettes-effective-tools-for-smoking-cessation-or-are-we-just-blowing-smoke-frankly-speaking-ep-117/</link>
                    <comments>https://primedfranklyspeaking.podbean.com/e/are-e-cigarettes-effective-tools-for-smoking-cessation-or-are-we-just-blowing-smoke-frankly-speaking-ep-117/#comments</comments>        <pubDate>Mon, 22 Apr 2019 04:30:00 +0000</pubDate>
        <guid isPermaLink="false">757982d1fd1949d9892290ebb52dcae1</guid>
                                    <description><![CDATA[<p>Credits: 0.25 AMA PRA Category 1 Credits™</p>
<p>Claim CME/CE credit: <a href='https://www.pri-med.com/online-education/podcast/frankly-speaking-cme-117'>https://www.pri-med.com/online-education/podcast/frankly-speaking-cme-117</a></p>
<p>Overview: The FDA has not approved any ENDS product as an effective or safe smoking cessation tool. Earlier evidence did not indicate that ENDS were effective or sustainable. Most of these studies were done on earlier prototypes of e-cigarettes. A recent study from the UK found that newer generation ENDs were more successful than approved NRT products for smoking cessation. Join us as we discuss this new evidence and how it impacts strategies to assist with smoking cessation.</p>
<p>Guests: Jill Terrien PhD, ANP-BC & Susan Feeney, DNP, FNP </p>
<p>Landing Page: https://www.pri-med.com/online-education/podcast/frankly-speaking-cme-117-smoking</p>
<p> </p>
]]></description>
                                                            <content:encoded><![CDATA[<p>Credits: 0.25 AMA PRA Category 1 Credits™</p>
<p>Claim CME/CE credit: <a href='https://www.pri-med.com/online-education/podcast/frankly-speaking-cme-117'>https://www.pri-med.com/online-education/podcast/frankly-speaking-cme-117</a></p>
<p>Overview: The FDA has not approved any ENDS product as an effective or safe smoking cessation tool. Earlier evidence did not indicate that ENDS were effective or sustainable. Most of these studies were done on earlier prototypes of e-cigarettes. A recent study from the UK found that newer generation ENDs were more successful than approved NRT products for smoking cessation. Join us as we discuss this new evidence and how it impacts strategies to assist with smoking cessation.</p>
<p>Guests: Jill Terrien PhD, ANP-BC & Susan Feeney, DNP, FNP </p>
<p>Landing Page: https://www.pri-med.com/online-education/podcast/frankly-speaking-cme-117-smoking</p>
<p> </p>
]]></content:encoded>
                                    
        <enclosure url="https://mcdn.podbean.com/mf/web/vr1cen/secure_primed_ep-117-smoking-frankly-speaking.mp3" length="20201640" type="audio/mpeg"/>
                <itunes:summary><![CDATA[Credits: 0.25 AMA PRA Category 1 Credits™
Claim CME/CE credit: https://www.pri-med.com/online-education/podcast/frankly-speaking-cme-117
Overview: The FDA has not approved any ENDS product as an effective or safe smoking cessation tool. Earlier evidence did not indicate that ENDS were effective or sustainable. Most of these studies were done on earlier prototypes of e-cigarettes. A recent study from the UK found that newer generation ENDs were more successful than approved NRT products for smoking cessation. Join us as we discuss this new evidence and how it impacts strategies to assist with smoking cessation.
Guests: Jill Terrien PhD, ANP-BC & Susan Feeney, DNP, FNP 
Landing Page: https://www.pri-med.com/online-education/podcast/frankly-speaking-cme-117-smoking
 ]]></itunes:summary>
        <itunes:author>Pri-Med</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>631</itunes:duration>
        <itunes:season>1</itunes:season>
        <itunes:episode>1</itunes:episode>
        <itunes:episodeType>full</itunes:episodeType>
        <itunes:image href="https://pbcdn1.podbean.com/imglogo/ep-logo/pbblog13721080/aa4cb6499d86e88a82770ffc3b26768d.jpg" />    </item>
    <item>
        <title>Push-Ups: No-Cost Assessment of Future CV Risk? - Frankly Speaking EP 116</title>
        <itunes:title>Push-Ups: No-Cost Assessment of Future CV Risk? - Frankly Speaking EP 116</itunes:title>
        <link>https://primedfranklyspeaking.podbean.com/e/push-ups-no-cost-assessment-of-future-cv-risk-frankly-speaking-ep-116/</link>
                    <comments>https://primedfranklyspeaking.podbean.com/e/push-ups-no-cost-assessment-of-future-cv-risk-frankly-speaking-ep-116/#comments</comments>        <pubDate>Mon, 15 Apr 2019 04:30:00 +0000</pubDate>
        <guid isPermaLink="false">60d3887ad7664bc79f46329d202de44b</guid>
                                    <description><![CDATA[<p>Credits: 0.25 AMA PRA Category 1 Credits™</p>
<p>Claim CME/CE credit: <a href='https://www.pri-med.com/online-education/podcast/frankly-speaking-cme-116'>https://www.pri-med.com/online-education/podcast/frankly-speaking-cme-116</a></p>
<p>Overview: Join us as we discuss a recent study of push-up capacity in middle-aged men and the association with CVD risk.</p>
<p>Guest: Jill Terrien PhD, ANP-BC</p>
<p>Music Credit: Richard Onorato </p>
]]></description>
                                                            <content:encoded><![CDATA[<p>Credits: 0.25 AMA PRA Category 1 Credits™</p>
<p>Claim CME/CE credit: <a href='https://www.pri-med.com/online-education/podcast/frankly-speaking-cme-116'>https://www.pri-med.com/online-education/podcast/frankly-speaking-cme-116</a></p>
<p>Overview: Join us as we discuss a recent study of push-up capacity in middle-aged men and the association with CVD risk.</p>
<p>Guest: Jill Terrien PhD, ANP-BC</p>
<p>Music Credit: Richard Onorato </p>
]]></content:encoded>
                                    
        <enclosure url="https://mcdn.podbean.com/mf/web/mx01k5/secure_primed_ep-116-push-ups-frankly-speaking.mp3" length="16367973" type="audio/mpeg"/>
                <itunes:summary><![CDATA[Credits: 0.25 AMA PRA Category 1 Credits™
Claim CME/CE credit: https://www.pri-med.com/online-education/podcast/frankly-speaking-cme-116
Overview: Join us as we discuss a recent study of push-up capacity in middle-aged men and the association with CVD risk.
Guest: Jill Terrien PhD, ANP-BC
Music Credit: Richard Onorato ]]></itunes:summary>
        <itunes:author>Pri-Med</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>511</itunes:duration>
        <itunes:season>1</itunes:season>
        <itunes:episode>1</itunes:episode>
        <itunes:episodeType>full</itunes:episodeType>
        <itunes:image href="https://pbcdn1.podbean.com/imglogo/ep-logo/pbblog13721080/75270ae18aac8781c8005d2109f6aefb.jpg" />    </item>
    <item>
        <title>Putting the “Bite” on Type 2 Diabetes - Frankly Speaking EP 115</title>
        <itunes:title>Putting the “Bite” on Type 2 Diabetes - Frankly Speaking EP 115</itunes:title>
        <link>https://primedfranklyspeaking.podbean.com/e/putting-the-bite-on-type-2-diabetes-frankly-speaking-ep-115/</link>
                    <comments>https://primedfranklyspeaking.podbean.com/e/putting-the-bite-on-type-2-diabetes-frankly-speaking-ep-115/#comments</comments>        <pubDate>Mon, 08 Apr 2019 04:30:00 +0000</pubDate>
        <guid isPermaLink="false">52be61c8566940719d4eefc1f303cbe7</guid>
                                    <description><![CDATA[<p>Credits: 0.25 AMA PRA Category 1 Credits™</p>
<p>Claim CME/CE credit: <a href='https://www.pri-med.com/online-education/podcast/frankly-speaking-cme-115'>https://www.pri-med.com/online-education/podcast/frankly-speaking-cme-115</a></p>
<p>Overview: In this episode we discuss how periodontal disease worsens A1C and other clinical outcomes in T2DM.</p>
<p>Guest: Jill Terrien PhD, ANP-BC</p>
<p>Music Credit: Richard Onorato </p>
]]></description>
                                                            <content:encoded><![CDATA[<p>Credits: 0.25 AMA PRA Category 1 Credits™</p>
<p>Claim CME/CE credit: <a href='https://www.pri-med.com/online-education/podcast/frankly-speaking-cme-115'>https://www.pri-med.com/online-education/podcast/frankly-speaking-cme-115</a></p>
<p>Overview: In this episode we discuss how periodontal disease worsens A1C and other clinical outcomes in T2DM.</p>
<p>Guest: Jill Terrien PhD, ANP-BC</p>
<p>Music Credit: Richard Onorato </p>
]]></content:encoded>
                                    
        <enclosure url="https://mcdn.podbean.com/mf/web/3k974l/secure_primed_ep-115-peridontal-frankly-speaking.mp3" length="20461763" type="audio/mpeg"/>
                <itunes:summary><![CDATA[Credits: 0.25 AMA PRA Category 1 Credits™
Claim CME/CE credit: https://www.pri-med.com/online-education/podcast/frankly-speaking-cme-115
Overview: In this episode we discuss how periodontal disease worsens A1C and other clinical outcomes in T2DM.
Guest: Jill Terrien PhD, ANP-BC
Music Credit: Richard Onorato ]]></itunes:summary>
        <itunes:author>Pri-Med</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>639</itunes:duration>
        <itunes:season>1</itunes:season>
        <itunes:episode>1</itunes:episode>
        <itunes:episodeType>full</itunes:episodeType>
        <itunes:image href="https://pbcdn1.podbean.com/imglogo/ep-logo/pbblog13721080/1a6a1dd2bb07641de53e9f639c2fe731.jpg" />    </item>
    <item>
        <title>A Chief Complaint: Older Adults, Cognition and Sexuality - Frankly Speaking EP 114</title>
        <itunes:title>A Chief Complaint: Older Adults, Cognition and Sexuality - Frankly Speaking EP 114</itunes:title>
        <link>https://primedfranklyspeaking.podbean.com/e/a-chief-complaint-older-adults-cognition-and-sexuality-frankly-speaking-ep-114/</link>
                    <comments>https://primedfranklyspeaking.podbean.com/e/a-chief-complaint-older-adults-cognition-and-sexuality-frankly-speaking-ep-114/#comments</comments>        <pubDate>Mon, 01 Apr 2019 04:30:00 +0000</pubDate>
        <guid isPermaLink="false">fa37ab9e39e54b3492927e3cad387884</guid>
                                    <description><![CDATA[<p>Credits: 0.25 AMA PRA Category 1 Credits™</p>
<p>Claim CME/CE credit: <a href='https://www.pri-med.com/online-education/podcast/frankly-speaking-cme-114-older-sexuality-2'>https://www.pri-med.com/online-education/podcast/frankly-speaking-cme-114-older-sexuality-2</a></p>
<p>Overview: This episode focuses on older adults and caregivers/partners in relation to their intimacy and sexuality for patients experiencing changes in cognition.</p>
<p>Guest: Jill Terrien PhD, ANP-BC</p>
<p>Music Credit: Richard Onorato </p>
]]></description>
                                                            <content:encoded><![CDATA[<p>Credits: 0.25 AMA PRA Category 1 Credits™</p>
<p>Claim CME/CE credit: <a href='https://www.pri-med.com/online-education/podcast/frankly-speaking-cme-114-older-sexuality-2'>https://www.pri-med.com/online-education/podcast/frankly-speaking-cme-114-older-sexuality-2</a></p>
<p>Overview: This episode focuses on older adults and caregivers/partners in relation to their intimacy and sexuality for patients experiencing changes in cognition.</p>
<p>Guest: Jill Terrien PhD, ANP-BC</p>
<p>Music Credit: Richard Onorato </p>
]]></content:encoded>
                                    
        <enclosure url="https://mcdn.podbean.com/mf/web/97jpgs/secure_primed_ep-114-older-sexuality-frankly-speaking.mp3" length="16110047" type="audio/mpeg"/>
                <itunes:summary><![CDATA[Credits: 0.25 AMA PRA Category 1 Credits™
Claim CME/CE credit: https://www.pri-med.com/online-education/podcast/frankly-speaking-cme-114-older-sexuality-2
Overview: This episode focuses on older adults and caregivers/partners in relation to their intimacy and sexuality for patients experiencing changes in cognition.
Guest: Jill Terrien PhD, ANP-BC
Music Credit: Richard Onorato ]]></itunes:summary>
        <itunes:author>Pri-Med</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>503</itunes:duration>
        <itunes:season>1</itunes:season>
        <itunes:episode>1</itunes:episode>
        <itunes:episodeType>full</itunes:episodeType>
        <itunes:image href="https://pbcdn1.podbean.com/imglogo/ep-logo/pbblog13721080/b03130fd67559a15f8b2a0d05c5a25f8.jpg" />    </item>
    <item>
        <title>Older Patients, Less Medications: Just Ask - Frankly Speaking EP 113</title>
        <itunes:title>Older Patients, Less Medications: Just Ask - Frankly Speaking EP 113</itunes:title>
        <link>https://primedfranklyspeaking.podbean.com/e/older-patients-less-medications-just-ask-frankly-speaking-ep-113/</link>
                    <comments>https://primedfranklyspeaking.podbean.com/e/older-patients-less-medications-just-ask-frankly-speaking-ep-113/#comments</comments>        <pubDate>Thu, 21 Mar 2019 20:05:00 +0000</pubDate>
        <guid isPermaLink="false">2c54d5ce60fa4931a1772c844ba90494</guid>
                                    <description><![CDATA[<p>Credits: 0.25 AMA PRA Category 1 Credits™</p>
<p>Claim CME/CE credit: <a href='https://www.pri-med.com/online-education/podcast/frankly-speaking-cme-113-deprescribing-2'>https://www.pri-med.com/online-education/podcast/frankly-speaking-cme-113-deprescribing-2</a></p>
<p>Overview: Join us as we discuss deprescribing; the provider-supervised process of discontinuing inappropriate medication(s). We will review minimizing risk, improving quality of life and maximizing patient-centered care.</p>
<p>Guest: Jill Terrien PhD, ANP-BC</p>
<p>Music Credit: Richard Onorato </p>
]]></description>
                                                            <content:encoded><![CDATA[<p>Credits: 0.25 AMA PRA Category 1 Credits™</p>
<p>Claim CME/CE credit: <a href='https://www.pri-med.com/online-education/podcast/frankly-speaking-cme-113-deprescribing-2'>https://www.pri-med.com/online-education/podcast/frankly-speaking-cme-113-deprescribing-2</a></p>
<p>Overview: Join us as we discuss deprescribing; the provider-supervised process of discontinuing inappropriate medication(s). We will review minimizing risk, improving quality of life and maximizing patient-centered care.</p>
<p>Guest: Jill Terrien PhD, ANP-BC</p>
<p>Music Credit: Richard Onorato </p>
]]></content:encoded>
                                    
        <enclosure url="https://mcdn.podbean.com/mf/web/ezoy5c/secure_primed_ep-113-deprescribing-frankly-speaking.mp3" length="19457962" type="audio/mpeg"/>
                <itunes:summary><![CDATA[Credits: 0.25 AMA PRA Category 1 Credits™
Claim CME/CE credit: https://www.pri-med.com/online-education/podcast/frankly-speaking-cme-113-deprescribing-2
Overview: Join us as we discuss deprescribing; the provider-supervised process of discontinuing inappropriate medication(s). We will review minimizing risk, improving quality of life and maximizing patient-centered care.
Guest: Jill Terrien PhD, ANP-BC
Music Credit: Richard Onorato ]]></itunes:summary>
        <itunes:author>Pri-Med</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>608</itunes:duration>
        <itunes:season>1</itunes:season>
        <itunes:episode>1</itunes:episode>
        <itunes:episodeType>full</itunes:episodeType>
        <itunes:image href="https://pbcdn1.podbean.com/imglogo/ep-logo/pbblog13721080/9adacf2fd7e64fcd2701f4970f879471.jpg" />    </item>
    <item>
        <title>Sexting and US Teens: What Is It and What Should You Know About It? - Frankly Speaking EP 112</title>
        <itunes:title>Sexting and US Teens: What Is It and What Should You Know About It? - Frankly Speaking EP 112</itunes:title>
        <link>https://primedfranklyspeaking.podbean.com/e/sexting-and-us-teens-what-is-it-and-what-should-you-know-about-it-frankly-speaking-ep-112/</link>
                    <comments>https://primedfranklyspeaking.podbean.com/e/sexting-and-us-teens-what-is-it-and-what-should-you-know-about-it-frankly-speaking-ep-112/#comments</comments>        <pubDate>Mon, 18 Mar 2019 04:30:00 +0000</pubDate>
        <guid isPermaLink="false">2437871f28294426b6cb42e8cdb17f25</guid>
                                    <description><![CDATA[<p>Credits: 0.25 AMA PRA Category 1 Credits™</p>
<p>Claim CME/CE credit: <a href='https://www.pri-med.com/online-education/podcast/frankly-speaking-cme-112-teen-sexting'>https://www.pri-med.com/online-education/podcast/frankly-speaking-cme-112-teen-sexting</a></p>
<p>Overview: Sexting is increasing among U.S. youth. As cellular technology evolves, so does the behavior. There is some evidence that can help inform teens and their parents of risk, which includes increased risk of high-risk sexual behavior and non-consensual sharing of personal digital data. This episode provides clinicians important evidence on teens and sexting to inform their care of teens and their families.</p>
<p>Guest: Susan Feeney, DNP, FNP</p>
<p>Music Credit: Richard Onorato </p>
]]></description>
                                                            <content:encoded><![CDATA[<p>Credits: 0.25 AMA PRA Category 1 Credits™</p>
<p>Claim CME/CE credit: <a href='https://www.pri-med.com/online-education/podcast/frankly-speaking-cme-112-teen-sexting'>https://www.pri-med.com/online-education/podcast/frankly-speaking-cme-112-teen-sexting</a></p>
<p>Overview: Sexting is increasing among U.S. youth. As cellular technology evolves, so does the behavior. There is some evidence that can help inform teens and their parents of risk, which includes increased risk of high-risk sexual behavior and non-consensual sharing of personal digital data. This episode provides clinicians important evidence on teens and sexting to inform their care of teens and their families.</p>
<p>Guest: Susan Feeney, DNP, FNP</p>
<p>Music Credit: Richard Onorato </p>
]]></content:encoded>
                                    
        <enclosure url="https://mcdn.podbean.com/mf/web/duq93k/secure_primed_ep-112-teen-sexting-frankly-speaking.mp3" length="18688071" type="audio/mpeg"/>
                <itunes:summary><![CDATA[Credits: 0.25 AMA PRA Category 1 Credits™
Claim CME/CE credit: https://www.pri-med.com/online-education/podcast/frankly-speaking-cme-112-teen-sexting
Overview: Sexting is increasing among U.S. youth. As cellular technology evolves, so does the behavior. There is some evidence that can help inform teens and their parents of risk, which includes increased risk of high-risk sexual behavior and non-consensual sharing of personal digital data. This episode provides clinicians important evidence on teens and sexting to inform their care of teens and their families.
Guest: Susan Feeney, DNP, FNP
Music Credit: Richard Onorato ]]></itunes:summary>
        <itunes:author>Pri-Med</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>584</itunes:duration>
        <itunes:season>1</itunes:season>
        <itunes:episode>1</itunes:episode>
        <itunes:episodeType>full</itunes:episodeType>
        <itunes:image href="https://pbcdn1.podbean.com/imglogo/ep-logo/pbblog13721080/aa6abc5156b2d575a9f83607a02d607b.jpg" />    </item>
    <item>
        <title>What’s Cooking With Food Allergies In Adults?- Frankly Speaking EP 111</title>
        <itunes:title>What’s Cooking With Food Allergies In Adults?- Frankly Speaking EP 111</itunes:title>
        <link>https://primedfranklyspeaking.podbean.com/e/what-s-cooking-with-food-allergies-in-adults-frankly-speaking-ep-111/</link>
                    <comments>https://primedfranklyspeaking.podbean.com/e/what-s-cooking-with-food-allergies-in-adults-frankly-speaking-ep-111/#comments</comments>        <pubDate>Mon, 11 Mar 2019 16:00:00 +0000</pubDate>
        <guid isPermaLink="false">aeda30eb31584fd7b44fe20d75f1fce8</guid>
                                    <description><![CDATA[<p>Credits: 0.25 AMA PRA Category 1 Credits™</p>
<p>Claim CME/CE credit: <a href='https://www.pri-med.com/online-education/podcast/frankly-speaking-cme-111-allergies'>https://www.pri-med.com/online-education/podcast/frankly-speaking-cme-111-allergies</a></p>
<p>Overview: Many adults report having food allergies. However, many of those who have a food allergy have not been diagnosed by a physician and many who report having a food allergy may not have one at all. Join us for a discussion and recent review of data about the prevalence of food allergies in adults, and how to assess and manage food allergies.</p>
<p>Guest: Alan Ehrlich MD</p>
<p>Music Credit: Richard Onorato </p>
]]></description>
                                                            <content:encoded><![CDATA[<p>Credits: 0.25 AMA PRA Category 1 Credits™</p>
<p>Claim CME/CE credit: <a href='https://www.pri-med.com/online-education/podcast/frankly-speaking-cme-111-allergies'>https://www.pri-med.com/online-education/podcast/frankly-speaking-cme-111-allergies</a></p>
<p>Overview: Many adults report having food allergies. However, many of those who have a food allergy have not been diagnosed by a physician and many who report having a food allergy may not have one at all. Join us for a discussion and recent review of data about the prevalence of food allergies in adults, and how to assess and manage food allergies.</p>
<p>Guest: Alan Ehrlich MD</p>
<p>Music Credit: Richard Onorato </p>
]]></content:encoded>
                                    
        <enclosure url="https://mcdn.podbean.com/mf/web/kyekj9/secure_primed_ep-111-food-allergies-frankly-speaking.mp3" length="19181731" type="audio/mpeg"/>
                <itunes:summary><![CDATA[Credits: 0.25 AMA PRA Category 1 Credits™
Claim CME/CE credit: https://www.pri-med.com/online-education/podcast/frankly-speaking-cme-111-allergies
Overview: Many adults report having food allergies. However, many of those who have a food allergy have not been diagnosed by a physician and many who report having a food allergy may not have one at all. Join us for a discussion and recent review of data about the prevalence of food allergies in adults, and how to assess and manage food allergies.
Guest: Alan Ehrlich MD
Music Credit: Richard Onorato ]]></itunes:summary>
        <itunes:author>Pri-Med</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>599</itunes:duration>
        <itunes:season>1</itunes:season>
        <itunes:episode>1</itunes:episode>
        <itunes:episodeType>full</itunes:episodeType>
        <itunes:image href="https://pbcdn1.podbean.com/imglogo/ep-logo/pbblog13721080/336e3a63c8d4019b300838eb246b2e3a.jpg" />    </item>
    <item>
        <title>Pre-Exposure Prophylaxis: Preventing HIV at Hand - Frankly Speaking EP 110</title>
        <itunes:title>Pre-Exposure Prophylaxis: Preventing HIV at Hand - Frankly Speaking EP 110</itunes:title>
        <link>https://primedfranklyspeaking.podbean.com/e/pre-exposure-prophylaxis-preventing-hiv-at-hand-frankly-speaking-ep-110/</link>
                    <comments>https://primedfranklyspeaking.podbean.com/e/pre-exposure-prophylaxis-preventing-hiv-at-hand-frankly-speaking-ep-110/#comments</comments>        <pubDate>Mon, 04 Mar 2019 05:30:00 +0000</pubDate>
        <guid isPermaLink="false">2c6db0e2bec641fcb068b6960ab82222</guid>
                                    <description><![CDATA[<p>Credits: 0.25 AMA PRA Category 1 Credits™</p>
<p>Claim CME/CE credit: <a href='https://www.pri-med.com/online-education/podcast/frankly-speaking-cme-110-prep-2'>https://www.pri-med.com/online-education/podcast/frankly-speaking-cme-110-prep-2</a></p>
<p>Overview: The USPSTF recently issued a Draft Grade A recommendation that all at-risk patients be offered pre-exposure prophylaxis to prevent the transmission of HIV. This multi drug, single pill regimen can lower risk of HIV and potentially prevent lifelong burden of disease. While only a draft recommendation, the USPSTF expects, after stakeholder comment, to continue to support an A recommendation to offer for all patients who are increased risk.</p>
<p>Guest: Jill Terrien PhD, ANP-BC</p>
<p>Music Credit: Richard Onorato </p>
]]></description>
                                                            <content:encoded><![CDATA[<p>Credits: 0.25 AMA PRA Category 1 Credits™</p>
<p>Claim CME/CE credit: <a href='https://www.pri-med.com/online-education/podcast/frankly-speaking-cme-110-prep-2'>https://www.pri-med.com/online-education/podcast/frankly-speaking-cme-110-prep-2</a></p>
<p>Overview: The USPSTF recently issued a Draft Grade A recommendation that all at-risk patients be offered pre-exposure prophylaxis to prevent the transmission of HIV. This multi drug, single pill regimen can lower risk of HIV and potentially prevent lifelong burden of disease. While only a draft recommendation, the USPSTF expects, after stakeholder comment, to continue to support an A recommendation to offer for all patients who are increased risk.</p>
<p>Guest: Jill Terrien PhD, ANP-BC</p>
<p>Music Credit: Richard Onorato </p>
]]></content:encoded>
                                    
        <enclosure url="https://mcdn.podbean.com/mf/web/bzv21a/secure_primed_ep-110-PrEP-frankly-speaking.mp3" length="17867971" type="audio/mpeg"/>
                <itunes:summary><![CDATA[Credits: 0.25 AMA PRA Category 1 Credits™
Claim CME/CE credit: https://www.pri-med.com/online-education/podcast/frankly-speaking-cme-110-prep-2
Overview: The USPSTF recently issued a Draft Grade A recommendation that all at-risk patients be offered pre-exposure prophylaxis to prevent the transmission of HIV. This multi drug, single pill regimen can lower risk of HIV and potentially prevent lifelong burden of disease. While only a draft recommendation, the USPSTF expects, after stakeholder comment, to continue to support an A recommendation to offer for all patients who are increased risk.
Guest: Jill Terrien PhD, ANP-BC
Music Credit: Richard Onorato ]]></itunes:summary>
        <itunes:author>Pri-Med</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>558</itunes:duration>
        <itunes:season>1</itunes:season>
        <itunes:episode>1</itunes:episode>
        <itunes:episodeType>full</itunes:episodeType>
        <itunes:image href="https://pbcdn1.podbean.com/imglogo/ep-logo/pbblog13721080/7924d8383556fe881c29e1ad0746e4dd.jpg" />    </item>
    <item>
        <title>Alcohol Use: Perhaps It Is for the Faint of Heart - Frankly Speaking EP 109</title>
        <itunes:title>Alcohol Use: Perhaps It Is for the Faint of Heart - Frankly Speaking EP 109</itunes:title>
        <link>https://primedfranklyspeaking.podbean.com/e/alcohol-use-perhaps-it-is-for-the-faint-of-heart-frankly-speaking-ep-109/</link>
                    <comments>https://primedfranklyspeaking.podbean.com/e/alcohol-use-perhaps-it-is-for-the-faint-of-heart-frankly-speaking-ep-109/#comments</comments>        <pubDate>Mon, 25 Feb 2019 14:17:00 +0000</pubDate>
        <guid isPermaLink="false">7e5fd2e02e6d47f7bd6e5b7c2c541e83</guid>
                                    <description><![CDATA[<p>Credits: 0.25 AMA PRA Category 1 Credits™</p>
<p>Claim CME/CE credit: <a href='https://www.pri-med.com/online-education/podcast/frankly-speaking-cme-109-alcohol-hf'>https://www.pri-med.com/online-education/podcast/frankly-speaking-cme-109-alcohol-hf</a></p>
<p>Overview: In a recent study, data from the Cardiovascular Health Study examined the association between alcohol consumption and incident HF. It was found that moderate alcohol consumption was associated with a survival benefit, implying that individuals 65 years and older with newly diagnosed HF may not need to stop their alcohol use. Join the discussion about these findings and learn how they may impact the care of your patients with HF.</p>
<p>Guest: Susan Feeney, DNP, FNP</p>
<p>Music Credit: Richard Onorato </p>
]]></description>
                                                            <content:encoded><![CDATA[<p>Credits: 0.25 AMA PRA Category 1 Credits™</p>
<p>Claim CME/CE credit: <a href='https://www.pri-med.com/online-education/podcast/frankly-speaking-cme-109-alcohol-hf'>https://www.pri-med.com/online-education/podcast/frankly-speaking-cme-109-alcohol-hf</a></p>
<p>Overview: In a recent study, data from the Cardiovascular Health Study examined the association between alcohol consumption and incident HF. It was found that moderate alcohol consumption was associated with a survival benefit, implying that individuals 65 years and older with newly diagnosed HF may not need to stop their alcohol use. Join the discussion about these findings and learn how they may impact the care of your patients with HF.</p>
<p>Guest: Susan Feeney, DNP, FNP</p>
<p>Music Credit: Richard Onorato </p>
]]></content:encoded>
                                    
        <enclosure url="https://mcdn.podbean.com/mf/web/48atz5/secure_primed_ep109-alcohol-hf-frankly-speaking.mp3" length="18064427" type="audio/mpeg"/>
                <itunes:summary><![CDATA[Credits: 0.25 AMA PRA Category 1 Credits™
Claim CME/CE credit: https://www.pri-med.com/online-education/podcast/frankly-speaking-cme-109-alcohol-hf
Overview: In a recent study, data from the Cardiovascular Health Study examined the association between alcohol consumption and incident HF. It was found that moderate alcohol consumption was associated with a survival benefit, implying that individuals 65 years and older with newly diagnosed HF may not need to stop their alcohol use. Join the discussion about these findings and learn how they may impact the care of your patients with HF.
Guest: Susan Feeney, DNP, FNP
Music Credit: Richard Onorato ]]></itunes:summary>
        <itunes:author>Pri-Med</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>564</itunes:duration>
        <itunes:season>1</itunes:season>
        <itunes:episode>1</itunes:episode>
        <itunes:episodeType>full</itunes:episodeType>
        <itunes:image href="https://pbcdn1.podbean.com/imglogo/ep-logo/pbblog13721080/5906efba19f45bffb8b22830121e9fb2.jpg" />    </item>
    <item>
        <title>Finding Your Balance – Does Tai Chi Prevent Falls in Older Adults? - Frankly Speaking 108</title>
        <itunes:title>Finding Your Balance – Does Tai Chi Prevent Falls in Older Adults? - Frankly Speaking 108</itunes:title>
        <link>https://primedfranklyspeaking.podbean.com/e/finding-your-balance-%e2%80%93-does-tai-chi-prevent-falls-in-older-adults-frankly-speaking-108/</link>
                    <comments>https://primedfranklyspeaking.podbean.com/e/finding-your-balance-%e2%80%93-does-tai-chi-prevent-falls-in-older-adults-frankly-speaking-108/#comments</comments>        <pubDate>Mon, 18 Feb 2019 05:30:00 +0000</pubDate>
        <guid isPermaLink="false">4af46a4eb8ea418c891e83de625dad37</guid>
                                    <description><![CDATA[<p>Credits: 0.25 AMA PRA Category 1 Credits™</p>
<p>Claim CME/CE credit: <a href='https://www.pri-med.com/online-education/podcast/frankly-speaking-cme-108-tai-chi-2'>https://www.pri-med.com/online-education/podcast/frankly-speaking-cme-108-tai-chi-2</a></p>
<p>Overview: Falls in the older population are associated with significant morbidity and mortality yet little evidence exists to determine best practices for prevention. Join us while we discuss a recent RCT that examined Tai Chi versus more traditional exercising in older individuals and its impact on reduction in falls for those at greatest risk.</p>
<p>Guest: Susan Feeney, DNP, FNP</p>
<p>Music Credit: Richard Onorato </p>
]]></description>
                                                            <content:encoded><![CDATA[<p>Credits: 0.25 AMA PRA Category 1 Credits™</p>
<p>Claim CME/CE credit: <a href='https://www.pri-med.com/online-education/podcast/frankly-speaking-cme-108-tai-chi-2'>https://www.pri-med.com/online-education/podcast/frankly-speaking-cme-108-tai-chi-2</a></p>
<p>Overview: Falls in the older population are associated with significant morbidity and mortality yet little evidence exists to determine best practices for prevention. Join us while we discuss a recent RCT that examined Tai Chi versus more traditional exercising in older individuals and its impact on reduction in falls for those at greatest risk.</p>
<p>Guest: Susan Feeney, DNP, FNP</p>
<p>Music Credit: Richard Onorato </p>
]]></content:encoded>
                                    
        <enclosure url="https://mcdn.podbean.com/mf/web/g4nf4z/secure_primed_ep-108-tai-chi-frankly_speaking.mp3" length="17604826" type="audio/mpeg"/>
                <itunes:summary><![CDATA[Credits: 0.25 AMA PRA Category 1 Credits™
Claim CME/CE credit: https://www.pri-med.com/online-education/podcast/frankly-speaking-cme-108-tai-chi-2
Overview: Falls in the older population are associated with significant morbidity and mortality yet little evidence exists to determine best practices for prevention. Join us while we discuss a recent RCT that examined Tai Chi versus more traditional exercising in older individuals and its impact on reduction in falls for those at greatest risk.
Guest: Susan Feeney, DNP, FNP
Music Credit: Richard Onorato ]]></itunes:summary>
        <itunes:author>Pri-Med</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>550</itunes:duration>
        <itunes:season>1</itunes:season>
        <itunes:episode>1</itunes:episode>
        <itunes:episodeType>full</itunes:episodeType>
        <itunes:image href="https://pbcdn1.podbean.com/imglogo/ep-logo/pbblog13721080/3624dc4506ecd731aa408516dde35eee.jpg" />    </item>
    <item>
        <title>Postmenopausal Vaginal Dryness: What Are the Treatment Options? - Frankly Speaking EP 107</title>
        <itunes:title>Postmenopausal Vaginal Dryness: What Are the Treatment Options? - Frankly Speaking EP 107</itunes:title>
        <link>https://primedfranklyspeaking.podbean.com/e/postmenopausal-vaginal-dryness-what-are-the-treatment-options-frankly-speaking-ep-107/</link>
                    <comments>https://primedfranklyspeaking.podbean.com/e/postmenopausal-vaginal-dryness-what-are-the-treatment-options-frankly-speaking-ep-107/#comments</comments>        <pubDate>Mon, 11 Feb 2019 14:53:00 +0000</pubDate>
        <guid isPermaLink="false">c88b5a3046a84278853932ac5d83d1ee</guid>
                                    <description><![CDATA[<p>Credits: 0.25 AMA PRA Category 1 Credits™</p>
<p>Claim CME/CE credit: <a href='https://www.pri-med.com/online-education/podcast/frankly-speaking-cme-107-postmenopausal'>https://www.pri-med.com/online-education/podcast/frankly-speaking-cme-107-postmenopausal</a></p>
<p>Overview: Postmenopausal women experience vulvovaginal symptoms that in 50% of the population go untreated. Join us as we discuss a randomized trial that compares common treatments available to this population and help you determine best practice options.</p>
<p>Guest: Jill Terrien PhD, ANP-BC</p>
<p>Music Credit: Richard Onorato </p>
]]></description>
                                                            <content:encoded><![CDATA[<p>Credits: 0.25 AMA PRA Category 1 Credits™</p>
<p>Claim CME/CE credit: <a href='https://www.pri-med.com/online-education/podcast/frankly-speaking-cme-107-postmenopausal'>https://www.pri-med.com/online-education/podcast/frankly-speaking-cme-107-postmenopausal</a></p>
<p>Overview: Postmenopausal women experience vulvovaginal symptoms that in 50% of the population go untreated. Join us as we discuss a randomized trial that compares common treatments available to this population and help you determine best practice options.</p>
<p>Guest: Jill Terrien PhD, ANP-BC</p>
<p>Music Credit: Richard Onorato </p>
]]></content:encoded>
                                    
        <enclosure url="https://mcdn.podbean.com/mf/web/6fpvjs/secure_primed_ep-107-postmenopausal-frankly-speaking.mp3" length="14648597" type="audio/mpeg"/>
                <itunes:summary><![CDATA[Credits: 0.25 AMA PRA Category 1 Credits™
Claim CME/CE credit: https://www.pri-med.com/online-education/podcast/frankly-speaking-cme-107-postmenopausal
Overview: Postmenopausal women experience vulvovaginal symptoms that in 50% of the population go untreated. Join us as we discuss a randomized trial that compares common treatments available to this population and help you determine best practice options.
Guest: Jill Terrien PhD, ANP-BC
Music Credit: Richard Onorato ]]></itunes:summary>
        <itunes:author>Pri-Med</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>457</itunes:duration>
        <itunes:season>1</itunes:season>
        <itunes:episode>1</itunes:episode>
        <itunes:episodeType>full</itunes:episodeType>
        <itunes:image href="https://pbcdn1.podbean.com/imglogo/ep-logo/pbblog13721080/cb93e0da3f1265b4970c5f7e278e8320.jpg" />    </item>
    <item>
        <title>What’s the Skinny on Treating Blood Fats? - Frankly Speaking EP 106</title>
        <itunes:title>What’s the Skinny on Treating Blood Fats? - Frankly Speaking EP 106</itunes:title>
        <link>https://primedfranklyspeaking.podbean.com/e/what-s-the-skinny-on-treating-blood-fats-frankly-speaking-ep-106/</link>
                    <comments>https://primedfranklyspeaking.podbean.com/e/what-s-the-skinny-on-treating-blood-fats-frankly-speaking-ep-106/#comments</comments>        <pubDate>Mon, 04 Feb 2019 05:30:00 +0000</pubDate>
        <guid isPermaLink="false">f5c29a26a0c448878a199b3c1140c0d5</guid>
                                    <description><![CDATA[<p>Credits: 0.25 AMA PRA Category 1 Credits™</p>
 <p>Claim CME/CE credit: <a href='https://www.pri-med.com/online-education/podcast/frankly-speaking-cme-106-lipids'>https://www.pri-med.com/online-education/podcast/frankly-speaking-cme-106-lipids</a></p>
 <p>Overview: Managing cholesterol is one of the most common clinical problems. Recently, the American College of Cardiology and the American Heart Association issued new guidance on the management of blood cholesterol. Ten other societies participated in the development of the guidelines. Listen to find out who should be treated with statins, what the treatment targets are, and when other cholesterol-lowering medications should be added.</p>
 <p>Guest: Alan Ehrlich MD</p>
 <p>Music Credit: Richard Onorato </p>
]]></description>
                                                            <content:encoded><![CDATA[<p>Credits: 0.25 <em>AMA PRA Category 1 Credits</em>™</p>
 <p>Claim CME/CE credit: <a href='https://www.pri-med.com/online-education/podcast/frankly-speaking-cme-106-lipids'>https://www.pri-med.com/online-education/podcast/frankly-speaking-cme-106-lipids</a></p>
 <p>Overview: Managing cholesterol is one of the most common clinical problems. Recently, the American College of Cardiology and the American Heart Association issued new guidance on the management of blood cholesterol. Ten other societies participated in the development of the guidelines. Listen to find out who should be treated with statins, what the treatment targets are, and when other cholesterol-lowering medications should be added.</p>
 <p>Guest: Alan Ehrlich MD</p>
 <p>Music Credit: Richard Onorato </p>
]]></content:encoded>
                                    
        <enclosure url="https://mcdn.podbean.com/mf/web/xkvirc/secure_primed_ep-106-lipid-frankly-speaking.mp3" length="20425187" type="audio/mpeg"/>
                <itunes:summary><![CDATA[Credits: 0.25 AMA PRA Category 1 Credits™ Claim CME/CE credit: https://www.pri-med.com/online-education/podcast/frankly-speaking-cme-106-lipids Overview: Managing cholesterol is one of the most common clinical problems. Recently, the American College of Cardiology and the American Heart Association issued new guidance on the management of blood cholesterol. Ten other societies participated in the development of the guidelines. Listen to find out who should be treated with statins, what the treatment targets are, and when other cholesterol-lowering medications should be added. Guest: Alan Ehrlich MD Music Credit: Richard Onorato ]]></itunes:summary>
        <itunes:author>Pri-Med</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>638</itunes:duration>
                                <itunes:image href="https://pbcdn1.podbean.com/imglogo/ep-logo/pbblog13721080/eaa925474f9a39dd763a34f9981156eb.jpg" />    </item>
    <item>
        <title>Leg Cramps in Seniors: Could Alcohol be the Cause? - Frankly Speaking EP 105</title>
        <itunes:title>Leg Cramps in Seniors: Could Alcohol be the Cause? - Frankly Speaking EP 105</itunes:title>
        <link>https://primedfranklyspeaking.podbean.com/e/leg-cramps-in-seniors-could-alcohol-be-the-cause-frankly-speaking-ep-105/</link>
                    <comments>https://primedfranklyspeaking.podbean.com/e/leg-cramps-in-seniors-could-alcohol-be-the-cause-frankly-speaking-ep-105/#comments</comments>        <pubDate>Mon, 28 Jan 2019 05:30:00 +0000</pubDate>
        <guid isPermaLink="false">61495b41b4674e41b06d5009ad7d2221</guid>
                                    <description><![CDATA[<p>Credits: 0.25 AMA PRA Category 1 Credits™</p>
 <p>Claim CME/CE credit: <a href='https://www.pri-med.com/online-education/podcast/frankly-speaking-cme-105-leg-cramps'>https://www.pri-med.com/online-education/podcast/frankly-speaking-cme-105-leg-cramps</a></p>
 <p>Overview: This episode will discuss a Case Control study of seniors to determine if there is a relationship between regular alcohol consumption and nocturnal leg cramps.</p>
 <p>Guest: Alan Ehrlich MD</p>
 <p>Music Credit: Richard Onorato </p>
]]></description>
                                                            <content:encoded><![CDATA[<p>Credits: 0.25 <em>AMA PRA Category 1 Credits</em>™</p>
 <p>Claim CME/CE credit: <a href='https://www.pri-med.com/online-education/podcast/frankly-speaking-cme-105-leg-cramps'>https://www.pri-med.com/online-education/podcast/frankly-speaking-cme-105-leg-cramps</a></p>
 <p>Overview: This episode will discuss a Case Control study of seniors to determine if there is a relationship between regular alcohol consumption and nocturnal leg cramps.</p>
 <p>Guest: Alan Ehrlich MD</p>
 <p>Music Credit: Richard Onorato </p>
]]></content:encoded>
                                    
        <enclosure url="https://mcdn.podbean.com/mf/web/ln2kam/secure_primed_ep-105-leg-cramps-frankly-speaking.mp3" length="19403580" type="audio/mpeg"/>
                <itunes:summary><![CDATA[Credits: 0.25 AMA PRA Category 1 Credits™ Claim CME/CE credit: https://www.pri-med.com/online-education/podcast/frankly-speaking-cme-105-leg-cramps Overview: This episode will discuss a Case Control study of seniors to determine if there is a relationship between regular alcohol consumption and nocturnal leg cramps. Guest: Alan Ehrlich MD Music Credit: Richard Onorato ]]></itunes:summary>
        <itunes:author>Pri-Med</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>606</itunes:duration>
                                <itunes:image href="https://pbcdn1.podbean.com/imglogo/ep-logo/pbblog13721080/64bb062c0cee9a377f1808aef5241c34.jpg" />    </item>
    <item>
        <title>Is Aspirin Effective for Primary Prevention? - Frankly Speaking EP 104</title>
        <itunes:title>Is Aspirin Effective for Primary Prevention? - Frankly Speaking EP 104</itunes:title>
        <link>https://primedfranklyspeaking.podbean.com/e/is-aspirin-effective-for-primary-prevention-frankly-speaking-ep-104/</link>
                    <comments>https://primedfranklyspeaking.podbean.com/e/is-aspirin-effective-for-primary-prevention-frankly-speaking-ep-104/#comments</comments>        <pubDate>Mon, 21 Jan 2019 05:30:00 +0000</pubDate>
        <guid isPermaLink="false">be2fa4991e684a00b7ea8fad612835ac</guid>
                                    <description><![CDATA[<p>Credits: 0.25 AMA PRA Category 1 Credits™</p>
 <p>Claim CME/CE credit: <a href='https://www.pri-med.com/online-education/podcast/frankly-speaking-cme-104-aspirin'>https://www.pri-med.com/online-education/podcast/frankly-speaking-cme-104-aspirin</a></p>
 <p>Overview: For patients with established cardiovascular disease,aspirin is clearly beneficial as part of secondary prevention. However, when used as primary prevention in patients without documented cardiovascular disease, its benefit is much less certain. This podcast will explore 3 recent trials that evaluated aspirin in different populations and found nobenefit for its use as primary prevention.</p>
 <p>Guest: Alan Ehrlich MD</p>
 <p>Music Credit: Richard Onorato </p>
]]></description>
                                                            <content:encoded><![CDATA[<p>Credits: 0.25 <em>AMA PRA Category 1 Credits</em>™</p>
 <p>Claim CME/CE credit: <a href='https://www.pri-med.com/online-education/podcast/frankly-speaking-cme-104-aspirin'>https://www.pri-med.com/online-education/podcast/frankly-speaking-cme-104-aspirin</a></p>
 <p>Overview: For patients with established cardiovascular disease,aspirin is clearly beneficial as part of secondary prevention. However, when used as primary prevention in patients without documented cardiovascular disease, its benefit is much less certain. This podcast will explore 3 recent trials that evaluated aspirin in different populations and found nobenefit for its use as primary prevention.</p>
 <p>Guest: Alan Ehrlich MD</p>
 <p>Music Credit: Richard Onorato </p>
]]></content:encoded>
                                    
        <enclosure url="https://mcdn.podbean.com/mf/web/flov5g/secure_primed_ep-104-aspirin-frankly-speaking-podcast.mp3" length="19784479" type="audio/mpeg"/>
                <itunes:summary><![CDATA[Credits: 0.25 AMA PRA Category 1 Credits™ Claim CME/CE credit: https://www.pri-med.com/online-education/podcast/frankly-speaking-cme-104-aspirin Overview: For patients with established cardiovascular disease,aspirin is clearly beneficial as part of secondary prevention. However, when used as primary prevention in patients without documented cardiovascular disease, its benefit is much less certain. This podcast will explore 3 recent trials that evaluated aspirin in different populations and found nobenefit for its use as primary prevention. Guest: Alan Ehrlich MD Music Credit: Richard Onorato ]]></itunes:summary>
        <itunes:author>Pri-Med</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>618</itunes:duration>
                                <itunes:image href="https://pbcdn1.podbean.com/imglogo/ep-logo/pbblog13721080/d1daec7ad769934826e77bcd528b7d9b.jpg" />    </item>
    <item>
        <title>Screening and Management of High Blood Pressure in Children and Teens – Who, When, Why and What? - Frankly Speaking EP 103</title>
        <itunes:title>Screening and Management of High Blood Pressure in Children and Teens – Who, When, Why and What? - Frankly Speaking EP 103</itunes:title>
        <link>https://primedfranklyspeaking.podbean.com/e/screening-and-management-of-high-blood-pressure-in-children-and-teens-%e2%80%93-who-when-why-and-what-frankly-speaking-ep-103/</link>
                    <comments>https://primedfranklyspeaking.podbean.com/e/screening-and-management-of-high-blood-pressure-in-children-and-teens-%e2%80%93-who-when-why-and-what-frankly-speaking-ep-103/#comments</comments>        <pubDate>Mon, 14 Jan 2019 05:30:00 +0000</pubDate>
        <guid isPermaLink="false">f7de6f963e8f4cef96c2130c37a59c63</guid>
                                    <description><![CDATA[<p>Credits: 0.25 AMA PRA Category 1 Credits™</p>
 <p>Claim CME/CE credit: <a href='https://www.pri-med.com/online-education/podcast/frankly-speaking-cme-103-bp-screening'>https://www.pri-med.com/online-education/podcast/frankly-speaking-cme-103-bp-screening</a></p>
 <p>Overview: The AAP released new guidelines for the screening and management of high BP in children and teens in 2017. The last recommendations were published in 2004. Join us as we discuss these updated recommendations and their impact on your practice. </p>
 <p>Guest: Susan Feeney, DNP, FNP</p>
 <p>Music Credit: Richard Onorato </p>
]]></description>
                                                            <content:encoded><![CDATA[<p>Credits: 0.25 <em>AMA PRA Category 1 Credits</em>™</p>
 <p>Claim CME/CE credit: <a href='https://www.pri-med.com/online-education/podcast/frankly-speaking-cme-103-bp-screening'>https://www.pri-med.com/online-education/podcast/frankly-speaking-cme-103-bp-screening</a></p>
 <p>Overview: The AAP released new guidelines for the screening and management of high BP in children and teens in 2017. The last recommendations were published in 2004. Join us as we discuss these updated recommendations and their impact on your practice. </p>
 <p>Guest: Susan Feeney, DNP, FNP</p>
 <p>Music Credit: Richard Onorato </p>
]]></content:encoded>
                                    
        <enclosure url="https://mcdn.podbean.com/mf/web/d4dugh/secure_primed_ep-103-bp-screening-frankly-speaking.mp3" length="18747981" type="audio/mpeg"/>
                <itunes:summary><![CDATA[Credits: 0.25 AMA PRA Category 1 Credits™ Claim CME/CE credit: https://www.pri-med.com/online-education/podcast/frankly-speaking-cme-103-bp-screening Overview: The AAP released new guidelines for the screening and management of high BP in children and teens in 2017. The last recommendations were published in 2004. Join us as we discuss these updated recommendations and their impact on your practice.  Guest: Susan Feeney, DNP, FNP Music Credit: Richard Onorato ]]></itunes:summary>
        <itunes:author>Pri-Med</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>585</itunes:duration>
                                <itunes:image href="https://pbcdn1.podbean.com/imglogo/ep-logo/pbblog13721080/238c3c231d6af95e609639d08f4ad2b8.jpg" />    </item>
    <item>
        <title>Technology: Tetris Improves Flow, Lowers Stress; Social Media Increases Depression and Loneliness – Frankly Speaking EP 102</title>
        <itunes:title>Technology: Tetris Improves Flow, Lowers Stress; Social Media Increases Depression and Loneliness – Frankly Speaking EP 102</itunes:title>
        <link>https://primedfranklyspeaking.podbean.com/e/technology-tetris-improves-flow-lowers-stress-social-media-increases-depression-and-loneliness-%e2%80%93-frankly-speaking-ep-102/</link>
                    <comments>https://primedfranklyspeaking.podbean.com/e/technology-tetris-improves-flow-lowers-stress-social-media-increases-depression-and-loneliness-%e2%80%93-frankly-speaking-ep-102/#comments</comments>        <pubDate>Mon, 07 Jan 2019 05:30:00 +0000</pubDate>
        <guid isPermaLink="false">0a1e286825a74e15b24f6ebee159b0a4</guid>
                                    <description><![CDATA[ <p>Credits: 0.25 AMA PRA Category 1 Credits™</p>
 <p>Claim CME/CE credit: <a href='https://www.pri-med.com/online-education/podcast/frankly-speaking-cme-102-flow'>https://www.pri-med.com/online-education/podcast/frankly-speaking-cme-102-flow</a> </p>
 <p>Overview: This podcast will explore the results of 3 recent studies that evaluate how the “state of flow” or mental absorption (also called being “in the zone”) alters a person’s ability to handle stress and how intentional use of distractions affect emotions.</p>
 <p>Guest: Alan Ehrlich MD </p>
 <p>Music Credit: Richard Onorato </p>
 ]]></description>
                                                            <content:encoded><![CDATA[ <p>Credits: 0.25 <em>AMA PRA Category 1 Credits</em>™</p>
 <p>Claim CME/CE credit: <a href='https://www.pri-med.com/online-education/podcast/frankly-speaking-cme-102-flow'>https://www.pri-med.com/online-education/podcast/frankly-speaking-cme-102-flow</a> </p>
 <p>Overview: This podcast will explore the results of 3 recent studies that evaluate how the “state of flow” or mental absorption (also called being “in the zone”) alters a person’s ability to handle stress and how intentional use of distractions affect emotions.</p>
 <p>Guest: Alan Ehrlich MD </p>
 <p>Music Credit: Richard Onorato </p>
 ]]></content:encoded>
                                    
        <enclosure url="https://mcdn.podbean.com/mf/web/6kj2qu/secure_primed_ep-102-flow-frankly-speaking.mp3" length="22942087" type="audio/mpeg"/>
                <itunes:summary><![CDATA[ Credits: 0.25 AMA PRA Category 1 Credits™ Claim CME/CE credit: https://www.pri-med.com/online-education/podcast/frankly-speaking-cme-102-flow  Overview: This podcast will explore the results of 3 recent studies that evaluate how the “state of flow” or mental absorption (also called being “in the zone”) alters a person’s ability to handle stress and how intentional use of distractions affect emotions. Guest: Alan Ehrlich MD  Music Credit: Richard Onorato  ]]></itunes:summary>
        <itunes:author>Pri-Med</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>716</itunes:duration>
                                <itunes:image href="https://pbcdn1.podbean.com/imglogo/ep-logo/pbblog13721080/dd4060492949ebdc4acc428233663d43.jpg" />    </item>
    <item>
        <title>The 2018 Physical Activity Guidelines for Americans:  Get up and Go! More IS better! Don’t Give Up! - Frankly Speaking EP 101</title>
        <itunes:title>The 2018 Physical Activity Guidelines for Americans:  Get up and Go! More IS better! Don’t Give Up! - Frankly Speaking EP 101</itunes:title>
        <link>https://primedfranklyspeaking.podbean.com/e/the-2018-physical-activity-guidelines-for-americans-get-up-and-go-more-is-better-don-t-give-up-frankly-speaking-ep-101/</link>
                    <comments>https://primedfranklyspeaking.podbean.com/e/the-2018-physical-activity-guidelines-for-americans-get-up-and-go-more-is-better-don-t-give-up-frankly-speaking-ep-101/#comments</comments>        <pubDate>Mon, 31 Dec 2018 05:30:00 +0000</pubDate>
        <guid isPermaLink="false">20dc0cda9cf34b3d88e10315e8223b3e</guid>
                                    <description><![CDATA[<p>Health benefits and the potential lowering of healthcare costs by billions of dollars seem like enough reasons to increase physical activity. Why can’t we do it? Why is it so hard? We’ll discuss the new guidelines (11/2018) and strategies that may get your patients moving.</p>
<p> </p>
<p>Guest: Jill Terrien PhD, ANP-BC Associate Professor, Director NP Programs UMMS-GSN</p>
<p> </p>
<p>Landing Page: <a href='https://www.pri-med.com/online-education/Podcast/101-physical-activity-frankly-speaking'>https://www.pri-med.com/online-education/Podcast/101-physical-activity-frankly-speaking</a></p>
]]></description>
                                                            <content:encoded><![CDATA[<p>Health benefits and the potential lowering of healthcare costs by billions of dollars seem like enough reasons to increase physical activity. Why can’t we do it? Why is it so hard? We’ll discuss the new guidelines (11/2018) and strategies that may get your patients moving.</p>
<p> </p>
<p>Guest: Jill Terrien PhD, ANP-BC Associate Professor, Director NP Programs UMMS-GSN</p>
<p> </p>
<p>Landing Page: <a href='https://www.pri-med.com/online-education/Podcast/101-physical-activity-frankly-speaking'>https://www.pri-med.com/online-education/Podcast/101-physical-activity-frankly-speaking</a></p>
]]></content:encoded>
                                    
        <enclosure url="https://mcdn.podbean.com/mf/web/4bcs2l/secure_primed_ep-101-physical-activity-frankly-speaking-edited.mp3" length="21065904" type="audio/mpeg"/>
                <itunes:summary><![CDATA[Health benefits and the potential lowering of healthcare costs by billions of dollars seem like enough reasons to increase physical activity. Why can’t we do it? Why is it so hard? We’ll discuss the new guidelines (11/2018) and strategies that may get your patients moving.
 
Guest: Jill Terrien PhD, ANP-BC Associate Professor, Director NP Programs UMMS-GSN
 
Landing Page: https://www.pri-med.com/online-education/Podcast/101-physical-activity-frankly-speaking]]></itunes:summary>
        <itunes:author>Pri-Med</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>658</itunes:duration>
        <itunes:season>1</itunes:season>
        <itunes:episode>1</itunes:episode>
        <itunes:episodeType>full</itunes:episodeType>
        <itunes:image href="https://pbcdn1.podbean.com/imglogo/ep-logo/pbblog13721080/af69e0a603c964e0797e342052482771.jpg" />    </item>
    <item>
        <title>Evaluating and Managing Perimenopausal Depression: No Small Task, Are You up for It? - Frankly Speaking EP 100</title>
        <itunes:title>Evaluating and Managing Perimenopausal Depression: No Small Task, Are You up for It? - Frankly Speaking EP 100</itunes:title>
        <link>https://primedfranklyspeaking.podbean.com/e/evaluating-and-managing-perimenopausal-depression-no-small-task-are-you-up-for-it-frankly-speaking-ep-100/</link>
                    <comments>https://primedfranklyspeaking.podbean.com/e/evaluating-and-managing-perimenopausal-depression-no-small-task-are-you-up-for-it-frankly-speaking-ep-100/#comments</comments>        <pubDate>Mon, 24 Dec 2018 05:30:00 +0000</pubDate>
        <guid isPermaLink="false">3c998eb59e9e4f7cbff72ee8abed5195</guid>
                                    <description><![CDATA[<p>This episode is a discussion of the recent summary and recommendations of an expert panel that conducted a systemic review on the published perimenopausal literature to identify, characterize and treat women in this population.</p>
<p> </p>
<p>Guest: Jill Terrien PhD, ANP-BC Associate Professor, Director NP Programs UMMS-GSN</p>
<p> </p>
<p>Landing Page: <a href='https://www.pri-med.com/online-education/Podcast/100-perminopausal-depression-frankly-speaking'>https://www.pri-med.com/online-education/Podcast/100-perminopausal-depression-frankly-speaking</a></p>
<p> </p>
]]></description>
                                                            <content:encoded><![CDATA[<p>This episode is a discussion of the recent summary and recommendations of an expert panel that conducted a systemic review on the published perimenopausal literature to identify, characterize and treat women in this population.</p>
<p> </p>
<p>Guest: Jill Terrien PhD, ANP-BC Associate Professor, Director NP Programs UMMS-GSN</p>
<p> </p>
<p>Landing Page: <a href='https://www.pri-med.com/online-education/Podcast/100-perminopausal-depression-frankly-speaking'>https://www.pri-med.com/online-education/Podcast/100-perminopausal-depression-frankly-speaking</a></p>
<p> </p>
]]></content:encoded>
                                    
        <enclosure url="https://mcdn.podbean.com/mf/web/kpm306/secure_primed_ep-100-perminopausal-depression-frankly-speaking.mp3" length="18133473" type="audio/mpeg"/>
                <itunes:summary><![CDATA[This episode is a discussion of the recent summary and recommendations of an expert panel that conducted a systemic review on the published perimenopausal literature to identify, characterize and treat women in this population.
 
Guest: Jill Terrien PhD, ANP-BC Associate Professor, Director NP Programs UMMS-GSN
 
Landing Page: https://www.pri-med.com/online-education/Podcast/100-perminopausal-depression-frankly-speaking
 ]]></itunes:summary>
        <itunes:author>Pri-Med</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>566</itunes:duration>
        <itunes:season>1</itunes:season>
        <itunes:episode>1</itunes:episode>
        <itunes:episodeType>full</itunes:episodeType>
        <itunes:image href="https://pbcdn1.podbean.com/imglogo/ep-logo/pbblog13721080/cbb6b93e4f46e66dd7e017b38a259d99.jpg" />    </item>
    <item>
        <title>Cannabis and e-Cigarette: What Is in That Juul? - Frankly Speaking EP 99</title>
        <itunes:title>Cannabis and e-Cigarette: What Is in That Juul? - Frankly Speaking EP 99</itunes:title>
        <link>https://primedfranklyspeaking.podbean.com/e/cannabis-and-e-cigarette-what-is-in-that-juul-frankly-speaking-ep-99/</link>
                    <comments>https://primedfranklyspeaking.podbean.com/e/cannabis-and-e-cigarette-what-is-in-that-juul-frankly-speaking-ep-99/#comments</comments>        <pubDate>Mon, 17 Dec 2018 16:30:00 +0000</pubDate>
        <guid isPermaLink="false">6864d7a277ea4133955cbe10f8eff782</guid>
                                    <description><![CDATA[<p>Recently, there has been a deluge of research and news surrounding e-cigarettes and vaping – particularly regarding adolescent usage. Join us as we discuss a recent study describing the prevalence of cannabis use in e-Cigarettes and some strategies for addressing this in your practice.</p>
 <p> </p>
 <p>Guest: Susan Feeney, DNP, FNP-BC</p>
 <p> </p>
 <p>Landing Page: <a href='https://www.pri-med.com/online-education/Podcast/99-eCigarettes-frankly%20speaking'> https://www.pri-med.com/online-education/Podcast/99-eCigarettes-frankly%20speaking</a></p>
 <p> </p>
]]></description>
                                                            <content:encoded><![CDATA[<p>Recently, there has been a deluge of research and news surrounding e-cigarettes and vaping – particularly regarding adolescent usage. Join us as we discuss a recent study describing the prevalence of cannabis use in e-Cigarettes and some strategies for addressing this in your practice.</p>
 <p> </p>
 <p>Guest: Susan Feeney, DNP, FNP-BC</p>
 <p> </p>
 <p>Landing Page: <a href='https://www.pri-med.com/online-education/Podcast/99-eCigarettes-frankly%20speaking'> https://www.pri-med.com/online-education/Podcast/99-eCigarettes-frankly%20speaking</a></p>
 <p> </p>
]]></content:encoded>
                                    
        <enclosure url="https://mcdn.podbean.com/mf/web/o1ky5b/secure_primed_ep-99-eCigarettes-frankly-speaking.mp3" length="21869334" type="audio/mpeg"/>
                <itunes:summary><![CDATA[Recently, there has been a deluge of research and news surrounding e-cigarettes and vaping – particularly regarding adolescent usage. Join us as we discuss a recent study describing the prevalence of cannabis use in e-Cigarettes and some strategies for addressing this in your practice.   Guest: Susan Feeney, DNP, FNP-BC   Landing Page:  https://www.pri-med.com/online-education/Podcast/99-eCigarettes-frankly%20speaking  ]]></itunes:summary>
        <itunes:author>Pri-Med</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>682</itunes:duration>
                                <itunes:image href="https://pbcdn1.podbean.com/imglogo/ep-logo/pbblog13721080/dd5d7671c2d0ed42e0cb5e234693d5a1.jpg" />    </item>
    <item>
        <title>More is Not Better: Overutilization of Breast Imaging - Frankly Speaking EP 98</title>
        <itunes:title>More is Not Better: Overutilization of Breast Imaging - Frankly Speaking EP 98</itunes:title>
        <link>https://primedfranklyspeaking.podbean.com/e/more-is-not-better-overutilization-of-breast-imaging-frankly-speaking-ep-98/</link>
                    <comments>https://primedfranklyspeaking.podbean.com/e/more-is-not-better-overutilization-of-breast-imaging-frankly-speaking-ep-98/#comments</comments>        <pubDate>Mon, 10 Dec 2018 05:30:00 +0000</pubDate>
        <guid isPermaLink="false">8a530c35beee448c86bcd81ec7584ce4</guid>
                                    <description><![CDATA[<p>This episode reviews a study that looked at imaging that was performed over a one year period for women with a complaint of breast pain.</p>
 <p>Guest: Jill Terrien PhD, ANP-BC</p>
 <p> </p>
 <p>Landing Page: <a href='https://www.pri-med.com/online-education/Podcast/98-breast-imaging-frankly-speaking'>https://www.pri-med.com/online-education/Podcast/98-breast-imaging-frankly-speaking</a></p>
 <p> </p>
]]></description>
                                                            <content:encoded><![CDATA[<p>This episode reviews a study that looked at imaging that was performed over a one year period for women with a complaint of breast pain.</p>
 <p>Guest: Jill Terrien PhD, ANP-BC</p>
 <p> </p>
 <p>Landing Page: <a href='https://www.pri-med.com/online-education/Podcast/98-breast-imaging-frankly-speaking'>https://www.pri-med.com/online-education/Podcast/98-breast-imaging-frankly-speaking</a></p>
 <p> </p>
]]></content:encoded>
                                    
        <enclosure url="https://mcdn.podbean.com/mf/web/p5egvb/secure_primed_ep-98-breast-imaging-frankly-speaking.mp3" length="19118342" type="audio/mpeg"/>
                <itunes:summary><![CDATA[This episode reviews a study that looked at imaging that was performed over a one year period for women with a complaint of breast pain. Guest: Jill Terrien PhD, ANP-BC   Landing Page: https://www.pri-med.com/online-education/Podcast/98-breast-imaging-frankly-speaking  ]]></itunes:summary>
        <itunes:author>Pri-Med</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>597</itunes:duration>
                                <itunes:image href="https://pbcdn1.podbean.com/imglogo/ep-logo/pbblog13721080/d279a609a0768614e059b8d4b944127b.jpg" />    </item>
    <item>
        <title>Cannabinoids for Chronic Pain - Frankly Speaking EP 97</title>
        <itunes:title>Cannabinoids for Chronic Pain - Frankly Speaking EP 97</itunes:title>
        <link>https://primedfranklyspeaking.podbean.com/e/cannabinoids-for-chronic-pain-frankly-speaking-ep-97/</link>
                    <comments>https://primedfranklyspeaking.podbean.com/e/cannabinoids-for-chronic-pain-frankly-speaking-ep-97/#comments</comments>        <pubDate>Mon, 03 Dec 2018 16:43:00 +0000</pubDate>
        <guid isPermaLink="false">989aabf0188d42c6bcf5b44683d8796d</guid>
                                    <description><![CDATA[<p>Cannabinoids include tetrahydrocannabinol (THC) and cannabidiol, which are found in marijuana, as well as synthetic compounds such as nabilone. The agents have been studied for the treatment of various chronic pain conditions. A meta-analysis was performed that analyzed any cannabinoid, for any chronic pain condition.</p>
<p> </p>
<p>Guest: Alan Ehrlich MD</p>
<p> </p>
<p>Landing Page: <a href='https://www.pri-med.com/online-education/Podcast/97-cannabis-frankly-speaking'>https://www.pri-med.com/online-education/Podcast/97-cannabis-frankly-speaking</a></p>
]]></description>
                                                            <content:encoded><![CDATA[<p>Cannabinoids include tetrahydrocannabinol (THC) and cannabidiol, which are found in marijuana, as well as synthetic compounds such as nabilone. The agents have been studied for the treatment of various chronic pain conditions. A meta-analysis was performed that analyzed any cannabinoid, for any chronic pain condition.</p>
<p> </p>
<p>Guest: Alan Ehrlich MD</p>
<p> </p>
<p>Landing Page: <a href='https://www.pri-med.com/online-education/Podcast/97-cannabis-frankly-speaking'>https://www.pri-med.com/online-education/Podcast/97-cannabis-frankly-speaking</a></p>
]]></content:encoded>
                                    
        <enclosure url="https://mcdn.podbean.com/mf/web/9v00wy/secure_primed_ep-97-cannabis-frankly-speaking.mp3" length="21944476" type="audio/mpeg"/>
                <itunes:summary><![CDATA[Cannabinoids include tetrahydrocannabinol (THC) and cannabidiol, which are found in marijuana, as well as synthetic compounds such as nabilone. The agents have been studied for the treatment of various chronic pain conditions. A meta-analysis was performed that analyzed any cannabinoid, for any chronic pain condition.
 
Guest: Alan Ehrlich MD
 
Landing Page: https://www.pri-med.com/online-education/Podcast/97-cannabis-frankly-speaking]]></itunes:summary>
        <itunes:author>Pri-Med</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>685</itunes:duration>
        <itunes:season>1</itunes:season>
        <itunes:episode>1</itunes:episode>
        <itunes:episodeType>full</itunes:episodeType>
        <itunes:image href="https://pbcdn1.podbean.com/imglogo/ep-logo/pbblog13721080/4d07be5d5141494707f623cf40d37731.jpg" />    </item>
    <item>
        <title>Statins and the Older Population: When Is It Beneficial and When Is It Not? - Frankly Speaking EP 96</title>
        <itunes:title>Statins and the Older Population: When Is It Beneficial and When Is It Not? - Frankly Speaking EP 96</itunes:title>
        <link>https://primedfranklyspeaking.podbean.com/e/statins-and-the-older-population-when-is-it-beneficial-and-when-is-it-not-frankly-speaking-ep-96/</link>
                    <comments>https://primedfranklyspeaking.podbean.com/e/statins-and-the-older-population-when-is-it-beneficial-and-when-is-it-not-frankly-speaking-ep-96/#comments</comments>        <pubDate>Mon, 26 Nov 2018 16:15:00 +0000</pubDate>
        <guid isPermaLink="false">ff8a817dfeb04c619deea81c0780c120</guid>
                                    <description><![CDATA[<p>Evidence of the efficacy of statins to reduce ASCVD morbidity and mortality in individuals > 75 years who have known clinical ASCVD (secondary prevention) is well established. Primary prevention in this population has not been as clear. Join us while we discuss a recent study in the BMJ which assessed the benefits of statins for primary prevention of ASCVD morbidity and mortality in individuals > 75 years with and without DM.</p>
 <p> </p>
 <p>Guest: Susan Feeney, DNP, FNP-BC</p>
 <p> </p>
 <p>Landing Page: </p>
 <p><a href='https://www.pri-med.com/online-education/Podcast/96-statin-therapy-frankly-speaking.aspx#sm.0000akbf5ldmtfh2s4u14ah34rz3b'> https://www.pri-med.com/online-education/Podcast/96-statin-therapy-frankly-speaking.aspx#sm.0000akbf5ldmtfh2s4u14ah34rz3b</a></p>
]]></description>
                                                            <content:encoded><![CDATA[<p>Evidence of the efficacy of statins to reduce ASCVD morbidity and mortality in individuals > 75 years who have known clinical ASCVD (secondary prevention) is well established. Primary prevention in this population has not been as clear. Join us while we discuss a recent study in the BMJ which assessed the benefits of statins for primary prevention of ASCVD morbidity and mortality in individuals > 75 years with and without DM.</p>
 <p> </p>
 <p>Guest: Susan Feeney, DNP, FNP-BC</p>
 <p> </p>
 <p>Landing Page: </p>
 <p><a href='https://www.pri-med.com/online-education/Podcast/96-statin-therapy-frankly-speaking.aspx#sm.0000akbf5ldmtfh2s4u14ah34rz3b'> https://www.pri-med.com/online-education/Podcast/96-statin-therapy-frankly-speaking.aspx#sm.0000akbf5ldmtfh2s4u14ah34rz3b</a></p>
]]></content:encoded>
                                    
        <enclosure url="https://mcdn.podbean.com/mf/web/79bqec/secure_primed_ep-96-statin-treatment-frankly-speaking.mp3" length="20124174" type="audio/mpeg"/>
                <itunes:summary><![CDATA[Evidence of the efficacy of statins to reduce ASCVD morbidity and mortality in individuals > 75 years who have known clinical ASCVD (secondary prevention) is well established. Primary prevention in this population has not been as clear. Join us while we discuss a recent study in the BMJ which assessed the benefits of statins for primary prevention of ASCVD morbidity and mortality in individuals > 75 years with and without DM.   Guest: Susan Feeney, DNP, FNP-BC   Landing Page:   https://www.pri-med.com/online-education/Podcast/96-statin-therapy-frankly-speaking.aspx#sm.0000akbf5ldmtfh2s4u14ah34rz3b]]></itunes:summary>
        <itunes:author>Pri-Med</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>628</itunes:duration>
                                <itunes:image href="https://pbcdn1.podbean.com/imglogo/ep-logo/pbblog13721080/eab91616a48e12feabea81bcfc705d19.jpg" />    </item>
    <item>
        <title>Easy Weight Loss for Type 2 Diabetes - Frankly Speaking EP 95</title>
        <itunes:title>Easy Weight Loss for Type 2 Diabetes - Frankly Speaking EP 95</itunes:title>
        <link>https://primedfranklyspeaking.podbean.com/e/easy-weight-loss-for-type-2-diabetes-frankly-speaking-ep-95/</link>
                    <comments>https://primedfranklyspeaking.podbean.com/e/easy-weight-loss-for-type-2-diabetes-frankly-speaking-ep-95/#comments</comments>        <pubDate>Mon, 19 Nov 2018 20:36:00 +0000</pubDate>
        <guid isPermaLink="false">5750088cde0f4b4cbe4026c2a8b23570</guid>
                                    <description><![CDATA[<p>This episode will review a randomized controlled trial of adding 10.5 grams of a soluble fiber, psyllium, to a Type 2 Diabetes diet and its influence on weight loss, BMI and other parameters of diabetes.</p>
 <p> </p>
 <p>Guest: Jill Terrien PhD, ANP-BC</p>
 <p> </p>
 <p>Landing Page: https://www.pri-med.com/online-education/Podcast/95-psyllium-frankly-speaking.aspx</p>
]]></description>
                                                            <content:encoded><![CDATA[<p>This episode will review a randomized controlled trial of adding 10.5 grams of a soluble fiber, psyllium, to a Type 2 Diabetes diet and its influence on weight loss, BMI and other parameters of diabetes.</p>
 <p> </p>
 <p>Guest: Jill Terrien PhD, ANP-BC</p>
 <p> </p>
 <p>Landing Page: https://www.pri-med.com/online-education/Podcast/95-psyllium-frankly-speaking.aspx</p>
]]></content:encoded>
                                    
        <enclosure url="https://mcdn.podbean.com/mf/web/xbb6o4/secure_primed_psyllium.mp3" length="20339543" type="audio/mpeg"/>
                <itunes:summary><![CDATA[This episode will review a randomized controlled trial of adding 10.5 grams of a soluble fiber, psyllium, to a Type 2 Diabetes diet and its influence on weight loss, BMI and other parameters of diabetes.   Guest: Jill Terrien PhD, ANP-BC   Landing Page: https://www.pri-med.com/online-education/Podcast/95-psyllium-frankly-speaking.aspx]]></itunes:summary>
        <itunes:author>Pri-Med</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>635</itunes:duration>
                                <itunes:image href="https://pbcdn1.podbean.com/imglogo/ep-logo/pbblog13721080/e08a4fb2cad44890d8bc9bb9e9f407da.jpg" />    </item>
    <item>
        <title>Why Get A Flu Shot? - Frankly Speaking EP 94</title>
        <itunes:title>Why Get A Flu Shot? - Frankly Speaking EP 94</itunes:title>
        <link>https://primedfranklyspeaking.podbean.com/e/why-get-a-flu-shot-frankly-speaking-ep-94/</link>
                    <comments>https://primedfranklyspeaking.podbean.com/e/why-get-a-flu-shot-frankly-speaking-ep-94/#comments</comments>        <pubDate>Mon, 12 Nov 2018 05:30:00 +0000</pubDate>
        <guid isPermaLink="false">dfc6117b459049e8a146eb377919ca69</guid>
                                    <description><![CDATA[<p>As fall arrives, many patients question the need for an influenza vaccine while clinicians urge patients to get it. 2017-18 flu season data shows high influenza mortality. Learn how to help motivate patients to accept the vaccine.</p>
 <p> </p>
 <p>Guest: Susan Feeney, DNP, FNP-BC</p>
 <p> </p>
 <p>Landing Page: <a href='https://www.pri-med.com/online-education/Podcast/94-influenza-frankly-speaking'>https://www.pri-med.com/online-education/Podcast/94-influenza-frankly-speaking</a></p>
]]></description>
                                                            <content:encoded><![CDATA[<p>As fall arrives, many patients question the need for an influenza vaccine while clinicians urge patients to get it. 2017-18 flu season data shows high influenza mortality. Learn how to help motivate patients to accept the vaccine.</p>
 <p> </p>
 <p>Guest: Susan Feeney, DNP, FNP-BC</p>
 <p> </p>
 <p>Landing Page: <a href='https://www.pri-med.com/online-education/Podcast/94-influenza-frankly-speaking'>https://www.pri-med.com/online-education/Podcast/94-influenza-frankly-speaking</a></p>
]]></content:encoded>
                                    
        <enclosure url="https://mcdn.podbean.com/mf/web/f7e17l/secure_primed_ep-95-influenza-frankly-speaking-podcast.mp3" length="20613236" type="audio/mpeg"/>
                <itunes:summary><![CDATA[As fall arrives, many patients question the need for an influenza vaccine while clinicians urge patients to get it. 2017-18 flu season data shows high influenza mortality. Learn how to help motivate patients to accept the vaccine.   Guest: Susan Feeney, DNP, FNP-BC   Landing Page: https://www.pri-med.com/online-education/Podcast/94-influenza-frankly-speaking]]></itunes:summary>
        <itunes:author>Pri-Med</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>644</itunes:duration>
                                <itunes:image href="https://pbcdn1.podbean.com/imglogo/ep-logo/pbblog13721080/83a185493004e2b7c0a078e2e201c9cd.jpg" />    </item>
    <item>
        <title>Penicillin Allergy: Danger Is in the Diagnosis - Frankly Speaking 93</title>
        <itunes:title>Penicillin Allergy: Danger Is in the Diagnosis - Frankly Speaking 93</itunes:title>
        <link>https://primedfranklyspeaking.podbean.com/e/penicillin-allergy-danger-is-in-the-diagnosis-frankly-speaking-93/</link>
                    <comments>https://primedfranklyspeaking.podbean.com/e/penicillin-allergy-danger-is-in-the-diagnosis-frankly-speaking-93/#comments</comments>        <pubDate>Mon, 05 Nov 2018 05:30:00 +0000</pubDate>
        <guid isPermaLink="false">ed14e50e181943419b4cecff2def1edd</guid>
                                    <description><![CDATA[<p>8% of patients believe they have a penicillin allergy, yet the actual number is far less. Listen to this episode to learn about the incidence of penicillin allergy, the risks associated with reporting a believed allergy, and how you can better manage these patients.</p>
 <p>Guest: Susan Feeney, DNP, FNP-BC</p>
 <p>Landing Page: <a href='http://www.pri-med.com/online-education/Podcast/93-penicillin-frankly-speaking.aspx#sm.00003l2jxaw01e18x7v14nsri8xks'>http://www.pri-med.com/online-education/Podcast/93-penicillin-frankly-speaking</a></p>
 <p> </p>
]]></description>
                                                            <content:encoded><![CDATA[<p>8% of patients believe they have a penicillin allergy, yet the actual number is far less. Listen to this episode to learn about the incidence of penicillin allergy, the risks associated with reporting a believed allergy, and how you can better manage these patients.</p>
 <p>Guest: Susan Feeney, DNP, FNP-BC</p>
 <p>Landing Page: <a href='http://www.pri-med.com/online-education/Podcast/93-penicillin-frankly-speaking.aspx#sm.00003l2jxaw01e18x7v14nsri8xks'>http://www.pri-med.com/online-education/Podcast/93-penicillin-frankly-speaking</a></p>
 <p> </p>
]]></content:encoded>
                                    
        <enclosure url="https://mcdn.podbean.com/mf/web/yd5n6o/secure_primed_updated-ep-93-penicillin-frankly-speaking-podcast.mp3" length="18215929" type="audio/mpeg"/>
                <itunes:summary><![CDATA[8% of patients believe they have a penicillin allergy, yet the actual number is far less. Listen to this episode to learn about the incidence of penicillin allergy, the risks associated with reporting a believed allergy, and how you can better manage these patients. Guest: Susan Feeney, DNP, FNP-BC Landing Page: http://www.pri-med.com/online-education/Podcast/93-penicillin-frankly-speaking  ]]></itunes:summary>
        <itunes:author>Pri-Med</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>568</itunes:duration>
                                <itunes:image href="https://pbcdn1.podbean.com/imglogo/ep-logo/pbblog13721080/cd71e9df8042d5dbcfe8d5de9df128f9.jpg" />    </item>
    <item>
        <title>Eliminating the Unnecessary: Updates on Screening for Cervical Cancer - Frankly Speaking 92</title>
        <itunes:title>Eliminating the Unnecessary: Updates on Screening for Cervical Cancer - Frankly Speaking 92</itunes:title>
        <link>https://primedfranklyspeaking.podbean.com/e/eliminating-the-unnecessary-updates-on-screening-for-cervical-cancer-frankly-speaking-92/</link>
                    <comments>https://primedfranklyspeaking.podbean.com/e/eliminating-the-unnecessary-updates-on-screening-for-cervical-cancer-frankly-speaking-92/#comments</comments>        <pubDate>Mon, 29 Oct 2018 04:30:00 +0000</pubDate>
        <guid isPermaLink="false">29302604437444c5bc8a0f75425a317d</guid>
                                    <description><![CDATA[<p>Listen to this episode to learn about the update to the 2012 United States Preventive Services Task Force (USPSTF) recommendation on screening for cervical cancer. </p>
]]></description>
                                                            <content:encoded><![CDATA[<p>Listen to this episode to learn about the update to the 2012 United States Preventive Services Task Force (USPSTF) recommendation on screening for cervical cancer. </p>
]]></content:encoded>
                                    
        <enclosure url="https://mcdn.podbean.com/mf/web/ma6qtr/secure_primed_ep-92-cervical-cancer-frankly-speaking-podcast.mp3" length="16574581" type="audio/mpeg"/>
                <itunes:summary><![CDATA[Listen to this episode to learn about the update to the 2012 United States Preventive Services Task Force (USPSTF) recommendation on screening for cervical cancer. ]]></itunes:summary>
        <itunes:author>Pri-Med</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>516</itunes:duration>
                                <itunes:image href="https://pbcdn1.podbean.com/imglogo/ep-logo/pbblog13721080/5fda2a84d8c77c751ad7e93aa22d3b8c.jpg" />    </item>
    <item>
        <title>Lose Weight While Eating Whatever You Like; Maybe? - Frankly Speaking EP 91</title>
        <itunes:title>Lose Weight While Eating Whatever You Like; Maybe? - Frankly Speaking EP 91</itunes:title>
        <link>https://primedfranklyspeaking.podbean.com/e/lose-weight-while-eating-whatever-you-like-maybe-frankly-speaking-ep-91/</link>
                    <comments>https://primedfranklyspeaking.podbean.com/e/lose-weight-while-eating-whatever-you-like-maybe-frankly-speaking-ep-91/#comments</comments>        <pubDate>Mon, 22 Oct 2018 04:30:00 +0000</pubDate>
        <guid isPermaLink="false">b40b426c0bf1425a8ad4ebbaed31ee2d</guid>
                                    <description><![CDATA[<p>Listen to this episode to learn about a small study which found that adding 35 grams of fiber and 0.8 grams of protein/kg/day to the diets of obese patients—without making any other diet changes—led to weight loss at 12 weeks.</p>
 <p>Guest: Susan Feeney, DNP, FNP-BC</p>
]]></description>
                                                            <content:encoded><![CDATA[<p>Listen to this episode to learn about a small study which found that adding 35 grams of fiber and 0.8 grams of protein/kg/day to the diets of obese patients—without making any other diet changes—led to weight loss at 12 weeks.</p>
 <p>Guest: Susan Feeney, DNP, FNP-BC</p>
]]></content:encoded>
                                    
        <enclosure url="https://mcdn.podbean.com/mf/web/pxjb48/secure_primed_ep-91-diet-frankly-speaking-podcast-edited.mp3" length="13228515" type="audio/mpeg"/>
                <itunes:summary><![CDATA[Listen to this episode to learn about a small study which found that adding 35 grams of fiber and 0.8 grams of protein/kg/day to the diets of obese patients—without making any other diet changes—led to weight loss at 12 weeks. Guest: Susan Feeney, DNP, FNP-BC]]></itunes:summary>
        <itunes:author>Pri-Med</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>825</itunes:duration>
                                <itunes:image href="https://pbcdn1.podbean.com/imglogo/ep-logo/pbblog13721080/e3c94151bb13099c6046cf03c562cdfb.jpg" />    </item>
    <item>
        <title>A Good Night’s Sleep: The Possible Association Between the Early Introduction of Food and Infant Sleep  - Frankly Sleeping EP 90</title>
        <itunes:title>A Good Night’s Sleep: The Possible Association Between the Early Introduction of Food and Infant Sleep  - Frankly Sleeping EP 90</itunes:title>
        <link>https://primedfranklyspeaking.podbean.com/e/a-good-night-s-sleep-the-possible-association-between-the-early-introduction-of-food-and-infant-sleep-frankly-sleeping-ep-90/</link>
                    <comments>https://primedfranklyspeaking.podbean.com/e/a-good-night-s-sleep-the-possible-association-between-the-early-introduction-of-food-and-infant-sleep-frankly-sleeping-ep-90/#comments</comments>        <pubDate>Fri, 12 Oct 2018 19:01:00 +0000</pubDate>
        <guid isPermaLink="false">96c2fc95d54d4182b213224c6927a695</guid>
                                    <description><![CDATA[<p>Both the WHO and AAP recommend exclusive breastfeeding until 6 months of age then solids and breast milk until 12 months of age. The well-established benefits of breastfeeding include support of infant growth and development of immunity. Recently, a clinical trial from the UK found an association between the early introduction of foods and infant sleep. Join us while we discuss the findings of this study and possible implications to your care of moms and their infants.</p>
]]></description>
                                                            <content:encoded><![CDATA[<p>Both the WHO and AAP recommend exclusive breastfeeding until 6 months of age then solids and breast milk until 12 months of age. The well-established benefits of breastfeeding include support of infant growth and development of immunity. Recently, a clinical trial from the UK found an association between the early introduction of foods and infant sleep. Join us while we discuss the findings of this study and possible implications to your care of moms and their infants.</p>
]]></content:encoded>
                                    
        <enclosure url="https://mcdn.podbean.com/mf/web/thz772/secure_primed_frankly-speaking-podcast-ep-90-pediatric-sleep.mp3" length="24131591" type="audio/mpeg"/>
                <itunes:summary><![CDATA[Both the WHO and AAP recommend exclusive breastfeeding until 6 months of age then solids and breast milk until 12 months of age. The well-established benefits of breastfeeding include support of infant growth and development of immunity. Recently, a clinical trial from the UK found an association between the early introduction of foods and infant sleep. Join us while we discuss the findings of this study and possible implications to your care of moms and their infants.]]></itunes:summary>
        <itunes:author>Pri-Med</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>754</itunes:duration>
                                <itunes:image href="https://pbcdn1.podbean.com/imglogo/ep-logo/pbblog13721080/8187901de8680e04f0a166115a532ae5.jpg" />    </item>
    <item>
        <title>Preventing Opioid Dependence While Effectively Treating Pain - Frankly Speaking EP 89</title>
        <itunes:title>Preventing Opioid Dependence While Effectively Treating Pain - Frankly Speaking EP 89</itunes:title>
        <link>https://primedfranklyspeaking.podbean.com/e/preventing-opioid-dependence-while-effectively-treating-pain-frankly-speaking-ep-89/</link>
                    <comments>https://primedfranklyspeaking.podbean.com/e/preventing-opioid-dependence-while-effectively-treating-pain-frankly-speaking-ep-89/#comments</comments>        <pubDate>Mon, 08 Oct 2018 04:30:00 +0000</pubDate>
        <guid isPermaLink="false">29cfe3af768145898c59a191a59ff033</guid>
                                    <description><![CDATA[<p>Best practices in treating acute and chronic pain have been clouded by years of misinformation. Listen to this podcast episode to learn an evidence-based recommendations that dispels these myths and encourages a new and better approach to pain management.</p>
]]></description>
                                                            <content:encoded><![CDATA[<p>Best practices in treating acute and chronic pain have been clouded by years of misinformation. Listen to this podcast episode to learn an evidence-based recommendations that dispels these myths and encourages a new and better approach to pain management.</p>
]]></content:encoded>
                                    
        <enclosure url="https://mcdn.podbean.com/mf/web/mrs7fv/secure_primed_frankly-speaking-podcast-ep-89-opioid-dependence-edited.mp3" length="21399821" type="audio/mpeg"/>
                <itunes:summary><![CDATA[Best practices in treating acute and chronic pain have been clouded by years of misinformation. Listen to this podcast episode to learn an evidence-based recommendations that dispels these myths and encourages a new and better approach to pain management.]]></itunes:summary>
        <itunes:author>Pri-Med</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>668</itunes:duration>
                                <itunes:image href="https://pbcdn1.podbean.com/imglogo/ep-logo/pbblog13721080/0af8855167b9b7449a571e47abbf679f.jpg" />    </item>
    <item>
        <title>Depression and Medication Side Effects: Is Your Depression Due to Something You Are Taking? - Frankly Speaking EP 88</title>
        <itunes:title>Depression and Medication Side Effects: Is Your Depression Due to Something You Are Taking? - Frankly Speaking EP 88</itunes:title>
        <link>https://primedfranklyspeaking.podbean.com/e/depression-and-medication-side-effects-is-your-depression-due-to-something-you-are-taking-frankly-speaking-ep-88/</link>
                    <comments>https://primedfranklyspeaking.podbean.com/e/depression-and-medication-side-effects-is-your-depression-due-to-something-you-are-taking-frankly-speaking-ep-88/#comments</comments>        <pubDate>Mon, 01 Oct 2018 04:30:00 +0000</pubDate>
        <guid isPermaLink="false">21f10432ebd347feafca3a5510381f28</guid>
                                    <description><![CDATA[<p>The number of adults in the US on prescription medications is rising, with approximately 15% taking five or more daily medications. A recent study found that depression is a common side effect—37.2% prevalence among American adults taking prescription medications—and is associated with an increased risk of concurrent depression.</p>
 <p>Guest: Susan Feeney, DNP, FNP-BC</p>
]]></description>
                                                            <content:encoded><![CDATA[<p>The number of adults in the US on prescription medications is rising, with approximately 15% taking five or more daily medications. A recent study found that depression is a common side effect—37.2% prevalence among American adults taking prescription medications—and is associated with an increased risk of concurrent depression.</p>
 <p>Guest: Susan Feeney, DNP, FNP-BC</p>
]]></content:encoded>
                                    
        <enclosure url="https://mcdn.podbean.com/mf/web/jfqjlp/secure_primed_frankly-speaking-podcast-ep-88-depression.mp3" length="24350252" type="audio/mpeg"/>
                <itunes:summary><![CDATA[The number of adults in the US on prescription medications is rising, with approximately 15% taking five or more daily medications. A recent study found that depression is a common side effect—37.2% prevalence among American adults taking prescription medications—and is associated with an increased risk of concurrent depression. Guest: Susan Feeney, DNP, FNP-BC]]></itunes:summary>
        <itunes:author>Pri-Med</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>761</itunes:duration>
                                <itunes:image href="https://pbcdn1.podbean.com/imglogo/ep-logo/pbblog13721080/d829db39f38977972cf781c05a24c2e1.jpg" />    </item>
    <item>
        <title>Chronic Non-Cancer Pain in Older Adults: Can We Teach Our Patients to “Unlearn” it? - Frankly Speaking EP 87</title>
        <itunes:title>Chronic Non-Cancer Pain in Older Adults: Can We Teach Our Patients to “Unlearn” it? - Frankly Speaking EP 87</itunes:title>
        <link>https://primedfranklyspeaking.podbean.com/e/chronic-non-cancer-pain-in-older-adults-can-we-teach-our-patients-to-unlearn-it-frankly-speaking-ep-87/</link>
                    <comments>https://primedfranklyspeaking.podbean.com/e/chronic-non-cancer-pain-in-older-adults-can-we-teach-our-patients-to-unlearn-it-frankly-speaking-ep-87/#comments</comments>        <pubDate>Mon, 24 Sep 2018 04:30:00 +0000</pubDate>
        <guid isPermaLink="false">fa9567e6755f474a9cb5a65227d6efea</guid>
                                    <description><![CDATA[<p>Chronic non-cancer pain in adults over 60 years old is common. The consequences are a decreased quality of life, disability and increased healthcare costs which can be due to the cost of therapies or from adverse pharmacologic effects to name a few. This episode discusses the results of a systematic review and meta-analysis by Niknejad et al (2018) that looked at pain outcomes in this population using psychological modalities.</p>
 <p>Guest: Jill Terrien PhD, ANP-BC</p>
]]></description>
                                                            <content:encoded><![CDATA[<p>Chronic non-cancer pain in adults over 60 years old is common. The consequences are a decreased quality of life, disability and increased healthcare costs which can be due to the cost of therapies or from adverse pharmacologic effects to name a few. This episode discusses the results of a systematic review and meta-analysis by Niknejad et al (2018) that looked at pain outcomes in this population using psychological modalities.</p>
 <p>Guest: Jill Terrien PhD, ANP-BC</p>
]]></content:encoded>
                                    
        <enclosure url="https://mcdn.podbean.com/mf/web/0oiktj/secure_primed_frankly-speaking-podcast-ep-87-non-cancer.mp3" length="22281035" type="audio/mpeg"/>
                <itunes:summary><![CDATA[Chronic non-cancer pain in adults over 60 years old is common. The consequences are a decreased quality of life, disability and increased healthcare costs which can be due to the cost of therapies or from adverse pharmacologic effects to name a few. This episode discusses the results of a systematic review and meta-analysis by Niknejad et al (2018) that looked at pain outcomes in this population using psychological modalities. Guest: Jill Terrien PhD, ANP-BC]]></itunes:summary>
        <itunes:author>Pri-Med</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>696</itunes:duration>
                                <itunes:image href="https://pbcdn1.podbean.com/imglogo/ep-logo/pbblog13721080/0f15204e32364aa8ed4e0bdef4db9ee0.jpg" />    </item>
    <item>
        <title>Shoulder Surgery Usually Not Beneficial For Most - Frankly Speaking EP 86</title>
        <itunes:title>Shoulder Surgery Usually Not Beneficial For Most - Frankly Speaking EP 86</itunes:title>
        <link>https://primedfranklyspeaking.podbean.com/e/shoulder-surgery-usually-not-beneficial-for-most-frankly-speaking-ep-86/</link>
                    <comments>https://primedfranklyspeaking.podbean.com/e/shoulder-surgery-usually-not-beneficial-for-most-frankly-speaking-ep-86/#comments</comments>        <pubDate>Mon, 17 Sep 2018 04:30:00 +0000</pubDate>
        <guid isPermaLink="false">9f0c526aae644cbab1bf315273885069</guid>
                                    <description><![CDATA[<p>Adults often present with atraumatic shoulder pain around age 50 and are diagnosed with impingement syndrome (rotator cuff tendonitis). However, as this recent study demonstrates, the standard of care for treatment should not be surgery.</p>
 <p>Guest: Susan Feeney, DNP, FNP-BC</p>
]]></description>
                                                            <content:encoded><![CDATA[<p>Adults often present with atraumatic shoulder pain around age 50 and are diagnosed with impingement syndrome (rotator cuff tendonitis). However, as this recent study demonstrates, the standard of care for treatment should not be surgery.</p>
 <p>Guest: Susan Feeney, DNP, FNP-BC</p>
]]></content:encoded>
                                    
        <enclosure url="https://mcdn.podbean.com/mf/web/5l279n/secure_primed_frankly-speaking-podcast-ep-86-shoulder-edited.mp3" length="20385159" type="audio/mpeg"/>
                <itunes:summary><![CDATA[Adults often present with atraumatic shoulder pain around age 50 and are diagnosed with impingement syndrome (rotator cuff tendonitis). However, as this recent study demonstrates, the standard of care for treatment should not be surgery. Guest: Susan Feeney, DNP, FNP-BC]]></itunes:summary>
        <itunes:author>Pri-Med</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>637</itunes:duration>
                                <itunes:image href="https://pbcdn1.podbean.com/imglogo/ep-logo/pbblog13721080/eeed50bfab5ae885e0d57976105bb518.jpg" />    </item>
    <item>
        <title>Digital Media Use and ADHD Symptoms in Teenagers – Is There an Association? - Frankly Speaking EP 85</title>
        <itunes:title>Digital Media Use and ADHD Symptoms in Teenagers – Is There an Association? - Frankly Speaking EP 85</itunes:title>
        <link>https://primedfranklyspeaking.podbean.com/e/digital-media-use-and-adhd-symptoms-in-teenagers-%e2%80%93-is-there-an-association-frankly-speaking-ep-85/</link>
                    <comments>https://primedfranklyspeaking.podbean.com/e/digital-media-use-and-adhd-symptoms-in-teenagers-%e2%80%93-is-there-an-association-frankly-speaking-ep-85/#comments</comments>        <pubDate>Mon, 10 Sep 2018 13:40:00 +0000</pubDate>
        <guid isPermaLink="false">b6fe6f46829d40408a22235e6a121760</guid>
                                    <description><![CDATA[<p>A recent longitudinal study of high school students in the LA area found a modest but significant association between high-frequency digital media use (phones, tablets) and subsequent ADHD symptoms. Join us as we discuss these findings and the possible impact on adolescent primary care.</p>
 <p>Guest: Susan Feeney, DNP, FNP-BC</p>
]]></description>
                                                            <content:encoded><![CDATA[<p>A recent longitudinal study of high school students in the LA area found a modest but significant association between high-frequency digital media use (phones, tablets) and subsequent ADHD symptoms. Join us as we discuss these findings and the possible impact on adolescent primary care.</p>
 <p>Guest: Susan Feeney, DNP, FNP-BC</p>
]]></content:encoded>
                                    
        <enclosure url="https://mcdn.podbean.com/mf/web/8twovi/secure_primed_frankly-speaking-podcast-ep-85-adhd-edited-3.mp3" length="21639369" type="audio/mpeg"/>
                <itunes:summary><![CDATA[A recent longitudinal study of high school students in the LA area found a modest but significant association between high-frequency digital media use (phones, tablets) and subsequent ADHD symptoms. Join us as we discuss these findings and the possible impact on adolescent primary care. Guest: Susan Feeney, DNP, FNP-BC]]></itunes:summary>
        <itunes:author>Pri-Med</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>676</itunes:duration>
                                <itunes:image href="https://pbcdn1.podbean.com/imglogo/ep-logo/pbblog13721080/c071697f640f7daeef267861f3ec281f.jpg" />    </item>
    <item>
        <title>Physician Burnout: What Degree Have We Reached? - Frankly Speaking EP 84</title>
        <itunes:title>Physician Burnout: What Degree Have We Reached? - Frankly Speaking EP 84</itunes:title>
        <link>https://primedfranklyspeaking.podbean.com/e/physician-burnout-what-degree-have-we-reached-frankly-speaking-ep-84/</link>
                    <comments>https://primedfranklyspeaking.podbean.com/e/physician-burnout-what-degree-have-we-reached-frankly-speaking-ep-84/#comments</comments>        <pubDate>Mon, 03 Sep 2018 04:30:00 +0000</pubDate>
        <guid isPermaLink="false">41d7fe3086264c58a594357bd20f9e0b</guid>
                                    <description><![CDATA[<p>This episode is an introductory discussion of the very real problem of physician burnout. It affects you and those around you. What do we know about burnout and how can we move beyond it?</p>
 <p>Guest: Jill Terrien PhD, ANP-BC</p>
]]></description>
                                                            <content:encoded><![CDATA[<p>This episode is an introductory discussion of the very real problem of physician burnout. It affects you and those around you. What do we know about burnout and how can we move beyond it?</p>
 <p>Guest: Jill Terrien PhD, ANP-BC</p>
]]></content:encoded>
                                    
        <enclosure url="https://mcdn.podbean.com/mf/web/buacjj/secure_primed_frankly-speaking-podcast-ep-84-burnout-edit.mp3" length="21948610" type="audio/mpeg"/>
                <itunes:summary><![CDATA[This episode is an introductory discussion of the very real problem of physician burnout. It affects you and those around you. What do we know about burnout and how can we move beyond it? Guest: Jill Terrien PhD, ANP-BC]]></itunes:summary>
        <itunes:author>Pri-Med</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>686</itunes:duration>
                                <itunes:image href="https://pbcdn1.podbean.com/imglogo/ep-logo/pbblog13721080/2c9afbe9c41686297925b796f467c345.jpg" />    </item>
    <item>
        <title>Should You Use Budesonide-Formoterol as Needed for Mild Asthma? - Frankly Speaking EP 83</title>
        <itunes:title>Should You Use Budesonide-Formoterol as Needed for Mild Asthma? - Frankly Speaking EP 83</itunes:title>
        <link>https://primedfranklyspeaking.podbean.com/e/should-you-use-budesonide-formoterol-as-needed-for-mild-asthma-frankly-speaking-ep-83/</link>
                    <comments>https://primedfranklyspeaking.podbean.com/e/should-you-use-budesonide-formoterol-as-needed-for-mild-asthma-frankly-speaking-ep-83/#comments</comments>        <pubDate>Mon, 27 Aug 2018 14:48:00 +0000</pubDate>
        <guid isPermaLink="false">960baff1859d43938afb3761e130611f</guid>
                                    <description><![CDATA[<p>In this episode, we will discuss using an inhaled steroid twice a day to control mild asthma symptoms, versus using the combination budesonide and formoterol.</p>
 <p>Guest: Jill Terrien PhD, ANP-BC</p>
]]></description>
                                                            <content:encoded><![CDATA[<p>In this episode, we will discuss using an inhaled steroid twice a day to control mild asthma symptoms, versus using the combination budesonide and formoterol.</p>
 <p>Guest: Jill Terrien PhD, ANP-BC</p>
]]></content:encoded>
                                    
        <enclosure url="https://mcdn.podbean.com/mf/web/1v1f4m/secure_primed_frankly-speaking-podcast-ep-83-budesonide-edit.mp3" length="19284320" type="audio/mpeg"/>
                <itunes:summary><![CDATA[In this episode, we will discuss using an inhaled steroid twice a day to control mild asthma symptoms, versus using the combination budesonide and formoterol. Guest: Jill Terrien PhD, ANP-BC]]></itunes:summary>
        <itunes:author>Pri-Med</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>602</itunes:duration>
                                <itunes:image href="https://pbcdn1.podbean.com/imglogo/ep-logo/pbblog13721080/b4c6153655180f9fc0bf5e5d162c3b2e.jpg" />    </item>
    <item>
        <title>More Than Beauty: Length and Quality of Sleep and Its Impact on CV Risk Factors in Teens - Frankly Speaking EP 82</title>
        <itunes:title>More Than Beauty: Length and Quality of Sleep and Its Impact on CV Risk Factors in Teens - Frankly Speaking EP 82</itunes:title>
        <link>https://primedfranklyspeaking.podbean.com/e/more-than-beauty-length-and-quality-of-sleep-and-its-impact-on-cv-risk-factors-in-teens-frankly-speaking-ep-82/</link>
                    <comments>https://primedfranklyspeaking.podbean.com/e/more-than-beauty-length-and-quality-of-sleep-and-its-impact-on-cv-risk-factors-in-teens-frankly-speaking-ep-82/#comments</comments>        <pubDate>Mon, 20 Aug 2018 04:30:00 +0000</pubDate>
        <guid isPermaLink="false">4deca9437a9a4226827872b955176552</guid>
                                    <description><![CDATA[<p>It has been fairly established that short duration of sleep is associated with obesity in teens and adults; however, the impact of quantity and quality of sleep has not been as well established. A cross-sectional study by Feliciano et al. found that longer and better sleep was associated with better cardiometabolic profiles in early adolescence – independent of other factors.</p>
 <p>Guest: Susan Feeney, DNP, FNP-BC</p>
]]></description>
                                                            <content:encoded><![CDATA[<p>It has been fairly established that short duration of sleep is associated with obesity in teens and adults; however, the impact of quantity and quality of sleep has not been as well established. A cross-sectional study by Feliciano et al. found that longer and better sleep was associated with better cardiometabolic profiles in early adolescence – independent of other factors.</p>
 <p>Guest: Susan Feeney, DNP, FNP-BC</p>
]]></content:encoded>
                                    
        <enclosure url="https://mcdn.podbean.com/mf/web/znp7k4/secure_primed_frankly-speaking-podcast-ep-81-cardiometabolic-risk-edited.mp3" length="21244083" type="audio/mpeg"/>
                <itunes:summary><![CDATA[It has been fairly established that short duration of sleep is associated with obesity in teens and adults; however, the impact of quantity and quality of sleep has not been as well established. A cross-sectional study by Feliciano et al. found that longer and better sleep was associated with better cardiometabolic profiles in early adolescence – independent of other factors. Guest: Susan Feeney, DNP, FNP-BC]]></itunes:summary>
        <itunes:author>Pri-Med</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>663</itunes:duration>
                                <itunes:image href="https://pbcdn1.podbean.com/imglogo/ep-logo/pbblog13721080/bbea51f544693d7aad43ac35f4766672.jpg" />    </item>
    <item>
        <title>Goals of Care Discussions in Patients with Serious Illness: Is It a Downer? - Frankly Speaking EP 81</title>
        <itunes:title>Goals of Care Discussions in Patients with Serious Illness: Is It a Downer? - Frankly Speaking EP 81</itunes:title>
        <link>https://primedfranklyspeaking.podbean.com/e/goals-of-care-discussions-in-patients-with-serious-illness-is-it-a-downer-frankly-speaking-ep-81/</link>
                    <comments>https://primedfranklyspeaking.podbean.com/e/goals-of-care-discussions-in-patients-with-serious-illness-is-it-a-downer-frankly-speaking-ep-81/#comments</comments>        <pubDate>Mon, 13 Aug 2018 04:30:00 +0000</pubDate>
        <guid isPermaLink="false">96d21027e8a14f939906dfad6bb94364</guid>
                                    <description><![CDATA[<p>Discussing goals of care with patients that have a serious, life-limiting illness does not affect the patient’s anxiety or depression—but can increase the quality of the communication. Listen to this podcast episode for tips that are easily adaptable to any outpatient or specialty practice.</p>
 <p>Guest: Jill Terrien PhD, ANP-BC</p>
]]></description>
                                                            <content:encoded><![CDATA[<p>Discussing goals of care with patients that have a serious, life-limiting illness does not affect the patient’s anxiety or depression—but can increase the quality of the communication. Listen to this podcast episode for tips that are easily adaptable to any outpatient or specialty practice.</p>
 <p>Guest: Jill Terrien PhD, ANP-BC</p>
]]></content:encoded>
                                    
        <enclosure url="https://mcdn.podbean.com/mf/web/g1p0vf/secure_primed_frankly-speaking-goals-of-care.mp3" length="22519079" type="audio/mpeg"/>
                <itunes:summary><![CDATA[Discussing goals of care with patients that have a serious, life-limiting illness does not affect the patient’s anxiety or depression—but can increase the quality of the communication. Listen to this podcast episode for tips that are easily adaptable to any outpatient or specialty practice. Guest: Jill Terrien PhD, ANP-BC]]></itunes:summary>
        <itunes:author>Pri-Med</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>703</itunes:duration>
                                <itunes:image href="https://pbcdn1.podbean.com/imglogo/ep-logo/pbblog13721080/3989662888e0c0e74a07dc056c13b784.jpg" />    </item>
    <item>
        <title>Breastfeeding Supplemented with Formula; When Is It the Right Thing to Do? - Frankly Speaking EP 80</title>
        <itunes:title>Breastfeeding Supplemented with Formula; When Is It the Right Thing to Do? - Frankly Speaking EP 80</itunes:title>
        <link>https://primedfranklyspeaking.podbean.com/e/breastfeeding-supplemented-with-formula-when-is-it-the-right-thing-to-do-frankly-speaking-ep-80/</link>
                    <comments>https://primedfranklyspeaking.podbean.com/e/breastfeeding-supplemented-with-formula-when-is-it-the-right-thing-to-do-frankly-speaking-ep-80/#comments</comments>        <pubDate>Mon, 06 Aug 2018 04:30:00 +0000</pubDate>
        <guid isPermaLink="false">97482c35542348c09ad3a53762964e8d</guid>
                                    <description><![CDATA[<p>Breastfeeding exclusively in the first six months of life is widely recommended. However, in this study of newborns who were losing weight because their mother’s milk had not yet come in, post-breastfeeding supplementation improved weight and did not alter breastfeeding rates at one month. </p>
 <p>Guest: Susan Feeney, DNP, FNP-BC </p>
]]></description>
                                                            <content:encoded><![CDATA[<p>Breastfeeding exclusively in the first six months of life is widely recommended. However, in this study of newborns who were losing weight because their mother’s milk had not yet come in, post-breastfeeding supplementation improved weight and did not alter breastfeeding rates at one month. </p>
 <p>Guest: Susan Feeney, DNP, FNP-BC </p>
]]></content:encoded>
                                    
        <enclosure url="https://mcdn.podbean.com/mf/web/m7jhgt/secure_primed_frankly-speaking-podcast-ep-80-breastfeeding.mp3" length="21126496" type="audio/mpeg"/>
                <itunes:summary><![CDATA[Breastfeeding exclusively in the first six months of life is widely recommended. However, in this study of newborns who were losing weight because their mother’s milk had not yet come in, post-breastfeeding supplementation improved weight and did not alter breastfeeding rates at one month.  Guest: Susan Feeney, DNP, FNP-BC ]]></itunes:summary>
        <itunes:author>Pri-Med</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>660</itunes:duration>
                                <itunes:image href="https://pbcdn1.podbean.com/imglogo/ep-logo/pbblog13721080/d5702177e48656373c90abf65e07e841.jpg" />    </item>
    <item>
        <title>Mangia: What Is the Truth about the Mediterranean Diet and CVD Health? - Frankly Speaking EP 79</title>
        <itunes:title>Mangia: What Is the Truth about the Mediterranean Diet and CVD Health? - Frankly Speaking EP 79</itunes:title>
        <link>https://primedfranklyspeaking.podbean.com/e/mangia-what-is-the-truth-about-the-mediterranean-diet-and-cvd-health-frankly-speaking-ep-79/</link>
                    <comments>https://primedfranklyspeaking.podbean.com/e/mangia-what-is-the-truth-about-the-mediterranean-diet-and-cvd-health-frankly-speaking-ep-79/#comments</comments>        <pubDate>Mon, 30 Jul 2018 04:30:00 +0000</pubDate>
        <guid isPermaLink="false">f76080d80c83419aa3a23198e186a313</guid>
                                    <description><![CDATA[<p>In 2013, a groundbreaking clinical trial from Spain touted the benefits of the Mediterranean Diet to reduce CVD risk. A recent review of the study found some irregularities in the randomization procedure that cast concern on the validity of the findings. After reanalysis of the data, however, the results were essentially the same.</p>
 <p>Guest: Susan Feeney, DNP, FNP-BC</p>
]]></description>
                                                            <content:encoded><![CDATA[<p>In 2013, a groundbreaking clinical trial from Spain touted the benefits of the Mediterranean Diet to reduce CVD risk. A recent review of the study found some irregularities in the randomization procedure that cast concern on the validity of the findings. After reanalysis of the data, however, the results were essentially the same.</p>
 <p>Guest: Susan Feeney, DNP, FNP-BC</p>
]]></content:encoded>
                                    
        <enclosure url="https://mcdn.podbean.com/mf/web/7v07c6/secure_primed_frankly-speaking-podcast-ep-79-med-diet.mp3" length="18984901" type="audio/mpeg"/>
                <itunes:summary><![CDATA[In 2013, a groundbreaking clinical trial from Spain touted the benefits of the Mediterranean Diet to reduce CVD risk. A recent review of the study found some irregularities in the randomization procedure that cast concern on the validity of the findings. After reanalysis of the data, however, the results were essentially the same. Guest: Susan Feeney, DNP, FNP-BC]]></itunes:summary>
        <itunes:author>Pri-Med</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>593</itunes:duration>
                                <itunes:image href="https://pbcdn1.podbean.com/imglogo/ep-logo/pbblog13721080/9d78bfa0c39e266081d723d215a19711.jpg" />    </item>
    <item>
        <title>Binge Drinking in Adolescents: A Sober Subject That Begs for Attention - Frankly Speaking EP 78</title>
        <itunes:title>Binge Drinking in Adolescents: A Sober Subject That Begs for Attention - Frankly Speaking EP 78</itunes:title>
        <link>https://primedfranklyspeaking.podbean.com/e/binge-drinking-in-adolescents-a-sober-subject-that-begs-for-attention-frankly-speaking-ep-78/</link>
                    <comments>https://primedfranklyspeaking.podbean.com/e/binge-drinking-in-adolescents-a-sober-subject-that-begs-for-attention-frankly-speaking-ep-78/#comments</comments>        <pubDate>Mon, 23 Jul 2018 04:30:00 +0000</pubDate>
        <guid isPermaLink="false">543038851c6e4962b78383334222ff2b</guid>
                                    <description><![CDATA[<p>For adolescents who binge drink, when they begin and how often they do it affects academic performance. This episode discusses the findings of a longitudinal analysis of secondary school students in Canada: The COMPASS study.</p>
 <p>Guest: Jill Terrien PhD, ANP-BC</p>
]]></description>
                                                            <content:encoded><![CDATA[<p>For adolescents who binge drink, when they begin and how often they do it affects academic performance. This episode discusses the findings of a longitudinal analysis of secondary school students in Canada: The COMPASS study.</p>
 <p>Guest: Jill Terrien PhD, ANP-BC</p>
]]></content:encoded>
                                    
        <enclosure url="https://mcdn.podbean.com/mf/web/0qrdc9/secure_primed_frankly-speaking-podcast-ep-78-drinking.mp3" length="19489810" type="audio/mpeg"/>
                <itunes:summary><![CDATA[For adolescents who binge drink, when they begin and how often they do it affects academic performance. This episode discusses the findings of a longitudinal analysis of secondary school students in Canada: The COMPASS study. Guest: Jill Terrien PhD, ANP-BC]]></itunes:summary>
        <itunes:author>Pri-Med</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>609</itunes:duration>
                                <itunes:image href="https://pbcdn1.podbean.com/imglogo/ep-logo/pbblog13721080/82ed2d427e62d378051b6a5d44ec26f3.jpg" />    </item>
    <item>
        <title>Treatment of Post-Op Pain Following Spine and Joint Surgery - Frankly Speaking EP 77</title>
        <itunes:title>Treatment of Post-Op Pain Following Spine and Joint Surgery - Frankly Speaking EP 77</itunes:title>
        <link>https://primedfranklyspeaking.podbean.com/e/treatment-of-post-op-pain-following-spine-and-joint-surgery-frankly-speaking-ep-77/</link>
                    <comments>https://primedfranklyspeaking.podbean.com/e/treatment-of-post-op-pain-following-spine-and-joint-surgery-frankly-speaking-ep-77/#comments</comments>        <pubDate>Mon, 16 Jul 2018 04:30:00 +0000</pubDate>
        <guid isPermaLink="false">e79b488e5516430689e7fd5848f081b9</guid>
                                    <description><![CDATA[<p>This study looked at how pain was treated following spine and joint surgery and found the majority of patients were not encouraged to use non-opioid analgesia and that most had a supply of unused opioids at home.</p>
 <p>Guest: Jill Terrien PhD, ANP-BC</p>
]]></description>
                                                            <content:encoded><![CDATA[<p>This study looked at how pain was treated following spine and joint surgery and found the majority of patients were not encouraged to use non-opioid analgesia and that most had a supply of unused opioids at home.</p>
 <p>Guest: Jill Terrien PhD, ANP-BC</p>
]]></content:encoded>
                                    
        <enclosure url="https://mcdn.podbean.com/mf/web/2ghu46/secure_primed_frankly-speaking-podcast-ep-77-post-op-pain.mp3" length="19362029" type="audio/mpeg"/>
                <itunes:summary><![CDATA[This study looked at how pain was treated following spine and joint surgery and found the majority of patients were not encouraged to use non-opioid analgesia and that most had a supply of unused opioids at home. Guest: Jill Terrien PhD, ANP-BC]]></itunes:summary>
        <itunes:author>Pri-Med</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>605</itunes:duration>
                                <itunes:image href="https://pbcdn1.podbean.com/imglogo/ep-logo/pbblog13721080/272014595a6056cdae3708a1c13b63b8.jpg" />    </item>
    <item>
        <title>Assessing Blood Pressure: How Accurate Are the Blood Pressure Measurements You Use to Care for Your Patients? - Frankly Speaking EP 76</title>
        <itunes:title>Assessing Blood Pressure: How Accurate Are the Blood Pressure Measurements You Use to Care for Your Patients? - Frankly Speaking EP 76</itunes:title>
        <link>https://primedfranklyspeaking.podbean.com/e/assessing-blood-pressure-how-accurate-are-the-blood-pressure-measurements-you-use-to-care-for-your-patients-frankly-speaking-ep-76/</link>
                    <comments>https://primedfranklyspeaking.podbean.com/e/assessing-blood-pressure-how-accurate-are-the-blood-pressure-measurements-you-use-to-care-for-your-patients-frankly-speaking-ep-76/#comments</comments>        <pubDate>Mon, 09 Jul 2018 04:30:00 +0000</pubDate>
        <guid isPermaLink="false">b10791199599432a8ae0b21431fc4458</guid>
                                    <description><![CDATA[<p>Hypertension affects an estimated 80 million Americans. We diagnose, determine the need for medication therapy, and monitor treatment efficacy based on a simple office blood pressure measurement – but how accurate is that measurement, and what is the most valid method to obtain it?</p>
 <p>Guest: Susan Feeney, DNP, FNP-BC</p>
]]></description>
                                                            <content:encoded><![CDATA[<p>Hypertension affects an estimated 80 million Americans. We diagnose, determine the need for medication therapy, and monitor treatment efficacy based on a simple office blood pressure measurement – but how accurate is that measurement, and what is the most valid method to obtain it?</p>
 <p>Guest: Susan Feeney, DNP, FNP-BC</p>
]]></content:encoded>
                                    
        <enclosure url="https://mcdn.podbean.com/mf/web/dzzggx/secure_primed_frankly-speaking-podcast-ep-76-bp.mp3" length="24597308" type="audio/mpeg"/>
                <itunes:summary><![CDATA[Hypertension affects an estimated 80 million Americans. We diagnose, determine the need for medication therapy, and monitor treatment efficacy based on a simple office blood pressure measurement – but how accurate is that measurement, and what is the most valid method to obtain it? Guest: Susan Feeney, DNP, FNP-BC]]></itunes:summary>
        <itunes:author>Pri-Med</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>761</itunes:duration>
                                <itunes:image href="https://pbcdn1.podbean.com/imglogo/ep-logo/pbblog13721080/60595fefc3735dc80f6156180bb778d1.jpg" />    </item>
    <item>
        <title>Moving Fast, Moving Slow - Frankly Speaking EP 75</title>
        <itunes:title>Moving Fast, Moving Slow - Frankly Speaking EP 75</itunes:title>
        <link>https://primedfranklyspeaking.podbean.com/e/moving-fast-moving-slow-frankly-speaking-ep-75/</link>
                    <comments>https://primedfranklyspeaking.podbean.com/e/moving-fast-moving-slow-frankly-speaking-ep-75/#comments</comments>        <pubDate>Mon, 02 Jul 2018 04:30:00 +0000</pubDate>
        <guid isPermaLink="false">0568b03c93a64edfb6b15cb53ca8728a</guid>
                                    <description><![CDATA[<p>Fibromyalgia can be difficult to treat and often requires a multifaceted approach combining exercise, medications, cognitive behavioral therapy, and health education. For many patients, pain hinders participation in a vigorous exercise regimen. Listen to this review of a randomized trial comparing aerobic exercise to tai chi in a patient population with fibromyalgia.</p>
 <p>Guest: Alan Ehrlich, MD </p>
]]></description>
                                                            <content:encoded><![CDATA[<p>Fibromyalgia can be difficult to treat and often requires a multifaceted approach combining exercise, medications, cognitive behavioral therapy, and health education. For many patients, pain hinders participation in a vigorous exercise regimen. Listen to this review of a randomized trial comparing aerobic exercise to tai chi in a patient population with fibromyalgia.</p>
 <p>Guest: Alan Ehrlich, MD </p>
]]></content:encoded>
                                    
        <enclosure url="https://mcdn.podbean.com/mf/web/vhi3py/secure_primed_frankly-speaking-podcast-ep-75-tai-chi.mp3" length="24434707" type="audio/mpeg"/>
                <itunes:summary><![CDATA[Fibromyalgia can be difficult to treat and often requires a multifaceted approach combining exercise, medications, cognitive behavioral therapy, and health education. For many patients, pain hinders participation in a vigorous exercise regimen. Listen to this review of a randomized trial comparing aerobic exercise to tai chi in a patient population with fibromyalgia. Guest: Alan Ehrlich, MD ]]></itunes:summary>
        <itunes:author>Pri-Med</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>756</itunes:duration>
                                <itunes:image href="https://pbcdn1.podbean.com/imglogo/ep-logo/pbblog13721080/b87db262a504f6f8eba1558e1b8ef88f.jpg" />    </item>
    <item>
        <title>Uncomplicated UTI in Women: What a Pain! - Frankly Speaking EP 74</title>
        <itunes:title>Uncomplicated UTI in Women: What a Pain! - Frankly Speaking EP 74</itunes:title>
        <link>https://primedfranklyspeaking.podbean.com/e/uncomplicated-uti-in-women-what-a-pain-frankly-speaking-ep-74/</link>
                    <comments>https://primedfranklyspeaking.podbean.com/e/uncomplicated-uti-in-women-what-a-pain-frankly-speaking-ep-74/#comments</comments>        <pubDate>Mon, 25 Jun 2018 04:30:00 +0000</pubDate>
        <guid isPermaLink="false">5f2e8fa16c694f1c982640c84e961d97</guid>
                                    <description><![CDATA[<p>For women experiencing an uncomplicated UTI, nitrofurantoin and fosfomycin are two first-line options for treatment. Is one more effective than the other? Listen to this episode to learn about the results from a multinational, open-label, randomized clinical trial.</p>
 <p>Guest: Jill Terrien PhD, ANP-BC</p>
]]></description>
                                                            <content:encoded><![CDATA[<p>For women experiencing an uncomplicated UTI, nitrofurantoin and fosfomycin are two first-line options for treatment. Is one more effective than the other? Listen to this episode to learn about the results from a multinational, open-label, randomized clinical trial.</p>
 <p>Guest: Jill Terrien PhD, ANP-BC</p>
]]></content:encoded>
                                    
        <enclosure url="https://mcdn.podbean.com/mf/web/tn8ox7/secure_primed_frankly-speaking-podcast-ep-74-UTI-edited.mp3" length="22372997" type="audio/mpeg"/>
                <itunes:summary><![CDATA[For women experiencing an uncomplicated UTI, nitrofurantoin and fosfomycin are two first-line options for treatment. Is one more effective than the other? Listen to this episode to learn about the results from a multinational, open-label, randomized clinical trial. Guest: Jill Terrien PhD, ANP-BC]]></itunes:summary>
        <itunes:author>Pri-Med</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>698</itunes:duration>
                                <itunes:image href="https://pbcdn1.podbean.com/imglogo/ep-logo/pbblog13721080/40324102bdc8c9f82dc9f4e16aad3abb.jpg" />    </item>
    <item>
        <title>Put That Finger Down! The End of the Screening Rectal Exam - Frankly Speaking EP 73</title>
        <itunes:title>Put That Finger Down! The End of the Screening Rectal Exam - Frankly Speaking EP 73</itunes:title>
        <link>https://primedfranklyspeaking.podbean.com/e/put-that-finger-down-the-end-of-the-screening-rectal-exam-frankly-speaking-ep-73/</link>
                    <comments>https://primedfranklyspeaking.podbean.com/e/put-that-finger-down-the-end-of-the-screening-rectal-exam-frankly-speaking-ep-73/#comments</comments>        <pubDate>Mon, 18 Jun 2018 04:30:00 +0000</pubDate>
        <guid isPermaLink="false">eacab6ac4d98421d9b2e649e0de19f45</guid>
                                    <description><![CDATA[<p>Listen to this week’s podcast episode to learn about a meta-analysis showing no benefit to rectal examinations in men.</p>
 <p>Guest: Susan Feeney, DNP, FNP-BC </p>
]]></description>
                                                            <content:encoded><![CDATA[<p>Listen to this week’s podcast episode to learn about a meta-analysis showing no benefit to rectal examinations in men.</p>
 <p>Guest: Susan Feeney, DNP, FNP-BC </p>
]]></content:encoded>
                                    
        <enclosure url="https://mcdn.podbean.com/mf/web/r6i45g/secure_primed_frankly-speaking-podcast-ep-73-rectal.mp3" length="21714433" type="audio/mpeg"/>
                <itunes:summary><![CDATA[Listen to this week’s podcast episode to learn about a meta-analysis showing no benefit to rectal examinations in men. Guest: Susan Feeney, DNP, FNP-BC ]]></itunes:summary>
        <itunes:author>Pri-Med</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>671</itunes:duration>
                                <itunes:image href="https://pbcdn1.podbean.com/imglogo/ep-logo/pbblog13721080/100593f024cf65c2e9e3dd64c3a9dc84.jpg" />    </item>
    <item>
        <title>Don’t Make Me Exercise – Give Me Some Tea &amp; a Pill! - Frankly Speaking EP 72</title>
        <itunes:title>Don’t Make Me Exercise – Give Me Some Tea &amp; a Pill! - Frankly Speaking EP 72</itunes:title>
        <link>https://primedfranklyspeaking.podbean.com/e/don-t-make-me-exercise-%e2%80%93-give-me-some-tea-a-pill-frankly-speaking-ep-72/</link>
                    <comments>https://primedfranklyspeaking.podbean.com/e/don-t-make-me-exercise-%e2%80%93-give-me-some-tea-a-pill-frankly-speaking-ep-72/#comments</comments>        <pubDate>Mon, 11 Jun 2018 04:30:00 +0000</pubDate>
        <guid isPermaLink="false">cd81c2ee688a462ca1ff47969aef914d</guid>
                                    <description><![CDATA[<p>A recent AHA presentation offered data that showed an overwhelming amount of patients would prefer to take a pill or drink tea rather than exercise to lower their BP. This begs the questions: How much does drinking tea lower BP? Does exercise help those with primary HTN or resistant HTN who are already on medication? Finally, how do we get our patients to exercise? </p>
 <p>Guest: Robert A. Baldor, MD, FAAFP</p>
]]></description>
                                                            <content:encoded><![CDATA[<p>A recent AHA presentation offered data that showed an overwhelming amount of patients would prefer to take a pill or drink tea rather than exercise to lower their BP. This begs the questions: How much does drinking tea lower BP? Does exercise help those with primary HTN or resistant HTN who are already on medication? Finally, how do we get our patients to exercise? </p>
 <p>Guest: Robert A. Baldor, MD, FAAFP</p>
]]></content:encoded>
                                    
        <enclosure url="https://mcdn.podbean.com/mf/web/isq7vo/secure_primed_frankly-speaking-podcast-ep-72-hypertension.mp3" length="20381543" type="audio/mpeg"/>
                <itunes:summary><![CDATA[A recent AHA presentation offered data that showed an overwhelming amount of patients would prefer to take a pill or drink tea rather than exercise to lower their BP. This begs the questions: How much does drinking tea lower BP? Does exercise help those with primary HTN or resistant HTN who are already on medication? Finally, how do we get our patients to exercise?  Guest: Robert A. Baldor, MD, FAAFP]]></itunes:summary>
        <itunes:author>Pri-Med</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>629</itunes:duration>
                                <itunes:image href="https://pbcdn1.podbean.com/imglogo/ep-logo/pbblog13721080/eab27cb7e8ad762173cdba3a7996ef11.jpg" />    </item>
    <item>
        <title>Mom, Do I Have to Practice the Piano Again? The Benefit of Music Instruction on Executive Function - Frankly Speaking EP 71</title>
        <itunes:title>Mom, Do I Have to Practice the Piano Again? The Benefit of Music Instruction on Executive Function - Frankly Speaking EP 71</itunes:title>
        <link>https://primedfranklyspeaking.podbean.com/e/mom-do-i-have-to-practice-the-piano-again-the-benefit-of-music-instruction-on-executive-function-frankly-speaking-ep-71/</link>
                    <comments>https://primedfranklyspeaking.podbean.com/e/mom-do-i-have-to-practice-the-piano-again-the-benefit-of-music-instruction-on-executive-function-frankly-speaking-ep-71/#comments</comments>        <pubDate>Mon, 04 Jun 2018 04:30:00 +0000</pubDate>
        <guid isPermaLink="false">4d63c0ed7b324d2ca32b6ceb07afa650</guid>
                                    <description><![CDATA[<p>Listen to this week's episode to learn about a randomized trial of children in music vs. visual arts instruction. Music instruction led to improvements in verbal intelligence, executive functions, and academic performance.</p>
 <p>
Guest: Susan Feeney, DNP, FNP-BC</p>
]]></description>
                                                            <content:encoded><![CDATA[<p>Listen to this week's episode to learn about a randomized trial of children in music vs. visual arts instruction. Music instruction led to improvements in verbal intelligence, executive functions, and academic performance.</p>
 <p><br>
Guest: Susan Feeney, DNP, FNP-BC</p>
]]></content:encoded>
                                    
        <enclosure url="https://mcdn.podbean.com/mf/web/mb6u3y/secure_primed_frankly-speaking-podcast-ep-71-executive-function-edited.mp3" length="19953361" type="audio/mpeg"/>
                <itunes:summary><![CDATA[Listen to this week's episode to learn about a randomized trial of children in music vs. visual arts instruction. Music instruction led to improvements in verbal intelligence, executive functions, and academic performance. Guest: Susan Feeney, DNP, FNP-BC]]></itunes:summary>
        <itunes:author>Pri-Med</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>623</itunes:duration>
                                <itunes:image href="https://pbcdn1.podbean.com/imglogo/ep-logo/pbblog13721080/78d590b807469cba4bfeb8db4ca173fe.jpg" />    </item>
    <item>
        <title>Hot Flashes, Night Sweats, and Insomnia: Will I Ever Sleep Through the Night Again? - Frankly Speaking EP 70</title>
        <itunes:title>Hot Flashes, Night Sweats, and Insomnia: Will I Ever Sleep Through the Night Again? - Frankly Speaking EP 70</itunes:title>
        <link>https://primedfranklyspeaking.podbean.com/e/hot-flashes-night-sweats-and-insomnia-will-i-ever-sleep-through-the-night-again-frankly-speaking-ep-70/</link>
                    <comments>https://primedfranklyspeaking.podbean.com/e/hot-flashes-night-sweats-and-insomnia-will-i-ever-sleep-through-the-night-again-frankly-speaking-ep-70/#comments</comments>        <pubDate>Mon, 28 May 2018 04:30:00 +0000</pubDate>
        <guid isPermaLink="false">b83ddb09e79b403ea7e11741d9205a9b</guid>
                                    <description><![CDATA[<p>This episode will review The Menopause Strategies: Finding Lasting Answers for Symptoms and Health (MsFLASH) series of 4 randomized controlled trials, pooling individual data that will provide guidance for discussing pharmacologic and non-pharmacologic options for your peri- and postmenopausal patients.</p>
 <p>Guest: Jill Terrien PhD, ANP-BC</p>
 <p> </p>
]]></description>
                                                            <content:encoded><![CDATA[<p>This episode will review The Menopause Strategies: Finding Lasting Answers for Symptoms and Health (MsFLASH) series of 4 randomized controlled trials, pooling individual data that will provide guidance for discussing pharmacologic and non-pharmacologic options for your peri- and postmenopausal patients.</p>
 <p>Guest: Jill Terrien PhD, ANP-BC</p>
 <p> </p>
]]></content:encoded>
                                    
        <enclosure url="https://mcdn.podbean.com/mf/web/fmtj61/secure_primed_frankly-speaking-podcast-ep-70-insomnia-hot-flashes-edited.mp3" length="18596850" type="audio/mpeg"/>
                <itunes:summary><![CDATA[This episode will review The Menopause Strategies: Finding Lasting Answers for Symptoms and Health (MsFLASH) series of 4 randomized controlled trials, pooling individual data that will provide guidance for discussing pharmacologic and non-pharmacologic options for your peri- and postmenopausal patients. Guest: Jill Terrien PhD, ANP-BC  ]]></itunes:summary>
        <itunes:author>Pri-Med</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>573</itunes:duration>
                                <itunes:image href="https://pbcdn1.podbean.com/imglogo/ep-logo/pbblog13721080/1133d0b148104f9a3ab031b3fe24d05e.jpg" />    </item>
    <item>
        <title>Biomarkers for Alzheimer’s Diagnosis? - Frankly Speaking EP 69</title>
        <itunes:title>Biomarkers for Alzheimer’s Diagnosis? - Frankly Speaking EP 69</itunes:title>
        <link>https://primedfranklyspeaking.podbean.com/e/biomarkers-for-alzheimer-s-diagnosis-frankly-speaking-ep-69/</link>
                    <comments>https://primedfranklyspeaking.podbean.com/e/biomarkers-for-alzheimer-s-diagnosis-frankly-speaking-ep-69/#comments</comments>        <pubDate>Mon, 21 May 2018 04:30:00 +0000</pubDate>
        <guid isPermaLink="false">7214f478ad704f5f15f5059369782156</guid>
                                    <description><![CDATA[<p>The National Institute on Aging-Alzheimer’s Association (NIA-AA) just released an updated Framework of the 2011 Guidelines for Alzheimer’s Disease Research, focusing on the use of biomarkers rather than clinical criteria to make the diagnosis. Listen to this week’s episode to learn more.</p>
 <p>
 Guest: Robert A. Baldor, MD, FAAFP</p>
]]></description>
                                                            <content:encoded><![CDATA[<p>The National Institute on Aging-Alzheimer’s Association (NIA-AA) just released an updated Framework of the 2011 Guidelines for Alzheimer’s Disease Research, focusing on the use of biomarkers rather than clinical criteria to make the diagnosis. Listen to this week’s episode to learn more.</p>
 <p><br>
 Guest: Robert A. Baldor, MD, FAAFP</p>
]]></content:encoded>
                                    
        <enclosure url="https://mcdn.podbean.com/mf/web/hzlkgt/secure_primed_frankly-speaking-podcast-ep-69-alz-edited.mp3" length="20257740" type="audio/mpeg"/>
                <itunes:summary><![CDATA[The National Institute on Aging-Alzheimer’s Association (NIA-AA) just released an updated Framework of the 2011 Guidelines for Alzheimer’s Disease Research, focusing on the use of biomarkers rather than clinical criteria to make the diagnosis. Listen to this week’s episode to learn more.  Guest: Robert A. Baldor, MD, FAAFP]]></itunes:summary>
        <itunes:author>Pri-Med</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>625</itunes:duration>
                                <itunes:image href="https://pbcdn1.podbean.com/imglogo/ep-logo/pbblog13721080/52f0ae8c8a347c97067af94c6a75e010.jpg" />    </item>
    <item>
        <title>My Joints Are Killing Me! Opioids vs. NSAIDs for Chronic Pain - Frankly Speaking EP 68</title>
        <itunes:title>My Joints Are Killing Me! Opioids vs. NSAIDs for Chronic Pain - Frankly Speaking EP 68</itunes:title>
        <link>https://primedfranklyspeaking.podbean.com/e/my-joints-are-killing-me-opioids-vs-nsaids-for-chronic-pain-frankly-speaking-ep-68/</link>
                    <comments>https://primedfranklyspeaking.podbean.com/e/my-joints-are-killing-me-opioids-vs-nsaids-for-chronic-pain-frankly-speaking-ep-68/#comments</comments>        <pubDate>Mon, 14 May 2018 04:30:00 +0000</pubDate>
        <guid isPermaLink="false">da3e3dfc89c4542524669e1f71095f53</guid>
                                    <description><![CDATA[<p>Chronic pain is a difficult but common problem in primary care. Patients are often desperate for any form of relief, and as a result, many are eventually started on opioid analgesics. This can be associated with many adverse effects. But is it worth it? A recent randomized trial compared opioid to non-opioid management of patients with chronic low back pain or chronic hip pain or knee pain due to osteoarthritis.</p>
 <p>Guest: Alan Ehrlich, MD</p>
]]></description>
                                                            <content:encoded><![CDATA[<p>Chronic pain is a difficult but common problem in primary care. Patients are often desperate for any form of relief, and as a result, many are eventually started on opioid analgesics. This can be associated with many adverse effects. But is it worth it? A recent randomized trial compared opioid to non-opioid management of patients with chronic low back pain or chronic hip pain or knee pain due to osteoarthritis.</p>
 <p>Guest: Alan Ehrlich, MD</p>
]]></content:encoded>
                                    
        <enclosure url="https://mcdn.podbean.com/mf/web/ao2msy/secure_primed_frankly-speaking-chronic-pain-ep-68.mp3" length="23861303" type="audio/mpeg"/>
                <itunes:summary><![CDATA[Chronic pain is a difficult but common problem in primary care. Patients are often desperate for any form of relief, and as a result, many are eventually started on opioid analgesics. This can be associated with many adverse effects. But is it worth it? A recent randomized trial compared opioid to non-opioid management of patients with chronic low back pain or chronic hip pain or knee pain due to osteoarthritis. Guest: Alan Ehrlich, MD]]></itunes:summary>
        <itunes:author>Pri-Med</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>738</itunes:duration>
                                <itunes:image href="https://pbcdn1.podbean.com/imglogo/ep-logo/pbblog13721080/1622bb7e0f08461b0aefb50b9165e7e0.jpg" />    </item>
    <item>
        <title>Antibiotics and Sinusitis – How Long is Too Long? - Frankly Speaking EP 67</title>
        <itunes:title>Antibiotics and Sinusitis – How Long is Too Long? - Frankly Speaking EP 67</itunes:title>
        <link>https://primedfranklyspeaking.podbean.com/e/antibiotics-and-sinusitis-%e2%80%93-how-long-is-too-long-frankly-speaking-ep-67/</link>
                    <comments>https://primedfranklyspeaking.podbean.com/e/antibiotics-and-sinusitis-%e2%80%93-how-long-is-too-long-frankly-speaking-ep-67/#comments</comments>        <pubDate>Mon, 07 May 2018 04:30:00 +0000</pubDate>
        <guid isPermaLink="false">0cf36d60f2819eb5da8f7535380a17ae</guid>
                                    <description><![CDATA[<p>A recent research study published in JAMA Internal Medicine examined the use of antibiotics to treat acute sinusitis based upon the Infectious Diseases Society of America (IDSA) guideline recommending 5-7 days when antibiotics are indicated and found that most courses of antibiotics are too long. Listen to this week’s episode to learn more.</p>
 <p>Guest: Robert A. Baldor, MD, FAAFP</p>
]]></description>
                                                            <content:encoded><![CDATA[<p>A recent research study published in JAMA Internal Medicine examined the use of antibiotics to treat acute sinusitis based upon the Infectious Diseases Society of America (IDSA) guideline recommending 5-7 days when antibiotics are indicated and found that most courses of antibiotics are too long. Listen to this week’s episode to learn more.</p>
 <p>Guest: Robert A. Baldor, MD, FAAFP</p>
]]></content:encoded>
                                    
        <enclosure url="https://mcdn.podbean.com/mf/web/dxx25t/secure_primed_frankly-speaking-podcast-ep-67-sinusitis.mp3" length="21020974" type="audio/mpeg"/>
                <itunes:summary><![CDATA[A recent research study published in JAMA Internal Medicine examined the use of antibiotics to treat acute sinusitis based upon the Infectious Diseases Society of America (IDSA) guideline recommending 5-7 days when antibiotics are indicated and found that most courses of antibiotics are too long. Listen to this week’s episode to learn more. Guest: Robert A. Baldor, MD, FAAFP]]></itunes:summary>
        <itunes:author>Pri-Med</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>649</itunes:duration>
                                <itunes:image href="https://pbcdn1.podbean.com/imglogo/ep-logo/pbblog13721080/4d16276161a51e1d7c54f43d4bfb8cd6.jpg" />    </item>
    <item>
        <title>Best Evidence Goals for Type 2 Diabetes - Frankly Speaking EP 66</title>
        <itunes:title>Best Evidence Goals for Type 2 Diabetes - Frankly Speaking EP 66</itunes:title>
        <link>https://primedfranklyspeaking.podbean.com/e/best-evidence-goals-for-type-2-diabetes-frankly-speaking-ep-66/</link>
                    <comments>https://primedfranklyspeaking.podbean.com/e/best-evidence-goals-for-type-2-diabetes-frankly-speaking-ep-66/#comments</comments>        <pubDate>Mon, 30 Apr 2018 04:30:00 +0000</pubDate>
        <guid isPermaLink="false">604e67b8709753ec562cb18a72eeee88</guid>
                                    <description><![CDATA[<p>The American College of Physicians supported an evidence-based review of the topic guidelines for type 2 diabetes and concluded clinicians should aim for an A1c goal between 7.0-8.0 and recommended even less aggressive care for those over the age 80 years. Listen to this podcast episode to learn more about these new guidelines.</p>
 <p>Guest: Alan Ehrlich MD</p>
]]></description>
                                                            <content:encoded><![CDATA[<p>The American College of Physicians supported an evidence-based review of the topic guidelines for type 2 diabetes and concluded clinicians should aim for an A1c goal between 7.0-8.0 and recommended even less aggressive care for those over the age 80 years. Listen to this podcast episode to learn more about these new guidelines.</p>
 <p>Guest: Alan Ehrlich MD</p>
]]></content:encoded>
                                    
        <enclosure url="https://mcdn.podbean.com/mf/web/hklkia/secure_primed_frankly-speaking-podcast-ep-66-diabetes-edited.mp3" length="21083995" type="audio/mpeg"/>
                <itunes:summary><![CDATA[The American College of Physicians supported an evidence-based review of the topic guidelines for type 2 diabetes and concluded clinicians should aim for an A1c goal between 7.0-8.0 and recommended even less aggressive care for those over the age 80 years. Listen to this podcast episode to learn more about these new guidelines. Guest: Alan Ehrlich MD]]></itunes:summary>
        <itunes:author>Pri-Med</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>651</itunes:duration>
                                <itunes:image href="https://pbcdn1.podbean.com/imglogo/ep-logo/pbblog13721080/4a576da783190193165b51704edcba6d.jpg" />    </item>
    <item>
        <title>Is Screen Time Taking Your Child’s Sleep Time? - Frankly Speaking EP 65</title>
        <itunes:title>Is Screen Time Taking Your Child’s Sleep Time? - Frankly Speaking EP 65</itunes:title>
        <link>https://primedfranklyspeaking.podbean.com/e/is-screen-time-taking-your-child-s-sleep-time-frankly-speaking-ep-65/</link>
                    <comments>https://primedfranklyspeaking.podbean.com/e/is-screen-time-taking-your-child-s-sleep-time-frankly-speaking-ep-65/#comments</comments>        <pubDate>Mon, 23 Apr 2018 04:30:00 +0000</pubDate>
        <guid isPermaLink="false">d40434befab2a4092eee0c09ebd65d67</guid>
                                    <description><![CDATA[<p>Listen to this podcast episode for a brief summary of the literature on electronic media and its relation to sleep—specifically delayed bedtimes and decreased sleep duration. Screen-based media consumption is eating up our sleep health!</p>
 <p>Guest: Jill Terrien PhD, ANP-BC</p>
]]></description>
                                                            <content:encoded><![CDATA[<p>Listen to this podcast episode for a brief summary of the literature on electronic media and its relation to sleep—specifically delayed bedtimes and decreased sleep duration. Screen-based media consumption is eating up our sleep health!</p>
 <p>Guest: Jill Terrien PhD, ANP-BC</p>
]]></content:encoded>
                                    
        <enclosure url="https://mcdn.podbean.com/mf/web/1zqgc7/secure_primed_frankly-speaking-podcast-ep-65-edited.mp3" length="22225996" type="audio/mpeg"/>
                <itunes:summary><![CDATA[Listen to this podcast episode for a brief summary of the literature on electronic media and its relation to sleep—specifically delayed bedtimes and decreased sleep duration. Screen-based media consumption is eating up our sleep health! Guest: Jill Terrien PhD, ANP-BC]]></itunes:summary>
        <itunes:author>Pri-Med</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>687</itunes:duration>
                                <itunes:image href="https://pbcdn1.podbean.com/imglogo/ep-logo/pbblog13721080/952b391589b6c2b5ef9a049d507c22fb.jpg" />    </item>
    <item>
        <title>Diet! Diet! Who’s Got the Best Diet? - Frankly Speaking EP 64</title>
        <itunes:title>Diet! Diet! Who’s Got the Best Diet? - Frankly Speaking EP 64</itunes:title>
        <link>https://primedfranklyspeaking.podbean.com/e/diet-diet-who-s-got-the-best-diet-frankly-speaking-ep-64/</link>
                    <comments>https://primedfranklyspeaking.podbean.com/e/diet-diet-who-s-got-the-best-diet-frankly-speaking-ep-64/#comments</comments>        <pubDate>Mon, 16 Apr 2018 04:30:00 +0000</pubDate>
        <guid isPermaLink="false">194bf6e1554fd3b0e21f6fb45a7a7b7e</guid>
                                    <description><![CDATA[<p>71% of adults in the United States are overweight or obese. To tackle this problem, primary care providers must stay up to date on the best evidence for addressing overweight and obese status in their patients. The DIETFITS Randomized Clinical Trial offers direction for nutritional advice in this important and serious public health concern.</p>
 <p>Guest: Kenneth Peterson, PhD, FNP-BC</p>
]]></description>
                                                            <content:encoded><![CDATA[<p>71% of adults in the United States are overweight or obese. To tackle this problem, primary care providers must stay up to date on the best evidence for addressing overweight and obese status in their patients. The DIETFITS Randomized Clinical Trial offers direction for nutritional advice in this important and serious public health concern.</p>
 <p>Guest: Kenneth Peterson, PhD, FNP-BC</p>
]]></content:encoded>
                                    
        <enclosure url="https://mcdn.podbean.com/mf/web/xc059k/secure_primed_frankly-speaking-podcast-ep-64-diet-edited.mp3" length="20587417" type="audio/mpeg"/>
                <itunes:summary><![CDATA[71% of adults in the United States are overweight or obese. To tackle this problem, primary care providers must stay up to date on the best evidence for addressing overweight and obese status in their patients. The DIETFITS Randomized Clinical Trial offers direction for nutritional advice in this important and serious public health concern. Guest: Kenneth Peterson, PhD, FNP-BC]]></itunes:summary>
        <itunes:author>Pri-Med</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>635</itunes:duration>
                                <itunes:image href="https://pbcdn1.podbean.com/imglogo/ep-logo/pbblog13721080/431e5eaf470b4fa04350dc8d9f50af5d.jpg" />    </item>
    <item>
        <title>Changing Immunization Practices: 2-Dose Vaccines - Frankly Speaking EP 63</title>
        <itunes:title>Changing Immunization Practices: 2-Dose Vaccines - Frankly Speaking EP 63</itunes:title>
        <link>https://primedfranklyspeaking.podbean.com/e/changing-immunization-practices-2-dose-vaccines-frankly-speaking-ep-63/</link>
                    <comments>https://primedfranklyspeaking.podbean.com/e/changing-immunization-practices-2-dose-vaccines-frankly-speaking-ep-63/#comments</comments>        <pubDate>Mon, 09 Apr 2018 04:30:00 +0000</pubDate>
        <guid isPermaLink="false">20ee55e6c9b2fc06aee31adee3420653</guid>
                                    <description><![CDATA[<p>Immunization practices are constantly in flux as new vaccines are approved and guidelines are updated. Recently, the FDA approved a 2-dose hepatitis B virus (HBV) vaccine and a new 2-dose herpes zoster (HZ) vaccine. Additionally, the CDC now recommends a 2-dose human papillomavirus (HPV) vaccine schedule, a change from the previous recommendation for a 3-dose schedule. This session will discuss the changing landscape of immunization practices and recent changes to recommendations.</p>
 <p>Guest: Robert A. Baldor, MD, FAAFP</p>
]]></description>
                                                            <content:encoded><![CDATA[<p>Immunization practices are constantly in flux as new vaccines are approved and guidelines are updated. Recently, the FDA approved a 2-dose hepatitis B virus (HBV) vaccine and a new 2-dose herpes zoster (HZ) vaccine. Additionally, the CDC now recommends a 2-dose human papillomavirus (HPV) vaccine schedule, a change from the previous recommendation for a 3-dose schedule. This session will discuss the changing landscape of immunization practices and recent changes to recommendations.</p>
 <p>Guest: Robert A. Baldor, MD, FAAFP</p>
]]></content:encoded>
                                    
        <enclosure url="https://mcdn.podbean.com/mf/web/n1aufg/secure_primed_frankly-speaking-podcast-ep-63-immunization-edited.mp3" length="22241868" type="audio/mpeg"/>
                <itunes:summary><![CDATA[Immunization practices are constantly in flux as new vaccines are approved and guidelines are updated. Recently, the FDA approved a 2-dose hepatitis B virus (HBV) vaccine and a new 2-dose herpes zoster (HZ) vaccine. Additionally, the CDC now recommends a 2-dose human papillomavirus (HPV) vaccine schedule, a change from the previous recommendation for a 3-dose schedule. This session will discuss the changing landscape of immunization practices and recent changes to recommendations. Guest: Robert A. Baldor, MD, FAAFP]]></itunes:summary>
        <itunes:author>Pri-Med</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>687</itunes:duration>
                                <itunes:image href="https://pbcdn1.podbean.com/imglogo/ep-logo/pbblog13721080/ff144e3a4d4ecf5382ce5d72762e2f73.jpg" />    </item>
    <item>
        <title>I’ve Got Rhythm: Catheter Ablation Therapy for Patients with Atrial Fibrillation and Heart Failure - Frankly Speaking EP 62</title>
        <itunes:title>I’ve Got Rhythm: Catheter Ablation Therapy for Patients with Atrial Fibrillation and Heart Failure - Frankly Speaking EP 62</itunes:title>
        <link>https://primedfranklyspeaking.podbean.com/e/i-ve-got-rhythm-catheter-ablation-therapy-for-patients-with-atrial-fibrillation-and-heart-failure-frankly-speaking-ep-62/</link>
                    <comments>https://primedfranklyspeaking.podbean.com/e/i-ve-got-rhythm-catheter-ablation-therapy-for-patients-with-atrial-fibrillation-and-heart-failure-frankly-speaking-ep-62/#comments</comments>        <pubDate>Mon, 02 Apr 2018 04:30:00 +0000</pubDate>
        <guid isPermaLink="false">0d3b03adb429ff93cf7723ffac485164</guid>
                                    <description><![CDATA[<p>Management of patients with atrial fibrillation has long centered on the relative merits of rate control versus rhythm control. The CASTLE-AF trial evaluated catheter ablation as a treatment for patients with both heart failure with reduced ejection fraction and atrial fibrillation. Listen to this week’s podcast episode to learn about the results of this new trial and how the catheter ablation impacted clinical outcomes. </p>
 <p>Guest: Alan Ehrlich MD</p>
]]></description>
                                                            <content:encoded><![CDATA[<p>Management of patients with atrial fibrillation has long centered on the relative merits of rate control versus rhythm control. The CASTLE-AF trial evaluated catheter ablation as a treatment for patients with both heart failure with reduced ejection fraction and atrial fibrillation. Listen to this week’s podcast episode to learn about the results of this new trial and how the catheter ablation impacted clinical outcomes. </p>
 <p>Guest: Alan Ehrlich MD</p>
]]></content:encoded>
                                    
        <enclosure url="https://mcdn.podbean.com/mf/web/vv9vta/secure_primed_frankly-speaking-podcast-ep-62-afib.mp3" length="17814474" type="audio/mpeg"/>
                <itunes:summary><![CDATA[Management of patients with atrial fibrillation has long centered on the relative merits of rate control versus rhythm control. The CASTLE-AF trial evaluated catheter ablation as a treatment for patients with both heart failure with reduced ejection fraction and atrial fibrillation. Listen to this week’s podcast episode to learn about the results of this new trial and how the catheter ablation impacted clinical outcomes.  Guest: Alan Ehrlich MD]]></itunes:summary>
        <itunes:author>Pri-Med</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>549</itunes:duration>
                                <itunes:image href="https://pbcdn1.podbean.com/imglogo/ep-logo/pbblog13721080/8321e0d477b8dfd9f83dd5a2dd80af57.jpg" />    </item>
    <item>
        <title>How to Best Treat Cognitive Impairment – 2018 AAN Recommendations - Frankly Speaking EP 61</title>
        <itunes:title>How to Best Treat Cognitive Impairment – 2018 AAN Recommendations - Frankly Speaking EP 61</itunes:title>
        <link>https://primedfranklyspeaking.podbean.com/e/how-to-best-treat-cognitive-impairment-%e2%80%93-2018-aan-recommendations-frankly-speaking-ep-61/</link>
                    <comments>https://primedfranklyspeaking.podbean.com/e/how-to-best-treat-cognitive-impairment-%e2%80%93-2018-aan-recommendations-frankly-speaking-ep-61/#comments</comments>        <pubDate>Mon, 26 Mar 2018 04:30:00 +0000</pubDate>
        <guid isPermaLink="false">464bb2f05cd5a8e41ca872092175cf2b</guid>
                                    <description><![CDATA[<p>In this week’s episode, we’ll be continuing the discussion on the AAN’s updated practice guideline on mild cognitive impairment. Last week’s podcast episode provided overview of the updated practice guideline, and this week’s episode focuses on treatment recommendations.</p>
 <p>Guest: Robert A. Baldor, MD, FAAFP</p>
]]></description>
                                                            <content:encoded><![CDATA[<p>In this week’s episode, we’ll be continuing the discussion on the AAN’s updated practice guideline on mild cognitive impairment. Last week’s podcast episode provided overview of the updated practice guideline, and this week’s episode focuses on treatment recommendations.</p>
 <p>Guest: Robert A. Baldor, MD, FAAFP</p>
]]></content:encoded>
                                    
        <enclosure url="https://mcdn.podbean.com/mf/web/wn06ym/secure_primed_frankly-speaking-podcast-ep-61-ci-impairment-pt-2-edited.mp3" length="22268502" type="audio/mpeg"/>
                <itunes:summary><![CDATA[In this week’s episode, we’ll be continuing the discussion on the AAN’s updated practice guideline on mild cognitive impairment. Last week’s podcast episode provided overview of the updated practice guideline, and this week’s episode focuses on treatment recommendations. Guest: Robert A. Baldor, MD, FAAFP]]></itunes:summary>
        <itunes:author>Pri-Med</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>688</itunes:duration>
                                <itunes:image href="https://pbcdn1.podbean.com/imglogo/ep-logo/pbblog13721080/c0cf3df49275a048c7ed904a98491e3a.jpg" />    </item>
    <item>
        <title>Screening for Dementia; Better Than MMSE (Mini Mental Status Exam) - Frankly Speaking EP 60</title>
        <itunes:title>Screening for Dementia; Better Than MMSE (Mini Mental Status Exam) - Frankly Speaking EP 60</itunes:title>
        <link>https://primedfranklyspeaking.podbean.com/e/screening-for-dementia-better-than-mmse-mini-mental-status-exam-frankly-speaking-ep-60/</link>
                    <comments>https://primedfranklyspeaking.podbean.com/e/screening-for-dementia-better-than-mmse-mini-mental-status-exam-frankly-speaking-ep-60/#comments</comments>        <pubDate>Mon, 19 Mar 2018 04:30:00 +0000</pubDate>
        <guid isPermaLink="false">c2c304288cc347fb7e43b0c5241035f2</guid>
                                    <description><![CDATA[<p>The American Academy of Neurology recently published the first updated practice guideline on mild cognitive impairment since 2001. Listen to this week’s episode for an overview of the updated practice guideline, which includes a systematic review of prevalence, prognosis, screening, and treatment research with clear recommendations for practicing clinicians.</p>
 <p>Guest: Robert A. Baldor, MD, FAAFP</p>
]]></description>
                                                            <content:encoded><![CDATA[<p>The American Academy of Neurology recently published the first updated practice guideline on mild cognitive impairment since 2001. Listen to this week’s episode for an overview of the updated practice guideline, which includes a systematic review of prevalence, prognosis, screening, and treatment research with clear recommendations for practicing clinicians.</p>
 <p>Guest: Robert A. Baldor, MD, FAAFP</p>
]]></content:encoded>
                                    
        <enclosure url="https://mcdn.podbean.com/mf/web/d46x0h/secure_primed_frankly-speaking-podcast-ep-60-cognitive-impairment.mp3" length="19428693" type="audio/mpeg"/>
                <itunes:summary><![CDATA[The American Academy of Neurology recently published the first updated practice guideline on mild cognitive impairment since 2001. Listen to this week’s episode for an overview of the updated practice guideline, which includes a systematic review of prevalence, prognosis, screening, and treatment research with clear recommendations for practicing clinicians. Guest: Robert A. Baldor, MD, FAAFP]]></itunes:summary>
        <itunes:author>Pri-Med</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>599</itunes:duration>
                                <itunes:image href="https://pbcdn1.podbean.com/imglogo/ep-logo/pbblog13721080/1ab2aa3d7031b662852e45fc0d3707f9.jpg" />    </item>
    <item>
        <title>GET UP: A Small Bit of Movement Makes a Big Impact - Frankly Speaking EP 59</title>
        <itunes:title>GET UP: A Small Bit of Movement Makes a Big Impact - Frankly Speaking EP 59</itunes:title>
        <link>https://primedfranklyspeaking.podbean.com/e/get-up-a-small-bit-of-movement-makes-a-big-impact-frankly-speaking-ep-59/</link>
                    <comments>https://primedfranklyspeaking.podbean.com/e/get-up-a-small-bit-of-movement-makes-a-big-impact-frankly-speaking-ep-59/#comments</comments>        <pubDate>Mon, 12 Mar 2018 04:30:00 +0000</pubDate>
        <guid isPermaLink="false">4d1a84dde01b1baff7b92670c7fb15c5</guid>
                                    <description><![CDATA[<p>This observational study found adding very little activity, akin to going for a 30-minute walk or converting to a standing desk for half your workday, lowered all-cause and cardiovascular mortality.</p>
 <p>Guest: Alan Ehrlich, MD</p>
]]></description>
                                                            <content:encoded><![CDATA[<p>This observational study found adding very little activity, akin to going for a 30-minute walk or converting to a standing desk for half your workday, lowered all-cause and cardiovascular mortality.</p>
 <p>Guest: Alan Ehrlich, MD</p>
]]></content:encoded>
                                    
        <enclosure url="https://mcdn.podbean.com/mf/web/i8cppn/secure_primed_frankly-speaking-podcast-ep-59-excersise.mp3" length="16803842" type="audio/mpeg"/>
                <itunes:summary><![CDATA[This observational study found adding very little activity, akin to going for a 30-minute walk or converting to a standing desk for half your workday, lowered all-cause and cardiovascular mortality. Guest: Alan Ehrlich, MD]]></itunes:summary>
        <itunes:author>Pri-Med</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>517</itunes:duration>
                                <itunes:image href="https://pbcdn1.podbean.com/imglogo/ep-logo/pbblog13721080/6db57872191a8263ce0ff02a30e1c53f.jpg" />    </item>
    <item>
        <title>Do We Still Use Warfarin? - Frankly Speaking EP 58</title>
        <itunes:title>Do We Still Use Warfarin? - Frankly Speaking EP 58</itunes:title>
        <link>https://primedfranklyspeaking.podbean.com/e/do-we-still-use-warfarin-frankly-speaking-ep-58/</link>
                    <comments>https://primedfranklyspeaking.podbean.com/e/do-we-still-use-warfarin-frankly-speaking-ep-58/#comments</comments>        <pubDate>Mon, 05 Mar 2018 05:30:00 +0000</pubDate>
        <guid isPermaLink="false">8cbe9981380ba1c2cfda76e9e4c55060</guid>
                                    <description><![CDATA[<p>Direct acting oral anticoagulants are increasingly used for stroke prevention for individuals with atrial fibrillation. Whether these agents are as safe and effective as warfarin has been a concern for many clinicians, but recent comparative effectiveness analyses are providing answers. In this week’s podcast episode, we will review these recent studies and draw some conclusions about which agents are best.</p>
 <p>
Guest: Robert A. Baldor, MD, FAAFP</p>
]]></description>
                                                            <content:encoded><![CDATA[<p>Direct acting oral anticoagulants are increasingly used for stroke prevention for individuals with atrial fibrillation. Whether these agents are as safe and effective as warfarin has been a concern for many clinicians, but recent comparative effectiveness analyses are providing answers. In this week’s podcast episode, we will review these recent studies and draw some conclusions about which agents are best.</p>
 <p><br>
Guest: Robert A. Baldor, MD, FAAFP</p>
]]></content:encoded>
                                    
        <enclosure url="https://mcdn.podbean.com/mf/web/36cmc9/secure_primed_frankly-speaking-podcast-ep-58-DAOCs-edited.mp3" length="19071666" type="audio/mpeg"/>
                <itunes:summary><![CDATA[Direct acting oral anticoagulants are increasingly used for stroke prevention for individuals with atrial fibrillation. Whether these agents are as safe and effective as warfarin has been a concern for many clinicians, but recent comparative effectiveness analyses are providing answers. In this week’s podcast episode, we will review these recent studies and draw some conclusions about which agents are best. Guest: Robert A. Baldor, MD, FAAFP]]></itunes:summary>
        <itunes:author>Pri-Med</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>588</itunes:duration>
                                <itunes:image href="https://pbcdn1.podbean.com/imglogo/ep-logo/pbblog13721080/5ffe5e3ac7a5d1430c09a12029480ba1.jpg" />    </item>
    <item>
        <title>Helping Depressed Patients Change: Behavioral Activation - Frankly Speaking EP 57</title>
        <itunes:title>Helping Depressed Patients Change: Behavioral Activation - Frankly Speaking EP 57</itunes:title>
        <link>https://primedfranklyspeaking.podbean.com/e/helping-depressed-patients-change-behavioral-activation-frankly-speaking-ep-57/</link>
                    <comments>https://primedfranklyspeaking.podbean.com/e/helping-depressed-patients-change-behavioral-activation-frankly-speaking-ep-57/#comments</comments>        <pubDate>Mon, 26 Feb 2018 05:30:00 +0000</pubDate>
        <guid isPermaLink="false">275eb295519328c84f7d515a003090c5</guid>
                                    <description><![CDATA[<p>Listen to this week’s episode to learn about the basic concepts of behavioral activation (BA), what research has demonstrated about its use in depression, and how to apply BA in everyday care. </p>
 <p>Guest: Susan Feeney, DNP, FNP-BC</p>
]]></description>
                                                            <content:encoded><![CDATA[<p>Listen to this week’s episode to learn about the basic concepts of behavioral activation (BA), what research has demonstrated about its use in depression, and how to apply BA in everyday care. </p>
 <p>Guest: Susan Feeney, DNP, FNP-BC</p>
]]></content:encoded>
                                    
        <enclosure url="https://mcdn.podbean.com/mf/web/jaq28w/secure_primed_frankly-speaking-podcast-ep-57-behavioral-activation-edited.mp3" length="18980673" type="audio/mpeg"/>
                <itunes:summary><![CDATA[Listen to this week’s episode to learn about the basic concepts of behavioral activation (BA), what research has demonstrated about its use in depression, and how to apply BA in everyday care.  Guest: Susan Feeney, DNP, FNP-BC]]></itunes:summary>
        <itunes:author>Pri-Med</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>585</itunes:duration>
                                <itunes:image href="https://pbcdn1.podbean.com/imglogo/ep-logo/pbblog13721080/5794dd2d3d1dff8b870e46c173479c2a.jpg" />    </item>
    <item>
        <title>The Flu is Bad for Your Heart - Frankly Speaking EP 56</title>
        <itunes:title>The Flu is Bad for Your Heart - Frankly Speaking EP 56</itunes:title>
        <link>https://primedfranklyspeaking.podbean.com/e/the-flu-is-bad-for-your-heart-frankly-speaking-ep-56/</link>
                    <comments>https://primedfranklyspeaking.podbean.com/e/the-flu-is-bad-for-your-heart-frankly-speaking-ep-56/#comments</comments>        <pubDate>Mon, 19 Feb 2018 05:30:00 +0000</pubDate>
        <guid isPermaLink="false">d6d7c0b825a4c68eb2bc381900b85718</guid>
                                    <description><![CDATA[<p>Patients with chronic diseases, including coronary artery disease, are advised to get yearly flu shots because they are at higher risk for having a more severe illness. Canadian researchers have found that in the week following being diagnosed with the flu, adults over 65 years old have a significantly increased risk of myocardial infection.</p>
]]></description>
                                                            <content:encoded><![CDATA[<p>Patients with chronic diseases, including coronary artery disease, are advised to get yearly flu shots because they are at higher risk for having a more severe illness. Canadian researchers have found that in the week following being diagnosed with the flu, adults over 65 years old have a significantly increased risk of myocardial infection.</p>
]]></content:encoded>
                                    
        <enclosure url="https://mcdn.podbean.com/mf/web/2q55qv/secure_primed_frankly-speaking-podcast-ep-56-influenza.mp3" length="17685449" type="audio/mpeg"/>
                <itunes:summary><![CDATA[Patients with chronic diseases, including coronary artery disease, are advised to get yearly flu shots because they are at higher risk for having a more severe illness. Canadian researchers have found that in the week following being diagnosed with the flu, adults over 65 years old have a significantly increased risk of myocardial infection.]]></itunes:summary>
        <itunes:author>Pri-Med</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>545</itunes:duration>
                                <itunes:image href="https://pbcdn1.podbean.com/imglogo/ep-logo/pbblog13721080/cc6888a7c9a6de756a2b25bdc01542bd.jpg" />    </item>
    <item>
        <title>Too Little, Too Much: How Much Sleep is Just Right? - Frankly Speaking EP 55</title>
        <itunes:title>Too Little, Too Much: How Much Sleep is Just Right? - Frankly Speaking EP 55</itunes:title>
        <link>https://primedfranklyspeaking.podbean.com/e/too-little-too-much-how-much-sleep-is-just-right-frankly-speaking-ep-55/</link>
                    <comments>https://primedfranklyspeaking.podbean.com/e/too-little-too-much-how-much-sleep-is-just-right-frankly-speaking-ep-55/#comments</comments>        <pubDate>Mon, 12 Feb 2018 05:30:00 +0000</pubDate>
        <guid isPermaLink="false">98c66c252a87c8a81f33a52bf2956442</guid>
                                    <description><![CDATA[<p>In this session we discuss the impact of length of sleep on obesity and DM II.</p>
]]></description>
                                                            <content:encoded><![CDATA[<p>In this session we discuss the impact of length of sleep on obesity and DM II.</p>
]]></content:encoded>
                                    
        <enclosure url="https://mcdn.podbean.com/mf/web/vu24mk/secure_primed_frankly-speaking-podcast-ep-55-edited.mp3" length="10581690" type="audio/mpeg"/>
                <itunes:summary><![CDATA[In this session we discuss the impact of length of sleep on obesity and DM II.]]></itunes:summary>
        <itunes:author>Pri-Med</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>645</itunes:duration>
                                <itunes:image href="https://pbcdn1.podbean.com/imglogo/ep-logo/pbblog13721080/982729198c10678766baebf8194f172b.jpg" />    </item>
    <item>
        <title>Your Morning “Cup of Joe” Could Be Doing More Than Starting Your Day - Frankly Speaking EP 54</title>
        <itunes:title>Your Morning “Cup of Joe” Could Be Doing More Than Starting Your Day - Frankly Speaking EP 54</itunes:title>
        <link>https://primedfranklyspeaking.podbean.com/e/your-morning-cup-of-joe-could-be-doing-more-than-starting-your-day-frankly-speaking-ep-54/</link>
                    <comments>https://primedfranklyspeaking.podbean.com/e/your-morning-cup-of-joe-could-be-doing-more-than-starting-your-day-frankly-speaking-ep-54/#comments</comments>        <pubDate>Mon, 05 Feb 2018 05:30:00 +0000</pubDate>
        <guid isPermaLink="false">9368a6bb0b1c01b14bdd210680c6c1dc</guid>
                                    <description><![CDATA[<p>This session will review the existing evidence between coffee consumption and multiple health outcomes. </p>
]]></description>
                                                            <content:encoded><![CDATA[<p>This session will review the existing evidence between coffee consumption and multiple health outcomes. </p>
]]></content:encoded>
                                    
        <enclosure url="https://mcdn.podbean.com/mf/web/v00yll/secure_primed_frankly-speaking-podcast-ep-53-coffee-edited.mp3" length="18771549" type="audio/mpeg"/>
                <itunes:summary><![CDATA[This session will review the existing evidence between coffee consumption and multiple health outcomes. ]]></itunes:summary>
        <itunes:author>Pri-Med</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>579</itunes:duration>
                                <itunes:image href="https://pbcdn1.podbean.com/imglogo/ep-logo/pbblog13721080/824ea4204bdd3faf367600694807bf53.jpg" />    </item>
    <item>
        <title>An Oral Fecal Transplant for Lunch?- Frankly Speaking EP 53</title>
        <itunes:title>An Oral Fecal Transplant for Lunch?- Frankly Speaking EP 53</itunes:title>
        <link>https://primedfranklyspeaking.podbean.com/e/an-oral-fecal-transplant-for-lunch-frankly-speaking-ep-53/</link>
                    <comments>https://primedfranklyspeaking.podbean.com/e/an-oral-fecal-transplant-for-lunch-frankly-speaking-ep-53/#comments</comments>        <pubDate>Mon, 29 Jan 2018 05:30:00 +0000</pubDate>
        <guid isPermaLink="false">301ec7b1bfacda63ef8fa1dbcef6d1bb</guid>
                                    <description><![CDATA[<p>Treating recurrent C. difficile colitis can be difficult, but recent trials have demonstrated the benefit of treating with fecal transplantation. Questions exist, however, about around the best mode of administration. Listen to this week’s episode to learn about a recent RCT that compares oral and colonoscopic delivery methods and provides an answer.</p>
 <p> </p>
 <p>Learning Objectives: </p>
 <ol><li>Appreciate the current guidelines for treating recurrent difficile colitis</li>
 <li>Understand the pharmacology of fecal transplantation</li>
 <li>Learn about the latest research on how best to administer such treatment</li>
 </ol>]]></description>
                                                            <content:encoded><![CDATA[<p>Treating recurrent C. difficile colitis can be difficult, but recent trials have demonstrated the benefit of treating with fecal transplantation. Questions exist, however, about around the best mode of administration. Listen to this week’s episode to learn about a recent RCT that compares oral and colonoscopic delivery methods and provides an answer.</p>
 <p> </p>
 <p>Learning Objectives: </p>
 <ol><li>Appreciate the current guidelines for treating recurrent <em>difficile</em> colitis</li>
 <li>Understand the pharmacology of fecal transplantation</li>
 <li>Learn about the latest research on how best to administer such treatment</li>
 </ol>]]></content:encoded>
                                    
        <enclosure url="https://mcdn.podbean.com/mf/web/h2as91/secure_primed_frankly-speaking-podcast-ep-52-c-diff-edited.mp3" length="22349859" type="audio/mpeg"/>
                <itunes:summary><![CDATA[Treating recurrent C. difficile colitis can be difficult, but recent trials have demonstrated the benefit of treating with fecal transplantation. Questions exist, however, about around the best mode of administration. Listen to this week’s episode to learn about a recent RCT that compares oral and colonoscopic delivery methods and provides an answer.   Learning Objectives:  Appreciate the current guidelines for treating recurrent difficile colitis Understand the pharmacology of fecal transplantation Learn about the latest research on how best to administer such treatment ]]></itunes:summary>
        <itunes:author>Pri-Med</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>690</itunes:duration>
                                <itunes:image href="https://pbcdn1.podbean.com/imglogo/ep-logo/pbblog13721080/e9270047c80d5461375801382525ea8f.jpg" />    </item>
    <item>
        <title>The New Hypertension Guidelines - Frankly Speaking EP 52</title>
        <itunes:title>The New Hypertension Guidelines - Frankly Speaking EP 52</itunes:title>
        <link>https://primedfranklyspeaking.podbean.com/e/the-new-hypertension-guidelines-frankly-speaking-ep-52/</link>
                    <comments>https://primedfranklyspeaking.podbean.com/e/the-new-hypertension-guidelines-frankly-speaking-ep-52/#comments</comments>        <pubDate>Mon, 22 Jan 2018 16:35:00 +0000</pubDate>
        <guid isPermaLink="false">a1b6f78b0f77bccfe124fb51155eadda</guid>
                                    <description><![CDATA[<p>New hypertension guidelines from the American College of Cardiology have introduced a new blood pressure classification system and lowered the threshold for initiating pharmacotherapy in certain patient populations.</p>
 <p>Learning Objectives:</p>
 <ol><li>Understand the new classification categories of hypertension</li>
 <li>Understand the new thresholds for starting treatment</li>
 <li>Understand the limitations of the new recommendations to specific patient populations</li>
 </ol>]]></description>
                                                            <content:encoded><![CDATA[<p>New hypertension guidelines from the American College of Cardiology have introduced a new blood pressure classification system and lowered the threshold for initiating pharmacotherapy in certain patient populations.</p>
 <p>Learning Objectives:</p>
 <ol><li>Understand the new classification categories of hypertension</li>
 <li>Understand the new thresholds for starting treatment</li>
 <li>Understand the limitations of the new recommendations to specific patient populations</li>
 </ol>]]></content:encoded>
                                    
        <enclosure url="https://mcdn.podbean.com/mf/web/6in0n4/secure_primed_frankly-speaking-ep-52-edited.mp3" length="22873745" type="audio/mpeg"/>
                <itunes:summary><![CDATA[New hypertension guidelines from the American College of Cardiology have introduced a new blood pressure classification system and lowered the threshold for initiating pharmacotherapy in certain patient populations. Learning Objectives: Understand the new classification categories of hypertension Understand the new thresholds for starting treatment Understand the limitations of the new recommendations to specific patient populations ]]></itunes:summary>
        <itunes:author>Pri-Med</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>707</itunes:duration>
                                <itunes:image href="https://pbcdn1.podbean.com/imglogo/ep-logo/pbblog13721080/864903fba73dc869f3c9bfd73047059f.jpg" />    </item>
    <item>
        <title>Preventing Opioid Addiction: Treating Acute Pain Safely - Frankly Speaking EP 51</title>
        <itunes:title>Preventing Opioid Addiction: Treating Acute Pain Safely - Frankly Speaking EP 51</itunes:title>
        <link>https://primedfranklyspeaking.podbean.com/e/preventing-opioid-addiction-treating-acute-pain-safely-frankly-speaking-ep-51/</link>
                    <comments>https://primedfranklyspeaking.podbean.com/e/preventing-opioid-addiction-treating-acute-pain-safely-frankly-speaking-ep-51/#comments</comments>        <pubDate>Mon, 15 Jan 2018 05:30:00 +0000</pubDate>
        <guid isPermaLink="false">02682e44c9450caa5c1f325d7ea015c3</guid>
                                    <description><![CDATA[<p>For severe, acute pain, 1000 mg of acetaminophen PLUS 400 mg of ibuprofen is as effective as acetaminophen/oxycodone, acetaminophen/hydrocodone, or acetaminophen/codeine. Listen to this week’s episode to learn more about treating acute pain safely. </p>
 <p> </p>
 <p>Learning Objectives: </p>
 <ol><li>Review the current trial comparing Acetaminophen plus Ibuprofen to other acetaminophen/opioid combinations on pain outcomes</li>
 <li>Summarize the other data supporting this combination in children and adults</li>
 <li>Understand the path that can lead from acute pain to dependence.</li>
 </ol>]]></description>
                                                            <content:encoded><![CDATA[<p>For severe, acute pain, 1000 mg of acetaminophen PLUS 400 mg of ibuprofen is as effective as acetaminophen/oxycodone, acetaminophen/hydrocodone, or acetaminophen/codeine. Listen to this week’s episode to learn more about treating acute pain safely. </p>
 <p> </p>
 <p>Learning Objectives: </p>
 <ol><li>Review the current trial comparing Acetaminophen plus Ibuprofen to other acetaminophen/opioid combinations on pain outcomes</li>
 <li>Summarize the other data supporting this combination in children and adults</li>
 <li>Understand the path that can lead from acute pain to dependence.</li>
 </ol>]]></content:encoded>
                                    
        <enclosure url="https://mcdn.podbean.com/mf/web/un0dqb/secure_primed_frankly-speaking-podcast-ep-51-opioids.mp3" length="20223823" type="audio/mpeg"/>
                <itunes:summary><![CDATA[For severe, acute pain, 1000 mg of acetaminophen PLUS 400 mg of ibuprofen is as effective as acetaminophen/oxycodone, acetaminophen/hydrocodone, or acetaminophen/codeine. Listen to this week’s episode to learn more about treating acute pain safely.    Learning Objectives:  Review the current trial comparing Acetaminophen plus Ibuprofen to other acetaminophen/opioid combinations on pain outcomes Summarize the other data supporting this combination in children and adults Understand the path that can lead from acute pain to dependence. ]]></itunes:summary>
        <itunes:author>Pri-Med</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>624</itunes:duration>
                                <itunes:image href="https://pbcdn1.podbean.com/imglogo/ep-logo/pbblog13721080/9e7f741535b40858051d2523627b5127.jpg" />    </item>
    <item>
        <title>Herpes Zoster Vaccination: New Recommendations for Shingles Prevention - Frankly Speaking EP 50</title>
        <itunes:title>Herpes Zoster Vaccination: New Recommendations for Shingles Prevention - Frankly Speaking EP 50</itunes:title>
        <link>https://primedfranklyspeaking.podbean.com/e/herpes-zoster-vaccination-new-recommendations-for-shingles-prevention-frankly-speaking-ep-50/</link>
                    <comments>https://primedfranklyspeaking.podbean.com/e/herpes-zoster-vaccination-new-recommendations-for-shingles-prevention-frankly-speaking-ep-50/#comments</comments>        <pubDate>Mon, 08 Jan 2018 05:30:00 +0000</pubDate>
        <guid isPermaLink="false">6374ba5f9de909094567d8a284fdb537</guid>
                                    <description><![CDATA[<p>This session will review the recommendations put forth by the CDC’s Advisory Committee on Immunization Practices for the use of a new shingles vaccine. Dosing, use, and efficacy will be discussed.</p>
 <p> </p>
 <p>Learning Objectives:</p>
 <ol><li>Review the new vaccine recommendations for the prevention of shingles.</li>
 <li>Discuss the use of the current vaccine and new vaccine with dosage and schedule.</li>
 <li>Provide a resource for the treatment of post herpetic neuralgia.</li>
 </ol>]]></description>
                                                            <content:encoded><![CDATA[<p>This session will review the recommendations put forth by the CDC’s Advisory Committee on Immunization Practices for the use of a new shingles vaccine. Dosing, use, and efficacy will be discussed.</p>
 <p> </p>
 <p>Learning Objectives:</p>
 <ol><li>Review the new vaccine recommendations for the prevention of shingles.</li>
 <li>Discuss the use of the current vaccine and new vaccine with dosage and schedule.</li>
 <li>Provide a resource for the treatment of post herpetic neuralgia.</li>
 </ol>]]></content:encoded>
                                    
        <enclosure url="https://mcdn.podbean.com/mf/web/gorwpj/secure_primed_frankly-speaking-podcast-ep-50-zoster-edited.mp3" length="9803253" type="audio/mpeg"/>
                <itunes:summary><![CDATA[This session will review the recommendations put forth by the CDC’s Advisory Committee on Immunization Practices for the use of a new shingles vaccine. Dosing, use, and efficacy will be discussed.   Learning Objectives: Review the new vaccine recommendations for the prevention of shingles. Discuss the use of the current vaccine and new vaccine with dosage and schedule. Provide a resource for the treatment of post herpetic neuralgia. ]]></itunes:summary>
        <itunes:author>Pri-Med</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>596</itunes:duration>
                                <itunes:image href="https://pbcdn1.podbean.com/imglogo/ep-logo/pbblog13721080/d18514a60cf995a0de0e70971573253d.jpg" />    </item>
    <item>
        <title>Diabetes Remission with Weight Loss - Frankly Speaking EP 49</title>
        <itunes:title>Diabetes Remission with Weight Loss - Frankly Speaking EP 49</itunes:title>
        <link>https://primedfranklyspeaking.podbean.com/e/diabetes-remission-with-weight-loss-frankly-speaking-ep-49/</link>
                    <comments>https://primedfranklyspeaking.podbean.com/e/diabetes-remission-with-weight-loss-frankly-speaking-ep-49/#comments</comments>        <pubDate>Tue, 02 Jan 2018 14:40:00 +0000</pubDate>
        <guid isPermaLink="false">ed756509c727125d00362ea8aefe894d</guid>
                                    <description><![CDATA[<p>Diabetes remission is defined as a return to normal blood sugar control without the use of medications. Listen to this episode to learn about a trial in which the use of a very low calorie diet in a primary care setting resulted in significant weight loss and remission of diabetes.</p>
 <p> </p>
 <p>Learning Objectives:</p>
 <ol><li>Understand what is meant by diabetes remission</li>
 <li>Understand what treatments can lead to diabetes remission</li>
 </ol><p> </p>
]]></description>
                                                            <content:encoded><![CDATA[<p>Diabetes remission is defined as a return to normal blood sugar control without the use of medications. Listen to this episode to learn about a trial in which the use of a very low calorie diet in a primary care setting resulted in significant weight loss and remission of diabetes.</p>
 <p> </p>
 <p>Learning Objectives:</p>
 <ol><li>Understand what is meant by diabetes remission</li>
 <li>Understand what treatments can lead to diabetes remission</li>
 </ol><p> </p>
]]></content:encoded>
                                    
        <enclosure url="https://mcdn.podbean.com/mf/web/89z3og/secure_primed_frankly-speaking-diabetes-episode-49.mp3" length="21108130" type="audio/mpeg"/>
                <itunes:summary><![CDATA[Diabetes remission is defined as a return to normal blood sugar control without the use of medications. Listen to this episode to learn about a trial in which the use of a very low calorie diet in a primary care setting resulted in significant weight loss and remission of diabetes.   Learning Objectives: Understand what is meant by diabetes remission Understand what treatments can lead to diabetes remission  ]]></itunes:summary>
        <itunes:author>Pri-Med</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>652</itunes:duration>
                                <itunes:image href="https://pbcdn1.podbean.com/imglogo/ep-logo/pbblog13721080/0a68f99b65cb5749a1ece82bcd420ef2.jpg" />    </item>
    <item>
        <title>What Does the Evidence Tell Us About Diagnosing and Treating Sinusitis? - Frankly Speaking EP 48</title>
        <itunes:title>What Does the Evidence Tell Us About Diagnosing and Treating Sinusitis? - Frankly Speaking EP 48</itunes:title>
        <link>https://primedfranklyspeaking.podbean.com/e/what-does-the-evidence-tell-us-about-diagnosing-and-treating-sinusitis-frankly-speaking-ep-48/</link>
                    <comments>https://primedfranklyspeaking.podbean.com/e/what-does-the-evidence-tell-us-about-diagnosing-and-treating-sinusitis-frankly-speaking-ep-48/#comments</comments>        <pubDate>Tue, 26 Dec 2017 16:15:00 +0000</pubDate>
        <guid isPermaLink="false">e6525bc35f2a192f8729546421768cc3</guid>
                                    <description><![CDATA[<p>Listen to this episode to learn about the evidence-based guidelines for the diagnosis and management of acute sinusitis.</p>
 <p>Learning Objectives:</p>
 <ol><li>Discuss the most recent EBP Guidelines on diagnosis and management of acute sinusitis</li>
 <li>Discuss application of best practices for appropriate management of acute sinusitis and strategies for good antibiotic stewardship.</li>
 </ol><p>Guest: Susan Feeney, DNP, FNP-BC</p>
]]></description>
                                                            <content:encoded><![CDATA[<p>Listen to this episode to learn about the evidence-based guidelines for the diagnosis and management of acute sinusitis.</p>
 <p>Learning Objectives:</p>
 <ol><li>Discuss the most recent EBP Guidelines on diagnosis and management of acute sinusitis</li>
 <li>Discuss application of best practices for appropriate management of acute sinusitis and strategies for good antibiotic stewardship.</li>
 </ol><p>Guest: Susan Feeney, DNP, FNP-BC</p>
]]></content:encoded>
                                    
        <enclosure url="https://mcdn.podbean.com/mf/web/dtmiae/secure_primed_frankly-speaking-podcast-48-sinusitis-edited.mp3" length="23332351" type="audio/mpeg"/>
                <itunes:summary><![CDATA[Listen to this episode to learn about the evidence-based guidelines for the diagnosis and management of acute sinusitis. Learning Objectives: Discuss the most recent EBP Guidelines on diagnosis and management of acute sinusitis Discuss application of best practices for appropriate management of acute sinusitis and strategies for good antibiotic stewardship. Guest: Susan Feeney, DNP, FNP-BC]]></itunes:summary>
        <itunes:author>Pri-Med</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>721</itunes:duration>
                                <itunes:image href="https://pbcdn1.podbean.com/imglogo/ep-logo/pbblog13721080/bf86fa3bd46cc913687da59c8eedadd4.jpg" />    </item>
    <item>
        <title>Treatment Options in Opioid Dependence - Frankly Speaking EP 47</title>
        <itunes:title>Treatment Options in Opioid Dependence - Frankly Speaking EP 47</itunes:title>
        <link>https://primedfranklyspeaking.podbean.com/e/treatment-options-in-opioid-dependence-frankly-speaking-ep-47/</link>
                    <comments>https://primedfranklyspeaking.podbean.com/e/treatment-options-in-opioid-dependence-frankly-speaking-ep-47/#comments</comments>        <pubDate>Mon, 18 Dec 2017 05:30:00 +0000</pubDate>
        <guid isPermaLink="false">c89a7c03e9308f9d82bbfddec48fbfb3</guid>
                                    <description><![CDATA[<p>Medication-based maintenance therapy is recommended for patients with opioid dependence. Listen to this week’s episode to learn how once monthly naltrexone injections are as effective as daily treatment with buprenorphine/naloxone.</p>
 <p> </p>
 <p>Learning Objectives: </p>
 <ol><li>Understand data comparing long-acting naltrexone to daily buprenorphine/naloxone</li>
 <li>Understand importance of medication-based maintenance therapy</li>
 </ol>]]></description>
                                                            <content:encoded><![CDATA[<p>Medication-based maintenance therapy is recommended for patients with opioid dependence. Listen to this week’s episode to learn how once monthly naltrexone injections are as effective as daily treatment with buprenorphine/naloxone.</p>
 <p> </p>
 <p>Learning Objectives: </p>
 <ol><li>Understand data comparing long-acting naltrexone to daily buprenorphine/naloxone</li>
 <li>Understand importance of medication-based maintenance therapy</li>
 </ol>]]></content:encoded>
                                    
        <enclosure url="https://mcdn.podbean.com/mf/web/dvv2nc/secure_primed_frankly-speaking-podcast-47-opioids-edited.mp3" length="19361501" type="audio/mpeg"/>
                <itunes:summary><![CDATA[Medication-based maintenance therapy is recommended for patients with opioid dependence. Listen to this week’s episode to learn how once monthly naltrexone injections are as effective as daily treatment with buprenorphine/naloxone.   Learning Objectives:  Understand data comparing long-acting naltrexone to daily buprenorphine/naloxone Understand importance of medication-based maintenance therapy ]]></itunes:summary>
        <itunes:author>Pri-Med</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>597</itunes:duration>
                                <itunes:image href="https://pbcdn1.podbean.com/imglogo/ep-logo/pbblog13721080/f3d3fbbef0084c19beb4ebe9c41379fa.jpg" />    </item>
    <item>
        <title>New Treatment for Asthma - Frankly Speaking EP 46</title>
        <itunes:title>New Treatment for Asthma - Frankly Speaking EP 46</itunes:title>
        <link>https://primedfranklyspeaking.podbean.com/e/new-treatment-for-asthma-frankly-speaking-ep-46/</link>
                    <comments>https://primedfranklyspeaking.podbean.com/e/new-treatment-for-asthma-frankly-speaking-ep-46/#comments</comments>        <pubDate>Mon, 11 Dec 2017 05:30:00 +0000</pubDate>
        <guid isPermaLink="false">f43a903204954cee3e70c3dd34b58507</guid>
                                    <description><![CDATA[<p>We will discuss the use of azithromycin as a therapeutic option for patients with persistent symptomatic asthma despite controller maintenance therapy with inhaled corticosteroids and a long-acting bronchodilator.</p>
 <p>Learning Objectives:</p>
 <ol><li>Understand the effect of chronic azithromycin for reducing asthma exacerbation</li>
 <li>Understand the role azithromycin can play in asthma step-wise therapy</li>
 </ol>]]></description>
                                                            <content:encoded><![CDATA[<p>We will discuss the use of azithromycin as a therapeutic option for patients with persistent symptomatic asthma despite controller maintenance therapy with inhaled corticosteroids and a long-acting bronchodilator.</p>
 <p>Learning Objectives:</p>
 <ol><li>Understand the effect of chronic azithromycin for reducing asthma exacerbation</li>
 <li>Understand the role azithromycin can play in asthma step-wise therapy</li>
 </ol>]]></content:encoded>
                                    
        <enclosure url="https://mcdn.podbean.com/mf/web/skge07/secure_primed_frankly-speaking-podcast-46-asthma-new-outro.mp3" length="19524281" type="audio/mpeg"/>
                <itunes:summary><![CDATA[We will discuss the use of azithromycin as a therapeutic option for patients with persistent symptomatic asthma despite controller maintenance therapy with inhaled corticosteroids and a long-acting bronchodilator. Learning Objectives: Understand the effect of chronic azithromycin for reducing asthma exacerbation Understand the role azithromycin can play in asthma step-wise therapy ]]></itunes:summary>
        <itunes:author>Pri-Med</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>610</itunes:duration>
                                <itunes:image href="https://pbcdn1.podbean.com/imglogo/ep-logo/pbblog13721080/358c6a205257faa51d723c89f07c0c57.jpg" />    </item>
    <item>
        <title>Endurance Sports: In it for the long haul - Frankly Speaking EP 45</title>
        <itunes:title>Endurance Sports: In it for the long haul - Frankly Speaking EP 45</itunes:title>
        <link>https://primedfranklyspeaking.podbean.com/e/endurance-sports-in-it-for-the-long-haul-frankly-speaking-ep-45/</link>
                    <comments>https://primedfranklyspeaking.podbean.com/e/endurance-sports-in-it-for-the-long-haul-frankly-speaking-ep-45/#comments</comments>        <pubDate>Mon, 04 Dec 2017 05:30:00 +0000</pubDate>
        <guid isPermaLink="false">3acb4259c8fbee75d33df69be848a2c5</guid>
                                    <description><![CDATA[<p>What do you say when your 50-year-old patient that has been relatively sedentary in the last 3 decades wants to do a triathlon? In this episode, we will review a U.S. case series of participants in triathlon races from 1985-2016, and discuss risk, reward, and reality.</p>
 <p>Learning Objectives: </p>
 <ol><li>Review data collected over 30 years on triathlon events and the risks to participants.</li>
 <li>Discuss recommendations for patients embarking on extreme physical activity.</li>
 <li>Review strategies to promote well-being and lower risk when considering endurance sports.</li>
 </ol>]]></description>
                                                            <content:encoded><![CDATA[<p>What do you say when your 50-year-old patient that has been relatively sedentary in the last 3 decades wants to do a triathlon? In this episode, we will review a U.S. case series of participants in triathlon races from 1985-2016, and discuss risk, reward, and reality.</p>
 <p>Learning Objectives: </p>
 <ol><li>Review data collected over 30 years on triathlon events and the risks to participants.</li>
 <li>Discuss recommendations for patients embarking on extreme physical activity.</li>
 <li>Review strategies to promote well-being and lower risk when considering endurance sports.</li>
 </ol>]]></content:encoded>
                                    
        <enclosure url="https://mcdn.podbean.com/mf/web/8kzn67/secure_primed_frankly-speaking-podcast-45-endurance-sports-edited.mp3" length="21693094" type="audio/mpeg"/>
                <itunes:summary><![CDATA[What do you say when your 50-year-old patient that has been relatively sedentary in the last 3 decades wants to do a triathlon? In this episode, we will review a U.S. case series of participants in triathlon races from 1985-2016, and discuss risk, reward, and reality. Learning Objectives:  Review data collected over 30 years on triathlon events and the risks to participants. Discuss recommendations for patients embarking on extreme physical activity. Review strategies to promote well-being and lower risk when considering endurance sports. ]]></itunes:summary>
        <itunes:author>Pri-Med</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>669</itunes:duration>
                                <itunes:image href="https://pbcdn1.podbean.com/imglogo/ep-logo/pbblog13721080/22b7b6be7c479b6baa5a20c8888ecc69.jpg" />    </item>
    <item>
        <title>Blood Pressure Determination on Obese Arms - Frankly Speaking EP 44</title>
        <itunes:title>Blood Pressure Determination on Obese Arms - Frankly Speaking EP 44</itunes:title>
        <link>https://primedfranklyspeaking.podbean.com/e/blood-pressure-determination-on-obese-arms-frankly-speaking-ep-44/</link>
                    <comments>https://primedfranklyspeaking.podbean.com/e/blood-pressure-determination-on-obese-arms-frankly-speaking-ep-44/#comments</comments>        <pubDate>Mon, 27 Nov 2017 05:30:00 +0000</pubDate>
        <guid isPermaLink="false">1b8bd1dcab50f7652deea86ac6abc474</guid>
                                    <description><![CDATA[<p>If you become frustrated trying to get a thigh cuff onto the arm of an obese patient, we may have the answer.</p>
 <p>Learning Objectives: </p>
 <ol><li>Review the comparison of standard BP determination with using the forearm and radial pulse with a large cuff</li>
 <li>Appreciate the benefits of systolic hypertension control</li>
 <li>Review the causes of secondary hypertension in obese patients </li>
 </ol>]]></description>
                                                            <content:encoded><![CDATA[<p>If you become frustrated trying to get a thigh cuff onto the arm of an obese patient, we may have the answer.</p>
 <p>Learning Objectives: </p>
 <ol><li>Review the comparison of standard BP determination with using the forearm and radial pulse with a large cuff</li>
 <li>Appreciate the benefits of systolic hypertension control</li>
 <li>Review the causes of secondary hypertension in obese patients </li>
 </ol>]]></content:encoded>
                                    
        <enclosure url="https://mcdn.podbean.com/mf/web/elp5z2/secure_primed_frankly-speaking-podcast-44-blood-pressure-edited.mp3" length="17482468" type="audio/mpeg"/>
                <itunes:summary><![CDATA[If you become frustrated trying to get a thigh cuff onto the arm of an obese patient, we may have the answer. Learning Objectives:  Review the comparison of standard BP determination with using the forearm and radial pulse with a large cuff Appreciate the benefits of systolic hypertension control Review the causes of secondary hypertension in obese patients  ]]></itunes:summary>
        <itunes:author>Pri-Med</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>537</itunes:duration>
                                <itunes:image href="https://pbcdn1.podbean.com/imglogo/ep-logo/pbblog13721080/f699a6ef1333cb9656e79514782383b6.jpg" />    </item>
    <item>
        <title>Tattooing and Body Modification: From Risky to Mainstream – What are the Implications for Patient Care? - Frankly Speaking EP 43</title>
        <itunes:title>Tattooing and Body Modification: From Risky to Mainstream – What are the Implications for Patient Care? - Frankly Speaking EP 43</itunes:title>
        <link>https://primedfranklyspeaking.podbean.com/e/tattooing-and-body-modification-from-risky-to-mainstream-%e2%80%93-what-are-the-implications-for-patient-care-frankly-speaking-ep-43/</link>
                    <comments>https://primedfranklyspeaking.podbean.com/e/tattooing-and-body-modification-from-risky-to-mainstream-%e2%80%93-what-are-the-implications-for-patient-care-frankly-speaking-ep-43/#comments</comments>        <pubDate>Mon, 20 Nov 2017 05:30:00 +0000</pubDate>
        <guid isPermaLink="false">bf85d4772937e60813a2a66c5f6e8339</guid>
                                    <description><![CDATA[<p>In this episode, we discuss the first evidence-based guidelines by the American Academy of Pediatrics on body modification, piercing, and scarification, including complications and assessment of risk. </p>
 <p>Learning Objectives: </p>
 <ol><li>Discuss the AAP’s EBP Guidelines on body modification, piercing and scarification in children, adolescents and young adults</li>
 <li>Discuss best practices for counseling adolescents and strategies for reducing associated risks regarding these practices.</li>
 </ol><p> </p>
 <p> </p>
]]></description>
                                                            <content:encoded><![CDATA[<p>In this episode, we discuss the first evidence-based guidelines by the American Academy of Pediatrics on body modification, piercing, and scarification, including complications and assessment of risk. </p>
 <p>Learning Objectives: </p>
 <ol><li>Discuss the AAP’s EBP Guidelines on body modification, piercing and scarification in children, adolescents and young adults</li>
 <li>Discuss best practices for counseling adolescents and strategies for reducing associated risks regarding these practices.</li>
 </ol><p> </p>
 <p> </p>
]]></content:encoded>
                                    
        <enclosure url="https://mcdn.podbean.com/mf/web/sg6pew/secure_primed_frankly-speaking-podcast-43-body-mods-outro.mp3" length="26747765" type="audio/mpeg"/>
                <itunes:summary><![CDATA[In this episode, we discuss the first evidence-based guidelines by the American Academy of Pediatrics on body modification, piercing, and scarification, including complications and assessment of risk.  Learning Objectives:  Discuss the AAP’s EBP Guidelines on body modification, piercing and scarification in children, adolescents and young adults Discuss best practices for counseling adolescents and strategies for reducing associated risks regarding these practices.    ]]></itunes:summary>
        <itunes:author>Pri-Med</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>835</itunes:duration>
                                <itunes:image href="https://pbcdn1.podbean.com/imglogo/ep-logo/pbblog13721080/1abd13d97f49cdcfd943d02aa10b380d.jpg" />    </item>
    <item>
        <title>‘Tis the Season … for Depression; Get Your Patients Moving. - Frankly Speaking EP 42</title>
        <itunes:title>‘Tis the Season … for Depression; Get Your Patients Moving. - Frankly Speaking EP 42</itunes:title>
        <link>https://primedfranklyspeaking.podbean.com/e/tis-the-season-%e2%80%a6-for-depression-get-your-patients-moving-frankly-speaking-ep-42/</link>
                    <comments>https://primedfranklyspeaking.podbean.com/e/tis-the-season-%e2%80%a6-for-depression-get-your-patients-moving-frankly-speaking-ep-42/#comments</comments>        <pubDate>Mon, 13 Nov 2017 05:30:00 +0000</pubDate>
        <guid isPermaLink="false">072e0514158072bd374f4e9cf3191073</guid>
                                    <description><![CDATA[<p>How much exercise makes a difference in the primary prevention of depression and anxiety? Find out in this podcast which will provide insights from Norway’s HUNT cohort study that followed a healthy cohort of 33,908 individuals for 11 years.</p>
 <p>Learning Objectives: </p>
 <ol><li>Review the relation of exercise and the development of depression and anxiety in a healthy population.</li>
 <li>Discuss strategies and options to alleviate stress and promote wellness.</li>
 </ol><p> </p>
]]></description>
                                                            <content:encoded><![CDATA[<p>How much exercise makes a difference in the primary prevention of depression and anxiety? Find out in this podcast which will provide insights from Norway’s HUNT cohort study that followed a healthy cohort of 33,908 individuals for 11 years.</p>
 <p>Learning Objectives: </p>
 <ol><li>Review the relation of exercise and the development of depression and anxiety in a healthy population.</li>
 <li>Discuss strategies and options to alleviate stress and promote wellness.</li>
 </ol><p> </p>
]]></content:encoded>
                                    
        <enclosure url="https://mcdn.podbean.com/mf/web/04ht77/secure_primed_frankly-speaking-podcast-42-seasonal-depression-edited.mp3" length="16227352" type="audio/mpeg"/>
                <itunes:summary><![CDATA[How much exercise makes a difference in the primary prevention of depression and anxiety? Find out in this podcast which will provide insights from Norway’s HUNT cohort study that followed a healthy cohort of 33,908 individuals for 11 years. Learning Objectives:  Review the relation of exercise and the development of depression and anxiety in a healthy population. Discuss strategies and options to alleviate stress and promote wellness.  ]]></itunes:summary>
        <itunes:author>Pri-Med</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>498</itunes:duration>
                                <itunes:image href="https://pbcdn1.podbean.com/imglogo/ep-logo/pbblog13721080/d76886eb9b19fb2031225adb6c63127d.jpg" />    </item>
    <item>
        <title>Is Oxygen Helpful for Patients with Acute Stroke? - Frankly Speaking EP 41</title>
        <itunes:title>Is Oxygen Helpful for Patients with Acute Stroke? - Frankly Speaking EP 41</itunes:title>
        <link>https://primedfranklyspeaking.podbean.com/e/is-oxygen-helpful-for-patients-with-acute-stroke-frankly-speaking-ep-41/</link>
                    <comments>https://primedfranklyspeaking.podbean.com/e/is-oxygen-helpful-for-patients-with-acute-stroke-frankly-speaking-ep-41/#comments</comments>        <pubDate>Mon, 06 Nov 2017 05:30:00 +0000</pubDate>
        <guid isPermaLink="false">2baf4946a1f4af5ca320d63e5356f39d</guid>
                                    <description><![CDATA[<p>Learning Objectives: </p>
 <ol><li>Understand the results of the Stroke Oxygen Study</li>
 <li>Understand which patients will benefit from supplemental oxygen</li>
 </ol>]]></description>
                                                            <content:encoded><![CDATA[<p>Learning Objectives: </p>
 <ol><li>Understand the results of the Stroke Oxygen Study</li>
 <li>Understand which patients will benefit from supplemental oxygen</li>
 </ol>]]></content:encoded>
                                    
        <enclosure url="https://mcdn.podbean.com/mf/web/0e5es9/secure_primed_frankly-speaking-podcast-41-stroke.mp3" length="19142086" type="audio/mpeg"/>
                <itunes:summary><![CDATA[Learning Objectives:  Understand the results of the Stroke Oxygen Study Understand which patients will benefit from supplemental oxygen ]]></itunes:summary>
        <itunes:author>Pri-Med</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>589</itunes:duration>
                                <itunes:image href="https://pbcdn1.podbean.com/imglogo/ep-logo/pbblog13721080/879492e4912c044db2efaee609c2c6f3.jpg" />    </item>
    <item>
        <title>The Sun is Setting for Sulfonylureas - Frankly Speaking EP 40</title>
        <itunes:title>The Sun is Setting for Sulfonylureas - Frankly Speaking EP 40</itunes:title>
        <link>https://primedfranklyspeaking.podbean.com/e/the-sun-is-setting-for-sulfonylureas-frankly-speaking-ep-40/</link>
                    <comments>https://primedfranklyspeaking.podbean.com/e/the-sun-is-setting-for-sulfonylureas-frankly-speaking-ep-40/#comments</comments>        <pubDate>Mon, 30 Oct 2017 04:30:00 +0000</pubDate>
        <guid isPermaLink="false">82780ee124c3418c0b7d4dee061258f8</guid>
                                    <description><![CDATA[<p>Learning Objectives: </p>
 <ol><li>Review the data on the risks of SU use</li>
 <li>Consider other second line approaches to Type 2 DM</li>
 <li>Review Primary Treatment Goals for T2DM</li>
 </ol>]]></description>
                                                            <content:encoded><![CDATA[<p>Learning Objectives: </p>
 <ol><li>Review the data on the risks of SU use</li>
 <li>Consider other second line approaches to Type 2 DM</li>
 <li>Review Primary Treatment Goals for T2DM</li>
 </ol>]]></content:encoded>
                                    
        <enclosure url="https://mcdn.podbean.com/mf/web/nc127f/secure_primed_frankly-speaking-podcast-4-sulphonylureas-edited.mp3" length="23921158" type="audio/mpeg"/>
                <itunes:summary><![CDATA[Learning Objectives:  Review the data on the risks of SU use Consider other second line approaches to Type 2 DM Review Primary Treatment Goals for T2DM ]]></itunes:summary>
        <itunes:author>Pri-Med</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>738</itunes:duration>
                                <itunes:image href="https://pbcdn1.podbean.com/imglogo/ep-logo/pbblog13721080/1d4b948382a2ad09d9fd0b7877897528.jpg" />    </item>
    <item>
        <title>Rare Risks with Pediatric Cough &amp; Cold Medications - Frankly Speaking EP 39</title>
        <itunes:title>Rare Risks with Pediatric Cough &amp; Cold Medications - Frankly Speaking EP 39</itunes:title>
        <link>https://primedfranklyspeaking.podbean.com/e/rare-risks-with-pediatric-cough-cold-medications-frankly-speaking-ep-39/</link>
                    <comments>https://primedfranklyspeaking.podbean.com/e/rare-risks-with-pediatric-cough-cold-medications-frankly-speaking-ep-39/#comments</comments>        <pubDate>Mon, 23 Oct 2017 04:30:00 +0000</pubDate>
        <guid isPermaLink="false">3e8512dba58ed27a2ac888dd8d03ad01</guid>
                                    <description><![CDATA[<p>Learning Objectives:</p>
 <ol><li>Discuss the AAP position and why</li>
 <li>Review findings of adverse events and where the danger lies</li>
 <li>Offer advice on what to use and how to dose.</li>
 </ol>]]></description>
                                                            <content:encoded><![CDATA[<p>Learning Objectives:</p>
 <ol><li>Discuss the AAP position and why</li>
 <li>Review findings of adverse events and where the danger lies</li>
 <li>Offer advice on what to use and how to dose.</li>
 </ol>]]></content:encoded>
                                    
        <enclosure url="https://mcdn.podbean.com/mf/web/voubr3/secure_primed_pediatric-cough-frankly-speaking-ep-39-edited.mp3" length="21214207" type="audio/mpeg"/>
                <itunes:summary><![CDATA[Learning Objectives: Discuss the AAP position and why Review findings of adverse events and where the danger lies Offer advice on what to use and how to dose. ]]></itunes:summary>
        <itunes:author>Pri-Med</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>654</itunes:duration>
                                <itunes:image href="https://pbcdn1.podbean.com/imglogo/ep-logo/pbblog13721080/61c1d66116d68a466eab29bca51250d9.jpg" />    </item>
    <item>
        <title>Treating Major Depressive Disorder: Considerations in Applying the Evidence - Frankly Speaking EP 38</title>
        <itunes:title>Treating Major Depressive Disorder: Considerations in Applying the Evidence - Frankly Speaking EP 38</itunes:title>
        <link>https://primedfranklyspeaking.podbean.com/e/treating-major-depressive-disorder-considerations-in-applying-the-evidence-frankly-speaking-ep-38/</link>
                    <comments>https://primedfranklyspeaking.podbean.com/e/treating-major-depressive-disorder-considerations-in-applying-the-evidence-frankly-speaking-ep-38/#comments</comments>        <pubDate>Mon, 16 Oct 2017 04:30:00 +0000</pubDate>
        <guid isPermaLink="false">99a99e83677e065793c0c210f258ad18</guid>
                                    <description><![CDATA[<p>Learning Objectives: </p>
 <ol><li>Identify the concerns surrounding depression screening and treatment.</li>
 <li>Discuss the numerous factors primary care providers need to take into consideration to improve management of depression in their patients.</li>
 </ol>]]></description>
                                                            <content:encoded><![CDATA[<p>Learning Objectives: </p>
 <ol><li>Identify the concerns surrounding depression screening and treatment.</li>
 <li>Discuss the numerous factors primary care providers need to take into consideration to improve management of depression in their patients.</li>
 </ol>]]></content:encoded>
                                    
        <enclosure url="https://mcdn.podbean.com/mf/web/dy99x0/secure_primed_frankly-speaking-podcast-38-depression-edited.mp3" length="22252559" type="audio/mpeg"/>
                <itunes:summary><![CDATA[Learning Objectives:  Identify the concerns surrounding depression screening and treatment. Discuss the numerous factors primary care providers need to take into consideration to improve management of depression in their patients. ]]></itunes:summary>
        <itunes:author>Pri-Med</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>686</itunes:duration>
                                <itunes:image href="https://pbcdn1.podbean.com/imglogo/ep-logo/pbblog13721080/3e64765f6ac414c0f8f1252c61886d52.jpg" />    </item>
    <item>
        <title>PPIs: Too Much of a Good Thing? When and How to Discontinue Them - Frankly Speaking EP 37</title>
        <itunes:title>PPIs: Too Much of a Good Thing? When and How to Discontinue Them - Frankly Speaking EP 37</itunes:title>
        <link>https://primedfranklyspeaking.podbean.com/e/ppis-too-much-of-a-good-thing-when-and-how-to-discontinue-them-frankly-speaking-ep-37/</link>
                    <comments>https://primedfranklyspeaking.podbean.com/e/ppis-too-much-of-a-good-thing-when-and-how-to-discontinue-them-frankly-speaking-ep-37/#comments</comments>        <pubDate>Mon, 09 Oct 2017 04:30:00 +0000</pubDate>
        <guid isPermaLink="false">56bb5bfe713c59c1da4291bb3bde5dfe</guid>
                                    <description><![CDATA[<p>Learning Objectives: </p>
 <ol><li>Discuss EBP Guidelines on management of Acid related GI condition and PPI prescribing</li>
 <li>Discuss best practice for appropriate PPI use in primary care and strategies for discontinuation. </li>
 </ol>]]></description>
                                                            <content:encoded><![CDATA[<p>Learning Objectives: </p>
 <ol><li>Discuss EBP Guidelines on management of Acid related GI condition and PPI prescribing</li>
 <li>Discuss best practice for appropriate PPI use in primary care and strategies for discontinuation. </li>
 </ol>]]></content:encoded>
                                    
        <enclosure url="https://mcdn.podbean.com/mf/web/1q6v0a/secure_primed_frankly-speaking-podcast-37-ppi.mp3" length="27660878" type="audio/mpeg"/>
                <itunes:summary><![CDATA[Learning Objectives:  Discuss EBP Guidelines on management of Acid related GI condition and PPI prescribing Discuss best practice for appropriate PPI use in primary care and strategies for discontinuation.  ]]></itunes:summary>
        <itunes:author>Pri-Med</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>856</itunes:duration>
                                <itunes:image href="https://pbcdn1.podbean.com/imglogo/ep-logo/pbblog13721080/de4d0c00f6024870387b01f40baff20a.jpg" />    </item>
    <item>
        <title>The Flu Stops with You – 2017/2018 Influenza Vaccination Recommendations - Frankly Speaking EP 36</title>
        <itunes:title>The Flu Stops with You – 2017/2018 Influenza Vaccination Recommendations - Frankly Speaking EP 36</itunes:title>
        <link>https://primedfranklyspeaking.podbean.com/e/the-flu-stops-with-you-%e2%80%93-20172018-influenza-vaccination-recommendations-frankly-speaking-ep-36/</link>
                    <comments>https://primedfranklyspeaking.podbean.com/e/the-flu-stops-with-you-%e2%80%93-20172018-influenza-vaccination-recommendations-frankly-speaking-ep-36/#comments</comments>        <pubDate>Mon, 02 Oct 2017 04:30:00 +0000</pubDate>
        <guid isPermaLink="false">1f37b74e63a9676d3643d6613e2bf68d</guid>
                                    <description><![CDATA[<p>Learning Objectives:</p>
 <ol><li>Discuss the 2017-2018 American College of Advisory Committee on Immunization Practices (ACIP) 2017-2018 Seasonal Influenza Vaccine.</li>
 <li>Review age recommendations, high-risk populations and contraindications for seasonal influenza vaccination.</li>
 <li>Discuss best practices and dispel myths your patients may believe that prevent influenza vaccination.</li>
 </ol>]]></description>
                                                            <content:encoded><![CDATA[<p>Learning Objectives:</p>
 <ol><li>Discuss the 2017-2018 American College of Advisory Committee on Immunization Practices (ACIP) 2017-2018 Seasonal Influenza Vaccine.</li>
 <li>Review age recommendations, high-risk populations and contraindications for seasonal influenza vaccination.</li>
 <li>Discuss best practices and dispel myths your patients may believe that prevent influenza vaccination.</li>
 </ol>]]></content:encoded>
                                    
        <enclosure url="https://mcdn.podbean.com/mf/web/petckp/secure_primed_frankly-speaking-podcast-36-influenza-edited.mp3" length="23852924" type="audio/mpeg"/>
                <itunes:summary><![CDATA[Learning Objectives: Discuss the 2017-2018 American College of Advisory Committee on Immunization Practices (ACIP) 2017-2018 Seasonal Influenza Vaccine. Review age recommendations, high-risk populations and contraindications for seasonal influenza vaccination. Discuss best practices and dispel myths your patients may believe that prevent influenza vaccination. ]]></itunes:summary>
        <itunes:author>Pri-Med</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>737</itunes:duration>
                                <itunes:image href="https://pbcdn1.podbean.com/imglogo/ep-logo/pbblog13721080/6305abc1923a4363c5bbbf51ceb53d01.jpg" />    </item>
    <item>
        <title>Tonsillectomy Improves Sleep Disordered Breathing In Children - Frankly Speaking EP 35</title>
        <itunes:title>Tonsillectomy Improves Sleep Disordered Breathing In Children - Frankly Speaking EP 35</itunes:title>
        <link>https://primedfranklyspeaking.podbean.com/e/tonsillectomy-improves-sleep-disordered-breathing-in-children-frankly-speaking-ep-35/</link>
                    <comments>https://primedfranklyspeaking.podbean.com/e/tonsillectomy-improves-sleep-disordered-breathing-in-children-frankly-speaking-ep-35/#comments</comments>        <pubDate>Mon, 25 Sep 2017 04:30:00 +0000</pubDate>
        <guid isPermaLink="false">c8f29d4c2094afa755651dd8fc8a6685</guid>
                                    <description><![CDATA[<p>Learning Objectives: </p>
 <ol><li>Understand the scope of the problems associated with sleep disordered breathing in children</li>
 <li>Review outcomes from this systematic review and meta analysis</li>
 <li>Appreciate the possible indications for surgery in children with sleep disordered breathing</li>
 </ol>]]></description>
                                                            <content:encoded><![CDATA[<p>Learning Objectives: </p>
 <ol><li>Understand the scope of the problems associated with sleep disordered breathing in children</li>
 <li>Review outcomes from this systematic review and meta analysis</li>
 <li>Appreciate the possible indications for surgery in children with sleep disordered breathing</li>
 </ol>]]></content:encoded>
                                    
        <enclosure url="https://mcdn.podbean.com/mf/web/0v6zz1/secure_primed_frankly-speaking-podcast-35-sleep-disordered-breathing-edited.mp3" length="24181033" type="audio/mpeg"/>
                <itunes:summary><![CDATA[Learning Objectives:  Understand the scope of the problems associated with sleep disordered breathing in children Review outcomes from this systematic review and meta analysis Appreciate the possible indications for surgery in children with sleep disordered breathing ]]></itunes:summary>
        <itunes:author>Pri-Med</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>747</itunes:duration>
                                <itunes:image href="https://pbcdn1.podbean.com/imglogo/ep-logo/pbblog13721080/6dda0b6c4e2d4266fe6bd525a4509dc9.jpg" />    </item>
    <item>
        <title>Putting E-cigarettes to Good Use: Evidence on Smoking Cessation Impact and Population Health - Frankly Speaking EP 34</title>
        <itunes:title>Putting E-cigarettes to Good Use: Evidence on Smoking Cessation Impact and Population Health - Frankly Speaking EP 34</itunes:title>
        <link>https://primedfranklyspeaking.podbean.com/e/putting-e-cigarettes-to-good-use-evidence-on-smoking-cessation-impact-and-population-health-frankly-speaking-ep-34/</link>
                    <comments>https://primedfranklyspeaking.podbean.com/e/putting-e-cigarettes-to-good-use-evidence-on-smoking-cessation-impact-and-population-health-frankly-speaking-ep-34/#comments</comments>        <pubDate>Mon, 18 Sep 2017 04:30:00 +0000</pubDate>
        <guid isPermaLink="false">8483886aec0e9becba8a376383873908</guid>
                                    <description><![CDATA[<p>Learning Objectives:</p>
 <ol><li>Clarify the concerns surrounding e-cigarette use.</li>
 <li>Discuss the potential for incorporating e-cigarette use as a smoking cessation strategy for patients.</li>
 </ol>]]></description>
                                                            <content:encoded><![CDATA[<p>Learning Objectives:</p>
 <ol><li>Clarify the concerns surrounding e-cigarette use.</li>
 <li>Discuss the potential for incorporating e-cigarette use as a smoking cessation strategy for patients.</li>
 </ol>]]></content:encoded>
                                    
        <enclosure url="https://mcdn.podbean.com/mf/web/lz1q3h/secure_primed_frankly-speaking-podcast-34-smoking-edited.mp3" length="23032050" type="audio/mpeg"/>
                <itunes:summary><![CDATA[Learning Objectives: Clarify the concerns surrounding e-cigarette use. Discuss the potential for incorporating e-cigarette use as a smoking cessation strategy for patients. ]]></itunes:summary>
        <itunes:author>Pri-Med</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>711</itunes:duration>
                                <itunes:image href="https://pbcdn1.podbean.com/imglogo/ep-logo/pbblog13721080/decff4f33f237dc7fb693b3b4f97095b.jpg" />    </item>
    <item>
        <title>Treating an Abscess: When are Antibiotics Needed? - Frankly Speaking EP 33</title>
        <itunes:title>Treating an Abscess: When are Antibiotics Needed? - Frankly Speaking EP 33</itunes:title>
        <link>https://primedfranklyspeaking.podbean.com/e/treating-an-abscess-when-are-antibiotics-needed-frankly-speaking-ep-33/</link>
                    <comments>https://primedfranklyspeaking.podbean.com/e/treating-an-abscess-when-are-antibiotics-needed-frankly-speaking-ep-33/#comments</comments>        <pubDate>Mon, 11 Sep 2017 04:30:00 +0000</pubDate>
        <guid isPermaLink="false">9980b07bc18ae611c0f2624face9e0b4</guid>
                                    <description><![CDATA[<p>Learning Objectives: </p>
 <ol><li>Know which patients are most likely to benefit from antibiotics following incision and drainage of and abscess</li>
 <li>Know which antibiotics are preferred to use for patients following incision and drainage </li>
 </ol>]]></description>
                                                            <content:encoded><![CDATA[<p>Learning Objectives: </p>
 <ol><li>Know which patients are most likely to benefit from antibiotics following incision and drainage of and abscess</li>
 <li>Know which antibiotics are preferred to use for patients following incision and drainage </li>
 </ol>]]></content:encoded>
                                    
        <enclosure url="https://mcdn.podbean.com/mf/web/ncorma/secure_primed_frankly-speaking-podcast-33-skin-edited.mp3" length="23173866" type="audio/mpeg"/>
                <itunes:summary><![CDATA[Learning Objectives:  Know which patients are most likely to benefit from antibiotics following incision and drainage of and abscess Know which antibiotics are preferred to use for patients following incision and drainage  ]]></itunes:summary>
        <itunes:author>Pri-Med</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>715</itunes:duration>
                                <itunes:image href="https://pbcdn1.podbean.com/imglogo/ep-logo/pbblog13721080/8f721ed7652c7f84d5adb15ea6f39c09.jpg" />    </item>
    <item>
        <title>Infant Sleep Safety: AAP Recommendations Explained - Frankly Speaking EP 32</title>
        <itunes:title>Infant Sleep Safety: AAP Recommendations Explained - Frankly Speaking EP 32</itunes:title>
        <link>https://primedfranklyspeaking.podbean.com/e/infant-sleep-safety-aap-recommendations-explained-frankly-speaking-ep-32/</link>
                    <comments>https://primedfranklyspeaking.podbean.com/e/infant-sleep-safety-aap-recommendations-explained-frankly-speaking-ep-32/#comments</comments>        <pubDate>Mon, 04 Sep 2017 04:30:00 +0000</pubDate>
        <guid isPermaLink="false">514b6865901b3b878a5040d8cb3bfb3d</guid>
                                    <description><![CDATA[<p>Learning Objectives:</p>
 <ol><li>Discuss the most recent evidence based practice guidelines on safe infant sleep environment</li>
 <li>Discuss barriers to implementing the EBP safe sleep environment guidelines</li>
 <li>Discuss strategies to improve compliance with EBP safe sleep environment guidelines</li>
 </ol>]]></description>
                                                            <content:encoded><![CDATA[<p>Learning Objectives:</p>
 <ol><li>Discuss the most recent evidence based practice guidelines on safe infant sleep environment</li>
 <li>Discuss barriers to implementing the EBP safe sleep environment guidelines</li>
 <li>Discuss strategies to improve compliance with EBP safe sleep environment guidelines</li>
 </ol>]]></content:encoded>
                                    
        <enclosure url="https://mcdn.podbean.com/mf/web/a3igtn/secure_primed_frankly-speaking-podcast-32-sleep-study-edited.mp3" length="24128182" type="audio/mpeg"/>
                <itunes:summary><![CDATA[Learning Objectives: Discuss the most recent evidence based practice guidelines on safe infant sleep environment Discuss barriers to implementing the EBP safe sleep environment guidelines Discuss strategies to improve compliance with EBP safe sleep environment guidelines ]]></itunes:summary>
        <itunes:author>Pri-Med</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>745</itunes:duration>
                                <itunes:image href="https://pbcdn1.podbean.com/imglogo/ep-logo/pbblog13721080/28a2901719253125b8dceb4992edeae4.jpg" />    </item>
    <item>
        <title>Late Breaking News: Let’s Talk About Alcohol Consumption and Health Outcomes - Frankly Speaking EP 31</title>
        <itunes:title>Late Breaking News: Let’s Talk About Alcohol Consumption and Health Outcomes - Frankly Speaking EP 31</itunes:title>
        <link>https://primedfranklyspeaking.podbean.com/e/late-breaking-news-let-s-talk-about-alcohol-consumption-and-health-outcomes-frankly-speaking-ep-31/</link>
                    <comments>https://primedfranklyspeaking.podbean.com/e/late-breaking-news-let-s-talk-about-alcohol-consumption-and-health-outcomes-frankly-speaking-ep-31/#comments</comments>        <pubDate>Mon, 28 Aug 2017 04:30:00 +0000</pubDate>
        <guid isPermaLink="false">8b61a4fbb7816c5ed042032b255d95ec</guid>
                                    <description><![CDATA[<p>Learning Objectives:</p>
 <ol><li>Discuss the results of a longitudinal cohort study re: alcohol consumption and cognitive decline.</li>
 <li>Review U.S. Guidelines for alcohol consumption.</li>
 <li>Discuss best practice recommendations for primary care patient discussions on the use of alcohol.</li>
 </ol>]]></description>
                                                            <content:encoded><![CDATA[<p>Learning Objectives:</p>
 <ol><li>Discuss the results of a longitudinal cohort study re: alcohol consumption and cognitive decline.</li>
 <li>Review U.S. Guidelines for alcohol consumption.</li>
 <li>Discuss best practice recommendations for primary care patient discussions on the use of alcohol.</li>
 </ol>]]></content:encoded>
                                    
        <enclosure url="https://mcdn.podbean.com/mf/web/42iawa/secure_primed_frankly-speaking-ep-31-edited-alcohol.mp3" length="18288072" type="audio/mpeg"/>
                <itunes:summary><![CDATA[Learning Objectives: Discuss the results of a longitudinal cohort study re: alcohol consumption and cognitive decline. Review U.S. Guidelines for alcohol consumption. Discuss best practice recommendations for primary care patient discussions on the use of alcohol. ]]></itunes:summary>
        <itunes:author>Pri-Med</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>562</itunes:duration>
                                <itunes:image href="https://pbcdn1.podbean.com/imglogo/ep-logo/pbblog13721080/cd5b9bf23e1827a1e4b20cf8d08449f6.jpg" />    </item>
    <item>
        <title>Help Me with My Headache—Please! - Frankly Speaking EP 30</title>
        <itunes:title>Help Me with My Headache—Please! - Frankly Speaking EP 30</itunes:title>
        <link>https://primedfranklyspeaking.podbean.com/e/help-me-with-my-headache%e2%80%94please-frankly-speaking-ep-30/</link>
                    <comments>https://primedfranklyspeaking.podbean.com/e/help-me-with-my-headache%e2%80%94please-frankly-speaking-ep-30/#comments</comments>        <pubDate>Mon, 21 Aug 2017 04:30:00 +0000</pubDate>
        <guid isPermaLink="false">d98130b5dc7644daf44cd290e5ada770</guid>
                                    <description><![CDATA[<p>Learning Objectives: </p>
 <ol><li>Review best practices in the identification of migraine headache.</li>
 <li> <p>Discuss recent updates for the prevention and treatment of migraines.</p>
 </li>
 <li>Review the use of technology in the care of headache patients.</li>
 </ol><p> </p>
]]></description>
                                                            <content:encoded><![CDATA[<p>Learning Objectives: </p>
 <ol><li>Review best practices in the identification of migraine headache.</li>
 <li> <p>Discuss recent updates for the prevention and treatment of migraines.</p>
 </li>
 <li>Review the use of technology in the care of headache patients.</li>
 </ol><p> </p>
]]></content:encoded>
                                    
        <enclosure url="https://mcdn.podbean.com/mf/web/34lyil/secure_primed_frankly-speaking-ep-30-edited-2.mp3" length="21673967" type="audio/mpeg"/>
                <itunes:summary><![CDATA[Learning Objectives:  Review best practices in the identification of migraine headache.  Discuss recent updates for the prevention and treatment of migraines.  Review the use of technology in the care of headache patients.  ]]></itunes:summary>
        <itunes:author>Pri-Med</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>668</itunes:duration>
                                <itunes:image href="https://pbcdn1.podbean.com/imglogo/ep-logo/pbblog13721080/60dcfc9f1e05cd32e0fbc59baa8f99f8.jpg" />    </item>
    <item>
        <title>Practical Approaches to the New Guidelines on Breast Cancer Screening - Frankly Speaking EP 29</title>
        <itunes:title>Practical Approaches to the New Guidelines on Breast Cancer Screening - Frankly Speaking EP 29</itunes:title>
        <link>https://primedfranklyspeaking.podbean.com/e/practical-approaches-to-the-new-guidelines-on-breast-cancer-screening-frankly-speaking-ep-29/</link>
                    <comments>https://primedfranklyspeaking.podbean.com/e/practical-approaches-to-the-new-guidelines-on-breast-cancer-screening-frankly-speaking-ep-29/#comments</comments>        <pubDate>Mon, 14 Aug 2017 16:00:00 +0000</pubDate>
        <guid isPermaLink="false">a97c1b06e2bc8aee7808de66a59ac496</guid>
                                    <description><![CDATA[<p>Learning Objectives:</p>
 <ol><li>Review and compare current EB guidelines from the ACS, ACOG and USPSTF</li>
 <li>Discuss breast cancer risk and its impact on screening recommendations</li>
 <li>Discuss strategies to apply guidelines in practice</li>
 </ol>]]></description>
                                                            <content:encoded><![CDATA[<p>Learning Objectives:</p>
 <ol><li>Review and compare current EB guidelines from the ACS, ACOG and USPSTF</li>
 <li>Discuss breast cancer risk and its impact on screening recommendations</li>
 <li>Discuss strategies to apply guidelines in practice</li>
 </ol>]]></content:encoded>
                                    
        <enclosure url="https://mcdn.podbean.com/mf/web/k8knko/secure_primed_frankly-speaking-ep-30-edited.mp3" length="27335709" type="audio/mpeg"/>
                <itunes:summary><![CDATA[Learning Objectives: Review and compare current EB guidelines from the ACS, ACOG and USPSTF Discuss breast cancer risk and its impact on screening recommendations Discuss strategies to apply guidelines in practice ]]></itunes:summary>
        <itunes:author>Pri-Med</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>845</itunes:duration>
                                <itunes:image href="https://pbcdn1.podbean.com/imglogo/ep-logo/pbblog13721080/4ff35590dba4e4c3e550c778fb6511ad.jpg" />    </item>
    <item>
        <title>E-Cigarettes – Risks of Teen Vaping - Frankly Speaking EP 28</title>
        <itunes:title>E-Cigarettes – Risks of Teen Vaping - Frankly Speaking EP 28</itunes:title>
        <link>https://primedfranklyspeaking.podbean.com/e/e-cigarettes-%e2%80%93-risks-of-teen-vaping-frankly-speaking-ep-28/</link>
                    <comments>https://primedfranklyspeaking.podbean.com/e/e-cigarettes-%e2%80%93-risks-of-teen-vaping-frankly-speaking-ep-28/#comments</comments>        <pubDate>Mon, 07 Aug 2017 04:30:00 +0000</pubDate>
        <guid isPermaLink="false">2857db27533cb231fe5cd188d463afea</guid>
                                    <description><![CDATA[<p>Learning Objectives:</p>
 <ol><li>Discuss the history of e-Cigarettes and how they function</li>
 <li>Discuss the findings of the recent meta-analysis/systematic review regarding US teen use and the association with future tobacco smoking behavior</li>
 <li>Discuss the potential public health concerns, implication for health policy and best practice for family and pediatric providers</li>
 </ol>]]></description>
                                                            <content:encoded><![CDATA[<p>Learning Objectives:</p>
 <ol><li>Discuss the history of e-Cigarettes and how they function</li>
 <li>Discuss the findings of the recent meta-analysis/systematic review regarding US teen use and the association with future tobacco smoking behavior</li>
 <li>Discuss the potential public health concerns, implication for health policy and best practice for family and pediatric providers</li>
 </ol>]]></content:encoded>
                                    
        <enclosure url="https://mcdn.podbean.com/mf/web/1a24h2/secure_primed_frankly-speaking-podcast-28-edited.mp3" length="22663498" type="audio/mpeg"/>
                <itunes:summary><![CDATA[Learning Objectives: Discuss the history of e-Cigarettes and how they function Discuss the findings of the recent meta-analysis/systematic review regarding US teen use and the association with future tobacco smoking behavior Discuss the potential public health concerns, implication for health policy and best practice for family and pediatric providers ]]></itunes:summary>
        <itunes:author>Pri-Med</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>699</itunes:duration>
                                <itunes:image href="https://pbcdn1.podbean.com/imglogo/ep-logo/pbblog13721080/bc52250ca9b6d665d7497e949c55f20a.jpg" />    </item>
    <item>
        <title>The American Heart Association Update on the Role of Fat in Your Diet - Frankly Speaking EP 27</title>
        <itunes:title>The American Heart Association Update on the Role of Fat in Your Diet - Frankly Speaking EP 27</itunes:title>
        <link>https://primedfranklyspeaking.podbean.com/e/the-american-heart-association-update-on-the-role-of-fat-in-your-diet-frankly-speaking-ep-27/</link>
                    <comments>https://primedfranklyspeaking.podbean.com/e/the-american-heart-association-update-on-the-role-of-fat-in-your-diet-frankly-speaking-ep-27/#comments</comments>        <pubDate>Mon, 31 Jul 2017 17:52:00 +0000</pubDate>
        <guid isPermaLink="false">e55ab97ab9443bdc1465da55ec4c35e5</guid>
                                    <description><![CDATA[<p>Learning Objectives:</p>
 <ol><li>Discuss the AHA position statement on fats in the diet</li>
 <li> <p>Review the types of fat and what is known about their relationship to heart disease</p>
 </li>
 <li>Recommend a dietary approach that is based upon best evidence</li>
 </ol>]]></description>
                                                            <content:encoded><![CDATA[<p>Learning Objectives:</p>
 <ol><li>Discuss the AHA position statement on fats in the diet</li>
 <li> <p>Review the types of fat and what is known about their relationship to heart disease</p>
 </li>
 <li>Recommend a dietary approach that is based upon best evidence</li>
 </ol>]]></content:encoded>
                                    
        <enclosure url="https://mcdn.podbean.com/mf/web/93gt0s/secure_primed_saturated-fat-edited-version-2.mp3" length="20407081" type="audio/mpeg"/>
                <itunes:summary><![CDATA[Learning Objectives: Discuss the AHA position statement on fats in the diet  Review the types of fat and what is known about their relationship to heart disease  Recommend a dietary approach that is based upon best evidence ]]></itunes:summary>
        <itunes:author>Pri-Med</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>629</itunes:duration>
                                <itunes:image href="https://pbcdn1.podbean.com/imglogo/ep-logo/pbblog13721080/5dfb382f599fd3dbbd761e58014d7e35.jpg" />    </item>
    <item>
        <title>The Opioid Epidemic: Is Your Practice Changing?  - Frankly Speaking EP 26</title>
        <itunes:title>The Opioid Epidemic: Is Your Practice Changing?  - Frankly Speaking EP 26</itunes:title>
        <link>https://primedfranklyspeaking.podbean.com/e/the-opioid-epidemic-is-your-practice-changing-frankly-speaking-ep-26/</link>
                    <comments>https://primedfranklyspeaking.podbean.com/e/the-opioid-epidemic-is-your-practice-changing-frankly-speaking-ep-26/#comments</comments>        <pubDate>Mon, 24 Jul 2017 04:30:00 +0000</pubDate>
        <guid isPermaLink="false">339a3ce097ddd64b2080742dcb341ce8</guid>
                                    <description><![CDATA[<p>Learning Objectives:</p>
 <ol><li>Discuss the findings of Martins et al survey results in the context of primary care practice</li>
 <li>Identify validated tools useful in your practice to identify opioid misuse</li>
 <li>Discuss methods to promote effective pain management including utilizing safe prescribing strategies</li>
 </ol>]]></description>
                                                            <content:encoded><![CDATA[<p>Learning Objectives:</p>
 <ol><li>Discuss the findings of Martins et al survey results in the context of primary care practice</li>
 <li>Identify validated tools useful in your practice to identify opioid misuse</li>
 <li>Discuss methods to promote effective pain management including utilizing safe prescribing strategies</li>
 </ol>]]></content:encoded>
                                    
        <enclosure url="https://mcdn.podbean.com/mf/web/xd3cp5/secure_primed_frankly-speaking-podcast-26-edited.mp3" length="23276441" type="audio/mpeg"/>
                <itunes:summary><![CDATA[Learning Objectives: Discuss the findings of Martins et al survey results in the context of primary care practice Identify validated tools useful in your practice to identify opioid misuse Discuss methods to promote effective pain management including utilizing safe prescribing strategies ]]></itunes:summary>
        <itunes:author>Pri-Med</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>727</itunes:duration>
                                <itunes:image href="https://pbcdn1.podbean.com/imglogo/ep-logo/pbblog13721080/84dad842be114bee4e0f17a4b987003c.jpg" />    </item>
    <item>
        <title>Artificial Sweeteners: Does Diet Soda Do More Harm Than Good? - Frankly Speaking EP 25</title>
        <itunes:title>Artificial Sweeteners: Does Diet Soda Do More Harm Than Good? - Frankly Speaking EP 25</itunes:title>
        <link>https://primedfranklyspeaking.podbean.com/e/artificial-sweeteners-does-diet-soda-do-more-harm-than-good-frankly-speaking-ep-25/</link>
                    <comments>https://primedfranklyspeaking.podbean.com/e/artificial-sweeteners-does-diet-soda-do-more-harm-than-good-frankly-speaking-ep-25/#comments</comments>        <pubDate>Mon, 17 Jul 2017 04:30:00 +0000</pubDate>
        <guid isPermaLink="false">434bde596714a1f65f985607c0db15ab</guid>
                                    <description><![CDATA[<p>Learning Objectives:</p>
 <ol><li>Review how the correlation of artificial sweeteners and CNS outcomes were related</li>
 <li>Summarize how artificial sweeteners may increase risk for obesity and Type 2 Diabetes</li>
 <li>Remind listeners that use of sucrose in appropriate dosages is safer than artificial sweeteners</li>
 </ol>]]></description>
                                                            <content:encoded><![CDATA[<p>Learning Objectives:</p>
 <ol><li>Review how the correlation of artificial sweeteners and CNS outcomes were related</li>
 <li>Summarize how artificial sweeteners may increase risk for obesity and Type 2 Diabetes</li>
 <li>Remind listeners that use of sucrose in appropriate dosages is safer than artificial sweeteners</li>
 </ol>]]></content:encoded>
                                    
        <enclosure url="https://mcdn.podbean.com/mf/web/5y6qft/secure_primed_frankly-speaking-ep-25.mp3" length="18523443" type="audio/mpeg"/>
                <itunes:summary><![CDATA[Learning Objectives: Review how the correlation of artificial sweeteners and CNS outcomes were related Summarize how artificial sweeteners may increase risk for obesity and Type 2 Diabetes Remind listeners that use of sucrose in appropriate dosages is safer than artificial sweeteners ]]></itunes:summary>
        <itunes:author>Pri-Med</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>570</itunes:duration>
                                <itunes:image href="https://pbcdn1.podbean.com/imglogo/ep-logo/pbblog13721080/45d30f84c4816c80aff5bbb1c4992053.jpg" />    </item>
    <item>
        <title>Whole Milk Does Not Increase Adverse Cardiovascular Outcomes - Frankly Speaking EP 24</title>
        <itunes:title>Whole Milk Does Not Increase Adverse Cardiovascular Outcomes - Frankly Speaking EP 24</itunes:title>
        <link>https://primedfranklyspeaking.podbean.com/e/whole-milk-does-not-increase-adverse-cardiovascular-outcomes-frankly-speaking-ep-24/</link>
                    <comments>https://primedfranklyspeaking.podbean.com/e/whole-milk-does-not-increase-adverse-cardiovascular-outcomes-frankly-speaking-ep-24/#comments</comments>        <pubDate>Mon, 10 Jul 2017 04:00:00 +0000</pubDate>
        <guid isPermaLink="false">6d7371ac8344e0b5e4bec3829e02e460</guid>
                                    <description><![CDATA[<p>This podcast reviews the results of a meta-analysis that found no negative relationship between whole milk consumption and cardiovascular disease or with mortality.</p>
 <p>Learning Objectives</p>
 <ol><li>Understand the rationale that led to decreased milk intake in the 80's and 90's</li>
 <li>Appreciate how a meta analysis can shed light on the role whole milk might play on heart disease</li>
 <li>Be reminded that using "logic" without scientific rigor can lead to false conclusions</li>
 </ol>]]></description>
                                                            <content:encoded><![CDATA[<p>This podcast reviews the results of a meta-analysis that found no negative relationship between whole milk consumption and cardiovascular disease or with mortality.</p>
 <p>Learning Objectives</p>
 <ol><li>Understand the rationale that led to decreased milk intake in the 80's and 90's</li>
 <li>Appreciate how a meta analysis can shed light on the role whole milk might play on heart disease</li>
 <li>Be reminded that using "logic" without scientific rigor can lead to false conclusions</li>
 </ol>]]></content:encoded>
                                    
        <enclosure url="https://mcdn.podbean.com/mf/web/87axji/secure_primed_frankly-speaking-podcast-24.mp3" length="21794463" type="audio/mpeg"/>
                <itunes:summary><![CDATA[This podcast reviews the results of a meta-analysis that found no negative relationship between whole milk consumption and cardiovascular disease or with mortality. Learning Objectives Understand the rationale that led to decreased milk intake in the 80's and 90's Appreciate how a meta analysis can shed light on the role whole milk might play on heart disease Be reminded that using "logic" without scientific rigor can lead to false conclusions ]]></itunes:summary>
        <itunes:author>Pri-Med</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>681</itunes:duration>
                                <itunes:image href="https://pbcdn1.podbean.com/imglogo/ep-logo/pbblog13721080/3c0cc1574a2ca06affcaf93c70707d64.jpg" />    </item>
    <item>
        <title>Here’s to Your Health: What Meat Shall You Eat? - Frankly Speaking EP 23</title>
        <itunes:title>Here’s to Your Health: What Meat Shall You Eat? - Frankly Speaking EP 23</itunes:title>
        <link>https://primedfranklyspeaking.podbean.com/e/here-s-to-your-health-what-meat-shall-you-eat-frankly-speaking-ep-23/</link>
                    <comments>https://primedfranklyspeaking.podbean.com/e/here-s-to-your-health-what-meat-shall-you-eat-frankly-speaking-ep-23/#comments</comments>        <pubDate>Mon, 03 Jul 2017 04:30:00 +0000</pubDate>
        <guid isPermaLink="false">5db9fbe57b9cf3e168486934223b0a48</guid>
                                    <description><![CDATA[<p>Teaching patients lifestyle management strategies to improve health is no easy task. First steps involve increasing provider knowledge of the impact foods have on health. This episode discusses the latest evidence on different types of meat intake and meat associated compounds on health.  </p>
 <p>Learning Objectives:</p>
 <ol><li>Review the current evidence on meat intake and mortality</li>
 <li>Discuss the “real” world impact for patients in primary care</li>
 </ol>]]></description>
                                                            <content:encoded><![CDATA[<p>Teaching patients lifestyle management strategies to improve health is no easy task. First steps involve increasing provider knowledge of the impact foods have on health. This episode discusses the latest evidence on different types of meat intake and meat associated compounds on health.  </p>
 <p>Learning Objectives:</p>
 <ol><li>Review the current evidence on meat intake and mortality</li>
 <li>Discuss the “real” world impact for patients in primary care</li>
 </ol>]]></content:encoded>
                                    
        <enclosure url="https://mcdn.podbean.com/mf/web/4n36dh/secure_primed_frankly-speaking-podcast-23.mp3" length="20596810" type="audio/mpeg"/>
                <itunes:summary><![CDATA[Teaching patients lifestyle management strategies to improve health is no easy task. First steps involve increasing provider knowledge of the impact foods have on health. This episode discusses the latest evidence on different types of meat intake and meat associated compounds on health.   Learning Objectives: Review the current evidence on meat intake and mortality Discuss the “real” world impact for patients in primary care ]]></itunes:summary>
        <itunes:author>Pri-Med</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>635</itunes:duration>
                                <itunes:image href="https://pbcdn1.podbean.com/imglogo/ep-logo/pbblog13721080/5f13b895cebc5889d4e7084a15c2cec4.jpg" />    </item>
    <item>
        <title>Fruit Juice and Kids: How Sweet it is - Frankly Speaking EP 22</title>
        <itunes:title>Fruit Juice and Kids: How Sweet it is - Frankly Speaking EP 22</itunes:title>
        <link>https://primedfranklyspeaking.podbean.com/e/fruit-juice-and-kids-how-sweet-it-is-frankly-speaking-ep-22/</link>
                    <comments>https://primedfranklyspeaking.podbean.com/e/fruit-juice-and-kids-how-sweet-it-is-frankly-speaking-ep-22/#comments</comments>        <pubDate>Mon, 26 Jun 2017 04:30:00 +0000</pubDate>
        <guid isPermaLink="false">a639fc61100b4bb617ab10be09518f22</guid>
                                    <description><![CDATA[<p>Kids love fruit juice. But how much is OK? What are the facts on fruit juice consumption in kids and what should you advise the families you care for? In this episode, we will discuss the latest recommendations from the American Academy of Pediatrics and how they may impact your practice.</p>
 <p>Learning Objectives:</p>
 <ol><li>Identify the AAP recommendations for fruit juice consumption across childhood from infancy through adolescence</li>
 <li>Discuss health risks associated with increased fruit juice consumption</li>
 <li>Discuss strategies to promote healthy consumption of beverages in children and families</li>
 </ol>]]></description>
                                                            <content:encoded><![CDATA[<p>Kids love fruit juice. But how much is OK? What are the facts on fruit juice consumption in kids and what should you advise the families you care for? In this episode, we will discuss the latest recommendations from the American Academy of Pediatrics and how they may impact your practice.</p>
 <p>Learning Objectives:</p>
 <ol><li>Identify the AAP recommendations for fruit juice consumption across childhood from infancy through adolescence</li>
 <li>Discuss health risks associated with increased fruit juice consumption</li>
 <li>Discuss strategies to promote healthy consumption of beverages in children and families</li>
 </ol>]]></content:encoded>
                                    
        <enclosure url="https://mcdn.podbean.com/mf/web/nyg0dl/secure_primed_frankly-speaking-podcast-22.mp3" length="15061404" type="audio/mpeg"/>
                <itunes:summary><![CDATA[Kids love fruit juice. But how much is OK? What are the facts on fruit juice consumption in kids and what should you advise the families you care for? In this episode, we will discuss the latest recommendations from the American Academy of Pediatrics and how they may impact your practice. Learning Objectives: Identify the AAP recommendations for fruit juice consumption across childhood from infancy through adolescence Discuss health risks associated with increased fruit juice consumption Discuss strategies to promote healthy consumption of beverages in children and families ]]></itunes:summary>
        <itunes:author>Pri-Med</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>627</itunes:duration>
                                <itunes:image href="https://pbcdn1.podbean.com/imglogo/ep-logo/pbblog13721080/f91a7416cb37d3b8fbe397f82991164e.jpg" />    </item>
    <item>
        <title>New Simpler HPV Vaccine Schedule - Frankly Speaking EP 21</title>
        <itunes:title>New Simpler HPV Vaccine Schedule - Frankly Speaking EP 21</itunes:title>
        <link>https://primedfranklyspeaking.podbean.com/e/new-simpler-hpv-vaccine-schedule-frankly-speaking-ep-21/</link>
                    <comments>https://primedfranklyspeaking.podbean.com/e/new-simpler-hpv-vaccine-schedule-frankly-speaking-ep-21/#comments</comments>        <pubDate>Mon, 19 Jun 2017 04:30:00 +0000</pubDate>
        <guid isPermaLink="false">4c16a49667c264955866adae0dfd3b72</guid>
                                    <description><![CDATA[<p>HPV immunization has been recommended for pre-teens and teens for over a decade, however vaccination rates remain low. In October 2016 the CDC changed their recommendations to 2 doses of HPV vaccine in teens before their 15th birthday (from 3 doses), does this make it easier for completion? </p>
 <p>Learning Objectives:</p>
 <ol><li>Review the current recommendations for Human Papilloma Vaccination (HPV) in the young adolescent population including immunogenicity.</li>
 <li>Discuss the prevalence of HPV and associated diseases and cancer</li>
 <li>Review strategies to increase vaccination rates</li>
 </ol>]]></description>
                                                            <content:encoded><![CDATA[<p>HPV immunization has been recommended for pre-teens and teens for over a decade, however vaccination rates remain low. In October 2016 the CDC changed their recommendations to 2 doses of HPV vaccine in teens before their 15th birthday (from 3 doses), does this make it easier for completion? </p>
 <p>Learning Objectives:</p>
 <ol><li>Review the current recommendations for Human Papilloma Vaccination (HPV) in the young adolescent population including immunogenicity.</li>
 <li>Discuss the prevalence of HPV and associated diseases and cancer</li>
 <li>Review strategies to increase vaccination rates</li>
 </ol>]]></content:encoded>
                                    
        <enclosure url="https://mcdn.podbean.com/mf/web/fomywa/secure_primed_frankly-speaking-ep-21.mp3" length="22230011" type="audio/mpeg"/>
                <itunes:summary><![CDATA[HPV immunization has been recommended for pre-teens and teens for over a decade, however vaccination rates remain low. In October 2016 the CDC changed their recommendations to 2 doses of HPV vaccine in teens before their 15th birthday (from 3 doses), does this make it easier for completion?  Learning Objectives: Review the current recommendations for Human Papilloma Vaccination (HPV) in the young adolescent population including immunogenicity. Discuss the prevalence of HPV and associated diseases and cancer Review strategies to increase vaccination rates ]]></itunes:summary>
        <itunes:author>Pri-Med</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>549</itunes:duration>
                                <itunes:image href="https://pbcdn1.podbean.com/imglogo/ep-logo/pbblog13721080/2aaa3355271f197dfa99ea30be02df9b.jpg" />    </item>
    <item>
        <title>Are Short-term Corticosteroids Dangerous? - Frankly Speaking EP 20</title>
        <itunes:title>Are Short-term Corticosteroids Dangerous? - Frankly Speaking EP 20</itunes:title>
        <link>https://primedfranklyspeaking.podbean.com/e/are-short-term-corticosteroids-dangerous-frankly-speaking-ep-20/</link>
                    <comments>https://primedfranklyspeaking.podbean.com/e/are-short-term-corticosteroids-dangerous-frankly-speaking-ep-20/#comments</comments>        <pubDate>Mon, 12 Jun 2017 04:30:00 +0000</pubDate>
        <guid isPermaLink="false">5602a1b968e6b64785e6ee7b4f3f86bd</guid>
                                    <description><![CDATA[<p>Corticosteroids are often prescribed for short-term use for conditions such as asthma exacerbation, contact dermatitis, gout, and Bell’s palsy. Adverse effects from chronic use of corticosteroids is well known, but many clinicians believe that the risk of significant adverse effects from short-term use is minimal. A recent retrospective cohort study was done reviewing the records of 1.5 million adults to assess the adverse effects of treatment with corticosteroids for less than 30 days.</p>
 <p>Learning Objectives: </p>
 <ol><li>Review the conditions for which corticosteroids may be used for short-term treatment</li>
 <li>Understand the potential risks associated with short-term treatment</li>
 <li>Understand the magnitude of the potential risks relative to possible benefits</li>
 </ol>]]></description>
                                                            <content:encoded><![CDATA[<p>Corticosteroids are often prescribed for short-term use for conditions such as asthma exacerbation, contact dermatitis, gout, and Bell’s palsy. Adverse effects from chronic use of corticosteroids is well known, but many clinicians believe that the risk of significant adverse effects from short-term use is minimal. A recent retrospective cohort study was done reviewing the records of 1.5 million adults to assess the adverse effects of treatment with corticosteroids for less than 30 days.</p>
 <p>Learning Objectives: </p>
 <ol><li>Review the conditions for which corticosteroids may be used for short-term treatment</li>
 <li>Understand the potential risks associated with short-term treatment</li>
 <li>Understand the magnitude of the potential risks relative to possible benefits</li>
 </ol>]]></content:encoded>
                                    
        <enclosure url="https://mcdn.podbean.com/mf/web/psv1gr/secure_primed_frankly-speaking-ep-20.mp3" length="17500828" type="audio/mpeg"/>
                <itunes:summary><![CDATA[Corticosteroids are often prescribed for short-term use for conditions such as asthma exacerbation, contact dermatitis, gout, and Bell’s palsy. Adverse effects from chronic use of corticosteroids is well known, but many clinicians believe that the risk of significant adverse effects from short-term use is minimal. A recent retrospective cohort study was done reviewing the records of 1.5 million adults to assess the adverse effects of treatment with corticosteroids for less than 30 days. Learning Objectives:  Review the conditions for which corticosteroids may be used for short-term treatment Understand the potential risks associated with short-term treatment Understand the magnitude of the potential risks relative to possible benefits ]]></itunes:summary>
        <itunes:author>Pri-Med</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>538</itunes:duration>
                                <itunes:image href="https://pbcdn1.podbean.com/imglogo/ep-logo/pbblog13721080/74941f1b919f83401177ff633fb7cc7d.jpg" />    </item>
    <item>
        <title>Alternate-day Fasting for Weight Loss - Frankly Speaking EP 19</title>
        <itunes:title>Alternate-day Fasting for Weight Loss - Frankly Speaking EP 19</itunes:title>
        <link>https://primedfranklyspeaking.podbean.com/e/alternate-day-fasting-for-weight-loss-frankly-speaking-ep-19/</link>
                    <comments>https://primedfranklyspeaking.podbean.com/e/alternate-day-fasting-for-weight-loss-frankly-speaking-ep-19/#comments</comments>        <pubDate>Mon, 05 Jun 2017 04:30:00 +0000</pubDate>
        <guid isPermaLink="false">21add18e2584ea41086497cf041a8344</guid>
                                    <description><![CDATA[<p>Is Alternate day fasting the future of weight loss?  Maybe not...</p>
 <p>Learning Objectives</p>
 <ol><li>Understand how Alternate day fasting is practiced</li>
 <li>Appreciate why Alternate day fasting might make physiologic sense</li>
 <li>Review the recent literature on its strengths and weaknesses</li>
 </ol>]]></description>
                                                            <content:encoded><![CDATA[<p>Is Alternate day fasting the future of weight loss?  Maybe not...</p>
 <p>Learning Objectives</p>
 <ol><li>Understand how Alternate day fasting is practiced</li>
 <li>Appreciate why Alternate day fasting might make physiologic sense</li>
 <li>Review the recent literature on its strengths and weaknesses</li>
 </ol>]]></content:encoded>
                                    
        <enclosure url="https://mcdn.podbean.com/mf/web/4te0c8/secure_primed_frankly-speaking-ep-19-edited.mp3" length="22358176" type="audio/mpeg"/>
                <itunes:summary><![CDATA[Is Alternate day fasting the future of weight loss?  Maybe not... Learning Objectives Understand how Alternate day fasting is practiced Appreciate why Alternate day fasting might make physiologic sense Review the recent literature on its strengths and weaknesses ]]></itunes:summary>
        <itunes:author>Pri-Med</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>690</itunes:duration>
                                <itunes:image href="https://pbcdn1.podbean.com/imglogo/ep-logo/pbblog13721080/4a0c89599adcd5800ffc5204043b9611.jpg" />    </item>
    <item>
        <title>Do Corticosteroids Decrease the Pain of Acute Pharyngitis? - Frankly Speaking EP 18</title>
        <itunes:title>Do Corticosteroids Decrease the Pain of Acute Pharyngitis? - Frankly Speaking EP 18</itunes:title>
        <link>https://primedfranklyspeaking.podbean.com/e/do-corticosteroids-decrease-the-pain-of-acute-pharyngitis-frankly-speaking-ep-18/</link>
                    <comments>https://primedfranklyspeaking.podbean.com/e/do-corticosteroids-decrease-the-pain-of-acute-pharyngitis-frankly-speaking-ep-18/#comments</comments>        <pubDate>Mon, 29 May 2017 04:30:00 +0000</pubDate>
        <guid isPermaLink="false">fae805376f430a69dd2d17a739205bff</guid>
                                    <description><![CDATA[<p>When patients present with symptoms of a sore throat, an option for managing the pain  that is sometimes used is corticosteroids. A randomized trial of a 1-time dose of 10 mg in patients with moderate to severe pharyngitis who were deemed to not need antibiotics found higher rates of symptom resolution at 48 hours.</p>
 <p>Learning Objectives:</p>
 <ol><li>Understand potential benefits of corticosteroids for treatment of pain of acute pharyngitis</li>
 <li>Understand limitations of evidence for benefit</li>
 <li>Understand other options for symptom relief</li>
 </ol>]]></description>
                                                            <content:encoded><![CDATA[<p>When patients present with symptoms of a sore throat, an option for managing the pain  that is sometimes used is corticosteroids. A randomized trial of a 1-time dose of 10 mg in patients with moderate to severe pharyngitis who were deemed to not need antibiotics found higher rates of symptom resolution at 48 hours.</p>
 <p>Learning Objectives:</p>
 <ol><li>Understand potential benefits of corticosteroids for treatment of pain of acute pharyngitis</li>
 <li>Understand limitations of evidence for benefit</li>
 <li>Understand other options for symptom relief</li>
 </ol>]]></content:encoded>
                                    
        <enclosure url="https://mcdn.podbean.com/mf/web/0z1m4o/secure_primed_frankly-speaking-ep-18.mp3" length="20255003" type="audio/mpeg"/>
                <itunes:summary><![CDATA[When patients present with symptoms of a sore throat, an option for managing the pain  that is sometimes used is corticosteroids. A randomized trial of a 1-time dose of 10 mg in patients with moderate to severe pharyngitis who were deemed to not need antibiotics found higher rates of symptom resolution at 48 hours. Learning Objectives: Understand potential benefits of corticosteroids for treatment of pain of acute pharyngitis Understand limitations of evidence for benefit Understand other options for symptom relief ]]></itunes:summary>
        <itunes:author>Pri-Med</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>624</itunes:duration>
                                <itunes:image href="https://pbcdn1.podbean.com/imglogo/ep-logo/pbblog13721080/5b36e8c682e285884bcde503a4506dd0.jpg" />    </item>
    <item>
        <title>Contraception: The Pill Needs to Share - Frankly Speaking EP17</title>
        <itunes:title>Contraception: The Pill Needs to Share - Frankly Speaking EP17</itunes:title>
        <link>https://primedfranklyspeaking.podbean.com/e/contraception-the-pill-needs-to-share-frankly-speaking-ep17/</link>
                    <comments>https://primedfranklyspeaking.podbean.com/e/contraception-the-pill-needs-to-share-frankly-speaking-ep17/#comments</comments>        <pubDate>Mon, 22 May 2017 12:30:00 +0000</pubDate>
        <guid isPermaLink="false">16b7e57314b60a1f67c19401b70795b2</guid>
                                    <description><![CDATA[<p>Sensitive and important conversations with your adolescent population include contraceptive options.  How do long acting reversible contraceptive methods (LARC’s) fit into your conversation?  Let’s discuss a recent review and update your talk!</p>
 <p>Learning Objectives:</p>
 <ol><li>Discuss the use of long acting reversible contraceptive methods (LARC’s).</li>
 <li>Describe the efficacy or LARC’s compared to other birth control methods.</li>
 <li>Describe communication strategies useful in discussing contraception with adolescents. </li>
 </ol>]]></description>
                                                            <content:encoded><![CDATA[<p>Sensitive and important conversations with your adolescent population include contraceptive options.  How do long acting reversible contraceptive methods (LARC’s) fit into your conversation?  Let’s discuss a recent review and update your talk!</p>
 <p>Learning Objectives:</p>
 <ol><li>Discuss the use of long acting reversible contraceptive methods (LARC’s).</li>
 <li>Describe the efficacy or LARC’s compared to other birth control methods.</li>
 <li>Describe communication strategies useful in discussing contraception with adolescents. </li>
 </ol>]]></content:encoded>
                                    
        <enclosure url="https://mcdn.podbean.com/mf/web/k1owhe/secure_primed_frankly-speaking-ep-17-edited.mp3" length="16351178" type="audio/mpeg"/>
                <itunes:summary><![CDATA[Sensitive and important conversations with your adolescent population include contraceptive options.  How do long acting reversible contraceptive methods (LARC’s) fit into your conversation?  Let’s discuss a recent review and update your talk! Learning Objectives: Discuss the use of long acting reversible contraceptive methods (LARC’s). Describe the efficacy or LARC’s compared to other birth control methods. Describe communication strategies useful in discussing contraception with adolescents.  ]]></itunes:summary>
        <itunes:author>Pri-Med</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>502</itunes:duration>
                                <itunes:image href="https://pbcdn1.podbean.com/imglogo/ep-logo/pbblog13721080/f29eaf50ad400a4f99d8bd79d62488e8.jpg" />    </item>
    <item>
        <title>Safe and Effective Narcotic Use in Chronic Pain - Frankly Speaking EP 16</title>
        <itunes:title>Safe and Effective Narcotic Use in Chronic Pain - Frankly Speaking EP 16</itunes:title>
        <link>https://primedfranklyspeaking.podbean.com/e/safe-and-effective-narcotic-use-in-chronic-pain-frankly-speaking-ep-16/</link>
                    <comments>https://primedfranklyspeaking.podbean.com/e/safe-and-effective-narcotic-use-in-chronic-pain-frankly-speaking-ep-16/#comments</comments>        <pubDate>Mon, 15 May 2017 04:30:00 +0000</pubDate>
        <guid isPermaLink="false">7e98733d7df501e00e8125f50932128e</guid>
                                    <description><![CDATA[<p>Based upon CDC data of death, narcotic prescription length of less than 5 days provided the best outcomes and the lowest risk of continued narcotic use.</p>
 <p>Learning Objectives:</p>
 <ol><li>Understand the scope of the death attributable to narcotics</li>
 <li>Learn how to prevent a patient from becoming dependent upon opioids</li>
 <li>Consider methods to wean off opioids and use other proven agents for chronic non-cancerous pain</li>
 </ol>]]></description>
                                                            <content:encoded><![CDATA[<p>Based upon CDC data of death, narcotic prescription length of less than 5 days provided the best outcomes and the lowest risk of continued narcotic use.</p>
 <p>Learning Objectives:</p>
 <ol><li>Understand the scope of the death attributable to narcotics</li>
 <li>Learn how to prevent a patient from becoming dependent upon opioids</li>
 <li>Consider methods to wean off opioids and use other proven agents for chronic non-cancerous pain</li>
 </ol>]]></content:encoded>
                                    
        <enclosure url="https://mcdn.podbean.com/mf/web/00zv6m/secure_primed_frankly-speaking-podcast-episode-16.mp3" length="26177422" type="audio/mpeg"/>
                <itunes:summary><![CDATA[Based upon CDC data of death, narcotic prescription length of less than 5 days provided the best outcomes and the lowest risk of continued narcotic use. Learning Objectives: Understand the scope of the death attributable to narcotics Learn how to prevent a patient from becoming dependent upon opioids Consider methods to wean off opioids and use other proven agents for chronic non-cancerous pain ]]></itunes:summary>
        <itunes:author>Pri-Med</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>809</itunes:duration>
                                <itunes:image href="https://pbcdn1.podbean.com/imglogo/ep-logo/pbblog13721080/3bba5c27b24dc4cbd47a38e58dd1f71c.jpg" />    </item>
    <item>
        <title>Oxygen for patients with STEMI: Who benefits? - Frankly Speaking EP 15</title>
        <itunes:title>Oxygen for patients with STEMI: Who benefits? - Frankly Speaking EP 15</itunes:title>
        <link>https://primedfranklyspeaking.podbean.com/e/oxygen-for-patients-with-stemi-who-benefits-frankly-speaking-ep-15/</link>
                    <comments>https://primedfranklyspeaking.podbean.com/e/oxygen-for-patients-with-stemi-who-benefits-frankly-speaking-ep-15/#comments</comments>        <pubDate>Mon, 08 May 2017 04:30:00 +0000</pubDate>
        <guid isPermaLink="false">6bb8b8c26e6d9a1480b830088b84e97d</guid>
                                    <description><![CDATA[<p>Oxygen is frequently  given to patients routinely during the initial treatment of a myocardial infarction, but there is a lack of data to support or refute this. A recent systematic review found no benefit in patients who did not have baseline hypoxia. Oxygen therapy continues to be indicated for those with hypoxia and needs to be used with caution in COPD patients with carbon dioxide retention.</p>
 <p>Learning Objectives</p>
 <ol><li>Understand the role of oxygen in the management of acute myocardial infarction</li>
 <li>Understand the potential for harm of unnecessary oxygen therapy</li>
 </ol>]]></description>
                                                            <content:encoded><![CDATA[<p>Oxygen is frequently  given to patients routinely during the initial treatment of a myocardial infarction, but there is a lack of data to support or refute this. A recent systematic review found no benefit in patients who did not have baseline hypoxia. Oxygen therapy continues to be indicated for those with hypoxia and needs to be used with caution in COPD patients with carbon dioxide retention.</p>
 <p>Learning Objectives</p>
 <ol><li>Understand the role of oxygen in the management of acute myocardial infarction</li>
 <li>Understand the potential for harm of unnecessary oxygen therapy</li>
 </ol>]]></content:encoded>
                                    
        <enclosure url="https://mcdn.podbean.com/mf/web/po1w1l/secure_primed_frankly-speaking-podcast-episode-14.mp3" length="21999511" type="audio/mpeg"/>
                <itunes:summary><![CDATA[Oxygen is frequently  given to patients routinely during the initial treatment of a myocardial infarction, but there is a lack of data to support or refute this. A recent systematic review found no benefit in patients who did not have baseline hypoxia. Oxygen therapy continues to be indicated for those with hypoxia and needs to be used with caution in COPD patients with carbon dioxide retention. Learning Objectives Understand the role of oxygen in the management of acute myocardial infarction Understand the potential for harm of unnecessary oxygen therapy ]]></itunes:summary>
        <itunes:author>Pri-Med</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>679</itunes:duration>
                                <itunes:image href="https://pbcdn1.podbean.com/imglogo/ep-logo/pbblog13721080/6982e091769ab276f4cf6f886cf2f672.jpg" />    </item>
    <item>
        <title>Back Pain is Here to Stay! - Frankly Speaking EP 14</title>
        <itunes:title>Back Pain is Here to Stay! - Frankly Speaking EP 14</itunes:title>
        <link>https://primedfranklyspeaking.podbean.com/e/back-pain-is-here-to-stay-frankly-speaking-ep-14/</link>
                    <comments>https://primedfranklyspeaking.podbean.com/e/back-pain-is-here-to-stay-frankly-speaking-ep-14/#comments</comments>        <pubDate>Mon, 01 May 2017 04:30:00 +0000</pubDate>
        <guid isPermaLink="false">a8edacec1dc2eaad60ae6a65f4056c63</guid>
                                    <description><![CDATA[<p>What are your evidence-based strategies for managing acute, subacute and chronic low back pain?  A review of the current American College of Physicians Clinical Practice Guideline can renew your toolkit as you help your patients with back pain maintain a healthy and active lifestyle.</p>
 <p>Learning Objectives</p>
 <ol><li>Review the latest guidelines on acute, subacute and chronic low back pain (ACP 2/2017)</li>
 <li> <p>Discuss non-pharmacologic and pharmacologic therapies available to the primary care provider</p>
 </li>
 </ol>]]></description>
                                                            <content:encoded><![CDATA[<p>What are your evidence-based strategies for managing acute, subacute and chronic low back pain?  A review of the current American College of Physicians Clinical Practice Guideline can renew your toolkit as you help your patients with back pain maintain a healthy and active lifestyle.</p>
 <p>Learning Objectives</p>
 <ol><li>Review the latest guidelines on acute, subacute and chronic low back pain (ACP 2/2017)</li>
 <li> <p>Discuss non-pharmacologic and pharmacologic therapies available to the primary care provider</p>
 </li>
 </ol>]]></content:encoded>
                                    
        <enclosure url="https://mcdn.podbean.com/mf/web/x6cy5o/secure_primed_frankly-speaking-podcast-episode-15.mp3" length="23567535" type="audio/mpeg"/>
                <itunes:summary><![CDATA[What are your evidence-based strategies for managing acute, subacute and chronic low back pain?  A review of the current American College of Physicians Clinical Practice Guideline can renew your toolkit as you help your patients with back pain maintain a healthy and active lifestyle. Learning Objectives Review the latest guidelines on acute, subacute and chronic low back pain (ACP 2/2017)  Discuss non-pharmacologic and pharmacologic therapies available to the primary care provider  ]]></itunes:summary>
        <itunes:author>Pri-Med</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>728</itunes:duration>
                                <itunes:image href="https://pbcdn1.podbean.com/imglogo/ep-logo/pbblog13721080/a58ff64d5c6d350afee3130e2253e407.jpg" />    </item>
    <item>
        <title>When Can We Start Preventing Recurrence of Acute Gout? - Frankly Speaking EP13</title>
        <itunes:title>When Can We Start Preventing Recurrence of Acute Gout? - Frankly Speaking EP13</itunes:title>
        <link>https://primedfranklyspeaking.podbean.com/e/when-can-we-start-preventing-recurrence-of-acute-gout-frankly-speaking-ep13/</link>
                    <comments>https://primedfranklyspeaking.podbean.com/e/when-can-we-start-preventing-recurrence-of-acute-gout-frankly-speaking-ep13/#comments</comments>        <pubDate>Mon, 24 Apr 2017 04:30:00 +0000</pubDate>
        <guid isPermaLink="false">022a8c3d78eedb0589f944c89979cc48</guid>
                                    <description><![CDATA[<p>Most patients who suffer an acute gout attack should be started on urate lowering therapy. It is known that starting urate lowering therapy can itself precipitate a gout attack and concern for not worsening the acute symptoms has been the reason some guidelines recommend waiting until after the acute episode has subsided to start urate lowering therapy. A look at recent data indicates waiting for the acute attack to subside may not be necessary</p>
 <p>Learning Objectives:</p>
 <ol><li>Understand the principles of urate lowering therapy for preventing gout attacks</li>
 <li>Be familiar with the risks and benefits or starting urate lowering therapy during an acute gout attack</li>
 </ol>]]></description>
                                                            <content:encoded><![CDATA[<p>Most patients who suffer an acute gout attack should be started on urate lowering therapy. It is known that starting urate lowering therapy can itself precipitate a gout attack and concern for not worsening the acute symptoms has been the reason some guidelines recommend waiting until after the acute episode has subsided to start urate lowering therapy. A look at recent data indicates waiting for the acute attack to subside may not be necessary</p>
 <p>Learning Objectives:</p>
 <ol><li>Understand the principles of urate lowering therapy for preventing gout attacks</li>
 <li>Be familiar with the risks and benefits or starting urate lowering therapy during an acute gout attack</li>
 </ol>]]></content:encoded>
                                    
        <enclosure url="https://mcdn.podbean.com/mf/web/dbyv6j/secure_primed_frankly-speaking-podcast-ep-13.mp3" length="21737356" type="audio/mpeg"/>
                <itunes:summary><![CDATA[Most patients who suffer an acute gout attack should be started on urate lowering therapy. It is known that starting urate lowering therapy can itself precipitate a gout attack and concern for not worsening the acute symptoms has been the reason some guidelines recommend waiting until after the acute episode has subsided to start urate lowering therapy. A look at recent data indicates waiting for the acute attack to subside may not be necessary Learning Objectives: Understand the principles of urate lowering therapy for preventing gout attacks Be familiar with the risks and benefits or starting urate lowering therapy during an acute gout attack ]]></itunes:summary>
        <itunes:author>Pri-Med</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>670</itunes:duration>
                                <itunes:image href="https://pbcdn1.podbean.com/imglogo/ep-logo/pbblog13721080/537e299ab61823f8dffa43c97e6c4936.jpg" />    </item>
    <item>
        <title>Constipation: Going With the Flow - Frankly Speaking EP12</title>
        <itunes:title>Constipation: Going With the Flow - Frankly Speaking EP12</itunes:title>
        <link>https://primedfranklyspeaking.podbean.com/e/constipation-going-with-the-flow-frankly-speaking-ep12/</link>
                    <comments>https://primedfranklyspeaking.podbean.com/e/constipation-going-with-the-flow-frankly-speaking-ep12/#comments</comments>        <pubDate>Mon, 17 Apr 2017 04:30:00 +0000</pubDate>
        <guid isPermaLink="false">84e544d0d4003100846c9d3dea8aeed5</guid>
                                    <description><![CDATA[<p>In this week's podcast episode, we will review recent literature on ineffectiveness of laxatives and learn about indications for newer agents. </p>
]]></description>
                                                            <content:encoded><![CDATA[<p>In this week's podcast episode, we will review recent literature on ineffectiveness of laxatives and learn about indications for newer agents. </p>
]]></content:encoded>
                                    
        <enclosure url="https://mcdn.podbean.com/mf/web/lm9mt3/secure_primed_frankly-speaking-episode-12-constipation-edited.mp3" length="26595130" type="audio/mpeg"/>
                <itunes:summary><![CDATA[In this week's podcast episode, we will review recent literature on ineffectiveness of laxatives and learn about indications for newer agents. ]]></itunes:summary>
        <itunes:author>Pri-Med</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>822</itunes:duration>
                                <itunes:image href="https://pbcdn1.podbean.com/imglogo/ep-logo/pbblog13721080/f707311dcada63be01a7fd58274259e5.jpg" />    </item>
    <item>
        <title>Physical Activity Following a Concussion - Frankly Speaking EP11</title>
        <itunes:title>Physical Activity Following a Concussion - Frankly Speaking EP11</itunes:title>
        <link>https://primedfranklyspeaking.podbean.com/e/physical-activity-following-a-concussion-frankly-speaking-ep11/</link>
                    <comments>https://primedfranklyspeaking.podbean.com/e/physical-activity-following-a-concussion-frankly-speaking-ep11/#comments</comments>        <pubDate>Mon, 10 Apr 2017 04:30:00 +0000</pubDate>
        <guid isPermaLink="false">0af515e42662f4a3183fde0b863733c7</guid>
                                    <description><![CDATA[<p>In this podcast episode, we will discuss current guidelines for a concussion evaluation or work-up as well as return to activity following a concussion. We will also put into context this paper and consider what impact this should have on your practice.</p>
]]></description>
                                                            <content:encoded><![CDATA[<p>In this podcast episode, we will discuss current guidelines for a concussion evaluation or work-up as well as return to activity following a concussion. We will also put into context this paper and consider what impact this should have on your practice.</p>
]]></content:encoded>
                                    
        <enclosure url="https://mcdn.podbean.com/mf/web/tfbmr8/secure_primed_frankly-speaking-episode-11-concussion.mp3" length="35749874" type="audio/mpeg"/>
                <itunes:summary><![CDATA[In this podcast episode, we will discuss current guidelines for a concussion evaluation or work-up as well as return to activity following a concussion. We will also put into context this paper and consider what impact this should have on your practice.]]></itunes:summary>
        <itunes:author>Pri-Med</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>1116</itunes:duration>
                                <itunes:image href="https://pbcdn1.podbean.com/imglogo/ep-logo/pbblog13721080/ae59ee4627e834e50ed06a2b56e50908.jpg" />    </item>
    <item>
        <title>Treating Systolic Hypertension in the Elderly - Frankly Speaking EP10</title>
        <itunes:title>Treating Systolic Hypertension in the Elderly - Frankly Speaking EP10</itunes:title>
        <link>https://primedfranklyspeaking.podbean.com/e/treating-systolic-hypertension-in-the-elderly-frankly-speaking-ep10/</link>
                    <comments>https://primedfranklyspeaking.podbean.com/e/treating-systolic-hypertension-in-the-elderly-frankly-speaking-ep10/#comments</comments>        <pubDate>Mon, 03 Apr 2017 04:30:00 +0000</pubDate>
        <guid isPermaLink="false">20c92df58303c3e4496741a6609a7cfc</guid>
                                    <description><![CDATA[<p>In this podcast episode, we will talk about how systolic hypertension effects outcomes, put into context a recent JACC systematic review paper on the topic and JNC 8 and discuss NNT and NNH.</p>
]]></description>
                                                            <content:encoded><![CDATA[<p>In this podcast episode, we will talk about how systolic hypertension effects outcomes, put into context a recent JACC systematic review paper on the topic and JNC 8 and discuss NNT and NNH.</p>
]]></content:encoded>
                                    
        <enclosure url="https://mcdn.podbean.com/mf/web/ocgk1q/secure_primed_frankly-speaking-ep-10.mp3" length="28207228" type="audio/mpeg"/>
                <itunes:summary><![CDATA[In this podcast episode, we will talk about how systolic hypertension effects outcomes, put into context a recent JACC systematic review paper on the topic and JNC 8 and discuss NNT and NNH.]]></itunes:summary>
        <itunes:author>Pri-Med</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>880</itunes:duration>
                                <itunes:image href="https://pbcdn1.podbean.com/imglogo/ep-logo/pbblog13721080/3b5dc66ba770e692e861b80b3d3f9882.jpg" />    </item>
    <item>
        <title>Obstructive Sleep Apnea: Recommendations for Screening Adults - Frankly Speaking EP9</title>
        <itunes:title>Obstructive Sleep Apnea: Recommendations for Screening Adults - Frankly Speaking EP9</itunes:title>
        <link>https://primedfranklyspeaking.podbean.com/e/obstructive-sleep-apnea-recommendations-for-screening-adults-frankly-speaking-ep9/</link>
                    <comments>https://primedfranklyspeaking.podbean.com/e/obstructive-sleep-apnea-recommendations-for-screening-adults-frankly-speaking-ep9/#comments</comments>        <pubDate>Mon, 27 Mar 2017 04:30:00 +0000</pubDate>
        <guid isPermaLink="false">caa2198967c0897ffbc8de56f84ebd3c</guid>
                                    <description><![CDATA[<p>In this week's podcast episode, we will identify the known health risks of OSA and outcomes of OSA treatment, discuss the new USPSTF screening recommendations on OSA and consider application of the new recommendations, known risks and outcomes of practice.</p>
]]></description>
                                                            <content:encoded><![CDATA[<p>In this week's podcast episode, we will identify the known health risks of OSA and outcomes of OSA treatment, discuss the new USPSTF screening recommendations on OSA and consider application of the new recommendations, known risks and outcomes of practice.</p>
]]></content:encoded>
                                    
        <enclosure url="https://mcdn.podbean.com/mf/web/b80v2m/secure_primed_frankly-speaking-podcast-episode-9-edited.mp3" length="29044690" type="audio/mpeg"/>
                <itunes:summary><![CDATA[In this week's podcast episode, we will identify the known health risks of OSA and outcomes of OSA treatment, discuss the new USPSTF screening recommendations on OSA and consider application of the new recommendations, known risks and outcomes of practice.]]></itunes:summary>
        <itunes:author>Pri-Med</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>906</itunes:duration>
                                <itunes:image href="https://pbcdn1.podbean.com/imglogo/ep-logo/pbblog13721080/16c5267e36d118b5c121012cb0aa7a69.jpg" />    </item>
    <item>
        <title>Non-Fasting Lipids for Cardiovascular Risk Evaluation - Frankly Speaking EP8</title>
        <itunes:title>Non-Fasting Lipids for Cardiovascular Risk Evaluation - Frankly Speaking EP8</itunes:title>
        <link>https://primedfranklyspeaking.podbean.com/e/non-fasting-lipids-for-cardiovascular-risk-evaluation-frankly-speaking-ep8/</link>
                    <comments>https://primedfranklyspeaking.podbean.com/e/non-fasting-lipids-for-cardiovascular-risk-evaluation-frankly-speaking-ep8/#comments</comments>        <pubDate>Mon, 20 Mar 2017 04:30:00 +0000</pubDate>
        <guid isPermaLink="false">ed0e2697a08e3fb3097ecb568fe4949e</guid>
                                    <description><![CDATA[<p>In this podcast episode, we will consider the rationale for using non-fasting labs to screen for ASCVD as well as review the controversies around their use and talk about the differential diagnosis of hypertriglyceridemia.</p>
]]></description>
                                                            <content:encoded><![CDATA[<p>In this podcast episode, we will consider the rationale for using non-fasting labs to screen for ASCVD as well as review the controversies around their use and talk about the differential diagnosis of hypertriglyceridemia.</p>
]]></content:encoded>
                                    
        <enclosure url="https://mcdn.podbean.com/mf/web/gsbuxy/secure_primed_frankly-speaking-episode-8-lipids.mp3" length="26920915" type="audio/mpeg"/>
                <itunes:summary><![CDATA[In this podcast episode, we will consider the rationale for using non-fasting labs to screen for ASCVD as well as review the controversies around their use and talk about the differential diagnosis of hypertriglyceridemia.]]></itunes:summary>
        <itunes:author>Pri-Med</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>840</itunes:duration>
                                <itunes:image href="https://pbcdn1.podbean.com/imglogo/ep-logo/pbblog13721080/2905a590f69bb9b2c343ce21351e3465.jpg" />    </item>
    <item>
        <title>Helping Kidney Stones Pass: Use of Alpha Antagonists – Frankly Speaking EP7</title>
        <itunes:title>Helping Kidney Stones Pass: Use of Alpha Antagonists – Frankly Speaking EP7</itunes:title>
        <link>https://primedfranklyspeaking.podbean.com/e/helping-kidney-stones-pass-use-of-alpha-antagonists-%e2%80%93-frankly-speaking-ep7/</link>
                    <comments>https://primedfranklyspeaking.podbean.com/e/helping-kidney-stones-pass-use-of-alpha-antagonists-%e2%80%93-frankly-speaking-ep7/#comments</comments>        <pubDate>Mon, 13 Mar 2017 04:00:00 +0000</pubDate>
        <guid isPermaLink="false">cc2dfe6ae805dbf749f94657b921566b</guid>
                                    <description><![CDATA[<p>In this podcast episode, we will talk about the benefits of alpha antagonists on passing larger kidney stones as well as discuss the need for stone collection and analysis to prevent future stones. We will also learn how to effectively counsel patients about alpha antagonist use including risks and benefits.</p>
]]></description>
                                                            <content:encoded><![CDATA[<p>In this podcast episode, we will talk about the benefits of alpha antagonists on passing larger kidney stones as well as discuss the need for stone collection and analysis to prevent future stones. We will also learn how to effectively counsel patients about alpha antagonist use including risks and benefits.</p>
]]></content:encoded>
                                    
        <enclosure url="https://mcdn.podbean.com/mf/web/252med/secure_primed_frankly-speaking-ep-7-kidney-stones.mp3" length="34079370" type="audio/mpeg"/>
                <itunes:summary><![CDATA[In this podcast episode, we will talk about the benefits of alpha antagonists on passing larger kidney stones as well as discuss the need for stone collection and analysis to prevent future stones. We will also learn how to effectively counsel patients about alpha antagonist use including risks and benefits.]]></itunes:summary>
        <itunes:author>Pri-Med</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>1064</itunes:duration>
                                <itunes:image href="https://pbcdn1.podbean.com/imglogo/ep-logo/pbblog13721080/072ec91a1ff26aa598fc1d9fa2680389.jpg" />    </item>
    <item>
        <title>Breast Cancer and the Harms of Overdiagnosis - Frankly Speaking EP6</title>
        <itunes:title>Breast Cancer and the Harms of Overdiagnosis - Frankly Speaking EP6</itunes:title>
        <link>https://primedfranklyspeaking.podbean.com/e/breast-cancer-and-the-harms-of-overdiagnosis-frankly-speaking-ep6/</link>
                    <comments>https://primedfranklyspeaking.podbean.com/e/breast-cancer-and-the-harms-of-overdiagnosis-frankly-speaking-ep6/#comments</comments>        <pubDate>Mon, 06 Mar 2017 05:00:00 +0000</pubDate>
        <guid isPermaLink="false">c5f2977d891a0b92bc6e81301d4f3587</guid>
                                    <description><![CDATA[<p>In this podcast episode, we consider the premise of overdiagnosis and how it applies to women being screened for breast cancer and highlight ways to mitigate the risks of overdiagnosis of breast cancer.</p>
]]></description>
                                                            <content:encoded><![CDATA[<p>In this podcast episode, we consider the premise of overdiagnosis and how it applies to women being screened for breast cancer and highlight ways to mitigate the risks of overdiagnosis of breast cancer.</p>
]]></content:encoded>
                                    
        <enclosure url="https://mcdn.podbean.com/mf/web/9dtisa/secure_primed_frankly-speaking-6-breast-cancer-screening.mp3" length="34219078" type="audio/mpeg"/>
                <itunes:summary><![CDATA[In this podcast episode, we consider the premise of overdiagnosis and how it applies to women being screened for breast cancer and highlight ways to mitigate the risks of overdiagnosis of breast cancer.]]></itunes:summary>
        <itunes:author>Pri-Med</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>1068</itunes:duration>
                                <itunes:image href="https://pbcdn1.podbean.com/imglogo/ep-logo/pbblog13721080/c41a58246c4ddc19d677882ce45b273d.jpg" />    </item>
    <item>
        <title>Weekend Warrior: Exercising on the Weekends can be enough - Frankly Speaking EP5</title>
        <itunes:title>Weekend Warrior: Exercising on the Weekends can be enough - Frankly Speaking EP5</itunes:title>
        <link>https://primedfranklyspeaking.podbean.com/e/weekend-warrior-exercising-on-the-weekends-can-be-enough-frankly-speaking-ep5/</link>
                    <comments>https://primedfranklyspeaking.podbean.com/e/weekend-warrior-exercising-on-the-weekends-can-be-enough-frankly-speaking-ep5/#comments</comments>        <pubDate>Mon, 27 Feb 2017 05:00:00 +0000</pubDate>
        <guid isPermaLink="false">c16c4a494d7995c0b00345938cd496d8</guid>
                                    <description><![CDATA[<p>Objectives:</p>
 <ol><li>Appreciate the data on different exercise timelines</li>
 <li>Learn new options when counseling patients for exercise</li>
 <li>Understand the need to include exercise counseling for most adults</li>
 </ol>]]></description>
                                                            <content:encoded><![CDATA[<p>Objectives:</p>
 <ol><li>Appreciate the data on different exercise timelines</li>
 <li>Learn new options when counseling patients for exercise</li>
 <li>Understand the need to include exercise counseling for most adults</li>
 </ol>]]></content:encoded>
                                    
        <enclosure url="https://mcdn.podbean.com/mf/web/ol0wjy/secure_primed_frankly-speaking-episode-4a.mp3" length="29929824" type="audio/mpeg"/>
                <itunes:summary><![CDATA[Objectives: Appreciate the data on different exercise timelines Learn new options when counseling patients for exercise Understand the need to include exercise counseling for most adults ]]></itunes:summary>
        <itunes:author>Pri-Med</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>934</itunes:duration>
                                <itunes:image href="https://pbcdn1.podbean.com/imglogo/ep-logo/pbblog13721080/1edab6e1385d1ce9838cbee675eab123.jpg" />    </item>
    <item>
        <title>Easy Management of Statin Induced Myalgias - Frankly Speaking EP4</title>
        <itunes:title>Easy Management of Statin Induced Myalgias - Frankly Speaking EP4</itunes:title>
        <link>https://primedfranklyspeaking.podbean.com/e/easy-management-of-statin-induced-myalgias-frankly-speaking-ep4/</link>
                    <comments>https://primedfranklyspeaking.podbean.com/e/easy-management-of-statin-induced-myalgias-frankly-speaking-ep4/#comments</comments>        <pubDate>Fri, 17 Feb 2017 13:31:00 +0000</pubDate>
        <guid isPermaLink="false">d24c2ecd8652067d13d84c152bf31cd6</guid>
                                    <description><![CDATA[<p>Have a patient with Statin Induced Myalgias? This episode will give you the best evidence on a simple and cost effective solution, and dispel common myths about this problem.</p>
]]></description>
                                                            <content:encoded><![CDATA[<p>Have a patient with Statin Induced Myalgias? This episode will give you the best evidence on a simple and cost effective solution, and dispel common myths about this problem.</p>
]]></content:encoded>
                                    
        <enclosure url="https://mcdn.podbean.com/mf/web/i1orwg/secure_primed_frankly-speaking-episode-4.mp3" length="32155152" type="audio/mpeg"/>
                <itunes:summary><![CDATA[Have a patient with Statin Induced Myalgias? This episode will give you the best evidence on a simple and cost effective solution, and dispel common myths about this problem.]]></itunes:summary>
        <itunes:author>Pri-Med</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>1005</itunes:duration>
                                <itunes:image href="https://pbcdn1.podbean.com/imglogo/ep-logo/pbblog13721080/a2a1ecb82ce10209b93a9eb1af057e31.jpg" />    </item>
    <item>
        <title>Introduction of Food to Infants: Preventing Peanut Allergies - Frankly Speaking EP3</title>
        <itunes:title>Introduction of Food to Infants: Preventing Peanut Allergies - Frankly Speaking EP3</itunes:title>
        <link>https://primedfranklyspeaking.podbean.com/e/introduction-of-food-to-infants-preventing-peanut-allergies-frankly-speaking-ep3/</link>
                    <comments>https://primedfranklyspeaking.podbean.com/e/introduction-of-food-to-infants-preventing-peanut-allergies-frankly-speaking-ep3/#comments</comments>        <pubDate>Wed, 25 Jan 2017 16:57:00 +0000</pubDate>
        <guid isPermaLink="false">3e01a7720e527d36ca504de4d40dbd76</guid>
                                    <description><![CDATA[<p>Can peanut allergy be prevented in children? This podcast will review the newest AAP recommendations on feeding in the first year of life, with a special emphasis on preventing atopic disorders. After listening to the podcast, listeners will be able to summarize essential points of current AAP EBP guidelines for introduction of complementary foods to infants and current EBP recommendations for introducing potentially allergenic foods, specifically peanut products, to low risk and high risk infants. </p>
]]></description>
                                                            <content:encoded><![CDATA[<p>Can peanut allergy be prevented in children? This podcast will review the newest AAP recommendations on feeding in the first year of life, with a special emphasis on preventing atopic disorders. After listening to the podcast, listeners will be able to summarize essential points of current AAP EBP guidelines for introduction of complementary foods to infants and current EBP recommendations for introducing potentially allergenic foods, specifically peanut products, to low risk and high risk infants. </p>
]]></content:encoded>
                                    
        <enclosure url="https://mcdn.podbean.com/mf/web/zfjf2q/secure_primed_frankly-speaking-episode-3.mp3" length="26723421" type="audio/mpeg"/>
                <itunes:summary><![CDATA[Can peanut allergy be prevented in children? This podcast will review the newest AAP recommendations on feeding in the first year of life, with a special emphasis on preventing atopic disorders. After listening to the podcast, listeners will be able to summarize essential points of current AAP EBP guidelines for introduction of complementary foods to infants and current EBP recommendations for introducing potentially allergenic foods, specifically peanut products, to low risk and high risk infants. ]]></itunes:summary>
        <itunes:author>Pri-Med</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>835</itunes:duration>
                                <itunes:image href="https://pbcdn1.podbean.com/imglogo/ep-logo/pbblog13721080/2bc6557bebf2c695072436da02e85f1d.jpg" />    </item>
    <item>
        <title>Getting the Complicated Asthmatic Under Control - Frankly Speaking EP2</title>
        <itunes:title>Getting the Complicated Asthmatic Under Control - Frankly Speaking EP2</itunes:title>
        <link>https://primedfranklyspeaking.podbean.com/e/getting-the-complicated-asthmatic-under-control-frankly-speaking-ep2/</link>
                    <comments>https://primedfranklyspeaking.podbean.com/e/getting-the-complicated-asthmatic-under-control-frankly-speaking-ep2/#comments</comments>        <pubDate>Tue, 24 Jan 2017 13:26:00 +0000</pubDate>
        <guid isPermaLink="false">a58f3e64763822318ef543b85471b73b</guid>
                                    <description><![CDATA[<p>This episode will build on the previous podcast with a focus on how to apply the management guidelines in Asthma with a focus on critical features to know for board preparation.</p>
]]></description>
                                                            <content:encoded><![CDATA[<p>This episode will build on the previous podcast with a focus on how to apply the management guidelines in Asthma with a focus on critical features to know for board preparation.</p>
]]></content:encoded>
                                    
        <enclosure url="https://mcdn.podbean.com/mf/web/hfw7is/secure_primed_frankly-speaking-episode-2.mp3" length="35716374" type="audio/mpeg"/>
                <itunes:summary><![CDATA[This episode will build on the previous podcast with a focus on how to apply the management guidelines in Asthma with a focus on critical features to know for board preparation.]]></itunes:summary>
        <itunes:author>Pri-Med</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>1116</itunes:duration>
                                <itunes:image href="https://pbcdn1.podbean.com/imglogo/ep-logo/pbblog13721080/42e340b2a65f1e7f713e31209db87fef.jpg" />    </item>
    <item>
        <title>Asthma: Critical Risk Stratification to Decide Care - Frankly Speaking EP1</title>
        <itunes:title>Asthma: Critical Risk Stratification to Decide Care - Frankly Speaking EP1</itunes:title>
        <link>https://primedfranklyspeaking.podbean.com/e/asthma-critical-risk-stratification-to-decide-care-frankly-speaking-ep1/</link>
                    <comments>https://primedfranklyspeaking.podbean.com/e/asthma-critical-risk-stratification-to-decide-care-frankly-speaking-ep1/#comments</comments>        <pubDate>Tue, 10 Jan 2017 16:11:00 +0000</pubDate>
        <guid isPermaLink="false">e6320a559c55435b51818a104d56d865</guid>
                                    <description><![CDATA[<p>This episode will review the basics of asthma diagnosis and management, covering the critical content for both patient management and board preparation.</p>
]]></description>
                                                            <content:encoded><![CDATA[<p>This episode will review the basics of asthma diagnosis and management, covering the critical content for both patient management and board preparation.</p>
]]></content:encoded>
                                    
        <enclosure url="https://mcdn.podbean.com/mf/web/x1k6ct/secure_primed_frankly-speaking-podcast-1-asthma.mp3" length="29853729" type="audio/mpeg"/>
                <itunes:summary><![CDATA[This episode will review the basics of asthma diagnosis and management, covering the critical content for both patient management and board preparation.]]></itunes:summary>
        <itunes:author>Pri-Med</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>914</itunes:duration>
                                <itunes:image href="https://pbcdn1.podbean.com/imglogo/ep-logo/pbblog13721080/6d1bf297ab0b6aaed313ef9eac743c85.jpg" />    </item>
</channel>
</rss>
